D129266@2170@2188@deletion@19@17248515@17275421@1@chr1:17248515-17275421@25.2@932@556@0.597@CNVR94.4, CNVR94.5@CROCC_1, CROCC_2, CROCC_3, CROCC_4, CROCC_5, CROCC_6, CROCC_7, CROCC_8, CROCC_9, CROCC_10, CROCC_11, CROCC_12, CROCC_13, CROCC_14, CROCC_15, CROCC_16, CROCC_17, CROCC_18, CROCC_19@0@0@0@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
D129266@8068@8072@duplication@5@78392402@78407893@1@chr1:78392402-78407893@8.35@488@659@1.35@NA@NEXN_8, NEXN_9, NEXN_10, NEXN_11, NEXN_12@0@0@0@:nexilin (F actin binding protein)@:cell-substrate adherens junction;Z disc;regulation of cell migration;regulation of cytoskeleton organization;structural constituent of muscle;protein binding;actin filament binding;cytoskeleton@: CARDIOMYOPATHY, DILATED, 1CC; CMD1CC; CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 20; CMH20
D129266@8506@8507@duplication@2@89475076@89476799@1@chr1:89475076-89476799@5.2@367@523@1.43@NA@GBP3_9, GBP3_8@0@0@0@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
D129266@8803@8806@duplication@4@93659174@93672955@1@chr1:93659174-93672955@7.14@263@382@1.45@NA@CCDC18_6, CCDC18_7, CCDC18_8, CCDC18_9@0@0@0@:coiled-coil domain containing 18@:nucleotide binding@NA
D129266@8815@8821@duplication@7@93697984@93720171@1@chr1:93697984-93720171@8.74@590@772@1.31@NA@CCDC18_18, CCDC18_19, CCDC18_20, CCDC18_21, CCDC18_22, CCDC18_23, CCDC18_24@0@0@0@:coiled-coil domain containing 18@:nucleotide binding@NA
D129266@9365@9386@duplication@22@104202983@104297436@1@chr1:104202983-104297436@14.7@210@374@1.78@CNVR266.3, CNVR266.5@AMY1A_7, AMY1A_8, AMY1A_9, AMY1A_10, AMY1A_11, AMY1B_11, AMY1B_10, AMY1B_9, AMY1B_8, AMY1B_7, AMY1B_6, AMY1B_5, AMY1B_4, AMY1B_3, AMY1B_2, AMY1C_1, AMY1C_2, AMY1C_3, AMY1C_4, AMY1C_5, AMY1C_6, AMY1C_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D129266@11566@11566@deletion@1@149949362@149949445@1@chr1:149949362-149949445@5.16@101@46@0.455@NA@OTUD7B_2@0@0@0@:OTU domain containing 7B@:protein deubiquitination;cysteine-type peptidase activity;ubiquitin thiolesterase activity;DNA binding;negative regulation of I-kappaB kinase/NF-kappaB cascade;cytoplasm;microtubule cytoskeleton;protein binding;proteolysis;nucleus;zinc ion binding@NA
D129266@12117@12118@duplication@2@152573209@152586574@1@chr1:152573209-152586574@10.9@24@112@4.67@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
D129266@16026@16040@duplication@15@196712583@196801129@1@chr1:196712583-196801129@43.7@1855@2813@1.52@CNVR459.1@CFH_20, CFH_21, CFH_22, CFHR3_1, CFHR3_2, CFHR3_3, CFHR3_4, CFHR3_5, CFHR3_6, CFHR1_1, CFHR1_2, CFHR1_3, CFHR1_4, CFHR1_5, CFHR1_6@0@0@0@:complement factor H:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:complement activation, alternative pathway;extracellular space;complement activation;extracellular region;regulation of complement activation;innate immune response:extracellular space:extracellular space;complement activation:extracellular region@: HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1; MACULAR DEGENERATION, AGE-RELATED, 4; ARMD4; COMPLEMENT FACTOR H DEFICIENCY; CFHD; BASAL LAMINAR DRUSEN
D129266@19775@19778@duplication@4@248756132@248814185@1@chr1:248756132-248814185@14.2@1135@1609@1.42@CNVR600.1@OR2T10_1, OR2T11_1, OR2T35_1, OR2T27_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 10:olfactory receptor, family 2, subfamily T, member 11:olfactory receptor, family 2, subfamily T, member 35:olfactory receptor, family 2, subfamily T, member 27@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
D129266@24943@24954@duplication@12@89309480@89417308@2@chr2:89309480-89417308@8.12@782@1025@1.31@CNVR866.7, CNVR866.10, CNVR866.11@IGKV1-9_2, IGKV1-9_1, IGKV3-11_2, IGKV3-11_1, IGKV1-12_2, IGKV1-12_1, IGKV3-15_2, IGKV3-15_1, IGKV1-16_2, IGKV1-16_1, IGKV1-17_2, IGKV1-17_1@0@0@0@@:protein binding:regulation of immune response;complement activation;immune response;complement activation, classical pathway;innate immune response;antigen binding;protein binding;extracellular region;plasma membrane:protein binding:protein binding:protein binding:protein binding@NA
D129266@25101@25105@duplication@5@96614279@96622564@2@chr2:96614279-96622564@5.89@544@715@1.31@CNVR881.1, CNVR881.2@ANKRD36C_17, ANKRD36C_16, ANKRD36C_15, ANKRD36C_14, ANKRD36C_13@0@0@0@:ankyrin repeat domain-containing protein 36A-like@:ion channel inhibitor activity;protein binding@NA
D129266@27342@27342@duplication@1@132289238@132289375@2@chr2:132289238-132289375@4.62@36@83@2.31@NA@CCDC74A_4@0@0@0@:coiled-coil domain containing 74A@NA@NA
D129266@45726@45727@duplication@2@59324@60050@4@chr4:59324-60050@8.07@1262@1865@1.48@NA@ZNF595_2, ZNF595_3@0@0@0@@:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding@NA
D129266@48555@48561@duplication@7@69362362@69434202@4@chr4:69362362-69434202@41.2@282@799@2.83@CNVR1953.1@TMPRSS11E_10, UGT2B17_6, UGT2B17_5, UGT2B17_4, UGT2B17_3, UGT2B17_2, UGT2B17_1@0@0@0@:transmembrane protease, serine 11E:UDP glucuronosyltransferase 2 family, polypeptide B17@:serine-type peptidase activity;catalytic activity;proteolysis;protein binding;extracellular region;plasma membrane;integral to plasma membrane;serine-type endopeptidase activity:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
D129266@48589@48597@duplication@9@70074070@70160527@4@chr4:70074070-70160527@19.9@959@1400@1.46@CNVR1957.2@UGT2B11_3, UGT2B11_2, UGT2B11_1, UGT2B28_1, UGT2B28_2, UGT2B28_3, UGT2B28_4, UGT2B28_5, UGT2B28_6@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B11:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;estrogen metabolic process:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
D129266@48972@48974@duplication@3@75482007@75486006@4@chr4:75482007-75486006@5.67@73@135@1.85@NA@AREGB_2, AREGB_3, AREGB_4@0@0@0@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
D129266@53183@53189@duplication@7@190876193@190947616@4@chr4:190876193-190947616@9.17@1557@2032@1.31@NA@FRG1_5, FRG1_6, FRG1_7, FRG1_8, FRG1_9, FRG2_4, FRG2_3@0@0@0@:protein FRG1-like;FSHD region gene 1:FSHD region gene 2-like;FSHD region gene 2@:actin filament binding;nuclear speck;nucleolus;Cajal body;mRNA splicing, via spliceosome;protein binding, bridging;catalytic step 2 spliceosome;rRNA processing:nucleus@NA
D129266@53308@53319@deletion@12@748520@837595@5@chr5:748520-837595@17.4@1018@677@0.665@CNVR2280.3@ZDHHC11B_5, ZDHHC11B_4, ZDHHC11B_3, ZDHHC11B_2, ZDHHC11B_1, ZDHHC11_12, ZDHHC11_11, ZDHHC11_10, ZDHHC11_9, ZDHHC11_8, ZDHHC11_7, ZDHHC11_6@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
D129266@59046@59047@deletion@2@140228082@140238021@5@chr5:140228082-140238021@7.61@1448@898@0.62@CNVR2622.1@PCDHA9_1, PCDHA10_1@0@0@0@:protocadherin alpha 1:protocadherin alpha 2:protocadherin alpha 3:protocadherin alpha 4:protocadherin alpha 5:protocadherin alpha 6:protocadherin alpha 7:protocadherin alpha 8:protocadherin alpha 9:protocadherin alpha 10@:extracellular region;cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:integral to membrane;cell adhesion;homophilic cell adhesion;plasma membrane;integral to plasma membrane;membrane;nervous system development;calcium ion binding:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:extracellular region;cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding:extracellular region;cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development@NA
D129266@59065@59065@duplication@1@140557617@140560021@5@chr5:140557617-140560021@5.25@642@997@1.55@CNVR2624.1@PCDHB8_1@0@0@0@:protocadherin beta 8@:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding@NA
D129266@60876@60879@deletion@4@175388055@175394270@5@chr5:175388055-175394270@7.21@89@37@0.416@NA@THOC3_5, THOC3_4, THOC3_3, THOC3_2@0@0@0@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
D129266@63725@63733@duplication@9@31962023@31964377@6@chr6:31962023-31964377@7.34@125@200@1.6@CNVR2843.6, CNVR2843.3@C4A_20, C4A_21, C4A_22, C4A_23, C4A_24, C4A_25, C4A_26, C4A_27, C4A_28@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
D129266@63966@63974@duplication@9@32609088@32634384@6@chr6:32609088-32634384@13.5@601@852@1.42@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20@HLA-DQA1_2, HLA-DQA1_3, HLA-DQA1_4, HLA-DQB1_6, HLA-DQB1_5, HLA-DQB1_4, HLA-DQB1_3, HLA-DQB1_2, HLA-DQB1_1@0@0@0@:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
D129266@64059@64061@duplication@3@33052728@33054015@6@chr6:33052728-33054015@5.36@231@335@1.45@CNVR2846.4, CNVR2846.3, CNVR2846.5@HLA-DPB1_3, HLA-DPB1_4, HLA-DPB1_5@0@0@0@:major histocompatibility complex, class II, DP beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D129266@71028@71032@duplication@5@167787840@167794824@6@chr6:167787840-167794824@13.3@236@398@1.69@NA@TCP10_7, TCP10_6, TCP10_5, TCP10_4, TCP10_3@0@0@0@:t-complex 10@:cytosol@NA
D129266@71942@71944@duplication@3@6840580@6844686@7@chr7:6840580-6844686@5.5@97@166@1.71@NA@CCZ1B_14, CCZ1B_13, CCZ1B_12@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D129266@71948@71951@duplication@4@6854396@6862991@7@chr7:6854396-6862991@6.35@360@491@1.36@NA@CCZ1B_8, CCZ1B_7, CCZ1B_6, CCZ1B_5@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D129266@72395@72415@duplication@21@21654733@21750321@7@chr7:21654733-21750321@23.8@2476@3236@1.31@NA@DNAH11_21, DNAH11_22, DNAH11_23, DNAH11_24, DNAH11_25, DNAH11_26, DNAH11_27, DNAH11_28, DNAH11_29, DNAH11_30, DNAH11_31, DNAH11_32, DNAH11_33, DNAH11_34, DNAH11_35, DNAH11_36, DNAH11_37, DNAH11_38, DNAH11_39, DNAH11_40, DNAH11_41, DNAH11_42@0@0@0@:dynein, axonemal, heavy chain 11@:microtubule motor activity;ciliary or flagellar motility;nucleoside-triphosphatase activity;cilium;nucleotide binding;ATP binding;cytoplasm;dynein complex;microtubule-based movement;axonemal dynein complex;ATPase activity;microtubule;determination of left/right symmetry;cilium axoneme@: CILIARY DYSKINESIA, PRIMARY, 1; CILD1; CILIARY DYSKINESIA, PRIMARY, 7; CILD7
D129266@73249@73250@duplication@2@38301773@38305279@7@chr7:38301773-38305279@6.97@592@849@1.43@CNVR3353.1@TRGC1_2, TRGC1_1@0@0@0@:TCR gamma alternate reading frame protein@:protein binding@NA
D129266@74127@74134@duplication@8@57187548@57529655@7@chr7:57187548-57529655@12.2@1561@2090@1.34@NA@ZNF479_5, ZNF479_4, ZNF479_3, ZNF479_2, ZNF716_1, ZNF716_2, ZNF716_3, ZNF716_4@0@0@0@:zinc finger protein 479:zinc finger protein 716@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
D129266@74146@74162@duplication@17@63796638@64439914@7@chr7:63796638-64439914@16.2@4970@6324@1.27@NA@ZNF736_3, ZNF736_4, ZNF736_5, ZNF680_4, ZNF680_3, ZNF680_2, ZNF107_4, ZNF138_2, ZNF138_3, ZNF273_1, ZNF273_2, ZNF273_3, ZNF273_4, ZNF117_4@0@0@0@:zinc finger protein 736:zinc finger protein 680:zinc finger protein 107:zinc finger protein 138:zinc finger protein 273:zinc finger protein 117@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;DNA binding;regulation of transcription, DNA-dependent;nucleus;transcription, DNA-dependent;molecular_function;zinc ion binding;cellular_component;biological_process:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;sequence-specific DNA binding transcription factor activity;nucleic acid binding:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;sequence-specific DNA binding transcription factor activity@NA
D129266@74792@74793@duplication@2@76240783@76241130@7@chr7:76240783-76241130@8.46@140@255@1.82@CNVR3463.10@POMZP3_6, POMZP3_5@0@0@0@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
D129266@78431@78433@duplication@3@134617740@134625988@7@chr7:134617740-134625988@5.42@732@956@1.31@NA@CALD1_5, CALD1_6, CALD1_7@0@0@0@:caldesmon 1@:neuronal cell body;calmodulin binding;tropomyosin binding;myofibril;myosin binding;actin filament bundle assembly;plasma membrane;cellular component movement;postsynaptic density;actin cytoskeleton;positive regulation of protein binding;cytosol;actin filament;actin binding;cytoskeleton;actin cap;membrane;muscle contraction@NA
D129266@79311@79323@deletion@13@143929005@144070377@7@chr7:143929005-144070377@16.7@1431@974@0.681@CNVR3598.4@OR2A42_1, OR2A7_1, CTAGE8_1, OR2A1_1, ARHGEF5_2, ARHGEF5_3, ARHGEF5_4, ARHGEF5_5, ARHGEF5_6, ARHGEF5_7, ARHGEF5_8, ARHGEF5_9, ARHGEF5_10@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:olfactory receptor, family 2, subfamily A, member 7:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
D129266@80395@80399@deletion@5@7681292@7698716@8@chr8:7681292-7698716@10.5@133@56@0.421@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@DEFB105A_1, DEFB106A_1, DEFB106A_2, DEFB104A_1, DEFB104A_2@0@0@0@:defensin, beta 105B;defensin, beta 105A:defensin, beta 106B;defensin, beta 106A:defensin, beta 104A;defensin, beta 104B@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
D129266@94806@94813@duplication@8@7605005@7658061@10@chr10:7605005-7658061@14.9@1112@1493@1.34@NA@ITIH5_14, ITIH5_13, ITIH5_12, ITIH5_11, ITIH5_10, ITIH5_9, ITIH5_8, ITIH5_7@0@0@0@:inter-alpha-trypsin inhibitor heavy chain family, member 5@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region;hyaluronan metabolic process@NA
D129266@95346@95360@deletion@15@17813309@17908770@10@chr10:17813309-17908770@63@340@1@0.00294@NA@TMEM236_2, TMEM236_3, TMEM236_4, MRC1L1_1, MRC1L1_2, MRC1L1_3, MRC1L1_4, MRC1L1_5, MRC1L1_6, MRC1L1_7, MRC1L1_8, MRC1L1_9, MRC1L1_10, MRC1L1_11, MRC1L1_12@0@0@0@:transmembrane protein 236;transmembrane protein 236-like:macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding@NA
D129266@95376@95393@duplication@18@17949551@18152611@10@chr10:17949551-18152611@35.2@352@796@2.26@NA@MRC1L1_28, MRC1L1_29, MRC1L1_30, TMEM236_1, TMEM236_2, TMEM236_3, TMEM236_4, MRC1_1, MRC1_2, MRC1_3, MRC1_4, MRC1_5, MRC1_6, MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11@0@0@0@:macrophage mannose receptor 1-like:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D129266@96247@96251@duplication@5@37488656@37508825@10@chr10:37488656-37508825@5.86@970@1246@1.28@NA@ANKRD30A_30, ANKRD30A_31, ANKRD30A_32, ANKRD30A_33, ANKRD30A_34@0@0@0@:ankyrin repeat domain 30A@:protein binding;nucleus;DNA binding;regulation of transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity@NA
D129266@96581@96581@deletion@1@48054984@48055018@10@chr10:48054984-48055018@14@74@0@0@CNVR4715.2@ASAH2C_1@0@0@0@@:ceramidase activity;sphingolipid metabolic process@NA
D129266@96933@96937@duplication@5@51970584@51978390@10@chr10:51970584-51978390@7.33@126@206@1.63@NA@ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
D129266@102337@102337@duplication@1@135439427@135439503@10@chr10:135439427-135439503@5.78@113@214@1.89@CNVR4989.11, CNVR4989.4@FRG2B_3@0@0@0@:FSHD region gene 2 family, member B@:nucleus@NA
D129266@103289@103290@deletion@2@5270599@5271034@11@chr11:5270599-5271034@9.31@45@0@0@NA@HBG1_2, HBG1_1@0@0@0@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
D129266@106046@106048@deletion@3@55370918@55419315@11@chr11:55370918-55419315@95.5@731@3@0.0041@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
D129266@110120@110124@deletion@5@89608779@89771883@11@chr11:89608779-89771883@8.1@40@3@0.075@NA@TRIM64B_1, TRIM49C_3, TRIM49C_4, TRIM49C_5, TRIM49C_6@0@0@0@:tripartite motif containing 64;tripartite motif containing 64C;tripartite motif containing 64B:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;zinc ion binding:protein binding;intracellular;DNA binding;zinc ion binding@NA
D129266@113106@113109@duplication@4@537936@542488@12@chr12:537936-542488@5.61@543@716@1.32@NA@CCDC77_6, CCDC77_7, CCDC77_8, CCDC77_9@0@0@0@:coiled-coil domain containing 77@:centrosome@NA
D129266@114483@114483@deletion@1@11243900@11244828@12@chr12:11243900-11244828@37.9@466@23@0.0494@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
D129266@114493@114499@duplication@7@11506042@11548463@12@chr12:11506042-11548463@18.7@604@938@1.55@CNVR5435.2, CNVR5435.1@PRB1_4, PRB1_3, PRB1_2, PRB1_1, PRB2_3, PRB2_2, PRB2_1@0@0@0@:proline-rich protein BstNI subfamily 1:proline-rich protein BstNI subfamily 2@:extracellular region;molecular_function;cellular_component;biological_process@NA
D129266@117170@117171@duplication@2@52865457@52866064@12@chr12:52865457-52866064@5.52@188@282@1.5@NA@KRT6C_3, KRT6C_2@0@0@0@:keratin 6C@:intermediate filament;structural molecule activity;keratin filament;cytoskeleton organization@NA
D129266@122315@122316@duplication@2@117996312@118017007@12@chr12:117996312-118017007@5.09@172@259@1.51@NA@KSR2_8, KSR2_7@0@0@0@:kinase suppressor of ras 2@:MAP-kinase scaffold activity;protein tyrosine kinase activity;positive regulation of MAPK cascade;transferase activity, transferring phosphorus-containing groups;ATP binding;plasma membrane;intracellular signal transduction;protein serine/threonine kinase activity;protein phosphorylation;calcium-mediated signaling;intracellular;protein kinase activity;mitogen-activated protein kinase kinase binding;cytoplasm;cytosol;protein binding;membrane;metal ion binding@NA
D129266@123970@123972@duplication@3@20220584@20224400@13@chr13:20220584-20224400@6.41@687@925@1.35@NA@MPHOSPH8_3, MPHOSPH8_4, MPHOSPH8_5@0@0@0@:M-phase phosphoprotein 8@:nuclear heterochromatin;nuclear nucleosome;negative regulation of transcription, DNA-dependent;cytoplasm;protein binding;nucleolus;regulation of DNA methylation;nucleus;plasma membrane;methylated histone residue binding;transcription, DNA-dependent;cell cycle@NA
D129266@127304@127313@duplication@10@115002121@115012479@13@chr13:115002121-115012479@15.7@847@1170@1.38@CNVR6071.3@CDC16_2, CDC16_3, CDC16_4, CDC16_5, CDC16_6, CDC16_7, CDC16_8, CDC16_9, CDC16_10, CDC16_11@0@0@0@:cell division cycle 16 homolog (S. cerevisiae)@:nucleoplasm;mitotic cell cycle;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;mitotic cell cycle spindle assembly checkpoint;protein K11-linked ubiquitination;nucleus;cell cycle checkpoint;cell division;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;spindle;spindle microtubule;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;anaphase-promoting complex;centrosome;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;cytoplasm;cell proliferation;cytosol;protein binding;mitosis;regulation of mitosis@NA
D129266@133409@133413@deletion@5@106373070@106379096@14@chr14:106373070-106379096@6.96@168@96@0.571@CNVR6294.27, CNVR6294.36, CNVR6294.48, CNVR6294.25, CNVR6294.57, CNVR6294.29@IGHD2-8_1, IGHD1-7_1, IGHD6-6_1, IGHD5-5_1, IGHD4-4_1@0@0@0@NA@NA@NA
D129266@133432@133434@deletion@3@106539080@106552592@14@chr14:106539080-106552592@10.6@536@316@0.59@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2@0@0@0@@:protein binding:protein binding@NA
D129266@133437@133451@duplication@15@106573636@106725654@14@chr14:106573636-106725654@9.65@2206@2722@1.23@CNVR6294.48, CNVR6294.24, CNVR6294.40@IGHV3-11_1, IGHV3-13_2, IGHV3-13_1, IGHV3-15_2, IGHV3-15_1, IGHV3-16_2, IGHV3-16_1, IGHV1-18_2, IGHV1-18_1, IGHV3-20_2, IGHV3-20_1, IGHV3-21_2, IGHV3-21_1, IGHV3-23_2, IGHV3-23_1@0@0@0@@:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding@NA
D129266@133458@133463@deletion@6@106791006@106816173@14@chr14:106791006-106816173@12@602@382@0.635@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-30_2, IGHV3-30_1, IGHV4-31_2, IGHV4-31_1, IGHV3-33_2, IGHV3-33_1@0@0@0@@:protein binding:protein binding:protein binding@NA
D129266@133484@133485@duplication@2@107048673@107049120@14@chr14:107048673-107049120@5.2@250@364@1.46@CNVR6294.56, CNVR6294.16, CNVR6294.89@IGHV3-53_2, IGHV3-53_1@0@0@0@@:protein binding@NA
D129266@133491@133492@deletion@2@107095127@107095561@14@chr14:107095127-107095561@9.7@55@5@0.0909@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61_2, IGHV4-61_1@0@0@0@@:protein binding@NA
D129266@142692@142703@duplication@12@15091611@15116611@16@chr16:15091611-15116611@15@1460@1910@1.31@CNVR6646.1@PDXDC1_2, PDXDC1_3, PDXDC1_4, PDXDC1_5, PDXDC1_6, PDXDC1_7, PDXDC1_8, PDXDC1_9, PDXDC1_10, PDXDC1_11, PDXDC1_12, PDXDC1_13@0@0@0@:pyridoxal-dependent decarboxylase domain containing 1;pyridoxal-dependent decarboxylase domain-containing protein 1-like@:carboxylic acid metabolic process;pyridoxal phosphate binding;carboxy-lyase activity@NA
D129266@144038@144039@deletion@2@28403074@28403463@16@chr16:28403074-28403463@20.6@110@3@0.0273@CNVR6684.2@EIF3CL_10, EIF3CL_9@0@0@0@:eukaryotic translation initiation factor 3, subunit C-like@:protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;translation initiation factor activity@NA
D129266@145917@145918@deletion@2@57714178@57714529@16@chr16:57714178-57714529@4.91@147@85@0.578@NA@GPR97_7, GPR97_8@0@0@0@:G protein-coupled receptor 97@:transmembrane signaling receptor activity;neuropeptide signaling pathway;integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;membrane;cell surface receptor signaling pathway@NA
D129266@147274@147276@duplication@3@70714698@70719694@16@chr16:70714698-70719694@5.3@144@214@1.49@NA@MTSS1L_3, MTSS1L_2, MTSS1L_1@0@0@0@:metastasis suppressor 1-like@:filopodium assembly;actin binding;signal transduction;SH3 domain binding;cytoskeletal adaptor activity@NA
D129266@151556@151561@deletion@6@16664740@16676947@17@chr17:16664740-16676947@7.31@759@523@0.689@NA@CCDC144A_13, CCDC144A_13, CCDC144A_14, CCDC144A_14, CCDC144A_15, CCDC144A_15, CCDC144A_16, CCDC144A_16, CCDC144A_17, CCDC144A_18, CCDC144A_17@0@0@0@:coiled-coil domain containing 144A@NA@NA
D129266@151874@151884@duplication@11@18291534@18396173@17@chr17:18291534-18396173@16.4@273@462@1.69@NA@EVPLL_10, LGALS9C_1, LGALS9C_2, LGALS9C_3, LGALS9C_4, LGALS9C_5, LGALS9C_6, LGALS9C_7, LGALS9C_8, LGALS9C_9, LGALS9C_10@0@0@0@:envoplakin-like:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
D129266@151959@151961@duplication@3@18996779@19036052@17@chr17:18996779-19036052@8.87@118@258@2.19@CNVR7018.2, CNVR7018.3, CNVR7018.1@AC007952.5_2, GRAPL_1, GRAPL_2@0@0@0@:GRB2-related adaptor protein-like@:protein binding@NA
D129266@153650@153659@duplication@10@36351930@36375177@17@chr17:36351930-36375177@37.8@2078@3297@1.59@CNVR7083.3@RP11-1407O15.2_12, RP11-1407O15.2_11, RP11-1407O15.2_10, RP11-1407O15.2_9, RP11-1407O15.2_8, RP11-1407O15.2_7, RP11-1407O15.2_6, RP11-1407O15.2_5, RP11-1407O15.2_4, RP11-1407O15.2_3@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
D129266@155588@155595@deletion@8@44400320@44415089@17@chr17:44400320-44415089@11.1@88@29@0.33@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_7, LRRC37A_8, LRRC37A_9, LRRC37A_10, LRRC37A_11, LRRC37A_12, LRRC37A_13, LRRC37A_14@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
D129266@160962@160964@duplication@3@14848716@14852479@18@chr18:14848716-14852479@7.17@792@1069@1.35@NA@ANKRD30B_34, ANKRD30B_35, ANKRD30B_36@0@0@0@:ankyrin repeat domain 30B@:protein binding;molecular_function;cellular_component;biological_process@NA
D129266@162017@162017@deletion@1@44542732@44544371@18@chr18:44542732-44544371@7.28@55@11@0.2@CNVR7319.1@TCEB3CL2_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
D129266@163083@163086@duplication@4@77724737@77730451@18@chr18:77724737-77730451@5.57@239@332@1.39@NA@HSBP1L1_1, HSBP1L1_2, HSBP1L1_3, HSBP1L1_4@0@0@0@:heat shock factor binding protein 1-like 1@:viral entry into host cell via membrane fusion with the plasma membrane;viral envelope;host cell surface receptor binding@NA
D129266@166916@166917@deletion@2@14508471@14508747@19@chr19:14508471-14508747@12.8@86@14@0.163@NA@CD97_7, CD97_8@0@0@0@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
D129266@167044@167049@duplication@6@14876337@14884866@19@chr19:14876337-14884866@7.34@526@698@1.33@NA@EMR2_9, EMR2_8, EMR2_7, EMR2_6, EMR2_5, EMR2_4@0@0@0@:egf-like module containing, mucin-like, hormone receptor-like 2@:transmembrane signaling receptor activity;inflammatory response;G-protein coupled receptor activity;ruffle membrane;integral to membrane;plasma membrane;cell surface receptor signaling pathway;neuropeptide signaling pathway;granulocyte chemotaxis;cell migration;leading edge membrane;G-protein coupled receptor signaling pathway;protein binding;cell adhesion;membrane;calcium ion binding;chondroitin sulfate binding@NA
D129266@168336@168394@duplication@59@19905362@21493429@19@chr19:19905362-21493429@51.5@14338@18239@1.27@NA@ZNF506_4, ZNF253_4, ZNF93_4, ZNF682_4, ZNF90_4, ZNF486_4, ZNF737_4, ZNF626_4, ZNF66P_4, ZNF85_4, ZNF430_5, ZNF714_5, ZNF431_5, ZNF708_4@0@0@0@:zinc finger protein 506:zinc finger protein 253:zinc finger protein 93:zinc finger protein 682:zinc finger protein 90:zinc finger protein 486:zinc finger protein 737:zinc finger protein 626:zinc finger protein 85:zinc finger protein 430:zinc finger protein 714:zinc finger protein 431:zinc finger protein 708@:nucleolus;intracellular;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:nucleus;intracellular;DNA binding;regulation of transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;DNA binding;regulation of transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity;nucleus;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding:Golgi apparatus;intracellular;DNA binding;regulation of transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity;nucleus;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;transcription corepressor activity;DNA binding;regulation of transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity;nucleus;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
D129266@168402@168435@duplication@34@21587932@22585686@19@chr19:21587932-22585686@29.7@10606@13515@1.27@NA@ZNF493_2, CTD-2561J22.3_1, ZNF493_4, ZNF429_2, ZNF429_4, ZNF100_5, ZNF100_3, ZNF43_4, ZNF43_2, ZNF208_4, ZNF208_2, ZNF257_2, ZNF257_4, ZNF676_3, ZNF729_2, ZNF729_4, ZNF98_4@0@0@0@:zinc finger protein 493:zinc finger protein 429:zinc finger protein 100:zinc finger protein 43:zinc finger protein 208:zinc finger protein 257:zinc finger protein 676:zinc finger protein 729:zinc finger protein 98@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
D129266@168443@168482@duplication@40@22939742@29699065@19@chr19:22939742-29699065@31.3@9600@12212@1.27@NA@ZNF99_5, ZNF728_4, ZNF730_4, ZNF724P_4, ZNF91_4, ZNF675_4, ZNF681_4, RPSAP58_4, ZNF254_4@0@0@0@:zinc finger protein 99:zinc finger protein 728:zinc finger protein 730:zinc finger protein 91:zinc finger protein 675:zinc finger protein 681:zinc finger protein 726:zinc finger protein 254:ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;DNA binding;regulation of transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity;nucleus;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:negative regulation of tumor necrosis factor-mediated signaling pathway;negative regulation of NF-kappaB transcription factor activity;DNA binding;bone resorption;nucleus;negative regulation of transcription regulatory region DNA binding;cytokine-mediated signaling pathway;ubiquitin protein ligase binding;intracellular;regulation of transcription, DNA-dependent;negative regulation of JUN kinase activity;I-kappaB kinase/NF-kappaB cascade;perinuclear region of cytoplasm;negative regulation of JNK cascade;protein binding;negative regulation of osteoclast differentiation;negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent;negative regulation of interleukin-1-mediated signaling pathway;zinc ion binding;nucleic acid binding:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:structural constituent of ribosome;small ribosomal subunit;ribosome;intracellular;translation:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding:negative regulation of transcription from RNA polymerase II promoter;nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding:oxidation-reduction process;mitochondrion;response to antibiotic;small molecule metabolic process;ubiquinol-cytochrome-c reductase activity;mitochondrial inner membrane;response to drug;respiratory electron transport chain;protein binding;oxidoreductase activity;integral to membrane;response to hormone stimulus;protein complex binding;mitochondrial membrane;2 iron, 2 sulfur cluster binding;mitochondrial respiratory chain complex III;metal ion binding@NA
D129266@168952@168952@duplication@1@35862263@35863302@19@chr19:35862263-35863302@5.89@35@95@2.71@CNVR7627.1@GPR42_2@0@0@0@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
D129266@170772@170775@duplication@4@43093610@43228177@19@chr19:43093610-43228177@5.99@502@674@1.34@NA@CEACAM8_3, CEACAM8_2, CEACAM8_1, PSG3_6@0@0@0@:carcinoembryonic antigen-related cell adhesion molecule 8:pregnancy specific beta-1-glycoprotein 3@:protein binding;extracellular space;immune response;plasma membrane;integral to plasma membrane;anchored to membrane:protein binding;extracellular region;female pregnancy;defense response@NA
D129266@170813@170816@deletion@4@43674248@43689299@19@chr19:43674248-43689299@6.43@424@274@0.646@CNVR7658.5, CNVR7658.8@PSG5_5, PSG5_4, PSG5_3, PSG5_2@0@0@0@:pregnancy specific beta-1-glycoprotein 5@:protein binding;extracellular region;female pregnancy@NA
D129266@170821@170825@duplication@5@43702150@43762608@19@chr19:43702150-43762608@10.6@390@578@1.48@CNVR7658.5, CNVR7658.1@PSG4_3, PSG4_2, PSG4_1, PSG9_6, PSG9_5@0@0@0@:pregnancy specific beta-1-glycoprotein 4:pregnancy specific beta-1-glycoprotein 9@:protein binding;extracellular region;female pregnancy;defense response:protein binding;extracellular region;female pregnancy;defense response@NA
D129266@173132@173141@duplication@10@53848760@53990012@19@chr19:53848760-53990012@8.67@4164@5248@1.26@NA@ZNF845_3, ZNF845_4, ZNF525_3, ZNF525_4, ZNF765_3, ZNF765_4, ZNF813_3@0@0@0@:zinc finger protein 845:zinc finger protein 765:zinc finger protein 813@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
D129266@173470@173476@deletion@7@55281304@55294990@19@chr19:55281304-55294990@12.5@605@394@0.651@CNVR7725.2, CNVR7725.1@KIR2DL1_1, KIR2DL1_2, KIR2DL1_3, KIR2DL1_4, KIR2DL1_5, KIR2DL1_6, KIR2DL1_7@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
D129266@173844@173849@duplication@6@56283172@56303837@19@chr19:56283172-56303837@8.2@1144@1488@1.3@NA@CTD-2611O12.2_2, CTD-2611O12.2_3, NLRP11_12, NLRP11_11, NLRP11_10, NLRP11_9@0@0@0@:ret finger protein-like 4A-like:NLR family, pyrin domain containing 11@:protein binding;zinc ion binding:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen;ATP binding@NA
D129266@174395@174395@deletion@1@1569207@1569278@20@chr20:1569207-1569278@7.5@35@0@0@CNVR7763.1@RP4-576H24.4_1@0@0@0@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
D129266@181670@181671@deletion@2@22048883@22049106@22@chr22:22048883-22049106@6.64@112@52@0.464@NA@PPIL2_17, PPIL2_18@0@0@0@:peptidylprolyl isomerase (cyclophilin)-like 2@:ubiquitin-protein ligase activity;ubiquitin ligase complex;ubiquitin-ubiquitin ligase activity;Golgi lumen;protein folding;blood coagulation;peptidyl-prolyl cis-trans isomerase activity;nucleus;protein polyubiquitination;protein ubiquitination;leukocyte migration@NA
D129266@181936@181938@deletion@3@24300473@24302568@22@chr22:24300473-24302568@5.47@35@8@0.229@CNVR8114.6, CNVR8114.12, CNVR8114.13, CNVR8114.8@GSTT2B_4, GSTT2B_3, GSTT2B_2@0@0@0@:glutathione S-transferase theta 2B (gene/pseudogene);glutathione S-transferase theta 2@:protein binding;glutathione transferase activity;nucleus;transferase activity;cytoplasm@NA
D129266@181948@181949@deletion@2@24324820@24325235@22@chr22:24324820-24325235@5.22@31@5@0.161@CNVR8114.6, CNVR8114.13, CNVR8114.8, CNVR8114.14@GSTT2_3, GSTT2_4@0@0@0@@:protein binding;glutathione transferase activity;nucleus;cytoplasm@NA
D129266@181951@181955@duplication@5@24376424@24384231@22@chr22:24376424-24384231@25.6@175@441@2.52@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTT1_5, GSTT1_4, GSTT1_3, GSTT1_2, GSTT1_1@0@0@0@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
D129266@184145@184151@duplication@7@42523450@42526793@22@chr22:42523450-42526793@12.9@539@770@1.43@CNVR8168.1, CNVR8168.3, CNVR8168.2@CYP2D6_7, CYP2D6_6, CYP2D6_5, CYP2D6_4, CYP2D6_3, CYP2D6_2, CYP2D6_1@0@0@0@:cytochrome P450, family 2, subfamily D, polypeptide 6@:oxidation-reduction process;mitochondrion;alkaloid catabolic process;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;drug catabolic process;endoplasmic reticulum membrane;response to organic substance;oxidative demethylation;endoplasmic reticulum;alkaloid metabolic process;negative regulation of binding;heme binding;xenobiotic metabolic process;dopamine metabolic process;steroid metabolic process;isoquinoline alkaloid metabolic process;arachidonic acid monooxygenase activity;arachidonic acid metabolic process;steroid 21-monooxygenase activity;negative regulation of cellular organofluorine metabolic process;oxidoreductase activity;monoterpenoid metabolic process;heterocycle metabolic process;drug binding;drug metabolic process;electron carrier activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;coumarin metabolic process@: DRUG METABOLISM, POOR, CYP2D6-RELATED
D129266@184165@184172@duplication@8@42908917@42950048@22@chr22:42908917-42950048@7.18@320@431@1.35@CNVR8171.2, CNVR8171.3@RRP7A_7, RRP7A_6, RRP7A_5, RRP7A_4, RRP7A_3, RRP7A_2, RRP7A_1, SERHL2_1@0@0@0@:ribosomal RNA processing 7 homolog A (S. cerevisiae):serine hydrolase-like 2@:RNA binding;nucleotide binding:hydrolase activity;mitochondrion;peroxisome;cytoplasmic membrane-bounded vesicle;molecular_function;cellular_component;perinuclear region of cytoplasm;biological_process@NA
D129266@4070@4071@deletion@2@101581178@101581428@X@chrX:101581178-101581428@4.97@23@0@0@NA@NXF2_33, NXF2_34@0@0@0@NA@NA@NA
D129266@6284@6285@deletion@2@153416129@153418581@X@chrX:153416129-153418581@7.56@36@0@0@CNVR8489.1@OPN1LW_2, OPN1LW_3@0@0@0@NA@NA@NA
D134130@6@7@deletion@2@69092@139309@1@chr1:69092-139309@8.21@43@4@0.093@CNVR1.2@OR4F5_1, AL627309.1_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
D134130@301@305@duplication@5@1355433@1371201@1@chr1:1355433-1371201@7.83@193@285@1.48@NA@ANKRD65_3, ANKRD65_2, TMEM88B_1, TMEM88B_2, VWA1_1@0@0@0@:ankyrin repeat domain 65:transmembrane protein 88B:von Willebrand factor A domain containing 1@:protein binding:integral to membrane:extracellular matrix;protein binding;extracellular region;interstitial matrix;behavioral response to pain;basement membrane;extracellular matrix organization;identical protein binding@NA
D134130@399@400@duplication@2@1573863@1575813@1@chr1:1573863-1575813@7.15@172@261@1.52@CNVR17.1@CDK11B_13, CDK11B_12@0@0@0@:cyclin-dependent kinase 11B@:protein serine/threonine kinase activity;protein tyrosine kinase activity;protein phosphorylation;protein kinase activity;cell division;transferase activity, transferring phosphorus-containing groups;ATP binding@NA
D134130@2170@2173@deletion@4@17248515@17256526@1@chr1:17248515-17256526@6.76@755@517@0.685@CNVR94.4, CNVR94.5, CNVR94.6@CROCC_1, CROCC_2, CROCC_3, CROCC_4@0@0@0@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
D134130@8296@8297@duplication@2@85930427@86046730@1@chr1:85930427-86046730@5.06@235@325@1.38@NA@DDAH1_1, CYR61_1@0@0@0@:dimethylarginine dimethylaminohydrolase 1:cysteine-rich, angiogenic inducer, 61@:dimethylargininase activity;arginine metabolic process;mitochondrion;regulation of systemic arterial blood pressure;arginine catabolic process;catalytic activity;citrulline metabolic process;cytoplasm;positive regulation of angiogenesis;amino acid binding;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines;nitric oxide mediated signal transduction;positive regulation of nitric oxide biosynthetic process;metal ion binding:integrin binding;negative regulation of apoptotic process;cell-cell adhesion;regulation of ERK1 and ERK2 cascade;atrial septum morphogenesis;reactive oxygen species metabolic process;labyrinthine layer blood vessel development;chondroblast differentiation;extracellular matrix binding;atrioventricular valve morphogenesis;positive regulation of BMP signaling pathway;anatomical structure morphogenesis;intussusceptive angiogenesis;wound healing, spreading of cells;regulation of cell growth;positive regulation of cell-substrate adhesion;chemotaxis;positive regulation of cell migration;heparin binding;positive regulation of cell differentiation;apoptotic process involved in heart morphogenesis;positive regulation of ceramide biosynthetic process;positive regulation of transcription from RNA polymerase II promoter;ventricular septum development;osteoblast differentiation;positive regulation of osteoblast proliferation;extracellular matrix organization;insulin-like growth factor binding;positive regulation of protein kinase activity;chorio-allantoic fusion;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;cell proliferation;protein binding;positive regulation of protein phosphorylation;positive regulation of phospholipase activity;extracellular region;positive regulation of cartilage development;positive regulation of osteoblast differentiation;cell adhesion;positive regulation of apoptotic process@NA
D134130@8507@8508@duplication@2@89476588@89477710@1@chr1:89476588-89477710@6.32@476@647@1.36@CNVR244.1@GBP3_8, GBP3_7@0@0@0@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
D134130@9365@9374@duplication@10@104202983@104234232@1@chr1:104202983-104234232@12.6@102@209@2.05@CNVR266.3, CNVR266.1, CNVR266.15@AMY1A_7, AMY1A_8, AMY1A_9, AMY1A_10, AMY1A_11, AMY1B_11, AMY1B_10, AMY1B_9, AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D134130@9385@9386@deletion@2@104297122@104297436@1@chr1:104297122-104297436@14.8@267@127@0.476@CNVR266.3, CNVR266.5@AMY1C_6, AMY1C_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D134130@9436@9436@deletion@1@108769302@108769515@1@chr1:108769302-108769515@8.22@53@10@0.189@CNVR294.4@NBPF4_14@0@0@0@:neuroblastoma breakpoint family, member 4@:cytoplasm@NA
D134130@9766@9773@deletion@8@110230497@110235917@1@chr1:110230497-110235917@75.2@354@4@0.0113@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
D134130@12117@12118@duplication@2@152573209@152586574@1@chr1:152573209-152586574@9.25@103@190@1.84@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
D134130@13471@13472@duplication@2@158516919@158533394@1@chr1:158516919-158533394@9.73@1201@1629@1.36@NA@OR6Y1_1, OR6P1_1@0@0@0@:olfactory receptor, family 6, subfamily Y, member 1:olfactory receptor, family 6, subfamily P, member 1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
D134130@16029@16040@deletion@12@196744018@196801129@1@chr1:196744018-196801129@296@1490@16@0.0107@CNVR459.1@CFHR3_1, CFHR3_2, CFHR3_3, CFHR3_4, CFHR3_5, CFHR3_6, CFHR1_1, CFHR1_2, CFHR1_3, CFHR1_4, CFHR1_5, CFHR1_6@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
D134130@17624@17625@deletion@2@213003585@213009491@1@chr1:213003585-213009491@7.93@221@123@0.557@CNVR498.1@C1orf227_3, C1orf227_2@0@0@0@:chromosome 1 open reading frame 227@NA@NA
D134130@19777@19777@duplication@1@248801589@248802559@1@chr1:248801589-248802559@8.05@71@147@2.07@NA@OR2T35_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 35@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
D134130@22191@22194@duplication@4@38956699@38972329@2@chr2:38956699-38972329@16.4@580@847@1.46@CNVR759.1@GALM_5, GALM_6, GALM_7, SRSF7_8@0@0@0@:galactose mutarotase (aldose 1-epimerase):serine/arginine-rich splicing factor 7@:isomerase activity;carbohydrate binding;aldose 1-epimerase activity;hexose metabolic process;carbohydrate metabolic process;catalytic activity;cytoplasm:nucleoplasm;negative regulation of mRNA splicing, via spliceosome;mRNA 3'-end processing;termination of RNA polymerase II transcription;nucleotide binding;transcription from RNA polymerase II promoter;protein binding;mRNA export from nucleus;RNA binding;mRNA processing;nucleus;RNA splicing;mRNA splicing, via spliceosome;gene expression;zinc ion binding;nucleic acid binding@NA
D134130@25115@25117@duplication@3@96652500@96657456@2@chr2:96652500-96657456@10.8@312@471@1.51@NA@ANKRD36C_3, ANKRD36C_2, ANKRD36C_1@0@0@0@:ankyrin repeat domain-containing protein 36A-like@:ion channel inhibitor activity;protein binding@NA
D134130@25338@25339@deletion@2@97783802@97784254@2@chr2:97783802-97784254@5.46@227@140@0.617@NA@ANKRD36_2, ANKRD36_3@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
D134130@43421@43425@deletion@5@151531952@151545960@3@chr3:151531952-151545960@46.7@1046@502@0.48@CNVR1586.1@AADAC_1, AADAC_2, AADAC_3, AADAC_4, AADAC_5@0@0@0@:arylacetamide deacetylase@:hydrolase activity;serine hydrolase activity;deacetylase activity;positive regulation of triglyceride catabolic process;catalytic activity;retinyl-palmitate esterase activity;lipase activity;integral to membrane;triglyceride lipase activity;endoplasmic reticulum membrane;carboxylesterase activity;metabolic process@NA
D134130@43588@43588@deletion@1@156742550@156742713@3@chr3:156742550-156742713@5.06@69@31@0.449@NA@LEKR1_12@0@0@0@:leucine, glutamate and lysine rich 1@:structural constituent of ribosome;ribosome;intracellular;translation@NA
D134130@45434@45438@duplication@5@195451552@195475935@3@chr3:195451552-195475935@26.7@1618@2396@1.48@CNVR1703.1, CNVR1703.2, CNVR1703.5, CNVR1703.3@MUC20_2, MUC20_3, MUC20_4, MUC4_25, MUC4_24@0@0@0@:mucin 20, cell surface associated:mucin 4, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane:ErbB-2 class receptor binding;Golgi lumen;cell-matrix adhesion;post-translational protein modification;extracellular matrix structural constituent;protein binding;O-glycan processing;cellular protein metabolic process;proteinaceous extracellular matrix;integral to plasma membrane;membrane;extracellular matrix constituent, lubricant activity;biological_process@NA
D134130@48592@48597@deletion@6@70146220@70160527@4@chr4:70146220-70160527@13.7@761@493@0.648@CNVR1957.2, CNVR1957.1@UGT2B28_1, UGT2B28_2, UGT2B28_3, UGT2B28_4, UGT2B28_5, UGT2B28_6@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
D134130@56389@56389@duplication@1@78365344@78365443@5@chr5:78365344-78365443@4.63@82@135@1.65@NA@DMGDH_1@0@0@0@:dimethylglycine dehydrogenase@:oxidation-reduction process;electron carrier activity;mitochondrion;folic acid binding;flavin adenine dinucleotide binding;cytoplasm;glycine catabolic process;choline metabolic process;oxidoreductase activity;glycine metabolic process;dimethylglycine dehydrogenase activity;aminomethyltransferase activity;amino-acid betaine catabolic process;mitochondrial matrix@: DIMETHYLGLYCINE DEHYDROGENASE DEFICIENCY; DMGDHD
D134130@58678@58678@deletion@1@137664174@137664218@5@chr5:137664174-137664218@11.7@194@85@0.438@NA@CDC25C_4@0@0@0@:cell division cycle 25 homolog C (S. pombe)@:nucleoplasm;mitotic cell cycle;protein kinase binding;protein dephosphorylation;nucleus;M phase of mitotic cell cycle;cell cycle checkpoint;cell division;virus-host interaction;peptidyl-tyrosine dephosphorylation;WW domain binding;regulation of cell cycle;protein tyrosine phosphatase activity;intracellular;cytoplasm;cytosol;cell proliferation;G2/M transition of mitotic cell cycle;protein binding;mitosis;regulation of cyclin-dependent protein kinase activity;traversing start control point of mitotic cell cycle;DNA replication;regulation of mitosis@NA
D134130@59065@59065@deletion@1@140557617@140560021@5@chr5:140557617-140560021@9.36@1486@945@0.636@CNVR2624.1@PCDHB8_1@0@0@0@:protocadherin beta 8@:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding@NA
D134130@59488@59488@deletion@1@147553798@147553933@5@chr5:147553798-147553933@22@110@3@0.0273@CNVR2637.2, CNVR2637.1@SPINK14_3@0@0@0@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
D134130@60877@60877@deletion@1@175388277@175388437@5@chr5:175388277-175388437@6.43@32@2@0.0625@NA@THOC3_4@0@0@0@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
D134130@60887@60889@duplication@3@175523828@175525561@5@chr5:175523828-175525561@6.35@171@251@1.47@NA@FAM153B_6, FAM153B_7, FAM153B_8@0@0@0@:uncharacterized LOC100507387;family with sequence similarity 153, member B@NA@NA
D134130@61266@61266@deletion@1@177163581@177163610@5@chr5:177163581-177163610@5.61@51@17@0.333@NA@FAM153A_11@0@0@0@:family with sequence similarity 153, member A@NA@NA
D134130@61269@61271@deletion@3@177166602@177168333@5@chr5:177166602-177168333@15.7@78@4@0.0513@NA@FAM153A_8, FAM153A_7, FAM153A_6@0@0@0@:family with sequence similarity 153, member A@NA@NA
D134130@61642@61644@duplication@3@180416030@180424488@5@chr5:180416030-180424488@6.54@363@494@1.36@CNVR2719.1@BTNL3_1, BTNL3_2, BTNL3_3@0@0@0@:butyrophilin-like 3@:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
D134130@63281@63282@duplication@2@31237744@31238262@6@chr6:31237744-31238262@20@281@525@1.87@CNVR2838.2, CNVR2838.1@HLA-C_5, HLA-C_4@0@0@0@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
D134130@63296@63296@deletion@1@31379725@31380002@6@chr6:31379725-31380002@6.28@128@66@0.516@CNVR2842.1@MICA_4@0@0@0@:MHC class I polypeptide-related sequence A@:MHC class I protein complex;protein binding;regulation of immune response;antigen processing and presentation;immune response;plasma membrane;membrane@: PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO; PSORIASIS SUSCEPTIBILITY 1; PSORS1
D134130@63953@63957@deletion@5@32485517@32489951@6@chr6:32485517-32489951@38.1@262@54@0.206@CNVR2845.21, CNVR2845.25, CNVR2845.30@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D134130@63963@63973@deletion@11@32551887@32632844@6@chr6:32551887-32632844@65.5@985@461@0.468@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.34@HLA-DRB1_2, HLA-DRB1_1, HLA-DQA1_1, HLA-DQA1_2, HLA-DQA1_3, HLA-DQA1_4, HLA-DQB1_6, HLA-DQB1_5, HLA-DQB1_4, HLA-DQB1_3, HLA-DQB1_2@0@0@0@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
D134130@64605@64606@duplication@2@35763509@35765065@6@chr6:35763509-35765065@4.92@484@644@1.33@CNVR2861.1@CLPS_2, CLPS_1@0@0@0@:colipase, pancreatic@:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
D134130@71030@71030@deletion@1@167790035@167790192@6@chr6:167790035-167790192@6.91@33@1@0.0303@NA@TCP10_5@0@0@0@:t-complex 10@:cytosol@NA
D134130@71746@71749@duplication@4@5940487@5944900@7@chr7:5940487-5944900@8.33@444@606@1.36@NA@CCZ1_4, CCZ1_5, CCZ1_6, CCZ1_7@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D134130@71926@71927@deletion@2@6805338@6806508@7@chr7:6805338-6806508@8.81@118@50@0.424@NA@RSPH10B2_6, RSPH10B2_7@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D134130@71932@71934@duplication@3@6819242@6821107@7@chr7:6819242-6821107@6.82@255@364@1.43@NA@RSPH10B2_12, RSPH10B2_13, RSPH10B2_14@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D134130@71936@71942@duplication@7@6826510@6840706@7@chr7:6826510-6840706@14.4@169@306@1.81@NA@RSPH10B2_16, RSPH10B2_17, RSPH10B2_18, RSPH10B2_19, RSPH10B2_20, CCZ1B_15, CCZ1B_14@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D134130@71945@71949@deletion@5@6845636@6859572@7@chr7:6845636-6859572@15@549@336@0.612@NA@CCZ1B_11, CCZ1B_10, CCZ1B_9, CCZ1B_8, CCZ1B_7@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D134130@73260@73262@deletion@3@38388957@38393626@7@chr7:38388957-38393626@7.39@691@466@0.674@CNVR3354.3, CNVR3354.1@TRGV5_2, TRGV5_1, TRGV4_2@0@0@0@@:protein binding:protein binding@NA
D134130@74616@74616@deletion@1@74466819@74466903@7@chr7:74466819-74466903@4.85@22@0@0@NA@WBSCR16_10@0@0@0@:RCC1-like G exchanging factor-like;Williams-Beuren syndrome chromosome region 16@:mitochondrion;cellular_component;biological_process@: WILLIAMS-BEUREN SYNDROME; WBS
D134130@76428@76431@duplication@4@100333344@100334972@7@chr7:100333344-100334972@8.2@650@863@1.33@CNVR3509.1@ZAN_2, ZAN_3, ZAN_4, ZAN_5@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
D134130@76754@76765@deletion@12@102219880@102235816@7@chr7:102219880-102235816@17.3@102@15@0.147@CNVR3518.1@AC093668.1_1, RASA4_21, RASA4_20, RASA4_19, RASA4_18, RASA4_17, RASA4_16, RASA4_15, RASA4_14, RASA4_13, RASA4_12, RASA4_11@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
D134130@77956@77956@duplication@1@128128156@128128215@7@chr7:128128156-128128215@4.87@48@92@1.92@NA@METTL2B_5@0@0@0@:methyltransferase like 2B@:methyltransferase activity;metabolic process@NA
D134130@78412@78412@deletion@1@134221804@134221909@7@chr7:134221804-134221909@7.23@93@39@0.419@NA@AKR1B10_6@0@0@0@:aldo-keto reductase family 1, member B10 (aldose reductase)@:steroid metabolic process;cellular aldehyde metabolic process;indanol dehydrogenase activity;daunorubicin metabolic process;retinal dehydrogenase activity;farnesol catabolic process;geranylgeranyl reductase activity;protein binding;extracellular region;aldo-keto reductase (NADP) activity;digestion;doxorubicin metabolic process;cellular_component;lysosome@NA
D134130@79287@79287@deletion@1@143400089@143400710@7@chr7:143400089-143400710@5.14@47@16@0.34@CNVR3594.2, CNVR3594.1@FAM115C_2@0@0@0@:family with sequence similarity 115, member C;protein FAM115C-like@NA@NA
D134130@79311@79325@duplication@15@143929005@144072768@7@chr7:143929005-144072768@43.3@1774@2701@1.52@CNVR3598.4@OR2A42_1, OR2A7_1, CTAGE8_1, OR2A1_1, ARHGEF5_2, ARHGEF5_3, ARHGEF5_4, ARHGEF5_5, ARHGEF5_6, ARHGEF5_7, ARHGEF5_8, ARHGEF5_9, ARHGEF5_10, ARHGEF5_11, ARHGEF5_12@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:olfactory receptor, family 2, subfamily A, member 7:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
D134130@80371@80371@deletion@1@7308236@7308422@8@chr8:7308236-7308422@5.8@264@161@0.61@CNVR3771.8, CNVR3771.10, CNVR3771.4@SPAG11B_3@0@0@0@:sperm associated antigen 11B@:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response@NA
D134130@88136@88136@duplication@1@35675759@35675928@9@chr9:35675759-35675928@5.51@95@158@1.66@NA@CA9_3@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 39:carbonic anhydrase IX@:positive regulation of cell migration;phospholipid binding;protein binding;plasma membrane;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity:microvillus membrane;cellular response to stress;small molecule metabolic process;bicarbonate transport;carbonate dehydratase activity;cellular response to hypoxia;regulation of transcription from RNA polymerase II promoter in response to hypoxia;integral to membrane;secretion;one-carbon metabolic process;nucleolus;plasma membrane;zinc ion binding;morphogenesis of an epithelium@NA
D134130@88594@88594@deletion@1@43818042@43818184@9@chr9:43818042-43818184@6.02@107@53@0.495@CNVR4294.1@CNTNAP3B_7@0@0@0@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
D134130@91242@91246@duplication@5@117085415@117087432@9@chr9:117085415-117087432@40.2@1045@1707@1.63@CNVR4448.1@ORM1_1, ORM1_2, ORM1_3, ORM1_4, ORM1_5@0@0@0@:orosomucoid 1@:protein binding;extracellular space;regulation of immune system process;transport;inflammatory response;extracellular region;acute-phase response@NA
D134130@93657@93660@duplication@4@139089172@139091726@9@chr9:139089172-139091726@7.65@492@663@1.35@NA@LHX3_6, LHX3_5, LHX3_4, LHX3_3@0@0@0@:LIM homeobox 3@:cell differentiation;negative regulation of apoptotic process;inner ear development;sequence-specific DNA binding;DNA binding;sequence-specific DNA binding transcription factor activity;placenta development;spinal cord association neuron differentiation;transcription factor complex;ventral spinal cord interneuron specification;nucleus;medial motor column neuron differentiation;organ morphogenesis;positive regulation of transcription from RNA polymerase II promoter;spinal cord motor neuron cell fate specification;pituitary gland development;dorsal/ventral pattern formation;protein binding transcription factor activity;intracellular;regulation of transcription, DNA-dependent;protein binding;positive regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;motor neuron axon guidance@: PITUITARY HORMONE DEFICIENCY, COMBINED, 3; CPHD3
D134130@94186@94188@duplication@3@140135814@140136473@9@chr9:140135814-140136473@5.65@283@387@1.37@NA@TUBB4B_1, TUBB4B_2, TUBB4B_3@0@0@0@:tubulin, beta 4B class IVb@:mitotic cell cycle;spindle assembly;structural constituent of cytoskeleton;protein folding;protein polymerization;GTP binding;plasma membrane;nucleus;MHC class I protein binding;cellular component movement;unfolded protein binding;natural killer cell mediated cytotoxicity;GTPase activity;protein complex;GTP catabolic process;cytoplasm;microtubule cytoskeleton;G2/M transition of mitotic cell cycle;cytosol;cellular protein metabolic process;microtubule-based movement;'de novo' posttranslational protein folding;microtubule;cytoskeleton@NA
D134130@95350@95352@duplication@3@17865074@17875838@10@chr10:17865074-17875838@5.62@171@249@1.46@NA@MRC1L1_2, MRC1L1_3, MRC1L1_4@0@0@0@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
D134130@95380@95386@deletion@7@18060293@18122792@10@chr10:18060293-18122792@18.4@158@51@0.323@NA@TMEM236_2, TMEM236_3, TMEM236_4, MRC1_1, MRC1_2, MRC1_3, MRC1_4@0@0@0@:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D134130@95389@95389@duplication@1@18138509@18138693@10@chr10:18138509-18138693@6.06@99@168@1.7@NA@MRC1_7@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D134130@95391@95393@deletion@3@18145172@18152611@10@chr10:18145172-18152611@6.07@30@2@0.0667@NA@MRC1_9, MRC1_10, MRC1_11@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D134130@95947@95947@deletion@1@29578048@29578159@10@chr10:29578048-29578159@6.04@91@42@0.462@NA@LYZL1_1@0@0@0@:lysozyme-like 1@:extracellular region;lysozyme activity;cell wall macromolecule catabolic process@NA
D134130@96531@96531@duplication@1@47758847@47758904@10@chr10:47758847-47758904@10.8@14@91@6.5@CNVR4714.1@ANXA8L2_10@0@0@0@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:calcium-dependent phospholipid binding;calcium ion binding@NA
D134130@96573@96579@deletion@7@48025301@48049021@10@chr10:48025301-48049021@15.7@343@188@0.548@CNVR4715.2@ASAH2C_9, ASAH2C_8, ASAH2C_7, ASAH2C_6, ASAH2C_5, ASAH2C_4, ASAH2C_3@0@0@0@@:ceramidase activity;sphingolipid metabolic process@NA
D134130@96933@96939@duplication@7@51970584@51994312@10@chr10:51970584-51994312@16@157@295@1.88@NA@ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7, ASAH2_6, ASAH2_5@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
D134130@106046@106048@deletion@3@55370918@55419315@11@chr11:55370918-55419315@25@1972@1229@0.623@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
D134130@114424@114427@deletion@4@10583717@10587129@12@chr12:10583717-10587129@12.3@536@339@0.632@CNVR5430.1@KLRC2_6, KLRC2_5, KLRC2_4, KLRC2_3, NKG2-E_3@0@0@0@:killer cell lectin-like receptor subfamily C, member 2@:carbohydrate binding:transmembrane signaling receptor activity;carbohydrate binding;protein binding;signal transduction;cellular defense response;integral to plasma membrane@NA
D134130@114483@114483@duplication@1@11243900@11244828@12@chr12:11243900-11244828@5@856@1154@1.35@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
D134130@115537@115537@duplication@1@31249276@31249313@12@chr12:31249276-31249313@6.83@60@123@2.05@CNVR5483.1@DDX11_15@0@0@0@:DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11@:nucleoplasm;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;S phase of mitotic cell cycle;DNA binding;nucleobase-containing compound metabolic process;ATP binding;ATP-dependent DNA helicase activity;DNA helicase activity;midbody;RNA binding;DNA-dependent ATPase activity;nucleus;positive regulation of cell proliferation;virus-host interaction;nuclear chromatin;4 iron, 4 sulfur cluster binding;helicase activity;hydrolase activity, acting on acid anhydrides;DNA duplex unwinding;endoplasmic reticulum unfolded protein response;G2/M transition of mitotic cell cycle;protein binding;sister chromatid cohesion;activation of signaling protein activity involved in unfolded protein response;nucleolus;spindle pole;ATP-dependent helicase activity;metal ion binding;nucleic acid binding;mitotic sister chromatid segregation@: WARSAW BREAKAGE SYNDROME
D134130@124199@124199@deletion@1@25015985@25016106@13@chr13:25015985-25016106@11@123@44@0.358@NA@PARP4_30@0@0@0@:poly (ADP-ribose) polymerase family, member 4@:NAD+ ADP-ribosyltransferase activity;transport;inflammatory response;response to drug;DNA binding;DNA repair;cellular protein modification process;cell death;nucleus;spindle microtubule;ribonucleoprotein complex;enzyme binding;response to DNA damage stimulus;cytoplasm;protein ADP-ribosylation;protein binding@NA
D134130@127356@127356@deletion@1@20344428@20345371@14@chr14:20344428-20345371@4.7@1361@949@0.697@CNVR6072.12, CNVR6072.4, CNVR6072.5@OR4K2_1@0@0@0@:olfactory receptor, family 4, subfamily K, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
D134130@131032@131034@deletion@3@74004127@74010359@14@chr14:74004127-74010359@47.9@357@87@0.244@CNVR6188.1, CNVR6188.4@ACOT1_1, ACOT1_2, ACOT1_3@0@0@0@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
D134130@133345@133359@duplication@15@106066404@106175002@14@chr14:106066404-106175002@88.4@2154@3440@1.6@CNVR6294.46, CNVR6294.20, CNVR6294.43, CNVR6294.65, CNVR6294.66@IGHE_4, IGHE_3, IGHE_2, IGHE_1, IGHG4_4, IGHG4_3, IGHG4_2, IGHG4_1, IGHG2_4, IGHG2_3, IGHG2_2, IGHG2_1, IGHA1_3, IGHA1_2, IGHA1_1@0@0@0@@:antigen binding;protein binding;immune response:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response:antigen binding;protein binding;immune response;protein-chromophore linkage@NA
D134130@133425@133427@duplication@3@106471637@106478539@14@chr14:106471637-106478539@13.7@190@333@1.75@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV1-3_1, IGHV4-4_2, IGHV4-4_1@0@0@0@@:protein binding:protein binding@NA
D134130@133432@133436@duplication@5@106539080@106573537@14@chr14:106539080-106573537@48.5@712@1313@1.84@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1, IGHV3-11_2@0@0@0@@:protein binding:protein binding:protein binding@NA
D134130@133450@133451@duplication@2@106725202@106725654@14@chr14:106725202-106725654@9.23@710@994@1.4@CNVR6294.48, CNVR6294.24, CNVR6294.40, CNVR6294.38, CNVR6294.17, CNVR6294.23@IGHV3-23_2, IGHV3-23_1@0@0@0@@:protein binding@NA
D134130@133460@133463@deletion@4@106805210@106816173@14@chr14:106805210-106816173@16.8@432@236@0.546@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.41@IGHV4-31_2, IGHV4-31_1, IGHV3-33_2, IGHV3-33_1@0@0@0@@:protein binding:protein binding@NA
D134130@133541@133542@deletion@2@22368577@22383423@15@chr15:22368577-22383423@54.8@3613@1668@0.462@CNVR6297.4, CNVR6297.17, CNVR6297.2@OR4M2_1, OR4N4_1@0@0@0@:olfactory receptor, family 4, subfamily M, member 2:olfactory receptor, family 4, subfamily N, member 4@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
D134130@133999@134012@duplication@14@30433542@30665348@15@chr15:30433542-30665348@8.67@361@498@1.38@CNVR6337.1@GOLGA8T_11, GOLGA8T_12, GOLGA8T_13, GOLGA8T_14, GOLGA8T_15, GOLGA8T_16, GOLGA8T_17, GOLGA8T_18, GOLGA8T_19, CHRFAM7A_10, CHRFAM7A_9, CHRFAM7A_8, CHRFAM7A_7, CHRFAM7A_6@0@0@0@:golgin A8 family, member J;golgin A8 family, member K:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:Golgi apparatus:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
D134130@140776@140777@duplication@2@734067@734382@16@chr16:734067-734382@7.11@182@275@1.51@NA@JMJD8_2, JMJD8_1@0@0@0@:mesothelin:jumonji domain containing 8@:pancreas development;Golgi apparatus;protein binding;extracellular space;cell adhesion;plasma membrane;membrane;cell surface;anchored to membrane:protein binding@NA
D134130@141531@141533@duplication@3@2296861@2301567@16@chr16:2296861-2301567@7.29@127@203@1.6@NA@ECI1_3, ECI1_2, ECI1_1@0@0@0@:enoyl-CoA delta isomerase 1@:fatty acid beta-oxidation;small molecule metabolic process;mitochondrial inner membrane;cellular lipid metabolic process;dodecenoyl-CoA delta-isomerase activity;catalytic activity;intramolecular oxidoreductase activity;metabolic process;mitochondrial matrix;identical protein binding@NA
D134130@141638@141639@duplication@2@2647653@2732801@16@chr16:2647653-2732801@7.86@260@393@1.51@CNVR6602.2@PDPK1_14, KCTD5_1@0@0@0@:3-phosphoinositide dependent protein kinase-1:potassium channel tetramerisation domain containing 5@:3-phosphoinositide-dependent protein kinase activity;nucleoplasm;fibroblast growth factor receptor signaling pathway;protein tyrosine kinase activity;negative regulation of transforming growth factor beta receptor signaling pathway;negative regulation of toll-like receptor signaling pathway;regulation of endothelial cell migration;focal adhesion assembly;ATP binding;insulin receptor signaling pathway;plasma membrane;intracellular signal transduction;positive regulation of establishment of protein localization to plasma membrane;platelet activation;protein kinase activity;regulation of mast cell degranulation;cytosol;epidermal growth factor receptor signaling pathway;hyperosmotic response;nerve growth factor receptor signaling pathway;type B pancreatic cell development;synaptic transmission;regulation of apoptotic process;transcription, DNA-dependent;protein autophosphorylation;regulation of I-kappaB kinase/NF-kappaB cascade;protein kinase binding;T cell costimulation;insulin receptor binding;transferase activity, transferring phosphorus-containing groups;actin cytoskeleton organization;blood coagulation;negative regulation of protein kinase activity;cellular response to insulin stimulus;focal adhesion;phosphatidylinositol-mediated signaling;negative regulation of cardiac muscle cell apoptotic process;protein serine/threonine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;cytoplasm;activation of protein kinase B activity;protein binding;T cell receptor signaling pathway;cytoplasmic membrane-bounded vesicle;peptidyl-threonine phosphorylation;kinase activity:cytosol;protein binding;nucleus;protein homooligomerization;virus-host interaction@NA
D134130@142698@142698@duplication@1@15103539@15103616@16@chr16:15103539-15103616@4.79@131@200@1.53@CNVR6646.1@PDXDC1_8@0@0@0@:pyridoxal-dependent decarboxylase domain containing 1;pyridoxal-dependent decarboxylase domain-containing protein 1-like@:carboxylic acid metabolic process;pyridoxal phosphate binding;carboxy-lyase activity@NA
D134130@143481@143485@deletion@5@21763257@21771861@16@chr16:21763257-21771861@9.94@142@68@0.479@CNVR6668.5, CNVR6668.2, CNVR6668.7@OTOA_24, OTOA_25, OTOA_26, OTOA_27, OTOA_28@0@0@0@:otoancorin@:proteinaceous extracellular matrix;apical plasma membrane;sensory perception of sound;anchored to membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22
D134130@144038@144039@duplication@2@28403074@28403463@16@chr16:28403074-28403463@16@134@285@2.13@CNVR6684.2@EIF3CL_10, EIF3CL_9@0@0@0@:eukaryotic translation initiation factor 3, subunit C-like@:protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;translation initiation factor activity@NA
D134130@144097@144101@deletion@5@28617378@28619924@16@chr16:28617378-28619924@11.1@787@538@0.684@CNVR6685.1, CNVR6685.2@SULT1A1_9, SULT1A1_8, SULT1A1_7, SULT1A1_6, SULT1A1_5@0@0@0@:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1@:small molecule metabolic process;sulfation;aryl sulfotransferase activity;amine metabolic process;catecholamine metabolic process;xenobiotic metabolic process;cytosol;steroid sulfotransferase activity;integral to membrane;sulfotransferase activity;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process;estrogen metabolic process@NA
D134130@144117@144117@duplication@1@28734486@28734644@16@chr16:28734486-28734644@6.96@412@596@1.45@CNVR6686.3, CNVR6686.2@EIF3C_9@0@0@0@:eukaryotic translation initiation factor 3, subunit C@:cytosol;protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;cellular protein metabolic process;binding;gene expression;translation;translation initiation factor activity@NA
D134130@144268@144268@deletion@1@29370587@29370656@16@chr16:29370587-29370656@5.45@83@39@0.47@NA@SNX29P2_3@0@0@0@NA@NA@NA
D134130@145556@145560@duplication@5@55846816@55855433@16@chr16:55846816-55855433@7.9@675@897@1.33@CNVR6731.1@CES1_9, CES1_8, CES1_7, CES1_6, CES1_5@0@0@0@:carboxylesterase 1;liver carboxylesterase 1-like@:hydrolase activity;methyl salicylate esterase activity;response to toxin;methylumbelliferyl-acetate deacetylase activity;endoplasmic reticulum lumen;retinyl-palmitate esterase activity;methyl jasmonate esterase activity;metabolic process;carboxylesterase activity;methyl indole-3-acetate esterase activity@: CARBOXYLESTERASE 1; CES1
D134130@147101@147101@duplication@1@70010292@70010635@16@chr16:70010292-70010635@6.58@54@112@2.07@CNVR6762.3, CNVR6762.2@RP11-419C5.2_7@0@0@0@NA@NA@NA
D134130@147124@147127@deletion@4@70190379@70211383@16@chr16:70190379-70211383@7.12@937@637@0.68@CNVR6764.1@PDPR_19, CLEC18C_1, CLEC18C_2, CLEC18C_3@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit:C-type lectin domain family 18, member C@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix:carbohydrate binding;protein binding;extracellular region@NA
D134130@151959@151961@deletion@3@18996779@19036052@17@chr17:18996779-19036052@10@185@91@0.492@CNVR7018.2, CNVR7018.3, CNVR7018.1@AC007952.5_2, GRAPL_1, GRAPL_2@0@0@0@:GRB2-related adaptor protein-like@:protein binding@NA
D134130@152122@152123@deletion@2@20353287@20354956@17@chr17:20353287-20354956@7.01@53@15@0.283@CNVR7021.1, CNVR7021.3@LGALS9B_11, LGALS9B_10@0@0@0@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
D134130@153380@153381@deletion@2@34539179@34539971@17@chr17:34539179-34539971@8.83@40@0@0@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1_2, CCL4L1_3@0@0@0@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
D134130@153651@153652@duplication@2@36352423@36353765@17@chr17:36352423-36353765@8.03@622@852@1.37@CNVR7083.3@RP11-1407O15.2_11, RP11-1407O15.2_10@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
D134130@154346@154346@deletion@1@39421631@39422112@17@chr17:39421631-39422112@5.08@36@9@0.25@CNVR7096.1@KRTAP9-6_1@0@0@0@:keratin associated protein 9-6@:keratin filament@NA
D134130@155587@155599@deletion@13@44399689@44592687@17@chr17:44399689-44592687@24.5@166@39@0.235@CNVR7114.2, CNVR7114.1@LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9, LRRC37A_10, LRRC37A_11, LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane@NA
D134130@162019@162019@deletion@1@44554574@44556213@18@chr18:44554574-44556213@21.3@101@0@0@CNVR7319.1@TCEB3C_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C (elongin A3);RNA polymerase II transcription factor SIII subunit A3-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
D134130@164338@164339@duplication@2@4357251@4357582@19@chr19:4357251-4357582@5.37@220@310@1.41@NA@MPND_9, MPND_10@0@0@0@:MPN domain containing@:peptidase activity;protein binding;proteolysis@NA
D134130@168952@168952@deletion@1@35862263@35863302@19@chr19:35862263-35863302@7.57@133@64@0.481@CNVR7627.1@GPR42_2@0@0@0@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
D134130@170093@170100@duplication@8@40367299@40382826@19@chr19:40367299-40382826@12.4@359@523@1.46@CNVR7639.2@FCGBP_29, FCGBP_28, FCGBP_27, FCGBP_26, FCGBP_25, FCGBP_24, FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D134130@170106@170109@deletion@4@40392317@40399855@19@chr19:40392317-40399855@9.13@219@125@0.571@CNVR7639.2, CNVR7639.3@FCGBP_16, FCGBP_15, FCGBP_14, FCGBP_13@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D134130@170367@170376@duplication@10@41381599@41397976@19@chr19:41381599-41397976@70.2@1222@2086@1.71@CNVR7642.1@CYP2A7_9, CYP2A7_8, CYP2A7_7, CYP2A7_6, CYP2A7_5, CYP2A7_4, CYP2A7_3, CYP2A7_2, CYP2A7_1, CTC-490E21.12_2@0@0@0@:cytochrome P450, family 2, subfamily A, polypeptide 7@:oxidation-reduction process;electron carrier activity;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;oxygen binding;heme binding;monooxygenase activity;endoplasmic reticulum membrane;iron ion binding@NA
D134130@170821@170825@deletion@5@43702150@43762608@19@chr19:43702150-43762608@23.4@623@341@0.547@CNVR7658.5, CNVR7658.1@PSG4_3, PSG4_2, PSG4_1, PSG9_6, PSG9_5@0@0@0@:pregnancy specific beta-1-glycoprotein 4:pregnancy specific beta-1-glycoprotein 9@:protein binding;extracellular region;female pregnancy;defense response:protein binding;extracellular region;female pregnancy;defense response@NA
D134130@172987@172987@deletion@1@52133087@52133469@19@chr19:52133087-52133469@8.38@48@6@0.125@CNVR7702.1@SIGLEC5_2, SIGLEC5_2@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion@NA
D134130@172993@172994@duplication@2@52149036@52149893@19@chr19:52149036-52149893@5.87@84@141@1.68@CNVR7702.1@SIGLEC14_3, SIGLEC14_2@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 14@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion;plasma membrane@NA
D134130@173295@173295@duplication@1@54724399@54724700@19@chr19:54724399-54724700@6.51@133@217@1.63@CNVR7721.3, CNVR7721.4@LILRB3_6@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D134130@173467@173469@duplication@3@55263102@55263971@19@chr19:55263102-55263971@6.36@297@409@1.38@CNVR7725.2, CNVR7725.1@KIR2DL3_6, KIR2DL3_7, KIR2DL3_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity@NA
D134130@173489@173492@duplication@4@55333021@55341435@19@chr19:55333021-55341435@9.7@413@580@1.4@CNVR7725.1, CNVR7725.6, CNVR7725.8@KIR3DL1_5, KIR3DL1_6, KIR3DL1_7, KIR3DL1_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
D134130@173499@173501@deletion@3@55358640@55359398@19@chr19:55358640-55359398@10.1@741@487@0.657@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4_6, KIR2DS4_7, KIR2DS4_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
D134130@173842@173842@deletion@1@56273168@56273452@19@chr19:56273168-56273452@13.4@132@41@0.311@CNVR7734.1@RFPL4A_2@0@0@0@:ret finger protein-like 4A;ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
D134130@174394@174395@deletion@2@1558985@1569278@20@chr20:1558985-1569278@23.9@445@201@0.452@CNVR7763.1@RP4-576H24.4_2, SIRPB1_2, RP4-576H24.4_1@0@0@0@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
D134130@180968@180976@deletion@9@16266930@16287885@22@chr22:16266930-16287885@10.7@103@36@0.35@CNVR8071.2, CNVR8071.3@POTEH_9, POTEH_8, POTEH_7, POTEH_6, POTEH_5, POTEH_4, POTEH_3, POTEH_2, POTEH_1@0@0@0@:POTE ankyrin domain family, member H@:protein binding@NA
D134130@181632@181632@duplication@1@21576156@21576241@22@chr22:21576156-21576241@5.23@42@87@2.07@CNVR8100.4, CNVR8100.10, CNVR8100.7@GGT2_6@0@0@0@:gamma-glutamyltransferase 2;gamma-glutamyltranspeptidase 2-like@:hydrolase activity;small molecule metabolic process;leukotriene biosynthetic process;anchored to external side of plasma membrane;glutathione biosynthetic process;xenobiotic metabolic process;integral to membrane;glutathione metabolic process;plasma membrane;gamma-glutamyltransferase activity;cellular_component@NA
D134130@181951@181955@duplication@5@24376424@24384231@22@chr22:24376424-24384231@24.6@502@805@1.6@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTT1_5, GSTT1_4, GSTT1_3, GSTT1_2, GSTT1_1@0@0@0@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
D134130@183631@183636@duplication@6@39357393@39382096@22@chr22:39357393-39382096@6.42@397@529@1.33@CNVR8164.1@APOBEC3A_4, APOBEC3A_5, APOBEC3A_6, APOBEC3B_1, APOBEC3B_2, APOBEC3B_3@0@0@0@:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A;APOBEC3A and APOBEC3B deletion hybrid:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B@:cytidine deamination;defense response to virus;negative regulation of viral genome replication;DNA cytosine deamination;clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine;catalytic activity;DNA demethylation;cytoplasm;innate immune response;cytidine deaminase activity;nucleus;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;cellular response to xenobiotic stimulus;zinc ion binding;negative regulation of transposition:RNA binding;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;negative regulation of transposition;catalytic activity;zinc ion binding@NA
D134130@4072@4079@deletion@8@101615523@101620252@X@chrX:101615523-101620252@15.7@71@0@0@NA@NXF2B_34, NXF2B_33, NXF2B_32, NXF2B_31, NXF2B_30, NXF2B_29, NXF2B_28, NXF2B_27@0@0@0@NA@NA@NA
D134130@5718@5719@deletion@2@140335651@140336590@X@chrX:140335651-140336590@13.2@72@8@0.111@CNVR8456.1@SPANXC_2, SPANXC_1@0@0@0@NA@NA@NA
D134130@6285@6285@deletion@1@153418414@153418581@X@chrX:153418414-153418581@7.6@37@2@0.0541@CNVR8489.1@OPN1LW_3@0@0@0@NA@NA@NA
D180850@6@7@deletion@2@69092@139309@1@chr1:69092-139309@8.51@45@5@0.111@CNVR1.2@OR4F5_1, AL627309.1_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
D180850@323@324@deletion@2@1414430@1416316@1@chr1:1414430-1416316@6.55@94@44@0.468@CNVR15.1@ATAD3B_4, ATAD3B_5@0@0@0@:ATPase family, AAA domain containing 3B@:nucleoside-triphosphatase activity;mitochondrial inner membrane;nucleotide binding;ATP binding@NA
D180850@337@340@duplication@4@1451393@1454370@1@chr1:1451393-1454370@9.53@298@440@1.48@NA@ATAD3A_2, ATAD3A_3, ATAD3A_4, ATAD3A_5@0@0@0@:ATPase family, AAA domain containing 3A@:negative regulation of apoptotic process;mitochondrion;nucleoside-triphosphatase activity;mitochondrial inner membrane;cell growth;nucleotide binding;ATP binding;mitochondrial nucleoid;integral to membrane@NA
D180850@418@419@deletion@2@1607504@1608138@1@chr1:1607504-1608138@5.7@58@23@0.397@CNVR17.1@SLC35E2B_4, SLC35E2B_3@0@0@0@:solute carrier family 35, member E2B@:integral to membrane;membrane;transmembrane transport@NA
D180850@2170@2188@deletion@19@17248515@17275421@1@chr1:17248515-17275421@29.3@1759@1162@0.661@CNVR94.4, CNVR94.5@CROCC_1, CROCC_2, CROCC_3, CROCC_4, CROCC_5, CROCC_6, CROCC_7, CROCC_8, CROCC_9, CROCC_10, CROCC_11, CROCC_12, CROCC_13, CROCC_14, CROCC_15, CROCC_16, CROCC_17, CROCC_18, CROCC_19@0@0@0@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
D180850@3335@3341@duplication@7@25617133@25648453@1@chr1:25617133-25648453@19.7@686@981@1.43@CNVR116.1, CNVR116.2@RHD_3, RHD_4, RHD_5, RHD_6, RHD_7, RHD_8, RHD_9@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
D180850@3357@3357@duplication@1@25735175@25735360@1@chr1:25735175-25735360@10.6@92@202@2.2@CNVR117.1@RHCE_2@0@0@0@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
D180850@9365@9374@duplication@10@104202983@104234232@1@chr1:104202983-104234232@33@75@324@4.32@CNVR266.3, CNVR266.1, CNVR266.15@AMY1A_7, AMY1A_8, AMY1A_9, AMY1A_10, AMY1A_11, AMY1B_11, AMY1B_10, AMY1B_9, AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D180850@9385@9386@deletion@2@104297122@104297436@1@chr1:104297122-104297436@7.8@176@99@0.562@CNVR266.3, CNVR266.5@AMY1C_6, AMY1C_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D180850@9436@9436@duplication@1@108769302@108769515@1@chr1:108769302-108769515@6.17@30@78@2.6@CNVR294.4@NBPF4_14@0@0@0@:neuroblastoma breakpoint family, member 4@:cytoplasm@NA
D180850@9766@9773@duplication@8@110230497@110235917@1@chr1:110230497-110235917@35.3@293@593@2.02@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
D180850@12117@12118@duplication@2@152573209@152586574@1@chr1:152573209-152586574@17.3@63@197@3.13@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
D180850@14051@14051@deletion@1@161518802@161518821@1@chr1:161518802-161518821@4.62@103@57@0.553@CNVR383.3, CNVR383.1@FCGR3A_2@0@0@0@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane@NA
D180850@14061@14062@duplication@2@161641183@161643019@1@chr1:161641183-161643019@8.5@281@412@1.47@CNVR383.1@FCGR2B_3, FCGR2B_4@0@0@0@:Fc fragment of IgG, low affinity IIb, receptor (CD32)@:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
D180850@19771@19771@deletion@1@248651891@248652837@1@chr1:248651891-248652837@5.88@105@53@0.505@NA@OR2T5_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
D180850@25115@25116@duplication@2@96652500@96652954@2@chr2:96652500-96652954@8.45@175@284@1.62@NA@ANKRD36C_3, ANKRD36C_2@0@0@0@:ankyrin repeat domain-containing protein 36A-like@:ion channel inhibitor activity;protein binding@NA
D180850@34944@34945@duplication@2@10089602@10091189@3@chr3:10089602-10091189@5.99@141@215@1.52@NA@FANCD2_16, FANCD2_17@0@0@0@:Fanconi anemia, complementation group D2@:nucleoplasm;synapsis;binding;response to DNA damage stimulus;gamete generation;DNA repair;condensed chromosome;protein binding;response to gamma radiation@: FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2
D180850@40233@40249@duplication@17@100348443@100438902@3@chr3:100348443-100438902@41.8@3334@4443@1.33@NA@GPR128_2, GPR128_3, GPR128_4, GPR128_5, GPR128_6, GPR128_7, GPR128_8, GPR128_9, GPR128_10, GPR128_11, GPR128_12, GPR128_13, GPR128_14, GPR128_15, GPR128_16, TFG_2, TFG_3@0@0@0@:G protein-coupled receptor 128:TRK-fused gene@:transmembrane signaling receptor activity;neuropeptide signaling pathway;integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;membrane;cell surface receptor signaling pathway:positive regulation of I-kappaB kinase/NF-kappaB cascade;signal transduction;protein binding;identical protein binding;signal transducer activity;cytoplasm@: THYROID CARCINOMA, PAPILLARY
D180850@48556@48561@duplication@6@69403344@69434202@4@chr4:69403344-69434202@41@764@1321@1.73@CNVR1953.1@UGT2B17_6, UGT2B17_5, UGT2B17_4, UGT2B17_3, UGT2B17_2, UGT2B17_1@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
D180850@48592@48597@deletion@6@70146220@70160527@4@chr4:70146220-70160527@119@615@6@0.00976@CNVR1957.2, CNVR1957.1@UGT2B28_1, UGT2B28_2, UGT2B28_3, UGT2B28_4, UGT2B28_5, UGT2B28_6@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
D180850@51672@51672@deletion@1@145041644@145041741@4@chr4:145041644-145041741@8.95@109@43@0.394@NA@GYPA_2@0@0@0@:glycophorin B (MNS blood group):glycophorin A (MNS blood group)@:integral to membrane;plasma membrane;integral to plasma membrane:external side of plasma membrane;integral to membrane;cytoskeletal anchoring at plasma membrane;plasma membrane;molecular_function;protein homodimerization activity;integral to plasma membrane;cellular_component;identical protein binding;membrane;biological_process;regulation of response to osmotic stress;virus-host interaction@: BLOOD GROUP--Ss LOCUS; Ss: MALARIA, SUSCEPTIBILITY TO; BLOOD GROUP--MN LOCUS; MN
D180850@53308@53308@duplication@1@748520@748674@5@chr5:748520-748674@7.95@96@181@1.89@CNVR2280.3@ZDHHC11B_5@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
D180850@59065@59065@duplication@1@140557617@140560021@5@chr5:140557617-140560021@15.4@1272@2099@1.65@CNVR2624.1@PCDHB8_1@0@0@0@:protocadherin beta 8@:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding@NA
D180850@60876@60879@deletion@4@175388055@175394270@5@chr5:175388055-175394270@13.3@160@71@0.444@NA@THOC3_5, THOC3_4, THOC3_3, THOC3_2@0@0@0@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
D180850@61638@61645@deletion@8@180375356@180429785@5@chr5:180375356-180429785@29.5@1020@618@0.606@CNVR2719.1@BTNL8_5, BTNL8_6, BTNL8_7, BTNL8_8, BTNL3_1, BTNL3_2, BTNL3_3, BTNL3_4@0@0@0@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
D180850@63966@63971@duplication@6@32609088@32629234@6@chr6:32609088-32629234@7.5@687@884@1.29@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20@HLA-DQA1_2, HLA-DQA1_3, HLA-DQA1_4, HLA-DQB1_6, HLA-DQB1_5, HLA-DQB1_4@0@0@0@:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
D180850@64602@64606@duplication@5@35754776@35765065@6@chr6:35754776-35765065@20@969@1361@1.4@CNVR2861.1@CLPSL1_2, CLPSL1_3, CLPS_3, CLPS_2, CLPS_1@0@0@0@:colipase-like 1:colipase, pancreatic@:extracellular region;enzyme activator activity;digestion;lipid catabolic process:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
D180850@66822@66824@duplication@3@74063044@74063948@6@chr6:74063044-74063948@5.24@532@684@1.29@NA@DPPA5_3, DPPA5_2, DPPA5_1@0@0@0@:developmental pluripotency associated 5@:multicellular organismal development;RNA binding;cytoplasm@NA
D180850@71030@71031@deletion@2@167790035@167791580@6@chr6:167790035-167791580@7.68@182@108@0.593@NA@TCP10_5, TCP10_4@0@0@0@:t-complex 10@:cytosol@NA
D180850@71754@71756@deletion@3@5959481@5963593@7@chr7:5959481-5963593@8.77@320@195@0.609@NA@CCZ1_12, CCZ1_13, CCZ1_14@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D180850@71765@71765@duplication@1@5983543@5983621@7@chr7:5983543-5983621@5.03@132@202@1.53@NA@RSPH10B_13@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D180850@71772@71772@deletion@1@5998625@5998709@7@chr7:5998625-5998709@5.53@215@130@0.605@NA@RSPH10B_6@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D180850@71776@71776@deletion@1@6006495@6006747@7@chr7:6006495-6006747@5.04@103@55@0.534@NA@RSPH10B_2@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D180850@71939@71944@duplication@6@6836200@6844686@7@chr7:6836200-6844686@13.8@155@274@1.77@NA@RSPH10B2_19, RSPH10B2_20, CCZ1B_15, CCZ1B_14, CCZ1B_13, CCZ1B_12@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D180850@73247@73263@deletion@17@38295939@38393784@7@chr7:38295939-38393784@135@3331@1728@0.519@NA@TRGJP2_1, TRGC1_3, TRGC1_2, TRGC1_1, TRGJ1_1, TRGJP_1, TRGJP1_1, TRGV11_1, TRGV10_1, TRGV9_2, TRGV9_1, TRGV8_2, TRGV8_1, TRGV5_2, TRGV5_1, TRGV4_2, TRGV4_1@0@0@0@:TCR gamma alternate reading frame protein@:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding@NA
D180850@74605@74605@deletion@1@74251403@74251500@7@chr7:74251403-74251500@4.91@22@0@0@NA@GTF2IRD2_2@0@0@0@:GTF2I repeat domain containing 2@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
D180850@74775@74775@deletion@1@76063356@76063472@7@chr7:76063356-76063472@4.85@46@17@0.37@CNVR3462.1@ZP3_5@0@0@0@:zona pellucida glycoprotein 3 (sperm receptor)@:negative regulation of transcription, DNA-dependent;manganese ion transmembrane transporter activity;intracellular protein transport;proteinaceous extracellular matrix;plasma membrane;positive regulation of acrosome reaction;outer acrosomal membrane;protein kinase C signaling cascade;manganese ion transmembrane transport;intracellular signal transduction;humoral immune response mediated by circulating immunoglobulin;negative regulation of binding of sperm to zona pellucida;positive regulation of inflammatory response;endoplasmic reticulum;signal transducer activity;perinuclear region of cytoplasm;secretory granule;positive regulation of transcription, DNA-dependent;positive regulation of ovarian follicle development;positive regulation of interferon-gamma production;carbohydrate binding;manganese ion transport;positive regulation of antral ovarian follicle growth;extracellular matrix;positive regulation of leukocyte migration;positive regulation of humoral immune response;extracellular space;blastocyst formation;integral to membrane;store-operated calcium channel activity;oocyte development;multivesicular body;phosphatidylinositol-mediated signaling;acrosomal vesicle;positive regulation of protein kinase B signaling cascade;Golgi apparatus;positive regulation of calcium ion import;positive regulation of protein kinase activity;positive regulation of acrosomal vesicle exocytosis;positive regulation of interleukin-4 production;cytoplasm;protein binding;binding of sperm to zona pellucida;positive regulation of phosphatidylinositol biosynthetic process;extracellular region;positive regulation of T cell proliferation;acrosin binding;positive regulation of type IV hypersensitivity;egg coat formation@NA
D180850@74792@74793@deletion@2@76240783@76241130@7@chr7:76240783-76241130@16.6@179@71@0.397@CNVR3463.10@POMZP3_6, POMZP3_5@0@0@0@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
D180850@76427@76432@deletion@6@100331793@100336236@7@chr7:100331793-100336236@132@674@6@0.0089@CNVR3509.1@ZAN_1, ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
D180850@79013@79013@duplication@1@141760112@141760173@7@chr7:141760112-141760173@6.38@168@263@1.57@CNVR3585.3, CNVR3585.2@MGAM_34@0@0@0@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
D180850@79065@79068@deletion@4@142120274@142131705@7@chr7:142120274-142131705@6.24@973@694@0.713@NA@TRBV7-7_1, TRBV6-8_2, TRBV6-8_1, TRBV5-6_2@0@0@0@@:protein binding:protein binding:protein binding@NA
D180850@79101@79122@deletion@22@142334611@142494579@7@chr7:142334611-142494579@53.4@3654@2480@0.679@NA@TRBV20-1_2, TRBV23-1_1, TRBV23-1_2, TRBV24-1_1, TRBV24-1_2, TRBV25-1_1, TRBV25-1_2, TRBV27_1, TRBV27_2, TRBV28_1, TRBV28_2, TRBV29-1_1, TRBV29-1_2, PRSS1_1, PRSS1_2, PRSS1_3, PRSS1_4, PRSS1_5, TRBJ2-1_1, TRBJ2-2_1, TRBJ2-2P_1, TRBJ2-3_1@0@0@0@:protease, serine, 1 (trypsin 1)@:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:extracellular matrix organization;catalytic activity;extracellular matrix disassembly;proteolysis;extracellular space;extracellular region;digestion;metal ion binding;serine-type endopeptidase activity@: PANCREATITIS, HEREDITARY; PCTT
D180850@79312@79323@deletion@12@143955790@144070377@7@chr7:143955790-144070377@42.2@1391@795@0.572@CNVR3598.4@OR2A7_1, CTAGE8_1, OR2A1_1, ARHGEF5_2, ARHGEF5_3, ARHGEF5_4, ARHGEF5_5, ARHGEF5_6, ARHGEF5_7, ARHGEF5_8, ARHGEF5_9, ARHGEF5_10@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor, family 2, subfamily A, member 7:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
D180850@80397@80398@duplication@2@7686328@7694064@8@chr8:7686328-7694064@4.98@86@136@1.58@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@DEFB106A_2, DEFB104A_1@0@0@0@:defensin, beta 106B;defensin, beta 106A:defensin, beta 104A;defensin, beta 104B@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
D180850@95354@95355@deletion@2@17887290@17891768@10@chr10:17887290-17891768@12.4@298@146@0.49@NA@MRC1L1_6, MRC1L1_7@0@0@0@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
D180850@95384@95384@deletion@1@18112045@18112445@10@chr10:18112045-18112445@8.73@39@0@0@NA@MRC1_2@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D180850@95387@95391@duplication@5@18129623@18145281@10@chr10:18129623-18145281@17@36@164@4.56@NA@MRC1_5, MRC1_6, MRC1_7, MRC1_8, MRC1_9@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D180850@96280@96280@deletion@1@42924565@42924599@10@chr10:42924565-42924599@11.9@88@20@0.227@NA@CCNYL2_5@0@0@0@@:regulation of cyclin-dependent protein kinase activity;protein kinase binding@NA
D180850@96914@96914@deletion@1@51877667@51877818@10@chr10:51877667-51877818@4.67@20@0@0@CNVR4734.2@FAM21A_22@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
D180850@96932@96937@deletion@6@51965743@51978390@10@chr10:51965743-51978390@13@138@59@0.428@NA@ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
D180850@101608@101613@deletion@6@124344788@124352111@10@chr10:124344788-124352111@16.3@593@373@0.629@CNVR4912.4, CNVR4912.3, CNVR4912.2@DMBT1_15, DMBT1_16, DMBT1_17, DMBT1_18, DMBT1_19, DMBT1_20@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
D180850@102336@102337@duplication@2@135438604@135439503@10@chr10:135438604-135439503@6.61@353@481@1.36@CNVR4989.11, CNVR4989.4@FRG2B_4, FRG2B_3@0@0@0@:FSHD region gene 2 family, member B@:nucleus@NA
D180850@103268@103268@deletion@1@4967390@4968330@11@chr11:4967390-4968330@9.01@859@532@0.619@CNVR5040.1@OR51A4_1@0@0@0@:matrix metallopeptidase 26:olfactory receptor, family 51, subfamily A, member 4@:metallopeptidase activity;extracellular matrix;proteolysis;proteinaceous extracellular matrix;collagen catabolic process;metalloendopeptidase activity;zinc ion binding;metabolic process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
D180850@103289@103290@deletion@2@5270599@5271034@11@chr11:5270599-5271034@7.28@60@18@0.3@NA@HBG1_2, HBG1_1@0@0@0@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
D180850@114483@114483@deletion@1@11243900@11244828@12@chr12:11243900-11244828@85.8@730@21@0.0288@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
D180850@124177@124178@deletion@2@24465429@24468340@13@chr13:24465429-24468340@23.1@965@502@0.52@NA@C1QTNF9B_3, C1QTNF9B_2@0@0@0@:C1q and tumor necrosis factor related protein 9B@:collagen;protein binding@NA
D180850@124193@124194@duplication@2@24892957@24895906@13@chr13:24892957-24895906@12.5@1018@1459@1.43@NA@C1QTNF9_3, C1QTNF9_4, C1QTNF9B-AS1_1@0@0@0@:spermatogenesis associated 13:C1q and tumor necrosis factor related protein 9:C1QTNF9B antisense RNA 1@:lamellipodium assembly;phospholipid binding;Rac guanyl-nucleotide exchange factor activity;guanyl-nucleotide exchange factor activity;ruffle membrane;nucleus;regulation of cell migration;cell migration;regulation of Rho protein signal transduction;intracellular;Rho guanyl-nucleotide exchange factor activity;cytoplasm;filopodium assembly;filopodium;protein binding;lamellipodium:collagen;protein binding;hormone activity@NA
D180850@127333@127358@duplication@26@19553418@20404761@14@chr14:19553418-20404761@62.6@7628@10745@1.41@CNVR6072.12@POTEG_1, POTEG_2, POTEG_3, POTEG_4, POTEG_5, POTEG_9, POTEG_10, POTEM_10, POTEM_9, POTEM_5, POTEM_4, POTEM_3, POTEM_2, POTEM_1, OR4Q3_1, OR4M1_1, OR4N2_1, OR4K2_1, OR4K5_1, OR4K1_1@0@0@0@:POTE ankyrin domain family, member G:POTE ankyrin domain family, member M:olfactory receptor, family 4, subfamily N, member 2:olfactory receptor, family 4, subfamily Q, member 3:olfactory receptor, family 4, subfamily M, member 1:olfactory receptor, family 4, subfamily K, member 2:olfactory receptor, family 4, subfamily K, member 5:olfactory receptor, family 4, subfamily K, member 1@:protein binding:protein binding:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
D180850@127739@127824@deletion@86@22446920@22970647@14@chr14:22446920-22970647@373@13220@7995@0.605@NA@TRAV8-6_2, TRAV16_2, TRAV17_2, TRAV18_2, TRAV19_2, TRAV20_2, TRAV21_2, TRAV22_2, TRAV23DV6_2, TRDV1_2, TRAV24_1, TRAV24_2, TRAV25_2, TRAV26-1_2, TRAV8-7_2, TRAV27_2, TRAV29DV5_2, TRAV30_2, TRAV26-2_2, TRAV34_2, TRAV35_2, TRAV36DV7_2, TRAV38-1_2, TRAV38-2DV8_2, TRAV39_2, TRAV40_2, TRAV41_2, TRDV2_2, TRDJ2_1, TRDJ3_1, TRDC_1, TRDC_2, TRDC_3, TRDV3_2, TRAJ61_1, TRAJ59_1, TRAJ58_1, TRAJ57_1, TRAJ56_1, TRAJ54_1, TRAJ53_1, TRAJ52_1, TRAJ50_1, TRAJ49_1, TRAJ48_1, TRAJ47_1, TRAJ46_1, TRAJ45_1, TRAJ44_1, TRAJ43_1, TRAJ42_1, TRAJ41_1, TRAJ40_1, TRAJ39_1@0@0@0@@:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:integral to membrane:protein binding@NA
D180850@128218@128224@duplication@7@24458158@24473579@14@chr14:24458158-24473579@7.73@720@918@1.27@NA@DHRS4L2_1, DHRS4L2_2, DHRS4L2_3, DHRS4L2_4, DHRS4L2_5, DHRS4L2_6, DHRS4L2_7@0@0@0@:dehydrogenase/reductase (SDR family) member 4 like 2@:extracellular region;oxidoreductase activity;nucleotide binding;metabolic process@NA
D180850@131032@131033@duplication@2@74004127@74008399@14@chr14:74004127-74008399@7.83@236@349@1.48@CNVR6188.1, CNVR6188.4@ACOT1_1, ACOT1_2@0@0@0@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
D180850@131037@131037@duplication@1@74041613@74042217@14@chr14:74041613-74042217@4.94@95@153@1.61@CNVR6188.1, CNVR6188.6@ACOT2_3@0@0@0@:acyl-CoA thioesterase 2@:acyl-CoA metabolic process;mitochondrion;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity;receptor binding@NA
D180850@133345@133348@duplication@4@106066404@106068065@14@chr14:106066404-106068065@20.7@851@1238@1.45@CNVR6294.46, CNVR6294.20, CNVR6294.54@IGHE_4, IGHE_3, IGHE_2, IGHE_1@0@0@0@@:antigen binding;protein binding;immune response@NA
D180850@133352@133359@duplication@8@106092110@106175002@14@chr14:106092110-106175002@25.9@1059@1515@1.43@CNVR6294.46, CNVR6294.20, CNVR6294.43, CNVR6294.65, CNVR6294.66@IGHG4_1, IGHG2_4, IGHG2_3, IGHG2_2, IGHG2_1, IGHA1_3, IGHA1_2, IGHA1_1@0@0@0@@:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response:antigen binding;protein binding;immune response;protein-chromophore linkage@NA
D180850@133425@133427@deletion@3@106471637@106478539@14@chr14:106471637-106478539@16.4@179@72@0.402@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV1-3_1, IGHV4-4_2, IGHV4-4_1@0@0@0@@:protein binding:protein binding@NA
D180850@133432@133436@duplication@5@106539080@106573537@14@chr14:106539080-106573537@17.4@873@1222@1.4@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1, IGHV3-11_2@0@0@0@@:protein binding:protein binding:protein binding@NA
D180850@133460@133463@deletion@4@106805210@106816173@14@chr14:106805210-106816173@7.3@484@325@0.671@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.41@IGHV4-31_2, IGHV4-31_1, IGHV3-33_2, IGHV3-33_1@0@0@0@@:protein binding:protein binding@NA
D180850@133541@133542@deletion@2@22368577@22383423@15@chr15:22368577-22383423@21.2@3019@1769@0.586@CNVR6297.4, CNVR6297.17, CNVR6297.2@OR4M2_1, OR4N4_1@0@0@0@:olfactory receptor, family 4, subfamily M, member 2:olfactory receptor, family 4, subfamily N, member 4@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
D180850@134153@134153@deletion@1@32449810@32449976@15@chr15:32449810-32449976@9.67@44@0@0@CNVR6345.2, CNVR6345.1@CHRNA7_6@0@0@0@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
D180850@135712@135713@deletion@2@43903118@43903513@15@chr15:43903118-43903513@6.11@150@84@0.56@CNVR6365.1@STRC_14, STRC_13@0@0@0@:diphosphoinositol pentakisphosphate kinase 1:stereocilin@:inositol hexakisphosphate 3-kinase activity;inositol hexakisphosphate 1-kinase activity;inositol metabolic process;diphosphoinositol-pentakisphosphate kinase activity;ATP binding;acid phosphatase activity;cytoplasm;cytosol;inositol hexakisphosphate 5-kinase activity;nucleus;kinase activity;inositol-1,3,4,5,6-pentakisphosphate kinase activity:detection of mechanical stimulus involved in sensory perception of sound;stereocilium bundle tip;stereocilium;cell surface;kinocilium;auditory receptor cell stereocilium organization@: DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16; DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY
D180850@142691@142706@deletion@16@15069058@15123913@16@chr16:15069058-15123913@54.3@2177@1358@0.624@CNVR6646.1@PDXDC1_1, PDXDC1_2, PDXDC1_3, PDXDC1_4, PDXDC1_5, PDXDC1_6, PDXDC1_7, PDXDC1_8, PDXDC1_9, PDXDC1_10, PDXDC1_11, PDXDC1_12, PDXDC1_13, PDXDC1_14, PDXDC1_15, PDXDC1_16@0@0@0@:pyridoxal-dependent decarboxylase domain containing 1;pyridoxal-dependent decarboxylase domain-containing protein 1-like@:carboxylic acid metabolic process;pyridoxal phosphate binding;carboxy-lyase activity@NA
D180850@144038@144039@duplication@2@28403074@28403463@16@chr16:28403074-28403463@17.4@121@280@2.31@CNVR6684.2@EIF3CL_10, EIF3CL_9@0@0@0@:eukaryotic translation initiation factor 3, subunit C-like@:protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;translation initiation factor activity@NA
D180850@144117@144117@duplication@1@28734486@28734644@16@chr16:28734486-28734644@6.18@421@596@1.42@CNVR6686.3, CNVR6686.2@EIF3C_9@0@0@0@:eukaryotic translation initiation factor 3, subunit C@:cytosol;protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;cellular protein metabolic process;binding;gene expression;translation;translation initiation factor activity@NA
D180850@145564@145564@duplication@1@55866917@55866967@16@chr16:55866917-55866967@5.24@88@146@1.66@NA@CES1_1@0@0@0@:carboxylesterase 1;liver carboxylesterase 1-like@:hydrolase activity;methyl salicylate esterase activity;response to toxin;methylumbelliferyl-acetate deacetylase activity;endoplasmic reticulum lumen;retinyl-palmitate esterase activity;methyl jasmonate esterase activity;metabolic process;carboxylesterase activity;methyl indole-3-acetate esterase activity@: CARBOXYLESTERASE 1; CES1
D180850@147109@147112@deletion@4@70161164@70164447@16@chr16:70161164-70164447@12.5@1041@703@0.675@CNVR6764.1, CNVR6764.3@PDPR_4, PDPR_5, PDPR_6, PDPR_7@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
D180850@147123@147124@deletion@2@70187295@70190782@16@chr16:70187295-70190782@4.96@1313@944@0.719@CNVR6764.1, CNVR6764.3@PDPR_18, PDPR_19@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
D180850@147497@147513@deletion@17@74415415@74452196@16@chr16:74415415-74452196@15.8@558@350@0.627@CNVR6778.2, CNVR6778.3@NPIPL2_2, NPIPL2_3, NPIPL2_4, NPIPL2_5, NPIPL2_6, NPIPL2_7, CLEC18B_13, CLEC18B_12, CLEC18B_11, CLEC18B_10, CLEC18B_9, CLEC18B_8, CLEC18B_7, CLEC18B_6, CLEC18B_5, CLEC18B_4, CLEC18B_3@0@0@0@:C-type lectin domain family 18, member B@:extracellular region:carbohydrate binding;protein binding;extracellular region@NA
D180850@151556@151561@deletion@6@16664740@16676947@17@chr17:16664740-16676947@23.5@859@522@0.608@NA@CCDC144A_13, CCDC144A_13, CCDC144A_14, CCDC144A_14, CCDC144A_15, CCDC144A_15, CCDC144A_16, CCDC144A_16, CCDC144A_17, CCDC144A_18, CCDC144A_17@0@0@0@:coiled-coil domain containing 144A@NA@NA
D180850@151875@151885@duplication@11@18380170@18397681@17@chr17:18380170-18397681@24.4@397@661@1.66@CNVR7014.1@LGALS9C_1, LGALS9C_2, LGALS9C_3, LGALS9C_4, LGALS9C_5, LGALS9C_6, LGALS9C_7, LGALS9C_8, LGALS9C_9, LGALS9C_10, LGALS9C_11@0@0@0@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
D180850@155580@155581@deletion@2@44171927@44249509@17@chr17:44171927-44249509@9.14@1594@1055@0.662@CNVR7114.3, CNVR7114.2@KANSL1_3, KANSL1_2@0@0@0@:KAT8 regulatory NSL complex subunit 1@:histone acetyltransferase activity (H4-K8 specific);histone acetyltransferase activity (H4-K16 specific);histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase complex;histone H4-K5 acetylation;MLL1 complex;histone H4-K16 acetylation;protein binding;histone H4-K8 acetylation;nucleus@NA
D180850@155587@155599@duplication@13@44399689@44592687@17@chr17:44399689-44592687@36.8@157@465@2.96@CNVR7114.2, CNVR7114.1@LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9, LRRC37A_10, LRRC37A_11, LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane@NA
D180850@155610@155612@deletion@3@44632519@44632945@17@chr17:44632519-44632945@19.9@93@1@0.0108@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2_13, LRRC37A2_14, LRRC37A2_15@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
D180850@156877@156878@duplication@2@57656834@57657240@17@chr17:57656834-57657240@5.67@79@135@1.71@NA@DHX40_9, DHX40_10@0@0@0@:DEAH (Asp-Glu-Ala-His) box polypeptide 40@:transport;helicase activity;intracellular;ATP-dependent helicase activity;nucleic acid binding;ATP binding@NA
D180850@164384@164385@duplication@2@4493701@4494054@19@chr19:4493701-4494054@5.43@275@375@1.36@NA@HDGFRP2_7, HDGFRP2_8@0@0@0@:hepatoma-derived growth factor-related protein 2@:nucleus;DNA binding;transcription, DNA-dependent@NA
D180850@166811@166812@duplication@2@14070580@14070881@19@chr19:14070580-14070881@8.84@360@515@1.43@NA@DCAF15_9, DCAF15_10@0@0@0@:DDB1 and CUL4 associated factor 15@:protein ubiquitination@NA
D180850@167047@167047@deletion@1@14877791@14877921@19@chr19:14877791-14877921@9.23@106@40@0.377@NA@EMR2_6@0@0@0@:egf-like module containing, mucin-like, hormone receptor-like 2@:transmembrane signaling receptor activity;inflammatory response;G-protein coupled receptor activity;ruffle membrane;integral to membrane;plasma membrane;cell surface receptor signaling pathway;neuropeptide signaling pathway;granulocyte chemotaxis;cell migration;leading edge membrane;G-protein coupled receptor signaling pathway;protein binding;cell adhesion;membrane;calcium ion binding;chondroitin sulfate binding@NA
D180850@168952@168952@duplication@1@35862263@35863302@19@chr19:35862263-35863302@11.3@104@226@2.17@CNVR7627.1@GPR42_2@0@0@0@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
D180850@170096@170100@duplication@5@40373946@40382826@19@chr19:40373946-40382826@29.4@244@516@2.11@CNVR7639.2@FCGBP_26, FCGBP_25, FCGBP_24, FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D180850@170104@170109@deletion@6@40389653@40399855@19@chr19:40389653-40399855@45.3@337@90@0.267@CNVR7639.2, CNVR7639.3@FCGBP_18, FCGBP_17, FCGBP_16, FCGBP_15, FCGBP_14, FCGBP_13@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D180850@170373@170374@deletion@2@41386385@41387656@19@chr19:41386385-41387656@7.72@244@148@0.607@CNVR7642.1@CYP2A7_3, CYP2A7_2@0@0@0@:cytochrome P450, family 2, subfamily A, polypeptide 7@:oxidation-reduction process;electron carrier activity;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;oxygen binding;heme binding;monooxygenase activity;endoplasmic reticulum membrane;iron ion binding@NA
D180850@170781@170785@duplication@5@43258448@43269733@19@chr19:43258448-43269733@11.1@695@934@1.34@NA@PSG8_5, PSG8_4, PSG8_3, PSG8_2, PSG8_1@0@0@0@:pregnancy specific beta-1-glycoprotein 8@:protein binding;extracellular region@NA
D180850@172799@172799@deletion@1@51330919@51331071@19@chr19:51330919-51331071@8.1@111@48@0.432@NA@KLK15_2@0@0@0@:kallikrein-related peptidase 15@:serine-type peptidase activity;proteolysis;extracellular region;catalytic activity;serine-type endopeptidase activity@NA
D180850@172989@172993@deletion@5@52146609@52149313@19@chr19:52146609-52149313@14.7@416@247@0.594@CNVR7702.1@SIGLEC14_7, SIGLEC14_6, SIGLEC14_5, SIGLEC14_4, SIGLEC14_3@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 14@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion;plasma membrane@NA
D180850@173297@173300@deletion@4@54725701@54726848@19@chr19:54725701-54726848@9.59@173@93@0.538@CNVR7721.3, CNVR7721.4@LILRB3_4, LILRB3_3, LILRB3_2, LILRB3_1@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D180850@173499@173501@deletion@3@55358640@55359398@19@chr19:55358640-55359398@11.3@707@462@0.653@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4_6, KIR2DS4_7, KIR2DS4_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
D180850@173844@173844@deletion@1@56283172@56283456@19@chr19:56283172-56283456@10.3@208@100@0.481@CNVR7734.1@CTD-2611O12.2_2@0@0@0@:ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
D180850@174403@174403@duplication@1@1895746@1896101@20@chr20:1895746-1896101@8.44@138@243@1.76@CNVR7764.2@SIRPA_2@0@0@0@:signal-regulatory protein alpha@:blood coagulation;protein binding;integral to membrane;SH3 domain binding;cell adhesion;plasma membrane;membrane;leukocyte migration@NA
D180850@174720@174721@duplication@2@3653185@3653545@20@chr20:3653185-3653545@4.94@231@317@1.37@NA@ADAM33_13, ADAM33_12@0@0@0@:ADAM metallopeptidase domain 33@:protein binding;proteolysis;integral to membrane;metalloendopeptidase activity;zinc ion binding@: ASTHMA, SUSCEPTIBILITY TO
D180850@181936@181938@duplication@3@24300473@24302568@22@chr22:24300473-24302568@15@58@167@2.88@CNVR8114.6, CNVR8114.12, CNVR8114.13, CNVR8114.8@GSTT2B_4, GSTT2B_3, GSTT2B_2@0@0@0@:glutathione S-transferase theta 2B (gene/pseudogene);glutathione S-transferase theta 2@:protein binding;glutathione transferase activity;nucleus;transferase activity;cytoplasm@NA
D180850@181949@181955@duplication@7@24325063@24384231@22@chr22:24325063-24384231@21.2@559@836@1.5@CNVR8114.13, CNVR8114.1@GSTT2_4, GSTT2_5, GSTT1_5, GSTT1_4, GSTT1_3, GSTT1_2, GSTT1_1@0@0@0@:glutathione S-transferase theta 1@:protein binding;glutathione transferase activity;nucleus;cytoplasm:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
D180850@183631@183631@duplication@1@39357393@39357686@22@chr22:39357393-39357686@4.96@48@92@1.92@CNVR8164.1@APOBEC3A_4@0@0@0@:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A;APOBEC3A and APOBEC3B deletion hybrid@:cytidine deamination;defense response to virus;negative regulation of viral genome replication;DNA cytosine deamination;clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine;catalytic activity;DNA demethylation;cytoplasm;innate immune response;cytidine deaminase activity;nucleus;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;cellular response to xenobiotic stimulus;zinc ion binding;negative regulation of transposition@NA
D180850@183637@183640@deletion@4@39382304@39388154@22@chr22:39382304-39388154@16.5@303@159@0.525@CNVR8164.1@APOBEC3B_4, APOBEC3B_5, APOBEC3B_6, APOBEC3B_7@0@0@0@:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B@:RNA binding;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;negative regulation of transposition;catalytic activity;zinc ion binding@NA
D180850@1889@1889@deletion@1@48244795@48244889@X@chrX:48244795-48244889@4.84@22@0@0@CNVR8324.2@SSX4_4@0@0@0@NA@NA@NA
D180850@4052@4071@deletion@20@101571921@101581428@X@chrX:101571921-101581428@19.2@94@4@0.0426@NA@NXF2_15, NXF2_16, NXF2_17, NXF2_18, NXF2_19, NXF2_20, NXF2_21, NXF2_22, NXF2_23, NXF2_24, NXF2_25, NXF2_26, NXF2_27, NXF2_28, NXF2_29, NXF2_30, NXF2_31, NXF2_32, NXF2_33, NXF2_34@0@0@0@NA@NA@NA
D180850@5719@5719@deletion@1@140336520@140336590@X@chrX:140336520-140336590@6.17@37@6@0.162@CNVR8456.1@SPANXC_1@0@0@0@NA@NA@NA
D180850@6286@6286@deletion@1@153420050@153420214@X@chrX:153420050-153420214@13.8@64@0@0@CNVR8489.1@OPN1LW_4@0@0@0@NA@NA@NA
F00603@6@7@deletion@2@69092@139309@1@chr1:69092-139309@10@46@1@0.0217@CNVR1.2@OR4F5_1, AL627309.1_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F00603@418@418@deletion@1@1607504@1607638@1@chr1:1607504-1607638@12.1@57@1@0.0175@CNVR17.1@SLC35E2B_4@0@0@0@:solute carrier family 35, member E2B@:integral to membrane;membrane;transmembrane transport@NA
F00603@1806@1810@deletion@5@12853378@12887689@1@chr1:12853378-12887689@13.9@372@221@0.594@CNVR72.3, CNVR72.10@PRAMEF1_2, PRAMEF1_3, PRAMEF1_4, PRAMEF11_4, PRAMEF11_3@0@0@0@:PRAME family member 1:PRAME family member 11@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
F00603@1813@1824@deletion@12@12918866@12980233@1@chr1:12918866-12980233@23.7@482@264@0.548@CNVR72.3, CNVR72.4, CNVR72.12, CNVR72.2@PRAMEF2_2, PRAMEF2_3, PRAMEF2_4, PRAMEF4_4, PRAMEF4_3, PRAMEF4_2, PRAMEF10_4, PRAMEF10_3, PRAMEF10_2, PRAMEF7_2, PRAMEF7_3, PRAMEF7_4@0@0@0@:PRAME family member 2:PRAME family member 4:PRAME family member 10:PRAME family member 7@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
F00603@2788@2792@duplication@5@21806545@21809879@1@chr1:21806545-21809879@11.1@207@322@1.56@CNVR107.2, CNVR107.1@NBPF3_11, NBPF3_12, NBPF3_13, NBPF3_14, NBPF3_15@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 3@:cytoplasm@NA
F00603@2965@2972@deletion@8@22328169@22338960@1@chr1:22328169-22338960@43.5@934@505@0.541@CNVR108.2, CNVR108.1@CELA3A_1, CELA3A_2, CELA3A_3, CELA3A_4, CELA3A_5, CELA3A_6, CELA3A_7, CELA3A_8@0@0@0@:chymotrypsin-like elastase family, member 3A@:proteolysis;digestion;cholesterol metabolic process;catalytic activity;serine-type endopeptidase activity@NA
F00603@3334@3341@deletion@8@25611065@25648453@1@chr1:25611065-25648453@17.7@1138@765@0.672@CNVR116.1, CNVR116.2@RHD_2, RHD_3, RHD_4, RHD_5, RHD_6, RHD_7, RHD_8, RHD_9@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
F00603@9365@9374@deletion@10@104202983@104234232@1@chr1:104202983-104234232@20@90@0@0@CNVR266.3, CNVR266.1, CNVR266.15@AMY1A_7, AMY1A_8, AMY1A_9, AMY1A_10, AMY1A_11, AMY1B_11, AMY1B_10, AMY1B_9, AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
F00603@9385@9386@duplication@2@104297122@104297436@1@chr1:104297122-104297436@10.6@347@514@1.48@CNVR266.3, CNVR266.5@AMY1C_6, AMY1C_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
F00603@9766@9773@deletion@8@110230497@110235917@1@chr1:110230497-110235917@52.2@237@0@0@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
F00603@12117@12118@deletion@2@152573209@152586574@1@chr1:152573209-152586574@30.5@141@0@0@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
F00603@12129@12129@deletion@1@152770272@152770615@1@chr1:152770272-152770615@4.75@77@39@0.506@CNVR360.1@LCE1D_2@0@0@0@:late cornified envelope 1D@:cytoplasmic part;cornified envelope;cellular response to calcium ion;keratinization;perinuclear region of cytoplasm;cytoplasm@NA
F00603@17625@17625@deletion@1@213009216@213009491@1@chr1:213009216-213009491@11.1@239@122@0.51@CNVR498.1@C1orf227_2@0@0@0@:chromosome 1 open reading frame 227@NA@NA
F00603@25006@25009@duplication@4@90198717@90212253@2@chr2:90198717-90212253@6.45@139@212@1.53@CNVR867.10, CNVR867.3, CNVR867.2@IGKV1D-12_1, IGKV1D-12_2, IGKV3D-11_1, IGKV3D-11_2@0@0@0@@:protein binding:protein binding@NA
F00603@25012@25015@duplication@4@90248921@90260248@2@chr2:90248921-90260248@6.65@939@1204@1.28@CNVR867.10, CNVR867.3, CNVR867.2, CNVR867.16@IGKV1D-43_1, IGKV1D-43_2, IGKV1D-8_1, IGKV1D-8_2@0@0@0@@:protein binding:protein binding@NA
F00603@25115@25116@deletion@2@96652500@96652954@2@chr2:96652500-96652954@21.2@167@42@0.251@NA@ANKRD36C_3, ANKRD36C_2@0@0@0@:ankyrin repeat domain-containing protein 36A-like@:ion channel inhibitor activity;protein binding@NA
F00603@25137@25138@deletion@2@96697782@96698107@2@chr2:96697782-96698107@12.2@126@48@0.381@NA@GPAT2_4, GPAT2_3@0@0@0@:glycerol-3-phosphate acyltransferase 2, mitochondrial@:glycerol-3-phosphate O-acyltransferase activity;mitochondrion;phospholipid metabolic process;triglyceride biosynthetic process;glycerophospholipid biosynthetic process;small molecule metabolic process;transferase activity, transferring acyl groups;mitochondrial outer membrane;phosphatidic acid biosynthetic process;integral to membrane;glycerol-3-phosphate metabolic process;CDP-diacylglycerol biosynthetic process;membrane;metabolic process;phospholipid biosynthetic process@NA
F00603@26310@26310@deletion@1@112551656@112551708@2@chr2:112551656-112551708@5.28@71@33@0.465@CNVR928.1@ANAPC1_37@0@0@0@:anaphase-promoting complex subunit 1-like;anaphase promoting complex subunit 1@:nucleoplasm;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle;anaphase-promoting complex;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle spindle assembly checkpoint;cytosol;protein K11-linked ubiquitination;protein binding;mitosis;nucleus;cell cycle checkpoint;cell division;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle@NA
F00603@32590@32590@deletion@1@220197884@220197899@2@chr2:220197884-220197899@6.11@105@53@0.505@NA@RESP18_1@0@0@0@:regulated endocrine-specific protein 18 homolog (rat)@:secretory granule;rough endoplasmic reticulum lumen;extracellular region;endoplasmic reticulum;Golgi apparatus;perikaryon@NA
F00603@33054@33054@duplication@1@228243803@228243984@2@chr2:228243803-228243984@5.08@253@354@1.4@CNVR1156.1@TM4SF20_1@0@0@0@:transmembrane 4 L six family member 20@:integral to membrane;plasma membrane@NA
F00603@34148@34148@deletion@1@241621649@241622254@2@chr2:241621649-241622254@10.2@119@47@0.395@NA@AQP12B_1@0@0@0@:aquaporin 12B@:transport;integral to membrane;transporter activity;membrane@NA
F00603@48592@48596@duplication@5@70146220@70156529@4@chr4:70146220-70156529@9.72@702@934@1.33@CNVR1957.2, CNVR1957.1@UGT2B28_1, UGT2B28_2, UGT2B28_3, UGT2B28_4, UGT2B28_5@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
F00603@51672@51672@deletion@1@145041644@145041741@4@chr4:145041644-145041741@5.53@122@67@0.549@NA@GYPA_2@0@0@0@:glycophorin B (MNS blood group):glycophorin A (MNS blood group)@:integral to membrane;plasma membrane;integral to plasma membrane:external side of plasma membrane;integral to membrane;cytoskeletal anchoring at plasma membrane;plasma membrane;molecular_function;protein homodimerization activity;integral to plasma membrane;cellular_component;identical protein binding;membrane;biological_process;regulation of response to osmotic stress;virus-host interaction@: BLOOD GROUP--Ss LOCUS; Ss: MALARIA, SUSCEPTIBILITY TO; BLOOD GROUP--MN LOCUS; MN
F00603@59044@59045@deletion@2@140213970@140223300@5@chr5:140213970-140223300@36.6@2380@1342@0.564@CNVR2621.1@PCDHA7_1, PCDHA8_1@0@0@0@:protocadherin alpha 1:protocadherin alpha 2:protocadherin alpha 3:protocadherin alpha 4:protocadherin alpha 5:protocadherin alpha 6:protocadherin alpha 7:protocadherin alpha 8@:extracellular region;cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:integral to membrane;cell adhesion;homophilic cell adhesion;plasma membrane;integral to plasma membrane;membrane;nervous system development;calcium ion binding:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:extracellular region;cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development@NA
F00603@59065@59065@duplication@1@140557617@140560021@5@chr5:140557617-140560021@18.8@1594@2500@1.57@CNVR2624.1@PCDHB8_1@0@0@0@:protocadherin beta 8@:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding@NA
F00603@59487@59489@duplication@3@147550494@147554961@5@chr5:147550494-147554961@22.1@285@548@1.92@NA@SPINK14_2, SPINK14_3, SPINK14_4@0@0@0@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
F00603@60876@60877@deletion@2@175388055@175388437@5@chr5:175388055-175388437@6.9@56@18@0.321@NA@THOC3_5, THOC3_4@0@0@0@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
F00603@61270@61271@duplication@2@177167779@177168333@5@chr5:177167779-177168333@6.18@72@127@1.76@NA@FAM153A_7, FAM153A_6@0@0@0@:family with sequence similarity 153, member A@NA@NA
F00603@61638@61644@deletion@7@180375356@180424488@5@chr5:180375356-180424488@13.2@964@671@0.696@CNVR2719.1@BTNL8_5, BTNL8_6, BTNL8_7, BTNL8_8, BTNL3_1, BTNL3_2, BTNL3_3@0@0@0@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
F00603@63281@63282@duplication@2@31237744@31238262@6@chr6:31237744-31238262@22.5@357@637@1.78@CNVR2838.2, CNVR2838.1@HLA-C_5, HLA-C_4@0@0@0@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
F00603@63730@63733@deletion@4@31963497@31964377@6@chr6:31963497-31964377@11.1@318@191@0.601@CNVR2843.6, CNVR2843.3@C4A_25, C4A_26, C4A_27, C4A_28@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
F00603@63747@63748@deletion@2@31973946@31974881@6@chr6:31973946-31974881@4.94@124@73@0.589@CNVR2843.6, CNVR2843.3@AL645922.1_2, AL645922.1_1@0@0@0@NA@NA@NA
F00603@63768@63768@deletion@1@31994761@31994899@6@chr6:31994761-31994899@6@69@29@0.42@CNVR2843.6, CNVR2843.5@C4B_20@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
F00603@63953@63960@deletion@8@32485517@32548047@6@chr6:32485517-32548047@39.4@349@121@0.347@CNVR2845.21, CNVR2845.25, CNVR2845.24@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2, HLA-DRB5_1, HLA-DRB1_6, HLA-DRB1_5@0@0@0@:major histocompatibility complex, class II, DR beta 5:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
F00603@63963@63974@deletion@12@32551887@32634384@6@chr6:32551887-32634384@114@1204@454@0.377@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.34@HLA-DRB1_2, HLA-DRB1_1, HLA-DQA1_1, HLA-DQA1_2, HLA-DQA1_3, HLA-DQA1_4, HLA-DQB1_6, HLA-DQB1_5, HLA-DQB1_4, HLA-DQB1_3, HLA-DQB1_2, HLA-DQB1_1@0@0@0@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
F00603@64603@64605@duplication@3@35755645@35763630@6@chr6:35755645-35763630@7.75@831@1086@1.31@CNVR2861.1@CLPSL1_3, CLPS_3, CLPS_2@0@0@0@:colipase-like 1:colipase, pancreatic@:extracellular region;enzyme activator activity;digestion;lipid catabolic process:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
F00603@71030@71030@deletion@1@167790035@167790192@6@chr6:167790035-167790192@6.53@32@2@0.0625@NA@TCP10_5@0@0@0@:t-complex 10@:cytosol@NA
F00603@74296@74297@deletion@2@72430414@72430782@7@chr7:72430414-72430782@6.1@83@39@0.47@NA@TRIM74_5, TRIM74_4@0@0@0@:tripartite motif containing 74@:protein binding;intracellular;zinc ion binding@NA
F00603@74564@74564@duplication@1@74152388@74152445@7@chr7:74152388-74152445@7.53@143@233@1.63@NA@GTF2I_19@0@0@0@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
F00603@74616@74616@deletion@1@74466819@74466903@7@chr7:74466819-74466903@5.47@24@0@0@NA@WBSCR16_10@0@0@0@:RCC1-like G exchanging factor-like;Williams-Beuren syndrome chromosome region 16@:mitochondrion;cellular_component;biological_process@: WILLIAMS-BEUREN SYNDROME; WBS
F00603@74775@74777@duplication@3@76063356@76069928@7@chr7:76063356-76069928@24.4@503@818@1.63@CNVR3462.1@ZP3_5, ZP3_6, ZP3_7@0@0@0@:zona pellucida glycoprotein 3 (sperm receptor)@:negative regulation of transcription, DNA-dependent;manganese ion transmembrane transporter activity;intracellular protein transport;proteinaceous extracellular matrix;plasma membrane;positive regulation of acrosome reaction;outer acrosomal membrane;protein kinase C signaling cascade;manganese ion transmembrane transport;intracellular signal transduction;humoral immune response mediated by circulating immunoglobulin;negative regulation of binding of sperm to zona pellucida;positive regulation of inflammatory response;endoplasmic reticulum;signal transducer activity;perinuclear region of cytoplasm;secretory granule;positive regulation of transcription, DNA-dependent;positive regulation of ovarian follicle development;positive regulation of interferon-gamma production;carbohydrate binding;manganese ion transport;positive regulation of antral ovarian follicle growth;extracellular matrix;positive regulation of leukocyte migration;positive regulation of humoral immune response;extracellular space;blastocyst formation;integral to membrane;store-operated calcium channel activity;oocyte development;multivesicular body;phosphatidylinositol-mediated signaling;acrosomal vesicle;positive regulation of protein kinase B signaling cascade;Golgi apparatus;positive regulation of calcium ion import;positive regulation of protein kinase activity;positive regulation of acrosomal vesicle exocytosis;positive regulation of interleukin-4 production;cytoplasm;protein binding;binding of sperm to zona pellucida;positive regulation of phosphatidylinositol biosynthetic process;extracellular region;positive regulation of T cell proliferation;acrosin binding;positive regulation of type IV hypersensitivity;egg coat formation@NA
F00603@74792@74793@deletion@2@76240783@76241130@7@chr7:76240783-76241130@42.2@217@11@0.0507@CNVR3463.10@POMZP3_6, POMZP3_5@0@0@0@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
F00603@76718@76718@deletion@1@102114809@102114982@7@chr7:102114809-102114982@7.47@35@1@0.0286@CNVR3518.1@POLR2J_3@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J, 13.3kDa@:nucleoplasm;DNA binding;DNA repair;protein dimerization activity;nucleus;viral reproduction;gene expression;transcription initiation from RNA polymerase II promoter;7-methylguanosine mRNA capping;protein phosphorylation;LRR domain binding;protein kinase activity;DNA-directed RNA polymerase II, core complex;nucleotide-excision repair;transcription from RNA polymerase II promoter;DNA-directed RNA polymerase activity;protein binding;transcription-coupled nucleotide-excision repair;RNA splicing;mRNA splicing, via spliceosome;transcription, DNA-dependent;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription@NA
F00603@76754@76754@deletion@1@102219880@102220243@7@chr7:102219880-102220243@7.14@81@33@0.407@CNVR3518.1@AC093668.1_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
F00603@76779@76779@deletion@1@102279571@102279646@7@chr7:102279571-102279646@5.93@137@76@0.555@CNVR3518.1@UPK3BL_4, UPK3BL_4@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
F00603@77956@77956@duplication@1@128128156@128128215@7@chr7:128128156-128128215@6.02@64@119@1.86@NA@METTL2B_5@0@0@0@:methyltransferase like 2B@:methyltransferase activity;metabolic process@NA
F00603@79287@79287@duplication@1@143400089@143400710@7@chr7:143400089-143400710@11.9@68@170@2.5@CNVR3594.2, CNVR3594.1@FAM115C_2@0@0@0@:family with sequence similarity 115, member C;protein FAM115C-like@NA@NA
F00603@80375@80403@duplication@29@7332534@7721057@8@chr8:7332534-7721057@56.6@942@1639@1.74@CNVR3772.4, CNVR3772.6@DEFB104B_1, DEFB106B_2, DEFB106B_1, DEFB105B_1, DEFB105B_2, DEFB105B_3, DEFB107B_1, DEFB107B_2, RP11-1118M6.1_1, RP11-1118M6.1_2, RP11-1118M6.1_3, RP11-1118M6.1_4, AC084121.16_4, AC084121.16_3, AC084121.16_2, AC084121.16_1, DEFB107A_2, DEFB107A_1, DEFB105A_3, DEFB105A_2, DEFB105A_1, DEFB106A_1, DEFB106A_2, DEFB104A_1, DEFB104A_2, SPAG11A_1, SPAG11A_2, SPAG11A_3@0@0@0@:defensin, beta 104A;defensin, beta 104B:defensin, beta 106B;defensin, beta 106A:defensin, beta 105B;defensin, beta 105A:defensin, beta 107B;defensin, beta 107A:uncharacterized LOC100133251:uncharacterized LOC100133251:defensin, beta 107B;defensin, beta 107A:defensin, beta 105B;defensin, beta 105A:defensin, beta 106B;defensin, beta 106A:defensin, beta 104A;defensin, beta 104B:sperm associated antigen 11A;sperm associated antigen 11B@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response@NA
F00603@88584@88594@deletion@11@43624656@43818184@9@chr9:43624656-43818184@52@386@94@0.244@CNVR4294.1@SPATA31A6_4, SPATA31A6_3, SPATA31A6_2, SPATA31A6_1, CNTNAP3B_1, CNTNAP3B_2, CNTNAP3B_3, CNTNAP3B_4, CNTNAP3B_5, CNTNAP3B_6, CNTNAP3B_7@0@0@0@:SPATA31 subfamily A, member 6:contactin associated protein-like 3B;contactin associated protein-like 3@:integral to membrane:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
F00603@95389@95393@duplication@5@18138509@18152611@10@chr10:18138509-18152611@9.6@216@332@1.54@NA@MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F00603@95410@95410@duplication@1@18196464@18196627@10@chr10:18196464-18196627@5.69@28@71@2.54@NA@MRC1_28@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F00603@96280@96280@duplication@1@42924565@42924599@10@chr10:42924565-42924599@5.72@123@193@1.57@NA@CCNYL2_5@0@0@0@@:regulation of cyclin-dependent protein kinase activity;protein kinase binding@NA
F00603@96505@96531@duplication@27@47658500@47758904@10@chr10:47658500-47758904@65.6@3408@4683@1.37@NA@ANTXRL_1, ANTXRL_2, ANTXRL_3, ANTXRL_4, ANTXRL_5, ANTXRL_6, ANTXRL_7, ANTXRL_8, ANTXRL_9, ANTXRL_10, ANTXRL_11, ANTXRL_12, ANTXRL_13, ANTXRL_14, ANTXRL_15, ANTXRL_16, ANTXRL_17, ANXA8L2_1, ANXA8L2_2, ANXA8L2_3, ANXA8L2_4, ANXA8L2_5, ANXA8L2_6, ANXA8L2_7, ANXA8L2_8, ANXA8L2_9, ANXA8L2_10@0@0@0@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:protein binding;integral to membrane;receptor activity;metal ion binding:calcium-dependent phospholipid binding;calcium ion binding@NA
F00603@96933@96939@deletion@7@51970584@51994312@10@chr10:51970584-51994312@10.7@164@87@0.53@NA@ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7, ASAH2_6, ASAH2_5@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
F00603@101608@101614@deletion@7@124344788@124353114@10@chr10:124344788-124353114@23.2@921@583@0.633@CNVR4912.4, CNVR4912.3, CNVR4912.2@DMBT1_15, DMBT1_16, DMBT1_17, DMBT1_18, DMBT1_19, DMBT1_20, DMBT1_21@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
F00603@103269@103269@deletion@1@4976003@4976943@11@chr11:4976003-4976943@41.3@661@211@0.319@CNVR5040.1@OR51A2_1@0@0@0@:matrix metallopeptidase 26:olfactory receptor, family 51, subfamily A, member 2@:metallopeptidase activity;extracellular matrix;proteolysis;proteinaceous extracellular matrix;collagen catabolic process;metalloendopeptidase activity;zinc ion binding;metabolic process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F00603@103342@103342@duplication@1@5798891@5799864@11@chr11:5798891-5799864@10.6@663@966@1.46@CNVR5049.1@OR52N5_1@0@0@0@:tripartite motif containing 5:olfactory receptor, family 52, subfamily N, member 5@:defense response to virus;Golgi apparatus;intracellular;protein trimerization;ligase activity;cytoplasm;protein binding;nucleus;protein homodimerization activity;identical protein binding;zinc ion binding;cytoplasmic mRNA processing body;protein ubiquitination;virus-host interaction:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F00603@106047@106048@duplication@2@55405835@55419315@11@chr11:55405835-55419315@5.17@1754@2224@1.27@CNVR5179.1@OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F00603@110109@110109@duplication@1@89531299@89531797@11@chr11:89531299-89531797@5.19@426@577@1.35@NA@TRIM49_8@0@0@0@:tripartite motif containing 49@:protein binding;intracellular;DNA binding;zinc ion binding@NA
F00603@114483@114483@duplication@1@11243900@11244828@12@chr12:11243900-11244828@8.09@1036@1421@1.37@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
F00603@115537@115537@duplication@1@31249276@31249313@12@chr12:31249276-31249313@5.68@75@131@1.75@CNVR5483.1@DDX11_15@0@0@0@:DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11@:nucleoplasm;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;S phase of mitotic cell cycle;DNA binding;nucleobase-containing compound metabolic process;ATP binding;ATP-dependent DNA helicase activity;DNA helicase activity;midbody;RNA binding;DNA-dependent ATPase activity;nucleus;positive regulation of cell proliferation;virus-host interaction;nuclear chromatin;4 iron, 4 sulfur cluster binding;helicase activity;hydrolase activity, acting on acid anhydrides;DNA duplex unwinding;endoplasmic reticulum unfolded protein response;G2/M transition of mitotic cell cycle;protein binding;sister chromatid cohesion;activation of signaling protein activity involved in unfolded protein response;nucleolus;spindle pole;ATP-dependent helicase activity;metal ion binding;nucleic acid binding;mitotic sister chromatid segregation@: WARSAW BREAKAGE SYNDROME
F00603@127353@127358@duplication@6@20215588@20404761@14@chr14:20215588-20404761@30.7@8208@10724@1.31@CNVR6072.12, CNVR6072.4, CNVR6072.5@OR4Q3_1, OR4M1_1, OR4N2_1, OR4K2_1, OR4K5_1, OR4K1_1@0@0@0@:olfactory receptor, family 4, subfamily N, member 2:olfactory receptor, family 4, subfamily Q, member 3:olfactory receptor, family 4, subfamily M, member 1:olfactory receptor, family 4, subfamily K, member 2:olfactory receptor, family 4, subfamily K, member 5:olfactory receptor, family 4, subfamily K, member 1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F00603@129921@129922@duplication@2@58724644@58727738@14@chr14:58724644-58727738@5.62@173@249@1.44@NA@PSMA3_5, PSMA3_6@0@0@0@:chromosome 14 open reading frame 37:proteasome (prosome, macropain) subunit, alpha type, 3@:integral to membrane:nucleoplasm;proteasome complex;S phase of mitotic cell cycle;mitotic cell cycle;antigen processing and presentation of peptide antigen via MHC class I;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;mRNA metabolic process;nucleus;viral reproduction;gene expression;cell cycle checkpoint;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;cytosol;proteasome core complex, alpha-subunit complex;antigen processing and presentation of exogenous peptide antigen via MHC class I;proteolysis involved in cellular protein catabolic process;regulation of apoptotic process;cellular nitrogen compound metabolic process;proteasome core complex;endopeptidase activity;RNA metabolic process;G1/S transition of mitotic cell cycle;regulation of cellular amino acid metabolic process;apoptotic process;virus-host interaction;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;small molecule metabolic process;threonine-type endopeptidase activity;M/G1 transition of mitotic cell cycle;ubiquitin-dependent protein catabolic process;cytoplasm;protein binding;protein polyubiquitination@NA
F00603@131032@131033@duplication@2@74004127@74008399@14@chr14:74004127-74008399@8.95@299@432@1.44@CNVR6188.1, CNVR6188.4@ACOT1_1, ACOT1_2@0@0@0@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
F00603@133426@133426@deletion@1@106478111@106478411@14@chr14:106478111-106478411@11.9@94@25@0.266@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV4-4_2@0@0@0@@:protein binding@NA
F00603@133432@133435@deletion@4@106539080@106552729@14@chr14:106539080-106552729@106@517@2@0.00387@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1@0@0@0@@:protein binding:protein binding@NA
F00603@133450@133451@deletion@2@106725202@106725654@14@chr14:106725202-106725654@7.71@786@552@0.702@CNVR6294.48, CNVR6294.24, CNVR6294.40, CNVR6294.38, CNVR6294.17, CNVR6294.23@IGHV3-23_2, IGHV3-23_1@0@0@0@@:protein binding@NA
F00603@133462@133463@deletion@2@106815723@106816173@14@chr14:106815723-106816173@15.5@313@153@0.489@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.56, CNVR6294.51@IGHV3-33_2, IGHV3-33_1@0@0@0@@:protein binding@NA
F00603@133491@133492@deletion@2@107095127@107095561@14@chr14:107095127-107095561@13.8@75@8@0.107@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61_2, IGHV4-61_1@0@0@0@@:protein binding@NA
F00603@133495@133495@deletion@1@107131034@107131334@14@chr14:107131034-107131334@13.4@191@81@0.424@CNVR6294.56, CNVR6294.16@IGHV3-66_2@0@0@0@@:protein binding@NA
F00603@134011@134012@deletion@2@30664351@30665348@15@chr15:30664351-30665348@16.7@163@58@0.356@CNVR6337.1@CHRFAM7A_7, CHRFAM7A_6@0@0@0@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
F00603@134155@134156@deletion@2@32451771@32455536@15@chr15:32451771-32455536@6.68@33@2@0.0606@CNVR6345.2, CNVR6345.1@CHRNA7_8, CHRNA7_9@0@0@0@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
F00603@135059@135061@duplication@3@41865507@41870474@15@chr15:41865507-41870474@11.2@609@834@1.37@NA@TYRO3_17, TYRO3_18, TYRO3_19@0@0@0@:TYRO3 protein tyrosine kinase@:protein tyrosine kinase activity;platelet aggregation;negative regulation of toll-like receptor signaling pathway;ATP binding;vagina development;substrate adhesion-dependent cell spreading;nucleus;negative regulation of lymphocyte activation;endoplasmic reticulum membrane;phosphatidylinositol 3-kinase cascade;nuclear envelope;platelet activation;protein kinase activity;protein kinase B signaling cascade;neuron homeostasis;negative regulation of neuron apoptotic process;negative regulation of innate immune response;protein autophosphorylation;transmembrane receptor protein tyrosine kinase activity;apoptotic cell clearance;transferase activity, transferring phosphorus-containing groups;spermatogenesis;forebrain cell migration;integral to membrane;integral to plasma membrane;ovulation cycle;natural killer cell differentiation;phosphatidylinositol 3-kinase binding;negative regulation of inflammatory response;protein phosphorylation;receptor signaling protein tyrosine kinase activity;protein heterodimerization activity;secretion by cell;protein binding;signal transduction;cell adhesion;signal transduction by phosphorylation@NA
F00603@149172@149172@duplication@1@2965964@2966901@17@chr17:2965964-2966901@8.06@575@809@1.41@NA@OR1D5_1@0@0@0@:olfactory receptor, family 1, subfamily D, member 5@:integral to membrane;sensory perception of smell;G-protein coupled receptor activity;plasma membrane;detection of chemical stimulus involved in sensory perception of smell;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F00603@149469@149469@deletion@1@4439372@4439469@17@chr17:4439372-4439469@5.05@113@63@0.558@NA@SPNS2_10@0@0@0@:spinster homolog 2 (Drosophila)@:integral to membrane;transmembrane transporter activity;lipid transport;transmembrane transport@NA
F00603@151875@151884@duplication@10@18380170@18396173@17@chr17:18380170-18396173@39@486@878@1.81@CNVR7014.1@LGALS9C_1, LGALS9C_2, LGALS9C_3, LGALS9C_4, LGALS9C_5, LGALS9C_6, LGALS9C_7, LGALS9C_8, LGALS9C_9, LGALS9C_10@0@0@0@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
F00603@152125@152130@duplication@6@20355665@20361697@17@chr17:20355665-20361697@8.85@217@326@1.5@CNVR7021.1, CNVR7021.3@LGALS9B_8, LGALS9B_7, LGALS9B_6, LGALS9B_5, LGALS9B_4, LGALS9B_3@0@0@0@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
F00603@153380@153381@deletion@2@34539179@34539971@17@chr17:34539179-34539971@10.4@47@0@0@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1_2, CCL4L1_3@0@0@0@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
F00603@153650@153659@duplication@10@36351930@36375177@17@chr17:36351930-36375177@41.6@4039@5439@1.35@CNVR7083.3@RP11-1407O15.2_12, RP11-1407O15.2_11, RP11-1407O15.2_10, RP11-1407O15.2_9, RP11-1407O15.2_8, RP11-1407O15.2_7, RP11-1407O15.2_6, RP11-1407O15.2_5, RP11-1407O15.2_4, RP11-1407O15.2_3@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
F00603@154346@154346@duplication@1@39421631@39422112@17@chr17:39421631-39422112@5.21@43@86@2@CNVR7096.1@KRTAP9-6_1@0@0@0@:keratin associated protein 9-6@:keratin filament@NA
F00603@155587@155594@duplication@8@44399689@44414934@17@chr17:44399689-44414934@14@212@352@1.66@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9, LRRC37A_10, LRRC37A_11, LRRC37A_12, LRRC37A_13@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
F00603@155610@155612@deletion@3@44632519@44632945@17@chr17:44632519-44632945@9.4@134@63@0.47@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2_13, LRRC37A2_14, LRRC37A2_15@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
F00603@162017@162017@deletion@1@44542732@44544371@18@chr18:44542732-44544371@6@43@11@0.256@CNVR7319.1@TCEB3CL2_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
F00603@162019@162019@duplication@1@44554574@44556213@18@chr18:44554574-44556213@9.19@124@222@1.79@CNVR7319.1@TCEB3C_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C (elongin A3);RNA polymerase II transcription factor SIII subunit A3-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
F00603@166916@166917@deletion@2@14508471@14508747@19@chr19:14508471-14508747@12.3@97@28@0.289@NA@CD97_7, CD97_8@0@0@0@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
F00603@167047@167047@deletion@1@14877791@14877921@19@chr19:14877791-14877921@7.7@87@35@0.402@NA@EMR2_6@0@0@0@:egf-like module containing, mucin-like, hormone receptor-like 2@:transmembrane signaling receptor activity;inflammatory response;G-protein coupled receptor activity;ruffle membrane;integral to membrane;plasma membrane;cell surface receptor signaling pathway;neuropeptide signaling pathway;granulocyte chemotaxis;cell migration;leading edge membrane;G-protein coupled receptor signaling pathway;protein binding;cell adhesion;membrane;calcium ion binding;chondroitin sulfate binding@NA
F00603@169918@169918@deletion@1@39759793@39759869@19@chr19:39759793-39759869@6.86@103@49@0.476@NA@IFNL2_3@0@0@0@:interleukin 28A (interferon, lambda 2)@:defense response to virus;extracellular space;cytokine activity@NA
F00603@170781@170785@deletion@5@43258448@43269733@19@chr19:43258448-43269733@28.4@747@417@0.558@NA@PSG8_5, PSG8_4, PSG8_3, PSG8_2, PSG8_1@0@0@0@:pregnancy specific beta-1-glycoprotein 8@:protein binding;extracellular region@NA
F00603@170821@170826@deletion@6@43702150@43763287@19@chr19:43702150-43763287@25.5@746@434@0.582@CNVR7658.5, CNVR7658.1@PSG4_3, PSG4_2, PSG4_1, PSG9_6, PSG9_5, PSG9_4@0@0@0@:pregnancy specific beta-1-glycoprotein 4:pregnancy specific beta-1-glycoprotein 9@:protein binding;extracellular region;female pregnancy;defense response:protein binding;extracellular region;female pregnancy;defense response@NA
F00603@172987@172987@deletion@1@52133087@52133469@19@chr19:52133087-52133469@6.18@48@14@0.292@CNVR7702.1@SIGLEC5_2, SIGLEC5_2@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion@NA
F00603@172990@172993@duplication@4@52146791@52149313@19@chr19:52146791-52149313@7.16@373@503@1.35@CNVR7702.1@SIGLEC14_6, SIGLEC14_5, SIGLEC14_4, SIGLEC14_3@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 14@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion;plasma membrane@NA
F00603@173295@173296@deletion@2@54724399@54725251@19@chr19:54724399-54725251@9.28@151@75@0.497@CNVR7721.3, CNVR7721.4@LILRB3_6, LILRB3_5@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F00603@173301@173302@deletion@2@54742830@54743827@19@chr19:54742830-54743827@9.76@431@269@0.624@CNVR7721.3, CNVR7721.4, CNVR7721.1, CNVR7721.6@LILRA6_8, LILRA6_7@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F00603@173308@173308@deletion@1@54746568@54746600@19@chr19:54746568-54746600@5.76@91@45@0.495@CNVR7721.3, CNVR7721.6@LILRA6_1@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F00603@173467@173489@duplication@23@55263102@55333313@19@chr19:55263102-55333313@143@4325@6532@1.51@CNVR7725.2, CNVR7725.1@KIR2DL3_6, KIR2DL3_7, KIR2DL3_8, KIR2DL1_1, KIR2DL1_2, KIR2DL1_3, KIR2DL1_4, KIR2DL1_5, KIR2DL1_6, KIR2DL1_7, KIR2DL1_8, KIR2DL4_1, KIR2DL4_2, KIR2DL4_3, KIR2DL4_4, KIR2DL4_5, KIR2DL4_6, KIR2DL4_7, KIR3DL1_1, KIR3DL1_2, KIR3DL1_3, KIR3DL1_4, KIR3DL1_5@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
F00603@173491@173493@deletion@3@55340817@55341730@19@chr19:55340817-55341730@15.7@497@294@0.592@CNVR7725.1, CNVR7725.6@KIR3DL1_7, KIR3DL1_8, KIR3DL1_9@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
F00603@173497@173497@deletion@1@55350884@55351154@19@chr19:55350884-55351154@10.5@174@82@0.471@CNVR7725.1, CNVR7725.6@KIR2DS4_4@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
F00603@173499@173501@duplication@3@55358640@55359398@19@chr19:55358640-55359398@36.1@867@1443@1.66@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4_6, KIR2DS4_7, KIR2DS4_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
F00603@174394@174395@deletion@2@1558985@1569278@20@chr20:1558985-1569278@23.8@478@225@0.471@CNVR7763.1@RP4-576H24.4_2, SIRPB1_2, RP4-576H24.4_1@0@0@0@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
F00603@174403@174403@deletion@1@1895746@1896101@20@chr20:1895746-1896101@11.7@188@86@0.457@CNVR7764.2@SIRPA_2@0@0@0@:signal-regulatory protein alpha@:blood coagulation;protein binding;integral to membrane;SH3 domain binding;cell adhesion;plasma membrane;membrane;leukocyte migration@NA
F00603@175736@175739@duplication@4@26061801@29624092@20@chr20:26061801-29624092@8.08@217@321@1.48@NA@NA@0@500@0@:protein FRG1-like@NA@NA
F00603@178076@178076@deletion@1@55108399@55108646@20@chr20:55108399-55108646@21.5@231@74@0.32@NA@FAM209B_1@0@0@0@:family with sequence similarity 209, member B@:integral to membrane@NA
F00603@178987@179000@duplication@14@10906906@10944787@21@chr21:10906906-10944787@25.4@4767@6070@1.27@CNVR7947.10, CNVR7947.6, CNVR7947.11@TPTE_24, TPTE_23, TPTE_22, TPTE_21, TPTE_20, TPTE_19, TPTE_18, TPTE_17, TPTE_16, TPTE_15, TPTE_14, TPTE_13, TPTE_12, TPTE_11@0@0@0@:transmembrane phosphatase with tensin homology@:phosphatase activity;ion channel activity;protein tyrosine phosphatase activity;ion transport;protein dephosphorylation;transmembrane transport;protein binding;signal transduction;integral to membrane;protein tyrosine/serine/threonine phosphatase activity;dephosphorylation;membrane;peptidyl-tyrosine dephosphorylation@NA
F00603@181806@181807@deletion@2@23243157@23247205@22@chr22:23243157-23247205@5.69@351@231@0.658@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11, CNVR8103.35@IGLC2_1, IGLJ3_1@0@0@0@@:protein binding@NA
F00603@183631@183631@deletion@1@39357393@39357686@22@chr22:39357393-39357686@9.39@58@10@0.172@CNVR8164.1@APOBEC3A_4@0@0@0@:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A;APOBEC3A and APOBEC3B deletion hybrid@:cytidine deamination;defense response to virus;negative regulation of viral genome replication;DNA cytosine deamination;clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine;catalytic activity;DNA demethylation;cytoplasm;innate immune response;cytidine deaminase activity;nucleus;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;cellular response to xenobiotic stimulus;zinc ion binding;negative regulation of transposition@NA
F00603@184152@184154@deletion@3@42536290@42537296@22@chr22:42536290-42537296@17.9@234@104@0.444@CNVR8168.1, CNVR8168.3, CNVR8168.4@CYP2D7P1_5, CYP2D7P1_4, CYP2D7P1_3@0@0@0@@:oxidation-reduction process;electron carrier activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;heme binding@NA
F00603@135@136@deletion@2@2833598@2836268@X@chrX:2833598-2836268@6.09@358@239@0.668@NA@ARSD_6, ARSD_5@0@0@0@NA@NA@NA
F00603@4072@4079@deletion@8@101615523@101620252@X@chrX:101615523-101620252@15@70@2@0.0286@NA@NXF2B_34, NXF2B_33, NXF2B_32, NXF2B_31, NXF2B_30, NXF2B_29, NXF2B_28, NXF2B_27@0@0@0@NA@NA@NA
F00603@4884@4884@deletion@1@119210843@119211253@X@chrX:119210843-119211253@6.23@28@0@0@NA@RHOXF2B_2@0@0@0@NA@NA@NA
F00603@5495@5495@duplication@1@134988571@134988710@X@chrX:134988571-134988710@6.55@202@301@1.49@NA@SAGE1_7@0@0@0@NA@NA@NA
F02209@2185@2188@duplication@4@17272755@17275421@1@chr1:17272755-17275421@6.28@260@359@1.38@CNVR94.4, CNVR94.5@CROCC_16, CROCC_17, CROCC_18, CROCC_19@0@0@0@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
F02209@3333@3342@deletion@10@25599040@25655415@1@chr1:25599040-25655415@145@764@22@0.0288@CNVR116.1, CNVR116.2@RHD_1, RHD_2, RHD_3, RHD_4, RHD_5, RHD_6, RHD_7, RHD_8, RHD_9, RHD_10@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
F02209@3357@3357@duplication@1@25735175@25735360@1@chr1:25735175-25735360@6.33@109@191@1.75@CNVR117.1@RHCE_2@0@0@0@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
F02209@9365@9374@deletion@10@104202983@104234232@1@chr1:104202983-104234232@21.2@97@0@0@CNVR266.3, CNVR266.1, CNVR266.15@AMY1A_7, AMY1A_8, AMY1A_9, AMY1A_10, AMY1A_11, AMY1B_11, AMY1B_10, AMY1B_9, AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
F02209@9766@9773@deletion@8@110230497@110235917@1@chr1:110230497-110235917@82.8@395@2@0.00506@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
F02209@12117@12118@deletion@2@152573209@152586574@1@chr1:152573209-152586574@6.59@31@1@0.0323@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
F02209@12129@12129@deletion@1@152770272@152770615@1@chr1:152770272-152770615@10.9@56@3@0.0536@CNVR360.1@LCE1D_2@0@0@0@:late cornified envelope 1D@:cytoplasmic part;cornified envelope;cellular response to calcium ion;keratinization;perinuclear region of cytoplasm;cytoplasm@NA
F02209@16038@16038@deletion@1@196797201@196797376@1@chr1:196797201-196797376@11.1@174@69@0.397@CNVR459.1@CFHR1_4@0@0@0@:complement factor H-related 1:complement factor H-related 2@:extracellular space;complement activation:extracellular region@NA
F02209@41794@41795@duplication@2@126723729@126724086@3@chr3:126723729-126724086@5.08@266@367@1.38@NA@PLXNA1_5, PLXNA1_6@0@0@0@:plexin A1@:multicellular organismal development;intracellular;axon guidance;cytoplasm;protein binding;signal transduction;semaphorin-plexin signaling pathway;dichotomous subdivision of terminal units involved in salivary gland branching;integral to membrane;semaphorin receptor activity;nucleus;plasma membrane;receptor activity;semaphorin receptor complex;membrane@NA
F02209@48556@48560@deletion@5@69403344@69431438@4@chr4:69403344-69431438@58.3@326@26@0.0798@CNVR1953.1@UGT2B17_6, UGT2B17_5, UGT2B17_4, UGT2B17_3, UGT2B17_2@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
F02209@54099@54102@duplication@4@32108076@32143986@5@chr5:32108076-32143986@10.9@808@1089@1.35@NA@PDZD2_25, GOLPH3_4, GOLPH3_3, GOLPH3_2@0@0@0@:PDZ domain containing 2:golgi phosphoprotein 3 (coat-protein)@:cell-cell junction;protein binding;extracellular region;endoplasmic reticulum;cell adhesion;nucleus;cytoplasm:endosome;mitochondrion;Golgi apparatus;regulation of mitochondrion organization;mitochondrial intermembrane space;cytoplasm;positive regulation of TOR signaling cascade;lipid binding;Golgi cisterna membrane;nuclear membrane;cell proliferation;cytosol;trans-Golgi network;protein binding;plasma membrane@NA
F02209@55783@55783@duplication@1@68862417@68862452@5@chr5:68862417-68862452@4.92@40@85@2.12@CNVR2494.7, CNVR2494.46@GTF2H2C_4@0@0@0@:general transcription factor IIH, polypeptide 2C;general transcription factor IIH, polypeptide 2D@:regulation of transcription, DNA-dependent;nucleotide-excision repair;DNA repair;core TFIIH complex;protein binding;nucleus;transcription, DNA-dependent;zinc ion binding@NA
F02209@59488@59488@deletion@1@147553798@147553933@5@chr5:147553798-147553933@23.6@121@0@0@CNVR2637.2, CNVR2637.1@SPINK14_3@0@0@0@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
F02209@60878@60889@duplication@12@175391955@175525561@5@chr5:175391955-175525561@9.6@269@389@1.45@NA@THOC3_3, THOC3_2, THOC3_1, RP11-826N14.2_3, RP11-826N14.2_2, FAM153B_3, FAM153B_4, FAM153B_5, FAM153B_6, FAM153B_7, FAM153B_8@0@0@0@:THO complex 3:uncharacterized LOC100507387;family with sequence similarity 153, member B@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
F02209@62773@62773@deletion@1@26637574@26638781@6@chr6:26637574-26638781@4.6@432@280@0.648@NA@ZNF322_4@0@0@0@:zinc finger protein 322@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;cytoplasm@NA
F02209@62951@62955@duplication@5@29910332@29912393@6@chr6:29910332-29912393@7.12@569@744@1.31@CNVR2829.7, CNVR2829.2, CNVR2829.3@HLA-A_3, HLA-A_4, HLA-A_5, HLA-A_6, HLA-A_7@0@0@0@:major histocompatibility complex, class I, A@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO
F02209@63768@63776@deletion@9@31994761@31997115@6@chr6:31994761-31997115@22@281@125@0.445@CNVR2843.6, CNVR2843.5@C4B_20, C4B_21, C4B_22, C4B_23, C4B_24, C4B_25, C4B_26, C4B_27, C4B_28@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
F02209@63953@63958@deletion@6@32485517@32498001@6@chr6:32485517-32498001@52.1@333@51@0.153@CNVR2845.21, CNVR2845.25, CNVR2845.30, CNVR2845.43, CNVR2845.6@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2, HLA-DRB5_1@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
F02209@63962@63963@deletion@2@32549335@32552155@6@chr6:32549335-32552155@5.91@242@151@0.624@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.5, CNVR2845.54, CNVR2845.55, CNVR2845.56, CNVR2845.34@HLA-DRB1_3, HLA-DRB1_2@0@0@0@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
F02209@63965@63974@duplication@10@32605237@32634384@6@chr6:32605237-32634384@25.7@950@1372@1.44@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20@HLA-DQA1_1, HLA-DQA1_2, HLA-DQA1_3, HLA-DQA1_4, HLA-DQB1_6, HLA-DQB1_5, HLA-DQB1_4, HLA-DQB1_3, HLA-DQB1_2, HLA-DQB1_1@0@0@0@:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
F02209@64602@64606@deletion@5@35754776@35765065@6@chr6:35754776-35765065@9.83@837@578@0.691@CNVR2861.1@CLPSL1_2, CLPSL1_3, CLPS_3, CLPS_2, CLPS_1@0@0@0@:colipase-like 1:colipase, pancreatic@:extracellular region;enzyme activator activity;digestion;lipid catabolic process:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
F02209@71935@71947@duplication@13@6825581@6852668@7@chr7:6825581-6852668@9.88@401@546@1.36@NA@RSPH10B2_15, RSPH10B2_16, RSPH10B2_17, RSPH10B2_18, RSPH10B2_19, RSPH10B2_20, CCZ1B_15, CCZ1B_14, CCZ1B_13, CCZ1B_12, CCZ1B_11, CCZ1B_10, CCZ1B_9@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F02209@76427@76432@duplication@6@100331793@100336236@7@chr7:100331793-100336236@26.3@504@844@1.67@CNVR3509.1@ZAN_1, ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
F02209@79120@79125@duplication@6@142494245@142494975@7@chr7:142494245-142494975@6.53@515@667@1.3@NA@TRBJ2-2_1, TRBJ2-2P_1, TRBJ2-3_1, TRBJ2-4_1, TRBJ2-5_1, TRBJ2-6_1@0@0@0@NA@NA@NA
F02209@79287@79287@duplication@1@143400089@143400710@7@chr7:143400089-143400710@5.46@48@100@2.08@CNVR3594.2, CNVR3594.1@FAM115C_2@0@0@0@:family with sequence similarity 115, member C;protein FAM115C-like@NA@NA
F02209@79309@79327@duplication@19@143880598@144075959@7@chr7:143880598-144075959@71.4@1521@2646@1.74@CNVR3598.4@CTAGE4_1, ARHGEF35_2, OR2A42_1, OR2A7_1, CTAGE8_1, OR2A1_1, ARHGEF5_2, ARHGEF5_3, ARHGEF5_4, ARHGEF5_5, ARHGEF5_6, ARHGEF5_7, ARHGEF5_8, ARHGEF5_9, ARHGEF5_10, ARHGEF5_11, ARHGEF5_12, ARHGEF5_13, ARHGEF5_14@0@0@0@:CTAGE family, member 4:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:olfactory receptor, family 2, subfamily A, member 7:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:integral to membrane;nucleotide binding;cellular_component;biological_process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
F02209@80368@80376@deletion@9@7274293@7340274@8@chr8:7274293-7340274@23.1@273@100@0.366@CNVR3771.8, CNVR3771.10, CNVR3771.4@DEFB4B_1, DEFB103B_2, DEFB103B_1, SPAG11B_3, SPAG11B_2, SPAG11B_1, DEFB104B_2, DEFB104B_1, DEFB106B_2@0@0@0@:defensin, beta 4B;defensin, beta 4A:defensin, beta 103B;defensin, beta 103A:sperm associated antigen 11B:defensin, beta 104A;defensin, beta 104B:defensin, beta 106B;defensin, beta 106A@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
F02209@80388@80394@deletion@7@7637545@7680945@8@chr8:7637545-7680945@15.2@165@63@0.382@CNVR3772.4, CNVR3772.6, CNVR3772.2, CNVR3772.8, CNVR3772.10@AC084121.16_3, AC084121.16_2, AC084121.16_1, DEFB107A_2, DEFB107A_1, DEFB105A_3, DEFB105A_2@0@0@0@:uncharacterized LOC100133251:defensin, beta 107B;defensin, beta 107A:defensin, beta 105B;defensin, beta 105A@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
F02209@80399@80406@deletion@8@7698557@7752292@8@chr8:7698557-7752292@14@297@157@0.529@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@DEFB104A_2, SPAG11A_1, SPAG11A_2, SPAG11A_3, SPAG11A_4, DEFB103A_1, DEFB103A_2, DEFB4A_1@0@0@0@:defensin, beta 104A;defensin, beta 104B:sperm associated antigen 11A;sperm associated antigen 11B:defensin, beta 103B;defensin, beta 103A:defensin, beta 4B;defensin, beta 4A@:extracellular region;defense response to bacterium:extracellular region;defense response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response@NA
F02209@85563@85600@deletion@38@134024147@134276895@8@chr8:134024147-134276895@170@3989@2103@0.527@NA@TG_36, TG_37, TG_38, TG_39, TG_40, TG_41, SLA_7, SLA_6, SLA_5, SLA_4, SLA_3, SLA_2, SLA_1, TG_42, TG_43, TG_44, TG_45, TG_46, TG_47, TG_48, WISP1_1, WISP1_2, WISP1_3, WISP1_4, WISP1_5, NDRG1_16, NDRG1_15, NDRG1_14, NDRG1_13, NDRG1_12, NDRG1_11, NDRG1_10, NDRG1_9, NDRG1_8, NDRG1_7, NDRG1_6, NDRG1_5, NDRG1_4@0@0@0@:thyroglobulin:Src-like-adaptor:WNT1 inducible signaling pathway protein 1:N-myc downstream regulated 1@:thyroid hormone metabolic process;hormone activity;Golgi apparatus;endoplasmic reticulum;transcytosis;perinuclear region of cytoplasm;regulation of myelination;iodide transport;thyroid gland development;hormone biosynthetic process;signal transduction;extracellular space;extracellular region;response to pH;chaperone binding;thyroid hormone generation;response to lipopolysaccharide:SH3/SH2 adaptor activity;endosome;protein binding:regulation of cell growth;insulin-like growth factor binding;cytoplasm;cell-cell signaling;protein binding;signal transduction;extracellular space;extracellular region;cell adhesion;Wnt receptor signaling pathway:gamma-tubulin binding;microtubule binding;mast cell activation;Rab GTPase binding;cadherin binding;nucleus;plasma membrane;recycling endosome membrane;peripheral nervous system myelin maintenance;centrosome;cell-cell adherens junction;DNA damage response, signal transduction by p53 class mediator;cytoplasm;perinuclear region of cytoplasm;cytosol;microtubule cytoskeleton;cellular response to hypoxia;protein binding;positive regulation of spindle checkpoint;microtubule;response to metal ion@: AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3; AITD3; THYROID DYSHORMONOGENESIS 3; TDH3: CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D; CMT4D
F02209@86631@86694@deletion@64@116801@464219@9@chr9:116801-464219@944@4938@37@0.00749@NA@FOXD4_1, CBWD1_15, CBWD1_14, CBWD1_13, CBWD1_12, CBWD1_11, CBWD1_10, CBWD1_9, CBWD1_8, CBWD1_7, CBWD1_6, CBWD1_5, CBWD1_4, CBWD1_3, CBWD1_2, CBWD1_1, C9orf66_1, DOCK8_1, DOCK8_2, DOCK8_3, DOCK8_4, DOCK8_5, DOCK8_6, DOCK8_7, DOCK8_8, DOCK8_9, DOCK8_10, DOCK8_11, DOCK8_12, DOCK8_13, DOCK8_14, DOCK8_15, DOCK8_16, DOCK8_17, DOCK8_18, DOCK8_19, DOCK8_20, DOCK8_21, DOCK8_22, DOCK8_23, DOCK8_24, DOCK8_25, DOCK8_26, DOCK8_27, DOCK8_28, DOCK8_29, DOCK8_30, DOCK8_31, DOCK8_32, DOCK8_33, DOCK8_34, DOCK8_35, DOCK8_36, DOCK8_37, DOCK8_38, DOCK8_39, DOCK8_40, DOCK8_41, DOCK8_42, DOCK8_43, DOCK8_44, DOCK8_45, DOCK8_46, DOCK8_47, DOCK8_48@0@0@0@:forkhead box D4:COBW domain containing 1;COBW domain-containing protein 1-like;COBW domain containing 5:chromosome 9 open reading frame 66:dedicator of cytokinesis 8@:positive regulation of BMP signaling pathway;positive regulation of kidney development;axon extension involved in axon guidance;lateral line nerve glial cell development;DNA binding, bending;sequence-specific DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;regulation of sequence-specific DNA binding transcription factor activity;transcription factor complex;nucleus;dichotomous subdivision of terminal units involved in ureteric bud branching;sympathetic nervous system development;melanocyte differentiation;enteric nervous system development;positive regulation of transcription from RNA polymerase II promoter;multicellular organismal development;regulation of transcription, DNA-dependent;neural crest cell migration;peripheral nervous system development;double-stranded DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity;iridophore differentiation;transcription factor binding;cartilage development;pattern specification process:ATP binding:cytosol;GTPase binding;blood coagulation;binding;GTP binding;guanyl-nucleotide exchange factor activity@: MENTAL RETARDATION, AUTOSOMAL DOMINANT 2; MRD2; HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL RECESSIVE
F02209@88592@88594@deletion@3@43815786@43818184@9@chr9:43815786-43818184@16.5@295@137@0.464@CNVR4294.1@CNTNAP3B_5, CNTNAP3B_6, CNTNAP3B_7@0@0@0@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
F02209@95376@95394@deletion@19@17949551@18155690@10@chr10:17949551-18155690@34@197@29@0.147@NA@MRC1L1_28, MRC1L1_29, MRC1L1_30, TMEM236_1, TMEM236_2, TMEM236_3, TMEM236_4, MRC1_1, MRC1_2, MRC1_3, MRC1_4, MRC1_5, MRC1_6, MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11, MRC1_12@0@0@0@:macrophage mannose receptor 1-like:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F02209@96472@96480@duplication@9@46961971@47000257@10@chr10:46961971-47000257@13.2@2911@3674@1.26@CNVR4712.9, CNVR4712.2, CNVR4712.7, CNVR4712.4@SYT15_8, SYT15_7, SYT15_6, SYT15_5, SYT15_4, SYT15_3, SYT15_2, SYT15_1, GPRIN2_1@0@0@0@:synaptotagmin XV:G protein regulated inducer of neurite outgrowth 2@:protein binding;synaptic vesicle;integral to membrane;transporter activity;plasma membrane;membrane;extrinsic to membrane@NA
F02209@96573@96577@duplication@5@48025301@48033105@10@chr10:48025301-48033105@7.18@199@289@1.45@CNVR4715.2@ASAH2C_9, ASAH2C_8, ASAH2C_7, ASAH2C_6, ASAH2C_5@0@0@0@@:ceramidase activity;sphingolipid metabolic process@NA
F02209@96932@96937@deletion@6@51965743@51978390@10@chr10:51965743-51978390@18.6@160@54@0.338@NA@ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
F02209@101607@101614@duplication@8@124343839@124353114@10@chr10:124343839-124353114@22.4@513@791@1.54@CNVR4912.4, CNVR4912.3, CNVR4912.2@DMBT1_14, DMBT1_15, DMBT1_16, DMBT1_17, DMBT1_18, DMBT1_19, DMBT1_20, DMBT1_21@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
F02209@103268@103269@deletion@2@4967390@4976943@11@chr11:4967390-4976943@13.9@1013@621@0.613@CNVR5040.1@OR51A4_1, OR51A2_1@0@0@0@:matrix metallopeptidase 26:olfactory receptor, family 51, subfamily A, member 4:olfactory receptor, family 51, subfamily A, member 2@:metallopeptidase activity;extracellular matrix;proteolysis;proteinaceous extracellular matrix;collagen catabolic process;metalloendopeptidase activity;zinc ion binding;metabolic process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F02209@103342@103342@deletion@1@5798891@5799864@11@chr11:5798891-5799864@5.78@409@252@0.616@CNVR5049.1@OR52N5_1@0@0@0@:tripartite motif containing 5:olfactory receptor, family 52, subfamily N, member 5@:defense response to virus;Golgi apparatus;intracellular;protein trimerization;ligase activity;cytoplasm;protein binding;nucleus;protein homodimerization activity;identical protein binding;zinc ion binding;cytoplasmic mRNA processing body;protein ubiquitination;virus-host interaction:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F02209@106040@106040@deletion@1@55035827@55035848@11@chr11:55035827-55035848@6.83@84@33@0.393@CNVR5178.5@TRIM48_4@0@0@0@:tripartite motif containing 48@:protein binding;intracellular;zinc ion binding@NA
F02209@107591@107594@duplication@4@64601211@64602049@11@chr11:64601211-64602049@5.51@315@419@1.33@NA@CDC42BPG_22, CDC42BPG_21, CDC42BPG_20, CDC42BPG_19@0@0@0@:CDC42 binding protein kinase gamma (DMPK-like)@:phospholipid binding;protein serine/threonine kinase activity;cell leading edge;protein tyrosine kinase activity;small GTPase regulator activity;magnesium ion binding;centrosome;protein phosphorylation;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;actin cytoskeleton reorganization;protein binding;intracellular signal transduction@NA
F02209@111508@111508@duplication@1@117076714@117077072@11@chr11:117076714-117077072@6.86@121@214@1.77@NA@PCSK7_17@0@0@0@:proprotein convertase subtilisin/kexin type 7@:proteolysis;integral to Golgi membrane;serine-type endopeptidase activity;peptide hormone processing@NA
F02209@111510@111511@deletion@2@117077784@117078780@11@chr11:117077784-117078780@6.18@96@44@0.458@NA@PCSK7_15, PCSK7_14@0@0@0@:proprotein convertase subtilisin/kexin type 7@:proteolysis;integral to Golgi membrane;serine-type endopeptidase activity;peptide hormone processing@NA
F02209@114468@114469@duplication@2@11034835@11035297@12@chr12:11034835-11035297@8.12@104@188@1.81@NA@PRH1_4, PRH1_3@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):proline-rich protein HaeIII subfamily 1@:extracellular space;visual perception:protein binding;extracellular space@NA
F02209@114483@114483@deletion@1@11243900@11244828@12@chr12:11243900-11244828@11.2@507@260@0.513@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
F02209@117162@117163@duplication@2@52844191@52845862@12@chr12:52844191-52845862@5.83@225@322@1.43@NA@KRT6B_2, KRT6B_1@0@0@0@:keratin 6B@:keratin filament;structural constituent of cytoskeleton;ectoderm development@: PACHYONYCHIA CONGENITA, TYPE 2; PC2
F02209@117170@117171@deletion@2@52865457@52866064@12@chr12:52865457-52866064@13.3@253@129@0.51@NA@KRT6C_3, KRT6C_2@0@0@0@:keratin 6C@:intermediate filament;structural molecule activity;keratin filament;cytoskeleton organization@NA
F02209@127333@127341@deletion@9@19553418@19574352@14@chr14:19553418-19574352@10@83@27@0.325@CNVR6072.1@POTEG_1, POTEG_2, POTEG_3, POTEG_4, POTEG_5, POTEG_6, POTEG_7, POTEG_8, POTEG_9@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
F02209@133368@133373@duplication@6@106236443@106303493@14@chr14:106236443-106303493@6.47@460@602@1.31@CNVR6294.66, CNVR6294.19, CNVR6294.31@IGHG3_5, IGHG3_4, IGHG3_3, IGHG3_2, IGHG3_1, IGHD_7@0@0@0@@:protein binding:protein binding@NA
F02209@133434@133435@deletion@2@106552286@106552729@14@chr14:106552286-106552729@5.81@288@180@0.625@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV3-9_2, IGHV3-9_1@0@0@0@@:protein binding@NA
F02209@133458@133463@duplication@6@106791006@106816173@14@chr14:106791006-106816173@19.8@815@1168@1.43@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-30_2, IGHV3-30_1, IGHV4-31_2, IGHV4-31_1, IGHV3-33_2, IGHV3-33_1@0@0@0@@:protein binding:protein binding:protein binding@NA
F02209@133491@133492@deletion@2@107095127@107095561@14@chr14:107095127-107095561@14.4@75@5@0.0667@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61_2, IGHV4-61_1@0@0@0@@:protein binding@NA
F02209@134011@134012@deletion@2@30664351@30665348@15@chr15:30664351-30665348@6.47@148@83@0.561@CNVR6337.1@CHRFAM7A_7, CHRFAM7A_6@0@0@0@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
F02209@134152@134154@duplication@3@32446109@32450807@15@chr15:32446109-32450807@7.77@99@175@1.77@CNVR6345.2, CNVR6345.1@CHRNA7_5, CHRNA7_6, CHRNA7_7@0@0@0@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
F02209@135680@135681@deletion@2@43873201@43873586@15@chr15:43873201-43873586@5.9@397@264@0.665@CNVR6365.1@PPIP5K1_10, PPIP5K1_9@0@0@0@:diphosphoinositol pentakisphosphate kinase 1@:inositol hexakisphosphate 3-kinase activity;inositol hexakisphosphate 1-kinase activity;inositol metabolic process;diphosphoinositol-pentakisphosphate kinase activity;ATP binding;acid phosphatase activity;cytoplasm;cytosol;inositol hexakisphosphate 5-kinase activity;nucleus;kinase activity;inositol-1,3,4,5,6-pentakisphosphate kinase activity@NA
F02209@144038@144039@deletion@2@28403074@28403463@16@chr16:28403074-28403463@18.2@91@4@0.044@CNVR6684.2@EIF3CL_10, EIF3CL_9@0@0@0@:eukaryotic translation initiation factor 3, subunit C-like@:protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;translation initiation factor activity@NA
F02209@144422@144427@duplication@6@30018107@30020878@16@chr16:30018107-30020878@7.08@693@896@1.29@NA@DOC2A_8, DOC2A_7, DOC2A_6, DOC2A_5, DOC2A_4, DOC2A_3@0@0@0@:double C2-like domains, alpha@:calcium-dependent phospholipid binding;synaptic vesicle exocytosis;binding;transporter activity;regulation of calcium ion-dependent exocytosis;neuron projection;protein binding;synaptic vesicle membrane;cell junction;synaptic transmission;nervous system development;lysosome@NA
F02209@147109@147127@deletion@19@70161164@70211383@16@chr16:70161164-70211383@34.6@4155@2876@0.692@CNVR6764.1, CNVR6764.3@PDPR_4, PDPR_5, PDPR_6, PDPR_7, PDPR_8, PDPR_9, PDPR_10, PDPR_11, PDPR_12, PDPR_13, PDPR_14, PDPR_15, PDPR_16, PDPR_17, PDPR_18, PDPR_19, CLEC18C_1, CLEC18C_2, CLEC18C_3@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit:C-type lectin domain family 18, member C@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix:carbohydrate binding;protein binding;extracellular region@NA
F02209@151556@151560@deletion@5@16664740@16676023@17@chr17:16664740-16676023@7.75@580@399@0.688@NA@CCDC144A_13, CCDC144A_13, CCDC144A_14, CCDC144A_14, CCDC144A_15, CCDC144A_15, CCDC144A_16, CCDC144A_16, CCDC144A_17@0@0@0@:coiled-coil domain containing 144A@NA@NA
F02209@151876@151885@duplication@10@18387190@18397681@17@chr17:18387190-18397681@17.7@368@572@1.55@CNVR7014.1@LGALS9C_2, LGALS9C_3, LGALS9C_4, LGALS9C_5, LGALS9C_6, LGALS9C_7, LGALS9C_8, LGALS9C_9, LGALS9C_10, LGALS9C_11@0@0@0@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
F02209@151896@151897@deletion@2@18584055@18584964@17@chr17:18584055-18584964@5.77@120@65@0.542@NA@ZNF286B_3, ZNF286B_2@0@0@0@:zinc finger protein 286B@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding@NA
F02209@151959@151959@deletion@1@18996779@18997166@17@chr17:18996779-18997166@10.2@146@57@0.39@CNVR7018.4, CNVR7018.2, CNVR7018.6@AC007952.5_2@0@0@0@NA@NA@NA
F02209@152122@152122@deletion@1@20353287@20353432@17@chr17:20353287-20353432@4.68@21@0@0@CNVR7021.1, CNVR7021.3@LGALS9B_11@0@0@0@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
F02209@155587@155599@deletion@13@44399689@44592687@17@chr17:44399689-44592687@26.3@156@27@0.173@CNVR7114.2, CNVR7114.1@LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9, LRRC37A_10, LRRC37A_11, LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane@NA
F02209@158370@158370@duplication@1@73094134@73094276@17@chr17:73094134-73094276@8.5@174@311@1.79@NA@SLC16A5_3@0@0@0@:solute carrier family 16, member 5 (monocarboxylic acid transporter 6)@:monocarboxylic acid transmembrane transporter activity;organic anion transport;transmembrane transport;monocarboxylic acid transport;integral to membrane;secondary active monocarboxylate transmembrane transporter activity;integral to plasma membrane;symporter activity;membrane@NA
F02209@166810@166812@duplication@3@14070395@14070881@19@chr19:14070395-14070881@5.87@409@545@1.33@NA@DCAF15_8, DCAF15_9, DCAF15_10@0@0@0@:DDB1 and CUL4 associated factor 15@:protein ubiquitination@NA
F02209@167942@167947@duplication@6@18542164@18543414@19@chr19:18542164-18543414@6.54@461@597@1.3@NA@SSBP4_6, SSBP4_7, SSBP4_8, SSBP4_9, SSBP4_10, SSBP4_11@0@0@0@:single stranded DNA binding protein 4@:protein binding;single-stranded DNA binding;nucleus;DNA binding@NA
F02209@173295@173298@deletion@4@54724399@54726434@19@chr19:54724399-54726434@35.7@208@19@0.0913@CNVR7721.3, CNVR7721.4@LILRB3_6, LILRB3_5, LILRB3_4, LILRB3_3@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F02209@173494@173501@duplication@8@55344221@55359398@19@chr19:55344221-55359398@7.11@891@1130@1.27@CNVR7725.1, CNVR7725.6@KIR2DS4_1, KIR2DS4_2, KIR2DS4_3, KIR2DS4_4, KIR2DS4_5, KIR2DS4_6, KIR2DS4_7, KIR2DS4_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
F02209@177360@177362@deletion@3@44351008@44354274@20@chr20:44351008-44354274@72.5@388@4@0.0103@NA@SPINT4_1, SPINT4_2, SPINT4_3@0@0@0@:serine peptidase inhibitor, Kunitz type 4@:serine-type endopeptidase inhibitor activity;extracellular region@NA
F02209@181806@181807@duplication@2@23243157@23247205@22@chr22:23243157-23247205@8.25@184@301@1.64@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11, CNVR8103.35@IGLC2_1, IGLJ3_1@0@0@0@@:protein binding@NA
F02209@181948@181955@deletion@8@24324820@24384231@22@chr22:24324820-24384231@14.3@560@357@0.638@CNVR8114.13, CNVR8114.1@GSTT2_3, GSTT2_4, GSTT2_5, GSTT1_5, GSTT1_4, GSTT1_3, GSTT1_2, GSTT1_1@0@0@0@:glutathione S-transferase theta 1@:protein binding;glutathione transferase activity;nucleus;cytoplasm:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
F02209@183631@183631@deletion@1@39357393@39357686@22@chr22:39357393-39357686@8.23@44@4@0.0909@CNVR8164.1@APOBEC3A_4@0@0@0@:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A;APOBEC3A and APOBEC3B deletion hybrid@:cytidine deamination;defense response to virus;negative regulation of viral genome replication;DNA cytosine deamination;clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine;catalytic activity;DNA demethylation;cytoplasm;innate immune response;cytidine deaminase activity;nucleus;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;cellular response to xenobiotic stimulus;zinc ion binding;negative regulation of transposition@NA
F02209@183633@183641@duplication@9@39358501@39388450@22@chr22:39358501-39388450@19.9@542@798@1.47@CNVR8164.1@APOBEC3A_6, APOBEC3B_1, APOBEC3B_2, APOBEC3B_3, APOBEC3B_4, APOBEC3B_5, APOBEC3B_6, APOBEC3B_7, APOBEC3B_8@0@0@0@:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A;APOBEC3A and APOBEC3B deletion hybrid:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B@:cytidine deamination;defense response to virus;negative regulation of viral genome replication;DNA cytosine deamination;clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine;catalytic activity;DNA demethylation;cytoplasm;innate immune response;cytidine deaminase activity;nucleus;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;cellular response to xenobiotic stimulus;zinc ion binding;negative regulation of transposition:RNA binding;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;negative regulation of transposition;catalytic activity;zinc ion binding@NA
F02209@184165@184172@duplication@8@42908917@42950048@22@chr22:42908917-42950048@17.5@441@658@1.49@CNVR8171.2, CNVR8171.3@RRP7A_7, RRP7A_6, RRP7A_5, RRP7A_4, RRP7A_3, RRP7A_2, RRP7A_1, SERHL2_1@0@0@0@:ribosomal RNA processing 7 homolog A (S. cerevisiae):serine hydrolase-like 2@:RNA binding;nucleotide binding:hydrolase activity;mitochondrion;peroxisome;cytoplasmic membrane-bounded vesicle;molecular_function;cellular_component;perinuclear region of cytoplasm;biological_process@NA
F02209@185028@185030@duplication@3@50964200@50964905@22@chr22:50964200-50964905@5.22@207@287@1.39@NA@TYMP_10, TYMP_9, TYMP_8@0@0@0@:SCO2 cytochrome c oxidase assembly protein:thymidine phosphorylase@:oxidation-reduction process;mitochondrion;muscle system process;mitochondrial inner membrane;copper ion binding;in utero embryonic development;respiratory electron transport chain;copper ion transport;respiratory chain complex IV assembly;cellular copper ion homeostasis;copper ion homeostasis;response to activity:cell differentiation;pyrimidine-nucleoside phosphorylase activity;nucleobase-containing small molecule metabolic process;pyrimidine nucleotide metabolic process;chemotaxis;pyrimidine nucleobase metabolic process;pyrimidine nucleoside metabolic process;pyrimidine nucleoside salvage;metabolic process;thymidine phosphorylase activity;angiogenesis;growth factor activity;small molecule metabolic process;phosphorylase activity;transferase activity, transferring glycosyl groups;pyrimidine nucleoside catabolic process;mitochondrial genome maintenance;cytosol;transferase activity, transferring pentosyl groups;platelet-derived growth factor receptor binding;DNA replication@: CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE: MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1
F02209@190@190@duplication@1@3761383@3761523@X@chrX:3761383-3761523@8.2@44@120@2.73@CNVR8259.1, CNVR8259.3, CNVR8259.5@RP11-706O15.1_1@0@0@0@NA@NA@NA
F02209@5719@5719@duplication@1@140336520@140336590@X@chrX:140336520-140336590@5.24@89@153@1.72@CNVR8456.1@SPANXC_1@0@0@0@NA@NA@NA
F02209@6276@6279@duplication@4@153284427@153285263@X@chrX:153284427-153285263@7.03@507@665@1.31@NA@IRAK1_4, IRAK1_3, IRAK1_2, IRAK1_1@0@0@0@NA@NA@NA
F02209@6297@6297@deletion@1@153458900@153459138@X@chrX:153458900-153459138@6.34@90@39@0.433@CNVR8489.1@OPN1MW_5@0@0@0@NA@NA@NA
F03513@6@6@duplication@1@69092@70008@1@chr1:69092-70008@8.13@27@83@3.07@CNVR1.1, CNVR1.2@OR4F5_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F03513@428@434@deletion@7@1637082@1643839@1@chr1:1637082-1643839@7.32@169@100@0.592@CNVR17.1@CDK11A_12, CDK11A_11, CDK11A_10, CDK11A_9, CDK11A_8, CDK11A_7, CDK11A_6@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
F03513@2790@2792@duplication@3@21808091@21809879@1@chr1:21808091-21809879@5.56@121@182@1.5@CNVR107.2, CNVR107.1@NBPF3_13, NBPF3_14, NBPF3_15@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 3@:cytoplasm@NA
F03513@3334@3341@deletion@8@25611065@25648453@1@chr1:25611065-25648453@27.4@969@604@0.623@CNVR116.1, CNVR116.2@RHD_2, RHD_3, RHD_4, RHD_5, RHD_6, RHD_7, RHD_8, RHD_9@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
F03513@3357@3357@duplication@1@25735175@25735360@1@chr1:25735175-25735360@12.1@88@186@2.11@CNVR117.1@RHCE_2@0@0@0@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
F03513@8507@8508@deletion@2@89476588@89477710@1@chr1:89476588-89477710@6.92@490@333@0.68@CNVR244.1@GBP3_8, GBP3_7@0@0@0@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
F03513@9365@9366@duplication@2@104202983@104203298@1@chr1:104202983-104203298@6.07@71@123@1.73@CNVR266.3, CNVR266.1@AMY1A_7, AMY1A_8@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
F03513@9373@9374@deletion@2@104233917@104234232@1@chr1:104233917-104234232@10.9@49@0@0@CNVR266.3, CNVR266.5@AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
F03513@9385@9386@duplication@2@104297122@104297436@1@chr1:104297122-104297436@14.4@269@428@1.59@CNVR266.3, CNVR266.5@AMY1C_6, AMY1C_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
F03513@9766@9773@duplication@8@110230497@110235917@1@chr1:110230497-110235917@41.7@324@650@2.01@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
F03513@12117@12118@deletion@2@152573209@152586574@1@chr1:152573209-152586574@23.8@108@0@0@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
F03513@14050@14050@duplication@1@161518212@161518468@1@chr1:161518212-161518468@8.09@261@379@1.45@CNVR383.3, CNVR383.1@FCGR3A_3@0@0@0@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane@NA
F03513@14053@14058@duplication@6@161565346@161600992@1@chr1:161565346-161600992@42.4@947@1466@1.55@CNVR383.1@FCGR2C_1, FCGR3B_5, FCGR3B_4, FCGR3B_3, FCGR3B_2, FCGR3B_1@0@0@0@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene):Fc fragment of IgG, low affinity IIIb, receptor (CD16b)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction:IgG binding;protein binding;extracellular region;immune response;plasma membrane;anchored to membrane@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
F03513@16029@16040@duplication@12@196744018@196801129@1@chr1:196744018-196801129@80.3@1531@2424@1.58@CNVR459.1@CFHR3_1, CFHR3_2, CFHR3_3, CFHR3_4, CFHR3_5, CFHR3_6, CFHR1_1, CFHR1_2, CFHR1_3, CFHR1_4, CFHR1_5, CFHR1_6@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
F03513@19775@19778@deletion@4@248756132@248814185@1@chr1:248756132-248814185@39.3@1786@1108@0.62@CNVR600.1@OR2T10_1, OR2T11_1, OR2T35_1, OR2T27_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 10:olfactory receptor, family 2, subfamily T, member 11:olfactory receptor, family 2, subfamily T, member 35:olfactory receptor, family 2, subfamily T, member 27@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F03513@26328@26332@duplication@5@112592182@112605442@2@chr2:112592182-112605442@6.65@218@309@1.42@CNVR929.1, CNVR929.2@ANAPC1_19, ANAPC1_18, ANAPC1_17, ANAPC1_16, ANAPC1_15@0@0@0@:anaphase-promoting complex subunit 1-like;anaphase promoting complex subunit 1@:nucleoplasm;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle;anaphase-promoting complex;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle spindle assembly checkpoint;cytosol;protein K11-linked ubiquitination;protein binding;mitosis;nucleus;cell cycle checkpoint;cell division;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle@NA
F03513@27341@27342@duplication@2@132288153@132289375@2@chr2:132288153-132289375@5.65@150@218@1.45@NA@CCDC74A_3, CCDC74A_4@0@0@0@:coiled-coil domain containing 74A@NA@NA
F03513@32590@32590@duplication@1@220197884@220197899@2@chr2:220197884-220197899@5.46@111@171@1.54@NA@RESP18_1@0@0@0@:regulated endocrine-specific protein 18 homolog (rat)@:secretory granule;rough endoplasmic reticulum lumen;extracellular region;endoplasmic reticulum;Golgi apparatus;perikaryon@NA
F03513@48556@48561@duplication@6@69403344@69434202@4@chr4:69403344-69434202@43.5@937@1468@1.57@CNVR1953.1@UGT2B17_6, UGT2B17_5, UGT2B17_4, UGT2B17_3, UGT2B17_2, UGT2B17_1@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
F03513@48592@48597@duplication@6@70146220@70160527@4@chr4:70146220-70160527@7.67@764@985@1.29@CNVR1957.2, CNVR1957.1@UGT2B28_1, UGT2B28_2, UGT2B28_3, UGT2B28_4, UGT2B28_5, UGT2B28_6@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
F03513@51672@51672@deletion@1@145041644@145041741@4@chr4:145041644-145041741@5.76@98@51@0.52@NA@GYPA_2@0@0@0@:glycophorin B (MNS blood group):glycophorin A (MNS blood group)@:integral to membrane;plasma membrane;integral to plasma membrane:external side of plasma membrane;integral to membrane;cytoskeletal anchoring at plasma membrane;plasma membrane;molecular_function;protein homodimerization activity;integral to plasma membrane;cellular_component;identical protein binding;membrane;biological_process;regulation of response to osmotic stress;virus-host interaction@: BLOOD GROUP--Ss LOCUS; Ss: MALARIA, SUSCEPTIBILITY TO; BLOOD GROUP--MN LOCUS; MN
F03513@53189@53189@deletion@1@190947540@190947616@4@chr4:190947540-190947616@13.2@189@87@0.46@CNVR2258.3@FRG2_3@0@0@0@:FSHD region gene 2-like;FSHD region gene 2@:nucleus@NA
F03513@53307@53308@duplication@2@745299@748674@5@chr5:745299-748674@10.1@257@379@1.47@CNVR2280.3@ZDHHC11B_6, ZDHHC11B_5@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
F03513@60876@60879@deletion@4@175388055@175394270@5@chr5:175388055-175394270@9.06@149@78@0.523@NA@THOC3_5, THOC3_4, THOC3_3, THOC3_2@0@0@0@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
F03513@61640@61645@deletion@6@180376240@180429785@5@chr5:180376240-180429785@30.9@893@534@0.598@CNVR2719.1@BTNL8_7, BTNL8_8, BTNL3_1, BTNL3_2, BTNL3_3, BTNL3_4@0@0@0@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
F03513@63281@63282@deletion@2@31237744@31238262@6@chr6:31237744-31238262@15.3@277@146@0.527@CNVR2838.2, CNVR2838.1@HLA-C_5, HLA-C_4@0@0@0@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
F03513@63296@63296@deletion@1@31379725@31380002@6@chr6:31379725-31380002@4.96@130@77@0.592@CNVR2842.1@MICA_4@0@0@0@:MHC class I polypeptide-related sequence A@:MHC class I protein complex;protein binding;regulation of immune response;antigen processing and presentation;immune response;plasma membrane;membrane@: PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO; PSORIASIS SUSCEPTIBILITY 1; PSORS1
F03513@63725@63726@deletion@2@31962023@31962484@6@chr6:31962023-31962484@7.69@121@63@0.521@CNVR2843.6, CNVR2843.3@C4A_20, C4A_21@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
F03513@63773@63776@deletion@4@31996235@31997115@6@chr6:31996235-31997115@20.8@264@120@0.455@CNVR2843.6, CNVR2843.5@C4B_25, C4B_26, C4B_27, C4B_28@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
F03513@63800@63803@deletion@4@32009127@32010139@6@chr6:32009127-32010139@10.6@82@24@0.293@CNVR2843.6, CNVR2843.5@TNXB_13, TNXB_12, TNXB_11, TNXB_10@0@0@0@:cytochrome P450, family 21, subfamily A, polypeptide 2:tenascin-X-like;tenascin XB@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
F03513@63953@63960@deletion@8@32485517@32548047@6@chr6:32485517-32548047@45.3@344@98@0.285@CNVR2845.21, CNVR2845.25, CNVR2845.24@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2, HLA-DRB5_1, HLA-DRB1_6, HLA-DRB1_5@0@0@0@:major histocompatibility complex, class II, DR beta 5:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
F03513@63971@63973@duplication@3@32629125@32632844@6@chr6:32629125-32632844@9.82@285@411@1.44@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20, CNVR2845.31@HLA-DQB1_4, HLA-DQB1_3, HLA-DQB1_2@0@0@0@:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
F03513@64602@64606@duplication@5@35754776@35765065@6@chr6:35754776-35765065@11.8@1053@1369@1.3@CNVR2861.1@CLPSL1_2, CLPSL1_3, CLPS_3, CLPS_2, CLPS_1@0@0@0@:colipase-like 1:colipase, pancreatic@:extracellular region;enzyme activator activity;digestion;lipid catabolic process:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
F03513@71015@71015@deletion@1@167595214@167595404@6@chr6:167595214-167595404@5.32@80@40@0.5@NA@TCP10L2_8@0@0@0@:t-complex 10;t-complex 10-like 2@NA@NA
F03513@71029@71032@deletion@4@167789455@167794824@6@chr6:167789455-167794824@9.11@269@167@0.621@NA@TCP10_6, TCP10_5, TCP10_4, TCP10_3@0@0@0@:t-complex 10@:cytosol@NA
F03513@71756@71758@deletion@3@5963467@5966179@7@chr7:5963467-5966179@8.07@430@286@0.665@NA@CCZ1_14, CCZ1_15, RSPH10B_20@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae):radial spoke head 10 homolog B (Chlamydomonas)@:lysosomal membrane@NA
F03513@71765@71765@duplication@1@5983543@5983621@7@chr7:5983543-5983621@7.16@131@208@1.59@NA@RSPH10B_13@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F03513@71772@71772@deletion@1@5998625@5998709@7@chr7:5998625-5998709@10.1@262@150@0.573@NA@RSPH10B_6@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F03513@71926@71926@duplication@1@6805338@6805422@7@chr7:6805338-6805422@5.71@114@177@1.55@NA@RSPH10B2_6@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F03513@71940@71944@duplication@5@6837995@6844686@7@chr7:6837995-6844686@19@134@277@2.07@NA@RSPH10B2_20, CCZ1B_15, CCZ1B_14, CCZ1B_13, CCZ1B_12@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F03513@73260@73262@duplication@3@38388957@38393626@7@chr7:38388957-38393626@6.23@719@928@1.29@CNVR3354.3, CNVR3354.1@TRGV5_2, TRGV5_1, TRGV4_2@0@0@0@@:protein binding:protein binding@NA
F03513@76427@76432@duplication@6@100331793@100336236@7@chr7:100331793-100336236@25.8@759@1101@1.45@CNVR3509.1@ZAN_1, ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
F03513@76539@76543@duplication@5@100606197@100608891@7@chr7:100606197-100608891@10.4@1024@1322@1.29@CNVR3510.2@MUC3A_3, MUC3A_4, MUC3A_5, MUC3A_6, MUC3A_7@0@0@0@:mucin 3A, cell surface associated;uncharacterized LOC100134216@:Golgi lumen;post-translational protein modification;maintenance of gastrointestinal epithelium;extracellular matrix structural constituent;O-glycan processing;protein binding;cellular protein metabolic process;integral to membrane;extracellular region;digestion;extracellular matrix constituent, lubricant activity@NA
F03513@77902@77908@deletion@7@127721413@127732110@7@chr7:127721413-127732110@55.5@873@432@0.495@NA@SND1_18, SND1_19, SND1_20, SND1_21, SND1_22, SND1_23, SND1_24@0@0@0@:staphylococcal nuclease and tudor domain containing 1@:mitochondrion;transcription cofactor activity;regulation of transcription, DNA-dependent;nuclease activity;cytoplasm;RNA-induced silencing complex;protein binding;hydrolase activity, acting on ester bonds;nucleus;transcription, DNA-dependent;melanosome;nucleic acid binding;gene silencing by RNA;virus-host interaction@NA
F03513@79056@79057@duplication@2@142045364@142045816@7@chr7:142045364-142045816@9.17@485@660@1.36@NA@TRBV4-2_1, TRBV4-2_2@0@0@0@@:protein binding@NA
F03513@79310@79310@deletion@1@143884023@143885476@7@chr7:143884023-143885476@13.4@62@1@0.0161@CNVR3598.4, CNVR3598.3, CNVR3598.7@ARHGEF35_2@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35@NA@NA
F03513@79312@79314@duplication@3@143955790@144016150@7@chr7:143955790-144016150@23.7@952@1411@1.48@CNVR3598.4@OR2A7_1, CTAGE8_1, OR2A1_1@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor, family 2, subfamily A, member 7:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F03513@79319@79324@duplication@6@144068255@144071982@7@chr7:144068255-144071982@13.3@397@571@1.44@CNVR3598.4, CNVR3598.5, CNVR3598.11@ARHGEF5_6, ARHGEF5_7, ARHGEF5_8, ARHGEF5_9, ARHGEF5_10, ARHGEF5_11@0@0@0@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
F03513@79501@79501@duplication@1@149981843@149981934@7@chr7:149981843-149981934@8@220@326@1.48@NA@ACTR3C_6@0@0@0@:ARP3 actin-related protein 3 homolog C (yeast)@:actin binding;regulation of actin filament polymerization;cytoskeleton;ATP binding@NA
F03513@80367@80377@deletion@11@7272484@7343904@8@chr8:7272484-7343904@28.4@506@260@0.514@CNVR3771.8, CNVR3771.10, CNVR3771.4@DEFB4B_2, DEFB4B_1, DEFB103B_2, DEFB103B_1, SPAG11B_3, SPAG11B_2, SPAG11B_1, DEFB104B_2, DEFB104B_1, DEFB106B_2, DEFB106B_1@0@0@0@:defensin, beta 4B;defensin, beta 4A:defensin, beta 103B;defensin, beta 103A:sperm associated antigen 11B:defensin, beta 104A;defensin, beta 104B:defensin, beta 106B;defensin, beta 106A@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
F03513@80388@80394@deletion@7@7637545@7680945@8@chr8:7637545-7680945@20.5@228@93@0.408@CNVR3772.4, CNVR3772.6, CNVR3772.2, CNVR3772.8, CNVR3772.10@AC084121.16_3, AC084121.16_2, AC084121.16_1, DEFB107A_2, DEFB107A_1, DEFB105A_3, DEFB105A_2@0@0@0@:uncharacterized LOC100133251:defensin, beta 107B;defensin, beta 107A:defensin, beta 105B;defensin, beta 105A@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
F03513@80565@80567@deletion@3@11994678@12043034@8@chr8:11994678-12043034@5.41@40@11@0.275@CNVR3785.8, CNVR3785.5, CNVR3785.2, CNVR3785.3@USP17L2_1, FAM86B1_8, FAM86B1_7@0@0@0@:ubiquitin specific peptidase 17-like family member 1, pseudogene;ubiquitin specific peptidase 17-like family member 2;ubiquitin specific peptidase 17-like family member 4;ubiquitin specific peptidase 17-like family member 7;ubiquitin specific peptidase 17-like family member 8;ubiquitin specific peptidase 17-like family member 3:family with sequence similarity 86, member B2;family with sequence similarity 86, member B1@:protein deubiquitination;ubiquitin-specific protease activity;mitotic cell cycle G1/S transition checkpoint;nucleus;G2/M transition checkpoint;apoptotic process;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
F03513@88584@88594@duplication@11@43624656@43818184@9@chr9:43624656-43818184@19.3@322@515@1.6@CNVR4294.1@SPATA31A6_4, SPATA31A6_3, SPATA31A6_2, SPATA31A6_1, CNTNAP3B_1, CNTNAP3B_2, CNTNAP3B_3, CNTNAP3B_4, CNTNAP3B_5, CNTNAP3B_6, CNTNAP3B_7@0@0@0@:SPATA31 subfamily A, member 6:contactin associated protein-like 3B;contactin associated protein-like 3@:integral to membrane:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
F03513@91242@91243@deletion@2@117085415@117086085@9@chr9:117085415-117086085@5.6@603@421@0.698@CNVR4448.1@ORM1_1, ORM1_2@0@0@0@:orosomucoid 1@:protein binding;extracellular space;regulation of immune system process;transport;inflammatory response;extracellular region;acute-phase response@NA
F03513@95346@95350@duplication@5@17813309@17865474@10@chr10:17813309-17865474@6.68@134@205@1.53@NA@TMEM236_2, TMEM236_3, TMEM236_4, MRC1L1_1, MRC1L1_2@0@0@0@:transmembrane protein 236;transmembrane protein 236-like:macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding@NA
F03513@95384@95386@deletion@3@18112045@18122792@10@chr10:18112045-18122792@17@149@51@0.342@NA@MRC1_2, MRC1_3, MRC1_4@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F03513@95389@95391@duplication@3@18138509@18145281@10@chr10:18138509-18145281@10.3@101@190@1.88@NA@MRC1_7, MRC1_8, MRC1_9@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F03513@95947@95947@deletion@1@29578048@29578159@10@chr10:29578048-29578159@5.83@91@46@0.505@NA@LYZL1_1@0@0@0@:lysozyme-like 1@:extracellular region;lysozyme activity;cell wall macromolecule catabolic process@NA
F03513@96573@96581@deletion@9@48025301@48055018@10@chr10:48025301-48055018@17@471@284@0.603@CNVR4715.2@ASAH2C_9, ASAH2C_8, ASAH2C_7, ASAH2C_6, ASAH2C_5, ASAH2C_4, ASAH2C_3, ASAH2C_2, ASAH2C_1@0@0@0@@:ceramidase activity;sphingolipid metabolic process@NA
F03513@96932@96939@duplication@8@51965743@51994312@10@chr10:51965743-51994312@20.7@158@316@2@NA@ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7, ASAH2_6, ASAH2_5@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
F03513@101148@101149@duplication@2@117154170@117185812@10@chr10:117154170-117185812@6.11@127@193@1.52@NA@ATRNL1_20, ATRNL1_21@0@0@0@:attractin-like 1@:carbohydrate binding;multicellular organismal development;protein binding;integral to membrane;receptor activity;G-protein coupled receptor signaling pathway;membrane@NA
F03513@101609@101611@duplication@3@124345577@124350210@10@chr10:124345577-124350210@7.68@295@409@1.39@CNVR4912.4, CNVR4912.3, CNVR4912.2@DMBT1_16, DMBT1_17, DMBT1_18@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
F03513@102337@102337@duplication@1@135439427@135439503@10@chr10:135439427-135439503@11.4@143@252@1.76@CNVR4989.11, CNVR4989.4@FRG2B_3@0@0@0@:FSHD region gene 2 family, member B@:nucleus@NA
F03513@103269@103269@duplication@1@4976003@4976943@11@chr11:4976003-4976943@41.9@474@1003@2.12@CNVR5040.1@OR51A2_1@0@0@0@:matrix metallopeptidase 26:olfactory receptor, family 51, subfamily A, member 2@:metallopeptidase activity;extracellular matrix;proteolysis;proteinaceous extracellular matrix;collagen catabolic process;metalloendopeptidase activity;zinc ion binding;metabolic process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F03513@103289@103289@deletion@1@5270599@5270820@11@chr11:5270599-5270820@4.6@46@18@0.391@NA@HBG1_2@0@0@0@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
F03513@103342@103342@deletion@1@5798891@5799864@11@chr11:5798891-5799864@5.73@590@409@0.693@CNVR5049.1@OR52N5_1@0@0@0@:tripartite motif containing 5:olfactory receptor, family 52, subfamily N, member 5@:defense response to virus;Golgi apparatus;intracellular;protein trimerization;ligase activity;cytoplasm;protein binding;nucleus;protein homodimerization activity;identical protein binding;zinc ion binding;cytoplasmic mRNA processing body;protein ubiquitination;virus-host interaction:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F03513@106046@106047@deletion@2@55370918@55406772@11@chr11:55370918-55406772@11.6@1408@984@0.699@CNVR5179.1@OR4C11_1, OR4P4_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F03513@110109@110109@deletion@1@89531299@89531797@11@chr11:89531299-89531797@14.9@329@176@0.535@NA@TRIM49_8@0@0@0@:tripartite motif containing 49@:protein binding;intracellular;DNA binding;zinc ion binding@NA
F03513@110126@110126@duplication@1@89774220@89774718@11@chr11:89774220-89774718@13@228@374@1.64@NA@TRIM49C_8@0@0@0@:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;DNA binding;zinc ion binding@NA
F03513@114083@114083@deletion@1@7966913@7967130@12@chr12:7966913-7967130@4.9@155@95@0.613@NA@SLC2A14_16@0@0@0@:NECAP endocytosis associated 1:solute carrier family 2 (facilitated glucose transporter), member 14@:coated pit;protein binding;endocytosis;protein transport;clathrin vesicle coat;plasma membrane;membrane:multicellular organismal development;cell differentiation;substrate-specific transmembrane transporter activity;transport;folic acid binding;glucose transmembrane transporter activity;transmembrane transport;spermatogenesis;reduced folate carrier activity;integral to membrane;transmembrane transporter activity;membrane@NA
F03513@114426@114426@deletion@1@10586391@10586541@12@chr12:10586391-10586541@6.34@188@113@0.601@CNVR5430.1@KLRC2_4@0@0@0@:killer cell lectin-like receptor subfamily C, member 2@:carbohydrate binding:transmembrane signaling receptor activity;carbohydrate binding;protein binding;signal transduction;cellular defense response;integral to plasma membrane@NA
F03513@114468@114469@duplication@2@11034835@11035297@12@chr12:11034835-11035297@6.33@126@194@1.54@NA@PRH1_4, PRH1_3@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):proline-rich protein HaeIII subfamily 1@:extracellular space;visual perception:protein binding;extracellular space@NA
F03513@115344@115346@deletion@3@27648614@27786393@12@chr12:27648614-27786393@17.5@280@141@0.504@NA@C12orf70_8, C12orf70_9, PPFIBP1_3@0@0@0@:chromosome 12 open reading frame 70:PTPRF interacting protein, binding protein 1 (liprin beta 1)@:integral to membrane:protein binding;integrase activity;cell adhesion;DNA integration;plasma membrane;DNA binding@NA
F03513@116793@116793@deletion@1@50528330@50528485@12@chr12:50528330-50528485@21.1@255@102@0.4@NA@CERS5_9@0@0@0@:cytochrome c oxidase assembly homolog 14 (S. cerevisiae):ceramide synthase 5@:mitochondrion;mitochondrial respiratory chain complex IV assembly;integral to membrane;mitochondrial membrane:phospholipid metabolic process;sphingosine N-acyltransferase activity;small molecule metabolic process;endoplasmic reticulum;sequence-specific DNA binding;DNA binding;regulation of transcription, DNA-dependent;sphingolipid metabolic process;sequence-specific DNA binding transcription factor activity;ceramide biosynthetic process;nuclear membrane;integral to membrane;nucleus;endoplasmic reticulum membrane;sphingolipid biosynthetic process@NA
F03513@117171@117171@deletion@1@52865851@52866064@12@chr12:52865851-52866064@5.35@123@70@0.569@NA@KRT6C_2@0@0@0@:keratin 6C@:intermediate filament;structural molecule activity;keratin filament;cytoskeleton organization@NA
F03513@127258@127301@duplication@44@114498122@114839312@13@chr13:114498122-114839312@164@5019@7201@1.43@NA@TMEM255B_4, TMEM255B_5, TMEM255B_6, TMEM255B_7, TMEM255B_8, TMEM255B_9, GAS6_15, GAS6_14, GAS6_13, GAS6_12, GAS6_11, GAS6_10, GAS6_9, GAS6_8, GAS6_7, GAS6_6, GAS6_5, GAS6_4, GAS6_2, GAS6_1, RASA3_24, RASA3_23, RASA3_22, RASA3_21, RASA3_20, RASA3_19, RASA3_18, RASA3_17, RASA3_16, RASA3_15, RASA3_14, RASA3_13, RASA3_12, RASA3_11, RASA3_10, RASA3_9, RASA3_8, RASA3_7, RASA3_6, RASA3_5, RASA3_4, RASA3_3, RASA3_2@0@0@0@:family with sequence similarity 70, member B:growth arrest-specific 6:RAS p21 protein activator 3@:integral to membrane:platelet degranulation;hematopoietic stem cell migration to bone marrow;dendritic cell differentiation;negative regulation of oligodendrocyte apoptotic process;platelet aggregation;peptidyl-serine phosphorylation;negative regulation of renal albumin absorption;positive regulation of ERK1 and ERK2 cascade;neuron migration;enzyme linked receptor protein signaling pathway;negative regulation of transcription, DNA-dependent;negative regulation of interleukin-6 secretion;positive regulation of fibroblast proliferation;cysteine-type endopeptidase inhibitor activity involved in apoptotic process;regulation of growth;cellular response to drug;virion attachment, binding of host cell surface receptor;protein targeting to plasma membrane;platelet activation;phosphatidylserine binding;cell migration;endoplasmic reticulum lumen;protein kinase B signaling cascade;negative regulation of dendritic cell apoptotic process;negative regulation of interleukin-6 production;positive regulation of protein tyrosine kinase activity;negative regulation of tumor necrosis factor-mediated signaling pathway;receptor tyrosine kinase binding;viral entry into host cell;protein tyrosine kinase activator activity;cell cycle arrest;macrophage cytokine production;cellular response to interferon-alpha;cellular response to growth factor stimulus;positive regulation of protein kinase B signaling cascade;protein phosphorylation;positive regulation of protein kinase activity;cytoplasm;activation of protein kinase B activity;cell proliferation;positive regulation of protein phosphorylation;signal transduction;extracellular region;cellular protein metabolic process;cell adhesion;leukocyte migration;voltage-gated calcium channel activity;negative regulation of apoptotic process;negative regulation of interferon-gamma production;phagocytosis;post-translational protein modification;positive regulation of protein export from nucleus;positive regulation of TOR signaling cascade;proteolysis;negative regulation of interleukin-1 secretion;cellular response to glucose stimulus;extracellular matrix assembly;receptor binding;positive regulation of dendritic cell chemotaxis;cell-substrate adhesion;intracellular;platelet alpha granule lumen;Golgi lumen;negative regulation of tumor necrosis factor production;negative regulation of fibroblast apoptotic process;cellular response to vitamin K;organ regeneration;positive regulation of natural killer cell differentiation;B cell chemotaxis;calcium ion binding;positive regulation of peptidyl-serine phosphorylation;negative regulation of endothelial cell apoptotic process;viral entry into host cell via membrane fusion with the plasma membrane;negative regulation of biomineral tissue development;apoptotic cell clearance;viral genome replication;extracellular space;blood coagulation;negative regulation of sequence-specific DNA binding transcription factor activity;positive regulation of phagocytosis;positive regulation of cytokine-mediated signaling pathway;cellular response to starvation;negative regulation of protein import into nucleus, translocation;positive regulation of gene expression;binding, bridging;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;peptidyl-glutamic acid carboxylation;positive regulation of glomerular filtration;protein binding;receptor agonist activity:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;intrinsic to internal side of plasma membrane;signal transduction;protein binding;calcium-release channel activity;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
F03513@127352@127353@deletion@2@20019701@20216528@14@chr14:20019701-20216528@5.51@585@417@0.713@CNVR6072.6, CNVR6072.12, CNVR6072.14@POTEM_1, OR4Q3_1@0@0@0@:POTE ankyrin domain family, member M:olfactory receptor, family 4, subfamily N, member 2:olfactory receptor, family 4, subfamily Q, member 3@:protein binding:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F03513@133349@133351@duplication@3@106090814@106091716@14@chr14:106090814-106091716@8.63@371@508@1.37@CNVR6294.46, CNVR6294.20, CNVR6294.54, CNVR6294.43, CNVR6294.50, CNVR6294.61@IGHG4_4, IGHG4_3, IGHG4_2@0@0@0@@:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response@NA
F03513@133450@133451@duplication@2@106725202@106725654@14@chr14:106725202-106725654@15.5@673@956@1.42@CNVR6294.48, CNVR6294.24, CNVR6294.40, CNVR6294.38, CNVR6294.17, CNVR6294.23@IGHV3-23_2, IGHV3-23_1@0@0@0@@:protein binding@NA
F03513@133460@133463@deletion@4@106805210@106816173@14@chr14:106805210-106816173@13@479@301@0.628@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.41@IGHV4-31_2, IGHV4-31_1, IGHV3-33_2, IGHV3-33_1@0@0@0@@:protein binding:protein binding@NA
F03513@133491@133492@duplication@2@107095127@107095561@14@chr14:107095127-107095561@12.4@63@153@2.43@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61_2, IGHV4-61_1@0@0@0@@:protein binding@NA
F03513@133495@133496@duplication@2@107131034@107131481@14@chr14:107131034-107131481@10.6@244@371@1.52@CNVR6294.56, CNVR6294.16@IGHV3-66_2, IGHV3-66_1@0@0@0@@:protein binding@NA
F03513@134008@134011@deletion@4@30654497@30664544@15@chr15:30654497-30664544@16@244@124@0.508@CNVR6337.1@CHRFAM7A_10, CHRFAM7A_9, CHRFAM7A_8, CHRFAM7A_7@0@0@0@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
F03513@138281@138288@deletion@8@72953606@72958039@15@chr15:72953606-72958039@10.2@57@8@0.14@CNVR6443.1@GOLGA6B_8, GOLGA6B_9, GOLGA6B_10, GOLGA6B_11, GOLGA6B_12, GOLGA6B_13, GOLGA6B_14, GOLGA6B_15@0@0@0@:golgin A6 family, member B@:Golgi apparatus@NA
F03513@140958@140964@duplication@7@1278901@1291700@16@chr16:1278901-1291700@6.84@177@256@1.45@CNVR6591.1@TPSB2_6, TPSB2_5, TPSB2_4, TPSB2_3, TPSB2_2, TPSAB1_2, TPSAB1_3, TPSAB1_4@0@0@0@:tryptase beta 2 (gene/pseudogene):tryptase alpha/beta 1@:proteolysis;catalytic activity;serine-type endopeptidase activity:serine-type peptidase activity;extracellular matrix;extracellular matrix organization;catalytic activity;extracellular matrix disassembly;proteolysis;extracellular space;protein binding;extracellular region;defense response;serine-type endopeptidase activity@NA
F03513@144097@144099@deletion@3@28617378@28618398@16@chr16:28617378-28618398@7.27@543@372@0.685@CNVR6685.1, CNVR6685.2@SULT1A1_9, SULT1A1_8, SULT1A1_7@0@0@0@:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1@:small molecule metabolic process;sulfation;aryl sulfotransferase activity;amine metabolic process;catecholamine metabolic process;xenobiotic metabolic process;cytosol;steroid sulfotransferase activity;integral to membrane;sulfotransferase activity;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process;estrogen metabolic process@NA
F03513@147091@147099@deletion@9@69988238@69996970@16@chr16:69988238-69996970@16.1@94@15@0.16@CNVR6762.3, CNVR6762.1, CNVR6762.4@CLEC18A_3, CLEC18A_4, CLEC18A_5, CLEC18A_6, CLEC18A_7, CLEC18A_8, CLEC18A_9, CLEC18A_10, CLEC18A_11@0@0@0@:C-type lectin domain family 18, member A@:carbohydrate binding;protein binding;extracellular region@NA
F03513@147101@147101@duplication@1@70010292@70010635@16@chr16:70010292-70010635@7.27@57@115@2.02@CNVR6762.3, CNVR6762.2@RP11-419C5.2_7@0@0@0@NA@NA@NA
F03513@147135@147135@duplication@1@70219789@70219879@16@chr16:70219789-70219879@6.05@46@94@2.04@CNVR6764.1, CNVR6764.5@CLEC18C_11@0@0@0@:C-type lectin domain family 18, member C@:carbohydrate binding;protein binding;extracellular region@NA
F03513@151404@151404@duplication@1@15468848@15469578@17@chr17:15468848-15469578@6.53@751@988@1.32@NA@CDRT1_1@0@0@0@:CMT1A duplicated region transcript 1@:protein binding;molecular_function;cellular_component;biological_process@NA
F03513@151430@151431@deletion@2@15638664@15638993@17@chr17:15638664-15638993@5.3@113@64@0.566@CNVR7003.1@TBC1D26_3, TBC1D26_4@0@0@0@:zinc finger protein 286A:zinc finger protein 286A:TBC1 domain family, member 26@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
F03513@151556@151561@duplication@6@16664740@16676947@17@chr17:16664740-16676947@45.9@942@1472@1.56@NA@CCDC144A_13, CCDC144A_13, CCDC144A_14, CCDC144A_14, CCDC144A_15, CCDC144A_15, CCDC144A_16, CCDC144A_16, CCDC144A_17, CCDC144A_18, CCDC144A_17@0@0@0@:coiled-coil domain containing 144A@NA@NA
F03513@151876@151883@deletion@8@18387190@18395859@17@chr17:18387190-18395859@50.1@382@103@0.27@CNVR7014.1@LGALS9C_2, LGALS9C_3, LGALS9C_4, LGALS9C_5, LGALS9C_6, LGALS9C_7, LGALS9C_8, LGALS9C_9@0@0@0@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
F03513@151958@151959@deletion@2@18996506@18997166@17@chr17:18996506-18997166@10.8@179@90@0.503@CNVR7018.4, CNVR7018.2, CNVR7018.6@AC007952.5_1, AC007952.5_2@0@0@0@NA@NA@NA
F03513@152124@152126@duplication@3@20355109@20356380@17@chr17:20355109-20356380@5.81@158@229@1.45@CNVR7021.1, CNVR7021.3@LGALS9B_9, LGALS9B_8, LGALS9B_7@0@0@0@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
F03513@153380@153381@deletion@2@34539179@34539971@17@chr17:34539179-34539971@7.19@34@1@0.0294@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1_2, CCL4L1_3@0@0@0@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
F03513@153650@153660@deletion@11@36351930@36398302@17@chr17:36351930-36398302@165@4004@2162@0.54@CNVR7083.3@RP11-1407O15.2_12, RP11-1407O15.2_11, RP11-1407O15.2_10, RP11-1407O15.2_9, RP11-1407O15.2_8, RP11-1407O15.2_7, RP11-1407O15.2_6, RP11-1407O15.2_5, RP11-1407O15.2_4, RP11-1407O15.2_3, RP11-1407O15.2_2@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
F03513@154346@154346@deletion@1@39421631@39422112@17@chr17:39421631-39422112@5.48@46@15@0.326@CNVR7096.1@KRTAP9-6_1@0@0@0@:keratin associated protein 9-6@:keratin filament@NA
F03513@155581@155581@duplication@1@44248222@44249509@17@chr17:44248222-44249509@13.4@1699@2305@1.36@CNVR7114.3, CNVR7114.2, CNVR7114.8@KANSL1_2@0@0@0@:KAT8 regulatory NSL complex subunit 1@:histone acetyltransferase activity (H4-K8 specific);histone acetyltransferase activity (H4-K16 specific);histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase complex;histone H4-K5 acetylation;MLL1 complex;histone H4-K16 acetylation;protein binding;histone H4-K8 acetylation;nucleus@NA
F03513@155587@155590@deletion@4@44399689@44409347@17@chr17:44399689-44409347@13.1@74@10@0.135@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
F03513@155593@155595@deletion@3@44414663@44415089@17@chr17:44414663-44415089@15.6@72@1@0.0139@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_12, LRRC37A_13, LRRC37A_14@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
F03513@155604@155628@duplication@25@44617543@44782220@17@chr17:44617543-44782220@63.6@812@1441@1.77@CNVR7114.2, CNVR7114.4@LRRC37A2_7, LRRC37A2_8, LRRC37A2_9, LRRC37A2_10, LRRC37A2_11, LRRC37A2_12, LRRC37A2_13, LRRC37A2_14, LRRC37A2_15, ARL17A_4, ARL17A_3, ARL17A_2, NSF_2, NSF_3, NSF_4, NSF_5, NSF_6, NSF_7, NSF_8, NSF_9, NSF_10, NSF_11, NSF_12, NSF_13@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:N-ethylmaleimide-sensitive factor@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:PDZ domain binding;Rab GTPase binding;regulation of exocytosis;ATP binding;Golgi stack;protein transport;protein C-terminus binding;plasma membrane;dendritic shaft;potassium ion transport;nucleoside-triphosphatase activity;exocytosis;positive regulation of receptor recycling;nucleotide binding;plasma membrane fusion;cytoplasm;cytosol;protein binding;vesicle-mediated transport;ATPase activity, coupled;protein complex binding;synaptic transmission;syntaxin binding;metal ion binding@NA
F03513@156877@156878@duplication@2@57656834@57657240@17@chr17:57656834-57657240@8.04@85@154@1.81@NA@DHX40_9, DHX40_10@0@0@0@:DEAH (Asp-Glu-Ala-His) box polypeptide 40@:transport;helicase activity;intracellular;ATP-dependent helicase activity;nucleic acid binding;ATP binding@NA
F03513@162019@162019@deletion@1@44554574@44556213@18@chr18:44554574-44556213@9.69@119@52@0.437@CNVR7319.1@TCEB3C_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C (elongin A3);RNA polymerase II transcription factor SIII subunit A3-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
F03513@166364@166364@deletion@1@12404048@12404190@19@chr19:12404048-12404190@5.58@122@69@0.566@NA@ZNF44_2@0@0@0@:zinc finger protein ZnFP12-like;zinc finger protein 44@:intracellular;DNA binding;regulation of transcription, DNA-dependent;cytoplasm;microtubule cytoskeleton;nucleus;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
F03513@166811@166811@deletion@1@14070580@14070707@19@chr19:14070580-14070707@10.9@183@92@0.503@NA@DCAF15_9@0@0@0@:DDB1 and CUL4 associated factor 15@:protein ubiquitination@NA
F03513@166916@166917@duplication@2@14508471@14508747@19@chr19:14508471-14508747@5.64@90@144@1.6@NA@CD97_7, CD97_8@0@0@0@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
F03513@168952@168952@deletion@1@35862263@35863302@19@chr19:35862263-35863302@31.4@148@2@0.0135@CNVR7627.1@GPR42_2@0@0@0@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
F03513@170098@170100@duplication@3@40376632@40382826@19@chr19:40376632-40382826@11.3@131@230@1.76@CNVR7639.2@FCGBP_24, FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F03513@170104@170109@deletion@6@40389653@40399855@19@chr19:40389653-40399855@14.8@335@193@0.576@CNVR7639.2, CNVR7639.3@FCGBP_18, FCGBP_17, FCGBP_16, FCGBP_15, FCGBP_14, FCGBP_13@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F03513@172563@172566@duplication@4@50462618@50464192@19@chr19:50462618-50464192@5.8@527@689@1.31@NA@SIGLEC11_5, SIGLEC11_4, SIGLEC11_3, SIGLEC11_2@0@0@0@:sialic acid binding Ig-like lectin 11@:carbohydrate binding;protein binding;integral to membrane;cell adhesion@NA
F03513@173296@173296@duplication@1@54724956@54725251@19@chr19:54724956-54725251@5.06@14@48@3.43@CNVR7721.3, CNVR7721.4@LILRB3_5@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F03513@173298@173298@deletion@1@54726151@54726434@19@chr19:54726151-54726434@13.8@64@1@0.0156@CNVR7721.3, CNVR7721.4@LILRB3_3@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F03513@173305@173308@duplication@4@54745453@54746600@19@chr19:54745453-54746600@20.2@522@775@1.48@CNVR7721.3, CNVR7721.6@LILRA6_4, LILRA6_3, LILRA6_2, LILRA6_1@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F03513@173490@173491@duplication@2@55336484@55340920@19@chr19:55336484-55340920@8.07@146@229@1.57@CNVR7725.1, CNVR7725.6, CNVR7725.8@KIR3DL1_6, KIR3DL1_7@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
F03513@173499@173501@deletion@3@55358640@55359398@19@chr19:55358640-55359398@14@756@496@0.656@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4_6, KIR2DS4_7, KIR2DS4_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
F03513@174395@174395@duplication@1@1569207@1569278@20@chr20:1569207-1569278@7.59@44@101@2.3@CNVR7763.1@RP4-576H24.4_1@0@0@0@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
F03513@174403@174403@duplication@1@1895746@1896101@20@chr20:1895746-1896101@10.5@168@278@1.65@CNVR7764.2@SIRPA_2@0@0@0@:signal-regulatory protein alpha@:blood coagulation;protein binding;integral to membrane;SH3 domain binding;cell adhesion;plasma membrane;membrane;leukocyte migration@NA
F03513@181807@181808@deletion@2@23247056@23248831@22@chr22:23247056-23248831@5.08@289@192@0.664@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11@IGLJ3_1, IGLC3_1@0@0@0@@:protein binding@NA
F03513@181948@181949@deletion@2@24324820@24325235@22@chr22:24324820-24325235@5.57@44@14@0.318@CNVR8114.6, CNVR8114.13, CNVR8114.8, CNVR8114.14@GSTT2_3, GSTT2_4@0@0@0@@:protein binding;glutathione transferase activity;nucleus;cytoplasm@NA
F03513@181951@181955@duplication@5@24376424@24384231@22@chr22:24376424-24384231@14.2@576@794@1.38@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTT1_5, GSTT1_4, GSTT1_3, GSTT1_2, GSTT1_1@0@0@0@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
F03513@184154@184154@deletion@1@42537163@42537296@22@chr22:42537163-42537296@6.18@99@50@0.505@CNVR8168.1, CNVR8168.3, CNVR8168.4@CYP2D7P1_3@0@0@0@@:oxidation-reduction process;electron carrier activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;heme binding@NA
F03513@1896@1896@duplication@1@48269422@48269516@X@chrX:48269422-48269516@4.87@12@43@3.58@CNVR8324.2@SSX4B_4@0@0@0@NA@NA@NA
F03513@4072@4079@deletion@8@101615523@101620252@X@chrX:101615523-101620252@16.1@74@1@0.0135@NA@NXF2B_34, NXF2B_33, NXF2B_32, NXF2B_31, NXF2B_30, NXF2B_29, NXF2B_28, NXF2B_27@0@0@0@NA@NA@NA
F03513@4884@4884@duplication@1@119210843@119211253@X@chrX:119210843-119211253@5.74@25@64@2.56@NA@RHOXF2B_2@0@0@0@NA@NA@NA
F03513@5719@5719@duplication@1@140336520@140336590@X@chrX:140336520-140336590@6.41@62@114@1.84@CNVR8456.1@SPANXC_1@0@0@0@NA@NA@NA
F03513@6284@6285@duplication@2@153416129@153418581@X@chrX:153416129-153418581@6.59@53@104@1.96@CNVR8489.1@OPN1LW_2, OPN1LW_3@0@0@0@NA@NA@NA
F03566@6@6@deletion@1@69092@70008@1@chr1:69092-70008@9.97@45@0@0@CNVR1.1, CNVR1.2@OR4F5_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F03566@418@419@duplication@2@1607504@1608138@1@chr1:1607504-1608138@11.4@84@177@2.11@CNVR17.1@SLC35E2B_4, SLC35E2B_3@0@0@0@:solute carrier family 35, member E2B@:integral to membrane;membrane;transmembrane transport@NA
F03566@422@422@deletion@1@1634916@1635063@1@chr1:1634916-1635063@6.1@161@95@0.59@CNVR17.1@CDK11A_18@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
F03566@442@443@deletion@2@1670362@1670996@1@chr1:1670362-1670996@11.8@123@48@0.39@CNVR17.1@SLC35E2_3, SLC35E2_2@0@0@0@:solute carrier family 35, member E2@:integral to membrane;membrane@NA
F03566@2788@2788@deletion@1@21806545@21806716@1@chr1:21806545-21806716@5.24@29@4@0.138@CNVR107.2, CNVR107.1@NBPF3_11@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 3@:cytoplasm@NA
F03566@2966@2966@deletion@1@22329497@22329581@1@chr1:22329497-22329581@8.35@79@29@0.367@CNVR108.2, CNVR108.1@CELA3A_2@0@0@0@:chymotrypsin-like elastase family, member 3A@:proteolysis;digestion;cholesterol metabolic process;catalytic activity;serine-type endopeptidase activity@NA
F03566@3333@3342@duplication@10@25599040@25655415@1@chr1:25599040-25655415@53.3@1393@2087@1.5@CNVR116.1, CNVR116.2@RHD_1, RHD_2, RHD_3, RHD_4, RHD_5, RHD_6, RHD_7, RHD_8, RHD_9, RHD_10@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
F03566@3357@3357@deletion@1@25735175@25735360@1@chr1:25735175-25735360@24@117@4@0.0342@CNVR117.1@RHCE_2@0@0@0@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
F03566@5196@5196@duplication@1@40235375@40236927@1@chr1:40235375-40236927@6.12@402@542@1.35@NA@OXCT2_1@0@0@0@:bone morphogenetic protein 8b:3-oxoacid CoA transferase 2@:cell differentiation;growth factor activity;extracellular space;growth;extracellular region;cytokine activity;cartilage development;skeletal system development;ossification:mitochondrion;microtubule-based flagellum;CoA-transferase activity;ketone body catabolic process;3-oxoacid CoA-transferase activity;metabolic process@NA
F03566@9365@9374@duplication@10@104202983@104234232@1@chr1:104202983-104234232@10.3@103@186@1.81@CNVR266.3, CNVR266.1, CNVR266.15@AMY1A_7, AMY1A_8, AMY1A_9, AMY1A_10, AMY1A_11, AMY1B_11, AMY1B_10, AMY1B_9, AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
F03566@9436@9437@deletion@2@108769302@108771778@1@chr1:108769302-108771778@19.6@198@76@0.384@CNVR294.4@NBPF4_14, NBPF4_13@0@0@0@:neuroblastoma breakpoint family, member 4@:cytoplasm@NA
F03566@9460@9461@duplication@2@109007811@109010287@1@chr1:109007811-109010287@5.87@198@277@1.4@CNVR294.4@NBPF6_13, NBPF6_14@0@0@0@:neuroblastoma breakpoint family, member 6@:cytoplasm@NA
F03566@9766@9773@duplication@8@110230497@110235917@1@chr1:110230497-110235917@61.5@323@784@2.43@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
F03566@12117@12118@duplication@2@152573209@152586574@1@chr1:152573209-152586574@38.1@143@444@3.1@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
F03566@14053@14058@deletion@6@161565346@161600992@1@chr1:161565346-161600992@44.3@1124@658@0.585@CNVR383.1@FCGR2C_1, FCGR3B_5, FCGR3B_4, FCGR3B_3, FCGR3B_2, FCGR3B_1@0@0@0@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene):Fc fragment of IgG, low affinity IIIb, receptor (CD16b)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction:IgG binding;protein binding;extracellular region;immune response;plasma membrane;anchored to membrane@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
F03566@16026@16026@duplication@1@196712583@196712758@1@chr1:196712583-196712758@8.88@498@694@1.39@CNVR459.1@CFH_20@0@0@0@:complement factor H@:complement activation, alternative pathway;extracellular space;complement activation;extracellular region;regulation of complement activation;innate immune response@: HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1; MACULAR DEGENERATION, AGE-RELATED, 4; ARMD4; COMPLEMENT FACTOR H DEFICIENCY; CFHD; BASAL LAMINAR DRUSEN
F03566@16029@16037@duplication@9@196744018@196796135@1@chr1:196744018-196796135@51.9@1315@1978@1.5@CNVR459.1@CFHR3_1, CFHR3_2, CFHR3_3, CFHR3_4, CFHR3_5, CFHR3_6, CFHR1_1, CFHR1_2, CFHR1_3@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
F03566@16039@16040@duplication@2@196799631@196801129@1@chr1:196799631-196801129@18.5@659@959@1.46@CNVR459.1@CFHR1_5, CFHR1_6@0@0@0@:complement factor H-related 1:complement factor H-related 2@:extracellular space;complement activation:extracellular region@NA
F03566@17294@17295@deletion@2@207737210@207737579@1@chr1:207737210-207737579@7.07@37@4@0.108@CNVR485.1, CNVR485.2@CR1_22, CR1_23@0@0@0@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
F03566@18283@18283@deletion@1@226074428@226074790@1@chr1:226074428-226074790@4.69@132@80@0.606@NA@LEFTY1_4, RP4-559A3.7_8@0@0@0@:left-right determination factor 1@:growth factor activity;cell growth;transforming growth factor beta receptor signaling pathway;extracellular space;negative regulation of transcription from RNA polymerase II promoter;growth;transforming growth factor beta receptor binding;heart morphogenesis;cytokine activity;determination of left/right symmetry:oxidation-reduction process;oxidoreductase activity;proline biosynthetic process;pyrroline-5-carboxylate reductase activity;nucleotide binding@NA
F03566@19770@19770@duplication@1@248636653@248637608@1@chr1:248636653-248637608@8.88@1050@1406@1.34@NA@OR2T3_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 3@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F03566@19774@19776@deletion@3@248737103@248790429@1@chr1:248737103-248790429@291@2556@540@0.211@CNVR600.1@OR2T34_1, OR2T10_1, OR2T11_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 34:olfactory receptor, family 2, subfamily T, member 10:olfactory receptor, family 2, subfamily T, member 11@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F03566@19778@19778@deletion@1@248813233@248814185@1@chr1:248813233-248814185@65.1@578@110@0.19@NA@OR2T27_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 27@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F03566@24407@24407@duplication@1@79253840@79253957@2@chr2:79253840-79253957@4.65@98@149@1.52@NA@REG3G_3@0@0@0@:regenerating islet-derived 3 gamma@:carbohydrate binding;extracellular region;acute-phase response@NA
F03566@24967@24968@deletion@2@89567759@89568232@2@chr2:89567759-89568232@5.98@105@57@0.543@CNVR866.7, CNVR866.1@IGKV1-33_2, IGKV1-33_1@0@0@0@@:protein binding@NA
F03566@24982@24997@deletion@16@89975705@90109080@2@chr2:89975705-90109080@100@2343@1300@0.555@CNVR867.10, CNVR867.1@IGKV2D-30_1, IGKV2D-30_2, IGKV2D-29_1, IGKV2D-29_2, IGKV2D-28_1, IGKV2D-28_2, IGKV2D-26_1, IGKV2D-26_2, IGKV2D-24_1, IGKV2D-24_2, IGKV6D-21_1, IGKV6D-21_2, IGKV3D-20_1, IGKV3D-20_2, IGKV6D-41_1, IGKV6D-41_2@0@0@0@@:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding@NA
F03566@25001@25004@deletion@4@90139286@90193002@2@chr2:90139286-90193002@7.81@309@199@0.644@CNVR867.10, CNVR867.5, CNVR867.3, CNVR867.9@IGKV1D-16_2, IGKV3D-15_1, IGKV3D-15_2, IGKV1D-13_1@0@0@0@@:protein binding:protein binding:protein binding@NA
F03566@25006@25015@deletion@10@90198717@90260248@2@chr2:90198717-90260248@74@1585@848@0.535@CNVR867.10, CNVR867.3, CNVR867.2, CNVR867.16@IGKV1D-12_1, IGKV1D-12_2, IGKV3D-11_1, IGKV3D-11_2, IGKV1D-42_1, IGKV1D-42_2, IGKV1D-43_1, IGKV1D-43_2, IGKV1D-8_1, IGKV1D-8_2@0@0@0@@:protein binding:protein binding:protein binding:protein binding:protein binding@NA
F03566@25383@25384@deletion@2@97867940@97868130@2@chr2:97867940-97868130@8.55@320@203@0.634@CNVR886.1@ANKRD36_47, ANKRD36_48@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
F03566@25393@25401@deletion@9@97877284@97884815@2@chr2:97877284-97884815@18.5@791@510@0.645@NA@ANKRD36_57, ANKRD36_58, ANKRD36_59, ANKRD36_60, ANKRD36_61, ANKRD36_62, ANKRD36_63, ANKRD36_64, ANKRD36_65@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
F03566@27341@27342@deletion@2@132288153@132289375@2@chr2:132288153-132289375@19.4@189@70@0.37@NA@CCDC74A_3, CCDC74A_4@0@0@0@:coiled-coil domain containing 74A@NA@NA
F03566@33043@33043@duplication@1@228195343@228195562@2@chr2:228195343-228195562@5.17@144@210@1.46@NA@MFF_4@0@0@0@:mitochondrial fission factor@:mitochondrion;integral to mitochondrial membrane;positive regulation of release of cytochrome c from mitochondria;peroxisome fission;peroxisome;mitochondrion morphogenesis;regulation of mitochondrion organization;release of cytochrome c from mitochondria;cytoplasm;mitochondrial fragmentation involved in apoptotic process;mitochondrial outer membrane;protein binding;regulation of peroxisome organization;protein homooligomerization;protein targeting to mitochondrion@NA
F03566@34455@34461@duplication@7@242794774@242841289@2@chr2:242794774-242841289@34.5@2399@3292@1.37@NA@PDCD1_2, PDCD1_1, CXXC11_1, CXXC11_2, AC131097.4_3, AC131097.4_2, AC131097.4_1@0@0@0@:programmed cell death 1:CXXC finger protein 11:uncharacterized LOC285095@:multicellular organismal development;T cell costimulation;external side of plasma membrane;signal transducer activity;signal transduction;protein binding;humoral immune response;integral to membrane;apoptotic process;plasma membrane:integral to membrane@: AUTOIMMUNE DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 2; SLEB2
F03566@39502@39502@duplication@1@62267239@62267384@3@chr3:62267239-62267384@9.52@214@333@1.56@NA@PTPRG_27@0@0@0@:protein tyrosine phosphatase, receptor type, G@:phosphatase activity;protein tyrosine phosphatase activity;protein dephosphorylation;protein binding;transmembrane receptor protein tyrosine kinase signaling pathway;dephosphorylation;integral to plasma membrane;identical protein binding;transmembrane receptor protein tyrosine phosphatase activity;peptidyl-tyrosine dephosphorylation@NA
F03566@45434@45438@deletion@5@195451552@195475935@3@chr3:195451552-195475935@27@2240@1487@0.664@CNVR1703.1, CNVR1703.2, CNVR1703.5, CNVR1703.3@MUC20_2, MUC20_3, MUC20_4, MUC4_25, MUC4_24@0@0@0@:mucin 20, cell surface associated:mucin 4, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane:ErbB-2 class receptor binding;Golgi lumen;cell-matrix adhesion;post-translational protein modification;extracellular matrix structural constituent;protein binding;O-glycan processing;cellular protein metabolic process;proteinaceous extracellular matrix;integral to plasma membrane;membrane;extracellular matrix constituent, lubricant activity;biological_process@NA
F03566@48556@48561@duplication@6@69403344@69434202@4@chr4:69403344-69434202@102@955@2109@2.21@CNVR1953.1@UGT2B17_6, UGT2B17_5, UGT2B17_4, UGT2B17_3, UGT2B17_2, UGT2B17_1@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
F03566@48592@48597@deletion@6@70146220@70160527@4@chr4:70146220-70160527@28@1101@690@0.627@CNVR1957.2, CNVR1957.1@UGT2B28_1, UGT2B28_2, UGT2B28_3, UGT2B28_4, UGT2B28_5, UGT2B28_6@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
F03566@53188@53189@duplication@2@190946717@190947616@4@chr4:190946717-190947616@25.9@701@1083@1.54@CNVR2258.3@FRG2_4, FRG2_3@0@0@0@:FSHD region gene 2-like;FSHD region gene 2@:nucleus@NA
F03566@53306@53317@deletion@12@741710@825366@5@chr5:741710-825366@114@1791@863@0.482@CNVR2280.3@ZDHHC11B_7, ZDHHC11B_6, ZDHHC11B_5, ZDHHC11B_4, ZDHHC11B_3, ZDHHC11B_2, ZDHHC11B_1, ZDHHC11_12, ZDHHC11_11, ZDHHC11_10, ZDHHC11_9, ZDHHC11_8@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
F03566@54849@54849@deletion@1@42629141@42629205@5@chr5:42629141-42629205@42.8@208@2@0.00962@CNVR2445.1@GHR_3@0@0@0@:growth hormone receptor@:neuronal cell body;mitochondrion;proline-rich region binding;JAK-STAT cascade;growth factor binding;nucleus;succinate metabolic process;positive regulation of JAK-STAT cascade;JAK-STAT cascade involved in growth hormone signaling pathway;response to morphine;activation of MAPK activity;peptide hormone binding;response to estradiol stimulus;2-oxoglutarate metabolic process;valine metabolic process;response to cytokine stimulus;hormone-mediated signaling pathway;response to food;SH2 domain binding;oxaloacetate metabolic process;growth hormone receptor signaling pathway;allantoin metabolic process;integral to membrane;response to hormone stimulus;cartilage development involved in endochondral bone morphogenesis;positive regulation of peptidyl-tyrosine phosphorylation;receptor internalization;cytoplasm;cellular response to hormone stimulus;extracellular region;growth hormone receptor complex;positive regulation of tyrosine phosphorylation of Stat5 protein;regulation of multicellular organism growth;growth hormone receptor activity;positive regulation of tyrosine phosphorylation of Stat3 protein;response to peptide hormone stimulus;fatty acid metabolic process;creatinine metabolic process;plasma membrane;positive regulation of multicellular organism growth;receptor complex;protein phosphatase binding;protein kinase binding;creatine metabolic process;response to interleukin-1;response to cycloheximide;extracellular space;positive regulation of cell differentiation;activation of Janus kinase activity;taurine metabolic process;cellular response to insulin stimulus;integral to plasma membrane;protein homodimerization activity;negative regulation of neuron death;citrate metabolic process;endocytosis;isoleucine metabolic process;activation of JAK2 kinase activity;extrinsic to membrane;response to glucocorticoid stimulus;protein binding;insulin-like growth factor receptor signaling pathway;multicellular organismal metabolic process;cell surface@: HYPERCHOLESTEROLEMIA, FAMILIAL; LARON SYNDROME; SHORT STATURE, IDIOPATHIC, AUTOSOMAL
F03566@59065@59065@deletion@1@140557617@140560021@5@chr5:140557617-140560021@19.1@1966@1223@0.622@CNVR2624.1@PCDHB8_1@0@0@0@:protocadherin beta 8@:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding@NA
F03566@60876@60877@deletion@2@175388055@175388437@5@chr5:175388055-175388437@7.77@55@15@0.273@NA@THOC3_5, THOC3_4@0@0@0@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
F03566@61638@61645@duplication@8@180375356@180429785@5@chr5:180375356-180429785@39@1152@1688@1.47@CNVR2719.1@BTNL8_5, BTNL8_6, BTNL8_7, BTNL8_8, BTNL3_1, BTNL3_2, BTNL3_3, BTNL3_4@0@0@0@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
F03566@63290@63292@deletion@3@31323945@31324935@6@chr6:31323945-31324935@9.01@361@236@0.654@CNVR2841.12, CNVR2841.14, CNVR2841.8@HLA-B_3, HLA-B_2, HLA-B_1@0@0@0@:major histocompatibility complex, class I, B@:MHC class I protein complex;regulation of immune response;regulation of interleukin-12 production;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;regulation of T cell anergy;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;receptor binding;early endosome membrane;virus-host interaction;regulation of interleukin-6 production;regulation of dendritic cell differentiation;phagocytic vesicle membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO; SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1
F03566@63726@63726@duplication@1@31962276@31962484@6@chr6:31962276-31962484@5.8@91@149@1.64@CNVR2843.6, CNVR2843.3@C4A_21@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
F03566@63747@63748@duplication@2@31973946@31974881@6@chr6:31973946-31974881@13.2@139@253@1.82@CNVR2843.6, CNVR2843.3@AL645922.1_2, AL645922.1_1@0@0@0@NA@NA@NA
F03566@63768@63776@duplication@9@31994761@31997115@6@chr6:31994761-31997115@20.8@476@712@1.5@CNVR2843.6, CNVR2843.5@C4B_20, C4B_21, C4B_22, C4B_23, C4B_24, C4B_25, C4B_26, C4B_27, C4B_28@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
F03566@63953@63957@deletion@5@32485517@32489951@6@chr6:32485517-32489951@32.9@235@61@0.26@CNVR2845.21, CNVR2845.25, CNVR2845.30@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
F03566@63963@63974@deletion@12@32551887@32634384@6@chr6:32551887-32634384@103@1275@559@0.438@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.34@HLA-DRB1_2, HLA-DRB1_1, HLA-DQA1_1, HLA-DQA1_2, HLA-DQA1_3, HLA-DQA1_4, HLA-DQB1_6, HLA-DQB1_5, HLA-DQB1_4, HLA-DQB1_3, HLA-DQB1_2, HLA-DQB1_1@0@0@0@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
F03566@64602@64606@deletion@5@35754776@35765065@6@chr6:35754776-35765065@24.6@1350@889@0.659@CNVR2861.1@CLPSL1_2, CLPSL1_3, CLPS_3, CLPS_2, CLPS_1@0@0@0@:colipase-like 1:colipase, pancreatic@:extracellular region;enzyme activator activity;digestion;lipid catabolic process:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
F03566@71010@71011@duplication@2@167587242@167590622@6@chr6:167587242-167590622@7.06@261@365@1.4@NA@TCP10L2_3, TCP10L2_4@0@0@0@:t-complex 10;t-complex 10-like 2@NA@NA
F03566@71031@71032@deletion@2@167791444@167794824@6@chr6:167791444-167794824@10.4@206@113@0.549@NA@TCP10_4, TCP10_3@0@0@0@:t-complex 10@:cytosol@NA
F03566@71748@71748@deletion@1@5942293@5942375@7@chr7:5942293-5942375@4.95@165@103@0.624@NA@CCZ1_6@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F03566@71753@71772@duplication@20@5958499@5998709@7@chr7:5958499-5998709@47.3@1768@2491@1.41@NA@CCZ1_11, CCZ1_12, CCZ1_13, CCZ1_14, CCZ1_15, RSPH10B_20, RSPH10B_19, RSPH10B_18, RSPH10B_17, RSPH10B_16, RSPH10B_15, RSPH10B_14, RSPH10B_13, RSPH10B_12, RSPH10B_11, RSPH10B_10, RSPH10B_9, RSPH10B_8, RSPH10B_7, RSPH10B_6@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae):radial spoke head 10 homolog B (Chlamydomonas)@:lysosomal membrane@NA
F03566@71778@71780@duplication@3@6017220@6022622@7@chr7:6017220-6022622@11@215@332@1.54@NA@PMS2_14, PMS2_13, PMS2_12@0@0@0@:PMS2 postmeiotic segregation increased 2 (S. cerevisiae)@:response to drug;DNA binding;MutSalpha complex binding;ATP binding;mismatch repair;DNA repair;mismatched DNA binding;ATPase activity;nucleus;mismatch repair complex;reciprocal meiotic recombination;ATP catabolic process;single-stranded DNA binding;response to DNA damage stimulus;single base insertion or deletion binding;protein binding;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;MutLalpha complex;endonuclease activity@: COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4; MISMATCH REPAIR CANCER SYNDROME
F03566@71926@71934@deletion@9@6805338@6821107@7@chr7:6805338-6821107@47.8@547@214@0.391@NA@RSPH10B2_6, RSPH10B2_7, RSPH10B2_8, RSPH10B2_9, RSPH10B2_10, RSPH10B2_11, RSPH10B2_12, RSPH10B2_13, RSPH10B2_14@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F03566@71936@71944@deletion@9@6826510@6844686@7@chr7:6826510-6844686@67.5@311@4@0.0129@NA@RSPH10B2_16, RSPH10B2_17, RSPH10B2_18, RSPH10B2_19, RSPH10B2_20, CCZ1B_15, CCZ1B_14, CCZ1B_13, CCZ1B_12@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F03566@74246@74246@duplication@1@66660158@66660324@7@chr7:66660158-66660324@5.46@202@285@1.41@NA@TYW1_15@0@0@0@:tRNA-yW synthesizing protein 1 homolog (S. cerevisiae);tRNA-yW synthesizing protein 1 homolog B (S. cerevisiae)@:tRNA processing;4 iron, 4 sulfur cluster binding;iron-sulfur cluster binding;oxidoreductase activity;FMN binding;iron ion binding;catalytic activity@NA
F03566@74792@74793@duplication@2@76240783@76241130@7@chr7:76240783-76241130@19@224@403@1.8@CNVR3463.10@POMZP3_6, POMZP3_5@0@0@0@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
F03566@76428@76432@duplication@5@100333344@100336236@7@chr7:100333344-100336236@13.7@966@1264@1.31@CNVR3509.1@ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
F03566@76549@76549@duplication@1@100633913@100648800@7@chr7:100633913-100648800@9.59@5182@6795@1.31@CNVR3511.1@MUC12_2@0@0@0@:mucin 12, cell surface associated@:O-glycan processing;cellular protein metabolic process;regulation of cell growth;Golgi lumen;molecular_function;integral to plasma membrane;post-translational protein modification@NA
F03566@76779@76779@duplication@1@102279571@102279646@7@chr7:102279571-102279646@7.87@156@246@1.58@CNVR3518.1@UPK3BL_4, UPK3BL_4@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
F03566@79287@79287@deletion@1@143400089@143400710@7@chr7:143400089-143400710@4.74@83@44@0.53@CNVR3594.2, CNVR3594.1@FAM115C_2@0@0@0@:family with sequence similarity 115, member C;protein FAM115C-like@NA@NA
F03566@79309@79311@duplication@3@143880598@143929936@7@chr7:143880598-143929936@11.6@130@229@1.76@CNVR3598.4, CNVR3598.3, CNVR3598.7@CTAGE4_1, ARHGEF35_2, OR2A42_1@0@0@0@:CTAGE family, member 4:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1@:integral to membrane;nucleotide binding;cellular_component;biological_process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F03566@80379@80381@duplication@3@7345659@7353525@8@chr8:7345659-7353525@6.59@8@48@6@CNVR3771.8, CNVR3771.10, CNVR3771.4, CNVR3771.6@DEFB105B_2, DEFB105B_3, DEFB107B_1@0@0@0@:defensin, beta 105B;defensin, beta 105A:defensin, beta 107B;defensin, beta 107A@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
F03566@80388@80403@deletion@16@7637545@7721057@8@chr8:7637545-7721057@51.1@765@384@0.502@CNVR3772.4, CNVR3772.6, CNVR3772.2, CNVR3772.8, CNVR3772.10@AC084121.16_3, AC084121.16_2, AC084121.16_1, DEFB107A_2, DEFB107A_1, DEFB105A_3, DEFB105A_2, DEFB105A_1, DEFB106A_1, DEFB106A_2, DEFB104A_1, DEFB104A_2, SPAG11A_1, SPAG11A_2, SPAG11A_3, SPAG11A_4@0@0@0@:uncharacterized LOC100133251:defensin, beta 107B;defensin, beta 107A:defensin, beta 105B;defensin, beta 105A:defensin, beta 106B;defensin, beta 106A:defensin, beta 104A;defensin, beta 104B:sperm associated antigen 11A;sperm associated antigen 11B@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response@NA
F03566@80738@80738@deletion@1@17581182@17581342@8@chr8:17581182-17581342@10.5@450@278@0.618@CNVR3804.1@MTUS1_4@0@0@0@:microtubule associated tumor suppressor 1@:oxidation-reduction process;mitochondrion;Golgi apparatus;microtubule organizing center;oxidoreductase activity;cellular response to peptide hormone stimulus;nucleus;plasma membrane;microtubule;transition metal ion binding;spindle@: HEPATOCELLULAR CARCINOMA
F03566@88530@88532@duplication@3@40772096@40784603@9@chr9:40772096-40784603@13.1@856@1158@1.35@CNVR4274.1@ZNF658_5, ZNF658_4, ZNF658_3@0@0@0@:zinc finger protein 658@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
F03566@88594@88602@duplication@9@43818042@43885072@9@chr9:43818042-43885072@8.83@294@411@1.4@NA@CNTNAP3B_7, CNTNAP3B_8, CNTNAP3B_9, CNTNAP3B_10, CNTNAP3B_11, CNTNAP3B_12, CNTNAP3B_13, CNTNAP3B_14, CNTNAP3B_15@0@0@0@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
F03566@95346@95357@duplication@12@17813309@17898362@10@chr10:17813309-17898362@33.1@496@837@1.69@NA@TMEM236_2, TMEM236_3, TMEM236_4, MRC1L1_1, MRC1L1_2, MRC1L1_3, MRC1L1_4, MRC1L1_5, MRC1L1_6, MRC1L1_7, MRC1L1_8, MRC1L1_9@0@0@0@:transmembrane protein 236;transmembrane protein 236-like:macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding@NA
F03566@95380@95384@deletion@5@18060293@18112445@10@chr10:18060293-18112445@27.4@131@4@0.0305@NA@TMEM236_2, TMEM236_3, TMEM236_4, MRC1_1, MRC1_2@0@0@0@:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F03566@95389@95389@deletion@1@18138509@18138693@10@chr10:18138509-18138693@37.2@213@20@0.0939@NA@MRC1_7@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F03566@96531@96531@deletion@1@47758847@47758904@10@chr10:47758847-47758904@7.4@33@0@0@CNVR4714.1@ANXA8L2_10@0@0@0@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:calcium-dependent phospholipid binding;calcium ion binding@NA
F03566@96579@96581@deletion@3@48048895@48055018@10@chr10:48048895-48055018@6.68@180@108@0.6@CNVR4715.2@ASAH2C_3, ASAH2C_2, ASAH2C_1@0@0@0@@:ceramidase activity;sphingolipid metabolic process@NA
F03566@96852@96852@duplication@1@51374371@51374428@10@chr10:51374371-51374428@5.55@68@118@1.74@NA@TIMM23B_2@0@0@0@:translocase of inner mitochondrial membrane 23 homolog B (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process@NA
F03566@96914@96914@deletion@1@51877667@51877818@10@chr10:51877667-51877818@5.89@26@0@0@CNVR4734.2@FAM21A_22@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
F03566@96933@96934@deletion@2@51970584@51970894@10@chr10:51970584-51970894@5.02@22@0@0@NA@ASAH2_11, ASAH2_10@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
F03566@98344@98350@deletion@7@81463367@81472241@10@chr10:81463367-81472241@7.09@38@5@0.132@CNVR4815.2, CNVR4815.4@FAM22B_1, FAM22B_2, FAM22B_3, FAM22B_4, FAM22B_5, FAM22B_6, FAM22B_7@0@0@0@NA@NA@NA
F03566@98819@98820@deletion@2@92678623@92679025@10@chr10:92678623-92679025@6.18@394@270@0.685@NA@ANKRD1_4, ANKRD1_3@0@0@0@:ankyrin repeat domain 1 (cardiac muscle)@:nucleoplasm;positive regulation of DNA damage response, signal transduction by p53 class mediator;response to muscle stretch;cellular response to transforming growth factor beta stimulus;R-SMAD binding;cytoplasmic part;cellular response to organic cyclic compound;cardiac muscle tissue morphogenesis;cellular response to mechanical stimulus;myofibril;nucleus;cellular response to drug;cellular response to lipopolysaccharide;p53 binding;cytosol;cellular response to interleukin-1;cellular response to hypoxia;transcription factor binding;DNA binding;transcription corepressor activity;cellular response to tumor necrosis factor;histone deacetylase binding;transcription factor complex;negative regulation of DNA biosynthetic process;positive regulation of transcription from RNA polymerase II promoter;RNA polymerase II transcription coactivator activity;RNA polymerase II transcription factor binding;small molecule metabolic process;titin binding;cellular lipid metabolic process;regulation of transcription from RNA polymerase II promoter;cytoplasm;protein binding;negative regulation of transcription from RNA polymerase II promoter;positive regulation of neuron projection development;positive regulation of protein secretion;I band;sarcomere organization;positive regulation of apoptotic process@: TOTAL ANOMALOUS PULMONARY VENOUS RETURN 1; TAPVR1
F03566@102336@102338@deletion@3@135438604@135439807@10@chr10:135438604-135439807@46@636@272@0.428@CNVR4989.11, CNVR4989.4@FRG2B_4, FRG2B_3, FRG2B_2@0@0@0@:FSHD region gene 2 family, member B@:nucleus@NA
F03566@103289@103290@deletion@2@5270599@5271034@11@chr11:5270599-5271034@8.39@62@17@0.274@NA@HBG1_2, HBG1_1@0@0@0@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
F03566@103342@103342@deletion@1@5798891@5799864@11@chr11:5798891-5799864@126@750@2@0.00267@CNVR5049.1@OR52N5_1@0@0@0@:tripartite motif containing 5:olfactory receptor, family 52, subfamily N, member 5@:defense response to virus;Golgi apparatus;intracellular;protein trimerization;ligase activity;cytoplasm;protein binding;nucleus;protein homodimerization activity;identical protein binding;zinc ion binding;cytoplasmic mRNA processing body;protein ubiquitination;virus-host interaction:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F03566@104444@104444@deletion@1@18288436@18288525@11@chr11:18288436-18288525@6.37@158@92@0.582@NA@SAA1_2@0@0@0@:serum amyloid A1@:regulation of protein secretion;platelet activation;neutrophil chemotaxis;negative regulation of inflammatory response;positive regulation of cytokine secretion;macrophage chemotaxis;positive regulation of cell adhesion;positive regulation of interleukin-1 secretion;extracellular region;lymphocyte chemotaxis;high-density lipoprotein particle;elevation of cytosolic calcium ion concentration;acute-phase response;G-protein coupled receptor binding@NA
F03566@106046@106048@deletion@3@55370918@55419315@11@chr11:55370918-55419315@33.3@2838@1867@0.658@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F03566@114424@114427@deletion@4@10583717@10587129@12@chr12:10583717-10587129@16.4@778@509@0.654@CNVR5430.1@KLRC2_6, KLRC2_5, KLRC2_4, KLRC2_3, NKG2-E_3@0@0@0@:killer cell lectin-like receptor subfamily C, member 2@:carbohydrate binding:transmembrane signaling receptor activity;carbohydrate binding;protein binding;signal transduction;cellular defense response;integral to plasma membrane@NA
F03566@114483@114483@duplication@1@11243900@11244828@12@chr12:11243900-11244828@9.66@1191@1602@1.35@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
F03566@115537@115537@deletion@1@31249276@31249313@12@chr12:31249276-31249313@8.99@91@35@0.385@CNVR5483.1@DDX11_15@0@0@0@:DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11@:nucleoplasm;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;S phase of mitotic cell cycle;DNA binding;nucleobase-containing compound metabolic process;ATP binding;ATP-dependent DNA helicase activity;DNA helicase activity;midbody;RNA binding;DNA-dependent ATPase activity;nucleus;positive regulation of cell proliferation;virus-host interaction;nuclear chromatin;4 iron, 4 sulfur cluster binding;helicase activity;hydrolase activity, acting on acid anhydrides;DNA duplex unwinding;endoplasmic reticulum unfolded protein response;G2/M transition of mitotic cell cycle;protein binding;sister chromatid cohesion;activation of signaling protein activity involved in unfolded protein response;nucleolus;spindle pole;ATP-dependent helicase activity;metal ion binding;nucleic acid binding;mitotic sister chromatid segregation@: WARSAW BREAKAGE SYNDROME
F03566@115577@115580@duplication@4@31814889@31825311@12@chr12:31814889-31825311@19.6@1127@1522@1.35@NA@METTL20_2, METTL20_3, METTL20_4, AMN1_7@0@0@0@:methyltransferase like 20:antagonist of mitotic exit network 1 homolog (S. cerevisiae)@:protein methyltransferase activity;protein methylation;cytoplasm@NA
F03566@126269@126269@duplication@1@88327645@88330520@13@chr13:88327645-88330520@18.9@3932@5598@1.42@NA@SLITRK5_2@0@0@0@:SLIT and NTRK-like family, member 5@:protein binding;axonogenesis;integral to membrane@NA
F03566@127353@127358@duplication@6@20215588@20404761@14@chr14:20215588-20404761@39.7@9344@12143@1.3@CNVR6072.12, CNVR6072.4, CNVR6072.5@OR4Q3_1, OR4M1_1, OR4N2_1, OR4K2_1, OR4K5_1, OR4K1_1@0@0@0@:olfactory receptor, family 4, subfamily N, member 2:olfactory receptor, family 4, subfamily Q, member 3:olfactory receptor, family 4, subfamily M, member 1:olfactory receptor, family 4, subfamily K, member 2:olfactory receptor, family 4, subfamily K, member 5:olfactory receptor, family 4, subfamily K, member 1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F03566@128213@128214@deletion@2@24434972@24435192@14@chr14:24434972-24435192@13.7@302@169@0.56@NA@DHRS4_4, DHRS4_5@0@0@0@:dehydrogenase/reductase (SDR family) member 4@:steroid metabolic process;oxidation-reduction process;mitochondrion;protein tetramerization;oxidoreductase activity;peroxisomal membrane;nucleus;cellular ketone metabolic process;metabolic process;receptor binding;alcohol dehydrogenase [NAD(P)+] activity;peroxisome;nucleotide binding;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;3-keto sterol reductase activity;alcohol metabolic process;carbonyl reductase (NADPH) activity@NA
F03566@128223@128223@deletion@1@24470594@24470726@14@chr14:24470594-24470726@19.9@187@60@0.321@NA@DHRS4L2_6@0@0@0@:dehydrogenase/reductase (SDR family) member 4 like 2@:extracellular region;oxidoreductase activity;nucleotide binding;metabolic process@NA
F03566@131032@131034@deletion@3@74004127@74010359@14@chr14:74004127-74010359@72.7@505@109@0.216@CNVR6188.1, CNVR6188.4@ACOT1_1, ACOT1_2, ACOT1_3@0@0@0@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
F03566@133342@133342@duplication@1@106053275@106053668@14@chr14:106053275-106053668@6.3@64@118@1.84@CNVR6294.46@IGHA2_3@0@0@0@@:protein binding@NA
F03566@133345@133350@duplication@6@106066404@106091562@14@chr14:106066404-106091562@14.8@1287@1666@1.29@CNVR6294.46, CNVR6294.20, CNVR6294.54, CNVR6294.43, CNVR6294.50@IGHE_4, IGHE_3, IGHE_2, IGHE_1, IGHG4_4, IGHG4_3@0@0@0@@:antigen binding;protein binding;immune response:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response@NA
F03566@133358@133358@duplication@1@106174123@106174481@14@chr14:106174123-106174481@7.41@370@514@1.39@CNVR6294.46, CNVR6294.43, CNVR6294.65, CNVR6294.66, CNVR6294.68@IGHA1_2@0@0@0@@:antigen binding;protein binding;immune response;protein-chromophore linkage@NA
F03566@133404@133410@deletion@7@106367001@106375782@14@chr14:106367001-106375782@40.5@615@297@0.483@CNVR6294.11, CNVR6294.27, CNVR6294.39, CNVR6294.36, CNVR6294.48, CNVR6294.25, CNVR6294.57@IGHD6-13_1, IGHD5-12_1, IGHD4-11_1, IGHD3-10_1, IGHD3-9_1, IGHD2-8_1, IGHD1-7_1@0@0@0@NA@NA@NA
F03566@133425@133427@deletion@3@106471637@106478539@14@chr14:106471637-106478539@23@232@90@0.388@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV1-3_1, IGHV4-4_2, IGHV4-4_1@0@0@0@@:protein binding:protein binding@NA
F03566@133432@133436@deletion@5@106539080@106573537@14@chr14:106539080-106573537@138@893@168@0.188@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1, IGHV3-11_2@0@0@0@@:protein binding:protein binding:protein binding@NA
F03566@133491@133492@deletion@2@107095127@107095561@14@chr14:107095127-107095561@18.4@93@7@0.0753@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61_2, IGHV4-61_1@0@0@0@@:protein binding@NA
F03566@133495@133495@deletion@1@107131034@107131334@14@chr14:107131034-107131334@11.8@236@123@0.521@CNVR6294.56, CNVR6294.16@IGHV3-66_2@0@0@0@@:protein binding@NA
F03566@133541@133543@deletion@3@22368577@22456919@15@chr15:22368577-22456919@23.7@5296@3698@0.698@CNVR6297.4, CNVR6297.17, CNVR6297.6, CNVR6297.19@OR4M2_1, OR4N4_1, AC010760.1_1@0@0@0@:olfactory receptor, family 4, subfamily M, member 2:olfactory receptor, family 4, subfamily N, member 4@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F03566@133875@133875@deletion@1@28632749@28632839@15@chr15:28632749-28632839@5.42@38@10@0.263@CNVR6329.4@GOLGA8F_15@0@0@0@@:Golgi apparatus@NA
F03566@134008@134012@duplication@5@30654497@30665348@15@chr15:30654497-30665348@15@429@613@1.43@CNVR6337.1@CHRFAM7A_10, CHRFAM7A_9, CHRFAM7A_8, CHRFAM7A_7, CHRFAM7A_6@0@0@0@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
F03566@134152@134156@deletion@5@32446109@32455536@15@chr15:32446109-32455536@11@251@150@0.598@CNVR6345.2, CNVR6345.1@CHRNA7_5, CHRNA7_6, CHRNA7_7, CHRNA7_8, CHRNA7_9@0@0@0@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
F03566@135680@135681@deletion@2@43873201@43873586@15@chr15:43873201-43873586@8.08@576@397@0.689@CNVR6365.1@PPIP5K1_10, PPIP5K1_9@0@0@0@:diphosphoinositol pentakisphosphate kinase 1@:inositol hexakisphosphate 3-kinase activity;inositol hexakisphosphate 1-kinase activity;inositol metabolic process;diphosphoinositol-pentakisphosphate kinase activity;ATP binding;acid phosphatase activity;cytoplasm;cytosol;inositol hexakisphosphate 5-kinase activity;nucleus;kinase activity;inositol-1,3,4,5,6-pentakisphosphate kinase activity@NA
F03566@140317@140317@deletion@1@100348377@100348507@15@chr15:100348377-100348507@8.09@43@5@0.116@CNVR6545.2@CTD-2054N24.2_2@0@0@0@NA@NA@NA
F03566@140958@140961@deletion@4@1278901@1279952@16@chr16:1278901-1279952@7.9@82@35@0.427@CNVR6591.1@TPSB2_6, TPSB2_5, TPSB2_4, TPSB2_3, TPSB2_2@0@0@0@:tryptase beta 2 (gene/pseudogene)@:proteolysis;catalytic activity;serine-type endopeptidase activity@NA
F03566@142690@142706@deletion@17@15045473@15123913@16@chr16:15045473-15123913@64.2@3255@2156@0.662@CNVR6646.1@NPIP_8, PDXDC1_1, PDXDC1_2, PDXDC1_3, PDXDC1_4, PDXDC1_5, PDXDC1_6, PDXDC1_7, PDXDC1_8, PDXDC1_9, PDXDC1_10, PDXDC1_11, PDXDC1_12, PDXDC1_13, PDXDC1_14, PDXDC1_15, PDXDC1_16@0@0@0@:nuclear pore complex-interacting protein-like;nuclear pore complex interacting protein;nuclear pore complex-interacting protein-like 1-like:pyridoxal-dependent decarboxylase domain containing 1;pyridoxal-dependent decarboxylase domain-containing protein 1-like@:nuclear membrane;protein transport;nuclear pore;mRNA transport:carboxylic acid metabolic process;pyridoxal phosphate binding;carboxy-lyase activity@NA
F03566@144097@144101@duplication@5@28617378@28619924@16@chr16:28617378-28619924@40.2@1049@1589@1.51@CNVR6685.1, CNVR6685.2@SULT1A1_9, SULT1A1_8, SULT1A1_7, SULT1A1_6, SULT1A1_5@0@0@0@:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1@:small molecule metabolic process;sulfation;aryl sulfotransferase activity;amine metabolic process;catecholamine metabolic process;xenobiotic metabolic process;cytosol;steroid sulfotransferase activity;integral to membrane;sulfotransferase activity;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process;estrogen metabolic process@NA
F03566@144268@144268@duplication@1@29370587@29370656@16@chr16:29370587-29370656@4.72@116@172@1.48@NA@SNX29P2_3@0@0@0@NA@NA@NA
F03566@145554@145560@duplication@7@55844430@55855433@16@chr16:55844430-55855433@15.2@1156@1507@1.3@CNVR6731.1@CES1_11, CES1_10, CES1_9, CES1_8, CES1_7, CES1_6, CES1_5@0@0@0@:carboxylesterase 1;liver carboxylesterase 1-like@:hydrolase activity;methyl salicylate esterase activity;response to toxin;methylumbelliferyl-acetate deacetylase activity;endoplasmic reticulum lumen;retinyl-palmitate esterase activity;methyl jasmonate esterase activity;metabolic process;carboxylesterase activity;methyl indole-3-acetate esterase activity@: CARBOXYLESTERASE 1; CES1
F03566@147111@147111@deletion@1@70162863@70163025@16@chr16:70162863-70163025@8.32@487@317@0.651@CNVR6764.1, CNVR6764.3@PDPR_6@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
F03566@147274@147275@duplication@2@70714698@70714928@16@chr16:70714698-70714928@5.19@174@243@1.4@NA@MTSS1L_3, MTSS1L_2@0@0@0@:metastasis suppressor 1-like@:filopodium assembly;actin binding;signal transduction;SH3 domain binding;cytoskeletal adaptor activity@NA
F03566@149172@149172@deletion@1@2965964@2966901@17@chr17:2965964-2966901@4.99@661@467@0.707@NA@OR1D5_1@0@0@0@:olfactory receptor, family 1, subfamily D, member 5@:integral to membrane;sensory perception of smell;G-protein coupled receptor activity;plasma membrane;detection of chemical stimulus involved in sensory perception of smell;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F03566@149469@149469@deletion@1@4439372@4439469@17@chr17:4439372-4439469@4.75@121@72@0.595@NA@SPNS2_10@0@0@0@:spinster homolog 2 (Drosophila)@:integral to membrane;transmembrane transporter activity;lipid transport;transmembrane transport@NA
F03566@151556@151561@deletion@6@16664740@16676947@17@chr17:16664740-16676947@30@1408@913@0.648@NA@CCDC144A_13, CCDC144A_13, CCDC144A_14, CCDC144A_14, CCDC144A_15, CCDC144A_15, CCDC144A_16, CCDC144A_16, CCDC144A_17, CCDC144A_18, CCDC144A_17@0@0@0@:coiled-coil domain containing 144A@NA@NA
F03566@151875@151885@duplication@11@18380170@18397681@17@chr17:18380170-18397681@51.7@614@1101@1.79@CNVR7014.1@LGALS9C_1, LGALS9C_2, LGALS9C_3, LGALS9C_4, LGALS9C_5, LGALS9C_6, LGALS9C_7, LGALS9C_8, LGALS9C_9, LGALS9C_10, LGALS9C_11@0@0@0@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
F03566@151958@151959@duplication@2@18996506@18997166@17@chr17:18996506-18997166@31.7@254@609@2.4@CNVR7018.4, CNVR7018.2, CNVR7018.6@AC007952.5_1, AC007952.5_2@0@0@0@NA@NA@NA
F03566@153378@153381@duplication@4@34523998@34539971@17@chr17:34523998-34539971@8.73@66@135@2.05@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL3L3_1, CCL4L1_1, CCL4L1_2, CCL4L1_3@0@0@0@:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
F03566@153650@153661@deletion@12@36351930@36413159@17@chr17:36351930-36413159@257@4885@2160@0.442@CNVR7083.3@RP11-1407O15.2_12, RP11-1407O15.2_11, RP11-1407O15.2_10, RP11-1407O15.2_9, RP11-1407O15.2_8, RP11-1407O15.2_7, RP11-1407O15.2_6, RP11-1407O15.2_5, RP11-1407O15.2_4, RP11-1407O15.2_3, RP11-1407O15.2_2, RP11-1407O15.2_1@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
F03566@154346@154346@duplication@1@39421631@39422112@17@chr17:39421631-39422112@6.43@43@93@2.16@CNVR7096.1@KRTAP9-6_1@0@0@0@:keratin associated protein 9-6@:keratin filament@NA
F03566@155587@155594@duplication@8@44399689@44414934@17@chr17:44399689-44414934@29.5@276@538@1.95@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9, LRRC37A_10, LRRC37A_11, LRRC37A_12, LRRC37A_13@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
F03566@155610@155611@deletion@2@44632519@44632790@17@chr17:44632519-44632790@14@139@52@0.374@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2_13, LRRC37A2_14@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
F03566@162017@162017@duplication@1@44542732@44544371@18@chr18:44542732-44544371@5@55@98@1.78@CNVR7319.1@TCEB3CL2_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
F03566@162019@162019@deletion@1@44554574@44556213@18@chr18:44554574-44556213@26@120@0@0@CNVR7319.1@TCEB3C_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C (elongin A3);RNA polymerase II transcription factor SIII subunit A3-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
F03566@162709@162709@duplication@1@61308109@61308225@18@chr18:61308109-61308225@5.68@136@204@1.5@NA@SERPINB4_5@0@0@0@:serpin peptidase inhibitor, clade B (ovalbumin), member 4@:serine-type endopeptidase inhibitor activity;negative regulation of endopeptidase activity;extracellular region;immune response;cytoplasm;regulation of proteolysis@NA
F03566@162716@162716@deletion@1@61325748@61325864@18@chr18:61325748-61325864@7.44@102@48@0.471@NA@SERPINB3_5@0@0@0@:serpin peptidase inhibitor, clade B (ovalbumin), member 11 (gene/pseudogene):serpin peptidase inhibitor, clade B (ovalbumin), member 3@:serine-type endopeptidase inhibitor activity;negative regulation of endopeptidase activity;cytoplasm;regulation of proteolysis:serine-type endopeptidase inhibitor activity;negative regulation of endopeptidase activity;extracellular region;cytoplasm;regulation of proteolysis@NA
F03566@167047@167047@deletion@1@14877791@14877921@19@chr19:14877791-14877921@8.3@91@37@0.407@NA@EMR2_6@0@0@0@:egf-like module containing, mucin-like, hormone receptor-like 2@:transmembrane signaling receptor activity;inflammatory response;G-protein coupled receptor activity;ruffle membrane;integral to membrane;plasma membrane;cell surface receptor signaling pathway;neuropeptide signaling pathway;granulocyte chemotaxis;cell migration;leading edge membrane;G-protein coupled receptor signaling pathway;protein binding;cell adhesion;membrane;calcium ion binding;chondroitin sulfate binding@NA
F03566@170093@170100@deletion@8@40367299@40382826@19@chr19:40367299-40382826@35.9@440@195@0.443@CNVR7639.2@FCGBP_29, FCGBP_28, FCGBP_27, FCGBP_26, FCGBP_25, FCGBP_24, FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F03566@170367@170367@deletion@1@41381599@41381779@19@chr19:41381599-41381779@7.98@146@77@0.527@CNVR7642.1@CYP2A7_9@0@0@0@:cytochrome P450, family 2, subfamily A, polypeptide 7@:oxidation-reduction process;electron carrier activity;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;oxygen binding;heme binding;monooxygenase activity;endoplasmic reticulum membrane;iron ion binding@NA
F03566@170373@170374@deletion@2@41386385@41387656@19@chr19:41386385-41387656@5.66@246@161@0.654@CNVR7642.1@CYP2A7_3, CYP2A7_2@0@0@0@:cytochrome P450, family 2, subfamily A, polypeptide 7@:oxidation-reduction process;electron carrier activity;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;oxygen binding;heme binding;monooxygenase activity;endoplasmic reticulum membrane;iron ion binding@NA
F03566@172563@172565@deletion@3@50462618@50463678@19@chr19:50462618-50463678@14.9@145@52@0.359@NA@SIGLEC11_5, SIGLEC11_4, SIGLEC11_3@0@0@0@:sialic acid binding Ig-like lectin 11@:carbohydrate binding;protein binding;integral to membrane;cell adhesion@NA
F03566@172987@172994@deletion@8@52133087@52149893@19@chr19:52133087-52149893@26.8@605@349@0.577@CNVR7702.1@SIGLEC5_2, SIGLEC5_2, SIGLEC5_1, SIGLEC14_7, SIGLEC14_6, SIGLEC14_5, SIGLEC14_4, SIGLEC14_3, SIGLEC14_2@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 14@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion;plasma membrane@NA
F03566@173305@173308@deletion@4@54745453@54746600@19@chr19:54745453-54746600@15.7@681@448@0.658@CNVR7721.3, CNVR7721.6@LILRA6_4, LILRA6_3, LILRA6_2, LILRA6_1@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F03566@173336@173341@deletion@6@54801928@54804173@19@chr19:54801928-54804173@41.6@1211@718@0.593@CNVR7722.1@LILRA3_6, LILRA3_5, LILRA3_4, LILRA3_3, LILRA3_2, LILRA3_1@0@0@0@:leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3@:antigen binding;signal transduction;protein binding;extracellular region;plasma membrane;receptor activity;defense response@NA
F03566@173467@173474@duplication@8@55263102@55290114@19@chr19:55263102-55290114@31.7@1210@1711@1.41@CNVR7725.2, CNVR7725.1@KIR2DL3_6, KIR2DL3_7, KIR2DL3_8, KIR2DL1_1, KIR2DL1_2, KIR2DL1_3, KIR2DL1_4, KIR2DL1_5@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
F03566@173491@173493@deletion@3@55340817@55341730@19@chr19:55340817-55341730@21@573@332@0.579@CNVR7725.1, CNVR7725.6@KIR3DL1_7, KIR3DL1_8, KIR3DL1_9@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
F03566@173496@173498@deletion@3@55349032@55354373@19@chr19:55349032-55354373@19.8@431@238@0.552@CNVR7725.1, CNVR7725.6@KIR2DS4_3, KIR2DS4_4, KIR2DS4_5@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
F03566@173844@173844@duplication@1@56283172@56283456@19@chr19:56283172-56283456@5.66@294@402@1.37@CNVR7734.1@CTD-2611O12.2_2@0@0@0@:ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
F03566@174395@174395@deletion@1@1569207@1569278@20@chr20:1569207-1569278@6.91@31@0@0@CNVR7763.1@RP4-576H24.4_1@0@0@0@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
F03566@180976@180976@duplication@1@16287255@16287885@22@chr22:16287255-16287885@6.26@70@125@1.79@CNVR8071.2, CNVR8071.3, CNVR8071.9@POTEH_1@0@0@0@:POTE ankyrin domain family, member H@:protein binding@NA
F03566@181631@181633@deletion@3@21570761@21576503@22@chr22:21570761-21576503@7.78@75@29@0.387@CNVR8100.4, CNVR8100.10, CNVR8100.7@GGT2_7, GGT2_6, GGT2_5@0@0@0@:gamma-glutamyltransferase 2;gamma-glutamyltranspeptidase 2-like@:hydrolase activity;small molecule metabolic process;leukotriene biosynthetic process;anchored to external side of plasma membrane;glutathione biosynthetic process;xenobiotic metabolic process;integral to membrane;glutathione metabolic process;plasma membrane;gamma-glutamyltransferase activity;cellular_component@NA
F03566@181737@181742@duplication@6@22724017@22735715@22@chr22:22724017-22735715@35.1@1790@2476@1.38@CNVR8103.20, CNVR8103.5, CNVR8103.2, CNVR8103.12, CNVR8103.9, CNVR8103.23@IGLV7-46_1, IGLV7-46_2, IGLV5-45_1, IGLV5-45_2, IGLV1-44_1, IGLV1-44_2@0@0@0@@:protein binding:protein binding:protein binding@NA
F03566@181806@181807@duplication@2@23243157@23247205@22@chr22:23243157-23247205@6.53@405@538@1.33@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11, CNVR8103.35@IGLC2_1, IGLJ3_1@0@0@0@@:protein binding@NA
F03566@183631@183631@duplication@1@39357393@39357686@22@chr22:39357393-39357686@4.96@62@107@1.73@CNVR8164.1@APOBEC3A_4@0@0@0@:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A;APOBEC3A and APOBEC3B deletion hybrid@:cytidine deamination;defense response to virus;negative regulation of viral genome replication;DNA cytosine deamination;clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine;catalytic activity;DNA demethylation;cytoplasm;innate immune response;cytidine deaminase activity;nucleus;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;cellular response to xenobiotic stimulus;zinc ion binding;negative regulation of transposition@NA
F03566@4052@4071@deletion@20@101571921@101581428@X@chrX:101571921-101581428@40.8@195@8@0.041@NA@NXF2_15, NXF2_16, NXF2_17, NXF2_18, NXF2_19, NXF2_20, NXF2_21, NXF2_22, NXF2_23, NXF2_24, NXF2_25, NXF2_26, NXF2_27, NXF2_28, NXF2_29, NXF2_30, NXF2_31, NXF2_32, NXF2_33, NXF2_34@0@0@0@NA@NA@NA
F03566@4073@4079@duplication@7@101615714@101620252@X@chrX:101615714-101620252@6.6@62@114@1.84@NA@NXF2B_33, NXF2B_32, NXF2B_31, NXF2B_30, NXF2B_29, NXF2B_28, NXF2B_27@0@0@0@NA@NA@NA
F03566@4090@4091@duplication@2@101624508@101625073@X@chrX:101624508-101625073@5.06@29@65@2.24@NA@NXF2B_16, NXF2B_15@0@0@0@NA@NA@NA
F03566@4883@4884@duplication@2@119209866@119211253@X@chrX:119209866-119211253@8.68@138@224@1.62@NA@RHOXF2B_3, RHOXF2B_2@0@0@0@NA@NA@NA
F03566@5495@5495@duplication@1@134988571@134988710@X@chrX:134988571-134988710@5.77@495@649@1.31@NA@SAGE1_7@0@0@0@NA@NA@NA
F03566@6307@6307@deletion@1@153496018@153496256@X@chrX:153496018-153496256@10.5@48@1@0.0208@CNVR8489.1@OPN1MW2_5@0@0@0@NA@NA@NA
F03665@6@7@duplication@2@69092@139309@1@chr1:69092-139309@10.2@59@140@2.37@CNVR1.2@OR4F5_1, AL627309.1_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F03665@434@434@deletion@1@1643704@1643839@1@chr1:1643704-1643839@5.23@23@0@0@CNVR17.1@CDK11A_6@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
F03665@438@438@deletion@1@1654148@1654257@1@chr1:1654148-1654257@7.68@162@87@0.537@CNVR17.1@CDK11A_2@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
F03665@2788@2788@duplication@1@21806545@21806716@1@chr1:21806545-21806716@6.42@38@87@2.29@CNVR107.2, CNVR107.1@NBPF3_11@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 3@:cytoplasm@NA
F03665@2790@2790@deletion@1@21808091@21808262@1@chr1:21808091-21808262@6.74@96@45@0.469@CNVR107.2, CNVR107.1@NBPF3_13@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 3@:cytoplasm@NA
F03665@3336@3342@duplication@7@25627438@25655415@1@chr1:25627438-25655415@12.8@878@1155@1.32@CNVR116.1, CNVR116.2@RHD_4, RHD_5, RHD_6, RHD_7, RHD_8, RHD_9, RHD_10@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
F03665@8507@8508@deletion@2@89476588@89477710@1@chr1:89476588-89477710@8.63@602@403@0.669@CNVR244.1@GBP3_8, GBP3_7@0@0@0@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
F03665@9365@9366@duplication@2@104202983@104203298@1@chr1:104202983-104203298@8.96@109@190@1.74@CNVR266.3, CNVR266.1@AMY1A_7, AMY1A_8@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
F03665@9523@9523@deletion@1@109369828@109369924@1@chr1:109369828-109369924@7.33@99@45@0.455@CNVR296.1@AKNAD1_11@0@0@0@:AKNA domain containing 1@:cytoplasm@NA
F03665@9769@9772@duplication@4@110231671@110233186@1@chr1:110231671-110233186@14.9@380@561@1.48@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
F03665@12117@12118@duplication@2@152573209@152586574@1@chr1:152573209-152586574@6.26@152@225@1.48@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
F03665@14056@14056@deletion@1@161599569@161599825@1@chr1:161599569-161599825@7.01@94@43@0.457@CNVR383.1@FCGR3B_3@0@0@0@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIIb, receptor (CD16b)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction:IgG binding;protein binding;extracellular region;immune response;plasma membrane;anchored to membrane@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
F03665@16033@16037@duplication@5@196759176@196796135@1@chr1:196759176-196796135@20.8@741@1060@1.43@CNVR459.1@CFHR3_5, CFHR3_6, CFHR1_1, CFHR1_2, CFHR1_3@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
F03665@17624@17625@deletion@2@213003585@213009491@1@chr1:213003585-213009491@11.4@273@150@0.549@CNVR498.1@C1orf227_3, C1orf227_2@0@0@0@:chromosome 1 open reading frame 227@NA@NA
F03665@19775@19776@duplication@2@248756132@248790429@1@chr1:248756132-248790429@23.7@1419@2074@1.46@CNVR600.1@OR2T10_1, OR2T11_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 10:olfactory receptor, family 2, subfamily T, member 11@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F03665@19778@19778@duplication@1@248813233@248814185@1@chr1:248813233-248814185@8.93@491@701@1.43@NA@OR2T27_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 27@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F03665@25089@25091@duplication@3@96259773@96262180@2@chr2:96259773-96262180@13.8@392@573@1.46@NA@TRIM43_2, TRIM43_3, TRIM43_4@0@0@0@:tripartite motif containing 43B;tripartite motif containing 43@:protein binding;intracellular;zinc ion binding@NA
F03665@25138@25138@deletion@1@96698046@96698107@2@chr2:96698046-96698107@4.95@90@48@0.533@NA@GPAT2_3@0@0@0@:glycerol-3-phosphate acyltransferase 2, mitochondrial@:glycerol-3-phosphate O-acyltransferase activity;mitochondrion;phospholipid metabolic process;triglyceride biosynthetic process;glycerophospholipid biosynthetic process;small molecule metabolic process;transferase activity, transferring acyl groups;mitochondrial outer membrane;phosphatidic acid biosynthetic process;integral to membrane;glycerol-3-phosphate metabolic process;CDP-diacylglycerol biosynthetic process;membrane;metabolic process;phospholipid biosynthetic process@NA
F03665@33410@33412@duplication@3@233273415@233274158@2@chr2:233273415-233274158@7.58@135@211@1.56@NA@ALPPL2_8, ALPPL2_9, ALPPL2_10@0@0@0@:alkaline phosphatase, placental-like 2@:phosphatase activity;catalytic activity;phosphorylation;plasma membrane;metabolic process;membrane;anchored to membrane;alkaline phosphatase activity;metal ion binding@NA
F03665@39502@39502@duplication@1@62267239@62267384@3@chr3:62267239-62267384@4.87@225@313@1.39@NA@PTPRG_27@0@0@0@:protein tyrosine phosphatase, receptor type, G@:phosphatase activity;protein tyrosine phosphatase activity;protein dephosphorylation;protein binding;transmembrane receptor protein tyrosine kinase signaling pathway;dephosphorylation;integral to plasma membrane;identical protein binding;transmembrane receptor protein tyrosine phosphatase activity;peptidyl-tyrosine dephosphorylation@NA
F03665@48593@48597@deletion@5@70148233@70160527@4@chr4:70148233-70160527@6.31@556@392@0.705@CNVR1957.2, CNVR1957.1@UGT2B28_2, UGT2B28_3, UGT2B28_4, UGT2B28_5, UGT2B28_6@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
F03665@48967@48967@deletion@1@75312252@75312499@4@chr4:75312252-75312499@6.83@96@45@0.469@NA@AREG_2@0@0@0@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
F03665@50492@50492@deletion@1@107092253@107092427@4@chr4:107092253-107092427@6.61@201@119@0.592@NA@TBCK_24@0@0@0@:TBC1 domain containing kinase@:Rab GTPase activator activity;regulation of Rab GTPase activity;protein tyrosine kinase activity;intracellular;protein phosphorylation;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding@NA
F03665@53188@53191@duplication@4@190946717@190948359@4@chr4:190946717-190948359@6.48@751@968@1.29@CNVR2258.3@FRG2_4, FRG2_3, FRG2_2, FRG2_1@0@0@0@:FSHD region gene 2-like;FSHD region gene 2@:nucleus@NA
F03665@53305@53308@duplication@4@733868@748674@5@chr5:733868-748674@22.9@635@951@1.5@CNVR2280.3@ZDHHC11B_8, ZDHHC11B_7, ZDHHC11B_6, ZDHHC11B_5@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
F03665@59065@59065@deletion@1@140557617@140560021@5@chr5:140557617-140560021@23.5@1850@1023@0.553@CNVR2624.1@PCDHB8_1@0@0@0@:protocadherin beta 8@:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding@NA
F03665@60875@60877@duplication@3@175386973@175388437@5@chr5:175386973-175388437@10.4@184@289@1.57@NA@THOC3_6, THOC3_5, THOC3_4@0@0@0@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
F03665@61269@61271@duplication@3@177166602@177168333@5@chr5:177166602-177168333@9.09@119@200@1.68@NA@FAM153A_8, FAM153A_7, FAM153A_6@0@0@0@:family with sequence similarity 153, member A@NA@NA
F03665@63768@63776@deletion@9@31994761@31997115@6@chr6:31994761-31997115@26.6@428@217@0.507@CNVR2843.6, CNVR2843.5@C4B_20, C4B_21, C4B_22, C4B_23, C4B_24, C4B_25, C4B_26, C4B_27, C4B_28@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
F03665@63797@63802@deletion@6@32008184@32009950@6@chr6:32008184-32009950@8.55@300@189@0.63@CNVR2843.6, CNVR2843.5@CYP21A2_8, CYP21A2_9, CYP21A2_10, TNXB_13, TNXB_12, TNXB_11@0@0@0@:cytochrome P450, family 21, subfamily A, polypeptide 2:tenascin-X-like;tenascin XB@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
F03665@63942@63942@deletion@1@32361747@32361834@6@chr6:32361747-32361834@5.51@192@118@0.615@NA@BTNL2_7@0@0@0@:butyrophilin-like 2 (MHC class II associated)@:protein binding;integral to membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2
F03665@63953@63958@deletion@6@32485517@32498001@6@chr6:32485517-32498001@16@144@52@0.361@CNVR2845.21, CNVR2845.25, CNVR2845.30, CNVR2845.43, CNVR2845.6@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2, HLA-DRB5_1@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
F03665@63961@63961@duplication@1@32548524@32548633@6@chr6:32548524-32548633@5.66@100@161@1.61@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.5, CNVR2845.4@HLA-DRB1_4@0@0@0@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
F03665@63963@63974@duplication@12@32551887@32634384@6@chr6:32551887-32634384@135@1035@2335@2.26@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.34@HLA-DRB1_2, HLA-DRB1_1, HLA-DQA1_1, HLA-DQA1_2, HLA-DQA1_3, HLA-DQA1_4, HLA-DQB1_6, HLA-DQB1_5, HLA-DQB1_4, HLA-DQB1_3, HLA-DQB1_2, HLA-DQB1_1@0@0@0@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
F03665@69212@69212@deletion@1@132021610@132022541@6@chr6:132021610-132022541@6.62@430@281@0.653@CNVR3068.1, CNVR3068.2@OR2A4_1@0@0@0@:ectonucleotide pyrophosphatase/phosphodiesterase 3:olfactory receptor, family 2, subfamily A, member 4@:nucleotide diphosphatase activity;immune response;phosphate-containing compound metabolic process;catalytic activity;phosphodiesterase I activity;integral to plasma membrane;metabolic process;hydrolase activity;nucleoside-triphosphate diphosphatase activity;nucleoside triphosphate catabolic process;polysaccharide binding;perinuclear region of cytoplasm;extracellular region;scavenger receptor activity;NADH pyrophosphatase activity;nucleic acid binding;metal ion binding:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F03665@71028@71030@deletion@3@167787840@167790192@6@chr6:167787840-167790192@9.37@149@81@0.544@NA@TCP10_7, TCP10_6, TCP10_5@0@0@0@:t-complex 10@:cytosol@NA
F03665@71746@71749@deletion@4@5940487@5944900@7@chr7:5940487-5944900@26.1@547@293@0.536@NA@CCZ1_4, CCZ1_5, CCZ1_6, CCZ1_7@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F03665@71926@71934@deletion@9@6805338@6821107@7@chr7:6805338-6821107@25.1@408@201@0.493@NA@RSPH10B2_6, RSPH10B2_7, RSPH10B2_8, RSPH10B2_9, RSPH10B2_10, RSPH10B2_11, RSPH10B2_12, RSPH10B2_13, RSPH10B2_14@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F03665@71936@71939@deletion@4@6826510@6836397@7@chr7:6826510-6836397@5.81@61@25@0.41@NA@RSPH10B2_16, RSPH10B2_17, RSPH10B2_18, RSPH10B2_19@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F03665@71941@71942@deletion@2@6838856@6840706@7@chr7:6838856-6840706@8.36@45@6@0.133@NA@CCZ1B_15, CCZ1B_14@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F03665@71945@71952@duplication@8@6845636@6863797@7@chr7:6845636-6863797@26.7@944@1331@1.41@NA@CCZ1B_11, CCZ1B_10, CCZ1B_9, CCZ1B_8, CCZ1B_7, CCZ1B_6, CCZ1B_5, CCZ1B_4@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F03665@73242@73242@deletion@1@38279626@38279767@7@chr7:38279626-38279767@4.8@43@15@0.349@NA@TRGC2_4@0@0@0@@:protein binding@NA
F03665@74663@74664@duplication@2@75054919@75055735@7@chr7:75054919-75055735@6.6@80@138@1.72@NA@POM121C_9, POM121C_8@0@0@0@:POM121 transmembrane nucleoporin C@:nuclear membrane;protein binding;protein transport;endoplasmic reticulum membrane;nuclear pore;mRNA transport@NA
F03665@74775@74775@duplication@1@76063356@76063472@7@chr7:76063356-76063472@4.62@81@130@1.6@CNVR3462.1@ZP3_5@0@0@0@:zona pellucida glycoprotein 3 (sperm receptor)@:negative regulation of transcription, DNA-dependent;manganese ion transmembrane transporter activity;intracellular protein transport;proteinaceous extracellular matrix;plasma membrane;positive regulation of acrosome reaction;outer acrosomal membrane;protein kinase C signaling cascade;manganese ion transmembrane transport;intracellular signal transduction;humoral immune response mediated by circulating immunoglobulin;negative regulation of binding of sperm to zona pellucida;positive regulation of inflammatory response;endoplasmic reticulum;signal transducer activity;perinuclear region of cytoplasm;secretory granule;positive regulation of transcription, DNA-dependent;positive regulation of ovarian follicle development;positive regulation of interferon-gamma production;carbohydrate binding;manganese ion transport;positive regulation of antral ovarian follicle growth;extracellular matrix;positive regulation of leukocyte migration;positive regulation of humoral immune response;extracellular space;blastocyst formation;integral to membrane;store-operated calcium channel activity;oocyte development;multivesicular body;phosphatidylinositol-mediated signaling;acrosomal vesicle;positive regulation of protein kinase B signaling cascade;Golgi apparatus;positive regulation of calcium ion import;positive regulation of protein kinase activity;positive regulation of acrosomal vesicle exocytosis;positive regulation of interleukin-4 production;cytoplasm;protein binding;binding of sperm to zona pellucida;positive regulation of phosphatidylinositol biosynthetic process;extracellular region;positive regulation of T cell proliferation;acrosin binding;positive regulation of type IV hypersensitivity;egg coat formation@NA
F03665@74781@74783@duplication@3@76121471@76129837@7@chr7:76121471-76129837@5.65@74@124@1.68@CNVR3462.1@DTX2_6, DTX2_7, DTX2_8@0@0@0@:deltex homolog 2 (Drosophila)@:ligase activity;cytoplasm;nuclear membrane;Notch signaling pathway;protein binding;nucleus;zinc ion binding;protein ubiquitination@NA
F03665@74792@74793@duplication@2@76240783@76241130@7@chr7:76240783-76241130@10.3@296@438@1.48@CNVR3463.10@POMZP3_6, POMZP3_5@0@0@0@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
F03665@76430@76432@duplication@3@100334433@100336236@7@chr7:100334433-100336236@6.71@506@661@1.31@CNVR3509.1@ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
F03665@76718@76718@deletion@1@102114809@102114982@7@chr7:102114809-102114982@7.3@34@1@0.0294@CNVR3518.1@POLR2J_3@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J, 13.3kDa@:nucleoplasm;DNA binding;DNA repair;protein dimerization activity;nucleus;viral reproduction;gene expression;transcription initiation from RNA polymerase II promoter;7-methylguanosine mRNA capping;protein phosphorylation;LRR domain binding;protein kinase activity;DNA-directed RNA polymerase II, core complex;nucleotide-excision repair;transcription from RNA polymerase II promoter;DNA-directed RNA polymerase activity;protein binding;transcription-coupled nucleotide-excision repair;RNA splicing;mRNA splicing, via spliceosome;transcription, DNA-dependent;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription@NA
F03665@76754@76754@deletion@1@102219880@102220243@7@chr7:102219880-102220243@12.5@57@0@0@CNVR3518.1@AC093668.1_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
F03665@76765@76765@duplication@1@102235753@102235816@7@chr7:102235753-102235816@5.15@56@102@1.82@CNVR3518.1@RASA4_11@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
F03665@79309@79325@duplication@17@143880598@144072768@7@chr7:143880598-144072768@58.4@1943@2946@1.52@CNVR3598.4@CTAGE4_1, ARHGEF35_2, OR2A42_1, OR2A7_1, CTAGE8_1, OR2A1_1, ARHGEF5_2, ARHGEF5_3, ARHGEF5_4, ARHGEF5_5, ARHGEF5_6, ARHGEF5_7, ARHGEF5_8, ARHGEF5_9, ARHGEF5_10, ARHGEF5_11, ARHGEF5_12@0@0@0@:CTAGE family, member 4:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:olfactory receptor, family 2, subfamily A, member 7:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:integral to membrane;nucleotide binding;cellular_component;biological_process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
F03665@80367@80376@deletion@10@7272484@7340274@8@chr8:7272484-7340274@15.4@600@371@0.618@CNVR3771.8, CNVR3771.10, CNVR3771.4@DEFB4B_2, DEFB4B_1, DEFB103B_2, DEFB103B_1, SPAG11B_3, SPAG11B_2, SPAG11B_1, DEFB104B_2, DEFB104B_1, DEFB106B_2@0@0@0@:defensin, beta 4B;defensin, beta 4A:defensin, beta 103B;defensin, beta 103A:sperm associated antigen 11B:defensin, beta 104A;defensin, beta 104B:defensin, beta 106B;defensin, beta 106A@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
F03665@80388@80388@deletion@1@7637545@7637611@8@chr8:7637545-7637611@8.34@37@0@0@CNVR3772.4, CNVR3772.6, CNVR3772.2, CNVR3772.8, CNVR3772.10@AC084121.16_3@0@0@0@:uncharacterized LOC100133251@NA@NA
F03665@80402@80402@duplication@1@7718169@7718245@8@chr8:7718169-7718245@14.2@80@202@2.52@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@SPAG11A_3@0@0@0@:sperm associated antigen 11A;sperm associated antigen 11B@:extracellular region;defense response@NA
F03665@80565@80565@duplication@1@11994678@11996269@8@chr8:11994678-11996269@5.51@38@81@2.13@CNVR3785.8, CNVR3785.5, CNVR3785.6, CNVR3785.2, CNVR3785.1, CNVR3785.3@USP17L2_1@0@0@0@:ubiquitin specific peptidase 17-like family member 1, pseudogene;ubiquitin specific peptidase 17-like family member 2;ubiquitin specific peptidase 17-like family member 4;ubiquitin specific peptidase 17-like family member 7;ubiquitin specific peptidase 17-like family member 8;ubiquitin specific peptidase 17-like family member 3@:protein deubiquitination;ubiquitin-specific protease activity;mitotic cell cycle G1/S transition checkpoint;nucleus;G2/M transition checkpoint;apoptotic process;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
F03665@89885@89890@duplication@6@97080748@97088216@9@chr9:97080748-97088216@7.91@146@228@1.56@CNVR4405.1@FAM22F_7, FAM22F_6, FAM22F_5, FAM22F_4, FAM22F_3, FAM22F_2@0@0@0@:family with sequence similarity 22, member F@NA@NA
F03665@91249@91249@deletion@1@117092715@117092856@9@chr9:117092715-117092856@14@412@223@0.541@CNVR4448.1@ORM2_2@0@0@0@:orosomucoid 2@:extracellular space;regulation of immune system process;transport;acute-phase response@NA
F03665@93185@93194@duplication@10@135939792@135947151@9@chr9:135939792-135947151@17.8@2138@2711@1.27@NA@CEL_2, CEL_3, CEL_4, CEL_5, CEL_6, CEL_7, CEL_8, CEL_9, CEL_10, CEL_11@0@0@0@:carboxyl ester lipase (bile salt-stimulated lipase)@:intestinal lipid catabolic process;pancreatic juice secretion;catalytic activity;extracellular space;heparin binding;sterol esterase activity;carboxylesterase activity;metabolic process;ceramide catabolic process;hydrolase activity;small molecule metabolic process;acylglycerol lipase activity;lipid metabolic process;cytoplasm;protein esterification;cytosol;retinyl-palmitate esterase activity;fatty acid catabolic process;extracellular region;triglyceride lipase activity;lipid digestion;triglyceride metabolic process;cholesterol catabolic process;intestinal cholesterol absorption@: MATURITY-ONSET DIABETES OF THE YOUNG; MODY; MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION;
F03665@94106@94107@deletion@2@140008696@140009028@9@chr9:140008696-140009028@5.54@94@50@0.532@NA@DPP7_3, DPP7_2@0@0@0@:dipeptidyl-peptidase 7@:dipeptidyl-peptidase activity;serine-type peptidase activity;aminopeptidase activity;cytosol;proteolysis;extracellular region;cytoplasmic membrane-bounded vesicle;lysosome@NA
F03665@95350@95353@duplication@4@17865074@17882805@10@chr10:17865074-17882805@7.93@293@408@1.39@NA@MRC1L1_2, MRC1L1_3, MRC1L1_4, MRC1L1_5@0@0@0@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
F03665@95384@95394@deletion@11@18112045@18155690@10@chr10:18112045-18155690@58.2@296@20@0.0676@NA@MRC1_2, MRC1_3, MRC1_4, MRC1_5, MRC1_6, MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11, MRC1_12@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F03665@95947@95948@deletion@2@29578048@29580935@10@chr10:29578048-29580935@14.6@177@81@0.458@NA@LYZL1_1, LYZL1_2@0@0@0@:lysozyme-like 1@:extracellular region;lysozyme activity;cell wall macromolecule catabolic process@NA
F03665@96430@96430@deletion@1@46242049@46242095@10@chr10:46242049-46242095@5.89@258@163@0.632@NA@FAM21C_8@0@0@0@:family with sequence similarity 21, member C@:endosome;protein binding;plasma membrane;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
F03665@96444@96444@deletion@1@46272722@46272873@10@chr10:46272722-46272873@12.9@234@113@0.483@CNVR4711.1@FAM21C_22@0@0@0@:family with sequence similarity 21, member C@:endosome;protein binding;plasma membrane;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
F03665@96577@96581@duplication@5@48032986@48055018@10@chr10:48032986-48055018@11.9@286@430@1.5@CNVR4715.2@ASAH2C_5, ASAH2C_4, ASAH2C_3, ASAH2C_2, ASAH2C_1@0@0@0@@:ceramidase activity;sphingolipid metabolic process@NA
F03665@96932@96939@deletion@8@51965743@51994312@10@chr10:51965743-51994312@23.7@216@80@0.37@NA@ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7, ASAH2_6, ASAH2_5@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
F03665@97182@97184@deletion@3@63519818@63525771@10@chr10:63519818-63525771@24@465@239@0.514@NA@C10orf107_5, C10orf107_6, C10orf107_7@0@0@0@:chromosome 10 open reading frame 107@NA@NA
F03665@97302@97303@deletion@2@69750662@69750956@10@chr10:69750662-69750956@5.57@441@307@0.696@NA@HERC4_13, HERC4_12@0@0@0@:HECT and RLD domain containing E3 ubiquitin protein ligase 4@:ubiquitin-protein ligase activity;cell differentiation;intracellular;protein ubiquitination involved in ubiquitin-dependent protein catabolic process;cytoplasm;cytosol;spermatogenesis;cellular protein modification process;nucleus@NA
F03665@98819@98820@deletion@2@92678623@92679025@10@chr10:92678623-92679025@7.49@336@218@0.649@NA@ANKRD1_4, ANKRD1_3@0@0@0@:ankyrin repeat domain 1 (cardiac muscle)@:nucleoplasm;positive regulation of DNA damage response, signal transduction by p53 class mediator;response to muscle stretch;cellular response to transforming growth factor beta stimulus;R-SMAD binding;cytoplasmic part;cellular response to organic cyclic compound;cardiac muscle tissue morphogenesis;cellular response to mechanical stimulus;myofibril;nucleus;cellular response to drug;cellular response to lipopolysaccharide;p53 binding;cytosol;cellular response to interleukin-1;cellular response to hypoxia;transcription factor binding;DNA binding;transcription corepressor activity;cellular response to tumor necrosis factor;histone deacetylase binding;transcription factor complex;negative regulation of DNA biosynthetic process;positive regulation of transcription from RNA polymerase II promoter;RNA polymerase II transcription coactivator activity;RNA polymerase II transcription factor binding;small molecule metabolic process;titin binding;cellular lipid metabolic process;regulation of transcription from RNA polymerase II promoter;cytoplasm;protein binding;negative regulation of transcription from RNA polymerase II promoter;positive regulation of neuron projection development;positive regulation of protein secretion;I band;sarcomere organization;positive regulation of apoptotic process@: TOTAL ANOMALOUS PULMONARY VENOUS RETURN 1; TAPVR1
F03665@101604@101611@duplication@8@124340383@124350210@10@chr10:124340383-124350210@7.99@736@945@1.28@CNVR4912.4, CNVR4912.3, CNVR4912.2@DMBT1_11, DMBT1_12, DMBT1_13, DMBT1_14, DMBT1_15, DMBT1_16, DMBT1_17, DMBT1_18@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
F03665@101620@101620@deletion@1@124359581@124359609@10@chr10:124359581-124359609@7.11@237@142@0.599@CNVR4912.4, CNVR4912.3@DMBT1_27@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
F03665@102336@102338@deletion@3@135438604@135439807@10@chr10:135438604-135439807@26.7@513@276@0.538@CNVR4989.11, CNVR4989.4@FRG2B_4, FRG2B_3, FRG2B_2@0@0@0@:FSHD region gene 2 family, member B@:nucleus@NA
F03665@103139@103139@deletion@1@3239175@3240043@11@chr11:3239175-3240043@13.7@403@219@0.543@CNVR5028.1@MRGPRG_1@0@0@0@:MAS-related GPR, member G@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway@NA
F03665@103342@103342@duplication@1@5798891@5799864@11@chr11:5798891-5799864@12.5@701@1036@1.48@CNVR5049.1@OR52N5_1@0@0@0@:tripartite motif containing 5:olfactory receptor, family 52, subfamily N, member 5@:defense response to virus;Golgi apparatus;intracellular;protein trimerization;ligase activity;cytoplasm;protein binding;nucleus;protein homodimerization activity;identical protein binding;zinc ion binding;cytoplasmic mRNA processing body;protein ubiquitination;virus-host interaction:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F03665@104572@104572@duplication@1@18955364@18956331@11@chr11:18955364-18956331@19.2@1134@1792@1.58@CNVR5091.2, CNVR5091.1@MRGPRX1_1@0@0@0@:MAS-related GPR, member X1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;acute-phase response;G-protein coupled receptor signaling pathway@NA
F03665@106038@106040@duplication@3@55032377@55035848@11@chr11:55032377-55035848@5.65@180@255@1.42@CNVR5178.5@TRIM48_2, TRIM48_3, TRIM48_4@0@0@0@:tripartite motif containing 48@:protein binding;intracellular;zinc ion binding@NA
F03665@106046@106048@deletion@3@55370918@55419315@11@chr11:55370918-55419315@347@2249@8@0.00356@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F03665@110109@110109@deletion@1@89531299@89531797@11@chr11:89531299-89531797@53.4@418@61@0.146@NA@TRIM49_8@0@0@0@:tripartite motif containing 49@:protein binding;intracellular;DNA binding;zinc ion binding@NA
F03665@110115@110124@deletion@10@89603790@89771883@11@chr11:89603790-89771883@21.3@377@201@0.533@NA@TRIM64B_6, TRIM64B_5, TRIM64B_4, TRIM64B_3, TRIM64B_2, TRIM64B_1, TRIM49C_3, TRIM49C_4, TRIM49C_5, TRIM49C_6@0@0@0@:tripartite motif containing 64;tripartite motif containing 64C;tripartite motif containing 64B:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;zinc ion binding:protein binding;intracellular;DNA binding;zinc ion binding@NA
F03665@110126@110126@duplication@1@89774220@89774718@11@chr11:89774220-89774718@14.2@284@485@1.71@NA@TRIM49C_8@0@0@0@:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;DNA binding;zinc ion binding@NA
F03665@114093@114105@duplication@13@8048094@8088630@12@chr12:8048094-8088630@36@3339@4353@1.3@CNVR5421.1@NANOGP1_2, NANOGP1_3, NANOGP1_4, SLC2A3_10, SLC2A3_9, SLC2A3_8, SLC2A3_7, SLC2A3_6, SLC2A3_5, SLC2A3_4, SLC2A3_3, SLC2A3_2, SLC2A3_1@0@0@0@:NECAP endocytosis associated 1:solute carrier family 2 (facilitated glucose transporter), member 3@:coated pit;protein binding;endocytosis;protein transport;clathrin vesicle coat;plasma membrane;membrane:sequence-specific DNA binding;nucleus;DNA binding;regulation of transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity:substrate-specific transmembrane transporter activity;transport;glucose transmembrane transporter activity;transmembrane transport;integral to membrane;transmembrane transporter activity;plasma membrane;hexose transport;glucose transport;small molecule metabolic process;folic acid binding;carbohydrate metabolic process;L-ascorbic acid metabolic process;reduced folate carrier activity;water-soluble vitamin metabolic process;vitamin metabolic process;membrane@NA
F03665@114483@114483@duplication@1@11243900@11244828@12@chr12:11243900-11244828@4.99@1153@1495@1.3@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
F03665@124100@124101@duplication@2@21742128@21746643@13@chr13:21742128-21746643@15.2@711@1041@1.46@NA@SKA3_4, SKA3_3@0@0@0@:spindle and kinetochore associated complex subunit 3@:spindle microtubule;chromosome segregation;cytoplasm;mitosis;protein binding;regulation of microtubule polymerization or depolymerization;cell division;condensed chromosome outer kinetochore@NA
F03665@128217@128224@deletion@8@24437967@24473579@14@chr14:24437967-24473579@46.4@1261@739@0.586@NA@DHRS4_8, DHRS4L2_1, DHRS4L2_2, DHRS4L2_3, DHRS4L2_4, DHRS4L2_5, DHRS4L2_6, DHRS4L2_7@0@0@0@:dehydrogenase/reductase (SDR family) member 4:dehydrogenase/reductase (SDR family) member 4 like 2@:steroid metabolic process;oxidation-reduction process;mitochondrion;protein tetramerization;oxidoreductase activity;peroxisomal membrane;nucleus;cellular ketone metabolic process;metabolic process;receptor binding;alcohol dehydrogenase [NAD(P)+] activity;peroxisome;nucleotide binding;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;3-keto sterol reductase activity;alcohol metabolic process;carbonyl reductase (NADPH) activity:extracellular region;oxidoreductase activity;nucleotide binding;metabolic process@NA
F03665@131032@131033@duplication@2@74004127@74008399@14@chr14:74004127-74008399@19.1@244@451@1.85@CNVR6188.1, CNVR6188.4@ACOT1_1, ACOT1_2@0@0@0@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
F03665@131037@131037@duplication@1@74041613@74042217@14@chr14:74041613-74042217@6.79@111@184@1.66@CNVR6188.1, CNVR6188.6@ACOT2_3@0@0@0@:acyl-CoA thioesterase 2@:acyl-CoA metabolic process;mitochondrion;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity;receptor binding@NA
F03665@133409@133414@deletion@6@106373070@106380248@14@chr14:106373070-106380248@19.6@463@268@0.579@CNVR6294.27, CNVR6294.36, CNVR6294.48, CNVR6294.25, CNVR6294.57, CNVR6294.29@IGHD2-8_1, IGHD1-7_1, IGHD6-6_1, IGHD5-5_1, IGHD4-4_1, IGHD3-3_1@0@0@0@NA@NA@NA
F03665@133426@133426@deletion@1@106478111@106478411@14@chr14:106478111-106478411@11.1@84@22@0.262@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV4-4_2@0@0@0@@:protein binding@NA
F03665@133432@133435@deletion@4@106539080@106552729@14@chr14:106539080-106552729@77@368@4@0.0109@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1@0@0@0@@:protein binding:protein binding@NA
F03665@133541@133542@deletion@2@22368577@22383423@15@chr15:22368577-22383423@35.5@4403@2482@0.564@CNVR6297.4, CNVR6297.17, CNVR6297.2@OR4M2_1, OR4N4_1@0@0@0@:olfactory receptor, family 4, subfamily M, member 2:olfactory receptor, family 4, subfamily N, member 4@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F03665@133670@133671@duplication@2@23690458@23692328@15@chr15:23690458-23692328@8.1@52@113@2.17@NA@GOLGA6L2_2, GOLGA6L2_1@0@0@0@:golgin A6 family-like 2@NA@NA
F03665@140317@140317@deletion@1@100348377@100348507@15@chr15:100348377-100348507@7.07@39@5@0.128@CNVR6545.2@CTD-2054N24.2_2@0@0@0@NA@NA@NA
F03665@144038@144039@duplication@2@28403074@28403463@16@chr16:28403074-28403463@5.81@188@267@1.42@CNVR6684.2@EIF3CL_10, EIF3CL_9@0@0@0@:eukaryotic translation initiation factor 3, subunit C-like@:protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;translation initiation factor activity@NA
F03665@144097@144099@deletion@3@28617378@28618398@16@chr16:28617378-28618398@5.31@649@465@0.716@CNVR6685.1, CNVR6685.2@SULT1A1_9, SULT1A1_8, SULT1A1_7@0@0@0@:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1@:small molecule metabolic process;sulfation;aryl sulfotransferase activity;amine metabolic process;catecholamine metabolic process;xenobiotic metabolic process;cytosol;steroid sulfotransferase activity;integral to membrane;sulfotransferase activity;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process;estrogen metabolic process@NA
F03665@145554@145564@duplication@11@55844430@55866967@16@chr16:55844430-55866967@86.3@2204@3414@1.55@CNVR6731.1@CES1_11, CES1_10, CES1_9, CES1_8, CES1_7, CES1_6, CES1_5, CES1_4, CES1_3, CES1_2, CES1_1@0@0@0@:carboxylesterase 1;liver carboxylesterase 1-like@:hydrolase activity;methyl salicylate esterase activity;response to toxin;methylumbelliferyl-acetate deacetylase activity;endoplasmic reticulum lumen;retinyl-palmitate esterase activity;methyl jasmonate esterase activity;metabolic process;carboxylesterase activity;methyl indole-3-acetate esterase activity@: CARBOXYLESTERASE 1; CES1
F03665@147101@147102@deletion@2@70010292@70012015@16@chr16:70010292-70012015@14.4@65@0@0@CNVR6762.3, CNVR6762.2@RP11-419C5.2_7, RP11-419C5.2_6@0@0@0@NA@NA@NA
F03665@147110@147121@deletion@12@70162688@70180131@16@chr16:70162688-70180131@71.5@3514@2228@0.634@CNVR6764.1, CNVR6764.3@PDPR_5, PDPR_6, PDPR_7, PDPR_8, PDPR_9, PDPR_10, PDPR_11, PDPR_12, PDPR_13, PDPR_14, PDPR_15, PDPR_16@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
F03665@147123@147124@deletion@2@70187295@70190782@16@chr16:70187295-70190782@25.3@1536@913@0.594@CNVR6764.1, CNVR6764.3@PDPR_18, PDPR_19@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
F03665@147135@147135@deletion@1@70219789@70219879@16@chr16:70219789-70219879@6.37@53@17@0.321@CNVR6764.1, CNVR6764.5@CLEC18C_11@0@0@0@:C-type lectin domain family 18, member C@:carbohydrate binding;protein binding;extracellular region@NA
F03665@151404@151404@deletion@1@15468848@15469578@17@chr17:15468848-15469578@17.6@897@508@0.566@NA@CDRT1_1@0@0@0@:CMT1A duplicated region transcript 1@:protein binding;molecular_function;cellular_component;biological_process@NA
F03665@151875@151885@duplication@11@18380170@18397681@17@chr17:18380170-18397681@50.4@774@1345@1.74@CNVR7014.1@LGALS9C_1, LGALS9C_2, LGALS9C_3, LGALS9C_4, LGALS9C_5, LGALS9C_6, LGALS9C_7, LGALS9C_8, LGALS9C_9, LGALS9C_10, LGALS9C_11@0@0@0@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
F03665@151915@151915@duplication@1@18681789@18682611@17@chr17:18681789-18682611@4.88@834@1086@1.3@NA@FBXW10_14@0@0@0@:F-box/WD repeat-containing protein 10-like;F-box and WD repeat domain containing 10@:protein binding@NA
F03665@153380@153381@deletion@2@34539179@34539971@17@chr17:34539179-34539971@15.5@70@0@0@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1_2, CCL4L1_3@0@0@0@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
F03665@153651@153652@deletion@2@36352423@36353765@17@chr17:36352423-36353765@10.5@734@488@0.665@CNVR7083.3@RP11-1407O15.2_11, RP11-1407O15.2_10@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
F03665@154346@154346@duplication@1@39421631@39422112@17@chr17:39421631-39422112@5.76@52@101@1.94@CNVR7096.1@KRTAP9-6_1@0@0@0@:keratin associated protein 9-6@:keratin filament@NA
F03665@155581@155581@duplication@1@44248222@44249509@17@chr17:44248222-44249509@5.94@2288@2974@1.3@CNVR7114.3, CNVR7114.2, CNVR7114.8@KANSL1_2@0@0@0@:KAT8 regulatory NSL complex subunit 1@:histone acetyltransferase activity (H4-K8 specific);histone acetyltransferase activity (H4-K16 specific);histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase complex;histone H4-K5 acetylation;MLL1 complex;histone H4-K16 acetylation;protein binding;histone H4-K8 acetylation;nucleus@NA
F03665@155587@155590@deletion@4@44399689@44409347@17@chr17:44399689-44409347@9.85@59@10@0.169@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
F03665@155593@155599@deletion@7@44414663@44592687@17@chr17:44414663-44592687@16.3@79@4@0.0506@CNVR7114.2, CNVR7114.1@LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane@NA
F03665@155609@155612@duplication@4@44630767@44632945@17@chr17:44630767-44632945@12.6@198@329@1.66@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2_12, LRRC37A2_13, LRRC37A2_14, LRRC37A2_15@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
F03665@158243@158244@duplication@2@72613258@72619760@17@chr17:72613258-72619760@4.98@395@519@1.31@NA@CD300E_2, CD300E_1@0@0@0@:CD300e molecule@:protein binding;integral to membrane;plasma membrane@NA
F03665@162017@162017@deletion@1@44542732@44544371@18@chr18:44542732-44544371@8.61@52@9@0.173@CNVR7319.1@TCEB3CL2_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
F03665@162019@162019@duplication@1@44554574@44556213@18@chr18:44554574-44556213@12.1@102@214@2.1@CNVR7319.1@TCEB3C_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C (elongin A3);RNA polymerase II transcription factor SIII subunit A3-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
F03665@163101@163104@duplication@4@77906043@77926820@18@chr18:77906043-77926820@16.2@1215@1641@1.35@NA@AC139100.2_1, PARD6G_3, AC139100.2_2, AC139100.2_3@0@0@0@:par-6 partitioning defective 6 homolog gamma (C. elegans)@:cell-cell junction organization;protein complex;cytosol;tight junction;protein binding;plasma membrane;cell cycle;cell division;cell junction assembly;tight junction assembly@NA
F03665@166916@166917@deletion@2@14508471@14508747@19@chr19:14508471-14508747@14.3@116@36@0.31@NA@CD97_7, CD97_8@0@0@0@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
F03665@167047@167047@duplication@1@14877791@14877921@19@chr19:14877791-14877921@5.32@96@154@1.6@NA@EMR2_6@0@0@0@:egf-like module containing, mucin-like, hormone receptor-like 2@:transmembrane signaling receptor activity;inflammatory response;G-protein coupled receptor activity;ruffle membrane;integral to membrane;plasma membrane;cell surface receptor signaling pathway;neuropeptide signaling pathway;granulocyte chemotaxis;cell migration;leading edge membrane;G-protein coupled receptor signaling pathway;protein binding;cell adhesion;membrane;calcium ion binding;chondroitin sulfate binding@NA
F03665@170093@170096@deletion@4@40367299@40374086@19@chr19:40367299-40374086@17.9@196@79@0.403@CNVR7639.2@FCGBP_29, FCGBP_28, FCGBP_27, FCGBP_26@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F03665@170367@170367@deletion@1@41381599@41381779@19@chr19:41381599-41381779@8.65@147@73@0.497@CNVR7642.1@CYP2A7_9@0@0@0@:cytochrome P450, family 2, subfamily A, polypeptide 7@:oxidation-reduction process;electron carrier activity;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;oxygen binding;heme binding;monooxygenase activity;endoplasmic reticulum membrane;iron ion binding@NA
F03665@170402@170402@duplication@1@41631399@41631539@19@chr19:41631399-41631539@6.32@177@264@1.49@NA@CYP2F1_9@0@0@0@:cytochrome P450, family 2, subfamily F, polypeptide 1@:trichloroethylene metabolic process;oxidation-reduction process;aromatase activity;response to toxin;oxygen binding;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;endoplasmic reticulum membrane;naphthalene metabolic process;intracellular membrane-bounded organelle;electron carrier activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;heme binding;xenobiotic metabolic process;monooxygenase activity;iron ion binding@NA
F03665@172987@172987@deletion@1@52133087@52133469@19@chr19:52133087-52133469@9.84@52@5@0.0962@CNVR7702.1@SIGLEC5_2, SIGLEC5_2@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion@NA
F03665@172991@172994@duplication@4@52147033@52149893@19@chr19:52147033-52149893@8.97@406@553@1.36@CNVR7702.1@SIGLEC14_5, SIGLEC14_4, SIGLEC14_3, SIGLEC14_2@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 14@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion;plasma membrane@NA
F03665@173336@173341@deletion@6@54801928@54804173@19@chr19:54801928-54804173@24.6@1068@682@0.639@CNVR7722.1@LILRA3_6, LILRA3_5, LILRA3_4, LILRA3_3, LILRA3_2, LILRA3_1@0@0@0@:leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3@:antigen binding;signal transduction;protein binding;extracellular region;plasma membrane;receptor activity;defense response@NA
F03665@173415@173422@deletion@8@55098478@55107956@19@chr19:55098478-55107956@61.1@1374@734@0.534@NA@LILRA2_8, LILRA2_9, LILRA1_2, LILRA1_3, LILRA1_4, LILRA1_5, LILRA1_6, LILRA1_7@0@0@0@:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1@:antigen binding;signal transduction;protein binding;integral to membrane;receptor activity;defense response:interferon-gamma secretion;defense response to virus;dendritic cell differentiation;negative regulation of interferon-gamma production;regulation of immune response;negative regulation of dendritic cell differentiation;HLA-A specific inhibitory MHC class I receptor activity;negative regulation of alpha-beta T cell activation;negative regulation of transforming growth factor-beta secretion;negative regulation of interleukin-10 secretion;T cell proliferation involved in immune response;plasma membrane;negative regulation of mononuclear cell proliferation;positive regulation of gamma-delta T cell activation involved in immune response;negative regulation of interferon-beta secretion;negative regulation of calcium ion transport;response to virus;negative regulation of serotonin secretion;negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell;cellular response to lipopolysaccharide;negative regulation of cell cycle;positive regulation of cytolysis;negative regulation of T cell mediated cytotoxicity;positive regulation of defense response to virus by host;MHC class I receptor activity;negative regulation of natural killer cell mediated cytotoxicity;negative regulation of dendritic cell apoptotic process;negative regulation of T cell proliferation;negative regulation of CD8-positive, alpha-beta T cell activation;immune response-inhibiting cell surface receptor signaling pathway;Fc receptor mediated inhibitory signaling pathway;negative regulation of cytokine secretion involved in immune response;SH2 domain binding;negative regulation of interleukin-12 secretion;HLA-B specific inhibitory MHC class I receptor activity;negative regulation of osteoclast development;integral to membrane;interferon-gamma production;MHC class I protein binding;protein homodimerization activity;positive regulation of transcription from RNA polymerase II promoter;protein phosphatase 1 binding;positive regulation of gene expression;external side of plasma membrane;receptor internalization;cytoplasm;negative regulation of tumor necrosis factor biosynthetic process;protein binding;signal transduction;negative regulation of interferon-gamma biosynthetic process;negative regulation of endocytosis;positive regulation of apoptotic process:transmembrane signaling receptor activity;regulation of immune response;antigen binding;protein binding;integral to membrane;plasma membrane;defense response;cell surface receptor signaling pathway@NA
F03665@173472@173475@duplication@4@55284786@55294475@19@chr19:55284786-55294475@8.97@862@1122@1.3@CNVR7725.2, CNVR7725.1@KIR2DL1_3, KIR2DL1_4, KIR2DL1_5, KIR2DL1_6@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
F03665@173492@173493@deletion@2@55341384@55341730@19@chr19:55341384-55341730@12.3@371@218@0.588@CNVR7725.1, CNVR7725.6@KIR3DL1_8, KIR3DL1_9@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
F03665@173496@173497@deletion@2@55349032@55351154@19@chr19:55349032-55351154@4.91@334@228@0.683@CNVR7725.1, CNVR7725.6@KIR2DS4_3, KIR2DS4_4@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
F03665@173499@173501@duplication@3@55358640@55359398@19@chr19:55358640-55359398@25.8@1002@1479@1.48@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4_6, KIR2DS4_7, KIR2DS4_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
F03665@173844@173845@deletion@2@56283172@56284545@19@chr19:56283172-56284545@15.1@816@518@0.635@CNVR7734.1@CTD-2611O12.2_2, CTD-2611O12.2_3@0@0@0@:ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
F03665@174395@174395@deletion@1@1569207@1569278@20@chr20:1569207-1569278@9.94@45@0@0@CNVR7763.1@RP4-576H24.4_1@0@0@0@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
F03665@175736@175737@duplication@2@26061801@26063616@20@chr20:26061801-26063616@9.5@220@334@1.52@CNVR7823.4, CNVR7823.3, CNVR7823.5, CNVR7823.1@FAM182A_4, FAM182A_5@0@0@0@NA@NA@NA
F03665@180976@180976@deletion@1@16287255@16287885@22@chr22:16287255-16287885@11.3@91@26@0.286@CNVR8071.2, CNVR8071.3, CNVR8071.9@POTEH_1@0@0@0@:POTE ankyrin domain family, member H@:protein binding@NA
F03665@181948@181949@duplication@2@24324820@24325235@22@chr22:24324820-24325235@5.29@51@94@1.84@CNVR8114.6, CNVR8114.13, CNVR8114.8, CNVR8114.14@GSTT2_3, GSTT2_4@0@0@0@@:protein binding;glutathione transferase activity;nucleus;cytoplasm@NA
F03665@181952@181955@deletion@4@24376823@24384231@22@chr22:24376823-24384231@12.1@494@317@0.642@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTT1_4, GSTT1_3, GSTT1_2, GSTT1_1@0@0@0@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
F03665@183631@183631@deletion@1@39357393@39357686@22@chr22:39357393-39357686@16.5@77@1@0.013@CNVR8164.1@APOBEC3A_4@0@0@0@:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A;APOBEC3A and APOBEC3B deletion hybrid@:cytidine deamination;defense response to virus;negative regulation of viral genome replication;DNA cytosine deamination;clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine;catalytic activity;DNA demethylation;cytoplasm;innate immune response;cytidine deaminase activity;nucleus;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;cellular response to xenobiotic stimulus;zinc ion binding;negative regulation of transposition@NA
F03665@183635@183640@duplication@6@39380081@39388154@22@chr22:39380081-39388154@14.4@618@846@1.37@CNVR8164.1@APOBEC3B_2, APOBEC3B_3, APOBEC3B_4, APOBEC3B_5, APOBEC3B_6, APOBEC3B_7@0@0@0@:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B@:RNA binding;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;negative regulation of transposition;catalytic activity;zinc ion binding@NA
F03665@184165@184177@duplication@13@42908917@42952594@22@chr22:42908917-42952594@55.9@728@1285@1.77@CNVR8171.2, CNVR8171.3@RRP7A_7, RRP7A_6, RRP7A_5, RRP7A_4, RRP7A_3, RRP7A_2, RRP7A_1, SERHL2_1, SERHL2_2, SERHL2_3, SERHL2_4, SERHL2_5, SERHL2_6@0@0@0@:ribosomal RNA processing 7 homolog A (S. cerevisiae):serine hydrolase-like 2@:RNA binding;nucleotide binding:hydrolase activity;mitochondrion;peroxisome;cytoplasmic membrane-bounded vesicle;molecular_function;cellular_component;perinuclear region of cytoplasm;biological_process@NA
F03665@4052@4065@deletion@14@101571921@101576984@X@chrX:101571921-101576984@8.54@73@26@0.356@NA@NXF2_15, NXF2_16, NXF2_17, NXF2_18, NXF2_19, NXF2_20, NXF2_21, NXF2_22, NXF2_23, NXF2_24, NXF2_25, NXF2_26, NXF2_27, NXF2_28@0@0@0@NA@NA@NA
F03665@6297@6297@duplication@1@153458900@153459138@X@chrX:153458900-153459138@4.81@118@172@1.46@CNVR8489.1@OPN1MW_5@0@0@0@NA@NA@NA
F03665@6307@6307@deletion@1@153496018@153496256@X@chrX:153496018-153496256@7.02@31@0@0@CNVR8489.1@OPN1MW2_5@0@0@0@NA@NA@NA
F05163@418@418@deletion@1@1607504@1607638@1@chr1:1607504-1607638@8.58@77@27@0.351@CNVR17.1@SLC35E2B_4@0@0@0@:solute carrier family 35, member E2B@:integral to membrane;membrane;transmembrane transport@NA
F05163@479@479@deletion@1@1854807@1854938@1@chr1:1854807-1854938@6.27@115@62@0.539@NA@C1orf222_19@0@0@0@:KIAA1751@NA@NA
F05163@2170@2183@duplication@14@17248515@17270777@1@chr1:17248515-17270777@11@1578@1965@1.25@CNVR94.4, CNVR94.5@CROCC_1, CROCC_2, CROCC_3, CROCC_4, CROCC_5, CROCC_6, CROCC_7, CROCC_8, CROCC_9, CROCC_10, CROCC_11, CROCC_12, CROCC_13, CROCC_14@0@0@0@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
F05163@2789@2792@duplication@4@21807424@21809879@1@chr1:21807424-21809879@6.45@177@251@1.42@CNVR107.2, CNVR107.1@NBPF3_12, NBPF3_13, NBPF3_14, NBPF3_15@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 3@:cytoplasm@NA
F05163@3335@3342@deletion@8@25617133@25655415@1@chr1:25617133-25655415@17@946@652@0.689@CNVR116.1, CNVR116.2@RHD_3, RHD_4, RHD_5, RHD_6, RHD_7, RHD_8, RHD_9, RHD_10@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
F05163@5148@5149@deletion@2@39977429@39987242@1@chr1:39977429-39987242@6.86@73@32@0.438@NA@BMP8A_3, BMP8A_4@0@0@0@:bone morphogenetic protein 8a@:cell differentiation;growth factor activity;extracellular space;growth;cytokine activity;cartilage development;ossification@NA
F05163@6306@6309@duplication@4@47512140@47515846@1@chr1:47512140-47515846@24.1@1161@1596@1.37@NA@CYP4X1_9, CYP4X1_10, CYP4X1_11, CYP4X1_12@0@0@0@:cytochrome P450, family 4, subfamily X, polypeptide 1@:oxidation-reduction process;electron carrier activity;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;endoplasmic reticulum membrane;heme binding@NA
F05163@8507@8508@duplication@2@89476588@89477710@1@chr1:89476588-89477710@35.3@523@956@1.83@CNVR244.1@GBP3_8, GBP3_7@0@0@0@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
F05163@9365@9374@deletion@10@104202983@104234232@1@chr1:104202983-104234232@37.7@173@2@0.0116@CNVR266.3, CNVR266.1, CNVR266.15@AMY1A_7, AMY1A_8, AMY1A_9, AMY1A_10, AMY1A_11, AMY1B_11, AMY1B_10, AMY1B_9, AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
F05163@9436@9436@duplication@1@108769302@108769515@1@chr1:108769302-108769515@6.99@112@183@1.63@CNVR294.4@NBPF4_14@0@0@0@:neuroblastoma breakpoint family, member 4@:cytoplasm@NA
F05163@9766@9773@deletion@8@110230497@110235917@1@chr1:110230497-110235917@134@634@11@0.0174@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
F05163@12117@12118@deletion@2@152573209@152586574@1@chr1:152573209-152586574@35@161@1@0.00621@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
F05163@14053@14058@duplication@6@161565346@161600992@1@chr1:161565346-161600992@15.2@1079@1389@1.29@CNVR383.1@FCGR2C_1, FCGR3B_5, FCGR3B_4, FCGR3B_3, FCGR3B_2, FCGR3B_1@0@0@0@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene):Fc fragment of IgG, low affinity IIIb, receptor (CD16b)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction:IgG binding;protein binding;extracellular region;immune response;plasma membrane;anchored to membrane@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
F05163@16033@16037@deletion@5@196759176@196796135@1@chr1:196759176-196796135@10.1@825@580@0.703@CNVR459.1@CFHR3_5, CFHR3_6, CFHR1_1, CFHR1_2, CFHR1_3@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
F05163@16039@16039@deletion@1@196799631@196799812@1@chr1:196799631-196799812@8.46@349@219@0.628@CNVR459.1@CFHR1_5@0@0@0@:complement factor H-related 1:complement factor H-related 2@:extracellular space;complement activation:extracellular region@NA
F05163@17286@17287@deletion@2@207718654@207719023@1@chr1:207718654-207719023@6.28@27@0@0@CNVR485.1@CR1_14, CR1_15@0@0@0@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
F05163@17297@17297@duplication@1@207741170@207741387@1@chr1:207741170-207741387@6.98@227@328@1.44@CNVR485.1, CNVR485.2@CR1_25@0@0@0@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
F05163@19775@19776@deletion@2@248756132@248790429@1@chr1:248756132-248790429@15.1@1526@1049@0.687@CNVR600.1@OR2T10_1, OR2T11_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 10:olfactory receptor, family 2, subfamily T, member 11@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F05163@19778@19778@deletion@1@248813233@248814185@1@chr1:248813233-248814185@15.7@554@317@0.572@NA@OR2T27_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 27@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F05163@25007@25009@duplication@3@90198896@90212253@2@chr2:90198896-90212253@6.48@167@243@1.46@CNVR867.10, CNVR867.3, CNVR867.2@IGKV1D-12_2, IGKV3D-11_1, IGKV3D-11_2@0@0@0@@:protein binding:protein binding@NA
F05163@25350@25351@duplication@2@97818242@97820478@2@chr2:97818242-97820478@4.99@276@362@1.31@CNVR886.2@ANKRD36_14, ANKRD36_15@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
F05163@25377@25394@duplication@18@97862331@97877478@2@chr2:97862331-97877478@14.4@1205@1549@1.29@CNVR886.1@ANKRD36_41, ANKRD36_42, ANKRD36_43, ANKRD36_44, ANKRD36_45, ANKRD36_46, ANKRD36_47, ANKRD36_48, ANKRD36_49, ANKRD36_50, ANKRD36_51, ANKRD36_52, ANKRD36_53, ANKRD36_54, ANKRD36_55, ANKRD36_56, ANKRD36_57, ANKRD36_58@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
F05163@26327@26332@duplication@6@112590798@112605442@2@chr2:112590798-112605442@8.29@356@482@1.35@CNVR929.1, CNVR929.2@ANAPC1_20, ANAPC1_19, ANAPC1_18, ANAPC1_17, ANAPC1_16, ANAPC1_15@0@0@0@:anaphase-promoting complex subunit 1-like;anaphase promoting complex subunit 1@:nucleoplasm;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle;anaphase-promoting complex;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle spindle assembly checkpoint;cytosol;protein K11-linked ubiquitination;protein binding;mitosis;nucleus;cell cycle checkpoint;cell division;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle@NA
F05163@27342@27342@deletion@1@132289238@132289375@2@chr2:132289238-132289375@4.93@58@26@0.448@NA@CCDC74A_4@0@0@0@:coiled-coil domain containing 74A@NA@NA
F05163@29624@29624@duplication@1@179296825@179296981@2@chr2:179296825-179296981@5.01@319@425@1.33@CNVR1065.1@PRKRA_8@0@0@0@:protein kinase, interferon-inducible double stranded RNA dependent activator@:double-stranded RNA binding;negative regulation of cell proliferation;immune response;pyridoxal phosphate binding;middle ear morphogenesis;production of siRNA involved in RNA interference;induction of apoptosis;protein homodimerization activity;skeletal system morphogenesis;response to virus;positive regulation of catalytic activity;protein phosphorylation;intracellular;response to stress;cytoplasm;perinuclear region of cytoplasm;outer ear morphogenesis;protein binding;enzyme activator activity;kinase activity@: DYSTONIA 16; DYT16
F05163@33409@33412@deletion@4@233273212@233274158@2@chr2:233273212-233274158@20.5@263@123@0.468@NA@ALPPL2_7, ALPPL2_8, ALPPL2_9, ALPPL2_10@0@0@0@:alkaline phosphatase, placental-like 2@:phosphatase activity;catalytic activity;phosphorylation;plasma membrane;metabolic process;membrane;anchored to membrane;alkaline phosphatase activity;metal ion binding@NA
F05163@39892@39893@duplication@2@75786030@75790519@3@chr3:75786030-75790519@5.93@6305@7633@1.21@CNVR1432.5, CNVR1432.9, CNVR1432.4@ZNF717_5, ZNF717_4@0@0@0@:zinc finger protein 717;zinc finger protein 717-like@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
F05163@48556@48561@deletion@6@69403344@69434202@4@chr4:69403344-69434202@205@1079@20@0.0185@CNVR1953.1@UGT2B17_6, UGT2B17_5, UGT2B17_4, UGT2B17_3, UGT2B17_2, UGT2B17_1@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
F05163@53303@53305@duplication@3@716924@733954@5@chr5:716924-733954@41.4@1146@1801@1.57@CNVR2280.3@ZDHHC11B_10, ZDHHC11B_9, ZDHHC11B_8@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
F05163@53312@53312@duplication@1@766814@767067@5@chr5:766814-767067@13.2@268@439@1.64@CNVR2280.3@ZDHHC11B_1@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
F05163@53318@53322@duplication@5@833889@847730@5@chr5:833889-847730@27.1@898@1335@1.49@CNVR2280.3, CNVR2280.8@ZDHHC11_7, ZDHHC11_6, ZDHHC11_5, ZDHHC11_4, ZDHHC11_3@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
F05163@54333@54335@deletion@3@35860955@35871315@5@chr5:35860955-35871315@17.9@470@282@0.6@NA@IL7R_2, IL7R_3, IL7R_4@0@0@0@:interleukin 7 receptor@:immune response;interleukin-7-mediated signaling pathway;interleukin-7 receptor activity;homeostasis of number of cells;integral to membrane;plasma membrane;regulation of DNA recombination;cell surface receptor signaling pathway;cell morphogenesis;B cell proliferation;positive regulation of gene expression;positive regulation of T cell differentiation in thymus;cell growth;external side of plasma membrane;T cell differentiation;cytokine receptor activity;antigen binding;protein binding;negative regulation of T cell mediated cytotoxicity;signal transduction;extracellular region;immunoglobulin production;lymph node development;membrane;regulation of cell size@: SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE,; MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 3; MS3
F05163@54849@54849@duplication@1@42629141@42629205@5@chr5:42629141-42629205@6.46@197@285@1.45@CNVR2445.1@GHR_3@0@0@0@:growth hormone receptor@:neuronal cell body;mitochondrion;proline-rich region binding;JAK-STAT cascade;growth factor binding;nucleus;succinate metabolic process;positive regulation of JAK-STAT cascade;JAK-STAT cascade involved in growth hormone signaling pathway;response to morphine;activation of MAPK activity;peptide hormone binding;response to estradiol stimulus;2-oxoglutarate metabolic process;valine metabolic process;response to cytokine stimulus;hormone-mediated signaling pathway;response to food;SH2 domain binding;oxaloacetate metabolic process;growth hormone receptor signaling pathway;allantoin metabolic process;integral to membrane;response to hormone stimulus;cartilage development involved in endochondral bone morphogenesis;positive regulation of peptidyl-tyrosine phosphorylation;receptor internalization;cytoplasm;cellular response to hormone stimulus;extracellular region;growth hormone receptor complex;positive regulation of tyrosine phosphorylation of Stat5 protein;regulation of multicellular organism growth;growth hormone receptor activity;positive regulation of tyrosine phosphorylation of Stat3 protein;response to peptide hormone stimulus;fatty acid metabolic process;creatinine metabolic process;plasma membrane;positive regulation of multicellular organism growth;receptor complex;protein phosphatase binding;protein kinase binding;creatine metabolic process;response to interleukin-1;response to cycloheximide;extracellular space;positive regulation of cell differentiation;activation of Janus kinase activity;taurine metabolic process;cellular response to insulin stimulus;integral to plasma membrane;protein homodimerization activity;negative regulation of neuron death;citrate metabolic process;endocytosis;isoleucine metabolic process;activation of JAK2 kinase activity;extrinsic to membrane;response to glucocorticoid stimulus;protein binding;insulin-like growth factor receptor signaling pathway;multicellular organismal metabolic process;cell surface@: HYPERCHOLESTEROLEMIA, FAMILIAL; LARON SYNDROME; SHORT STATURE, IDIOPATHIC, AUTOSOMAL
F05163@60875@60877@deletion@3@175386973@175388437@5@chr5:175386973-175388437@10.4@156@82@0.526@NA@THOC3_6, THOC3_5, THOC3_4@0@0@0@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
F05163@61641@61645@duplication@5@180376905@180429785@5@chr5:180376905-180429785@6@1088@1339@1.23@CNVR2719.1@BTNL8_8, BTNL3_1, BTNL3_2, BTNL3_3, BTNL3_4@0@0@0@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
F05163@62773@62773@duplication@1@26637574@26638781@6@chr6:26637574-26638781@14.2@766@1121@1.46@NA@ZNF322_4@0@0@0@:zinc finger protein 322@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;cytoplasm@NA
F05163@63281@63282@duplication@2@31237744@31238262@6@chr6:31237744-31238262@8.72@345@476@1.38@CNVR2838.2, CNVR2838.1@HLA-C_5, HLA-C_4@0@0@0@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
F05163@63725@63734@deletion@10@31962023@31964838@6@chr6:31962023-31964838@32.9@444@211@0.475@CNVR2843.6, CNVR2843.3@C4A_20, C4A_21, C4A_22, C4A_23, C4A_24, C4A_25, C4A_26, C4A_27, C4A_28, C4A_29@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
F05163@63802@63804@deletion@3@32009790@32010383@6@chr6:32009790-32010383@7.66@119@63@0.529@CNVR2843.6, CNVR2843.5@TNXB_11, TNXB_10, TNXB_9@0@0@0@:tenascin-X-like;tenascin XB@:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
F05163@63959@63960@deletion@2@32546869@32548047@6@chr6:32546869-32548047@7.35@95@46@0.484@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.5, CNVR2845.4@HLA-DRB1_6, HLA-DRB1_5@0@0@0@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
F05163@63963@63974@deletion@12@32551887@32634384@6@chr6:32551887-32634384@97.9@1326@628@0.474@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.34@HLA-DRB1_2, HLA-DRB1_1, HLA-DQA1_1, HLA-DQA1_2, HLA-DQA1_3, HLA-DQA1_4, HLA-DQB1_6, HLA-DQB1_5, HLA-DQB1_4, HLA-DQB1_3, HLA-DQB1_2, HLA-DQB1_1@0@0@0@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
F05163@63994@64002@duplication@9@32798396@32809512@6@chr6:32798396-32809512@9.55@1493@1843@1.23@NA@TAP2_8, TAP2_8, TAP2_7, TAP2_7, TAP2_6, TAP2_6, TAP2_5, TAP2_5, TAP2_4, TAP2_4, TAP2_3, TAP2_3, TAP2_2, TAP2_2, PSMB8_6, PSMB8_5@0@0@0@:transporter 2, ATP-binding cassette, sub-family B (MDR/TAP):proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional peptidase 7)@:ATPase activity, coupled to transmembrane movement of substances;transport;immune response;transporter activity;ATP binding;transmembrane transport;integral to membrane;peptide transporter activity;ATPase activity;nucleus;nucleoside-triphosphatase activity;endoplasmic reticulum;nucleotide binding;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;antigen processing and presentation;membrane:ATPase activity, coupled to transmembrane movement of substances;antigen processing and presentation of peptide antigen via MHC class I;transporter activity;ATP binding;transmembrane transport;integral to endoplasmic reticulum membrane;positive regulation of antigen processing and presentation of peptide antigen via MHC class I;peptide antigen binding;peptide transporter activity;ATPase activity;plasma membrane;nucleus;antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent;endoplasmic reticulum membrane;antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;antigen processing and presentation of endogenous peptide antigen via MHC class I;endoplasmic reticulum;peptide transport;antigen processing and presentation of exogenous peptide antigen via MHC class I;oligopeptide-transporting ATPase activity;TAP2 binding;transport;peptide antigen-transporting ATPase activity;antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent;integral to membrane;MHC class I protein binding;intracellular transport of viral proteins in host cell;cytosol to ER transport;nucleoside-triphosphatase activity;positive regulation of T cell mediated cytotoxicity;nucleotide binding;tapasin binding;protein binding;peptide antigen transport;TAP complex;TAP1 binding:nucleoplasm;proteasome complex;fat cell differentiation;S phase of mitotic cell cycle;mitotic cell cycle;antigen processing and presentation of peptide antigen via MHC class I;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;mRNA metabolic process;viral reproduction;gene expression;cell cycle checkpoint;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;type I interferon-mediated signaling pathway;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;cytosol;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;proteolysis involved in cellular protein catabolic process;regulation of apoptotic process;cellular nitrogen compound metabolic process;proteasome core complex;RNA metabolic process;G1/S transition of mitotic cell cycle;regulation of cellular amino acid metabolic process;apoptotic process;cytokine-mediated signaling pathway;virus-host interaction;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;small molecule metabolic process;threonine-type endopeptidase activity;M/G1 transition of mitotic cell cycle;protein polyubiquitination@: BARE LYMPHOCYTE SYNDROME, TYPE I: AUTOINFLAMMATION, LIPODYSTROPHY, AND DERMATOSIS SYNDROME; ALDD
F05163@64059@64061@deletion@3@33052728@33054015@6@chr6:33052728-33054015@10.1@515@345@0.67@CNVR2846.4, CNVR2846.3, CNVR2846.5@HLA-DPB1_3, HLA-DPB1_4, HLA-DPB1_5@0@0@0@:major histocompatibility complex, class II, DP beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
F05163@64603@64606@duplication@4@35755645@35765065@6@chr6:35755645-35765065@10.8@1144@1454@1.27@CNVR2861.1@CLPSL1_3, CLPS_3, CLPS_2, CLPS_1@0@0@0@:colipase-like 1:colipase, pancreatic@:extracellular region;enzyme activator activity;digestion;lipid catabolic process:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
F05163@66572@66575@deletion@4@65612007@65655807@6@chr6:65612007-65655807@32.9@1138@686@0.603@NA@EYS_18, EYS_17, EYS_16, EYS_15@0@0@0@:eyes shut homolog (Drosophila)@:protein binding;response to stimulus;extracellular region;visual perception;calcium ion binding@: RETINITIS PIGMENTOSA 25; RP25
F05163@70084@70084@duplication@1@150343117@150343379@6@chr6:150343117-150343379@5.65@110@170@1.55@NA@RAET1L_2@0@0@0@:retinoic acid early transcript 1L@:MHC class I protein complex;antigen processing and presentation;immune response;anchored to membrane;membrane@NA
F05163@70086@70087@deletion@2@150385744@150386809@6@chr6:150385744-150386809@18.5@448@254@0.567@NA@ULBP3_4, ULBP3_3@0@0@0@:UL16 binding protein 3@:MHC class I protein complex;regulation of immune response;immune response;antigen processing and presentation;natural killer cell activation;MHC class I receptor activity;plasma membrane;anchored to membrane;membrane;virus-host interaction@NA
F05163@71029@71029@deletion@1@167789455@167789565@6@chr6:167789455-167789565@5.15@63@29@0.46@NA@TCP10_6@0@0@0@:t-complex 10@:cytosol@NA
F05163@71031@71032@deletion@2@167791444@167794824@6@chr6:167791444-167794824@13.5@196@97@0.495@NA@TCP10_4, TCP10_3@0@0@0@:t-complex 10@:cytosol@NA
F05163@71747@71749@duplication@3@5941289@5944900@7@chr7:5941289-5944900@12.9@558@763@1.37@NA@CCZ1_5, CCZ1_6, CCZ1_7@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F05163@71760@71766@deletion@7@5972414@5984809@7@chr7:5972414-5984809@11.9@381@247@0.648@NA@RSPH10B_18, RSPH10B_17, RSPH10B_16, RSPH10B_15, RSPH10B_14, RSPH10B_13, RSPH10B_12@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F05163@71933@71939@duplication@7@6820441@6836397@7@chr7:6820441-6836397@18.6@629@881@1.4@NA@RSPH10B2_13, RSPH10B2_14, RSPH10B2_15, RSPH10B2_16, RSPH10B2_17, RSPH10B2_18, RSPH10B2_19@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F05163@71945@71952@deletion@8@6845636@6863797@7@chr7:6845636-6863797@34.5@1067@677@0.634@NA@CCZ1B_11, CCZ1B_10, CCZ1B_9, CCZ1B_8, CCZ1B_7, CCZ1B_6, CCZ1B_5, CCZ1B_4@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F05163@72395@72415@deletion@21@21654733@21750321@7@chr7:21654733-21750321@199@5673@3294@0.581@NA@DNAH11_21, DNAH11_22, DNAH11_23, DNAH11_24, DNAH11_25, DNAH11_26, DNAH11_27, DNAH11_28, DNAH11_29, DNAH11_30, DNAH11_31, DNAH11_32, DNAH11_33, DNAH11_34, DNAH11_35, DNAH11_36, DNAH11_37, DNAH11_38, DNAH11_39, DNAH11_40, DNAH11_41, DNAH11_42@0@0@0@:dynein, axonemal, heavy chain 11@:microtubule motor activity;ciliary or flagellar motility;nucleoside-triphosphatase activity;cilium;nucleotide binding;ATP binding;cytoplasm;dynein complex;microtubule-based movement;axonemal dynein complex;ATPase activity;microtubule;determination of left/right symmetry;cilium axoneme@: CILIARY DYSKINESIA, PRIMARY, 1; CILD1; CILIARY DYSKINESIA, PRIMARY, 7; CILD7
F05163@73260@73263@duplication@4@38388957@38393784@7@chr7:38388957-38393784@10.7@1065@1369@1.29@CNVR3354.3, CNVR3354.1@TRGV5_2, TRGV5_1, TRGV4_2, TRGV4_1@0@0@0@@:protein binding:protein binding@NA
F05163@74775@74775@deletion@1@76063356@76063472@7@chr7:76063356-76063472@14.4@100@23@0.23@CNVR3462.1@ZP3_5@0@0@0@:zona pellucida glycoprotein 3 (sperm receptor)@:negative regulation of transcription, DNA-dependent;manganese ion transmembrane transporter activity;intracellular protein transport;proteinaceous extracellular matrix;plasma membrane;positive regulation of acrosome reaction;outer acrosomal membrane;protein kinase C signaling cascade;manganese ion transmembrane transport;intracellular signal transduction;humoral immune response mediated by circulating immunoglobulin;negative regulation of binding of sperm to zona pellucida;positive regulation of inflammatory response;endoplasmic reticulum;signal transducer activity;perinuclear region of cytoplasm;secretory granule;positive regulation of transcription, DNA-dependent;positive regulation of ovarian follicle development;positive regulation of interferon-gamma production;carbohydrate binding;manganese ion transport;positive regulation of antral ovarian follicle growth;extracellular matrix;positive regulation of leukocyte migration;positive regulation of humoral immune response;extracellular space;blastocyst formation;integral to membrane;store-operated calcium channel activity;oocyte development;multivesicular body;phosphatidylinositol-mediated signaling;acrosomal vesicle;positive regulation of protein kinase B signaling cascade;Golgi apparatus;positive regulation of calcium ion import;positive regulation of protein kinase activity;positive regulation of acrosomal vesicle exocytosis;positive regulation of interleukin-4 production;cytoplasm;protein binding;binding of sperm to zona pellucida;positive regulation of phosphatidylinositol biosynthetic process;extracellular region;positive regulation of T cell proliferation;acrosin binding;positive regulation of type IV hypersensitivity;egg coat formation@NA
F05163@74781@74783@deletion@3@76121471@76129837@7@chr7:76121471-76129837@9.03@85@34@0.4@CNVR3462.1@DTX2_6, DTX2_7, DTX2_8@0@0@0@:deltex homolog 2 (Drosophila)@:ligase activity;cytoplasm;nuclear membrane;Notch signaling pathway;protein binding;nucleus;zinc ion binding;protein ubiquitination@NA
F05163@74792@74793@deletion@2@76240783@76241130@7@chr7:76240783-76241130@12.3@317@187@0.59@CNVR3463.10@POMZP3_6, POMZP3_5@0@0@0@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
F05163@76428@76432@duplication@5@100333344@100336236@7@chr7:100333344-100336236@16.8@914@1221@1.34@CNVR3509.1@ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
F05163@76754@76754@deletion@1@102219880@102220243@7@chr7:102219880-102220243@13.2@59@0@0@CNVR3518.1@AC093668.1_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
F05163@79056@79057@duplication@2@142045364@142045816@7@chr7:142045364-142045816@5.19@698@888@1.27@NA@TRBV4-2_1, TRBV4-2_2@0@0@0@@:protein binding@NA
F05163@80402@80403@duplication@2@7718169@7721057@8@chr8:7718169-7721057@11.7@165@279@1.69@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@SPAG11A_3, SPAG11A_4@0@0@0@:sperm associated antigen 11A;sperm associated antigen 11B@:extracellular region;defense response@NA
F05163@88592@88593@duplication@2@43815786@43816821@9@chr9:43815786-43816821@6.72@249@344@1.38@CNVR4294.1@CNTNAP3B_5, CNTNAP3B_6@0@0@0@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
F05163@91244@91249@deletion@6@117086299@117092856@9@chr9:117086299-117092856@15.7@1188@824@0.694@CNVR4448.1@ORM1_3, ORM1_4, ORM1_5, ORM1_6, ORM2_1, ORM2_2@0@0@0@:orosomucoid 1:orosomucoid 2@:protein binding;extracellular space;regulation of immune system process;transport;inflammatory response;extracellular region;acute-phase response:extracellular space;regulation of immune system process;transport;acute-phase response@NA
F05163@95350@95350@duplication@1@17865074@17865474@10@chr10:17865074-17865474@5.7@158@231@1.46@NA@MRC1L1_2@0@0@0@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
F05163@95384@95386@deletion@3@18112045@18122792@10@chr10:18112045-18122792@21.1@183@63@0.344@NA@MRC1_2, MRC1_3, MRC1_4@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F05163@95389@95389@duplication@1@18138509@18138693@10@chr10:18138509-18138693@15.3@129@271@2.1@NA@MRC1_7@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F05163@95393@95393@deletion@1@18152464@18152611@10@chr10:18152464-18152611@7.49@33@0@0@NA@MRC1_11@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F05163@96581@96581@duplication@1@48054984@48055018@10@chr10:48054984-48055018@4.9@185@258@1.39@CNVR4715.2@ASAH2C_1@0@0@0@@:ceramidase activity;sphingolipid metabolic process@NA
F05163@96933@96934@deletion@2@51970584@51970894@10@chr10:51970584-51970894@7.67@33@0@0@NA@ASAH2_11, ASAH2_10@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
F05163@96937@96937@deletion@1@51978271@51978390@10@chr10:51978271-51978390@6.01@26@0@0@NA@ASAH2_7@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
F05163@102313@102336@duplication@24@135340901@135439108@10@chr10:135340901-135439108@86.8@4129@5585@1.35@CNVR4989.7, CNVR4989.11, CNVR4989.4@CYP2E1_3, AL161645.2_2, CYP2E1_4, AL161645.2_1, CYP2E1_5, CYP2E1_6, CYP2E1_7, CYP2E1_8, CYP2E1_9, CYP2E1_10, CYP2E1_11, SYCE1_13, SYCE1_12, SYCE1_11, SYCE1_10, SYCE1_9, SYCE1_8, SYCE1_7, SYCE1_6, SYCE1_5, SYCE1_4, SYCE1_3, SYCE1_2, SYCE1_1, FRG2B_4@0@0@0@:shadow of prion protein homolog (zebrafish):cytochrome P450, family 2, subfamily E, polypeptide 1:synaptonemal complex central element protein 1:FSHD region gene 2 family, member B@:plasma membrane;membrane;anchored to membrane:steroid metabolic process;oxidation-reduction process;mitochondrion;response to drug;oxygen binding;Golgi membrane;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;response to organic nitrogen;oxidoreductase activity;endoplasmic reticulum membrane;heterocycle metabolic process;monoterpenoid metabolic process;response to ethanol;electron carrier activity;drug metabolic process;intracellular membrane-bounded organelle;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;endoplasmic reticulum;enzyme binding;heme binding;response to ozone;intrinsic to endoplasmic reticulum membrane;xenobiotic metabolic process;monooxygenase activity;triglyceride metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NADH or NADPH as one donor, and incorporation of one atom of oxygen;iron ion binding:protein binding;synaptonemal complex;meiotic prophase I;cell division;central element:nucleus@NA
F05163@103288@103289@duplication@2@5269590@5270820@11@chr11:5269590-5270820@5.63@287@380@1.32@NA@HBG1_3, HBG1_2@0@0@0@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
F05163@103342@103342@duplication@1@5798891@5799864@11@chr11:5798891-5799864@26.4@676@1204@1.78@CNVR5049.1@OR52N5_1@0@0@0@:tripartite motif containing 5:olfactory receptor, family 52, subfamily N, member 5@:defense response to virus;Golgi apparatus;intracellular;protein trimerization;ligase activity;cytoplasm;protein binding;nucleus;protein homodimerization activity;identical protein binding;zinc ion binding;cytoplasmic mRNA processing body;protein ubiquitination;virus-host interaction:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F05163@110109@110109@duplication@1@89531299@89531797@11@chr11:89531299-89531797@12.5@387@590@1.52@NA@TRIM49_8@0@0@0@:tripartite motif containing 49@:protein binding;intracellular;DNA binding;zinc ion binding@NA
F05163@114424@114426@deletion@3@10583717@10586541@12@chr12:10583717-10586541@16.6@520@318@0.612@CNVR5430.1@KLRC2_6, KLRC2_5, KLRC2_4@0@0@0@:killer cell lectin-like receptor subfamily C, member 2@:carbohydrate binding:transmembrane signaling receptor activity;carbohydrate binding;protein binding;signal transduction;cellular defense response;integral to plasma membrane@NA
F05163@114483@114483@deletion@1@11243900@11244828@12@chr12:11243900-11244828@13.2@1327@862@0.65@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
F05163@117171@117171@deletion@1@52865851@52866064@12@chr12:52865851-52866064@6.65@142@80@0.563@NA@KRT6C_2@0@0@0@:keratin 6C@:intermediate filament;structural molecule activity;keratin filament;cytoskeleton organization@NA
F05163@125114@125114@deletion@1@41239721@41240349@13@chr13:41239721-41240349@5.02@208@135@0.649@NA@FOXO1_1@0@0@0@:forkhead box O1@:nucleoplasm;negative regulation of apoptotic process;fat cell differentiation;fibroblast growth factor receptor signaling pathway;sequence-specific DNA binding;negative regulation of transcription, DNA-dependent;negative regulation of fat cell differentiation;regulation of sequence-specific DNA binding transcription factor activity;insulin receptor signaling pathway;mitochondrial part;nucleus;blood vessel development;protein phosphatase 2A binding;regulation of cell proliferation;cytosol;chromatin binding;epidermal growth factor receptor signaling pathway;positive regulation of transcription, DNA-dependent;positive regulation of gluconeogenesis;cellular response to nitric oxide;RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity;cellular response to cold;nerve growth factor receptor signaling pathway;transcription factor binding;temperature homeostasis;RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription;protein kinase binding;DNA binding, bending;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;transcription factor complex;apoptotic process;cellular glucose homeostasis;phosphatidylinositol-mediated signaling;positive regulation of transcription from RNA polymerase II promoter;cellular response to starvation;tissue development;regulation of energy homeostasis;endocrine pancreas development;regulation of transcription from RNA polymerase II promoter;regulation of transcription, DNA-dependent;response to DNA damage stimulus;cytoplasm;organ development;double-stranded DNA binding;protein binding;cellular response to oxidative stress;protein acetylation;negative regulation of stress-activated MAPK cascade;pattern specification process@: RHABDOMYOSARCOMA 2; RMS2
F05163@131032@131034@duplication@3@74004127@74010359@14@chr14:74004127-74010359@25.8@424@717@1.69@CNVR6188.1, CNVR6188.4@ACOT1_1, ACOT1_2, ACOT1_3@0@0@0@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
F05163@133425@133427@duplication@3@106471637@106478539@14@chr14:106471637-106478539@20.8@201@385@1.92@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV1-3_1, IGHV4-4_2, IGHV4-4_1@0@0@0@@:protein binding:protein binding@NA
F05163@133432@133436@duplication@5@106539080@106573537@14@chr14:106539080-106573537@84@827@1709@2.07@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1, IGHV3-11_2@0@0@0@@:protein binding:protein binding:protein binding@NA
F05163@133450@133451@duplication@2@106725202@106725654@14@chr14:106725202-106725654@14.4@895@1218@1.36@CNVR6294.48, CNVR6294.24, CNVR6294.40, CNVR6294.38, CNVR6294.17, CNVR6294.23@IGHV3-23_2, IGHV3-23_1@0@0@0@@:protein binding@NA
F05163@133491@133492@duplication@2@107095127@107095561@14@chr14:107095127-107095561@11.3@93@187@2.01@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61_2, IGHV4-61_1@0@0@0@@:protein binding@NA
F05163@133495@133495@duplication@1@107131034@107131334@14@chr14:107131034-107131334@8.57@254@376@1.48@CNVR6294.56, CNVR6294.16@IGHV3-66_2@0@0@0@@:protein binding@NA
F05163@134008@134024@deletion@17@30654497@30700195@15@chr15:30654497-30700195@19.7@697@444@0.637@CNVR6337.1@CHRFAM7A_10, CHRFAM7A_9, CHRFAM7A_8, CHRFAM7A_7, CHRFAM7A_6, CHRFAM7A_5, CHRFAM7A_4, CHRFAM7A_3, GOLGA8R_19, GOLGA8R_18, GOLGA8R_17, GOLGA8R_16, GOLGA8R_15, GOLGA8R_14, GOLGA8R_13, GOLGA8R_12, GOLGA8R_11@0@0@0@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity:Golgi apparatus@NA
F05163@135742@135743@deletion@2@43988238@43988561@15@chr15:43988238-43988561@10.3@233@133@0.571@CNVR6365.1@CKMT1A_5, CKMT1A_6@0@0@0@:stereocilin:creatine kinase, mitochondrial 1A;creatine kinase, mitochondrial 1B@:detection of mechanical stimulus involved in sensory perception of sound;stereocilium bundle tip;stereocilium;cell surface;kinocilium;auditory receptor cell stereocilium organization:mitochondrion;small molecule metabolic process;mitochondrial inner membrane;creatine metabolic process;creatine kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cellular nitrogen compound metabolic process;kinase activity@: DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16; DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY
F05163@139803@139804@deletion@2@90176052@90176497@15@chr15:90176052-90176497@10.7@192@103@0.536@NA@KIF7_14, KIF7_13@0@0@0@:kinesin family member 7@:negative regulation of smoothened signaling pathway;microtubule motor activity;microtubule associated complex;cilium;ATP binding;positive regulation of smoothened signaling pathway;protein binding;microtubule-based movement;microtubule@: PALLISTER-HALL SYNDROME; PHS; ACROCALLOSAL SYNDROME; ACLS; BARDET-BIEDL SYNDROME; BBS; HYDROLETHALUS SYNDROME 2; HLS2
F05163@140317@140317@duplication@1@100348377@100348507@15@chr15:100348377-100348507@10.7@42@120@2.86@CNVR6545.2@CTD-2054N24.2_2@0@0@0@NA@NA@NA
F05163@140964@140965@deletion@2@1291436@1291991@16@chr16:1291436-1291991@4.99@101@58@0.574@CNVR6591.1@TPSAB1_4, TPSAB1_5@0@0@0@:tryptase alpha/beta 1@:serine-type peptidase activity;extracellular matrix;extracellular matrix organization;catalytic activity;extracellular matrix disassembly;proteolysis;extracellular space;protein binding;extracellular region;defense response;serine-type endopeptidase activity@NA
F05163@142690@142705@duplication@16@15045473@15122823@16@chr16:15045473-15122823@51.1@3034@4034@1.33@CNVR6646.1@NPIP_8, PDXDC1_1, PDXDC1_2, PDXDC1_3, PDXDC1_4, PDXDC1_5, PDXDC1_6, PDXDC1_7, PDXDC1_8, PDXDC1_9, PDXDC1_10, PDXDC1_11, PDXDC1_12, PDXDC1_13, PDXDC1_14, PDXDC1_15@0@0@0@:nuclear pore complex-interacting protein-like;nuclear pore complex interacting protein;nuclear pore complex-interacting protein-like 1-like:pyridoxal-dependent decarboxylase domain containing 1;pyridoxal-dependent decarboxylase domain-containing protein 1-like@:nuclear membrane;protein transport;nuclear pore;mRNA transport:carboxylic acid metabolic process;pyridoxal phosphate binding;carboxy-lyase activity@NA
F05163@143477@143477@duplication@1@21742159@21742251@16@chr16:21742159-21742251@5.69@163@237@1.45@CNVR6668.5, CNVR6668.2, CNVR6668.7@OTOA_20@0@0@0@:otoancorin@:proteinaceous extracellular matrix;apical plasma membrane;sensory perception of sound;anchored to membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22
F05163@144038@144039@duplication@2@28403074@28403463@16@chr16:28403074-28403463@20.7@223@417@1.87@CNVR6684.2@EIF3CL_10, EIF3CL_9@0@0@0@:eukaryotic translation initiation factor 3, subunit C-like@:protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;translation initiation factor activity@NA
F05163@144118@144118@deletion@1@28734770@28734872@16@chr16:28734770-28734872@12.7@279@149@0.534@CNVR6686.3, CNVR6686.2@EIF3C_10@0@0@0@:eukaryotic translation initiation factor 3, subunit C@:cytosol;protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;cellular protein metabolic process;binding;gene expression;translation;translation initiation factor activity@NA
F05163@144501@144503@deletion@3@30208296@30208787@16@chr16:30208296-30208787@5.81@44@14@0.318@CNVR6694.1, CNVR6694.2, CNVR6694.3@SLX1A_4, SLX1A_5, SLX1A_6@0@0@0@:structure-specific endonuclease subunit SLX1-like;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae);SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae):sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3;sulfotransferase 1A3/1A4-like@:Slx1-Slx4 complex;5'-flap endonuclease activity;DNA repair;protein binding;DNA double-strand break processing involved in repair via single-strand annealing;double-strand break repair via homologous recombination;metal ion binding;crossover junction endodeoxyribonuclease activity:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;cytoplasm;catecholamine metabolic process;cytosol;endoplasmic reticulum unfolded protein response;xenobiotic metabolic process;sulfotransferase activity;activation of signaling protein activity involved in unfolded protein response;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process@NA
F05163@145554@145560@deletion@7@55844430@55855433@16@chr16:55844430-55855433@17.7@1409@982@0.697@CNVR6731.1@CES1_11, CES1_10, CES1_9, CES1_8, CES1_7, CES1_6, CES1_5@0@0@0@:carboxylesterase 1;liver carboxylesterase 1-like@:hydrolase activity;methyl salicylate esterase activity;response to toxin;methylumbelliferyl-acetate deacetylase activity;endoplasmic reticulum lumen;retinyl-palmitate esterase activity;methyl jasmonate esterase activity;metabolic process;carboxylesterase activity;methyl indole-3-acetate esterase activity@: CARBOXYLESTERASE 1; CES1
F05163@147091@147099@deletion@9@69988238@69996970@16@chr16:69988238-69996970@19.6@112@17@0.152@CNVR6762.3, CNVR6762.1, CNVR6762.4@CLEC18A_3, CLEC18A_4, CLEC18A_5, CLEC18A_6, CLEC18A_7, CLEC18A_8, CLEC18A_9, CLEC18A_10, CLEC18A_11@0@0@0@:C-type lectin domain family 18, member A@:carbohydrate binding;protein binding;extracellular region@NA
F05163@147101@147101@duplication@1@70010292@70010635@16@chr16:70010292-70010635@10.1@46@122@2.65@CNVR6762.3, CNVR6762.2@RP11-419C5.2_7@0@0@0@NA@NA@NA
F05163@147110@147119@duplication@10@70162688@70177561@16@chr16:70162688-70177561@69@3469@4821@1.39@CNVR6764.1, CNVR6764.3@PDPR_5, PDPR_6, PDPR_7, PDPR_8, PDPR_9, PDPR_10, PDPR_11, PDPR_12, PDPR_13, PDPR_14@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
F05163@147123@147124@duplication@2@70187295@70190782@16@chr16:70187295-70190782@22.7@1620@2295@1.42@CNVR6764.1, CNVR6764.3@PDPR_18, PDPR_19@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
F05163@147135@147135@duplication@1@70219789@70219879@16@chr16:70219789-70219879@9.13@49@119@2.43@CNVR6764.1, CNVR6764.5@CLEC18C_11@0@0@0@:C-type lectin domain family 18, member C@:carbohydrate binding;protein binding;extracellular region@NA
F05163@147421@147421@duplication@1@72093014@72093087@16@chr16:72093014-72093087@4.95@303@404@1.33@CNVR6769.1, CNVR6769.2@HP_6@0@0@0@:thioredoxin-like 4B:haptoglobin:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:cellular iron ion homeostasis;negative regulation of oxidoreductase activity;catalytic activity;negative regulation of hydrogen peroxide catabolic process;positive regulation of cell death;haptoglobin-hemoglobin complex;extracellular space;proteolysis;response to hydrogen peroxide;extracellular region;hemoglobin binding;defense response;serine-type endopeptidase activity:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@: ANHAPTOGLOBINEMIA; AHP
F05163@147513@147513@duplication@1@74451958@74452196@16@chr16:74451958-74452196@4.98@60@104@1.73@CNVR6778.2, CNVR6778.3@CLEC18B_3@0@0@0@:C-type lectin domain family 18, member B@:carbohydrate binding;protein binding;extracellular region@NA
F05163@151875@151884@deletion@10@18380170@18396173@17@chr17:18380170-18396173@26.3@810@500@0.617@CNVR7014.1@LGALS9C_1, LGALS9C_2, LGALS9C_3, LGALS9C_4, LGALS9C_5, LGALS9C_6, LGALS9C_7, LGALS9C_8, LGALS9C_9, LGALS9C_10@0@0@0@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
F05163@151956@151959@deletion@4@18945121@18997166@17@chr17:18945121-18997166@14.2@250@126@0.504@CNVR7018.4, CNVR7018.2, CNVR7018.6@GRAP_2, GRAP_1, AC007952.5_1, AC007952.5_2@0@0@0@:GRB2-related adaptor protein@:SH3/SH2 adaptor activity;cytosol;protein binding;Ras protein signal transduction;cytoplasm;cell-cell signaling@NA
F05163@152122@152126@deletion@5@20353287@20356380@17@chr17:20353287-20356380@9.65@277@174@0.628@CNVR7021.1, CNVR7021.3@LGALS9B_11, LGALS9B_10, LGALS9B_9, LGALS9B_8, LGALS9B_7@0@0@0@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
F05163@153380@153400@duplication@21@34539179@34641537@17@chr17:34539179-34641537@12@262@393@1.5@CNVR7077.1, CNVR7077.13, CNVR7077.19, CNVR7077.2@CCL4L1_2, CCL4L1_3, TBC1D3C_14, TBC1D3C_13, TBC1D3C_12, TBC1D3C_11, TBC1D3C_10, TBC1D3C_9, TBC1D3C_8, TBC1D3C_7, TBC1D3C_6, TBC1D3C_5, TBC1D3C_4, TBC1D3C_3, TBC1D3C_2, CCL3L1_3, CCL3L1_2, CCL3L1_1, CCL4L2_1, CCL4L2_2, CCL4L2_3@0@0@0@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
F05163@154346@154346@deletion@1@39421631@39422112@17@chr17:39421631-39422112@9.69@59@11@0.186@CNVR7096.1@KRTAP9-6_1@0@0@0@:keratin associated protein 9-6@:keratin filament@NA
F05163@155581@155581@duplication@1@44248222@44249509@17@chr17:44248222-44249509@10.8@2347@3138@1.34@CNVR7114.3, CNVR7114.2, CNVR7114.8@KANSL1_2@0@0@0@:KAT8 regulatory NSL complex subunit 1@:histone acetyltransferase activity (H4-K8 specific);histone acetyltransferase activity (H4-K16 specific);histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase complex;histone H4-K5 acetylation;MLL1 complex;histone H4-K16 acetylation;protein binding;histone H4-K8 acetylation;nucleus@NA
F05163@155587@155590@deletion@4@44399689@44409347@17@chr17:44399689-44409347@14.7@88@15@0.17@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
F05163@155593@155595@deletion@3@44414663@44415089@17@chr17:44414663-44415089@14.5@64@0@0@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_12, LRRC37A_13, LRRC37A_14@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
F05163@155604@155611@duplication@8@44617543@44632790@17@chr17:44617543-44632790@27.2@763@1151@1.51@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2_7, LRRC37A2_8, LRRC37A2_9, LRRC37A2_10, LRRC37A2_11, LRRC37A2_12, LRRC37A2_13, LRRC37A2_14@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
F05163@155625@155628@duplication@4@44770270@44782220@17@chr17:44770270-44782220@15.8@523@761@1.46@CNVR7114.2, CNVR7114.4@NSF_10, NSF_11, NSF_12, NSF_13@0@0@0@:N-ethylmaleimide-sensitive factor@:PDZ domain binding;Rab GTPase binding;regulation of exocytosis;ATP binding;Golgi stack;protein transport;protein C-terminus binding;plasma membrane;dendritic shaft;potassium ion transport;nucleoside-triphosphatase activity;exocytosis;positive regulation of receptor recycling;nucleotide binding;plasma membrane fusion;cytoplasm;cytosol;protein binding;vesicle-mediated transport;ATPase activity, coupled;protein complex binding;synaptic transmission;syntaxin binding;metal ion binding@NA
F05163@156877@156878@duplication@2@57656834@57657240@17@chr17:57656834-57657240@8.34@122@203@1.66@NA@DHX40_9, DHX40_10@0@0@0@:DEAH (Asp-Glu-Ala-His) box polypeptide 40@:transport;helicase activity;intracellular;ATP-dependent helicase activity;nucleic acid binding;ATP binding@NA
F05163@162017@162017@duplication@1@44542732@44544371@18@chr18:44542732-44544371@19.7@75@234@3.12@CNVR7319.1@TCEB3CL2_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
F05163@162019@162019@deletion@1@44554574@44556213@18@chr18:44554574-44556213@20.1@94@1@0.0106@CNVR7319.1@TCEB3C_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C (elongin A3);RNA polymerase II transcription factor SIII subunit A3-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
F05163@166916@166917@duplication@2@14508471@14508747@19@chr19:14508471-14508747@16.2@133@266@2@NA@CD97_7, CD97_8@0@0@0@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
F05163@167044@167047@deletion@4@14876337@14877921@19@chr19:14876337-14877921@19@795@530@0.667@NA@EMR2_9, EMR2_8, EMR2_7, EMR2_6@0@0@0@:egf-like module containing, mucin-like, hormone receptor-like 2@:transmembrane signaling receptor activity;inflammatory response;G-protein coupled receptor activity;ruffle membrane;integral to membrane;plasma membrane;cell surface receptor signaling pathway;neuropeptide signaling pathway;granulocyte chemotaxis;cell migration;leading edge membrane;G-protein coupled receptor signaling pathway;protein binding;cell adhesion;membrane;calcium ion binding;chondroitin sulfate binding@NA
F05163@168952@168952@deletion@1@35862263@35863302@19@chr19:35862263-35863302@14@125@41@0.328@CNVR7627.1@GPR42_2@0@0@0@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
F05163@170098@170099@duplication@2@40376632@40380711@19@chr19:40376632-40380711@6.26@116@178@1.53@CNVR7639.2@FCGBP_24, FCGBP_23@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F05163@170101@170108@deletion@8@40383552@40398510@19@chr19:40383552-40398510@36.2@500@241@0.482@CNVR7639.2, CNVR7639.3@FCGBP_21, FCGBP_20, FCGBP_19, FCGBP_18, FCGBP_17, FCGBP_16, FCGBP_15, FCGBP_14@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F05163@170821@170825@deletion@5@43702150@43762608@19@chr19:43702150-43762608@38.8@875@482@0.551@CNVR7658.5, CNVR7658.1@PSG4_3, PSG4_2, PSG4_1, PSG9_6, PSG9_5@0@0@0@:pregnancy specific beta-1-glycoprotein 4:pregnancy specific beta-1-glycoprotein 9@:protein binding;extracellular region;female pregnancy;defense response:protein binding;extracellular region;female pregnancy;defense response@NA
F05163@170836@170836@duplication@1@43864418@43864425@19@chr19:43864418-43864425@6.7@309@428@1.39@NA@CD177_7@0@0@0@@:blood coagulation;plasma membrane;anchored to membrane;leukocyte migration@NA
F05163@172987@172987@deletion@1@52133087@52133469@19@chr19:52133087-52133469@5.93@41@11@0.268@CNVR7702.1@SIGLEC5_2, SIGLEC5_2@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion@NA
F05163@172989@172994@duplication@6@52146609@52149893@19@chr19:52146609-52149893@14@474@659@1.39@CNVR7702.1@SIGLEC14_7, SIGLEC14_6, SIGLEC14_5, SIGLEC14_4, SIGLEC14_3, SIGLEC14_2@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 14@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion;plasma membrane@NA
F05163@173158@173158@deletion@1@54308535@54308704@19@chr19:54308535-54308704@8.71@124@59@0.476@NA@NLRP12_5@0@0@0@:NLR family, pyrin domain containing 12@:negative regulation of Toll signaling pathway;negative regulation of signal transduction;regulation of interleukin-18 biosynthetic process;cysteine-type endopeptidase activator activity involved in apoptotic process;negative regulation of NF-kappaB transcription factor activity;negative regulation of I-kappaB kinase/NF-kappaB cascade;ATP binding;negative regulation of cytokine secretion;activation of cysteine-type endopeptidase activity involved in apoptotic process;negative regulation of protein autophosphorylation;negative regulation of interleukin-1 secretion;positive regulation of interleukin-1 beta secretion;negative regulation of interleukin-6 biosynthetic process;positive regulation of inflammatory response;negative regulation of inflammatory response;cytoplasm;release of cytoplasmic sequestered NF-kappaB;protein binding;signal transduction@: FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2
F05163@173295@173296@duplication@2@54724399@54725251@19@chr19:54724399-54725251@14.7@196@341@1.74@CNVR7721.3, CNVR7721.4@LILRB3_6, LILRB3_5@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F05163@173298@173300@deletion@3@54726151@54726848@19@chr19:54726151-54726848@15.8@128@42@0.328@CNVR7721.3, CNVR7721.4@LILRB3_3, LILRB3_2, LILRB3_1@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F05163@173302@173305@deletion@4@54743778@54745754@19@chr19:54743778-54745754@39.3@759@385@0.507@CNVR7721.3, CNVR7721.6@LILRA6_7, LILRA6_6, LILRA6_5, LILRA6_4@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F05163@173336@173341@deletion@6@54801928@54804173@19@chr19:54801928-54804173@24.6@1049@676@0.644@CNVR7722.1@LILRA3_6, LILRA3_5, LILRA3_4, LILRA3_3, LILRA3_2, LILRA3_1@0@0@0@:leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3@:antigen binding;signal transduction;protein binding;extracellular region;plasma membrane;receptor activity;defense response@NA
F05163@173490@173490@deletion@1@55336484@55336533@19@chr19:55336484-55336533@8.54@65@19@0.292@CNVR7725.1, CNVR7725.6, CNVR7725.8@KIR3DL1_6@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
F05163@173496@173497@duplication@2@55349032@55351154@19@chr19:55349032-55351154@6.16@373@489@1.31@CNVR7725.1, CNVR7725.6@KIR2DS4_3, KIR2DS4_4@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
F05163@174395@174395@deletion@1@1569207@1569278@20@chr20:1569207-1569278@10.5@47@0@0@CNVR7763.1@RP4-576H24.4_1@0@0@0@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
F05163@175736@175737@deletion@2@26061801@26063616@20@chr20:26061801-26063616@6.39@253@166@0.656@CNVR7823.4, CNVR7823.3, CNVR7823.5, CNVR7823.1@FAM182A_4, FAM182A_5@0@0@0@NA@NA@NA
F05163@181951@181955@deletion@5@24376424@24384231@22@chr22:24376424-24384231@120@557@0@0@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTT1_5, GSTT1_4, GSTT1_3, GSTT1_2, GSTT1_1@0@0@0@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
F05163@190@190@deletion@1@3761383@3761523@X@chrX:3761383-3761523@5.28@23@0@0@CNVR8259.1, CNVR8259.3, CNVR8259.5@RP11-706O15.1_1@0@0@0@NA@NA@NA
F05163@4052@4071@deletion@20@101571921@101581428@X@chrX:101571921-101581428@32.9@152@0@0@NA@NXF2_15, NXF2_16, NXF2_17, NXF2_18, NXF2_19, NXF2_20, NXF2_21, NXF2_22, NXF2_23, NXF2_24, NXF2_25, NXF2_26, NXF2_27, NXF2_28, NXF2_29, NXF2_30, NXF2_31, NXF2_32, NXF2_33, NXF2_34@0@0@0@NA@NA@NA
F05163@4884@4884@deletion@1@119210843@119211253@X@chrX:119210843-119211253@8.72@41@1@0.0244@NA@RHOXF2B_2@0@0@0@NA@NA@NA
F05163@6297@6297@deletion@1@153458900@153459138@X@chrX:153458900-153459138@13.4@65@1@0.0154@CNVR8489.1@OPN1MW_5@0@0@0@NA@NA@NA
F05460@6@6@deletion@1@69092@70008@1@chr1:69092-70008@6.52@29@0@0@CNVR1.1, CNVR1.2@OR4F5_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F05460@418@418@deletion@1@1607504@1607638@1@chr1:1607504-1607638@12.7@60@1@0.0167@CNVR17.1@SLC35E2B_4@0@0@0@:solute carrier family 35, member E2B@:integral to membrane;membrane;transmembrane transport@NA
F05460@3334@3341@duplication@8@25611065@25648453@1@chr1:25611065-25648453@15.9@1163@1553@1.34@CNVR116.1, CNVR116.2@RHD_2, RHD_3, RHD_4, RHD_5, RHD_6, RHD_7, RHD_8, RHD_9@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
F05460@3357@3357@deletion@1@25735175@25735360@1@chr1:25735175-25735360@14.1@69@2@0.029@CNVR117.1@RHCE_2@0@0@0@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
F05460@5148@5149@duplication@2@39977429@39987242@1@chr1:39977429-39987242@7.44@68@130@1.91@NA@BMP8A_3, BMP8A_4@0@0@0@:bone morphogenetic protein 8a@:cell differentiation;growth factor activity;extracellular space;growth;cytokine activity;cartilage development;ossification@NA
F05460@8507@8508@deletion@2@89476588@89477710@1@chr1:89476588-89477710@6.73@487@329@0.676@CNVR244.1@GBP3_8, GBP3_7@0@0@0@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
F05460@9343@9345@deletion@3@104116331@104117967@1@chr1:104116331-104117967@10.6@410@248@0.605@CNVR266.8, CNVR266.10@AMY2B_6, AMY2B_7, AMY2B_8@0@0@0@:actin, gamma 1 pseudogene 4;amylase, alpha 2B (pancreatic)@:extracellular region;cation binding;digestion;carbohydrate metabolic process;catalytic activity;alpha-amylase activity;metal ion binding@NA
F05460@9365@9374@deletion@10@104202983@104234232@1@chr1:104202983-104234232@23.3@109@2@0.0183@CNVR266.3, CNVR266.1, CNVR266.15@AMY1A_7, AMY1A_8, AMY1A_9, AMY1A_10, AMY1A_11, AMY1B_11, AMY1B_10, AMY1B_9, AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
F05460@9436@9436@duplication@1@108769302@108769515@1@chr1:108769302-108769515@13.7@41@153@3.73@CNVR294.4@NBPF4_14@0@0@0@:neuroblastoma breakpoint family, member 4@:cytoplasm@NA
F05460@9766@9773@deletion@8@110230497@110235917@1@chr1:110230497-110235917@87.5@410@3@0.00732@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
F05460@12117@12118@duplication@2@152573209@152586574@1@chr1:152573209-152586574@10.9@110@212@1.93@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
F05460@16038@16039@deletion@2@196797201@196799812@1@chr1:196797201-196799812@13.2@319@178@0.558@CNVR459.1@CFHR1_4, CFHR1_5@0@0@0@:complement factor H-related 1:complement factor H-related 2@:extracellular space;complement activation:extracellular region@NA
F05460@19777@19777@duplication@1@248801589@248802559@1@chr1:248801589-248802559@6@94@160@1.7@NA@OR2T35_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 35@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F05460@25116@25116@duplication@1@96652841@96652954@2@chr2:96652841-96652954@6.22@159@247@1.55@NA@ANKRD36C_2@0@0@0@:ankyrin repeat domain-containing protein 36A-like@:ion channel inhibitor activity;protein binding@NA
F05460@33408@33412@deletion@5@233272978@233274158@2@chr2:233272978-233274158@31.4@331@126@0.381@NA@ALPPL2_6, ALPPL2_7, ALPPL2_8, ALPPL2_9, ALPPL2_10@0@0@0@:alkaline phosphatase, placental-like 2@:phosphatase activity;catalytic activity;phosphorylation;plasma membrane;metabolic process;membrane;anchored to membrane;alkaline phosphatase activity;metal ion binding@NA
F05460@48556@48561@duplication@6@69403344@69434202@4@chr4:69403344-69434202@23.5@975@1433@1.47@CNVR1953.1@UGT2B17_6, UGT2B17_5, UGT2B17_4, UGT2B17_3, UGT2B17_2, UGT2B17_1@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
F05460@48967@48969@deletion@3@75312252@75316249@4@chr4:75312252-75316249@13.8@118@36@0.305@NA@AREG_2, AREG_3, AREG_4@0@0@0@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
F05460@48972@48973@duplication@2@75482007@75484724@4@chr4:75482007-75484724@6.67@93@162@1.74@NA@AREGB_2, AREGB_3@0@0@0@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
F05460@51672@51673@deletion@2@145041644@145061788@4@chr4:145041644-145061788@11.1@221@117@0.529@NA@GYPA_2, GYPA_1@0@0@0@:glycophorin B (MNS blood group):glycophorin A (MNS blood group)@:integral to membrane;plasma membrane;integral to plasma membrane:external side of plasma membrane;integral to membrane;cytoskeletal anchoring at plasma membrane;plasma membrane;molecular_function;protein homodimerization activity;integral to plasma membrane;cellular_component;identical protein binding;membrane;biological_process;regulation of response to osmotic stress;virus-host interaction@: BLOOD GROUP--Ss LOCUS; Ss: MALARIA, SUSCEPTIBILITY TO; BLOOD GROUP--MN LOCUS; MN
F05460@53189@53190@deletion@2@190947540@190947920@4@chr4:190947540-190947920@13.9@204@84@0.412@CNVR2258.3@FRG2_3, FRG2_2@0@0@0@:FSHD region gene 2-like;FSHD region gene 2@:nucleus@NA
F05460@55806@55806@deletion@1@69372349@69372398@5@chr5:69372349-69372398@5.72@120@64@0.533@CNVR2494.48, CNVR2494.39, CNVR2494.15, CNVR2494.18, CNVR2494.26, CNVR2494.43, CNVR2494.52, CNVR2494.28, CNVR2494.2, CNVR2494.36@SMN2_8@0@0@0@:survival of motor neuron 2, centromeric;survival of motor neuron 1, telomeric@:nucleoplasm;ncRNA metabolic process;Cajal body;RNA metabolic process;spliceosomal complex;cytoplasm;cytosol;protein binding;cell death;spliceosomal complex assembly;RNA binding;mRNA processing;nucleus;gene expression;spliceosomal snRNP assembly@: SPINAL MUSCULAR ATROPHY, TYPE II; SMA2; SPINAL MUSCULAR ATROPHY, TYPE I; SMA1; SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4; SPINAL MUSCULAR ATROPHY, TYPE III; SMA3
F05460@55830@55831@duplication@2@70307103@70308742@5@chr5:70307103-70308742@16.5@657@1007@1.53@CNVR2494.41, CNVR2494.14, CNVR2494.30, CNVR2494.20, CNVR2494.62, CNVR2494.8, CNVR2494.35@NAIP_5, NAIP_4@0@0@0@:baculoviral IAP repeat-containing protein 1-like;NLR family, apoptosis inhibitory protein@:negative regulation of apoptotic process;inflammatory response;basolateral plasma membrane;nucleoside-triphosphatase activity;cysteine-type endopeptidase inhibitor activity;intracellular;nucleotide binding;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;ATP binding;cytoplasm;innate immune response;protein binding;negative regulation of neuron apoptotic process;metal ion binding;nervous system development@NA
F05460@59065@59065@duplication@1@140557617@140560021@5@chr5:140557617-140560021@27@1537@3073@2@CNVR2624.1@PCDHB8_1@0@0@0@:protocadherin beta 8@:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding@NA
F05460@60876@60877@duplication@2@175388055@175388437@5@chr5:175388055-175388437@7.16@78@142@1.82@NA@THOC3_5, THOC3_4@0@0@0@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
F05460@61368@61370@deletion@3@178152378@178156023@5@chr5:178152378-178156023@5.82@339@221@0.652@NA@ZNF354A_4, ZNF354A_3, ZNF354A_2@0@0@0@:zinc finger protein 354A@:intracellular;kidney development;DNA binding;regulation of transcription from RNA polymerase II promoter;sensory perception of sound;response to hypoxia;regulation of transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity;response to folic acid;negative regulation of transcription from RNA polymerase II promoter;nucleolus;nucleolar fragmentation;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
F05460@63290@63293@duplication@4@31323945@31371479@6@chr6:31323945-31371479@10.9@379@547@1.44@CNVR2841.12@HLA-B_3, HLA-B_2, HLA-B_1, MICA_1@0@0@0@:major histocompatibility complex, class I, B:MHC class I polypeptide-related sequence A@:MHC class I protein complex;regulation of immune response;regulation of interleukin-12 production;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;regulation of T cell anergy;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;receptor binding;early endosome membrane;virus-host interaction;regulation of interleukin-6 production;regulation of dendritic cell differentiation;phagocytic vesicle membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane:MHC class I protein complex;protein binding;regulation of immune response;antigen processing and presentation;immune response;plasma membrane;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO; SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1: PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO; PSORIASIS SUSCEPTIBILITY 1; PSORS1
F05460@63730@63733@duplication@4@31963497@31964377@6@chr6:31963497-31964377@9.1@337@476@1.41@CNVR2843.6, CNVR2843.3@C4A_25, C4A_26, C4A_27, C4A_28@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
F05460@63747@63748@duplication@2@31973946@31974881@6@chr6:31973946-31974881@8.66@139@230@1.65@CNVR2843.6, CNVR2843.3@AL645922.1_2, AL645922.1_1@0@0@0@NA@NA@NA
F05460@63953@63958@duplication@6@32485517@32498001@6@chr6:32485517-32498001@45.6@287@691@2.41@CNVR2845.21, CNVR2845.25, CNVR2845.30, CNVR2845.43, CNVR2845.6@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2, HLA-DRB5_1@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
F05460@63962@63963@duplication@2@32549335@32552155@6@chr6:32549335-32552155@6.24@251@353@1.41@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.5, CNVR2845.54, CNVR2845.55, CNVR2845.56, CNVR2845.34@HLA-DRB1_3, HLA-DRB1_2@0@0@0@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
F05460@63973@63973@deletion@1@32632576@32632844@6@chr6:32632576-32632844@6.55@108@52@0.481@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20, CNVR2845.31@HLA-DQB1_2@0@0@0@:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
F05460@71032@71032@duplication@1@167794610@167794824@6@chr6:167794610-167794824@4.82@35@74@2.11@NA@TCP10_3@0@0@0@:t-complex 10@:cytosol@NA
F05460@71773@71776@deletion@4@6000323@6006747@7@chr7:6000323-6006747@10.3@155@72@0.465@NA@RSPH10B_5, RSPH10B_4, RSPH10B_3, RSPH10B_2@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F05460@71940@71944@duplication@5@6837995@6844686@7@chr7:6837995-6844686@12.3@130@240@1.85@NA@RSPH10B2_20, CCZ1B_15, CCZ1B_14, CCZ1B_13, CCZ1B_12@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F05460@72492@72492@deletion@1@22532944@22533455@7@chr7:22532944-22533455@4.85@838@577@0.689@NA@STEAP1B_3@0@0@0@:STEAP family member 1B@:integral to membrane@NA
F05460@73244@73246@deletion@3@38284785@38293030@7@chr7:38284785-38293030@5.34@872@654@0.75@CNVR3353.1@TRGC2_2, TRGC2_1, TRGJ2_1@0@0@0@@:protein binding@NA
F05460@74578@74578@deletion@1@74172293@74172333@7@chr7:74172293-74172333@8.76@43@2@0.0465@NA@GTF2I_33@0@0@0@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
F05460@74793@74793@deletion@1@76241040@76241130@7@chr7:76241040-76241130@5.57@95@47@0.495@CNVR3463.10@POMZP3_5@0@0@0@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
F05460@76427@76432@deletion@6@100331793@100336236@7@chr7:100331793-100336236@31.5@960@553@0.576@CNVR3509.1@ZAN_1, ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
F05460@76718@76732@deletion@15@102114809@102137066@7@chr7:102114809-102137066@18@216@81@0.375@CNVR3518.1@POLR2J_3, POLR2J_2, POLR2J_1, RASA4B_21, RASA4B_20, RASA4B_19, RASA4B_18, RASA4B_17, RASA4B_16, RASA4B_15, RASA4B_14, RASA4B_13, RASA4B_12, RASA4B_11, RASA4B_10@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J, 13.3kDa:RAS p21 protein activator 4B@:nucleoplasm;DNA binding;DNA repair;protein dimerization activity;nucleus;viral reproduction;gene expression;transcription initiation from RNA polymerase II promoter;7-methylguanosine mRNA capping;protein phosphorylation;LRR domain binding;protein kinase activity;DNA-directed RNA polymerase II, core complex;nucleotide-excision repair;transcription from RNA polymerase II promoter;DNA-directed RNA polymerase activity;protein binding;transcription-coupled nucleotide-excision repair;RNA splicing;mRNA splicing, via spliceosome;transcription, DNA-dependent;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction@NA
F05460@76754@76754@deletion@1@102219880@102220243@7@chr7:102219880-102220243@12@58@2@0.0345@CNVR3518.1@AC093668.1_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
F05460@76765@76779@duplication@15@102235753@102279646@7@chr7:102235753-102279646@15.9@203@360@1.77@CNVR3518.1@RASA4_11, RASA4_10, RASA4_9, RASA4_8, RASA4_7, RASA4_6, RASA4_5, RASA4_4, RASA4_3, RASA4_2, UPK3BL_7, RASA4_1, UPK3BL_6, UPK3BL_6, UPK3BL_5, UPK3BL_5, UPK3BL_4, UPK3BL_4@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
F05460@76795@76795@duplication@1@102318940@102319303@7@chr7:102318940-102319303@5.92@203@303@1.49@CNVR3518.1@AC105052.1_1@0@0@0@NA@NA@NA
F05460@77956@77956@deletion@1@128128156@128128215@7@chr7:128128156-128128215@5.92@66@26@0.394@NA@METTL2B_5@0@0@0@:methyltransferase like 2B@:methyltransferase activity;metabolic process@NA
F05460@79287@79287@duplication@1@143400089@143400710@7@chr7:143400089-143400710@5.06@46@90@1.96@CNVR3594.2, CNVR3594.1@FAM115C_2@0@0@0@:family with sequence similarity 115, member C;protein FAM115C-like@NA@NA
F05460@79309@79311@deletion@3@143880598@143929936@7@chr7:143880598-143929936@11.6@135@59@0.437@CNVR3598.4, CNVR3598.3, CNVR3598.7@CTAGE4_1, ARHGEF35_2, OR2A42_1@0@0@0@:CTAGE family, member 4:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1@:integral to membrane;nucleotide binding;cellular_component;biological_process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F05460@79323@79325@deletion@3@144070289@144072768@7@chr7:144070289-144072768@12@184@86@0.467@CNVR3598.4, CNVR3598.5, CNVR3598.11@ARHGEF5_10, ARHGEF5_11, ARHGEF5_12@0@0@0@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
F05460@80387@80388@duplication@2@7636684@7637611@8@chr8:7636684-7637611@5.33@35@78@2.23@CNVR3772.4, CNVR3772.6, CNVR3772.2, CNVR3772.8, CNVR3772.10@AC084121.16_4, AC084121.16_3@0@0@0@:uncharacterized LOC100133251@NA@NA
F05460@88481@88481@deletion@1@38603157@38603209@9@chr9:38603157-38603209@11.1@140@55@0.393@NA@ANKRD18A_7@0@0@0@:ankyrin repeat domain 18A@:protein binding@NA
F05460@91242@91245@deletion@4@117085415@117087177@9@chr9:117085415-117087177@6.29@1136@838@0.738@CNVR4448.1@ORM1_1, ORM1_2, ORM1_3, ORM1_4@0@0@0@:orosomucoid 1@:protein binding;extracellular space;regulation of immune system process;transport;inflammatory response;extracellular region;acute-phase response@NA
F05460@95350@95354@deletion@5@17865074@17887435@10@chr10:17865074-17887435@47.2@237@7@0.0295@NA@MRC1L1_2, MRC1L1_3, MRC1L1_4, MRC1L1_5, MRC1L1_6@0@0@0@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
F05460@95360@95377@deletion@18@17908572@17951363@10@chr10:17908572-17951363@15.5@133@42@0.316@NA@MRC1L1_12, MRC1L1_13, MRC1L1_14, MRC1L1_15, MRC1L1_16, MRC1L1_17, MRC1L1_18, MRC1L1_19, MRC1L1_20, MRC1L1_21, MRC1L1_22, MRC1L1_23, MRC1L1_24, MRC1L1_25, MRC1L1_26, MRC1L1_27, MRC1L1_28, MRC1L1_29@0@0@0@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
F05460@95382@95387@duplication@6@18084908@18129735@10@chr10:18084908-18129735@24.8@132@348@2.64@NA@TMEM236_4, MRC1_1, MRC1_2, MRC1_3, MRC1_4, MRC1_5@0@0@0@:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F05460@95389@95393@deletion@5@18138509@18152611@10@chr10:18138509-18152611@13.7@70@5@0.0714@NA@MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F05460@95410@95411@duplication@2@18196464@18198276@10@chr10:18196464-18198276@6.06@57@108@1.89@NA@MRC1_28, MRC1_29@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F05460@96280@96280@deletion@1@42924565@42924599@10@chr10:42924565-42924599@17.6@106@13@0.123@NA@CCNYL2_5@0@0@0@@:regulation of cyclin-dependent protein kinase activity;protein kinase binding@NA
F05460@96473@96481@deletion@9@46963841@47087911@10@chr10:46963841-47087911@21@6112@4443@0.727@CNVR4712.9, CNVR4712.2, CNVR4712.7, CNVR4712.4@SYT15_7, SYT15_6, SYT15_5, SYT15_4, SYT15_3, SYT15_2, GPRIN2_1, PPYR1_3@0@0@0@:synaptotagmin XV:G protein regulated inducer of neurite outgrowth 2:pancreatic polypeptide receptor 1;neuropeptide Y receptor type 4-like@:protein binding;synaptic vesicle;integral to membrane;transporter activity;plasma membrane;membrane;extrinsic to membrane:blood circulation;peptide YY receptor activity;peptide binding;pancreatic polypeptide receptor activity;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;integral to membrane;digestion;plasma membrane;integral to plasma membrane;feeding behavior@NA
F05460@96573@96581@duplication@9@48025301@48055018@10@chr10:48025301-48055018@12.4@415@589@1.42@CNVR4715.2@ASAH2C_9, ASAH2C_8, ASAH2C_7, ASAH2C_6, ASAH2C_5, ASAH2C_4, ASAH2C_3, ASAH2C_2, ASAH2C_1@0@0@0@@:ceramidase activity;sphingolipid metabolic process@NA
F05460@96849@96852@deletion@4@51243389@51374428@10@chr10:51243389-51374428@9.47@69@17@0.246@NA@AGAP8_2, AGAP8_1, TIMM23B_1, TIMM23B_2@0@0@0@:ArfGAP with GTPase domain, ankyrin repeat and PH domain 8:translocase of inner mitochondrial membrane 23 homolog B (yeast)@:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process@NA
F05460@96932@96939@deletion@8@51965743@51994312@10@chr10:51965743-51994312@25.8@244@91@0.373@NA@ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7, ASAH2_6, ASAH2_5@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
F05460@102337@102337@duplication@1@135439427@135439503@10@chr10:135439427-135439503@7.45@156@255@1.63@CNVR4989.11, CNVR4989.4@FRG2B_3@0@0@0@:FSHD region gene 2 family, member B@:nucleus@NA
F05460@103269@103269@deletion@1@4976003@4976943@11@chr11:4976003-4976943@57.3@496@59@0.119@CNVR5040.1@OR51A2_1@0@0@0@:matrix metallopeptidase 26:olfactory receptor, family 51, subfamily A, member 2@:metallopeptidase activity;extracellular matrix;proteolysis;proteinaceous extracellular matrix;collagen catabolic process;metalloendopeptidase activity;zinc ion binding;metabolic process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F05460@103342@103342@duplication@1@5798891@5799864@11@chr11:5798891-5799864@17.8@456@841@1.84@CNVR5049.1@OR52N5_1@0@0@0@:tripartite motif containing 5:olfactory receptor, family 52, subfamily N, member 5@:defense response to virus;Golgi apparatus;intracellular;protein trimerization;ligase activity;cytoplasm;protein binding;nucleus;protein homodimerization activity;identical protein binding;zinc ion binding;cytoplasmic mRNA processing body;protein ubiquitination;virus-host interaction:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F05460@106038@106040@deletion@3@55032377@55035848@11@chr11:55032377-55035848@26.9@129@2@0.0155@CNVR5178.5@TRIM48_2, TRIM48_3, TRIM48_4@0@0@0@:tripartite motif containing 48@:protein binding;intracellular;zinc ion binding@NA
F05460@106046@106048@duplication@3@55370918@55419315@11@chr11:55370918-55419315@9.68@2114@2752@1.3@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F05460@110121@110126@deletion@6@89768381@89774718@11@chr11:89768381-89774718@18.6@329@160@0.486@NA@TRIM49C_3, TRIM49C_4, TRIM49C_5, TRIM49C_6, TRIM49C_7, TRIM49C_8@0@0@0@:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;DNA binding;zinc ion binding@NA
F05460@114483@114483@deletion@1@11243900@11244828@12@chr12:11243900-11244828@21.1@1145@572@0.5@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
F05460@124176@124178@deletion@3@24463272@24468340@13@chr13:24463272-24468340@21.6@1310@874@0.667@NA@MIPEP_1, C1QTNF9B_3, C1QTNF9B_2@0@0@0@:mitochondrial intermediate peptidase:C1q and tumor necrosis factor related protein 9B@:mitochondrion;proteolysis;protein processing involved in protein targeting to mitochondrion;metalloendopeptidase activity;mitochondrial matrix;metal ion binding:collagen;protein binding@NA
F05460@124193@124193@duplication@1@24892957@24893018@13@chr13:24892957-24893018@4.74@309@428@1.39@NA@C1QTNF9_3@0@0@0@:spermatogenesis associated 13:C1q and tumor necrosis factor related protein 9@:lamellipodium assembly;phospholipid binding;Rac guanyl-nucleotide exchange factor activity;guanyl-nucleotide exchange factor activity;ruffle membrane;nucleus;regulation of cell migration;cell migration;regulation of Rho protein signal transduction;intracellular;Rho guanyl-nucleotide exchange factor activity;cytoplasm;filopodium assembly;filopodium;protein binding;lamellipodium:collagen;protein binding;hormone activity@NA
F05460@125680@125680@duplication@1@50366575@50366642@13@chr13:50366575-50366642@5.64@122@194@1.59@NA@KPNA3_1@0@0@0@:karyopherin alpha 3 (importin alpha 4)@:nucleoplasm;binding;viral entry into host cell;protein complex assembly;cytoplasm;protein transporter activity;cytosol;protein binding;NLS-bearing substrate import into nucleus;protein C-terminus binding;nucleus;protein import into nucleus;nuclear localization sequence binding;nuclear pore;cytokine-mediated signaling pathway;viral penetration into host nucleus@NA
F05460@133349@133351@deletion@3@106090814@106091716@14@chr14:106090814-106091716@7.77@423@279@0.66@CNVR6294.46, CNVR6294.20, CNVR6294.54, CNVR6294.43, CNVR6294.50, CNVR6294.61@IGHG4_4, IGHG4_3, IGHG4_2@0@0@0@@:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response@NA
F05460@133450@133451@deletion@2@106725202@106725654@14@chr14:106725202-106725654@11.3@710@447@0.63@CNVR6294.48, CNVR6294.24, CNVR6294.40, CNVR6294.38, CNVR6294.17, CNVR6294.23@IGHV3-23_2, IGHV3-23_1@0@0@0@@:protein binding@NA
F05460@133458@133463@deletion@6@106791006@106816173@14@chr14:106791006-106816173@113@1177@288@0.245@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-30_2, IGHV3-30_1, IGHV4-31_2, IGHV4-31_1, IGHV3-33_2, IGHV3-33_1@0@0@0@@:protein binding:protein binding:protein binding@NA
F05460@133541@133542@deletion@2@22368577@22383423@15@chr15:22368577-22383423@107@3239@1553@0.479@CNVR6297.4, CNVR6297.17, CNVR6297.2@OR4M2_1, OR4N4_1@0@0@0@:olfactory receptor, family 4, subfamily M, member 2:olfactory receptor, family 4, subfamily N, member 4@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F05460@134011@134012@deletion@2@30664351@30665348@15@chr15:30664351-30665348@11@171@88@0.515@CNVR6337.1@CHRFAM7A_7, CHRFAM7A_6@0@0@0@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
F05460@140317@140317@deletion@1@100348377@100348507@15@chr15:100348377-100348507@6.1@27@0@0@CNVR6545.2@CTD-2054N24.2_2@0@0@0@NA@NA@NA
F05460@144501@144503@deletion@3@30208296@30208787@16@chr16:30208296-30208787@7.01@31@0@0@CNVR6694.1, CNVR6694.2, CNVR6694.3@SLX1A_4, SLX1A_5, SLX1A_6@0@0@0@:structure-specific endonuclease subunit SLX1-like;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae);SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae):sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3;sulfotransferase 1A3/1A4-like@:Slx1-Slx4 complex;5'-flap endonuclease activity;DNA repair;protein binding;DNA double-strand break processing involved in repair via single-strand annealing;double-strand break repair via homologous recombination;metal ion binding;crossover junction endodeoxyribonuclease activity:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;cytoplasm;catecholamine metabolic process;cytosol;endoplasmic reticulum unfolded protein response;xenobiotic metabolic process;sulfotransferase activity;activation of signaling protein activity involved in unfolded protein response;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process@NA
F05460@147117@147121@duplication@5@70176138@70180131@16@chr16:70176138-70180131@8.57@1213@1566@1.29@CNVR6764.1, CNVR6764.3@PDPR_12, PDPR_13, PDPR_14, PDPR_15, PDPR_16@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
F05460@147502@147513@duplication@12@74425290@74452196@16@chr16:74425290-74452196@11.6@459@649@1.41@CNVR6778.2, CNVR6778.3@NPIPL2_7, CLEC18B_13, CLEC18B_12, CLEC18B_11, CLEC18B_10, CLEC18B_9, CLEC18B_8, CLEC18B_7, CLEC18B_6, CLEC18B_5, CLEC18B_4, CLEC18B_3@0@0@0@:C-type lectin domain family 18, member B@:extracellular region:carbohydrate binding;protein binding;extracellular region@NA
F05460@151876@151885@duplication@10@18387190@18397681@17@chr17:18387190-18397681@20@409@649@1.59@CNVR7014.1@LGALS9C_2, LGALS9C_3, LGALS9C_4, LGALS9C_5, LGALS9C_6, LGALS9C_7, LGALS9C_8, LGALS9C_9, LGALS9C_10, LGALS9C_11@0@0@0@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
F05460@152122@152126@deletion@5@20353287@20356380@17@chr17:20353287-20356380@26.2@241@80@0.332@CNVR7021.1, CNVR7021.3@LGALS9B_11, LGALS9B_10, LGALS9B_9, LGALS9B_8, LGALS9B_7@0@0@0@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
F05460@153378@153381@duplication@4@34523998@34539971@17@chr17:34523998-34539971@6.91@43@97@2.26@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL3L3_1, CCL4L1_1, CCL4L1_2, CCL4L1_3@0@0@0@:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
F05460@153650@153659@duplication@10@36351930@36375177@17@chr17:36351930-36375177@164@4006@7425@1.85@CNVR7083.3@RP11-1407O15.2_12, RP11-1407O15.2_11, RP11-1407O15.2_10, RP11-1407O15.2_9, RP11-1407O15.2_8, RP11-1407O15.2_7, RP11-1407O15.2_6, RP11-1407O15.2_5, RP11-1407O15.2_4, RP11-1407O15.2_3@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
F05460@155588@155594@duplication@7@44400320@44414934@17@chr17:44400320-44414934@12.5@161@279@1.73@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_7, LRRC37A_8, LRRC37A_9, LRRC37A_10, LRRC37A_11, LRRC37A_12, LRRC37A_13@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
F05460@164336@164337@duplication@2@4354947@4355170@19@chr19:4354947-4355170@4.97@156@224@1.44@NA@MPND_7, MPND_8@0@0@0@:MPN domain containing@:peptidase activity;protein binding;proteolysis@NA
F05460@166811@166812@duplication@2@14070580@14070881@19@chr19:14070580-14070881@7.46@357@499@1.4@NA@DCAF15_9, DCAF15_10@0@0@0@:DDB1 and CUL4 associated factor 15@:protein ubiquitination@NA
F05460@166916@166917@duplication@2@14508471@14508747@19@chr19:14508471-14508747@13@114@231@2.03@NA@CD97_7, CD97_8@0@0@0@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
F05460@167044@167045@deletion@2@14876337@14876616@19@chr19:14876337-14876616@6.28@419@279@0.666@NA@EMR2_9, EMR2_8@0@0@0@:egf-like module containing, mucin-like, hormone receptor-like 2@:transmembrane signaling receptor activity;inflammatory response;G-protein coupled receptor activity;ruffle membrane;integral to membrane;plasma membrane;cell surface receptor signaling pathway;neuropeptide signaling pathway;granulocyte chemotaxis;cell migration;leading edge membrane;G-protein coupled receptor signaling pathway;protein binding;cell adhesion;membrane;calcium ion binding;chondroitin sulfate binding@NA
F05460@168952@168952@duplication@1@35862263@35863302@19@chr19:35862263-35863302@19@128@343@2.68@CNVR7627.1@GPR42_2@0@0@0@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
F05460@170096@170100@duplication@5@40373946@40382826@19@chr19:40373946-40382826@43.2@199@560@2.81@CNVR7639.2@FCGBP_26, FCGBP_25, FCGBP_24, FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F05460@170104@170109@deletion@6@40389653@40399855@19@chr19:40389653-40399855@66.2@426@78@0.183@CNVR7639.2, CNVR7639.3@FCGBP_18, FCGBP_17, FCGBP_16, FCGBP_15, FCGBP_14, FCGBP_13@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F05460@170782@170785@duplication@4@43259141@43269733@19@chr19:43259141-43269733@7.38@597@796@1.33@NA@PSG8_4, PSG8_3, PSG8_2, PSG8_1@0@0@0@:pregnancy specific beta-1-glycoprotein 8@:protein binding;extracellular region@NA
F05460@172987@172987@deletion@1@52133087@52133469@19@chr19:52133087-52133469@7.33@45@8@0.178@CNVR7702.1@SIGLEC5_2, SIGLEC5_2@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion@NA
F05460@172989@172994@duplication@6@52146609@52149893@19@chr19:52146609-52149893@19.7@426@657@1.54@CNVR7702.1@SIGLEC14_7, SIGLEC14_6, SIGLEC14_5, SIGLEC14_4, SIGLEC14_3, SIGLEC14_2@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 14@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion;plasma membrane@NA
F05460@173109@173109@duplication@1@53517345@53518777@19@chr19:53517345-53518777@8.78@668@969@1.45@CNVR7709.2, CNVR7709.1@ERVV-1_1@0@0@0@:endogenous retrovirus group V, member 1@:integral to membrane@NA
F05460@173295@173303@deletion@9@54724399@54744452@19@chr19:54724399-54744452@33.1@1047@598@0.571@CNVR7721.3, CNVR7721.4, CNVR7721.1@LILRB3_6, LILRB3_5, LILRB3_4, LILRB3_3, LILRB3_2, LILRB3_1, LILRA6_8, LILRA6_7, LILRA6_6@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F05460@173306@173308@deletion@3@54745903@54746600@19@chr19:54745903-54746600@17@509@293@0.576@CNVR7721.3, CNVR7721.6@LILRA6_3, LILRA6_2, LILRA6_1@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F05460@173462@173465@duplication@4@55250012@55255536@19@chr19:55250012-55255536@19.4@568@853@1.5@CNVR7725.2, CNVR7725.4, CNVR7725.1@KIR2DL3_1, KIR2DL3_2, KIR2DL3_3, KIR2DL3_4@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity@NA
F05460@173467@173474@deletion@8@55263102@55290114@19@chr19:55263102-55290114@99.7@1053@365@0.347@CNVR7725.2, CNVR7725.1@KIR2DL3_6, KIR2DL3_7, KIR2DL3_8, KIR2DL1_1, KIR2DL1_2, KIR2DL1_3, KIR2DL1_4, KIR2DL1_5@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
F05460@173499@173501@duplication@3@55358640@55359398@19@chr19:55358640-55359398@10.5@804@1084@1.35@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4_6, KIR2DS4_7, KIR2DS4_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
F05460@174395@174395@duplication@1@1569207@1569278@20@chr20:1569207-1569278@4.89@50@94@1.88@CNVR7763.1@RP4-576H24.4_1@0@0@0@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
F05460@178264@178264@duplication@1@58180071@58180187@20@chr20:58180071-58180187@4.72@44@85@1.93@NA@PHACTR3_1@0@0@0@:phosphatase and actin regulator 3@:actin binding;protein phosphatase inhibitor activity;nuclear matrix@NA
F05460@178985@179007@deletion@23@10862623@10973733@21@chr21:10862623-10973733@155@6604@3778@0.572@CNVR7947.10, CNVR7947.6, CNVR7947.11@IGHV1OR21-1_1, IGHV1OR21-1_2, TPTE_24, TPTE_23, TPTE_22, TPTE_21, TPTE_20, TPTE_19, TPTE_18, TPTE_17, TPTE_16, TPTE_15, TPTE_14, TPTE_13, TPTE_12, TPTE_11, TPTE_10, TPTE_9, TPTE_8, TPTE_7, TPTE_6, TPTE_5@0@0@0@:transmembrane phosphatase with tensin homology@:protein binding;extracellular region:phosphatase activity;ion channel activity;protein tyrosine phosphatase activity;ion transport;protein dephosphorylation;transmembrane transport;protein binding;signal transduction;integral to membrane;protein tyrosine/serine/threonine phosphatase activity;dephosphorylation;membrane;peptidyl-tyrosine dephosphorylation@NA
F05460@181806@181807@deletion@2@23243157@23247205@22@chr22:23243157-23247205@5.59@316@207@0.655@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11, CNVR8103.35@IGLC2_1, IGLJ3_1@0@0@0@@:protein binding@NA
F05460@182312@182322@duplication@11@29091116@29126536@22@chr22:29091116-29126536@37.8@1593@2262@1.42@NA@CHEK2_13, CHEK2_12, CHEK2_11, CHEK2_10, CHEK2_9, CHEK2_8, CHEK2_7, CHEK2_6, CHEK2_5, CHEK2_4, CHEK2_3@0@0@0@:checkpoint kinase 2@:nucleoplasm;protein tyrosine kinase activity;ATP binding;PML body;response to gamma radiation;cell cycle checkpoint;cell division;ubiquitin protein ligase binding;protein kinase activity;positive regulation of transcription, DNA-dependent;intrinsic apoptotic signaling pathway in response to DNA damage response;transcription, DNA-dependent;signal transduction in response to DNA damage;double-strand break repair;regulation of protein catabolic process;protein autophosphorylation;protein kinase binding;transferase activity, transferring phosphorus-containing groups;chromosome, telomeric region;apoptotic process;protein homodimerization activity;DNA damage induced protein phosphorylation;cellular protein catabolic process;protein serine/threonine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;response to DNA damage stimulus;DNA damage checkpoint;G2/M transition of mitotic cell cycle;protein binding;spindle assembly involved in mitosis;kinase activity;replicative senescence;signal transduction involved in intra-S DNA damage checkpoint;metal ion binding@: LI-FRAUMENI SYNDROME 2; LFS2; CHECKPOINT KINASE 2, S. POMBE, HOMOLOG OF; CHEK2; OSTEOGENIC SARCOMA; BREAST CANCER; PROSTATE CANCER
F05460@184165@184172@duplication@8@42908917@42950048@22@chr22:42908917-42950048@47.1@629@1134@1.8@CNVR8171.2, CNVR8171.3@RRP7A_7, RRP7A_6, RRP7A_5, RRP7A_4, RRP7A_3, RRP7A_2, RRP7A_1, SERHL2_1@0@0@0@:ribosomal RNA processing 7 homolog A (S. cerevisiae):serine hydrolase-like 2@:RNA binding;nucleotide binding:hydrolase activity;mitochondrion;peroxisome;cytoplasmic membrane-bounded vesicle;molecular_function;cellular_component;perinuclear region of cytoplasm;biological_process@NA
F05460@198@220@duplication@23@6968338@7894160@X@chrX:6968338-7894160@117@1657@3037@1.83@NA@HDHD1_5, HDHD1_4, HDHD1_3, STS_2, STS_3, STS_4, STS_5, STS_6, STS_7, STS_8, STS_9, STS_10, VCX_2, VCX_3, PNPLA4_7, PNPLA4_6, PNPLA4_4, PNPLA4_3, PNPLA4_2@0@0@0@NA@NA@NA
F05460@2788@2788@deletion@1@55117766@55117890@X@chrX:55117766-55117890@5.51@95@46@0.484@CNVR8342.1@PAGE2_4@0@0@0@NA@NA@NA
F05460@4072@4079@deletion@8@101615523@101620252@X@chrX:101615523-101620252@17.1@78@0@0@NA@NXF2B_34, NXF2B_33, NXF2B_32, NXF2B_31, NXF2B_30, NXF2B_29, NXF2B_28, NXF2B_27@0@0@0@NA@NA@NA
F05460@6285@6285@deletion@1@153418414@153418581@X@chrX:153418414-153418581@9.49@43@0@0@CNVR8489.1@OPN1LW_3@0@0@0@NA@NA@NA
F05460@6307@6307@deletion@1@153496018@153496256@X@chrX:153496018-153496256@9.94@47@1@0.0213@CNVR8489.1@OPN1MW2_5@0@0@0@NA@NA@NA
F05506@6@6@duplication@1@69092@70008@1@chr1:69092-70008@5.9@49@98@2@CNVR1.1, CNVR1.2@OR4F5_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F05506@323@324@deletion@2@1414430@1416316@1@chr1:1414430-1416316@7.18@116@58@0.5@CNVR15.1@ATAD3B_4, ATAD3B_5@0@0@0@:ATPase family, AAA domain containing 3B@:nucleoside-triphosphatase activity;mitochondrial inner membrane;nucleotide binding;ATP binding@NA
F05506@1806@1810@deletion@5@12853378@12887689@1@chr1:12853378-12887689@7.23@385@258@0.67@CNVR72.3, CNVR72.10@PRAMEF1_2, PRAMEF1_3, PRAMEF1_4, PRAMEF11_4, PRAMEF11_3@0@0@0@:PRAME family member 1:PRAME family member 11@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
F05506@1816@1818@deletion@3@12939366@12943215@1@chr1:12939366-12943215@7.31@75@30@0.4@CNVR72.3, CNVR72.4, CNVR72.12, CNVR72.13@PRAMEF4_4, PRAMEF4_3, PRAMEF4_2@0@0@0@:PRAME family member 4@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
F05506@2174@2187@deletion@14@17256620@17275019@1@chr1:17256620-17275019@19.5@873@566@0.648@CNVR94.4, CNVR94.5@CROCC_5, CROCC_6, CROCC_7, CROCC_8, CROCC_9, CROCC_10, CROCC_11, CROCC_12, CROCC_13, CROCC_14, CROCC_15, CROCC_16, CROCC_17, CROCC_18@0@0@0@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
F05506@3335@3339@deletion@5@25617133@25633220@1@chr1:25617133-25633220@21.6@720@439@0.61@CNVR116.1, CNVR116.2@RHD_3, RHD_4, RHD_5, RHD_6, RHD_7@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
F05506@8507@8508@deletion@2@89476588@89477710@1@chr1:89476588-89477710@8.5@575@382@0.664@CNVR244.1@GBP3_8, GBP3_7@0@0@0@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
F05506@9342@9354@duplication@13@104115686@104163306@1@chr1:104115686-104163306@97.6@914@2021@2.21@CNVR266.8, CNVR266.3@AMY2B_5, AMY2B_6, AMY2B_7, AMY2B_8, AMY2B_9, AMY2B_10, AMY2B_11, AMY2B_12, AMY2A_1, AMY2A_2, AMY2A_3, AMY2A_4, AMY2A_5@0@0@0@:actin, gamma 1 pseudogene 4;amylase, alpha 2B (pancreatic):amylase, alpha 2A (pancreatic)@:extracellular region;cation binding;digestion;carbohydrate metabolic process;catalytic activity;alpha-amylase activity;metal ion binding:chloride ion binding;cation binding;small molecule metabolic process;carbohydrate metabolic process;catalytic activity;extracellular space;polysaccharide digestion;extracellular region;carbohydrate catabolic process;alpha-amylase activity;calcium ion binding@NA
F05506@9373@9374@deletion@2@104233917@104234232@1@chr1:104233917-104234232@12.8@58@0@0@CNVR266.3, CNVR266.5@AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
F05506@9385@9386@duplication@2@104297122@104297436@1@chr1:104297122-104297436@33.2@329@696@2.12@CNVR266.3, CNVR266.5@AMY1C_6, AMY1C_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
F05506@9436@9437@duplication@2@108769302@108771778@1@chr1:108769302-108771778@4.97@160@229@1.43@CNVR294.4@NBPF4_14, NBPF4_13@0@0@0@:neuroblastoma breakpoint family, member 4@:cytoplasm@NA
F05506@9766@9773@duplication@8@110230497@110235917@1@chr1:110230497-110235917@35.9@417@742@1.78@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
F05506@10822@10840@duplication@19@144867922@144912294@1@chr1:144867922-144912294@53.9@5280@6951@1.32@NA@PDE4DIP_33, PDE4DIP_32, PDE4DIP_31, PDE4DIP_30, PDE4DIP_29, PDE4DIP_28, PDE4DIP_27, PDE4DIP_26, PDE4DIP_25, PDE4DIP_24, PDE4DIP_23, PDE4DIP_22, PDE4DIP_21, PDE4DIP_20, PDE4DIP_19, PDE4DIP_18, PDE4DIP_17, PDE4DIP_16, PDE4DIP_15@0@0@0@:phosphodiesterase 4D interacting protein;uncharacterized LOC101060344;myomegalin-like@:Golgi apparatus;binding;centrosome;enzyme binding;cytoplasm;protein binding;myofibril;cellular protein complex assembly;nucleus@NA
F05506@10843@10846@duplication@4@144917500@144922047@1@chr1:144917500-144922047@11.8@1518@1976@1.3@NA@PDE4DIP_12, PDE4DIP_11, PDE4DIP_10, PDE4DIP_9@0@0@0@:phosphodiesterase 4D interacting protein;uncharacterized LOC101060344;myomegalin-like@:Golgi apparatus;binding;centrosome;enzyme binding;cytoplasm;protein binding;myofibril;cellular protein complex assembly;nucleus@NA
F05506@10850@10853@duplication@4@144946626@144955292@1@chr1:144946626-144955292@13.8@936@1268@1.35@CNVR339.1@PDE4DIP_5, PDE4DIP_4, PDE4DIP_3, PDE4DIP_2@0@0@0@:phosphodiesterase 4D interacting protein;uncharacterized LOC101060344;myomegalin-like@:Golgi apparatus;binding;centrosome;enzyme binding;cytoplasm;protein binding;myofibril;cellular protein complex assembly;nucleus@NA
F05506@12117@12118@deletion@2@152573209@152586574@1@chr1:152573209-152586574@31.2@143@0@0@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
F05506@14053@14058@deletion@6@161565346@161600992@1@chr1:161565346-161600992@60@1097@539@0.491@CNVR383.1@FCGR2C_1, FCGR3B_5, FCGR3B_4, FCGR3B_3, FCGR3B_2, FCGR3B_1@0@0@0@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene):Fc fragment of IgG, low affinity IIIb, receptor (CD16b)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction:IgG binding;protein binding;extracellular region;immune response;plasma membrane;anchored to membrane@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
F05506@16030@16031@deletion@2@196748293@196749103@1@chr1:196748293-196749103@5.03@278@184@0.662@CNVR459.1, CNVR459.3@CFHR3_2, CFHR3_3@0@0@0@:complement factor H-related 3@:extracellular space@NA
F05506@16034@16036@deletion@3@196762448@196794801@1@chr1:196762448-196794801@5.34@446@305@0.684@CNVR459.1@CFHR3_6, CFHR1_1, CFHR1_2@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
F05506@17294@17295@deletion@2@207737210@207737579@1@chr1:207737210-207737579@6@34@5@0.147@CNVR485.1, CNVR485.2@CR1_22, CR1_23@0@0@0@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
F05506@19775@19778@duplication@4@248756132@248814185@1@chr1:248756132-248814185@33.4@2052@2874@1.4@CNVR600.1@OR2T10_1, OR2T11_1, OR2T35_1, OR2T27_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 10:olfactory receptor, family 2, subfamily T, member 11:olfactory receptor, family 2, subfamily T, member 35:olfactory receptor, family 2, subfamily T, member 27@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F05506@24407@24407@deletion@1@79253840@79253957@2@chr2:79253840-79253957@4.8@89@47@0.528@NA@REG3G_3@0@0@0@:regenerating islet-derived 3 gamma@:carbohydrate binding;extracellular region;acute-phase response@NA
F05506@25115@25116@deletion@2@96652500@96652954@2@chr2:96652500-96652954@22.5@158@33@0.209@NA@ANKRD36C_3, ANKRD36C_2@0@0@0@:ankyrin repeat domain-containing protein 36A-like@:ion channel inhibitor activity;protein binding@NA
F05506@26310@26310@deletion@1@112551656@112551708@2@chr2:112551656-112551708@4.92@74@36@0.486@CNVR928.1@ANAPC1_37@0@0@0@:anaphase-promoting complex subunit 1-like;anaphase promoting complex subunit 1@:nucleoplasm;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle;anaphase-promoting complex;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle spindle assembly checkpoint;cytosol;protein K11-linked ubiquitination;protein binding;mitosis;nucleus;cell cycle checkpoint;cell division;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle@NA
F05506@26332@26332@deletion@1@112605303@112605442@2@chr2:112605303-112605442@5.26@117@65@0.556@CNVR929.1@ANAPC1_15@0@0@0@:anaphase-promoting complex subunit 1-like;anaphase promoting complex subunit 1@:nucleoplasm;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle;anaphase-promoting complex;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle spindle assembly checkpoint;cytosol;protein K11-linked ubiquitination;protein binding;mitosis;nucleus;cell cycle checkpoint;cell division;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle@NA
F05506@27180@27180@deletion@1@130898732@130898869@2@chr2:130898732-130898869@9.53@110@44@0.4@NA@CCDC74B_4@0@0@0@:coiled-coil domain containing 74A;coiled-coil domain containing 74B@NA@NA
F05506@27341@27342@duplication@2@132288153@132289375@2@chr2:132288153-132289375@9.93@171@275@1.61@NA@CCDC74A_3, CCDC74A_4@0@0@0@:coiled-coil domain containing 74A@NA@NA
F05506@39502@39502@deletion@1@62267239@62267384@3@chr3:62267239-62267384@6.7@200@117@0.585@NA@PTPRG_27@0@0@0@:protein tyrosine phosphatase, receptor type, G@:phosphatase activity;protein tyrosine phosphatase activity;protein dephosphorylation;protein binding;transmembrane receptor protein tyrosine kinase signaling pathway;dephosphorylation;integral to plasma membrane;identical protein binding;transmembrane receptor protein tyrosine phosphatase activity;peptidyl-tyrosine dephosphorylation@NA
F05506@45436@45436@deletion@1@195460022@195460089@3@chr3:195460022-195460089@4.7@122@71@0.582@CNVR1703.1, CNVR1703.2, CNVR1703.5, CNVR1703.3@MUC20_4@0@0@0@:mucin 20, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane@NA
F05506@46005@46005@deletion@1@1940179@1940259@4@chr4:1940179-1940259@4.98@37@10@0.27@NA@WHSC1_10@0@0@0@:Wolf-Hirschhorn syndrome candidate 1@:anatomical structure morphogenesis;atrial septum primum morphogenesis;histone lysine methylation;bone development;DNA binding;membranous septum morphogenesis;chromosome;nucleus;cytoplasm;atrial septum secundum morphogenesis;nuclear membrane;protein binding;chromatin binding;negative regulation of transcription from RNA polymerase II promoter;nucleolus;chromatin modification;transcription, DNA-dependent;zinc ion binding;histone-lysine N-methyltransferase activity@NA
F05506@48593@48597@duplication@5@70148233@70160527@4@chr4:70148233-70160527@8.76@589@787@1.34@CNVR1957.2, CNVR1957.1@UGT2B28_2, UGT2B28_3, UGT2B28_4, UGT2B28_5, UGT2B28_6@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
F05506@51672@51672@deletion@1@145041644@145041741@4@chr4:145041644-145041741@9.62@124@53@0.427@NA@GYPA_2@0@0@0@:glycophorin B (MNS blood group):glycophorin A (MNS blood group)@:integral to membrane;plasma membrane;integral to plasma membrane:external side of plasma membrane;integral to membrane;cytoskeletal anchoring at plasma membrane;plasma membrane;molecular_function;protein homodimerization activity;integral to plasma membrane;cellular_component;identical protein binding;membrane;biological_process;regulation of response to osmotic stress;virus-host interaction@: BLOOD GROUP--Ss LOCUS; Ss: MALARIA, SUSCEPTIBILITY TO; BLOOD GROUP--MN LOCUS; MN
F05506@52397@52397@duplication@1@165890631@165891154@4@chr4:165890631-165891154@4.62@221@308@1.39@NA@TRIM61_3@0@0@0@:tripartite motif containing 61@:protein binding;intracellular;zinc ion binding@NA
F05506@52408@52408@duplication@1@166159931@166160051@4@chr4:166159931-166160051@5.71@180@265@1.47@NA@KLHL2_4@0@0@0@:kelch-like 2, Mayven (Drosophila)@:intracellular protein transport;actin binding;protein binding;transporter activity;cytoskeleton;actin cytoskeleton;cytoplasm@NA
F05506@53306@53311@duplication@6@741710@756259@5@chr5:741710-756259@25.8@381@658@1.73@CNVR2280.3@ZDHHC11B_7, ZDHHC11B_6, ZDHHC11B_5, ZDHHC11B_4, ZDHHC11B_3, ZDHHC11B_2@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
F05506@53320@53321@deletion@2@840611@843839@5@chr5:840611-843839@7.43@450@295@0.656@CNVR2280.3, CNVR2280.8@ZDHHC11_5, ZDHHC11_4@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
F05506@55830@55831@deletion@2@70307103@70308742@5@chr5:70307103-70308742@20.9@692@387@0.559@CNVR2494.41, CNVR2494.14, CNVR2494.30, CNVR2494.20, CNVR2494.62, CNVR2494.8, CNVR2494.35@NAIP_5, NAIP_4@0@0@0@:baculoviral IAP repeat-containing protein 1-like;NLR family, apoptosis inhibitory protein@:negative regulation of apoptotic process;inflammatory response;basolateral plasma membrane;nucleoside-triphosphatase activity;cysteine-type endopeptidase inhibitor activity;intracellular;nucleotide binding;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;ATP binding;cytoplasm;innate immune response;protein binding;negative regulation of neuron apoptotic process;metal ion binding;nervous system development@NA
F05506@59065@59065@deletion@1@140557617@140560021@5@chr5:140557617-140560021@14.2@1748@1103@0.631@CNVR2624.1@PCDHB8_1@0@0@0@:protocadherin beta 8@:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding@NA
F05506@60875@60877@duplication@3@175386973@175388437@5@chr5:175386973-175388437@10.3@150@248@1.65@NA@THOC3_6, THOC3_5, THOC3_4@0@0@0@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
F05506@61638@61645@deletion@8@180375356@180429785@5@chr5:180375356-180429785@27.8@1235@783@0.634@CNVR2719.1@BTNL8_5, BTNL8_6, BTNL8_7, BTNL8_8, BTNL3_1, BTNL3_2, BTNL3_3, BTNL3_4@0@0@0@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
F05506@63281@63282@deletion@2@31237744@31238262@6@chr6:31237744-31238262@39@378@117@0.31@CNVR2838.2, CNVR2838.1@HLA-C_5, HLA-C_4@0@0@0@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
F05506@63725@63726@deletion@2@31962023@31962484@6@chr6:31962023-31962484@13.2@133@51@0.383@CNVR2843.6, CNVR2843.3@C4A_20, C4A_21@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
F05506@63733@63748@deletion@16@31964207@31974881@6@chr6:31964207-31974881@33.7@307@111@0.362@CNVR2843.6, CNVR2843.3@C4A_28, C4A_29, C4A_30, C4A_31, C4A_32, C4A_33, C4A_34, C4A_35, C4A_36, C4A_37, C4A_38, C4A_39, C4A_40, C4A_41, AL645922.1_2, AL645922.1_1@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
F05506@63773@63779@deletion@7@31996235@31998278@6@chr6:31996235-31998278@69.1@361@28@0.0776@CNVR2843.6, CNVR2843.5@C4B_25, C4B_26, C4B_27, C4B_28, C4B_29, C4B_30, C4B_31@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
F05506@63792@63794@deletion@3@32006872@32007424@6@chr6:32006872-32007424@34.4@458@192@0.419@CNVR2843.6, CNVR2843.5@CYP21A2_3, CYP21A2_4, CYP21A2_5@0@0@0@:cytochrome P450, family 21, subfamily A, polypeptide 2@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY
F05506@63797@63798@deletion@2@32008184@32008548@6@chr6:32008184-32008548@5.67@211@133@0.63@CNVR2843.6, CNVR2843.5@CYP21A2_8, CYP21A2_9@0@0@0@:cytochrome P450, family 21, subfamily A, polypeptide 2@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY
F05506@63812@63812@deletion@1@32012784@32012996@6@chr6:32012784-32012996@6.92@115@57@0.496@CNVR2843.6, CNVR2843.5@TNXB_1@0@0@0@:tenascin-X-like;tenascin XB@:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
F05506@63953@63958@deletion@6@32485517@32498001@6@chr6:32485517-32498001@48.1@297@50@0.168@CNVR2845.21, CNVR2845.25, CNVR2845.30, CNVR2845.43, CNVR2845.6@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2, HLA-DRB5_1@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
F05506@63963@63974@deletion@12@32551887@32634384@6@chr6:32551887-32634384@115@1210@469@0.388@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.34@HLA-DRB1_2, HLA-DRB1_1, HLA-DQA1_1, HLA-DQA1_2, HLA-DQA1_3, HLA-DQA1_4, HLA-DQB1_6, HLA-DQB1_5, HLA-DQB1_4, HLA-DQB1_3, HLA-DQB1_2, HLA-DQB1_1@0@0@0@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
F05506@63991@64014@deletion@24@32797178@32818926@6@chr6:32797178-32818926@745@3614@11@0.00304@NA@TAP2_11, TAP2_11, TAP2_10, TAP2_10, TAP2_9, TAP2_9, TAP2_8, TAP2_8, TAP2_7, TAP2_7, TAP2_6, TAP2_6, TAP2_5, TAP2_5, TAP2_4, TAP2_4, TAP2_3, TAP2_3, TAP2_2, TAP2_2, PSMB8_6, PSMB8_5, PSMB8_4, PSMB8_3, PSMB8_2, PSMB8_1, TAP1_11, TAP1_10, TAP1_9, TAP1_8, TAP1_7, TAP1_6, TAP1_5, TAP1_4@0@0@0@:transporter 2, ATP-binding cassette, sub-family B (MDR/TAP):proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional peptidase 7):proteasome (prosome, macropain) subunit, beta type, 9 (large multifunctional peptidase 2):transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)@:ATPase activity, coupled to transmembrane movement of substances;transport;immune response;transporter activity;ATP binding;transmembrane transport;integral to membrane;peptide transporter activity;ATPase activity;nucleus;nucleoside-triphosphatase activity;endoplasmic reticulum;nucleotide binding;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;antigen processing and presentation;membrane:ATPase activity, coupled to transmembrane movement of substances;antigen processing and presentation of peptide antigen via MHC class I;transporter activity;ATP binding;transmembrane transport;integral to endoplasmic reticulum membrane;positive regulation of antigen processing and presentation of peptide antigen via MHC class I;peptide antigen binding;peptide transporter activity;ATPase activity;plasma membrane;nucleus;antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent;endoplasmic reticulum membrane;antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;antigen processing and presentation of endogenous peptide antigen via MHC class I;endoplasmic reticulum;peptide transport;antigen processing and presentation of exogenous peptide antigen via MHC class I;oligopeptide-transporting ATPase activity;TAP2 binding;transport;peptide antigen-transporting ATPase activity;antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent;integral to membrane;MHC class I protein binding;intracellular transport of viral proteins in host cell;cytosol to ER transport;nucleoside-triphosphatase activity;positive regulation of T cell mediated cytotoxicity;nucleotide binding;tapasin binding;protein binding;peptide antigen transport;TAP complex;TAP1 binding:nucleoplasm;proteasome complex;fat cell differentiation;S phase of mitotic cell cycle;mitotic cell cycle;antigen processing and presentation of peptide antigen via MHC class I;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;mRNA metabolic process;viral reproduction;gene expression;cell cycle checkpoint;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;type I interferon-mediated signaling pathway;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;cytosol;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;proteolysis involved in cellular protein catabolic process;regulation of apoptotic process;cellular nitrogen compound metabolic process;proteasome core complex;RNA metabolic process;G1/S transition of mitotic cell cycle;regulation of cellular amino acid metabolic process;apoptotic process;cytokine-mediated signaling pathway;virus-host interaction;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;small molecule metabolic process;threonine-type endopeptidase activity;M/G1 transition of mitotic cell cycle;protein polyubiquitination:nucleoplasm;proteasome complex;S phase of mitotic cell cycle;mitotic cell cycle;antigen processing and presentation of peptide antigen via MHC class I;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;mRNA metabolic process;viral reproduction;nucleus;gene expression;cell cycle checkpoint;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;cytosol;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;proteolysis involved in cellular protein catabolic process;regulation of apoptotic process;cellular nitrogen compound metabolic process;proteasome core complex;RNA metabolic process;G1/S transition of mitotic cell cycle;regulation of cellular amino acid metabolic process;apoptotic process;virus-host interaction;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;small molecule metabolic process;threonine-type endopeptidase activity;M/G1 transition of mitotic cell cycle;cytoplasm;protein binding;protein polyubiquitination:ADP binding;ATPase activity, coupled to transmembrane movement of substances;mitochondrion;antigen processing and presentation of peptide antigen via MHC class I;transporter activity;ATP binding;transmembrane transport;integral to endoplasmic reticulum membrane;peptide antigen binding;peptide transporter activity;ATPase activity;plasma membrane;endoplasmic reticulum membrane;defense response;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;antigen processing and presentation of endogenous peptide antigen via MHC class I;peptide transport;cytosol;antigen processing and presentation of exogenous peptide antigen via MHC class I;oligopeptide-transporting ATPase activity;TAP2 binding;transport;integral to membrane;protein homodimerization activity;MHC class I protein binding;intracellular transport of viral proteins in host cell;cytosol to ER transport;nucleoside-triphosphatase activity;protection from natural killer cell mediated cytotoxicity;positive regulation of T cell mediated cytotoxicity;protein heterodimerization activity;nucleotide binding;tapasin binding;protein binding;TAP complex;TAP1 binding@: BARE LYMPHOCYTE SYNDROME, TYPE I: AUTOINFLAMMATION, LIPODYSTROPHY, AND DERMATOSIS SYNDROME; ALDD: BARE LYMPHOCYTE SYNDROME, TYPE I
F05506@70084@70084@deletion@1@150343117@150343379@6@chr6:150343117-150343379@6.04@104@53@0.51@NA@RAET1L_2@0@0@0@:retinoic acid early transcript 1L@:MHC class I protein complex;antigen processing and presentation;immune response;anchored to membrane;membrane@NA
F05506@71030@71033@duplication@4@167790035@167796361@6@chr6:167790035-167796361@6.71@248@343@1.38@NA@TCP10_5, TCP10_4, TCP10_3, TCP10_2@0@0@0@:t-complex 10@:cytosol@NA
F05506@71763@71766@deletion@4@5978354@5984809@7@chr7:5978354-5984809@12.9@337@197@0.585@NA@RSPH10B_15, RSPH10B_14, RSPH10B_13, RSPH10B_12@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F05506@71774@71779@deletion@6@6004134@6018327@7@chr7:6004134-6018327@29.2@385@168@0.436@NA@RSPH10B_4, RSPH10B_3, RSPH10B_2, PMS2_15, PMS2_14, PMS2_13@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas):PMS2 postmeiotic segregation increased 2 (S. cerevisiae)@:response to drug;DNA binding;MutSalpha complex binding;ATP binding;mismatch repair;DNA repair;mismatched DNA binding;ATPase activity;nucleus;mismatch repair complex;reciprocal meiotic recombination;ATP catabolic process;single-stranded DNA binding;response to DNA damage stimulus;single base insertion or deletion binding;protein binding;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;MutLalpha complex;endonuclease activity@: COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4; MISMATCH REPAIR CANCER SYNDROME
F05506@71922@71922@duplication@1@6797310@6797562@7@chr7:6797310-6797562@6.31@180@270@1.5@NA@RSPH10B2_2@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F05506@71927@71934@duplication@8@6806389@6821107@7@chr7:6806389-6821107@20.6@305@531@1.74@NA@RSPH10B2_7, RSPH10B2_8, RSPH10B2_9, RSPH10B2_10, RSPH10B2_11, RSPH10B2_12, RSPH10B2_13, RSPH10B2_14@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F05506@71939@71941@deletion@3@6836200@6838910@7@chr7:6836200-6838910@16.5@115@28@0.243@NA@RSPH10B2_19, RSPH10B2_20, CCZ1B_15@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F05506@73260@73263@duplication@4@38388957@38393784@7@chr7:38388957-38393784@13.6@942@1285@1.36@CNVR3354.3, CNVR3354.1@TRGV5_2, TRGV5_1, TRGV4_2, TRGV4_1@0@0@0@@:protein binding:protein binding@NA
F05506@74574@74583@duplication@10@74167427@74193768@7@chr7:74167427-74193768@10.2@325@463@1.42@NA@GTF2I_29, GTF2I_30, GTF2I_31, GTF2I_32, GTF2I_33, GTF2I_34, NCF1_1, NCF1_2, NCF1_3, NCF1_4@0@0@0@:general transcription factor IIi:neutrophil cytosolic factor 1@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration:inflammatory response;antigen processing and presentation of peptide antigen via MHC class I;phagosome maturation;NADPH oxidase complex;neutrophil mediated killing of gram-positive bacterium;cell communication;interaction with host;leukotriene metabolic process;response to yeast;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;respiratory burst;GTPase activity;negative regulation of smooth muscle contraction;GTP catabolic process;cytosol;defense response to fungus;defense response to bacterium;antigen processing and presentation of exogenous peptide antigen via MHC class I;leukocyte mediated cytotoxicity;neutrophil mediated killing of fungus;phosphatidylinositol binding;defense response to Gram-positive bacterium;GTP binding;respiratory burst involved in defense response;superoxide-generating NADPH oxidase activity;hydrogen peroxide biosynthetic process;protein targeting to membrane;electron carrier activity;superoxide metabolic process;innate immune response;phagolysosome;cytoplasm;cell proliferation;superoxide anion generation;protein binding;SH3 domain binding;cellular defense response;response to bacterium@: GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE,
F05506@74663@74664@deletion@2@75054919@75055735@7@chr7:75054919-75055735@4.97@83@43@0.518@NA@POM121C_9, POM121C_8@0@0@0@:POM121 transmembrane nucleoporin C@:nuclear membrane;protein binding;protein transport;endoplasmic reticulum membrane;nuclear pore;mRNA transport@NA
F05506@74792@74793@deletion@2@76240783@76241130@7@chr7:76240783-76241130@15.1@259@129@0.498@CNVR3463.10@POMZP3_6, POMZP3_5@0@0@0@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
F05506@76427@76432@deletion@6@100331793@100336236@7@chr7:100331793-100336236@30.9@985@586@0.595@CNVR3509.1@ZAN_1, ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
F05506@76754@76754@duplication@1@102219880@102220243@7@chr7:102219880-102220243@10.7@75@167@2.23@CNVR3518.1@AC093668.1_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
F05506@76765@76765@deletion@1@102235753@102235816@7@chr7:102235753-102235816@10.4@47@0@0@CNVR3518.1@RASA4_11@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
F05506@76795@76795@deletion@1@102318940@102319303@7@chr7:102318940-102319303@4.73@218@139@0.638@CNVR3518.1@AC105052.1_1@0@0@0@NA@NA@NA
F05506@78412@78412@deletion@1@134221804@134221909@7@chr7:134221804-134221909@8.17@110@49@0.445@NA@AKR1B10_6@0@0@0@:aldo-keto reductase family 1, member B10 (aldose reductase)@:steroid metabolic process;cellular aldehyde metabolic process;indanol dehydrogenase activity;daunorubicin metabolic process;retinal dehydrogenase activity;farnesol catabolic process;geranylgeranyl reductase activity;protein binding;extracellular region;aldo-keto reductase (NADP) activity;digestion;doxorubicin metabolic process;cellular_component;lysosome@NA
F05506@79311@79312@deletion@2@143929005@143956721@7@chr7:143929005-143956721@6.74@1038@764@0.736@CNVR3598.4, CNVR3598.7@OR2A42_1, OR2A7_1@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:olfactory receptor, family 2, subfamily A, member 7@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F05506@80401@80402@deletion@2@7706214@7718245@8@chr8:7706214-7718245@5.59@157@93@0.592@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@SPAG11A_2, SPAG11A_3@0@0@0@:sperm associated antigen 11A;sperm associated antigen 11B@:extracellular region;defense response@NA
F05506@88593@88594@deletion@2@43816638@43818184@9@chr9:43816638-43818184@11.8@303@172@0.568@CNVR4294.1@CNTNAP3B_6, CNTNAP3B_7@0@0@0@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
F05506@91242@91247@duplication@6@117085415@117088637@9@chr9:117085415-117088637@156@1287@3675@2.86@CNVR4448.1@ORM1_1, ORM1_2, ORM1_3, ORM1_4, ORM1_5, ORM1_6@0@0@0@:orosomucoid 1@:protein binding;extracellular space;regulation of immune system process;transport;inflammatory response;extracellular region;acute-phase response@NA
F05506@95355@95359@duplication@5@17891584@17905692@10@chr10:17891584-17905692@9.98@394@563@1.43@NA@MRC1L1_7, MRC1L1_8, MRC1L1_9, MRC1L1_10, MRC1L1_11@0@0@0@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
F05506@95377@95380@deletion@4@17951323@18060364@10@chr10:17951323-18060364@5.56@25@0@0@NA@MRC1L1_29, MRC1L1_30, TMEM236_1, TMEM236_2@0@0@0@:macrophage mannose receptor 1-like:transmembrane protein 236;transmembrane protein 236-like@:carbohydrate binding:integral to membrane@NA
F05506@95389@95394@deletion@6@18138509@18155690@10@chr10:18138509-18155690@38.6@201@14@0.0697@NA@MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11, MRC1_12@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F05506@96573@96579@deletion@7@48025301@48049021@10@chr10:48025301-48049021@11.5@416@261@0.627@CNVR4715.2@ASAH2C_9, ASAH2C_8, ASAH2C_7, ASAH2C_6, ASAH2C_5, ASAH2C_4, ASAH2C_3@0@0@0@@:ceramidase activity;sphingolipid metabolic process@NA
F05506@96933@96937@duplication@5@51970584@51978390@10@chr10:51970584-51978390@23@167@351@2.1@NA@ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
F05506@101607@101612@deletion@6@124343839@124351033@10@chr10:124343839-124351033@21.4@668@406@0.608@CNVR4912.4, CNVR4912.3, CNVR4912.2@DMBT1_14, DMBT1_15, DMBT1_16, DMBT1_17, DMBT1_18, DMBT1_19@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
F05506@101620@101620@deletion@1@124359581@124359609@10@chr10:124359581-124359609@7.53@227@132@0.581@CNVR4912.4, CNVR4912.3@DMBT1_27@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
F05506@103268@103269@deletion@2@4967390@4976943@11@chr11:4967390-4976943@33.3@1851@1106@0.598@CNVR5040.1@OR51A4_1, OR51A2_1@0@0@0@:matrix metallopeptidase 26:olfactory receptor, family 51, subfamily A, member 4:olfactory receptor, family 51, subfamily A, member 2@:metallopeptidase activity;extracellular matrix;proteolysis;proteinaceous extracellular matrix;collagen catabolic process;metalloendopeptidase activity;zinc ion binding;metabolic process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F05506@103342@103342@deletion@1@5798891@5799864@11@chr11:5798891-5799864@4.85@768@538@0.701@CNVR5049.1@OR52N5_1@0@0@0@:tripartite motif containing 5:olfactory receptor, family 52, subfamily N, member 5@:defense response to virus;Golgi apparatus;intracellular;protein trimerization;ligase activity;cytoplasm;protein binding;nucleus;protein homodimerization activity;identical protein binding;zinc ion binding;cytoplasmic mRNA processing body;protein ubiquitination;virus-host interaction:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F05506@105904@105904@deletion@1@47701526@47701625@11@chr11:47701526-47701625@8.87@87@31@0.356@NA@AGBL2_13@0@0@0@:ATP/GTP binding protein-like 2@:cytosol;metallocarboxypeptidase activity;proteolysis;zinc ion binding@NA
F05506@106047@106048@deletion@2@55405835@55419315@11@chr11:55405835-55419315@5.01@1600@1172@0.732@CNVR5179.1@OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F05506@110109@110109@deletion@1@89531299@89531797@11@chr11:89531299-89531797@9.36@404@244@0.604@NA@TRIM49_8@0@0@0@:tripartite motif containing 49@:protein binding;intracellular;DNA binding;zinc ion binding@NA
F05506@110111@110114@duplication@4@89534135@89537637@11@chr11:89534135-89537637@9.12@104@184@1.77@NA@TRIM49_6, TRIM49_5, TRIM49_4, TRIM49_3@0@0@0@:tripartite motif containing 49@:protein binding;intracellular;DNA binding;zinc ion binding@NA
F05506@110121@110124@deletion@4@89768381@89771883@11@chr11:89768381-89771883@10.1@46@0@0@NA@TRIM49C_3, TRIM49C_4, TRIM49C_5, TRIM49C_6@0@0@0@:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;DNA binding;zinc ion binding@NA
F05506@114424@114427@duplication@4@10583717@10587129@12@chr12:10583717-10587129@6.47@641@830@1.29@CNVR5430.1@KLRC2_6, KLRC2_5, KLRC2_4, KLRC2_3, NKG2-E_3@0@0@0@:killer cell lectin-like receptor subfamily C, member 2@:carbohydrate binding:transmembrane signaling receptor activity;carbohydrate binding;protein binding;signal transduction;cellular defense response;integral to plasma membrane@NA
F05506@115537@115537@duplication@1@31249276@31249313@12@chr12:31249276-31249313@8.77@82@161@1.96@CNVR5483.1@DDX11_15@0@0@0@:DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11@:nucleoplasm;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;S phase of mitotic cell cycle;DNA binding;nucleobase-containing compound metabolic process;ATP binding;ATP-dependent DNA helicase activity;DNA helicase activity;midbody;RNA binding;DNA-dependent ATPase activity;nucleus;positive regulation of cell proliferation;virus-host interaction;nuclear chromatin;4 iron, 4 sulfur cluster binding;helicase activity;hydrolase activity, acting on acid anhydrides;DNA duplex unwinding;endoplasmic reticulum unfolded protein response;G2/M transition of mitotic cell cycle;protein binding;sister chromatid cohesion;activation of signaling protein activity involved in unfolded protein response;nucleolus;spindle pole;ATP-dependent helicase activity;metal ion binding;nucleic acid binding;mitotic sister chromatid segregation@: WARSAW BREAKAGE SYNDROME
F05506@123374@123374@duplication@1@124496693@124497477@12@chr12:124496693-124497477@7.34@678@929@1.37@CNVR5712.1@ZNF664_6@0@0@0@:zinc finger protein 664@:intracellular;nucleus;DNA binding;molecular_function;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;biological_process@NA
F05506@123943@123947@deletion@5@19752387@19761466@13@chr13:19752387-19761466@41.1@945@509@0.539@NA@TUBA3C_3, TUBA3C_2, TUBA3C_1, RP11-408E5.4_2, RP11-408E5.4_3@0@0@0@:tubulin, alpha 3c;tubulin, alpha 3d@:microtubule-based process;structural constituent of cytoskeleton;protein folding;protein polymerization;cytoplasmic microtubule;GTP binding;microtubule cytoskeleton organization;GTPase activity;GTP catabolic process;protein complex;cytoplasm;microtubule cytoskeleton;protein binding;'de novo' posttranslational protein folding;cellular protein metabolic process;microtubule-based movement;structural molecule activity;microtubule;protein domain specific binding@NA
F05506@127333@127334@deletion@2@19553418@19558831@14@chr14:19553418-19558831@7.29@61@19@0.311@CNVR6072.1@POTEG_1, POTEG_2@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
F05506@127352@127352@duplication@1@20019701@20020220@14@chr14:20019701-20020220@8.63@29@91@3.14@CNVR6072.6, CNVR6072.12@POTEM_1@0@0@0@:POTE ankyrin domain family, member M@:protein binding@NA
F05506@133426@133426@duplication@1@106478111@106478411@14@chr14:106478111-106478411@6.21@101@167@1.65@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV4-4_2@0@0@0@@:protein binding@NA
F05506@133432@133456@deletion@25@106539080@106780817@14@chr14:106539080-106780817@271@5244@2711@0.517@CNVR6294.48, CNVR6294.24, CNVR6294.40@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1, IGHV3-11_2, IGHV3-11_1, IGHV3-13_2, IGHV3-13_1, IGHV3-15_2, IGHV3-15_1, IGHV3-16_2, IGHV3-16_1, IGHV1-18_2, IGHV1-18_1, IGHV3-20_2, IGHV3-20_1, IGHV3-21_2, IGHV3-21_1, IGHV3-23_2, IGHV3-23_1, IGHV1-24_2, IGHV1-24_1, IGHV2-26_2, IGHV2-26_1, IGHV4-28_2@0@0@0@:uncharacterized LOC100653243;uncharacterized LOC642131@:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding@NA
F05506@133458@133460@duplication@3@106791006@106805516@14@chr14:106791006-106805516@6.8@895@1170@1.31@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-30_2, IGHV3-30_1, IGHV4-31_2@0@0@0@@:protein binding:protein binding@NA
F05506@133491@133492@deletion@2@107095127@107095561@14@chr14:107095127-107095561@9.9@76@21@0.276@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61_2, IGHV4-61_1@0@0@0@@:protein binding@NA
F05506@133542@133542@duplication@1@22382474@22383423@15@chr15:22382474-22383423@11.5@951@1359@1.43@CNVR6297.4, CNVR6297.17, CNVR6297.2@OR4N4_1@0@0@0@:olfactory receptor, family 4, subfamily N, member 4@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F05506@140958@140960@duplication@3@1278901@1279738@16@chr16:1278901-1279738@7.27@58@115@1.98@CNVR6591.1@TPSB2_6, TPSB2_5, TPSB2_4, TPSB2_3@0@0@0@:tryptase beta 2 (gene/pseudogene)@:proteolysis;catalytic activity;serine-type endopeptidase activity@NA
F05506@140964@140965@deletion@2@1291436@1291991@16@chr16:1291436-1291991@5.91@106@56@0.528@CNVR6591.1@TPSAB1_4, TPSAB1_5@0@0@0@:tryptase alpha/beta 1@:serine-type peptidase activity;extracellular matrix;extracellular matrix organization;catalytic activity;extracellular matrix disassembly;proteolysis;extracellular space;protein binding;extracellular region;defense response;serine-type endopeptidase activity@NA
F05506@142997@143006@duplication@10@18532088@18550286@16@chr16:18532088-18550286@13.6@467@666@1.43@NA@NOMO2_19, NOMO2_18, NOMO2_17, NOMO2_16, NOMO2_15, NOMO2_14, NOMO2_13, NOMO2_12, NOMO2_11, NOMO2_10@0@0@0@:NODAL modulator 2@:carbohydrate binding;protein binding;integral to membrane;carboxypeptidase activity;endoplasmic reticulum membrane@NA
F05506@143477@143477@deletion@1@21742159@21742251@16@chr16:21742159-21742251@5.01@161@97@0.602@CNVR6668.5, CNVR6668.2, CNVR6668.7@OTOA_20@0@0@0@:otoancorin@:proteinaceous extracellular matrix;apical plasma membrane;sensory perception of sound;anchored to membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22
F05506@144117@144118@duplication@2@28734486@28734872@16@chr16:28734486-28734872@6.29@748@970@1.3@CNVR6686.3, CNVR6686.2@EIF3C_9, EIF3C_10@0@0@0@:eukaryotic translation initiation factor 3, subunit C@:cytosol;protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;cellular protein metabolic process;binding;gene expression;translation;translation initiation factor activity@NA
F05506@147101@147101@deletion@1@70010292@70010635@16@chr16:70010292-70010635@14.3@65@0@0@CNVR6762.3, CNVR6762.2@RP11-419C5.2_7@0@0@0@NA@NA@NA
F05506@147121@147121@duplication@1@70180038@70180131@16@chr16:70180038-70180131@10.8@268@426@1.59@CNVR6764.1, CNVR6764.3@PDPR_16@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
F05506@147135@147135@deletion@1@70219789@70219879@16@chr16:70219789-70219879@10@55@6@0.109@CNVR6764.1, CNVR6764.5@CLEC18C_11@0@0@0@:C-type lectin domain family 18, member C@:carbohydrate binding;protein binding;extracellular region@NA
F05506@147423@147423@duplication@1@72097156@72097159@16@chr16:72097156-72097159@5.2@84@138@1.64@CNVR6769.1@HPR_1@0@0@0@:thioredoxin-like 4B:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@NA
F05506@149172@149172@duplication@1@2965964@2966901@17@chr17:2965964-2966901@5.51@595@797@1.34@NA@OR1D5_1@0@0@0@:olfactory receptor, family 1, subfamily D, member 5@:integral to membrane;sensory perception of smell;G-protein coupled receptor activity;plasma membrane;detection of chemical stimulus involved in sensory perception of smell;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F05506@151404@151404@duplication@1@15468848@15469578@17@chr17:15468848-15469578@4.79@907@1187@1.31@NA@CDRT1_1@0@0@0@:CMT1A duplicated region transcript 1@:protein binding;molecular_function;cellular_component;biological_process@NA
F05506@151556@151561@deletion@6@16664740@16676947@17@chr17:16664740-16676947@10.9@1159@814@0.702@NA@CCDC144A_13, CCDC144A_13, CCDC144A_14, CCDC144A_14, CCDC144A_15, CCDC144A_15, CCDC144A_16, CCDC144A_16, CCDC144A_17, CCDC144A_18, CCDC144A_17@0@0@0@:coiled-coil domain containing 144A@NA@NA
F05506@151874@151878@duplication@5@18291534@18391071@17@chr17:18291534-18391071@21.1@257@452@1.76@NA@EVPLL_10, LGALS9C_1, LGALS9C_2, LGALS9C_3, LGALS9C_4@0@0@0@:envoplakin-like:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
F05506@151883@151884@duplication@2@18395772@18396173@17@chr17:18395772-18396173@17.7@298@509@1.71@CNVR7014.1@LGALS9C_9, LGALS9C_10@0@0@0@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
F05506@151915@151915@deletion@1@18681789@18682611@17@chr17:18681789-18682611@5.86@761@523@0.687@NA@FBXW10_14@0@0@0@:F-box/WD repeat-containing protein 10-like;F-box and WD repeat domain containing 10@:protein binding@NA
F05506@151958@151961@deletion@4@18996506@19036052@17@chr17:18996506-19036052@48.1@237@2@0.00844@CNVR7018.2, CNVR7018.3, CNVR7018.1@AC007952.5_1, AC007952.5_2, GRAPL_1, GRAPL_2@0@0@0@:GRB2-related adaptor protein-like@:protein binding@NA
F05506@152122@152131@duplication@10@20353287@20363756@17@chr17:20353287-20363756@42.6@494@902@1.83@CNVR7021.1, CNVR7021.3@LGALS9B_11, LGALS9B_10, LGALS9B_9, LGALS9B_8, LGALS9B_7, LGALS9B_6, LGALS9B_5, LGALS9B_4, LGALS9B_3, LGALS9B_2@0@0@0@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
F05506@153380@153381@duplication@2@34539179@34539971@17@chr17:34539179-34539971@5.29@45@89@1.98@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1_2, CCL4L1_3@0@0@0@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
F05506@153397@153400@duplication@4@34625572@34641537@17@chr17:34625572-34641537@5.92@173@252@1.46@CNVR7077.1, CNVR7077.2, CNVR7077.12@CCL3L1_1, CCL4L2_1, CCL4L2_2, CCL4L2_3@0@0@0@:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
F05506@155587@155590@deletion@4@44399689@44409347@17@chr17:44399689-44409347@14@76@8@0.105@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
F05506@155593@155599@deletion@7@44414663@44592687@17@chr17:44414663-44592687@17.5@91@8@0.0879@CNVR7114.2, CNVR7114.1@LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane@NA
F05506@162019@162019@deletion@1@44554574@44556213@18@chr18:44554574-44556213@26.7@125@0@0@CNVR7319.1@TCEB3C_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C (elongin A3);RNA polymerase II transcription factor SIII subunit A3-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
F05506@167047@167047@duplication@1@14877791@14877921@19@chr19:14877791-14877921@5.95@105@170@1.62@NA@EMR2_6@0@0@0@:egf-like module containing, mucin-like, hormone receptor-like 2@:transmembrane signaling receptor activity;inflammatory response;G-protein coupled receptor activity;ruffle membrane;integral to membrane;plasma membrane;cell surface receptor signaling pathway;neuropeptide signaling pathway;granulocyte chemotaxis;cell migration;leading edge membrane;G-protein coupled receptor signaling pathway;protein binding;cell adhesion;membrane;calcium ion binding;chondroitin sulfate binding@NA
F05506@168952@168952@deletion@1@35862263@35863302@19@chr19:35862263-35863302@7.72@168@90@0.536@CNVR7627.1@GPR42_2@0@0@0@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
F05506@169062@169063@duplication@2@36168715@36168921@19@chr19:36168715-36168921@5.41@81@133@1.64@NA@UPK1A_6, UPK1A_7@0@0@0@:uroplakin 1A@:protein binding;integral to membrane;protein oligomerization;apical plasma membrane;endoplasmic reticulum;plasma membrane;protein homodimerization activity;monosaccharide binding;epithelial cell differentiation@NA
F05506@170096@170100@deletion@5@40373946@40382826@19@chr19:40373946-40382826@16.7@221@103@0.466@CNVR7639.2@FCGBP_26, FCGBP_25, FCGBP_24, FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F05506@170104@170109@duplication@6@40389653@40399855@19@chr19:40389653-40399855@11.4@416@580@1.39@CNVR7639.2, CNVR7639.3@FCGBP_18, FCGBP_17, FCGBP_16, FCGBP_15, FCGBP_14, FCGBP_13@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F05506@170373@170374@deletion@2@41386385@41387656@19@chr19:41386385-41387656@14@265@134@0.506@CNVR7642.1@CYP2A7_3, CYP2A7_2@0@0@0@:cytochrome P450, family 2, subfamily A, polypeptide 7@:oxidation-reduction process;electron carrier activity;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;oxygen binding;heme binding;monooxygenase activity;endoplasmic reticulum membrane;iron ion binding@NA
F05506@170376@170376@duplication@1@41397897@41397976@19@chr19:41397897-41397976@4.72@146@213@1.46@NA@CTC-490E21.12_2@0@0@0@NA@NA@NA
F05506@172988@172994@deletion@7@52133553@52149893@19@chr19:52133553-52149893@111@523@2@0.00382@CNVR7702.1@SIGLEC5_1, SIGLEC14_7, SIGLEC14_6, SIGLEC14_5, SIGLEC14_4, SIGLEC14_3, SIGLEC14_2@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 14@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion;plasma membrane@NA
F05506@173295@173296@deletion@2@54724399@54725251@19@chr19:54724399-54725251@39.4@188@0@0@CNVR7721.3, CNVR7721.4@LILRB3_6, LILRB3_5@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F05506@173298@173298@deletion@1@54726151@54726434@19@chr19:54726151-54726434@15.7@74@1@0.0135@CNVR7721.3, CNVR7721.4@LILRB3_3@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F05506@173499@173501@deletion@3@55358640@55359398@19@chr19:55358640-55359398@22.4@925@560@0.605@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4_6, KIR2DS4_7, KIR2DS4_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
F05506@174395@174395@deletion@1@1569207@1569278@20@chr20:1569207-1569278@8.48@38@0@0@CNVR7763.1@RP4-576H24.4_1@0@0@0@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
F05506@174402@174403@deletion@2@1876095@1896101@20@chr20:1876095-1896101@17.2@243@105@0.432@NA@SIRPA_1, SIRPA_2@0@0@0@:signal-regulatory protein alpha@:blood coagulation;protein binding;integral to membrane;SH3 domain binding;cell adhesion;plasma membrane;membrane;leukocyte migration@NA
F05506@181948@181955@duplication@8@24324820@24384231@22@chr22:24324820-24384231@18.4@670@949@1.42@CNVR8114.13, CNVR8114.1@GSTT2_3, GSTT2_4, GSTT2_5, GSTT1_5, GSTT1_4, GSTT1_3, GSTT1_2, GSTT1_1@0@0@0@:glutathione S-transferase theta 1@:protein binding;glutathione transferase activity;nucleus;cytoplasm:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
F05506@183633@183638@deletion@6@39358501@39385615@22@chr22:39358501-39385615@16.9@572@351@0.614@CNVR8164.1@APOBEC3A_6, APOBEC3B_1, APOBEC3B_2, APOBEC3B_3, APOBEC3B_4, APOBEC3B_5@0@0@0@:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A;APOBEC3A and APOBEC3B deletion hybrid:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B@:cytidine deamination;defense response to virus;negative regulation of viral genome replication;DNA cytosine deamination;clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine;catalytic activity;DNA demethylation;cytoplasm;innate immune response;cytidine deaminase activity;nucleus;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;cellular response to xenobiotic stimulus;zinc ion binding;negative regulation of transposition:RNA binding;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;negative regulation of transposition;catalytic activity;zinc ion binding@NA
F05506@184900@184901@deletion@2@50750773@50751054@22@chr22:50750773-50751054@8.71@259@153@0.591@NA@DENND6B_19, DENND6B_18@0@0@0@:DENN/MADD domain containing 6B@:Rab guanyl-nucleotide exchange factor activity@NA
F05506@4070@4071@deletion@2@101581178@101581428@X@chrX:101581178-101581428@21@94@0@0@NA@NXF2_33, NXF2_34@0@0@0@NA@NA@NA
F05506@4078@4079@deletion@2@101619967@101620252@X@chrX:101619967-101620252@6.03@26@0@0@NA@NXF2B_28, NXF2B_27@0@0@0@NA@NA@NA
F05506@4090@4091@deletion@2@101624508@101625073@X@chrX:101624508-101625073@6.03@26@0@0@NA@NXF2B_16, NXF2B_15@0@0@0@NA@NA@NA
F05506@4890@4891@deletion@2@119292922@119294309@X@chrX:119292922-119294309@9.93@127@59@0.465@NA@RHOXF2_2, RHOXF2_3@0@0@0@NA@NA@NA
F05506@6307@6307@deletion@1@153496018@153496256@X@chrX:153496018-153496256@9.85@44@0@0@CNVR8489.1@OPN1MW2_5@0@0@0@NA@NA@NA
F06341@6@6@deletion@1@69092@70008@1@chr1:69092-70008@8.81@41@1@0.0244@CNVR1.1, CNVR1.2@OR4F5_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F06341@2170@2182@deletion@13@17248515@17266588@1@chr1:17248515-17266588@18.1@1257@858@0.683@CNVR94.4, CNVR94.5, CNVR94.6@CROCC_1, CROCC_2, CROCC_3, CROCC_4, CROCC_5, CROCC_6, CROCC_7, CROCC_8, CROCC_9, CROCC_10, CROCC_11, CROCC_12, CROCC_13@0@0@0@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
F06341@2186@2187@deletion@2@17273257@17275019@1@chr1:17273257-17275019@5.06@152@93@0.612@CNVR94.4, CNVR94.5@CROCC_17, CROCC_18@0@0@0@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
F06341@3335@3339@duplication@5@25617133@25633220@1@chr1:25617133-25633220@11@657@880@1.34@CNVR116.1, CNVR116.2@RHD_3, RHD_4, RHD_5, RHD_6, RHD_7@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
F06341@5150@5150@duplication@1@39988076@39988154@1@chr1:39988076-39988154@9.54@71@151@2.13@NA@BMP8A_5@0@0@0@:bone morphogenetic protein 8a@:cell differentiation;growth factor activity;extracellular space;growth;cytokine activity;cartilage development;ossification@NA
F06341@5194@5194@deletion@1@40229385@40229463@1@chr1:40229385-40229463@14.5@74@5@0.0676@NA@BMP8B_5@0@0@0@:peptidylprolyl isomerase E (cyclophilin E):bone morphogenetic protein 8b@:regulation of transcription, DNA-dependent;nucleotide binding;catalytic step 2 spliceosome;protein folding;protein binding;protein peptidyl-prolyl isomerization;peptidyl-prolyl cis-trans isomerase activity;cyclosporin A binding;RNA binding;mRNA splicing, via spliceosome;nucleus;nucleic acid binding:cell differentiation;growth factor activity;extracellular space;growth;extracellular region;cytokine activity;cartilage development;skeletal system development;ossification@NA
F06341@8507@8508@duplication@2@89476588@89477710@1@chr1:89476588-89477710@15.5@509@751@1.48@CNVR244.1@GBP3_8, GBP3_7@0@0@0@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
F06341@9342@9366@duplication@25@104115686@104203298@1@chr1:104115686-104203298@31.4@876@1281@1.46@CNVR266.8, CNVR266.3, CNVR266.1@AMY2B_5, AMY2B_6, AMY2B_7, AMY2B_8, AMY2B_9, AMY2B_10, AMY2B_11, AMY2B_12, AMY2A_1, AMY2A_2, AMY2A_3, AMY2A_4, AMY2A_5, AMY2A_6, AMY2A_7, AMY2A_8, AMY2A_9, AMY2A_10, AMY1A_2, AMY1A_3, AMY1A_4, AMY1A_5, AMY1A_6, AMY1A_7, AMY1A_8@0@0@0@:actin, gamma 1 pseudogene 4;amylase, alpha 2B (pancreatic):amylase, alpha 2A (pancreatic):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:extracellular region;cation binding;digestion;carbohydrate metabolic process;catalytic activity;alpha-amylase activity;metal ion binding:chloride ion binding;cation binding;small molecule metabolic process;carbohydrate metabolic process;catalytic activity;extracellular space;polysaccharide digestion;extracellular region;carbohydrate catabolic process;alpha-amylase activity;calcium ion binding:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
F06341@9385@9386@deletion@2@104297122@104297436@1@chr1:104297122-104297436@47.5@305@47@0.154@CNVR266.3, CNVR266.5@AMY1C_6, AMY1C_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
F06341@9436@9436@deletion@1@108769302@108769515@1@chr1:108769302-108769515@6.72@62@22@0.355@CNVR294.4@NBPF4_14@0@0@0@:neuroblastoma breakpoint family, member 4@:cytoplasm@NA
F06341@9766@9773@deletion@8@110230497@110235917@1@chr1:110230497-110235917@76.2@351@2@0.0057@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
F06341@12117@12118@duplication@2@152573209@152586574@1@chr1:152573209-152586574@8.59@121@203@1.68@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
F06341@16026@16026@duplication@1@196712583@196712758@1@chr1:196712583-196712758@6.79@412@569@1.38@CNVR459.1@CFH_20@0@0@0@:complement factor H@:complement activation, alternative pathway;extracellular space;complement activation;extracellular region;regulation of complement activation;innate immune response@: HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1; MACULAR DEGENERATION, AGE-RELATED, 4; ARMD4; COMPLEMENT FACTOR H DEFICIENCY; CFHD; BASAL LAMINAR DRUSEN
F06341@16029@16031@duplication@3@196744018@196749103@1@chr1:196744018-196749103@7.66@345@473@1.37@CNVR459.1, CNVR459.3@CFHR3_1, CFHR3_2, CFHR3_3@0@0@0@:complement factor H-related 3@:extracellular space@NA
F06341@16034@16037@duplication@4@196762448@196796135@1@chr1:196762448-196796135@11.7@509@710@1.39@CNVR459.1@CFHR3_6, CFHR1_1, CFHR1_2, CFHR1_3@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
F06341@16039@16040@duplication@2@196799631@196801129@1@chr1:196799631-196801129@13.8@533@764@1.43@CNVR459.1@CFHR1_5, CFHR1_6@0@0@0@:complement factor H-related 1:complement factor H-related 2@:extracellular space;complement activation:extracellular region@NA
F06341@16049@16049@duplication@1@196884087@196884268@1@chr1:196884087-196884268@8.03@121@204@1.69@CNVR459.2@CFHR4_9@0@0@0@:complement factor H-related 2:complement factor H-related 4@:extracellular region:extracellular region;lipid transporter activity;lipid transport@NA
F06341@17286@17291@duplication@6@207718654@207726196@1@chr1:207718654-207726196@6.35@27@70@2.59@CNVR485.1@CR1_14, CR1_15, CR1_16, CR1_17, CR1_18, CR1_19@0@0@0@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
F06341@17294@17295@deletion@2@207737210@207737579@1@chr1:207737210-207737579@5.53@32@5@0.156@CNVR485.1, CNVR485.2@CR1_22, CR1_23@0@0@0@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
F06341@19579@19579@deletion@1@245006344@245006478@1@chr1:245006344-245006478@16.7@213@86@0.404@NA@COX20_4@0@0@0@:COX20 Cox2 chaperone homolog (S. cerevisiae)@:mitochondrion;integral to membrane;mitochondrial membrane@NA
F06341@19771@19771@deletion@1@248651891@248652837@1@chr1:248651891-248652837@8.63@119@54@0.454@NA@OR2T5_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F06341@19775@19776@deletion@2@248756132@248790429@1@chr1:248756132-248790429@26@1335@813@0.609@CNVR600.1@OR2T10_1, OR2T11_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 10:olfactory receptor, family 2, subfamily T, member 11@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F06341@24967@24969@duplication@3@89567759@89597316@2@chr2:89567759-89597316@6.61@122@190@1.56@CNVR866.7, CNVR866.1@IGKV1-33_2, IGKV1-33_1, IGKV1-37_2@0@0@0@@:protein binding:protein binding@NA
F06341@25097@25097@duplication@1@96604736@96604763@2@chr2:96604736-96604763@4.72@90@142@1.58@CNVR881.1, CNVR881.2@ANKRD36C_21@0@0@0@:ankyrin repeat domain-containing protein 36A-like@:ion channel inhibitor activity;protein binding@NA
F06341@25377@25384@deletion@8@97862331@97868130@2@chr2:97862331-97868130@10.4@445@286@0.643@CNVR886.1@ANKRD36_41, ANKRD36_42, ANKRD36_43, ANKRD36_44, ANKRD36_45, ANKRD36_46, ANKRD36_47, ANKRD36_48@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
F06341@25394@25394@deletion@1@97877407@97877478@2@chr2:97877407-97877478@6.05@297@190@0.64@CNVR886.1@ANKRD36_58@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
F06341@27211@27211@deletion@1@130955932@130955933@2@chr2:130955932-130955933@6.23@29@1@0.0345@CNVR985.1@TUBA3E_1@0@0@0@:tubulin, alpha 3e@:GTPase activity;structural constituent of cytoskeleton;protein complex;GTP catabolic process;cytoplasm;microtubule cytoskeleton;protein polymerization;microtubule-based movement;structural molecule activity;cytoplasmic microtubule;GTP binding;microtubule;microtubule cytoskeleton organization;protein domain specific binding@NA
F06341@39502@39502@deletion@1@62267239@62267384@3@chr3:62267239-62267384@6.95@183@105@0.574@NA@PTPRG_27@0@0@0@:protein tyrosine phosphatase, receptor type, G@:phosphatase activity;protein tyrosine phosphatase activity;protein dephosphorylation;protein binding;transmembrane receptor protein tyrosine kinase signaling pathway;dephosphorylation;integral to plasma membrane;identical protein binding;transmembrane receptor protein tyrosine phosphatase activity;peptidyl-tyrosine dephosphorylation@NA
F06341@44950@44950@deletion@1@185307903@185307957@3@chr3:185307903-185307957@5.18@49@18@0.367@NA@SENP2_2@0@0@0@:SUMO1/sentrin/SMT3 specific peptidase 2@:cysteine-type peptidase activity;nuclear body;mRNA transport;proteolysis;PML body;protein transport;Wnt receptor signaling pathway;positive regulation of transcription from RNA polymerase II promoter;SUMO-specific protease activity;negative regulation of chromatin binding;cytoplasm;negative regulation of protein binding;dorsal/ventral axis specification;regulation of protein metabolic process;nuclear membrane;protein binding;positive regulation of protein phosphorylation;regulation of Wnt receptor signaling pathway;protein desumoylation;heart development;nuclear pore;protein domain specific binding@NA
F06341@48592@48596@duplication@5@70146220@70156529@4@chr4:70146220-70156529@5.93@599@774@1.29@CNVR1957.2, CNVR1957.1@UGT2B28_1, UGT2B28_2, UGT2B28_3, UGT2B28_4, UGT2B28_5@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
F06341@48967@48967@deletion@1@75312252@75312499@4@chr4:75312252-75312499@6.32@73@31@0.425@NA@AREG_2@0@0@0@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
F06341@51672@51672@duplication@1@145041644@145041741@4@chr4:145041644-145041741@7.99@112@192@1.71@NA@GYPA_2@0@0@0@:glycophorin B (MNS blood group):glycophorin A (MNS blood group)@:integral to membrane;plasma membrane;integral to plasma membrane:external side of plasma membrane;integral to membrane;cytoskeletal anchoring at plasma membrane;plasma membrane;molecular_function;protein homodimerization activity;integral to plasma membrane;cellular_component;identical protein binding;membrane;biological_process;regulation of response to osmotic stress;virus-host interaction@: BLOOD GROUP--Ss LOCUS; Ss: MALARIA, SUSCEPTIBILITY TO; BLOOD GROUP--MN LOCUS; MN
F06341@53303@53305@duplication@3@716924@733954@5@chr5:716924-733954@10.9@842@1119@1.33@CNVR2280.3@ZDHHC11B_10, ZDHHC11B_9, ZDHHC11B_8@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
F06341@53308@53308@duplication@1@748520@748674@5@chr5:748520-748674@8.18@101@180@1.78@CNVR2280.3@ZDHHC11B_5@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
F06341@59065@59065@deletion@1@140557617@140560021@5@chr5:140557617-140560021@27@1636@906@0.554@CNVR2624.1@PCDHB8_1@0@0@0@:protocadherin beta 8@:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding@NA
F06341@60877@60878@deletion@2@175388277@175392158@5@chr5:175388277-175392158@6.45@112@60@0.536@NA@THOC3_4, THOC3_3@0@0@0@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
F06341@60882@60889@duplication@8@175487236@175525561@5@chr5:175487236-175525561@7.28@177@261@1.47@NA@RP11-826N14.2_2, FAM153B_3, FAM153B_4, FAM153B_5, FAM153B_6, FAM153B_7, FAM153B_8@0@0@0@:uncharacterized LOC100507387;family with sequence similarity 153, member B@NA@NA
F06341@61288@61289@deletion@2@177473874@177474122@5@chr5:177473874-177474122@5.01@202@129@0.639@NA@FAM153C_10, FAM153C_11@0@0@0@NA@NA@NA
F06341@61638@61641@duplication@4@180375356@180377544@5@chr5:180375356-180377544@7.56@550@726@1.32@CNVR2719.1@BTNL8_5, BTNL8_6, BTNL8_7, BTNL8_8@0@0@0@:butyrophilin-like 8@:protein binding;integral to membrane@NA
F06341@62773@62773@duplication@1@26637574@26638781@6@chr6:26637574-26638781@7.58@598@818@1.37@NA@ZNF322_4@0@0@0@:zinc finger protein 322@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;cytoplasm@NA
F06341@63768@63773@deletion@6@31994761@31996309@6@chr6:31994761-31996309@14.4@165@70@0.424@CNVR2843.6, CNVR2843.5@C4B_20, C4B_21, C4B_22, C4B_23, C4B_24, C4B_25@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
F06341@63790@63810@duplication@21@32006201@32011906@6@chr6:32006201-32011906@25.7@1331@1795@1.35@CNVR2843.6, CNVR2843.5@CYP21A2_1, CYP21A2_2, CYP21A2_3, CYP21A2_4, CYP21A2_5, CYP21A2_6, CYP21A2_7, CYP21A2_8, CYP21A2_9, CYP21A2_10, TNXB_13, TNXB_12, TNXB_11, TNXB_10, TNXB_9, TNXB_8, TNXB_7, TNXB_6, TNXB_5, TNXB_4, TNXB_3@0@0@0@:cytochrome P450, family 21, subfamily A, polypeptide 2:tenascin-X-like;tenascin XB@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
F06341@63953@63958@deletion@6@32485517@32498001@6@chr6:32485517-32498001@51.7@317@53@0.167@CNVR2845.21, CNVR2845.25, CNVR2845.30, CNVR2845.43, CNVR2845.6@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2, HLA-DRB5_1@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
F06341@63962@63965@deletion@4@32549335@32605317@6@chr6:32549335-32605317@7.17@364@240@0.659@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.34@HLA-DRB1_3, HLA-DRB1_2, HLA-DRB1_1, HLA-DQA1_1@0@0@0@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
F06341@63973@63973@duplication@1@32632576@32632844@6@chr6:32632576-32632844@8.33@118@203@1.72@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20, CNVR2845.31@HLA-DQB1_2@0@0@0@:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
F06341@71030@71030@deletion@1@167790035@167790192@6@chr6:167790035-167790192@5.29@32@6@0.188@NA@TCP10_5@0@0@0@:t-complex 10@:cytosol@NA
F06341@71751@71752@duplication@2@5951493@5952585@7@chr7:5951493-5952585@6.38@182@264@1.45@NA@CCZ1_9, CCZ1_10@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F06341@71764@71766@duplication@3@5982956@5984809@7@chr7:5982956-5984809@10.6@302@440@1.46@NA@RSPH10B_14, RSPH10B_13, RSPH10B_12@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F06341@71773@71780@duplication@8@6000323@6022622@7@chr7:6000323-6022622@18.5@356@553@1.55@NA@RSPH10B_5, RSPH10B_4, RSPH10B_3, RSPH10B_2, PMS2_15, PMS2_14, PMS2_13, PMS2_12@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas):PMS2 postmeiotic segregation increased 2 (S. cerevisiae)@:response to drug;DNA binding;MutSalpha complex binding;ATP binding;mismatch repair;DNA repair;mismatched DNA binding;ATPase activity;nucleus;mismatch repair complex;reciprocal meiotic recombination;ATP catabolic process;single-stranded DNA binding;response to DNA damage stimulus;single base insertion or deletion binding;protein binding;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;MutLalpha complex;endonuclease activity@: COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4; MISMATCH REPAIR CANCER SYNDROME
F06341@71922@71925@deletion@4@6797310@6803732@7@chr7:6797310-6803732@9.1@233@138@0.592@NA@RSPH10B2_2, RSPH10B2_3, RSPH10B2_4, RSPH10B2_5@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F06341@71932@71934@deletion@3@6819242@6821107@7@chr7:6819242-6821107@19.1@251@111@0.442@NA@RSPH10B2_12, RSPH10B2_13, RSPH10B2_14@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F06341@71939@71939@deletion@1@6836200@6836397@7@chr7:6836200-6836397@4.91@42@14@0.333@NA@RSPH10B2_19@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F06341@71941@71942@deletion@2@6838856@6840706@7@chr7:6838856-6840706@10.3@54@5@0.0926@NA@CCZ1B_15, CCZ1B_14@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F06341@73260@73263@duplication@4@38388957@38393784@7@chr7:38388957-38393784@8.85@875@1137@1.3@CNVR3354.3, CNVR3354.1@TRGV5_2, TRGV5_1, TRGV4_2, TRGV4_1@0@0@0@@:protein binding:protein binding@NA
F06341@74775@74775@deletion@1@76063356@76063472@7@chr7:76063356-76063472@7.93@76@27@0.355@CNVR3462.1@ZP3_5@0@0@0@:zona pellucida glycoprotein 3 (sperm receptor)@:negative regulation of transcription, DNA-dependent;manganese ion transmembrane transporter activity;intracellular protein transport;proteinaceous extracellular matrix;plasma membrane;positive regulation of acrosome reaction;outer acrosomal membrane;protein kinase C signaling cascade;manganese ion transmembrane transport;intracellular signal transduction;humoral immune response mediated by circulating immunoglobulin;negative regulation of binding of sperm to zona pellucida;positive regulation of inflammatory response;endoplasmic reticulum;signal transducer activity;perinuclear region of cytoplasm;secretory granule;positive regulation of transcription, DNA-dependent;positive regulation of ovarian follicle development;positive regulation of interferon-gamma production;carbohydrate binding;manganese ion transport;positive regulation of antral ovarian follicle growth;extracellular matrix;positive regulation of leukocyte migration;positive regulation of humoral immune response;extracellular space;blastocyst formation;integral to membrane;store-operated calcium channel activity;oocyte development;multivesicular body;phosphatidylinositol-mediated signaling;acrosomal vesicle;positive regulation of protein kinase B signaling cascade;Golgi apparatus;positive regulation of calcium ion import;positive regulation of protein kinase activity;positive regulation of acrosomal vesicle exocytosis;positive regulation of interleukin-4 production;cytoplasm;protein binding;binding of sperm to zona pellucida;positive regulation of phosphatidylinositol biosynthetic process;extracellular region;positive regulation of T cell proliferation;acrosin binding;positive regulation of type IV hypersensitivity;egg coat formation@NA
F06341@74793@74794@duplication@2@76241040@76247617@7@chr7:76241040-76247617@5.49@220@305@1.39@CNVR3463.10@POMZP3_5, POMZP3_4@0@0@0@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
F06341@76427@76432@deletion@6@100331793@100336236@7@chr7:100331793-100336236@27.3@861@515@0.598@CNVR3509.1@ZAN_1, ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
F06341@76765@76795@deletion@31@102235753@102319303@7@chr7:102235753-102319303@38.8@438@175@0.4@CNVR3518.1@RASA4_11, RASA4_10, RASA4_9, RASA4_8, RASA4_7, RASA4_6, RASA4_5, RASA4_4, RASA4_3, RASA4_2, UPK3BL_7, RASA4_1, UPK3BL_6, UPK3BL_6, UPK3BL_5, UPK3BL_5, UPK3BL_4, UPK3BL_4, UPK3BL_3, UPK3BL_3, UPK3BL_2, UPK3BL_2, UPK3BL_1, UPK3BL_1, SPDYE2L_2, SPDYE2L_3, SPDYE2L_4, SPDYE2L_5, SPDYE2L_6, SPDYE2L_7, SPDYE2L_8, POLR2J2_4, POLR2J2_4, POLR2J2_3, POLR2J2_3, POLR2J2_2, POLR2J2_2, POLR2J2_1, POLR2J2_1, AC105052.1_3, AC105052.1_2, AC105052.1_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2:WBSCR19-like protein 3;speedy homolog E6 (Xenopus laevis)@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
F06341@79312@79324@deletion@13@143955790@144071982@7@chr7:143955790-144071982@54.6@1669@922@0.552@CNVR3598.4@OR2A7_1, CTAGE8_1, OR2A1_1, ARHGEF5_2, ARHGEF5_3, ARHGEF5_4, ARHGEF5_5, ARHGEF5_6, ARHGEF5_7, ARHGEF5_8, ARHGEF5_9, ARHGEF5_10, ARHGEF5_11@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor, family 2, subfamily A, member 7:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
F06341@80388@80388@deletion@1@7637545@7637611@8@chr8:7637545-7637611@7.05@32@0@0@CNVR3772.4, CNVR3772.6, CNVR3772.2, CNVR3772.8, CNVR3772.10@AC084121.16_3@0@0@0@:uncharacterized LOC100133251@NA@NA
F06341@80402@80402@deletion@1@7718169@7718245@8@chr8:7718169-7718245@23@128@13@0.102@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@SPAG11A_3@0@0@0@:sperm associated antigen 11A;sperm associated antigen 11B@:extracellular region;defense response@NA
F06341@88582@88594@deletion@13@43133231@43818184@9@chr9:43133231-43818184@52.9@356@73@0.205@NA@ANKRD20A3_1, AL513478.1_1, SPATA31A6_4, SPATA31A6_1, CNTNAP3B_1, CNTNAP3B_2, CNTNAP3B_3, CNTNAP3B_4, CNTNAP3B_5, CNTNAP3B_6, CNTNAP3B_7@0@0@0@:coiled-coil domain-containing protein 29-like;ankyrin repeat domain 20 family, member A3:SPATA31 subfamily A, member 6:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding:integral to membrane:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
F06341@93193@93194@deletion@2@135945849@135947151@9@chr9:135945849-135947151@35.6@770@384@0.499@CNVR4502.1@CEL_10, CEL_11@0@0@0@:carboxyl ester lipase (bile salt-stimulated lipase)@:intestinal lipid catabolic process;pancreatic juice secretion;catalytic activity;extracellular space;heparin binding;sterol esterase activity;carboxylesterase activity;metabolic process;ceramide catabolic process;hydrolase activity;small molecule metabolic process;acylglycerol lipase activity;lipid metabolic process;cytoplasm;protein esterification;cytosol;retinyl-palmitate esterase activity;fatty acid catabolic process;extracellular region;triglyceride lipase activity;lipid digestion;triglyceride metabolic process;cholesterol catabolic process;intestinal cholesterol absorption@: MATURITY-ONSET DIABETES OF THE YOUNG; MODY; MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION;
F06341@94608@94613@duplication@6@5018044@5038057@10@chr10:5018044-5038057@8.43@256@365@1.43@NA@AKR1C1_8, AKR1C1_9, AKR1C2_9, AKR1C2_8, AKR1C2_7, AKR1C2_6@0@0@0@:aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase):aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III);aldo-keto reductase family 1 member C2-like@:trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity;bile acid and bile salt transport;oxidation-reduction process;phenanthrene 9,10-monooxygenase activity;indanol dehydrogenase activity;daunorubicin metabolic process;carboxylic acid binding;retinal metabolic process;response to organophosphorus;cholesterol homeostasis;ketosteroid monooxygenase activity;progesterone metabolic process;oxidoreductase activity;17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity;aldo-keto reductase (NADP) activity;digestion;androsterone dehydrogenase (B-specific) activity;doxorubicin metabolic process;alditol:NADP+ 1-oxidoreductase activity;bile acid binding;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;bile acid metabolic process;xenobiotic metabolic process;cytosol;protein homooligomerization;intestinal cholesterol absorption;cellular response to jasmonic acid stimulus:trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity;steroid metabolic process;oxidation-reduction process;phenanthrene 9,10-monooxygenase activity;prostaglandin F receptor activity;daunorubicin metabolic process;carboxylic acid binding;ketosteroid monooxygenase activity;progesterone metabolic process;oxidoreductase activity;digestion;positive regulation of cell proliferation;prostaglandin metabolic process;doxorubicin metabolic process;response to prostaglandin stimulus;positive regulation of protein kinase B signaling cascade;alditol:NADP+ 1-oxidoreductase activity;androsterone dehydrogenase (A-specific) activity;bile acid binding;G-protein coupled receptor signaling pathway;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;cytoplasm;cellular response to jasmonic acid stimulus@: 46,XY SEX REVERSAL 8; SRXY8
F06341@95389@95393@deletion@5@18138509@18152611@10@chr10:18138509-18152611@29.6@144@5@0.0347@NA@MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F06341@95410@95411@deletion@2@18196464@18198276@10@chr10:18196464-18198276@5.3@67@31@0.463@NA@MRC1_28, MRC1_29@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F06341@96463@96463@duplication@1@46552470@46552531@10@chr10:46552470-46552531@5.06@3@34@11.3@CNVR4712.3@PTPN20A_9@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
F06341@96572@96579@deletion@8@48020451@48049021@10@chr10:48020451-48049021@11.9@392@243@0.62@CNVR4715.2@ASAH2C_10, ASAH2C_9, ASAH2C_8, ASAH2C_7, ASAH2C_6, ASAH2C_5, ASAH2C_4, ASAH2C_3@0@0@0@@:ceramidase activity;sphingolipid metabolic process@NA
F06341@96850@96852@duplication@3@51246188@51374428@10@chr10:51246188-51374428@5.43@66@114@1.73@NA@AGAP8_1, TIMM23B_1, TIMM23B_2@0@0@0@:ArfGAP with GTPase domain, ankyrin repeat and PH domain 8:translocase of inner mitochondrial membrane 23 homolog B (yeast)@:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process@NA
F06341@96900@96914@deletion@15@51847036@51877818@10@chr10:51847036-51877818@10.5@49@1@0.0204@NA@FAM21A_8, FAM21A_9, FAM21A_10, FAM21A_11, FAM21A_12, FAM21A_13, FAM21A_14, FAM21A_15, FAM21A_16, FAM21A_17, FAM21A_18, FAM21A_19, FAM21A_20, FAM21A_21, FAM21A_22@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
F06341@96932@96937@duplication@6@51965743@51978390@10@chr10:51965743-51978390@24.7@136@319@2.35@NA@ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
F06341@97302@97303@deletion@2@69750662@69750956@10@chr10:69750662-69750956@6.82@414@279@0.674@NA@HERC4_13, HERC4_12@0@0@0@:HECT and RLD domain containing E3 ubiquitin protein ligase 4@:ubiquitin-protein ligase activity;cell differentiation;intracellular;protein ubiquitination involved in ubiquitin-dependent protein catabolic process;cytoplasm;cytosol;spermatogenesis;cellular protein modification process;nucleus@NA
F06341@101607@101614@deletion@8@124343839@124353114@10@chr10:124343839-124353114@29.9@853@507@0.594@CNVR4912.4, CNVR4912.3, CNVR4912.2@DMBT1_14, DMBT1_15, DMBT1_16, DMBT1_17, DMBT1_18, DMBT1_19, DMBT1_20, DMBT1_21@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
F06341@103139@103139@deletion@1@3239175@3240043@11@chr11:3239175-3240043@13.2@367@202@0.55@CNVR5028.1@MRGPRG_1@0@0@0@:MAS-related GPR, member G@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway@NA
F06341@103342@103342@deletion@1@5798891@5799864@11@chr11:5798891-5799864@6.37@674@460@0.682@CNVR5049.1@OR52N5_1@0@0@0@:tripartite motif containing 5:olfactory receptor, family 52, subfamily N, member 5@:defense response to virus;Golgi apparatus;intracellular;protein trimerization;ligase activity;cytoplasm;protein binding;nucleus;protein homodimerization activity;identical protein binding;zinc ion binding;cytoplasmic mRNA processing body;protein ubiquitination;virus-host interaction:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F06341@106038@106040@deletion@3@55032377@55035848@11@chr11:55032377-55035848@30.5@144@2@0.0139@CNVR5178.5@TRIM48_2, TRIM48_3, TRIM48_4@0@0@0@:tripartite motif containing 48@:protein binding;intracellular;zinc ion binding@NA
F06341@106046@106048@duplication@3@55370918@55419315@11@chr11:55370918-55419315@17@2208@2919@1.32@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F06341@110120@110126@duplication@7@89608779@89774718@11@chr11:89608779-89774718@11.9@308@459@1.49@NA@TRIM64B_1, TRIM49C_3, TRIM49C_4, TRIM49C_5, TRIM49C_6, TRIM49C_7, TRIM49C_8@0@0@0@:tripartite motif containing 64;tripartite motif containing 64C;tripartite motif containing 64B:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;zinc ion binding:protein binding;intracellular;DNA binding;zinc ion binding@NA
F06341@114093@114105@duplication@13@8048094@8088630@12@chr12:8048094-8088630@58.5@2741@3805@1.39@CNVR5421.1@NANOGP1_2, NANOGP1_3, NANOGP1_4, SLC2A3_10, SLC2A3_9, SLC2A3_8, SLC2A3_7, SLC2A3_6, SLC2A3_5, SLC2A3_4, SLC2A3_3, SLC2A3_2, SLC2A3_1@0@0@0@:NECAP endocytosis associated 1:solute carrier family 2 (facilitated glucose transporter), member 3@:coated pit;protein binding;endocytosis;protein transport;clathrin vesicle coat;plasma membrane;membrane:sequence-specific DNA binding;nucleus;DNA binding;regulation of transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity:substrate-specific transmembrane transporter activity;transport;glucose transmembrane transporter activity;transmembrane transport;integral to membrane;transmembrane transporter activity;plasma membrane;hexose transport;glucose transport;small molecule metabolic process;folic acid binding;carbohydrate metabolic process;L-ascorbic acid metabolic process;reduced folate carrier activity;water-soluble vitamin metabolic process;vitamin metabolic process;membrane@NA
F06341@114468@114469@duplication@2@11034835@11035297@12@chr12:11034835-11035297@14.3@126@249@1.98@NA@PRH1_4, PRH1_3@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):proline-rich protein HaeIII subfamily 1@:extracellular space;visual perception:protein binding;extracellular space@NA
F06341@114483@114483@deletion@1@11243900@11244828@12@chr12:11243900-11244828@5.27@947@669@0.706@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
F06341@115344@115345@deletion@2@27648614@27655054@12@chr12:27648614-27655054@15.4@260@130@0.5@CNVR5465.1@C12orf70_8, C12orf70_9@0@0@0@:chromosome 12 open reading frame 70@:integral to membrane@NA
F06341@131032@131033@duplication@2@74004127@74008399@14@chr14:74004127-74008399@9.37@279@411@1.47@CNVR6188.1, CNVR6188.4@ACOT1_1, ACOT1_2@0@0@0@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
F06341@133349@133351@duplication@3@106090814@106091716@14@chr14:106090814-106091716@43.5@338@734@2.17@CNVR6294.46, CNVR6294.20, CNVR6294.54, CNVR6294.43, CNVR6294.50, CNVR6294.61@IGHG4_4, IGHG4_3, IGHG4_2@0@0@0@@:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response@NA
F06341@133432@133435@duplication@4@106539080@106552729@14@chr14:106539080-106552729@5.96@441@578@1.31@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1@0@0@0@@:protein binding:protein binding@NA
F06341@133458@133463@duplication@6@106791006@106816173@14@chr14:106791006-106816173@43.1@1062@1688@1.59@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-30_2, IGHV3-30_1, IGHV4-31_2, IGHV4-31_1, IGHV3-33_2, IGHV3-33_1@0@0@0@@:protein binding:protein binding:protein binding@NA
F06341@133491@133492@deletion@2@107095127@107095561@14@chr14:107095127-107095561@13.5@70@6@0.0857@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61_2, IGHV4-61_1@0@0@0@@:protein binding@NA
F06341@133541@133542@deletion@2@22368577@22383423@15@chr15:22368577-22383423@75.3@3776@1915@0.507@CNVR6297.4, CNVR6297.17, CNVR6297.2@OR4M2_1, OR4N4_1@0@0@0@:olfactory receptor, family 4, subfamily M, member 2:olfactory receptor, family 4, subfamily N, member 4@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F06341@135680@135681@duplication@2@43873201@43873586@15@chr15:43873201-43873586@7.41@483@651@1.35@CNVR6365.1@PPIP5K1_10, PPIP5K1_9@0@0@0@:diphosphoinositol pentakisphosphate kinase 1@:inositol hexakisphosphate 3-kinase activity;inositol hexakisphosphate 1-kinase activity;inositol metabolic process;diphosphoinositol-pentakisphosphate kinase activity;ATP binding;acid phosphatase activity;cytoplasm;cytosol;inositol hexakisphosphate 5-kinase activity;nucleus;kinase activity;inositol-1,3,4,5,6-pentakisphosphate kinase activity@NA
F06341@135712@135712@deletion@1@43903118@43903182@15@chr15:43903118-43903182@6.7@157@88@0.561@CNVR6365.1@STRC_14@0@0@0@:diphosphoinositol pentakisphosphate kinase 1:stereocilin@:inositol hexakisphosphate 3-kinase activity;inositol hexakisphosphate 1-kinase activity;inositol metabolic process;diphosphoinositol-pentakisphosphate kinase activity;ATP binding;acid phosphatase activity;cytoplasm;cytosol;inositol hexakisphosphate 5-kinase activity;nucleus;kinase activity;inositol-1,3,4,5,6-pentakisphosphate kinase activity:detection of mechanical stimulus involved in sensory perception of sound;stereocilium bundle tip;stereocilium;cell surface;kinocilium;auditory receptor cell stereocilium organization@: DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16; DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY
F06341@143003@143003@deletion@1@18542789@18542929@16@chr16:18542789-18542929@6.68@167@95@0.569@NA@NOMO2_13@0@0@0@:NODAL modulator 2@:carbohydrate binding;protein binding;integral to membrane;carboxypeptidase activity;endoplasmic reticulum membrane@NA
F06341@144555@144555@duplication@1@30393847@30393863@16@chr16:30393847-30393863@4.7@61@105@1.72@NA@SEPT1_2@0@0@0@:zinc finger protein 48:septin 1@:nucleus;intracellular;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:protein binding;septin complex;GTP binding;GTPase activity;cell cycle;cell division;microtubule organizing center@NA
F06341@145564@145564@deletion@1@55866917@55866967@16@chr16:55866917-55866967@4.9@96@52@0.542@NA@CES1_1@0@0@0@:carboxylesterase 1;liver carboxylesterase 1-like@:hydrolase activity;methyl salicylate esterase activity;response to toxin;methylumbelliferyl-acetate deacetylase activity;endoplasmic reticulum lumen;retinyl-palmitate esterase activity;methyl jasmonate esterase activity;metabolic process;carboxylesterase activity;methyl indole-3-acetate esterase activity@: CARBOXYLESTERASE 1; CES1
F06341@146406@146407@duplication@2@67211914@67212407@16@chr16:67211914-67212407@5.8@317@429@1.35@NA@KIAA0895L_7, KIAA0895L_6@0@0@0@:KIAA0895-like@NA@NA
F06341@147099@147102@duplication@4@69996880@70012015@16@chr16:69996880-70012015@8.8@114@194@1.7@CNVR6762.3, CNVR6762.1@CLEC18A_11, CLEC18A_12, RP11-419C5.2_7, RP11-419C5.2_6@0@0@0@:C-type lectin domain family 18, member A@:carbohydrate binding;protein binding;extracellular region@NA
F06341@147110@147119@deletion@10@70162688@70177561@16@chr16:70162688-70177561@75.7@2792@1679@0.601@CNVR6764.1, CNVR6764.3@PDPR_5, PDPR_6, PDPR_7, PDPR_8, PDPR_9, PDPR_10, PDPR_11, PDPR_12, PDPR_13, PDPR_14@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
F06341@147123@147127@deletion@5@70187295@70211383@16@chr16:70187295-70211383@33.9@1381@795@0.576@CNVR6764.1@PDPR_18, PDPR_19, CLEC18C_1, CLEC18C_2, CLEC18C_3@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit:C-type lectin domain family 18, member C@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix:carbohydrate binding;protein binding;extracellular region@NA
F06341@147418@147420@duplication@3@72090430@72092254@16@chr16:72090430-72092254@5.27@70@117@1.67@CNVR6769.1, CNVR6769.2@HP_3, HP_4, HP_5@0@0@0@:thioredoxin-like 4B:haptoglobin:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:cellular iron ion homeostasis;negative regulation of oxidoreductase activity;catalytic activity;negative regulation of hydrogen peroxide catabolic process;positive regulation of cell death;haptoglobin-hemoglobin complex;extracellular space;proteolysis;response to hydrogen peroxide;extracellular region;hemoglobin binding;defense response;serine-type endopeptidase activity:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@: ANHAPTOGLOBINEMIA; AHP
F06341@147497@147512@deletion@16@74415415@74447574@16@chr16:74415415-74447574@42.3@516@215@0.417@CNVR6778.2, CNVR6778.3@NPIPL2_2, NPIPL2_3, NPIPL2_4, NPIPL2_5, NPIPL2_6, NPIPL2_7, CLEC18B_13, CLEC18B_12, CLEC18B_11, CLEC18B_10, CLEC18B_9, CLEC18B_8, CLEC18B_7, CLEC18B_6, CLEC18B_5, CLEC18B_4@0@0@0@:C-type lectin domain family 18, member B@:extracellular region:carbohydrate binding;protein binding;extracellular region@NA
F06341@147618@147620@duplication@3@75239232@75239890@16@chr16:75239232-75239890@5.76@22@61@2.77@NA@CTRB2_5, CTRB2_4, CTRB2_3@0@0@0@:chymotrypsinogen B2@:extracellular space;proteolysis;extracellular region;digestion;extracellular matrix organization;catalytic activity;serine-type endopeptidase activity;extracellular matrix disassembly@NA
F06341@149172@149172@deletion@1@2965964@2966901@17@chr17:2965964-2966901@6.7@519@346@0.667@NA@OR1D5_1@0@0@0@:olfactory receptor, family 1, subfamily D, member 5@:integral to membrane;sensory perception of smell;G-protein coupled receptor activity;plasma membrane;detection of chemical stimulus involved in sensory perception of smell;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F06341@151558@151561@deletion@4@16667280@16676947@17@chr17:16667280-16676947@16.8@623@385@0.618@NA@CCDC144A_15, CCDC144A_15, CCDC144A_16, CCDC144A_16, CCDC144A_17, CCDC144A_18, CCDC144A_17@0@0@0@:coiled-coil domain containing 144A@NA@NA
F06341@151884@151884@duplication@1@18396012@18396173@17@chr17:18396012-18396173@4.78@54@97@1.8@CNVR7014.1@LGALS9C_10@0@0@0@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
F06341@152124@152124@duplication@1@20355109@20355196@17@chr17:20355109-20355196@5.18@91@146@1.6@CNVR7021.1, CNVR7021.3@LGALS9B_9@0@0@0@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
F06341@153380@153381@deletion@2@34539179@34539971@17@chr17:34539179-34539971@9.35@42@0@0@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1_2, CCL4L1_3@0@0@0@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
F06341@155587@155590@deletion@4@44399689@44409347@17@chr17:44399689-44409347@14.7@70@2@0.0286@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
F06341@156877@156878@duplication@2@57656834@57657240@17@chr17:57656834-57657240@8@99@172@1.74@NA@DHX40_9, DHX40_10@0@0@0@:DEAH (Asp-Glu-Ala-His) box polypeptide 40@:transport;helicase activity;intracellular;ATP-dependent helicase activity;nucleic acid binding;ATP binding@NA
F06341@166916@166917@duplication@2@14508471@14508747@19@chr19:14508471-14508747@5.83@101@160@1.58@NA@CD97_7, CD97_8@0@0@0@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
F06341@170098@170100@deletion@3@40376632@40382826@19@chr19:40376632-40382826@9.9@123@55@0.447@CNVR7639.2@FCGBP_24, FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F06341@170367@170367@duplication@1@41381599@41381779@19@chr19:41381599-41381779@8.01@131@217@1.66@CNVR7642.1@CYP2A7_9@0@0@0@:cytochrome P450, family 2, subfamily A, polypeptide 7@:oxidation-reduction process;electron carrier activity;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;oxygen binding;heme binding;monooxygenase activity;endoplasmic reticulum membrane;iron ion binding@NA
F06341@170399@170399@deletion@1@41627863@41628038@19@chr19:41627863-41628038@5.37@120@67@0.558@CNVR7644.1@CYP2F1_6@0@0@0@:cytochrome P450, family 2, subfamily F, polypeptide 1@:trichloroethylene metabolic process;oxidation-reduction process;aromatase activity;response to toxin;oxygen binding;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;endoplasmic reticulum membrane;naphthalene metabolic process;intracellular membrane-bounded organelle;electron carrier activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;heme binding;xenobiotic metabolic process;monooxygenase activity;iron ion binding@NA
F06341@172989@172994@deletion@6@52146609@52149893@19@chr19:52146609-52149893@22.2@474@264@0.557@CNVR7702.1@SIGLEC14_7, SIGLEC14_6, SIGLEC14_5, SIGLEC14_4, SIGLEC14_3, SIGLEC14_2@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 14@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion;plasma membrane@NA
F06341@173298@173300@deletion@3@54726151@54726848@19@chr19:54726151-54726848@15.3@125@39@0.312@CNVR7721.3, CNVR7721.4@LILRB3_3, LILRB3_2, LILRB3_1@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F06341@173467@173474@duplication@8@55263102@55290114@19@chr19:55263102-55290114@27.1@1025@1454@1.42@CNVR7725.2, CNVR7725.1@KIR2DL3_6, KIR2DL3_7, KIR2DL3_8, KIR2DL1_1, KIR2DL1_2, KIR2DL1_3, KIR2DL1_4, KIR2DL1_5@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
F06341@173497@173498@deletion@2@55350884@55354373@19@chr19:55350884-55354373@5.85@185@112@0.605@CNVR7725.1, CNVR7725.6@KIR2DS4_4, KIR2DS4_5@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
F06341@174395@174395@deletion@1@1569207@1569278@20@chr20:1569207-1569278@8.2@37@0@0@CNVR7763.1@RP4-576H24.4_1@0@0@0@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
F06341@175736@175738@deletion@3@26061801@29623254@20@chr20:26061801-29623254@6.77@201@122@0.607@NA@NA@0@500@0@:protein FRG1-like@NA@NA
F06341@181805@181807@deletion@3@23241695@23247205@22@chr22:23241695-23247205@9.21@455@300@0.659@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11@IGLJ2_1, IGLC2_1, IGLJ3_1@0@0@0@@:protein binding@NA
F06341@181948@181949@deletion@2@24324820@24325235@22@chr22:24324820-24325235@5.57@49@17@0.347@CNVR8114.6, CNVR8114.13, CNVR8114.8, CNVR8114.14@GSTT2_3, GSTT2_4@0@0@0@@:protein binding;glutathione transferase activity;nucleus;cytoplasm@NA
F06341@181951@181955@duplication@5@24376424@24384231@22@chr22:24376424-24384231@23.2@540@820@1.52@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTT1_5, GSTT1_4, GSTT1_3, GSTT1_2, GSTT1_1@0@0@0@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
F06341@182140@182143@duplication@4@25747767@25756059@22@chr22:25747767-25756059@20.7@778@1106@1.42@CNVR8120.1@LRP5L_6, LRP5L_5, LRP5L_4, LRP5L_3@0@0@0@:low density lipoprotein receptor-related protein 5-like@:Wnt-activated receptor activity;Wnt-protein binding;Wnt receptor signaling pathway involved in dorsal/ventral axis specification;canonical Wnt receptor signaling pathway@NA
F06341@183631@183633@duplication@3@39357393@39358514@22@chr22:39357393-39358514@7.15@140@216@1.54@CNVR8164.1@APOBEC3A_4, APOBEC3A_5, APOBEC3A_6@0@0@0@:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A;APOBEC3A and APOBEC3B deletion hybrid@:cytidine deamination;defense response to virus;negative regulation of viral genome replication;DNA cytosine deamination;clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine;catalytic activity;DNA demethylation;cytoplasm;innate immune response;cytidine deaminase activity;nucleus;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;cellular response to xenobiotic stimulus;zinc ion binding;negative regulation of transposition@NA
F06341@2247@2247@deletion@1@49192694@49192818@X@chrX:49192694-49192818@6.4@34@4@0.118@CNVR8331.1@GAGE13_4@0@0@0@NA@NA@NA
F06341@3356@3356@deletion@1@70812388@70812420@X@chrX:70812388-70812420@6.33@67@28@0.418@NA@ACRC_3@0@0@0@NA@NA@NA
F06341@3358@3358@duplication@1@70814597@70814629@X@chrX:70814597-70814629@4.92@89@139@1.56@NA@ACRC_5@0@0@0@NA@NA@NA
F06341@4884@4884@deletion@1@119210843@119211253@X@chrX:119210843-119211253@7.51@102@49@0.48@NA@RHOXF2B_2@0@0@0@NA@NA@NA
F06341@6294@6297@deletion@4@153453260@153459138@X@chrX:153453260-153459138@10.4@109@44@0.404@CNVR8489.1@OPN1MW_2, OPN1MW_3, OPN1MW_4, OPN1MW_5@0@0@0@NA@NA@NA
F07191@2170@2171@deletion@2@17248515@17249293@1@chr1:17248515-17249293@11.2@730@479@0.656@CNVR94.4, CNVR94.5, CNVR94.6@CROCC_1, CROCC_2@0@0@0@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
F07191@2176@2181@deletion@6@17256925@17265637@1@chr1:17256925-17265637@12.5@409@252@0.616@CNVR94.4, CNVR94.5@CROCC_7, CROCC_8, CROCC_9, CROCC_10, CROCC_11, CROCC_12@0@0@0@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
F07191@3334@3339@deletion@6@25611065@25633220@1@chr1:25611065-25633220@26.4@919@570@0.62@CNVR116.1, CNVR116.2@RHD_2, RHD_3, RHD_4, RHD_5, RHD_6, RHD_7@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
F07191@3357@3357@duplication@1@25735175@25735360@1@chr1:25735175-25735360@11@114@214@1.88@CNVR117.1@RHCE_2@0@0@0@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
F07191@5196@5197@deletion@2@40235375@40240128@1@chr1:40235375-40240128@17.4@368@190@0.516@NA@OXCT2_1, BMP8B_3@0@0@0@:bone morphogenetic protein 8b:3-oxoacid CoA transferase 2@:cell differentiation;growth factor activity;extracellular space;growth;extracellular region;cytokine activity;cartilage development;skeletal system development;ossification:mitochondrion;microtubule-based flagellum;CoA-transferase activity;ketone body catabolic process;3-oxoacid CoA-transferase activity;metabolic process@NA
F07191@8507@8508@duplication@2@89476588@89477710@1@chr1:89476588-89477710@8.73@550@737@1.34@CNVR244.1@GBP3_8, GBP3_7@0@0@0@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
F07191@9365@9374@deletion@10@104202983@104234232@1@chr1:104202983-104234232@27.3@124@0@0@CNVR266.3, CNVR266.1, CNVR266.15@AMY1A_7, AMY1A_8, AMY1A_9, AMY1A_10, AMY1A_11, AMY1B_11, AMY1B_10, AMY1B_9, AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
F07191@9385@9386@duplication@2@104297122@104297436@1@chr1:104297122-104297436@35.4@320@670@2.09@CNVR266.3, CNVR266.5@AMY1C_6, AMY1C_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
F07191@9766@9773@deletion@8@110230497@110235917@1@chr1:110230497-110235917@74.4@345@4@0.0116@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
F07191@10684@10685@duplication@2@120539621@120548211@1@chr1:120539621-120548211@12.9@612@851@1.39@CNVR319.3, CNVR319.2@NOTCH2_4, NOTCH2_3@0@0@0@:notch 2@:nucleoplasm;negative regulation of apoptotic process;cell differentiation;negative regulation of cell proliferation;pulmonary valve morphogenesis;atrial septum morphogenesis;stem cell maintenance;placenta blood vessel development;placenta development;bone remodeling;induction of apoptosis;tissue regeneration;plasma membrane;nucleus;endoplasmic reticulum membrane;gene expression;cell fate determination;in utero embryonic development;Notch receptor processing;humoral immune response;inflammatory response to antigenic stimulus;embryonic limb morphogenesis;hemopoiesis;membrane;calcium ion binding;Notch signaling involved in heart development;nervous system development;Golgi membrane;morphogenesis of an epithelial sheet;integral to membrane;interleukin-4 secretion;cell cycle arrest;receptor activity;integral to plasma membrane;organ morphogenesis;determination of left/right symmetry;transcription initiation from RNA polymerase II promoter;multicellular organismal development;cell growth;regulation of transcription, DNA-dependent;positive regulation of Ras protein signal transduction;protein binding;regulation of developmental process;Notch signaling pathway;extracellular region;cell surface;positive regulation of apoptotic process@: ALAGILLE SYNDROME 2; ALGS2; HAJDU-CHENEY SYNDROME; HJCYS
F07191@12117@12118@duplication@2@152573209@152586574@1@chr1:152573209-152586574@11.2@136@238@1.75@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
F07191@12566@12569@deletion@4@154919894@154920842@1@chr1:154919894-154920842@41.3@775@398@0.514@NA@PBXIP1_9, PBXIP1_8, PBXIP1_7, PBXIP1_6@0@0@0@:pre-B-cell leukemia homeobox interacting protein 1@:multicellular organismal development;cell differentiation;intracellular membrane-bounded organelle;DNA binding;transcription corepressor activity;negative regulation of transcription, DNA-dependent;cytoplasm;cytosol;protein binding;nucleus;microtubule@NA
F07191@14053@14054@deletion@2@161565346@161594429@1@chr1:161565346-161594429@17.9@539@318@0.59@CNVR383.1@FCGR2C_1, FCGR3B_5@0@0@0@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene):Fc fragment of IgG, low affinity IIIb, receptor (CD16b)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction:IgG binding;protein binding;extracellular region;immune response;plasma membrane;anchored to membrane@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
F07191@14057@14058@deletion@2@161600159@161600992@1@chr1:161600159-161600992@6.36@307@201@0.655@CNVR383.1@FCGR3B_2, FCGR3B_1@0@0@0@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIIb, receptor (CD16b)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction:IgG binding;protein binding;extracellular region;immune response;plasma membrane;anchored to membrane@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
F07191@16030@16032@deletion@3@196748293@196757528@1@chr1:196748293-196757528@5.34@411@283@0.689@CNVR459.1@CFHR3_2, CFHR3_3, CFHR3_4@0@0@0@:complement factor H-related 3@:extracellular space@NA
F07191@16036@16040@deletion@5@196794608@196801129@1@chr1:196794608-196801129@34.7@985@588@0.597@CNVR459.1@CFHR1_2, CFHR1_3, CFHR1_4, CFHR1_5, CFHR1_6@0@0@0@:complement factor H-related 1:complement factor H-related 2@:extracellular space;complement activation:extracellular region@NA
F07191@19777@19777@deletion@1@248801589@248802559@1@chr1:248801589-248802559@16.5@78@2@0.0256@NA@OR2T35_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 35@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F07191@24979@25015@deletion@37@89923730@90260248@2@chr2:89923730-90260248@322@4671@2140@0.458@CNVR867.10@IGKV1D-37_2, IGKV1D-33_1, IGKV1D-33_2, IGKV2D-30_1, IGKV2D-30_2, IGKV2D-29_1, IGKV2D-29_2, IGKV2D-28_1, IGKV2D-28_2, IGKV2D-26_1, IGKV2D-26_2, IGKV2D-24_1, IGKV2D-24_2, IGKV6D-21_1, IGKV6D-21_2, IGKV3D-20_1, IGKV3D-20_2, IGKV6D-41_1, IGKV6D-41_2, IGKV1D-17_1, IGKV1D-17_2, IGKV1D-16_1, IGKV1D-16_2, IGKV3D-15_1, IGKV3D-15_2, IGKV1D-13_1, IGKV1D-13_2, IGKV1D-12_1, IGKV1D-12_2, IGKV3D-11_1, IGKV3D-11_2, IGKV1D-42_1, IGKV1D-42_2, IGKV1D-43_1, IGKV1D-43_2, IGKV1D-8_1, IGKV1D-8_2@0@0@0@@:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding@NA
F07191@33399@33401@deletion@3@233245334@233246077@2@chr2:233245334-233246077@6.23@281@185@0.658@NA@ALPP_8, ALPP_9, ALPP_10@0@0@0@:alkaline phosphatase, placental@:phosphatase activity;catalytic activity;integral to membrane;plasma membrane;metabolic process;cell surface;anchored to membrane;alkaline phosphatase activity;metal ion binding@NA
F07191@33410@33412@duplication@3@233273415@233274158@2@chr2:233273415-233274158@5.53@130@192@1.48@NA@ALPPL2_8, ALPPL2_9, ALPPL2_10@0@0@0@:alkaline phosphatase, placental-like 2@:phosphatase activity;catalytic activity;phosphorylation;plasma membrane;metabolic process;membrane;anchored to membrane;alkaline phosphatase activity;metal ion binding@NA
F07191@48556@48561@deletion@6@69403344@69434202@4@chr4:69403344-69434202@204@1028@25@0.0243@CNVR1953.1@UGT2B17_6, UGT2B17_5, UGT2B17_4, UGT2B17_3, UGT2B17_2, UGT2B17_1@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
F07191@48966@48967@deletion@2@75311064@75312499@4@chr4:75311064-75312499@9.51@99@39@0.394@NA@AREG_1, AREG_2@0@0@0@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
F07191@53306@53308@deletion@3@741710@748674@5@chr5:741710-748674@28.1@302@125@0.414@CNVR2280.3@ZDHHC11B_7, ZDHHC11B_6, ZDHHC11B_5@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
F07191@53320@53320@duplication@1@840611@840765@5@chr5:840611-840765@5.16@357@480@1.34@CNVR2280.3, CNVR2280.8@ZDHHC11_5@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
F07191@55778@55783@deletion@6@68843758@68862452@5@chr5:68843758-68862452@16.3@234@112@0.479@CNVR2494.7, CNVR2494.46@OCLN_7, OCLN_8, OCLN_9, GTF2H2C_2, GTF2H2C_3, GTF2H2C_4@0@0@0@:occludin:general transcription factor IIH, polypeptide 2C;general transcription factor IIH, polypeptide 2D@:S-adenosylmethionine metabolic process;cell-cell junction organization;cellular component disassembly involved in execution phase of apoptosis;response to testosterone stimulus;tight junction;integral to membrane;cell junction;plasma membrane;apoptotic process;thiopurine S-methyltransferase activity;S-adenosylhomocysteine metabolic process;apical plasma membrane;protein complex assembly;cytosol;cell-cell junction;protein binding;structural molecule activity;response to organic cyclic compound;apicolateral plasma membrane:regulation of transcription, DNA-dependent;nucleotide-excision repair;DNA repair;core TFIIH complex;protein binding;nucleus;transcription, DNA-dependent;zinc ion binding@: BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;
F07191@55806@55806@duplication@1@69372349@69372398@5@chr5:69372349-69372398@10.8@130@234@1.8@CNVR2494.48, CNVR2494.39, CNVR2494.15, CNVR2494.18, CNVR2494.26, CNVR2494.43, CNVR2494.52, CNVR2494.28, CNVR2494.2, CNVR2494.36@SMN2_8@0@0@0@:survival of motor neuron 2, centromeric;survival of motor neuron 1, telomeric@:nucleoplasm;ncRNA metabolic process;Cajal body;RNA metabolic process;spliceosomal complex;cytoplasm;cytosol;protein binding;cell death;spliceosomal complex assembly;RNA binding;mRNA processing;nucleus;gene expression;spliceosomal snRNP assembly@: SPINAL MUSCULAR ATROPHY, TYPE II; SMA2; SPINAL MUSCULAR ATROPHY, TYPE I; SMA1; SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4; SPINAL MUSCULAR ATROPHY, TYPE III; SMA3
F07191@59065@59065@deletion@1@140557617@140560021@5@chr5:140557617-140560021@32.2@1775@979@0.552@CNVR2624.1@PCDHB8_1@0@0@0@:protocadherin beta 8@:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding@NA
F07191@59488@59488@deletion@1@147553798@147553933@5@chr5:147553798-147553933@31.8@148@0@0@CNVR2637.2, CNVR2637.1@SPINK14_3@0@0@0@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
F07191@60876@60877@deletion@2@175388055@175388437@5@chr5:175388055-175388437@7.74@60@18@0.3@NA@THOC3_5, THOC3_4@0@0@0@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
F07191@61638@61645@deletion@8@180375356@180429785@5@chr5:180375356-180429785@33.9@1173@728@0.621@CNVR2719.1@BTNL8_5, BTNL8_6, BTNL8_7, BTNL8_8, BTNL3_1, BTNL3_2, BTNL3_3, BTNL3_4@0@0@0@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
F07191@63282@63282@deletion@1@31237988@31238262@6@chr6:31237988-31238262@16.8@198@79@0.399@CNVR2838.1@HLA-C_4@0@0@0@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
F07191@63296@63296@deletion@1@31379725@31380002@6@chr6:31379725-31380002@8.86@152@77@0.507@CNVR2842.1@MICA_4@0@0@0@:MHC class I polypeptide-related sequence A@:MHC class I protein complex;protein binding;regulation of immune response;antigen processing and presentation;immune response;plasma membrane;membrane@: PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO; PSORIASIS SUSCEPTIBILITY 1; PSORS1
F07191@63953@63961@deletion@9@32485517@32548633@6@chr6:32485517-32548633@59.6@530@185@0.349@CNVR2845.21, CNVR2845.25, CNVR2845.24@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2, HLA-DRB5_1, HLA-DRB1_6, HLA-DRB1_5, HLA-DRB1_4@0@0@0@:major histocompatibility complex, class II, DR beta 5:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
F07191@64058@64059@deletion@2@33048450@33053008@6@chr6:33048450-33053008@18.2@535@313@0.585@CNVR2846.4, CNVR2846.3@HLA-DPB1_2, HLA-DPB1_3@0@0@0@:major histocompatibility complex, class II, DP alpha 1:major histocompatibility complex, class II, DP beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;cellular response to interferon-gamma;membrane;trans-Golgi network membrane:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
F07191@64061@64061@deletion@1@33053997@33054015@6@chr6:33053997-33054015@14.8@127@39@0.307@CNVR2846.4, CNVR2846.3, CNVR2846.5@HLA-DPB1_5@0@0@0@:major histocompatibility complex, class II, DP beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
F07191@64602@64606@deletion@5@35754776@35765065@6@chr6:35754776-35765065@19.8@1216@808@0.664@CNVR2861.1@CLPSL1_2, CLPSL1_3, CLPS_3, CLPS_2, CLPS_1@0@0@0@:colipase-like 1:colipase, pancreatic@:extracellular region;enzyme activator activity;digestion;lipid catabolic process:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
F07191@71030@71030@duplication@1@167790035@167790192@6@chr6:167790035-167790192@5.8@30@72@2.4@NA@TCP10_5@0@0@0@:t-complex 10@:cytosol@NA
F07191@71756@71756@deletion@1@5963467@5963593@7@chr7:5963467-5963593@5.77@209@130@0.622@NA@CCZ1_14@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F07191@71772@71773@deletion@2@5998625@6000495@7@chr7:5998625-6000495@14.3@317@171@0.539@NA@RSPH10B_6, RSPH10B_5@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F07191@71926@71926@duplication@1@6805338@6805422@7@chr7:6805338-6805422@10.8@128@232@1.81@NA@RSPH10B2_6@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F07191@71941@71944@duplication@4@6838856@6844686@7@chr7:6838856-6844686@5.68@125@187@1.5@NA@CCZ1B_15, CCZ1B_14, CCZ1B_13, CCZ1B_12@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F07191@71948@71948@duplication@1@6854396@6854476@7@chr7:6854396-6854476@9.24@283@420@1.48@NA@CCZ1B_8@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F07191@73242@73242@deletion@1@38279626@38279767@7@chr7:38279626-38279767@6.35@44@11@0.25@NA@TRGC2_4@0@0@0@@:protein binding@NA
F07191@73260@73265@deletion@6@38388957@38398580@7@chr7:38388957-38398580@143@1430@542@0.379@CNVR3354.3, CNVR3354.1@TRGV5_2, TRGV5_1, TRGV4_2, TRGV4_1, TRGV3_2, TRGV3_1@0@0@0@@:protein binding:protein binding:protein binding;immune response;peptide antigen binding;plasma membrane;MHC protein binding@NA
F07191@74605@74607@deletion@3@74251403@74422230@7@chr7:74251403-74422230@8.36@38@0@0@NA@GTF2IRD2_2, GATSL1_1, GATSL1_2@0@0@0@:GTF2I repeat domain containing 2:GATS protein-like 1@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
F07191@74663@74664@duplication@2@75054919@75055735@7@chr7:75054919-75055735@4.94@84@134@1.6@NA@POM121C_9, POM121C_8@0@0@0@:POM121 transmembrane nucleoporin C@:nuclear membrane;protein binding;protein transport;endoplasmic reticulum membrane;nuclear pore;mRNA transport@NA
F07191@74781@74783@deletion@3@76121471@76129837@7@chr7:76121471-76129837@7.63@68@24@0.353@CNVR3462.1@DTX2_6, DTX2_7, DTX2_8@0@0@0@:deltex homolog 2 (Drosophila)@:ligase activity;cytoplasm;nuclear membrane;Notch signaling pathway;protein binding;nucleus;zinc ion binding;protein ubiquitination@NA
F07191@76427@76432@duplication@6@100331793@100336236@7@chr7:100331793-100336236@36.2@852@1304@1.53@CNVR3509.1@ZAN_1, ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
F07191@76718@76731@duplication@14@102114809@102136651@7@chr7:102114809-102136651@20.7@242@446@1.84@CNVR3518.1@POLR2J_3, POLR2J_2, POLR2J_1, RASA4B_21, RASA4B_20, RASA4B_19, RASA4B_18, RASA4B_17, RASA4B_16, RASA4B_15, RASA4B_14, RASA4B_13, RASA4B_12, RASA4B_11@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J, 13.3kDa:RAS p21 protein activator 4B@:nucleoplasm;DNA binding;DNA repair;protein dimerization activity;nucleus;viral reproduction;gene expression;transcription initiation from RNA polymerase II promoter;7-methylguanosine mRNA capping;protein phosphorylation;LRR domain binding;protein kinase activity;DNA-directed RNA polymerase II, core complex;nucleotide-excision repair;transcription from RNA polymerase II promoter;DNA-directed RNA polymerase activity;protein binding;transcription-coupled nucleotide-excision repair;RNA splicing;mRNA splicing, via spliceosome;transcription, DNA-dependent;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction@NA
F07191@76754@76754@duplication@1@102219880@102220243@7@chr7:102219880-102220243@14.1@66@174@2.64@CNVR3518.1@AC093668.1_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
F07191@79314@79315@deletion@2@144015219@144062916@7@chr7:144015219-144062916@9.59@311@191@0.614@CNVR3598.4, CNVR3598.5@OR2A1_1, ARHGEF5_2@0@0@0@:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
F07191@80371@80394@duplication@24@7308236@7680945@8@chr8:7308236-7680945@54.2@917@1520@1.66@NA@SPAG11B_3, SPAG11B_2, SPAG11B_1, DEFB104B_2, DEFB104B_1, DEFB106B_2, DEFB106B_1, DEFB105B_1, DEFB105B_2, DEFB105B_3, DEFB107B_1, DEFB107B_2, RP11-1118M6.1_1, RP11-1118M6.1_2, RP11-1118M6.1_3, RP11-1118M6.1_4, AC084121.16_4, AC084121.16_3, AC084121.16_2, AC084121.16_1, DEFB107A_2, DEFB107A_1, DEFB105A_3, DEFB105A_2@0@0@0@:sperm associated antigen 11B:defensin, beta 104A;defensin, beta 104B:defensin, beta 106B;defensin, beta 106A:defensin, beta 105B;defensin, beta 105A:defensin, beta 107B;defensin, beta 107A:uncharacterized LOC100133251:uncharacterized LOC100133251:defensin, beta 107B;defensin, beta 107A:defensin, beta 105B;defensin, beta 105A@:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
F07191@80398@80406@duplication@9@7694008@7752292@8@chr8:7694008-7752292@26.9@475@763@1.61@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@DEFB104A_1, DEFB104A_2, SPAG11A_1, SPAG11A_2, SPAG11A_3, SPAG11A_4, DEFB103A_1, DEFB103A_2, DEFB4A_1@0@0@0@:defensin, beta 104A;defensin, beta 104B:sperm associated antigen 11A;sperm associated antigen 11B:defensin, beta 103B;defensin, beta 103A:defensin, beta 4B;defensin, beta 4A@:extracellular region;defense response to bacterium:extracellular region;defense response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response@NA
F07191@80565@80565@duplication@1@11994678@11996269@8@chr8:11994678-11996269@5.61@32@73@2.28@CNVR3785.8, CNVR3785.5, CNVR3785.6, CNVR3785.2, CNVR3785.1, CNVR3785.3@USP17L2_1@0@0@0@:ubiquitin specific peptidase 17-like family member 1, pseudogene;ubiquitin specific peptidase 17-like family member 2;ubiquitin specific peptidase 17-like family member 4;ubiquitin specific peptidase 17-like family member 7;ubiquitin specific peptidase 17-like family member 8;ubiquitin specific peptidase 17-like family member 3@:protein deubiquitination;ubiquitin-specific protease activity;mitotic cell cycle G1/S transition checkpoint;nucleus;G2/M transition checkpoint;apoptotic process;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
F07191@80577@80577@duplication@1@12285167@12285315@8@chr8:12285167-12285315@6.26@7@46@6.57@CNVR3786.4, CNVR3786.16@FAM86B2_7@0@0@0@:family with sequence similarity 86, member B2@NA@NA
F07191@88584@88594@duplication@11@43624656@43818184@9@chr9:43624656-43818184@14.2@383@561@1.46@CNVR4294.1@SPATA31A6_4, SPATA31A6_3, SPATA31A6_2, SPATA31A6_1, CNTNAP3B_1, CNTNAP3B_2, CNTNAP3B_3, CNTNAP3B_4, CNTNAP3B_5, CNTNAP3B_6, CNTNAP3B_7@0@0@0@:SPATA31 subfamily A, member 6:contactin associated protein-like 3B;contactin associated protein-like 3@:integral to membrane:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
F07191@94604@94604@deletion@1@5010502@5010578@10@chr10:5010502-5010578@5.91@71@31@0.437@NA@AKR1C1_4@0@0@0@:aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)@:trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity;bile acid and bile salt transport;oxidation-reduction process;phenanthrene 9,10-monooxygenase activity;indanol dehydrogenase activity;daunorubicin metabolic process;carboxylic acid binding;retinal metabolic process;response to organophosphorus;cholesterol homeostasis;ketosteroid monooxygenase activity;progesterone metabolic process;oxidoreductase activity;17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity;aldo-keto reductase (NADP) activity;digestion;androsterone dehydrogenase (B-specific) activity;doxorubicin metabolic process;alditol:NADP+ 1-oxidoreductase activity;bile acid binding;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;bile acid metabolic process;xenobiotic metabolic process;cytosol;protein homooligomerization;intestinal cholesterol absorption;cellular response to jasmonic acid stimulus@NA
F07191@95346@95360@deletion@15@17813309@17908770@10@chr10:17813309-17908770@138@654@4@0.00612@NA@TMEM236_2, TMEM236_3, TMEM236_4, MRC1L1_1, MRC1L1_2, MRC1L1_3, MRC1L1_4, MRC1L1_5, MRC1L1_6, MRC1L1_7, MRC1L1_8, MRC1L1_9, MRC1L1_10, MRC1L1_11, MRC1L1_12@0@0@0@:transmembrane protein 236;transmembrane protein 236-like:macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding@NA
F07191@95380@95394@duplication@15@18060293@18155690@10@chr10:18060293-18155690@76.1@381@993@2.61@NA@TMEM236_2, TMEM236_3, TMEM236_4, MRC1_1, MRC1_2, MRC1_3, MRC1_4, MRC1_5, MRC1_6, MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11, MRC1_12@0@0@0@:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F07191@95952@95952@deletion@1@29747177@29747262@10@chr10:29747177-29747262@5.79@159@94@0.591@NA@SVIL_40@0@0@0@:supervillin@:podosome;actin cytoskeleton;invadopodium;cytoplasm;actin binding;actin filament binding;cell junction;nucleus;plasma membrane;cytoskeleton organization;skeletal muscle tissue development;costamere@NA
F07191@96472@96481@duplication@10@46961971@47087911@10@chr10:46961971-47087911@73.8@7123@9770@1.37@CNVR4712.9, CNVR4712.2, CNVR4712.7, CNVR4712.4@SYT15_8, SYT15_7, SYT15_6, SYT15_5, SYT15_4, SYT15_3, SYT15_2, GPRIN2_1, PPYR1_3@0@0@0@:synaptotagmin XV:G protein regulated inducer of neurite outgrowth 2:pancreatic polypeptide receptor 1;neuropeptide Y receptor type 4-like@:protein binding;synaptic vesicle;integral to membrane;transporter activity;plasma membrane;membrane;extrinsic to membrane:blood circulation;peptide YY receptor activity;peptide binding;pancreatic polypeptide receptor activity;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;integral to membrane;digestion;plasma membrane;integral to plasma membrane;feeding behavior@NA
F07191@96505@96531@duplication@27@47658500@47758904@10@chr10:47658500-47758904@81.7@3408@4843@1.42@NA@ANTXRL_1, ANTXRL_2, ANTXRL_3, ANTXRL_4, ANTXRL_5, ANTXRL_6, ANTXRL_7, ANTXRL_8, ANTXRL_9, ANTXRL_10, ANTXRL_11, ANTXRL_12, ANTXRL_13, ANTXRL_14, ANTXRL_15, ANTXRL_16, ANTXRL_17, ANXA8L2_1, ANXA8L2_2, ANXA8L2_3, ANXA8L2_4, ANXA8L2_5, ANXA8L2_6, ANXA8L2_7, ANXA8L2_8, ANXA8L2_9, ANXA8L2_10@0@0@0@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:protein binding;integral to membrane;receptor activity;metal ion binding:calcium-dependent phospholipid binding;calcium ion binding@NA
F07191@96932@96937@deletion@6@51965743@51978390@10@chr10:51965743-51978390@9.01@162@93@0.574@NA@ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
F07191@103269@103269@duplication@1@4976003@4976943@11@chr11:4976003-4976943@27.6@592@1036@1.75@CNVR5040.1@OR51A2_1@0@0@0@:matrix metallopeptidase 26:olfactory receptor, family 51, subfamily A, member 2@:metallopeptidase activity;extracellular matrix;proteolysis;proteinaceous extracellular matrix;collagen catabolic process;metalloendopeptidase activity;zinc ion binding;metabolic process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F07191@103289@103291@deletion@3@5270599@5274635@11@chr11:5270599-5274635@14.5@235@125@0.532@NA@HBG1_2, HBG1_1, HBG2_8@0@0@0@:hemoglobin, gamma A:hemoglobin, gamma G@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@: CYANOSIS, TRANSIENT NEONATAL; TNCY
F07191@103342@103342@duplication@1@5798891@5799864@11@chr11:5798891-5799864@11.1@675@947@1.4@CNVR5049.1@OR52N5_1@0@0@0@:tripartite motif containing 5:olfactory receptor, family 52, subfamily N, member 5@:defense response to virus;Golgi apparatus;intracellular;protein trimerization;ligase activity;cytoplasm;protein binding;nucleus;protein homodimerization activity;identical protein binding;zinc ion binding;cytoplasmic mRNA processing body;protein ubiquitination;virus-host interaction:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F07191@104444@104444@duplication@1@18288436@18288525@11@chr11:18288436-18288525@7.55@134@215@1.6@NA@SAA1_2@0@0@0@:serum amyloid A1@:regulation of protein secretion;platelet activation;neutrophil chemotaxis;negative regulation of inflammatory response;positive regulation of cytokine secretion;macrophage chemotaxis;positive regulation of cell adhesion;positive regulation of interleukin-1 secretion;extracellular region;lymphocyte chemotaxis;high-density lipoprotein particle;elevation of cytosolic calcium ion concentration;acute-phase response;G-protein coupled receptor binding@NA
F07191@106046@106048@duplication@3@55370918@55419315@11@chr11:55370918-55419315@23.3@2353@3152@1.34@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F07191@110122@110126@deletion@5@89769057@89774718@11@chr11:89769057-89774718@15.1@283@145@0.512@NA@TRIM49C_4, TRIM49C_5, TRIM49C_6, TRIM49C_7, TRIM49C_8@0@0@0@:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;DNA binding;zinc ion binding@NA
F07191@114483@114483@duplication@1@11243900@11244828@12@chr12:11243900-11244828@7.31@985@1303@1.32@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
F07191@114493@114496@deletion@4@11506042@11508487@12@chr12:11506042-11508487@32.8@636@331@0.52@CNVR5435.2, CNVR5435.1@PRB1_4, PRB1_3, PRB1_2, PRB1_1@0@0@0@:proline-rich protein BstNI subfamily 1@NA@NA
F07191@115537@115537@deletion@1@31249276@31249313@12@chr12:31249276-31249313@8.76@78@26@0.333@CNVR5483.1@DDX11_15@0@0@0@:DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11@:nucleoplasm;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;S phase of mitotic cell cycle;DNA binding;nucleobase-containing compound metabolic process;ATP binding;ATP-dependent DNA helicase activity;DNA helicase activity;midbody;RNA binding;DNA-dependent ATPase activity;nucleus;positive regulation of cell proliferation;virus-host interaction;nuclear chromatin;4 iron, 4 sulfur cluster binding;helicase activity;hydrolase activity, acting on acid anhydrides;DNA duplex unwinding;endoplasmic reticulum unfolded protein response;G2/M transition of mitotic cell cycle;protein binding;sister chromatid cohesion;activation of signaling protein activity involved in unfolded protein response;nucleolus;spindle pole;ATP-dependent helicase activity;metal ion binding;nucleic acid binding;mitotic sister chromatid segregation@: WARSAW BREAKAGE SYNDROME
F07191@116970@116970@deletion@1@51740408@51740422@12@chr12:51740408-51740422@8.11@123@60@0.488@NA@CELA1_1@0@0@0@:chymotrypsin-like elastase family, member 1@:inflammatory response;regulation of cell differentiation;exocrine pancreas development;digestive system development;catalytic activity;proteolysis;Wnt receptor signaling pathway;positive regulation of transcription from RNA polymerase II promoter;post-embryonic development;regulation of cell proliferation;multicellular organism growth;negative regulation of transcription from RNA polymerase II promoter;extracellular region;pancreas morphogenesis;metal ion binding;serine-type endopeptidase activity@NA
F07191@123374@123374@duplication@1@124496693@124497477@12@chr12:124496693-124497477@5.72@630@831@1.32@CNVR5712.1@ZNF664_6@0@0@0@:zinc finger protein 664@:intracellular;nucleus;DNA binding;molecular_function;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;biological_process@NA
F07191@127333@127335@duplication@3@19553418@19559164@14@chr14:19553418-19559164@6.84@79@138@1.75@CNVR6072.1@POTEG_1, POTEG_2, POTEG_3@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
F07191@131032@131034@duplication@3@74004127@74010359@14@chr14:74004127-74010359@49.4@449@932@2.08@CNVR6188.1, CNVR6188.4@ACOT1_1, ACOT1_2, ACOT1_3@0@0@0@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
F07191@133396@133396@deletion@1@106354410@106354436@14@chr14:106354410-106354436@7.13@134@71@0.53@CNVR6294.11, CNVR6294.27, CNVR6294.52, CNVR6294.39, CNVR6294.36, CNVR6294.48, CNVR6294.75@IGHD2-21_1@0@0@0@NA@NA@NA
F07191@133450@133451@duplication@2@106725202@106725654@14@chr14:106725202-106725654@13.8@797@1105@1.39@CNVR6294.48, CNVR6294.24, CNVR6294.40, CNVR6294.38, CNVR6294.17, CNVR6294.23@IGHV3-23_2, IGHV3-23_1@0@0@0@@:protein binding@NA
F07191@133458@133460@deletion@3@106791006@106805516@14@chr14:106791006-106805516@8.5@924@656@0.71@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-30_2, IGHV3-30_1, IGHV4-31_2@0@0@0@@:protein binding:protein binding@NA
F07191@133491@133492@duplication@2@107095127@107095561@14@chr14:107095127-107095561@15@78@194@2.49@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61_2, IGHV4-61_1@0@0@0@@:protein binding@NA
F07191@133495@133495@duplication@1@107131034@107131334@14@chr14:107131034-107131334@10@196@314@1.6@CNVR6294.56, CNVR6294.16@IGHV3-66_2@0@0@0@@:protein binding@NA
F07191@133499@133500@duplication@2@107178821@107179262@14@chr14:107178821-107179262@9.62@522@716@1.37@CNVR6294.6, CNVR6294.92@IGHV2-70_2, IGHV2-70_1@0@0@0@@:protein binding@NA
F07191@134023@134024@duplication@2@30699479@30700195@15@chr15:30699479-30700195@6.08@225@319@1.42@NA@GOLGA8R_12, GOLGA8R_11@0@0@0@@:Golgi apparatus@NA
F07191@139803@139803@deletion@1@90176052@90176227@15@chr15:90176052-90176227@8.95@137@66@0.482@NA@KIF7_14@0@0@0@:kinesin family member 7@:negative regulation of smoothened signaling pathway;microtubule motor activity;microtubule associated complex;cilium;ATP binding;positive regulation of smoothened signaling pathway;protein binding;microtubule-based movement;microtubule@: PALLISTER-HALL SYNDROME; PHS; ACROCALLOSAL SYNDROME; ACLS; BARDET-BIEDL SYNDROME; BBS; HYDROLETHALUS SYNDROME 2; HLS2
F07191@140317@140317@deletion@1@100348377@100348507@15@chr15:100348377-100348507@7.88@35@0@0@CNVR6545.2@CTD-2054N24.2_2@0@0@0@NA@NA@NA
F07191@143003@143003@deletion@1@18542789@18542929@16@chr16:18542789-18542929@10.5@192@98@0.51@NA@NOMO2_13@0@0@0@:NODAL modulator 2@:carbohydrate binding;protein binding;integral to membrane;carboxypeptidase activity;endoplasmic reticulum membrane@NA
F07191@144038@144039@duplication@2@28403074@28403463@16@chr16:28403074-28403463@16.4@149@290@1.95@CNVR6684.2@EIF3CL_10, EIF3CL_9@0@0@0@:eukaryotic translation initiation factor 3, subunit C-like@:protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;translation initiation factor activity@NA
F07191@144118@144118@deletion@1@28734770@28734872@16@chr16:28734770-28734872@11.1@246@133@0.541@CNVR6686.3, CNVR6686.2@EIF3C_10@0@0@0@:eukaryotic translation initiation factor 3, subunit C@:cytosol;protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;cellular protein metabolic process;binding;gene expression;translation;translation initiation factor activity@NA
F07191@144289@144290@deletion@2@29469250@29469445@16@chr16:29469250-29469445@5.13@37@10@0.27@CNVR6690.2, CNVR6690.3, CNVR6690.4@SLX1B_5, SLX1B_6@0@0@0@:structure-specific endonuclease subunit SLX1-like;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae);SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae):sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3;sulfotransferase 1A3/1A4-like@:Slx1-Slx4 complex;5'-flap endonuclease activity;DNA repair;protein binding;DNA double-strand break processing involved in repair via single-strand annealing;double-strand break repair via homologous recombination;metal ion binding;crossover junction endodeoxyribonuclease activity:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;cytoplasm;catecholamine metabolic process;cytosol;endoplasmic reticulum unfolded protein response;xenobiotic metabolic process;sulfotransferase activity;activation of signaling protein activity involved in unfolded protein response;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process@NA
F07191@147101@147102@deletion@2@70010292@70012015@16@chr16:70010292-70012015@16.5@77@1@0.013@CNVR6762.3, CNVR6762.2@RP11-419C5.2_7, RP11-419C5.2_6@0@0@0@NA@NA@NA
F07191@147110@147110@deletion@1@70162688@70162768@16@chr16:70162688-70162768@5.91@232@146@0.629@CNVR6764.1, CNVR6764.3@PDPR_5@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
F07191@147118@147121@deletion@4@70176457@70180131@16@chr16:70176457-70180131@6.64@948@676@0.713@CNVR6764.1, CNVR6764.3@PDPR_13, PDPR_14, PDPR_15, PDPR_16@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
F07191@147135@147135@deletion@1@70219789@70219879@16@chr16:70219789-70219879@9.92@58@9@0.155@CNVR6764.1, CNVR6764.5@CLEC18C_11@0@0@0@:C-type lectin domain family 18, member C@:carbohydrate binding;protein binding;extracellular region@NA
F07191@147513@147513@deletion@1@74451958@74452196@16@chr16:74451958-74452196@5.83@63@26@0.413@CNVR6778.2, CNVR6778.3@CLEC18B_3@0@0@0@:C-type lectin domain family 18, member B@:carbohydrate binding;protein binding;extracellular region@NA
F07191@151422@151422@deletion@1@15539351@15539583@17@chr17:15539351-15539583@6.83@187@110@0.588@NA@TRIM16_3, TRIM16_8@0@0@0@:tripartite motif containing 16@:protein binding;intracellular;zinc ion binding;cytoplasm:histone H4 acetylation;response to growth hormone stimulus;NACHT domain binding;DNA binding;positive regulation of keratinocyte differentiation;response to organophosphorus;interleukin-1 binding;PML body;positive regulation of interleukin-1 beta secretion;intracellular;regulation of transcription, DNA-dependent;response to retinoic acid;cytoplasm;positive regulation of transcription, DNA-dependent;protein binding;positive regulation of retinoic acid receptor signaling pathway;histone H3 acetylation;zinc ion binding;nucleic acid binding@NA
F07191@151898@151898@duplication@1@18630872@18631071@17@chr17:18630872-18631071@10.6@196@318@1.62@NA@TRIM16L_4@0@0@0@:tripartite motif containing 16-like@:protein binding;cytoplasm@NA
F07191@151958@151961@deletion@4@18996506@19036052@17@chr17:18996506-19036052@21.3@242@94@0.388@CNVR7018.2, CNVR7018.3, CNVR7018.1@AC007952.5_1, AC007952.5_2, GRAPL_1, GRAPL_2@0@0@0@:GRB2-related adaptor protein-like@:protein binding@NA
F07191@152179@152180@deletion@2@21730700@21731615@17@chr17:21730700-21731615@10.5@270@156@0.578@NA@UBBP4_1, UBBP4_2@0@0@0@@:protein binding@NA
F07191@153381@153381@deletion@1@34539885@34539971@17@chr17:34539885-34539971@6.33@28@0@0@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1_3@0@0@0@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
F07191@153650@153660@deletion@11@36351930@36398302@17@chr17:36351930-36398302@82.7@4337@2782@0.641@CNVR7083.3@RP11-1407O15.2_12, RP11-1407O15.2_11, RP11-1407O15.2_10, RP11-1407O15.2_9, RP11-1407O15.2_8, RP11-1407O15.2_7, RP11-1407O15.2_6, RP11-1407O15.2_5, RP11-1407O15.2_4, RP11-1407O15.2_3, RP11-1407O15.2_2@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
F07191@154346@154346@deletion@1@39421631@39422112@17@chr17:39421631-39422112@7.17@55@16@0.291@CNVR7096.1@KRTAP9-6_1@0@0@0@:keratin associated protein 9-6@:keratin filament@NA
F07191@155581@155581@deletion@1@44248222@44249509@17@chr17:44248222-44249509@10.5@1865@1286@0.69@CNVR7114.3, CNVR7114.2, CNVR7114.8@KANSL1_2@0@0@0@:KAT8 regulatory NSL complex subunit 1@:histone acetyltransferase activity (H4-K8 specific);histone acetyltransferase activity (H4-K16 specific);histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase complex;histone H4-K5 acetylation;MLL1 complex;histone H4-K16 acetylation;protein binding;histone H4-K8 acetylation;nucleus@NA
F07191@155587@155590@duplication@4@44399689@44409347@17@chr17:44399689-44409347@7.28@83@146@1.76@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
F07191@155593@155595@duplication@3@44414663@44415089@17@chr17:44414663-44415089@11.6@81@172@2.12@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_12, LRRC37A_13, LRRC37A_14@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
F07191@155604@155612@deletion@9@44617543@44632945@17@chr17:44617543-44632945@50@539@204@0.378@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2_7, LRRC37A2_8, LRRC37A2_9, LRRC37A2_10, LRRC37A2_11, LRRC37A2_12, LRRC37A2_13, LRRC37A2_14, LRRC37A2_15@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
F07191@166339@166339@deletion@1@12175690@12175691@19@chr19:12175690-12175691@8.93@175@93@0.531@NA@ZNF844_1@0@0@0@:zinc finger protein 844@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
F07191@167047@167047@duplication@1@14877791@14877921@19@chr19:14877791-14877921@6.42@106@172@1.62@NA@EMR2_6@0@0@0@:egf-like module containing, mucin-like, hormone receptor-like 2@:transmembrane signaling receptor activity;inflammatory response;G-protein coupled receptor activity;ruffle membrane;integral to membrane;plasma membrane;cell surface receptor signaling pathway;neuropeptide signaling pathway;granulocyte chemotaxis;cell migration;leading edge membrane;G-protein coupled receptor signaling pathway;protein binding;cell adhesion;membrane;calcium ion binding;chondroitin sulfate binding@NA
F07191@168952@168952@duplication@1@35862263@35863302@19@chr19:35862263-35863302@28.5@162@424@2.62@CNVR7627.1@GPR42_2@0@0@0@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
F07191@170092@170101@duplication@10@40366029@40384167@19@chr19:40366029-40384167@15.7@633@871@1.38@CNVR7639.2@FCGBP_30, FCGBP_29, FCGBP_28, FCGBP_27, FCGBP_26, FCGBP_25, FCGBP_24, FCGBP_23, FCGBP_22, FCGBP_21@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F07191@170367@170367@deletion@1@41381599@41381779@19@chr19:41381599-41381779@12.2@170@77@0.453@CNVR7642.1@CYP2A7_9@0@0@0@:cytochrome P450, family 2, subfamily A, polypeptide 7@:oxidation-reduction process;electron carrier activity;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;oxygen binding;heme binding;monooxygenase activity;endoplasmic reticulum membrane;iron ion binding@NA
F07191@170808@170820@duplication@13@43570710@43699425@19@chr19:43570710-43699425@42.7@2193@2994@1.37@CNVR7658.4, CNVR7658.5@PSG2_5, PSG2_4, PSG2_3, PSG2_2, PSG2_1, PSG5_5, PSG5_4, PSG5_3, PSG5_2, PSG5_1, PSG4_6, PSG4_5, PSG4_4@0@0@0@:pregnancy specific beta-1-glycoprotein 2:pregnancy specific beta-1-glycoprotein 5:pregnancy specific beta-1-glycoprotein 4@:protein binding;extracellular region;female pregnancy;cell migration;molecular_function;cellular_component:protein binding;extracellular region;female pregnancy:protein binding;extracellular region;female pregnancy;defense response@NA
F07191@170824@170826@deletion@3@43757762@43763287@19@chr19:43757762-43763287@11.7@255@143@0.561@CNVR7658.5, CNVR7658.1@PSG9_6, PSG9_5, PSG9_4@0@0@0@:pregnancy specific beta-1-glycoprotein 9@:protein binding;extracellular region;female pregnancy;defense response@NA
F07191@172428@172429@deletion@2@50213578@50214114@19@chr19:50213578-50214114@25.9@495@250@0.505@NA@CPT1C_15, CPT1C_16@0@0@0@:carnitine palmitoyltransferase 1C@:carnitine O-palmitoyltransferase activity;mitochondrial outer membrane;mitochondrion;integral to membrane;fatty acid beta-oxidation;carnitine metabolic process;transferase activity, transferring acyl groups;endoplasmic reticulum membrane@NA
F07191@172986@172987@deletion@2@52132612@52133469@19@chr19:52132612-52133469@10.3@106@43@0.406@CNVR7702.1@SIGLEC5_3, SIGLEC5_3, SIGLEC5_2, SIGLEC5_2@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion@NA
F07191@172989@172994@duplication@6@52146609@52149893@19@chr19:52146609-52149893@10.5@526@707@1.34@CNVR7702.1@SIGLEC14_7, SIGLEC14_6, SIGLEC14_5, SIGLEC14_4, SIGLEC14_3, SIGLEC14_2@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 14@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion;plasma membrane@NA
F07191@173294@173300@duplication@7@54724026@54726848@19@chr19:54724026-54726848@31.9@386@673@1.74@CNVR7721.3, CNVR7721.4@LILRB3_7, LILRB3_6, LILRB3_5, LILRB3_4, LILRB3_3, LILRB3_2, LILRB3_1@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F07191@173307@173308@deletion@2@54746372@54746600@19@chr19:54746372-54746600@6.14@118@64@0.542@CNVR7721.3, CNVR7721.6@LILRA6_2, LILRA6_1@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F07191@173468@173470@deletion@3@55263669@55281336@19@chr19:55263669-55281336@7.76@386@253@0.655@CNVR7725.2, CNVR7725.1@KIR2DL3_7, KIR2DL3_8, KIR2DL1_1@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
F07191@173478@173496@deletion@19@55315108@55349330@19@chr19:55315108-55349330@138@3317@1862@0.561@CNVR7725.1, CNVR7725.3, CNVR7725.6@KIR2DL4_1, KIR2DL4_2, KIR2DL4_3, KIR2DL4_4, KIR2DL4_5, KIR2DL4_6, KIR2DL4_7, KIR3DL1_1, KIR3DL1_2, KIR3DL1_3, KIR3DL1_4, KIR3DL1_5, KIR3DL1_6, KIR3DL1_7, KIR3DL1_8, KIR3DL1_9, KIR2DS4_1, KIR2DS4_2, KIR2DS4_3@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
F07191@173842@173842@duplication@1@56273168@56273452@19@chr19:56273168-56273452@13.9@166@304@1.83@CNVR7734.1@RFPL4A_2@0@0@0@:ret finger protein-like 4A;ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
F07191@173844@173844@deletion@1@56283172@56283456@19@chr19:56283172-56283456@17.8@278@127@0.457@CNVR7734.1@CTD-2611O12.2_2@0@0@0@:ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
F07191@173890@173890@deletion@1@56531742@56531797@19@chr19:56531742-56531797@6.19@255@161@0.631@NA@NLRP5_6@0@0@0@:NLR family, pyrin domain containing 5@:fertilization;mitochondrion;regulation of protein stability;regulation of RNA stability;embryo implantation;in utero embryonic development;protein complex;ATP binding;apical cortex;cell cortex;cytosol;protein binding;nucleolus;cellular protein complex assembly;organ morphogenesis@NA
F07191@174395@174395@deletion@1@1569207@1569278@20@chr20:1569207-1569278@10.6@48@0@0@CNVR7763.1@RP4-576H24.4_1@0@0@0@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
F07191@178997@178998@deletion@2@10941909@10942774@21@chr21:10941909-10942774@5.29@1334@976@0.732@CNVR7947.10, CNVR7947.6, CNVR7947.11@TPTE_14, TPTE_13@0@0@0@:transmembrane phosphatase with tensin homology@:phosphatase activity;ion channel activity;protein tyrosine phosphatase activity;ion transport;protein dephosphorylation;transmembrane transport;protein binding;signal transduction;integral to membrane;protein tyrosine/serine/threonine phosphatase activity;dephosphorylation;membrane;peptidyl-tyrosine dephosphorylation@NA
F07191@181487@181487@deletion@1@21065630@21065749@22@chr22:21065630-21065749@5.14@27@3@0.111@CNVR8099.6, CNVR8099.2@PI4KA_51@0@0@0@:phosphatidylinositol 4-kinase, catalytic, alpha@:phospholipid metabolic process;1-phosphatidylinositol 4-kinase activity;small molecule metabolic process;phosphatidylinositol phosphorylation;binding;transferase activity, transferring phosphorus-containing groups;phosphotransferase activity, alcohol group as acceptor;ATP binding;Golgi-associated vesicle;phosphatidylinositol biosynthetic process;cytosol;protein binding;signal transduction;synaptic transmission;kinase activity;phosphatidylinositol-mediated signaling@NA
F07191@181766@181767@deletion@2@22989225@22989508@22@chr22:22989225-22989508@9.02@84@30@0.357@CNVR8103.5, CNVR8103.2, CNVR8103.13@GGTLC2_2, GGTLC2_3@0@0@0@:gamma-glutamyltransferase light chain 2@:leukotriene biosynthetic process;glutathione metabolic process;gamma-glutamyltransferase activity;anchored to external side of plasma membrane@NA
F07191@181806@181808@deletion@3@23243157@23248831@22@chr22:23243157-23248831@15.1@374@209@0.559@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11@IGLC2_1, IGLJ3_1, IGLC3_1@0@0@0@@:protein binding:protein binding@NA
F07191@181948@181949@duplication@2@24324820@24325235@22@chr22:24324820-24325235@11.5@49@130@2.65@CNVR8114.6, CNVR8114.13, CNVR8114.8, CNVR8114.14@GSTT2_3, GSTT2_4@0@0@0@@:protein binding;glutathione transferase activity;nucleus;cytoplasm@NA
F07191@181951@181955@deletion@5@24376424@24384231@22@chr22:24376424-24384231@151@707@0@0@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTT1_5, GSTT1_4, GSTT1_3, GSTT1_2, GSTT1_1@0@0@0@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
F07191@184143@184151@deletion@9@42522577@42526793@22@chr22:42522577-42526793@45.2@997@561@0.563@CNVR8168.1, CNVR8168.3, CNVR8168.2@CYP2D6_9, CYP2D6_8, CYP2D6_7, CYP2D6_6, CYP2D6_5, CYP2D6_4, CYP2D6_3, CYP2D6_2, CYP2D6_1@0@0@0@:cytochrome P450, family 2, subfamily D, polypeptide 6@:oxidation-reduction process;mitochondrion;alkaloid catabolic process;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;drug catabolic process;endoplasmic reticulum membrane;response to organic substance;oxidative demethylation;endoplasmic reticulum;alkaloid metabolic process;negative regulation of binding;heme binding;xenobiotic metabolic process;dopamine metabolic process;steroid metabolic process;isoquinoline alkaloid metabolic process;arachidonic acid monooxygenase activity;arachidonic acid metabolic process;steroid 21-monooxygenase activity;negative regulation of cellular organofluorine metabolic process;oxidoreductase activity;monoterpenoid metabolic process;heterocycle metabolic process;drug binding;drug metabolic process;electron carrier activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;coumarin metabolic process@: DRUG METABOLISM, POOR, CYP2D6-RELATED
F07191@1889@1889@deletion@1@48244795@48244889@X@chrX:48244795-48244889@5.55@25@0@0@CNVR8324.2@SSX4_4@0@0@0@NA@NA@NA
F07191@1896@1896@duplication@1@48269422@48269516@X@chrX:48269422-48269516@4.62@14@44@3.14@CNVR8324.2@SSX4B_4@0@0@0@NA@NA@NA
F07191@4052@4071@deletion@20@101571921@101581428@X@chrX:101571921-101581428@23.9@108@0@0@NA@NXF2_15, NXF2_16, NXF2_17, NXF2_18, NXF2_19, NXF2_20, NXF2_21, NXF2_22, NXF2_23, NXF2_24, NXF2_25, NXF2_26, NXF2_27, NXF2_28, NXF2_29, NXF2_30, NXF2_31, NXF2_32, NXF2_33, NXF2_34@0@0@0@NA@NA@NA
F07191@4884@4884@deletion@1@119210843@119211253@X@chrX:119210843-119211253@6.43@29@0@0@NA@RHOXF2B_2@0@0@0@NA@NA@NA
F07191@6307@6307@deletion@1@153496018@153496256@X@chrX:153496018-153496256@11.4@51@0@0@CNVR8489.1@OPN1MW2_5@0@0@0@NA@NA@NA
F08196@442@442@deletion@1@1670362@1670496@1@chr1:1670362-1670496@5.15@81@38@0.469@CNVR17.1@SLC35E2_3@0@0@0@:solute carrier family 35, member E2@:integral to membrane;membrane@NA
F08196@1813@1818@duplication@6@12918866@12943215@1@chr1:12918866-12943215@9.98@378@535@1.42@CNVR72.3, CNVR72.4, CNVR72.7, CNVR72.12@PRAMEF2_2, PRAMEF2_3, PRAMEF2_4, PRAMEF4_4, PRAMEF4_3, PRAMEF4_2@0@0@0@:PRAME family member 2:PRAME family member 4@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
F08196@2289@2299@duplication@11@17594333@17609574@1@chr1:17594333-17609574@42.3@1538@2281@1.48@NA@PADI3_6, PADI3_7, PADI3_8, PADI3_9, PADI3_10, PADI3_11, PADI3_12, PADI3_13, PADI3_14, PADI3_15, PADI3_16@0@0@0@:peptidyl arginine deiminase, type III@:protein-arginine deiminase activity;nucleus;peptidyl-citrulline biosynthetic process from peptidyl-arginine;calcium ion binding;cytoplasm@NA
F08196@3334@3339@duplication@6@25611065@25633220@1@chr1:25611065-25633220@10.1@808@1095@1.36@CNVR116.1, CNVR116.2@RHD_2, RHD_3, RHD_4, RHD_5, RHD_6, RHD_7@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
F08196@3357@3357@deletion@1@25735175@25735360@1@chr1:25735175-25735360@17.3@84@1@0.0119@CNVR117.1@RHCE_2@0@0@0@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
F08196@8507@8508@deletion@2@89476588@89477710@1@chr1:89476588-89477710@8.84@473@294@0.622@CNVR244.1@GBP3_8, GBP3_7@0@0@0@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
F08196@9766@9773@deletion@8@110230497@110235917@1@chr1:110230497-110235917@63.3@293@0@0@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
F08196@11089@11097@duplication@9@145788768@145826929@1@chr1:145788768-145826929@16.5@679@971@1.43@NA@GPR89A_9, GPR89A_8, GPR89A_7, GPR89A_6, GPR89A_5, GPR89A_4, GPR89A_3, GPR89A_2, GPR89A_1@0@0@0@:G protein-coupled receptor 89A;G protein-coupled receptor 89B;Golgi pH regulator B-like@:Golgi-associated vesicle membrane;voltage-gated anion channel activity;regulation of anion transport;Golgi membrane;signal transducer activity;intracellular pH reduction;voltage-gated ion channel activity;positive regulation of I-kappaB kinase/NF-kappaB cascade;Golgi cisterna membrane;signal transduction;integral to membrane;protein transport@NA
F08196@12117@12118@deletion@2@152573209@152586574@1@chr1:152573209-152586574@21.4@99@0@0@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
F08196@16029@16040@deletion@12@196744018@196801129@1@chr1:196744018-196801129@30.5@1431@916@0.64@CNVR459.1@CFHR3_1, CFHR3_2, CFHR3_3, CFHR3_4, CFHR3_5, CFHR3_6, CFHR1_1, CFHR1_2, CFHR1_3, CFHR1_4, CFHR1_5, CFHR1_6@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
F08196@19777@19777@duplication@1@248801589@248802559@1@chr1:248801589-248802559@7.19@67@138@2.06@NA@OR2T35_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 35@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F08196@20131@20131@duplication@1@10091964@10091982@2@chr2:10091964-10091982@4.81@57@105@1.84@NA@GRHL1_1@0@0@0@:grainyhead-like 1 (Drosophila)@:nucleoplasm;multicellular organismal development;small molecule metabolic process;Golgi apparatus;DNA binding;regulation of transcription, DNA-dependent;cellular lipid metabolic process;cytoplasm;nucleus;transcription, DNA-dependent@NA
F08196@25115@25116@deletion@2@96652500@96652954@2@chr2:96652500-96652954@19.3@152@34@0.224@NA@ANKRD36C_3, ANKRD36C_2@0@0@0@:ankyrin repeat domain-containing protein 36A-like@:ion channel inhibitor activity;protein binding@NA
F08196@25398@25407@deletion@10@97881163@97911808@2@chr2:97881163-97911808@10.4@218@115@0.528@NA@ANKRD36_62, ANKRD36_63, ANKRD36_64, ANKRD36_65, ANKRD36_66, ANKRD36_67, ANKRD36_68, ANKRD36_69, ANKRD36_70, ANKRD36_71@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
F08196@30835@30835@duplication@1@198175303@198175328@2@chr2:198175303-198175328@5.09@120@191@1.59@NA@ANKRD44_1@0@0@0@:ankyrin repeat domain 44@:protein binding@NA
F08196@43918@43918@deletion@1@167758575@167758657@3@chr3:167758575-167758657@4.99@96@49@0.51@NA@GOLIM4_7@0@0@0@:golgi integral membrane protein 4@:endocytic vesicle;transport;Golgi apparatus;Golgi lumen;cis-Golgi network;Golgi cisterna membrane;endosome membrane;integral to membrane;nucleus@NA
F08196@47774@47774@deletion@1@47527575@47527659@4@chr4:47527575-47527659@5.19@260@159@0.612@NA@ATP10D_5@0@0@0@:ATPase, class V, type 10D@:cation transport;magnesium ion binding;catalytic activity;ATP binding;transmembrane transport;integral to membrane;plasma membrane;endoplasmic reticulum membrane;metabolic process;hydrolase activity;phospholipid-translocating ATPase activity;endoplasmic reticulum;hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances;nucleotide binding;ion transmembrane transport;phospholipid transport;phospholipid translocation;protein binding;membrane;ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism;metal ion binding@NA
F08196@48556@48561@deletion@6@69403344@69434202@4@chr4:69403344-69434202@147@801@7@0.00874@CNVR1953.1@UGT2B17_6, UGT2B17_5, UGT2B17_4, UGT2B17_3, UGT2B17_2, UGT2B17_1@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
F08196@48967@48969@deletion@3@75312252@75316249@4@chr4:75312252-75316249@5.48@78@37@0.474@NA@AREG_2, AREG_3, AREG_4@0@0@0@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
F08196@50233@50234@duplication@2@100870821@100871327@4@chr4:100870821-100871327@5.57@293@411@1.4@CNVR2017.1@H2AFZ_2, H2AFZ_1@0@0@0@:H2A histone family, member Z@:nucleus;protein heterodimerization activity;DNA binding;nucleosome assembly;nucleosome@NA
F08196@53303@53307@duplication@5@716924@745413@5@chr5:716924-745413@23.9@912@1380@1.51@CNVR2280.3@ZDHHC11B_10, ZDHHC11B_9, ZDHHC11B_8, ZDHHC11B_7, ZDHHC11B_6@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
F08196@53311@53312@duplication@2@756082@767067@5@chr5:756082-767067@10.7@214@374@1.75@CNVR2280.3@ZDHHC11B_2, ZDHHC11B_1@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
F08196@53318@53323@duplication@6@833889@848775@5@chr5:833889-848775@23.8@717@1161@1.62@CNVR2280.3, CNVR2280.8@ZDHHC11_7, ZDHHC11_6, ZDHHC11_5, ZDHHC11_4, ZDHHC11_3, ZDHHC11_2@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
F08196@60875@60877@deletion@3@175386973@175388437@5@chr5:175386973-175388437@7.2@123@63@0.512@NA@THOC3_6, THOC3_5, THOC3_4@0@0@0@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
F08196@61419@61421@duplication@3@178772192@178987199@5@chr5:178772192-178987199@5.33@196@278@1.42@NA@ADAMTS2_1, RUFY1_1, RUFY1_2@0@0@0@:ADAM metallopeptidase with thrombospondin type 1 motif, 2:RUN and FYVE domain containing 1@:metallopeptidase activity;skin development;extracellular matrix;collagen catabolic process;protein processing;extracellular matrix organization;collagen fibril organization;lung development;peptidase activity;proteolysis;spermatogenesis;extracellular region;proteinaceous extracellular matrix;metalloendopeptidase activity;zinc ion binding:endocytosis;cytoplasm;protein transporter activity;lipid binding;regulation of endocytosis;protein binding;protein transport;zinc ion binding;early endosome membrane;metal ion binding@: EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE
F08196@61638@61645@deletion@8@180375356@180429785@5@chr5:180375356-180429785@29.5@999@578@0.579@CNVR2719.1@BTNL8_5, BTNL8_6, BTNL8_7, BTNL8_8, BTNL3_1, BTNL3_2, BTNL3_3, BTNL3_4@0@0@0@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
F08196@63282@63282@duplication@1@31237988@31238262@6@chr6:31237988-31238262@5.18@145@224@1.54@CNVR2838.1@HLA-C_4@0@0@0@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
F08196@63725@63726@duplication@2@31962023@31962484@6@chr6:31962023-31962484@6.27@121@191@1.58@CNVR2843.6, CNVR2843.3@C4A_20, C4A_21@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
F08196@63768@63773@deletion@6@31994761@31996309@6@chr6:31994761-31996309@9.43@145@70@0.483@CNVR2843.6, CNVR2843.5@C4B_20, C4B_21, C4B_22, C4B_23, C4B_24, C4B_25@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
F08196@63791@63796@duplication@6@32006500@32007982@6@chr6:32006500-32007982@9.06@617@822@1.33@CNVR2843.6, CNVR2843.5@CYP21A2_2, CYP21A2_3, CYP21A2_4, CYP21A2_5, CYP21A2_6, CYP21A2_7@0@0@0@:cytochrome P450, family 21, subfamily A, polypeptide 2@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY
F08196@63808@63810@duplication@3@32011215@32011906@6@chr6:32011215-32011906@6.75@257@372@1.45@CNVR2843.6, CNVR2843.5@TNXB_5, TNXB_4, TNXB_3@0@0@0@:tenascin-X-like;tenascin XB@:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
F08196@63953@63958@deletion@6@32485517@32498001@6@chr6:32485517-32498001@48.2@275@31@0.113@CNVR2845.21, CNVR2845.25, CNVR2845.30, CNVR2845.43, CNVR2845.6@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2, HLA-DRB5_1@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
F08196@63962@63974@deletion@13@32549335@32634384@6@chr6:32549335-32634384@121@1233@421@0.341@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.34@HLA-DRB1_3, HLA-DRB1_2, HLA-DRB1_1, HLA-DQA1_1, HLA-DQA1_2, HLA-DQA1_3, HLA-DQA1_4, HLA-DQB1_6, HLA-DQB1_5, HLA-DQB1_4, HLA-DQB1_3, HLA-DQB1_2, HLA-DQB1_1@0@0@0@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
F08196@64602@64606@deletion@5@35754776@35765065@6@chr6:35754776-35765065@9.2@966@664@0.687@CNVR2861.1@CLPSL1_2, CLPSL1_3, CLPS_3, CLPS_2, CLPS_1@0@0@0@:colipase-like 1:colipase, pancreatic@:extracellular region;enzyme activator activity;digestion;lipid catabolic process:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
F08196@71754@71756@deletion@3@5959481@5963593@7@chr7:5959481-5963593@15.5@286@135@0.472@NA@CCZ1_12, CCZ1_13, CCZ1_14@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F08196@71772@71776@deletion@5@5998625@6006747@7@chr7:5998625-6006747@34.2@385@143@0.371@NA@RSPH10B_6, RSPH10B_5, RSPH10B_4, RSPH10B_3, RSPH10B_2@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F08196@71922@71927@duplication@6@6797310@6806508@7@chr7:6797310-6806508@15.7@330@539@1.63@NA@RSPH10B2_2, RSPH10B2_3, RSPH10B2_4, RSPH10B2_5, RSPH10B2_6, RSPH10B2_7@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F08196@71939@71939@deletion@1@6836200@6836397@7@chr7:6836200-6836397@8.93@43@1@0.0233@NA@RSPH10B2_19@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F08196@71941@71944@duplication@4@6838856@6844686@7@chr7:6838856-6844686@13.9@106@229@2.16@NA@CCZ1B_15, CCZ1B_14, CCZ1B_13, CCZ1B_12@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F08196@73260@73263@duplication@4@38388957@38393784@7@chr7:38388957-38393784@8.11@779@1041@1.34@CNVR3354.3, CNVR3354.1@TRGV5_2, TRGV5_1, TRGV4_2, TRGV4_1@0@0@0@@:protein binding:protein binding@NA
F08196@74568@74568@duplication@1@74160677@74160750@7@chr7:74160677-74160750@6.49@6@49@8.17@NA@GTF2I_23@0@0@0@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
F08196@74605@74605@deletion@1@74251403@74251500@7@chr7:74251403-74251500@4.95@22@0@0@NA@GTF2IRD2_2@0@0@0@:GTF2I repeat domain containing 2@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
F08196@74776@74776@deletion@1@76069568@76069658@7@chr7:76069568-76069658@6.48@130@65@0.5@CNVR3462.1@ZP3_6@0@0@0@:zona pellucida glycoprotein 3 (sperm receptor)@:negative regulation of transcription, DNA-dependent;manganese ion transmembrane transporter activity;intracellular protein transport;proteinaceous extracellular matrix;plasma membrane;positive regulation of acrosome reaction;outer acrosomal membrane;protein kinase C signaling cascade;manganese ion transmembrane transport;intracellular signal transduction;humoral immune response mediated by circulating immunoglobulin;negative regulation of binding of sperm to zona pellucida;positive regulation of inflammatory response;endoplasmic reticulum;signal transducer activity;perinuclear region of cytoplasm;secretory granule;positive regulation of transcription, DNA-dependent;positive regulation of ovarian follicle development;positive regulation of interferon-gamma production;carbohydrate binding;manganese ion transport;positive regulation of antral ovarian follicle growth;extracellular matrix;positive regulation of leukocyte migration;positive regulation of humoral immune response;extracellular space;blastocyst formation;integral to membrane;store-operated calcium channel activity;oocyte development;multivesicular body;phosphatidylinositol-mediated signaling;acrosomal vesicle;positive regulation of protein kinase B signaling cascade;Golgi apparatus;positive regulation of calcium ion import;positive regulation of protein kinase activity;positive regulation of acrosomal vesicle exocytosis;positive regulation of interleukin-4 production;cytoplasm;protein binding;binding of sperm to zona pellucida;positive regulation of phosphatidylinositol biosynthetic process;extracellular region;positive regulation of T cell proliferation;acrosin binding;positive regulation of type IV hypersensitivity;egg coat formation@NA
F08196@74793@74793@duplication@1@76241040@76241130@7@chr7:76241040-76241130@7.97@93@181@1.95@CNVR3463.10@POMZP3_5@0@0@0@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
F08196@75500@75500@duplication@1@92219583@92219605@7@chr7:92219583-92219605@6.12@165@261@1.58@NA@FAM133B_1@0@0@0@:family with sequence similarity 133, member B@NA@NA
F08196@76429@76430@duplication@2@100334107@100334703@7@chr7:100334107-100334703@11.6@419@634@1.51@CNVR3509.1@ZAN_3, ZAN_4@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
F08196@76775@76779@duplication@5@102257073@102279646@7@chr7:102257073-102279646@7.55@150@243@1.62@CNVR3518.1@RASA4_1, UPK3BL_6, UPK3BL_6, UPK3BL_5, UPK3BL_5, UPK3BL_4, UPK3BL_4@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
F08196@79312@79314@deletion@3@143955790@144016150@7@chr7:143955790-144016150@15.1@911@549@0.603@CNVR3598.4@OR2A7_1, CTAGE8_1, OR2A1_1@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor, family 2, subfamily A, member 7:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F08196@80367@80406@deletion@40@7272484@7752292@8@chr8:7272484-7752292@78.8@1168@539@0.461@NA@DEFB4B_2, DEFB4B_1, DEFB103B_2, DEFB103B_1, SPAG11B_3, SPAG11B_2, SPAG11B_1, DEFB104B_2, DEFB104B_1, DEFB106B_2, DEFB106B_1, DEFB105B_1, DEFB105B_3, DEFB107B_1, DEFB107B_2, RP11-1118M6.1_1, RP11-1118M6.1_2, RP11-1118M6.1_3, RP11-1118M6.1_4, AC084121.16_4, AC084121.16_3, AC084121.16_2, AC084121.16_1, DEFB107A_2, DEFB107A_1, DEFB105A_3, DEFB105A_1, DEFB106A_1, DEFB106A_2, DEFB104A_1, DEFB104A_2, SPAG11A_1, SPAG11A_2, SPAG11A_3, DEFB103A_1, DEFB103A_2, DEFB4A_1@0@0@0@:defensin, beta 4B;defensin, beta 4A:defensin, beta 103B;defensin, beta 103A:sperm associated antigen 11B:defensin, beta 104A;defensin, beta 104B:defensin, beta 106B;defensin, beta 106A:defensin, beta 105B;defensin, beta 105A:defensin, beta 107B;defensin, beta 107A:uncharacterized LOC100133251:uncharacterized LOC100133251:defensin, beta 107B;defensin, beta 107A:defensin, beta 105B;defensin, beta 105A:defensin, beta 106B;defensin, beta 106A:defensin, beta 104A;defensin, beta 104B:sperm associated antigen 11A;sperm associated antigen 11B:defensin, beta 103B;defensin, beta 103A:defensin, beta 4B;defensin, beta 4A@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response@NA
F08196@80565@80567@deletion@3@11994678@12043034@8@chr8:11994678-12043034@8.23@37@0@0@CNVR3785.8, CNVR3785.5, CNVR3785.2, CNVR3785.3@USP17L2_1, FAM86B1_8, FAM86B1_7@0@0@0@:ubiquitin specific peptidase 17-like family member 1, pseudogene;ubiquitin specific peptidase 17-like family member 2;ubiquitin specific peptidase 17-like family member 4;ubiquitin specific peptidase 17-like family member 7;ubiquitin specific peptidase 17-like family member 8;ubiquitin specific peptidase 17-like family member 3:family with sequence similarity 86, member B2;family with sequence similarity 86, member B1@:protein deubiquitination;ubiquitin-specific protease activity;mitotic cell cycle G1/S transition checkpoint;nucleus;G2/M transition checkpoint;apoptotic process;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process@NA
F08196@80738@80738@deletion@1@17581182@17581342@8@chr8:17581182-17581342@11.2@331@167@0.505@CNVR3804.1@MTUS1_4@0@0@0@:microtubule associated tumor suppressor 1@:oxidation-reduction process;mitochondrion;Golgi apparatus;microtubule organizing center;oxidoreductase activity;cellular response to peptide hormone stimulus;nucleus;plasma membrane;microtubule;transition metal ion binding;spindle@: HEPATOCELLULAR CARCINOMA
F08196@80818@80818@duplication@1@18871074@18871093@8@chr8:18871074-18871093@4.83@153@232@1.52@NA@PSD3_1@0@0@0@:pleckstrin and Sec7 domain containing 3@:phospholipid binding;intracellular;ARF guanyl-nucleotide exchange factor activity;postsynaptic density;protein binding;neuron differentiation;cell junction;plasma membrane;regulation of ARF protein signal transduction;postsynaptic membrane;membrane@NA
F08196@88046@88046@deletion@1@35258991@35259047@9@chr9:35258991-35259047@8.25@158@75@0.475@NA@UNC13B_7@0@0@0@:unc-13 homolog B (C. elegans)@:neuromuscular junction development;synaptic vesicle docking involved in exocytosis;induction of apoptosis;cell junction;plasma membrane;excretion;receptor activity;innervation;intracellular signal transduction;Golgi apparatus;intracellular;signal transducer activity;cytoplasm;neuromuscular junction;signal transduction;protein binding;synapse;synaptic vesicle priming;regulation of short-term neuronal synaptic plasticity;synaptic transmission;synaptic transmission, glutamatergic;metal ion binding@NA
F08196@88584@88602@deletion@19@43624656@43885072@9@chr9:43624656-43885072@39.9@405@148@0.365@CNVR4294.1@SPATA31A6_4, SPATA31A6_3, SPATA31A6_2, SPATA31A6_1, CNTNAP3B_1, CNTNAP3B_2, CNTNAP3B_3, CNTNAP3B_4, CNTNAP3B_5, CNTNAP3B_6, CNTNAP3B_7, CNTNAP3B_8, CNTNAP3B_9, CNTNAP3B_10, CNTNAP3B_11, CNTNAP3B_12, CNTNAP3B_13, CNTNAP3B_14, CNTNAP3B_15@0@0@0@:SPATA31 subfamily A, member 6:contactin associated protein-like 3B;contactin associated protein-like 3@:integral to membrane:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
F08196@88666@88672@deletion@7@69238231@69256889@9@chr9:69238231-69256889@12.1@95@25@0.263@NA@CBWD6_8, CBWD6_7, CBWD6_6, CBWD6_5, BX255923.1_1, CBWD6_4, CBWD6_3@0@0@0@:COBW domain containing 6@:ATP binding@NA
F08196@95376@95386@deletion@11@17949551@18122792@10@chr10:17949551-18122792@21.5@214@78@0.364@NA@MRC1L1_28, MRC1L1_29, MRC1L1_30, TMEM236_1, TMEM236_2, TMEM236_3, TMEM236_4, MRC1_1, MRC1_2, MRC1_3, MRC1_4@0@0@0@:macrophage mannose receptor 1-like:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F08196@95388@95410@duplication@23@18134219@18196627@10@chr10:18134219-18196627@18.4@171@339@1.98@NA@MRC1_6, MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11, MRC1_12, MRC1_13, MRC1_14, MRC1_15, MRC1_16, MRC1_17, MRC1_18, MRC1_19, MRC1_20, MRC1_21, MRC1_22, MRC1_23, MRC1_24, MRC1_25, MRC1_26, MRC1_27, MRC1_28@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F08196@96280@96280@deletion@1@42924565@42924599@10@chr10:42924565-42924599@10.3@78@18@0.231@NA@CCNYL2_5@0@0@0@@:regulation of cyclin-dependent protein kinase activity;protein kinase binding@NA
F08196@96558@96558@duplication@1@47941963@47942084@10@chr10:47941963-47942084@5.27@8@44@5.5@CNVR4715.2, CNVR4715.1@FAM21B_24@0@0@0@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
F08196@96572@96581@deletion@10@48020451@48055018@10@chr10:48020451-48055018@77.8@439@42@0.0957@CNVR4715.2@ASAH2C_10, ASAH2C_9, ASAH2C_8, ASAH2C_7, ASAH2C_6, ASAH2C_5, ASAH2C_4, ASAH2C_3, ASAH2C_2, ASAH2C_1@0@0@0@@:ceramidase activity;sphingolipid metabolic process@NA
F08196@96932@96939@duplication@8@51965743@51994312@10@chr10:51965743-51994312@31.6@156@412@2.64@NA@ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7, ASAH2_6, ASAH2_5@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
F08196@106038@106040@deletion@3@55032377@55035848@11@chr11:55032377-55035848@23.6@111@0@0@CNVR5178.5@TRIM48_2, TRIM48_3, TRIM48_4@0@0@0@:tripartite motif containing 48@:protein binding;intracellular;zinc ion binding@NA
F08196@113033@113033@duplication@1@176050@176602@12@chr12:176050-176602@4.88@83@139@1.67@CNVR5380.1, CNVR5380.4, CNVR5380.3@IQSEC3_1@0@0@0@:IQ motif and Sec7 domain 3;IQ motif and SEC7 domain-containing protein 3-like@:phospholipid binding;inhibitory synapse;intracellular;ARF guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;protein binding;cell junction;nucleus;regulation of ARF protein signal transduction;postsynaptic membrane@NA
F08196@117170@117171@deletion@2@52865457@52866064@12@chr12:52865457-52866064@16.6@304@152@0.5@NA@KRT6C_3, KRT6C_2@0@0@0@:keratin 6C@:intermediate filament;structural molecule activity;keratin filament;cytoskeleton organization@NA
F08196@121268@121268@duplication@1@108956400@108956512@12@chr12:108956400-108956512@5.46@89@153@1.72@NA@ISCU_1@0@0@0@:iron-sulfur cluster scaffold homolog (E. coli)@:mitochondrion;protein complex scaffold;cytoplasm;cytosol;protein binding;iron-sulfur cluster assembly;iron-sulfur cluster binding;nucleus;iron ion binding;nitrogen fixation@: MYOPATHY WITH LACTIC ACIDOSIS, HEREDITARY; HML
F08196@124100@124100@duplication@1@21742128@21742538@13@chr13:21742128-21742538@6.06@429@617@1.44@NA@SKA3_4@0@0@0@:spindle and kinetochore associated complex subunit 3@:spindle microtubule;chromosome segregation;cytoplasm;mitosis;protein binding;regulation of microtubule polymerization or depolymerization;cell division;condensed chromosome outer kinetochore@NA
F08196@124444@124444@duplication@1@28196122@28196146@13@chr13:28196122-28196146@5.45@163@251@1.54@NA@POLR1D_2@0@0@0@:polymerase (RNA) I polypeptide D, 16kDa@:nucleoplasm;termination of RNA polymerase I transcription;transcription elongation from RNA polymerase I promoter;transcription initiation from RNA polymerase I promoter;DNA-directed RNA polymerase I complex;termination of RNA polymerase III transcription;transcription from RNA polymerase I promoter;DNA binding;transcription from RNA polymerase III promoter;protein binding;DNA-directed RNA polymerase activity;transcription elongation from RNA polymerase III promoter;protein dimerization activity;transcription, DNA-dependent;gene expression@: TREACHER COLLINS SYNDROME 2; TCS2
F08196@133350@133354@deletion@5@106091234@106110286@14@chr14:106091234-106110286@7.25@448@296@0.661@CNVR6294.46, CNVR6294.20, CNVR6294.54, CNVR6294.43, CNVR6294.50@IGHG4_3, IGHG4_2, IGHG4_1, IGHG2_4, IGHG2_3@0@0@0@@:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response@NA
F08196@133409@133414@deletion@6@106373070@106380248@14@chr14:106373070-106380248@21.7@378@185@0.489@CNVR6294.27, CNVR6294.36, CNVR6294.48, CNVR6294.25, CNVR6294.57, CNVR6294.29@IGHD2-8_1, IGHD1-7_1, IGHD6-6_1, IGHD5-5_1, IGHD4-4_1, IGHD3-3_1@0@0@0@NA@NA@NA
F08196@133426@133427@deletion@2@106478111@106478539@14@chr14:106478111-106478539@11.3@92@25@0.272@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV4-4_2, IGHV4-4_1@0@0@0@@:protein binding@NA
F08196@133432@133436@deletion@5@106539080@106573537@14@chr14:106539080-106573537@94.8@641@120@0.187@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1, IGHV3-11_2@0@0@0@@:protein binding:protein binding:protein binding@NA
F08196@133458@133462@deletion@5@106791006@106816026@14@chr14:106791006-106816026@34.9@924@513@0.555@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-30_2, IGHV3-30_1, IGHV4-31_2, IGHV4-31_1, IGHV3-33_2@0@0@0@@:protein binding:protein binding:protein binding@NA
F08196@133491@133492@deletion@2@107095127@107095561@14@chr14:107095127-107095561@10@66@13@0.197@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61_2, IGHV4-61_1@0@0@0@@:protein binding@NA
F08196@133495@133495@deletion@1@107131034@107131334@14@chr14:107131034-107131334@5.93@164@90@0.549@CNVR6294.56, CNVR6294.16@IGHV3-66_2@0@0@0@@:protein binding@NA
F08196@133541@133542@deletion@2@22368577@22383423@15@chr15:22368577-22383423@45.3@2910@1425@0.49@CNVR6297.4, CNVR6297.17, CNVR6297.2@OR4M2_1, OR4N4_1@0@0@0@:olfactory receptor, family 4, subfamily M, member 2:olfactory receptor, family 4, subfamily N, member 4@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F08196@134008@134011@deletion@4@30654497@30664544@15@chr15:30654497-30664544@10.5@223@120@0.538@CNVR6337.1@CHRFAM7A_10, CHRFAM7A_9, CHRFAM7A_8, CHRFAM7A_7@0@0@0@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
F08196@134024@134025@deletion@2@30700112@30700498@15@chr15:30700112-30700498@10.9@181@79@0.436@NA@GOLGA8R_11, GOLGA8R_10@0@0@0@@:Golgi apparatus@NA
F08196@134444@134448@duplication@5@34678827@34820278@15@chr15:34678827-34820278@6.45@51@103@2.02@CNVR6351.3@GOLGA8A_11, GOLGA8A_10, GOLGA8A_9, GOLGA8B_25, GOLGA8B_24@0@0@0@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
F08196@138281@138287@deletion@7@72953606@72957376@15@chr15:72953606-72957376@6.94@51@14@0.275@CNVR6443.1@GOLGA6B_8, GOLGA6B_9, GOLGA6B_10, GOLGA6B_11, GOLGA6B_12, GOLGA6B_13, GOLGA6B_14@0@0@0@:golgin A6 family, member B@:Golgi apparatus@NA
F08196@143483@143485@duplication@3@21764349@21771861@16@chr16:21764349-21771861@7.34@128@211@1.65@CNVR6668.5, CNVR6668.2, CNVR6668.7@OTOA_26, OTOA_27, OTOA_28@0@0@0@:otoancorin@:proteinaceous extracellular matrix;apical plasma membrane;sensory perception of sound;anchored to membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22
F08196@144038@144039@deletion@2@28403074@28403463@16@chr16:28403074-28403463@6.03@137@76@0.555@CNVR6684.2@EIF3CL_10, EIF3CL_9@0@0@0@:eukaryotic translation initiation factor 3, subunit C-like@:protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;translation initiation factor activity@NA
F08196@144501@144503@deletion@3@30208296@30208787@16@chr16:30208296-30208787@7.03@32@0@0@CNVR6694.1, CNVR6694.2, CNVR6694.3@SLX1A_4, SLX1A_5, SLX1A_6@0@0@0@:structure-specific endonuclease subunit SLX1-like;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae);SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae):sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3;sulfotransferase 1A3/1A4-like@:Slx1-Slx4 complex;5'-flap endonuclease activity;DNA repair;protein binding;DNA double-strand break processing involved in repair via single-strand annealing;double-strand break repair via homologous recombination;metal ion binding;crossover junction endodeoxyribonuclease activity:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;cytoplasm;catecholamine metabolic process;cytosol;endoplasmic reticulum unfolded protein response;xenobiotic metabolic process;sulfotransferase activity;activation of signaling protein activity involved in unfolded protein response;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process@NA
F08196@145554@145563@duplication@10@55844430@55862886@16@chr16:55844430-55862886@36.1@1628@2343@1.44@CNVR6731.1@CES1_11, CES1_10, CES1_9, CES1_8, CES1_7, CES1_6, CES1_5, CES1_4, CES1_3, CES1_2@0@0@0@:carboxylesterase 1;liver carboxylesterase 1-like@:hydrolase activity;methyl salicylate esterase activity;response to toxin;methylumbelliferyl-acetate deacetylase activity;endoplasmic reticulum lumen;retinyl-palmitate esterase activity;methyl jasmonate esterase activity;metabolic process;carboxylesterase activity;methyl indole-3-acetate esterase activity@: CARBOXYLESTERASE 1; CES1
F08196@147513@147513@deletion@1@74451958@74452196@16@chr16:74451958-74452196@7.65@45@6@0.133@CNVR6778.2, CNVR6778.3@CLEC18B_3@0@0@0@:C-type lectin domain family 18, member B@:carbohydrate binding;protein binding;extracellular region@NA
F08196@152124@152130@duplication@7@20355109@20361697@17@chr17:20355109-20361697@9.06@246@367@1.49@CNVR7021.1, CNVR7021.3@LGALS9B_9, LGALS9B_8, LGALS9B_7, LGALS9B_6, LGALS9B_5, LGALS9B_4, LGALS9B_3@0@0@0@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
F08196@153381@153381@deletion@1@34539885@34539971@17@chr17:34539885-34539971@5.05@23@0@0@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1_3@0@0@0@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
F08196@153653@153659@deletion@7@36357159@36375177@17@chr17:36357159-36375177@14@2600@1861@0.716@CNVR7083.3@RP11-1407O15.2_9, RP11-1407O15.2_8, RP11-1407O15.2_7, RP11-1407O15.2_6, RP11-1407O15.2_5, RP11-1407O15.2_4, RP11-1407O15.2_3@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
F08196@154365@154371@duplication@7@39534312@39538624@17@chr17:39534312-39538624@20.3@904@1288@1.42@CNVR7098.1@KRT34_7, KRT34_6, KRT34_5, KRT34_4, KRT34_3, KRT34_2, KRT34_1@0@0@0@:keratin 34;keratin, type I cuticular Ha4-like@:intermediate filament;structural molecule activity;epidermis development@NA
F08196@155587@155590@duplication@4@44399689@44409347@17@chr17:44399689-44409347@6.94@57@116@2.04@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
F08196@162019@162019@deletion@1@44554574@44556213@18@chr18:44554574-44556213@24.8@121@0@0@CNVR7319.1@TCEB3C_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C (elongin A3);RNA polymerase II transcription factor SIII subunit A3-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
F08196@164276@164279@duplication@4@4219589@4224502@19@chr19:4219589-4224502@12.3@544@779@1.43@NA@ANKRD24_19, ANKRD24_20, ANKRD24_21, ANKRD24_22@0@0@0@:ankyrin repeat domain 24@:protein binding@NA
F08196@165743@165743@duplication@1@10230517@10230535@19@chr19:10230517-10230535@4.94@125@196@1.57@NA@EIF3G_1@0@0@0@:eukaryotic translation initiation factor 3, subunit G@:nucleotide binding;translation initiation factor activity;perinuclear region of cytoplasm;cytosol;protein binding;cellular protein metabolic process;translational initiation;eukaryotic translation initiation factor 3 complex;nucleus;translation;gene expression;nucleic acid binding@NA
F08196@166916@166917@deletion@2@14508471@14508747@19@chr19:14508471-14508747@6.75@79@33@0.418@NA@CD97_7, CD97_8@0@0@0@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
F08196@170096@170100@deletion@5@40373946@40382826@19@chr19:40373946-40382826@17@224@100@0.446@CNVR7639.2@FCGBP_26, FCGBP_25, FCGBP_24, FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F08196@170373@170374@deletion@2@41386385@41387656@19@chr19:41386385-41387656@7.32@233@138@0.592@CNVR7642.1@CYP2A7_3, CYP2A7_2@0@0@0@:cytochrome P450, family 2, subfamily A, polypeptide 7@:oxidation-reduction process;electron carrier activity;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;oxygen binding;heme binding;monooxygenase activity;endoplasmic reticulum membrane;iron ion binding@NA
F08196@170399@170399@deletion@1@41627863@41628038@19@chr19:41627863-41628038@4.73@110@59@0.536@CNVR7644.1@CYP2F1_6@0@0@0@:cytochrome P450, family 2, subfamily F, polypeptide 1@:trichloroethylene metabolic process;oxidation-reduction process;aromatase activity;response to toxin;oxygen binding;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;endoplasmic reticulum membrane;naphthalene metabolic process;intracellular membrane-bounded organelle;electron carrier activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;heme binding;xenobiotic metabolic process;monooxygenase activity;iron ion binding@NA
F08196@171352@171352@deletion@1@46184863@46184903@19@chr19:46184863-46184903@5.35@88@42@0.477@NA@GIPR_13@0@0@0@:gastric inhibitory polypeptide receptor@:transmembrane signaling receptor activity;activation of adenylate cyclase activity;G-protein coupled receptor activity;response to axon injury;gastric inhibitory peptide receptor activity;generation of precursor metabolites and energy;integral to membrane;plasma membrane;positive regulation of cAMP biosynthetic process;response to nutrient;cell surface receptor signaling pathway;response to calcium ion;endocrine pancreas development;peptide hormone binding;G-protein coupled receptor signaling pathway;positive regulation of insulin secretion;response to glucose stimulus;response to fatty acid;desensitization of G-protein coupled receptor protein signaling pathway;elevation of cytosolic calcium ion concentration;membrane@NA
F08196@173000@173000@duplication@1@52227179@52227186@19@chr19:52227179-52227186@8.55@31@99@3.19@NA@HAS1_1@0@0@0@:hyaluronan synthase 1@:hyaluronan synthase activity;transferase activity, transferring hexosyl groups;hyaluronan biosynthetic process;small molecule metabolic process;hyaluronan metabolic process;carbohydrate metabolic process;glycosaminoglycan metabolic process;glycosaminoglycan biosynthetic process;cellular response to platelet-derived growth factor stimulus;cell adhesion;plasma membrane;integral to plasma membrane;membrane;negative regulation of fibroblast migration@NA
F08196@173109@173109@duplication@1@53517345@53518777@19@chr19:53517345-53518777@4.69@590@810@1.37@CNVR7709.2, CNVR7709.1@ERVV-1_1@0@0@0@:endogenous retrovirus group V, member 1@:integral to membrane@NA
F08196@173305@173308@deletion@4@54745453@54746600@19@chr19:54745453-54746600@8.48@491@318@0.648@CNVR7721.3, CNVR7721.6@LILRA6_4, LILRA6_3, LILRA6_2, LILRA6_1@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F08196@173467@173469@deletion@3@55263102@55263971@19@chr19:55263102-55263971@7.27@297@183@0.616@CNVR7725.2, CNVR7725.1@KIR2DL3_6, KIR2DL3_7, KIR2DL3_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity@NA
F08196@173491@173497@deletion@7@55340817@55351154@19@chr19:55340817-55351154@29.1@746@410@0.55@CNVR7725.1, CNVR7725.6@KIR3DL1_7, KIR3DL1_8, KIR3DL1_9, KIR2DS4_1, KIR2DS4_2, KIR2DS4_3, KIR2DS4_4@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
F08196@173534@173539@deletion@6@55485869@55497683@19@chr19:55485869-55497683@38.3@1036@525@0.507@NA@NLRP2_3, NLRP2_4, NLRP2_5, NLRP2_6, NLRP2_7, NLRP2_8@0@0@0@:NLR family, pyrin domain containing 2@:protein binding;Pyrin domain binding;positive regulation of interleukin-1 beta secretion;ATP binding;cytoplasm;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process@NA
F08196@176233@176233@duplication@1@33296545@33296667@20@chr20:33296545-33296667@4.72@79@133@1.68@NA@TP53INP2_3@0@0@0@:nuclear receptor coactivator 6:tumor protein p53 inducible nuclear protein 2@:nucleoplasm;intracellular estrogen receptor signaling pathway;estrogen receptor binding;DNA repair;transcription coactivator activity;transcription factor complex;myeloid cell differentiation;glucocorticoid receptor signaling pathway;response to hormone stimulus;nucleus;protein homodimerization activity;DNA recombination;histone methyltransferase complex;positive regulation of transcription from RNA polymerase II promoter;transcription initiation from RNA polymerase II promoter;labyrinthine layer blood vessel development;intracellular membrane-bounded organelle;small molecule metabolic process;enzyme binding;cellular lipid metabolic process;response to DNA damage stimulus;retinoid X receptor binding;DNA-dependent transcription, initiation;chromatin binding;protein binding;brain development;positive regulation of transcription, DNA-dependent;ligand-dependent nuclear receptor binding;thyroid hormone receptor binding;heart development;DNA replication;ligand-dependent nuclear receptor transcription coactivator activity:osteoblast differentiation;autophagic vacuole;autophagic vacuole assembly;cytoplasmic vesicle;cytosol;protein binding;positive regulation of transcription, DNA-dependent;positive regulation of autophagy;PML body;nucleus;transcription, DNA-dependent@NA
F08196@180976@180976@deletion@1@16287255@16287885@22@chr22:16287255-16287885@6.38@70@26@0.371@CNVR8071.2, CNVR8071.3, CNVR8071.9@POTEH_1@0@0@0@:POTE ankyrin domain family, member H@:protein binding@NA
F08196@181486@181487@deletion@2@21064988@21065749@22@chr22:21064988-21065749@8.11@73@25@0.342@CNVR8099.6, CNVR8099.2@PI4KA_52, PI4KA_51@0@0@0@:phosphatidylinositol 4-kinase, catalytic, alpha@:phospholipid metabolic process;1-phosphatidylinositol 4-kinase activity;small molecule metabolic process;phosphatidylinositol phosphorylation;binding;transferase activity, transferring phosphorus-containing groups;phosphotransferase activity, alcohol group as acceptor;ATP binding;Golgi-associated vesicle;phosphatidylinositol biosynthetic process;cytosol;protein binding;signal transduction;synaptic transmission;kinase activity;phosphatidylinositol-mediated signaling@NA
F08196@181948@181955@deletion@8@24324820@24384231@22@chr22:24324820-24384231@107@560@27@0.0482@CNVR8114.13, CNVR8114.1@GSTT2_3, GSTT2_4, GSTT2_5, GSTT1_5, GSTT1_4, GSTT1_3, GSTT1_2, GSTT1_1@0@0@0@:glutathione S-transferase theta 1@:protein binding;glutathione transferase activity;nucleus;cytoplasm:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
F08196@1888@1889@deletion@2@48244004@48244889@X@chrX:48244004-48244889@9.79@46@1@0.0217@CNVR8324.2@SSX4_3, SSX4_4@0@0@0@NA@NA@NA
F08196@1896@1896@duplication@1@48269422@48269516@X@chrX:48269422-48269516@7.27@20@72@3.6@CNVR8324.2@SSX4B_4@0@0@0@NA@NA@NA
F08196@2786@2788@duplication@3@55116455@55117890@X@chrX:55116455-55117890@9.79@466@644@1.38@CNVR8342.1@PAGE2_2, PAGE2_3, PAGE2_4@0@0@0@NA@NA@NA
F08196@5719@5719@deletion@1@140336520@140336590@X@chrX:140336520-140336590@4.8@130@75@0.577@CNVR8456.1@SPANXC_1@0@0@0@NA@NA@NA
F08196@6297@6297@duplication@1@153458900@153459138@X@chrX:153458900-153459138@7.74@87@164@1.89@CNVR8489.1@OPN1MW_5@0@0@0@NA@NA@NA
F0852@940@940@deletion@1@6445555@6445726@1@chr1:6445555-6445726@11.8@176@83@0.472@CNVR44.1@ACOT7_1@0@0@0@:acyl-CoA thioesterase 7@:mitochondrion;catalytic activity;cell body;acyl-CoA hydrolase activity;cytoplasm;lipid metabolic process;cytosol;neuron projection;palmitoyl-CoA hydrolase activity;fatty acid catabolic process;fatty-acyl-CoA binding;carboxylesterase activity@NA
F0852@2788@2788@deletion@1@21806545@21806716@1@chr1:21806545-21806716@6.15@33@4@0.121@CNVR107.2, CNVR107.1@NBPF3_11@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 3@:cytoplasm@NA
F0852@8507@8508@deletion@2@89476588@89477710@1@chr1:89476588-89477710@8.42@556@378@0.68@CNVR244.1@GBP3_8, GBP3_7@0@0@0@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
F0852@9365@9366@duplication@2@104202983@104203298@1@chr1:104202983-104203298@13.9@85@190@2.24@CNVR266.3, CNVR266.1@AMY1A_7, AMY1A_8@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
F0852@9436@9436@duplication@1@108769302@108769515@1@chr1:108769302-108769515@12.4@62@156@2.52@CNVR294.4@NBPF4_14@0@0@0@:neuroblastoma breakpoint family, member 4@:cytoplasm@NA
F0852@9766@9773@deletion@8@110230497@110235917@1@chr1:110230497-110235917@89.5@410@1@0.00244@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
F0852@12117@12118@duplication@2@152573209@152586574@1@chr1:152573209-152586574@12.8@119@225@1.89@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
F0852@12129@12129@deletion@1@152770272@152770615@1@chr1:152770272-152770615@18.1@85@2@0.0235@CNVR360.1@LCE1D_2@0@0@0@:late cornified envelope 1D@:cytoplasmic part;cornified envelope;cellular response to calcium ion;keratinization;perinuclear region of cytoplasm;cytoplasm@NA
F0852@14437@14438@deletion@2@168511232@168513202@1@chr1:168511232-168513202@5.63@177@110@0.621@NA@XCL2_2, XCL2_1@0@0@0@:chemokine (C motif) ligand 2@:blood circulation;chemotaxis;extracellular space;signal transduction;extracellular region;immune response;chemokine activity@NA
F0852@14440@14440@duplication@1@168549302@168549415@1@chr1:168549302-168549415@4.69@142@205@1.44@NA@XCL1_2@0@0@0@:chemokine (C motif) ligand 1@:cellular response to interleukin-4;negative regulation of interferon-gamma production;immune response;regulation of inflammatory response;negative regulation of transcription, DNA-dependent;cellular response to transforming growth factor beta stimulus;positive regulation of T cell chemotaxis;positive regulation of release of sequestered calcium ion into cytosol;mature natural killer cell chemotaxis;positive regulation of thymocyte migration;chemokine activity;positive regulation of neutrophil chemotaxis;positive regulation of leukocyte chemotaxis;response to virus;negative regulation of T-helper 1 type immune response;positive regulation of granzyme A production;cell-cell signaling;positive regulation of immunoglobulin production in mucosal tissue;positive regulation of T-helper 1 cell cytokine production;positive regulation of T cell cytokine production;positive regulation of granzyme B production;positive regulation of CD8-positive, alpha-beta T cell proliferation;negative regulation of interleukin-2 production;positive regulation of interleukin-10 production;extracellular space;release of sequestered calcium ion into cytosol;negative regulation of sequence-specific DNA binding transcription factor activity;negative regulation of CD4-positive, alpha-beta T cell proliferation;protein homodimerization activity;positive regulation of transforming growth factor beta production;negative regulation of T cell cytokine production;positive regulation of B cell chemotaxis;neutrophil chemotaxis;chemokine receptor binding;positive regulation of T-helper 2 cell cytokine production;positive regulation of T cell mediated cytotoxicity;signal transduction;negative regulation of T-helper 1 cell activation;extracellular region;positive regulation of natural killer cell chemotaxis;positive regulation of CD4-positive, alpha-beta T cell proliferation@NA
F0852@16029@16040@duplication@12@196744018@196801129@1@chr1:196744018-196801129@76.3@1900@2871@1.51@CNVR459.1@CFHR3_1, CFHR3_2, CFHR3_3, CFHR3_4, CFHR3_5, CFHR3_6, CFHR1_1, CFHR1_2, CFHR1_3, CFHR1_4, CFHR1_5, CFHR1_6@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
F0852@24998@24999@duplication@2@90121659@90122133@2@chr2:90121659-90122133@7.9@328@455@1.39@CNVR867.10, CNVR867.5, CNVR867.3, CNVR867.9, CNVR867.14@IGKV1D-17_1, IGKV1D-17_2@0@0@0@@:protein binding@NA
F0852@25003@25004@deletion@2@90153964@90193002@2@chr2:90153964-90193002@9.04@106@45@0.425@CNVR867.10, CNVR867.5, CNVR867.3, CNVR867.9@IGKV3D-15_2, IGKV1D-13_1@0@0@0@@:protein binding:protein binding@NA
F0852@25350@25351@deletion@2@97818242@97820478@2@chr2:97818242-97820478@14.3@242@124@0.512@CNVR886.2@ANKRD36_14, ANKRD36_15@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
F0852@34150@34150@deletion@1@241631332@241631938@2@chr2:241631332-241631938@8.29@115@54@0.47@NA@AQP12A_1, AQP12A_2@0@0@0@:aquaporin 12A@:transport;integral to membrane;transporter activity;membrane@NA
F0852@43489@43489@deletion@1@154834269@154834348@3@chr3:154834269-154834348@4.94@84@44@0.524@NA@MME_5@0@0@0@:membrane metallo-endopeptidase@:metallopeptidase activity;endopeptidase activity;synaptic vesicle;kidney development;sensory perception of pain;cellular response to cytokine stimulus;peptidase activity;proteolysis;integral to membrane;creatinine metabolic process;plasma membrane;metalloendopeptidase activity;integral to plasma membrane;dendrite;peptide metabolic process;axon;neuron projection terminus;cellular response to UV-B;peptide binding;cellular response to UV-A;cytoplasm;beta-amyloid metabolic process;brush border;protein binding;synapse;membrane;zinc ion binding;replicative senescence@NA
F0852@45433@45438@deletion@6@195447880@195475935@3@chr3:195447880-195475935@19.5@1988@1380@0.694@CNVR1703.1, CNVR1703.2, CNVR1703.5, CNVR1703.3@MUC20_1, MUC20_2, MUC20_3, MUC20_4, MUC4_25, MUC4_24@0@0@0@:mucin 20, cell surface associated:mucin 4, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane:ErbB-2 class receptor binding;Golgi lumen;cell-matrix adhesion;post-translational protein modification;extracellular matrix structural constituent;protein binding;O-glycan processing;cellular protein metabolic process;proteinaceous extracellular matrix;integral to plasma membrane;membrane;extracellular matrix constituent, lubricant activity;biological_process@NA
F0852@48556@48561@duplication@6@69403344@69434202@4@chr4:69403344-69434202@92@933@1870@2@CNVR1953.1@UGT2B17_6, UGT2B17_5, UGT2B17_4, UGT2B17_3, UGT2B17_2, UGT2B17_1@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
F0852@48592@48597@deletion@6@70146220@70160527@4@chr4:70146220-70160527@20.3@934@609@0.652@CNVR1957.2, CNVR1957.1@UGT2B28_1, UGT2B28_2, UGT2B28_3, UGT2B28_4, UGT2B28_5, UGT2B28_6@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
F0852@48967@48967@deletion@1@75312252@75312499@4@chr4:75312252-75312499@7.95@83@33@0.398@NA@AREG_2@0@0@0@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
F0852@48972@48974@duplication@3@75482007@75486006@4@chr4:75482007-75486006@6.7@130@202@1.55@NA@AREGB_2, AREGB_3, AREGB_4@0@0@0@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
F0852@54334@54334@deletion@1@35867409@35867565@5@chr5:35867409-35867565@5.99@137@78@0.569@NA@IL7R_3@0@0@0@:interleukin 7 receptor@:immune response;interleukin-7-mediated signaling pathway;interleukin-7 receptor activity;homeostasis of number of cells;integral to membrane;plasma membrane;regulation of DNA recombination;cell surface receptor signaling pathway;cell morphogenesis;B cell proliferation;positive regulation of gene expression;positive regulation of T cell differentiation in thymus;cell growth;external side of plasma membrane;T cell differentiation;cytokine receptor activity;antigen binding;protein binding;negative regulation of T cell mediated cytotoxicity;signal transduction;extracellular region;immunoglobulin production;lymph node development;membrane;regulation of cell size@: SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE,; MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 3; MS3
F0852@59065@59065@duplication@1@140557617@140560021@5@chr5:140557617-140560021@5.2@1657@2126@1.28@CNVR2624.1@PCDHB8_1@0@0@0@:protocadherin beta 8@:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding@NA
F0852@59488@59488@duplication@1@147553798@147553933@5@chr5:147553798-147553933@22.2@162@363@2.24@CNVR2637.2, CNVR2637.1@SPINK14_3@0@0@0@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
F0852@60876@60879@deletion@4@175388055@175394270@5@chr5:175388055-175394270@11.7@172@87@0.506@NA@THOC3_5, THOC3_4, THOC3_3, THOC3_2@0@0@0@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
F0852@61454@61454@duplication@1@179071801@179072021@5@chr5:179071801-179072021@10.4@505@714@1.41@NA@C5orf60_1@0@0@0@:chromosome 5 open reading frame 60@:integral to membrane@NA
F0852@61638@61645@duplication@8@180375356@180429785@5@chr5:180375356-180429785@31.8@1140@1615@1.42@CNVR2719.1@BTNL8_5, BTNL8_6, BTNL8_7, BTNL8_8, BTNL3_1, BTNL3_2, BTNL3_3, BTNL3_4@0@0@0@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
F0852@63281@63282@deletion@2@31237744@31238262@6@chr6:31237744-31238262@27.1@366@165@0.451@CNVR2838.2, CNVR2838.1@HLA-C_5, HLA-C_4@0@0@0@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
F0852@63291@63292@deletion@2@31324466@31324935@6@chr6:31324466-31324935@20.3@208@79@0.38@CNVR2841.12, CNVR2841.14, CNVR2841.8@HLA-B_2, HLA-B_1@0@0@0@:major histocompatibility complex, class I, B@:MHC class I protein complex;regulation of immune response;regulation of interleukin-12 production;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;regulation of T cell anergy;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;receptor binding;early endosome membrane;virus-host interaction;regulation of interleukin-6 production;regulation of dendritic cell differentiation;phagocytic vesicle membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO; SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1
F0852@63730@63733@duplication@4@31963497@31964377@6@chr6:31963497-31964377@19.9@340@544@1.6@CNVR2843.6, CNVR2843.3@C4A_25, C4A_26, C4A_27, C4A_28@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
F0852@63773@63776@deletion@4@31996235@31997115@6@chr6:31996235-31997115@19.7@302@151@0.5@CNVR2843.6, CNVR2843.5@C4B_25, C4B_26, C4B_27, C4B_28@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
F0852@63942@63942@deletion@1@32361747@32361834@6@chr6:32361747-32361834@9.8@184@96@0.522@NA@BTNL2_7@0@0@0@:butyrophilin-like 2 (MHC class II associated)@:protein binding;integral to membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2
F0852@63953@63958@deletion@6@32485517@32498001@6@chr6:32485517-32498001@52@321@57@0.178@CNVR2845.21, CNVR2845.25, CNVR2845.30, CNVR2845.43, CNVR2845.6@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2, HLA-DRB5_1@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
F0852@63961@63963@deletion@3@32548524@32552155@6@chr6:32548524-32552155@35.6@372@142@0.382@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.5, CNVR2845.54@HLA-DRB1_4, HLA-DRB1_3, HLA-DRB1_2@0@0@0@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
F0852@63965@63971@duplication@7@32605237@32629234@6@chr6:32605237-32629234@51.6@679@1181@1.74@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20@HLA-DQA1_1, HLA-DQA1_2, HLA-DQA1_3, HLA-DQA1_4, HLA-DQB1_6, HLA-DQB1_5, HLA-DQB1_4@0@0@0@:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
F0852@63973@63973@deletion@1@32632576@32632844@6@chr6:32632576-32632844@10@136@62@0.456@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20, CNVR2845.31@HLA-DQB1_2@0@0@0@:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
F0852@71030@71030@deletion@1@167790035@167790192@6@chr6:167790035-167790192@7.18@35@2@0.0571@NA@TCP10_5@0@0@0@:t-complex 10@:cytosol@NA
F0852@71746@71749@duplication@4@5940487@5944900@7@chr7:5940487-5944900@16.1@515@737@1.43@NA@CCZ1_4, CCZ1_5, CCZ1_6, CCZ1_7@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F0852@71756@71756@deletion@1@5963467@5963593@7@chr7:5963467-5963593@4.82@223@144@0.646@NA@CCZ1_14@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F0852@71758@71758@deletion@1@5966000@5966179@7@chr7:5966000-5966179@5.06@128@75@0.586@NA@RSPH10B_20@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F0852@71922@71922@deletion@1@6797310@6797562@7@chr7:6797310-6797562@8.12@192@108@0.562@NA@RSPH10B2_2@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F0852@71932@71934@duplication@3@6819242@6821107@7@chr7:6819242-6821107@20.3@288@495@1.72@NA@RSPH10B2_12, RSPH10B2_13, RSPH10B2_14@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F0852@71936@71944@duplication@9@6826510@6844686@7@chr7:6826510-6844686@23.4@238@434@1.82@NA@RSPH10B2_16, RSPH10B2_17, RSPH10B2_18, RSPH10B2_19, RSPH10B2_20, CCZ1B_15, CCZ1B_14, CCZ1B_13, CCZ1B_12@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F0852@71946@71947@deletion@2@6851584@6852668@7@chr7:6851584-6852668@8.12@177@100@0.565@NA@CCZ1B_10, CCZ1B_9@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F0852@71949@71952@deletion@4@6859398@6863797@7@chr7:6859398-6863797@16@429@254@0.592@NA@CCZ1B_7, CCZ1B_6, CCZ1B_5, CCZ1B_4@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F0852@73260@73263@deletion@4@38388957@38393784@7@chr7:38388957-38393784@10@905@629@0.695@CNVR3354.3, CNVR3354.1@TRGV5_2, TRGV5_1, TRGV4_2, TRGV4_1@0@0@0@@:protein binding:protein binding@NA
F0852@74605@74607@deletion@3@74251403@74422230@7@chr7:74251403-74422230@8.13@37@0@0@NA@GTF2IRD2_2, GATSL1_1, GATSL1_2@0@0@0@:GTF2I repeat domain containing 2:GATS protein-like 1@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
F0852@74775@74775@duplication@1@76063356@76063472@7@chr7:76063356-76063472@6.93@81@143@1.77@CNVR3462.1@ZP3_5@0@0@0@:zona pellucida glycoprotein 3 (sperm receptor)@:negative regulation of transcription, DNA-dependent;manganese ion transmembrane transporter activity;intracellular protein transport;proteinaceous extracellular matrix;plasma membrane;positive regulation of acrosome reaction;outer acrosomal membrane;protein kinase C signaling cascade;manganese ion transmembrane transport;intracellular signal transduction;humoral immune response mediated by circulating immunoglobulin;negative regulation of binding of sperm to zona pellucida;positive regulation of inflammatory response;endoplasmic reticulum;signal transducer activity;perinuclear region of cytoplasm;secretory granule;positive regulation of transcription, DNA-dependent;positive regulation of ovarian follicle development;positive regulation of interferon-gamma production;carbohydrate binding;manganese ion transport;positive regulation of antral ovarian follicle growth;extracellular matrix;positive regulation of leukocyte migration;positive regulation of humoral immune response;extracellular space;blastocyst formation;integral to membrane;store-operated calcium channel activity;oocyte development;multivesicular body;phosphatidylinositol-mediated signaling;acrosomal vesicle;positive regulation of protein kinase B signaling cascade;Golgi apparatus;positive regulation of calcium ion import;positive regulation of protein kinase activity;positive regulation of acrosomal vesicle exocytosis;positive regulation of interleukin-4 production;cytoplasm;protein binding;binding of sperm to zona pellucida;positive regulation of phosphatidylinositol biosynthetic process;extracellular region;positive regulation of T cell proliferation;acrosin binding;positive regulation of type IV hypersensitivity;egg coat formation@NA
F0852@74792@74793@duplication@2@76240783@76241130@7@chr7:76240783-76241130@11.9@251@387@1.54@CNVR3463.10@POMZP3_6, POMZP3_5@0@0@0@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
F0852@76427@76432@deletion@6@100331793@100336236@7@chr7:100331793-100336236@195@932@8@0.00858@CNVR3509.1@ZAN_1, ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
F0852@76549@76549@duplication@1@100633913@100648800@7@chr7:100633913-100648800@11.1@4461@5899@1.32@CNVR3511.1@MUC12_2@0@0@0@:mucin 12, cell surface associated@:O-glycan processing;cellular protein metabolic process;regulation of cell growth;Golgi lumen;molecular_function;integral to plasma membrane;post-translational protein modification@NA
F0852@76718@76732@deletion@15@102114809@102137066@7@chr7:102114809-102137066@19.7@240@101@0.421@CNVR3518.1@POLR2J_3, POLR2J_2, POLR2J_1, RASA4B_21, RASA4B_20, RASA4B_19, RASA4B_18, RASA4B_17, RASA4B_16, RASA4B_15, RASA4B_14, RASA4B_13, RASA4B_12, RASA4B_11, RASA4B_10@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J, 13.3kDa:RAS p21 protein activator 4B@:nucleoplasm;DNA binding;DNA repair;protein dimerization activity;nucleus;viral reproduction;gene expression;transcription initiation from RNA polymerase II promoter;7-methylguanosine mRNA capping;protein phosphorylation;LRR domain binding;protein kinase activity;DNA-directed RNA polymerase II, core complex;nucleotide-excision repair;transcription from RNA polymerase II promoter;DNA-directed RNA polymerase activity;protein binding;transcription-coupled nucleotide-excision repair;RNA splicing;mRNA splicing, via spliceosome;transcription, DNA-dependent;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction@NA
F0852@76754@76754@deletion@1@102219880@102220243@7@chr7:102219880-102220243@14.8@67@0@0@CNVR3518.1@AC093668.1_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
F0852@76765@76795@duplication@31@102235753@102319303@7@chr7:102235753-102319303@30@463@768@1.66@CNVR3518.1@RASA4_11, RASA4_10, RASA4_9, RASA4_8, RASA4_7, RASA4_6, RASA4_5, RASA4_4, RASA4_3, RASA4_2, UPK3BL_7, RASA4_1, UPK3BL_6, UPK3BL_6, UPK3BL_5, UPK3BL_5, UPK3BL_4, UPK3BL_4, UPK3BL_3, UPK3BL_3, UPK3BL_2, UPK3BL_2, UPK3BL_1, UPK3BL_1, SPDYE2L_2, SPDYE2L_3, SPDYE2L_4, SPDYE2L_5, SPDYE2L_6, SPDYE2L_7, SPDYE2L_8, POLR2J2_4, POLR2J2_4, POLR2J2_3, POLR2J2_3, POLR2J2_2, POLR2J2_2, POLR2J2_1, POLR2J2_1, AC105052.1_3, AC105052.1_2, AC105052.1_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2:WBSCR19-like protein 3;speedy homolog E6 (Xenopus laevis)@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
F0852@78412@78412@deletion@1@134221804@134221909@7@chr7:134221804-134221909@7.47@111@54@0.486@NA@AKR1B10_6@0@0@0@:aldo-keto reductase family 1, member B10 (aldose reductase)@:steroid metabolic process;cellular aldehyde metabolic process;indanol dehydrogenase activity;daunorubicin metabolic process;retinal dehydrogenase activity;farnesol catabolic process;geranylgeranyl reductase activity;protein binding;extracellular region;aldo-keto reductase (NADP) activity;digestion;doxorubicin metabolic process;cellular_component;lysosome@NA
F0852@79310@79311@deletion@2@143884023@143929936@7@chr7:143884023-143929936@10@113@49@0.434@CNVR3598.4, CNVR3598.3, CNVR3598.7@ARHGEF35_2, OR2A42_1@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F0852@79315@79315@deletion@1@144059764@144062916@7@chr7:144059764-144062916@12.1@148@63@0.426@CNVR3598.4, CNVR3598.5@ARHGEF5_2@0@0@0@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
F0852@79317@79323@deletion@7@144063940@144070377@7@chr7:144063940-144070377@20.4@448@252@0.562@CNVR3598.4, CNVR3598.5, CNVR3598.11@ARHGEF5_4, ARHGEF5_5, ARHGEF5_6, ARHGEF5_7, ARHGEF5_8, ARHGEF5_9, ARHGEF5_10@0@0@0@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
F0852@79505@79505@duplication@1@149992342@149992385@7@chr7:149992342-149992385@7.34@213@313@1.47@NA@ACTR3C_2@0@0@0@:ARP3 actin-related protein 3 homolog C (yeast)@:actin binding;regulation of actin filament polymerization;cytoskeleton;ATP binding@NA
F0852@79851@79852@deletion@2@152498707@152511730@7@chr7:152498707-152511730@14.2@221@107@0.484@NA@ACTR3B_4, ACTR3B_5@0@0@0@:ARP3 actin-related protein 3 homolog B (yeast)@:actin binding;regulation of actin filament polymerization;cytoskeleton;cell projection;ATP binding;cytoplasm@NA
F0852@80368@80371@duplication@4@7274293@7308422@8@chr8:7274293-7308422@6.98@320@435@1.36@CNVR3771.8, CNVR3771.10, CNVR3771.4@DEFB4B_1, DEFB103B_2, DEFB103B_1, SPAG11B_3@0@0@0@:defensin, beta 4B;defensin, beta 4A:defensin, beta 103B;defensin, beta 103A:sperm associated antigen 11B@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response@NA
F0852@80402@80403@deletion@2@7718169@7721057@8@chr8:7718169-7721057@32@207@41@0.198@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@SPAG11A_3, SPAG11A_4@0@0@0@:sperm associated antigen 11A;sperm associated antigen 11B@:extracellular region;defense response@NA
F0852@88594@88594@duplication@1@43818042@43818184@9@chr9:43818042-43818184@20@116@283@2.44@CNVR4294.1@CNTNAP3B_7@0@0@0@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
F0852@95346@95377@deletion@32@17813309@17951363@10@chr10:17813309-17951363@148@798@79@0.099@NA@TMEM236_2, TMEM236_3, TMEM236_4, MRC1L1_1, MRC1L1_2, MRC1L1_3, MRC1L1_4, MRC1L1_5, MRC1L1_6, MRC1L1_7, MRC1L1_8, MRC1L1_9, MRC1L1_10, MRC1L1_11, MRC1L1_12, MRC1L1_13, MRC1L1_14, MRC1L1_15, MRC1L1_16, MRC1L1_17, MRC1L1_18, MRC1L1_19, MRC1L1_20, MRC1L1_21, MRC1L1_22, MRC1L1_23, MRC1L1_24, MRC1L1_25, MRC1L1_26, MRC1L1_27, MRC1L1_28, MRC1L1_29@0@0@0@:transmembrane protein 236;transmembrane protein 236-like:macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding@NA
F0852@95380@95411@duplication@32@18060293@18198276@10@chr10:18060293-18198276@101@458@1247@2.72@NA@TMEM236_2, TMEM236_3, TMEM236_4, MRC1_1, MRC1_2, MRC1_3, MRC1_4, MRC1_5, MRC1_6, MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11, MRC1_12, MRC1_13, MRC1_14, MRC1_15, MRC1_16, MRC1_17, MRC1_18, MRC1_19, MRC1_20, MRC1_21, MRC1_22, MRC1_23, MRC1_24, MRC1_25, MRC1_26, MRC1_27, MRC1_28, MRC1_29@0@0@0@:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F0852@95948@95948@duplication@1@29580773@29580935@10@chr10:29580773-29580935@7.47@63@124@1.97@NA@LYZL1_2@0@0@0@:lysozyme-like 1@:extracellular region;lysozyme activity;cell wall macromolecule catabolic process@NA
F0852@96463@96463@duplication@1@46552470@46552531@10@chr10:46552470-46552531@4.78@3@32@10.7@CNVR4712.3@PTPN20A_9@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
F0852@96531@96531@deletion@1@47758847@47758904@10@chr10:47758847-47758904@5.38@24@0@0@CNVR4714.1@ANXA8L2_10@0@0@0@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:calcium-dependent phospholipid binding;calcium ion binding@NA
F0852@96554@96558@duplication@5@47933808@47942084@10@chr10:47933808-47942084@7.25@17@63@3.71@CNVR4715.2, CNVR4715.1@FAM21B_20, FAM21B_21, FAM21B_22, FAM21B_23, FAM21B_24@0@0@0@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
F0852@96573@96581@duplication@9@48025301@48055018@10@chr10:48025301-48055018@24.9@562@853@1.52@CNVR4715.2@ASAH2C_9, ASAH2C_8, ASAH2C_7, ASAH2C_6, ASAH2C_5, ASAH2C_4, ASAH2C_3, ASAH2C_2, ASAH2C_1@0@0@0@@:ceramidase activity;sphingolipid metabolic process@NA
F0852@96617@96617@deletion@1@48739389@48739450@10@chr10:48739389-48739450@5.5@64@28@0.438@CNVR4716.10@PTPN20B_9@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
F0852@96851@96852@deletion@2@51371542@51374428@10@chr10:51371542-51374428@15.2@73@3@0.0411@NA@TIMM23B_1, TIMM23B_2@0@0@0@:translocase of inner mitochondrial membrane 23 homolog B (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process@NA
F0852@96900@96939@deletion@40@51847036@51994312@10@chr10:51847036-51994312@54.1@247@0@0@NA@FAM21A_8, FAM21A_9, FAM21A_10, FAM21A_11, FAM21A_12, FAM21A_13, FAM21A_14, FAM21A_15, FAM21A_16, FAM21A_17, FAM21A_18, FAM21A_19, FAM21A_20, FAM21A_21, FAM21A_22, FAM21A_23, FAM21A_24, FAM21A_25, FAM21A_26, FAM21A_27, FAM21A_28, FAM21A_29, FAM21A_30, FAM21A_31, ASAH2_20, ASAH2_19, ASAH2_18, ASAH2_17, ASAH2_16, ASAH2_15, ASAH2_14, ASAH2_13, ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7, ASAH2_6, ASAH2_5@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
F0852@101608@101614@deletion@7@124344788@124353114@10@chr10:124344788-124353114@15.3@923@620@0.672@CNVR4912.4, CNVR4912.3, CNVR4912.2@DMBT1_15, DMBT1_16, DMBT1_17, DMBT1_18, DMBT1_19, DMBT1_20, DMBT1_21@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
F0852@102337@102337@duplication@1@135439427@135439503@10@chr10:135439427-135439503@4.66@153@219@1.43@CNVR4989.11, CNVR4989.4@FRG2B_3@0@0@0@:FSHD region gene 2 family, member B@:nucleus@NA
F0852@103269@103269@duplication@1@4976003@4976943@11@chr11:4976003-4976943@42.2@592@1213@2.05@CNVR5040.1@OR51A2_1@0@0@0@:matrix metallopeptidase 26:olfactory receptor, family 51, subfamily A, member 2@:metallopeptidase activity;extracellular matrix;proteolysis;proteinaceous extracellular matrix;collagen catabolic process;metalloendopeptidase activity;zinc ion binding;metabolic process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F0852@103342@103342@duplication@1@5798891@5799864@11@chr11:5798891-5799864@10.3@700@967@1.38@CNVR5049.1@OR52N5_1@0@0@0@:tripartite motif containing 5:olfactory receptor, family 52, subfamily N, member 5@:defense response to virus;Golgi apparatus;intracellular;protein trimerization;ligase activity;cytoplasm;protein binding;nucleus;protein homodimerization activity;identical protein binding;zinc ion binding;cytoplasmic mRNA processing body;protein ubiquitination;virus-host interaction:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F0852@106046@106048@duplication@3@55370918@55419315@11@chr11:55370918-55419315@53.7@2184@3270@1.5@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F0852@110109@110109@duplication@1@89531299@89531797@11@chr11:89531299-89531797@6.18@384@521@1.36@NA@TRIM49_8@0@0@0@:tripartite motif containing 49@:protein binding;intracellular;DNA binding;zinc ion binding@NA
F0852@114426@114426@duplication@1@10586391@10586541@12@chr12:10586391-10586541@5.06@225@312@1.39@CNVR5430.1@KLRC2_4@0@0@0@:killer cell lectin-like receptor subfamily C, member 2@:carbohydrate binding:transmembrane signaling receptor activity;carbohydrate binding;protein binding;signal transduction;cellular defense response;integral to plasma membrane@NA
F0852@114483@114483@deletion@1@11243900@11244828@12@chr12:11243900-11244828@8.88@1067@733@0.687@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
F0852@115537@115537@duplication@1@31249276@31249313@12@chr12:31249276-31249313@8.29@75@145@1.93@CNVR5483.1@DDX11_15@0@0@0@:DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11@:nucleoplasm;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;S phase of mitotic cell cycle;DNA binding;nucleobase-containing compound metabolic process;ATP binding;ATP-dependent DNA helicase activity;DNA helicase activity;midbody;RNA binding;DNA-dependent ATPase activity;nucleus;positive regulation of cell proliferation;virus-host interaction;nuclear chromatin;4 iron, 4 sulfur cluster binding;helicase activity;hydrolase activity, acting on acid anhydrides;DNA duplex unwinding;endoplasmic reticulum unfolded protein response;G2/M transition of mitotic cell cycle;protein binding;sister chromatid cohesion;activation of signaling protein activity involved in unfolded protein response;nucleolus;spindle pole;ATP-dependent helicase activity;metal ion binding;nucleic acid binding;mitotic sister chromatid segregation@: WARSAW BREAKAGE SYNDROME
F0852@117171@117171@duplication@1@52865851@52866064@12@chr12:52865851-52866064@5.1@139@204@1.47@NA@KRT6C_2@0@0@0@:keratin 6C@:intermediate filament;structural molecule activity;keratin filament;cytoskeleton organization@NA
F0852@124178@124178@deletion@1@24468279@24468340@13@chr13:24468279-24468340@27.8@207@48@0.232@NA@C1QTNF9B_2@0@0@0@:C1q and tumor necrosis factor related protein 9B@:collagen;protein binding@NA
F0852@124193@124193@duplication@1@24892957@24893018@13@chr13:24892957-24893018@7.85@308@439@1.43@NA@C1QTNF9_3@0@0@0@:spermatogenesis associated 13:C1q and tumor necrosis factor related protein 9@:lamellipodium assembly;phospholipid binding;Rac guanyl-nucleotide exchange factor activity;guanyl-nucleotide exchange factor activity;ruffle membrane;nucleus;regulation of cell migration;cell migration;regulation of Rho protein signal transduction;intracellular;Rho guanyl-nucleotide exchange factor activity;cytoplasm;filopodium assembly;filopodium;protein binding;lamellipodium:collagen;protein binding;hormone activity@NA
F0852@131032@131034@deletion@3@74004127@74010359@14@chr14:74004127-74010359@56.6@456@135@0.296@CNVR6188.1, CNVR6188.4@ACOT1_1, ACOT1_2, ACOT1_3@0@0@0@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
F0852@131036@131037@duplication@2@74040093@74042217@14@chr14:74040093-74042217@12.5@522@746@1.43@CNVR6188.1, CNVR6188.5, CNVR6188.6@ACOT2_2, ACOT2_3@0@0@0@:acyl-CoA thioesterase 2@:acyl-CoA metabolic process;mitochondrion;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity;receptor binding@NA
F0852@133426@133427@deletion@2@106478111@106478539@14@chr14:106478111-106478539@15.5@122@35@0.287@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV4-4_2, IGHV4-4_1@0@0@0@@:protein binding@NA
F0852@133450@133450@deletion@1@106725202@106725505@14@chr14:106725202-106725505@5.69@630@438@0.695@CNVR6294.48, CNVR6294.24, CNVR6294.40, CNVR6294.38, CNVR6294.17, CNVR6294.23@IGHV3-23_2@0@0@0@@:protein binding@NA
F0852@133452@133453@duplication@2@106733145@106733579@14@chr14:106733145-106733579@6.61@408@547@1.34@CNVR6294.48, CNVR6294.24, CNVR6294.40, CNVR6294.38, CNVR6294.17@IGHV1-24_2, IGHV1-24_1@0@0@0@@:protein binding@NA
F0852@133457@133459@deletion@3@106780901@106791456@14@chr14:106780901-106791456@28.9@682@355@0.521@CNVR6294.48, CNVR6294.24, CNVR6294.40, CNVR6294.38, CNVR6294.17, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV4-28_1, IGHV3-30_2, IGHV3-30_1@0@0@0@:uncharacterized LOC100653243;uncharacterized LOC642131@:protein binding:protein binding@NA
F0852@133470@133471@deletion@2@106877620@106878076@14@chr14:106877620-106878076@29.5@274@93@0.339@CNVR6294.26, CNVR6294.56, CNVR6294.2, CNVR6294.18@IGHV4-39_2, IGHV4-39_1@0@0@0@@:protein binding@NA
F0852@133478@133478@deletion@1@106993815@106994118@14@chr14:106993815-106994118@8.29@255@152@0.596@CNVR6294.56, CNVR6294.16, CNVR6294.87@IGHV3-48_2@0@0@0@@:protein binding@NA
F0852@133491@133492@duplication@2@107095127@107095561@14@chr14:107095127-107095561@10.5@82@165@2.01@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61_2, IGHV4-61_1@0@0@0@@:protein binding@NA
F0852@133495@133500@duplication@6@107131034@107179262@14@chr14:107131034-107179262@93.6@1415@2485@1.76@CNVR6294.56, CNVR6294.16, CNVR6294.6, CNVR6294.92@IGHV3-66_2, IGHV3-66_1, IGHV1-69_2, IGHV1-69_1, IGHV2-70_2, IGHV2-70_1@0@0@0@@:protein binding:protein binding:protein binding@NA
F0852@133541@133542@duplication@2@22368577@22383423@15@chr15:22368577-22383423@56.1@4186@6136@1.47@CNVR6297.4, CNVR6297.17, CNVR6297.2@OR4M2_1, OR4N4_1@0@0@0@:olfactory receptor, family 4, subfamily M, member 2:olfactory receptor, family 4, subfamily N, member 4@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F0852@134008@134012@deletion@5@30654497@30665348@15@chr15:30654497-30665348@27.1@413@207@0.501@CNVR6337.1@CHRFAM7A_10, CHRFAM7A_9, CHRFAM7A_8, CHRFAM7A_7, CHRFAM7A_6@0@0@0@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
F0852@134153@134156@duplication@4@32449810@32455536@15@chr15:32449810-32455536@6.15@202@284@1.41@CNVR6345.2, CNVR6345.1@CHRNA7_6, CHRNA7_7, CHRNA7_8, CHRNA7_9@0@0@0@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
F0852@135059@135061@duplication@3@41865507@41870474@15@chr15:41865507-41870474@21.1@607@893@1.47@NA@TYRO3_17, TYRO3_18, TYRO3_19@0@0@0@:TYRO3 protein tyrosine kinase@:protein tyrosine kinase activity;platelet aggregation;negative regulation of toll-like receptor signaling pathway;ATP binding;vagina development;substrate adhesion-dependent cell spreading;nucleus;negative regulation of lymphocyte activation;endoplasmic reticulum membrane;phosphatidylinositol 3-kinase cascade;nuclear envelope;platelet activation;protein kinase activity;protein kinase B signaling cascade;neuron homeostasis;negative regulation of neuron apoptotic process;negative regulation of innate immune response;protein autophosphorylation;transmembrane receptor protein tyrosine kinase activity;apoptotic cell clearance;transferase activity, transferring phosphorus-containing groups;spermatogenesis;forebrain cell migration;integral to membrane;integral to plasma membrane;ovulation cycle;natural killer cell differentiation;phosphatidylinositol 3-kinase binding;negative regulation of inflammatory response;protein phosphorylation;receptor signaling protein tyrosine kinase activity;protein heterodimerization activity;secretion by cell;protein binding;signal transduction;cell adhesion;signal transduction by phosphorylation@NA
F0852@147419@147421@deletion@3@72091292@72093087@16@chr16:72091292-72093087@19.8@358@183@0.511@CNVR6769.1, CNVR6769.2@HP_4, HP_5, HP_6@0@0@0@:thioredoxin-like 4B:haptoglobin:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:cellular iron ion homeostasis;negative regulation of oxidoreductase activity;catalytic activity;negative regulation of hydrogen peroxide catabolic process;positive regulation of cell death;haptoglobin-hemoglobin complex;extracellular space;proteolysis;response to hydrogen peroxide;extracellular region;hemoglobin binding;defense response;serine-type endopeptidase activity:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@: ANHAPTOGLOBINEMIA; AHP
F0852@149172@149172@duplication@1@2965964@2966901@17@chr17:2965964-2966901@4.97@561@734@1.31@NA@OR1D5_1@0@0@0@:olfactory receptor, family 1, subfamily D, member 5@:integral to membrane;sensory perception of smell;G-protein coupled receptor activity;plasma membrane;detection of chemical stimulus involved in sensory perception of smell;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F0852@153381@153381@duplication@1@34539885@34539971@17@chr17:34539885-34539971@10.1@35@106@3.03@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1_3@0@0@0@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
F0852@153397@153400@deletion@4@34625572@34641537@17@chr17:34625572-34641537@31.2@165@15@0.0909@CNVR7077.1, CNVR7077.2, CNVR7077.12@CCL3L1_1, CCL4L2_1, CCL4L2_2, CCL4L2_3@0@0@0@:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
F0852@153650@153651@duplication@2@36351930@36352526@17@chr17:36351930-36352526@15.7@869@1200@1.38@CNVR7083.3@RP11-1407O15.2_12, RP11-1407O15.2_11@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
F0852@153654@153654@duplication@1@36358126@36358158@17@chr17:36358126-36358158@6.18@218@311@1.43@CNVR7083.3@RP11-1407O15.2_8@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
F0852@154346@154346@deletion@1@39421631@39422112@17@chr17:39421631-39422112@4.91@50@20@0.4@CNVR7096.1@KRTAP9-6_1@0@0@0@:keratin associated protein 9-6@:keratin filament@NA
F0852@155587@155590@deletion@4@44399689@44409347@17@chr17:44399689-44409347@15.8@78@4@0.0513@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
F0852@155593@155599@deletion@7@44414663@44592687@17@chr17:44414663-44592687@18.4@90@5@0.0556@CNVR7114.2, CNVR7114.1@LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane@NA
F0852@155610@155611@duplication@2@44632519@44632790@17@chr17:44632519-44632790@7.99@151@237@1.57@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2_13, LRRC37A2_14@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
F0852@166916@166917@deletion@2@14508471@14508747@19@chr19:14508471-14508747@15.3@102@23@0.225@NA@CD97_7, CD97_8@0@0@0@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
F0852@168951@168951@deletion@1@35849794@35850833@19@chr19:35849794-35850833@11.8@476@291@0.611@CNVR7627.1@FFAR3_2@0@0@0@:free fatty acid receptor 3@:lipid binding;integral to membrane;G-protein coupled receptor activity;plasma membrane;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
F0852@170093@170100@duplication@8@40367299@40382826@19@chr19:40367299-40382826@20.9@382@594@1.55@CNVR7639.2@FCGBP_29, FCGBP_28, FCGBP_27, FCGBP_26, FCGBP_25, FCGBP_24, FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F0852@170104@170109@deletion@6@40389653@40399855@19@chr19:40389653-40399855@19.6@409@230@0.562@CNVR7639.2, CNVR7639.3@FCGBP_18, FCGBP_17, FCGBP_16, FCGBP_15, FCGBP_14, FCGBP_13@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F0852@172994@172994@duplication@1@52149511@52149893@19@chr19:52149511-52149893@6.79@57@112@1.96@CNVR7702.1@SIGLEC14_2@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 14@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion;plasma membrane@NA
F0852@173295@173295@duplication@1@54724399@54724700@19@chr19:54724399-54724700@10.9@168@282@1.68@CNVR7721.3, CNVR7721.4@LILRB3_6@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F0852@173298@173305@duplication@8@54726151@54745754@19@chr19:54726151-54745754@39.1@1202@1764@1.47@CNVR7721.3, CNVR7721.4, CNVR7721.1@LILRB3_3, LILRB3_2, LILRB3_1, LILRA6_8, LILRA6_7, LILRA6_6, LILRA6_5, LILRA6_4@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F0852@173468@173474@deletion@7@55263669@55290114@19@chr19:55263669-55290114@40.7@1041@594@0.571@CNVR7725.2, CNVR7725.1@KIR2DL3_7, KIR2DL3_8, KIR2DL1_1, KIR2DL1_2, KIR2DL1_3, KIR2DL1_4, KIR2DL1_5@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
F0852@173490@173493@duplication@4@55336484@55341730@19@chr19:55336484-55341730@16.6@537@772@1.44@CNVR7725.1, CNVR7725.6, CNVR7725.8@KIR3DL1_6, KIR3DL1_7, KIR3DL1_8, KIR3DL1_9@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
F0852@174395@174395@duplication@1@1569207@1569278@20@chr20:1569207-1569278@7.04@41@93@2.27@CNVR7763.1@RP4-576H24.4_1@0@0@0@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
F0852@174403@174403@duplication@1@1895746@1896101@20@chr20:1895746-1896101@9.83@193@306@1.59@CNVR7764.2@SIRPA_2@0@0@0@:signal-regulatory protein alpha@:blood coagulation;protein binding;integral to membrane;SH3 domain binding;cell adhesion;plasma membrane;membrane;leukocyte migration@NA
F0852@175737@175737@duplication@1@26063531@26063616@20@chr20:26063531-26063616@4.8@103@157@1.52@CNVR7823.4, CNVR7823.3, CNVR7823.5, CNVR7823.1@FAM182A_5@0@0@0@NA@NA@NA
F0852@180976@180976@deletion@1@16287255@16287885@22@chr22:16287255-16287885@4.66@74@38@0.514@CNVR8071.2, CNVR8071.3, CNVR8071.9@POTEH_1@0@0@0@:POTE ankyrin domain family, member H@:protein binding@NA
F0852@181135@181152@deletion@18@18893889@18918711@22@chr22:18893889-18918711@102@1820@948@0.521@CNVR8087.2, CNVR8087.14@DGCR6_1, DGCR6_2, DGCR6_3, DGCR6_4, DGCR6_5, PRODH_14, PRODH_13, PRODH_12, PRODH_11, PRODH_10, PRODH_9, PRODH_8, PRODH_7, PRODH_6, PRODH_5, PRODH_4, PRODH_3, PRODH_2@0@0@0@:DiGeorge syndrome critical region gene 6:proline dehydrogenase (oxidase) 1@:proteinaceous extracellular matrix;cell adhesion;nucleus;molecular_function;organ morphogenesis:oxidation-reduction process;mitochondrion;small molecule metabolic process;proline dehydrogenase activity;mitochondrial inner membrane;glutamate biosynthetic process;proline catabolic process to glutamate;proline catabolic process;4-hydroxyproline catabolic process;FAD binding;mitochondrial matrix;proline metabolic process;cellular nitrogen compound metabolic process;intrinsic apoptotic signaling pathway in response to oxidative stress@: SCHIZOPHRENIA; SCZD; SCHIZOPHRENIA 4; SCZD4; HYPERPROLINEMIA, TYPE I; HPI
F0852@181487@181488@deletion@2@21065630@21066899@22@chr22:21065630-21066899@7.28@49@12@0.245@CNVR8099.6, CNVR8099.2@PI4KA_51, PI4KA_50@0@0@0@:phosphatidylinositol 4-kinase, catalytic, alpha@:phospholipid metabolic process;1-phosphatidylinositol 4-kinase activity;small molecule metabolic process;phosphatidylinositol phosphorylation;binding;transferase activity, transferring phosphorus-containing groups;phosphotransferase activity, alcohol group as acceptor;ATP binding;Golgi-associated vesicle;phosphatidylinositol biosynthetic process;cytosol;protein binding;signal transduction;synaptic transmission;kinase activity;phosphatidylinositol-mediated signaling@NA
F0852@181948@181949@deletion@2@24324820@24325235@22@chr22:24324820-24325235@5.74@54@20@0.37@CNVR8114.6, CNVR8114.13, CNVR8114.8, CNVR8114.14@GSTT2_3, GSTT2_4@0@0@0@@:protein binding;glutathione transferase activity;nucleus;cytoplasm@NA
F0852@181951@181955@duplication@5@24376424@24384231@22@chr22:24376424-24384231@13.6@623@850@1.36@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTT1_5, GSTT1_4, GSTT1_3, GSTT1_2, GSTT1_1@0@0@0@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
F0852@184154@184154@deletion@1@42537163@42537296@22@chr22:42537163-42537296@7.63@111@53@0.477@CNVR8168.1, CNVR8168.3, CNVR8168.4@CYP2D7P1_3@0@0@0@@:oxidation-reduction process;electron carrier activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;heme binding@NA
F0852@1869@1871@deletion@3@48116678@48118066@X@chrX:48116678-48118066@23.5@455@251@0.552@CNVR8324.2@SSX1_2, SSX1_3, SSX1_4@0@0@0@NA@NA@NA
F0852@4078@4079@deletion@2@101619967@101620252@X@chrX:101619967-101620252@5.27@23@0@0@NA@NXF2B_28, NXF2B_27@0@0@0@NA@NA@NA
F0852@4090@4091@deletion@2@101624508@101625073@X@chrX:101624508-101625073@5.43@24@0@0@NA@NXF2B_16, NXF2B_15@0@0@0@NA@NA@NA
F0852@6297@6297@deletion@1@153458900@153459138@X@chrX:153458900-153459138@6.37@112@61@0.545@CNVR8489.1@OPN1MW_5@0@0@0@NA@NA@NA
F0852@6307@6307@duplication@1@153496018@153496256@X@chrX:153496018-153496256@8.58@45@106@2.36@CNVR8489.1@OPN1MW2_5@0@0@0@NA@NA@NA
F08560@440@440@deletion@1@1666130@1666274@1@chr1:1666130-1666274@5.73@65@28@0.431@CNVR17.1@SLC35E2_5@0@0@0@:solute carrier family 35, member E2@:integral to membrane;membrane@NA
F08560@2170@2187@duplication@18@17248515@17275019@1@chr1:17248515-17275019@59.9@1571@2333@1.49@CNVR94.4, CNVR94.5@CROCC_1, CROCC_2, CROCC_3, CROCC_4, CROCC_5, CROCC_6, CROCC_7, CROCC_8, CROCC_9, CROCC_10, CROCC_11, CROCC_12, CROCC_13, CROCC_14, CROCC_15, CROCC_16, CROCC_17, CROCC_18@0@0@0@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
F08560@3334@3342@duplication@9@25611065@25655415@1@chr1:25611065-25655415@38.8@1051@1537@1.46@CNVR116.1, CNVR116.2@RHD_2, RHD_3, RHD_4, RHD_5, RHD_6, RHD_7, RHD_8, RHD_9, RHD_10@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
F08560@3357@3357@deletion@1@25735175@25735360@1@chr1:25735175-25735360@19.8@93@2@0.0215@CNVR117.1@RHCE_2@0@0@0@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
F08560@5195@5196@duplication@2@40230296@40236927@1@chr1:40230296-40236927@9.39@416@576@1.38@NA@BMP8B_4, OXCT2_1@0@0@0@:bone morphogenetic protein 8b:3-oxoacid CoA transferase 2@:cell differentiation;growth factor activity;extracellular space;growth;extracellular region;cytokine activity;cartilage development;skeletal system development;ossification:mitochondrion;microtubule-based flagellum;CoA-transferase activity;ketone body catabolic process;3-oxoacid CoA-transferase activity;metabolic process@NA
F08560@9365@9386@deletion@22@104202983@104297436@1@chr1:104202983-104297436@42.4@413@155@0.375@CNVR266.3, CNVR266.5@AMY1A_7, AMY1A_8, AMY1A_9, AMY1A_10, AMY1A_11, AMY1B_11, AMY1B_10, AMY1B_9, AMY1B_8, AMY1B_7, AMY1B_6, AMY1B_5, AMY1B_4, AMY1B_3, AMY1B_2, AMY1C_1, AMY1C_2, AMY1C_3, AMY1C_4, AMY1C_5, AMY1C_6, AMY1C_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
F08560@9436@9436@deletion@1@108769302@108769515@1@chr1:108769302-108769515@7.53@51@12@0.235@CNVR294.4@NBPF4_14@0@0@0@:neuroblastoma breakpoint family, member 4@:cytoplasm@NA
F08560@9766@9773@deletion@8@110230497@110235917@1@chr1:110230497-110235917@75.4@343@0@0@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
F08560@12117@12118@duplication@2@152573209@152586574@1@chr1:152573209-152586574@12.2@115@214@1.86@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
F08560@16031@16033@deletion@3@196748928@196759357@1@chr1:196748928-196759357@13.8@309@181@0.586@CNVR459.1@CFHR3_3, CFHR3_4, CFHR3_5@0@0@0@:complement factor H-related 3@:extracellular space@NA
F08560@16037@16040@deletion@4@196795960@196801129@1@chr1:196795960-196801129@27.1@745@447@0.6@CNVR459.1@CFHR1_3, CFHR1_4, CFHR1_5, CFHR1_6@0@0@0@:complement factor H-related 1:complement factor H-related 2@:extracellular space;complement activation:extracellular region@NA
F08560@17297@17297@duplication@1@207741170@207741387@1@chr1:207741170-207741387@18@204@376@1.84@CNVR485.1, CNVR485.2@CR1_25@0@0@0@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
F08560@17624@17625@deletion@2@213003585@213009491@1@chr1:213003585-213009491@10.8@231@129@0.558@CNVR498.1@C1orf227_3, C1orf227_2@0@0@0@:chromosome 1 open reading frame 227@NA@NA
F08560@24407@24407@duplication@1@79253840@79253957@2@chr2:79253840-79253957@6.05@85@141@1.66@NA@REG3G_3@0@0@0@:regenerating islet-derived 3 gamma@:carbohydrate binding;extracellular region;acute-phase response@NA
F08560@24967@24969@deletion@3@89567759@89597316@2@chr2:89567759-89597316@6.17@122@68@0.557@CNVR866.7, CNVR866.1@IGKV1-33_2, IGKV1-33_1, IGKV1-37_2@0@0@0@@:protein binding:protein binding@NA
F08560@25003@25007@duplication@5@90153964@90199190@2@chr2:90153964-90199190@13.1@400@572@1.43@CNVR867.10, CNVR867.5, CNVR867.3, CNVR867.9@IGKV3D-15_2, IGKV1D-13_1, IGKV1D-13_2, IGKV1D-12_1, IGKV1D-12_2@0@0@0@@:protein binding:protein binding:protein binding@NA
F08560@25141@25143@duplication@3@96795564@96798460@2@chr2:96795564-96798460@5.32@227@309@1.36@NA@ASTL_8, ASTL_7, ASTL_6@0@0@0@:astacin-like metallo-endopeptidase (M12 family)@:metallopeptidase activity;positive regulation of protein processing;aspartic-type peptidase activity;peptidase activity;proteolysis;glutamic-type peptidase activity;plasma membrane;metalloendopeptidase activity;fertilization;negative regulation of binding of sperm to zona pellucida;transport vesicle;cytoplasm;cortical granule;protein binding;prevention of polyspermy;cell adhesion;zinc ion binding@NA
F08560@25377@25384@deletion@8@97862331@97868130@2@chr2:97862331-97868130@19.4@425@241@0.567@CNVR886.1@ANKRD36_41, ANKRD36_42, ANKRD36_43, ANKRD36_44, ANKRD36_45, ANKRD36_46, ANKRD36_47, ANKRD36_48@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
F08560@25393@25394@deletion@2@97877284@97877478@2@chr2:97877284-97877478@5.1@371@254@0.685@CNVR886.1@ANKRD36_57, ANKRD36_58@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
F08560@45962@45962@duplication@1@1741430@1741505@4@chr4:1741430-1741505@5.28@53@97@1.83@NA@TACC3_11@0@0@0@:transforming, acidic coiled-coil containing protein 3@:regulation of microtubule-based process;regulation of cell cycle;interkinetic nuclear migration;centrosome;astral microtubule organization;cytoplasmic sequestering of transcription factor;cytoplasm;response to stress;cerebral cortex development;cell proliferation;neurogenesis;microtubule cytoskeleton organization;hemopoiesis;protein domain specific binding@NA
F08560@48556@48561@duplication@6@69403344@69434202@4@chr4:69403344-69434202@58.6@992@1620@1.63@CNVR1953.1@UGT2B17_6, UGT2B17_5, UGT2B17_4, UGT2B17_3, UGT2B17_2, UGT2B17_1@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
F08560@48592@48596@duplication@5@70146220@70156529@4@chr4:70146220-70156529@8.16@569@747@1.31@CNVR1957.2, CNVR1957.1@UGT2B28_1, UGT2B28_2, UGT2B28_3, UGT2B28_4, UGT2B28_5@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
F08560@48967@48967@deletion@1@75312252@75312499@4@chr4:75312252-75312499@7.8@69@24@0.348@NA@AREG_2@0@0@0@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
F08560@53188@53191@duplication@4@190946717@190948359@4@chr4:190946717-190948359@29.8@604@956@1.58@CNVR2258.3@FRG2_4, FRG2_3, FRG2_2, FRG2_1@0@0@0@:FSHD region gene 2-like;FSHD region gene 2@:nucleus@NA
F08560@53308@53308@deletion@1@748520@748674@5@chr5:748520-748674@21.2@100@2@0.02@CNVR2280.3@ZDHHC11B_5@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
F08560@53320@53320@duplication@1@840611@840765@5@chr5:840611-840765@5.06@324@433@1.34@CNVR2280.3, CNVR2280.8@ZDHHC11_5@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
F08560@55806@55806@duplication@1@69372349@69372398@5@chr5:69372349-69372398@9.36@118@204@1.73@CNVR2494.48, CNVR2494.39, CNVR2494.15, CNVR2494.18, CNVR2494.26, CNVR2494.43, CNVR2494.52, CNVR2494.28, CNVR2494.2, CNVR2494.36@SMN2_8@0@0@0@:survival of motor neuron 2, centromeric;survival of motor neuron 1, telomeric@:nucleoplasm;ncRNA metabolic process;Cajal body;RNA metabolic process;spliceosomal complex;cytoplasm;cytosol;protein binding;cell death;spliceosomal complex assembly;RNA binding;mRNA processing;nucleus;gene expression;spliceosomal snRNP assembly@: SPINAL MUSCULAR ATROPHY, TYPE II; SMA2; SPINAL MUSCULAR ATROPHY, TYPE I; SMA1; SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4; SPINAL MUSCULAR ATROPHY, TYPE III; SMA3
F08560@59046@59047@deletion@2@140228082@140238021@5@chr5:140228082-140238021@67.5@2493@1356@0.544@CNVR2622.1@PCDHA9_1, PCDHA10_1@0@0@0@:protocadherin alpha 1:protocadherin alpha 2:protocadherin alpha 3:protocadherin alpha 4:protocadherin alpha 5:protocadherin alpha 6:protocadherin alpha 7:protocadherin alpha 8:protocadherin alpha 9:protocadherin alpha 10@:extracellular region;cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:integral to membrane;cell adhesion;homophilic cell adhesion;plasma membrane;integral to plasma membrane;membrane;nervous system development;calcium ion binding:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:extracellular region;cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding:extracellular region;cell adhesion;homophilic cell adhesion;integral to plasma membrane;membrane;calcium ion binding;nervous system development@NA
F08560@59065@59065@deletion@1@140557617@140560021@5@chr5:140557617-140560021@59.3@1764@843@0.478@CNVR2624.1@PCDHB8_1@0@0@0@:protocadherin beta 8@:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding@NA
F08560@60875@60879@duplication@5@175386973@175394270@5@chr5:175386973-175394270@16.2@228@375@1.64@NA@THOC3_6, THOC3_5, THOC3_4, THOC3_3, THOC3_2@0@0@0@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
F08560@63282@63282@duplication@1@31237988@31238262@6@chr6:31237988-31238262@4.63@162@228@1.41@CNVR2838.1@HLA-C_4@0@0@0@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
F08560@63290@63291@duplication@2@31323945@31324734@6@chr6:31323945-31324734@20@244@427@1.75@CNVR2841.12, CNVR2841.14, CNVR2841.8@HLA-B_3, HLA-B_2@0@0@0@:major histocompatibility complex, class I, B@:MHC class I protein complex;regulation of immune response;regulation of interleukin-12 production;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;regulation of T cell anergy;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;receptor binding;early endosome membrane;virus-host interaction;regulation of interleukin-6 production;regulation of dendritic cell differentiation;phagocytic vesicle membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO; SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1
F08560@63725@63725@deletion@1@31962023@31962161@6@chr6:31962023-31962161@6.96@33@1@0.0303@CNVR2843.6, CNVR2843.3@C4A_20@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
F08560@63768@63768@duplication@1@31994761@31994899@6@chr6:31994761-31994899@4.93@73@120@1.64@CNVR2843.6, CNVR2843.5@C4B_20@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
F08560@63953@63974@duplication@22@32485517@32634384@6@chr6:32485517-32634384@143@1673@2947@1.76@CNVR2845.21, CNVR2845.25, CNVR2845.24@HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2, HLA-DRB5_1, HLA-DRB1_5, HLA-DRB1_4, HLA-DRB1_3, HLA-DRB1_2, HLA-DRB1_1, HLA-DQA1_1, HLA-DQA1_2, HLA-DQA1_3, HLA-DQA1_4, HLA-DQB1_5, HLA-DQB1_4, HLA-DQB1_3, HLA-DQB1_2, HLA-DQB1_1@0@0@0@:major histocompatibility complex, class II, DR beta 5:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
F08560@71747@71749@deletion@3@5941289@5944900@7@chr7:5941289-5944900@27@403@196@0.486@NA@CCZ1_5, CCZ1_6, CCZ1_7@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F08560@71756@71756@duplication@1@5963467@5963593@7@chr7:5963467-5963593@7.42@196@289@1.47@NA@CCZ1_14@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F08560@71777@71779@deletion@3@6013031@6018327@7@chr7:6013031-6018327@16.3@171@69@0.404@NA@PMS2_15, PMS2_14, PMS2_13@0@0@0@:PMS2 postmeiotic segregation increased 2 (S. cerevisiae)@:response to drug;DNA binding;MutSalpha complex binding;ATP binding;mismatch repair;DNA repair;mismatched DNA binding;ATPase activity;nucleus;mismatch repair complex;reciprocal meiotic recombination;ATP catabolic process;single-stranded DNA binding;response to DNA damage stimulus;single base insertion or deletion binding;protein binding;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;MutLalpha complex;endonuclease activity@: COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4; MISMATCH REPAIR CANCER SYNDROME
F08560@71926@71926@deletion@1@6805338@6805422@7@chr7:6805338-6805422@7.96@121@60@0.496@NA@RSPH10B2_6@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F08560@71939@71942@deletion@4@6836200@6840706@7@chr7:6836200-6840706@25.4@143@20@0.14@NA@RSPH10B2_19, RSPH10B2_20, CCZ1B_15, CCZ1B_14@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F08560@71949@71951@duplication@3@6859398@6862991@7@chr7:6859398-6862991@16.9@342@525@1.54@NA@CCZ1B_7, CCZ1B_6, CCZ1B_5@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F08560@73260@73263@duplication@4@38388957@38393784@7@chr7:38388957-38393784@11@831@1092@1.31@CNVR3354.3, CNVR3354.1@TRGV5_2, TRGV5_1, TRGV4_2, TRGV4_1@0@0@0@@:protein binding:protein binding@NA
F08560@74775@74775@duplication@1@76063356@76063472@7@chr7:76063356-76063472@4.75@73@118@1.62@CNVR3462.1@ZP3_5@0@0@0@:zona pellucida glycoprotein 3 (sperm receptor)@:negative regulation of transcription, DNA-dependent;manganese ion transmembrane transporter activity;intracellular protein transport;proteinaceous extracellular matrix;plasma membrane;positive regulation of acrosome reaction;outer acrosomal membrane;protein kinase C signaling cascade;manganese ion transmembrane transport;intracellular signal transduction;humoral immune response mediated by circulating immunoglobulin;negative regulation of binding of sperm to zona pellucida;positive regulation of inflammatory response;endoplasmic reticulum;signal transducer activity;perinuclear region of cytoplasm;secretory granule;positive regulation of transcription, DNA-dependent;positive regulation of ovarian follicle development;positive regulation of interferon-gamma production;carbohydrate binding;manganese ion transport;positive regulation of antral ovarian follicle growth;extracellular matrix;positive regulation of leukocyte migration;positive regulation of humoral immune response;extracellular space;blastocyst formation;integral to membrane;store-operated calcium channel activity;oocyte development;multivesicular body;phosphatidylinositol-mediated signaling;acrosomal vesicle;positive regulation of protein kinase B signaling cascade;Golgi apparatus;positive regulation of calcium ion import;positive regulation of protein kinase activity;positive regulation of acrosomal vesicle exocytosis;positive regulation of interleukin-4 production;cytoplasm;protein binding;binding of sperm to zona pellucida;positive regulation of phosphatidylinositol biosynthetic process;extracellular region;positive regulation of T cell proliferation;acrosin binding;positive regulation of type IV hypersensitivity;egg coat formation@NA
F08560@74781@74783@duplication@3@76121471@76129837@7@chr7:76121471-76129837@10.9@65@144@2.22@CNVR3462.1@DTX2_6, DTX2_7, DTX2_8@0@0@0@:deltex homolog 2 (Drosophila)@:ligase activity;cytoplasm;nuclear membrane;Notch signaling pathway;protein binding;nucleus;zinc ion binding;protein ubiquitination@NA
F08560@74792@74793@duplication@2@76240783@76241130@7@chr7:76240783-76241130@11.3@226@349@1.54@CNVR3463.10@POMZP3_6, POMZP3_5@0@0@0@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
F08560@76427@76432@duplication@6@100331793@100336236@7@chr7:100331793-100336236@17@803@1092@1.36@CNVR3509.1@ZAN_1, ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
F08560@76731@76731@duplication@1@102136588@102136651@7@chr7:102136588-102136651@7.02@185@273@1.48@CNVR3518.1@RASA4B_11@0@0@0@:RAS p21 protein activator 4B@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction@NA
F08560@76754@76754@duplication@1@102219880@102220243@7@chr7:102219880-102220243@14.1@62@165@2.66@CNVR3518.1@AC093668.1_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
F08560@76795@76795@deletion@1@102318940@102319303@7@chr7:102318940-102319303@5.02@202@129@0.639@CNVR3518.1@AC105052.1_1@0@0@0@NA@NA@NA
F08560@77956@77956@duplication@1@128128156@128128215@7@chr7:128128156-128128215@5.98@54@103@1.91@NA@METTL2B_5@0@0@0@:methyltransferase like 2B@:methyltransferase activity;metabolic process@NA
F08560@79058@79061@deletion@4@142099456@142104553@7@chr7:142099456-142104553@36.3@856@479@0.56@NA@TRBV7-8_2, TRBV7-8_1, TRBV6-9_2, TRBV6-9_1@0@0@0@@:protein binding:protein binding@NA
F08560@79064@79069@duplication@6@142119821@142131877@7@chr7:142119821-142131877@50.4@1476@2173@1.47@NA@TRBV7-7_2, TRBV7-7_1, TRBV6-8_2, TRBV6-8_1, TRBV5-6_2, TRBV5-6_1@0@0@0@@:protein binding:protein binding:protein binding@NA
F08560@88584@88594@duplication@11@43624656@43818184@9@chr9:43624656-43818184@17@341@523@1.53@CNVR4294.1@SPATA31A6_4, SPATA31A6_3, SPATA31A6_2, SPATA31A6_1, CNTNAP3B_1, CNTNAP3B_2, CNTNAP3B_3, CNTNAP3B_4, CNTNAP3B_5, CNTNAP3B_6, CNTNAP3B_7@0@0@0@:SPATA31 subfamily A, member 6:contactin associated protein-like 3B;contactin associated protein-like 3@:integral to membrane:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
F08560@91249@91249@deletion@1@117092715@117092856@9@chr9:117092715-117092856@9.48@396@250@0.631@CNVR4448.1@ORM2_2@0@0@0@:orosomucoid 2@:extracellular space;regulation of immune system process;transport;acute-phase response@NA
F08560@93566@93566@deletion@1@138441155@138441176@9@chr9:138441155-138441176@5.24@66@30@0.455@CNVR4529.1@OBP2A_6@0@0@0@:odorant binding protein 2A@:odorant binding;sensory perception of chemical stimulus;response to stimulus;transport;extracellular region;sensory perception of smell;cellular_component@NA
F08560@95353@95355@duplication@3@17882693@17891768@10@chr10:17882693-17891768@7.65@271@381@1.41@NA@MRC1L1_5, MRC1L1_6, MRC1L1_7@0@0@0@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
F08560@95387@95393@deletion@7@18129623@18152611@10@chr10:18129623-18152611@28.2@139@7@0.0504@NA@MRC1_5, MRC1_6, MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F08560@95948@95948@deletion@1@29580773@29580935@10@chr10:29580773-29580935@7.68@60@18@0.3@NA@LYZL1_2@0@0@0@:lysozyme-like 1@:extracellular region;lysozyme activity;cell wall macromolecule catabolic process@NA
F08560@96579@96581@duplication@3@48048895@48055018@10@chr10:48048895-48055018@6.37@135@204@1.51@CNVR4715.2@ASAH2C_3, ASAH2C_2, ASAH2C_1@0@0@0@@:ceramidase activity;sphingolipid metabolic process@NA
F08560@96933@96937@deletion@5@51970584@51978390@10@chr10:51970584-51978390@8.52@144@79@0.549@NA@ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
F08560@101604@101614@duplication@11@124340383@124353114@10@chr10:124340383-124353114@15.2@957@1263@1.32@CNVR4912.4, CNVR4912.3, CNVR4912.2@DMBT1_11, DMBT1_12, DMBT1_13, DMBT1_14, DMBT1_15, DMBT1_16, DMBT1_17, DMBT1_18, DMBT1_19, DMBT1_20, DMBT1_21@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
F08560@101620@101630@deletion@11@124359581@124376776@10@chr10:124359581-124376776@20.2@378@201@0.532@CNVR4912.1@DMBT1_27, DMBT1_28, DMBT1_29, DMBT1_30, DMBT1_31, DMBT1_32, DMBT1_33, DMBT1_34, DMBT1_35, DMBT1_36, DMBT1_37@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
F08560@102336@102339@deletion@4@135438604@135440246@10@chr10:135438604-135440246@35.8@499@235@0.471@CNVR4989.11, CNVR4989.4@FRG2B_4, FRG2B_3, FRG2B_2, FRG2B_1@0@0@0@:FSHD region gene 2 family, member B@:nucleus@NA
F08560@103269@103269@duplication@1@4976003@4976943@11@chr11:4976003-4976943@33.2@502@911@1.81@CNVR5040.1@OR51A2_1@0@0@0@:matrix metallopeptidase 26:olfactory receptor, family 51, subfamily A, member 2@:metallopeptidase activity;extracellular matrix;proteolysis;proteinaceous extracellular matrix;collagen catabolic process;metalloendopeptidase activity;zinc ion binding;metabolic process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F08560@103342@103342@duplication@1@5798891@5799864@11@chr11:5798891-5799864@8.57@624@840@1.35@CNVR5049.1@OR52N5_1@0@0@0@:tripartite motif containing 5:olfactory receptor, family 52, subfamily N, member 5@:defense response to virus;Golgi apparatus;intracellular;protein trimerization;ligase activity;cytoplasm;protein binding;nucleus;protein homodimerization activity;identical protein binding;zinc ion binding;cytoplasmic mRNA processing body;protein ubiquitination;virus-host interaction:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F08560@104444@104444@deletion@1@18288436@18288525@11@chr11:18288436-18288525@11@119@48@0.403@NA@SAA1_2@0@0@0@:serum amyloid A1@:regulation of protein secretion;platelet activation;neutrophil chemotaxis;negative regulation of inflammatory response;positive regulation of cytokine secretion;macrophage chemotaxis;positive regulation of cell adhesion;positive regulation of interleukin-1 secretion;extracellular region;lymphocyte chemotaxis;high-density lipoprotein particle;elevation of cytosolic calcium ion concentration;acute-phase response;G-protein coupled receptor binding@NA
F08560@106046@106048@duplication@3@55370918@55419315@11@chr11:55370918-55419315@32.8@2089@2859@1.37@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F08560@110111@110114@deletion@4@89534135@89537637@11@chr11:89534135-89537637@8.04@95@42@0.442@NA@TRIM49_6, TRIM49_5, TRIM49_4, TRIM49_3@0@0@0@:tripartite motif containing 49@:protein binding;intracellular;DNA binding;zinc ion binding@NA
F08560@110120@110126@duplication@7@89608779@89774718@11@chr11:89608779-89774718@15.7@299@465@1.56@NA@TRIM64B_1, TRIM49C_3, TRIM49C_4, TRIM49C_5, TRIM49C_6, TRIM49C_7, TRIM49C_8@0@0@0@:tripartite motif containing 64;tripartite motif containing 64C;tripartite motif containing 64B:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;zinc ion binding:protein binding;intracellular;DNA binding;zinc ion binding@NA
F08560@114083@114083@duplication@1@7966913@7967130@12@chr12:7966913-7967130@10.9@164@273@1.66@NA@SLC2A14_16@0@0@0@:NECAP endocytosis associated 1:solute carrier family 2 (facilitated glucose transporter), member 14@:coated pit;protein binding;endocytosis;protein transport;clathrin vesicle coat;plasma membrane;membrane:multicellular organismal development;cell differentiation;substrate-specific transmembrane transporter activity;transport;folic acid binding;glucose transmembrane transporter activity;transmembrane transport;spermatogenesis;reduced folate carrier activity;integral to membrane;transmembrane transporter activity;membrane@NA
F08560@114483@114483@duplication@1@11243900@11244828@12@chr12:11243900-11244828@6.06@933@1207@1.29@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
F08560@115537@115537@deletion@1@31249276@31249313@12@chr12:31249276-31249313@10@75@21@0.28@CNVR5483.1@DDX11_15@0@0@0@:DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11@:nucleoplasm;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;S phase of mitotic cell cycle;DNA binding;nucleobase-containing compound metabolic process;ATP binding;ATP-dependent DNA helicase activity;DNA helicase activity;midbody;RNA binding;DNA-dependent ATPase activity;nucleus;positive regulation of cell proliferation;virus-host interaction;nuclear chromatin;4 iron, 4 sulfur cluster binding;helicase activity;hydrolase activity, acting on acid anhydrides;DNA duplex unwinding;endoplasmic reticulum unfolded protein response;G2/M transition of mitotic cell cycle;protein binding;sister chromatid cohesion;activation of signaling protein activity involved in unfolded protein response;nucleolus;spindle pole;ATP-dependent helicase activity;metal ion binding;nucleic acid binding;mitotic sister chromatid segregation@: WARSAW BREAKAGE SYNDROME
F08560@117170@117172@deletion@3@52865457@52867521@12@chr12:52865457-52867521@30.6@408@189@0.463@NA@KRT6C_3, KRT6C_2, KRT6C_1@0@0@0@:keratin 6C@:intermediate filament;structural molecule activity;keratin filament;cytoskeleton organization@NA
F08560@124096@124097@duplication@2@21729833@21732264@13@chr13:21729833-21732264@10.1@278@405@1.46@NA@SKA3_8, SKA3_7@0@0@0@:spindle and kinetochore associated complex subunit 3@:spindle microtubule;chromosome segregation;cytoplasm;mitosis;protein binding;regulation of microtubule polymerization or depolymerization;cell division;condensed chromosome outer kinetochore@NA
F08560@124100@124100@duplication@1@21742128@21742538@13@chr13:21742128-21742538@14@442@653@1.48@NA@SKA3_4@0@0@0@:spindle and kinetochore associated complex subunit 3@:spindle microtubule;chromosome segregation;cytoplasm;mitosis;protein binding;regulation of microtubule polymerization or depolymerization;cell division;condensed chromosome outer kinetochore@NA
F08560@127353@127358@deletion@6@20215588@20404761@14@chr14:20215588-20404761@28@8308@6140@0.739@CNVR6072.12, CNVR6072.4, CNVR6072.5@OR4Q3_1, OR4M1_1, OR4N2_1, OR4K2_1, OR4K5_1, OR4K1_1@0@0@0@:olfactory receptor, family 4, subfamily N, member 2:olfactory receptor, family 4, subfamily Q, member 3:olfactory receptor, family 4, subfamily M, member 1:olfactory receptor, family 4, subfamily K, member 2:olfactory receptor, family 4, subfamily K, member 5:olfactory receptor, family 4, subfamily K, member 1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F08560@128217@128223@deletion@7@24437967@24470726@14@chr14:24437967-24470726@46.3@959@532@0.555@NA@DHRS4_8, DHRS4L2_1, DHRS4L2_2, DHRS4L2_3, DHRS4L2_4, DHRS4L2_5, DHRS4L2_6@0@0@0@:dehydrogenase/reductase (SDR family) member 4:dehydrogenase/reductase (SDR family) member 4 like 2@:steroid metabolic process;oxidation-reduction process;mitochondrion;protein tetramerization;oxidoreductase activity;peroxisomal membrane;nucleus;cellular ketone metabolic process;metabolic process;receptor binding;alcohol dehydrogenase [NAD(P)+] activity;peroxisome;nucleotide binding;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;3-keto sterol reductase activity;alcohol metabolic process;carbonyl reductase (NADPH) activity:extracellular region;oxidoreductase activity;nucleotide binding;metabolic process@NA
F08560@131032@131034@duplication@3@74004127@74010359@14@chr14:74004127-74010359@20.1@386@601@1.56@CNVR6188.1, CNVR6188.4@ACOT1_1, ACOT1_2, ACOT1_3@0@0@0@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
F08560@133432@133456@deletion@25@106539080@106780817@14@chr14:106539080-106780817@270@4713@2459@0.522@CNVR6294.48, CNVR6294.24, CNVR6294.40@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1, IGHV3-11_2, IGHV3-11_1, IGHV3-13_2, IGHV3-13_1, IGHV3-15_2, IGHV3-15_1, IGHV3-16_2, IGHV3-16_1, IGHV1-18_2, IGHV1-18_1, IGHV3-20_2, IGHV3-20_1, IGHV3-21_2, IGHV3-21_1, IGHV3-23_2, IGHV3-23_1, IGHV1-24_2, IGHV1-24_1, IGHV2-26_2, IGHV2-26_1, IGHV4-28_2@0@0@0@:uncharacterized LOC100653243;uncharacterized LOC642131@:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding@NA
F08560@133458@133460@duplication@3@106791006@106805516@14@chr14:106791006-106805516@7.25@808@1043@1.29@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-30_2, IGHV3-30_1, IGHV4-31_2@0@0@0@@:protein binding:protein binding@NA
F08560@133478@133478@deletion@1@106993815@106994118@14@chr14:106993815-106994118@13@232@119@0.513@CNVR6294.56, CNVR6294.16, CNVR6294.87@IGHV3-48_2@0@0@0@@:protein binding@NA
F08560@133495@133495@deletion@1@107131034@107131334@14@chr14:107131034-107131334@11.2@173@85@0.491@CNVR6294.56, CNVR6294.16@IGHV3-66_2@0@0@0@@:protein binding@NA
F08560@134024@134024@deletion@1@30700112@30700195@15@chr15:30700112-30700195@10.9@202@106@0.525@NA@GOLGA8R_11@0@0@0@@:Golgi apparatus@NA
F08560@134155@134156@deletion@2@32451771@32455536@15@chr15:32451771-32455536@5.43@26@1@0.0385@CNVR6345.2, CNVR6345.1@CHRNA7_8, CHRNA7_9@0@0@0@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
F08560@138289@138290@deletion@2@72958124@72958469@15@chr15:72958124-72958469@5.2@63@29@0.46@CNVR6443.1@GOLGA6B_16, GOLGA6B_17@0@0@0@:golgin A6 family, member B@:Golgi apparatus@NA
F08560@142661@142670@deletion@10@14951075@14969111@16@chr16:14951075-14969111@41.9@802@429@0.535@NA@NOMO1_10, NOMO1_11, NOMO1_12, NOMO1_13, NOMO1_14, NOMO1_15, NOMO1_16, NOMO1_17, NOMO1_18, NOMO1_19@0@0@0@:NODAL modulator 1;nodal modulator 1-like@:carbohydrate binding;integral to membrane;carboxypeptidase activity;molecular_function;cellular_component;biological_process@NA
F08560@144096@144104@duplication@9@28617143@28659638@16@chr16:28617143-28659638@76.5@898@1619@1.8@NA@SULT1A1_10, SULT1A1_9, SULT1A1_8, SULT1A1_7, SULT1A1_6, SULT1A1_5, SULT1A1_4, A-575C2.4_1, A-575C2.4_2@0@0@0@:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1:nuclear pore complex-interacting protein-like 2-like;putative NPIP-like protein LOC613037-like@:small molecule metabolic process;sulfation;aryl sulfotransferase activity;amine metabolic process;catecholamine metabolic process;xenobiotic metabolic process;cytosol;steroid sulfotransferase activity;integral to membrane;sulfotransferase activity;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process;estrogen metabolic process@NA
F08560@145554@145560@duplication@7@55844430@55855433@16@chr16:55844430-55855433@10.4@938@1213@1.29@CNVR6731.1@CES1_11, CES1_10, CES1_9, CES1_8, CES1_7, CES1_6, CES1_5@0@0@0@:carboxylesterase 1;liver carboxylesterase 1-like@:hydrolase activity;methyl salicylate esterase activity;response to toxin;methylumbelliferyl-acetate deacetylase activity;endoplasmic reticulum lumen;retinyl-palmitate esterase activity;methyl jasmonate esterase activity;metabolic process;carboxylesterase activity;methyl indole-3-acetate esterase activity@: CARBOXYLESTERASE 1; CES1
F08560@149172@149172@duplication@1@2965964@2966901@17@chr17:2965964-2966901@7.19@523@700@1.34@NA@OR1D5_1@0@0@0@:olfactory receptor, family 1, subfamily D, member 5@:integral to membrane;sensory perception of smell;G-protein coupled receptor activity;plasma membrane;detection of chemical stimulus involved in sensory perception of smell;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F08560@151556@151561@duplication@6@16664740@16676947@17@chr17:16664740-16676947@31.1@996@1432@1.44@NA@CCDC144A_13, CCDC144A_13, CCDC144A_14, CCDC144A_14, CCDC144A_15, CCDC144A_15, CCDC144A_16, CCDC144A_16, CCDC144A_17, CCDC144A_18, CCDC144A_17@0@0@0@:coiled-coil domain containing 144A@NA@NA
F08560@151875@151885@deletion@11@18380170@18397681@17@chr17:18380170-18397681@80@549@125@0.228@CNVR7014.1@LGALS9C_1, LGALS9C_2, LGALS9C_3, LGALS9C_4, LGALS9C_5, LGALS9C_6, LGALS9C_7, LGALS9C_8, LGALS9C_9, LGALS9C_10, LGALS9C_11@0@0@0@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
F08560@153230@153231@duplication@2@33513319@33521326@17@chr17:33513319-33521326@11.9@352@508@1.44@NA@UNC45B_20, SLC35G3_1@0@0@0@:unc-45 homolog B (C. elegans):solute carrier family 35, member G3@:cytosol;cell differentiation;protein binding;Hsp90 protein binding;binding;chaperone-mediated protein folding;muscle organ development:integral to membrane;membrane@NA
F08560@153380@153381@deletion@2@34539179@34539971@17@chr17:34539179-34539971@7.95@36@0@0@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1_2, CCL4L1_3@0@0@0@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
F08560@153399@153400@duplication@2@34640745@34641537@17@chr17:34640745-34641537@7.27@116@187@1.61@CNVR7077.1, CNVR7077.2, CNVR7077.12@CCL4L2_2, CCL4L2_3@0@0@0@:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
F08560@153650@153652@deletion@3@36351930@36353765@17@chr17:36351930-36353765@17@1147@775@0.676@CNVR7083.3@RP11-1407O15.2_12, RP11-1407O15.2_11, RP11-1407O15.2_10@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
F08560@154346@154346@duplication@1@39421631@39422112@17@chr17:39421631-39422112@7.99@48@108@2.25@CNVR7096.1@KRTAP9-6_1@0@0@0@:keratin associated protein 9-6@:keratin filament@NA
F08560@155580@155581@duplication@2@44171927@44249509@17@chr17:44171927-44249509@16@1884@2516@1.34@CNVR7114.3, CNVR7114.2@KANSL1_3, KANSL1_2@0@0@0@:KAT8 regulatory NSL complex subunit 1@:histone acetyltransferase activity (H4-K8 specific);histone acetyltransferase activity (H4-K16 specific);histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase complex;histone H4-K5 acetylation;MLL1 complex;histone H4-K16 acetylation;protein binding;histone H4-K8 acetylation;nucleus@NA
F08560@155587@155599@deletion@13@44399689@44592687@17@chr17:44399689-44592687@31.1@196@40@0.204@CNVR7114.2, CNVR7114.1@LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9, LRRC37A_10, LRRC37A_11, LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane@NA
F08560@155610@155611@duplication@2@44632519@44632790@17@chr17:44632519-44632790@8.88@119@200@1.68@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2_13, LRRC37A2_14@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
F08560@162019@162019@duplication@1@44554574@44556213@18@chr18:44554574-44556213@20.1@126@289@2.29@CNVR7319.1@TCEB3C_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C (elongin A3);RNA polymerase II transcription factor SIII subunit A3-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
F08560@166811@166812@deletion@2@14070580@14070881@19@chr19:14070580-14070881@13.5@398@241@0.606@NA@DCAF15_9, DCAF15_10@0@0@0@:DDB1 and CUL4 associated factor 15@:protein ubiquitination@NA
F08560@166916@166917@deletion@2@14508471@14508747@19@chr19:14508471-14508747@9.65@95@37@0.389@NA@CD97_7, CD97_8@0@0@0@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
F08560@168952@168952@deletion@1@35862263@35863302@19@chr19:35862263-35863302@10.8@157@75@0.478@CNVR7627.1@GPR42_2@0@0@0@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
F08560@169783@169784@deletion@2@39281330@39282333@19@chr19:39281330-39282333@5.77@54@20@0.37@NA@LGALS7B_3, LGALS7B_4@0@0@0@:lectin, galactoside-binding, soluble, 7;lectin, galactoside-binding, soluble, 7B@:carbohydrate binding;heterophilic cell-cell adhesion;extracellular space;nucleus;apoptotic process;cytoplasm@NA
F08560@170098@170101@deletion@4@40376632@40384167@19@chr19:40376632-40384167@17.7@193@80@0.415@CNVR7639.2@FCGBP_24, FCGBP_23, FCGBP_22, FCGBP_21@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F08560@170104@170109@duplication@6@40389653@40399855@19@chr19:40389653-40399855@21.7@354@564@1.59@CNVR7639.2, CNVR7639.3@FCGBP_18, FCGBP_17, FCGBP_16, FCGBP_15, FCGBP_14, FCGBP_13@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F08560@170398@170398@deletion@1@41627364@41627523@19@chr19:41627364-41627523@8.57@162@87@0.537@CNVR7644.1@CYP2F1_5@0@0@0@:cytochrome P450, family 2, subfamily F, polypeptide 1@:trichloroethylene metabolic process;oxidation-reduction process;aromatase activity;response to toxin;oxygen binding;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;endoplasmic reticulum membrane;naphthalene metabolic process;intracellular membrane-bounded organelle;electron carrier activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;heme binding;xenobiotic metabolic process;monooxygenase activity;iron ion binding@NA
F08560@172565@172566@duplication@2@50463395@50464192@19@chr19:50463395-50464192@8.38@543@718@1.32@NA@SIGLEC11_3, SIGLEC11_2@0@0@0@:sialic acid binding Ig-like lectin 11@:carbohydrate binding;protein binding;integral to membrane;cell adhesion@NA
F08560@172987@172987@duplication@1@52133087@52133469@19@chr19:52133087-52133469@9.24@52@120@2.31@CNVR7702.1@SIGLEC5_2, SIGLEC5_2@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion@NA
F08560@172990@172994@deletion@5@52146791@52149893@19@chr19:52146791-52149893@24.7@433@232@0.536@CNVR7702.1@SIGLEC14_6, SIGLEC14_5, SIGLEC14_4, SIGLEC14_3, SIGLEC14_2@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 14@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion;plasma membrane@NA
F08560@173296@173308@duplication@13@54724956@54746600@19@chr19:54724956-54746600@185@1629@3373@2.07@CNVR7721.3, CNVR7721.4@LILRB3_5, LILRB3_4, LILRB3_3, LILRB3_2, LILRB3_1, LILRA6_8, LILRA6_7, LILRA6_6, LILRA6_5, LILRA6_4, LILRA6_3, LILRA6_2, LILRA6_1@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F08560@173468@173469@duplication@2@55263669@55263971@19@chr19:55263669-55263971@7.26@267@373@1.4@CNVR7725.2, CNVR7725.1@KIR2DL3_7, KIR2DL3_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity@NA
F08560@173491@173493@duplication@3@55340817@55341730@19@chr19:55340817-55341730@5.62@436@569@1.31@CNVR7725.1, CNVR7725.6@KIR3DL1_7, KIR3DL1_8, KIR3DL1_9@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
F08560@173499@173501@deletion@3@55358640@55359398@19@chr19:55358640-55359398@30.5@800@461@0.576@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4_6, KIR2DS4_7, KIR2DS4_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
F08560@174394@174394@deletion@1@1558985@1559340@20@chr20:1558985-1559340@11@411@254@0.618@CNVR7763.1, CNVR7763.2@RP4-576H24.4_2, SIRPB1_2@0@0@0@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
F08560@174403@174403@deletion@1@1895746@1896101@20@chr20:1895746-1896101@9.89@178@93@0.522@CNVR7764.2@SIRPA_2@0@0@0@:signal-regulatory protein alpha@:blood coagulation;protein binding;integral to membrane;SH3 domain binding;cell adhesion;plasma membrane;membrane;leukocyte migration@NA
F08560@180981@180981@duplication@1@17288630@17288963@22@chr22:17288630-17288963@25.2@543@888@1.64@NA@XKR3_2@0@0@0@:XK, Kell blood group complex subunit-related family, member 3@:integral to membrane;plasma membrane@NA
F08560@181135@181152@duplication@18@18893889@18918711@22@chr22:18893889-18918711@77.1@1716@2581@1.5@CNVR8087.2, CNVR8087.14@DGCR6_1, DGCR6_2, DGCR6_3, DGCR6_4, DGCR6_5, PRODH_14, PRODH_13, PRODH_12, PRODH_11, PRODH_10, PRODH_9, PRODH_8, PRODH_7, PRODH_6, PRODH_5, PRODH_4, PRODH_3, PRODH_2@0@0@0@:DiGeorge syndrome critical region gene 6:proline dehydrogenase (oxidase) 1@:proteinaceous extracellular matrix;cell adhesion;nucleus;molecular_function;organ morphogenesis:oxidation-reduction process;mitochondrion;small molecule metabolic process;proline dehydrogenase activity;mitochondrial inner membrane;glutamate biosynthetic process;proline catabolic process to glutamate;proline catabolic process;4-hydroxyproline catabolic process;FAD binding;mitochondrial matrix;proline metabolic process;cellular nitrogen compound metabolic process;intrinsic apoptotic signaling pathway in response to oxidative stress@: SCHIZOPHRENIA; SCZD; SCHIZOPHRENIA 4; SCZD4; HYPERPROLINEMIA, TYPE I; HPI
F08560@181806@181807@duplication@2@23243157@23247205@22@chr22:23243157-23247205@5.36@305@410@1.34@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11, CNVR8103.35@IGLC2_1, IGLJ3_1@0@0@0@@:protein binding@NA
F08560@181938@181938@duplication@1@24302482@24302568@22@chr22:24302482-24302568@6.41@15@56@3.73@CNVR8114.6, CNVR8114.12, CNVR8114.13, CNVR8114.8@GSTT2B_2@0@0@0@:glutathione S-transferase theta 2B (gene/pseudogene);glutathione S-transferase theta 2@:protein binding;glutathione transferase activity;nucleus;transferase activity;cytoplasm@NA
F08560@181947@181949@duplication@3@24323140@24325235@22@chr22:24323140-24325235@14.8@202@336@1.66@CNVR8114.6, CNVR8114.13, CNVR8114.8, CNVR8114.14@GSTT2_2, GSTT2_3, GSTT2_4@0@0@0@@:protein binding;glutathione transferase activity;nucleus;cytoplasm@NA
F08560@181951@181955@deletion@5@24376424@24384231@22@chr22:24376424-24384231@132@609@1@0.00164@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTT1_5, GSTT1_4, GSTT1_3, GSTT1_2, GSTT1_1@0@0@0@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
F08560@3356@3356@deletion@1@70812388@70812420@X@chrX:70812388-70812420@8.28@70@23@0.329@NA@ACRC_3@0@0@0@NA@NA@NA
F08560@3358@3358@duplication@1@70814597@70814629@X@chrX:70814597-70814629@5.99@87@144@1.66@NA@ACRC_5@0@0@0@NA@NA@NA
F08560@4052@4070@duplication@19@101571921@101581237@X@chrX:101571921-101581237@11.9@92@181@1.97@NA@NXF2_15, NXF2_16, NXF2_17, NXF2_18, NXF2_19, NXF2_20, NXF2_21, NXF2_22, NXF2_23, NXF2_24, NXF2_25, NXF2_26, NXF2_27, NXF2_28, NXF2_29, NXF2_30, NXF2_31, NXF2_32, NXF2_33@0@0@0@NA@NA@NA
F08560@4072@4080@deletion@9@101615523@101620439@X@chrX:101615523-101620439@37.8@172@0@0@NA@NXF2B_34, NXF2B_33, NXF2B_32, NXF2B_31, NXF2B_30, NXF2B_29, NXF2B_28, NXF2B_27, NXF2B_26@0@0@0@NA@NA@NA
F08560@4090@4091@deletion@2@101624508@101625073@X@chrX:101624508-101625073@5.09@22@0@0@NA@NXF2B_16, NXF2B_15@0@0@0@NA@NA@NA
F08560@5718@5719@deletion@2@140335651@140336590@X@chrX:140335651-140336590@37.3@185@9@0.0486@CNVR8456.1@SPANXC_2, SPANXC_1@0@0@0@NA@NA@NA
F08560@6307@6307@duplication@1@153496018@153496256@X@chrX:153496018-153496256@13.3@46@139@3.02@CNVR8489.1@OPN1MW2_5@0@0@0@NA@NA@NA
F08744@6@7@deletion@2@69092@139309@1@chr1:69092-139309@12.4@58@1@0.0172@CNVR1.2@OR4F5_1, AL627309.1_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F08744@308@335@deletion@28@1386065@1431197@1@chr1:1386065-1431197@170@2858@1354@0.474@NA@ATAD3C_1, ATAD3C_2, ATAD3C_3, ATAD3C_4, ATAD3C_5, ATAD3C_6, ATAD3C_7, ATAD3C_8, ATAD3C_9, ATAD3C_10, ATAD3C_11, ATAD3C_12, ATAD3B_1, ATAD3B_2, ATAD3B_3, ATAD3B_4, ATAD3B_5, ATAD3B_6, ATAD3B_7, ATAD3B_8, ATAD3B_9, ATAD3B_10, ATAD3B_11, ATAD3B_12, ATAD3B_13, ATAD3B_14, ATAD3B_15, ATAD3B_16@0@0@0@:ATPase family, AAA domain containing 3C:ATPase family, AAA domain containing 3B@:four-way junction helicase activity;DNA repair;nucleoside-triphosphatase activity;nucleotide binding;DNA recombination;ATP binding:nucleoside-triphosphatase activity;mitochondrial inner membrane;nucleotide binding;ATP binding@NA
F08744@422@422@deletion@1@1634916@1635063@1@chr1:1634916-1635063@4.63@123@71@0.577@CNVR17.1@CDK11A_18@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
F08744@1808@1826@deletion@19@12855588@13001395@1@chr1:12855588-13001395@32.3@1889@1236@0.654@CNVR72.3, CNVR72.4@PRAMEF1_4, PRAMEF11_4, PRAMEF11_3, PRAMEF11_2, HNRNPCL1_2, PRAMEF2_2, PRAMEF2_3, PRAMEF2_4, PRAMEF4_4, PRAMEF4_3, PRAMEF4_2, PRAMEF10_4, PRAMEF10_3, PRAMEF10_2, PRAMEF7_2, PRAMEF7_3, PRAMEF7_4, PRAMEF6_4, PRAMEF6_3@0@0@0@:PRAME family member 1:PRAME family member 11:heterogeneous nuclear ribonucleoprotein C-like 1-like;heterogeneous nuclear ribonucleoprotein C-like;heterogeneous nuclear ribonucleoprotein C-like 1:PRAME family member 2:PRAME family member 4:PRAME family member 10:PRAME family member 7:PRAME family member 6;PRAME family member 23;PRAME family member 9/15-like;PRAME family member 5@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:ribonucleoprotein complex;RNA binding;nucleus;nucleotide binding;nucleic acid binding:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
F08744@3334@3342@deletion@9@25611065@25655415@1@chr1:25611065-25655415@39.9@1210@704@0.582@CNVR116.1, CNVR116.2@RHD_2, RHD_3, RHD_4, RHD_5, RHD_6, RHD_7, RHD_8, RHD_9, RHD_10@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
F08744@3357@3357@duplication@1@25735175@25735360@1@chr1:25735175-25735360@9.22@110@206@1.87@CNVR117.1@RHCE_2@0@0@0@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
F08744@5196@5198@deletion@3@40235375@40240710@1@chr1:40235375-40240710@10.1@398@238@0.598@NA@OXCT2_1, BMP8B_3, BMP8B_2@0@0@0@:bone morphogenetic protein 8b:3-oxoacid CoA transferase 2@:cell differentiation;growth factor activity;extracellular space;growth;extracellular region;cytokine activity;cartilage development;skeletal system development;ossification:mitochondrion;microtubule-based flagellum;CoA-transferase activity;ketone body catabolic process;3-oxoacid CoA-transferase activity;metabolic process@NA
F08744@8507@8508@duplication@2@89476588@89477710@1@chr1:89476588-89477710@10.4@602@842@1.4@CNVR244.1@GBP3_8, GBP3_7@0@0@0@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
F08744@9373@9374@duplication@2@104233917@104234232@1@chr1:104233917-104234232@24.6@60@258@4.3@CNVR266.3, CNVR266.5@AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
F08744@9385@9386@deletion@2@104297122@104297436@1@chr1:104297122-104297436@13.3@302@160@0.53@CNVR266.3, CNVR266.5@AMY1C_6, AMY1C_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
F08744@9436@9436@deletion@1@108769302@108769515@1@chr1:108769302-108769515@11@61@7@0.115@CNVR294.4@NBPF4_14@0@0@0@:neuroblastoma breakpoint family, member 4@:cytoplasm@NA
F08744@9766@9773@duplication@8@110230497@110235917@1@chr1:110230497-110235917@140@401@1604@4@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
F08744@12117@12118@duplication@2@152573209@152586574@1@chr1:152573209-152586574@10@137@238@1.74@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
F08744@14056@14056@duplication@1@161599569@161599825@1@chr1:161599569-161599825@5.75@96@159@1.66@CNVR383.1@FCGR3B_3@0@0@0@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIIb, receptor (CD16b)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction:IgG binding;protein binding;extracellular region;immune response;plasma membrane;anchored to membrane@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
F08744@16036@16040@deletion@5@196794608@196801129@1@chr1:196794608-196801129@34.8@1083@649@0.599@CNVR459.1@CFHR1_2, CFHR1_3, CFHR1_4, CFHR1_5, CFHR1_6@0@0@0@:complement factor H-related 1:complement factor H-related 2@:extracellular space;complement activation:extracellular region@NA
F08744@19775@19777@deletion@3@248756132@248802559@1@chr1:248756132-248802559@24.1@1601@991@0.619@CNVR600.1@OR2T10_1, OR2T11_1, OR2T35_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 10:olfactory receptor, family 2, subfamily T, member 11:olfactory receptor, family 2, subfamily T, member 35@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F08744@24407@24407@deletion@1@79253840@79253957@2@chr2:79253840-79253957@7.12@95@42@0.442@NA@REG3G_3@0@0@0@:regenerating islet-derived 3 gamma@:carbohydrate binding;extracellular region;acute-phase response@NA
F08744@24953@24954@deletion@2@89416834@89417308@2@chr2:89416834-89417308@17.2@266@116@0.436@CNVR866.7, CNVR866.10, CNVR866.11@IGKV1-17_2, IGKV1-17_1@0@0@0@@:protein binding@NA
F08744@24966@24969@deletion@4@89545002@89597316@2@chr2:89545002-89597316@8.72@182@101@0.555@CNVR866.7, CNVR866.1@IGKV2-30_1, IGKV1-33_2, IGKV1-33_1, IGKV1-37_2@0@0@0@@:protein binding:protein binding:protein binding@NA
F08744@25004@25006@duplication@3@90192949@90198770@2@chr2:90192949-90198770@11.8@341@514@1.51@CNVR867.10, CNVR867.5, CNVR867.3, CNVR867.9, CNVR867.15@IGKV1D-13_1, IGKV1D-13_2, IGKV1D-12_1@0@0@0@@:protein binding:protein binding@NA
F08744@25013@25013@duplication@1@90249101@90249395@2@chr2:90249101-90249395@6.31@472@657@1.39@CNVR867.10, CNVR867.3, CNVR867.2, CNVR867.8, CNVR867.16@IGKV1D-43_2@0@0@0@@:protein binding@NA
F08744@25089@25089@duplication@1@96259773@96260182@2@chr2:96259773-96260182@6.73@136@219@1.61@NA@TRIM43_2@0@0@0@:tripartite motif containing 43B;tripartite motif containing 43@:protein binding;intracellular;zinc ion binding@NA
F08744@27341@27342@deletion@2@132288153@132289375@2@chr2:132288153-132289375@15.2@183@81@0.443@NA@CCDC74A_3, CCDC74A_4@0@0@0@:coiled-coil domain containing 74A@NA@NA
F08744@45434@45438@deletion@5@195451552@195475935@3@chr3:195451552-195475935@10.8@1969@1390@0.706@CNVR1703.1, CNVR1703.2, CNVR1703.5, CNVR1703.3@MUC20_2, MUC20_3, MUC20_4, MUC4_25, MUC4_24@0@0@0@:mucin 20, cell surface associated:mucin 4, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane:ErbB-2 class receptor binding;Golgi lumen;cell-matrix adhesion;post-translational protein modification;extracellular matrix structural constituent;protein binding;O-glycan processing;cellular protein metabolic process;proteinaceous extracellular matrix;integral to plasma membrane;membrane;extracellular matrix constituent, lubricant activity;biological_process@NA
F08744@48967@48967@deletion@1@75312252@75312499@4@chr4:75312252-75312499@6.49@80@34@0.425@NA@AREG_2@0@0@0@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
F08744@53306@53308@deletion@3@741710@748674@5@chr5:741710-748674@29.1@347@150@0.432@CNVR2280.3@ZDHHC11B_7, ZDHHC11B_6, ZDHHC11B_5@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
F08744@54099@54102@duplication@4@32108076@32143986@5@chr5:32108076-32143986@63.3@1290@2317@1.8@NA@PDZD2_25, GOLPH3_4, GOLPH3_3, GOLPH3_2@0@0@0@:PDZ domain containing 2:golgi phosphoprotein 3 (coat-protein)@:cell-cell junction;protein binding;extracellular region;endoplasmic reticulum;cell adhesion;nucleus;cytoplasm:endosome;mitochondrion;Golgi apparatus;regulation of mitochondrion organization;mitochondrial intermembrane space;cytoplasm;positive regulation of TOR signaling cascade;lipid binding;Golgi cisterna membrane;nuclear membrane;cell proliferation;cytosol;trans-Golgi network;protein binding;plasma membrane@NA
F08744@59065@59065@duplication@1@140557617@140560021@5@chr5:140557617-140560021@21.7@1749@2905@1.66@CNVR2624.1@PCDHB8_1@0@0@0@:protocadherin beta 8@:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding@NA
F08744@60876@60877@duplication@2@175388055@175388437@5@chr5:175388055-175388437@11.2@65@152@2.34@NA@THOC3_5, THOC3_4@0@0@0@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
F08744@63281@63282@duplication@2@31237744@31238262@6@chr6:31237744-31238262@32@347@736@2.12@CNVR2838.2, CNVR2838.1@HLA-C_5, HLA-C_4@0@0@0@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
F08744@63290@63290@duplication@1@31323945@31324219@6@chr6:31323945-31324219@6.67@129@210@1.63@CNVR2841.12, CNVR2841.14, CNVR2841.8@HLA-B_3@0@0@0@:major histocompatibility complex, class I, B@:MHC class I protein complex;regulation of immune response;regulation of interleukin-12 production;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;regulation of T cell anergy;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;receptor binding;early endosome membrane;virus-host interaction;regulation of interleukin-6 production;regulation of dendritic cell differentiation;phagocytic vesicle membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO; SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1
F08744@63747@63748@deletion@2@31973946@31974881@6@chr6:31973946-31974881@29.5@136@0@0@CNVR2843.6, CNVR2843.3@AL645922.1_2, AL645922.1_1@0@0@0@NA@NA@NA
F08744@63790@63810@duplication@21@32006201@32011906@6@chr6:32006201-32011906@97.8@1519@2678@1.76@CNVR2843.6, CNVR2843.5@CYP21A2_1, CYP21A2_2, CYP21A2_3, CYP21A2_4, CYP21A2_5, CYP21A2_6, CYP21A2_7, CYP21A2_8, CYP21A2_9, CYP21A2_10, TNXB_13, TNXB_12, TNXB_11, TNXB_10, TNXB_9, TNXB_8, TNXB_7, TNXB_6, TNXB_5, TNXB_4, TNXB_3@0@0@0@:cytochrome P450, family 21, subfamily A, polypeptide 2:tenascin-X-like;tenascin XB@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
F08744@63953@63958@deletion@6@32485517@32498001@6@chr6:32485517-32498001@63.5@367@46@0.125@CNVR2845.21, CNVR2845.25, CNVR2845.30, CNVR2845.43, CNVR2845.6@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2, HLA-DRB5_1@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
F08744@63962@63974@deletion@13@32549335@32634384@6@chr6:32549335-32634384@148@1559@565@0.362@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.34@HLA-DRB1_3, HLA-DRB1_2, HLA-DRB1_1, HLA-DQA1_1, HLA-DQA1_2, HLA-DQA1_3, HLA-DQA1_4, HLA-DQB1_6, HLA-DQB1_5, HLA-DQB1_4, HLA-DQB1_3, HLA-DQB1_2, HLA-DQB1_1@0@0@0@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
F08744@64013@64013@duplication@1@32818098@32818294@6@chr6:32818098-32818294@4.63@141@209@1.48@NA@TAP1_5@0@0@0@:proteasome (prosome, macropain) subunit, beta type, 9 (large multifunctional peptidase 2):transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)@:nucleoplasm;proteasome complex;S phase of mitotic cell cycle;mitotic cell cycle;antigen processing and presentation of peptide antigen via MHC class I;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;mRNA metabolic process;viral reproduction;nucleus;gene expression;cell cycle checkpoint;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;cytosol;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;proteolysis involved in cellular protein catabolic process;regulation of apoptotic process;cellular nitrogen compound metabolic process;proteasome core complex;RNA metabolic process;G1/S transition of mitotic cell cycle;regulation of cellular amino acid metabolic process;apoptotic process;virus-host interaction;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;small molecule metabolic process;threonine-type endopeptidase activity;M/G1 transition of mitotic cell cycle;cytoplasm;protein binding;protein polyubiquitination:ADP binding;ATPase activity, coupled to transmembrane movement of substances;mitochondrion;antigen processing and presentation of peptide antigen via MHC class I;transporter activity;ATP binding;transmembrane transport;integral to endoplasmic reticulum membrane;peptide antigen binding;peptide transporter activity;ATPase activity;plasma membrane;endoplasmic reticulum membrane;defense response;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;antigen processing and presentation of endogenous peptide antigen via MHC class I;peptide transport;cytosol;antigen processing and presentation of exogenous peptide antigen via MHC class I;oligopeptide-transporting ATPase activity;TAP2 binding;transport;integral to membrane;protein homodimerization activity;MHC class I protein binding;intracellular transport of viral proteins in host cell;cytosol to ER transport;nucleoside-triphosphatase activity;protection from natural killer cell mediated cytotoxicity;positive regulation of T cell mediated cytotoxicity;protein heterodimerization activity;nucleotide binding;tapasin binding;protein binding;TAP complex;TAP1 binding@: BARE LYMPHOCYTE SYNDROME, TYPE I
F08744@64059@64061@duplication@3@33052728@33054015@6@chr6:33052728-33054015@9.84@522@728@1.39@CNVR2846.4, CNVR2846.3, CNVR2846.5@HLA-DPB1_3, HLA-DPB1_4, HLA-DPB1_5@0@0@0@:major histocompatibility complex, class II, DP beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
F08744@71030@71030@duplication@1@167790035@167790192@6@chr6:167790035-167790192@9.62@34@107@3.15@NA@TCP10_5@0@0@0@:t-complex 10@:cytosol@NA
F08744@71744@71754@deletion@11@5939916@5959597@7@chr7:5939916-5959597@35.4@1380@892@0.646@NA@CCZ1_2, CCZ1_3, CCZ1_4, CCZ1_5, CCZ1_6, CCZ1_7, CCZ1_8, CCZ1_9, CCZ1_10, CCZ1_11, CCZ1_12@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F08744@71926@71926@deletion@1@6805338@6805422@7@chr7:6805338-6805422@7.49@138@69@0.5@NA@RSPH10B2_6@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F08744@71949@71951@duplication@3@6859398@6862991@7@chr7:6859398-6862991@10.5@385@550@1.43@NA@CCZ1B_7, CCZ1B_6, CCZ1B_5@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F08744@73242@73242@duplication@1@38279626@38279767@7@chr7:38279626-38279767@4.67@44@84@1.91@NA@TRGC2_4@0@0@0@@:protein binding@NA
F08744@73260@73263@duplication@4@38388957@38393784@7@chr7:38388957-38393784@17.8@929@1314@1.41@CNVR3354.3, CNVR3354.1@TRGV5_2, TRGV5_1, TRGV4_2, TRGV4_1@0@0@0@@:protein binding:protein binding@NA
F08744@74775@74775@duplication@1@76063356@76063472@7@chr7:76063356-76063472@5.65@74@130@1.76@CNVR3462.1@ZP3_5@0@0@0@:zona pellucida glycoprotein 3 (sperm receptor)@:negative regulation of transcription, DNA-dependent;manganese ion transmembrane transporter activity;intracellular protein transport;proteinaceous extracellular matrix;plasma membrane;positive regulation of acrosome reaction;outer acrosomal membrane;protein kinase C signaling cascade;manganese ion transmembrane transport;intracellular signal transduction;humoral immune response mediated by circulating immunoglobulin;negative regulation of binding of sperm to zona pellucida;positive regulation of inflammatory response;endoplasmic reticulum;signal transducer activity;perinuclear region of cytoplasm;secretory granule;positive regulation of transcription, DNA-dependent;positive regulation of ovarian follicle development;positive regulation of interferon-gamma production;carbohydrate binding;manganese ion transport;positive regulation of antral ovarian follicle growth;extracellular matrix;positive regulation of leukocyte migration;positive regulation of humoral immune response;extracellular space;blastocyst formation;integral to membrane;store-operated calcium channel activity;oocyte development;multivesicular body;phosphatidylinositol-mediated signaling;acrosomal vesicle;positive regulation of protein kinase B signaling cascade;Golgi apparatus;positive regulation of calcium ion import;positive regulation of protein kinase activity;positive regulation of acrosomal vesicle exocytosis;positive regulation of interleukin-4 production;cytoplasm;protein binding;binding of sperm to zona pellucida;positive regulation of phosphatidylinositol biosynthetic process;extracellular region;positive regulation of T cell proliferation;acrosin binding;positive regulation of type IV hypersensitivity;egg coat formation@NA
F08744@74792@74793@duplication@2@76240783@76241130@7@chr7:76240783-76241130@5.9@265@368@1.39@CNVR3463.10@POMZP3_6, POMZP3_5@0@0@0@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
F08744@76428@76432@deletion@5@100333344@100336236@7@chr7:100333344-100336236@12.7@869@584@0.672@CNVR3509.1@ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
F08744@78412@78412@duplication@1@134221804@134221909@7@chr7:134221804-134221909@5.55@115@182@1.58@NA@AKR1B10_6@0@0@0@:aldo-keto reductase family 1, member B10 (aldose reductase)@:steroid metabolic process;cellular aldehyde metabolic process;indanol dehydrogenase activity;daunorubicin metabolic process;retinal dehydrogenase activity;farnesol catabolic process;geranylgeranyl reductase activity;protein binding;extracellular region;aldo-keto reductase (NADP) activity;digestion;doxorubicin metabolic process;cellular_component;lysosome@NA
F08744@79056@79057@deletion@2@142045364@142045816@7@chr7:142045364-142045816@8.7@615@401@0.652@NA@TRBV4-2_1, TRBV4-2_2@0@0@0@@:protein binding@NA
F08744@79311@79325@deletion@15@143929005@144072768@7@chr7:143929005-144072768@64.4@2005@1099@0.548@CNVR3598.4@OR2A42_1, OR2A7_1, CTAGE8_1, OR2A1_1, ARHGEF5_2, ARHGEF5_3, ARHGEF5_4, ARHGEF5_5, ARHGEF5_6, ARHGEF5_7, ARHGEF5_8, ARHGEF5_9, ARHGEF5_10, ARHGEF5_11, ARHGEF5_12@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:olfactory receptor, family 2, subfamily A, member 7:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
F08744@80371@80376@duplication@6@7308236@7340274@8@chr8:7308236-7340274@22.8@472@783@1.66@CNVR3771.8, CNVR3771.10, CNVR3771.4@SPAG11B_3, SPAG11B_2, SPAG11B_1, DEFB104B_2, DEFB104B_1, DEFB106B_2@0@0@0@:sperm associated antigen 11B:defensin, beta 104A;defensin, beta 104B:defensin, beta 106B;defensin, beta 106A@:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
F08744@80388@80388@duplication@1@7637545@7637611@8@chr8:7637545-7637611@5.15@36@77@2.14@CNVR3772.4, CNVR3772.6, CNVR3772.2, CNVR3772.8, CNVR3772.10@AC084121.16_3@0@0@0@:uncharacterized LOC100133251@NA@NA
F08744@80402@80402@deletion@1@7718169@7718245@8@chr8:7718169-7718245@24@138@13@0.0942@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@SPAG11A_3@0@0@0@:sperm associated antigen 11A;sperm associated antigen 11B@:extracellular region;defense response@NA
F08744@80406@80406@duplication@1@7752236@7752292@8@chr8:7752236-7752292@7.81@165@267@1.62@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@DEFB4A_1@0@0@0@:defensin, beta 4B;defensin, beta 4A@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response@NA
F08744@86286@86288@deletion@3@145193411@145194003@8@chr8:145193411-145194003@7.33@89@38@0.427@NA@FAM203A_2, FAM203A_3, FAM203A_4@0@0@0@:family with sequence similarity 203, member B;family with sequence similarity 203, member A@:binding;molecular_function;cellular_component;biological_process@NA
F08744@86351@86351@duplication@1@145438827@145438924@8@chr8:145438827-145438924@5.52@6@42@7@NA@FAM203B_3@0@0@0@:family with sequence similarity 203, member B@:binding@NA
F08744@93184@93194@duplication@11@135937382@135947151@9@chr9:135937382-135947151@53.2@2077@3047@1.47@NA@CEL_1, CEL_2, CEL_3, CEL_4, CEL_5, CEL_6, CEL_7, CEL_8, CEL_9, CEL_10, CEL_11@0@0@0@:carboxyl ester lipase (bile salt-stimulated lipase)@:intestinal lipid catabolic process;pancreatic juice secretion;catalytic activity;extracellular space;heparin binding;sterol esterase activity;carboxylesterase activity;metabolic process;ceramide catabolic process;hydrolase activity;small molecule metabolic process;acylglycerol lipase activity;lipid metabolic process;cytoplasm;protein esterification;cytosol;retinyl-palmitate esterase activity;fatty acid catabolic process;extracellular region;triglyceride lipase activity;lipid digestion;triglyceride metabolic process;cholesterol catabolic process;intestinal cholesterol absorption@: MATURITY-ONSET DIABETES OF THE YOUNG; MODY; MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION;
F08744@95131@95135@deletion@5@14987105@15014640@10@chr10:14987105-15014640@152@774@4@0.00517@NA@DCLRE1C_3, DCLRE1C_2, DCLRE1C_1, MEIG1_2, MEIG1_3@0@0@0@:DNA cross-link repair 1C:meiosis expressed gene 1 homolog (mouse)@:double-strand break repair;response to ionizing radiation;chromosome organization;B cell differentiation;nucleus;5'-3' exonuclease activity;telomere maintenance;single-stranded DNA specific endodeoxyribonuclease activity;DNA recombination:cell differentiation;spermatogenesis;nucleus@: OMENN SYNDROME; SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION
F08744@95346@95346@deletion@1@17813309@17813380@10@chr10:17813309-17813380@5.26@28@3@0.107@NA@TMEM236_2@0@0@0@:transmembrane protein 236;transmembrane protein 236-like@:integral to membrane@NA
F08744@95350@95355@duplication@6@17865074@17891768@10@chr10:17865074-17891768@13.3@524@742@1.42@NA@MRC1L1_2, MRC1L1_3, MRC1L1_4, MRC1L1_5, MRC1L1_6, MRC1L1_7@0@0@0@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
F08744@95384@95393@deletion@10@18112045@18152611@10@chr10:18112045-18152611@63.6@331@21@0.0634@NA@MRC1_2, MRC1_3, MRC1_4, MRC1_5, MRC1_6, MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F08744@95947@95948@duplication@2@29578048@29580935@10@chr10:29578048-29580935@5.08@166@238@1.43@NA@LYZL1_1, LYZL1_2@0@0@0@:lysozyme-like 1@:extracellular region;lysozyme activity;cell wall macromolecule catabolic process@NA
F08744@96900@96914@deletion@15@51847036@51877818@10@chr10:51847036-51877818@10.6@48@0@0@NA@FAM21A_8, FAM21A_9, FAM21A_10, FAM21A_11, FAM21A_12, FAM21A_13, FAM21A_14, FAM21A_15, FAM21A_16, FAM21A_17, FAM21A_18, FAM21A_19, FAM21A_20, FAM21A_21, FAM21A_22@0@0@0@:family with sequence similarity 21, member B;family with sequence similarity 21, member A@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
F08744@96932@96934@deletion@3@51965743@51970894@10@chr10:51965743-51970894@6.78@30@0@0@NA@ASAH2_12, ASAH2_11, ASAH2_10@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
F08744@96937@96937@deletion@1@51978271@51978390@10@chr10:51978271-51978390@4.99@22@0@0@NA@ASAH2_7@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
F08744@98344@98350@deletion@7@81463367@81472241@10@chr10:81463367-81472241@6.44@32@2@0.0625@CNVR4815.2, CNVR4815.4@FAM22B_1, FAM22B_2, FAM22B_3, FAM22B_4, FAM22B_5, FAM22B_6, FAM22B_7@0@0@0@NA@NA@NA
F08744@103138@103139@deletion@2@3150244@3240043@11@chr11:3150244-3240043@10.8@489@291@0.595@NA@OSBPL5_2, MRGPRG_1@0@0@0@:oxysterol binding protein-like 5:MAS-related GPR, member G@:phospholipid binding;Golgi to plasma membrane transport;oxysterol binding;cytosol;protein binding;integral to membrane;cholesterol metabolic process;cholesterol transport;endoplasmic reticulum membrane;lipid transport:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway@NA
F08744@103269@103269@deletion@1@4976003@4976943@11@chr11:4976003-4976943@68@644@91@0.141@CNVR5040.1@OR51A2_1@0@0@0@:matrix metallopeptidase 26:olfactory receptor, family 51, subfamily A, member 2@:metallopeptidase activity;extracellular matrix;proteolysis;proteinaceous extracellular matrix;collagen catabolic process;metalloendopeptidase activity;zinc ion binding;metabolic process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F08744@103289@103290@duplication@2@5270599@5271034@11@chr11:5270599-5271034@9.7@62@144@2.32@NA@HBG1_2, HBG1_1@0@0@0@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
F08744@104572@104572@deletion@1@18955364@18956331@11@chr11:18955364-18956331@8.57@1226@806@0.657@CNVR5091.2, CNVR5091.1@MRGPRX1_1@0@0@0@:MAS-related GPR, member X1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;acute-phase response;G-protein coupled receptor signaling pathway@NA
F08744@106046@106048@duplication@3@55370918@55419315@11@chr11:55370918-55419315@26.7@2169@3099@1.43@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F08744@110109@110109@duplication@1@89531299@89531797@11@chr11:89531299-89531797@5.51@383@531@1.39@NA@TRIM49_8@0@0@0@:tripartite motif containing 49@:protein binding;intracellular;DNA binding;zinc ion binding@NA
F08744@110121@110126@deletion@6@89768381@89774718@11@chr11:89768381-89774718@27.5@334@117@0.35@NA@TRIM49C_3, TRIM49C_4, TRIM49C_5, TRIM49C_6, TRIM49C_7, TRIM49C_8@0@0@0@:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;DNA binding;zinc ion binding@NA
F08744@114424@114426@duplication@3@10583717@10586541@12@chr12:10583717-10586541@5.64@427@562@1.32@CNVR5430.1@KLRC2_6, KLRC2_5, KLRC2_4@0@0@0@:killer cell lectin-like receptor subfamily C, member 2@:carbohydrate binding:transmembrane signaling receptor activity;carbohydrate binding;protein binding;signal transduction;cellular defense response;integral to plasma membrane@NA
F08744@131032@131034@duplication@3@74004127@74010359@14@chr14:74004127-74010359@15.1@471@712@1.51@CNVR6188.1, CNVR6188.4@ACOT1_1, ACOT1_2, ACOT1_3@0@0@0@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
F08744@133342@133342@duplication@1@106053275@106053668@14@chr14:106053275-106053668@6.28@62@119@1.92@CNVR6294.46@IGHA2_3@0@0@0@@:protein binding@NA
F08744@133359@133360@deletion@2@106174697@106204182@14@chr14:106174697-106204182@7.42@336@209@0.622@CNVR6294.46, CNVR6294.43, CNVR6294.66, CNVR6294.68, CNVR6294.69, CNVR6294.19@IGHA1_1, IGHG1_6@0@0@0@@:antigen binding;protein binding;immune response;protein-chromophore linkage:antigen binding;complement activation;protein binding;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response@: MYELOMA, MULTIPLE
F08744@133369@133370@deletion@2@106236631@106236862@14@chr14:106236631-106236862@13.6@265@136@0.513@CNVR6294.66, CNVR6294.68, CNVR6294.19, CNVR6294.35, CNVR6294.47@IGHG3_4, IGHG3_3@0@0@0@@:protein binding@NA
F08744@133432@133436@deletion@5@106539080@106573537@14@chr14:106539080-106573537@131@862@153@0.177@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1, IGHV3-11_2@0@0@0@@:protein binding:protein binding:protein binding@NA
F08744@133450@133451@deletion@2@106725202@106725654@14@chr14:106725202-106725654@14.9@872@536@0.615@CNVR6294.48, CNVR6294.24, CNVR6294.40, CNVR6294.38, CNVR6294.17, CNVR6294.23@IGHV3-23_2, IGHV3-23_1@0@0@0@@:protein binding@NA
F08744@133458@133463@deletion@6@106791006@106816173@14@chr14:106791006-106816173@63.1@1275@638@0.5@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-30_2, IGHV3-30_1, IGHV4-31_2, IGHV4-31_1, IGHV3-33_2, IGHV3-33_1@0@0@0@@:protein binding:protein binding:protein binding@NA
F08744@133491@133492@deletion@2@107095127@107095561@14@chr14:107095127-107095561@8.85@86@31@0.36@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61_2, IGHV4-61_1@0@0@0@@:protein binding@NA
F08744@133495@133495@deletion@1@107131034@107131334@14@chr14:107131034-107131334@10.4@214@107@0.5@CNVR6294.56, CNVR6294.16@IGHV3-66_2@0@0@0@@:protein binding@NA
F08744@133541@133542@duplication@2@22368577@22383423@15@chr15:22368577-22383423@39.3@4209@7434@1.77@CNVR6297.4, CNVR6297.17, CNVR6297.2@OR4M2_1, OR4N4_1@0@0@0@:olfactory receptor, family 4, subfamily M, member 2:olfactory receptor, family 4, subfamily N, member 4@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F08744@134443@134448@deletion@6@34677942@34820278@15@chr15:34677942-34820278@8.58@60@15@0.25@CNVR6351.3@GOLGA8A_12, GOLGA8A_11, GOLGA8A_10, GOLGA8A_9, GOLGA8B_25, GOLGA8B_24@0@0@0@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
F08744@140317@140317@deletion@1@100348377@100348507@15@chr15:100348377-100348507@8.39@43@3@0.0698@CNVR6545.2@CTD-2054N24.2_2@0@0@0@NA@NA@NA
F08744@140958@140961@deletion@4@1278901@1279952@16@chr16:1278901-1279952@6.9@65@24@0.369@CNVR6591.1@TPSB2_6, TPSB2_5, TPSB2_4, TPSB2_3, TPSB2_2@0@0@0@:tryptase beta 2 (gene/pseudogene)@:proteolysis;catalytic activity;serine-type endopeptidase activity@NA
F08744@142918@142921@deletion@4@16349578@16357072@16@chr16:16349578-16357072@22.5@503@268@0.533@NA@NOMO3_10, NOMO3_11, NOMO3_12, NOMO3_13@0@0@0@:NODAL modulator 3@:carbohydrate binding;integral to membrane;carboxypeptidase activity@NA
F08744@143003@143005@duplication@3@18542789@18549998@16@chr16:18542789-18549998@5.85@343@468@1.36@NA@NOMO2_13, NOMO2_12, NOMO2_11@0@0@0@:NODAL modulator 2@:carbohydrate binding;protein binding;integral to membrane;carboxypeptidase activity;endoplasmic reticulum membrane@NA
F08744@144860@144862@deletion@3@31232218@31236076@16@chr16:31232218-31236076@34.5@759@367@0.484@NA@TRIM72_5, TRIM72_6, TRIM72_7@0@0@0@:tripartite motif containing 72@:cytoplasmic vesicle membrane;plasma membrane repair;muscle system process;phosphatidylserine binding;exocytosis;sarcolemma;intracellular;protein binding;protein homooligomerization;zinc ion binding;muscle organ development@NA
F08744@146139@146140@deletion@2@58621106@58621317@16@chr16:58621106-58621317@5.19@123@71@0.577@NA@CNOT1_6, CNOT1_5@0@0@0@:CCR4-NOT transcription complex, subunit 1@:binding;RNA metabolic process;regulation of transcription, DNA-dependent;nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay;cytosol;protein binding;mRNA metabolic process;peroxisomal membrane;transcription, DNA-dependent;gene expression;nuclear-transcribed mRNA poly(A) tail shortening;cytoplasmic mRNA processing body@NA
F08744@147101@147102@deletion@2@70010292@70012015@16@chr16:70010292-70012015@16@74@0@0@CNVR6762.3, CNVR6762.2@RP11-419C5.2_7, RP11-419C5.2_6@0@0@0@NA@NA@NA
F08744@147109@147109@duplication@1@70161164@70161296@16@chr16:70161164-70161296@4.67@147@217@1.48@CNVR6764.1, CNVR6764.3@PDPR_4@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
F08744@147135@147135@deletion@1@70219789@70219879@16@chr16:70219789-70219879@8.55@57@12@0.211@CNVR6764.1, CNVR6764.5@CLEC18C_11@0@0@0@:C-type lectin domain family 18, member C@:carbohydrate binding;protein binding;extracellular region@NA
F08744@147502@147513@duplication@12@74425290@74452196@16@chr16:74425290-74452196@13.8@568@801@1.41@CNVR6778.2, CNVR6778.3@NPIPL2_7, CLEC18B_13, CLEC18B_12, CLEC18B_11, CLEC18B_10, CLEC18B_9, CLEC18B_8, CLEC18B_7, CLEC18B_6, CLEC18B_5, CLEC18B_4, CLEC18B_3@0@0@0@:C-type lectin domain family 18, member B@:extracellular region:carbohydrate binding;protein binding;extracellular region@NA
F08744@151410@151412@deletion@3@15501847@15510997@17@chr17:15501847-15510997@13.5@415@254@0.612@NA@CDRT1_8, TRIM16_14, CDRT1_7, TRIM16_13, CDRT1_6, TRIM16_12@0@0@0@:CMT1A duplicated region transcript 1@:protein binding;molecular_function;cellular_component;biological_process:protein binding;intracellular;zinc ion binding;cytoplasm@NA
F08744@151415@151415@deletion@1@15517148@15517347@17@chr17:15517148-15517347@6.87@193@109@0.565@NA@CDRT1_3, TRIM16_9@0@0@0@:CMT1A duplicated region transcript 1@:protein binding;molecular_function;cellular_component;biological_process:protein binding;intracellular;zinc ion binding;cytoplasm@NA
F08744@151422@151423@deletion@2@15539351@15546130@17@chr17:15539351-15546130@7.77@206@116@0.563@NA@TRIM16_3, TRIM16_8, TRIM16_2, TRIM16_7@0@0@0@:tripartite motif containing 16@:protein binding;intracellular;zinc ion binding;cytoplasm:histone H4 acetylation;response to growth hormone stimulus;NACHT domain binding;DNA binding;positive regulation of keratinocyte differentiation;response to organophosphorus;interleukin-1 binding;PML body;positive regulation of interleukin-1 beta secretion;intracellular;regulation of transcription, DNA-dependent;response to retinoic acid;cytoplasm;positive regulation of transcription, DNA-dependent;protein binding;positive regulation of retinoic acid receptor signaling pathway;histone H3 acetylation;zinc ion binding;nucleic acid binding@NA
F08744@151875@151885@duplication@11@18380170@18397681@17@chr17:18380170-18397681@31.8@599@976@1.63@CNVR7014.1@LGALS9C_1, LGALS9C_2, LGALS9C_3, LGALS9C_4, LGALS9C_5, LGALS9C_6, LGALS9C_7, LGALS9C_8, LGALS9C_9, LGALS9C_10, LGALS9C_11@0@0@0@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
F08744@151958@151959@deletion@2@18996506@18997166@17@chr17:18996506-18997166@7.13@220@128@0.582@CNVR7018.4, CNVR7018.2, CNVR7018.6@AC007952.5_1, AC007952.5_2@0@0@0@NA@NA@NA
F08744@153380@153381@deletion@2@34539179@34539971@17@chr17:34539179-34539971@8.81@40@0@0@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1_2, CCL4L1_3@0@0@0@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
F08744@154346@154346@duplication@1@39421631@39422112@17@chr17:39421631-39422112@4.74@53@96@1.81@CNVR7096.1@KRTAP9-6_1@0@0@0@:keratin associated protein 9-6@:keratin filament@NA
F08744@155580@155581@duplication@2@44171927@44249509@17@chr17:44171927-44249509@9.05@2220@2928@1.32@CNVR7114.3, CNVR7114.2@KANSL1_3, KANSL1_2@0@0@0@:KAT8 regulatory NSL complex subunit 1@:histone acetyltransferase activity (H4-K8 specific);histone acetyltransferase activity (H4-K16 specific);histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase complex;histone H4-K5 acetylation;MLL1 complex;histone H4-K16 acetylation;protein binding;histone H4-K8 acetylation;nucleus@NA
F08744@155587@155595@deletion@9@44399689@44415089@17@chr17:44399689-44415089@30.2@177@27@0.153@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9, LRRC37A_10, LRRC37A_11, LRRC37A_12, LRRC37A_13, LRRC37A_14@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
F08744@156877@156878@deletion@2@57656834@57657240@17@chr17:57656834-57657240@22.7@109@2@0.0183@NA@DHX40_9, DHX40_10@0@0@0@:DEAH (Asp-Glu-Ala-His) box polypeptide 40@:transport;helicase activity;intracellular;ATP-dependent helicase activity;nucleic acid binding;ATP binding@NA
F08744@159386@159387@deletion@2@78165123@78166418@17@chr17:78165123-78166418@18.5@315@149@0.473@NA@CARD14_10, CARD14_11@0@0@0@:caspase recruitment domain family, member 14@:aggresome;intracellular;CARD domain binding;cytoplasm;positive regulation of protein phosphorylation;protein binding;plasma membrane;regulation of apoptotic process;activation of NF-kappaB-inducing kinase activity@: PSORIASIS SUSCEPTIBILITY 2; PSORS2
F08744@162017@162017@deletion@1@44542732@44544371@18@chr18:44542732-44544371@6.78@31@0@0@CNVR7319.1@TCEB3CL2_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
F08744@162019@162019@duplication@1@44554574@44556213@18@chr18:44554574-44556213@12.8@136@274@2.01@CNVR7319.1@TCEB3C_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C (elongin A3);RNA polymerase II transcription factor SIII subunit A3-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
F08744@166811@166812@duplication@2@14070580@14070881@19@chr19:14070580-14070881@5.83@428@574@1.34@NA@DCAF15_9, DCAF15_10@0@0@0@:DDB1 and CUL4 associated factor 15@:protein ubiquitination@NA
F08744@166916@166917@duplication@2@14508471@14508747@19@chr19:14508471-14508747@9.29@104@188@1.81@NA@CD97_7, CD97_8@0@0@0@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
F08744@167044@167047@deletion@4@14876337@14877921@19@chr19:14876337-14877921@26@803@483@0.601@NA@EMR2_9, EMR2_8, EMR2_7, EMR2_6@0@0@0@:egf-like module containing, mucin-like, hormone receptor-like 2@:transmembrane signaling receptor activity;inflammatory response;G-protein coupled receptor activity;ruffle membrane;integral to membrane;plasma membrane;cell surface receptor signaling pathway;neuropeptide signaling pathway;granulocyte chemotaxis;cell migration;leading edge membrane;G-protein coupled receptor signaling pathway;protein binding;cell adhesion;membrane;calcium ion binding;chondroitin sulfate binding@NA
F08744@169783@169783@deletion@1@39281330@39281530@19@chr19:39281330-39281530@5.15@57@23@0.404@NA@LGALS7B_3@0@0@0@:lectin, galactoside-binding, soluble, 7;lectin, galactoside-binding, soluble, 7B@:carbohydrate binding;heterophilic cell-cell adhesion;extracellular space;nucleus;apoptotic process;cytoplasm@NA
F08744@170093@170100@deletion@8@40367299@40382826@19@chr19:40367299-40382826@25.6@436@223@0.511@CNVR7639.2@FCGBP_29, FCGBP_28, FCGBP_27, FCGBP_26, FCGBP_25, FCGBP_24, FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F08744@170104@170105@deletion@2@40389653@40392197@19@chr19:40389653-40392197@5.58@140@81@0.579@CNVR7639.2, CNVR7639.3@FCGBP_18, FCGBP_17@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F08744@170821@170826@deletion@6@43702150@43763287@19@chr19:43702150-43763287@22.2@767@459@0.598@CNVR7658.5, CNVR7658.1@PSG4_3, PSG4_2, PSG4_1, PSG9_6, PSG9_5, PSG9_4@0@0@0@:pregnancy specific beta-1-glycoprotein 4:pregnancy specific beta-1-glycoprotein 9@:protein binding;extracellular region;female pregnancy;defense response:protein binding;extracellular region;female pregnancy;defense response@NA
F08744@172565@172567@deletion@3@50463395@50464338@19@chr19:50463395-50464338@38.7@622@252@0.405@NA@SIGLEC11_3, SIGLEC11_2, SIGLEC11_1@0@0@0@:sialic acid binding Ig-like lectin 11@:carbohydrate binding;protein binding;integral to membrane;cell adhesion@NA
F08744@172987@172987@duplication@1@52133087@52133469@19@chr19:52133087-52133469@9.05@57@133@2.33@CNVR7702.1@SIGLEC5_2, SIGLEC5_2@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion@NA
F08744@173417@173418@deletion@2@55105711@55105941@19@chr19:55105711-55105941@10.6@137@60@0.438@NA@LILRA1_2, LILRA1_3@0@0@0@:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1@:interferon-gamma secretion;defense response to virus;dendritic cell differentiation;negative regulation of interferon-gamma production;regulation of immune response;negative regulation of dendritic cell differentiation;HLA-A specific inhibitory MHC class I receptor activity;negative regulation of alpha-beta T cell activation;negative regulation of transforming growth factor-beta secretion;negative regulation of interleukin-10 secretion;T cell proliferation involved in immune response;plasma membrane;negative regulation of mononuclear cell proliferation;positive regulation of gamma-delta T cell activation involved in immune response;negative regulation of interferon-beta secretion;negative regulation of calcium ion transport;response to virus;negative regulation of serotonin secretion;negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell;cellular response to lipopolysaccharide;negative regulation of cell cycle;positive regulation of cytolysis;negative regulation of T cell mediated cytotoxicity;positive regulation of defense response to virus by host;MHC class I receptor activity;negative regulation of natural killer cell mediated cytotoxicity;negative regulation of dendritic cell apoptotic process;negative regulation of T cell proliferation;negative regulation of CD8-positive, alpha-beta T cell activation;immune response-inhibiting cell surface receptor signaling pathway;Fc receptor mediated inhibitory signaling pathway;negative regulation of cytokine secretion involved in immune response;SH2 domain binding;negative regulation of interleukin-12 secretion;HLA-B specific inhibitory MHC class I receptor activity;negative regulation of osteoclast development;integral to membrane;interferon-gamma production;MHC class I protein binding;protein homodimerization activity;positive regulation of transcription from RNA polymerase II promoter;protein phosphatase 1 binding;positive regulation of gene expression;external side of plasma membrane;receptor internalization;cytoplasm;negative regulation of tumor necrosis factor biosynthetic process;protein binding;signal transduction;negative regulation of interferon-gamma biosynthetic process;negative regulation of endocytosis;positive regulation of apoptotic process:transmembrane signaling receptor activity;regulation of immune response;antigen binding;protein binding;integral to membrane;plasma membrane;defense response;cell surface receptor signaling pathway@NA
F08744@173438@173439@deletion@2@55147373@55148103@19@chr19:55147373-55148103@17.6@112@19@0.17@NA@AC009892.10_2, LILRB1_14@0@0@0@:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1@:interferon-gamma secretion;defense response to virus;dendritic cell differentiation;negative regulation of interferon-gamma production;regulation of immune response;negative regulation of dendritic cell differentiation;HLA-A specific inhibitory MHC class I receptor activity;negative regulation of alpha-beta T cell activation;negative regulation of transforming growth factor-beta secretion;negative regulation of interleukin-10 secretion;T cell proliferation involved in immune response;plasma membrane;negative regulation of mononuclear cell proliferation;positive regulation of gamma-delta T cell activation involved in immune response;negative regulation of interferon-beta secretion;negative regulation of calcium ion transport;response to virus;negative regulation of serotonin secretion;negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell;cellular response to lipopolysaccharide;negative regulation of cell cycle;positive regulation of cytolysis;negative regulation of T cell mediated cytotoxicity;positive regulation of defense response to virus by host;MHC class I receptor activity;negative regulation of natural killer cell mediated cytotoxicity;negative regulation of dendritic cell apoptotic process;negative regulation of T cell proliferation;negative regulation of CD8-positive, alpha-beta T cell activation;immune response-inhibiting cell surface receptor signaling pathway;Fc receptor mediated inhibitory signaling pathway;negative regulation of cytokine secretion involved in immune response;SH2 domain binding;negative regulation of interleukin-12 secretion;HLA-B specific inhibitory MHC class I receptor activity;negative regulation of osteoclast development;integral to membrane;interferon-gamma production;MHC class I protein binding;protein homodimerization activity;positive regulation of transcription from RNA polymerase II promoter;protein phosphatase 1 binding;positive regulation of gene expression;external side of plasma membrane;receptor internalization;cytoplasm;negative regulation of tumor necrosis factor biosynthetic process;protein binding;signal transduction;negative regulation of interferon-gamma biosynthetic process;negative regulation of endocytosis;positive regulation of apoptotic process@NA
F08744@173468@173469@deletion@2@55263669@55263971@19@chr19:55263669-55263971@9.56@292@170@0.582@CNVR7725.2, CNVR7725.1@KIR2DL3_7, KIR2DL3_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity@NA
F08744@173490@173491@deletion@2@55336484@55340920@19@chr19:55336484-55340920@8.63@172@93@0.541@CNVR7725.1, CNVR7725.6, CNVR7725.8@KIR3DL1_6, KIR3DL1_7@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
F08744@173844@173845@duplication@2@56283172@56284545@19@chr19:56283172-56284545@8.02@797@1059@1.33@CNVR7734.1@CTD-2611O12.2_2, CTD-2611O12.2_3@0@0@0@:ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
F08744@174395@174395@duplication@1@1569207@1569278@20@chr20:1569207-1569278@19.9@44@208@4.73@CNVR7763.1@RP4-576H24.4_1@0@0@0@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
F08744@178074@178074@deletion@1@55099866@55100113@20@chr20:55099866-55100113@10.6@279@148@0.53@NA@FAM209A_1@0@0@0@:glucosaminyl (N-acetyl) transferase family member 7:family with sequence similarity 209, member A@:integral to membrane;protein glycosylation;acetylglucosaminyltransferase activity;Golgi membrane;membrane:integral to membrane@NA
F08744@179345@179345@duplication@1@31933418@31933608@21@chr21:31933418-31933608@7.24@228@346@1.52@NA@KRTAP19-7_1@0@0@0@:keratin associated protein 19-7@:intermediate filament@NA
F08744@181936@181938@deletion@3@24300473@24302568@22@chr22:24300473-24302568@7.52@49@11@0.224@CNVR8114.6, CNVR8114.12, CNVR8114.13, CNVR8114.8@GSTT2B_4, GSTT2B_3, GSTT2B_2@0@0@0@:glutathione S-transferase theta 2B (gene/pseudogene);glutathione S-transferase theta 2@:protein binding;glutathione transferase activity;nucleus;transferase activity;cytoplasm@NA
F08744@181948@181949@deletion@2@24324820@24325235@22@chr22:24324820-24325235@7.06@55@16@0.291@CNVR8114.6, CNVR8114.13, CNVR8114.8, CNVR8114.14@GSTT2_3, GSTT2_4@0@0@0@@:protein binding;glutathione transferase activity;nucleus;cytoplasm@NA
F08744@181951@181955@duplication@5@24376424@24384231@22@chr22:24376424-24384231@20.7@674@991@1.47@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTT1_5, GSTT1_4, GSTT1_3, GSTT1_2, GSTT1_1@0@0@0@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
F08744@184168@184168@deletion@1@42911158@42911274@22@chr22:42911158-42911274@4.67@25@3@0.12@CNVR8171.2, CNVR8171.3@RRP7A_4@0@0@0@:ribosomal RNA processing 7 homolog A (S. cerevisiae)@:RNA binding;nucleotide binding@NA
F08744@4072@4079@deletion@8@101615523@101620252@X@chrX:101615523-101620252@19.3@88@0@0@NA@NXF2B_34, NXF2B_33, NXF2B_32, NXF2B_31, NXF2B_30, NXF2B_29, NXF2B_28, NXF2B_27@0@0@0@NA@NA@NA
F08744@4884@4884@deletion@1@119210843@119211253@X@chrX:119210843-119211253@6.98@31@0@0@NA@RHOXF2B_2@0@0@0@NA@NA@NA
F08744@5718@5719@deletion@2@140335651@140336590@X@chrX:140335651-140336590@17.9@86@3@0.0349@CNVR8456.1@SPANXC_2, SPANXC_1@0@0@0@NA@NA@NA
F08744@6302@6307@duplication@6@153482657@153496256@X@chrX:153482657-153496256@10.4@69@152@2.2@CNVR8489.1@TEX28P1_1, OPN1MW2_1, OPN1MW2_2, OPN1MW2_3, OPN1MW2_4, OPN1MW2_5@0@0@0@NA@NA@NA
F08744@6365@6367@duplication@3@153594393@153595007@X@chrX:153594393-153595007@6.51@424@563@1.33@NA@FLNA_9, FLNA_8, FLNA_7@0@0@0@NA@NA@NA
F09507@5194@5194@deletion@1@40229385@40229463@1@chr1:40229385-40229463@5.08@49@16@0.327@NA@BMP8B_5@0@0@0@:peptidylprolyl isomerase E (cyclophilin E):bone morphogenetic protein 8b@:regulation of transcription, DNA-dependent;nucleotide binding;catalytic step 2 spliceosome;protein folding;protein binding;protein peptidyl-prolyl isomerization;peptidyl-prolyl cis-trans isomerase activity;cyclosporin A binding;RNA binding;mRNA splicing, via spliceosome;nucleus;nucleic acid binding:cell differentiation;growth factor activity;extracellular space;growth;extracellular region;cytokine activity;cartilage development;skeletal system development;ossification@NA
F09507@6306@6309@duplication@4@47512140@47515846@1@chr1:47512140-47515846@7.24@469@641@1.37@NA@CYP4X1_9, CYP4X1_10, CYP4X1_11, CYP4X1_12@0@0@0@:cytochrome P450, family 4, subfamily X, polypeptide 1@:oxidation-reduction process;electron carrier activity;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;endoplasmic reticulum membrane;heme binding@NA
F09507@9365@9374@deletion@10@104202983@104234232@1@chr1:104202983-104234232@9.88@45@0@0@CNVR266.3, CNVR266.1, CNVR266.15@AMY1A_7, AMY1A_8, AMY1A_9, AMY1A_10, AMY1A_11, AMY1B_11, AMY1B_10, AMY1B_9, AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
F09507@9766@9773@deletion@8@110230497@110235917@1@chr1:110230497-110235917@36.8@169@0@0@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
F09507@12117@12118@duplication@2@152573209@152586574@1@chr1:152573209-152586574@6.41@70@133@1.9@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
F09507@14046@14053@duplication@8@161487766@161565521@1@chr1:161487766-161565521@22.5@1488@2164@1.45@CNVR383.3, CNVR383.1@FCGR2A_7, HSPA6_1, FCGR3A_5, FCGR3A_4, FCGR3A_3, FCGR3A_2, FCGR3A_1, FCGR2C_1@0@0@0@:Fc fragment of IgG, low affinity IIa, receptor (CD32):heat shock 70kDa protein 6 (HSP70B'):Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene)@:IgG binding;protein binding;integral to membrane;plasma membrane:signalosome;cell morphogenesis;response to unfolded protein;ATP binding:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
F09507@33397@33399@duplication@3@233244897@233245467@2@chr2:233244897-233245467@7.43@230@344@1.5@NA@ALPP_6, ALPP_7, ALPP_8@0@0@0@:alkaline phosphatase, placental@:phosphatase activity;catalytic activity;integral to membrane;plasma membrane;metabolic process;cell surface;anchored to membrane;alkaline phosphatase activity;metal ion binding@NA
F09507@42358@42360@deletion@3@132277816@132280061@3@chr3:132277816-132280061@7.97@182@100@0.549@NA@ACAD11_20, ACAD11_19, ACAD11_18@0@0@0@:acyl-CoA dehydrogenase family, member 11:nephronophthisis 3 (adolescent)@:oxidation-reduction process;acyl-CoA dehydrogenase activity;oxidoreductase activity, acting on the CH-CH group of donors;mitochondrion;very-long-chain-acyl-CoA dehydrogenase activity;fatty acid beta-oxidation using acyl-CoA dehydrogenase;long-chain-acyl-CoA dehydrogenase activity;peroxisome;flavin adenine dinucleotide binding;transferase activity, transferring phosphorus-containing groups;oxidoreductase activity;medium-chain-acyl-CoA dehydrogenase activity;nucleus;mitochondrial membrane;metabolic process:photoreceptor cell maintenance;negative regulation of canonical Wnt receptor signaling pathway;cilium;ureter development;lipid metabolic process;protein binding;regulation of Wnt receptor signaling pathway, planar cell polarity pathway;regulation of planar cell polarity pathway involved in neural tube closure;cilium morphogenesis;primary cilium;maintenance of organ identity;Wnt receptor signaling pathway;determination of left/right symmetry;convergent extension involved in gastrulation;kidney morphogenesis@: NEPHRONOPHTHISIS 3; NPHP3; RENAL-HEPATIC-PANCREATIC DYSPLASIA; RHPD; MECKEL SYNDROME, TYPE 7; MKS7
F09507@45726@45728@deletion@3@59324@60296@4@chr4:59324-60296@6.87@1184@787@0.665@NA@ZNF595_2, ZNF595_3, ZNF595_4@0@0@0@@:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding@NA
F09507@48966@48969@duplication@4@75311064@75316249@4@chr4:75311064-75316249@9.11@58@140@2.41@NA@AREG_1, AREG_2, AREG_3, AREG_4@0@0@0@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
F09507@48972@48974@deletion@3@75482007@75486006@4@chr4:75482007-75486006@16.9@81@0@0@NA@AREGB_2, AREGB_3, AREGB_4@0@0@0@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
F09507@54849@54849@deletion@1@42629141@42629205@5@chr5:42629141-42629205@13.6@66@0@0@CNVR2445.1@GHR_3@0@0@0@:growth hormone receptor@:neuronal cell body;mitochondrion;proline-rich region binding;JAK-STAT cascade;growth factor binding;nucleus;succinate metabolic process;positive regulation of JAK-STAT cascade;JAK-STAT cascade involved in growth hormone signaling pathway;response to morphine;activation of MAPK activity;peptide hormone binding;response to estradiol stimulus;2-oxoglutarate metabolic process;valine metabolic process;response to cytokine stimulus;hormone-mediated signaling pathway;response to food;SH2 domain binding;oxaloacetate metabolic process;growth hormone receptor signaling pathway;allantoin metabolic process;integral to membrane;response to hormone stimulus;cartilage development involved in endochondral bone morphogenesis;positive regulation of peptidyl-tyrosine phosphorylation;receptor internalization;cytoplasm;cellular response to hormone stimulus;extracellular region;growth hormone receptor complex;positive regulation of tyrosine phosphorylation of Stat5 protein;regulation of multicellular organism growth;growth hormone receptor activity;positive regulation of tyrosine phosphorylation of Stat3 protein;response to peptide hormone stimulus;fatty acid metabolic process;creatinine metabolic process;plasma membrane;positive regulation of multicellular organism growth;receptor complex;protein phosphatase binding;protein kinase binding;creatine metabolic process;response to interleukin-1;response to cycloheximide;extracellular space;positive regulation of cell differentiation;activation of Janus kinase activity;taurine metabolic process;cellular response to insulin stimulus;integral to plasma membrane;protein homodimerization activity;negative regulation of neuron death;citrate metabolic process;endocytosis;isoleucine metabolic process;activation of JAK2 kinase activity;extrinsic to membrane;response to glucocorticoid stimulus;protein binding;insulin-like growth factor receptor signaling pathway;multicellular organismal metabolic process;cell surface@: HYPERCHOLESTEROLEMIA, FAMILIAL; LARON SYNDROME; SHORT STATURE, IDIOPATHIC, AUTOSOMAL
F09507@55830@55831@deletion@2@70307103@70308742@5@chr5:70307103-70308742@14.9@389@178@0.458@CNVR2494.41, CNVR2494.14, CNVR2494.30, CNVR2494.20, CNVR2494.62, CNVR2494.8, CNVR2494.35@NAIP_5, NAIP_4@0@0@0@:baculoviral IAP repeat-containing protein 1-like;NLR family, apoptosis inhibitory protein@:negative regulation of apoptotic process;inflammatory response;basolateral plasma membrane;nucleoside-triphosphatase activity;cysteine-type endopeptidase inhibitor activity;intracellular;nucleotide binding;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;ATP binding;cytoplasm;innate immune response;protein binding;negative regulation of neuron apoptotic process;metal ion binding;nervous system development@NA
F09507@59488@59488@deletion@1@147553798@147553933@5@chr5:147553798-147553933@13.7@67@0@0@CNVR2637.2, CNVR2637.1@SPINK14_3@0@0@0@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
F09507@60877@60878@deletion@2@175388277@175392158@5@chr5:175388277-175392158@5.3@67@30@0.448@NA@THOC3_4, THOC3_3@0@0@0@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
F09507@61454@61454@duplication@1@179071801@179072021@5@chr5:179071801-179072021@5.73@242@385@1.59@NA@C5orf60_1@0@0@0@:chromosome 5 open reading frame 60@:integral to membrane@NA
F09507@61724@61724@deletion@1@598022@598123@6@chr6:598022-598123@4.61@45@15@0.333@NA@EXOC2_10@0@0@0@:exocyst complex component 2@:protein binding;exocytosis;protein transport;Ral GTPase binding;plasma membrane;protein N-terminus binding;exocyst@NA
F09507@62954@62957@duplication@4@29911900@29913058@6@chr6:29911900-29913058@12.2@415@632@1.52@CNVR2829.7, CNVR2829.2, CNVR2829.3@HLA-A_6, HLA-A_7, HLA-A_8, HLA-A_9@0@0@0@:major histocompatibility complex, class I, A@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO
F09507@63281@63283@duplication@3@31237744@31239125@6@chr6:31237744-31239125@9.83@250@393@1.57@CNVR2838.1@HLA-C_5, HLA-C_4, HLA-C_3@0@0@0@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
F09507@63725@63734@deletion@10@31962023@31964838@6@chr6:31962023-31964838@17@289@142@0.491@CNVR2843.6, CNVR2843.3@C4A_20, C4A_21, C4A_22, C4A_23, C4A_24, C4A_25, C4A_26, C4A_27, C4A_28, C4A_29@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
F09507@63953@63974@deletion@22@32485517@32634384@6@chr6:32485517-32634384@93.2@1241@543@0.438@CNVR2845.21, CNVR2845.25, CNVR2845.24@HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2, HLA-DRB5_1, HLA-DRB1_5, HLA-DRB1_4, HLA-DRB1_3, HLA-DRB1_2, HLA-DRB1_1, HLA-DQA1_1, HLA-DQA1_2, HLA-DQA1_3, HLA-DQA1_4, HLA-DQB1_5, HLA-DQB1_4, HLA-DQB1_3, HLA-DQB1_2, HLA-DQB1_1@0@0@0@:major histocompatibility complex, class II, DR beta 5:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
F09507@71028@71031@deletion@4@167787840@167791580@6@chr6:167787840-167791580@6.12@192@120@0.625@NA@TCP10_7, TCP10_6, TCP10_5, TCP10_4@0@0@0@:t-complex 10@:cytosol@NA
F09507@71754@71764@deletion@11@5959481@5983103@7@chr7:5959481-5983103@28.6@517@257@0.497@NA@CCZ1_12, CCZ1_13, CCZ1_14, CCZ1_15, RSPH10B_20, RSPH10B_19, RSPH10B_18, RSPH10B_17, RSPH10B_16, RSPH10B_15, RSPH10B_14@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae):radial spoke head 10 homolog B (Chlamydomonas)@:lysosomal membrane@NA
F09507@71772@71772@deletion@1@5998625@5998709@7@chr7:5998625-5998709@10.2@109@32@0.294@NA@RSPH10B_6@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F09507@71778@71779@deletion@2@6017220@6018327@7@chr7:6017220-6018327@5.09@97@50@0.515@NA@PMS2_14, PMS2_13@0@0@0@:PMS2 postmeiotic segregation increased 2 (S. cerevisiae)@:response to drug;DNA binding;MutSalpha complex binding;ATP binding;mismatch repair;DNA repair;mismatched DNA binding;ATPase activity;nucleus;mismatch repair complex;reciprocal meiotic recombination;ATP catabolic process;single-stranded DNA binding;response to DNA damage stimulus;single base insertion or deletion binding;protein binding;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;MutLalpha complex;endonuclease activity@: COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4; MISMATCH REPAIR CANCER SYNDROME
F09507@71932@71945@duplication@14@6819242@6845668@7@chr7:6819242-6845668@27.6@384@668@1.74@NA@RSPH10B2_12, RSPH10B2_13, RSPH10B2_14, RSPH10B2_15, RSPH10B2_16, RSPH10B2_17, RSPH10B2_18, RSPH10B2_19, RSPH10B2_20, CCZ1B_15, CCZ1B_14, CCZ1B_13, CCZ1B_12, CCZ1B_11@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F09507@74792@74793@duplication@2@76240783@76241130@7@chr7:76240783-76241130@6.16@100@170@1.7@CNVR3463.10@POMZP3_6, POMZP3_5@0@0@0@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
F09507@76427@76432@duplication@6@100331793@100336236@7@chr7:100331793-100336236@16.5@419@664@1.58@CNVR3509.1@ZAN_1, ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
F09507@79322@79323@deletion@2@144069777@144070377@7@chr7:144069777-144070377@8.12@79@29@0.367@CNVR3598.4, CNVR3598.5, CNVR3598.11@ARHGEF5_9, ARHGEF5_10@0@0@0@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
F09507@86439@86440@duplication@2@145618668@145619011@8@chr8:145618668-145619011@5.5@140@216@1.54@NA@CPSF1_37, CPSF1_36@0@0@0@:microRNA 939;microRNA 1234;cleavage and polyadenylation specific factor 1, 160kDa@:nucleoplasm;mRNA 3'-end processing;mRNA 3'-UTR binding;mRNA cleavage and polyadenylation specificity factor complex;nucleus;gene expression;mRNA cleavage;termination of RNA polymerase II transcription;transcription from RNA polymerase II promoter;mRNA export from nucleus;protein binding;mRNA processing;mRNA polyadenylation;mRNA splicing, via spliceosome;RNA splicing;nucleic acid binding@NA
F09507@91242@91246@duplication@5@117085415@117087432@9@chr9:117085415-117087432@38.3@601@1277@2.12@CNVR4448.1@ORM1_1, ORM1_2, ORM1_3, ORM1_4, ORM1_5@0@0@0@:orosomucoid 1@:protein binding;extracellular space;regulation of immune system process;transport;inflammatory response;extracellular region;acute-phase response@NA
F09507@93566@93566@deletion@1@138441155@138441176@9@chr9:138441155-138441176@7.92@40@2@0.05@CNVR4529.1@OBP2A_6@0@0@0@:odorant binding protein 2A@:odorant binding;sensory perception of chemical stimulus;response to stimulus;transport;extracellular region;sensory perception of smell;cellular_component@NA
F09507@95389@95393@deletion@5@18138509@18152611@10@chr10:18138509-18152611@12.5@64@3@0.0469@NA@MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F09507@96472@96481@duplication@10@46961971@47087911@10@chr10:46961971-47087911@51@4074@6314@1.55@CNVR4712.9, CNVR4712.2, CNVR4712.7, CNVR4712.4@SYT15_8, SYT15_7, SYT15_6, SYT15_5, SYT15_4, SYT15_3, SYT15_2, GPRIN2_1, PPYR1_3@0@0@0@:synaptotagmin XV:G protein regulated inducer of neurite outgrowth 2:pancreatic polypeptide receptor 1;neuropeptide Y receptor type 4-like@:protein binding;synaptic vesicle;integral to membrane;transporter activity;plasma membrane;membrane;extrinsic to membrane:blood circulation;peptide YY receptor activity;peptide binding;pancreatic polypeptide receptor activity;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;integral to membrane;digestion;plasma membrane;integral to plasma membrane;feeding behavior@NA
F09507@96505@96509@duplication@5@47658500@47667488@10@chr10:47658500-47667488@8.06@481@658@1.37@CNVR4713.1@ANTXRL_1, ANTXRL_2, ANTXRL_3, ANTXRL_4, ANTXRL_5@0@0@0@@:protein binding;integral to membrane;receptor activity;metal ion binding@NA
F09507@96515@96521@duplication@7@47678040@47701320@10@chr10:47678040-47701320@12.7@1075@1426@1.33@CNVR4713.1@ANTXRL_11, ANTXRL_12, ANTXRL_13, ANTXRL_14, ANTXRL_15, ANTXRL_16, ANTXRL_17@0@0@0@@:protein binding;integral to membrane;receptor activity;metal ion binding@NA
F09507@96572@96581@deletion@10@48020451@48055018@10@chr10:48020451-48055018@12@253@142@0.561@CNVR4715.2@ASAH2C_10, ASAH2C_9, ASAH2C_8, ASAH2C_7, ASAH2C_6, ASAH2C_5, ASAH2C_4, ASAH2C_3, ASAH2C_2, ASAH2C_1@0@0@0@@:ceramidase activity;sphingolipid metabolic process@NA
F09507@102457@102461@duplication@5@420719@428394@11@chr11:420719-428394@7.76@347@486@1.4@NA@ANO9_18, ANO9_17, ANO9_16, ANO9_15, ANO9_14@0@0@0@:anoctamin 9@:chloride channel activity;chloride channel complex;intracellular@NA
F09507@103289@103289@deletion@1@5270599@5270820@11@chr11:5270599-5270820@5.54@25@0@0@NA@HBG1_2@0@0@0@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
F09507@114424@114429@deletion@6@10583717@10588585@12@chr12:10583717-10588585@13.5@537@329@0.613@CNVR5430.1@KLRC2_6, KLRC2_5, KLRC2_4, KLRC2_3, NKG2-E_3, KLRC2_2, NKG2-E_2, KLRC2_1, NKG2-E_1@0@0@0@:killer cell lectin-like receptor subfamily C, member 2@:carbohydrate binding:transmembrane signaling receptor activity;carbohydrate binding;protein binding;signal transduction;cellular defense response;integral to plasma membrane@NA
F09507@114494@114497@duplication@4@11506725@11546911@12@chr12:11506725-11546911@7.69@477@656@1.38@CNVR5435.2, CNVR5435.1@PRB1_3, PRB1_2, PRB1_1, PRB2_3@0@0@0@:proline-rich protein BstNI subfamily 1:proline-rich protein BstNI subfamily 2@:extracellular region;molecular_function;cellular_component;biological_process@NA
F09507@127353@127358@deletion@6@20215588@20404761@14@chr14:20215588-20404761@38.6@5309@3100@0.584@CNVR6072.12, CNVR6072.4, CNVR6072.5@OR4Q3_1, OR4M1_1, OR4N2_1, OR4K2_1, OR4K5_1, OR4K1_1@0@0@0@:olfactory receptor, family 4, subfamily N, member 2:olfactory receptor, family 4, subfamily Q, member 3:olfactory receptor, family 4, subfamily M, member 1:olfactory receptor, family 4, subfamily K, member 2:olfactory receptor, family 4, subfamily K, member 5:olfactory receptor, family 4, subfamily K, member 1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F09507@133426@133427@deletion@2@106478111@106478539@14@chr14:106478111-106478539@7.37@58@15@0.259@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV4-4_2, IGHV4-4_1@0@0@0@@:protein binding@NA
F09507@133432@133435@duplication@4@106539080@106552729@14@chr14:106539080-106552729@6.35@440@599@1.36@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1@0@0@0@@:protein binding:protein binding@NA
F09507@133457@133461@duplication@5@106780901@106805644@14@chr14:106780901-106805644@20.3@444@785@1.77@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV4-28_1, IGHV3-30_2, IGHV3-30_1, IGHV4-31_2, IGHV4-31_1@0@0@0@:uncharacterized LOC100653243;uncharacterized LOC642131@:protein binding:protein binding:protein binding@NA
F09507@134153@134156@duplication@4@32449810@32455536@15@chr15:32449810-32455536@6.02@94@153@1.63@CNVR6345.2, CNVR6345.1@CHRNA7_6, CHRNA7_7, CHRNA7_8, CHRNA7_9@0@0@0@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
F09507@139030@139031@deletion@2@79065426@79066642@15@chr15:79065426-79066642@4.95@25@2@0.08@NA@ADAMTS7_14, ADAMTS7_13@0@0@0@:A disintegrin and metalloproteinase with thrombospondin motifs 7-like;ADAM metallopeptidase with thrombospondin type 1 motif, 7@:metallopeptidase activity;extracellular matrix;proteolysis;peptidase activity;proteinaceous extracellular matrix;metalloendopeptidase activity;cell surface;zinc ion binding@NA
F09507@144098@144100@duplication@3@28618083@28619709@16@chr16:28618083-28619709@5.22@339@464@1.37@CNVR6685.1, CNVR6685.2@SULT1A1_8, SULT1A1_7, SULT1A1_6@0@0@0@:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1@:small molecule metabolic process;sulfation;aryl sulfotransferase activity;amine metabolic process;catecholamine metabolic process;xenobiotic metabolic process;cytosol;steroid sulfotransferase activity;integral to membrane;sulfotransferase activity;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process;estrogen metabolic process@NA
F09507@147112@147117@deletion@6@70164327@70176292@16@chr16:70164327-70176292@11.1@1038@693@0.668@CNVR6764.1, CNVR6764.3@PDPR_7, PDPR_8, PDPR_9, PDPR_10, PDPR_11, PDPR_12@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
F09507@148611@148616@deletion@6@89831299@89838222@16@chr16:89831299-89838222@15@503@296@0.588@NA@FANCA_28, FANCA_27, FANCA_26, FANCA_25, FANCA_24, FANCA_23@0@0@0@:Fanconi anemia, complementation group A@:nucleoplasm;male gonad development;Fanconi anaemia nuclear complex;protein complex assembly;regulation of cell proliferation;cytoplasm;male meiosis;DNA repair;protein binding;female gonad development;nucleus@: FANCONI ANEMIA, COMPLEMENTATION GROUP A; FANCA
F09507@151399@151402@deletion@4@15449100@15458678@17@chr17:15449100-15458678@25.5@442@188@0.425@NA@TVP23C_5, TVP23C-CDRT4_5, TVP23C_4, TVP23C-CDRT4_4, TVP23C_3, TVP23C-CDRT4_3, TVP23C_2, TVP23C-CDRT4_2@0@0@0@:FAM18B2-CDRT4 readthrough:family with sequence similarity 18, member B2@:integral to membrane:integral to membrane@NA
F09507@151881@151885@deletion@5@18394588@18397681@17@chr17:18394588-18397681@11.4@238@120@0.504@CNVR7014.1@LGALS9C_7, LGALS9C_8, LGALS9C_9, LGALS9C_10, LGALS9C_11@0@0@0@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
F09507@153397@153400@duplication@4@34625572@34641537@17@chr17:34625572-34641537@9.2@78@176@2.26@CNVR7077.1, CNVR7077.2, CNVR7077.12@CCL3L1_1, CCL4L2_1, CCL4L2_2, CCL4L2_3@0@0@0@:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
F09507@155587@155599@deletion@13@44399689@44592687@17@chr17:44399689-44592687@25.7@144@17@0.118@CNVR7114.2, CNVR7114.1@LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9, LRRC37A_10, LRRC37A_11, LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane@NA
F09507@155610@155612@duplication@3@44632519@44632945@17@chr17:44632519-44632945@5.7@32@78@2.44@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2_13, LRRC37A2_14, LRRC37A2_15@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
F09507@156877@156878@deletion@2@57656834@57657240@17@chr17:57656834-57657240@8.63@40@0@0@NA@DHX40_9, DHX40_10@0@0@0@:DEAH (Asp-Glu-Ala-His) box polypeptide 40@:transport;helicase activity;intracellular;ATP-dependent helicase activity;nucleic acid binding;ATP binding@NA
F09507@163143@163147@duplication@5@436381@440932@19@chr19:436381-440932@7.86@371@516@1.39@NA@SHC2_6, SHC2_5, SHC2_4, SHC2_3, SHC2_2@0@0@0@:SHC (Src homology 2 domain containing) transforming protein 2@:cytosol;protein binding;insulin receptor signaling pathway;nerve growth factor receptor signaling pathway;Ras protein signal transduction;cellular_component@NA
F09507@166916@166917@duplication@2@14508471@14508747@19@chr19:14508471-14508747@9.02@55@133@2.42@NA@CD97_7, CD97_8@0@0@0@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
F09507@167044@167047@deletion@4@14876337@14877921@19@chr19:14876337-14877921@8.2@441@292@0.662@NA@EMR2_9, EMR2_8, EMR2_7, EMR2_6@0@0@0@:egf-like module containing, mucin-like, hormone receptor-like 2@:transmembrane signaling receptor activity;inflammatory response;G-protein coupled receptor activity;ruffle membrane;integral to membrane;plasma membrane;cell surface receptor signaling pathway;neuropeptide signaling pathway;granulocyte chemotaxis;cell migration;leading edge membrane;G-protein coupled receptor signaling pathway;protein binding;cell adhesion;membrane;calcium ion binding;chondroitin sulfate binding@NA
F09507@167610@167621@duplication@12@17443740@17452131@19@chr19:17443740-17452131@43.7@1402@2223@1.59@CNVR7562.1@ANO8_5, ANO8_4, ANO8_3, ANO8_2, ANO8_1, GTPBP3_1, GTPBP3_2, GTPBP3_3, GTPBP3_4, GTPBP3_5, GTPBP3_6, GTPBP3_7@0@0@0@:anoctamin 8:GTP binding protein 3 (mitochondrial)@:chloride channel activity;chloride channel complex;intracellular:mitochondrion;GTP binding;GTPase activity;metal ion binding;tRNA modification@: DEAFNESS, AMINOGLYCOSIDE-INDUCED
F09507@168952@168952@deletion@1@35862263@35863302@19@chr19:35862263-35863302@8.29@123@47@0.382@CNVR7627.1@GPR42_2@0@0@0@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
F09507@170093@170100@deletion@8@40367299@40382826@19@chr19:40367299-40382826@24.5@317@138@0.435@CNVR7639.2@FCGBP_29, FCGBP_28, FCGBP_27, FCGBP_26, FCGBP_25, FCGBP_24, FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F09507@172565@172566@duplication@2@50463395@50464192@19@chr19:50463395-50464192@7.73@278@423@1.52@NA@SIGLEC11_3, SIGLEC11_2@0@0@0@:sialic acid binding Ig-like lectin 11@:carbohydrate binding;protein binding;integral to membrane;cell adhesion@NA
F09507@172986@172987@duplication@2@52132612@52133469@19@chr19:52132612-52133469@7.18@49@112@2.29@CNVR7702.1@SIGLEC5_3, SIGLEC5_3, SIGLEC5_2, SIGLEC5_2@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion@NA
F09507@173298@173350@duplication@53@54726151@54845236@19@chr19:54726151-54845236@162@5005@7696@1.54@NA@LILRB3_3, LILRB3_2, LILRB3_1, LILRA6_8, LILRA6_7, LILRA6_6, LILRA6_5, LILRA6_4, LILRA6_3, LILRA6_2, LILRA6_1, LILRB5_13, LILRB5_12, LILRB5_11, LILRB5_10, LILRB5_9, LILRB5_8, LILRB5_7, LILRB5_6, LILRB5_5, LILRB5_4, LILRB5_3, LILRB5_2, LILRB5_1, LILRB2_14, LILRB2_13, LILRB2_12, LILRB2_11, LILRB2_10, LILRB2_9, LILRB2_8, LILRB2_7, LILRB2_6, LILRB2_5, LILRB2_4, LILRB2_3, LILRB2_2, LILRA3_7, LILRA3_6, LILRA3_5, LILRA3_4, LILRA3_3, LILRA3_2, LILRA3_1, LILRA5_7, LILRA5_6, LILRA5_5, LILRA5_4, LILRA5_3, LILRA5_2, LILRA4_8, LILRA4_7@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2:leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane:transmembrane signaling receptor activity;protein binding;integral to membrane;defense response;cell surface receptor signaling pathway:regulation of immune response;positive regulation of T cell tolerance induction;immune response;cell adhesion molecule binding;heterotypic cell-cell adhesion;eukaryotic cell surface binding;plasma membrane;negative regulation of calcium ion transport;inhibitory MHC class I receptor activity;cellular response to lipopolysaccharide;cell-cell signaling;membrane;negative regulation of T cell proliferation;Fc receptor mediated inhibitory signaling pathway;immune response-inhibiting cell surface receptor signaling pathway;positive regulation of regulatory T cell differentiation;negative regulation of antigen processing and presentation;extracellular space;integral to plasma membrane;receptor activity;MHC class I protein binding;cell surface receptor signaling pathway;regulation of dendritic cell differentiation;positive regulation of interleukin-6 production;protein phosphatase 1 binding;MHC class Ib protein binding;cytoplasm;signal transduction;protein binding;cellular defense response;positive regulation of T cell proliferation;cell surface:antigen binding;signal transduction;protein binding;extracellular region;plasma membrane;receptor activity;defense response:protein binding;extracellular region;integral to membrane;innate immune response:protein binding;integral to membrane@NA
F09507@173467@173474@duplication@8@55263102@55290114@19@chr19:55263102-55290114@14.4@552@801@1.45@CNVR7725.2, CNVR7725.1@KIR2DL3_6, KIR2DL3_7, KIR2DL3_8, KIR2DL1_1, KIR2DL1_2, KIR2DL1_3, KIR2DL1_4, KIR2DL1_5@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
F09507@173844@173844@deletion@1@56283172@56283456@19@chr19:56283172-56283456@6.89@111@46@0.414@CNVR7734.1@CTD-2611O12.2_2@0@0@0@:ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
F09507@175736@175737@deletion@2@26061801@26063616@20@chr20:26061801-26063616@18.9@117@15@0.128@CNVR7823.4, CNVR7823.3, CNVR7823.5, CNVR7823.1@FAM182A_4, FAM182A_5@0@0@0@NA@NA@NA
F09507@176218@176221@duplication@4@33147013@33148783@20@chr20:33147013-33148783@6.45@174@257@1.48@NA@MAP1LC3A_3, MAP1LC3A_4, MAP1LC3A_5, PIGU_12@0@0@0@:microtubule-associated protein 1 light chain 3 alpha:phosphatidylinositol glycan anchor biosynthesis, class U@:phosphatidylethanolamine binding;autophagy;phospholipid binding;late endosome;endomembrane system;autophagic vacuole membrane;autophagic vacuole;cytoplasm;autophagic vacuole assembly;organelle membrane;cytosol;cytoplasmic vesicle;protein binding;microtubule:GPI-anchor transamidase activity;C-terminal protein lipidation;GPI anchor biosynthetic process;post-translational protein modification;GPI-anchor transamidase complex;integral to endoplasmic reticulum membrane;cellular protein metabolic process;integral to membrane;attachment of GPI anchor to protein;regulation of JAK-STAT cascade;plasma membrane;GPI anchor binding;endoplasmic reticulum membrane;cell division@NA
F09507@180976@180976@deletion@1@16287255@16287885@22@chr22:16287255-16287885@10.3@51@1@0.0196@CNVR8071.2, CNVR8071.3, CNVR8071.9@POTEH_1@0@0@0@:POTE ankyrin domain family, member H@:protein binding@NA
F09507@181951@181955@duplication@5@24376424@24384231@22@chr22:24376424-24384231@18.6@321@550@1.71@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTT1_5, GSTT1_4, GSTT1_3, GSTT1_2, GSTT1_1@0@0@0@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
F09507@184857@184863@duplication@7@50705364@50708721@22@chr22:50705364-50708721@8.3@524@703@1.34@NA@MAPK11_7, MAPK11_6, MAPK11_5, MAPK11_4, MAPK11_3, MAPK11_2, MAPK11_1@0@0@0@:mitogen-activated protein kinase 11@:nucleoplasm;MAPK cascade;MAP kinase activity;protein tyrosine kinase activity;toll-like receptor 4 signaling pathway;Ras protein signal transduction;ATP binding;regulation of sequence-specific DNA binding transcription factor activity;mRNA metabolic process;toll-like receptor 2 signaling pathway;MyD88-dependent toll-like receptor signaling pathway;gene expression;MyD88-independent toll-like receptor signaling pathway;activation of MAPK activity;protein kinase activity;TRIF-dependent toll-like receptor signaling pathway;cytosol;toll-like receptor signaling pathway;nerve growth factor receptor signaling pathway;transcription, DNA-dependent;membrane;muscle cell differentiation;toll-like receptor 1 signaling pathway;intracellular protein kinase cascade;RNA metabolic process;transferase activity, transferring phosphorus-containing groups;phosphotransferase activity, alcohol group as acceptor;Toll signaling pathway;stress-activated MAPK cascade;toll-like receptor 3 signaling pathway;protein serine/threonine kinase activity;positive regulation of muscle cell differentiation;protein phosphorylation;lipopolysaccharide biosynthetic process;response to stress;innate immune response;signal transduction;protein binding@NA
F09507@4071@4071@deletion@1@101581385@101581428@X@chrX:101581385-101581428@5.9@29@1@0.0345@NA@NXF2_34@0@0@0@NA@NA@NA
F09507@5718@5719@duplication@2@140335651@140336590@X@chrX:140335651-140336590@5.41@20@63@3.15@CNVR8456.1@SPANXC_2, SPANXC_1@0@0@0@NA@NA@NA
F09508@6@6@duplication@1@69092@70008@1@chr1:69092-70008@7.37@46@103@2.24@CNVR1.1, CNVR1.2@OR4F5_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F09508@1813@1814@duplication@2@12918866@12920126@1@chr1:12918866-12920126@8.93@309@444@1.44@CNVR72.3, CNVR72.4, CNVR72.7, CNVR72.12@PRAMEF2_2, PRAMEF2_3@0@0@0@:PRAME family member 2@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
F09508@2171@2188@duplication@18@17249159@17275421@1@chr1:17249159-17275421@49.2@1858@2625@1.41@CNVR94.4, CNVR94.5@CROCC_2, CROCC_3, CROCC_4, CROCC_5, CROCC_6, CROCC_7, CROCC_8, CROCC_9, CROCC_10, CROCC_11, CROCC_12, CROCC_13, CROCC_14, CROCC_15, CROCC_16, CROCC_17, CROCC_18, CROCC_19@0@0@0@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
F09508@2788@2792@deletion@5@21806545@21809879@1@chr1:21806545-21809879@12.7@213@112@0.526@CNVR107.2, CNVR107.1@NBPF3_11, NBPF3_12, NBPF3_13, NBPF3_14, NBPF3_15@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 3@:cytoplasm@NA
F09508@3338@3341@deletion@4@25629814@25648453@1@chr1:25629814-25648453@11.3@517@333@0.644@CNVR116.1, CNVR116.2@RHD_6, RHD_7, RHD_8, RHD_9@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
F09508@5148@5150@duplication@3@39977429@39988154@1@chr1:39977429-39988154@6.87@170@250@1.47@NA@BMP8A_3, BMP8A_4, BMP8A_5@0@0@0@:bone morphogenetic protein 8a@:cell differentiation;growth factor activity;extracellular space;growth;cytokine activity;cartilage development;ossification@NA
F09508@5194@5194@deletion@1@40229385@40229463@1@chr1:40229385-40229463@9.6@92@33@0.359@NA@BMP8B_5@0@0@0@:peptidylprolyl isomerase E (cyclophilin E):bone morphogenetic protein 8b@:regulation of transcription, DNA-dependent;nucleotide binding;catalytic step 2 spliceosome;protein folding;protein binding;protein peptidyl-prolyl isomerization;peptidyl-prolyl cis-trans isomerase activity;cyclosporin A binding;RNA binding;mRNA splicing, via spliceosome;nucleus;nucleic acid binding:cell differentiation;growth factor activity;extracellular space;growth;extracellular region;cytokine activity;cartilage development;skeletal system development;ossification@NA
F09508@6306@6309@duplication@4@47512140@47515846@1@chr1:47512140-47515846@28.1@1012@1461@1.44@NA@CYP4X1_9, CYP4X1_10, CYP4X1_11, CYP4X1_12@0@0@0@:cytochrome P450, family 4, subfamily X, polypeptide 1@:oxidation-reduction process;electron carrier activity;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;endoplasmic reticulum membrane;heme binding@NA
F09508@8507@8507@duplication@1@89476588@89476799@1@chr1:89476588-89476799@5.77@410@553@1.35@CNVR244.1@GBP3_8@0@0@0@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
F09508@8545@8545@deletion@1@89652017@89652209@1@chr1:89652017-89652209@5.17@124@71@0.573@NA@GBP4_10@0@0@0@:guanylate binding protein 4@:GTP binding;nucleus;GTPase activity;cytoplasm@NA
F09508@9385@9386@deletion@2@104297122@104297436@1@chr1:104297122-104297436@16.8@295@148@0.502@CNVR266.3, CNVR266.5@AMY1C_6, AMY1C_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
F09508@9766@9773@duplication@8@110230497@110235917@1@chr1:110230497-110235917@32.2@424@719@1.7@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
F09508@12117@12118@duplication@2@152573209@152586574@1@chr1:152573209-152586574@9.32@168@266@1.58@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
F09508@14046@14053@duplication@8@161487766@161565521@1@chr1:161487766-161565521@58.5@3227@4559@1.41@CNVR383.3, CNVR383.1@FCGR2A_7, HSPA6_1, FCGR3A_5, FCGR3A_4, FCGR3A_3, FCGR3A_2, FCGR3A_1, FCGR2C_1@0@0@0@:Fc fragment of IgG, low affinity IIa, receptor (CD32):heat shock 70kDa protein 6 (HSP70B'):Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene)@:IgG binding;protein binding;integral to membrane;plasma membrane:signalosome;cell morphogenesis;response to unfolded protein;ATP binding:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
F09508@16031@16040@duplication@10@196748928@196801129@1@chr1:196748928-196801129@24.5@1909@2506@1.31@CNVR459.1@CFHR3_3, CFHR3_4, CFHR3_5, CFHR3_6, CFHR1_1, CFHR1_2, CFHR1_3, CFHR1_4, CFHR1_5, CFHR1_6@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
F09508@17286@17291@deletion@6@207718654@207726196@1@chr1:207718654-207726196@6.18@29@1@0.0345@CNVR485.1@CR1_14, CR1_15, CR1_16, CR1_17, CR1_18, CR1_19@0@0@0@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
F09508@17297@17297@duplication@1@207741170@207741387@1@chr1:207741170-207741387@6.55@270@382@1.41@CNVR485.1, CNVR485.2@CR1_25@0@0@0@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
F09508@17624@17625@deletion@2@213003585@213009491@1@chr1:213003585-213009491@11.2@274@154@0.562@CNVR498.1@C1orf227_3, C1orf227_2@0@0@0@:chromosome 1 open reading frame 227@NA@NA
F09508@19771@19771@deletion@1@248651891@248652837@1@chr1:248651891-248652837@4.73@143@87@0.608@NA@OR2T5_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F09508@19774@19776@deletion@3@248737103@248790429@1@chr1:248737103-248790429@19.3@2278@1577@0.692@CNVR600.1@OR2T34_1, OR2T10_1, OR2T11_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 34:olfactory receptor, family 2, subfamily T, member 10:olfactory receptor, family 2, subfamily T, member 11@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F09508@19778@19778@deletion@1@248813233@248814185@1@chr1:248813233-248814185@9.09@504@322@0.639@NA@OR2T27_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 27@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F09508@24967@24968@deletion@2@89567759@89568232@2@chr2:89567759-89568232@5.23@87@46@0.529@CNVR866.7, CNVR866.1@IGKV1-33_2, IGKV1-33_1@0@0@0@@:protein binding@NA
F09508@25100@25100@deletion@1@96610863@96610922@2@chr2:96610863-96610922@6.89@467@309@0.662@CNVR881.1, CNVR881.2@ANKRD36C_18@0@0@0@:ankyrin repeat domain-containing protein 36A-like@:ion channel inhibitor activity;protein binding@NA
F09508@25115@25116@duplication@2@96652500@96652954@2@chr2:96652500-96652954@12.4@207@342@1.65@NA@ANKRD36C_3, ANKRD36C_2@0@0@0@:ankyrin repeat domain-containing protein 36A-like@:ion channel inhibitor activity;protein binding@NA
F09508@26310@26310@deletion@1@112551656@112551708@2@chr2:112551656-112551708@6.88@81@35@0.432@CNVR928.1@ANAPC1_37@0@0@0@:anaphase-promoting complex subunit 1-like;anaphase promoting complex subunit 1@:nucleoplasm;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle;anaphase-promoting complex;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle spindle assembly checkpoint;cytosol;protein K11-linked ubiquitination;protein binding;mitosis;nucleus;cell cycle checkpoint;cell division;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle@NA
F09508@42358@42360@deletion@3@132277816@132280061@3@chr3:132277816-132280061@22.5@375@188@0.501@NA@ACAD11_20, ACAD11_19, ACAD11_18@0@0@0@:acyl-CoA dehydrogenase family, member 11:nephronophthisis 3 (adolescent)@:oxidation-reduction process;acyl-CoA dehydrogenase activity;oxidoreductase activity, acting on the CH-CH group of donors;mitochondrion;very-long-chain-acyl-CoA dehydrogenase activity;fatty acid beta-oxidation using acyl-CoA dehydrogenase;long-chain-acyl-CoA dehydrogenase activity;peroxisome;flavin adenine dinucleotide binding;transferase activity, transferring phosphorus-containing groups;oxidoreductase activity;medium-chain-acyl-CoA dehydrogenase activity;nucleus;mitochondrial membrane;metabolic process:photoreceptor cell maintenance;negative regulation of canonical Wnt receptor signaling pathway;cilium;ureter development;lipid metabolic process;protein binding;regulation of Wnt receptor signaling pathway, planar cell polarity pathway;regulation of planar cell polarity pathway involved in neural tube closure;cilium morphogenesis;primary cilium;maintenance of organ identity;Wnt receptor signaling pathway;determination of left/right symmetry;convergent extension involved in gastrulation;kidney morphogenesis@: NEPHRONOPHTHISIS 3; NPHP3; RENAL-HEPATIC-PANCREATIC DYSPLASIA; RHPD; MECKEL SYNDROME, TYPE 7; MKS7
F09508@53308@53308@duplication@1@748520@748674@5@chr5:748520-748674@7.36@110@185@1.68@CNVR2280.3@ZDHHC11B_5@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
F09508@55830@55831@deletion@2@70307103@70308742@5@chr5:70307103-70308742@32.3@724@359@0.496@CNVR2494.41, CNVR2494.14, CNVR2494.30, CNVR2494.20, CNVR2494.62, CNVR2494.8, CNVR2494.35@NAIP_5, NAIP_4@0@0@0@:baculoviral IAP repeat-containing protein 1-like;NLR family, apoptosis inhibitory protein@:negative regulation of apoptotic process;inflammatory response;basolateral plasma membrane;nucleoside-triphosphatase activity;cysteine-type endopeptidase inhibitor activity;intracellular;nucleotide binding;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;ATP binding;cytoplasm;innate immune response;protein binding;negative regulation of neuron apoptotic process;metal ion binding;nervous system development@NA
F09508@59488@59488@deletion@1@147553798@147553933@5@chr5:147553798-147553933@30@140@0@0@CNVR2637.2, CNVR2637.1@SPINK14_3@0@0@0@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
F09508@60875@60877@duplication@3@175386973@175388437@5@chr5:175386973-175388437@12.1@155@264@1.7@NA@THOC3_6, THOC3_5, THOC3_4@0@0@0@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
F09508@61641@61641@duplication@1@180376905@180377544@5@chr5:180376905-180377544@5.05@429@570@1.33@CNVR2719.1@BTNL8_8@0@0@0@:butyrophilin-like 8@:protein binding;integral to membrane@NA
F09508@63281@63282@deletion@2@31237744@31238262@6@chr6:31237744-31238262@31.1@373@150@0.402@CNVR2838.2, CNVR2838.1@HLA-C_5, HLA-C_4@0@0@0@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
F09508@63800@63804@deletion@5@32009127@32010383@6@chr6:32009127-32010383@22@177@54@0.305@CNVR2843.6, CNVR2843.5@TNXB_13, TNXB_12, TNXB_11, TNXB_10, TNXB_9@0@0@0@:cytochrome P450, family 21, subfamily A, polypeptide 2:tenascin-X-like;tenascin XB@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
F09508@63953@63957@deletion@5@32485517@32489951@6@chr6:32485517-32489951@58.6@379@77@0.203@CNVR2845.21, CNVR2845.25, CNVR2845.30@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
F09508@63959@63974@deletion@16@32546869@32634384@6@chr6:32546869-32634384@159@1741@723@0.415@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.34@HLA-DRB1_6, HLA-DRB1_5, HLA-DRB1_4, HLA-DRB1_3, HLA-DRB1_2, HLA-DRB1_1, HLA-DQA1_1, HLA-DQA1_2, HLA-DQA1_3, HLA-DQA1_4, HLA-DQB1_6, HLA-DQB1_5, HLA-DQB1_4, HLA-DQB1_3, HLA-DQB1_2, HLA-DQB1_1@0@0@0@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
F09508@64096@64096@duplication@1@33141943@33141995@6@chr6:33141943-33141995@6.17@163@243@1.49@NA@COL11A2_30@0@0@0@:collagen, type XI, alpha 2@:collagen fibril organization;tissue homeostasis;palate development;extracellular matrix structural constituent conferring tensile strength;receptor binding;ossification;collagen type XI;skeletal system morphogenesis;soft palate development;protein binding, bridging;sensory perception of sound;extracellular matrix organization;endoplasmic reticulum lumen;collagen;extracellular matrix structural constituent;signal transduction;extracellular region;cartilage development;chondrocyte differentiation;skeletal system development@: OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA; OSMED; DEAFNESS, AUTOSOMAL DOMINANT 13; DFNA13; FIBROCHONDROGENESIS 2; FBCG2; DEAFNESS, AUTOSOMAL RECESSIVE 53; DFNB53; WEISSENBACHER-ZWEYMULLER SYNDROME; WZS; STICKLER SYNDROME, TYPE III; STL3
F09508@64602@64605@duplication@4@35754776@35763630@6@chr6:35754776-35763630@17.2@1160@1562@1.35@CNVR2861.1@CLPSL1_2, CLPSL1_3, CLPS_3, CLPS_2@0@0@0@:colipase-like 1:colipase, pancreatic@:extracellular region;enzyme activator activity;digestion;lipid catabolic process:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
F09508@71030@71030@duplication@1@167790035@167790192@6@chr6:167790035-167790192@4.9@41@80@1.95@NA@TCP10_5@0@0@0@:t-complex 10@:cytosol@NA
F09508@71674@71675@duplication@2@5338620@5339058@7@chr7:5338620-5339058@5.36@164@234@1.43@NA@SLC29A4_8, SLC29A4_9@0@0@0@:solute carrier family 29 (nucleoside transporters), member 4@:transport;integral to membrane;apical plasma membrane;plasma membrane;transmembrane transport;nucleoside transmembrane transporter activity@NA
F09508@71758@71758@deletion@1@5966000@5966179@7@chr7:5966000-5966179@16.4@138@40@0.29@NA@RSPH10B_20@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F09508@71762@71763@deletion@2@5977390@5978460@7@chr7:5977390-5978460@4.98@26@3@0.115@NA@RSPH10B_16, RSPH10B_15@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F09508@71772@71774@deletion@3@5998625@6004201@7@chr7:5998625-6004201@8.73@351@222@0.632@NA@RSPH10B_6, RSPH10B_5, RSPH10B_4@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F09508@71926@71926@duplication@1@6805338@6805422@7@chr7:6805338-6805422@8.58@150@245@1.63@NA@RSPH10B2_6@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F09508@71939@71945@duplication@7@6836200@6845668@7@chr7:6836200-6845668@28.2@294@542@1.84@NA@RSPH10B2_19, RSPH10B2_20, CCZ1B_15, CCZ1B_14, CCZ1B_13, CCZ1B_12, CCZ1B_11@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F09508@73242@73242@deletion@1@38279626@38279767@7@chr7:38279626-38279767@8.1@50@9@0.18@NA@TRGC2_4@0@0@0@@:protein binding@NA
F09508@74775@74775@duplication@1@76063356@76063472@7@chr7:76063356-76063472@7.69@90@161@1.79@CNVR3462.1@ZP3_5@0@0@0@:zona pellucida glycoprotein 3 (sperm receptor)@:negative regulation of transcription, DNA-dependent;manganese ion transmembrane transporter activity;intracellular protein transport;proteinaceous extracellular matrix;plasma membrane;positive regulation of acrosome reaction;outer acrosomal membrane;protein kinase C signaling cascade;manganese ion transmembrane transport;intracellular signal transduction;humoral immune response mediated by circulating immunoglobulin;negative regulation of binding of sperm to zona pellucida;positive regulation of inflammatory response;endoplasmic reticulum;signal transducer activity;perinuclear region of cytoplasm;secretory granule;positive regulation of transcription, DNA-dependent;positive regulation of ovarian follicle development;positive regulation of interferon-gamma production;carbohydrate binding;manganese ion transport;positive regulation of antral ovarian follicle growth;extracellular matrix;positive regulation of leukocyte migration;positive regulation of humoral immune response;extracellular space;blastocyst formation;integral to membrane;store-operated calcium channel activity;oocyte development;multivesicular body;phosphatidylinositol-mediated signaling;acrosomal vesicle;positive regulation of protein kinase B signaling cascade;Golgi apparatus;positive regulation of calcium ion import;positive regulation of protein kinase activity;positive regulation of acrosomal vesicle exocytosis;positive regulation of interleukin-4 production;cytoplasm;protein binding;binding of sperm to zona pellucida;positive regulation of phosphatidylinositol biosynthetic process;extracellular region;positive regulation of T cell proliferation;acrosin binding;positive regulation of type IV hypersensitivity;egg coat formation@NA
F09508@76427@76432@duplication@6@100331793@100336236@7@chr7:100331793-100336236@19.3@1025@1394@1.36@CNVR3509.1@ZAN_1, ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
F09508@76718@76718@deletion@1@102114809@102114982@7@chr7:102114809-102114982@7.11@33@1@0.0303@CNVR3518.1@POLR2J_3@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J, 13.3kDa@:nucleoplasm;DNA binding;DNA repair;protein dimerization activity;nucleus;viral reproduction;gene expression;transcription initiation from RNA polymerase II promoter;7-methylguanosine mRNA capping;protein phosphorylation;LRR domain binding;protein kinase activity;DNA-directed RNA polymerase II, core complex;nucleotide-excision repair;transcription from RNA polymerase II promoter;DNA-directed RNA polymerase activity;protein binding;transcription-coupled nucleotide-excision repair;RNA splicing;mRNA splicing, via spliceosome;transcription, DNA-dependent;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription@NA
F09508@76754@76754@deletion@1@102219880@102220243@7@chr7:102219880-102220243@16.4@75@0@0@CNVR3518.1@AC093668.1_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
F09508@76779@76779@duplication@1@102279571@102279646@7@chr7:102279571-102279646@6.14@165@246@1.49@CNVR3518.1@UPK3BL_4, UPK3BL_4@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
F09508@79287@79287@duplication@1@143400089@143400710@7@chr7:143400089-143400710@10.4@64@146@2.28@CNVR3594.2, CNVR3594.1@FAM115C_2@0@0@0@:family with sequence similarity 115, member C;protein FAM115C-like@NA@NA
F09508@79309@79311@duplication@3@143880598@143929936@7@chr7:143880598-143929936@7.08@162@241@1.49@CNVR3598.4, CNVR3598.3, CNVR3598.7@CTAGE4_1, ARHGEF35_2, OR2A42_1@0@0@0@:CTAGE family, member 4:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1@:integral to membrane;nucleotide binding;cellular_component;biological_process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F09508@80371@80371@duplication@1@7308236@7308422@8@chr8:7308236-7308422@16.1@364@595@1.63@CNVR3771.8, CNVR3771.10, CNVR3771.4@SPAG11B_3@0@0@0@:sperm associated antigen 11B@:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response@NA
F09508@80387@80399@duplication@13@7636684@7698716@8@chr8:7636684-7698716@17.9@480@698@1.45@CNVR3772.4, CNVR3772.6, CNVR3772.2, CNVR3772.8, CNVR3772.10@AC084121.16_4, AC084121.16_3, AC084121.16_2, AC084121.16_1, DEFB107A_2, DEFB107A_1, DEFB105A_3, DEFB105A_2, DEFB105A_1, DEFB106A_1, DEFB106A_2, DEFB104A_1, DEFB104A_2@0@0@0@:uncharacterized LOC100133251:defensin, beta 107B;defensin, beta 107A:defensin, beta 105B;defensin, beta 105A:defensin, beta 106B;defensin, beta 106A:defensin, beta 104A;defensin, beta 104B@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
F09508@80403@80406@duplication@4@7721024@7752292@8@chr8:7721024-7752292@8.45@247@358@1.45@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@SPAG11A_4, DEFB103A_1, DEFB103A_2, DEFB4A_1@0@0@0@:sperm associated antigen 11A;sperm associated antigen 11B:defensin, beta 103B;defensin, beta 103A:defensin, beta 4B;defensin, beta 4A@:extracellular region;defense response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response@NA
F09508@91242@91246@duplication@5@117085415@117087432@9@chr9:117085415-117087432@66.6@1260@2170@1.72@CNVR4448.1@ORM1_1, ORM1_2, ORM1_3, ORM1_4, ORM1_5@0@0@0@:orosomucoid 1@:protein binding;extracellular space;regulation of immune system process;transport;inflammatory response;extracellular region;acute-phase response@NA
F09508@95355@95355@duplication@1@17891584@17891768@10@chr10:17891584-17891768@6.2@304@423@1.39@NA@MRC1L1_7@0@0@0@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
F09508@95389@95393@deletion@5@18138509@18152611@10@chr10:18138509-18152611@25.8@168@34@0.202@NA@MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F09508@95410@95410@deletion@1@18196464@18196627@10@chr10:18196464-18196627@5.45@24@0@0@NA@MRC1_28@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F09508@95947@95947@deletion@1@29578048@29578159@10@chr10:29578048-29578159@6.82@113@57@0.504@NA@LYZL1_1@0@0@0@:lysozyme-like 1@:extracellular region;lysozyme activity;cell wall macromolecule catabolic process@NA
F09508@96505@96521@deletion@17@47658500@47701320@10@chr10:47658500-47701320@171@3433@1734@0.505@CNVR4713.1@ANTXRL_1, ANTXRL_2, ANTXRL_3, ANTXRL_4, ANTXRL_5, ANTXRL_6, ANTXRL_7, ANTXRL_8, ANTXRL_9, ANTXRL_10, ANTXRL_11, ANTXRL_12, ANTXRL_13, ANTXRL_14, ANTXRL_15, ANTXRL_16, ANTXRL_17@0@0@0@@:protein binding;integral to membrane;receptor activity;metal ion binding@NA
F09508@96573@96577@deletion@5@48025301@48033105@10@chr10:48025301-48033105@10.6@430@277@0.644@CNVR4715.2@ASAH2C_9, ASAH2C_8, ASAH2C_7, ASAH2C_6, ASAH2C_5@0@0@0@@:ceramidase activity;sphingolipid metabolic process@NA
F09508@96933@96937@duplication@5@51970584@51978390@10@chr10:51970584-51978390@16@184@322@1.75@NA@ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
F09508@101608@101614@deletion@7@124344788@124353114@10@chr10:124344788-124353114@32.3@987@597@0.605@CNVR4912.4, CNVR4912.3, CNVR4912.2@DMBT1_15, DMBT1_16, DMBT1_17, DMBT1_18, DMBT1_19, DMBT1_20, DMBT1_21@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
F09508@103268@103269@deletion@2@4967390@4976943@11@chr11:4967390-4976943@36.3@1889@1157@0.612@CNVR5040.1@OR51A4_1, OR51A2_1@0@0@0@:matrix metallopeptidase 26:olfactory receptor, family 51, subfamily A, member 4:olfactory receptor, family 51, subfamily A, member 2@:metallopeptidase activity;extracellular matrix;proteolysis;proteinaceous extracellular matrix;collagen catabolic process;metalloendopeptidase activity;zinc ion binding;metabolic process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F09508@106038@106040@deletion@3@55032377@55035848@11@chr11:55032377-55035848@10.5@170@85@0.5@CNVR5178.5@TRIM48_2, TRIM48_3, TRIM48_4@0@0@0@:tripartite motif containing 48@:protein binding;intracellular;zinc ion binding@NA
F09508@106046@106048@deletion@3@55370918@55419315@11@chr11:55370918-55419315@34.2@2543@1644@0.646@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F09508@114483@114483@deletion@1@11243900@11244828@12@chr12:11243900-11244828@9.4@1067@720@0.675@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
F09508@114494@114496@duplication@3@11506725@11508487@12@chr12:11506725-11508487@47.2@674@1242@1.84@CNVR5435.2, CNVR5435.1@PRB1_3, PRB1_2, PRB1_1@0@0@0@:proline-rich protein BstNI subfamily 1@NA@NA
F09508@124199@124199@deletion@1@25015985@25016106@13@chr13:25015985-25016106@9.33@148@72@0.486@NA@PARP4_30@0@0@0@:poly (ADP-ribose) polymerase family, member 4@:NAD+ ADP-ribosyltransferase activity;transport;inflammatory response;response to drug;DNA binding;DNA repair;cellular protein modification process;cell death;nucleus;spindle microtubule;ribonucleoprotein complex;enzyme binding;response to DNA damage stimulus;cytoplasm;protein ADP-ribosylation;protein binding@NA
F09508@128223@128224@duplication@2@24470594@24473579@14@chr14:24470594-24473579@6.39@317@431@1.36@NA@DHRS4L2_6, DHRS4L2_7@0@0@0@:dehydrogenase/reductase (SDR family) member 4 like 2@:extracellular region;oxidoreductase activity;nucleotide binding;metabolic process@NA
F09508@133432@133435@duplication@4@106539080@106552729@14@chr14:106539080-106552729@50@722@1284@1.78@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1@0@0@0@@:protein binding:protein binding@NA
F09508@133450@133451@deletion@2@106725202@106725654@14@chr14:106725202-106725654@11.2@910@610@0.67@CNVR6294.48, CNVR6294.24, CNVR6294.40, CNVR6294.38, CNVR6294.17, CNVR6294.23@IGHV3-23_2, IGHV3-23_1@0@0@0@@:protein binding@NA
F09508@133458@133459@deletion@2@106791006@106791456@14@chr14:106791006-106791456@31.9@683@323@0.473@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-30_2, IGHV3-30_1@0@0@0@@:protein binding@NA
F09508@133541@133542@deletion@2@22368577@22383423@15@chr15:22368577-22383423@11.2@4595@3430@0.746@CNVR6297.4, CNVR6297.17, CNVR6297.2@OR4M2_1, OR4N4_1@0@0@0@:olfactory receptor, family 4, subfamily M, member 2:olfactory receptor, family 4, subfamily N, member 4@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F09508@133670@133670@duplication@1@23690458@23690585@15@chr15:23690458-23690585@5.59@8@43@5.38@NA@GOLGA6L2_2@0@0@0@:golgin A6 family-like 2@NA@NA
F09508@134153@134157@duplication@5@32449810@32460659@15@chr15:32449810-32460659@9.36@293@412@1.41@CNVR6345.2, CNVR6345.1@CHRNA7_6, CHRNA7_7, CHRNA7_8, CHRNA7_9, CHRNA7_10@0@0@0@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
F09508@138289@138291@duplication@3@72958124@72958683@15@chr15:72958124-72958683@5.97@92@148@1.61@CNVR6443.1@GOLGA6B_16, GOLGA6B_17, GOLGA6B_18@0@0@0@:golgin A6 family, member B@:Golgi apparatus@NA
F09508@140317@140317@deletion@1@100348377@100348507@15@chr15:100348377-100348507@7.79@36@1@0.0278@CNVR6545.2@CTD-2054N24.2_2@0@0@0@NA@NA@NA
F09508@143256@143257@deletion@2@20451123@20451749@16@chr16:20451123-20451749@5.9@164@99@0.604@NA@ACSM5_13, ACSM5_14@0@0@0@:acyl-CoA synthetase medium-chain family member 5@:butyrate-CoA ligase activity;catalytic activity;ATP binding;fatty acid metabolic process;GTP binding;metabolic process;mitochondrial matrix;metal ion binding@NA
F09508@144038@144039@duplication@2@28403074@28403463@16@chr16:28403074-28403463@7.63@169@256@1.51@CNVR6684.2@EIF3CL_10, EIF3CL_9@0@0@0@:eukaryotic translation initiation factor 3, subunit C-like@:protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;translation initiation factor activity@NA
F09508@151399@151402@deletion@4@15449100@15458678@17@chr17:15449100-15458678@51.9@996@497@0.499@NA@TVP23C_5, TVP23C-CDRT4_5, TVP23C_4, TVP23C-CDRT4_4, TVP23C_3, TVP23C-CDRT4_3, TVP23C_2, TVP23C-CDRT4_2@0@0@0@:FAM18B2-CDRT4 readthrough:family with sequence similarity 18, member B2@:integral to membrane:integral to membrane@NA
F09508@151557@151559@duplication@3@16665628@16675333@17@chr17:16665628-16675333@9.91@918@1194@1.3@NA@CCDC144A_14, CCDC144A_14, CCDC144A_15, CCDC144A_15, CCDC144A_16, CCDC144A_16@0@0@0@:coiled-coil domain containing 144A@NA@NA
F09508@151875@151884@deletion@10@18380170@18396173@17@chr17:18380170-18396173@48.3@466@171@0.367@CNVR7014.1@LGALS9C_1, LGALS9C_2, LGALS9C_3, LGALS9C_4, LGALS9C_5, LGALS9C_6, LGALS9C_7, LGALS9C_8, LGALS9C_9, LGALS9C_10@0@0@0@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
F09508@151917@151920@duplication@4@18692667@18702256@17@chr17:18692667-18702256@20.6@963@1346@1.4@NA@TVP23B_2, TVP23B_3, TVP23B_4, TVP23B_5@0@0@0@:family with sequence similarity 18, member B1@:integral to membrane@NA
F09508@153378@153381@duplication@4@34523998@34539971@17@chr17:34523998-34539971@11.4@48@130@2.71@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL3L3_1, CCL4L1_1, CCL4L1_2, CCL4L1_3@0@0@0@:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
F09508@153654@153655@duplication@2@36358126@36358395@17@chr17:36358126-36358395@12.2@321@475@1.48@CNVR7083.3@RP11-1407O15.2_8, RP11-1407O15.2_7@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
F09508@154346@154346@deletion@1@39421631@39422112@17@chr17:39421631-39422112@6.15@49@15@0.306@CNVR7096.1@KRTAP9-6_1@0@0@0@:keratin associated protein 9-6@:keratin filament@NA
F09508@155587@155605@deletion@19@44399689@44618247@17@chr17:44399689-44618247@40.1@248@47@0.19@CNVR7114.2, CNVR7114.1@LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9, LRRC37A_10, LRRC37A_11, LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2, LRRC37A2_3, LRRC37A2_4, LRRC37A2_5, LRRC37A2_6, LRRC37A2_7, LRRC37A2_8@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
F09508@156877@156878@deletion@2@57656834@57657240@17@chr17:57656834-57657240@22.4@102@0@0@NA@DHX40_9, DHX40_10@0@0@0@:DEAH (Asp-Glu-Ala-His) box polypeptide 40@:transport;helicase activity;intracellular;ATP-dependent helicase activity;nucleic acid binding;ATP binding@NA
F09508@160967@160967@duplication@1@18534745@18535005@18@chr18:18534745-18535005@5.16@599@787@1.31@NA@ROCK1_31@0@0@0@:Rho-associated, coiled-coil containing protein kinase 1@:protein tyrosine kinase activity;bleb;apical constriction;ATP binding;regulation of actin filament-based process;regulation of focal adhesion assembly;leukocyte cell-cell adhesion;cytokinesis;intracellular signal transduction;regulation of actin cytoskeleton organization;intracellular;protein kinase activity;Rho protein signal transduction;cytosol;negative regulation of neuron apoptotic process;regulation of keratinocyte differentiation;phospholipid binding;smooth muscle contraction;negative regulation of angiogenesis;cellular component disassembly involved in execution phase of apoptosis;transferase activity, transferring phosphorus-containing groups;Golgi membrane;actin cytoskeleton organization;leukocyte tethering or rolling;regulation of cell motility;membrane to membrane docking;apoptotic process;GTP-Rho binding;centriole;protein serine/threonine kinase activity;regulation of establishment of cell polarity;protein phosphorylation;regulation of cell adhesion;bleb assembly;axon guidance;regulation of stress fiber assembly;signal transduction;protein binding;metal ion binding;leukocyte migration@NA
F09508@162019@162019@deletion@1@44554574@44556213@18@chr18:44554574-44556213@19@148@38@0.257@CNVR7319.1@TCEB3C_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C (elongin A3);RNA polymerase II transcription factor SIII subunit A3-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
F09508@164336@164337@duplication@2@4354947@4355170@19@chr19:4354947-4355170@7.73@201@296@1.47@NA@MPND_7, MPND_8@0@0@0@:MPN domain containing@:peptidase activity;protein binding;proteolysis@NA
F09508@166811@166812@duplication@2@14070580@14070881@19@chr19:14070580-14070881@12.3@446@638@1.43@NA@DCAF15_9, DCAF15_10@0@0@0@:DDB1 and CUL4 associated factor 15@:protein ubiquitination@NA
F09508@166916@166917@duplication@2@14508471@14508747@19@chr19:14508471-14508747@17.3@118@256@2.17@NA@CD97_7, CD97_8@0@0@0@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
F09508@167044@167045@deletion@2@14876337@14876616@19@chr19:14876337-14876616@18.2@509@293@0.576@NA@EMR2_9, EMR2_8@0@0@0@:egf-like module containing, mucin-like, hormone receptor-like 2@:transmembrane signaling receptor activity;inflammatory response;G-protein coupled receptor activity;ruffle membrane;integral to membrane;plasma membrane;cell surface receptor signaling pathway;neuropeptide signaling pathway;granulocyte chemotaxis;cell migration;leading edge membrane;G-protein coupled receptor signaling pathway;protein binding;cell adhesion;membrane;calcium ion binding;chondroitin sulfate binding@NA
F09508@167047@167047@deletion@1@14877791@14877921@19@chr19:14877791-14877921@13.5@115@35@0.304@NA@EMR2_6@0@0@0@:egf-like module containing, mucin-like, hormone receptor-like 2@:transmembrane signaling receptor activity;inflammatory response;G-protein coupled receptor activity;ruffle membrane;integral to membrane;plasma membrane;cell surface receptor signaling pathway;neuropeptide signaling pathway;granulocyte chemotaxis;cell migration;leading edge membrane;G-protein coupled receptor signaling pathway;protein binding;cell adhesion;membrane;calcium ion binding;chondroitin sulfate binding@NA
F09508@168952@168952@deletion@1@35862263@35863302@19@chr19:35862263-35863302@15@179@72@0.402@CNVR7627.1@GPR42_2@0@0@0@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
F09508@170096@170100@deletion@5@40373946@40382826@19@chr19:40373946-40382826@37.7@253@55@0.217@CNVR7639.2@FCGBP_26, FCGBP_25, FCGBP_24, FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F09508@170104@170109@duplication@6@40389653@40399855@19@chr19:40389653-40399855@11.8@459@633@1.38@CNVR7639.2, CNVR7639.3@FCGBP_18, FCGBP_17, FCGBP_16, FCGBP_15, FCGBP_14, FCGBP_13@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F09508@170367@170367@deletion@1@41381599@41381779@19@chr19:41381599-41381779@8.82@174@92@0.529@CNVR7642.1@CYP2A7_9@0@0@0@:cytochrome P450, family 2, subfamily A, polypeptide 7@:oxidation-reduction process;electron carrier activity;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;oxygen binding;heme binding;monooxygenase activity;endoplasmic reticulum membrane;iron ion binding@NA
F09508@172987@172992@deletion@6@52133087@52148783@19@chr19:52133087-52148783@10.8@539@356@0.66@CNVR7702.1@SIGLEC5_2, SIGLEC5_2, SIGLEC5_1, SIGLEC14_7, SIGLEC14_6, SIGLEC14_5, SIGLEC14_4@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 14@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion;plasma membrane@NA
F09508@173294@173295@duplication@2@54724026@54724700@19@chr19:54724026-54724700@20.6@245@467@1.91@CNVR7721.3@LILRB3_7, LILRB3_6@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F09508@173298@173302@duplication@5@54726151@54743827@19@chr19:54726151-54743827@12.1@676@921@1.36@CNVR7721.3, CNVR7721.4, CNVR7721.1@LILRB3_3, LILRB3_2, LILRB3_1, LILRA6_8, LILRA6_7@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F09508@173304@173350@duplication@47@54744708@54845236@19@chr19:54744708-54845236@303@9071@13458@1.48@NA@LILRA6_5, LILRA6_4, LILRA6_3, LILRA6_2, LILRA6_1, LILRB5_13, LILRB5_12, LILRB5_11, LILRB5_10, LILRB5_9, LILRB5_8, LILRB5_7, LILRB5_6, LILRB5_5, LILRB5_4, LILRB5_3, LILRB5_2, LILRB5_1, LILRB2_14, LILRB2_13, LILRB2_12, LILRB2_11, LILRB2_10, LILRB2_9, LILRB2_8, LILRB2_7, LILRB2_6, LILRB2_5, LILRB2_4, LILRB2_3, LILRB2_2, LILRA3_7, LILRA3_6, LILRA3_5, LILRA3_4, LILRA3_3, LILRA3_2, LILRA3_1, LILRA5_7, LILRA5_6, LILRA5_5, LILRA5_4, LILRA5_3, LILRA5_2, LILRA4_8, LILRA4_7@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2:leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane:transmembrane signaling receptor activity;protein binding;integral to membrane;defense response;cell surface receptor signaling pathway:regulation of immune response;positive regulation of T cell tolerance induction;immune response;cell adhesion molecule binding;heterotypic cell-cell adhesion;eukaryotic cell surface binding;plasma membrane;negative regulation of calcium ion transport;inhibitory MHC class I receptor activity;cellular response to lipopolysaccharide;cell-cell signaling;membrane;negative regulation of T cell proliferation;Fc receptor mediated inhibitory signaling pathway;immune response-inhibiting cell surface receptor signaling pathway;positive regulation of regulatory T cell differentiation;negative regulation of antigen processing and presentation;extracellular space;integral to plasma membrane;receptor activity;MHC class I protein binding;cell surface receptor signaling pathway;regulation of dendritic cell differentiation;positive regulation of interleukin-6 production;protein phosphatase 1 binding;MHC class Ib protein binding;cytoplasm;signal transduction;protein binding;cellular defense response;positive regulation of T cell proliferation;cell surface:antigen binding;signal transduction;protein binding;extracellular region;plasma membrane;receptor activity;defense response:protein binding;extracellular region;integral to membrane;innate immune response:protein binding;integral to membrane@NA
F09508@173499@173501@deletion@3@55358640@55359398@19@chr19:55358640-55359398@21.4@901@565@0.627@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4_6, KIR2DS4_7, KIR2DS4_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
F09508@173844@173844@deletion@1@56283172@56283456@19@chr19:56283172-56283456@20.6@303@130@0.429@CNVR7734.1@CTD-2611O12.2_2@0@0@0@:ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
F09508@174395@174395@duplication@1@1569207@1569278@20@chr20:1569207-1569278@5.31@51@96@1.88@CNVR7763.1@RP4-576H24.4_1@0@0@0@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
F09508@178964@178964@duplication@1@62843402@62843491@20@chr20:62843402-62843491@7.8@181@279@1.54@NA@MYT1_9@0@0@0@:myelin transcription factor 1@:cell differentiation;DNA binding;regulation of transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity;protein binding;nucleus;transcription, DNA-dependent;zinc ion binding;nervous system development@NA
F09508@180976@180976@deletion@1@16287255@16287885@22@chr22:16287255-16287885@18.3@88@3@0.0341@CNVR8071.2, CNVR8071.3, CNVR8071.9@POTEH_1@0@0@0@:POTE ankyrin domain family, member H@:protein binding@NA
F09508@181806@181808@deletion@3@23243157@23248831@22@chr22:23243157-23248831@5.53@408@284@0.696@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11@IGLC2_1, IGLJ3_1, IGLC3_1@0@0@0@@:protein binding:protein binding@NA
F09508@181948@181949@duplication@2@24324820@24325235@22@chr22:24324820-24325235@5.2@55@99@1.8@CNVR8114.6, CNVR8114.13, CNVR8114.8, CNVR8114.14@GSTT2_3, GSTT2_4@0@0@0@@:protein binding;glutathione transferase activity;nucleus;cytoplasm@NA
F09508@181951@181955@deletion@5@24376424@24384231@22@chr22:24376424-24384231@9.28@745@515@0.691@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTT1_5, GSTT1_4, GSTT1_3, GSTT1_2, GSTT1_1@0@0@0@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
F09508@4052@4071@deletion@20@101571921@101581428@X@chrX:101571921-101581428@33.5@198@35@0.177@NA@NXF2_15, NXF2_16, NXF2_17, NXF2_18, NXF2_19, NXF2_20, NXF2_21, NXF2_22, NXF2_23, NXF2_24, NXF2_25, NXF2_26, NXF2_27, NXF2_28, NXF2_29, NXF2_30, NXF2_31, NXF2_32, NXF2_33, NXF2_34@0@0@0@NA@NA@NA
F09508@6307@6307@duplication@1@153496018@153496256@X@chrX:153496018-153496256@12.6@83@181@2.18@CNVR8489.1@OPN1MW2_5@0@0@0@NA@NA@NA
F09591@2964@2964@duplication@1@22315756@22315772@1@chr1:22315756-22315772@5.21@97@164@1.69@CNVR108.2@CELA3B_8@0@0@0@:chymotrypsin-like elastase family, member 3B@:peptidase activity;proteolysis;extracellular region;cholesterol metabolic process;catalytic activity;serine-type endopeptidase activity@NA
F09591@2971@2972@deletion@2@22336199@22338960@1@chr1:22336199-22338960@11.3@136@61@0.449@CNVR108.2, CNVR108.1@CELA3A_7, CELA3A_8@0@0@0@:chymotrypsin-like elastase family, member 3A@:proteolysis;digestion;cholesterol metabolic process;catalytic activity;serine-type endopeptidase activity@NA
F09591@3334@3335@deletion@2@25611065@25617282@1@chr1:25611065-25617282@12.3@345@178@0.516@CNVR116.1, CNVR116.2@RHD_2, RHD_3@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
F09591@3357@3357@duplication@1@25735175@25735360@1@chr1:25735175-25735360@9.73@80@190@2.38@CNVR117.1@RHCE_2@0@0@0@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
F09591@5196@5197@deletion@2@40235375@40240128@1@chr1:40235375-40240128@14.5@333@142@0.426@NA@OXCT2_1, BMP8B_3@0@0@0@:bone morphogenetic protein 8b:3-oxoacid CoA transferase 2@:cell differentiation;growth factor activity;extracellular space;growth;extracellular region;cytokine activity;cartilage development;skeletal system development;ossification:mitochondrion;microtubule-based flagellum;CoA-transferase activity;ketone body catabolic process;3-oxoacid CoA-transferase activity;metabolic process@NA
F09591@8507@8508@deletion@2@89476588@89477710@1@chr1:89476588-89477710@7.35@524@336@0.641@CNVR244.1@GBP3_8, GBP3_7@0@0@0@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
F09591@8811@8813@duplication@3@93683296@93687493@1@chr1:93683296-93687493@5.65@249@347@1.39@NA@CCDC18_14, CCDC18_15, CCDC18_16@0@0@0@:coiled-coil domain containing 18@:nucleotide binding@NA
F09591@9365@9366@duplication@2@104202983@104203298@1@chr1:104202983-104203298@15.4@51@177@3.47@CNVR266.3, CNVR266.1@AMY1A_7, AMY1A_8@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
F09591@9373@9386@deletion@14@104233917@104297436@1@chr1:104233917-104297436@34.8@295@61@0.207@CNVR266.3, CNVR266.5@AMY1B_8, AMY1B_7, AMY1B_6, AMY1B_5, AMY1B_4, AMY1B_3, AMY1B_2, AMY1C_1, AMY1C_2, AMY1C_3, AMY1C_4, AMY1C_5, AMY1C_6, AMY1C_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
F09591@9766@9773@duplication@8@110230497@110235917@1@chr1:110230497-110235917@94.9@267@1191@4.46@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
F09591@12117@12118@deletion@2@152573209@152586574@1@chr1:152573209-152586574@23.5@111@0@0@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
F09591@14061@14063@duplication@3@161641183@161643863@1@chr1:161641183-161643863@6.91@296@415@1.4@CNVR383.1@FCGR2B_3, FCGR2B_4, FCGR2B_5@0@0@0@:Fc fragment of IgG, low affinity IIb, receptor (CD32)@:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
F09591@19774@19778@duplication@5@248737103@248814185@1@chr1:248737103-248814185@12.8@2348@3112@1.33@CNVR600.1@OR2T34_1, OR2T10_1, OR2T11_1, OR2T35_1, OR2T27_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 34:olfactory receptor, family 2, subfamily T, member 10:olfactory receptor, family 2, subfamily T, member 11:olfactory receptor, family 2, subfamily T, member 35:olfactory receptor, family 2, subfamily T, member 27@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F09591@22298@22300@duplication@3@39552660@39553102@2@chr2:39552660-39553102@7.76@234@345@1.47@NA@MAP4K3_12, MAP4K3_11, MAP4K3_10@0@0@0@:mitogen-activated protein kinase kinase kinase kinase 3@:intracellular protein kinase cascade;protein serine/threonine kinase activity;protein tyrosine kinase activity;JNK cascade;small GTPase regulator activity;protein phosphorylation;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;response to stress;protein binding;kinase activity@NA
F09591@22862@22864@duplication@3@54024653@54026218@2@chr2:54024653-54026218@5.45@201@283@1.41@NA@ERLEC1_4, ERLEC1_5, ERLEC1_6@0@0@0@:GPR75-ASB3 readthrough;ankyrin repeat and SOCS box containing 3:endoplasmic reticulum lectin 1@:protein binding;intracellular;intracellular signal transduction;protein ubiquitination:protein binding;ER-associated protein catabolic process;glycoprotein binding;endoplasmic reticulum lumen@NA
F09591@24966@24972@duplication@7@89545002@89619857@2@chr2:89545002-89619857@7.1@156@234@1.5@CNVR866.7, CNVR866.1@IGKV2-30_1, IGKV1-33_2, IGKV1-33_1, IGKV1-37_2, IGKV1-37_1, IGKV1-39_2, IGKV1-39_1@0@0@0@@:protein binding:protein binding:protein binding:protein binding@NA
F09591@25115@25116@duplication@2@96652500@96652954@2@chr2:96652500-96652954@10.7@185@326@1.76@NA@ANKRD36C_3, ANKRD36C_2@0@0@0@:ankyrin repeat domain-containing protein 36A-like@:ion channel inhibitor activity;protein binding@NA
F09591@25350@25351@deletion@2@97818242@97820478@2@chr2:97818242-97820478@10.2@241@127@0.527@CNVR886.2@ANKRD36_14, ANKRD36_15@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
F09591@25382@25407@duplication@26@97866191@97911808@2@chr2:97866191-97911808@29@1019@1487@1.46@NA@ANKRD36_46, ANKRD36_47, ANKRD36_48, ANKRD36_49, ANKRD36_50, ANKRD36_51, ANKRD36_52, ANKRD36_53, ANKRD36_54, ANKRD36_55, ANKRD36_56, ANKRD36_57, ANKRD36_58, ANKRD36_59, ANKRD36_60, ANKRD36_61, ANKRD36_62, ANKRD36_63, ANKRD36_64, ANKRD36_65, ANKRD36_66, ANKRD36_67, ANKRD36_68, ANKRD36_69, ANKRD36_70, ANKRD36_71@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
F09591@26312@26314@duplication@3@112552396@112560083@2@chr2:112552396-112560083@7.08@96@163@1.7@CNVR928.1@ANAPC1_35, ANAPC1_34, ANAPC1_33@0@0@0@:anaphase-promoting complex subunit 1-like;anaphase promoting complex subunit 1@:nucleoplasm;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle;anaphase-promoting complex;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle spindle assembly checkpoint;cytosol;protein K11-linked ubiquitination;protein binding;mitosis;nucleus;cell cycle checkpoint;cell division;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle@NA
F09591@26757@26759@duplication@3@120634900@120639406@2@chr2:120634900-120639406@5.78@156@231@1.48@NA@PTPN4_4, PTPN4_5, PTPN4_6@0@0@0@:protein tyrosine phosphatase, non-receptor type 4 (megakaryocyte)@:phosphatase activity;protein tyrosine phosphatase activity;non-membrane spanning protein tyrosine phosphatase activity;internal side of plasma membrane;protein dephosphorylation;extrinsic to membrane;cytoplasm;cytoskeletal protein binding;protein binding;protein tyrosine/serine/threonine phosphatase activity;cytoskeleton;dephosphorylation@NA
F09591@39888@39889@duplication@2@75713532@75714047@3@chr3:75713532-75714047@6.48@147@229@1.56@CNVR1432.5@FRG2C_1, FRG2C_2@0@0@0@:FSHD region gene 2 family, member C;FSHD region gene 2-like@:nucleus@NA
F09591@43489@43491@duplication@3@154834269@154834775@3@chr3:154834269-154834775@6.41@394@525@1.33@NA@MME_5, MME_6, MME_7@0@0@0@:membrane metallo-endopeptidase@:metallopeptidase activity;endopeptidase activity;synaptic vesicle;kidney development;sensory perception of pain;cellular response to cytokine stimulus;peptidase activity;proteolysis;integral to membrane;creatinine metabolic process;plasma membrane;metalloendopeptidase activity;integral to plasma membrane;dendrite;peptide metabolic process;axon;neuron projection terminus;cellular response to UV-B;peptide binding;cellular response to UV-A;cytoplasm;beta-amyloid metabolic process;brush border;protein binding;synapse;membrane;zinc ion binding;replicative senescence@NA
F09591@43990@43990@duplication@1@169801762@169802777@3@chr3:169801762-169802777@6.93@676@1002@1.48@NA@GPR160_4@0@0@0@:G protein-coupled receptor 160@:integral to membrane;G-protein coupled receptor activity;plasma membrane@NA
F09591@44042@44043@duplication@2@170585803@170586179@3@chr3:170585803-170586179@5.24@100@159@1.59@NA@RPL22L1_3, RPL22L1_2@0@0@0@:ribosomal protein L22-like 1@:structural constituent of ribosome;ribosome;intracellular;translation@NA
F09591@48556@48561@deletion@6@69403344@69434202@4@chr4:69403344-69434202@140@848@20@0.0236@CNVR1953.1@UGT2B17_6, UGT2B17_5, UGT2B17_4, UGT2B17_3, UGT2B17_2, UGT2B17_1@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
F09591@48592@48597@duplication@6@70146220@70160527@4@chr4:70146220-70160527@11.3@838@1137@1.36@CNVR1957.2, CNVR1957.1@UGT2B28_1, UGT2B28_2, UGT2B28_3, UGT2B28_4, UGT2B28_5, UGT2B28_6@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
F09591@53306@53311@duplication@6@741710@756259@5@chr5:741710-756259@14.2@309@493@1.6@CNVR2280.3@ZDHHC11B_7, ZDHHC11B_6, ZDHHC11B_5, ZDHHC11B_4, ZDHHC11B_3, ZDHHC11B_2@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
F09591@53318@53322@deletion@5@833889@847730@5@chr5:833889-847730@10.9@773@510@0.66@CNVR2280.3, CNVR2280.8@ZDHHC11_7, ZDHHC11_6, ZDHHC11_5, ZDHHC11_4, ZDHHC11_3@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
F09591@55782@55784@duplication@3@68861959@68862880@5@chr5:68861959-68862880@10.7@71@180@2.54@CNVR2494.7, CNVR2494.46@GTF2H2C_3, GTF2H2C_4, GTF2H2C_5@0@0@0@:general transcription factor IIH, polypeptide 2C;general transcription factor IIH, polypeptide 2D@:regulation of transcription, DNA-dependent;nucleotide-excision repair;DNA repair;core TFIIH complex;protein binding;nucleus;transcription, DNA-dependent;zinc ion binding@NA
F09591@56009@56009@duplication@1@72864061@72864152@5@chr5:72864061-72864152@4.99@47@95@2.02@NA@UTP15_3@0@0@0@:UTP15, U3 small nucleolar ribonucleoprotein, homolog (S. cerevisiae)@:protein binding;nucleolus;rRNA processing;cytoplasm@NA
F09591@60887@60889@duplication@3@175523828@175525561@5@chr5:175523828-175525561@11.7@213@350@1.64@NA@FAM153B_6, FAM153B_7, FAM153B_8@0@0@0@:uncharacterized LOC100507387;family with sequence similarity 153, member B@NA@NA
F09591@61266@61271@deletion@6@177163581@177168333@5@chr5:177163581-177168333@12.8@262@156@0.595@NA@FAM153A_11, FAM153A_10, FAM153A_9, FAM153A_8, FAM153A_7, FAM153A_6@0@0@0@:family with sequence similarity 153, member A@NA@NA
F09591@61638@61645@deletion@8@180375356@180429785@5@chr5:180375356-180429785@172@974@18@0.0185@CNVR2719.1@BTNL8_5, BTNL8_6, BTNL8_7, BTNL8_8, BTNL3_1, BTNL3_2, BTNL3_3, BTNL3_4@0@0@0@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
F09591@62954@62958@duplication@5@29911900@29913232@6@chr6:29911900-29913232@6.8@773@995@1.29@CNVR2829.7, CNVR2829.2, CNVR2829.3@HLA-A_6, HLA-A_7, HLA-A_8, HLA-A_9, HLA-A_10@0@0@0@:major histocompatibility complex, class I, A@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO
F09591@63725@63733@deletion@9@31962023@31964377@6@chr6:31962023-31964377@16.2@331@179@0.541@CNVR2843.6, CNVR2843.3@C4A_20, C4A_21, C4A_22, C4A_23, C4A_24, C4A_25, C4A_26, C4A_27, C4A_28@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
F09591@63942@63942@deletion@1@32361747@32361834@6@chr6:32361747-32361834@6.19@169@90@0.533@NA@BTNL2_7@0@0@0@:butyrophilin-like 2 (MHC class II associated)@:protein binding;integral to membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2
F09591@63953@63958@deletion@6@32485517@32498001@6@chr6:32485517-32498001@32.2@228@51@0.224@CNVR2845.21, CNVR2845.25, CNVR2845.30, CNVR2845.43, CNVR2845.6@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2, HLA-DRB5_1@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
F09591@63964@63974@duplication@11@32557421@32634384@6@chr6:32557421-32634384@61.7@876@1638@1.87@CNVR2845.21, CNVR2845.25@HLA-DRB1_1, HLA-DQA1_1, HLA-DQA1_2, HLA-DQA1_3, HLA-DQA1_4, HLA-DQB1_6, HLA-DQB1_5, HLA-DQB1_4, HLA-DQB1_3, HLA-DQB1_2, HLA-DQB1_1@0@0@0@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
F09591@71029@71032@duplication@4@167789455@167794824@6@chr6:167789455-167794824@10.8@270@411@1.52@NA@TCP10_6, TCP10_5, TCP10_4, TCP10_3@0@0@0@:t-complex 10@:cytosol@NA
F09591@71059@71085@duplication@27@168343810@168479774@6@chr6:168343810-168479774@66.9@4412@6075@1.38@CNVR3170.2@MLLT4_23, MLLT4_24, MLLT4_25, MLLT4_26, MLLT4_27, MLLT4_28, MLLT4_29, MLLT4_30, KIF25_3, KIF25_4, KIF25_5, KIF25_6, KIF25_7, KIF25_8, KIF25_9, KIF25_10, FRMD1_11, FRMD1_10, FRMD1_9, FRMD1_8, FRMD1_7, FRMD1_6, FRMD1_5, FRMD1_4, FRMD1_3, FRMD1_2, FRMD1_1@0@0@0@:myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4:kinesin family member 25:FERM domain containing 1@:cell-cell junction organization;apical part of cell;cell adhesion molecule binding;adherens junction;adherens junction organization;cell junction;protein C-terminus binding;nucleus;plasma membrane;cell-cell adherens junction;cytoplasm;cell-cell signaling;cytosol;cell-cell junction;protein binding;signal transduction;cell adhesion;cell junction assembly:kinesin complex;microtubule motor activity;microtubule associated complex;ATP binding;cytoplasm;organelle organization;microtubule-based movement;microtubule;negative regulation of autophagy;mitotic sister chromatid segregation:cytoskeleton@NA
F09591@71753@71759@deletion@7@5958499@5968025@7@chr7:5958499-5968025@13.7@867@564@0.651@NA@CCZ1_11, CCZ1_12, CCZ1_13, CCZ1_14, CCZ1_15, RSPH10B_20, RSPH10B_19@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae):radial spoke head 10 homolog B (Chlamydomonas)@:lysosomal membrane@NA
F09591@71772@71772@deletion@1@5998625@5998709@7@chr7:5998625-5998709@16.5@302@109@0.361@NA@RSPH10B_6@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F09591@71776@71779@deletion@4@6006495@6018327@7@chr7:6006495-6018327@23.4@237@89@0.376@NA@RSPH10B_2, PMS2_15, PMS2_14, PMS2_13@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas):PMS2 postmeiotic segregation increased 2 (S. cerevisiae)@:response to drug;DNA binding;MutSalpha complex binding;ATP binding;mismatch repair;DNA repair;mismatched DNA binding;ATPase activity;nucleus;mismatch repair complex;reciprocal meiotic recombination;ATP catabolic process;single-stranded DNA binding;response to DNA damage stimulus;single base insertion or deletion binding;protein binding;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;MutLalpha complex;endonuclease activity@: COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4; MISMATCH REPAIR CANCER SYNDROME
F09591@71922@71924@duplication@3@6797310@6799925@7@chr7:6797310-6799925@7.19@236@353@1.5@NA@RSPH10B2_2, RSPH10B2_3, RSPH10B2_4@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F09591@71926@71949@duplication@24@6805338@6859572@7@chr7:6805338-6859572@61.8@1355@2128@1.57@NA@RSPH10B2_6, RSPH10B2_7, RSPH10B2_8, RSPH10B2_9, RSPH10B2_10, RSPH10B2_11, RSPH10B2_12, RSPH10B2_13, RSPH10B2_14, RSPH10B2_15, RSPH10B2_16, RSPH10B2_17, RSPH10B2_18, RSPH10B2_19, RSPH10B2_20, CCZ1B_15, CCZ1B_14, CCZ1B_13, CCZ1B_12, CCZ1B_11, CCZ1B_10, CCZ1B_9, CCZ1B_8, CCZ1B_7@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F09591@74605@74605@deletion@1@74251403@74251500@7@chr7:74251403-74251500@5.7@25@0@0@NA@GTF2IRD2_2@0@0@0@:GTF2I repeat domain containing 2@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
F09591@74619@74622@duplication@4@74474401@74480461@7@chr7:74474401-74480461@6.35@20@64@3.2@NA@WBSCR16_7, WBSCR16_6, WBSCR16_5, WBSCR16_4@0@0@0@:RCC1-like G exchanging factor-like;Williams-Beuren syndrome chromosome region 16@:mitochondrion;cellular_component;biological_process@: WILLIAMS-BEUREN SYNDROME; WBS
F09591@76765@76779@deletion@15@102235753@102279646@7@chr7:102235753-102279646@12.1@230@120@0.522@CNVR3518.1@RASA4_11, RASA4_10, RASA4_9, RASA4_8, RASA4_7, RASA4_6, RASA4_5, RASA4_4, RASA4_3, RASA4_2, UPK3BL_7, RASA4_1, UPK3BL_6, UPK3BL_6, UPK3BL_5, UPK3BL_5, UPK3BL_4, UPK3BL_4@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
F09591@76794@76795@deletion@2@102313398@102319303@7@chr7:102313398-102319303@6.93@238@133@0.559@CNVR3518.1@AC105052.1_3, AC105052.1_2, AC105052.1_1@0@0@0@NA@NA@NA
F09591@77956@77956@duplication@1@128128156@128128215@7@chr7:128128156-128128215@5.99@82@151@1.84@NA@METTL2B_5@0@0@0@:methyltransferase like 2B@:methyltransferase activity;metabolic process@NA
F09591@79312@79325@duplication@14@143955790@144072768@7@chr7:143955790-144072768@28.6@2190@3189@1.46@CNVR3598.4@OR2A7_1, CTAGE8_1, OR2A1_1, ARHGEF5_2, ARHGEF5_3, ARHGEF5_4, ARHGEF5_5, ARHGEF5_6, ARHGEF5_7, ARHGEF5_8, ARHGEF5_9, ARHGEF5_10, ARHGEF5_11, ARHGEF5_12@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor, family 2, subfamily A, member 7:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
F09591@80367@80371@duplication@5@7272484@7308422@8@chr8:7272484-7308422@9.24@304@485@1.6@CNVR3771.8, CNVR3771.10, CNVR3771.4@DEFB4B_2, DEFB4B_1, DEFB103B_2, DEFB103B_1, SPAG11B_3@0@0@0@:defensin, beta 4B;defensin, beta 4A:defensin, beta 103B;defensin, beta 103A:sperm associated antigen 11B@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response@NA
F09591@80391@80399@duplication@9@7669331@7698716@8@chr8:7669331-7698716@17.8@406@613@1.51@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10@DEFB107A_2, DEFB107A_1, DEFB105A_3, DEFB105A_2, DEFB105A_1, DEFB106A_1, DEFB106A_2, DEFB104A_1, DEFB104A_2@0@0@0@:defensin, beta 107B;defensin, beta 107A:defensin, beta 105B;defensin, beta 105A:defensin, beta 106B;defensin, beta 106A:defensin, beta 104A;defensin, beta 104B@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
F09591@82791@82793@duplication@3@57078803@57125468@8@chr8:57078803-57125468@9.76@1572@2138@1.36@NA@PLAG1_5, PLAG1_4, CHCHD7_2@0@0@0@:pleiomorphic adenoma gene 1:coiled-coil-helix-coiled-coil-helix domain containing 7@:negative regulation of gene expression;positive regulation of gene expression;intracellular;positive regulation of glial cell proliferation;organ growth;DNA binding;sequence-specific DNA binding transcription factor activity;multicellular organism growth;prostate gland growth;nucleus;transcription, DNA-dependent;zinc ion binding;nucleic acid binding;gland morphogenesis:mitochondrion;cytochrome-c oxidase activity@: SALIVARY GLAND ADENOMA, PLEOMORPHIC
F09591@89846@89846@deletion@1@96339057@96339153@9@chr9:96339057-96339153@4.88@66@29@0.439@NA@PHF2_1@0@0@0@:PHD finger protein 2@:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen;negative regulation of chromatin silencing at rDNA;liver development;histone H3-K9 demethylation;transcription coactivator activity;protein binding;nucleolus;nucleus;methylated histone residue binding;transcription, DNA-dependent;protein demethylation;iron ion binding;zinc ion binding;histone demethylase activity (H3-K9 specific)@NA
F09591@93566@93566@deletion@1@138441155@138441176@9@chr9:138441155-138441176@6@46@12@0.261@CNVR4529.1@OBP2A_6@0@0@0@:odorant binding protein 2A@:odorant binding;sensory perception of chemical stimulus;response to stimulus;transport;extracellular region;sensory perception of smell;cellular_component@NA
F09591@94301@94314@duplication@14@140409832@140450100@9@chr9:140409832-140450100@28@2438@3215@1.32@NA@PNPLA7_12, PNPLA7_11, PNPLA7_10, PNPLA7_9, PNPLA7_8, PNPLA7_7, PNPLA7_6, PNPLA7_5, PNPLA7_4, PNPLA7_3, PNPLA7_2, PNPLA7_1, MRPL41_2, WDR85_9@0@0@0@:patatin-like phospholipase domain containing 7:mitochondrial ribosomal protein L41:WD repeat domain 85@:hydrolase activity;endoplasmic reticulum;lysosomal membrane;lipid metabolic process;nuclear membrane;integral to membrane;mitochondrial membrane;metabolic process:structural constituent of ribosome;mitochondrion;ribonucleoprotein complex;apoptotic process;mitochondrial large ribosomal subunit;translation;cell cycle:protein binding;peptidyl-diphthamide biosynthetic process from peptidyl-histidine@NA
F09591@94615@94615@duplication@1@5041393@5041469@10@chr10:5041393-5041469@4.94@120@193@1.61@NA@AKR1C2_4@0@0@0@:aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III);aldo-keto reductase family 1 member C2-like@:trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity;steroid metabolic process;oxidation-reduction process;phenanthrene 9,10-monooxygenase activity;prostaglandin F receptor activity;daunorubicin metabolic process;carboxylic acid binding;ketosteroid monooxygenase activity;progesterone metabolic process;oxidoreductase activity;digestion;positive regulation of cell proliferation;prostaglandin metabolic process;doxorubicin metabolic process;response to prostaglandin stimulus;positive regulation of protein kinase B signaling cascade;alditol:NADP+ 1-oxidoreductase activity;androsterone dehydrogenase (A-specific) activity;bile acid binding;G-protein coupled receptor signaling pathway;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;cytoplasm;cellular response to jasmonic acid stimulus@: 46,XY SEX REVERSAL 8; SRXY8
F09591@95384@95385@duplication@2@18112045@18116668@10@chr10:18112045-18116668@6.87@36@94@2.61@NA@MRC1_2, MRC1_3@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F09591@95389@95393@deletion@5@18138509@18152611@10@chr10:18138509-18152611@18.8@125@24@0.192@NA@MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F09591@96531@96531@duplication@1@47758847@47758904@10@chr10:47758847-47758904@5.83@37@88@2.38@CNVR4714.1@ANXA8L2_10@0@0@0@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:calcium-dependent phospholipid binding;calcium ion binding@NA
F09591@96576@96581@deletion@6@48029221@48055018@10@chr10:48029221-48055018@9.29@363@226@0.623@CNVR4715.2@ASAH2C_6, ASAH2C_5, ASAH2C_4, ASAH2C_3, ASAH2C_2, ASAH2C_1@0@0@0@@:ceramidase activity;sphingolipid metabolic process@NA
F09591@96851@96852@deletion@2@51371542@51374428@10@chr10:51371542-51374428@8.02@66@18@0.273@NA@TIMM23B_1, TIMM23B_2@0@0@0@:translocase of inner mitochondrial membrane 23 homolog B (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process@NA
F09591@96932@96939@duplication@8@51965743@51994312@10@chr10:51965743-51994312@22.1@158@342@2.16@NA@ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7, ASAH2_6, ASAH2_5@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
F09591@97303@97303@duplication@1@69750898@69750956@10@chr10:69750898-69750956@5.97@102@179@1.75@NA@HERC4_12@0@0@0@:HECT and RLD domain containing E3 ubiquitin protein ligase 4@:ubiquitin-protein ligase activity;cell differentiation;intracellular;protein ubiquitination involved in ubiquitin-dependent protein catabolic process;cytoplasm;cytosol;spermatogenesis;cellular protein modification process;nucleus@NA
F09591@102192@102194@deletion@3@135002044@135003317@10@chr10:135002044-135003317@6.35@172@101@0.587@NA@KNDC1_7, KNDC1_8, KNDC1_9@0@0@0@:kinase non-catalytic C-lobe domain (KIND) containing 1@:neuronal cell body;regulation of dendrite development;transferase activity, transferring phosphorus-containing groups;guanyl-nucleotide exchange factor activity;cerebellar granule cell differentiation;regulation of small GTPase mediated signal transduction;Ras guanyl-nucleotide exchange factor activity;dendrite;biological_process;protein serine/threonine kinase activity;small GTPase mediated signal transduction;intracellular;regulation of dendrite morphogenesis;protein binding;positive regulation of protein phosphorylation;molecular_function;cellular_component;guanyl-nucleotide exchange factor complex@NA
F09591@102336@102338@duplication@3@135438604@135439807@10@chr10:135438604-135439807@8.44@416@583@1.4@CNVR4989.11, CNVR4989.4@FRG2B_4, FRG2B_3, FRG2B_2@0@0@0@:FSHD region gene 2 family, member B@:nucleus@NA
F09591@103269@103269@deletion@1@4976003@4976943@11@chr11:4976003-4976943@17.1@499@204@0.409@CNVR5040.1@OR51A2_1@0@0@0@:matrix metallopeptidase 26:olfactory receptor, family 51, subfamily A, member 2@:metallopeptidase activity;extracellular matrix;proteolysis;proteinaceous extracellular matrix;collagen catabolic process;metalloendopeptidase activity;zinc ion binding;metabolic process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F09591@103342@103343@deletion@2@5798891@5810046@11@chr11:5798891-5810046@69.6@1262@537@0.426@CNVR5049.1@OR52N5_1, OR52N1_1@0@0@0@:tripartite motif containing 5:olfactory receptor, family 52, subfamily N, member 5:olfactory receptor, family 52, subfamily N, member 1@:defense response to virus;Golgi apparatus;intracellular;protein trimerization;ligase activity;cytoplasm;protein binding;nucleus;protein homodimerization activity;identical protein binding;zinc ion binding;cytoplasmic mRNA processing body;protein ubiquitination;virus-host interaction:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F09591@104572@104572@duplication@1@18955364@18956331@11@chr11:18955364-18956331@7.91@972@1463@1.51@CNVR5091.2, CNVR5091.1@MRGPRX1_1@0@0@0@:MAS-related GPR, member X1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;acute-phase response;G-protein coupled receptor signaling pathway@NA
F09591@106046@106048@deletion@3@55370918@55419315@11@chr11:55370918-55419315@6.96@2053@1462@0.712@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F09591@114424@114427@duplication@4@10583717@10587129@12@chr12:10583717-10587129@16.6@587@887@1.51@CNVR5430.1@KLRC2_6, KLRC2_5, KLRC2_4, KLRC2_3, NKG2-E_3@0@0@0@:killer cell lectin-like receptor subfamily C, member 2@:carbohydrate binding:transmembrane signaling receptor activity;carbohydrate binding;protein binding;signal transduction;cellular defense response;integral to plasma membrane@NA
F09591@114493@114499@deletion@7@11506042@11548463@12@chr12:11506042-11548463@114@1173@351@0.299@CNVR5435.2, CNVR5435.1@PRB1_4, PRB1_3, PRB1_2, PRB1_1, PRB2_3, PRB2_2, PRB2_1@0@0@0@:proline-rich protein BstNI subfamily 1:proline-rich protein BstNI subfamily 2@:extracellular region;molecular_function;cellular_component;biological_process@NA
F09591@119360@119367@duplication@8@71441431@71532010@12@chr12:71441431-71532010@27.7@1193@1727@1.45@NA@CTD-2021H9.3_3, CTD-2021H9.3_2, CTD-2021H9.3_1, TSPAN8_12, TSPAN8_11, TSPAN8_10, TSPAN8_9, TSPAN8_8@0@0@0@:tetraspanin 8@:negative regulation of blood coagulation;signal transduction;integral to membrane;protein glycosylation;signal transducer activity;lysosome@NA
F09591@123252@123253@duplication@2@124144594@124144782@12@chr12:124144594-124144782@9.28@102@194@1.9@NA@GTF2H3_12, GTF2H3_13@0@0@0@:general transcription factor IIH, polypeptide 3, 34kDa@:damaged DNA binding;nucleoplasm;termination of RNA polymerase I transcription;nucleotide-excision repair, DNA damage removal;transcription from RNA polymerase I promoter;sequence-specific DNA binding transcription factor activity;DNA repair;RNA polymerase II carboxy-terminal domain kinase activity;DNA-dependent ATPase activity;viral reproduction;translation;gene expression;protein N-terminus binding;transcription elongation from RNA polymerase I promoter;transcription initiation from RNA polymerase II promoter;7-methylguanosine mRNA capping;transcription initiation from RNA polymerase I promoter;translation factor activity, nucleic acid binding;holo TFIIH complex;protein phosphorylation;protein kinase activity;regulation of transcription, DNA-dependent;nucleotide-excision repair;transcription from RNA polymerase II promoter;core TFIIH complex;transcription-coupled nucleotide-excision repair;transcription elongation from RNA polymerase II promoter;metal ion binding;positive regulation of viral transcription@NA
F09591@133409@133415@deletion@7@106373070@106382715@14@chr14:106373070-106382715@20.2@468@253@0.541@CNVR6294.27, CNVR6294.36, CNVR6294.48, CNVR6294.25, CNVR6294.57, CNVR6294.29@IGHD2-8_1, IGHD1-7_1, IGHD6-6_1, IGHD5-5_1, IGHD4-4_1, IGHD3-3_1, IGHD2-2_1@0@0@0@NA@NA@NA
F09591@133426@133426@deletion@1@106478111@106478411@14@chr14:106478111-106478411@10.3@92@25@0.272@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV4-4_2@0@0@0@@:protein binding@NA
F09591@133432@133436@duplication@5@106539080@106573537@14@chr14:106539080-106573537@35.6@851@1462@1.72@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1, IGHV3-11_2@0@0@0@@:protein binding:protein binding:protein binding@NA
F09591@133462@133463@duplication@2@106815723@106816173@14@chr14:106815723-106816173@7.46@207@317@1.53@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.56, CNVR6294.51@IGHV3-33_2, IGHV3-33_1@0@0@0@@:protein binding@NA
F09591@133541@133541@duplication@1@22368577@22369517@15@chr15:22368577-22369517@7.62@2670@3899@1.46@CNVR6297.9, CNVR6297.4, CNVR6297.17, CNVR6297.18@OR4M2_1@0@0@0@:olfactory receptor, family 4, subfamily M, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F09591@135742@135743@duplication@2@43988238@43988561@15@chr15:43988238-43988561@5.25@192@270@1.41@CNVR6365.1@CKMT1A_5, CKMT1A_6@0@0@0@:stereocilin:creatine kinase, mitochondrial 1A;creatine kinase, mitochondrial 1B@:detection of mechanical stimulus involved in sensory perception of sound;stereocilium bundle tip;stereocilium;cell surface;kinocilium;auditory receptor cell stereocilium organization:mitochondrion;small molecule metabolic process;mitochondrial inner membrane;creatine metabolic process;creatine kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cellular nitrogen compound metabolic process;kinase activity@: DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16; DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY
F09591@137161@137163@duplication@3@62173043@62174027@15@chr15:62173043-62174027@5.58@256@352@1.38@NA@VPS13C_72, VPS13C_71, VPS13C_70@0@0@0@:vacuolar protein sorting 13 homolog C (S. cerevisiae)@:protein localization@NA
F09591@140317@140317@deletion@1@100348377@100348507@15@chr15:100348377-100348507@5.83@39@8@0.205@CNVR6545.2@CTD-2054N24.2_2@0@0@0@NA@NA@NA
F09591@141631@141631@deletion@1@2627427@2627501@16@chr16:2627427-2627501@5.9@121@60@0.496@CNVR6601.1@PDPK1_7@0@0@0@:3-phosphoinositide dependent protein kinase-1@:3-phosphoinositide-dependent protein kinase activity;nucleoplasm;fibroblast growth factor receptor signaling pathway;protein tyrosine kinase activity;negative regulation of transforming growth factor beta receptor signaling pathway;negative regulation of toll-like receptor signaling pathway;regulation of endothelial cell migration;focal adhesion assembly;ATP binding;insulin receptor signaling pathway;plasma membrane;intracellular signal transduction;positive regulation of establishment of protein localization to plasma membrane;platelet activation;protein kinase activity;regulation of mast cell degranulation;cytosol;epidermal growth factor receptor signaling pathway;hyperosmotic response;nerve growth factor receptor signaling pathway;type B pancreatic cell development;synaptic transmission;regulation of apoptotic process;transcription, DNA-dependent;protein autophosphorylation;regulation of I-kappaB kinase/NF-kappaB cascade;protein kinase binding;T cell costimulation;insulin receptor binding;transferase activity, transferring phosphorus-containing groups;actin cytoskeleton organization;blood coagulation;negative regulation of protein kinase activity;cellular response to insulin stimulus;focal adhesion;phosphatidylinositol-mediated signaling;negative regulation of cardiac muscle cell apoptotic process;protein serine/threonine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;cytoplasm;activation of protein kinase B activity;protein binding;T cell receptor signaling pathway;cytoplasmic membrane-bounded vesicle;peptidyl-threonine phosphorylation;kinase activity@NA
F09591@142691@142706@deletion@16@15069058@15123913@16@chr16:15069058-15123913@42.4@2626@1706@0.65@CNVR6646.1@PDXDC1_1, PDXDC1_2, PDXDC1_3, PDXDC1_4, PDXDC1_5, PDXDC1_6, PDXDC1_7, PDXDC1_8, PDXDC1_9, PDXDC1_10, PDXDC1_11, PDXDC1_12, PDXDC1_13, PDXDC1_14, PDXDC1_15, PDXDC1_16@0@0@0@:pyridoxal-dependent decarboxylase domain containing 1;pyridoxal-dependent decarboxylase domain-containing protein 1-like@:carboxylic acid metabolic process;pyridoxal phosphate binding;carboxy-lyase activity@NA
F09591@144038@144039@deletion@2@28403074@28403463@16@chr16:28403074-28403463@6.19@176@101@0.574@CNVR6684.2@EIF3CL_10, EIF3CL_9@0@0@0@:eukaryotic translation initiation factor 3, subunit C-like@:protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;translation initiation factor activity@NA
F09591@144097@144101@deletion@5@28617378@28619924@16@chr16:28617378-28619924@7.16@851@596@0.7@CNVR6685.1, CNVR6685.2@SULT1A1_9, SULT1A1_8, SULT1A1_7, SULT1A1_6, SULT1A1_5@0@0@0@:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1@:small molecule metabolic process;sulfation;aryl sulfotransferase activity;amine metabolic process;catecholamine metabolic process;xenobiotic metabolic process;cytosol;steroid sulfotransferase activity;integral to membrane;sulfotransferase activity;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process;estrogen metabolic process@NA
F09591@145554@145562@duplication@9@55844430@55860207@16@chr16:55844430-55860207@31@1438@2085@1.45@CNVR6731.1@CES1_11, CES1_10, CES1_9, CES1_8, CES1_7, CES1_6, CES1_5, CES1_4, CES1_3@0@0@0@:carboxylesterase 1;liver carboxylesterase 1-like@:hydrolase activity;methyl salicylate esterase activity;response to toxin;methylumbelliferyl-acetate deacetylase activity;endoplasmic reticulum lumen;retinyl-palmitate esterase activity;methyl jasmonate esterase activity;metabolic process;carboxylesterase activity;methyl indole-3-acetate esterase activity@: CARBOXYLESTERASE 1; CES1
F09591@147101@147101@deletion@1@70010292@70010635@16@chr16:70010292-70010635@13.3@63@0@0@CNVR6762.3, CNVR6762.2@RP11-419C5.2_7@0@0@0@NA@NA@NA
F09591@147418@147419@duplication@2@72090430@72091365@16@chr16:72090430-72091365@5.62@59@109@1.85@CNVR6769.1, CNVR6769.2@HP_3, HP_4@0@0@0@:thioredoxin-like 4B:haptoglobin:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:cellular iron ion homeostasis;negative regulation of oxidoreductase activity;catalytic activity;negative regulation of hydrogen peroxide catabolic process;positive regulation of cell death;haptoglobin-hemoglobin complex;extracellular space;proteolysis;response to hydrogen peroxide;extracellular region;hemoglobin binding;defense response;serine-type endopeptidase activity:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@: ANHAPTOGLOBINEMIA; AHP
F09591@147421@147421@deletion@1@72093014@72093087@16@chr16:72093014-72093087@11.2@289@133@0.46@CNVR6769.1, CNVR6769.2@HP_6@0@0@0@:thioredoxin-like 4B:haptoglobin:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:cellular iron ion homeostasis;negative regulation of oxidoreductase activity;catalytic activity;negative regulation of hydrogen peroxide catabolic process;positive regulation of cell death;haptoglobin-hemoglobin complex;extracellular space;proteolysis;response to hydrogen peroxide;extracellular region;hemoglobin binding;defense response;serine-type endopeptidase activity:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@: ANHAPTOGLOBINEMIA; AHP
F09591@151556@151561@duplication@6@16664740@16676947@17@chr17:16664740-16676947@14.6@1191@1612@1.35@NA@CCDC144A_13, CCDC144A_13, CCDC144A_14, CCDC144A_14, CCDC144A_15, CCDC144A_15, CCDC144A_16, CCDC144A_16, CCDC144A_17, CCDC144A_18, CCDC144A_17@0@0@0@:coiled-coil domain containing 144A@NA@NA
F09591@151875@151878@deletion@4@18380170@18391071@17@chr17:18380170-18391071@22.5@117@9@0.0769@CNVR7014.1@LGALS9C_1, LGALS9C_2, LGALS9C_3, LGALS9C_4@0@0@0@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
F09591@151883@151884@deletion@2@18395772@18396173@17@chr17:18395772-18396173@10.4@210@107@0.51@CNVR7014.1@LGALS9C_9, LGALS9C_10@0@0@0@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
F09591@152122@152130@deletion@9@20353287@20361697@17@chr17:20353287-20361697@30@299@111@0.371@CNVR7021.1, CNVR7021.3@LGALS9B_11, LGALS9B_10, LGALS9B_9, LGALS9B_8, LGALS9B_7, LGALS9B_6, LGALS9B_5, LGALS9B_4, LGALS9B_3@0@0@0@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
F09591@153380@153381@deletion@2@34539179@34539971@17@chr17:34539179-34539971@7.17@32@0@0@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1_2, CCL4L1_3@0@0@0@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
F09591@153397@153400@deletion@4@34625572@34641537@17@chr17:34625572-34641537@11.1@171@73@0.427@CNVR7077.1, CNVR7077.2, CNVR7077.12@CCL3L1_1, CCL4L2_1, CCL4L2_2, CCL4L2_3@0@0@0@:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
F09591@153651@153654@deletion@4@36352423@36358158@17@chr17:36352423-36358158@7.08@1256@895@0.713@CNVR7083.3@RP11-1407O15.2_11, RP11-1407O15.2_10, RP11-1407O15.2_9, RP11-1407O15.2_8@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
F09591@155581@155581@deletion@1@44248222@44249509@17@chr17:44248222-44249509@6.3@1820@1168@0.642@CNVR7114.3, CNVR7114.2, CNVR7114.8@KANSL1_2@0@0@0@:KAT8 regulatory NSL complex subunit 1@:histone acetyltransferase activity (H4-K8 specific);histone acetyltransferase activity (H4-K16 specific);histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase complex;histone H4-K5 acetylation;MLL1 complex;histone H4-K16 acetylation;protein binding;histone H4-K8 acetylation;nucleus@NA
F09591@155587@155599@duplication@13@44399689@44592687@17@chr17:44399689-44592687@13.2@200@337@1.68@CNVR7114.2, CNVR7114.1@LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9, LRRC37A_10, LRRC37A_11, LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane@NA
F09591@155610@155611@deletion@2@44632519@44632790@17@chr17:44632519-44632790@15.2@149@45@0.302@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2_13, LRRC37A2_14@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
F09591@162017@162017@deletion@1@44542732@44544371@18@chr18:44542732-44544371@5.7@51@16@0.314@CNVR7319.1@TCEB3CL2_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
F09591@164931@164932@duplication@2@6897161@6897558@19@chr19:6897161-6897558@10.1@443@660@1.49@NA@EMR1_4, EMR1_5@0@0@0@:egf-like module containing, mucin-like, hormone receptor-like 1@:transmembrane signaling receptor activity;neuropeptide signaling pathway;G-protein coupled receptor activity;external side of plasma membrane;G-protein coupled receptor signaling pathway;cell periphery;protein binding;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway@NA
F09591@166811@166812@deletion@2@14070580@14070881@19@chr19:14070580-14070881@10.6@342@193@0.564@NA@DCAF15_9, DCAF15_10@0@0@0@:DDB1 and CUL4 associated factor 15@:protein ubiquitination@NA
F09591@168952@168952@deletion@1@35862263@35863302@19@chr19:35862263-35863302@6.19@76@30@0.395@CNVR7627.1@GPR42_2@0@0@0@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
F09591@170104@170107@duplication@4@40389653@40396396@19@chr19:40389653-40396396@10.4@292@437@1.5@CNVR7639.2, CNVR7639.3@FCGBP_18, FCGBP_17, FCGBP_16, FCGBP_15@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F09591@170821@170824@duplication@4@43702150@43757798@19@chr19:43702150-43757798@6.96@480@652@1.36@CNVR7658.5, CNVR7658.1@PSG4_3, PSG4_2, PSG4_1, PSG9_6@0@0@0@:pregnancy specific beta-1-glycoprotein 4:pregnancy specific beta-1-glycoprotein 9@:protein binding;extracellular region;female pregnancy;defense response:protein binding;extracellular region;female pregnancy;defense response@NA
F09591@172839@172839@deletion@1@51509715@51509979@19@chr19:51509715-51509979@7.04@213@113@0.531@CNVR7699.1@KLK9_3, KLK9_3@0@0@0@:kallikrein-related peptidase 9:kallikrein-related peptidase 9@:proteolysis;extracellular region;catalytic activity;serine-type endopeptidase activity:proteolysis;extracellular region;catalytic activity;serine-type endopeptidase activity@NA
F09591@172989@172992@deletion@4@52146609@52148783@19@chr19:52146609-52148783@5.94@356@237@0.666@CNVR7702.1@SIGLEC14_7, SIGLEC14_6, SIGLEC14_5, SIGLEC14_4@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 14@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion;plasma membrane@NA
F09591@173295@173298@deletion@4@54724399@54726434@19@chr19:54724399-54726434@24.5@286@106@0.371@CNVR7721.3, CNVR7721.4@LILRB3_6, LILRB3_5, LILRB3_4, LILRB3_3@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F09591@173305@173305@duplication@1@54745453@54745754@19@chr19:54745453-54745754@4.82@71@125@1.76@CNVR7721.3, CNVR7721.6@LILRA6_4@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F09591@173492@173493@duplication@2@55341384@55341730@19@chr19:55341384-55341730@5.94@325@458@1.41@CNVR7725.1, CNVR7725.6@KIR3DL1_8, KIR3DL1_9@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
F09591@174395@174395@duplication@1@1569207@1569278@20@chr20:1569207-1569278@13.7@37@169@4.57@CNVR7763.1@RP4-576H24.4_1@0@0@0@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
F09591@180976@180976@deletion@1@16287255@16287885@22@chr22:16287255-16287885@12@56@0@0@CNVR8071.2, CNVR8071.3, CNVR8071.9@POTEH_1@0@0@0@:POTE ankyrin domain family, member H@:protein binding@NA
F09591@181632@181633@deletion@2@21576156@21576503@22@chr22:21576156-21576503@5.66@48@15@0.312@CNVR8100.4, CNVR8100.10, CNVR8100.7@GGT2_6, GGT2_5@0@0@0@:gamma-glutamyltransferase 2;gamma-glutamyltranspeptidase 2-like@:hydrolase activity;small molecule metabolic process;leukotriene biosynthetic process;anchored to external side of plasma membrane;glutathione biosynthetic process;xenobiotic metabolic process;integral to membrane;glutathione metabolic process;plasma membrane;gamma-glutamyltransferase activity;cellular_component@NA
F09591@1889@1889@deletion@1@48244795@48244889@X@chrX:48244795-48244889@5.41@24@0@0@CNVR8324.2@SSX4_4@0@0@0@NA@NA@NA
F09591@4052@4071@deletion@20@101571921@101581428@X@chrX:101571921-101581428@21.3@99@0@0@NA@NXF2_15, NXF2_16, NXF2_17, NXF2_18, NXF2_19, NXF2_20, NXF2_21, NXF2_22, NXF2_23, NXF2_24, NXF2_25, NXF2_26, NXF2_27, NXF2_28, NXF2_29, NXF2_30, NXF2_31, NXF2_32, NXF2_33, NXF2_34@0@0@0@NA@NA@NA
F09591@4073@4079@duplication@7@101615714@101620252@X@chrX:101615714-101620252@9.72@25@92@3.68@NA@NXF2B_33, NXF2B_32, NXF2B_31, NXF2B_30, NXF2B_29, NXF2B_28, NXF2B_27@0@0@0@NA@NA@NA
F09591@6304@6307@deletion@4@153490378@153496256@X@chrX:153490378-153496256@9.58@44@0@0@CNVR8489.1@OPN1MW2_2, OPN1MW2_3, OPN1MW2_4, OPN1MW2_5@0@0@0@NA@NA@NA
F10149@6@7@duplication@2@69092@139309@1@chr1:69092-139309@5.9@60@111@1.85@CNVR1.2@OR4F5_1, AL627309.1_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F10149@2091@2093@duplication@3@16385990@16388687@1@chr1:16385990-16388687@5.61@176@252@1.43@CNVR92.1@FAM131C_6, FAM131C_5, FAM131C_4@0@0@0@:family with sequence similarity 131, member C@NA@NA
F10149@2170@2188@duplication@19@17248515@17275421@1@chr1:17248515-17275421@47.2@1761@2507@1.42@CNVR94.4, CNVR94.5@CROCC_1, CROCC_2, CROCC_3, CROCC_4, CROCC_5, CROCC_6, CROCC_7, CROCC_8, CROCC_9, CROCC_10, CROCC_11, CROCC_12, CROCC_13, CROCC_14, CROCC_15, CROCC_16, CROCC_17, CROCC_18, CROCC_19@0@0@0@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
F10149@2788@2788@duplication@1@21806545@21806716@1@chr1:21806545-21806716@5.68@32@75@2.34@CNVR107.2, CNVR107.1@NBPF3_11@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 3@:cytoplasm@NA
F10149@3333@3341@duplication@9@25599040@25648453@1@chr1:25599040-25648453@35.5@1234@1802@1.46@CNVR116.1, CNVR116.2@RHD_1, RHD_2, RHD_3, RHD_4, RHD_5, RHD_6, RHD_7, RHD_8, RHD_9@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
F10149@3357@3357@deletion@1@25735175@25735360@1@chr1:25735175-25735360@25.1@119@1@0.0084@CNVR117.1@RHCE_2@0@0@0@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
F10149@5148@5149@deletion@2@39977429@39987242@1@chr1:39977429-39987242@6.11@73@33@0.452@NA@BMP8A_3, BMP8A_4@0@0@0@:bone morphogenetic protein 8a@:cell differentiation;growth factor activity;extracellular space;growth;cytokine activity;cartilage development;ossification@NA
F10149@7792@7792@deletion@1@70779429@70779473@1@chr1:70779429-70779473@5.78@101@52@0.515@NA@ANKRD13C_5@0@0@0@:ankyrin repeat domain 13C@:regulation of receptor biosynthetic process;endoplasmic reticulum;perinuclear region of cytoplasm;protein retention in ER lumen;protein binding;endoplasmic reticulum membrane;regulation of anoikis;receptor binding@NA
F10149@9352@9366@deletion@15@104161534@104203298@1@chr1:104161534-104203298@12.8@137@56@0.409@CNVR266.3, CNVR266.1@AMY2A_3, AMY2A_4, AMY2A_5, AMY2A_6, AMY2A_7, AMY2A_8, AMY2A_9, AMY2A_10, AMY1A_2, AMY1A_3, AMY1A_4, AMY1A_5, AMY1A_6, AMY1A_7, AMY1A_8@0@0@0@:amylase, alpha 2A (pancreatic):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:chloride ion binding;cation binding;small molecule metabolic process;carbohydrate metabolic process;catalytic activity;extracellular space;polysaccharide digestion;extracellular region;carbohydrate catabolic process;alpha-amylase activity;calcium ion binding:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
F10149@9436@9436@deletion@1@108769302@108769515@1@chr1:108769302-108769515@11.1@55@3@0.0545@CNVR294.4@NBPF4_14@0@0@0@:neuroblastoma breakpoint family, member 4@:cytoplasm@NA
F10149@9766@9773@duplication@8@110230497@110235917@1@chr1:110230497-110235917@114@384@1276@3.32@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
F10149@10335@10338@deletion@4@115466071@115487076@1@chr1:115466071-115487076@8.15@329@211@0.641@CNVR306.1@SYCP1_21, SYCP1_22, SYCP1_23, SYCP1_24@0@0@0@:synaptonemal complex protein 1@:regulation of protein localization;DNA binding;central element;synaptonemal complex assembly;protein binding;spermatogenesis;male germ cell nucleus;synaptonemal complex;transverse filament;reciprocal meiotic recombination;cell division@NA
F10149@12117@12118@deletion@2@152573209@152586574@1@chr1:152573209-152586574@27@124@0@0@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
F10149@16030@16033@duplication@4@196748293@196759357@1@chr1:196748293-196759357@13.3@499@703@1.41@CNVR459.1@CFHR3_2, CFHR3_3, CFHR3_4, CFHR3_5@0@0@0@:complement factor H-related 3@:extracellular space@NA
F10149@16037@16038@duplication@2@196795960@196797376@1@chr1:196795960-196797376@8.72@305@436@1.43@CNVR459.1@CFHR1_3, CFHR1_4@0@0@0@:complement factor H-related 1:complement factor H-related 2@:extracellular space;complement activation:extracellular region@NA
F10149@17624@17625@deletion@2@213003585@213009491@1@chr1:213003585-213009491@10.5@248@135@0.544@CNVR498.1@C1orf227_3, C1orf227_2@0@0@0@:chromosome 1 open reading frame 227@NA@NA
F10149@22173@22173@deletion@1@38791325@38791379@2@chr2:38791325-38791379@6.2@114@59@0.518@NA@HNRPLL_14@0@0@0@:heterogeneous nuclear ribonucleoprotein L-like@:ribonucleoprotein complex;positive regulation of RNA splicing;nucleotide binding;protein binding;mRNA binding;mRNA processing;RNA binding;nucleus;nucleic acid binding@NA
F10149@22304@22304@deletion@1@39564062@39564108@2@chr2:39564062-39564108@6.53@95@45@0.474@NA@MAP4K3_6@0@0@0@:mitogen-activated protein kinase kinase kinase kinase 3@:intracellular protein kinase cascade;protein serine/threonine kinase activity;protein tyrosine kinase activity;JNK cascade;small GTPase regulator activity;protein phosphorylation;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;response to stress;protein binding;kinase activity@NA
F10149@23471@23471@deletion@1@64174518@64174624@2@chr2:64174518-64174624@4.76@57@25@0.439@NA@VPS54_9@0@0@0@:vacuolar protein sorting 54 homolog (S. cerevisiae)@:musculoskeletal movement;protein binding;growth;protein transport;GARP complex;neurofilament cytoskeleton organization;homeostasis of number of cells within a tissue;retrograde transport, endosome to Golgi@NA
F10149@24967@24969@deletion@3@89567759@89597316@2@chr2:89567759-89597316@9.77@134@64@0.478@CNVR866.7, CNVR866.1@IGKV1-33_2, IGKV1-33_1, IGKV1-37_2@0@0@0@@:protein binding:protein binding@NA
F10149@25004@25005@duplication@2@90192949@90193424@2@chr2:90192949-90193424@6.83@328@451@1.38@CNVR867.10, CNVR867.5, CNVR867.3, CNVR867.9, CNVR867.15@IGKV1D-13_1, IGKV1D-13_2@0@0@0@@:protein binding@NA
F10149@25369@25370@duplication@2@97854825@97855027@2@chr2:97854825-97855027@6.09@14@54@3.86@CNVR886.2, CNVR886.3@ANKRD36_33, ANKRD36_34@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
F10149@25377@25401@deletion@25@97862331@97884815@2@chr2:97862331-97884815@17.7@1128@763@0.676@CNVR886.1@ANKRD36_41, ANKRD36_42, ANKRD36_43, ANKRD36_44, ANKRD36_45, ANKRD36_46, ANKRD36_47, ANKRD36_48, ANKRD36_49, ANKRD36_50, ANKRD36_51, ANKRD36_52, ANKRD36_53, ANKRD36_54, ANKRD36_55, ANKRD36_56, ANKRD36_57, ANKRD36_58, ANKRD36_59, ANKRD36_60, ANKRD36_61, ANKRD36_62, ANKRD36_63, ANKRD36_64, ANKRD36_65@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
F10149@27177@27178@duplication@2@130897465@130897669@2@chr2:130897465-130897669@7.72@129@208@1.61@NA@CCDC74B_7, CCDC74B_6@0@0@0@:coiled-coil domain containing 74A;coiled-coil domain containing 74B@NA@NA
F10149@28323@28323@deletion@1@160116322@160116354@2@chr2:160116322-160116354@5.81@101@52@0.515@NA@WDSUB1_6@0@0@0@:WD repeat, sterile alpha motif and U-box domain containing 1@:ubiquitin-protein ligase activity;protein binding;ubiquitin ligase complex;sequence-specific DNA binding;nucleus;protein ubiquitination@NA
F10149@30283@30284@deletion@2@188250273@188331769@2@chr2:188250273-188331769@5.56@173@107@0.618@NA@CALCRL_5, TFPI_8@0@0@0@:calcitonin receptor-like:tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)@:transmembrane signaling receptor activity;adenylate cyclase-activating G-protein coupled receptor signaling pathway;calcium ion transport;G-protein coupled receptor activity;calcitonin receptor activity;integral to membrane;protein transport;positive regulation of cell proliferation;plasma membrane;cAMP biosynthetic process;integral to plasma membrane;positive regulation of cAMP biosynthetic process;lysosome;cell surface receptor signaling pathway;endosome;G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger;angiogenesis;cellular response to sucrose stimulus;adrenomedullin receptor activity;endoplasmic reticulum;negative regulation of inflammatory response;G-protein coupled receptor signaling pathway;receptor internalization;regulation of muscle contraction;protein transporter activity;protein binding;heart development;calcitonin gene-related polypeptide receptor activity;membrane;positive regulation of smooth muscle cell proliferation:endopeptidase inhibitor activity;serine-type endopeptidase inhibitor activity;peptidase inhibitor activity;negative regulation of endopeptidase activity;blood coagulation;extracellular space;negative regulation of peptidase activity;extracellular region;blood coagulation, extrinsic pathway;plasma membrane@NA
F10149@30288@30288@deletion@1@188353065@188353102@2@chr2:188353065-188353102@5.97@125@68@0.544@NA@TFPI_4@0@0@0@:tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)@:endopeptidase inhibitor activity;serine-type endopeptidase inhibitor activity;peptidase inhibitor activity;negative regulation of endopeptidase activity;blood coagulation;extracellular space;negative regulation of peptidase activity;extracellular region;blood coagulation, extrinsic pathway;plasma membrane@NA
F10149@30887@30888@deletion@2@198415000@198415370@2@chr2:198415000-198415370@5.04@146@89@0.61@NA@MOB4_7, MOB4_8@0@0@0@:HSPE1-MOB4 readthrough;MOB family member 4, phocein@:transport;Golgi apparatus;perinuclear region of cytoplasm;cytoplasm;Golgi cisterna membrane;protein binding;kinase binding;membrane;metal ion binding@NA
F10149@31146@31146@deletion@1@202412229@202412333@2@chr2:202412229-202412333@5.2@82@41@0.5@NA@ALS2CR11_10@0@0@0@:amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 11@:protein binding@NA
F10149@40554@40554@deletion@1@108367766@108367809@3@chr3:108367766-108367809@7.87@94@39@0.415@NA@DZIP3_17@0@0@0@:DAZ interacting protein 3, zinc finger@:phosphatase binding;ubiquitin-protein ligase activity;cytoplasm;protein binding;RNA binding;protein polyubiquitination;zinc ion binding;polyubiquitin binding@NA
F10149@48556@48561@deletion@6@69403344@69434202@4@chr4:69403344-69434202@187@954@9@0.00943@CNVR1953.1@UGT2B17_6, UGT2B17_5, UGT2B17_4, UGT2B17_3, UGT2B17_2, UGT2B17_1@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
F10149@48592@48597@deletion@6@70146220@70160527@4@chr4:70146220-70160527@21.7@897@572@0.638@CNVR1957.2, CNVR1957.1@UGT2B28_1, UGT2B28_2, UGT2B28_3, UGT2B28_4, UGT2B28_5, UGT2B28_6@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
F10149@48627@48629@deletion@3@70801645@70802325@4@chr4:70801645-70802325@7.56@224@136@0.607@NA@CSN1S1_5, CSN1S1_6, CSN1S1_7@0@0@0@:casein alpha s1@:extracellular region;transporter activity@NA
F10149@48967@48967@duplication@1@75312252@75312499@4@chr4:75312252-75312499@5.71@67@120@1.79@NA@AREG_2@0@0@0@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
F10149@50932@50932@deletion@1@119612688@119612767@4@chr4:119612688-119612767@6.32@133@72@0.541@NA@METTL14_4@0@0@0@:methyltransferase like 14@:methyltransferase activity;mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity;RNA methylation;nucleus;nucleobase-containing compound metabolic process@NA
F10149@51410@51411@deletion@2@130027743@130030513@4@chr4:130027743-130030513@6.06@187@114@0.61@NA@C4orf33_3, C4orf33_4@0@0@0@:chromosome 4 open reading frame 33@NA@NA
F10149@52360@52360@deletion@1@162431551@162431576@4@chr4:162431551-162431576@5.16@79@39@0.494@NA@FSTL5_11@0@0@0@:follistatin-like 5@:protein binding;extracellular region;calcium ion binding@NA
F10149@53303@53304@duplication@2@716924@730583@5@chr5:716924-730583@8.72@628@846@1.35@CNVR2280.3@ZDHHC11B_10, ZDHHC11B_9@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
F10149@53313@53319@deletion@7@801223@837595@5@chr5:801223-837595@46.2@1391@814@0.585@CNVR2280.3@ZDHHC11_12, ZDHHC11_11, ZDHHC11_10, ZDHHC11_9, ZDHHC11_8, ZDHHC11_7, ZDHHC11_6@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
F10149@54250@54252@deletion@3@34919946@34922693@5@chr5:34919946-34922693@5.54@263@172@0.654@NA@BRIX1_3, BRIX1_4, BRIX1_5@0@0@0@:BRX1, biogenesis of ribosomes, homolog (S. cerevisiae)@:nucleolus;nucleus;molecular_function;ribosome biogenesis@NA
F10149@54403@54403@deletion@1@36260883@36260966@5@chr5:36260883-36260966@6.57@95@45@0.474@NA@RANBP3L_9@0@0@0@:RAN binding protein 3-like@:intracellular;intracellular transport@NA
F10149@54849@54849@deletion@1@42629141@42629205@5@chr5:42629141-42629205@10.4@169@80@0.473@CNVR2445.1@GHR_3@0@0@0@:growth hormone receptor@:neuronal cell body;mitochondrion;proline-rich region binding;JAK-STAT cascade;growth factor binding;nucleus;succinate metabolic process;positive regulation of JAK-STAT cascade;JAK-STAT cascade involved in growth hormone signaling pathway;response to morphine;activation of MAPK activity;peptide hormone binding;response to estradiol stimulus;2-oxoglutarate metabolic process;valine metabolic process;response to cytokine stimulus;hormone-mediated signaling pathway;response to food;SH2 domain binding;oxaloacetate metabolic process;growth hormone receptor signaling pathway;allantoin metabolic process;integral to membrane;response to hormone stimulus;cartilage development involved in endochondral bone morphogenesis;positive regulation of peptidyl-tyrosine phosphorylation;receptor internalization;cytoplasm;cellular response to hormone stimulus;extracellular region;growth hormone receptor complex;positive regulation of tyrosine phosphorylation of Stat5 protein;regulation of multicellular organism growth;growth hormone receptor activity;positive regulation of tyrosine phosphorylation of Stat3 protein;response to peptide hormone stimulus;fatty acid metabolic process;creatinine metabolic process;plasma membrane;positive regulation of multicellular organism growth;receptor complex;protein phosphatase binding;protein kinase binding;creatine metabolic process;response to interleukin-1;response to cycloheximide;extracellular space;positive regulation of cell differentiation;activation of Janus kinase activity;taurine metabolic process;cellular response to insulin stimulus;integral to plasma membrane;protein homodimerization activity;negative regulation of neuron death;citrate metabolic process;endocytosis;isoleucine metabolic process;activation of JAK2 kinase activity;extrinsic to membrane;response to glucocorticoid stimulus;protein binding;insulin-like growth factor receptor signaling pathway;multicellular organismal metabolic process;cell surface@: HYPERCHOLESTEROLEMIA, FAMILIAL; LARON SYNDROME; SHORT STATURE, IDIOPATHIC, AUTOSOMAL
F10149@55452@55452@deletion@1@61772511@61772580@5@chr5:61772511-61772580@4.83@105@58@0.552@NA@IPO11_9@0@0@0@:kinesin heavy chain member 2A:importin 11@:cell differentiation;microtubule motor activity;mitotic cell cycle;microtubule associated complex;ATP binding;motor activity;blood coagulation;M phase of mitotic cell cycle;cell division;antigen processing and presentation of exogenous peptide antigen via MHC class II;spindle microtubule;centrosome;mitotic spindle organization;cytosol;protein binding;mitotic prometaphase;microtubule-based movement;microtubule;spindle pole;nervous system development:binding;intracellular;cytoplasm;ribosomal protein import into nucleus;intracellular protein transport;protein transporter activity;protein binding;nucleus;nuclear pore@NA
F10149@55806@55806@deletion@1@69372349@69372398@5@chr5:69372349-69372398@10.3@125@51@0.408@CNVR2494.48, CNVR2494.39, CNVR2494.15, CNVR2494.18, CNVR2494.26, CNVR2494.43, CNVR2494.52, CNVR2494.28, CNVR2494.2, CNVR2494.36@SMN2_8@0@0@0@:survival of motor neuron 2, centromeric;survival of motor neuron 1, telomeric@:nucleoplasm;ncRNA metabolic process;Cajal body;RNA metabolic process;spliceosomal complex;cytoplasm;cytosol;protein binding;cell death;spliceosomal complex assembly;RNA binding;mRNA processing;nucleus;gene expression;spliceosomal snRNP assembly@: SPINAL MUSCULAR ATROPHY, TYPE II; SMA2; SPINAL MUSCULAR ATROPHY, TYPE I; SMA1; SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4; SPINAL MUSCULAR ATROPHY, TYPE III; SMA3
F10149@55971@55973@deletion@3@72332971@72347233@5@chr5:72332971-72347233@10.4@295@178@0.603@NA@FCHO2_10, FCHO2_11, FCHO2_12@0@0@0@:FCH domain only 2@:phosphatidylinositol-4,5-bisphosphate binding;phosphatidylserine binding;clathrin coat assembly;phosphatidylinositol binding;clathrin-coated vesicle;coated pit;protein localization to plasma membrane;membrane invagination;protein binding;clathrin-mediated endocytosis;plasma membrane@NA
F10149@59065@59065@deletion@1@140557617@140560021@5@chr5:140557617-140560021@17.1@1729@1049@0.607@CNVR2624.1@PCDHB8_1@0@0@0@:protocadherin beta 8@:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding@NA
F10149@60877@60877@duplication@1@175388277@175388437@5@chr5:175388277-175388437@5.94@43@91@2.12@NA@THOC3_4@0@0@0@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
F10149@61640@61645@duplication@6@180376240@180429785@5@chr5:180376240-180429785@11.7@1015@1321@1.3@CNVR2719.1@BTNL8_7, BTNL8_8, BTNL3_1, BTNL3_2, BTNL3_3, BTNL3_4@0@0@0@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
F10149@63282@63282@deletion@1@31237988@31238262@6@chr6:31237988-31238262@12.2@174@76@0.437@CNVR2838.1@HLA-C_4@0@0@0@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
F10149@63725@63725@deletion@1@31962023@31962161@6@chr6:31962023-31962161@6.72@35@3@0.0857@CNVR2843.6, CNVR2843.3@C4A_20@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
F10149@63729@63748@duplication@20@31963108@31974881@6@chr6:31963108-31974881@20.8@551@811@1.47@CNVR2843.6, CNVR2843.3@C4A_24, C4A_25, C4A_26, C4A_27, C4A_28, C4A_29, C4A_30, C4A_31, C4A_32, C4A_33, C4A_34, C4A_35, C4A_36, C4A_37, C4A_38, C4A_39, C4A_40, C4A_41, AL645922.1_2, AL645922.1_1@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
F10149@63768@63778@duplication@11@31994761@31997825@6@chr6:31994761-31997825@14.7@449@644@1.43@CNVR2843.6, CNVR2843.5@C4B_20, C4B_21, C4B_22, C4B_23, C4B_24, C4B_25, C4B_26, C4B_27, C4B_28, C4B_29, C4B_30@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
F10149@63797@63799@duplication@3@32008184@32008911@6@chr6:32008184-32008911@11@236@365@1.55@CNVR2843.6, CNVR2843.5@CYP21A2_8, CYP21A2_9, CYP21A2_10@0@0@0@:cytochrome P450, family 21, subfamily A, polypeptide 2@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY
F10149@63812@63812@duplication@1@32012784@32012996@6@chr6:32012784-32012996@7.03@109@183@1.68@CNVR2843.6, CNVR2843.5@TNXB_1@0@0@0@:tenascin-X-like;tenascin XB@:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
F10149@63953@63958@duplication@6@32485517@32498001@6@chr6:32485517-32498001@38.4@382@738@1.93@CNVR2845.21, CNVR2845.25, CNVR2845.30, CNVR2845.43, CNVR2845.6@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2, HLA-DRB5_1@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
F10149@63963@63963@duplication@1@32551887@32552155@6@chr6:32551887-32552155@5.71@131@202@1.54@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.54, CNVR2845.56, CNVR2845.34@HLA-DRB1_2@0@0@0@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
F10149@63970@63974@deletion@5@32628637@32634384@6@chr6:32628637-32634384@36.3@620@321@0.518@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20, CNVR2845.31@HLA-DQB1_5, HLA-DQB1_4, HLA-DQB1_3, HLA-DQB1_2, HLA-DQB1_1@0@0@0@:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
F10149@68706@68706@deletion@1@118801035@118801084@6@chr6:118801035-118801084@5.17@92@48@0.522@NA@CEP85L_11@0@0@0@:centrosomal protein 85kDa-like@:centrosome@NA
F10149@69913@69913@deletion@1@147038673@147038735@6@chr6:147038673-147038735@5.51@103@54@0.524@NA@ADGB_16@0@0@0@:androglobin@:intracellular;oxygen binding;heme binding;oxygen transport;proteolysis;protein binding;iron ion binding;calcium-dependent cysteine-type endopeptidase activity@NA
F10149@71011@71011@deletion@1@167590486@167590622@6@chr6:167590486-167590622@7.89@135@67@0.496@NA@TCP10L2_4@0@0@0@:t-complex 10;t-complex 10-like 2@NA@NA
F10149@71030@71030@deletion@1@167790035@167790192@6@chr6:167790035-167790192@6.28@30@1@0.0333@NA@TCP10_5@0@0@0@:t-complex 10@:cytosol@NA
F10149@71744@71758@duplication@15@5939916@5966179@7@chr7:5939916-5966179@30.4@1712@2324@1.36@NA@CCZ1_2, CCZ1_3, CCZ1_4, CCZ1_5, CCZ1_6, CCZ1_7, CCZ1_8, CCZ1_9, CCZ1_10, CCZ1_11, CCZ1_12, CCZ1_13, CCZ1_14, CCZ1_15, RSPH10B_20@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae):radial spoke head 10 homolog B (Chlamydomonas)@:lysosomal membrane@NA
F10149@71776@71776@duplication@1@6006495@6006747@7@chr7:6006495-6006747@5.1@142@211@1.49@NA@RSPH10B_2@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F10149@71935@71952@deletion@18@6825581@6863797@7@chr7:6825581-6863797@101@1287@560@0.435@NA@RSPH10B2_15, RSPH10B2_16, RSPH10B2_17, RSPH10B2_18, RSPH10B2_19, RSPH10B2_20, CCZ1B_15, CCZ1B_14, CCZ1B_13, CCZ1B_12, CCZ1B_11, CCZ1B_10, CCZ1B_9, CCZ1B_8, CCZ1B_7, CCZ1B_6, CCZ1B_5, CCZ1B_4@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F10149@74246@74246@deletion@1@66660158@66660324@7@chr7:66660158-66660324@5.35@178@108@0.607@NA@TYW1_15@0@0@0@:tRNA-yW synthesizing protein 1 homolog (S. cerevisiae);tRNA-yW synthesizing protein 1 homolog B (S. cerevisiae)@:tRNA processing;4 iron, 4 sulfur cluster binding;iron-sulfur cluster binding;oxidoreductase activity;FMN binding;iron ion binding;catalytic activity@NA
F10149@74568@74568@duplication@1@74160677@74160750@7@chr7:74160677-74160750@10.7@4@73@18.2@NA@GTF2I_23@0@0@0@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
F10149@74581@74584@duplication@4@74191614@74195181@7@chr7:74191614-74195181@7.3@181@267@1.48@NA@NCF1_2, NCF1_3, NCF1_4, NCF1_5@0@0@0@:neutrophil cytosolic factor 1@:inflammatory response;antigen processing and presentation of peptide antigen via MHC class I;phagosome maturation;NADPH oxidase complex;neutrophil mediated killing of gram-positive bacterium;cell communication;interaction with host;leukotriene metabolic process;response to yeast;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;respiratory burst;GTPase activity;negative regulation of smooth muscle contraction;GTP catabolic process;cytosol;defense response to fungus;defense response to bacterium;antigen processing and presentation of exogenous peptide antigen via MHC class I;leukocyte mediated cytotoxicity;neutrophil mediated killing of fungus;phosphatidylinositol binding;defense response to Gram-positive bacterium;GTP binding;respiratory burst involved in defense response;superoxide-generating NADPH oxidase activity;hydrogen peroxide biosynthetic process;protein targeting to membrane;electron carrier activity;superoxide metabolic process;innate immune response;phagolysosome;cytoplasm;cell proliferation;superoxide anion generation;protein binding;SH3 domain binding;cellular defense response;response to bacterium@: GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE,
F10149@74616@74622@deletion@7@74466819@74480461@7@chr7:74466819-74480461@8.38@214@125@0.584@NA@WBSCR16_10, WBSCR16_9, WBSCR16_8, WBSCR16_7, WBSCR16_6, WBSCR16_5, WBSCR16_4@0@0@0@:RCC1-like G exchanging factor-like;Williams-Beuren syndrome chromosome region 16@:mitochondrion;cellular_component;biological_process@: WILLIAMS-BEUREN SYNDROME; WBS
F10149@74775@74775@deletion@1@76063356@76063472@7@chr7:76063356-76063472@11.7@72@12@0.167@CNVR3462.1@ZP3_5@0@0@0@:zona pellucida glycoprotein 3 (sperm receptor)@:negative regulation of transcription, DNA-dependent;manganese ion transmembrane transporter activity;intracellular protein transport;proteinaceous extracellular matrix;plasma membrane;positive regulation of acrosome reaction;outer acrosomal membrane;protein kinase C signaling cascade;manganese ion transmembrane transport;intracellular signal transduction;humoral immune response mediated by circulating immunoglobulin;negative regulation of binding of sperm to zona pellucida;positive regulation of inflammatory response;endoplasmic reticulum;signal transducer activity;perinuclear region of cytoplasm;secretory granule;positive regulation of transcription, DNA-dependent;positive regulation of ovarian follicle development;positive regulation of interferon-gamma production;carbohydrate binding;manganese ion transport;positive regulation of antral ovarian follicle growth;extracellular matrix;positive regulation of leukocyte migration;positive regulation of humoral immune response;extracellular space;blastocyst formation;integral to membrane;store-operated calcium channel activity;oocyte development;multivesicular body;phosphatidylinositol-mediated signaling;acrosomal vesicle;positive regulation of protein kinase B signaling cascade;Golgi apparatus;positive regulation of calcium ion import;positive regulation of protein kinase activity;positive regulation of acrosomal vesicle exocytosis;positive regulation of interleukin-4 production;cytoplasm;protein binding;binding of sperm to zona pellucida;positive regulation of phosphatidylinositol biosynthetic process;extracellular region;positive regulation of T cell proliferation;acrosin binding;positive regulation of type IV hypersensitivity;egg coat formation@NA
F10149@74781@74783@deletion@3@76121471@76129837@7@chr7:76121471-76129837@5.85@68@31@0.456@CNVR3462.1@DTX2_6, DTX2_7, DTX2_8@0@0@0@:deltex homolog 2 (Drosophila)@:ligase activity;cytoplasm;nuclear membrane;Notch signaling pathway;protein binding;nucleus;zinc ion binding;protein ubiquitination@NA
F10149@74792@74793@deletion@2@76240783@76241130@7@chr7:76240783-76241130@10.4@241@135@0.56@CNVR3463.10@POMZP3_6, POMZP3_5@0@0@0@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
F10149@76427@76432@duplication@6@100331793@100336236@7@chr7:100331793-100336236@37.9@788@1256@1.59@CNVR3509.1@ZAN_1, ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
F10149@76754@76779@deletion@26@102219880@102279646@7@chr7:102219880-102279646@34@290@93@0.321@CNVR3518.1@AC093668.1_1, RASA4_21, RASA4_20, RASA4_19, RASA4_18, RASA4_17, RASA4_16, RASA4_15, RASA4_14, RASA4_13, RASA4_12, RASA4_11, RASA4_10, RASA4_9, RASA4_8, RASA4_7, RASA4_6, RASA4_5, RASA4_4, RASA4_3, RASA4_2, UPK3BL_7, RASA4_1, UPK3BL_6, UPK3BL_6, UPK3BL_5, UPK3BL_5, UPK3BL_4, UPK3BL_4@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
F10149@76859@76860@deletion@2@102964046@102965009@7@chr7:102964046-102965009@8.34@193@110@0.57@NA@DNAJC2_7, DNAJC2_6@0@0@0@:peptidase (mitochondrial processing) beta:DnaJ (Hsp40) homolog, subfamily C, member 2@:mitochondrion;mitochondrial inner membrane;catalytic activity;proteolysis;cellular protein metabolic process;protein targeting to mitochondrion;metalloendopeptidase activity;mitochondrial matrix;zinc ion binding;metal ion binding:histone binding;DNA binding;ubiquitin binding;protein folding;negative regulation of cell growth;Hsp70 protein binding;nucleus;unfolded protein binding;'de novo' cotranslational protein folding;cytoplasm;cytosol;nuclear membrane;protein binding;positive regulation of transcription, DNA-dependent;chromatin binding;heat shock protein binding;chromatin modification;transcription, DNA-dependent;G2 phase of mitotic cell cycle;DNA replication@NA
F10149@77549@77550@deletion@2@117022124@117023164@7@chr7:117022124-117023164@5.3@151@91@0.603@NA@ASZ1_8, ASZ1_7@0@0@0@:ankyrin repeat, SAM and basic leucine zipper domain containing 1@:multicellular organismal development;cell differentiation;signal transducer activity;cytoplasm;male meiosis;pi-body;protein binding;spermatogenesis;signal transduction;DNA methylation involved in gamete generation;piRNA metabolic process;gene silencing by RNA@NA
F10149@79312@79312@deletion@1@143955790@143956721@7@chr7:143955790-143956721@16.7@842@483@0.574@CNVR3598.4, CNVR3598.7, CNVR3598.6@OR2A7_1@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor, family 2, subfamily A, member 7@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F10149@79316@79318@deletion@3@144063449@144064448@7@chr7:144063449-144064448@12.7@81@15@0.185@CNVR3598.4, CNVR3598.5, CNVR3598.11@ARHGEF5_3, ARHGEF5_4, ARHGEF5_5@0@0@0@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
F10149@79323@79323@deletion@1@144070289@144070377@7@chr7:144070289-144070377@5.66@96@49@0.51@CNVR3598.4, CNVR3598.5, CNVR3598.11@ARHGEF5_10@0@0@0@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
F10149@80385@80386@deletion@2@7398475@7399402@8@chr8:7398475-7399402@11.6@104@34@0.327@CNVR3771.8, CNVR3771.4, CNVR3771.2@RP11-1118M6.1_3, RP11-1118M6.1_4@0@0@0@:uncharacterized LOC100133251@NA@NA
F10149@80388@80388@duplication@1@7637545@7637611@8@chr8:7637545-7637611@15.9@39@157@4.03@CNVR3772.4, CNVR3772.6, CNVR3772.2, CNVR3772.8, CNVR3772.10@AC084121.16_3@0@0@0@:uncharacterized LOC100133251@NA@NA
F10149@80396@80397@deletion@2@7682700@7686475@8@chr8:7682700-7686475@11.4@56@3@0.0536@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10@DEFB106A_1, DEFB106A_2@0@0@0@:defensin, beta 106B;defensin, beta 106A@:extracellular region;defense response to bacterium@NA
F10149@81781@81782@deletion@2@30941216@30942762@8@chr8:30941216-30942762@4.92@215@139@0.647@NA@WRN_10, WRN_11@0@0@0@:Werner syndrome, RecQ helicase-like@:nucleoplasm;response to oxidative stress;ATP-dependent 3'-5' DNA helicase activity;ATP binding;four-way junction helicase activity;ATP-dependent DNA helicase activity;DNA repair;ATPase activity;nucleus;regulation of growth rate;telomere maintenance;base-excision repair;helicase activity;intracellular;replicative cell aging;DNA synthesis involved in DNA repair;DNA duplex unwinding;cell aging;Y-form DNA binding;bubble DNA binding;nucleolus;regulation of apoptotic process;DNA replication;multicellular organismal aging;DNA metabolic process;replication fork processing;aging;cellular metabolic process;magnesium ion binding;nucleobase-containing compound metabolic process;DNA binding;catalytic activity;DNA helicase activity;nucleolus to nucleoplasm transport;protein homodimerization activity;DNA recombination;ATP catabolic process;cellular response to starvation;response to UV-C;3'-5' exonuclease activity;positive regulation of hydrolase activity;centrosome;3'-5' DNA helicase activity;exonuclease activity;response to DNA damage stimulus;nucleotide binding;manganese ion binding;protein binding;protein complex binding;MutLalpha complex;G-quadruplex DNA binding;ATP-dependent helicase activity;nucleic acid binding@: COLORECTAL CANCER; CRC; WERNER SYNDROME; WRN
F10149@82858@82858@deletion@1@59544056@59544105@8@chr8:59544056-59544105@5.25@117@65@0.556@NA@NSMAF_6@0@0@0@:neutral sphingomyelinase (N-SMase) activation associated factor@:protein binding;signal transduction;ceramide metabolic process;receptor signaling protein activity;cytoplasm@NA
F10149@82887@82887@deletion@1@61531140@61531207@8@chr8:61531140-61531207@4.89@76@38@0.5@NA@RAB2A_7@0@0@0@:RAB2A, member RAS oncogene family@:neuronal cell body;endoplasmic reticulum-Golgi intermediate compartment membrane;Golgi membrane;GDP binding;intracellular protein transport;protein transport;GTP binding;nucleus;melanosome;endoplasmic reticulum membrane;Golgi apparatus;small GTPase mediated signal transduction;intracellular;GTPase activity;GTP catabolic process;cytoplasm;signal transduction;nucleocytoplasmic transport;ER to Golgi vesicle-mediated transport;membrane@NA
F10149@83008@83008@deletion@1@66651738@66651832@8@chr8:66651738-66651832@5.88@82@38@0.463@NA@PDE7A_6@0@0@0@:mitochondrial fission regulator 1:phosphodiesterase 7A@:mitochondrion;mitochondrial fission;plasma membrane;mitochondrion organization;aerobic respiration:cytosol;signal transduction;3',5'-cyclic-AMP phosphodiesterase activity;cAMP-mediated signaling;3',5'-cyclic-nucleotide phosphodiesterase activity;catalytic activity;cAMP catabolic process;metal ion binding@NA
F10149@83576@83576@deletion@1@82588470@82588514@8@chr8:82588470-82588514@4.61@102@57@0.559@NA@IMPA1_6@0@0@0@:inositol(myo)-1(or 4)-monophosphatase 1@:neuronal cell body;axon;mitochondrion;phosphatidylinositol phosphorylation;response to lithium ion;phosphate-containing compound metabolic process;inositol monophosphate 3-phosphatase activity;inositol biosynthetic process;cytoplasm;inositol monophosphate 1-phosphatase activity;inositol phosphate dephosphorylation;phosphatidylinositol biosynthetic process;signal transduction;inositol monophosphate 4-phosphatase activity;nucleus;protein homodimerization activity;metal ion binding@NA
F10149@84083@84083@deletion@1@95900156@95900301@8@chr8:95900156-95900301@5.17@71@33@0.465@NA@CCNE2_7@0@0@0@:cyclin E2@:nucleoplasm;regulation of cell cycle;mitotic cell cycle;protein kinase binding;G1/S transition of mitotic cell cycle;DNA replication initiation;cytosol;protein binding;regulation of cyclin-dependent protein kinase activity;cyclin-dependent protein kinase regulator activity;nucleus;cell cycle;cell cycle checkpoint;cell division@NA
F10149@88593@88601@duplication@9@43816638@43876145@9@chr9:43816638-43876145@30.1@418@741@1.77@NA@CNTNAP3B_6, CNTNAP3B_7, CNTNAP3B_8, CNTNAP3B_9, CNTNAP3B_10, CNTNAP3B_11, CNTNAP3B_12, CNTNAP3B_13, CNTNAP3B_14@0@0@0@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
F10149@90929@90929@deletion@1@114475381@114475452@9@chr9:114475381-114475452@5@124@71@0.573@NA@C9orf84_18@0@0@0@:chromosome 9 open reading frame 84@NA@NA
F10149@95346@95355@duplication@10@17813309@17891768@10@chr10:17813309-17891768@22.6@514@797@1.55@NA@TMEM236_2, TMEM236_3, TMEM236_4, MRC1L1_1, MRC1L1_2, MRC1L1_3, MRC1L1_4, MRC1L1_5, MRC1L1_6, MRC1L1_7@0@0@0@:transmembrane protein 236;transmembrane protein 236-like:macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding@NA
F10149@95376@95394@deletion@19@17949551@18155690@10@chr10:17949551-18155690@74@448@72@0.161@NA@MRC1L1_28, MRC1L1_29, MRC1L1_30, TMEM236_1, TMEM236_2, TMEM236_3, TMEM236_4, MRC1_1, MRC1_2, MRC1_3, MRC1_4, MRC1_5, MRC1_6, MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11, MRC1_12@0@0@0@:macrophage mannose receptor 1-like:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F10149@95410@95410@duplication@1@18196464@18196627@10@chr10:18196464-18196627@5.52@27@68@2.52@NA@MRC1_28@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F10149@95800@95801@deletion@2@27311488@27313488@10@chr10:27311488-27313488@8.25@145@76@0.524@NA@ANKRD26_29, ANKRD26_28@0@0@0@:ankyrin repeat domain 26@:regulation of feeding behavior;centrosome;transferase activity;cofactor binding;negative regulation of multicellular organism growth;regulation of fatty acid metabolic process;actin filament;protein binding;negative regulation of organ growth@NA
F10149@95948@95948@deletion@1@29580773@29580935@10@chr10:29580773-29580935@8.26@58@14@0.241@NA@LYZL1_2@0@0@0@:lysozyme-like 1@:extracellular region;lysozyme activity;cell wall macromolecule catabolic process@NA
F10149@96091@96093@deletion@3@32806874@32832313@10@chr10:32806874-32832313@5.55@195@123@0.631@NA@CCDC7_11, CCDC7_12, CCDC7_13@0@0@0@:coiled-coil domain containing 7:chromosome 10 open reading frame 68@NA@NA
F10149@96572@96581@deletion@10@48020451@48055018@10@chr10:48020451-48055018@116@548@3@0.00547@CNVR4715.2@ASAH2C_10, ASAH2C_9, ASAH2C_8, ASAH2C_7, ASAH2C_6, ASAH2C_5, ASAH2C_4, ASAH2C_3, ASAH2C_2, ASAH2C_1@0@0@0@@:ceramidase activity;sphingolipid metabolic process@NA
F10149@96849@96852@deletion@4@51243389@51374428@10@chr10:51243389-51374428@12.6@76@12@0.158@NA@AGAP8_2, AGAP8_1, TIMM23B_1, TIMM23B_2@0@0@0@:ArfGAP with GTPase domain, ankyrin repeat and PH domain 8:translocase of inner mitochondrial membrane 23 homolog B (yeast)@:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process@NA
F10149@96932@96939@duplication@8@51965743@51994312@10@chr10:51965743-51994312@53.3@179@581@3.25@NA@ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7, ASAH2_6, ASAH2_5@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
F10149@98780@98781@deletion@2@91487614@91489004@10@chr10:91487614-91489004@7.64@166@93@0.56@NA@KIF20B_17, KIF20B_18@0@0@0@:kinesin family member 20B@:nucleoplasm;WW domain binding;microtubule motor activity;microtubule associated complex;centrosome;ATP binding;mitosis;microtubule-based movement;cell cycle arrest;nucleolus;ATPase activity;microtubule;M phase of mitotic cell cycle;cell division;ATP catabolic process;regulation of mitosis;spindle@NA
F10149@101604@101614@deletion@11@124340383@124353114@10@chr10:124340383-124353114@25.3@1077@691@0.642@CNVR4912.4, CNVR4912.3, CNVR4912.2@DMBT1_11, DMBT1_12, DMBT1_13, DMBT1_14, DMBT1_15, DMBT1_16, DMBT1_17, DMBT1_18, DMBT1_19, DMBT1_20, DMBT1_21@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
F10149@102336@102337@deletion@2@135438604@135439503@10@chr10:135438604-135439503@8.7@504@327@0.649@CNVR4989.11, CNVR4989.4@FRG2B_4, FRG2B_3@0@0@0@:FSHD region gene 2 family, member B@:nucleus@NA
F10149@103268@103268@duplication@1@4967390@4968330@11@chr11:4967390-4968330@14.2@1001@1478@1.48@CNVR5040.1@OR51A4_1@0@0@0@:matrix metallopeptidase 26:olfactory receptor, family 51, subfamily A, member 4@:metallopeptidase activity;extracellular matrix;proteolysis;proteinaceous extracellular matrix;collagen catabolic process;metalloendopeptidase activity;zinc ion binding;metabolic process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F10149@103342@103342@deletion@1@5798891@5799864@11@chr11:5798891-5799864@6.53@708@479@0.677@CNVR5049.1@OR52N5_1@0@0@0@:tripartite motif containing 5:olfactory receptor, family 52, subfamily N, member 5@:defense response to virus;Golgi apparatus;intracellular;protein trimerization;ligase activity;cytoplasm;protein binding;nucleus;protein homodimerization activity;identical protein binding;zinc ion binding;cytoplasmic mRNA processing body;protein ubiquitination;virus-host interaction:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F10149@103620@103620@deletion@1@7817522@7818489@11@chr11:7817522-7818489@21.7@971@522@0.538@CNVR5059.1@OR5P2_1@0@0@0@:olfactory receptor, family 5, subfamily P, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F10149@104572@104572@duplication@1@18955364@18956331@11@chr11:18955364-18956331@5.19@1254@1639@1.31@CNVR5091.2, CNVR5091.1@MRGPRX1_1@0@0@0@:MAS-related GPR, member X1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;acute-phase response;G-protein coupled receptor signaling pathway@NA
F10149@104958@104959@deletion@2@32637487@32657376@11@chr11:32637487-32657376@8.19@195@111@0.569@NA@CCDC73_15, CCDC73_14@0@0@0@:coiled-coil domain containing 73@NA@NA
F10149@105023@105023@deletion@1@33129933@33129964@11@chr11:33129933-33129964@4.78@104@58@0.558@NA@CSTF3_4@0@0@0@:cleavage stimulation factor, 3' pre-RNA, subunit 3, 77kDa@:nucleoplasm;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA cleavage;intracellular;transcription from RNA polymerase II promoter;RNA binding;mRNA processing;nucleus;RNA splicing;mRNA splicing, via spliceosome;mRNA polyadenylation;gene expression;RNA processing@NA
F10149@106046@106048@deletion@3@55370918@55419315@11@chr11:55370918-55419315@13.5@2191@1550@0.707@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F10149@110147@110147@deletion@1@89935982@89936043@11@chr11:89935982-89936043@6.49@69@27@0.391@NA@CHORDC1_10@0@0@0@:cysteine and histidine-rich domain (CHORD) containing 1@:negative regulation of Rho-dependent protein serine/threonine kinase activity;regulation of centrosome duplication;protein binding;Hsp90 protein binding;regulation of response to stress;chaperone-mediated protein folding;zinc ion binding;cellular_component;response to stress@NA
F10149@113648@113648@duplication@1@6619242@6619299@12@chr12:6619242-6619299@4.94@168@243@1.45@NA@NCAPD2_4@0@0@0@:non-SMC condensin I complex, subunit D2@:nuclear chromosome;histone binding;binding;chromosome condensation;condensin complex;mitotic chromosome condensation;condensin core heterodimer;condensed chromosome;intracellular protein transport;nucleus;pronucleus;cell division;membrane coat;cytoplasm;mitosis;protein binding;vesicle-mediated transport@NA
F10149@114424@114429@deletion@6@10583717@10588585@12@chr12:10583717-10588585@34.1@1085@650@0.599@CNVR5430.1@KLRC2_6, KLRC2_5, KLRC2_4, KLRC2_3, NKG2-E_3, KLRC2_2, NKG2-E_2, KLRC2_1, NKG2-E_1@0@0@0@:killer cell lectin-like receptor subfamily C, member 2@:carbohydrate binding:transmembrane signaling receptor activity;carbohydrate binding;protein binding;signal transduction;cellular defense response;integral to plasma membrane@NA
F10149@114469@114469@deletion@1@11035135@11035297@12@chr12:11035135-11035297@6.01@98@49@0.5@NA@PRH1_3@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):proline-rich protein HaeIII subfamily 1@:extracellular space;visual perception:protein binding;extracellular space@NA
F10149@114483@114483@duplication@1@11243900@11244828@12@chr12:11243900-11244828@9.42@915@1273@1.39@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
F10149@115537@115537@deletion@1@31249276@31249313@12@chr12:31249276-31249313@9.87@72@18@0.25@CNVR5483.1@DDX11_15@0@0@0@:DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11@:nucleoplasm;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;S phase of mitotic cell cycle;DNA binding;nucleobase-containing compound metabolic process;ATP binding;ATP-dependent DNA helicase activity;DNA helicase activity;midbody;RNA binding;DNA-dependent ATPase activity;nucleus;positive regulation of cell proliferation;virus-host interaction;nuclear chromatin;4 iron, 4 sulfur cluster binding;helicase activity;hydrolase activity, acting on acid anhydrides;DNA duplex unwinding;endoplasmic reticulum unfolded protein response;G2/M transition of mitotic cell cycle;protein binding;sister chromatid cohesion;activation of signaling protein activity involved in unfolded protein response;nucleolus;spindle pole;ATP-dependent helicase activity;metal ion binding;nucleic acid binding;mitotic sister chromatid segregation@: WARSAW BREAKAGE SYNDROME
F10149@115963@115963@deletion@1@43884199@43884238@12@chr12:43884199-43884238@4.61@81@42@0.519@NA@ADAMTS20_7@0@0@0@:ADAM metallopeptidase with thrombospondin type 1 motif, 20@:negative regulation of apoptotic process;endopeptidase activity;extracellular matrix;extracellular matrix organization;positive regulation of melanocyte differentiation;positive regulation of signal transduction;regulation of developmental pigmentation;extracellular space;proteolysis;proteinaceous extracellular matrix;metalloendopeptidase activity;zinc ion binding@NA
F10149@119501@119501@deletion@1@75693618@75693691@12@chr12:75693618-75693691@4.64@64@30@0.469@NA@CAPS2_10@0@0@0@:calcyphosine 2@:calcium ion binding@NA
F10149@119902@119903@deletion@2@85423498@85423724@12@chr12:85423498-85423724@6.12@126@70@0.556@NA@TSPAN19_3, TSPAN19_2@0@0@0@:tetraspanin 19@:integral to membrane@NA
F10149@120006@120006@deletion@1@88523472@88523653@12@chr12:88523472-88523653@5.25@83@41@0.494@NA@CEP290_10@0@0@0@:centrosomal protein 290kDa@:pronephros development;mitotic cell cycle;retina development in camera-type eye;TCTN-B9D complex;otic vesicle formation;protein transport;nucleus;cilium assembly;photoreceptor connecting cilium;hindbrain development;centrosome;microtubule basal body;cytoplasm;G2/M transition of mitotic cell cycle;cytosol;protein binding;positive regulation of transcription, DNA-dependent;eye photoreceptor cell development;gamma-tubulin complex;cilium morphogenesis;cell surface@: LEBER CONGENITAL AMAUROSIS 10; LCA10; MECKEL SYNDROME, TYPE 4; MKS4; SENIOR-LOKEN SYNDROME 6; SLSN6; JOUBERT SYNDROME 5; JBTS5; BARDET-BIEDL SYNDROME; BBS
F10149@120011@120011@deletion@1@88532923@88532968@12@chr12:88532923-88532968@7.23@134@69@0.515@NA@CEP290_5@0@0@0@:centrosomal protein 290kDa@:pronephros development;mitotic cell cycle;retina development in camera-type eye;TCTN-B9D complex;otic vesicle formation;protein transport;nucleus;cilium assembly;photoreceptor connecting cilium;hindbrain development;centrosome;microtubule basal body;cytoplasm;G2/M transition of mitotic cell cycle;cytosol;protein binding;positive regulation of transcription, DNA-dependent;eye photoreceptor cell development;gamma-tubulin complex;cilium morphogenesis;cell surface@: LEBER CONGENITAL AMAUROSIS 10; LCA10; MECKEL SYNDROME, TYPE 4; MKS4; SENIOR-LOKEN SYNDROME 6; SLSN6; JOUBERT SYNDROME 5; JBTS5; BARDET-BIEDL SYNDROME; BBS
F10149@123246@123247@deletion@2@124137080@124137282@12@chr12:124137080-124137282@5.71@143@84@0.587@NA@GTF2H3_6, GTF2H3_7@0@0@0@:general transcription factor IIH, polypeptide 3, 34kDa@:damaged DNA binding;nucleoplasm;termination of RNA polymerase I transcription;nucleotide-excision repair, DNA damage removal;transcription from RNA polymerase I promoter;sequence-specific DNA binding transcription factor activity;DNA repair;RNA polymerase II carboxy-terminal domain kinase activity;DNA-dependent ATPase activity;viral reproduction;translation;gene expression;protein N-terminus binding;transcription elongation from RNA polymerase I promoter;transcription initiation from RNA polymerase II promoter;7-methylguanosine mRNA capping;transcription initiation from RNA polymerase I promoter;translation factor activity, nucleic acid binding;holo TFIIH complex;protein phosphorylation;protein kinase activity;regulation of transcription, DNA-dependent;nucleotide-excision repair;transcription from RNA polymerase II promoter;core TFIIH complex;transcription-coupled nucleotide-excision repair;transcription elongation from RNA polymerase II promoter;metal ion binding;positive regulation of viral transcription@NA
F10149@124101@124102@deletion@2@21746479@21746820@13@chr13:21746479-21746820@6.18@159@93@0.585@NA@SKA3_3, SKA3_2@0@0@0@:spindle and kinetochore associated complex subunit 3@:spindle microtubule;chromosome segregation;cytoplasm;mitosis;protein binding;regulation of microtubule polymerization or depolymerization;cell division;condensed chromosome outer kinetochore@NA
F10149@127333@127335@duplication@3@19553418@19559164@14@chr14:19553418-19559164@5.54@78@129@1.65@CNVR6072.1@POTEG_1, POTEG_2, POTEG_3@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
F10149@127353@127358@duplication@6@20215588@20404761@14@chr14:20215588-20404761@127@8383@13354@1.59@CNVR6072.12, CNVR6072.4, CNVR6072.5@OR4Q3_1, OR4M1_1, OR4N2_1, OR4K2_1, OR4K5_1, OR4K1_1@0@0@0@:olfactory receptor, family 4, subfamily N, member 2:olfactory receptor, family 4, subfamily Q, member 3:olfactory receptor, family 4, subfamily M, member 1:olfactory receptor, family 4, subfamily K, member 2:olfactory receptor, family 4, subfamily K, member 5:olfactory receptor, family 4, subfamily K, member 1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F10149@129155@129155@deletion@1@45577619@45577725@14@chr14:45577619-45577725@6.2@102@51@0.5@NA@PRPF39_7@0@0@0@:PRP39 pre-mRNA processing factor 39 homolog (S. cerevisiae)@:mRNA processing;intracellular;nucleus;RNA splicing;RNA processing@NA
F10149@129246@129246@deletion@1@50121503@50121556@14@chr14:50121503-50121556@7.08@81@33@0.407@CNVR6152.2@POLE2_13@0@0@0@:polymerase (DNA directed), epsilon 2, accessory subunit@:nucleoplasm;telomere maintenance via semi-conservative replication;S phase of mitotic cell cycle;mitotic cell cycle;DNA binding;G1/S transition of mitotic cell cycle;DNA replication initiation;DNA repair;nucleus;DNA-directed DNA polymerase activity;telomere maintenance;DNA-dependent DNA replication;intracellular membrane-bounded organelle;telomere maintenance via recombination;nucleotide-excision repair;M/G1 transition of mitotic cell cycle;transcription-coupled nucleotide-excision repair;epsilon DNA polymerase complex;DNA replication;nucleotide-excision repair, DNA gap filling@NA
F10149@129393@129393@deletion@1@50906732@50906791@14@chr14:50906732-50906791@6.02@87@41@0.471@CNVR6152.2@MAP4K5_23@0@0@0@:mitogen-activated protein kinase kinase kinase kinase 5@:intracellular protein kinase cascade;protein serine/threonine kinase activity;activation of JUN kinase activity;protein tyrosine kinase activity;small GTPase regulator activity;protein phosphorylation;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;response to stress;protein binding;plasma membrane@NA
F10149@130130@130132@deletion@3@60938271@60950535@14@chr14:60938271-60950535@7.76@263@165@0.627@NA@C14orf39_6, C14orf39_5, C14orf39_4@0@0@0@:chromosome 14 open reading frame 39@:multicellular organismal development;molecular_function;cellular_component;regulation of sequence-specific DNA binding transcription factor activity@NA
F10149@131032@131034@deletion@3@74004127@74010359@14@chr14:74004127-74010359@67.1@486@112@0.23@CNVR6188.1, CNVR6188.4@ACOT1_1, ACOT1_2, ACOT1_3@0@0@0@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
F10149@131769@131769@deletion@1@88899480@88899556@14@chr14:88899480-88899556@5.23@85@43@0.506@NA@SPATA7_10@0@0@0@:spermatogenesis associated 7@:response to stimulus;spermatogenesis;visual perception@: RETINITIS PIGMENTOSA; RP; LEBER CONGENITAL AMAUROSIS 3; LCA3
F10149@133409@133414@deletion@6@106373070@106380248@14@chr14:106373070-106380248@18.2@466@269@0.577@CNVR6294.27, CNVR6294.36, CNVR6294.48, CNVR6294.25, CNVR6294.57, CNVR6294.29@IGHD2-8_1, IGHD1-7_1, IGHD6-6_1, IGHD5-5_1, IGHD4-4_1, IGHD3-3_1@0@0@0@NA@NA@NA
F10149@133426@133427@deletion@2@106478111@106478539@14@chr14:106478111-106478539@17.2@121@27@0.223@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV4-4_2, IGHV4-4_1@0@0@0@@:protein binding@NA
F10149@133450@133451@deletion@2@106725202@106725654@14@chr14:106725202-106725654@12.4@777@504@0.649@CNVR6294.48, CNVR6294.24, CNVR6294.40, CNVR6294.38, CNVR6294.17, CNVR6294.23@IGHV3-23_2, IGHV3-23_1@0@0@0@@:protein binding@NA
F10149@133458@133463@deletion@6@106791006@106816173@14@chr14:106791006-106816173@41.4@1239@704@0.568@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-30_2, IGHV3-30_1, IGHV4-31_2, IGHV4-31_1, IGHV3-33_2, IGHV3-33_1@0@0@0@@:protein binding:protein binding:protein binding@NA
F10149@133542@133542@deletion@1@22382474@22383423@15@chr15:22382474-22383423@11.6@984@623@0.633@CNVR6297.4, CNVR6297.17, CNVR6297.2@OR4N4_1@0@0@0@:olfactory receptor, family 4, subfamily N, member 4@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F10149@133875@133875@deletion@1@28632749@28632839@15@chr15:28632749-28632839@8.04@36@0@0@CNVR6329.4@GOLGA8F_15@0@0@0@@:Golgi apparatus@NA
F10149@136123@136124@deletion@2@48458131@48458325@15@chr15:48458131-48458325@6.46@125@68@0.544@NA@MYEF2_5, MYEF2_4@0@0@0@:myelin expression factor 2@:myotube differentiation;Golgi apparatus;DNA binding;nucleotide binding;neuron differentiation;RNA binding;nucleus;transcription, DNA-dependent;nucleic acid binding@NA
F10149@136872@136872@deletion@1@56719804@56719937@15@chr15:56719804-56719937@6.33@80@35@0.438@NA@TEX9_11@0@0@0@:testis expressed 9:meiosis-specific nuclear structural 1@:vesicle-mediated transport;membrane:meiosis;nuclear envelope;intermediate filament@NA
F10149@137124@137124@deletion@1@60728343@60728426@15@chr15:60728343-60728426@4.75@127@74@0.583@NA@NARG2_13@0@0@0@:NMDA receptor regulated 2@:nucleus@NA
F10149@142664@142664@deletion@1@14958443@14958583@16@chr16:14958443-14958583@5.65@207@127@0.614@NA@NOMO1_13@0@0@0@:NODAL modulator 1;nodal modulator 1-like@:carbohydrate binding;integral to membrane;carboxypeptidase activity;molecular_function;cellular_component;biological_process@NA
F10149@142692@142706@deletion@15@15091611@15123913@16@chr16:15091611-15123913@68.5@2808@1752@0.624@CNVR6646.1@PDXDC1_2, PDXDC1_3, PDXDC1_4, PDXDC1_5, PDXDC1_6, PDXDC1_7, PDXDC1_8, PDXDC1_9, PDXDC1_10, PDXDC1_11, PDXDC1_12, PDXDC1_13, PDXDC1_14, PDXDC1_15, PDXDC1_16@0@0@0@:pyridoxal-dependent decarboxylase domain containing 1;pyridoxal-dependent decarboxylase domain-containing protein 1-like@:carboxylic acid metabolic process;pyridoxal phosphate binding;carboxy-lyase activity@NA
F10149@142710@142711@deletion@2@15128144@15128410@16@chr16:15128144-15128410@4.99@95@52@0.547@NA@PDXDC1_20, PDXDC1_21@0@0@0@:pyridoxal-dependent decarboxylase domain containing 1;pyridoxal-dependent decarboxylase domain-containing protein 1-like@:carboxylic acid metabolic process;pyridoxal phosphate binding;carboxy-lyase activity@NA
F10149@142918@142919@deletion@2@16349578@16350015@16@chr16:16349578-16350015@18.9@337@167@0.496@NA@NOMO3_10, NOMO3_11@0@0@0@:NODAL modulator 3@:carbohydrate binding;integral to membrane;carboxypeptidase activity@NA
F10149@143003@143006@duplication@4@18542789@18550286@16@chr16:18542789-18550286@7.82@400@546@1.36@NA@NOMO2_13, NOMO2_12, NOMO2_11, NOMO2_10@0@0@0@:NODAL modulator 2@:carbohydrate binding;protein binding;integral to membrane;carboxypeptidase activity;endoplasmic reticulum membrane@NA
F10149@143267@143267@duplication@1@20491896@20492022@16@chr16:20491896-20492022@7.98@192@299@1.56@NA@ACSM2A_11@0@0@0@:acyl-CoA synthetase medium-chain family member 2A@:mitochondrion;butyrate-CoA ligase activity;catalytic activity;ATP binding;glucose homeostasis;medium-chain fatty-acyl-CoA metabolic process;fatty acid metabolic process;triglyceride homeostasis;metabolic process;mitochondrial matrix;metal ion binding@NA
F10149@144288@144290@deletion@3@29468954@29469445@16@chr16:29468954-29469445@8.31@37@0@0@CNVR6690.2, CNVR6690.3, CNVR6690.4@SLX1B_4, SLX1B_5, SLX1B_6@0@0@0@:structure-specific endonuclease subunit SLX1-like;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae);SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae):sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3;sulfotransferase 1A3/1A4-like@:Slx1-Slx4 complex;5'-flap endonuclease activity;DNA repair;protein binding;DNA double-strand break processing involved in repair via single-strand annealing;double-strand break repair via homologous recombination;metal ion binding;crossover junction endodeoxyribonuclease activity:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;cytoplasm;catecholamine metabolic process;cytosol;endoplasmic reticulum unfolded protein response;xenobiotic metabolic process;sulfotransferase activity;activation of signaling protein activity involved in unfolded protein response;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process@NA
F10149@147274@147275@duplication@2@70714698@70714928@16@chr16:70714698-70714928@5.34@177@251@1.42@NA@MTSS1L_3, MTSS1L_2@0@0@0@:metastasis suppressor 1-like@:filopodium assembly;actin binding;signal transduction;SH3 domain binding;cytoskeletal adaptor activity@NA
F10149@151380@151381@deletion@2@14139174@14139747@17@chr17:14139174-14139747@5.74@78@37@0.474@NA@CDRT15_3, CDRT15_2@0@0@0@:CMT1A duplicated region transcript 15@NA@NA
F10149@151550@151550@deletion@1@16623513@16623545@17@chr17:16623513-16623545@8.66@117@52@0.444@NA@CCDC144A_7, CCDC144A_7@0@0@0@:coiled-coil domain containing 144A@NA@NA
F10149@151556@151561@deletion@6@16664740@16676947@17@chr17:16664740-16676947@26.6@1092@674@0.617@NA@CCDC144A_13, CCDC144A_13, CCDC144A_14, CCDC144A_14, CCDC144A_15, CCDC144A_15, CCDC144A_16, CCDC144A_16, CCDC144A_17, CCDC144A_18, CCDC144A_17@0@0@0@:coiled-coil domain containing 144A@NA@NA
F10149@151875@151877@duplication@3@18380170@18389449@17@chr17:18380170-18389449@8.77@167@259@1.55@CNVR7014.1@LGALS9C_1, LGALS9C_2, LGALS9C_3@0@0@0@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
F10149@151958@151959@duplication@2@18996506@18997166@17@chr17:18996506-18997166@24.1@205@473@2.31@CNVR7018.4, CNVR7018.2, CNVR7018.6@AC007952.5_1, AC007952.5_2@0@0@0@NA@NA@NA
F10149@153381@153381@duplication@1@34539885@34539971@17@chr17:34539885-34539971@7.73@24@78@3.25@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1_3@0@0@0@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
F10149@153657@153659@deletion@3@36361698@36375177@17@chr17:36361698-36375177@6.48@1113@799@0.718@CNVR7083.3@RP11-1407O15.2_5, RP11-1407O15.2_4, RP11-1407O15.2_3@0@0@0@:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
F10149@155580@155591@deletion@12@44171927@44410022@17@chr17:44171927-44410022@23.1@2142@1474@0.688@CNVR7114.3, CNVR7114.2@KANSL1_3, KANSL1_2, LRRC37A_1, LRRC37A_2, LRRC37A_3, LRRC37A_4, LRRC37A_5, LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9, LRRC37A_10@0@0@0@:KAT8 regulatory NSL complex subunit 1:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:histone acetyltransferase activity (H4-K8 specific);histone acetyltransferase activity (H4-K16 specific);histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase complex;histone H4-K5 acetylation;MLL1 complex;histone H4-K16 acetylation;protein binding;histone H4-K8 acetylation;nucleus:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
F10149@155593@155595@duplication@3@44414663@44415089@17@chr17:44414663-44415089@12.5@64@160@2.5@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_12, LRRC37A_13, LRRC37A_14@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
F10149@155610@155612@deletion@3@44632519@44632945@17@chr17:44632519-44632945@19@146@38@0.26@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2_13, LRRC37A2_14, LRRC37A2_15@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
F10149@156877@156878@deletion@2@57656834@57657240@17@chr17:57656834-57657240@22.2@102@0@0@NA@DHX40_9, DHX40_10@0@0@0@:DEAH (Asp-Glu-Ala-His) box polypeptide 40@:transport;helicase activity;intracellular;ATP-dependent helicase activity;nucleic acid binding;ATP binding@NA
F10149@158035@158035@deletion@1@67257777@67257889@17@chr17:67257777-67257889@4.74@152@92@0.605@NA@ABCA5_25@0@0@0@:ATP-binding cassette, sub-family A (ABC1), member 5@:late endosome;late endosome membrane;Golgi membrane;ATP binding;integral to membrane;GTP binding;ATPase activity;reverse cholesterol transport;negative regulation of macrophage derived foam cell differentiation;lysosome;cholesterol efflux;Golgi apparatus;nucleoside-triphosphatase activity;GTPase activity;lysosomal membrane;nucleotide binding;high-density lipoprotein particle remodeling@NA
F10149@160279@160279@deletion@1@2697031@2697120@18@chr18:2697031-2697120@7.83@86@34@0.395@NA@SMCHD1_9@0@0@0@:structural maintenance of chromosomes flexible hinge domain containing 1@:Barr body;inactivation of X chromosome by DNA methylation;protein binding;chromosome organization;chromosome;dosage compensation by inactivation of X chromosome;ATP binding@NA
F10149@160963@160963@deletion@1@14850214@14850381@18@chr18:14850214-14850381@4.81@193@121@0.627@NA@ANKRD30B_35@0@0@0@:ankyrin repeat domain 30B@:protein binding;molecular_function;cellular_component;biological_process@NA
F10149@161541@161541@deletion@1@29489631@29489723@18@chr18:29489631-29489723@4.75@91@49@0.538@NA@TRAPPC8_6@0@0@0@:trafficking protein particle complex 8@:Golgi apparatus;ER to Golgi vesicle-mediated transport;cis-Golgi network@NA
F10149@162019@162019@deletion@1@44554574@44556213@18@chr18:44554574-44556213@29.9@153@6@0.0392@CNVR7319.1@TCEB3C_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C (elongin A3);RNA polymerase II transcription factor SIII subunit A3-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
F10149@162794@162795@deletion@2@66378602@66381137@18@chr18:66378602-66381137@5.22@176@110@0.625@NA@TMX3_3, TMX3_2@0@0@0@:thioredoxin-related transmembrane protein 3@:isomerase activity;electron carrier activity;cell redox homeostasis;glycerol ether metabolic process;integral to membrane;protein disulfide isomerase activity;endoplasmic reticulum membrane;protein disulfide oxidoreductase activity;cell surface;calcium ion binding@NA
F10149@166916@166917@deletion@2@14508471@14508747@19@chr19:14508471-14508747@7.81@79@31@0.392@NA@CD97_7, CD97_8@0@0@0@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
F10149@170098@170100@deletion@3@40376632@40382826@19@chr19:40376632-40382826@17.4@151@47@0.311@CNVR7639.2@FCGBP_24, FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F10149@170104@170108@duplication@5@40389653@40398510@19@chr19:40389653-40398510@16.8@385@580@1.51@CNVR7639.2, CNVR7639.3@FCGBP_18, FCGBP_17, FCGBP_16, FCGBP_15, FCGBP_14@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F10149@170373@170373@duplication@1@41386385@41386533@19@chr19:41386385-41386533@4.94@221@311@1.41@CNVR7642.1@CYP2A7_3@0@0@0@:cytochrome P450, family 2, subfamily A, polypeptide 7@:oxidation-reduction process;electron carrier activity;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;oxygen binding;heme binding;monooxygenase activity;endoplasmic reticulum membrane;iron ion binding@NA
F10149@171767@171768@deletion@2@48482828@48484198@19@chr19:48482828-48484198@5.33@181@113@0.624@NA@BSPH1_3, BSPH1_2@0@0@0@:binder of sperm protein homolog 1@:extracellular region;single fertilization@NA
F10149@172565@172565@deletion@1@50463395@50463678@19@chr19:50463395-50463678@6.55@111@56@0.505@NA@SIGLEC11_3@0@0@0@:sialic acid binding Ig-like lectin 11@:carbohydrate binding;protein binding;integral to membrane;cell adhesion@NA
F10149@172987@172987@deletion@1@52133087@52133469@19@chr19:52133087-52133469@11.4@58@4@0.069@CNVR7702.1@SIGLEC5_2, SIGLEC5_2@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion@NA
F10149@172989@172994@duplication@6@52146609@52149893@19@chr19:52146609-52149893@11.2@531@719@1.35@CNVR7702.1@SIGLEC14_7, SIGLEC14_6, SIGLEC14_5, SIGLEC14_4, SIGLEC14_3, SIGLEC14_2@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 14@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion;plasma membrane@NA
F10149@173295@173298@duplication@4@54724399@54726434@19@chr19:54724399-54726434@10.7@288@434@1.51@CNVR7721.3, CNVR7721.4@LILRB3_6, LILRB3_5, LILRB3_4, LILRB3_3@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F10149@173303@173303@deletion@1@54744151@54744452@19@chr19:54744151-54744452@8.11@415@260@0.627@CNVR7721.3, CNVR7721.6@LILRA6_6@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F10149@173305@173308@deletion@4@54745453@54746600@19@chr19:54745453-54746600@31.4@643@337@0.524@CNVR7721.3, CNVR7721.6@LILRA6_4, LILRA6_3, LILRA6_2, LILRA6_1@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F10149@173470@173477@duplication@8@55281304@55295265@19@chr19:55281304-55295265@37.5@1434@2058@1.44@CNVR7725.2, CNVR7725.1@KIR2DL1_1, KIR2DL1_2, KIR2DL1_3, KIR2DL1_4, KIR2DL1_5, KIR2DL1_6, KIR2DL1_7, KIR2DL1_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
F10149@173491@173493@deletion@3@55340817@55341730@19@chr19:55340817-55341730@19.6@491@273@0.556@CNVR7725.1, CNVR7725.6@KIR3DL1_7, KIR3DL1_8, KIR3DL1_9@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
F10149@173496@173497@deletion@2@55349032@55351154@19@chr19:55349032-55351154@11.9@322@186@0.578@CNVR7725.1, CNVR7725.6@KIR2DS4_3, KIR2DS4_4@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
F10149@173499@173501@duplication@3@55358640@55359398@19@chr19:55358640-55359398@27.5@836@1285@1.54@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4_6, KIR2DS4_7, KIR2DS4_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
F10149@173611@173613@duplication@3@55658050@55658525@19@chr19:55658050-55658525@5.57@176@251@1.43@NA@TNNT1_4, TNNT1_3, TNNT1_2@0@0@0@:troponin T type 1 (skeletal, slow)@:muscle filament sliding;troponin complex;skeletal muscle contraction;troponin T binding;regulation of muscle contraction;slow-twitch skeletal muscle fiber contraction;tropomyosin binding;cytosol;negative regulation of muscle contraction@: NEMALINE MYOPATHY 5; NEM5
F10149@174395@174395@duplication@1@1569207@1569278@20@chr20:1569207-1569278@4.66@53@95@1.79@CNVR7763.1@RP4-576H24.4_1@0@0@0@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
F10149@174403@174403@deletion@1@1895746@1896101@20@chr20:1895746-1896101@12.7@194@87@0.448@CNVR7764.2@SIRPA_2@0@0@0@:signal-regulatory protein alpha@:blood coagulation;protein binding;integral to membrane;SH3 domain binding;cell adhesion;plasma membrane;membrane;leukocyte migration@NA
F10149@180976@180976@duplication@1@16287255@16287885@22@chr22:16287255-16287885@12.8@76@185@2.43@CNVR8071.2, CNVR8071.3, CNVR8071.9@POTEH_1@0@0@0@:POTE ankyrin domain family, member H@:protein binding@NA
F10149@181733@181734@deletion@2@22707290@22707781@22@chr22:22707290-22707781@10.2@507@322@0.635@CNVR8103.20, CNVR8103.5, CNVR8103.2, CNVR8103.12, CNVR8103.10, CNVR8103.9, CNVR8103.22@IGLV5-48_1, IGLV5-48_2@0@0@0@@:protein binding@NA
F10149@181812@181812@deletion@1@23263563@23263607@22@chr22:23263563-23263607@5.77@59@23@0.39@NA@IGLJ7_1@0@0@0@NA@NA@NA
F10149@181951@181955@deletion@5@24376424@24384231@22@chr22:24376424-24384231@12.1@700@465@0.664@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTT1_5, GSTT1_4, GSTT1_3, GSTT1_2, GSTT1_1@0@0@0@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
F10149@183633@183640@deletion@8@39358501@39388154@22@chr22:39358501-39388154@23.6@701@426@0.608@CNVR8164.1@APOBEC3A_6, APOBEC3B_1, APOBEC3B_2, APOBEC3B_3, APOBEC3B_4, APOBEC3B_5, APOBEC3B_6, APOBEC3B_7@0@0@0@:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A;APOBEC3A and APOBEC3B deletion hybrid:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B@:cytidine deamination;defense response to virus;negative regulation of viral genome replication;DNA cytosine deamination;clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine;catalytic activity;DNA demethylation;cytoplasm;innate immune response;cytidine deaminase activity;nucleus;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;cellular response to xenobiotic stimulus;zinc ion binding;negative regulation of transposition:RNA binding;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;negative regulation of transposition;catalytic activity;zinc ion binding@NA
F10149@184154@184154@duplication@1@42537163@42537296@22@chr22:42537163-42537296@6.01@116@185@1.59@CNVR8168.1, CNVR8168.3, CNVR8168.4@CYP2D7P1_3@0@0@0@@:oxidation-reduction process;electron carrier activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;heme binding@NA
F10149@4052@4071@deletion@20@101571921@101581428@X@chrX:101571921-101581428@41.7@193@1@0.00518@NA@NXF2_15, NXF2_16, NXF2_17, NXF2_18, NXF2_19, NXF2_20, NXF2_21, NXF2_22, NXF2_23, NXF2_24, NXF2_25, NXF2_26, NXF2_27, NXF2_28, NXF2_29, NXF2_30, NXF2_31, NXF2_32, NXF2_33, NXF2_34@0@0@0@NA@NA@NA
F10149@4884@4884@deletion@1@119210843@119211253@X@chrX:119210843-119211253@9.81@105@39@0.371@NA@RHOXF2B_2@0@0@0@NA@NA@NA
F10149@5484@5484@duplication@1@134947908@134948155@X@chrX:134947908-134948155@7.39@191@295@1.54@CNVR8449.4, CNVR8449.2, CNVR8449.1@CT45A5_3@0@0@0@NA@NA@NA
F10149@5718@5719@duplication@2@140335651@140336590@X@chrX:140335651-140336590@6.04@202@285@1.41@CNVR8456.1@SPANXC_2, SPANXC_1@0@0@0@NA@NA@NA
F10149@6203@6204@duplication@2@153175961@153176288@X@chrX:153175961-153176288@5.23@208@289@1.39@NA@ARHGAP4_17, ARHGAP4_16@0@0@0@NA@NA@NA
F10149@6307@6307@deletion@1@153496018@153496256@X@chrX:153496018-153496256@11.9@54@0@0@CNVR8489.1@OPN1MW2_5@0@0@0@NA@NA@NA
F11151@320@326@duplication@7@1407266@1417994@1@chr1:1407266-1417994@10@272@393@1.44@NA@ATAD3B_1, ATAD3B_2, ATAD3B_3, ATAD3B_4, ATAD3B_5, ATAD3B_6, ATAD3B_7@0@0@0@:ATPase family, AAA domain containing 3B@:nucleoside-triphosphatase activity;mitochondrial inner membrane;nucleotide binding;ATP binding@NA
F11151@422@442@deletion@21@1634916@1670496@1@chr1:1634916-1670496@86.9@2116@1189@0.562@CNVR17.1@CDK11A_18, CDK11A_17, CDK11A_16, CDK11A_15, CDK11A_14, CDK11A_13, CDK11A_12, CDK11A_11, CDK11A_10, CDK11A_9, CDK11A_8, CDK11A_7, CDK11A_6, CDK11A_5, CDK11A_4, CDK11A_3, CDK11A_2, SLC35E2_6, SLC35E2_5, SLC35E2_4, SLC35E2_3@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A:solute carrier family 35, member E2@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division:integral to membrane;membrane@NA
F11151@2170@2186@duplication@17@17248515@17273486@1@chr1:17248515-17273486@33.3@1699@2327@1.37@CNVR94.4, CNVR94.5@CROCC_1, CROCC_2, CROCC_3, CROCC_4, CROCC_5, CROCC_6, CROCC_7, CROCC_8, CROCC_9, CROCC_10, CROCC_11, CROCC_12, CROCC_13, CROCC_14, CROCC_15, CROCC_16, CROCC_17@0@0@0@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
F11151@2788@2792@duplication@5@21806545@21809879@1@chr1:21806545-21809879@13.1@194@321@1.65@CNVR107.2, CNVR107.1@NBPF3_11, NBPF3_12, NBPF3_13, NBPF3_14, NBPF3_15@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 3@:cytoplasm@NA
F11151@5149@5150@duplication@2@39987049@39988154@1@chr1:39987049-39988154@5.61@90@145@1.61@NA@BMP8A_4, BMP8A_5@0@0@0@:bone morphogenetic protein 8a@:cell differentiation;growth factor activity;extracellular space;growth;cytokine activity;cartilage development;ossification@NA
F11151@8507@8508@deletion@2@89476588@89477710@1@chr1:89476588-89477710@16.4@585@339@0.579@CNVR244.1@GBP3_8, GBP3_7@0@0@0@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
F11151@9373@9374@deletion@2@104233917@104234232@1@chr1:104233917-104234232@14.3@65@0@0@CNVR266.3, CNVR266.5@AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
F11151@9766@9773@deletion@8@110230497@110235917@1@chr1:110230497-110235917@97@448@0@0@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
F11151@12117@12118@deletion@2@152573209@152586574@1@chr1:152573209-152586574@17.7@80@0@0@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
F11151@16030@16040@duplication@11@196748293@196801129@1@chr1:196748293-196801129@69.6@1545@2465@1.6@CNVR459.1@CFHR3_2, CFHR3_3, CFHR3_4, CFHR3_5, CFHR3_6, CFHR1_1, CFHR1_2, CFHR1_3, CFHR1_4, CFHR1_5, CFHR1_6@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
F11151@19777@19777@duplication@1@248801589@248802559@1@chr1:248801589-248802559@4.89@60@106@1.77@NA@OR2T35_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 35@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F11151@25116@25116@duplication@1@96652841@96652954@2@chr2:96652841-96652954@7.53@153@248@1.62@NA@ANKRD36C_2@0@0@0@:ankyrin repeat domain-containing protein 36A-like@:ion channel inhibitor activity;protein binding@NA
F11151@25350@25351@deletion@2@97818242@97820478@2@chr2:97818242-97820478@10.1@232@129@0.556@CNVR886.2@ANKRD36_14, ANKRD36_15@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
F11151@25393@25401@duplication@9@97877284@97884815@2@chr2:97877284-97884815@9.2@591@786@1.33@NA@ANKRD36_57, ANKRD36_58, ANKRD36_59, ANKRD36_60, ANKRD36_61, ANKRD36_62, ANKRD36_63, ANKRD36_64, ANKRD36_65@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
F11151@33399@33402@duplication@4@233245334@233246505@2@chr2:233245334-233246505@9.58@480@652@1.36@NA@ALPP_8, ALPP_9, ALPP_10, ALPP_11@0@0@0@:alkaline phosphatase, placental@:phosphatase activity;catalytic activity;integral to membrane;plasma membrane;metabolic process;cell surface;anchored to membrane;alkaline phosphatase activity;metal ion binding@NA
F11151@53308@53308@duplication@1@748520@748674@5@chr5:748520-748674@9.12@94@183@1.95@CNVR2280.3@ZDHHC11B_5@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
F11151@59488@59489@duplication@2@147553798@147554961@5@chr5:147553798-147554961@16.6@150@324@2.16@CNVR2637.1@SPINK14_3, SPINK14_4@0@0@0@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
F11151@60876@60877@deletion@2@175388055@175388437@5@chr5:175388055-175388437@6.31@66@27@0.409@NA@THOC3_5, THOC3_4@0@0@0@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
F11151@61269@61271@duplication@3@177166602@177168333@5@chr5:177166602-177168333@6.07@97@155@1.6@NA@FAM153A_8, FAM153A_7, FAM153A_6@0@0@0@:family with sequence similarity 153, member A@NA@NA
F11151@61638@61643@duplication@6@180375356@180420160@5@chr5:180375356-180420160@14.2@821@1104@1.34@CNVR2719.1@BTNL8_5, BTNL8_6, BTNL8_7, BTNL8_8, BTNL3_1, BTNL3_2@0@0@0@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
F11151@63281@63282@duplication@2@31237744@31238262@6@chr6:31237744-31238262@10@274@413@1.51@CNVR2838.2, CNVR2838.1@HLA-C_5, HLA-C_4@0@0@0@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
F11151@63725@63725@deletion@1@31962023@31962161@6@chr6:31962023-31962161@7.77@35@0@0@CNVR2843.6, CNVR2843.3@C4A_20@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
F11151@63953@63960@duplication@8@32485517@32548047@6@chr6:32485517-32548047@29.1@474@778@1.64@CNVR2845.21, CNVR2845.25, CNVR2845.24@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2, HLA-DRB5_1, HLA-DRB1_6, HLA-DRB1_5@0@0@0@:major histocompatibility complex, class II, DR beta 5:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
F11151@63963@63964@duplication@2@32551887@32557519@6@chr6:32551887-32557519@9.02@182@289@1.59@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.56, CNVR2845.34@HLA-DRB1_2, HLA-DRB1_1@0@0@0@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
F11151@64603@64606@deletion@4@35755645@35765065@6@chr6:35755645-35765065@9.71@935@645@0.69@CNVR2861.1@CLPSL1_3, CLPS_3, CLPS_2, CLPS_1@0@0@0@:colipase-like 1:colipase, pancreatic@:extracellular region;enzyme activator activity;digestion;lipid catabolic process:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
F11151@71027@71028@duplication@2@167786658@167787939@6@chr6:167786658-167787939@8.49@413@568@1.38@NA@TCP10_8, TCP10_7@0@0@0@:t-complex 10@:cytosol@NA
F11151@71772@71772@deletion@1@5998625@5998709@7@chr7:5998625-5998709@8.21@241@136@0.564@NA@RSPH10B_6@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F11151@71939@71941@duplication@3@6836200@6838910@7@chr7:6836200-6838910@9.64@101@185@1.83@NA@RSPH10B2_19, RSPH10B2_20, CCZ1B_15@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F11151@72491@72492@deletion@2@22532185@22533455@7@chr7:22532185-22533455@24.1@1138@634@0.557@NA@STEAP1B_4, STEAP1B_3@0@0@0@:STEAP family member 1B@:integral to membrane@NA
F11151@73260@73262@deletion@3@38388957@38393626@7@chr7:38388957-38393626@12.3@804@522@0.649@CNVR3354.3, CNVR3354.1@TRGV5_2, TRGV5_1, TRGV4_2@0@0@0@@:protein binding:protein binding@NA
F11151@74578@74578@deletion@1@74172293@74172333@7@chr7:74172293-74172333@6.65@30@0@0@NA@GTF2I_33@0@0@0@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
F11151@74775@74776@deletion@2@76063356@76069658@7@chr7:76063356-76069658@11.5@227@126@0.555@CNVR3462.1@ZP3_5, ZP3_6@0@0@0@:zona pellucida glycoprotein 3 (sperm receptor)@:negative regulation of transcription, DNA-dependent;manganese ion transmembrane transporter activity;intracellular protein transport;proteinaceous extracellular matrix;plasma membrane;positive regulation of acrosome reaction;outer acrosomal membrane;protein kinase C signaling cascade;manganese ion transmembrane transport;intracellular signal transduction;humoral immune response mediated by circulating immunoglobulin;negative regulation of binding of sperm to zona pellucida;positive regulation of inflammatory response;endoplasmic reticulum;signal transducer activity;perinuclear region of cytoplasm;secretory granule;positive regulation of transcription, DNA-dependent;positive regulation of ovarian follicle development;positive regulation of interferon-gamma production;carbohydrate binding;manganese ion transport;positive regulation of antral ovarian follicle growth;extracellular matrix;positive regulation of leukocyte migration;positive regulation of humoral immune response;extracellular space;blastocyst formation;integral to membrane;store-operated calcium channel activity;oocyte development;multivesicular body;phosphatidylinositol-mediated signaling;acrosomal vesicle;positive regulation of protein kinase B signaling cascade;Golgi apparatus;positive regulation of calcium ion import;positive regulation of protein kinase activity;positive regulation of acrosomal vesicle exocytosis;positive regulation of interleukin-4 production;cytoplasm;protein binding;binding of sperm to zona pellucida;positive regulation of phosphatidylinositol biosynthetic process;extracellular region;positive regulation of T cell proliferation;acrosin binding;positive regulation of type IV hypersensitivity;egg coat formation@NA
F11151@76427@76432@deletion@6@100331793@100336236@7@chr7:100331793-100336236@178@903@8@0.00886@CNVR3509.1@ZAN_1, ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
F11151@79056@79057@duplication@2@142045364@142045816@7@chr7:142045364-142045816@19@545@870@1.6@NA@TRBV4-2_1, TRBV4-2_2@0@0@0@@:protein binding@NA
F11151@79073@79073@duplication@1@142144037@142144084@7@chr7:142144037-142144084@5.65@138@212@1.54@NA@TRBV6-7_1@0@0@0@NA@NA@NA
F11151@79287@79287@duplication@1@143400089@143400710@7@chr7:143400089-143400710@5.7@49@98@2@CNVR3594.2, CNVR3594.1@FAM115C_2@0@0@0@:family with sequence similarity 115, member C;protein FAM115C-like@NA@NA
F11151@79309@79309@deletion@1@143880598@143882930@7@chr7:143880598-143882930@5.03@27@3@0.111@CNVR3598.4, CNVR3598.3@CTAGE4_1@0@0@0@:CTAGE family, member 4@:integral to membrane;nucleotide binding;cellular_component;biological_process@NA
F11151@79312@79315@deletion@4@143955790@144062916@7@chr7:143955790-144062916@31.2@1180@616@0.522@CNVR3598.4@OR2A7_1, CTAGE8_1, OR2A1_1, ARHGEF5_2@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor, family 2, subfamily A, member 7:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
F11151@79321@79325@deletion@5@144069393@144072768@7@chr7:144069393-144072768@13@252@141@0.56@CNVR3598.4, CNVR3598.5, CNVR3598.11@ARHGEF5_8, ARHGEF5_9, ARHGEF5_10, ARHGEF5_11, ARHGEF5_12@0@0@0@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
F11151@80375@80377@duplication@3@7332534@7343904@8@chr8:7332534-7343904@5.76@125@187@1.5@CNVR3771.8, CNVR3771.10, CNVR3771.4@DEFB104B_1, DEFB106B_2, DEFB106B_1@0@0@0@:defensin, beta 104A;defensin, beta 104B:defensin, beta 106B;defensin, beta 106A@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
F11151@80401@80403@duplication@3@7706214@7721057@8@chr8:7706214-7721057@14.1@208@368@1.77@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@SPAG11A_2, SPAG11A_3, SPAG11A_4@0@0@0@:sperm associated antigen 11A;sperm associated antigen 11B@:extracellular region;defense response@NA
F11151@88481@88481@deletion@1@38603157@38603209@9@chr9:38603157-38603209@12.4@142@53@0.373@NA@ANKRD18A_7@0@0@0@:ankyrin repeat domain 18A@:protein binding@NA
F11151@88594@88594@duplication@1@43818042@43818184@9@chr9:43818042-43818184@4.6@106@163@1.54@CNVR4294.1@CNTNAP3B_7@0@0@0@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
F11151@94606@94606@duplication@1@5014394@5014502@10@chr10:5014394-5014502@4.66@246@342@1.39@NA@AKR1C1_6@0@0@0@:aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)@:trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity;bile acid and bile salt transport;oxidation-reduction process;phenanthrene 9,10-monooxygenase activity;indanol dehydrogenase activity;daunorubicin metabolic process;carboxylic acid binding;retinal metabolic process;response to organophosphorus;cholesterol homeostasis;ketosteroid monooxygenase activity;progesterone metabolic process;oxidoreductase activity;17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity;aldo-keto reductase (NADP) activity;digestion;androsterone dehydrogenase (B-specific) activity;doxorubicin metabolic process;alditol:NADP+ 1-oxidoreductase activity;bile acid binding;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;bile acid metabolic process;xenobiotic metabolic process;cytosol;protein homooligomerization;intestinal cholesterol absorption;cellular response to jasmonic acid stimulus@NA
F11151@94613@94613@deletion@1@5037949@5038057@10@chr10:5037949-5038057@6.02@114@59@0.518@NA@AKR1C2_6@0@0@0@:aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III);aldo-keto reductase family 1 member C2-like@:trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity;steroid metabolic process;oxidation-reduction process;phenanthrene 9,10-monooxygenase activity;prostaglandin F receptor activity;daunorubicin metabolic process;carboxylic acid binding;ketosteroid monooxygenase activity;progesterone metabolic process;oxidoreductase activity;digestion;positive regulation of cell proliferation;prostaglandin metabolic process;doxorubicin metabolic process;response to prostaglandin stimulus;positive regulation of protein kinase B signaling cascade;alditol:NADP+ 1-oxidoreductase activity;androsterone dehydrogenase (A-specific) activity;bile acid binding;G-protein coupled receptor signaling pathway;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;cytoplasm;cellular response to jasmonic acid stimulus@: 46,XY SEX REVERSAL 8; SRXY8
F11151@95350@95354@deletion@5@17865074@17887435@10@chr10:17865074-17887435@45.6@226@7@0.031@NA@MRC1L1_2, MRC1L1_3, MRC1L1_4, MRC1L1_5, MRC1L1_6@0@0@0@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
F11151@95384@95387@duplication@4@18112045@18129735@10@chr10:18112045-18129735@27.8@137@372@2.72@NA@MRC1_2, MRC1_3, MRC1_4, MRC1_5@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F11151@95389@95393@deletion@5@18138509@18152611@10@chr10:18138509-18152611@21.5@110@6@0.0545@NA@MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F11151@95947@95948@deletion@2@29578048@29580935@10@chr10:29578048-29580935@13.8@156@62@0.397@NA@LYZL1_1, LYZL1_2@0@0@0@:lysozyme-like 1@:extracellular region;lysozyme activity;cell wall macromolecule catabolic process@NA
F11151@96528@96531@duplication@4@47756034@47758904@10@chr10:47756034-47758904@11.5@76@167@2.2@CNVR4714.1@ANXA8L2_7, ANXA8L2_8, ANXA8L2_9, ANXA8L2_10@0@0@0@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:calcium-dependent phospholipid binding;calcium ion binding@NA
F11151@96932@96937@deletion@6@51965743@51978390@10@chr10:51965743-51978390@8.74@141@78@0.553@NA@ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
F11151@101608@101614@deletion@7@124344788@124353114@10@chr10:124344788-124353114@24.2@866@538@0.621@CNVR4912.4, CNVR4912.3, CNVR4912.2@DMBT1_15, DMBT1_16, DMBT1_17, DMBT1_18, DMBT1_19, DMBT1_20, DMBT1_21@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
F11151@103269@103269@deletion@1@4976003@4976943@11@chr11:4976003-4976943@56.5@526@83@0.158@CNVR5040.1@OR51A2_1@0@0@0@:matrix metallopeptidase 26:olfactory receptor, family 51, subfamily A, member 2@:metallopeptidase activity;extracellular matrix;proteolysis;proteinaceous extracellular matrix;collagen catabolic process;metalloendopeptidase activity;zinc ion binding;metabolic process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F11151@103288@103290@duplication@3@5269590@5271034@11@chr11:5269590-5271034@12@242@379@1.57@NA@HBG1_3, HBG1_2, HBG1_1@0@0@0@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
F11151@104572@104572@duplication@1@18955364@18956331@11@chr11:18955364-18956331@20.2@1195@2000@1.67@CNVR5091.2, CNVR5091.1@MRGPRX1_1@0@0@0@:MAS-related GPR, member X1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;acute-phase response;G-protein coupled receptor signaling pathway@NA
F11151@106046@106048@deletion@3@55370918@55419315@11@chr11:55370918-55419315@305@2025@13@0.00642@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F11151@110121@110124@deletion@4@89768381@89771883@11@chr11:89768381-89771883@9.02@43@2@0.0465@NA@TRIM49C_3, TRIM49C_4, TRIM49C_5, TRIM49C_6@0@0@0@:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;DNA binding;zinc ion binding@NA
F11151@114483@114483@deletion@1@11243900@11244828@12@chr12:11243900-11244828@9.4@914@583@0.638@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
F11151@114493@114496@duplication@4@11506042@11508487@12@chr12:11506042-11508487@23.6@566@885@1.56@CNVR5435.2, CNVR5435.1@PRB1_4, PRB1_3, PRB1_2, PRB1_1@0@0@0@:proline-rich protein BstNI subfamily 1@NA@NA
F11151@117170@117171@duplication@2@52865457@52866064@12@chr12:52865457-52866064@5.95@355@477@1.34@NA@KRT6C_3, KRT6C_2@0@0@0@:keratin 6C@:intermediate filament;structural molecule activity;keratin filament;cytoskeleton organization@NA
F11151@127352@127358@deletion@7@20019701@20404761@14@chr14:20019701-20404761@28.5@8632@6118@0.709@CNVR6072.12, CNVR6072.4@POTEM_1, OR4Q3_1, OR4M1_1, OR4N2_1, OR4K2_1, OR4K5_1, OR4K1_1@0@0@0@:POTE ankyrin domain family, member M:olfactory receptor, family 4, subfamily N, member 2:olfactory receptor, family 4, subfamily Q, member 3:olfactory receptor, family 4, subfamily M, member 1:olfactory receptor, family 4, subfamily K, member 2:olfactory receptor, family 4, subfamily K, member 5:olfactory receptor, family 4, subfamily K, member 1@:protein binding:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F11151@128217@128224@deletion@8@24437967@24473579@14@chr14:24437967-24473579@73.4@1075@488@0.454@NA@DHRS4_8, DHRS4L2_1, DHRS4L2_2, DHRS4L2_3, DHRS4L2_4, DHRS4L2_5, DHRS4L2_6, DHRS4L2_7@0@0@0@:dehydrogenase/reductase (SDR family) member 4:dehydrogenase/reductase (SDR family) member 4 like 2@:steroid metabolic process;oxidation-reduction process;mitochondrion;protein tetramerization;oxidoreductase activity;peroxisomal membrane;nucleus;cellular ketone metabolic process;metabolic process;receptor binding;alcohol dehydrogenase [NAD(P)+] activity;peroxisome;nucleotide binding;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;3-keto sterol reductase activity;alcohol metabolic process;carbonyl reductase (NADPH) activity:extracellular region;oxidoreductase activity;nucleotide binding;metabolic process@NA
F11151@133349@133351@duplication@3@106090814@106091716@14@chr14:106090814-106091716@16.7@371@583@1.57@CNVR6294.46, CNVR6294.20, CNVR6294.54, CNVR6294.43, CNVR6294.50, CNVR6294.61@IGHG4_4, IGHG4_3, IGHG4_2@0@0@0@@:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response@NA
F11151@133425@133427@duplication@3@106471637@106478539@14@chr14:106471637-106478539@13.6@202@344@1.7@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV1-3_1, IGHV4-4_2, IGHV4-4_1@0@0@0@@:protein binding:protein binding@NA
F11151@133432@133436@duplication@5@106539080@106573537@14@chr14:106539080-106573537@53.5@769@1423@1.85@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1, IGHV3-11_2@0@0@0@@:protein binding:protein binding:protein binding@NA
F11151@133460@133463@duplication@4@106805210@106816173@14@chr14:106805210-106816173@42@560@1111@1.98@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.41@IGHV4-31_2, IGHV4-31_1, IGHV3-33_2, IGHV3-33_1@0@0@0@@:protein binding:protein binding@NA
F11151@133470@133473@deletion@4@106877620@106926644@14@chr14:106877620-106926644@9.6@931@654@0.702@CNVR6294.26, CNVR6294.56, CNVR6294.18@IGHV4-39_2, IGHV4-39_1, IGHV3-43_2, IGHV3-43_1@0@0@0@@:protein binding:protein binding@NA
F11151@133491@133492@duplication@2@107095127@107095561@14@chr14:107095127-107095561@11.6@83@181@2.18@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61_2, IGHV4-61_1@0@0@0@@:protein binding@NA
F11151@133495@133495@duplication@1@107131034@107131334@14@chr14:107131034-107131334@7.58@187@294@1.57@CNVR6294.56, CNVR6294.16@IGHV3-66_2@0@0@0@@:protein binding@NA
F11151@133542@133542@duplication@1@22382474@22383423@15@chr15:22382474-22383423@10.4@782@1138@1.46@CNVR6297.4, CNVR6297.17, CNVR6297.2@OR4N4_1@0@0@0@:olfactory receptor, family 4, subfamily N, member 4@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F11151@134011@134012@duplication@2@30664351@30665348@15@chr15:30664351-30665348@16.9@196@364@1.86@CNVR6337.1@CHRFAM7A_7, CHRFAM7A_6@0@0@0@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
F11151@134153@134156@deletion@4@32449810@32455536@15@chr15:32449810-32455536@34.7@174@9@0.0517@CNVR6345.2, CNVR6345.1@CHRNA7_6, CHRNA7_7, CHRNA7_8, CHRNA7_9@0@0@0@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
F11151@135680@135737@duplication@58@43873201@43940259@15@chr15:43873201-43940259@138@4682@6832@1.46@CNVR6365.1@PPIP5K1_10, PPIP5K1_9, PPIP5K1_8, PPIP5K1_7, PPIP5K1_6, PPIP5K1_5, PPIP5K1_4, PPIP5K1_3, CKMT1B_2, CKMT1B_3, CKMT1B_4, CKMT1B_5, CKMT1B_6, CKMT1B_7, CKMT1B_8, CKMT1B_9, CKMT1B_10, STRC_29, STRC_28, STRC_27, STRC_26, STRC_25, STRC_24, STRC_23, STRC_22, STRC_21, STRC_20, STRC_19, STRC_18, STRC_17, STRC_16, STRC_15, STRC_14, STRC_13, STRC_12, STRC_11, STRC_10, STRC_9, STRC_8, STRC_7, STRC_6, STRC_5, STRC_4, STRC_3, STRC_2, STRC_1, CATSPER2_13, CATSPER2_12, CATSPER2_11, CATSPER2_10, CATSPER2_9, CATSPER2_8, CATSPER2_7, CATSPER2_6, CATSPER2_5, CATSPER2_4, CATSPER2_3, CATSPER2_2@0@0@0@:diphosphoinositol pentakisphosphate kinase 1:creatine kinase, mitochondrial 1A;creatine kinase, mitochondrial 1B:stereocilin:cation channel, sperm associated 2@:inositol hexakisphosphate 3-kinase activity;inositol hexakisphosphate 1-kinase activity;inositol metabolic process;diphosphoinositol-pentakisphosphate kinase activity;ATP binding;acid phosphatase activity;cytoplasm;cytosol;inositol hexakisphosphate 5-kinase activity;nucleus;kinase activity;inositol-1,3,4,5,6-pentakisphosphate kinase activity:mitochondrion;small molecule metabolic process;mitochondrial inner membrane;creatine metabolic process;creatine kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;kinase activity;cellular nitrogen compound metabolic process:detection of mechanical stimulus involved in sensory perception of sound;stereocilium bundle tip;stereocilium;cell surface;kinocilium;auditory receptor cell stereocilium organization:cell differentiation;CatSper complex;ion transport;transmembrane transport;voltage-gated ion channel activity;flagellar membrane;spermatogenesis;integral to membrane;multicellular organismal development;fertilization;sperm motility;ion channel activity;ciliary or flagellar motility;calcium channel activity;cilium;protein binding;microtubule-based flagellum;membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16; DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY: DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY
F11151@140958@140961@deletion@4@1278901@1279952@16@chr16:1278901-1279952@7.9@56@15@0.268@CNVR6591.1@TPSB2_6, TPSB2_5, TPSB2_4, TPSB2_3, TPSB2_2@0@0@0@:tryptase beta 2 (gene/pseudogene)@:proteolysis;catalytic activity;serine-type endopeptidase activity@NA
F11151@142701@142702@duplication@2@15111179@15112822@16@chr16:15111179-15112822@7.3@320@448@1.4@CNVR6646.1@PDXDC1_11, PDXDC1_12@0@0@0@:pyridoxal-dependent decarboxylase domain containing 1;pyridoxal-dependent decarboxylase domain-containing protein 1-like@:carboxylic acid metabolic process;pyridoxal phosphate binding;carboxy-lyase activity@NA
F11151@143481@143485@deletion@5@21763257@21771861@16@chr16:21763257-21771861@8.38@149@79@0.53@CNVR6668.5, CNVR6668.2, CNVR6668.7@OTOA_24, OTOA_25, OTOA_26, OTOA_27, OTOA_28@0@0@0@:otoancorin@:proteinaceous extracellular matrix;apical plasma membrane;sensory perception of sound;anchored to membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22
F11151@145554@145560@duplication@7@55844430@55855433@16@chr16:55844430-55855433@15.8@978@1308@1.34@CNVR6731.1@CES1_11, CES1_10, CES1_9, CES1_8, CES1_7, CES1_6, CES1_5@0@0@0@:carboxylesterase 1;liver carboxylesterase 1-like@:hydrolase activity;methyl salicylate esterase activity;response to toxin;methylumbelliferyl-acetate deacetylase activity;endoplasmic reticulum lumen;retinyl-palmitate esterase activity;methyl jasmonate esterase activity;metabolic process;carboxylesterase activity;methyl indole-3-acetate esterase activity@: CARBOXYLESTERASE 1; CES1
F11151@147109@147124@duplication@16@70161164@70190782@16@chr16:70161164-70190782@267@5013@9864@1.97@CNVR6764.1, CNVR6764.3@PDPR_4, PDPR_5, PDPR_6, PDPR_7, PDPR_8, PDPR_9, PDPR_10, PDPR_11, PDPR_12, PDPR_13, PDPR_14, PDPR_15, PDPR_16, PDPR_17, PDPR_18, PDPR_19@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
F11151@147497@147513@duplication@17@74415415@74452196@16@chr16:74415415-74452196@55.4@619@1194@1.93@CNVR6778.2, CNVR6778.3@NPIPL2_2, NPIPL2_3, NPIPL2_4, NPIPL2_5, NPIPL2_6, NPIPL2_7, CLEC18B_13, CLEC18B_12, CLEC18B_11, CLEC18B_10, CLEC18B_9, CLEC18B_8, CLEC18B_7, CLEC18B_6, CLEC18B_5, CLEC18B_4, CLEC18B_3@0@0@0@:C-type lectin domain family 18, member B@:extracellular region:carbohydrate binding;protein binding;extracellular region@NA
F11151@151958@151961@deletion@4@18996506@19036052@17@chr17:18996506-19036052@12.7@204@94@0.461@CNVR7018.2, CNVR7018.3, CNVR7018.1@AC007952.5_1, AC007952.5_2, GRAPL_1, GRAPL_2@0@0@0@:GRB2-related adaptor protein-like@:protein binding@NA
F11151@153380@153381@deletion@2@34539179@34539971@17@chr17:34539179-34539971@5.66@25@0@0@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1_2, CCL4L1_3@0@0@0@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
F11151@154346@154346@duplication@1@39421631@39422112@17@chr17:39421631-39422112@6.89@59@120@2.03@CNVR7096.1@KRTAP9-6_1@0@0@0@:keratin associated protein 9-6@:keratin filament@NA
F11151@155580@155581@deletion@2@44171927@44249509@17@chr17:44171927-44249509@12.5@2031@1328@0.654@CNVR7114.3, CNVR7114.2@KANSL1_3, KANSL1_2@0@0@0@:KAT8 regulatory NSL complex subunit 1@:histone acetyltransferase activity (H4-K8 specific);histone acetyltransferase activity (H4-K16 specific);histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase complex;histone H4-K5 acetylation;MLL1 complex;histone H4-K16 acetylation;protein binding;histone H4-K8 acetylation;nucleus@NA
F11151@155604@155611@deletion@8@44617543@44632790@17@chr17:44617543-44632790@23.8@531@278@0.524@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2_7, LRRC37A2_8, LRRC37A2_9, LRRC37A2_10, LRRC37A2_11, LRRC37A2_12, LRRC37A2_13, LRRC37A2_14@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
F11151@162019@162019@duplication@1@44554574@44556213@18@chr18:44554574-44556213@6.61@164@255@1.55@CNVR7319.1@TCEB3C_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C (elongin A3);RNA polymerase II transcription factor SIII subunit A3-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
F11151@166916@166917@deletion@2@14508471@14508747@19@chr19:14508471-14508747@9.96@86@28@0.326@NA@CD97_7, CD97_8@0@0@0@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
F11151@168951@168951@duplication@1@35849794@35850833@19@chr19:35849794-35850833@8.93@464@679@1.46@CNVR7627.1@FFAR3_2@0@0@0@:free fatty acid receptor 3@:lipid binding;integral to membrane;G-protein coupled receptor activity;plasma membrane;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
F11151@170096@170101@duplication@6@40373946@40384167@19@chr19:40373946-40384167@12.6@308@460@1.49@CNVR7639.2@FCGBP_26, FCGBP_25, FCGBP_24, FCGBP_23, FCGBP_22, FCGBP_21@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F11151@170104@170109@deletion@6@40389653@40399855@19@chr19:40389653-40399855@9.08@388@254@0.655@CNVR7639.2, CNVR7639.3@FCGBP_18, FCGBP_17, FCGBP_16, FCGBP_15, FCGBP_14, FCGBP_13@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F11151@170821@170825@deletion@5@43702150@43762608@19@chr19:43702150-43762608@28.2@674@365@0.542@CNVR7658.5, CNVR7658.1@PSG4_3, PSG4_2, PSG4_1, PSG9_6, PSG9_5@0@0@0@:pregnancy specific beta-1-glycoprotein 4:pregnancy specific beta-1-glycoprotein 9@:protein binding;extracellular region;female pregnancy;defense response:protein binding;extracellular region;female pregnancy;defense response@NA
F11151@173295@173295@duplication@1@54724399@54724700@19@chr19:54724399-54724700@9.08@166@280@1.69@CNVR7721.3, CNVR7721.4@LILRB3_6@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F11151@173303@173303@deletion@1@54744151@54744452@19@chr19:54744151-54744452@18.1@379@172@0.454@CNVR7721.3, CNVR7721.6@LILRA6_6@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F11151@173336@173341@deletion@6@54801928@54804173@19@chr19:54801928-54804173@42.2@1135@623@0.549@CNVR7722.1@LILRA3_6, LILRA3_5, LILRA3_4, LILRA3_3, LILRA3_2, LILRA3_1@0@0@0@:leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3@:antigen binding;signal transduction;protein binding;extracellular region;plasma membrane;receptor activity;defense response@NA
F11151@173492@173493@duplication@2@55341384@55341730@19@chr19:55341384-55341730@6.18@349@475@1.36@CNVR7725.1, CNVR7725.6@KIR3DL1_8, KIR3DL1_9@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
F11151@173499@173501@deletion@3@55358640@55359398@19@chr19:55358640-55359398@16.1@777@485@0.624@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4_6, KIR2DS4_7, KIR2DS4_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
F11151@173844@173844@duplication@1@56283172@56283456@19@chr19:56283172-56283456@6.51@259@378@1.46@CNVR7734.1@CTD-2611O12.2_2@0@0@0@:ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
F11151@174395@174395@deletion@1@1569207@1569278@20@chr20:1569207-1569278@13.9@64@0@0@CNVR7763.1@RP4-576H24.4_1@0@0@0@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
F11151@174403@174403@deletion@1@1895746@1896101@20@chr20:1895746-1896101@13.8@185@74@0.4@CNVR7764.2@SIRPA_2@0@0@0@:signal-regulatory protein alpha@:blood coagulation;protein binding;integral to membrane;SH3 domain binding;cell adhesion;plasma membrane;membrane;leukocyte migration@NA
F11151@178998@178999@deletion@2@10942712@10943020@21@chr21:10942712-10943020@6.57@959@678@0.707@CNVR7947.10, CNVR7947.6, CNVR7947.11@TPTE_13, TPTE_12@0@0@0@:transmembrane phosphatase with tensin homology@:phosphatase activity;ion channel activity;protein tyrosine phosphatase activity;ion transport;protein dephosphorylation;transmembrane transport;protein binding;signal transduction;integral to membrane;protein tyrosine/serine/threonine phosphatase activity;dephosphorylation;membrane;peptidyl-tyrosine dephosphorylation@NA
F11151@180976@180976@deletion@1@16287255@16287885@22@chr22:16287255-16287885@6.89@95@43@0.453@CNVR8071.2, CNVR8071.3, CNVR8071.9@POTEH_1@0@0@0@:POTE ankyrin domain family, member H@:protein binding@NA
F11151@181183@181185@duplication@3@19165241@19165753@22@chr22:19165241-19165753@6.79@264@368@1.39@NA@SLC25A1_4, SLC25A1_3, SLC25A1_2@0@0@0@:solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1@:mitochondrion;transport;triglyceride biosynthetic process;citrate transmembrane transporter activity;small molecule metabolic process;mitochondrial inner membrane;mitochondrial citrate transport;carbohydrate metabolic process;cellular lipid metabolic process;long-chain fatty-acyl-CoA biosynthetic process;integral to membrane;gluconeogenesis;glucose metabolic process@NA
F11151@181806@181807@deletion@2@23243157@23247205@22@chr22:23243157-23247205@5.82@331@219@0.662@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11, CNVR8103.35@IGLC2_1, IGLJ3_1@0@0@0@@:protein binding@NA
F11151@181936@181938@deletion@3@24300473@24302568@22@chr22:24300473-24302568@5.32@48@18@0.375@CNVR8114.6, CNVR8114.12, CNVR8114.13, CNVR8114.8@GSTT2B_4, GSTT2B_3, GSTT2B_2@0@0@0@:glutathione S-transferase theta 2B (gene/pseudogene);glutathione S-transferase theta 2@:protein binding;glutathione transferase activity;nucleus;transferase activity;cytoplasm@NA
F11151@181951@181955@duplication@5@24376424@24384231@22@chr22:24376424-24384231@28.2@609@960@1.58@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTT1_5, GSTT1_4, GSTT1_3, GSTT1_2, GSTT1_1@0@0@0@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
F11151@182584@182586@duplication@3@30768065@30770080@22@chr22:30768065-30770080@5.24@174@245@1.41@NA@CCDC157_7, CCDC157_8, CCDC157_9@0@0@0@:coiled-coil domain containing 157@:vesicle-mediated transport;membrane@NA
F11151@4052@4071@deletion@20@101571921@101581428@X@chrX:101571921-101581428@18.2@83@1@0.012@NA@NXF2_15, NXF2_16, NXF2_17, NXF2_18, NXF2_19, NXF2_20, NXF2_21, NXF2_22, NXF2_23, NXF2_24, NXF2_25, NXF2_26, NXF2_27, NXF2_28, NXF2_29, NXF2_30, NXF2_31, NXF2_32, NXF2_33, NXF2_34@0@0@0@NA@NA@NA
F11151@4884@4884@deletion@1@119210843@119211253@X@chrX:119210843-119211253@7.81@35@0@0@NA@RHOXF2B_2@0@0@0@NA@NA@NA
F11151@5719@5719@deletion@1@140336520@140336590@X@chrX:140336520-140336590@6.85@39@6@0.154@CNVR8456.1@SPANXC_1@0@0@0@NA@NA@NA
F11151@6307@6307@deletion@1@153496018@153496256@X@chrX:153496018-153496256@8.88@40@0@0@CNVR8489.1@OPN1MW2_5@0@0@0@NA@NA@NA
F13349@3334@3341@duplication@8@25611065@25648453@1@chr1:25611065-25648453@23.7@1159@1605@1.38@CNVR116.1, CNVR116.2@RHD_2, RHD_3, RHD_4, RHD_5, RHD_6, RHD_7, RHD_8, RHD_9@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
F13349@3357@3357@deletion@1@25735175@25735360@1@chr1:25735175-25735360@23.1@107@0@0@CNVR117.1@RHCE_2@0@0@0@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
F13349@8507@8508@duplication@2@89476588@89477710@1@chr1:89476588-89477710@15.5@570@836@1.47@CNVR244.1@GBP3_8, GBP3_7@0@0@0@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
F13349@9365@9374@duplication@10@104202983@104234232@1@chr1:104202983-104234232@26.7@146@349@2.39@CNVR266.3, CNVR266.1, CNVR266.15@AMY1A_7, AMY1A_8, AMY1A_9, AMY1A_10, AMY1A_11, AMY1B_11, AMY1B_10, AMY1B_9, AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
F13349@9385@9386@deletion@2@104297122@104297436@1@chr1:104297122-104297436@31.7@299@94@0.314@CNVR266.3, CNVR266.5@AMY1C_6, AMY1C_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
F13349@9766@9773@duplication@8@110230497@110235917@1@chr1:110230497-110235917@34.5@430@748@1.74@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
F13349@12117@12118@deletion@2@152573209@152586574@1@chr1:152573209-152586574@27.1@126@1@0.00794@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
F13349@14053@14058@deletion@6@161565346@161600992@1@chr1:161565346-161600992@56.4@1130@594@0.526@CNVR383.1@FCGR2C_1, FCGR3B_5, FCGR3B_4, FCGR3B_3, FCGR3B_2, FCGR3B_1@0@0@0@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene):Fc fragment of IgG, low affinity IIIb, receptor (CD16b)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction:IgG binding;protein binding;extracellular region;immune response;plasma membrane;anchored to membrane@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
F13349@16029@16040@duplication@12@196744018@196801129@1@chr1:196744018-196801129@74.3@1907@2919@1.53@CNVR459.1@CFHR3_1, CFHR3_2, CFHR3_3, CFHR3_4, CFHR3_5, CFHR3_6, CFHR1_1, CFHR1_2, CFHR1_3, CFHR1_4, CFHR1_5, CFHR1_6@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
F13349@19770@19771@duplication@2@248636653@248652837@1@chr1:248636653-248652837@22@1093@1589@1.45@NA@OR2T3_1, OR2T5_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 3:olfactory receptor, family 2, subfamily T, member 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F13349@19773@19776@deletion@4@248721846@248790429@1@chr1:248721846-248790429@36.8@2314@1463@0.632@CNVR600.1@OR2T29_1, OR2T34_1, OR2T10_1, OR2T11_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 29:olfactory receptor, family 2, subfamily T, member 34:olfactory receptor, family 2, subfamily T, member 10:olfactory receptor, family 2, subfamily T, member 11@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F13349@25115@25116@deletion@2@96652500@96652954@2@chr2:96652500-96652954@26.1@182@37@0.203@NA@ANKRD36C_3, ANKRD36C_2@0@0@0@:ankyrin repeat domain-containing protein 36A-like@:ion channel inhibitor activity;protein binding@NA
F13349@33409@33412@duplication@4@233273212@233274158@2@chr2:233273212-233274158@12.2@235@365@1.55@NA@ALPPL2_7, ALPPL2_8, ALPPL2_9, ALPPL2_10@0@0@0@:alkaline phosphatase, placental-like 2@:phosphatase activity;catalytic activity;phosphorylation;plasma membrane;metabolic process;membrane;anchored to membrane;alkaline phosphatase activity;metal ion binding@NA
F13349@43782@43782@deletion@1@160939803@160939845@3@chr3:160939803-160939845@4.76@150@91@0.607@NA@NMD3_1@0@0@0@:NMD3 homolog (S. cerevisiae)@:nucleoplasm;nucleolus;protein transport;nucleus;cytoplasm@NA
F13349@48561@48566@duplication@6@69433480@69533906@4@chr4:69433480-69533906@52.8@1563@2490@1.59@CNVR1953.1@UGT2B17_1, UGT2B15_6, UGT2B15_5, UGT2B15_4, UGT2B15_3, UGT2B15_2@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17:UDP glucuronosyltransferase 2 family, polypeptide B15@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;cellular glucuronidation;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
F13349@48592@48596@deletion@5@70146220@70156529@4@chr4:70146220-70156529@13.3@641@419@0.654@CNVR1957.2, CNVR1957.1@UGT2B28_1, UGT2B28_2, UGT2B28_3, UGT2B28_4, UGT2B28_5@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
F13349@51672@51672@duplication@1@145041644@145041741@4@chr4:145041644-145041741@8.25@125@212@1.7@NA@GYPA_2@0@0@0@:glycophorin B (MNS blood group):glycophorin A (MNS blood group)@:integral to membrane;plasma membrane;integral to plasma membrane:external side of plasma membrane;integral to membrane;cytoskeletal anchoring at plasma membrane;plasma membrane;molecular_function;protein homodimerization activity;integral to plasma membrane;cellular_component;identical protein binding;membrane;biological_process;regulation of response to osmotic stress;virus-host interaction@: BLOOD GROUP--Ss LOCUS; Ss: MALARIA, SUSCEPTIBILITY TO; BLOOD GROUP--MN LOCUS; MN
F13349@53306@53311@duplication@6@741710@756259@5@chr5:741710-756259@33.5@388@711@1.83@CNVR2280.3@ZDHHC11B_7, ZDHHC11B_6, ZDHHC11B_5, ZDHHC11B_4, ZDHHC11B_3, ZDHHC11B_2@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
F13349@53318@53322@deletion@5@833889@847730@5@chr5:833889-847730@31.5@830@469@0.565@CNVR2280.3, CNVR2280.8@ZDHHC11_7, ZDHHC11_6, ZDHHC11_5, ZDHHC11_4, ZDHHC11_3@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
F13349@55806@55806@deletion@1@69372349@69372398@5@chr5:69372349-69372398@27@127@1@0.00787@CNVR2494.48, CNVR2494.39, CNVR2494.15, CNVR2494.18, CNVR2494.26, CNVR2494.43, CNVR2494.52, CNVR2494.28, CNVR2494.2, CNVR2494.36@SMN2_8@0@0@0@:survival of motor neuron 2, centromeric;survival of motor neuron 1, telomeric@:nucleoplasm;ncRNA metabolic process;Cajal body;RNA metabolic process;spliceosomal complex;cytoplasm;cytosol;protein binding;cell death;spliceosomal complex assembly;RNA binding;mRNA processing;nucleus;gene expression;spliceosomal snRNP assembly@: SPINAL MUSCULAR ATROPHY, TYPE II; SMA2; SPINAL MUSCULAR ATROPHY, TYPE I; SMA1; SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4; SPINAL MUSCULAR ATROPHY, TYPE III; SMA3
F13349@58466@58467@deletion@2@134907544@134910375@5@chr5:134907544-134910375@6.75@192@114@0.594@NA@CXCL14_4, CXCL14_3@0@0@0@:chemokine (C-X-C motif) ligand 14@:inner ear development;immune response;Golgi apparatus;cell-cell signaling;chemotaxis;signal transduction;extracellular space;extracellular region;chemokine activity@NA
F13349@59065@59065@duplication@1@140557617@140560021@5@chr5:140557617-140560021@22@1719@2634@1.53@CNVR2624.1@PCDHB8_1@0@0@0@:protocadherin beta 8@:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding@NA
F13349@60876@60877@deletion@2@175388055@175388437@5@chr5:175388055-175388437@10.3@62@11@0.177@NA@THOC3_5, THOC3_4@0@0@0@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
F13349@60892@60892@duplication@1@175528555@175528584@5@chr5:175528555-175528584@4.83@112@170@1.52@NA@FAM153B_11@0@0@0@:uncharacterized LOC100507387;family with sequence similarity 153, member B@NA@NA
F13349@61266@61266@deletion@1@177163581@177163610@5@chr5:177163581-177163610@8.78@70@20@0.286@NA@FAM153A_11@0@0@0@:family with sequence similarity 153, member A@NA@NA
F13349@61269@61271@deletion@3@177166602@177168333@5@chr5:177166602-177168333@19.8@107@12@0.112@NA@FAM153A_8, FAM153A_7, FAM153A_6@0@0@0@:family with sequence similarity 153, member A@NA@NA
F13349@61638@61645@deletion@8@180375356@180429785@5@chr5:180375356-180429785@26.3@1141@737@0.646@CNVR2719.1@BTNL8_5, BTNL8_6, BTNL8_7, BTNL8_8, BTNL3_1, BTNL3_2, BTNL3_3, BTNL3_4@0@0@0@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
F13349@63282@63282@deletion@1@31237988@31238262@6@chr6:31237988-31238262@12.9@206@96@0.466@CNVR2838.1@HLA-C_4@0@0@0@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
F13349@63725@63726@duplication@2@31962023@31962484@6@chr6:31962023-31962484@6.63@127@197@1.55@CNVR2843.6, CNVR2843.3@C4A_20, C4A_21@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
F13349@63776@63776@deletion@1@31996945@31997115@6@chr6:31996945-31997115@5.99@98@49@0.5@CNVR2843.6, CNVR2843.5@C4B_28@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
F13349@63790@63792@deletion@3@32006201@32007025@6@chr6:32006201-32007025@7.27@199@119@0.598@CNVR2843.6, CNVR2843.5@CYP21A2_1, CYP21A2_2, CYP21A2_3@0@0@0@:cytochrome P450, family 21, subfamily A, polypeptide 2@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY
F13349@63953@63958@duplication@6@32485517@32498001@6@chr6:32485517-32498001@43.2@343@707@2.06@CNVR2845.21, CNVR2845.25, CNVR2845.30, CNVR2845.43, CNVR2845.6@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2, HLA-DRB5_1@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
F13349@63962@63965@duplication@4@32549335@32605317@6@chr6:32549335-32605317@19.4@409@640@1.56@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.34@HLA-DRB1_3, HLA-DRB1_2, HLA-DRB1_1, HLA-DQA1_1@0@0@0@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
F13349@63973@63973@deletion@1@32632576@32632844@6@chr6:32632576-32632844@18.3@143@36@0.252@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20, CNVR2845.31@HLA-DQB1_2@0@0@0@:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
F13349@64603@64605@duplication@3@35755645@35763630@6@chr6:35755645-35763630@16.4@895@1240@1.39@CNVR2861.1@CLPSL1_3, CLPS_3, CLPS_2@0@0@0@:colipase-like 1:colipase, pancreatic@:extracellular region;enzyme activator activity;digestion;lipid catabolic process:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
F13349@65135@65135@deletion@1@41254346@41254393@6@chr6:41254346-41254393@7@152@83@0.546@NA@TREM1_1@0@0@0@:triggering receptor expressed on myeloid cells 1@:intracellular;blood coagulation;humoral immune response;integral to membrane;extracellular region;plasma membrane;receptor activity;intracellular signal transduction;leukocyte migration@NA
F13349@71744@71749@duplication@6@5939916@5944900@7@chr7:5939916-5944900@16.4@603@855@1.42@NA@CCZ1_2, CCZ1_3, CCZ1_4, CCZ1_5, CCZ1_6, CCZ1_7@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F13349@71776@71776@duplication@1@6006495@6006747@7@chr7:6006495-6006747@11.3@147@264@1.8@NA@RSPH10B_2@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F13349@71922@71923@deletion@2@6797310@6798790@7@chr7:6797310-6798790@13.9@214@100@0.467@NA@RSPH10B2_2, RSPH10B2_3@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F13349@71926@71926@duplication@1@6805338@6805422@7@chr7:6805338-6805422@7.79@137@224@1.64@NA@RSPH10B2_6@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F13349@71941@71944@deletion@4@6838856@6844686@7@chr7:6838856-6844686@25.8@121@2@0.0165@NA@CCZ1B_15, CCZ1B_14, CCZ1B_13, CCZ1B_12@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F13349@71946@71953@deletion@8@6851584@6864179@7@chr7:6851584-6864179@25.4@913@576@0.631@NA@CCZ1B_10, CCZ1B_9, CCZ1B_8, CCZ1B_7, CCZ1B_6, CCZ1B_5, CCZ1B_4, CCZ1B_3@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F13349@73021@73021@duplication@1@33134847@33135044@7@chr7:33134847-33135044@7.31@108@183@1.69@NA@RP9_6@0@0@0@:retinitis pigmentosa 9 (autosomal dominant)@:protein binding;nucleus;RNA splicing;zinc ion binding;nucleic acid binding;signal recognition particle receptor complex@: RETINITIS PIGMENTOSA; RP; RETINITIS PIGMENTOSA 9; RP9
F13349@73248@73248@deletion@1@38299690@38299831@7@chr7:38299690-38299831@4.74@67@32@0.478@CNVR3353.1@TRGC1_3@0@0@0@:TCR gamma alternate reading frame protein@:protein binding@NA
F13349@73260@73265@duplication@6@38388957@38398580@7@chr7:38388957-38398580@23.4@1543@2089@1.35@CNVR3354.3, CNVR3354.1@TRGV5_2, TRGV5_1, TRGV4_2, TRGV4_1, TRGV3_2, TRGV3_1@0@0@0@@:protein binding:protein binding:protein binding;immune response;peptide antigen binding;plasma membrane;MHC protein binding@NA
F13349@74605@74607@deletion@3@74251403@74422230@7@chr7:74251403-74422230@7.9@36@0@0@NA@GTF2IRD2_2, GATSL1_1, GATSL1_2@0@0@0@:GTF2I repeat domain containing 2:GATS protein-like 1@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
F13349@74792@74793@duplication@2@76240783@76241130@7@chr7:76240783-76241130@6.41@248@347@1.4@CNVR3463.10@POMZP3_6, POMZP3_5@0@0@0@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
F13349@76428@76432@duplication@5@100333344@100336236@7@chr7:100333344-100336236@11.1@861@1139@1.32@CNVR3509.1@ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
F13349@76754@76754@duplication@1@102219880@102220243@7@chr7:102219880-102220243@14.2@68@181@2.66@CNVR3518.1@AC093668.1_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
F13349@76795@76795@deletion@1@102318940@102319303@7@chr7:102318940-102319303@5.96@222@137@0.617@CNVR3518.1@AC105052.1_1@0@0@0@NA@NA@NA
F13349@76831@76831@deletion@1@102738747@102739000@7@chr7:102738747-102739000@4.63@134@80@0.597@NA@ARMC10_7@0@0@0@:armadillo repeat containing 10@:mitochondrion;binding;hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances;vacuolar proton-transporting V-type ATPase, V1 domain;integral to membrane;endoplasmic reticulum membrane;ATP hydrolysis coupled proton transport;regulation of growth@NA
F13349@79058@79061@deletion@4@142099456@142104553@7@chr7:142099456-142104553@36.2@958@528@0.551@NA@TRBV7-8_2, TRBV7-8_1, TRBV6-9_2, TRBV6-9_1@0@0@0@@:protein binding:protein binding@NA
F13349@79287@79287@deletion@1@143400089@143400710@7@chr7:143400089-143400710@4.79@59@26@0.441@CNVR3594.2, CNVR3594.1@FAM115C_2@0@0@0@:family with sequence similarity 115, member C;protein FAM115C-like@NA@NA
F13349@79309@79324@duplication@16@143880598@144071982@7@chr7:143880598-144071982@53.6@2060@3101@1.51@CNVR3598.4@CTAGE4_1, ARHGEF35_2, OR2A42_1, OR2A7_1, CTAGE8_1, OR2A1_1, ARHGEF5_2, ARHGEF5_3, ARHGEF5_4, ARHGEF5_5, ARHGEF5_6, ARHGEF5_7, ARHGEF5_8, ARHGEF5_9, ARHGEF5_10, ARHGEF5_11@0@0@0@:CTAGE family, member 4:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:olfactory receptor, family 2, subfamily A, member 7:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:integral to membrane;nucleotide binding;cellular_component;biological_process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
F13349@80368@80371@deletion@4@7274293@7308422@8@chr8:7274293-7308422@17.9@326@155@0.475@CNVR3771.8, CNVR3771.10, CNVR3771.4@DEFB4B_1, DEFB103B_2, DEFB103B_1, SPAG11B_3@0@0@0@:defensin, beta 4B;defensin, beta 4A:defensin, beta 103B;defensin, beta 103A:sperm associated antigen 11B@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response@NA
F13349@80375@80376@deletion@2@7332534@7340274@8@chr8:7332534-7340274@6.53@67@27@0.403@CNVR3771.8, CNVR3771.10, CNVR3771.4@DEFB104B_1, DEFB106B_2@0@0@0@:defensin, beta 104A;defensin, beta 104B:defensin, beta 106B;defensin, beta 106A@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
F13349@80402@80402@duplication@1@7718169@7718245@8@chr8:7718169-7718245@8.53@153@250@1.63@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@SPAG11A_3@0@0@0@:sperm associated antigen 11A;sperm associated antigen 11B@:extracellular region;defense response@NA
F13349@86351@86351@duplication@1@145438827@145438924@8@chr8:145438827-145438924@5.25@6@39@6.5@NA@FAM203B_3@0@0@0@:family with sequence similarity 203, member B@:binding@NA
F13349@88288@88288@deletion@1@35845973@35846065@9@chr9:35845973-35846065@4.81@93@50@0.538@NA@TMEM8B_7@0@0@0@:transmembrane protein 8B@:regulation of mitotic cell cycle;mitochondrion;endoplasmic reticulum;cell-matrix adhesion;protein binding;integral to membrane;nucleus;plasma membrane;regulation of growth;cell surface@NA
F13349@95352@95354@deletion@3@17875675@17887435@10@chr10:17875675-17887435@20.9@97@1@0.0103@NA@MRC1L1_4, MRC1L1_5, MRC1L1_6@0@0@0@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
F13349@95357@95387@duplication@31@17898253@18129735@10@chr10:17898253-18129735@28.5@465@750@1.61@NA@MRC1L1_9, MRC1L1_10, MRC1L1_11, MRC1L1_12, MRC1L1_13, MRC1L1_14, MRC1L1_15, MRC1L1_16, MRC1L1_17, MRC1L1_18, MRC1L1_19, MRC1L1_20, MRC1L1_21, MRC1L1_22, MRC1L1_23, MRC1L1_24, MRC1L1_25, MRC1L1_26, MRC1L1_27, MRC1L1_28, MRC1L1_29, MRC1L1_30, TMEM236_1, TMEM236_2, TMEM236_3, TMEM236_4, MRC1_1, MRC1_2, MRC1_3, MRC1_4, MRC1_5@0@0@0@:macrophage mannose receptor 1-like:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F13349@95389@95411@deletion@23@18138509@18198276@10@chr10:18138509-18198276@48.9@261@23@0.0881@NA@MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11, MRC1_12, MRC1_13, MRC1_14, MRC1_15, MRC1_16, MRC1_17, MRC1_18, MRC1_19, MRC1_20, MRC1_21, MRC1_22, MRC1_23, MRC1_24, MRC1_25, MRC1_26, MRC1_27, MRC1_28, MRC1_29@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F13349@95947@95947@duplication@1@29578048@29578159@10@chr10:29578048-29578159@6.58@102@170@1.67@NA@LYZL1_1@0@0@0@:lysozyme-like 1@:extracellular region;lysozyme activity;cell wall macromolecule catabolic process@NA
F13349@96528@96531@deletion@4@47756034@47758904@10@chr10:47756034-47758904@6.76@83@38@0.458@CNVR4714.1@ANXA8L2_7, ANXA8L2_8, ANXA8L2_9, ANXA8L2_10@0@0@0@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:calcium-dependent phospholipid binding;calcium ion binding@NA
F13349@96581@96581@duplication@1@48054984@48055018@10@chr10:48054984-48055018@5.15@153@225@1.47@CNVR4715.2@ASAH2C_1@0@0@0@@:ceramidase activity;sphingolipid metabolic process@NA
F13349@96852@96852@duplication@1@51374371@51374428@10@chr10:51374371-51374428@6.83@68@128@1.88@NA@TIMM23B_2@0@0@0@:translocase of inner mitochondrial membrane 23 homolog B (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process@NA
F13349@96932@96937@deletion@6@51965743@51978390@10@chr10:51965743-51978390@11.8@162@81@0.5@NA@ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
F13349@101605@101614@deletion@10@124341310@124353114@10@chr10:124341310-124353114@33.8@927@544@0.587@CNVR4912.4, CNVR4912.3, CNVR4912.2@DMBT1_12, DMBT1_13, DMBT1_14, DMBT1_15, DMBT1_16, DMBT1_17, DMBT1_18, DMBT1_19, DMBT1_20, DMBT1_21@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
F13349@102268@102270@duplication@3@135139332@135141519@10@chr10:135139332-135141519@12.7@438@625@1.43@NA@CALY_5, CALY_4, CALY_3@0@0@0@:zinc finger protein 511:calcyon neuron-specific vesicular protein@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:cytoplasmic vesicle membrane;positive regulation of endocytosis;endocytosis;dopamine receptor binding;clathrin coat assembly;dopamine receptor signaling pathway;cytoplasmic vesicle;integral to membrane;clathrin light chain binding;integral to plasma membrane@NA
F13349@103139@103139@deletion@1@3239175@3240043@11@chr11:3239175-3240043@11.2@422@249@0.59@CNVR5028.1@MRGPRG_1@0@0@0@:MAS-related GPR, member G@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway@NA
F13349@103289@103290@deletion@2@5270599@5271034@11@chr11:5270599-5271034@11.2@63@8@0.127@NA@HBG1_2, HBG1_1@0@0@0@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
F13349@103342@103342@duplication@1@5798891@5799864@11@chr11:5798891-5799864@5.55@717@950@1.32@CNVR5049.1@OR52N5_1@0@0@0@:tripartite motif containing 5:olfactory receptor, family 52, subfamily N, member 5@:defense response to virus;Golgi apparatus;intracellular;protein trimerization;ligase activity;cytoplasm;protein binding;nucleus;protein homodimerization activity;identical protein binding;zinc ion binding;cytoplasmic mRNA processing body;protein ubiquitination;virus-host interaction:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F13349@106046@106048@deletion@3@55370918@55419315@11@chr11:55370918-55419315@8.56@2187@1588@0.726@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F13349@110109@110109@deletion@1@89531299@89531797@11@chr11:89531299-89531797@16.8@386@196@0.508@NA@TRIM49_8@0@0@0@:tripartite motif containing 49@:protein binding;intracellular;DNA binding;zinc ion binding@NA
F13349@110126@110126@duplication@1@89774220@89774718@11@chr11:89774220-89774718@9.9@285@434@1.52@NA@TRIM49C_8@0@0@0@:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;DNA binding;zinc ion binding@NA
F13349@110853@110853@duplication@1@107650220@107650492@11@chr11:107650220-107650492@5.49@88@144@1.64@NA@AP001024.1_1, AP001024.1_2@0@0@0@NA@NA@NA
F13349@114424@114426@deletion@3@10583717@10586541@12@chr12:10583717-10586541@20.4@437@237@0.542@CNVR5430.1@KLRC2_6, KLRC2_5, KLRC2_4@0@0@0@:killer cell lectin-like receptor subfamily C, member 2@:carbohydrate binding:transmembrane signaling receptor activity;carbohydrate binding;protein binding;signal transduction;cellular defense response;integral to plasma membrane@NA
F13349@114483@114483@deletion@1@11243900@11244828@12@chr12:11243900-11244828@6.68@1039@721@0.694@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
F13349@114493@114496@deletion@4@11506042@11508487@12@chr12:11506042-11508487@23.5@601@340@0.566@CNVR5435.2, CNVR5435.1@PRB1_4, PRB1_3, PRB1_2, PRB1_1@0@0@0@:proline-rich protein BstNI subfamily 1@NA@NA
F13349@118879@118900@duplication@22@63954293@64062173@12@chr12:63954293-64062173@49.6@2494@3446@1.38@CNVR5566.1@DPY19L2_22, DPY19L2_21, DPY19L2_20, DPY19L2_19, DPY19L2_18, DPY19L2_17, DPY19L2_16, DPY19L2_15, DPY19L2_14, DPY19L2_13, DPY19L2_12, DPY19L2_11, DPY19L2_10, DPY19L2_9, DPY19L2_8, DPY19L2_7, DPY19L2_6, DPY19L2_5, DPY19L2_4, DPY19L2_3, DPY19L2_2, DPY19L2_1@0@0@0@:dpy-19-like 2 (C. elegans)@:spermatid development;multicellular organismal development;integral to membrane@: SPERMATOGENIC FAILURE 9; SPGF9
F13349@123374@123374@duplication@1@124496693@124497477@12@chr12:124496693-124497477@9.06@653@910@1.39@CNVR5712.1@ZNF664_6@0@0@0@:zinc finger protein 664@:intracellular;nucleus;DNA binding;molecular_function;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;biological_process@NA
F13349@123874@123875@duplication@2@133362926@133363373@12@chr12:133362926-133363373@10@351@502@1.43@NA@GOLGA3_15, GOLGA3_14@0@0@0@:polymerase (DNA directed), epsilon, catalytic subunit:golgin A3@:nucleoplasm;telomere maintenance via semi-conservative replication;S phase of mitotic cell cycle;mitotic cell cycle;DNA binding;nucleobase-containing compound metabolic process;G1/S transition of mitotic cell cycle;DNA replication initiation;DNA repair;nucleus;telomere maintenance;DNA-directed DNA polymerase activity;4 iron, 4 sulfur cluster binding;telomere maintenance via recombination;in utero embryonic development;DNA synthesis involved in DNA repair;nucleotide binding;nucleotide-excision repair;M/G1 transition of mitotic cell cycle;chromatin binding;base-excision repair, gap-filling;transcription-coupled nucleotide-excision repair;epsilon DNA polymerase complex;zinc ion binding;DNA replication;nucleic acid binding;nucleotide-excision repair, DNA gap filling:endoplasmic reticulum-Golgi intermediate compartment;Golgi apparatus;transporter activity;intra-Golgi vesicle-mediated transport;Golgi transport complex;Golgi membrane;Golgi cisterna membrane;protein binding;nucleus@NA
F13349@127333@127335@duplication@3@19553418@19559164@14@chr14:19553418-19559164@14.2@85@193@2.27@CNVR6072.1@POTEG_1, POTEG_2, POTEG_3@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
F13349@127353@127358@duplication@6@20215588@20404761@14@chr14:20215588-20404761@144@8959@14263@1.59@CNVR6072.12, CNVR6072.4, CNVR6072.5@OR4Q3_1, OR4M1_1, OR4N2_1, OR4K2_1, OR4K5_1, OR4K1_1@0@0@0@:olfactory receptor, family 4, subfamily N, member 2:olfactory receptor, family 4, subfamily Q, member 3:olfactory receptor, family 4, subfamily M, member 1:olfactory receptor, family 4, subfamily K, member 2:olfactory receptor, family 4, subfamily K, member 5:olfactory receptor, family 4, subfamily K, member 1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F13349@133450@133451@duplication@2@106725202@106725654@14@chr14:106725202-106725654@6.29@833@1087@1.3@CNVR6294.48, CNVR6294.24, CNVR6294.40, CNVR6294.38, CNVR6294.17, CNVR6294.23@IGHV3-23_2, IGHV3-23_1@0@0@0@@:protein binding@NA
F13349@133457@133459@deletion@3@106780901@106791456@14@chr14:106780901-106791456@23.9@692@368@0.532@CNVR6294.48, CNVR6294.24, CNVR6294.40, CNVR6294.38, CNVR6294.17, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV4-28_1, IGHV3-30_2, IGHV3-30_1@0@0@0@:uncharacterized LOC100653243;uncharacterized LOC642131@:protein binding:protein binding@NA
F13349@133472@133473@duplication@2@106926189@106926644@14@chr14:106926189-106926644@10@620@849@1.37@CNVR6294.56, CNVR6294.1@IGHV3-43_2, IGHV3-43_1@0@0@0@@:protein binding@NA
F13349@133491@133492@deletion@2@107095127@107095561@14@chr14:107095127-107095561@14.6@83@11@0.133@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61_2, IGHV4-61_1@0@0@0@@:protein binding@NA
F13349@133495@133495@deletion@1@107131034@107131334@14@chr14:107131034-107131334@5.12@206@129@0.626@CNVR6294.56, CNVR6294.16@IGHV3-66_2@0@0@0@@:protein binding@NA
F13349@133542@133542@deletion@1@22382474@22383423@15@chr15:22382474-22383423@41.9@913@370@0.405@CNVR6297.4, CNVR6297.17, CNVR6297.2@OR4N4_1@0@0@0@:olfactory receptor, family 4, subfamily N, member 4@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F13349@134010@134011@duplication@2@30663302@30664544@15@chr15:30663302-30664544@7.74@183@275@1.5@CNVR6337.1@CHRFAM7A_8, CHRFAM7A_7@0@0@0@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
F13349@134024@134024@duplication@1@30700112@30700195@15@chr15:30700112-30700195@8.45@226@345@1.53@NA@GOLGA8R_11@0@0@0@@:Golgi apparatus@NA
F13349@134155@134156@deletion@2@32451771@32455536@15@chr15:32451771-32455536@6.01@33@4@0.121@CNVR6345.2, CNVR6345.1@CHRNA7_8, CHRNA7_9@0@0@0@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
F13349@139803@139804@deletion@2@90176052@90176497@15@chr15:90176052-90176497@5.66@194@121@0.624@NA@KIF7_14, KIF7_13@0@0@0@:kinesin family member 7@:negative regulation of smoothened signaling pathway;microtubule motor activity;microtubule associated complex;cilium;ATP binding;positive regulation of smoothened signaling pathway;protein binding;microtubule-based movement;microtubule@: PALLISTER-HALL SYNDROME; PHS; ACROCALLOSAL SYNDROME; ACLS; BARDET-BIEDL SYNDROME; BBS; HYDROLETHALUS SYNDROME 2; HLS2
F13349@140317@140317@duplication@1@100348377@100348507@15@chr15:100348377-100348507@8.87@39@104@2.67@CNVR6545.2@CTD-2054N24.2_2@0@0@0@NA@NA@NA
F13349@143267@143267@duplication@1@20491896@20492022@16@chr16:20491896-20492022@5.97@192@281@1.46@NA@ACSM2A_11@0@0@0@:acyl-CoA synthetase medium-chain family member 2A@:mitochondrion;butyrate-CoA ligase activity;catalytic activity;ATP binding;glucose homeostasis;medium-chain fatty-acyl-CoA metabolic process;fatty acid metabolic process;triglyceride homeostasis;metabolic process;mitochondrial matrix;metal ion binding@NA
F13349@143482@143483@duplication@2@21763691@21764445@16@chr16:21763691-21764445@5.23@89@143@1.61@CNVR6668.5, CNVR6668.2, CNVR6668.7@OTOA_25, OTOA_26@0@0@0@:otoancorin@:proteinaceous extracellular matrix;apical plasma membrane;sensory perception of sound;anchored to membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22
F13349@144268@144268@duplication@1@29370587@29370656@16@chr16:29370587-29370656@4.76@96@149@1.55@NA@SNX29P2_3@0@0@0@NA@NA@NA
F13349@145564@145564@deletion@1@55866917@55866967@16@chr16:55866917-55866967@19.7@114@14@0.123@NA@CES1_1@0@0@0@:carboxylesterase 1;liver carboxylesterase 1-like@:hydrolase activity;methyl salicylate esterase activity;response to toxin;methylumbelliferyl-acetate deacetylase activity;endoplasmic reticulum lumen;retinyl-palmitate esterase activity;methyl jasmonate esterase activity;metabolic process;carboxylesterase activity;methyl indole-3-acetate esterase activity@: CARBOXYLESTERASE 1; CES1
F13349@147100@147101@deletion@2@69997478@70010635@16@chr16:69997478-70010635@14@65@1@0.0154@CNVR6762.3, CNVR6762.1@CLEC18A_12, RP11-419C5.2_7@0@0@0@:C-type lectin domain family 18, member A@:carbohydrate binding;protein binding;extracellular region@NA
F13349@147111@147111@duplication@1@70162863@70163025@16@chr16:70162863-70163025@7.51@445@621@1.4@CNVR6764.1, CNVR6764.3@PDPR_6@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
F13349@147127@147127@duplication@1@70211145@70211383@16@chr16:70211145-70211383@8.37@54@121@2.24@CNVR6764.1@CLEC18C_3@0@0@0@:C-type lectin domain family 18, member C@:carbohydrate binding;protein binding;extracellular region@NA
F13349@147135@147135@deletion@1@70219789@70219879@16@chr16:70219789-70219879@9.41@55@8@0.145@CNVR6764.1, CNVR6764.5@CLEC18C_11@0@0@0@:C-type lectin domain family 18, member C@:carbohydrate binding;protein binding;extracellular region@NA
F13349@147513@147513@deletion@1@74451958@74452196@16@chr16:74451958-74452196@11.6@60@5@0.0833@CNVR6778.2, CNVR6778.3@CLEC18B_3@0@0@0@:C-type lectin domain family 18, member B@:carbohydrate binding;protein binding;extracellular region@NA
F13349@151958@151959@deletion@2@18996506@18997166@17@chr17:18996506-18997166@10.4@218@115@0.528@CNVR7018.4, CNVR7018.2, CNVR7018.6@AC007952.5_1, AC007952.5_2@0@0@0@NA@NA@NA
F13349@152122@152127@deletion@6@20353287@20356920@17@chr17:20353287-20356920@45.7@250@27@0.108@CNVR7021.1, CNVR7021.3@LGALS9B_11, LGALS9B_10, LGALS9B_9, LGALS9B_8, LGALS9B_7, LGALS9B_6@0@0@0@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
F13349@153378@153381@duplication@4@34523998@34539971@17@chr17:34523998-34539971@10.2@38@110@2.89@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL3L3_1, CCL4L1_1, CCL4L1_2, CCL4L1_3@0@0@0@:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
F13349@153395@153400@deletion@6@34624260@34641537@17@chr17:34624260-34641537@36.7@172@1@0.00581@CNVR7077.1, CNVR7077.2, CNVR7077.12@CCL3L1_3, CCL3L1_2, CCL3L1_1, CCL4L2_1, CCL4L2_2, CCL4L2_3@0@0@0@:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
F13349@153650@153659@duplication@10@36351930@36375177@17@chr17:36351930-36375177@133@4231@6747@1.59@CNVR7083.3@RP11-1407O15.2_12, RP11-1407O15.2_11, RP11-1407O15.2_10, RP11-1407O15.2_9, RP11-1407O15.2_8, RP11-1407O15.2_7, RP11-1407O15.2_6, RP11-1407O15.2_5, RP11-1407O15.2_4, RP11-1407O15.2_3@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
F13349@154346@154346@deletion@1@39421631@39422112@17@chr17:39421631-39422112@7.89@53@12@0.226@CNVR7096.1@KRTAP9-6_1@0@0@0@:keratin associated protein 9-6@:keratin filament@NA
F13349@155580@155608@duplication@29@44171927@44627885@17@chr17:44171927-44627885@40.1@2776@3903@1.41@CNVR7114.3, CNVR7114.2@KANSL1_3, KANSL1_2, LRRC37A_1, LRRC37A_2, LRRC37A_3, LRRC37A_4, LRRC37A_5, LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9, LRRC37A_10, LRRC37A_11, LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2, LRRC37A2_3, LRRC37A2_4, LRRC37A2_5, LRRC37A2_6, LRRC37A2_7, LRRC37A2_8, LRRC37A2_9, LRRC37A2_10, LRRC37A2_11@0@0@0@:KAT8 regulatory NSL complex subunit 1:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:histone acetyltransferase activity (H4-K8 specific);histone acetyltransferase activity (H4-K16 specific);histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase complex;histone H4-K5 acetylation;MLL1 complex;histone H4-K16 acetylation;protein binding;histone H4-K8 acetylation;nucleus:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
F13349@162017@162018@deletion@2@44542732@44550298@18@chr18:44542732-44550298@9.65@43@0@0@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
F13349@166811@166812@deletion@2@14070580@14070881@19@chr19:14070580-14070881@6.81@407@271@0.666@NA@DCAF15_9, DCAF15_10@0@0@0@:DDB1 and CUL4 associated factor 15@:protein ubiquitination@NA
F13349@166916@166917@duplication@2@14508471@14508747@19@chr19:14508471-14508747@5.66@101@159@1.57@NA@CD97_7, CD97_8@0@0@0@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
F13349@167047@167047@duplication@1@14877791@14877921@19@chr19:14877791-14877921@5.43@104@164@1.58@NA@EMR2_6@0@0@0@:egf-like module containing, mucin-like, hormone receptor-like 2@:transmembrane signaling receptor activity;inflammatory response;G-protein coupled receptor activity;ruffle membrane;integral to membrane;plasma membrane;cell surface receptor signaling pathway;neuropeptide signaling pathway;granulocyte chemotaxis;cell migration;leading edge membrane;G-protein coupled receptor signaling pathway;protein binding;cell adhesion;membrane;calcium ion binding;chondroitin sulfate binding@NA
F13349@168952@168952@duplication@1@35862263@35863302@19@chr19:35862263-35863302@5.45@156@231@1.48@CNVR7627.1@GPR42_2@0@0@0@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
F13349@170099@170100@deletion@2@40380120@40382826@19@chr19:40380120-40382826@6.39@29@0@0@CNVR7639.2@FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F13349@170358@170366@duplication@9@41349702@41356331@19@chr19:41349702-41356331@55.8@1558@2333@1.5@CNVR7642.1@CYP2A6_9, CYP2A6_8, CYP2A6_7, CYP2A6_6, CYP2A6_5, CYP2A6_4, CYP2A6_3, CYP2A6_2, CYP2A6_1@0@0@0@:cytochrome P450, family 2, subfamily A, polypeptide 6@:coumarin 7-hydroxylase activity;steroid metabolic process;oxidation-reduction process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;endoplasmic reticulum membrane;drug metabolic process;electron carrier activity;small molecule metabolic process;exogenous drug catabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;enzyme binding;heme binding;xenobiotic metabolic process;iron ion binding;coumarin catabolic process;coumarin metabolic process@: CYTOCHROME P450, SUBFAMILY IIA, POLYPEPTIDE 6; CYP2A6
F13349@170836@170836@duplication@1@43864418@43864425@19@chr19:43864418-43864425@7.49@267@389@1.46@NA@CD177_7@0@0@0@@:blood coagulation;plasma membrane;anchored to membrane;leukocyte migration@NA
F13349@172565@172566@duplication@2@50463395@50464192@19@chr19:50463395-50464192@21.5@603@971@1.61@NA@SIGLEC11_3, SIGLEC11_2@0@0@0@:sialic acid binding Ig-like lectin 11@:carbohydrate binding;protein binding;integral to membrane;cell adhesion@NA
F13349@172987@172987@duplication@1@52133087@52133469@19@chr19:52133087-52133469@11.6@53@142@2.68@CNVR7702.1@SIGLEC5_2, SIGLEC5_2@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion@NA
F13349@172989@172994@deletion@6@52146609@52149893@19@chr19:52146609-52149893@26.7@515@282@0.548@CNVR7702.1@SIGLEC14_7, SIGLEC14_6, SIGLEC14_5, SIGLEC14_4, SIGLEC14_3, SIGLEC14_2@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 14@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion;plasma membrane@NA
F13349@173296@173297@deletion@2@54724956@54726002@19@chr19:54724956-54726002@7.64@60@18@0.3@CNVR7721.3, CNVR7721.4@LILRB3_5, LILRB3_4@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F13349@173467@173474@duplication@8@55263102@55290114@19@chr19:55263102-55290114@18.6@1162@1573@1.35@CNVR7725.2, CNVR7725.1@KIR2DL3_6, KIR2DL3_7, KIR2DL3_8, KIR2DL1_1, KIR2DL1_2, KIR2DL1_3, KIR2DL1_4, KIR2DL1_5@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
F13349@173490@173496@deletion@7@55336484@55349330@19@chr19:55336484-55349330@23.9@838@519@0.619@CNVR7725.1, CNVR7725.6@KIR3DL1_6, KIR3DL1_7, KIR3DL1_8, KIR3DL1_9, KIR2DS4_1, KIR2DS4_2, KIR2DS4_3@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
F13349@173843@173844@duplication@2@56273965@56283456@19@chr19:56273965-56283456@13.5@989@1353@1.37@CNVR7734.1@RFPL4A_3, CTD-2611O12.2_2@0@0@0@:ret finger protein-like 4A;ret finger protein-like 4A-like:ret finger protein-like 4A-like@:protein binding;zinc ion binding:protein binding;zinc ion binding@NA
F13349@174395@174395@deletion@1@1569207@1569278@20@chr20:1569207-1569278@9.05@44@2@0.0455@CNVR7763.1@RP4-576H24.4_1@0@0@0@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
F13349@174403@174403@duplication@1@1895746@1896101@20@chr20:1895746-1896101@4.77@200@281@1.4@CNVR7764.2@SIRPA_2@0@0@0@:signal-regulatory protein alpha@:blood coagulation;protein binding;integral to membrane;SH3 domain binding;cell adhesion;plasma membrane;membrane;leukocyte migration@NA
F13349@178074@178074@duplication@1@55099866@55100113@20@chr20:55099866-55100113@5.72@276@386@1.4@NA@FAM209A_1@0@0@0@:glucosaminyl (N-acetyl) transferase family member 7:family with sequence similarity 209, member A@:integral to membrane;protein glycosylation;acetylglucosaminyltransferase activity;Golgi membrane;membrane:integral to membrane@NA
F13349@178985@179000@deletion@16@10862623@10944787@21@chr21:10862623-10944787@119@6120@3797@0.62@CNVR7947.10, CNVR7947.6, CNVR7947.11@IGHV1OR21-1_1, IGHV1OR21-1_2, TPTE_24, TPTE_23, TPTE_22, TPTE_21, TPTE_20, TPTE_19, TPTE_18, TPTE_17, TPTE_16, TPTE_15, TPTE_14, TPTE_13, TPTE_12, TPTE_11@0@0@0@:transmembrane phosphatase with tensin homology@:protein binding;extracellular region:phosphatase activity;ion channel activity;protein tyrosine phosphatase activity;ion transport;protein dephosphorylation;transmembrane transport;protein binding;signal transduction;integral to membrane;protein tyrosine/serine/threonine phosphatase activity;dephosphorylation;membrane;peptidyl-tyrosine dephosphorylation@NA
F13349@180976@180976@duplication@1@16287255@16287885@22@chr22:16287255-16287885@6.73@75@137@1.83@CNVR8071.2, CNVR8071.3, CNVR8071.9@POTEH_1@0@0@0@:POTE ankyrin domain family, member H@:protein binding@NA
F13349@182981@182981@deletion@1@32827335@32827401@22@chr22:32827335-32827401@10.8@159@73@0.459@NA@BPIFC_12@0@0@0@:BPI fold containing family C@:lipid binding;phospholipid binding;extracellular region;lipopolysaccharide binding@NA
F13349@184153@184154@deletion@2@42536567@42537296@22@chr22:42536567-42537296@7.65@185@106@0.573@CNVR8168.1, CNVR8168.3, CNVR8168.4@CYP2D7P1_4, CYP2D7P1_3@0@0@0@@:oxidation-reduction process;electron carrier activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;heme binding@NA
F13349@4072@4073@deletion@2@101615523@101615773@X@chrX:101615523-101615773@4.97@162@103@0.636@NA@NXF2B_34, NXF2B_33@0@0@0@NA@NA@NA
F13349@5495@5495@duplication@1@134988571@134988710@X@chrX:134988571-134988710@14.2@404@604@1.5@NA@SAGE1_7@0@0@0@NA@NA@NA
F13349@5719@5719@deletion@1@140336520@140336590@X@chrX:140336520-140336590@7@172@101@0.587@CNVR8456.1@SPANXC_1@0@0@0@NA@NA@NA
F98212@6@7@duplication@2@69092@139309@1@chr1:69092-139309@8.32@63@130@2.06@CNVR1.2@OR4F5_1, AL627309.1_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F98212@405@427@duplication@23@1580488@1636464@1@chr1:1580488-1636464@63.6@2765@3875@1.4@CNVR17.1@CDK11B_7, CDK11B_6, CDK11B_5, CDK11B_4, CDK11B_3, CDK11B_2, CDK11B_1, SLC35E2B_10, SLC35E2B_9, SLC35E2B_8, SLC35E2B_7, SLC35E2B_6, SLC35E2B_5, SLC35E2B_4, SLC35E2B_3, CDK11A_20, CDK11A_19, CDK11A_18, CDK11A_17, CDK11A_16, CDK11A_15, CDK11A_14, CDK11A_13@0@0@0@:cyclin-dependent kinase 11B:solute carrier family 35, member E2B:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;protein tyrosine kinase activity;protein phosphorylation;protein kinase activity;cell division;transferase activity, transferring phosphorus-containing groups;ATP binding:integral to membrane;membrane;transmembrane transport:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
F98212@1185@1185@duplication@1@9107670@9107793@1@chr1:9107670-9107793@8.39@440@622@1.41@NA@SLC2A5_4@0@0@0@:solute carrier family 2 (facilitated glucose/fructose transporter), member 5@:glucose transport;substrate-specific transmembrane transporter activity;small molecule metabolic process;glucose transmembrane transporter activity;fructose transport;carbohydrate metabolic process;transmembrane transport;integral to membrane;transmembrane transporter activity;plasma membrane;hexose transport;fructose transmembrane transporter activity;membrane@NA
F98212@2170@2186@duplication@17@17248515@17273486@1@chr1:17248515-17273486@22@2181@2835@1.3@CNVR94.4, CNVR94.5@CROCC_1, CROCC_2, CROCC_3, CROCC_4, CROCC_5, CROCC_6, CROCC_7, CROCC_8, CROCC_9, CROCC_10, CROCC_11, CROCC_12, CROCC_13, CROCC_14, CROCC_15, CROCC_16, CROCC_17@0@0@0@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
F98212@2788@2788@deletion@1@21806545@21806716@1@chr1:21806545-21806716@8.19@43@4@0.093@CNVR107.2, CNVR107.1@NBPF3_11@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 3@:cytoplasm@NA
F98212@2972@2972@duplication@1@22338944@22338960@1@chr1:22338944-22338960@5.3@80@133@1.66@CNVR108.2, CNVR108.1@CELA3A_8@0@0@0@:chymotrypsin-like elastase family, member 3A@:proteolysis;digestion;cholesterol metabolic process;catalytic activity;serine-type endopeptidase activity@NA
F98212@3333@3339@duplication@7@25599040@25633220@1@chr1:25599040-25633220@27.1@1370@1873@1.37@CNVR116.1, CNVR116.2@RHD_1, RHD_2, RHD_3, RHD_4, RHD_5, RHD_6, RHD_7@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
F98212@8507@8507@deletion@1@89476588@89476799@1@chr1:89476588-89476799@4.67@438@300@0.685@CNVR244.1@GBP3_8@0@0@0@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
F98212@9365@9374@deletion@10@104202983@104234232@1@chr1:104202983-104234232@36.9@169@0@0@CNVR266.3, CNVR266.1, CNVR266.15@AMY1A_7, AMY1A_8, AMY1A_9, AMY1A_10, AMY1A_11, AMY1B_11, AMY1B_10, AMY1B_9, AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
F98212@9766@9773@deletion@8@110230497@110235917@1@chr1:110230497-110235917@107@496@3@0.00605@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
F98212@11342@11357@deletion@16@148009345@148025848@1@chr1:148009345-148025848@12.2@58@2@0.0345@CNVR346.2, CNVR346.4@NBPF14_16, NBPF14_15, NBPF14_14, NBPF14_13, NBPF14_12, NBPF14_11, NBPF14_10, NBPF14_9, NBPF14_8, NBPF14_7, NBPF14_6, NBPF14_5, NBPF14_4, NBPF14_3, NBPF14_2, NBPF14_1@0@0@0@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
F98212@12117@12118@duplication@2@152573209@152586574@1@chr1:152573209-152586574@16.5@158@303@1.92@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
F98212@12842@12846@duplication@5@155580217@155581618@1@chr1:155580217-155581618@8.1@371@506@1.36@NA@MSTO1_2, MSTO1_3, MSTO1_4, MSTO1_5, MSTO1_6@0@0@0@:misato homolog 1 (Drosophila)@:mitochondrial outer membrane;protein polymerization;mitochondrion distribution;mitochondrion organization;molecular_function;protein complex;cytoplasm@NA
F98212@14056@14056@duplication@1@161599569@161599825@1@chr1:161599569-161599825@5.18@116@178@1.53@CNVR383.1@FCGR3B_3@0@0@0@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIIb, receptor (CD16b)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction:IgG binding;protein binding;extracellular region;immune response;plasma membrane;anchored to membrane@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
F98212@16029@16040@duplication@12@196744018@196801129@1@chr1:196744018-196801129@91.3@2351@3629@1.54@CNVR459.1@CFHR3_1, CFHR3_2, CFHR3_3, CFHR3_4, CFHR3_5, CFHR3_6, CFHR1_1, CFHR1_2, CFHR1_3, CFHR1_4, CFHR1_5, CFHR1_6@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
F98212@24562@24562@deletion@1@85570366@85570504@2@chr2:85570366-85570504@5.99@169@99@0.586@NA@RETSAT_11@0@0@0@:retinol saturase (all-trans-retinol 13,14-reductase)@:all-trans-retinol 13,14-reductase activity;nuclear membrane;oxidation-reduction process;oxidoreductase activity;retinol metabolic process;endoplasmic reticulum membrane;nuclear outer membrane@NA
F98212@25137@25138@deletion@2@96697782@96698107@2@chr2:96697782-96698107@12.4@166@76@0.458@NA@GPAT2_4, GPAT2_3@0@0@0@:glycerol-3-phosphate acyltransferase 2, mitochondrial@:glycerol-3-phosphate O-acyltransferase activity;mitochondrion;phospholipid metabolic process;triglyceride biosynthetic process;glycerophospholipid biosynthetic process;small molecule metabolic process;transferase activity, transferring acyl groups;mitochondrial outer membrane;phosphatidic acid biosynthetic process;integral to membrane;glycerol-3-phosphate metabolic process;CDP-diacylglycerol biosynthetic process;membrane;metabolic process;phospholipid biosynthetic process@NA
F98212@25350@25351@deletion@2@97818242@97820478@2@chr2:97818242-97820478@13.9@306@167@0.546@CNVR886.2@ANKRD36_14, ANKRD36_15@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
F98212@26583@26584@deletion@2@114256835@114386290@2@chr2:114256835-114386290@5.38@67@31@0.463@NA@FOXD4L1_1, RABL2A_2@0@0@0@:forkhead box D4-like 1:RAB, member of RAS oncogene family-like 2A@:positive regulation of BMP signaling pathway;positive regulation of kidney development;axon extension involved in axon guidance;lateral line nerve glial cell development;DNA binding, bending;sequence-specific DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;regulation of sequence-specific DNA binding transcription factor activity;transcription factor complex;nucleus;dichotomous subdivision of terminal units involved in ureteric bud branching;sympathetic nervous system development;melanocyte differentiation;enteric nervous system development;positive regulation of transcription from RNA polymerase II promoter;regulation of transcription, DNA-dependent;neural crest cell migration;peripheral nervous system development;double-stranded DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity;iridophore differentiation;transcription factor binding;cartilage development;pattern specification process:intracellular;small GTPase mediated signal transduction;GTPase activity;GTP catabolic process;cytoplasm;intracellular protein transport;signal transduction;nucleocytoplasmic transport;protein transport;GTP binding;nucleus;membrane@NA
F98212@27161@27163@deletion@3@130831818@130843568@2@chr2:130831818-130843568@5.72@105@56@0.533@NA@POTEF_15, POTEF_14, POTEF_13@0@0@0@:POTE ankyrin domain family, member F@:cell cortex;protein binding;ATP binding@NA
F98212@27180@27181@deletion@2@130898732@130899954@2@chr2:130898732-130899954@19.4@279@134@0.48@NA@CCDC74B_4, CCDC74B_3@0@0@0@:coiled-coil domain containing 74A;coiled-coil domain containing 74B@NA@NA
F98212@27342@27342@duplication@1@132289238@132289375@2@chr2:132289238-132289375@8.89@77@154@2@NA@CCDC74A_4@0@0@0@:coiled-coil domain containing 74A@NA@NA
F98212@47649@47649@duplication@1@42088100@42088143@4@chr4:42088100-42088143@5.77@214@307@1.43@NA@SLC30A9_18@0@0@0@:solute carrier family 30 (zinc transporter), member 9@:cation transmembrane transporter activity;zinc ion transport;cation transport;sequence-specific DNA binding transcription factor activity;nucleotide binding;nucleotide-excision repair;transmembrane transport;chromatin binding;ligand-dependent nuclear receptor binding;integral to membrane;nucleus;cytoskeleton;transcription, DNA-dependent;ligand-dependent nuclear receptor transcription coactivator activity;positive regulation of transcription from RNA polymerase II promoter@NA
F98212@48593@48597@duplication@5@70148233@70160527@4@chr4:70148233-70160527@12.3@716@968@1.35@CNVR1957.2, CNVR1957.1@UGT2B28_2, UGT2B28_3, UGT2B28_4, UGT2B28_5, UGT2B28_6@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
F98212@51672@51672@duplication@1@145041644@145041741@4@chr4:145041644-145041741@11.5@152@272@1.79@NA@GYPA_2@0@0@0@:glycophorin B (MNS blood group):glycophorin A (MNS blood group)@:integral to membrane;plasma membrane;integral to plasma membrane:external side of plasma membrane;integral to membrane;cytoskeletal anchoring at plasma membrane;plasma membrane;molecular_function;protein homodimerization activity;integral to plasma membrane;cellular_component;identical protein binding;membrane;biological_process;regulation of response to osmotic stress;virus-host interaction@: BLOOD GROUP--Ss LOCUS; Ss: MALARIA, SUSCEPTIBILITY TO; BLOOD GROUP--MN LOCUS; MN
F98212@53309@53309@deletion@1@751249@751372@5@chr5:751249-751372@6.59@31@1@0.0323@CNVR2280.3@ZDHHC11B_4@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
F98212@55806@55806@deletion@1@69372349@69372398@5@chr5:69372349-69372398@33.1@156@0@0@CNVR2494.48, CNVR2494.39, CNVR2494.15, CNVR2494.18, CNVR2494.26, CNVR2494.43, CNVR2494.52, CNVR2494.28, CNVR2494.2, CNVR2494.36@SMN2_8@0@0@0@:survival of motor neuron 2, centromeric;survival of motor neuron 1, telomeric@:nucleoplasm;ncRNA metabolic process;Cajal body;RNA metabolic process;spliceosomal complex;cytoplasm;cytosol;protein binding;cell death;spliceosomal complex assembly;RNA binding;mRNA processing;nucleus;gene expression;spliceosomal snRNP assembly@: SPINAL MUSCULAR ATROPHY, TYPE II; SMA2; SPINAL MUSCULAR ATROPHY, TYPE I; SMA1; SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4; SPINAL MUSCULAR ATROPHY, TYPE III; SMA3
F98212@55830@55831@deletion@2@70307103@70308742@5@chr5:70307103-70308742@27.7@886@493@0.556@CNVR2494.41, CNVR2494.14, CNVR2494.30, CNVR2494.20, CNVR2494.62, CNVR2494.8, CNVR2494.35@NAIP_5, NAIP_4@0@0@0@:baculoviral IAP repeat-containing protein 1-like;NLR family, apoptosis inhibitory protein@:negative regulation of apoptotic process;inflammatory response;basolateral plasma membrane;nucleoside-triphosphatase activity;cysteine-type endopeptidase inhibitor activity;intracellular;nucleotide binding;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;ATP binding;cytoplasm;innate immune response;protein binding;negative regulation of neuron apoptotic process;metal ion binding;nervous system development@NA
F98212@57180@57180@deletion@1@101595918@101596023@5@chr5:101595918-101596023@7.01@96@44@0.458@NA@SLCO4C1_6@0@0@0@:solute carrier organic anion transporter family, member 4C1@:multicellular organismal development;cell differentiation;transport;basolateral plasma membrane;transporter activity;transmembrane transport;spermatogenesis;sodium-independent organic anion transport;integral to membrane;plasma membrane;membrane@NA
F98212@58941@58941@duplication@1@139931568@139931769@5@chr5:139931568-139931769@5.17@184@264@1.43@NA@SRA1_3@0@0@0@:steroid receptor RNA activator 1@:cell differentiation;cell leading edge;ribonucleoprotein complex;DNA binding;cytoplasm;thyroid hormone receptor activator activity;cell proliferation;transcription coactivator activity;ligand-dependent nuclear receptor binding;transcription factor complex;apoptotic process;nucleus;transcription, DNA-dependent;ligand-dependent nuclear receptor transcription coactivator activity;positive regulation of transcription from RNA polymerase II promoter@NA
F98212@59205@59206@duplication@2@141303508@141304260@5@chr5:141303508-141304260@14.3@467@686@1.47@NA@KIAA0141_1, KIAA0141_2@0@0@0@:KIAA0141@:protein binding;mitochondrion;regulation of cysteine-type endopeptidase activity involved in apoptotic process;apoptotic process@NA
F98212@59488@59488@deletion@1@147553798@147553933@5@chr5:147553798-147553933@41.7@199@0@0@CNVR2637.2, CNVR2637.1@SPINK14_3@0@0@0@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
F98212@60876@60878@deletion@3@175388055@175392158@5@chr5:175388055-175392158@11.1@189@101@0.534@NA@THOC3_5, THOC3_4, THOC3_3@0@0@0@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
F98212@61269@61271@duplication@3@177166602@177168333@5@chr5:177166602-177168333@6.43@131@199@1.52@NA@FAM153A_8, FAM153A_7, FAM153A_6@0@0@0@:family with sequence similarity 153, member A@NA@NA
F98212@61638@61645@deletion@8@180375356@180429785@5@chr5:180375356-180429785@24.2@1454@953@0.655@CNVR2719.1@BTNL8_5, BTNL8_6, BTNL8_7, BTNL8_8, BTNL3_1, BTNL3_2, BTNL3_3, BTNL3_4@0@0@0@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
F98212@63281@63282@duplication@2@31237744@31238262@6@chr6:31237744-31238262@33.4@446@837@1.88@CNVR2838.2, CNVR2838.1@HLA-C_5, HLA-C_4@0@0@0@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
F98212@63290@63292@duplication@3@31323945@31324935@6@chr6:31323945-31324935@23.3@433@697@1.61@CNVR2841.12, CNVR2841.14, CNVR2841.8@HLA-B_3, HLA-B_2, HLA-B_1@0@0@0@:major histocompatibility complex, class I, B@:MHC class I protein complex;regulation of immune response;regulation of interleukin-12 production;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;regulation of T cell anergy;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;receptor binding;early endosome membrane;virus-host interaction;regulation of interleukin-6 production;regulation of dendritic cell differentiation;phagocytic vesicle membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO; SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1
F98212@63734@63735@duplication@2@31964607@31965088@6@chr6:31964607-31965088@5.63@12@48@4@CNVR2843.6, CNVR2843.3@C4A_29, C4A_30@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
F98212@63774@63776@duplication@3@31996471@31997115@6@chr6:31996471-31997115@5.42@302@404@1.34@CNVR2843.6, CNVR2843.5@C4B_26, C4B_27, C4B_28@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
F98212@63812@63812@deletion@1@32012784@32012996@6@chr6:32012784-32012996@6.84@138@74@0.536@CNVR2843.6, CNVR2843.5@TNXB_1@0@0@0@:tenascin-X-like;tenascin XB@:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
F98212@63953@63974@duplication@22@32485517@32634384@6@chr6:32485517-32634384@338@2537@5850@2.31@CNVR2845.21, CNVR2845.25, CNVR2845.24@HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2, HLA-DRB5_1, HLA-DRB1_5, HLA-DRB1_4, HLA-DRB1_3, HLA-DRB1_2, HLA-DRB1_1, HLA-DQA1_1, HLA-DQA1_2, HLA-DQA1_3, HLA-DQA1_4, HLA-DQB1_5, HLA-DQB1_4, HLA-DQB1_3, HLA-DQB1_2, HLA-DQB1_1@0@0@0@:major histocompatibility complex, class II, DR beta 5:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
F98212@64602@64603@duplication@2@35754776@35755787@6@chr6:35754776-35755787@7.22@681@894@1.31@CNVR2861.1@CLPSL1_2, CLPSL1_3@0@0@0@:colipase-like 1@:extracellular region;enzyme activator activity;digestion;lipid catabolic process@NA
F98212@71030@71030@deletion@1@167790035@167790192@6@chr6:167790035-167790192@8.38@42@3@0.0714@NA@TCP10_5@0@0@0@:t-complex 10@:cytosol@NA
F98212@71032@71032@deletion@1@167794610@167794824@6@chr6:167794610-167794824@7.3@45@8@0.178@NA@TCP10_3@0@0@0@:t-complex 10@:cytosol@NA
F98212@71762@71763@deletion@2@5977390@5978460@7@chr7:5977390-5978460@4.92@30@6@0.2@NA@RSPH10B_16, RSPH10B_15@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F98212@71775@71776@deletion@2@6005269@6006747@7@chr7:6005269-6006747@7.48@196@113@0.577@NA@RSPH10B_3, RSPH10B_2@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F98212@71941@71944@duplication@4@6838856@6844686@7@chr7:6838856-6844686@10.1@159@257@1.62@NA@CCZ1B_15, CCZ1B_14, CCZ1B_13, CCZ1B_12@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F98212@73246@73246@deletion@1@38292982@38293030@7@chr7:38292982-38293030@11.8@194@93@0.479@CNVR3353.1@TRGJ2_1@0@0@0@NA@NA@NA
F98212@73260@73263@deletion@4@38388957@38393784@7@chr7:38388957-38393784@171@1115@144@0.129@CNVR3354.3, CNVR3354.1@TRGV5_2, TRGV5_1, TRGV4_2, TRGV4_1@0@0@0@@:protein binding:protein binding@NA
F98212@73265@73265@deletion@1@38398539@38398580@7@chr7:38398539-38398580@13.5@168@69@0.411@CNVR3354.1@TRGV3_1@0@0@0@@:protein binding;immune response;peptide antigen binding;plasma membrane;MHC protein binding@NA
F98212@74246@74246@deletion@1@66660158@66660324@7@chr7:66660158-66660324@7.47@236@140@0.593@NA@TYW1_15@0@0@0@:tRNA-yW synthesizing protein 1 homolog (S. cerevisiae);tRNA-yW synthesizing protein 1 homolog B (S. cerevisiae)@:tRNA processing;4 iron, 4 sulfur cluster binding;iron-sulfur cluster binding;oxidoreductase activity;FMN binding;iron ion binding;catalytic activity@NA
F98212@74605@74607@duplication@3@74251403@74422230@7@chr7:74251403-74422230@14@46@142@3.09@NA@GTF2IRD2_2, GATSL1_1, GATSL1_2@0@0@0@:GTF2I repeat domain containing 2:GATS protein-like 1@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
F98212@74648@74648@deletion@1@74824184@74824253@7@chr7:74824184-74824253@6.54@119@62@0.521@NA@GATSL2_2@0@0@0@:GATS protein-like 2@NA@NA
F98212@74775@74775@deletion@1@76063356@76063472@7@chr7:76063356-76063472@10.1@97@34@0.351@CNVR3462.1@ZP3_5@0@0@0@:zona pellucida glycoprotein 3 (sperm receptor)@:negative regulation of transcription, DNA-dependent;manganese ion transmembrane transporter activity;intracellular protein transport;proteinaceous extracellular matrix;plasma membrane;positive regulation of acrosome reaction;outer acrosomal membrane;protein kinase C signaling cascade;manganese ion transmembrane transport;intracellular signal transduction;humoral immune response mediated by circulating immunoglobulin;negative regulation of binding of sperm to zona pellucida;positive regulation of inflammatory response;endoplasmic reticulum;signal transducer activity;perinuclear region of cytoplasm;secretory granule;positive regulation of transcription, DNA-dependent;positive regulation of ovarian follicle development;positive regulation of interferon-gamma production;carbohydrate binding;manganese ion transport;positive regulation of antral ovarian follicle growth;extracellular matrix;positive regulation of leukocyte migration;positive regulation of humoral immune response;extracellular space;blastocyst formation;integral to membrane;store-operated calcium channel activity;oocyte development;multivesicular body;phosphatidylinositol-mediated signaling;acrosomal vesicle;positive regulation of protein kinase B signaling cascade;Golgi apparatus;positive regulation of calcium ion import;positive regulation of protein kinase activity;positive regulation of acrosomal vesicle exocytosis;positive regulation of interleukin-4 production;cytoplasm;protein binding;binding of sperm to zona pellucida;positive regulation of phosphatidylinositol biosynthetic process;extracellular region;positive regulation of T cell proliferation;acrosin binding;positive regulation of type IV hypersensitivity;egg coat formation@NA
F98212@74792@74793@deletion@2@76240783@76241130@7@chr7:76240783-76241130@31.7@306@107@0.35@CNVR3463.10@POMZP3_6, POMZP3_5@0@0@0@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
F98212@75623@75626@deletion@4@94056940@94059705@7@chr7:94056940-94059705@8.22@1056@750@0.71@NA@COL1A2_49, COL1A2_50, COL1A2_51, COL1A2_52@0@0@0@:collagen, type I, alpha 2@:extracellular matrix;cellular response to amino acid stimulus;odontogenesis;collagen fibril organization;transforming growth factor beta receptor signaling pathway;extracellular space;blood coagulation;protein heterotrimerization;identical protein binding;blood vessel development;receptor binding;platelet-derived growth factor binding;platelet activation;protein binding, bridging;extracellular matrix organization;endoplasmic reticulum lumen;axon guidance;Rho protein signal transduction;SMAD binding;extracellular matrix structural constituent;collagen;protein binding;signal transduction;extracellular region;collagen type I;regulation of blood pressure;skin morphogenesis;skeletal system development;leukocyte migration@: OSTEOGENESIS IMPERFECTA, TYPE I; EHLERS-DANLOS SYNDROME, AUTOSOMAL RECESSIVE, CARDIAC VALVULAR FORM; EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL DOMINANT; OSTEOGENESIS IMPERFECTA, TYPE III; OSTEOGENESIS IMPERFECTA, TYPE IV; OSTEOGENESIS IMPERFECTA, TYPE II
F98212@76427@76432@deletion@6@100331793@100336236@7@chr7:100331793-100336236@25.7@1129@715@0.633@CNVR3509.1@ZAN_1, ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
F98212@76718@76718@duplication@1@102114809@102114982@7@chr7:102114809-102114982@5.93@37@82@2.22@CNVR3518.1@POLR2J_3@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J, 13.3kDa@:nucleoplasm;DNA binding;DNA repair;protein dimerization activity;nucleus;viral reproduction;gene expression;transcription initiation from RNA polymerase II promoter;7-methylguanosine mRNA capping;protein phosphorylation;LRR domain binding;protein kinase activity;DNA-directed RNA polymerase II, core complex;nucleotide-excision repair;transcription from RNA polymerase II promoter;DNA-directed RNA polymerase activity;protein binding;transcription-coupled nucleotide-excision repair;RNA splicing;mRNA splicing, via spliceosome;transcription, DNA-dependent;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription@NA
F98212@79073@79073@duplication@1@142144037@142144084@7@chr7:142144037-142144084@5.82@189@275@1.46@NA@TRBV6-7_1@0@0@0@NA@NA@NA
F98212@79309@79311@deletion@3@143880598@143929936@7@chr7:143880598-143929936@28.1@178@35@0.197@CNVR3598.4, CNVR3598.3, CNVR3598.7@CTAGE4_1, ARHGEF35_2, OR2A42_1@0@0@0@:CTAGE family, member 4:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1@:integral to membrane;nucleotide binding;cellular_component;biological_process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F98212@79315@79315@deletion@1@144059764@144062916@7@chr7:144059764-144062916@8.32@191@105@0.55@CNVR3598.4, CNVR3598.5@ARHGEF5_2@0@0@0@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
F98212@79322@79323@deletion@2@144069777@144070377@7@chr7:144069777-144070377@11.1@259@146@0.564@CNVR3598.4, CNVR3598.5, CNVR3598.11@ARHGEF5_9, ARHGEF5_10@0@0@0@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
F98212@80368@80376@deletion@9@7274293@7340274@8@chr8:7274293-7340274@16.2@609@381@0.626@CNVR3771.8, CNVR3771.10, CNVR3771.4@DEFB4B_1, DEFB103B_2, DEFB103B_1, SPAG11B_3, SPAG11B_2, SPAG11B_1, DEFB104B_2, DEFB104B_1, DEFB106B_2@0@0@0@:defensin, beta 4B;defensin, beta 4A:defensin, beta 103B;defensin, beta 103A:sperm associated antigen 11B:defensin, beta 104A;defensin, beta 104B:defensin, beta 106B;defensin, beta 106A@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
F98212@80387@80388@deletion@2@7636684@7637611@8@chr8:7636684-7637611@10.2@46@0@0@CNVR3772.4, CNVR3772.6, CNVR3772.2, CNVR3772.8, CNVR3772.10@AC084121.16_4, AC084121.16_3@0@0@0@:uncharacterized LOC100133251@NA@NA
F98212@80397@80397@duplication@1@7686328@7686475@8@chr8:7686328-7686475@5.49@80@134@1.68@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@DEFB106A_2@0@0@0@:defensin, beta 106B;defensin, beta 106A@:extracellular region;defense response to bacterium@NA
F98212@88584@88599@duplication@16@43624656@43853616@9@chr9:43624656-43853616@13@599@822@1.37@CNVR4294.1@SPATA31A6_4, SPATA31A6_3, SPATA31A6_2, SPATA31A6_1, CNTNAP3B_1, CNTNAP3B_2, CNTNAP3B_3, CNTNAP3B_4, CNTNAP3B_5, CNTNAP3B_6, CNTNAP3B_7, CNTNAP3B_8, CNTNAP3B_9, CNTNAP3B_10, CNTNAP3B_11, CNTNAP3B_12@0@0@0@:SPATA31 subfamily A, member 6:contactin associated protein-like 3B;contactin associated protein-like 3@:integral to membrane:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
F98212@93566@93566@duplication@1@138441155@138441176@9@chr9:138441155-138441176@5.7@90@148@1.64@CNVR4529.1@OBP2A_6@0@0@0@:odorant binding protein 2A@:odorant binding;sensory perception of chemical stimulus;response to stimulus;transport;extracellular region;sensory perception of smell;cellular_component@NA
F98212@95346@95360@deletion@15@17813309@17908770@10@chr10:17813309-17908770@82.9@857@337@0.393@NA@TMEM236_2, TMEM236_3, TMEM236_4, MRC1L1_1, MRC1L1_2, MRC1L1_3, MRC1L1_4, MRC1L1_5, MRC1L1_6, MRC1L1_7, MRC1L1_8, MRC1L1_9, MRC1L1_10, MRC1L1_11, MRC1L1_12@0@0@0@:transmembrane protein 236;transmembrane protein 236-like:macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding@NA
F98212@95380@95394@duplication@15@18060293@18155690@10@chr10:18060293-18155690@65.4@453@1008@2.23@NA@TMEM236_2, TMEM236_3, TMEM236_4, MRC1_1, MRC1_2, MRC1_3, MRC1_4, MRC1_5, MRC1_6, MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11, MRC1_12@0@0@0@:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F98212@96280@96280@duplication@1@42924565@42924599@10@chr10:42924565-42924599@5.21@147@217@1.48@NA@CCNYL2_5@0@0@0@@:regulation of cyclin-dependent protein kinase activity;protein kinase binding@NA
F98212@96531@96531@deletion@1@47758847@47758904@10@chr10:47758847-47758904@6.04@27@0@0@CNVR4714.1@ANXA8L2_10@0@0@0@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:calcium-dependent phospholipid binding;calcium ion binding@NA
F98212@96857@96857@duplication@1@51464465@51465939@10@chr10:51464465-51465939@8.46@64@134@2.09@CNVR4729.1@AGAP7_7@0@0@0@:translocase of inner mitochondrial membrane 23 homolog B (yeast):ArfGAP with GTPase domain, ankyrin repeat and PH domain 7@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
F98212@96932@96937@deletion@6@51965743@51978390@10@chr10:51965743-51978390@11.1@195@112@0.574@NA@ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
F98212@103139@103139@deletion@1@3239175@3240043@11@chr11:3239175-3240043@17.7@534@288@0.539@CNVR5028.1@MRGPRG_1@0@0@0@:MAS-related GPR, member G@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway@NA
F98212@103269@103269@duplication@1@4976003@4976943@11@chr11:4976003-4976943@9.42@712@990@1.39@CNVR5040.1@OR51A2_1@0@0@0@:matrix metallopeptidase 26:olfactory receptor, family 51, subfamily A, member 2@:metallopeptidase activity;extracellular matrix;proteolysis;proteinaceous extracellular matrix;collagen catabolic process;metalloendopeptidase activity;zinc ion binding;metabolic process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F98212@103289@103289@duplication@1@5270599@5270820@11@chr11:5270599-5270820@4.6@75@122@1.63@NA@HBG1_2@0@0@0@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
F98212@103342@103342@duplication@1@5798891@5799864@11@chr11:5798891-5799864@7.93@893@1206@1.35@CNVR5049.1@OR52N5_1@0@0@0@:tripartite motif containing 5:olfactory receptor, family 52, subfamily N, member 5@:defense response to virus;Golgi apparatus;intracellular;protein trimerization;ligase activity;cytoplasm;protein binding;nucleus;protein homodimerization activity;identical protein binding;zinc ion binding;cytoplasmic mRNA processing body;protein ubiquitination;virus-host interaction:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F98212@103620@103620@deletion@1@7817522@7818489@11@chr11:7817522-7818489@32@1294@653@0.505@CNVR5059.1@OR5P2_1@0@0@0@:olfactory receptor, family 5, subfamily P, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F98212@106046@106048@duplication@3@55370918@55419315@11@chr11:55370918-55419315@40.2@2743@3959@1.44@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F98212@114083@114083@deletion@1@7966913@7967130@12@chr12:7966913-7967130@10.6@224@118@0.527@NA@SLC2A14_16@0@0@0@:NECAP endocytosis associated 1:solute carrier family 2 (facilitated glucose transporter), member 14@:coated pit;protein binding;endocytosis;protein transport;clathrin vesicle coat;plasma membrane;membrane:multicellular organismal development;cell differentiation;substrate-specific transmembrane transporter activity;transport;folic acid binding;glucose transmembrane transporter activity;transmembrane transport;spermatogenesis;reduced folate carrier activity;integral to membrane;transmembrane transporter activity;membrane@NA
F98212@114483@114483@deletion@1@11243900@11244828@12@chr12:11243900-11244828@168@1248@33@0.0264@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
F98212@115537@115537@deletion@1@31249276@31249313@12@chr12:31249276-31249313@12.3@96@26@0.271@CNVR5483.1@DDX11_15@0@0@0@:DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11@:nucleoplasm;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;S phase of mitotic cell cycle;DNA binding;nucleobase-containing compound metabolic process;ATP binding;ATP-dependent DNA helicase activity;DNA helicase activity;midbody;RNA binding;DNA-dependent ATPase activity;nucleus;positive regulation of cell proliferation;virus-host interaction;nuclear chromatin;4 iron, 4 sulfur cluster binding;helicase activity;hydrolase activity, acting on acid anhydrides;DNA duplex unwinding;endoplasmic reticulum unfolded protein response;G2/M transition of mitotic cell cycle;protein binding;sister chromatid cohesion;activation of signaling protein activity involved in unfolded protein response;nucleolus;spindle pole;ATP-dependent helicase activity;metal ion binding;nucleic acid binding;mitotic sister chromatid segregation@: WARSAW BREAKAGE SYNDROME
F98212@131033@131034@duplication@2@74008198@74010359@14@chr14:74008198-74010359@20.3@495@776@1.57@CNVR6188.1, CNVR6188.4@ACOT1_2, ACOT1_3@0@0@0@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
F98212@133425@133427@duplication@3@106471637@106478539@14@chr14:106471637-106478539@19.4@272@468@1.72@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV1-3_1, IGHV4-4_2, IGHV4-4_1@0@0@0@@:protein binding:protein binding@NA
F98212@133432@133436@duplication@5@106539080@106573537@14@chr14:106539080-106573537@76.5@1054@1954@1.85@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1, IGHV3-11_2@0@0@0@@:protein binding:protein binding:protein binding@NA
F98212@133460@133463@deletion@4@106805210@106816173@14@chr14:106805210-106816173@26.9@693@381@0.55@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.41@IGHV4-31_2, IGHV4-31_1, IGHV3-33_2, IGHV3-33_1@0@0@0@@:protein binding:protein binding@NA
F98212@133470@133471@deletion@2@106877620@106878076@14@chr14:106877620-106878076@6.72@360@241@0.669@CNVR6294.26, CNVR6294.56, CNVR6294.2, CNVR6294.18@IGHV4-39_2, IGHV4-39_1@0@0@0@@:protein binding@NA
F98212@133541@133542@duplication@2@22368577@22383423@15@chr15:22368577-22383423@87.4@5076@9537@1.88@CNVR6297.4, CNVR6297.17, CNVR6297.2@OR4M2_1, OR4N4_1@0@0@0@:olfactory receptor, family 4, subfamily M, member 2:olfactory receptor, family 4, subfamily N, member 4@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F98212@134011@134011@deletion@1@30664351@30664544@15@chr15:30664351-30664544@13.7@64@1@0.0156@CNVR6337.1@CHRFAM7A_7@0@0@0@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
F98212@134024@134025@duplication@2@30700112@30700498@15@chr15:30700112-30700498@7.5@287@413@1.44@NA@GOLGA8R_11, GOLGA8R_10@0@0@0@@:Golgi apparatus@NA
F98212@134154@134157@duplication@4@32450614@32460659@15@chr15:32450614-32460659@12.8@244@379@1.55@CNVR6345.2, CNVR6345.1@CHRNA7_7, CHRNA7_8, CHRNA7_9, CHRNA7_10@0@0@0@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
F98212@144038@144039@deletion@2@28403074@28403463@16@chr16:28403074-28403463@43.6@211@5@0.0237@CNVR6684.2@EIF3CL_10, EIF3CL_9@0@0@0@:eukaryotic translation initiation factor 3, subunit C-like@:protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;translation initiation factor activity@NA
F98212@144289@144290@duplication@2@29469250@29469445@16@chr16:29469250-29469445@8.39@44@106@2.41@CNVR6690.2, CNVR6690.3, CNVR6690.4@SLX1B_5, SLX1B_6@0@0@0@:structure-specific endonuclease subunit SLX1-like;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae);SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae):sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3;sulfotransferase 1A3/1A4-like@:Slx1-Slx4 complex;5'-flap endonuclease activity;DNA repair;protein binding;DNA double-strand break processing involved in repair via single-strand annealing;double-strand break repair via homologous recombination;metal ion binding;crossover junction endodeoxyribonuclease activity:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;cytoplasm;catecholamine metabolic process;cytosol;endoplasmic reticulum unfolded protein response;xenobiotic metabolic process;sulfotransferase activity;activation of signaling protein activity involved in unfolded protein response;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process@NA
F98212@147101@147101@duplication@1@70010292@70010635@16@chr16:70010292-70010635@7.03@83@148@1.78@CNVR6762.3, CNVR6762.2@RP11-419C5.2_7@0@0@0@NA@NA@NA
F98212@147109@147124@duplication@16@70161164@70190782@16@chr16:70161164-70190782@93.1@6581@9025@1.37@CNVR6764.1, CNVR6764.3@PDPR_4, PDPR_5, PDPR_6, PDPR_7, PDPR_8, PDPR_9, PDPR_10, PDPR_11, PDPR_12, PDPR_13, PDPR_14, PDPR_15, PDPR_16, PDPR_17, PDPR_18, PDPR_19@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
F98212@147511@147513@duplication@3@74446936@74452196@16@chr16:74446936-74452196@11.8@220@347@1.58@CNVR6778.2, CNVR6778.3@CLEC18B_5, CLEC18B_4, CLEC18B_3@0@0@0@:C-type lectin domain family 18, member B@:carbohydrate binding;protein binding;extracellular region@NA
F98212@150864@150865@duplication@2@8656457@8656807@17@chr17:8656457-8656807@6.88@249@351@1.41@NA@SPDYE4_6, SPDYE4_5@0@0@0@:speedy homolog E4 (Xenopus laevis)@NA@NA
F98212@151554@151561@duplication@8@16635853@16676947@17@chr17:16635853-16676947@18.5@1724@2253@1.31@NA@CCDC144A_11, CCDC144A_11, CCDC144A_12, CCDC144A_12, CCDC144A_13, CCDC144A_13, CCDC144A_14, CCDC144A_14, CCDC144A_15, CCDC144A_15, CCDC144A_16, CCDC144A_16, CCDC144A_17, CCDC144A_18, CCDC144A_17@0@0@0@:coiled-coil domain containing 144A@NA@NA
F98212@151875@151885@deletion@11@18380170@18397681@17@chr17:18380170-18397681@79.8@747@250@0.335@CNVR7014.1@LGALS9C_1, LGALS9C_2, LGALS9C_3, LGALS9C_4, LGALS9C_5, LGALS9C_6, LGALS9C_7, LGALS9C_8, LGALS9C_9, LGALS9C_10, LGALS9C_11@0@0@0@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
F98212@151896@151897@deletion@2@18584055@18584964@17@chr17:18584055-18584964@10.4@277@165@0.596@NA@ZNF286B_3, ZNF286B_2@0@0@0@:zinc finger protein 286B@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding@NA
F98212@151958@151959@duplication@2@18996506@18997166@17@chr17:18996506-18997166@18.5@267@488@1.83@CNVR7018.4, CNVR7018.2, CNVR7018.6@AC007952.5_1, AC007952.5_2@0@0@0@NA@NA@NA
F98212@153378@153381@deletion@4@34523998@34539971@17@chr17:34523998-34539971@11@50@0@0@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL3L3_1, CCL4L1_1, CCL4L1_2, CCL4L1_3@0@0@0@:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
F98212@153397@153400@duplication@4@34625572@34641537@17@chr17:34625572-34641537@8.06@201@302@1.5@CNVR7077.1, CNVR7077.2, CNVR7077.12@CCL3L1_1, CCL4L2_1, CCL4L2_2, CCL4L2_3@0@0@0@:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
F98212@153654@153655@duplication@2@36358126@36358395@17@chr17:36358126-36358395@9.39@366@511@1.4@CNVR7083.3@RP11-1407O15.2_8, RP11-1407O15.2_7@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
F98212@154346@154346@deletion@1@39421631@39422112@17@chr17:39421631-39422112@5.36@67@30@0.448@CNVR7096.1@KRTAP9-6_1@0@0@0@:keratin associated protein 9-6@:keratin filament@NA
F98212@155581@155581@deletion@1@44248222@44249509@17@chr17:44248222-44249509@10.8@2514@1715@0.682@CNVR7114.3, CNVR7114.2, CNVR7114.8@KANSL1_2@0@0@0@:KAT8 regulatory NSL complex subunit 1@:histone acetyltransferase activity (H4-K8 specific);histone acetyltransferase activity (H4-K16 specific);histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase complex;histone H4-K5 acetylation;MLL1 complex;histone H4-K16 acetylation;protein binding;histone H4-K8 acetylation;nucleus@NA
F98212@155588@155590@duplication@3@44400320@44409347@17@chr17:44400320-44409347@7.45@103@175@1.7@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_7, LRRC37A_8, LRRC37A_9@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
F98212@155593@155595@duplication@3@44414663@44415089@17@chr17:44414663-44415089@6.22@102@164@1.61@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_12, LRRC37A_13, LRRC37A_14@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
F98212@155609@155612@deletion@4@44630767@44632945@17@chr17:44630767-44632945@18.1@189@70@0.37@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2_12, LRRC37A2_13, LRRC37A2_14, LRRC37A2_15@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
F98212@155953@155955@duplication@3@47013533@47018424@17@chr17:47013533-47018424@24.3@762@1150@1.51@NA@SNF8_5, SNF8_4, SNF8_3@0@0@0@:SNF8, ESCRT-II complex subunit, homolog (S. cerevisiae)@:late endosome membrane;endosomal transport;regulation of transcription from RNA polymerase II promoter;cytosol;cellular membrane organization;transcription factor complex;protein transport;transcription, DNA-dependent;transcription factor binding@NA
F98212@156877@156878@duplication@2@57656834@57657240@17@chr17:57656834-57657240@10.6@136@238@1.75@NA@DHX40_9, DHX40_10@0@0@0@:DEAH (Asp-Glu-Ala-His) box polypeptide 40@:transport;helicase activity;intracellular;ATP-dependent helicase activity;nucleic acid binding;ATP binding@NA
F98212@160947@160959@duplication@13@14797661@14840677@18@chr18:14797661-14840677@27.4@771@1122@1.46@NA@ANKRD30B_19, ANKRD30B_20, ANKRD30B_21, ANKRD30B_22, ANKRD30B_23, ANKRD30B_24, ANKRD30B_25, ANKRD30B_26, ANKRD30B_27, ANKRD30B_28, ANKRD30B_29, ANKRD30B_30, ANKRD30B_31@0@0@0@:ankyrin repeat domain 30B@:protein binding;molecular_function;cellular_component;biological_process@NA
F98212@160962@160964@duplication@3@14848716@14852479@18@chr18:14848716-14852479@30.5@1505@2206@1.47@NA@ANKRD30B_34, ANKRD30B_35, ANKRD30B_36@0@0@0@:ankyrin repeat domain 30B@:protein binding;molecular_function;cellular_component;biological_process@NA
F98212@160967@160967@duplication@1@18534745@18535005@18@chr18:18534745-18535005@6.54@695@931@1.34@NA@ROCK1_31@0@0@0@:Rho-associated, coiled-coil containing protein kinase 1@:protein tyrosine kinase activity;bleb;apical constriction;ATP binding;regulation of actin filament-based process;regulation of focal adhesion assembly;leukocyte cell-cell adhesion;cytokinesis;intracellular signal transduction;regulation of actin cytoskeleton organization;intracellular;protein kinase activity;Rho protein signal transduction;cytosol;negative regulation of neuron apoptotic process;regulation of keratinocyte differentiation;phospholipid binding;smooth muscle contraction;negative regulation of angiogenesis;cellular component disassembly involved in execution phase of apoptosis;transferase activity, transferring phosphorus-containing groups;Golgi membrane;actin cytoskeleton organization;leukocyte tethering or rolling;regulation of cell motility;membrane to membrane docking;apoptotic process;GTP-Rho binding;centriole;protein serine/threonine kinase activity;regulation of establishment of cell polarity;protein phosphorylation;regulation of cell adhesion;bleb assembly;axon guidance;regulation of stress fiber assembly;signal transduction;protein binding;metal ion binding;leukocyte migration@NA
F98212@166381@166381@deletion@1@12543192@12543251@19@chr19:12543192-12543251@5.38@179@109@0.609@CNVR7541.1@ZNF443_3@0@0@0@:zinc finger protein 443@:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding:intracellular;DNA binding;regulation of transcription, DNA-dependent;response to stress;induction of apoptosis;nucleus;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
F98212@166811@166812@deletion@2@14070580@14070881@19@chr19:14070580-14070881@22.7@523@280@0.535@NA@DCAF15_9, DCAF15_10@0@0@0@:DDB1 and CUL4 associated factor 15@:protein ubiquitination@NA
F98212@166916@166917@deletion@2@14508471@14508747@19@chr19:14508471-14508747@16.2@133@40@0.301@NA@CD97_7, CD97_8@0@0@0@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
F98212@168951@168951@deletion@1@35849794@35850833@19@chr19:35849794-35850833@7.99@606@399@0.658@CNVR7627.1@FFAR3_2@0@0@0@:free fatty acid receptor 3@:lipid binding;integral to membrane;G-protein coupled receptor activity;plasma membrane;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
F98212@170097@170100@duplication@4@40376314@40382826@19@chr19:40376314-40382826@13.4@262@413@1.58@CNVR7639.2@FCGBP_25, FCGBP_24, FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F98212@173294@173298@deletion@5@54724026@54726434@19@chr19:54724026-54726434@23@395@201@0.509@CNVR7721.3, CNVR7721.4@LILRB3_7, LILRB3_6, LILRB3_5, LILRB3_4, LILRB3_3@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F98212@173302@173308@duplication@7@54743778@54746600@19@chr19:54743778-54746600@26.2@1604@2178@1.36@CNVR7721.3, CNVR7721.6@LILRA6_7, LILRA6_6, LILRA6_5, LILRA6_4, LILRA6_3, LILRA6_2, LILRA6_1@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F98212@173467@173473@deletion@7@55263102@55286910@19@chr19:55263102-55286910@54.1@1345@733@0.545@CNVR7725.2, CNVR7725.1@KIR2DL3_6, KIR2DL3_7, KIR2DL3_8, KIR2DL1_1, KIR2DL1_2, KIR2DL1_3, KIR2DL1_4@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
F98212@173496@173498@duplication@3@55349032@55354373@19@chr19:55349032-55354373@5.55@459@600@1.31@CNVR7725.1, CNVR7725.6@KIR2DS4_3, KIR2DS4_4, KIR2DS4_5@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
F98212@174395@174395@deletion@1@1569207@1569278@20@chr20:1569207-1569278@13.6@62@0@0@CNVR7763.1@RP4-576H24.4_1@0@0@0@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
F98212@174403@174403@duplication@1@1895746@1896101@20@chr20:1895746-1896101@7.67@253@372@1.47@CNVR7764.2@SIRPA_2@0@0@0@:signal-regulatory protein alpha@:blood coagulation;protein binding;integral to membrane;SH3 domain binding;cell adhesion;plasma membrane;membrane;leukocyte migration@NA
F98212@178074@178074@duplication@1@55099866@55100113@20@chr20:55099866-55100113@8.05@344@493@1.43@NA@FAM209A_1@0@0@0@:glucosaminyl (N-acetyl) transferase family member 7:family with sequence similarity 209, member A@:integral to membrane;protein glycosylation;acetylglucosaminyltransferase activity;Golgi membrane;membrane:integral to membrane@NA
F98212@178076@178076@deletion@1@55108399@55108646@20@chr20:55108399-55108646@35.3@325@85@0.262@NA@FAM209B_1@0@0@0@:family with sequence similarity 209, member B@:integral to membrane@NA
F98212@180339@180340@duplication@2@44836623@44837654@21@chr21:44836623-44837654@12.2@468@670@1.43@CNVR8029.1@SIK1_14, SIK1_13@0@0@0@:salt-inducible kinase 1@:intracellular protein kinase cascade;regulation of mitotic cell cycle;anoikis by p53 class mediator;negative regulation of gluconeogenesis;protein autophosphorylation;regulation of cell differentiation;protein kinase binding;protein tyrosine kinase activity;magnesium ion binding;transferase activity, transferring phosphorus-containing groups;anoikis;ATP binding;negative regulation of triglyceride biosynthetic process;histone deacetylase binding;negative regulation of CREB transcription factor activity;regulation of myotube differentiation;nucleus;cardiac muscle cell differentiation;protein serine/threonine kinase activity;protein phosphorylation;protein kinase activity;cytoplasm;cytosol;protein binding;negative regulation of transcription from RNA polymerase II promoter;regulation of sodium ion transport;cAMP response element binding protein binding;cell cycle;14-3-3 protein binding@NA
F98212@180976@180976@deletion@1@16287255@16287885@22@chr22:16287255-16287885@20.6@97@1@0.0103@CNVR8071.2, CNVR8071.3, CNVR8071.9@POTEH_1@0@0@0@:POTE ankyrin domain family, member H@:protein binding@NA
F98212@181487@181487@deletion@1@21065630@21065749@22@chr22:21065630-21065749@7.17@38@4@0.105@CNVR8099.6, CNVR8099.2@PI4KA_51@0@0@0@:phosphatidylinositol 4-kinase, catalytic, alpha@:phospholipid metabolic process;1-phosphatidylinositol 4-kinase activity;small molecule metabolic process;phosphatidylinositol phosphorylation;binding;transferase activity, transferring phosphorus-containing groups;phosphotransferase activity, alcohol group as acceptor;ATP binding;Golgi-associated vesicle;phosphatidylinositol biosynthetic process;cytosol;protein binding;signal transduction;synaptic transmission;kinase activity;phosphatidylinositol-mediated signaling@NA
F98212@181633@181634@duplication@2@21576374@21579843@22@chr22:21576374-21579843@7.98@15@67@4.47@CNVR8100.4, CNVR8100.10, CNVR8100.7@GGT2_5, GGT2_4@0@0@0@:gamma-glutamyltransferase 2;gamma-glutamyltranspeptidase 2-like@:hydrolase activity;small molecule metabolic process;leukotriene biosynthetic process;anchored to external side of plasma membrane;glutathione biosynthetic process;xenobiotic metabolic process;integral to membrane;glutathione metabolic process;plasma membrane;gamma-glutamyltransferase activity;cellular_component@NA
F98212@181752@181813@duplication@62@22868327@23265085@22@chr22:22868327-23265085@1000@16371@30593@1.87@CNVR8103.5, CNVR8103.2, CNVR8103.1@ZNF280A_2, PRAME_5, PRAME_4, PRAME_3, LL22NC03-63E9.3_2, LL22NC03-63E9.3_3, IGLV2-33_1, IGLV2-33_2, IGLV3-32_1, IGLV3-32_2, POM121L1P_1, GGTLC2_1, GGTLC2_2, GGTLC2_3, GGTLC2_4, GGTLC2_5, IGLV3-27_1, IGLV3-27_2, IGLV3-25_1, IGLV3-25_2, IGLV2-23_1, IGLV2-23_2, IGLV3-22_1, IGLV3-22_2, IGLV3-21_2, IGLV3-21_3, IGLV3-19_1, IGLV3-19_2, IGLV2-18_1, IGLV2-18_2, IGLV3-16_1, IGLV3-16_2, IGLV2-14_1, IGLV2-14_2, IGLV3-12_1, IGLV3-12_2, IGLV2-11_1, IGLV2-11_2, IGLV3-10_1, IGLV3-10_2, IGLV3-9_1, IGLV3-9_2, IGLV2-8_1, IGLV2-8_2, IGLV4-3_1, IGLV4-3_2, IGLV3-1_1, IGLV3-1_2, IGLL5_1, IGLJ1_1, IGLL5_2, IGLC1_1, IGLL5_3, IGLJ2_1, IGLC2_1, IGLJ3_1, IGLC3_1, IGLJ5_1, IGLJ6_1, IGLJ7_1, IGLC7_1@0@0@0@:zinc finger protein 280A:preferentially expressed antigen in melanoma:putative POM121-like protein 1-like:gamma-glutamyltransferase light chain 2:immunoglobulin lambda-like polypeptide 5@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding:retinoic acid receptor binding;negative regulation of apoptotic process;cell differentiation;negative regulation of cell differentiation;negative regulation of transcription, DNA-dependent;protein binding;plasma membrane;nucleus;apoptotic process;positive regulation of cell proliferation;transcription, DNA-dependent;negative regulation of retinoic acid receptor signaling pathway;regulation of growth:protein binding:protein binding:leukotriene biosynthetic process;glutathione metabolic process;gamma-glutamyltransferase activity;anchored to external side of plasma membrane:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:regulation of immune response;complement activation;immune response;complement activation, classical pathway;innate immune response;antigen binding;protein binding;extracellular region;plasma membrane:protein binding:protein binding:protein binding:protein binding@NA
F98212@181867@181867@deletion@1@23964279@23964363@22@chr22:23964279-23964363@17.9@346@166@0.48@CNVR8112.1@C22orf43_4@0@0@0@:chromosome 22 open reading frame 43@NA@NA
F98212@181937@181938@deletion@2@24300739@24302568@22@chr22:24300739-24302568@5.01@33@8@0.242@CNVR8114.6, CNVR8114.12, CNVR8114.13, CNVR8114.8@GSTT2B_3, GSTT2B_2@0@0@0@:glutathione S-transferase theta 2B (gene/pseudogene);glutathione S-transferase theta 2@:protein binding;glutathione transferase activity;nucleus;transferase activity;cytoplasm@NA
F98212@181948@181949@deletion@2@24324820@24325235@22@chr22:24324820-24325235@5.68@68@30@0.441@CNVR8114.6, CNVR8114.13, CNVR8114.8, CNVR8114.14@GSTT2_3, GSTT2_4@0@0@0@@:protein binding;glutathione transferase activity;nucleus;cytoplasm@NA
F98212@181951@181955@duplication@5@24376424@24384231@22@chr22:24376424-24384231@28.8@792@1176@1.48@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTT1_5, GSTT1_4, GSTT1_3, GSTT1_2, GSTT1_1@0@0@0@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
F98212@183634@183640@deletion@7@39378460@39388154@22@chr22:39378460-39388154@29.1@877@530@0.604@CNVR8164.1@APOBEC3B_1, APOBEC3B_2, APOBEC3B_3, APOBEC3B_4, APOBEC3B_5, APOBEC3B_6, APOBEC3B_7@0@0@0@:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B@:RNA binding;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;negative regulation of transposition;catalytic activity;zinc ion binding@NA
F98212@184143@184150@deletion@8@42522577@42525911@22@chr22:42522577-42525911@54.9@1173@630@0.537@CNVR8168.1, CNVR8168.3, CNVR8168.2@CYP2D6_9, CYP2D6_8, CYP2D6_7, CYP2D6_6, CYP2D6_5, CYP2D6_4, CYP2D6_3, CYP2D6_2@0@0@0@:cytochrome P450, family 2, subfamily D, polypeptide 6@:oxidation-reduction process;mitochondrion;alkaloid catabolic process;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;drug catabolic process;endoplasmic reticulum membrane;response to organic substance;oxidative demethylation;endoplasmic reticulum;alkaloid metabolic process;negative regulation of binding;heme binding;xenobiotic metabolic process;dopamine metabolic process;steroid metabolic process;isoquinoline alkaloid metabolic process;arachidonic acid monooxygenase activity;arachidonic acid metabolic process;steroid 21-monooxygenase activity;negative regulation of cellular organofluorine metabolic process;oxidoreductase activity;monoterpenoid metabolic process;heterocycle metabolic process;drug binding;drug metabolic process;electron carrier activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;coumarin metabolic process@: DRUG METABOLISM, POOR, CYP2D6-RELATED
F98212@4070@4071@deletion@2@101581178@101581428@X@chrX:101581178-101581428@16.9@78@1@0.0128@NA@NXF2_33, NXF2_34@0@0@0@NA@NA@NA
F98212@4884@4884@duplication@1@119210843@119211253@X@chrX:119210843-119211253@6.22@37@82@2.22@NA@RHOXF2B_2@0@0@0@NA@NA@NA
F98212@4890@4890@deletion@1@119292922@119293332@X@chrX:119292922-119293332@8.59@109@50@0.459@NA@RHOXF2_2@0@0@0@NA@NA@NA
F98212@5495@5495@duplication@1@134988571@134988710@X@chrX:134988571-134988710@8.43@259@373@1.44@NA@SAGE1_7@0@0@0@NA@NA@NA
F98212@5718@5719@deletion@2@140335651@140336590@X@chrX:140335651-140336590@19@110@17@0.155@CNVR8456.1@SPANXC_2, SPANXC_1@0@0@0@NA@NA@NA
F98212@6285@6285@duplication@1@153418414@153418581@X@chrX:153418414-153418581@10.6@57@135@2.37@CNVR8489.1@OPN1LW_3@0@0@0@NA@NA@NA
F98407@6@6@deletion@1@69092@70008@1@chr1:69092-70008@5.01@34@8@0.235@CNVR1.1, CNVR1.2@OR4F5_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F98407@308@335@deletion@28@1386065@1431197@1@chr1:1386065-1431197@103@2754@1606@0.583@NA@ATAD3C_1, ATAD3C_2, ATAD3C_3, ATAD3C_4, ATAD3C_5, ATAD3C_6, ATAD3C_7, ATAD3C_8, ATAD3C_9, ATAD3C_10, ATAD3C_11, ATAD3C_12, ATAD3B_1, ATAD3B_2, ATAD3B_3, ATAD3B_4, ATAD3B_5, ATAD3B_6, ATAD3B_7, ATAD3B_8, ATAD3B_9, ATAD3B_10, ATAD3B_11, ATAD3B_12, ATAD3B_13, ATAD3B_14, ATAD3B_15, ATAD3B_16@0@0@0@:ATPase family, AAA domain containing 3C:ATPase family, AAA domain containing 3B@:four-way junction helicase activity;DNA repair;nucleoside-triphosphatase activity;nucleotide binding;DNA recombination;ATP binding:nucleoside-triphosphatase activity;mitochondrial inner membrane;nucleotide binding;ATP binding@NA
F98407@2180@2186@deletion@7@17264896@17273486@1@chr1:17264896-17273486@13.5@516@328@0.636@CNVR94.4, CNVR94.5@CROCC_11, CROCC_12, CROCC_13, CROCC_14, CROCC_15, CROCC_16, CROCC_17@0@0@0@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
F98407@2788@2788@deletion@1@21806545@21806716@1@chr1:21806545-21806716@4.61@30@7@0.233@CNVR107.2, CNVR107.1@NBPF3_11@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 3@:cytoplasm@NA
F98407@3336@3339@deletion@4@25627438@25633220@1@chr1:25627438-25633220@9.05@565@380@0.673@CNVR116.1, CNVR116.2@RHD_4, RHD_5, RHD_6, RHD_7@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
F98407@4666@4666@duplication@1@36203594@36203698@1@chr1:36203594-36203698@4.75@130@191@1.47@NA@CLSPN_22@0@0@0@:claspin@:nucleoplasm;G2/M transition DNA damage checkpoint;peptidyl-serine phosphorylation;cellular component disassembly involved in execution phase of apoptosis;DNA binding;DNA damage checkpoint;anaphase-promoting complex binding;DNA repair;protein binding;apoptotic process;cell cycle checkpoint;activation of protein kinase activity;DNA replication;mitotic cell cycle DNA replication checkpoint@NA
F98407@5196@5197@deletion@2@40235375@40240128@1@chr1:40235375-40240128@6.97@357@233@0.653@NA@OXCT2_1, BMP8B_3@0@0@0@:bone morphogenetic protein 8b:3-oxoacid CoA transferase 2@:cell differentiation;growth factor activity;extracellular space;growth;extracellular region;cytokine activity;cartilage development;skeletal system development;ossification:mitochondrion;microtubule-based flagellum;CoA-transferase activity;ketone body catabolic process;3-oxoacid CoA-transferase activity;metabolic process@NA
F98407@7186@7186@deletion@1@60106953@60107023@1@chr1:60106953-60107023@18.3@335@163@0.487@CNVR197.1@FGGY_12@0@0@0@:FGGY carbohydrate kinase domain containing@:cell death;neuron homeostasis;molecular_function;carbohydrate metabolic process;kinase activity;cellular_component;phosphotransferase activity, alcohol group as acceptor@: AMYOTROPHIC LATERAL SCLEROSIS 1; ALS1
F98407@8507@8508@duplication@2@89476588@89477710@1@chr1:89476588-89477710@22.6@542@840@1.55@CNVR244.1@GBP3_8, GBP3_7@0@0@0@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
F98407@9365@9374@deletion@10@104202983@104234232@1@chr1:104202983-104234232@30.2@137@0@0@CNVR266.3, CNVR266.1, CNVR266.15@AMY1A_7, AMY1A_8, AMY1A_9, AMY1A_10, AMY1A_11, AMY1B_11, AMY1B_10, AMY1B_9, AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
F98407@9436@9436@deletion@1@108769302@108769515@1@chr1:108769302-108769515@7.32@60@19@0.317@CNVR294.4@NBPF4_14@0@0@0@:neuroblastoma breakpoint family, member 4@:cytoplasm@NA
F98407@9766@9773@deletion@8@110230497@110235917@1@chr1:110230497-110235917@74.9@407@44@0.108@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
F98407@10684@10685@duplication@2@120539621@120548211@1@chr1:120539621-120548211@17.3@606@879@1.45@CNVR319.3, CNVR319.2@NOTCH2_4, NOTCH2_3@0@0@0@:notch 2@:nucleoplasm;negative regulation of apoptotic process;cell differentiation;negative regulation of cell proliferation;pulmonary valve morphogenesis;atrial septum morphogenesis;stem cell maintenance;placenta blood vessel development;placenta development;bone remodeling;induction of apoptosis;tissue regeneration;plasma membrane;nucleus;endoplasmic reticulum membrane;gene expression;cell fate determination;in utero embryonic development;Notch receptor processing;humoral immune response;inflammatory response to antigenic stimulus;embryonic limb morphogenesis;hemopoiesis;membrane;calcium ion binding;Notch signaling involved in heart development;nervous system development;Golgi membrane;morphogenesis of an epithelial sheet;integral to membrane;interleukin-4 secretion;cell cycle arrest;receptor activity;integral to plasma membrane;organ morphogenesis;determination of left/right symmetry;transcription initiation from RNA polymerase II promoter;multicellular organismal development;cell growth;regulation of transcription, DNA-dependent;positive regulation of Ras protein signal transduction;protein binding;regulation of developmental process;Notch signaling pathway;extracellular region;cell surface;positive regulation of apoptotic process@: ALAGILLE SYNDROME 2; ALGS2; HAJDU-CHENEY SYNDROME; HJCYS
F98407@12117@12118@deletion@2@152573209@152586574@1@chr1:152573209-152586574@28.4@131@1@0.00763@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
F98407@14053@14058@duplication@6@161565346@161600992@1@chr1:161565346-161600992@61.5@1102@1813@1.65@CNVR383.1@FCGR2C_1, FCGR3B_5, FCGR3B_4, FCGR3B_3, FCGR3B_2, FCGR3B_1@0@0@0@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene):Fc fragment of IgG, low affinity IIIb, receptor (CD16b)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction:IgG binding;protein binding;extracellular region;immune response;plasma membrane;anchored to membrane@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
F98407@16029@16040@deletion@12@196744018@196801129@1@chr1:196744018-196801129@377@1807@20@0.0111@CNVR459.1@CFHR3_1, CFHR3_2, CFHR3_3, CFHR3_4, CFHR3_5, CFHR3_6, CFHR1_1, CFHR1_2, CFHR1_3, CFHR1_4, CFHR1_5, CFHR1_6@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
F98407@17297@17297@duplication@1@207741170@207741387@1@chr1:207741170-207741387@7.02@227@330@1.45@CNVR485.1, CNVR485.2@CR1_25@0@0@0@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
F98407@22191@22194@duplication@4@38956699@38972329@2@chr2:38956699-38972329@11.2@677@904@1.34@CNVR759.1@GALM_5, GALM_6, GALM_7, SRSF7_8@0@0@0@:galactose mutarotase (aldose 1-epimerase):serine/arginine-rich splicing factor 7@:isomerase activity;carbohydrate binding;aldose 1-epimerase activity;hexose metabolic process;carbohydrate metabolic process;catalytic activity;cytoplasm:nucleoplasm;negative regulation of mRNA splicing, via spliceosome;mRNA 3'-end processing;termination of RNA polymerase II transcription;nucleotide binding;transcription from RNA polymerase II promoter;protein binding;mRNA export from nucleus;RNA binding;mRNA processing;nucleus;RNA splicing;mRNA splicing, via spliceosome;gene expression;zinc ion binding;nucleic acid binding@NA
F98407@24562@24563@duplication@2@85570366@85570921@2@chr2:85570366-85570921@8.02@301@424@1.41@NA@RETSAT_11, RETSAT_10@0@0@0@:retinol saturase (all-trans-retinol 13,14-reductase)@:all-trans-retinol 13,14-reductase activity;nuclear membrane;oxidation-reduction process;oxidoreductase activity;retinol metabolic process;endoplasmic reticulum membrane;nuclear outer membrane@NA
F98407@24969@24969@deletion@1@89597022@89597316@2@chr2:89597022-89597316@5.22@53@21@0.396@CNVR866.7, CNVR866.1@IGKV1-37_2@0@0@0@@:protein binding@NA
F98407@25003@25005@duplication@3@90153964@90193424@2@chr2:90153964-90193424@13.6@331@498@1.5@CNVR867.10, CNVR867.5, CNVR867.3, CNVR867.9@IGKV3D-15_2, IGKV1D-13_1, IGKV1D-13_2@0@0@0@@:protein binding:protein binding@NA
F98407@25007@25007@deletion@1@90198896@90199190@2@chr2:90198896-90199190@4.63@100@56@0.56@CNVR867.10, CNVR867.5, CNVR867.3, CNVR867.9, CNVR867.15, CNVR867.2@IGKV1D-12_2@0@0@0@@:protein binding@NA
F98407@25373@25378@duplication@6@97858596@97862525@2@chr2:97858596-97862525@6.46@294@399@1.36@CNVR886.1@ANKRD36_37, ANKRD36_38, ANKRD36_39, ANKRD36_40, ANKRD36_41, ANKRD36_42@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
F98407@25393@25402@duplication@10@97877284@97884983@2@chr2:97877284-97884983@10.7@657@877@1.33@NA@ANKRD36_57, ANKRD36_58, ANKRD36_59, ANKRD36_60, ANKRD36_61, ANKRD36_62, ANKRD36_63, ANKRD36_64, ANKRD36_65, ANKRD36_66@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
F98407@27177@27178@deletion@2@130897465@130897669@2@chr2:130897465-130897669@6.41@131@73@0.557@NA@CCDC74B_7, CCDC74B_6@0@0@0@:coiled-coil domain containing 74A;coiled-coil domain containing 74B@NA@NA
F98407@27211@27211@deletion@1@130955932@130955933@2@chr2:130955932-130955933@7.68@36@1@0.0278@CNVR985.1@TUBA3E_1@0@0@0@:tubulin, alpha 3e@:GTPase activity;structural constituent of cytoskeleton;protein complex;GTP catabolic process;cytoplasm;microtubule cytoskeleton;protein polymerization;microtubule-based movement;structural molecule activity;cytoplasmic microtubule;GTP binding;microtubule;microtubule cytoskeleton organization;protein domain specific binding@NA
F98407@27341@27345@duplication@5@132288153@132290642@2@chr2:132288153-132290642@14.7@472@671@1.42@NA@CCDC74A_3, CCDC74A_4, CCDC74A_5, CCDC74A_6, CCDC74A_7@0@0@0@:coiled-coil domain containing 74A@NA@NA
F98407@51672@51672@duplication@1@145041644@145041741@4@chr4:145041644-145041741@7.07@122@197@1.61@NA@GYPA_2@0@0@0@:glycophorin B (MNS blood group):glycophorin A (MNS blood group)@:integral to membrane;plasma membrane;integral to plasma membrane:external side of plasma membrane;integral to membrane;cytoskeletal anchoring at plasma membrane;plasma membrane;molecular_function;protein homodimerization activity;integral to plasma membrane;cellular_component;identical protein binding;membrane;biological_process;regulation of response to osmotic stress;virus-host interaction@: BLOOD GROUP--Ss LOCUS; Ss: MALARIA, SUSCEPTIBILITY TO; BLOOD GROUP--MN LOCUS; MN
F98407@53187@53189@duplication@3@190884249@190947616@4@chr4:190884249-190947616@13@727@997@1.37@NA@FRG1_9, FRG2_4, FRG2_3@0@0@0@:protein FRG1-like;FSHD region gene 1:FSHD region gene 2-like;FSHD region gene 2@:actin filament binding;nuclear speck;nucleolus;Cajal body;mRNA splicing, via spliceosome;protein binding, bridging;catalytic step 2 spliceosome;rRNA processing:nucleus@NA
F98407@55806@55806@deletion@1@69372349@69372398@5@chr5:69372349-69372398@5.29@121@69@0.57@CNVR2494.48, CNVR2494.39, CNVR2494.15, CNVR2494.18, CNVR2494.26, CNVR2494.43, CNVR2494.52, CNVR2494.28, CNVR2494.2, CNVR2494.36@SMN2_8@0@0@0@:survival of motor neuron 2, centromeric;survival of motor neuron 1, telomeric@:nucleoplasm;ncRNA metabolic process;Cajal body;RNA metabolic process;spliceosomal complex;cytoplasm;cytosol;protein binding;cell death;spliceosomal complex assembly;RNA binding;mRNA processing;nucleus;gene expression;spliceosomal snRNP assembly@: SPINAL MUSCULAR ATROPHY, TYPE II; SMA2; SPINAL MUSCULAR ATROPHY, TYPE I; SMA1; SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4; SPINAL MUSCULAR ATROPHY, TYPE III; SMA3
F98407@55817@55817@duplication@1@70247769@70247818@5@chr5:70247769-70247818@7.01@164@250@1.52@CNVR2494.41, CNVR2494.14, CNVR2494.30, CNVR2494.25, CNVR2494.20, CNVR2494.61, CNVR2494.22, CNVR2494.21, CNVR2494.62, CNVR2494.63@SMN1_8@0@0@0@:survival of motor neuron 2, centromeric;survival of motor neuron 1, telomeric@:nucleoplasm;ncRNA metabolic process;Cajal body;RNA metabolic process;spliceosomal complex;cytoplasm;cytosol;protein binding;cell death;spliceosomal complex assembly;RNA binding;mRNA processing;nucleus;gene expression;spliceosomal snRNP assembly@: SPINAL MUSCULAR ATROPHY, TYPE II; SMA2; SPINAL MUSCULAR ATROPHY, TYPE I; SMA1; SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4; SPINAL MUSCULAR ATROPHY, TYPE III; SMA3
F98407@57338@57338@deletion@1@109954131@109954263@5@chr5:109954131-109954263@15.4@395@216@0.547@NA@TMEM232_8@0@0@0@:transmembrane protein 232@:integral to membrane@NA
F98407@59065@59065@deletion@1@140557617@140560021@5@chr5:140557617-140560021@23.7@1848@1123@0.608@CNVR2624.1@PCDHB8_1@0@0@0@:protocadherin beta 8@:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding@NA
F98407@59488@59489@deletion@2@147553798@147554961@5@chr5:147553798-147554961@34.4@193@24@0.124@CNVR2637.1@SPINK14_3, SPINK14_4@0@0@0@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
F98407@60876@60877@deletion@2@175388055@175388437@5@chr5:175388055-175388437@7.64@62@20@0.323@NA@THOC3_5, THOC3_4@0@0@0@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
F98407@61641@61643@deletion@3@180376905@180420160@5@chr5:180376905-180420160@6.24@624@433@0.694@CNVR2719.1@BTNL8_8, BTNL3_1, BTNL3_2@0@0@0@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
F98407@62954@62954@deletion@1@29911900@29912174@6@chr6:29911900-29912174@10.8@220@117@0.532@CNVR2829.7, CNVR2829.2, CNVR2829.3@HLA-A_6@0@0@0@:major histocompatibility complex, class I, A@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO
F98407@63282@63282@deletion@1@31237988@31238262@6@chr6:31237988-31238262@12.1@197@96@0.487@CNVR2838.1@HLA-C_4@0@0@0@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
F98407@63953@63958@duplication@6@32485517@32498001@6@chr6:32485517-32498001@35@389@701@1.8@CNVR2845.21, CNVR2845.25, CNVR2845.30, CNVR2845.43, CNVR2845.6@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2, HLA-DRB5_1@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
F98407@63962@63963@duplication@2@32549335@32552155@6@chr6:32549335-32552155@5.77@302@408@1.35@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.5, CNVR2845.54, CNVR2845.55, CNVR2845.56, CNVR2845.34@HLA-DRB1_3, HLA-DRB1_2@0@0@0@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
F98407@63973@63974@duplication@2@32632576@32634384@6@chr6:32632576-32634384@15.6@213@367@1.72@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20, CNVR2845.31@HLA-DQB1_2, HLA-DQB1_1@0@0@0@:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
F98407@71029@71030@duplication@2@167789455@167790192@6@chr6:167789455-167790192@7.09@113@181@1.6@NA@TCP10_6, TCP10_5@0@0@0@:t-complex 10@:cytosol@NA
F98407@71764@71764@duplication@1@5982956@5983103@7@chr7:5982956-5983103@4.74@154@221@1.44@NA@RSPH10B_14@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F98407@71776@71779@deletion@4@6006495@6018327@7@chr7:6006495-6018327@30.3@317@125@0.394@NA@RSPH10B_2, PMS2_15, PMS2_14, PMS2_13@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas):PMS2 postmeiotic segregation increased 2 (S. cerevisiae)@:response to drug;DNA binding;MutSalpha complex binding;ATP binding;mismatch repair;DNA repair;mismatched DNA binding;ATPase activity;nucleus;mismatch repair complex;reciprocal meiotic recombination;ATP catabolic process;single-stranded DNA binding;response to DNA damage stimulus;single base insertion or deletion binding;protein binding;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;MutLalpha complex;endonuclease activity@: COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4; MISMATCH REPAIR CANCER SYNDROME
F98407@71922@71923@duplication@2@6797310@6798790@7@chr7:6797310-6798790@13.3@214@359@1.68@NA@RSPH10B2_2, RSPH10B2_3@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F98407@71933@71934@deletion@2@6820441@6821107@7@chr7:6820441-6821107@21.2@274@121@0.442@NA@RSPH10B2_13, RSPH10B2_14@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F98407@71940@71941@deletion@2@6837995@6838910@7@chr7:6837995-6838910@13.8@64@1@0.0156@NA@RSPH10B2_20, CCZ1B_15@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F98407@73246@73246@duplication@1@38292982@38293030@7@chr7:38292982-38293030@7.72@146@232@1.59@CNVR3353.1@TRGJ2_1@0@0@0@NA@NA@NA
F98407@73260@73263@duplication@4@38388957@38393784@7@chr7:38388957-38393784@20.2@849@1192@1.4@CNVR3354.3, CNVR3354.1@TRGV5_2, TRGV5_1, TRGV4_2, TRGV4_1@0@0@0@@:protein binding:protein binding@NA
F98407@74605@74607@deletion@3@74251403@74422230@7@chr7:74251403-74422230@7.71@35@0@0@NA@GTF2IRD2_2, GATSL1_1, GATSL1_2@0@0@0@:GTF2I repeat domain containing 2:GATS protein-like 1@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
F98407@74775@74775@duplication@1@76063356@76063472@7@chr7:76063356-76063472@5.24@79@130@1.65@CNVR3462.1@ZP3_5@0@0@0@:zona pellucida glycoprotein 3 (sperm receptor)@:negative regulation of transcription, DNA-dependent;manganese ion transmembrane transporter activity;intracellular protein transport;proteinaceous extracellular matrix;plasma membrane;positive regulation of acrosome reaction;outer acrosomal membrane;protein kinase C signaling cascade;manganese ion transmembrane transport;intracellular signal transduction;humoral immune response mediated by circulating immunoglobulin;negative regulation of binding of sperm to zona pellucida;positive regulation of inflammatory response;endoplasmic reticulum;signal transducer activity;perinuclear region of cytoplasm;secretory granule;positive regulation of transcription, DNA-dependent;positive regulation of ovarian follicle development;positive regulation of interferon-gamma production;carbohydrate binding;manganese ion transport;positive regulation of antral ovarian follicle growth;extracellular matrix;positive regulation of leukocyte migration;positive regulation of humoral immune response;extracellular space;blastocyst formation;integral to membrane;store-operated calcium channel activity;oocyte development;multivesicular body;phosphatidylinositol-mediated signaling;acrosomal vesicle;positive regulation of protein kinase B signaling cascade;Golgi apparatus;positive regulation of calcium ion import;positive regulation of protein kinase activity;positive regulation of acrosomal vesicle exocytosis;positive regulation of interleukin-4 production;cytoplasm;protein binding;binding of sperm to zona pellucida;positive regulation of phosphatidylinositol biosynthetic process;extracellular region;positive regulation of T cell proliferation;acrosin binding;positive regulation of type IV hypersensitivity;egg coat formation@NA
F98407@76428@76432@duplication@5@100333344@100336236@7@chr7:100333344-100336236@23.9@805@1149@1.43@CNVR3509.1@ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
F98407@76718@76718@deletion@1@102114809@102114982@7@chr7:102114809-102114982@4.81@30@6@0.2@CNVR3518.1@POLR2J_3@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J, 13.3kDa@:nucleoplasm;DNA binding;DNA repair;protein dimerization activity;nucleus;viral reproduction;gene expression;transcription initiation from RNA polymerase II promoter;7-methylguanosine mRNA capping;protein phosphorylation;LRR domain binding;protein kinase activity;DNA-directed RNA polymerase II, core complex;nucleotide-excision repair;transcription from RNA polymerase II promoter;DNA-directed RNA polymerase activity;protein binding;transcription-coupled nucleotide-excision repair;RNA splicing;mRNA splicing, via spliceosome;transcription, DNA-dependent;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription@NA
F98407@76754@76754@deletion@1@102219880@102220243@7@chr7:102219880-102220243@14.9@71@2@0.0282@CNVR3518.1@AC093668.1_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
F98407@76765@76779@duplication@15@102235753@102279646@7@chr7:102235753-102279646@19.9@230@407@1.77@CNVR3518.1@RASA4_11, RASA4_10, RASA4_9, RASA4_8, RASA4_7, RASA4_6, RASA4_5, RASA4_4, RASA4_3, RASA4_2, UPK3BL_7, RASA4_1, UPK3BL_6, UPK3BL_6, UPK3BL_5, UPK3BL_5, UPK3BL_4, UPK3BL_4@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
F98407@76794@76795@duplication@2@102313398@102319303@7@chr7:102313398-102319303@17.5@230@415@1.8@CNVR3518.1@AC105052.1_3, AC105052.1_2, AC105052.1_1@0@0@0@NA@NA@NA
F98407@79287@79287@deletion@1@143400089@143400710@7@chr7:143400089-143400710@4.72@62@29@0.468@CNVR3594.2, CNVR3594.1@FAM115C_2@0@0@0@:family with sequence similarity 115, member C;protein FAM115C-like@NA@NA
F98407@79309@79312@duplication@4@143880598@143956721@7@chr7:143880598-143956721@31.5@1080@1630@1.51@CNVR3598.4, CNVR3598.7@CTAGE4_1, ARHGEF35_2, OR2A42_1, OR2A7_1@0@0@0@:CTAGE family, member 4:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:olfactory receptor, family 2, subfamily A, member 7@:integral to membrane;nucleotide binding;cellular_component;biological_process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F98407@79315@79325@duplication@11@144059764@144072768@7@chr7:144059764-144072768@45.5@688@1139@1.66@CNVR3598.4, CNVR3598.5, CNVR3598.11@ARHGEF5_2, ARHGEF5_3, ARHGEF5_4, ARHGEF5_5, ARHGEF5_6, ARHGEF5_7, ARHGEF5_8, ARHGEF5_9, ARHGEF5_10, ARHGEF5_11, ARHGEF5_12@0@0@0@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
F98407@80368@80368@duplication@1@7274293@7274349@8@chr8:7274293-7274349@8@10@61@6.1@CNVR3771.8, CNVR3771.10, CNVR3771.4@DEFB4B_1@0@0@0@:defensin, beta 4B;defensin, beta 4A@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response@NA
F98407@80371@80375@deletion@5@7308236@7332590@8@chr8:7308236-7332590@16.4@434@248@0.571@CNVR3771.8, CNVR3771.10, CNVR3771.4@SPAG11B_3, SPAG11B_2, SPAG11B_1, DEFB104B_2, DEFB104B_1@0@0@0@:sperm associated antigen 11B:defensin, beta 104A;defensin, beta 104B@:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response:extracellular region;defense response to bacterium@NA
F98407@80393@80397@deletion@5@7679531@7686475@8@chr8:7679531-7686475@6.89@267@172@0.644@CNVR3772.4, CNVR3772.6, CNVR3772.2, CNVR3772.8, CNVR3772.10@DEFB105A_3, DEFB105A_2, DEFB105A_1, DEFB106A_1, DEFB106A_2@0@0@0@:defensin, beta 105B;defensin, beta 105A:defensin, beta 106B;defensin, beta 106A@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
F98407@80403@80406@deletion@4@7721024@7752292@8@chr8:7721024-7752292@18.5@220@92@0.418@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@SPAG11A_4, DEFB103A_1, DEFB103A_2, DEFB4A_1@0@0@0@:sperm associated antigen 11A;sperm associated antigen 11B:defensin, beta 103B;defensin, beta 103A:defensin, beta 4B;defensin, beta 4A@:extracellular region;defense response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response@NA
F98407@86351@86352@duplication@2@145438827@145439211@8@chr8:145438827-145439211@6.85@7@49@7@NA@FAM203B_3, FAM203B_4@0@0@0@:family with sequence similarity 203, member B@:binding@NA
F98407@88584@88602@deletion@19@43624656@43885072@9@chr9:43624656-43885072@54.7@523@188@0.359@CNVR4294.1@SPATA31A6_4, SPATA31A6_3, SPATA31A6_2, SPATA31A6_1, CNTNAP3B_1, CNTNAP3B_2, CNTNAP3B_3, CNTNAP3B_4, CNTNAP3B_5, CNTNAP3B_6, CNTNAP3B_7, CNTNAP3B_8, CNTNAP3B_9, CNTNAP3B_10, CNTNAP3B_11, CNTNAP3B_12, CNTNAP3B_13, CNTNAP3B_14, CNTNAP3B_15@0@0@0@:SPATA31 subfamily A, member 6:contactin associated protein-like 3B;contactin associated protein-like 3@:integral to membrane:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
F98407@95350@95360@duplication@11@17865074@17908770@10@chr10:17865074-17908770@30.5@615@959@1.56@NA@MRC1L1_2, MRC1L1_3, MRC1L1_4, MRC1L1_5, MRC1L1_6, MRC1L1_7, MRC1L1_8, MRC1L1_9, MRC1L1_10, MRC1L1_11, MRC1L1_12@0@0@0@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
F98407@95380@95393@deletion@14@18060293@18152611@10@chr10:18060293-18152611@52.7@367@88@0.24@NA@TMEM236_2, TMEM236_3, TMEM236_4, MRC1_1, MRC1_2, MRC1_3, MRC1_4, MRC1_5, MRC1_6, MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11@0@0@0@:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F98407@95947@95948@duplication@2@29578048@29580935@10@chr10:29578048-29580935@9.77@170@270@1.59@NA@LYZL1_1, LYZL1_2@0@0@0@:lysozyme-like 1@:extracellular region;lysozyme activity;cell wall macromolecule catabolic process@NA
F98407@96851@96852@duplication@2@51371542@51374428@10@chr10:51371542-51374428@5.69@70@121@1.73@NA@TIMM23B_1, TIMM23B_2@0@0@0@:translocase of inner mitochondrial membrane 23 homolog B (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process@NA
F98407@96933@96937@deletion@5@51970584@51978390@10@chr10:51970584-51978390@11.4@162@80@0.494@NA@ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
F98407@101608@101613@duplication@6@124344788@124352111@10@chr10:124344788-124352111@13@750@1000@1.33@CNVR4912.4, CNVR4912.3, CNVR4912.2@DMBT1_15, DMBT1_16, DMBT1_17, DMBT1_18, DMBT1_19, DMBT1_20@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
F98407@103269@103269@deletion@1@4976003@4976943@11@chr11:4976003-4976943@29.5@556@254@0.457@CNVR5040.1@OR51A2_1@0@0@0@:matrix metallopeptidase 26:olfactory receptor, family 51, subfamily A, member 2@:metallopeptidase activity;extracellular matrix;proteolysis;proteinaceous extracellular matrix;collagen catabolic process;metalloendopeptidase activity;zinc ion binding;metabolic process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F98407@103289@103289@duplication@1@5270599@5270820@11@chr11:5270599-5270820@5.25@59@105@1.78@NA@HBG1_2@0@0@0@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
F98407@103342@103342@deletion@1@5798891@5799864@11@chr11:5798891-5799864@10.3@676@440@0.651@CNVR5049.1@OR52N5_1@0@0@0@:tripartite motif containing 5:olfactory receptor, family 52, subfamily N, member 5@:defense response to virus;Golgi apparatus;intracellular;protein trimerization;ligase activity;cytoplasm;protein binding;nucleus;protein homodimerization activity;identical protein binding;zinc ion binding;cytoplasmic mRNA processing body;protein ubiquitination;virus-host interaction:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F98407@104442@104442@deletion@1@18267458@18267595@11@chr11:18267458-18267595@6.09@151@87@0.576@NA@SAA2_3@0@0@0@:serum amyloid A2@:extracellular region;high-density lipoprotein particle;acute-phase response@NA
F98407@104572@104572@duplication@1@18955364@18956331@11@chr11:18955364-18956331@16@1155@1645@1.42@CNVR5091.2, CNVR5091.1@MRGPRX1_1@0@0@0@:MAS-related GPR, member X1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;acute-phase response;G-protein coupled receptor signaling pathway@NA
F98407@106038@106040@deletion@3@55032377@55035848@11@chr11:55032377-55035848@33@153@1@0.00654@CNVR5178.5@TRIM48_2, TRIM48_3, TRIM48_4@0@0@0@:tripartite motif containing 48@:protein binding;intracellular;zinc ion binding@NA
F98407@106046@106048@duplication@3@55370918@55419315@11@chr11:55370918-55419315@16@2330@3032@1.3@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F98407@110121@110126@duplication@6@89768381@89774718@11@chr11:89768381-89774718@11.4@314@463@1.47@NA@TRIM49C_3, TRIM49C_4, TRIM49C_5, TRIM49C_6, TRIM49C_7, TRIM49C_8@0@0@0@:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;DNA binding;zinc ion binding@NA
F98407@114483@114483@duplication@1@11243900@11244828@12@chr12:11243900-11244828@15.8@992@1423@1.43@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
F98407@115537@115537@deletion@1@31249276@31249313@12@chr12:31249276-31249313@6.19@75@33@0.44@CNVR5483.1@DDX11_15@0@0@0@:DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11@:nucleoplasm;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;S phase of mitotic cell cycle;DNA binding;nucleobase-containing compound metabolic process;ATP binding;ATP-dependent DNA helicase activity;DNA helicase activity;midbody;RNA binding;DNA-dependent ATPase activity;nucleus;positive regulation of cell proliferation;virus-host interaction;nuclear chromatin;4 iron, 4 sulfur cluster binding;helicase activity;hydrolase activity, acting on acid anhydrides;DNA duplex unwinding;endoplasmic reticulum unfolded protein response;G2/M transition of mitotic cell cycle;protein binding;sister chromatid cohesion;activation of signaling protein activity involved in unfolded protein response;nucleolus;spindle pole;ATP-dependent helicase activity;metal ion binding;nucleic acid binding;mitotic sister chromatid segregation@: WARSAW BREAKAGE SYNDROME
F98407@124177@124177@deletion@1@24465429@24466200@13@chr13:24465429-24466200@6.65@1138@804@0.707@NA@C1QTNF9B_3@0@0@0@:C1q and tumor necrosis factor related protein 9B@:collagen;protein binding@NA
F98407@127333@127335@deletion@3@19553418@19559164@14@chr14:19553418-19559164@11.1@84@24@0.286@CNVR6072.1@POTEG_1, POTEG_2, POTEG_3@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
F98407@128880@128881@duplication@2@35565765@35565970@14@chr14:35565765-35565970@6.56@198@284@1.43@NA@PPP2R3C_9, PPP2R3C_8@0@0@0@:family with sequence similarity 177, member A1:protein phosphatase 2, regulatory subunit B'', gamma@:protein binding;centrosome;nucleus;calcium ion binding@NA
F98407@131032@131034@duplication@3@74004127@74010359@14@chr14:74004127-74010359@15.8@434@641@1.48@CNVR6188.1, CNVR6188.4@ACOT1_1, ACOT1_2, ACOT1_3@0@0@0@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
F98407@133432@133436@duplication@5@106539080@106573537@14@chr14:106539080-106573537@73.4@826@1562@1.89@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1, IGHV3-11_2@0@0@0@@:protein binding:protein binding:protein binding@NA
F98407@133458@133459@duplication@2@106791006@106791456@14@chr14:106791006-106791456@24.9@626@1009@1.61@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-30_2, IGHV3-30_1@0@0@0@@:protein binding@NA
F98407@133462@133463@deletion@2@106815723@106816173@14@chr14:106815723-106816173@55.2@276@8@0.029@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.56, CNVR6294.51@IGHV3-33_2, IGHV3-33_1@0@0@0@@:protein binding@NA
F98407@133467@133473@duplication@7@106845730@106926644@14@chr14:106845730-106926644@104@1695@3012@1.78@CNVR6294.26, CNVR6294.56, CNVR6294.18@IGHV3-35_1, IGHV3-38_2, IGHV3-38_1, IGHV4-39_2, IGHV4-39_1, IGHV3-43_2, IGHV3-43_1@0@0@0@@:protein binding:protein binding:protein binding:protein binding@NA
F98407@134431@134432@duplication@2@34673613@34674057@15@chr15:34673613-34674057@4.93@35@72@2.06@CNVR6351.4, CNVR6351.3@GOLGA8A_24, GOLGA8A_23@0@0@0@:golgin A8 family, member A@:Golgi cisterna membrane;Golgi apparatus@NA
F98407@134444@134448@deletion@5@34678827@34820278@15@chr15:34678827-34820278@10.4@55@6@0.109@CNVR6351.3@GOLGA8A_11, GOLGA8A_10, GOLGA8A_9, GOLGA8B_25, GOLGA8B_24@0@0@0@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
F98407@142703@142704@duplication@2@15116562@15120563@16@chr16:15116562-15120563@5@449@586@1.31@CNVR6646.1@PDXDC1_13, PDXDC1_14@0@0@0@:pyridoxal-dependent decarboxylase domain containing 1;pyridoxal-dependent decarboxylase domain-containing protein 1-like@:carboxylic acid metabolic process;pyridoxal phosphate binding;carboxy-lyase activity@NA
F98407@147109@147120@deletion@12@70161164@70178436@16@chr16:70161164-70178436@118@3299@1885@0.571@CNVR6764.1, CNVR6764.3@PDPR_4, PDPR_5, PDPR_6, PDPR_7, PDPR_8, PDPR_9, PDPR_10, PDPR_11, PDPR_12, PDPR_13, PDPR_14, PDPR_15@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
F98407@147122@147124@deletion@3@70182368@70190782@16@chr16:70182368-70190782@46.2@1645@911@0.554@CNVR6764.1, CNVR6764.3@PDPR_17, PDPR_18, PDPR_19@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
F98407@147421@147421@duplication@1@72093014@72093087@16@chr16:72093014-72093087@12@296@459@1.55@CNVR6769.1, CNVR6769.2@HP_6@0@0@0@:thioredoxin-like 4B:haptoglobin:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:cellular iron ion homeostasis;negative regulation of oxidoreductase activity;catalytic activity;negative regulation of hydrogen peroxide catabolic process;positive regulation of cell death;haptoglobin-hemoglobin complex;extracellular space;proteolysis;response to hydrogen peroxide;extracellular region;hemoglobin binding;defense response;serine-type endopeptidase activity:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@: ANHAPTOGLOBINEMIA; AHP
F98407@147497@147513@deletion@17@74415415@74452196@16@chr16:74415415-74452196@21.4@637@384@0.603@CNVR6778.2, CNVR6778.3@NPIPL2_2, NPIPL2_3, NPIPL2_4, NPIPL2_5, NPIPL2_6, NPIPL2_7, CLEC18B_13, CLEC18B_12, CLEC18B_11, CLEC18B_10, CLEC18B_9, CLEC18B_8, CLEC18B_7, CLEC18B_6, CLEC18B_5, CLEC18B_4, CLEC18B_3@0@0@0@:C-type lectin domain family 18, member B@:extracellular region:carbohydrate binding;protein binding;extracellular region@NA
F98407@149172@149172@deletion@1@2965964@2966901@17@chr17:2965964-2966901@11@563@355@0.631@NA@OR1D5_1@0@0@0@:olfactory receptor, family 1, subfamily D, member 5@:integral to membrane;sensory perception of smell;G-protein coupled receptor activity;plasma membrane;detection of chemical stimulus involved in sensory perception of smell;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F98407@151556@151561@duplication@6@16664740@16676947@17@chr17:16664740-16676947@12.1@1161@1511@1.3@NA@CCDC144A_13, CCDC144A_13, CCDC144A_14, CCDC144A_14, CCDC144A_15, CCDC144A_15, CCDC144A_16, CCDC144A_16, CCDC144A_17, CCDC144A_18, CCDC144A_17@0@0@0@:coiled-coil domain containing 144A@NA@NA
F98407@151875@151885@deletion@11@18380170@18397681@17@chr17:18380170-18397681@102@544@51@0.0938@CNVR7014.1@LGALS9C_1, LGALS9C_2, LGALS9C_3, LGALS9C_4, LGALS9C_5, LGALS9C_6, LGALS9C_7, LGALS9C_8, LGALS9C_9, LGALS9C_10, LGALS9C_11@0@0@0@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
F98407@152124@152124@duplication@1@20355109@20355196@17@chr17:20355109-20355196@4.72@95@147@1.55@CNVR7021.1, CNVR7021.3@LGALS9B_9@0@0@0@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
F98407@153380@153381@deletion@2@34539179@34539971@17@chr17:34539179-34539971@7.62@36@1@0.0278@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1_2, CCL4L1_3@0@0@0@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
F98407@153397@153400@duplication@4@34625572@34641537@17@chr17:34625572-34641537@8.23@154@240@1.56@CNVR7077.1, CNVR7077.2, CNVR7077.12@CCL3L1_1, CCL4L2_1, CCL4L2_2, CCL4L2_3@0@0@0@:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
F98407@153653@153660@duplication@8@36357159@36398302@17@chr17:36357159-36398302@67.1@3370@4697@1.39@CNVR7083.3@RP11-1407O15.2_9, RP11-1407O15.2_8, RP11-1407O15.2_7, RP11-1407O15.2_6, RP11-1407O15.2_5, RP11-1407O15.2_4, RP11-1407O15.2_3, RP11-1407O15.2_2@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
F98407@155580@155581@duplication@2@44171927@44249509@17@chr17:44171927-44249509@14.7@1978@2692@1.36@CNVR7114.3, CNVR7114.2@KANSL1_3, KANSL1_2@0@0@0@:KAT8 regulatory NSL complex subunit 1@:histone acetyltransferase activity (H4-K8 specific);histone acetyltransferase activity (H4-K16 specific);histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase complex;histone H4-K5 acetylation;MLL1 complex;histone H4-K16 acetylation;protein binding;histone H4-K8 acetylation;nucleus@NA
F98407@155587@155590@deletion@4@44399689@44409347@17@chr17:44399689-44409347@19.8@96@4@0.0417@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
F98407@155593@155595@deletion@3@44414663@44415089@17@chr17:44414663-44415089@20.3@92@0@0@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_12, LRRC37A_13, LRRC37A_14@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
F98407@155610@155612@duplication@3@44632519@44632945@17@chr17:44632519-44632945@10.8@125@220@1.76@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2_13, LRRC37A2_14, LRRC37A2_15@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
F98407@162017@162018@deletion@2@44542732@44550298@18@chr18:44542732-44550298@5.61@32@5@0.156@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
F98407@165960@165961@deletion@2@10751716@10752093@19@chr19:10751716-10752093@6.21@103@54@0.524@NA@AC011475.1_1, AC011475.1_2@0@0@0@:solute carrier family 44, member 2@:choline transmembrane transporter activity;phospholipid metabolic process;glycerophospholipid biosynthetic process;small molecule metabolic process;phosphatidylcholine biosynthetic process;signal transducer activity;transmembrane transport;positive regulation of I-kappaB kinase/NF-kappaB cascade;signal transduction;choline transport;integral to membrane;plasma membrane@NA
F98407@168952@168952@deletion@1@35862263@35863302@19@chr19:35862263-35863302@17.5@171@59@0.345@CNVR7627.1@GPR42_2@0@0@0@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
F98407@170099@170100@deletion@2@40380120@40382826@19@chr19:40380120-40382826@6.85@33@2@0.0606@CNVR7639.2@FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F98407@170109@170112@deletion@4@40399240@40406060@19@chr19:40399240-40406060@7.25@47@10@0.213@CNVR7639.2@FCGBP_13, FCGBP_12, FCGBP_11, FCGBP_10@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F98407@170367@170367@duplication@1@41381599@41381779@19@chr19:41381599-41381779@5.7@162@238@1.47@CNVR7642.1@CYP2A7_9@0@0@0@:cytochrome P450, family 2, subfamily A, polypeptide 7@:oxidation-reduction process;electron carrier activity;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;oxygen binding;heme binding;monooxygenase activity;endoplasmic reticulum membrane;iron ion binding@NA
F98407@170786@170802@duplication@17@43372216@43441228@19@chr19:43372216-43441228@60.1@2756@3790@1.38@CNVR7658.2@PSG1_5, PSG1_4, PSG1_3, PSG1_2, PSG1_1, PSG6_6, PSG6_5, PSG6_4, PSG6_3, PSG6_2, PSG6_1, PSG7_6, PSG7_5, PSG7_4, PSG7_3, PSG7_2, PSG7_1@0@0@0@:pregnancy specific beta-1-glycoprotein 1:pregnancy specific beta-1-glycoprotein 6:pregnancy specific beta-1-glycoprotein 7 (gene/pseudogene)@:protein binding;extracellular region;female pregnancy:protein binding;extracellular region;female pregnancy;molecular_function@NA
F98407@172989@172991@duplication@3@52146609@52147289@19@chr19:52146609-52147289@5.69@260@354@1.36@CNVR7702.1@SIGLEC14_7, SIGLEC14_6, SIGLEC14_5@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 14@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion;plasma membrane@NA
F98407@173296@173298@duplication@3@54724956@54726434@19@chr19:54724956-54726434@16.6@131@261@1.99@CNVR7721.3, CNVR7721.4@LILRB3_5, LILRB3_4, LILRB3_3@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F98407@173300@173301@deletion@2@54726816@54742965@19@chr19:54726816-54742965@5@374@256@0.684@CNVR7721.3, CNVR7721.4, CNVR7721.1@LILRB3_1, LILRA6_8@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F98407@173462@173464@duplication@3@55250012@55253725@19@chr19:55250012-55253725@6.61@392@522@1.33@CNVR7725.2, CNVR7725.4, CNVR7725.1@KIR2DL3_1, KIR2DL3_2, KIR2DL3_3@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity@NA
F98407@173467@173470@deletion@4@55263102@55281336@19@chr19:55263102-55281336@17@478@283@0.592@CNVR7725.2, CNVR7725.1@KIR2DL3_6, KIR2DL3_7, KIR2DL3_8, KIR2DL1_1@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
F98407@173492@173493@deletion@2@55341384@55341730@19@chr19:55341384-55341730@5.13@378@258@0.683@CNVR7725.1, CNVR7725.6@KIR3DL1_8, KIR3DL1_9@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
F98407@173500@173501@duplication@2@55359207@55359398@19@chr19:55359207-55359398@20.1@596@899@1.51@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4_7, KIR2DS4_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
F98407@174395@174395@deletion@1@1569207@1569278@20@chr20:1569207-1569278@10.9@51@1@0.0196@CNVR7763.1@RP4-576H24.4_1@0@0@0@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
F98407@178985@178988@duplication@4@10862623@10908895@21@chr21:10862623-10908895@13.3@2214@2840@1.28@CNVR7947.10, CNVR7947.6@IGHV1OR21-1_1, IGHV1OR21-1_2, TPTE_24, TPTE_23@0@0@0@:transmembrane phosphatase with tensin homology@:protein binding;extracellular region:phosphatase activity;ion channel activity;protein tyrosine phosphatase activity;ion transport;protein dephosphorylation;transmembrane transport;protein binding;signal transduction;integral to membrane;protein tyrosine/serine/threonine phosphatase activity;dephosphorylation;membrane;peptidyl-tyrosine dephosphorylation@NA
F98407@181487@181487@deletion@1@21065630@21065749@22@chr22:21065630-21065749@5.71@27@1@0.037@CNVR8099.6, CNVR8099.2@PI4KA_51@0@0@0@:phosphatidylinositol 4-kinase, catalytic, alpha@:phospholipid metabolic process;1-phosphatidylinositol 4-kinase activity;small molecule metabolic process;phosphatidylinositol phosphorylation;binding;transferase activity, transferring phosphorus-containing groups;phosphotransferase activity, alcohol group as acceptor;ATP binding;Golgi-associated vesicle;phosphatidylinositol biosynthetic process;cytosol;protein binding;signal transduction;synaptic transmission;kinase activity;phosphatidylinositol-mediated signaling@NA
F98407@181806@181808@deletion@3@23243157@23248831@22@chr22:23243157-23248831@13.5@361@207@0.573@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11@IGLC2_1, IGLJ3_1, IGLC3_1@0@0@0@@:protein binding:protein binding@NA
F98407@181948@181949@deletion@2@24324820@24325235@22@chr22:24324820-24325235@5.63@52@19@0.365@CNVR8114.6, CNVR8114.13, CNVR8114.8, CNVR8114.14@GSTT2_3, GSTT2_4@0@0@0@@:protein binding;glutathione transferase activity;nucleus;cytoplasm@NA
F98407@183631@183631@deletion@1@39357393@39357686@22@chr22:39357393-39357686@7.33@62@20@0.323@CNVR8164.1@APOBEC3A_4@0@0@0@:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A;APOBEC3A and APOBEC3B deletion hybrid@:cytidine deamination;defense response to virus;negative regulation of viral genome replication;DNA cytosine deamination;clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine;catalytic activity;DNA demethylation;cytoplasm;innate immune response;cytidine deaminase activity;nucleus;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;cellular response to xenobiotic stimulus;zinc ion binding;negative regulation of transposition@NA
F98407@184146@184154@deletion@9@42523845@42537296@22@chr22:42523845-42537296@31.9@954@580@0.608@CNVR8168.1, CNVR8168.3, CNVR8168.2, CNVR8168.4@CYP2D6_6, CYP2D6_5, CYP2D6_4, CYP2D6_3, CYP2D6_2, CYP2D6_1, CYP2D7P1_5, CYP2D7P1_4, CYP2D7P1_3@0@0@0@:cytochrome P450, family 2, subfamily D, polypeptide 6@:oxidation-reduction process;mitochondrion;alkaloid catabolic process;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;drug catabolic process;endoplasmic reticulum membrane;response to organic substance;oxidative demethylation;endoplasmic reticulum;alkaloid metabolic process;negative regulation of binding;heme binding;xenobiotic metabolic process;dopamine metabolic process;steroid metabolic process;isoquinoline alkaloid metabolic process;arachidonic acid monooxygenase activity;arachidonic acid metabolic process;steroid 21-monooxygenase activity;negative regulation of cellular organofluorine metabolic process;oxidoreductase activity;monoterpenoid metabolic process;heterocycle metabolic process;drug binding;drug metabolic process;electron carrier activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;coumarin metabolic process:oxidation-reduction process;electron carrier activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;heme binding@: DRUG METABOLISM, POOR, CYP2D6-RELATED
F98407@184165@184177@duplication@13@42908917@42952594@22@chr22:42908917-42952594@62.6@711@1277@1.8@CNVR8171.2, CNVR8171.3@RRP7A_7, RRP7A_6, RRP7A_5, RRP7A_4, RRP7A_3, RRP7A_2, RRP7A_1, SERHL2_1, SERHL2_2, SERHL2_3, SERHL2_4, SERHL2_5, SERHL2_6@0@0@0@:ribosomal RNA processing 7 homolog A (S. cerevisiae):serine hydrolase-like 2@:RNA binding;nucleotide binding:hydrolase activity;mitochondrion;peroxisome;cytoplasmic membrane-bounded vesicle;molecular_function;cellular_component;perinuclear region of cytoplasm;biological_process@NA
F98407@4072@4079@deletion@8@101615523@101620252@X@chrX:101615523-101620252@15.8@85@10@0.118@NA@NXF2B_34, NXF2B_33, NXF2B_32, NXF2B_31, NXF2B_30, NXF2B_29, NXF2B_28, NXF2B_27@0@0@0@NA@NA@NA
F98407@4884@4884@deletion@1@119210843@119211253@X@chrX:119210843-119211253@6.11@29@1@0.0345@NA@RHOXF2B_2@0@0@0@NA@NA@NA
F98407@5719@5719@duplication@1@140336520@140336590@X@chrX:140336520-140336590@8.66@72@141@1.96@CNVR8456.1@SPANXC_1@0@0@0@NA@NA@NA
F98407@6297@6307@duplication@11@153458900@153496256@X@chrX:153458900-153496256@14.5@123@236@1.92@CNVR8489.1@OPN1MW_5, OPN1MW_6, TEX28P1_4, TEX28P1_3, TEX28P1_2, TEX28P1_1, OPN1MW2_1, OPN1MW2_2, OPN1MW2_3, OPN1MW2_4, OPN1MW2_5@0@0@0@NA@NA@NA
F98468@6@7@deletion@2@69092@139309@1@chr1:69092-139309@11.7@62@6@0.0968@CNVR1.2@OR4F5_1, AL627309.1_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F98468@304@305@deletion@2@1362935@1371201@1@chr1:1362935-1371201@5.42@98@53@0.541@NA@TMEM88B_2, VWA1_1@0@0@0@:transmembrane protein 88B:von Willebrand factor A domain containing 1@:integral to membrane:extracellular matrix;protein binding;extracellular region;interstitial matrix;behavioral response to pain;basement membrane;extracellular matrix organization;identical protein binding@NA
F98468@338@338@deletion@1@1452548@1452792@1@chr1:1452548-1452792@11.8@60@3@0.05@NA@ATAD3A_3@0@0@0@:ATPase family, AAA domain containing 3A@:negative regulation of apoptotic process;mitochondrion;nucleoside-triphosphatase activity;mitochondrial inner membrane;cell growth;nucleotide binding;ATP binding;mitochondrial nucleoid;integral to membrane@NA
F98468@405@409@deletion@5@1580488@1581409@1@chr1:1580488-1581409@8.67@214@118@0.551@CNVR17.1@CDK11B_7, CDK11B_6, CDK11B_5, CDK11B_4, CDK11B_3@0@0@0@:cyclin-dependent kinase 11B@:protein serine/threonine kinase activity;protein tyrosine kinase activity;protein phosphorylation;protein kinase activity;cell division;transferase activity, transferring phosphorus-containing groups;ATP binding@NA
F98468@428@434@duplication@7@1637082@1643839@1@chr1:1637082-1643839@16.4@217@375@1.73@CNVR17.1@CDK11A_12, CDK11A_11, CDK11A_10, CDK11A_9, CDK11A_8, CDK11A_7, CDK11A_6@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
F98468@437@440@duplication@4@1653036@1666274@1@chr1:1653036-1666274@7.41@545@726@1.33@CNVR17.1@CDK11A_3, CDK11A_2, SLC35E2_6, SLC35E2_5@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A:solute carrier family 35, member E2@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division:integral to membrane;membrane@NA
F98468@606@606@deletion@1@2460909@2461188@1@chr1:2460909-2461188@6.58@104@49@0.471@NA@HES5_3@0@0@0@:hairy and enhancer of split 5 (Drosophila)@:nucleoplasm;regulation of cell differentiation;negative regulation of pro-B cell differentiation;cell maturation;negative regulation of transcription, DNA-dependent;comma-shaped body morphogenesis;negative regulation of forebrain neuron differentiation;neuron differentiation;positive regulation of tyrosine phosphorylation of Stat3 protein;oligodendrocyte development;auditory receptor cell differentiation;positive regulation of JAK-STAT cascade;specification of loop of Henle identity;chromatin binding;positive regulation of transcription, DNA-dependent;negative regulation of oligodendrocyte differentiation;positive regulation of Notch signaling pathway;transcription factor binding;cellular_component;camera-type eye development;negative regulation of astrocyte differentiation;positive regulation of BMP signaling pathway;RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription;neuronal stem cell maintenance;S-shaped body morphogenesis;smoothened signaling pathway;central nervous system myelination;DNA binding;telencephalon development;glial cell fate commitment;negative regulation of neuron differentiation;regulation of neurogenesis;protein dimerization activity;positive regulation of cell proliferation;positive regulation of transcription from RNA polymerase II promoter;negative regulation of inner ear receptor cell differentiation;astrocyte differentiation;negative regulation of stem cell differentiation;regulation of transcription, DNA-dependent;protein complex assembly;auditory receptor cell fate determination;regulation of myelination;protein binding;double-stranded DNA binding;Notch signaling pathway;brain development;negative regulation of transcription from RNA polymerase II promoter;forebrain radial glial cell differentiation;metanephric nephron tubule morphogenesis;cell adhesion;neural tube development;cartilage development;positive regulation of smooth muscle cell proliferation@NA
F98468@897@897@deletion@1@6240006@6240083@1@chr1:6240006-6240083@6.72@131@66@0.504@NA@CHD5_1@0@0@0@:chromodomain helicase DNA binding protein 5@:hydrolase activity;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;helicase activity;DNA binding;regulation of transcription, DNA-dependent;ATP binding;protein binding;nucleus;transcription, DNA-dependent;chromatin modification;zinc ion binding;ATP-dependent helicase activity;nucleic acid binding@NA
F98468@1259@1259@deletion@1@9883702@9883791@1@chr1:9883702-9883791@6.48@92@41@0.446@NA@CLSTN1_1@0@0@0@:calsyntenin 1@:Golgi membrane;integral to membrane;extracellular region;cell junction;homophilic cell adhesion;nucleus;plasma membrane;cell projection;endoplasmic reticulum membrane;postsynaptic membrane;membrane;calcium ion binding@NA
F98468@1825@1833@deletion@9@12998506@13219581@1@chr1:12998506-13219581@12@133@55@0.414@CNVR73.2@PRAMEF6_4, PRAMEF6_3, PRAMEF6_2, PRAMEF22_1, PRAMEF22_2, PRAMEF22_3, WI2-3308P17.2_1, WI2-2994D6.2_2, WI2-2994D6.2_1@0@0@0@:PRAME family member 6;PRAME family member 23;PRAME family member 9/15-like;PRAME family member 5:PRAME family member 22:PRAME family member@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
F98468@2170@2173@deletion@4@17248515@17256526@1@chr1:17248515-17256526@14.1@978@642@0.656@CNVR94.4, CNVR94.5, CNVR94.6@CROCC_1, CROCC_2, CROCC_3, CROCC_4@0@0@0@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
F98468@2181@2186@deletion@6@17265405@17273486@1@chr1:17265405-17273486@6.17@564@390@0.691@CNVR94.4, CNVR94.5@CROCC_12, CROCC_13, CROCC_14, CROCC_15, CROCC_16, CROCC_17@0@0@0@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
F98468@2788@2788@deletion@1@21806545@21806716@1@chr1:21806545-21806716@4.83@29@5@0.172@CNVR107.2, CNVR107.1@NBPF3_11@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 3@:cytoplasm@NA
F98468@3334@3342@duplication@9@25611065@25655415@1@chr1:25611065-25655415@18.3@1355@1828@1.35@CNVR116.1, CNVR116.2@RHD_2, RHD_3, RHD_4, RHD_5, RHD_6, RHD_7, RHD_8, RHD_9, RHD_10@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
F98468@3357@3357@deletion@1@25735175@25735360@1@chr1:25735175-25735360@20.4@99@1@0.0101@CNVR117.1@RHCE_2@0@0@0@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
F98468@5196@5196@duplication@1@40235375@40236927@1@chr1:40235375-40236927@5.33@395@552@1.4@NA@OXCT2_1@0@0@0@:bone morphogenetic protein 8b:3-oxoacid CoA transferase 2@:cell differentiation;growth factor activity;extracellular space;growth;extracellular region;cytokine activity;cartilage development;skeletal system development;ossification:mitochondrion;microtubule-based flagellum;CoA-transferase activity;ketone body catabolic process;3-oxoacid CoA-transferase activity;metabolic process@NA
F98468@9436@9436@deletion@1@108769302@108769515@1@chr1:108769302-108769515@9.15@56@9@0.161@CNVR294.4@NBPF4_14@0@0@0@:neuroblastoma breakpoint family, member 4@:cytoplasm@NA
F98468@9766@9773@deletion@8@110230497@110235917@1@chr1:110230497-110235917@96.8@455@2@0.0044@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
F98468@12117@12118@deletion@2@152573209@152586574@1@chr1:152573209-152586574@30.9@145@0@0@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
F98468@14437@14437@deletion@1@168511232@168511345@1@chr1:168511232-168511345@5.3@78@36@0.462@NA@XCL2_2@0@0@0@:chemokine (C motif) ligand 2@:blood circulation;chemotaxis;extracellular space;signal transduction;extracellular region;immune response;chemokine activity@NA
F98468@16029@16040@deletion@12@196744018@196801129@1@chr1:196744018-196801129@39.4@2239@1461@0.653@CNVR459.1@CFHR3_1, CFHR3_2, CFHR3_3, CFHR3_4, CFHR3_5, CFHR3_6, CFHR1_1, CFHR1_2, CFHR1_3, CFHR1_4, CFHR1_5, CFHR1_6@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
F98468@22310@22310@deletion@1@39893116@39893514@2@chr2:39893116-39893514@5.23@265@165@0.623@NA@TMEM178A_1@0@0@0@:transmembrane protein 178A@:integral to membrane@NA
F98468@24979@24981@deletion@3@89923730@89953355@2@chr2:89923730-89953355@5.83@118@66@0.559@CNVR867.4, CNVR867.10@IGKV1D-37_2, IGKV1D-33_1, IGKV1D-33_2@0@0@0@@:protein binding:protein binding@NA
F98468@33398@33399@duplication@2@233245131@233245467@2@chr2:233245131-233245467@6.23@249@354@1.42@NA@ALPP_7, ALPP_8@0@0@0@:alkaline phosphatase, placental@:phosphatase activity;catalytic activity;integral to membrane;plasma membrane;metabolic process;cell surface;anchored to membrane;alkaline phosphatase activity;metal ion binding@NA
F98468@33408@33412@deletion@5@233272978@233274158@2@chr2:233272978-233274158@42.4@441@159@0.361@NA@ALPPL2_6, ALPPL2_7, ALPPL2_8, ALPPL2_9, ALPPL2_10@0@0@0@:alkaline phosphatase, placental-like 2@:phosphatase activity;catalytic activity;phosphorylation;plasma membrane;metabolic process;membrane;anchored to membrane;alkaline phosphatase activity;metal ion binding@NA
F98468@34148@34148@duplication@1@241621649@241622254@2@chr2:241621649-241622254@10.1@136@258@1.9@NA@AQP12B_1@0@0@0@:aquaporin 12B@:transport;integral to membrane;transporter activity;membrane@NA
F98468@34150@34150@deletion@1@241631332@241631938@2@chr2:241631332-241631938@25.2@126@2@0.0159@NA@AQP12A_1, AQP12A_2@0@0@0@:aquaporin 12A@:transport;integral to membrane;transporter activity;membrane@NA
F98468@37500@37501@duplication@2@48607159@48607348@3@chr3:48607159-48607348@5.23@457@608@1.33@NA@COL7A1_100, COL7A1_99@0@0@0@:collagen, type VII, alpha 1@:extracellular matrix;extracellular matrix organization;endoplasmic reticulum lumen;serine-type endopeptidase inhibitor activity;protein binding;extracellular region;cell adhesion;basement membrane;collagen type VII;epidermis development@: NAIL DISORDER, NONSYNDROMIC CONGENITAL, 8; NDNC8; EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL; EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL DOMINANT; DDEB; EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB; EPIDERMOLYSIS BULLOSA WITH CONGENITAL LOCALIZED ABSENCE OF SKIN AND; EPIDERMOLYSIS BULLOSA PRURIGINOSA; TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN; TBDN
F98468@45433@45438@duplication@6@195447880@195475935@3@chr3:195447880-195475935@25.7@2160@3045@1.41@CNVR1703.1, CNVR1703.2, CNVR1703.5, CNVR1703.3@MUC20_1, MUC20_2, MUC20_3, MUC20_4, MUC4_25, MUC4_24@0@0@0@:mucin 20, cell surface associated:mucin 4, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane:ErbB-2 class receptor binding;Golgi lumen;cell-matrix adhesion;post-translational protein modification;extracellular matrix structural constituent;protein binding;O-glycan processing;cellular protein metabolic process;proteinaceous extracellular matrix;integral to plasma membrane;membrane;extracellular matrix constituent, lubricant activity;biological_process@NA
F98468@46035@46035@deletion@1@2061240@2061614@4@chr4:2061240-2061614@5@155@90@0.581@CNVR1760.1@NAT8L_1@0@0@0@:N-acetyltransferase 8-like (GCN5-related, putative)@:positive regulation of dopamine uptake involved in synaptic transmission;aspartate N-acetyltransferase activity;integral to membrane;mitochondrial membrane;endoplasmic reticulum membrane;N-acetyltransferase activity;rough endoplasmic reticulum membrane;cytoplasm@: N-ACETYLASPARTATE DEFICIENCY; NACED
F98468@48967@48969@duplication@3@75312252@75316249@4@chr4:75312252-75316249@19@124@307@2.48@NA@AREG_2, AREG_3, AREG_4@0@0@0@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
F98468@48972@48974@deletion@3@75482007@75486006@4@chr4:75482007-75486006@31.1@149@0@0@NA@AREGB_2, AREGB_3, AREGB_4@0@0@0@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
F98468@51672@51672@deletion@1@145041644@145041741@4@chr4:145041644-145041741@7.6@147@73@0.497@NA@GYPA_2@0@0@0@:glycophorin B (MNS blood group):glycophorin A (MNS blood group)@:integral to membrane;plasma membrane;integral to plasma membrane:external side of plasma membrane;integral to membrane;cytoskeletal anchoring at plasma membrane;plasma membrane;molecular_function;protein homodimerization activity;integral to plasma membrane;cellular_component;identical protein binding;membrane;biological_process;regulation of response to osmotic stress;virus-host interaction@: BLOOD GROUP--Ss LOCUS; Ss: MALARIA, SUSCEPTIBILITY TO; BLOOD GROUP--MN LOCUS; MN
F98468@53189@53191@deletion@3@190947540@190948359@4@chr4:190947540-190948359@5.85@259@160@0.618@CNVR2258.3@FRG2_3, FRG2_2, FRG2_1@0@0@0@:FSHD region gene 2-like;FSHD region gene 2@:nucleus@NA
F98468@53306@53311@deletion@6@741710@756259@5@chr5:741710-756259@27.9@391@184@0.471@CNVR2280.3@ZDHHC11B_7, ZDHHC11B_6, ZDHHC11B_5, ZDHHC11B_4, ZDHHC11B_3, ZDHHC11B_2@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
F98468@53318@53320@duplication@3@833889@840765@5@chr5:833889-840765@6.41@796@1042@1.31@CNVR2280.3, CNVR2280.8@ZDHHC11_7, ZDHHC11_6, ZDHHC11_5@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
F98468@53816@53816@deletion@1@14143836@14143991@5@chr5:14143836-14143991@6@50@15@0.3@CNVR2362.1@TRIO_1@0@0@0@:trio Rho guanine nucleotide exchange factor@:phospholipid binding;transmembrane receptor protein tyrosine phosphatase signaling pathway;protein tyrosine kinase activity;phosphotransferase activity, alcohol group as acceptor;transferase activity, transferring phosphorus-containing groups;guanyl-nucleotide exchange factor activity;ATP binding;apoptotic process;regulation of small GTPase mediated signal transduction;protein serine/threonine kinase activity;lipopolysaccharide biosynthetic process;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;protein phosphorylation;intracellular;protein kinase activity;axon guidance;Rho guanyl-nucleotide exchange factor activity;cytosol;protein binding;nerve growth factor receptor signaling pathway;membrane@NA
F98468@55783@55783@duplication@1@68862417@68862452@5@chr5:68862417-68862452@7.98@63@136@2.16@CNVR2494.7, CNVR2494.46@GTF2H2C_4@0@0@0@:general transcription factor IIH, polypeptide 2C;general transcription factor IIH, polypeptide 2D@:regulation of transcription, DNA-dependent;nucleotide-excision repair;DNA repair;core TFIIH complex;protein binding;nucleus;transcription, DNA-dependent;zinc ion binding@NA
F98468@59064@59065@duplication@2@140552418@140560021@5@chr5:140552418-140560021@35.8@3867@7316@1.89@CNVR2624.1@PCDHB7_1, PCDHB8_1@0@0@0@:protocadherin beta 7:protocadherin beta 8@:integral to membrane;calcium-dependent cell-cell adhesion;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding@NA
F98468@59488@59488@deletion@1@147553798@147553933@5@chr5:147553798-147553933@32.5@162@0@0@CNVR2637.2, CNVR2637.1@SPINK14_3@0@0@0@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
F98468@60875@60877@duplication@3@175386973@175388437@5@chr5:175386973-175388437@12@159@275@1.73@NA@THOC3_6, THOC3_5, THOC3_4@0@0@0@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
F98468@61266@61266@duplication@1@177163581@177163610@5@chr5:177163581-177163610@5.32@74@130@1.76@NA@FAM153A_11@0@0@0@:family with sequence similarity 153, member A@NA@NA
F98468@61369@61369@deletion@1@178154001@178154126@5@chr5:178154001-178154126@7.24@368@222@0.603@NA@ZNF354A_3@0@0@0@:zinc finger protein 354A@:intracellular;kidney development;DNA binding;regulation of transcription from RNA polymerase II promoter;sensory perception of sound;response to hypoxia;regulation of transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity;response to folic acid;negative regulation of transcription from RNA polymerase II promoter;nucleolus;nucleolar fragmentation;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
F98468@62954@62957@duplication@4@29911900@29913058@6@chr6:29911900-29913058@6.61@835@1080@1.29@CNVR2829.7, CNVR2829.2, CNVR2829.3@HLA-A_6, HLA-A_7, HLA-A_8, HLA-A_9@0@0@0@:major histocompatibility complex, class I, A@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO
F98468@63282@63282@deletion@1@31237988@31238262@6@chr6:31237988-31238262@12.5@194@81@0.418@CNVR2838.1@HLA-C_4@0@0@0@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
F98468@63725@63726@duplication@2@31962023@31962484@6@chr6:31962023-31962484@10.8@150@260@1.73@CNVR2843.6, CNVR2843.3@C4A_20, C4A_21@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
F98468@63733@63733@duplication@1@31964207@31964377@6@chr6:31964207-31964377@7.75@157@262@1.67@CNVR2843.6, CNVR2843.3@C4A_28@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
F98468@63772@63775@duplication@4@31995846@31996838@6@chr6:31995846-31996838@19.7@238@445@1.87@CNVR2843.6, CNVR2843.5@C4B_24, C4B_25, C4B_26, C4B_27@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
F98468@63790@63794@duplication@5@32006201@32007424@6@chr6:32006201-32007424@11@652@895@1.37@CNVR2843.6, CNVR2843.5@CYP21A2_1, CYP21A2_2, CYP21A2_3, CYP21A2_4, CYP21A2_5@0@0@0@:cytochrome P450, family 21, subfamily A, polypeptide 2@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY
F98468@63798@63803@duplication@6@32008446@32010139@6@chr6:32008446-32010139@7.42@205@298@1.45@CNVR2843.6, CNVR2843.5@CYP21A2_9, CYP21A2_10, TNXB_13, TNXB_12, TNXB_11, TNXB_10@0@0@0@:cytochrome P450, family 21, subfamily A, polypeptide 2:tenascin-X-like;tenascin XB@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
F98468@63811@63812@duplication@2@32012159@32012996@6@chr6:32012159-32012996@5.68@127@201@1.58@CNVR2843.6, CNVR2843.5@TNXB_2, TNXB_1@0@0@0@:tenascin-X-like;tenascin XB@:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
F98468@63953@63974@deletion@22@32485517@32634384@6@chr6:32485517-32634384@174@2258@974@0.431@CNVR2845.21, CNVR2845.25, CNVR2845.24@HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2, HLA-DRB5_1, HLA-DRB1_5, HLA-DRB1_4, HLA-DRB1_3, HLA-DRB1_2, HLA-DRB1_1, HLA-DQA1_1, HLA-DQA1_2, HLA-DQA1_3, HLA-DQA1_4, HLA-DQB1_5, HLA-DQB1_4, HLA-DQB1_3, HLA-DQB1_2, HLA-DQB1_1@0@0@0@:major histocompatibility complex, class II, DR beta 5:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
F98468@64602@64605@deletion@4@35754776@35763630@6@chr6:35754776-35763630@12.2@1136@769@0.677@CNVR2861.1@CLPSL1_2, CLPSL1_3, CLPS_3, CLPS_2@0@0@0@:colipase-like 1:colipase, pancreatic@:extracellular region;enzyme activator activity;digestion;lipid catabolic process:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
F98468@71013@71015@duplication@3@167592500@167595404@6@chr6:167592500-167595404@6.15@177@264@1.49@NA@TCP10L2_6, TCP10L2_7, TCP10L2_8@0@0@0@:t-complex 10;t-complex 10-like 2@NA@NA
F98468@71027@71028@deletion@2@167786658@167787939@6@chr6:167786658-167787939@11.3@479@301@0.628@NA@TCP10_8, TCP10_7@0@0@0@:t-complex 10@:cytosol@NA
F98468@71030@71030@deletion@1@167790035@167790192@6@chr6:167790035-167790192@9.08@43@1@0.0233@NA@TCP10_5@0@0@0@:t-complex 10@:cytosol@NA
F98468@71773@71778@duplication@6@6000323@6017388@7@chr7:6000323-6017388@7.33@310@433@1.4@NA@RSPH10B_5, RSPH10B_4, RSPH10B_3, RSPH10B_2, PMS2_15, PMS2_14@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas):PMS2 postmeiotic segregation increased 2 (S. cerevisiae)@:response to drug;DNA binding;MutSalpha complex binding;ATP binding;mismatch repair;DNA repair;mismatched DNA binding;ATPase activity;nucleus;mismatch repair complex;reciprocal meiotic recombination;ATP catabolic process;single-stranded DNA binding;response to DNA damage stimulus;single base insertion or deletion binding;protein binding;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;MutLalpha complex;endonuclease activity@: COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4; MISMATCH REPAIR CANCER SYNDROME
F98468@71922@71925@deletion@4@6797310@6803732@7@chr7:6797310-6803732@14.5@275@135@0.491@NA@RSPH10B2_2, RSPH10B2_3, RSPH10B2_4, RSPH10B2_5@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F98468@71932@71941@deletion@10@6819242@6838910@7@chr7:6819242-6838910@46.6@547@221@0.404@NA@RSPH10B2_12, RSPH10B2_13, RSPH10B2_14, RSPH10B2_15, RSPH10B2_16, RSPH10B2_17, RSPH10B2_18, RSPH10B2_19, RSPH10B2_20, CCZ1B_15@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F98468@73260@73263@duplication@4@38388957@38393784@7@chr7:38388957-38393784@7.58@1004@1314@1.31@CNVR3354.3, CNVR3354.1@TRGV5_2, TRGV5_1, TRGV4_2, TRGV4_1@0@0@0@@:protein binding:protein binding@NA
F98468@74296@74297@deletion@2@72430414@72430782@7@chr7:72430414-72430782@5@102@55@0.539@NA@TRIM74_5, TRIM74_4@0@0@0@:tripartite motif containing 74@:protein binding;intracellular;zinc ion binding@NA
F98468@74382@74382@deletion@1@73082290@73082426@7@chr7:73082290-73082426@5.82@89@42@0.472@NA@VPS37D_1@0@0@0@:vacuolar protein sorting 37 homolog D (S. cerevisiae)@:endosome membrane;egress of virus within host cell;cellular membrane organization;protein transport;late endosome membrane;endosomal transport;viral reproduction@NA
F98468@74578@74578@deletion@1@74172293@74172333@7@chr7:74172293-74172333@4.78@44@15@0.341@NA@GTF2I_33@0@0@0@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
F98468@74655@74656@duplication@2@75034123@75034491@7@chr7:75034123-75034491@6.35@121@194@1.6@NA@TRIM73_4, TRIM73_5@0@0@0@:tripartite motif containing 73@:protein binding;intracellular;zinc ion binding@NA
F98468@76427@76432@duplication@6@100331793@100336236@7@chr7:100331793-100336236@17.8@950@1313@1.38@CNVR3509.1@ZAN_1, ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
F98468@76779@76779@deletion@1@102279571@102279646@7@chr7:102279571-102279646@9.85@158@70@0.443@CNVR3518.1@UPK3BL_4, UPK3BL_4@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
F98468@78844@78844@deletion@1@139876545@139876737@7@chr7:139876545-139876737@8.35@249@136@0.546@CNVR3583.1@JHDM1D_1@0@0@0@:jumonji C domain containing histone demethylase 1 homolog D (S. cerevisiae)@:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors;histone H3-K36 demethylation;histone demethylase activity (H3-K27 specific);nucleus;methylated histone residue binding;histone demethylase activity (H3-K9 specific);histone H3-K9 demethylation;histone demethylase activity (H4-K20 specific);protein binding;positive regulation of transcription, DNA-dependent;nucleolus;transcription, DNA-dependent;iron ion binding;histone demethylase activity (H3-K36 specific);zinc ion binding;histone H3-K27 demethylation;histone H4-K20 demethylation;midbrain development@NA
F98468@79311@79311@deletion@1@143929005@143929936@7@chr7:143929005-143929936@6.14@47@13@0.277@CNVR3598.4, CNVR3598.7@OR2A42_1@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F98468@80387@80388@deletion@2@7636684@7637611@8@chr8:7636684-7637611@10.1@46@0@0@CNVR3772.4, CNVR3772.6, CNVR3772.2, CNVR3772.8, CNVR3772.10@AC084121.16_4, AC084121.16_3@0@0@0@:uncharacterized LOC100133251@NA@NA
F98468@80402@80403@deletion@2@7718169@7721057@8@chr8:7718169-7721057@26.8@195@45@0.231@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@SPAG11A_3, SPAG11A_4@0@0@0@:sperm associated antigen 11A;sperm associated antigen 11B@:extracellular region;defense response@NA
F98468@87484@87484@deletion@1@21440508@21441076@9@chr9:21440508-21441076@7.11@408@250@0.613@NA@IFNA1_1@0@0@0@:interferon, alpha 1@:defense response to virus;type I interferon-mediated signaling pathway;regulation of type I interferon-mediated signaling pathway;innate immune response;interferon-alpha/beta receptor binding;blood coagulation;extracellular space;extracellular region;cytokine receptor binding;cytokine activity;cytokine-mediated signaling pathway;defense response@NA
F98468@88530@88532@duplication@3@40772096@40784603@9@chr9:40772096-40784603@5.74@777@1012@1.3@CNVR4274.1@ZNF658_5, ZNF658_4, ZNF658_3@0@0@0@:zinc finger protein 658@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
F98468@88584@88602@deletion@19@43624656@43885072@9@chr9:43624656-43885072@67.4@595@176@0.296@CNVR4294.1@SPATA31A6_4, SPATA31A6_3, SPATA31A6_2, SPATA31A6_1, CNTNAP3B_1, CNTNAP3B_2, CNTNAP3B_3, CNTNAP3B_4, CNTNAP3B_5, CNTNAP3B_6, CNTNAP3B_7, CNTNAP3B_8, CNTNAP3B_9, CNTNAP3B_10, CNTNAP3B_11, CNTNAP3B_12, CNTNAP3B_13, CNTNAP3B_14, CNTNAP3B_15@0@0@0@:SPATA31 subfamily A, member 6:contactin associated protein-like 3B;contactin associated protein-like 3@:integral to membrane:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
F98468@91247@91252@deletion@6@117088573@117094209@9@chr9:117088573-117094209@25@889@533@0.6@CNVR4448.1@ORM1_6, ORM2_1, ORM2_2, ORM2_3, ORM2_4, ORM2_5@0@0@0@:orosomucoid 1:orosomucoid 2@:protein binding;extracellular space;regulation of immune system process;transport;inflammatory response;extracellular region;acute-phase response:extracellular space;regulation of immune system process;transport;acute-phase response@NA
F98468@91382@91382@deletion@1@120176776@120177216@9@chr9:120176776-120177216@5.99@30@2@0.0667@NA@ASTN2_1@0@0@0@:astrotactin 2@:protein binding;integral to membrane@NA
F98468@93566@93566@deletion@1@138441155@138441176@9@chr9:138441155-138441176@17.3@83@1@0.012@CNVR4529.1@OBP2A_6@0@0@0@:odorant binding protein 2A@:odorant binding;sensory perception of chemical stimulus;response to stimulus;transport;extracellular region;sensory perception of smell;cellular_component@NA
F98468@94044@94044@deletion@1@139922528@139922592@9@chr9:139922528-139922592@7.04@66@22@0.333@NA@ABCA2_1@0@0@0@:ATP-binding cassette, sub-family A (ABC1), member 2:chromosome 9 open reading frame 139@:ATPase activity, coupled to transmembrane movement of substances;transport;ATP-binding cassette (ABC) transporter complex;response to drug;ATP binding;microtubule organizing center;cholesterol homeostasis;integral to membrane;ATPase activity;ATP catabolic process;lysosome;endosome;nucleoside-triphosphatase activity;regulation of transcription from RNA polymerase II promoter;lysosomal membrane;regulation of intracellular cholesterol transport;nucleotide binding;lipid metabolic process;response to steroid hormone stimulus;cytoplasmic membrane-bounded vesicle@NA
F98468@94328@94329@deletion@2@140484666@140500287@9@chr9:140484666-140500287@5.34@58@24@0.414@NA@ZMYND19_1, ARRDC1_1@0@0@0@:zinc finger, MYND-type containing 19:arrestin domain containing 1@:intracellular membrane-bounded organelle;synapse;Golgi apparatus;plasma membrane;zinc ion binding;membrane;cytoplasm:vacuolar transport;retromer complex@NA
F98468@94606@94606@duplication@1@5014394@5014502@10@chr10:5014394-5014502@5.38@279@400@1.43@NA@AKR1C1_6@0@0@0@:aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)@:trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity;bile acid and bile salt transport;oxidation-reduction process;phenanthrene 9,10-monooxygenase activity;indanol dehydrogenase activity;daunorubicin metabolic process;carboxylic acid binding;retinal metabolic process;response to organophosphorus;cholesterol homeostasis;ketosteroid monooxygenase activity;progesterone metabolic process;oxidoreductase activity;17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity;aldo-keto reductase (NADP) activity;digestion;androsterone dehydrogenase (B-specific) activity;doxorubicin metabolic process;alditol:NADP+ 1-oxidoreductase activity;bile acid binding;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;bile acid metabolic process;xenobiotic metabolic process;cytosol;protein homooligomerization;intestinal cholesterol absorption;cellular response to jasmonic acid stimulus@NA
F98468@94613@94613@deletion@1@5037949@5038057@10@chr10:5037949-5038057@10.9@152@62@0.408@NA@AKR1C2_6@0@0@0@:aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III);aldo-keto reductase family 1 member C2-like@:trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity;steroid metabolic process;oxidation-reduction process;phenanthrene 9,10-monooxygenase activity;prostaglandin F receptor activity;daunorubicin metabolic process;carboxylic acid binding;ketosteroid monooxygenase activity;progesterone metabolic process;oxidoreductase activity;digestion;positive regulation of cell proliferation;prostaglandin metabolic process;doxorubicin metabolic process;response to prostaglandin stimulus;positive regulation of protein kinase B signaling cascade;alditol:NADP+ 1-oxidoreductase activity;androsterone dehydrogenase (A-specific) activity;bile acid binding;G-protein coupled receptor signaling pathway;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;cytoplasm;cellular response to jasmonic acid stimulus@: 46,XY SEX REVERSAL 8; SRXY8
F98468@95350@95352@duplication@3@17865074@17875838@10@chr10:17865074-17875838@11.4@201@339@1.69@NA@MRC1L1_2, MRC1L1_3, MRC1L1_4@0@0@0@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
F98468@95380@95386@deletion@7@18060293@18122792@10@chr10:18060293-18122792@30.7@235@58@0.247@NA@TMEM236_2, TMEM236_3, TMEM236_4, MRC1_1, MRC1_2, MRC1_3, MRC1_4@0@0@0@:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F98468@95389@95391@duplication@3@18138509@18145281@10@chr10:18138509-18145281@11.8@134@262@1.96@NA@MRC1_7, MRC1_8, MRC1_9@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F98468@95393@95394@deletion@2@18152464@18155690@10@chr10:18152464-18155690@7.58@49@11@0.224@NA@MRC1_11, MRC1_12@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F98468@95926@95926@deletion@1@28822510@28822549@10@chr10:28822510-28822549@8.4@100@39@0.39@NA@WAC_1@0@0@0@:WW domain containing adaptor with coiled-coil@:histone H2B conserved C-terminal lysine ubiquitination;nuclear speck;RNA polymerase II core binding;histone monoubiquitination;spliceosomal complex;response to DNA damage stimulus;chromatin binding;protein binding;positive regulation of transcription, DNA-dependent;negative regulation of proteasomal ubiquitin-dependent protein catabolic process;nucleus;transcription, DNA-dependent;cell cycle checkpoint;positive regulation of macroautophagy@NA
F98468@95947@95947@deletion@1@29578048@29578159@10@chr10:29578048-29578159@7.42@120@56@0.467@NA@LYZL1_1@0@0@0@:lysozyme-like 1@:extracellular region;lysozyme activity;cell wall macromolecule catabolic process@NA
F98468@96932@96937@deletion@6@51965743@51978390@10@chr10:51965743-51978390@12.4@180@95@0.528@NA@ASAH2_12, ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
F98468@100761@100761@deletion@1@112257881@112258258@10@chr10:112257881-112258258@6.66@241@140@0.581@NA@DUSP5_1@0@0@0@:dual specificity phosphatase 5@:phosphatase activity;nucleoplasm;protein tyrosine phosphatase activity;negative regulation of transcription, DNA-dependent;protein dephosphorylation;inactivation of MAPK activity;MAP kinase tyrosine/serine/threonine phosphatase activity;endoderm formation;protein tyrosine/serine/threonine phosphatase activity;dephosphorylation;peptidyl-tyrosine dephosphorylation@NA
F98468@101609@101614@duplication@6@124345577@124353114@10@chr10:124345577-124353114@8.66@810@1054@1.3@CNVR4912.4, CNVR4912.3, CNVR4912.2@DMBT1_16, DMBT1_17, DMBT1_18, DMBT1_19, DMBT1_20, DMBT1_21@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
F98468@102576@102577@deletion@2@639434@640306@11@chr11:639434-640306@7.39@343@218@0.636@NA@DRD4_2, DRD4_3@0@0@0@:dopamine receptor D4@:neuronal cell body;positive regulation of kinase activity;short-term memory;behavioral response to cocaine;response to amphetamine;behavioral response to ethanol;negative regulation of protein secretion;plasma membrane;dendrite;adenylate cyclase-inhibiting dopamine receptor signaling pathway;axon;behavioral fear response;olfactory learning;regulation of inhibitory postsynaptic membrane potential;activation of MAPK activity;regulation of synaptic transmission;synaptic transmission, dopaminergic;arachidonic acid secretion;fear response;positive regulation of sodium:hydrogen antiporter activity;dopamine receptor activity, coupled via Gi/Go;dopamine metabolic process;membrane;adult locomotory behavior;positive regulation of dopamine uptake involved in synaptic transmission;cellular calcium ion homeostasis;regulation of neurotransmitter secretion;negative regulation of adenylate cyclase activity;vesicle membrane;terminal button;response to histamine;dopamine receptor signaling pathway;cell cortex;regulation of calcium-mediated signaling;dendritic spine;integral to membrane;integral to plasma membrane;drug binding;regulation of dopamine metabolic process;negative regulation of voltage-gated calcium channel activity;associative learning;G-protein coupled receptor signaling pathway;cytoplasm;dopamine binding;social behavior;dopamine receptor activity;protein binding;SH3 domain binding;potassium channel regulator activity;negative regulation of cAMP biosynthetic process@NA
F98468@103289@103290@deletion@2@5270599@5271034@11@chr11:5270599-5271034@7.33@66@21@0.318@NA@HBG1_2, HBG1_1@0@0@0@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
F98468@103828@103828@deletion@1@9595482@9596056@11@chr11:9595482-9596056@5.9@199@116@0.583@NA@WEE1_1@0@0@0@:WEE1 homolog (S. pombe)@:nucleoplasm;S phase of mitotic cell cycle;non-membrane spanning protein tyrosine kinase activity;mitotic cell cycle;protein tyrosine kinase activity;magnesium ion binding;transferase activity, transferring phosphorus-containing groups;G1/S transition of mitotic cell cycle;ATP binding;blood coagulation;peptidyl-tyrosine phosphorylation;establishment of cell polarity;nucleus;cell cycle checkpoint;microtubule cytoskeleton organization;cell division;regulation of cell cycle;protein serine/threonine kinase activity;protein phosphorylation;protein kinase activity;cytoplasm;G2/M transition of mitotic cell cycle;mitosis;protein binding;neuron projection morphogenesis@NA
F98468@106038@106040@deletion@3@55032377@55035848@11@chr11:55032377-55035848@8.41@178@96@0.539@CNVR5178.5@TRIM48_2, TRIM48_3, TRIM48_4@0@0@0@:tripartite motif containing 48@:protein binding;intracellular;zinc ion binding@NA
F98468@106046@106048@duplication@3@55370918@55419315@11@chr11:55370918-55419315@5.84@2631@3345@1.27@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F98468@110126@110126@deletion@1@89774220@89774718@11@chr11:89774220-89774718@5.2@301@190@0.631@NA@TRIM49C_8@0@0@0@:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;DNA binding;zinc ion binding@NA
F98468@111509@111511@duplication@3@117077398@117078780@11@chr11:117077398-117078780@5.21@152@225@1.48@NA@PCSK7_16, PCSK7_15, PCSK7_14@0@0@0@:proprotein convertase subtilisin/kexin type 7@:proteolysis;integral to Golgi membrane;serine-type endopeptidase activity;peptide hormone processing@NA
F98468@114424@114426@deletion@3@10583717@10586541@12@chr12:10583717-10586541@11.1@469@293@0.625@CNVR5430.1@KLRC2_6, KLRC2_5, KLRC2_4@0@0@0@:killer cell lectin-like receptor subfamily C, member 2@:carbohydrate binding:transmembrane signaling receptor activity;carbohydrate binding;protein binding;signal transduction;cellular defense response;integral to plasma membrane@NA
F98468@115537@115537@duplication@1@31249276@31249313@12@chr12:31249276-31249313@6.61@78@145@1.86@CNVR5483.1@DDX11_15@0@0@0@:DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11@:nucleoplasm;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;S phase of mitotic cell cycle;DNA binding;nucleobase-containing compound metabolic process;ATP binding;ATP-dependent DNA helicase activity;DNA helicase activity;midbody;RNA binding;DNA-dependent ATPase activity;nucleus;positive regulation of cell proliferation;virus-host interaction;nuclear chromatin;4 iron, 4 sulfur cluster binding;helicase activity;hydrolase activity, acting on acid anhydrides;DNA duplex unwinding;endoplasmic reticulum unfolded protein response;G2/M transition of mitotic cell cycle;protein binding;sister chromatid cohesion;activation of signaling protein activity involved in unfolded protein response;nucleolus;spindle pole;ATP-dependent helicase activity;metal ion binding;nucleic acid binding;mitotic sister chromatid segregation@: WARSAW BREAKAGE SYNDROME
F98468@118987@118987@deletion@1@65004414@65004523@12@chr12:65004414-65004523@4.67@131@75@0.573@NA@RASSF3_1@0@0@0@:Ras association (RalGDS/AF-6) domain family member 3@:protein binding;signal transduction;microtubule;plasma membrane;identical protein binding;cytoplasm@NA
F98468@122586@122586@deletion@1@120806837@120806894@12@chr12:120806837-120806894@5.48@24@0@0@CNVR5701.1@MSI1_1@0@0@0@:musashi homolog 1 (Drosophila)@:single-stranded RNA binding;poly(U) RNA binding;nucleotide binding;cytoplasm;response to hormone stimulus;RNA binding;nucleus;polysome;nucleic acid binding;epithelial cell differentiation;nervous system development@NA
F98468@122599@122599@deletion@1@120907226@120907412@12@chr12:120907226-120907412@5.78@147@81@0.551@NA@SRSF9_1@0@0@0@:glutamyl-tRNA(Gln) amidotransferase, subunit C;serine/arginine-rich splicing factor 9@:nucleoplasm;mRNA 3'-end processing;RNA binding;nucleus;gene expression;mRNA splice site selection;negative regulation of mRNA splicing, via spliceosome;termination of RNA polymerase II transcription;nucleotide binding;transcription from RNA polymerase II promoter;mRNA export from nucleus;mRNA processing;nucleolus;mRNA splicing, via spliceosome;RNA splicing;nucleic acid binding@NA
F98468@123374@123374@duplication@1@124496693@124497477@12@chr12:124496693-124497477@5.17@737@1001@1.36@CNVR5712.1@ZNF664_6@0@0@0@:zinc finger protein 664@:intracellular;nucleus;DNA binding;molecular_function;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;biological_process@NA
F98468@124029@124029@deletion@1@21099894@21099933@13@chr13:21099894-21099933@4.65@47@18@0.383@NA@CRYL1_1@0@0@0@:crystallin, lambda 1@:L-gulonate 3-dehydrogenase activity;oxidation-reduction process;cytosol;oxidoreductase activity;fatty acid metabolic process;NAD+ binding;protein homodimerization activity;3-hydroxyacyl-CoA dehydrogenase activity@NA
F98468@124178@124178@duplication@1@24468279@24468340@13@chr13:24468279-24468340@4.96@223@321@1.44@NA@C1QTNF9B_2@0@0@0@:C1q and tumor necrosis factor related protein 9B@:collagen;protein binding@NA
F98468@127352@127353@deletion@2@20019701@20216528@14@chr14:20019701-20216528@4.97@706@504@0.714@CNVR6072.6, CNVR6072.12, CNVR6072.14@POTEM_1, OR4Q3_1@0@0@0@:POTE ankyrin domain family, member M:olfactory receptor, family 4, subfamily N, member 2:olfactory receptor, family 4, subfamily Q, member 3@:protein binding:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F98468@128787@128787@deletion@1@33408524@33408572@14@chr14:33408524-33408572@4.64@90@47@0.522@NA@NPAS3_1@0@0@0@:neuronal PAS domain protein 3@:locomotory behavior;maternal behavior;DNA binding;regulation of transcription, DNA-dependent;behavior;signal transducer activity;cytoplasm;social behavior;positive regulation of transcription, DNA-dependent;signal transduction;protein binding;protein dimerization activity;nucleus;transcription, DNA-dependent@NA
F98468@131032@131034@deletion@3@74004127@74010359@14@chr14:74004127-74010359@66@491@100@0.204@CNVR6188.1, CNVR6188.4@ACOT1_1, ACOT1_2, ACOT1_3@0@0@0@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
F98468@131037@131037@deletion@1@74041613@74042217@14@chr14:74041613-74042217@4.7@115@64@0.557@CNVR6188.1, CNVR6188.6@ACOT2_3@0@0@0@:acyl-CoA thioesterase 2@:acyl-CoA metabolic process;mitochondrion;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity;receptor binding@NA
F98468@132608@132608@deletion@1@100259815@100259880@14@chr14:100259815-100259880@4.91@52@20@0.385@CNVR6252.1@EML1_1@0@0@0@:echinoderm microtubule associated protein like 1@:protein binding;microtubule associated complex;microtubule;calcium ion binding;cytoplasm@NA
F98468@133426@133426@deletion@1@106478111@106478411@14@chr14:106478111-106478411@4.61@116@65@0.56@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV4-4_2@0@0@0@@:protein binding@NA
F98468@133432@133435@deletion@4@106539080@106552729@14@chr14:106539080-106552729@115@592@2@0.00338@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1@0@0@0@@:protein binding:protein binding@NA
F98468@133456@133463@duplication@8@106780514@106816173@14@chr14:106780514-106816173@69.1@1623@2988@1.84@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV4-28_2, IGHV4-28_1, IGHV3-30_2, IGHV3-30_1, IGHV4-31_2, IGHV4-31_1, IGHV3-33_2, IGHV3-33_1@0@0@0@:uncharacterized LOC100653243;uncharacterized LOC642131@:protein binding:protein binding:protein binding:protein binding@NA
F98468@133491@133492@deletion@2@107095127@107095561@14@chr14:107095127-107095561@14.6@91@15@0.165@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61_2, IGHV4-61_1@0@0@0@@:protein binding@NA
F98468@133495@133495@deletion@1@107131034@107131334@14@chr14:107131034-107131334@6.43@217@125@0.576@CNVR6294.56, CNVR6294.16@IGHV3-66_2@0@0@0@@:protein binding@NA
F98468@133542@133542@deletion@1@22382474@22383423@15@chr15:22382474-22383423@6.67@1087@718@0.661@CNVR6297.4, CNVR6297.17, CNVR6297.2@OR4N4_1@0@0@0@:olfactory receptor, family 4, subfamily N, member 4@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F98468@134011@134012@deletion@2@30664351@30665348@15@chr15:30664351-30665348@13.6@216@114@0.528@CNVR6337.1@CHRFAM7A_7, CHRFAM7A_6@0@0@0@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
F98468@134153@134154@duplication@2@32449810@32450807@15@chr15:32449810-32450807@9.16@184@294@1.6@CNVR6345.2, CNVR6345.1@CHRNA7_6, CHRNA7_7@0@0@0@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
F98468@137847@137847@deletion@1@66995598@66996413@15@chr15:66995598-66996413@6.76@205@115@0.561@NA@SMAD6_1@0@0@0@:SMAD family member 6@:negative regulation of apoptotic process;immune response;negative regulation of transforming growth factor beta receptor signaling pathway;R-SMAD binding;negative regulation of SMAD protein complex assembly;transforming growth factor beta receptor signaling pathway;response to estrogen stimulus;type I transforming growth factor beta receptor binding;nucleus;ubiquitin protein ligase binding;cell-substrate adhesion;intracellular;cytosol;chromatin binding;transcription, DNA-dependent;response to laminar fluid shear stress;negative regulation of BMP signaling pathway;type I activin receptor binding;ureteric bud development;sequence-specific DNA binding transcription factor activity;positive regulation of S phase of mitotic cell cycle;transcription factor complex;negative regulation of pathway-restricted SMAD protein phosphorylation;co-SMAD binding;transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity;I-SMAD binding;regulation of transcription, DNA-dependent;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;cytoplasm;protein binding;BMP signaling pathway;zygotic specification of dorsal/ventral axis;transcription regulatory region DNA binding@: AORTIC VALVE DISEASE 2; AOVD2
F98468@138284@138290@deletion@7@72954594@72958469@15@chr15:72954594-72958469@14.7@116@34@0.293@CNVR6443.1@GOLGA6B_11, GOLGA6B_12, GOLGA6B_13, GOLGA6B_14, GOLGA6B_15, GOLGA6B_16, GOLGA6B_17@0@0@0@:golgin A6 family, member B@:Golgi apparatus@NA
F98468@139134@139134@deletion@1@80696859@80696888@15@chr15:80696859-80696888@5.5@58@22@0.379@NA@ARNT2_1@0@0@0@:aryl-hydrocarbon receptor nuclear translocator 2@:negative regulation of apoptotic process;DNA binding;sequence-specific DNA binding transcription factor activity;transcription factor complex;aryl hydrocarbon receptor binding;protein dimerization activity;nucleus;positive regulation of cell proliferation;positive regulation of transcription from RNA polymerase II promoter;protein heterodimerization activity;regulation of transcription, DNA-dependent;response to hypoxia;in utero embryonic development;signal transducer activity;response to estradiol stimulus;cytoplasm;signal transduction;positive regulation of transcription, DNA-dependent;protein binding;central nervous system development;transcription, DNA-dependent@NA
F98468@140957@140960@duplication@4@1278651@1279738@16@chr16:1278651-1279738@5.64@145@213@1.47@CNVR6591.1@TPSB2_7, TPSB2_6, TPSB2_5, TPSB2_4, TPSB2_3@0@0@0@:tryptase beta 2 (gene/pseudogene)@:proteolysis;catalytic activity;serine-type endopeptidase activity@NA
F98468@142111@142112@deletion@2@4852384@4852572@16@chr16:4852384-4852572@7.27@115@58@0.504@CNVR6613.1@ROGDI_2, ROGDI_1@0@0@0@:rogdi homolog (Drosophila)@:nuclear envelope;intracellular;positive regulation of cell proliferation;hemopoiesis@: KOHLSCHUTTER-TONZ SYNDROME; KTZS
F98468@142918@142924@deletion@7@16349578@16360988@16@chr16:16349578-16360988@21.6@541@292@0.54@NA@NOMO3_10, NOMO3_11, NOMO3_12, NOMO3_13, NOMO3_14, NOMO3_15, NOMO3_16@0@0@0@:NODAL modulator 3@:carbohydrate binding;integral to membrane;carboxypeptidase activity@NA
F98468@143003@143005@duplication@3@18542789@18549998@16@chr16:18542789-18549998@6.02@379@518@1.37@NA@NOMO2_13, NOMO2_12, NOMO2_11@0@0@0@:NODAL modulator 2@:carbohydrate binding;protein binding;integral to membrane;carboxypeptidase activity;endoplasmic reticulum membrane@NA
F98468@144038@144039@deletion@2@28403074@28403463@16@chr16:28403074-28403463@8.14@156@81@0.519@CNVR6684.2@EIF3CL_10, EIF3CL_9@0@0@0@:eukaryotic translation initiation factor 3, subunit C-like@:protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;translation initiation factor activity@NA
F98468@144286@144289@duplication@4@29466720@29469336@16@chr16:29466720-29469336@6.03@38@84@2.21@CNVR6690.2, CNVR6690.3, CNVR6690.4@SLX1B_2, SLX1B_3, SLX1B_4, SLX1B_5@0@0@0@:structure-specific endonuclease subunit SLX1-like;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae);SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae):sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3;sulfotransferase 1A3/1A4-like@:Slx1-Slx4 complex;5'-flap endonuclease activity;DNA repair;protein binding;DNA double-strand break processing involved in repair via single-strand annealing;double-strand break repair via homologous recombination;metal ion binding;crossover junction endodeoxyribonuclease activity:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;cytoplasm;catecholamine metabolic process;cytosol;endoplasmic reticulum unfolded protein response;xenobiotic metabolic process;sulfotransferase activity;activation of signaling protein activity involved in unfolded protein response;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process@NA
F98468@144500@144503@deletion@4@30206208@30208787@16@chr16:30206208-30208787@6.47@49@14@0.286@CNVR6694.1, CNVR6694.2, CNVR6694.3@SLX1A_3, SLX1A_4, SLX1A_5, SLX1A_6@0@0@0@:structure-specific endonuclease subunit SLX1-like;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae);SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae):sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3;sulfotransferase 1A3/1A4-like@:Slx1-Slx4 complex;5'-flap endonuclease activity;DNA repair;protein binding;DNA double-strand break processing involved in repair via single-strand annealing;double-strand break repair via homologous recombination;metal ion binding;crossover junction endodeoxyribonuclease activity:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;cytoplasm;catecholamine metabolic process;cytosol;endoplasmic reticulum unfolded protein response;xenobiotic metabolic process;sulfotransferase activity;activation of signaling protein activity involved in unfolded protein response;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process@NA
F98468@147135@147135@duplication@1@70219789@70219879@16@chr16:70219789-70219879@5.22@53@102@1.92@CNVR6764.1, CNVR6764.5@CLEC18C_11@0@0@0@:C-type lectin domain family 18, member C@:carbohydrate binding;protein binding;extracellular region@NA
F98468@147276@147276@deletion@1@70719627@70719694@16@chr16:70719627-70719694@5.31@122@66@0.541@NA@MTSS1L_1@0@0@0@:metastasis suppressor 1-like@:filopodium assembly;actin binding;signal transduction;SH3 domain binding;cytoskeletal adaptor activity@NA
F98468@147420@147421@deletion@2@72092154@72093087@16@chr16:72092154-72093087@11@362@199@0.55@CNVR6769.1, CNVR6769.2@HP_5, HP_6@0@0@0@:thioredoxin-like 4B:haptoglobin:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:cellular iron ion homeostasis;negative regulation of oxidoreductase activity;catalytic activity;negative regulation of hydrogen peroxide catabolic process;positive regulation of cell death;haptoglobin-hemoglobin complex;extracellular space;proteolysis;response to hydrogen peroxide;extracellular region;hemoglobin binding;defense response;serine-type endopeptidase activity:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@: ANHAPTOGLOBINEMIA; AHP
F98468@147502@147513@deletion@12@74425290@74452196@16@chr16:74425290-74452196@14.6@635@402@0.633@CNVR6778.2, CNVR6778.3@NPIPL2_7, CLEC18B_13, CLEC18B_12, CLEC18B_11, CLEC18B_10, CLEC18B_9, CLEC18B_8, CLEC18B_7, CLEC18B_6, CLEC18B_5, CLEC18B_4, CLEC18B_3@0@0@0@:C-type lectin domain family 18, member B@:extracellular region:carbohydrate binding;protein binding;extracellular region@NA
F98468@148331@148331@deletion@1@88772580@88772733@16@chr16:88772580-88772733@5.26@57@22@0.386@NA@RNF166_1@0@0@0@:ring finger protein 166@:protein binding;intracellular;zinc ion binding@NA
F98468@148883@148883@deletion@1@1465836@1465854@17@chr17:1465836-1465854@5.2@76@35@0.461@NA@PITPNA_1@0@0@0@:phosphatidylinositol transfer protein, alpha@:phospholipid binding;transport;stearic acid binding;intracellular;phosphatidylinositol binding;axon guidance;phosphatidylcholine transporter activity;cytoplasm;phospholipid transport;lipid metabolic process;visual perception;phosphatidylinositol transporter activity;fatty-acyl-CoA binding@NA
F98468@151403@151405@deletion@3@15466752@15477497@17@chr17:15466752-15477497@14.3@1107@653@0.59@NA@TVP23C_1, TVP23C-CDRT4_1, CDRT1_1, TRIM16_17@0@0@0@:FAM18B2-CDRT4 readthrough:family with sequence similarity 18, member B2:CMT1A duplicated region transcript 1@:integral to membrane:integral to membrane:protein binding;molecular_function;cellular_component;biological_process:protein binding;intracellular;zinc ion binding;cytoplasm@NA
F98468@151533@151533@deletion@1@16395060@16395304@17@chr17:16395060-16395304@4.82@39@12@0.308@CNVR7007.1@FAM211A_1@0@0@0@:family with sequence similarity 211, member A@NA@NA
F98468@151556@151561@duplication@6@16664740@16676947@17@chr17:16664740-16676947@10.6@1279@1678@1.31@NA@CCDC144A_13, CCDC144A_13, CCDC144A_14, CCDC144A_14, CCDC144A_15, CCDC144A_15, CCDC144A_16, CCDC144A_16, CCDC144A_17, CCDC144A_18, CCDC144A_17@0@0@0@:coiled-coil domain containing 144A@NA@NA
F98468@151875@151885@deletion@11@18380170@18397681@17@chr17:18380170-18397681@94.4@564@69@0.122@CNVR7014.1@LGALS9C_1, LGALS9C_2, LGALS9C_3, LGALS9C_4, LGALS9C_5, LGALS9C_6, LGALS9C_7, LGALS9C_8, LGALS9C_9, LGALS9C_10, LGALS9C_11@0@0@0@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
F98468@151915@151915@duplication@1@18681789@18682611@17@chr17:18681789-18682611@6.74@792@1108@1.4@NA@FBXW10_14@0@0@0@:F-box/WD repeat-containing protein 10-like;F-box and WD repeat domain containing 10@:protein binding@NA
F98468@152012@152012@deletion@1@19437254@19437387@17@chr17:19437254-19437387@4.7@73@35@0.479@NA@SLC47A1_1@0@0@0@:solute carrier family 47, member 1@:drug transmembrane transport;drug transmembrane transporter activity;transmembrane transport;monovalent cation:hydrogen antiporter activity;antiporter activity;organic cation transport;integral to membrane;plasma membrane;membrane;membrane-bounded vesicle;drug transport@NA
F98468@152124@152124@duplication@1@20355109@20355196@17@chr17:20355109-20355196@5.17@119@187@1.57@CNVR7021.1, CNVR7021.3@LGALS9B_9@0@0@0@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
F98468@153381@153381@duplication@1@34539885@34539971@17@chr17:34539885-34539971@5.45@44@91@2.07@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1_3@0@0@0@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
F98468@153650@153660@duplication@11@36351930@36398302@17@chr17:36351930-36398302@89.2@4836@7455@1.54@CNVR7083.3@RP11-1407O15.2_12, RP11-1407O15.2_11, RP11-1407O15.2_10, RP11-1407O15.2_9, RP11-1407O15.2_8, RP11-1407O15.2_7, RP11-1407O15.2_6, RP11-1407O15.2_5, RP11-1407O15.2_4, RP11-1407O15.2_3, RP11-1407O15.2_2@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
F98468@154346@154346@deletion@1@39421631@39422112@17@chr17:39421631-39422112@7.98@52@10@0.192@CNVR7096.1@KRTAP9-6_1@0@0@0@:keratin associated protein 9-6@:keratin filament@NA
F98468@155587@155599@duplication@13@44399689@44592687@17@chr17:44399689-44592687@13@221@360@1.63@CNVR7114.2, CNVR7114.1@LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9, LRRC37A_10, LRRC37A_11, LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane@NA
F98468@157464@157464@deletion@1@61996128@61996136@17@chr17:61996128-61996136@5.32@64@27@0.422@CNVR7164.1@GH1_1@0@0@0@:chorionic somatomammotropin hormone-like 1:growth hormone 1@:hormone activity;extracellular region;cellular_component;metal ion binding;biological_process:positive regulation of MAP kinase activity;hormone activity;positive regulation of insulin-like growth factor receptor signaling pathway;JAK-STAT cascade;prolactin receptor binding;extracellular space;growth hormone receptor signaling pathway;positive regulation of tyrosine phosphorylation of Stat3 protein;positive regulation of JAK-STAT cascade;positive regulation of multicellular organism growth;glucose transport;growth hormone receptor binding;growth factor activity;JAK-STAT cascade involved in growth hormone signaling pathway;positive regulation of peptidyl-tyrosine phosphorylation;positive regulation of phosphatidylinositol 3-kinase cascade;response to estradiol stimulus;protein binding;bone maturation;extracellular region;positive regulation of tyrosine phosphorylation of Stat5 protein;positive regulation of activation of JAK2 kinase activity;metal ion binding@: ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IB; IGHD1B; KOWARSKI SYNDROME; ISOLATED GROWTH HORMONE DEFICIENCY, TYPE II; IGHD2; ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IA; IGHD1A
F98468@160319@160319@deletion@1@2847188@2847320@18@chr18:2847188-2847320@6.67@35@3@0.0857@NA@EMILIN2_1@0@0@0@:elastin microfibril interfacer 2@:collagen;protein binding;extracellular matrix constituent conferring elasticity;extracellular region;cell adhesion;biological_process@NA
F98468@162016@162018@deletion@3@44497286@44550298@18@chr18:44497286-44550298@8.31@271@172@0.635@NA@PIAS2_1, TCEB3CL2_1, TCEB3CL_1@0@0@0@:protein inhibitor of activated STAT, 2:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like@:nuclear body;nuclear speck;DNA binding;negative regulation of androgen receptor signaling pathway;transcription coactivator activity;protein sumoylation;PML body;nucleus;androgen receptor signaling pathway;androgen receptor binding;ubiquitin protein ligase binding;positive regulation of transcription from RNA polymerase II promoter;SUMO ligase activity;regulation of transcription from RNA polymerase II promoter;regulation of osteoblast differentiation;positive regulation of transcription, DNA-dependent;protein binding;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
F98468@164336@164337@duplication@2@4354947@4355170@19@chr19:4354947-4355170@9.55@193@309@1.6@NA@MPND_7, MPND_8@0@0@0@:MPN domain containing@:peptidase activity;protein binding;proteolysis@NA
F98468@166811@166812@duplication@2@14070580@14070881@19@chr19:14070580-14070881@8.81@425@605@1.42@NA@DCAF15_9, DCAF15_10@0@0@0@:DDB1 and CUL4 associated factor 15@:protein ubiquitination@NA
F98468@166916@166917@deletion@2@14508471@14508747@19@chr19:14508471-14508747@12.6@108@33@0.306@NA@CD97_7, CD97_8@0@0@0@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
F98468@167047@167047@deletion@1@14877791@14877921@19@chr19:14877791-14877921@12.3@126@41@0.325@NA@EMR2_6@0@0@0@:egf-like module containing, mucin-like, hormone receptor-like 2@:transmembrane signaling receptor activity;inflammatory response;G-protein coupled receptor activity;ruffle membrane;integral to membrane;plasma membrane;cell surface receptor signaling pathway;neuropeptide signaling pathway;granulocyte chemotaxis;cell migration;leading edge membrane;G-protein coupled receptor signaling pathway;protein binding;cell adhesion;membrane;calcium ion binding;chondroitin sulfate binding@NA
F98468@170093@170094@duplication@2@40367299@40368876@19@chr19:40367299-40368876@6.73@183@278@1.52@CNVR7639.2@FCGBP_29, FCGBP_28@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F98468@170098@170100@deletion@3@40376632@40382826@19@chr19:40376632-40382826@13.4@141@52@0.369@CNVR7639.2@FCGBP_24, FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F98468@170104@170109@duplication@6@40389653@40399855@19@chr19:40389653-40399855@25@470@762@1.62@CNVR7639.2, CNVR7639.3@FCGBP_18, FCGBP_17, FCGBP_16, FCGBP_15, FCGBP_14, FCGBP_13@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F98468@170788@170807@duplication@20@43375920@43530524@19@chr19:43375920-43530524@56.5@3872@5318@1.37@CNVR7658.2@PSG1_3, PSG1_2, PSG1_1, PSG6_6, PSG6_5, PSG6_4, PSG6_3, PSG6_2, PSG6_1, PSG7_6, PSG7_5, PSG7_4, PSG7_3, PSG7_2, PSG7_1, PSG11_5, PSG11_4, PSG11_3, PSG11_2, PSG11_1@0@0@0@:pregnancy specific beta-1-glycoprotein 1:pregnancy specific beta-1-glycoprotein 6:pregnancy specific beta-1-glycoprotein 7 (gene/pseudogene):pregnancy specific beta-1-glycoprotein 11@:protein binding;extracellular region;female pregnancy:protein binding;extracellular region;female pregnancy;molecular_function:protein binding;extracellular region;female pregnancy@NA
F98468@173295@173296@deletion@2@54724399@54725251@19@chr19:54724399-54725251@11.8@204@98@0.48@CNVR7721.3, CNVR7721.4@LILRB3_6, LILRB3_5@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F98468@173298@173302@deletion@5@54726151@54743827@19@chr19:54726151-54743827@9.61@637@423@0.664@CNVR7721.3, CNVR7721.4, CNVR7721.1@LILRB3_3, LILRB3_2, LILRB3_1, LILRA6_8, LILRA6_7@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F98468@173336@173341@deletion@6@54801928@54804173@19@chr19:54801928-54804173@30.9@1300@789@0.607@CNVR7722.1@LILRA3_6, LILRA3_5, LILRA3_4, LILRA3_3, LILRA3_2, LILRA3_1@0@0@0@:leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3@:antigen binding;signal transduction;protein binding;extracellular region;plasma membrane;receptor activity;defense response@NA
F98468@173469@173469@duplication@1@55263820@55263971@19@chr19:55263820-55263971@5.12@256@366@1.43@CNVR7725.2, CNVR7725.1@KIR2DL3_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity@NA
F98468@173499@173501@deletion@3@55358640@55359398@19@chr19:55358640-55359398@17.7@925@562@0.608@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4_6, KIR2DS4_7, KIR2DS4_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
F98468@174395@174395@deletion@1@1569207@1569278@20@chr20:1569207-1569278@10@47@1@0.0213@CNVR7763.1@RP4-576H24.4_1@0@0@0@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
F98468@178614@178614@deletion@1@61492377@61493022@20@chr20:61492377-61493022@4.91@116@64@0.552@NA@TCFL5_1@0@0@0@:DPH3, KTI11 homolog (S. cerevisiae) pseudogene 1;transcription factor-like 5 (basic helix-loop-helix)@:multicellular organismal development;cell differentiation;regulation of cell differentiation;DNA binding;regulation of transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity;regulation of cell proliferation;transcription from RNA polymerase II promoter;spermatogenesis;male germ cell nucleus;protein dimerization activity;nucleus@NA
F98468@181020@181020@deletion@1@17669230@17669337@22@chr22:17669230-17669337@5.35@91@45@0.495@NA@CECR1_7@0@0@0@:cat eye syndrome chromosome region, candidate 1@:multicellular organismal development;deaminase activity;growth factor activity;Golgi apparatus;adenosine deaminase activity;hypoxanthine salvage;proteoglycan binding;extracellular space;heparin binding;purine ribonucleoside monophosphate biosynthetic process;inosine biosynthetic process;protein homodimerization activity;adenosine catabolic process;zinc ion binding;adenosine receptor binding@NA
F98468@181686@181686@deletion@1@22221613@22221730@22@chr22:22221613-22221730@6.5@62@21@0.339@NA@MAPK1_1@0@0@0@:mitogen-activated protein kinase 1@:phosphatase binding;axon part;nucleoplasm;MAPK import into nucleus;mitochondrion;MAP kinase activity;toll-like receptor 4 signaling pathway;peptidyl-serine phosphorylation;response to toxin;sensory perception of pain;Ras protein signal transduction;pseudopodium;phosphotyrosine binding;response to estrogen stimulus;RNA polymerase II carboxy-terminal domain kinase activity;caveolin-mediated endocytosis;nucleus;response to lipopolysaccharide;mitogen-activated protein kinase kinase kinase binding;intracellular signal transduction;JAK-STAT cascade involved in growth hormone signaling pathway;platelet activation;activation of MAPK activity;protein kinase activity;regulation of cytoskeleton organization;early endosome;cytosol;positive regulation of transcription, DNA-dependent;cytoskeleton;nerve growth factor receptor signaling pathway;synaptic transmission;transcription, DNA-dependent;mammary gland epithelial cell proliferation;microtubule organizing center;caveola;chemotaxis;stress-activated MAPK cascade;regulation of Golgi inheritance;apoptotic process;activation of MAPKK activity;organ morphogenesis;cytosine metabolic process;toll-like receptor 3 signaling pathway;protein phosphorylation;axon guidance;response to DNA damage stimulus;cytoplasm;innate immune response;response to stress;microtubule cytoskeleton;signal transduction;perikaryon;kinase activity;late endosome;MAPK cascade;fibroblast growth factor receptor signaling pathway;protein tyrosine kinase activity;positive regulation of peptidyl-threonine phosphorylation;ATP binding;induction of apoptosis;regulation of sequence-specific DNA binding transcription factor activity;insulin receptor signaling pathway;positive regulation of translation;toll-like receptor 2 signaling pathway;MyD88-dependent toll-like receptor signaling pathway;labyrinthine layer blood vessel development;MyD88-independent toll-like receptor signaling pathway;regulation of stress-activated MAPK cascade;response to chemical stimulus;negative regulation of cell differentiation;TRIF-dependent toll-like receptor signaling pathway;epidermal growth factor receptor signaling pathway;B cell receptor signaling pathway;toll-like receptor signaling pathway;cell cycle;transcription factor binding;response to exogenous dsRNA;toll-like receptor 1 signaling pathway;DNA binding;transferase activity, transferring phosphorus-containing groups;Toll signaling pathway;positive regulation of cell migration;blood coagulation;focal adhesion;positive regulation of cell proliferation;virus-host interaction;protein serine/threonine kinase activity;Golgi apparatus;regulation of early endosome to late endosome transport;small GTPase mediated signal transduction;protein complex;ERK1 and ERK2 cascade;protein binding;dendrite cytoplasm;lipopolysaccharide-mediated signaling pathway;T cell receptor signaling pathway@NA
F98468@181766@181767@deletion@2@22989225@22989508@22@chr22:22989225-22989508@5.23@91@46@0.505@CNVR8103.5, CNVR8103.2, CNVR8103.13@GGTLC2_2, GGTLC2_3@0@0@0@:gamma-glutamyltransferase light chain 2@:leukotriene biosynthetic process;glutathione metabolic process;gamma-glutamyltransferase activity;anchored to external side of plasma membrane@NA
F98468@181805@181805@deletion@1@23241695@23241835@22@chr22:23241695-23241835@8.39@164@80@0.488@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11@IGLJ2_1@0@0@0@NA@NA@NA
F98468@181807@181808@duplication@2@23247056@23248831@22@chr22:23247056-23248831@20@395@773@1.96@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11@IGLJ3_1, IGLC3_1@0@0@0@@:protein binding@NA
F98468@181948@181949@deletion@2@24324820@24325235@22@chr22:24324820-24325235@5.35@55@22@0.4@CNVR8114.6, CNVR8114.13, CNVR8114.8, CNVR8114.14@GSTT2_3, GSTT2_4@0@0@0@@:protein binding;glutathione transferase activity;nucleus;cytoplasm@NA
F98468@181951@181955@duplication@5@24376424@24384231@22@chr22:24376424-24384231@10.8@761@1016@1.34@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTT1_5, GSTT1_4, GSTT1_3, GSTT1_2, GSTT1_1@0@0@0@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
F98468@183633@183640@deletion@8@39358501@39388154@22@chr22:39358501-39388154@22.5@772@475@0.615@CNVR8164.1@APOBEC3A_6, APOBEC3B_1, APOBEC3B_2, APOBEC3B_3, APOBEC3B_4, APOBEC3B_5, APOBEC3B_6, APOBEC3B_7@0@0@0@:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A;APOBEC3A and APOBEC3B deletion hybrid:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B@:cytidine deamination;defense response to virus;negative regulation of viral genome replication;DNA cytosine deamination;clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine;catalytic activity;DNA demethylation;cytoplasm;innate immune response;cytidine deaminase activity;nucleus;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;cellular response to xenobiotic stimulus;zinc ion binding;negative regulation of transposition:RNA binding;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;negative regulation of transposition;catalytic activity;zinc ion binding@NA
F98468@183677@183677@deletion@1@39548382@39548449@22@chr22:39548382-39548449@4.75@67@31@0.463@NA@CBX7_1@0@0@0@:chromobox homolog 7@:nuclear chromatin;single-stranded RNA binding;protein binding;negative regulation of transcription from RNA polymerase II promoter;nucleus;heterochromatin;transcription, DNA-dependent;chromatin modification;PcG protein complex;methylated histone residue binding;PRC1 complex@NA
F98468@184154@184154@duplication@1@42537163@42537296@22@chr22:42537163-42537296@4.69@128@195@1.52@CNVR8168.1, CNVR8168.3, CNVR8168.4@CYP2D7P1_3@0@0@0@@:oxidation-reduction process;electron carrier activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;heme binding@NA
F98468@184168@184168@deletion@1@42911158@42911274@22@chr22:42911158-42911274@5.2@28@3@0.107@CNVR8171.2, CNVR8171.3@RRP7A_4@0@0@0@:ribosomal RNA processing 7 homolog A (S. cerevisiae)@:RNA binding;nucleotide binding@NA
F98468@1896@1896@deletion@1@48269422@48269516@X@chrX:48269422-48269516@5.04@22@0@0@CNVR8324.2@SSX4B_4@0@0@0@NA@NA@NA
F98468@4052@4053@duplication@2@101571921@101572486@X@chrX:101571921-101572486@6.64@45@97@2.16@NA@NXF2_15, NXF2_16@0@0@0@NA@NA@NA
F98468@4078@4080@deletion@3@101619967@101620439@X@chrX:101619967-101620439@7.08@31@0@0@NA@NXF2B_28, NXF2B_27, NXF2B_26@0@0@0@NA@NA@NA
F98468@4090@4091@deletion@2@101624508@101625073@X@chrX:101624508-101625073@6.65@29@0@0@NA@NXF2B_16, NXF2B_15@0@0@0@NA@NA@NA
F98468@4161@4164@duplication@4@103267285@103295431@X@chrX:103267285-103295431@28.2@1496@2114@1.41@CNVR8407.1@H2BFWT_2, H2BFWT_1, H2BFM_1, H2BFM_2@0@0@0@NA@NA@NA
F98468@6294@6297@deletion@4@153453260@153459138@X@chrX:153453260-153459138@6.97@122@63@0.516@CNVR8489.1@OPN1MW_2, OPN1MW_3, OPN1MW_4, OPN1MW_5@0@0@0@NA@NA@NA
F99129@6@6@deletion@1@69092@70008@1@chr1:69092-70008@9.4@42@0@0@CNVR1.1, CNVR1.2@OR4F5_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F99129@308@335@deletion@28@1386065@1431197@1@chr1:1386065-1431197@123@2921@1619@0.554@NA@ATAD3C_1, ATAD3C_2, ATAD3C_3, ATAD3C_4, ATAD3C_5, ATAD3C_6, ATAD3C_7, ATAD3C_8, ATAD3C_9, ATAD3C_10, ATAD3C_11, ATAD3C_12, ATAD3B_1, ATAD3B_2, ATAD3B_3, ATAD3B_4, ATAD3B_5, ATAD3B_6, ATAD3B_7, ATAD3B_8, ATAD3B_9, ATAD3B_10, ATAD3B_11, ATAD3B_12, ATAD3B_13, ATAD3B_14, ATAD3B_15, ATAD3B_16@0@0@0@:ATPase family, AAA domain containing 3C:ATPase family, AAA domain containing 3B@:four-way junction helicase activity;DNA repair;nucleoside-triphosphatase activity;nucleotide binding;DNA recombination;ATP binding:nucleoside-triphosphatase activity;mitochondrial inner membrane;nucleotide binding;ATP binding@NA
F99129@2170@2186@deletion@17@17248515@17273486@1@chr1:17248515-17273486@31.1@1865@1222@0.655@CNVR94.4, CNVR94.5@CROCC_1, CROCC_2, CROCC_3, CROCC_4, CROCC_5, CROCC_6, CROCC_7, CROCC_8, CROCC_9, CROCC_10, CROCC_11, CROCC_12, CROCC_13, CROCC_14, CROCC_15, CROCC_16, CROCC_17@0@0@0@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
F99129@2788@2788@deletion@1@21806545@21806716@1@chr1:21806545-21806716@6.22@32@3@0.0938@CNVR107.2, CNVR107.1@NBPF3_11@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 3@:cytoplasm@NA
F99129@3336@3341@deletion@6@25627438@25648453@1@chr1:25627438-25648453@13.6@759@504@0.664@CNVR116.1, CNVR116.2@RHD_4, RHD_5, RHD_6, RHD_7, RHD_8, RHD_9@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
F99129@5149@5150@deletion@2@39987049@39988154@1@chr1:39987049-39988154@5.17@108@61@0.565@NA@BMP8A_4, BMP8A_5@0@0@0@:bone morphogenetic protein 8a@:cell differentiation;growth factor activity;extracellular space;growth;cytokine activity;cartilage development;ossification@NA
F99129@5196@5197@deletion@2@40235375@40240128@1@chr1:40235375-40240128@5.97@364@242@0.665@NA@OXCT2_1, BMP8B_3@0@0@0@:bone morphogenetic protein 8b:3-oxoacid CoA transferase 2@:cell differentiation;growth factor activity;extracellular space;growth;extracellular region;cytokine activity;cartilage development;skeletal system development;ossification:mitochondrion;microtubule-based flagellum;CoA-transferase activity;ketone body catabolic process;3-oxoacid CoA-transferase activity;metabolic process@NA
F99129@7186@7186@deletion@1@60106953@60107023@1@chr1:60106953-60107023@16.6@338@163@0.482@CNVR197.1@FGGY_12@0@0@0@:FGGY carbohydrate kinase domain containing@:cell death;neuron homeostasis;molecular_function;carbohydrate metabolic process;kinase activity;cellular_component;phosphotransferase activity, alcohol group as acceptor@: AMYOTROPHIC LATERAL SCLEROSIS 1; ALS1
F99129@9365@9374@deletion@10@104202983@104234232@1@chr1:104202983-104234232@27.3@124@0@0@CNVR266.3, CNVR266.1, CNVR266.15@AMY1A_7, AMY1A_8, AMY1A_9, AMY1A_10, AMY1A_11, AMY1B_11, AMY1B_10, AMY1B_9, AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
F99129@9436@9436@deletion@1@108769302@108769515@1@chr1:108769302-108769515@10.4@56@6@0.107@CNVR294.4@NBPF4_14@0@0@0@:neuroblastoma breakpoint family, member 4@:cytoplasm@NA
F99129@9766@9773@deletion@8@110230497@110235917@1@chr1:110230497-110235917@86.7@399@1@0.00251@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
F99129@10684@10685@duplication@2@120539621@120548211@1@chr1:120539621-120548211@7.24@682@899@1.32@CNVR319.3, CNVR319.2@NOTCH2_4, NOTCH2_3@0@0@0@:notch 2@:nucleoplasm;negative regulation of apoptotic process;cell differentiation;negative regulation of cell proliferation;pulmonary valve morphogenesis;atrial septum morphogenesis;stem cell maintenance;placenta blood vessel development;placenta development;bone remodeling;induction of apoptosis;tissue regeneration;plasma membrane;nucleus;endoplasmic reticulum membrane;gene expression;cell fate determination;in utero embryonic development;Notch receptor processing;humoral immune response;inflammatory response to antigenic stimulus;embryonic limb morphogenesis;hemopoiesis;membrane;calcium ion binding;Notch signaling involved in heart development;nervous system development;Golgi membrane;morphogenesis of an epithelial sheet;integral to membrane;interleukin-4 secretion;cell cycle arrest;receptor activity;integral to plasma membrane;organ morphogenesis;determination of left/right symmetry;transcription initiation from RNA polymerase II promoter;multicellular organismal development;cell growth;regulation of transcription, DNA-dependent;positive regulation of Ras protein signal transduction;protein binding;regulation of developmental process;Notch signaling pathway;extracellular region;cell surface;positive regulation of apoptotic process@: ALAGILLE SYNDROME 2; ALGS2; HAJDU-CHENEY SYNDROME; HJCYS
F99129@12117@12118@deletion@2@152573209@152586574@1@chr1:152573209-152586574@27.5@126@0@0@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
F99129@14053@14058@duplication@6@161565346@161600992@1@chr1:161565346-161600992@45.3@1277@1962@1.54@CNVR383.1@FCGR2C_1, FCGR3B_5, FCGR3B_4, FCGR3B_3, FCGR3B_2, FCGR3B_1@0@0@0@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene):Fc fragment of IgG, low affinity IIIb, receptor (CD16b)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction:IgG binding;protein binding;extracellular region;immune response;plasma membrane;anchored to membrane@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
F99129@16029@16040@deletion@12@196744018@196801129@1@chr1:196744018-196801129@363@1767@9@0.00509@CNVR459.1@CFHR3_1, CFHR3_2, CFHR3_3, CFHR3_4, CFHR3_5, CFHR3_6, CFHR1_1, CFHR1_2, CFHR1_3, CFHR1_4, CFHR1_5, CFHR1_6@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
F99129@22191@22194@duplication@4@38956699@38972329@2@chr2:38956699-38972329@18.7@761@1075@1.41@CNVR759.1@GALM_5, GALM_6, GALM_7, SRSF7_8@0@0@0@:galactose mutarotase (aldose 1-epimerase):serine/arginine-rich splicing factor 7@:isomerase activity;carbohydrate binding;aldose 1-epimerase activity;hexose metabolic process;carbohydrate metabolic process;catalytic activity;cytoplasm:nucleoplasm;negative regulation of mRNA splicing, via spliceosome;mRNA 3'-end processing;termination of RNA polymerase II transcription;nucleotide binding;transcription from RNA polymerase II promoter;protein binding;mRNA export from nucleus;RNA binding;mRNA processing;nucleus;RNA splicing;mRNA splicing, via spliceosome;gene expression;zinc ion binding;nucleic acid binding@NA
F99129@24563@24563@duplication@1@85570763@85570921@2@chr2:85570763-85570921@13.3@200@357@1.78@NA@RETSAT_10@0@0@0@:retinol saturase (all-trans-retinol 13,14-reductase)@:all-trans-retinol 13,14-reductase activity;nuclear membrane;oxidation-reduction process;oxidoreductase activity;retinol metabolic process;endoplasmic reticulum membrane;nuclear outer membrane@NA
F99129@24752@24752@duplication@1@86422462@86422505@2@chr2:86422462-86422505@4.78@97@151@1.56@NA@IMMT_1@0@0@0@:inner membrane protein, mitochondrial@:mitochondrion;protein binding;response to cold;mitochondrial inner membrane;mitochondrial calcium ion homeostasis;biological_process;integral to mitochondrial inner membrane@NA
F99129@24966@24969@deletion@4@89545002@89597316@2@chr2:89545002-89597316@6.05@184@114@0.62@CNVR866.7, CNVR866.1@IGKV2-30_1, IGKV1-33_2, IGKV1-33_1, IGKV1-37_2@0@0@0@@:protein binding:protein binding:protein binding@NA
F99129@25007@25007@deletion@1@90198896@90199190@2@chr2:90198896-90199190@6.08@113@59@0.522@CNVR867.10, CNVR867.5, CNVR867.3, CNVR867.9, CNVR867.15, CNVR867.2@IGKV1D-12_2@0@0@0@@:protein binding@NA
F99129@27177@27178@deletion@2@130897465@130897669@2@chr2:130897465-130897669@6.95@138@76@0.551@NA@CCDC74B_7, CCDC74B_6@0@0@0@:coiled-coil domain containing 74A;coiled-coil domain containing 74B@NA@NA
F99129@27211@27211@deletion@1@130955932@130955933@2@chr2:130955932-130955933@8.07@36@0@0@CNVR985.1@TUBA3E_1@0@0@0@:tubulin, alpha 3e@:GTPase activity;structural constituent of cytoskeleton;protein complex;GTP catabolic process;cytoplasm;microtubule cytoskeleton;protein polymerization;microtubule-based movement;structural molecule activity;cytoplasmic microtubule;GTP binding;microtubule;microtubule cytoskeleton organization;protein domain specific binding@NA
F99129@33410@33411@deletion@2@233273415@233273822@2@chr2:233273415-233273822@5.62@65@28@0.431@NA@ALPPL2_8, ALPPL2_9@0@0@0@:alkaline phosphatase, placental-like 2@:phosphatase activity;catalytic activity;phosphorylation;plasma membrane;metabolic process;membrane;anchored to membrane;alkaline phosphatase activity;metal ion binding@NA
F99129@45433@45433@duplication@1@195447880@195447954@3@chr3:195447880-195447954@6.57@84@148@1.76@CNVR1703.1, CNVR1703.2@MUC20_1@0@0@0@:mucin 20, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane@NA
F99129@57338@57338@deletion@1@109954131@109954263@5@chr5:109954131-109954263@13.5@402@220@0.547@NA@TMEM232_8@0@0@0@:transmembrane protein 232@:integral to membrane@NA
F99129@59065@59065@deletion@1@140557617@140560021@5@chr5:140557617-140560021@20@1792@1053@0.588@CNVR2624.1@PCDHB8_1@0@0@0@:protocadherin beta 8@:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding@NA
F99129@59488@59488@deletion@1@147553798@147553933@5@chr5:147553798-147553933@26.4@125@1@0.008@CNVR2637.2, CNVR2637.1@SPINK14_3@0@0@0@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
F99129@60876@60877@deletion@2@175388055@175388437@5@chr5:175388055-175388437@8.58@67@20@0.299@NA@THOC3_5, THOC3_4@0@0@0@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
F99129@61638@61645@deletion@8@180375356@180429785@5@chr5:180375356-180429785@21.2@1165@764@0.656@CNVR2719.1@BTNL8_5, BTNL8_6, BTNL8_7, BTNL8_8, BTNL3_1, BTNL3_2, BTNL3_3, BTNL3_4@0@0@0@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
F99129@62954@62954@deletion@1@29911900@29912174@6@chr6:29911900-29912174@9.58@226@122@0.54@CNVR2829.7, CNVR2829.2, CNVR2829.3@HLA-A_6@0@0@0@:major histocompatibility complex, class I, A@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO
F99129@63282@63282@deletion@1@31237988@31238262@6@chr6:31237988-31238262@13.7@202@89@0.441@CNVR2838.1@HLA-C_4@0@0@0@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
F99129@63953@63958@duplication@6@32485517@32498001@6@chr6:32485517-32498001@13.8@543@760@1.4@CNVR2845.21, CNVR2845.25, CNVR2845.30, CNVR2845.43, CNVR2845.6@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2, HLA-DRB5_1@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
F99129@71028@71030@duplication@3@167787840@167790192@6@chr6:167787840-167790192@5.76@204@285@1.4@NA@TCP10_7, TCP10_6, TCP10_5@0@0@0@:t-complex 10@:cytosol@NA
F99129@71776@71779@deletion@4@6006495@6018327@7@chr7:6006495-6018327@42.1@321@86@0.268@NA@RSPH10B_2, PMS2_15, PMS2_14, PMS2_13@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas):PMS2 postmeiotic segregation increased 2 (S. cerevisiae)@:response to drug;DNA binding;MutSalpha complex binding;ATP binding;mismatch repair;DNA repair;mismatched DNA binding;ATPase activity;nucleus;mismatch repair complex;reciprocal meiotic recombination;ATP catabolic process;single-stranded DNA binding;response to DNA damage stimulus;single base insertion or deletion binding;protein binding;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;MutLalpha complex;endonuclease activity@: COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4; MISMATCH REPAIR CANCER SYNDROME
F99129@71922@71923@duplication@2@6797310@6798790@7@chr7:6797310-6798790@11.7@252@407@1.62@NA@RSPH10B2_2, RSPH10B2_3@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F99129@71932@71934@deletion@3@6819242@6821107@7@chr7:6819242-6821107@22.6@286@120@0.42@NA@RSPH10B2_12, RSPH10B2_13, RSPH10B2_14@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F99129@71940@71944@deletion@5@6837995@6844686@7@chr7:6837995-6844686@13.6@174@83@0.477@NA@RSPH10B2_20, CCZ1B_15, CCZ1B_14, CCZ1B_13, CCZ1B_12@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F99129@73260@73260@duplication@1@38388957@38389266@7@chr7:38388957-38389266@4.76@423@566@1.34@CNVR3354.3, CNVR3354.1@TRGV5_2@0@0@0@@:protein binding@NA
F99129@74605@74607@deletion@3@74251403@74422230@7@chr7:74251403-74422230@9.02@41@0@0@NA@GTF2IRD2_2, GATSL1_1, GATSL1_2@0@0@0@:GTF2I repeat domain containing 2:GATS protein-like 1@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
F99129@74775@74775@duplication@1@76063356@76063472@7@chr7:76063356-76063472@7.05@76@141@1.86@CNVR3462.1@ZP3_5@0@0@0@:zona pellucida glycoprotein 3 (sperm receptor)@:negative regulation of transcription, DNA-dependent;manganese ion transmembrane transporter activity;intracellular protein transport;proteinaceous extracellular matrix;plasma membrane;positive regulation of acrosome reaction;outer acrosomal membrane;protein kinase C signaling cascade;manganese ion transmembrane transport;intracellular signal transduction;humoral immune response mediated by circulating immunoglobulin;negative regulation of binding of sperm to zona pellucida;positive regulation of inflammatory response;endoplasmic reticulum;signal transducer activity;perinuclear region of cytoplasm;secretory granule;positive regulation of transcription, DNA-dependent;positive regulation of ovarian follicle development;positive regulation of interferon-gamma production;carbohydrate binding;manganese ion transport;positive regulation of antral ovarian follicle growth;extracellular matrix;positive regulation of leukocyte migration;positive regulation of humoral immune response;extracellular space;blastocyst formation;integral to membrane;store-operated calcium channel activity;oocyte development;multivesicular body;phosphatidylinositol-mediated signaling;acrosomal vesicle;positive regulation of protein kinase B signaling cascade;Golgi apparatus;positive regulation of calcium ion import;positive regulation of protein kinase activity;positive regulation of acrosomal vesicle exocytosis;positive regulation of interleukin-4 production;cytoplasm;protein binding;binding of sperm to zona pellucida;positive regulation of phosphatidylinositol biosynthetic process;extracellular region;positive regulation of T cell proliferation;acrosin binding;positive regulation of type IV hypersensitivity;egg coat formation@NA
F99129@74793@74794@deletion@2@76241040@76247617@7@chr7:76241040-76247617@8.75@254@151@0.594@CNVR3463.10@POMZP3_5, POMZP3_4@0@0@0@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
F99129@76427@76432@duplication@6@100331793@100336236@7@chr7:100331793-100336236@17.8@938@1285@1.37@CNVR3509.1@ZAN_1, ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
F99129@76718@76718@deletion@1@102114809@102114982@7@chr7:102114809-102114982@6.74@33@2@0.0606@CNVR3518.1@POLR2J_3@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J, 13.3kDa@:nucleoplasm;DNA binding;DNA repair;protein dimerization activity;nucleus;viral reproduction;gene expression;transcription initiation from RNA polymerase II promoter;7-methylguanosine mRNA capping;protein phosphorylation;LRR domain binding;protein kinase activity;DNA-directed RNA polymerase II, core complex;nucleotide-excision repair;transcription from RNA polymerase II promoter;DNA-directed RNA polymerase activity;protein binding;transcription-coupled nucleotide-excision repair;RNA splicing;mRNA splicing, via spliceosome;transcription, DNA-dependent;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription@NA
F99129@76754@76754@deletion@1@102219880@102220243@7@chr7:102219880-102220243@16.7@77@0@0@CNVR3518.1@AC093668.1_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
F99129@76765@76780@duplication@16@102235753@102280861@7@chr7:102235753-102280861@18.8@264@449@1.7@CNVR3518.1@RASA4_11, RASA4_10, RASA4_9, RASA4_8, RASA4_7, RASA4_6, RASA4_5, RASA4_4, RASA4_3, RASA4_2, UPK3BL_7, RASA4_1, UPK3BL_6, UPK3BL_6, UPK3BL_5, UPK3BL_5, UPK3BL_4, UPK3BL_4, UPK3BL_3, UPK3BL_3@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
F99129@76795@76795@duplication@1@102318940@102319303@7@chr7:102318940-102319303@16.8@252@464@1.84@CNVR3518.1@AC105052.1_1@0@0@0@NA@NA@NA
F99129@79309@79324@duplication@16@143880598@144071982@7@chr7:143880598-144071982@42.4@2164@2996@1.38@CNVR3598.4@CTAGE4_1, ARHGEF35_2, OR2A42_1, OR2A7_1, CTAGE8_1, OR2A1_1, ARHGEF5_2, ARHGEF5_3, ARHGEF5_4, ARHGEF5_5, ARHGEF5_6, ARHGEF5_7, ARHGEF5_8, ARHGEF5_9, ARHGEF5_10, ARHGEF5_11@0@0@0@:CTAGE family, member 4:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:olfactory receptor, family 2, subfamily A, member 7:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:integral to membrane;nucleotide binding;cellular_component;biological_process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
F99129@80368@80368@duplication@1@7274293@7274349@8@chr8:7274293-7274349@10.4@16@85@5.31@CNVR3771.8, CNVR3771.10, CNVR3771.4@DEFB4B_1@0@0@0@:defensin, beta 4B;defensin, beta 4A@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response@NA
F99129@80371@80401@deletion@31@7308236@7706365@8@chr8:7308236-7706365@42@1114@648@0.582@NA@SPAG11B_3, SPAG11B_2, SPAG11B_1, DEFB104B_2, DEFB104B_1, DEFB106B_2, DEFB106B_1, DEFB105B_1, DEFB105B_2, DEFB105B_3, DEFB107B_1, DEFB107B_2, RP11-1118M6.1_1, RP11-1118M6.1_2, RP11-1118M6.1_3, RP11-1118M6.1_4, AC084121.16_4, AC084121.16_3, AC084121.16_2, AC084121.16_1, DEFB107A_2, DEFB107A_1, DEFB105A_3, DEFB105A_2, DEFB105A_1, DEFB106A_1, DEFB106A_2, DEFB104A_1, DEFB104A_2, SPAG11A_1, SPAG11A_2@0@0@0@:sperm associated antigen 11B:defensin, beta 104A;defensin, beta 104B:defensin, beta 106B;defensin, beta 106A:defensin, beta 105B;defensin, beta 105A:defensin, beta 107B;defensin, beta 107A:uncharacterized LOC100133251:uncharacterized LOC100133251:defensin, beta 107B;defensin, beta 107A:defensin, beta 105B;defensin, beta 105A:defensin, beta 106B;defensin, beta 106A:defensin, beta 104A;defensin, beta 104B:sperm associated antigen 11A;sperm associated antigen 11B@:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response@NA
F99129@80403@80406@deletion@4@7721024@7752292@8@chr8:7721024-7752292@20.6@228@86@0.377@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@SPAG11A_4, DEFB103A_1, DEFB103A_2, DEFB4A_1@0@0@0@:sperm associated antigen 11A;sperm associated antigen 11B:defensin, beta 103B;defensin, beta 103A:defensin, beta 4B;defensin, beta 4A@:extracellular region;defense response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response@NA
F99129@86350@86351@duplication@2@145438619@145438924@8@chr8:145438619-145438924@5.38@12@47@3.92@NA@FAM203B_2, FAM203B_3@0@0@0@:family with sequence similarity 203, member B@:binding@NA
F99129@88584@88602@deletion@19@43624656@43885072@9@chr9:43624656-43885072@56.7@552@199@0.361@CNVR4294.1@SPATA31A6_4, SPATA31A6_3, SPATA31A6_2, SPATA31A6_1, CNTNAP3B_1, CNTNAP3B_2, CNTNAP3B_3, CNTNAP3B_4, CNTNAP3B_5, CNTNAP3B_6, CNTNAP3B_7, CNTNAP3B_8, CNTNAP3B_9, CNTNAP3B_10, CNTNAP3B_11, CNTNAP3B_12, CNTNAP3B_13, CNTNAP3B_14, CNTNAP3B_15@0@0@0@:SPATA31 subfamily A, member 6:contactin associated protein-like 3B;contactin associated protein-like 3@:integral to membrane:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
F99129@95348@95355@duplication@8@17837921@17891768@10@chr10:17837921-17891768@20.1@558@840@1.51@NA@TMEM236_4, MRC1L1_1, MRC1L1_2, MRC1L1_3, MRC1L1_4, MRC1L1_5, MRC1L1_6, MRC1L1_7@0@0@0@:transmembrane protein 236;transmembrane protein 236-like:macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding@NA
F99129@95380@95393@deletion@14@18060293@18152611@10@chr10:18060293-18152611@47.4@320@71@0.222@NA@TMEM236_2, TMEM236_3, TMEM236_4, MRC1_1, MRC1_2, MRC1_3, MRC1_4, MRC1_5, MRC1_6, MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11@0@0@0@:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F99129@95947@95948@duplication@2@29578048@29580935@10@chr10:29578048-29580935@9.02@187@288@1.54@NA@LYZL1_1, LYZL1_2@0@0@0@:lysozyme-like 1@:extracellular region;lysozyme activity;cell wall macromolecule catabolic process@NA
F99129@95971@95971@duplication@1@29784022@29784110@10@chr10:29784022-29784110@4.97@46@88@1.91@NA@SVIL_21@0@0@0@:supervillin@:podosome;actin cytoskeleton;invadopodium;cytoplasm;actin binding;actin filament binding;cell junction;nucleus;plasma membrane;cytoskeleton organization;skeletal muscle tissue development;costamere@NA
F99129@96933@96934@deletion@2@51970584@51970894@10@chr10:51970584-51970894@8.28@37@0@0@NA@ASAH2_11, ASAH2_10@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
F99129@102336@102337@deletion@2@135438604@135439503@10@chr10:135438604-135439503@12.2@550@344@0.625@CNVR4989.11, CNVR4989.4@FRG2B_4, FRG2B_3@0@0@0@:FSHD region gene 2 family, member B@:nucleus@NA
F99129@103269@103269@deletion@1@4976003@4976943@11@chr11:4976003-4976943@33.5@550@207@0.376@CNVR5040.1@OR51A2_1@0@0@0@:matrix metallopeptidase 26:olfactory receptor, family 51, subfamily A, member 2@:metallopeptidase activity;extracellular matrix;proteolysis;proteinaceous extracellular matrix;collagen catabolic process;metalloendopeptidase activity;zinc ion binding;metabolic process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F99129@103342@103342@deletion@1@5798891@5799864@11@chr11:5798891-5799864@7.55@775@519@0.67@CNVR5049.1@OR52N5_1@0@0@0@:tripartite motif containing 5:olfactory receptor, family 52, subfamily N, member 5@:defense response to virus;Golgi apparatus;intracellular;protein trimerization;ligase activity;cytoplasm;protein binding;nucleus;protein homodimerization activity;identical protein binding;zinc ion binding;cytoplasmic mRNA processing body;protein ubiquitination;virus-host interaction:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F99129@104572@104572@duplication@1@18955364@18956331@11@chr11:18955364-18956331@7.91@1356@1824@1.35@CNVR5091.2, CNVR5091.1@MRGPRX1_1@0@0@0@:MAS-related GPR, member X1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;acute-phase response;G-protein coupled receptor signaling pathway@NA
F99129@106038@106040@deletion@3@55032377@55035848@11@chr11:55032377-55035848@31.1@144@0@0@CNVR5178.5@TRIM48_2, TRIM48_3, TRIM48_4@0@0@0@:tripartite motif containing 48@:protein binding;intracellular;zinc ion binding@NA
F99129@106046@106048@duplication@3@55370918@55419315@11@chr11:55370918-55419315@25.6@2455@3381@1.38@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F99129@114483@114483@duplication@1@11243900@11244828@12@chr12:11243900-11244828@9.38@964@1334@1.38@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
F99129@115537@115537@deletion@1@31249276@31249313@12@chr12:31249276-31249313@9.64@71@18@0.254@CNVR5483.1@DDX11_15@0@0@0@:DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11@:nucleoplasm;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;S phase of mitotic cell cycle;DNA binding;nucleobase-containing compound metabolic process;ATP binding;ATP-dependent DNA helicase activity;DNA helicase activity;midbody;RNA binding;DNA-dependent ATPase activity;nucleus;positive regulation of cell proliferation;virus-host interaction;nuclear chromatin;4 iron, 4 sulfur cluster binding;helicase activity;hydrolase activity, acting on acid anhydrides;DNA duplex unwinding;endoplasmic reticulum unfolded protein response;G2/M transition of mitotic cell cycle;protein binding;sister chromatid cohesion;activation of signaling protein activity involved in unfolded protein response;nucleolus;spindle pole;ATP-dependent helicase activity;metal ion binding;nucleic acid binding;mitotic sister chromatid segregation@: WARSAW BREAKAGE SYNDROME
F99129@127333@127341@deletion@9@19553418@19574352@14@chr14:19553418-19574352@15.7@111@28@0.252@CNVR6072.1@POTEG_1, POTEG_2, POTEG_3, POTEG_4, POTEG_5, POTEG_6, POTEG_7, POTEG_8, POTEG_9@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
F99129@131032@131033@duplication@2@74004127@74008399@14@chr14:74004127-74008399@9.7@358@513@1.43@CNVR6188.1, CNVR6188.4@ACOT1_1, ACOT1_2@0@0@0@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
F99129@133432@133435@duplication@4@106539080@106552729@14@chr14:106539080-106552729@36.9@782@1271@1.63@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1@0@0@0@@:protein binding:protein binding@NA
F99129@133458@133459@duplication@2@106791006@106791456@14@chr14:106791006-106791456@15.2@678@1028@1.52@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-30_2, IGHV3-30_1@0@0@0@@:protein binding@NA
F99129@133462@133463@deletion@2@106815723@106816173@14@chr14:106815723-106816173@51.7@254@1@0.00394@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.56, CNVR6294.51@IGHV3-33_2, IGHV3-33_1@0@0@0@@:protein binding@NA
F99129@133468@133473@duplication@6@106866407@106926644@14@chr14:106866407-106926644@71@1883@3096@1.64@CNVR6294.26, CNVR6294.56, CNVR6294.18@IGHV3-38_2, IGHV3-38_1, IGHV4-39_2, IGHV4-39_1, IGHV3-43_2, IGHV3-43_1@0@0@0@@:protein binding:protein binding:protein binding@NA
F99129@134431@134432@duplication@2@34673613@34674057@15@chr15:34673613-34674057@5.38@38@79@2.08@CNVR6351.4, CNVR6351.3@GOLGA8A_24, GOLGA8A_23@0@0@0@:golgin A8 family, member A@:Golgi cisterna membrane;Golgi apparatus@NA
F99129@134443@134448@deletion@6@34677942@34820278@15@chr15:34677942-34820278@8.98@63@16@0.254@CNVR6351.3@GOLGA8A_12, GOLGA8A_11, GOLGA8A_10, GOLGA8A_9, GOLGA8B_25, GOLGA8B_24@0@0@0@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
F99129@143003@143003@deletion@1@18542789@18542929@16@chr16:18542789-18542929@5.32@191@117@0.613@NA@NOMO2_13@0@0@0@:NODAL modulator 2@:carbohydrate binding;protein binding;integral to membrane;carboxypeptidase activity;endoplasmic reticulum membrane@NA
F99129@144095@144099@deletion@5@28607105@28618398@16@chr16:28607105-28618398@11.9@690@456@0.661@CNVR6685.1@SULT1A2_2, SULT1A1_10, SULT1A1_9, SULT1A1_8, SULT1A1_7@0@0@0@:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1@:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;catecholamine metabolic process;cytosol;xenobiotic metabolic process;phenol-containing compound metabolic process;sulfotransferase activity;amine biosynthetic process;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process:small molecule metabolic process;sulfation;aryl sulfotransferase activity;amine metabolic process;catecholamine metabolic process;xenobiotic metabolic process;cytosol;steroid sulfotransferase activity;integral to membrane;sulfotransferase activity;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process;estrogen metabolic process@NA
F99129@144288@144290@deletion@3@29468954@29469445@16@chr16:29468954-29469445@5.41@41@12@0.293@CNVR6690.2, CNVR6690.3, CNVR6690.4@SLX1B_4, SLX1B_5, SLX1B_6@0@0@0@:structure-specific endonuclease subunit SLX1-like;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae);SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae):sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3;sulfotransferase 1A3/1A4-like@:Slx1-Slx4 complex;5'-flap endonuclease activity;DNA repair;protein binding;DNA double-strand break processing involved in repair via single-strand annealing;double-strand break repair via homologous recombination;metal ion binding;crossover junction endodeoxyribonuclease activity:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;cytoplasm;catecholamine metabolic process;cytosol;endoplasmic reticulum unfolded protein response;xenobiotic metabolic process;sulfotransferase activity;activation of signaling protein activity involved in unfolded protein response;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process@NA
F99129@145564@145564@duplication@1@55866917@55866967@16@chr16:55866917-55866967@4.94@124@186@1.5@NA@CES1_1@0@0@0@:carboxylesterase 1;liver carboxylesterase 1-like@:hydrolase activity;methyl salicylate esterase activity;response to toxin;methylumbelliferyl-acetate deacetylase activity;endoplasmic reticulum lumen;retinyl-palmitate esterase activity;methyl jasmonate esterase activity;metabolic process;carboxylesterase activity;methyl indole-3-acetate esterase activity@: CARBOXYLESTERASE 1; CES1
F99129@147109@147127@deletion@19@70161164@70211383@16@chr16:70161164-70211383@180@5705@3144@0.551@CNVR6764.1, CNVR6764.3@PDPR_4, PDPR_5, PDPR_6, PDPR_7, PDPR_8, PDPR_9, PDPR_10, PDPR_11, PDPR_12, PDPR_13, PDPR_14, PDPR_15, PDPR_16, PDPR_17, PDPR_18, PDPR_19, CLEC18C_1, CLEC18C_2, CLEC18C_3@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit:C-type lectin domain family 18, member C@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix:carbohydrate binding;protein binding;extracellular region@NA
F99129@147421@147421@duplication@1@72093014@72093087@16@chr16:72093014-72093087@8.06@364@524@1.44@CNVR6769.1, CNVR6769.2@HP_6@0@0@0@:thioredoxin-like 4B:haptoglobin:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:cellular iron ion homeostasis;negative regulation of oxidoreductase activity;catalytic activity;negative regulation of hydrogen peroxide catabolic process;positive regulation of cell death;haptoglobin-hemoglobin complex;extracellular space;proteolysis;response to hydrogen peroxide;extracellular region;hemoglobin binding;defense response;serine-type endopeptidase activity:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@: ANHAPTOGLOBINEMIA; AHP
F99129@151556@151561@duplication@6@16664740@16676947@17@chr17:16664740-16676947@12.1@1209@1573@1.3@NA@CCDC144A_13, CCDC144A_13, CCDC144A_14, CCDC144A_14, CCDC144A_15, CCDC144A_15, CCDC144A_16, CCDC144A_16, CCDC144A_17, CCDC144A_18, CCDC144A_17@0@0@0@:coiled-coil domain containing 144A@NA@NA
F99129@151875@151885@deletion@11@18380170@18397681@17@chr17:18380170-18397681@98@569@76@0.134@CNVR7014.1@LGALS9C_1, LGALS9C_2, LGALS9C_3, LGALS9C_4, LGALS9C_5, LGALS9C_6, LGALS9C_7, LGALS9C_8, LGALS9C_9, LGALS9C_10, LGALS9C_11@0@0@0@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
F99129@151959@151961@duplication@3@18996779@19036052@17@chr17:18996779-19036052@10.2@228@359@1.57@CNVR7018.2, CNVR7018.3, CNVR7018.1@AC007952.5_2, GRAPL_1, GRAPL_2@0@0@0@:GRB2-related adaptor protein-like@:protein binding@NA
F99129@152124@152126@duplication@3@20355109@20356380@17@chr17:20355109-20356380@8.12@193@292@1.51@CNVR7021.1, CNVR7021.3@LGALS9B_9, LGALS9B_8, LGALS9B_7@0@0@0@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
F99129@153381@153381@deletion@1@34539885@34539971@17@chr17:34539885-34539971@5.22@23@0@0@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1_3@0@0@0@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
F99129@153653@153660@duplication@8@36357159@36398302@17@chr17:36357159-36398302@32.3@3725@4860@1.3@CNVR7083.3@RP11-1407O15.2_9, RP11-1407O15.2_8, RP11-1407O15.2_7, RP11-1407O15.2_6, RP11-1407O15.2_5, RP11-1407O15.2_4, RP11-1407O15.2_3, RP11-1407O15.2_2@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
F99129@155580@155581@duplication@2@44171927@44249509@17@chr17:44171927-44249509@6.94@2298@2926@1.27@CNVR7114.3, CNVR7114.2@KANSL1_3, KANSL1_2@0@0@0@:KAT8 regulatory NSL complex subunit 1@:histone acetyltransferase activity (H4-K8 specific);histone acetyltransferase activity (H4-K16 specific);histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase complex;histone H4-K5 acetylation;MLL1 complex;histone H4-K16 acetylation;protein binding;histone H4-K8 acetylation;nucleus@NA
F99129@155587@155599@deletion@13@44399689@44592687@17@chr17:44399689-44592687@28.7@193@46@0.238@CNVR7114.2, CNVR7114.1@LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9, LRRC37A_10, LRRC37A_11, LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane@NA
F99129@162017@162018@deletion@2@44542732@44550298@18@chr18:44542732-44550298@6.38@28@0@0@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
F99129@165960@165961@deletion@2@10751716@10752093@19@chr19:10751716-10752093@6.09@109@59@0.541@NA@AC011475.1_1, AC011475.1_2@0@0@0@:solute carrier family 44, member 2@:choline transmembrane transporter activity;phospholipid metabolic process;glycerophospholipid biosynthetic process;small molecule metabolic process;phosphatidylcholine biosynthetic process;signal transducer activity;transmembrane transport;positive regulation of I-kappaB kinase/NF-kappaB cascade;signal transduction;choline transport;integral to membrane;plasma membrane@NA
F99129@167047@167047@duplication@1@14877791@14877921@19@chr19:14877791-14877921@6.19@147@225@1.53@NA@EMR2_6@0@0@0@:egf-like module containing, mucin-like, hormone receptor-like 2@:transmembrane signaling receptor activity;inflammatory response;G-protein coupled receptor activity;ruffle membrane;integral to membrane;plasma membrane;cell surface receptor signaling pathway;neuropeptide signaling pathway;granulocyte chemotaxis;cell migration;leading edge membrane;G-protein coupled receptor signaling pathway;protein binding;cell adhesion;membrane;calcium ion binding;chondroitin sulfate binding@NA
F99129@168952@168952@deletion@1@35862263@35863302@19@chr19:35862263-35863302@22@176@43@0.244@CNVR7627.1@GPR42_2@0@0@0@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
F99129@170093@170093@deletion@1@40367299@40367914@19@chr19:40367299-40367914@4.79@21@0@0@CNVR7639.2@FCGBP_29@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F99129@170099@170100@deletion@2@40380120@40382826@19@chr19:40380120-40382826@8.86@43@2@0.0465@CNVR7639.2@FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F99129@170109@170112@deletion@4@40399240@40406060@19@chr19:40399240-40406060@5.87@52@18@0.346@CNVR7639.2@FCGBP_13, FCGBP_12, FCGBP_11, FCGBP_10@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F99129@170786@170802@duplication@17@43372216@43441228@19@chr19:43372216-43441228@71@2981@4206@1.41@CNVR7658.2@PSG1_5, PSG1_4, PSG1_3, PSG1_2, PSG1_1, PSG6_6, PSG6_5, PSG6_4, PSG6_3, PSG6_2, PSG6_1, PSG7_6, PSG7_5, PSG7_4, PSG7_3, PSG7_2, PSG7_1@0@0@0@:pregnancy specific beta-1-glycoprotein 1:pregnancy specific beta-1-glycoprotein 6:pregnancy specific beta-1-glycoprotein 7 (gene/pseudogene)@:protein binding;extracellular region;female pregnancy:protein binding;extracellular region;female pregnancy;molecular_function@NA
F99129@172989@172992@duplication@4@52146609@52148783@19@chr19:52146609-52148783@9.39@469@638@1.36@CNVR7702.1@SIGLEC14_7, SIGLEC14_6, SIGLEC14_5, SIGLEC14_4@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 14@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion;plasma membrane@NA
F99129@173296@173298@duplication@3@54724956@54726434@19@chr19:54724956-54726434@12@154@267@1.73@CNVR7721.3, CNVR7721.4@LILRB3_5, LILRB3_4, LILRB3_3@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F99129@173467@173469@deletion@3@55263102@55263971@19@chr19:55263102-55263971@17.9@384@205@0.534@CNVR7725.2, CNVR7725.1@KIR2DL3_6, KIR2DL3_7, KIR2DL3_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity@NA
F99129@173492@173493@deletion@2@55341384@55341730@19@chr19:55341384-55341730@7.29@402@264@0.657@CNVR7725.1, CNVR7725.6@KIR3DL1_8, KIR3DL1_9@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
F99129@173499@173501@duplication@3@55358640@55359398@19@chr19:55358640-55359398@18.1@943@1330@1.41@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4_6, KIR2DS4_7, KIR2DS4_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
F99129@173842@173842@deletion@1@56273168@56273452@19@chr19:56273168-56273452@5.98@176@104@0.591@CNVR7734.1@RFPL4A_2@0@0@0@:ret finger protein-like 4A;ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
F99129@174395@174395@deletion@1@1569207@1569278@20@chr20:1569207-1569278@12.3@56@0@0@CNVR7763.1@RP4-576H24.4_1@0@0@0@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
F99129@181487@181487@deletion@1@21065630@21065749@22@chr22:21065630-21065749@5.13@27@3@0.111@CNVR8099.6, CNVR8099.2@PI4KA_51@0@0@0@:phosphatidylinositol 4-kinase, catalytic, alpha@:phospholipid metabolic process;1-phosphatidylinositol 4-kinase activity;small molecule metabolic process;phosphatidylinositol phosphorylation;binding;transferase activity, transferring phosphorus-containing groups;phosphotransferase activity, alcohol group as acceptor;ATP binding;Golgi-associated vesicle;phosphatidylinositol biosynthetic process;cytosol;protein binding;signal transduction;synaptic transmission;kinase activity;phosphatidylinositol-mediated signaling@NA
F99129@181948@181949@deletion@2@24324820@24325235@22@chr22:24324820-24325235@5.91@56@21@0.375@CNVR8114.6, CNVR8114.13, CNVR8114.8, CNVR8114.14@GSTT2_3, GSTT2_4@0@0@0@@:protein binding;glutathione transferase activity;nucleus;cytoplasm@NA
F99129@181951@181955@duplication@5@24376424@24384231@22@chr22:24376424-24384231@14.5@762@1035@1.36@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTT1_5, GSTT1_4, GSTT1_3, GSTT1_2, GSTT1_1@0@0@0@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
F99129@183631@183631@deletion@1@39357393@39357686@22@chr22:39357393-39357686@8.43@63@17@0.27@CNVR8164.1@APOBEC3A_4@0@0@0@:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A;APOBEC3A and APOBEC3B deletion hybrid@:cytidine deamination;defense response to virus;negative regulation of viral genome replication;DNA cytosine deamination;clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine;catalytic activity;DNA demethylation;cytoplasm;innate immune response;cytidine deaminase activity;nucleus;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;cellular response to xenobiotic stimulus;zinc ion binding;negative regulation of transposition@NA
F99129@183635@183640@duplication@6@39380081@39388154@22@chr22:39380081-39388154@7.74@689@893@1.3@CNVR8164.1@APOBEC3B_2, APOBEC3B_3, APOBEC3B_4, APOBEC3B_5, APOBEC3B_6, APOBEC3B_7@0@0@0@:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B@:RNA binding;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;negative regulation of transposition;catalytic activity;zinc ion binding@NA
F99129@184146@184151@deletion@6@42523845@42526793@22@chr22:42523845-42526793@25.8@776@463@0.597@CNVR8168.1, CNVR8168.3, CNVR8168.2@CYP2D6_6, CYP2D6_5, CYP2D6_4, CYP2D6_3, CYP2D6_2, CYP2D6_1@0@0@0@:cytochrome P450, family 2, subfamily D, polypeptide 6@:oxidation-reduction process;mitochondrion;alkaloid catabolic process;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;drug catabolic process;endoplasmic reticulum membrane;response to organic substance;oxidative demethylation;endoplasmic reticulum;alkaloid metabolic process;negative regulation of binding;heme binding;xenobiotic metabolic process;dopamine metabolic process;steroid metabolic process;isoquinoline alkaloid metabolic process;arachidonic acid monooxygenase activity;arachidonic acid metabolic process;steroid 21-monooxygenase activity;negative regulation of cellular organofluorine metabolic process;oxidoreductase activity;monoterpenoid metabolic process;heterocycle metabolic process;drug binding;drug metabolic process;electron carrier activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;coumarin metabolic process@: DRUG METABOLISM, POOR, CYP2D6-RELATED
F99129@184154@184154@deletion@1@42537163@42537296@22@chr22:42537163-42537296@7.29@119@59@0.496@CNVR8168.1, CNVR8168.3, CNVR8168.4@CYP2D7P1_3@0@0@0@@:oxidation-reduction process;electron carrier activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;heme binding@NA
F99129@184165@184177@duplication@13@42908917@42952594@22@chr22:42908917-42952594@49.8@854@1407@1.65@CNVR8171.2, CNVR8171.3@RRP7A_7, RRP7A_6, RRP7A_5, RRP7A_4, RRP7A_3, RRP7A_2, RRP7A_1, SERHL2_1, SERHL2_2, SERHL2_3, SERHL2_4, SERHL2_5, SERHL2_6@0@0@0@:ribosomal RNA processing 7 homolog A (S. cerevisiae):serine hydrolase-like 2@:RNA binding;nucleotide binding:hydrolase activity;mitochondrion;peroxisome;cytoplasmic membrane-bounded vesicle;molecular_function;cellular_component;perinuclear region of cytoplasm;biological_process@NA
F99129@190@190@duplication@1@3761383@3761523@X@chrX:3761383-3761523@4.83@25@61@2.44@CNVR8259.1, CNVR8259.3, CNVR8259.5@RP11-706O15.1_1@0@0@0@NA@NA@NA
F99129@4072@4079@deletion@8@101615523@101620252@X@chrX:101615523-101620252@18.5@84@0@0@NA@NXF2B_34, NXF2B_33, NXF2B_32, NXF2B_31, NXF2B_30, NXF2B_29, NXF2B_28, NXF2B_27@0@0@0@NA@NA@NA
F99129@4883@4884@deletion@2@119209866@119211253@X@chrX:119209866-119211253@7.46@38@3@0.0789@NA@RHOXF2B_3, RHOXF2B_2@0@0@0@NA@NA@NA
F99129@6284@6285@deletion@2@153416129@153418581@X@chrX:153416129-153418581@6.95@66@25@0.379@CNVR8489.1@OPN1LW_2, OPN1LW_3@0@0@0@NA@NA@NA
F99129@6294@6307@duplication@14@153453260@153496256@X@chrX:153453260-153496256@20.9@153@326@2.13@CNVR8489.1@OPN1MW_2, OPN1MW_3, OPN1MW_4, OPN1MW_5, OPN1MW_6, TEX28P1_4, TEX28P1_3, TEX28P1_2, TEX28P1_1, OPN1MW2_1, OPN1MW2_2, OPN1MW2_3, OPN1MW2_4, OPN1MW2_5@0@0@0@NA@NA@NA
F99359@6@6@deletion@1@69092@70008@1@chr1:69092-70008@7.62@36@1@0.0278@CNVR1.1, CNVR1.2@OR4F5_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F99359@308@335@deletion@28@1386065@1431197@1@chr1:1386065-1431197@86.9@2348@1374@0.585@NA@ATAD3C_1, ATAD3C_2, ATAD3C_3, ATAD3C_4, ATAD3C_5, ATAD3C_6, ATAD3C_7, ATAD3C_8, ATAD3C_9, ATAD3C_10, ATAD3C_11, ATAD3C_12, ATAD3B_1, ATAD3B_2, ATAD3B_3, ATAD3B_4, ATAD3B_5, ATAD3B_6, ATAD3B_7, ATAD3B_8, ATAD3B_9, ATAD3B_10, ATAD3B_11, ATAD3B_12, ATAD3B_13, ATAD3B_14, ATAD3B_15, ATAD3B_16@0@0@0@:ATPase family, AAA domain containing 3C:ATPase family, AAA domain containing 3B@:four-way junction helicase activity;DNA repair;nucleoside-triphosphatase activity;nucleotide binding;DNA recombination;ATP binding:nucleoside-triphosphatase activity;mitochondrial inner membrane;nucleotide binding;ATP binding@NA
F99359@2170@2186@deletion@17@17248515@17273486@1@chr1:17248515-17273486@26.5@1496@995@0.665@CNVR94.4, CNVR94.5@CROCC_1, CROCC_2, CROCC_3, CROCC_4, CROCC_5, CROCC_6, CROCC_7, CROCC_8, CROCC_9, CROCC_10, CROCC_11, CROCC_12, CROCC_13, CROCC_14, CROCC_15, CROCC_16, CROCC_17@0@0@0@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
F99359@2788@2788@deletion@1@21806545@21806716@1@chr1:21806545-21806716@6.27@32@3@0.0938@CNVR107.2, CNVR107.1@NBPF3_11@0@0@0@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 3@:cytoplasm@NA
F99359@3335@3341@deletion@7@25617133@25648453@1@chr1:25617133-25648453@13.1@755@504@0.668@CNVR116.1, CNVR116.2@RHD_3, RHD_4, RHD_5, RHD_6, RHD_7, RHD_8, RHD_9@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
F99359@5196@5197@deletion@2@40235375@40240128@1@chr1:40235375-40240128@6.83@303@193@0.637@NA@OXCT2_1, BMP8B_3@0@0@0@:bone morphogenetic protein 8b:3-oxoacid CoA transferase 2@:cell differentiation;growth factor activity;extracellular space;growth;extracellular region;cytokine activity;cartilage development;skeletal system development;ossification:mitochondrion;microtubule-based flagellum;CoA-transferase activity;ketone body catabolic process;3-oxoacid CoA-transferase activity;metabolic process@NA
F99359@7186@7186@deletion@1@60106953@60107023@1@chr1:60106953-60107023@10.8@283@158@0.558@CNVR197.1@FGGY_12@0@0@0@:FGGY carbohydrate kinase domain containing@:cell death;neuron homeostasis;molecular_function;carbohydrate metabolic process;kinase activity;cellular_component;phosphotransferase activity, alcohol group as acceptor@: AMYOTROPHIC LATERAL SCLEROSIS 1; ALS1
F99359@8356@8357@duplication@2@86488517@86488690@1@chr1:86488517-86488690@5.92@187@267@1.43@NA@COL24A1_16, COL24A1_15@0@0@0@:collagen, type XXIV, alpha 1@:extracellular matrix structural constituent;collagen;extracellular region;extracellular matrix organization;endoplasmic reticulum lumen@NA
F99359@8507@8508@duplication@2@89476588@89477710@1@chr1:89476588-89477710@10.4@484@672@1.39@CNVR244.1@GBP3_8, GBP3_7@0@0@0@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
F99359@9365@9374@deletion@10@104202983@104234232@1@chr1:104202983-104234232@27.3@124@0@0@CNVR266.3, CNVR266.1, CNVR266.15@AMY1A_7, AMY1A_8, AMY1A_9, AMY1A_10, AMY1A_11, AMY1B_11, AMY1B_10, AMY1B_9, AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
F99359@9436@9436@deletion@1@108769302@108769515@1@chr1:108769302-108769515@9.48@58@10@0.172@CNVR294.4@NBPF4_14@0@0@0@:neuroblastoma breakpoint family, member 4@:cytoplasm@NA
F99359@9766@9773@deletion@8@110230497@110235917@1@chr1:110230497-110235917@82.3@384@5@0.013@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
F99359@10684@10687@duplication@4@120539621@120612020@1@chr1:120539621-120612020@13@599@831@1.39@CNVR319.3, CNVR319.2@NOTCH2_4, NOTCH2_3, NOTCH2_2, NOTCH2_1@0@0@0@:notch 2@:nucleoplasm;negative regulation of apoptotic process;cell differentiation;negative regulation of cell proliferation;pulmonary valve morphogenesis;atrial septum morphogenesis;stem cell maintenance;placenta blood vessel development;placenta development;bone remodeling;induction of apoptosis;tissue regeneration;plasma membrane;nucleus;endoplasmic reticulum membrane;gene expression;cell fate determination;in utero embryonic development;Notch receptor processing;humoral immune response;inflammatory response to antigenic stimulus;embryonic limb morphogenesis;hemopoiesis;membrane;calcium ion binding;Notch signaling involved in heart development;nervous system development;Golgi membrane;morphogenesis of an epithelial sheet;integral to membrane;interleukin-4 secretion;cell cycle arrest;receptor activity;integral to plasma membrane;organ morphogenesis;determination of left/right symmetry;transcription initiation from RNA polymerase II promoter;multicellular organismal development;cell growth;regulation of transcription, DNA-dependent;positive regulation of Ras protein signal transduction;protein binding;regulation of developmental process;Notch signaling pathway;extracellular region;cell surface;positive regulation of apoptotic process@: ALAGILLE SYNDROME 2; ALGS2; HAJDU-CHENEY SYNDROME; HJCYS
F99359@12117@12118@deletion@2@152573209@152586574@1@chr1:152573209-152586574@21.7@101@1@0.0099@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
F99359@14053@14058@duplication@6@161565346@161600992@1@chr1:161565346-161600992@41.5@1045@1605@1.54@CNVR383.1@FCGR2C_1, FCGR3B_5, FCGR3B_4, FCGR3B_3, FCGR3B_2, FCGR3B_1@0@0@0@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene):Fc fragment of IgG, low affinity IIIb, receptor (CD16b)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction:IgG binding;protein binding;extracellular region;immune response;plasma membrane;anchored to membrane@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
F99359@16029@16040@deletion@12@196744018@196801129@1@chr1:196744018-196801129@328@1557@7@0.0045@CNVR459.1@CFHR3_1, CFHR3_2, CFHR3_3, CFHR3_4, CFHR3_5, CFHR3_6, CFHR1_1, CFHR1_2, CFHR1_3, CFHR1_4, CFHR1_5, CFHR1_6@0@0@0@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
F99359@18461@18463@duplication@3@228290345@228290928@1@chr1:228290345-228290928@5.96@237@328@1.38@NA@C1orf35_3, C1orf35_2, C1orf35_1@0@0@0@:chromosome 1 open reading frame 35@NA@NA
F99359@22191@22194@duplication@4@38956699@38972329@2@chr2:38956699-38972329@10.9@610@822@1.35@CNVR759.1@GALM_5, GALM_6, GALM_7, SRSF7_8@0@0@0@:galactose mutarotase (aldose 1-epimerase):serine/arginine-rich splicing factor 7@:isomerase activity;carbohydrate binding;aldose 1-epimerase activity;hexose metabolic process;carbohydrate metabolic process;catalytic activity;cytoplasm:nucleoplasm;negative regulation of mRNA splicing, via spliceosome;mRNA 3'-end processing;termination of RNA polymerase II transcription;nucleotide binding;transcription from RNA polymerase II promoter;protein binding;mRNA export from nucleus;RNA binding;mRNA processing;nucleus;RNA splicing;mRNA splicing, via spliceosome;gene expression;zinc ion binding;nucleic acid binding@NA
F99359@24563@24563@duplication@1@85570763@85570921@2@chr2:85570763-85570921@13.8@160@299@1.87@NA@RETSAT_10@0@0@0@:retinol saturase (all-trans-retinol 13,14-reductase)@:all-trans-retinol 13,14-reductase activity;nuclear membrane;oxidation-reduction process;oxidoreductase activity;retinol metabolic process;endoplasmic reticulum membrane;nuclear outer membrane@NA
F99359@24752@24752@duplication@1@86422462@86422505@2@chr2:86422462-86422505@4.61@77@124@1.61@NA@IMMT_1@0@0@0@:inner membrane protein, mitochondrial@:mitochondrion;protein binding;response to cold;mitochondrial inner membrane;mitochondrial calcium ion homeostasis;biological_process;integral to mitochondrial inner membrane@NA
F99359@24945@24948@duplication@4@89326669@89340195@2@chr2:89326669-89340195@5.54@173@247@1.43@CNVR866.7, CNVR866.6, CNVR866.10, CNVR866.9, CNVR866.11@IGKV3-11_2, IGKV3-11_1, IGKV1-12_2, IGKV1-12_1@0@0@0@@:regulation of immune response;complement activation;immune response;complement activation, classical pathway;innate immune response;antigen binding;protein binding;extracellular region;plasma membrane:protein binding@NA
F99359@25006@25007@deletion@2@90198717@90199190@2@chr2:90198717-90199190@6.59@103@51@0.495@CNVR867.10, CNVR867.5, CNVR867.3, CNVR867.9, CNVR867.15, CNVR867.2@IGKV1D-12_1, IGKV1D-12_2@0@0@0@@:protein binding@NA
F99359@25393@25394@duplication@2@97877284@97877478@2@chr2:97877284-97877478@8.15@393@546@1.39@CNVR886.1@ANKRD36_57, ANKRD36_58@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
F99359@27177@27178@deletion@2@130897465@130897669@2@chr2:130897465-130897669@5.8@110@60@0.545@NA@CCDC74B_7, CCDC74B_6@0@0@0@:coiled-coil domain containing 74A;coiled-coil domain containing 74B@NA@NA
F99359@27211@27211@deletion@1@130955932@130955933@2@chr2:130955932-130955933@6.47@29@0@0@CNVR985.1@TUBA3E_1@0@0@0@:tubulin, alpha 3e@:GTPase activity;structural constituent of cytoskeleton;protein complex;GTP catabolic process;cytoplasm;microtubule cytoskeleton;protein polymerization;microtubule-based movement;structural molecule activity;cytoplasmic microtubule;GTP binding;microtubule;microtubule cytoskeleton organization;protein domain specific binding@NA
F99359@37204@37204@duplication@1@47205345@47205414@3@chr3:47205345-47205414@4.87@110@167@1.52@NA@SETD2_1@0@0@0@:SET domain containing 2@:oxidation-reduction process;histone lysine methylation;stem cell development;histone H3-K36 methylation;DNA binding;pericardium development;peptidyl-lysine trimethylation;mesoderm morphogenesis;oxidoreductase activity;chromosome;forebrain development;coronary vasculature morphogenesis;nucleus;embryonic placenta morphogenesis;regulation of gene expression;angiogenesis;vasculogenesis;regulation of transcription, DNA-dependent;neural tube closure;embryonic cranial skeleton morphogenesis;embryonic organ development;protein binding;cell migration involved in vasculogenesis;transcription, DNA-dependent;transition metal ion binding;morphogenesis of a branching structure;histone-lysine N-methyltransferase activity@NA
F99359@45876@45877@duplication@2@996521@996945@4@chr4:996521-996945@6.75@148@224@1.51@NA@IDUA_9, IDUA_10@0@0@0@:iduronidase, alpha-L-@:chondroitin sulfate metabolic process;glycosaminoglycan metabolic process;limb morphogenesis;lysosomal lumen;glycosaminoglycan catabolic process;receptor binding;lysosome;skeletal system morphogenesis;chemical homeostasis;cation binding;small molecule metabolic process;cell morphogenesis;lysosome organization;disaccharide metabolic process;carbohydrate metabolic process;chondroitin sulfate catabolic process;protein binding;coated vesicle;L-iduronidase activity;hydrolase activity, hydrolyzing O-glycosyl compounds@: SCHEIE SYNDROME; HURLER SYNDROME; HURLER-SCHEIE SYNDROME
F99359@48967@48968@duplication@2@75312252@75314965@4@chr4:75312252-75314965@6.39@88@148@1.68@NA@AREG_2, AREG_3@0@0@0@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
F99359@53187@53189@duplication@3@190884249@190947616@4@chr4:190884249-190947616@10.3@654@883@1.35@NA@FRG1_9, FRG2_4, FRG2_3@0@0@0@:protein FRG1-like;FSHD region gene 1:FSHD region gene 2-like;FSHD region gene 2@:actin filament binding;nuclear speck;nucleolus;Cajal body;mRNA splicing, via spliceosome;protein binding, bridging;catalytic step 2 spliceosome;rRNA processing:nucleus@NA
F99359@55817@55817@duplication@1@70247769@70247818@5@chr5:70247769-70247818@5.18@149@219@1.47@CNVR2494.41, CNVR2494.14, CNVR2494.30, CNVR2494.25, CNVR2494.20, CNVR2494.61, CNVR2494.22, CNVR2494.21, CNVR2494.62, CNVR2494.63@SMN1_8@0@0@0@:survival of motor neuron 2, centromeric;survival of motor neuron 1, telomeric@:nucleoplasm;ncRNA metabolic process;Cajal body;RNA metabolic process;spliceosomal complex;cytoplasm;cytosol;protein binding;cell death;spliceosomal complex assembly;RNA binding;mRNA processing;nucleus;gene expression;spliceosomal snRNP assembly@: SPINAL MUSCULAR ATROPHY, TYPE II; SMA2; SPINAL MUSCULAR ATROPHY, TYPE I; SMA1; SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4; SPINAL MUSCULAR ATROPHY, TYPE III; SMA3
F99359@57338@57338@deletion@1@109954131@109954263@5@chr5:109954131-109954263@10.8@337@195@0.579@NA@TMEM232_8@0@0@0@:transmembrane protein 232@:integral to membrane@NA
F99359@59065@59065@deletion@1@140557617@140560021@5@chr5:140557617-140560021@19@1490@909@0.61@CNVR2624.1@PCDHB8_1@0@0@0@:protocadherin beta 8@:integral to membrane;homophilic cell adhesion;plasma membrane;membrane;calcium ion binding@NA
F99359@59488@59488@deletion@1@147553798@147553933@5@chr5:147553798-147553933@30.6@146@2@0.0137@CNVR2637.2, CNVR2637.1@SPINK14_3@0@0@0@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
F99359@60876@60877@deletion@2@175388055@175388437@5@chr5:175388055-175388437@6.25@59@22@0.373@NA@THOC3_5, THOC3_4@0@0@0@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
F99359@61266@61266@deletion@1@177163581@177163610@5@chr5:177163581-177163610@5@57@24@0.421@NA@FAM153A_11@0@0@0@:family with sequence similarity 153, member A@NA@NA
F99359@61641@61645@deletion@5@180376905@180429785@5@chr5:180376905-180429785@9.65@762@523@0.686@CNVR2719.1@BTNL8_8, BTNL3_1, BTNL3_2, BTNL3_3, BTNL3_4@0@0@0@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
F99359@62954@62955@deletion@2@29911900@29912393@6@chr6:29911900-29912393@6.52@389@260@0.668@CNVR2829.7, CNVR2829.2, CNVR2829.3@HLA-A_6, HLA-A_7@0@0@0@:major histocompatibility complex, class I, A@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO
F99359@63281@63282@deletion@2@31237744@31238262@6@chr6:31237744-31238262@22.7@319@147@0.461@CNVR2838.2, CNVR2838.1@HLA-C_5, HLA-C_4@0@0@0@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
F99359@63803@63804@deletion@2@32010044@32010383@6@chr6:32010044-32010383@5.39@110@61@0.555@CNVR2843.6, CNVR2843.5@TNXB_10, TNXB_9@0@0@0@:tenascin-X-like;tenascin XB@:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
F99359@63953@63958@duplication@6@32485517@32498001@6@chr6:32485517-32498001@23.4@387@627@1.62@CNVR2845.21, CNVR2845.25, CNVR2845.30, CNVR2845.43, CNVR2845.6@HLA-DRB5_6, HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2, HLA-DRB5_1@0@0@0@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
F99359@63973@63975@duplication@3@32632576@32709302@6@chr6:32632576-32709302@7.87@287@404@1.41@CNVR2845.21, CNVR2845.39, CNVR2845.20@HLA-DQB1_2, HLA-DQB1_1, HLA-DQA2_1@0@0@0@:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1:major histocompatibility complex, class II, DQ alpha 2@:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
F99359@71440@71440@duplication@1@2309195@2309274@7@chr7:2309195-2309274@5.17@227@318@1.4@NA@SNX8_5@0@0@0@:sorting nexin 8@:intracellular protein transport;protein binding;early endosome to Golgi transport;phosphatidylinositol binding;retromer complex;early endosome membrane;cell communication@NA
F99359@71764@71765@duplication@2@5982956@5983621@7@chr7:5982956-5983621@5.22@273@370@1.36@NA@RSPH10B_14, RSPH10B_13@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F99359@71776@71779@deletion@4@6006495@6018327@7@chr7:6006495-6018327@27@254@94@0.37@NA@RSPH10B_2, PMS2_15, PMS2_14, PMS2_13@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas):PMS2 postmeiotic segregation increased 2 (S. cerevisiae)@:response to drug;DNA binding;MutSalpha complex binding;ATP binding;mismatch repair;DNA repair;mismatched DNA binding;ATPase activity;nucleus;mismatch repair complex;reciprocal meiotic recombination;ATP catabolic process;single-stranded DNA binding;response to DNA damage stimulus;single base insertion or deletion binding;protein binding;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;MutLalpha complex;endonuclease activity@: COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4; MISMATCH REPAIR CANCER SYNDROME
F99359@71922@71923@duplication@2@6797310@6798790@7@chr7:6797310-6798790@13.7@203@351@1.73@NA@RSPH10B2_2, RSPH10B2_3@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F99359@71932@71934@deletion@3@6819242@6821107@7@chr7:6819242-6821107@21@249@103@0.414@NA@RSPH10B2_12, RSPH10B2_13, RSPH10B2_14@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F99359@71940@71941@deletion@2@6837995@6838910@7@chr7:6837995-6838910@12@60@4@0.0667@NA@RSPH10B2_20, CCZ1B_15@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F99359@73246@73246@duplication@1@38292982@38293030@7@chr7:38292982-38293030@5.16@133@199@1.5@CNVR3353.1@TRGJ2_1@0@0@0@NA@NA@NA
F99359@73262@73263@duplication@2@38393317@38393784@7@chr7:38393317-38393784@8.56@333@471@1.41@CNVR3354.3, CNVR3354.1@TRGV4_2, TRGV4_1@0@0@0@@:protein binding@NA
F99359@74605@74607@deletion@3@74251403@74422230@7@chr7:74251403-74422230@6.87@31@0@0@NA@GTF2IRD2_2, GATSL1_1, GATSL1_2@0@0@0@:GTF2I repeat domain containing 2:GATS protein-like 1@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
F99359@74775@74775@duplication@1@76063356@76063472@7@chr7:76063356-76063472@4.77@75@123@1.64@CNVR3462.1@ZP3_5@0@0@0@:zona pellucida glycoprotein 3 (sperm receptor)@:negative regulation of transcription, DNA-dependent;manganese ion transmembrane transporter activity;intracellular protein transport;proteinaceous extracellular matrix;plasma membrane;positive regulation of acrosome reaction;outer acrosomal membrane;protein kinase C signaling cascade;manganese ion transmembrane transport;intracellular signal transduction;humoral immune response mediated by circulating immunoglobulin;negative regulation of binding of sperm to zona pellucida;positive regulation of inflammatory response;endoplasmic reticulum;signal transducer activity;perinuclear region of cytoplasm;secretory granule;positive regulation of transcription, DNA-dependent;positive regulation of ovarian follicle development;positive regulation of interferon-gamma production;carbohydrate binding;manganese ion transport;positive regulation of antral ovarian follicle growth;extracellular matrix;positive regulation of leukocyte migration;positive regulation of humoral immune response;extracellular space;blastocyst formation;integral to membrane;store-operated calcium channel activity;oocyte development;multivesicular body;phosphatidylinositol-mediated signaling;acrosomal vesicle;positive regulation of protein kinase B signaling cascade;Golgi apparatus;positive regulation of calcium ion import;positive regulation of protein kinase activity;positive regulation of acrosomal vesicle exocytosis;positive regulation of interleukin-4 production;cytoplasm;protein binding;binding of sperm to zona pellucida;positive regulation of phosphatidylinositol biosynthetic process;extracellular region;positive regulation of T cell proliferation;acrosin binding;positive regulation of type IV hypersensitivity;egg coat formation@NA
F99359@76427@76432@duplication@6@100331793@100336236@7@chr7:100331793-100336236@28.6@716@1082@1.51@CNVR3509.1@ZAN_1, ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
F99359@76754@76754@deletion@1@102219880@102220243@7@chr7:102219880-102220243@11.1@50@0@0@CNVR3518.1@AC093668.1_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
F99359@76765@76779@duplication@15@102235753@102279646@7@chr7:102235753-102279646@17.5@210@370@1.76@CNVR3518.1@RASA4_11, RASA4_10, RASA4_9, RASA4_8, RASA4_7, RASA4_6, RASA4_5, RASA4_4, RASA4_3, RASA4_2, UPK3BL_7, RASA4_1, UPK3BL_6, UPK3BL_6, UPK3BL_5, UPK3BL_5, UPK3BL_4, UPK3BL_4@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
F99359@76795@76795@duplication@1@102318940@102319303@7@chr7:102318940-102319303@12.3@203@345@1.7@CNVR3518.1@AC105052.1_1@0@0@0@NA@NA@NA
F99359@79309@79325@duplication@17@143880598@144072768@7@chr7:143880598-144072768@29.1@1799@2434@1.35@CNVR3598.4@CTAGE4_1, ARHGEF35_2, OR2A42_1, OR2A7_1, CTAGE8_1, OR2A1_1, ARHGEF5_2, ARHGEF5_3, ARHGEF5_4, ARHGEF5_5, ARHGEF5_6, ARHGEF5_7, ARHGEF5_8, ARHGEF5_9, ARHGEF5_10, ARHGEF5_11, ARHGEF5_12@0@0@0@:CTAGE family, member 4:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:olfactory receptor, family 2, subfamily A, member 7:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:integral to membrane;nucleotide binding;cellular_component;biological_process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
F99359@80368@80368@duplication@1@7274293@7274349@8@chr8:7274293-7274349@11.7@14@90@6.43@CNVR3771.8, CNVR3771.10, CNVR3771.4@DEFB4B_1@0@0@0@:defensin, beta 4B;defensin, beta 4A@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response@NA
F99359@80371@80372@deletion@2@7308236@7320381@8@chr8:7308236-7320381@13.3@328@183@0.558@CNVR3771.8, CNVR3771.10, CNVR3771.4@SPAG11B_3, SPAG11B_2@0@0@0@:sperm associated antigen 11B@:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response@NA
F99359@80385@80399@deletion@15@7398475@7698716@8@chr8:7398475-7698716@17.8@484@290@0.599@CNVR3772.4, CNVR3772.6@RP11-1118M6.1_3, RP11-1118M6.1_4, AC084121.16_4, AC084121.16_3, AC084121.16_2, AC084121.16_1, DEFB107A_2, DEFB107A_1, DEFB105A_3, DEFB105A_2, DEFB105A_1, DEFB106A_1, DEFB106A_2, DEFB104A_1, DEFB104A_2@0@0@0@:uncharacterized LOC100133251:uncharacterized LOC100133251:defensin, beta 107B;defensin, beta 107A:defensin, beta 105B;defensin, beta 105A:defensin, beta 106B;defensin, beta 106A:defensin, beta 104A;defensin, beta 104B@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
F99359@80406@80406@deletion@1@7752236@7752292@8@chr8:7752236-7752292@17.3@132@33@0.25@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@DEFB4A_1@0@0@0@:defensin, beta 4B;defensin, beta 4A@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response@NA
F99359@85996@85997@duplication@2@144462000@144462345@8@chr8:144462000-144462345@5.48@212@295@1.39@NA@RHPN1_9, RHPN1_10@0@0@0@:rhophilin, Rho GTPase binding protein 1@:protein binding;signal transduction;small GTPase regulator activity;intracellular@NA
F99359@86351@86352@duplication@2@145438827@145439211@8@chr8:145438827-145439211@5.75@9@45@5@NA@FAM203B_3, FAM203B_4@0@0@0@:family with sequence similarity 203, member B@:binding@NA
F99359@88584@88594@deletion@11@43624656@43818184@9@chr9:43624656-43818184@44.2@325@82@0.252@CNVR4294.1@SPATA31A6_4, SPATA31A6_3, SPATA31A6_2, SPATA31A6_1, CNTNAP3B_1, CNTNAP3B_2, CNTNAP3B_3, CNTNAP3B_4, CNTNAP3B_5, CNTNAP3B_6, CNTNAP3B_7@0@0@0@:SPATA31 subfamily A, member 6:contactin associated protein-like 3B;contactin associated protein-like 3@:integral to membrane:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
F99359@95348@95355@duplication@8@17837921@17891768@10@chr10:17837921-17891768@17.9@457@682@1.49@NA@TMEM236_4, MRC1L1_1, MRC1L1_2, MRC1L1_3, MRC1L1_4, MRC1L1_5, MRC1L1_6, MRC1L1_7@0@0@0@:transmembrane protein 236;transmembrane protein 236-like:macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding@NA
F99359@95380@95394@deletion@15@18060293@18155690@10@chr10:18060293-18155690@40.1@289@76@0.263@NA@TMEM236_2, TMEM236_3, TMEM236_4, MRC1_1, MRC1_2, MRC1_3, MRC1_4, MRC1_5, MRC1_6, MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11, MRC1_12@0@0@0@:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F99359@95947@95948@duplication@2@29578048@29580935@10@chr10:29578048-29580935@7.37@147@227@1.54@NA@LYZL1_1, LYZL1_2@0@0@0@:lysozyme-like 1@:extracellular region;lysozyme activity;cell wall macromolecule catabolic process@NA
F99359@96476@96480@duplication@5@46967427@47000257@10@chr10:46967427-47000257@10.3@2424@3086@1.27@CNVR4712.9, CNVR4712.2, CNVR4712.7, CNVR4712.4@SYT15_4, SYT15_3, SYT15_2, SYT15_1, GPRIN2_1@0@0@0@:synaptotagmin XV:G protein regulated inducer of neurite outgrowth 2@:protein binding;synaptic vesicle;integral to membrane;transporter activity;plasma membrane;membrane;extrinsic to membrane@NA
F99359@96883@96883@deletion@1@51620325@51620382@10@chr10:51620325-51620382@4.6@49@20@0.408@NA@TIMM23_2@0@0@0@:translocase of inner mitochondrial membrane 23 homolog B (yeast):translocase of inner mitochondrial membrane 23 homolog B (yeast);translocase of inner mitochondrial membrane 23 homolog (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:mitochondrion;mitochondrial inner membrane;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;mitochondrial intermembrane space;integral to mitochondrial inner membrane;intracellular protein transport;protein binding;integral to membrane;cellular protein metabolic process;protein targeting to mitochondrion@NA
F99359@96933@96937@deletion@5@51970584@51978390@10@chr10:51970584-51978390@10@147@75@0.51@NA@ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
F99359@101608@101614@duplication@7@124344788@124353114@10@chr10:124344788-124353114@9.37@764@995@1.3@CNVR4912.4, CNVR4912.3, CNVR4912.2@DMBT1_15, DMBT1_16, DMBT1_17, DMBT1_18, DMBT1_19, DMBT1_20, DMBT1_21@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
F99359@102336@102338@deletion@3@135438604@135439807@10@chr10:135438604-135439807@10.7@453@286@0.631@CNVR4989.11, CNVR4989.4@FRG2B_4, FRG2B_3, FRG2B_2@0@0@0@:FSHD region gene 2 family, member B@:nucleus@NA
F99359@103139@103139@duplication@1@3239175@3240043@11@chr11:3239175-3240043@4.71@363@486@1.34@CNVR5028.1@MRGPRG_1@0@0@0@:MAS-related GPR, member G@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway@NA
F99359@103269@103269@deletion@1@4976003@4976943@11@chr11:4976003-4976943@33@442@162@0.367@CNVR5040.1@OR51A2_1@0@0@0@:matrix metallopeptidase 26:olfactory receptor, family 51, subfamily A, member 2@:metallopeptidase activity;extracellular matrix;proteolysis;proteinaceous extracellular matrix;collagen catabolic process;metalloendopeptidase activity;zinc ion binding;metabolic process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F99359@103342@103342@deletion@1@5798891@5799864@11@chr11:5798891-5799864@14.9@636@375@0.59@CNVR5049.1@OR52N5_1@0@0@0@:tripartite motif containing 5:olfactory receptor, family 52, subfamily N, member 5@:defense response to virus;Golgi apparatus;intracellular;protein trimerization;ligase activity;cytoplasm;protein binding;nucleus;protein homodimerization activity;identical protein binding;zinc ion binding;cytoplasmic mRNA processing body;protein ubiquitination;virus-host interaction:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F99359@104572@104572@duplication@1@18955364@18956331@11@chr11:18955364-18956331@10.3@1102@1512@1.37@CNVR5091.2, CNVR5091.1@MRGPRX1_1@0@0@0@:MAS-related GPR, member X1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;acute-phase response;G-protein coupled receptor signaling pathway@NA
F99359@106038@106040@deletion@3@55032377@55035848@11@chr11:55032377-55035848@28@130@1@0.00769@CNVR5178.5@TRIM48_2, TRIM48_3, TRIM48_4@0@0@0@:tripartite motif containing 48@:protein binding;intracellular;zinc ion binding@NA
F99359@106046@106048@duplication@3@55370918@55419315@11@chr11:55370918-55419315@26.6@1912@2649@1.39@CNVR5179.1@OR4C11_1, OR4P4_1, OR4S2_1@0@0@0@:olfactory receptor, family 4, subfamily C, member 11:olfactory receptor, family 4, subfamily P, member 4:olfactory receptor, family 4, subfamily S, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F99359@114483@114483@duplication@1@11243900@11244828@12@chr12:11243900-11244828@11.2@853@1195@1.4@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
F99359@115537@115537@deletion@1@31249276@31249313@12@chr12:31249276-31249313@10@65@13@0.2@CNVR5483.1@DDX11_15@0@0@0@:DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11@:nucleoplasm;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;S phase of mitotic cell cycle;DNA binding;nucleobase-containing compound metabolic process;ATP binding;ATP-dependent DNA helicase activity;DNA helicase activity;midbody;RNA binding;DNA-dependent ATPase activity;nucleus;positive regulation of cell proliferation;virus-host interaction;nuclear chromatin;4 iron, 4 sulfur cluster binding;helicase activity;hydrolase activity, acting on acid anhydrides;DNA duplex unwinding;endoplasmic reticulum unfolded protein response;G2/M transition of mitotic cell cycle;protein binding;sister chromatid cohesion;activation of signaling protein activity involved in unfolded protein response;nucleolus;spindle pole;ATP-dependent helicase activity;metal ion binding;nucleic acid binding;mitotic sister chromatid segregation@: WARSAW BREAKAGE SYNDROME
F99359@127333@127335@deletion@3@19553418@19559164@14@chr14:19553418-19559164@11.2@71@14@0.197@CNVR6072.1@POTEG_1, POTEG_2, POTEG_3@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
F99359@131032@131034@duplication@3@74004127@74010359@14@chr14:74004127-74010359@14.1@414@606@1.46@CNVR6188.1, CNVR6188.4@ACOT1_1, ACOT1_2, ACOT1_3@0@0@0@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
F99359@133432@133435@duplication@4@106539080@106552729@14@chr14:106539080-106552729@47@592@1087@1.84@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1@0@0@0@@:protein binding:protein binding@NA
F99359@133458@133459@duplication@2@106791006@106791456@14@chr14:106791006-106791456@18.9@528@829@1.57@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-30_2, IGHV3-30_1@0@0@0@@:protein binding@NA
F99359@133462@133463@deletion@2@106815723@106816173@14@chr14:106815723-106816173@44.5@210@0@0@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.56, CNVR6294.51@IGHV3-33_2, IGHV3-33_1@0@0@0@@:protein binding@NA
F99359@133468@133473@duplication@6@106866407@106926644@14@chr14:106866407-106926644@85.7@1462@2600@1.78@CNVR6294.26, CNVR6294.56, CNVR6294.18@IGHV3-38_2, IGHV3-38_1, IGHV4-39_2, IGHV4-39_1, IGHV3-43_2, IGHV3-43_1@0@0@0@@:protein binding:protein binding:protein binding@NA
F99359@133541@133542@deletion@2@22368577@22383423@15@chr15:22368577-22383423@6.59@3540@2592@0.732@CNVR6297.4, CNVR6297.17, CNVR6297.2@OR4M2_1, OR4N4_1@0@0@0@:olfactory receptor, family 4, subfamily M, member 2:olfactory receptor, family 4, subfamily N, member 4@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F99359@134444@134448@deletion@5@34678827@34820278@15@chr15:34678827-34820278@7.84@48@9@0.188@CNVR6351.3@GOLGA8A_11, GOLGA8A_10, GOLGA8A_9, GOLGA8B_25, GOLGA8B_24@0@0@0@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
F99359@134751@134752@duplication@2@40656428@40656745@15@chr15:40656428-40656745@5.08@378@498@1.32@NA@DISP2_3, DISP2_4@0@0@0@:dispatched homolog 2 (Drosophila)@:integral to membrane;smoothened signaling pathway;molecular_function;cellular_component@NA
F99359@140410@140410@deletion@1@101814626@101814700@15@chr15:101814626-101814700@5.48@80@39@0.488@NA@VIMP_5@0@0@0@:VCP-interacting membrane protein@:negative regulation of apoptotic process;ER-associated protein catabolic process;regulation of gluconeogenesis;cell redox homeostasis;intracellular protein transport;integral to endoplasmic reticulum membrane;retrograde protein transport, ER to cytosol;plasma membrane;negative regulation of glucose import;endoplasmic reticulum;negative regulation of tumor necrosis factor production;cellular response to lipopolysaccharide;enzyme binding;response to glucose stimulus;response to redox state;negative regulation of interleukin-6 production;antioxidant activity;negative regulation of acute inflammatory response to antigenic stimulus;establishment of protein localization;low-density lipoprotein particle;very-low-density lipoprotein particle;negative regulation of glycogen biosynthetic process;cellular response to insulin stimulus;receptor activity;negative regulation of inflammatory response;regulation of nitric oxide metabolic process;ER overload response;endoplasmic reticulum unfolded protein response;negative regulation of nitric-oxide synthase biosynthetic process;cellular response to oxidative stress;protein binding;selenium binding@NA
F99359@142700@142706@duplication@7@15110978@15123913@16@chr16:15110978-15123913@12.5@1124@1462@1.3@CNVR6646.1@PDXDC1_10, PDXDC1_11, PDXDC1_12, PDXDC1_13, PDXDC1_14, PDXDC1_15, PDXDC1_16@0@0@0@:pyridoxal-dependent decarboxylase domain containing 1;pyridoxal-dependent decarboxylase domain-containing protein 1-like@:carboxylic acid metabolic process;pyridoxal phosphate binding;carboxy-lyase activity@NA
F99359@143003@143003@deletion@1@18542789@18542929@16@chr16:18542789-18542929@7.24@159@87@0.547@NA@NOMO2_13@0@0@0@:NODAL modulator 2@:carbohydrate binding;protein binding;integral to membrane;carboxypeptidase activity;endoplasmic reticulum membrane@NA
F99359@147109@147120@deletion@12@70161164@70178436@16@chr16:70161164-70178436@80.1@2883@1745@0.605@CNVR6764.1, CNVR6764.3@PDPR_4, PDPR_5, PDPR_6, PDPR_7, PDPR_8, PDPR_9, PDPR_10, PDPR_11, PDPR_12, PDPR_13, PDPR_14, PDPR_15@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
F99359@147123@147127@deletion@5@70187295@70211383@16@chr16:70187295-70211383@37.4@1336@749@0.561@CNVR6764.1@PDPR_18, PDPR_19, CLEC18C_1, CLEC18C_2, CLEC18C_3@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit:C-type lectin domain family 18, member C@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix:carbohydrate binding;protein binding;extracellular region@NA
F99359@147420@147421@duplication@2@72092154@72093087@16@chr16:72092154-72093087@8.09@294@423@1.44@CNVR6769.1, CNVR6769.2@HP_5, HP_6@0@0@0@:thioredoxin-like 4B:haptoglobin:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:cellular iron ion homeostasis;negative regulation of oxidoreductase activity;catalytic activity;negative regulation of hydrogen peroxide catabolic process;positive regulation of cell death;haptoglobin-hemoglobin complex;extracellular space;proteolysis;response to hydrogen peroxide;extracellular region;hemoglobin binding;defense response;serine-type endopeptidase activity:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@: ANHAPTOGLOBINEMIA; AHP
F99359@147497@147502@deletion@6@74415415@74425978@16@chr16:74415415-74425978@7.57@247@152@0.615@CNVR6778.2, CNVR6778.4@NPIPL2_2, NPIPL2_3, NPIPL2_4, NPIPL2_5, NPIPL2_6, NPIPL2_7@0@0@0@@:extracellular region@NA
F99359@147512@147512@deletion@1@74447478@74447574@16@chr16:74447478-74447574@5.94@97@49@0.505@CNVR6778.2, CNVR6778.3, CNVR6778.5@CLEC18B_4@0@0@0@:C-type lectin domain family 18, member B@:carbohydrate binding;protein binding;extracellular region@NA
F99359@149172@149172@deletion@1@2965964@2966901@17@chr17:2965964-2966901@12.6@497@295@0.594@NA@OR1D5_1@0@0@0@:olfactory receptor, family 1, subfamily D, member 5@:integral to membrane;sensory perception of smell;G-protein coupled receptor activity;plasma membrane;detection of chemical stimulus involved in sensory perception of smell;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F99359@151556@151561@duplication@6@16664740@16676947@17@chr17:16664740-16676947@12.2@1019@1334@1.31@NA@CCDC144A_13, CCDC144A_13, CCDC144A_14, CCDC144A_14, CCDC144A_15, CCDC144A_15, CCDC144A_16, CCDC144A_16, CCDC144A_17, CCDC144A_18, CCDC144A_17@0@0@0@:coiled-coil domain containing 144A@NA@NA
F99359@151875@151885@deletion@11@18380170@18397681@17@chr17:18380170-18397681@84.8@496@71@0.143@CNVR7014.1@LGALS9C_1, LGALS9C_2, LGALS9C_3, LGALS9C_4, LGALS9C_5, LGALS9C_6, LGALS9C_7, LGALS9C_8, LGALS9C_9, LGALS9C_10, LGALS9C_11@0@0@0@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
F99359@152124@152124@duplication@1@20355109@20355196@17@chr17:20355109-20355196@6.64@83@146@1.76@CNVR7021.1, CNVR7021.3@LGALS9B_9@0@0@0@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
F99359@153381@153381@deletion@1@34539885@34539971@17@chr17:34539885-34539971@4.88@22@0@0@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1_3@0@0@0@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
F99359@153654@153660@duplication@7@36358126@36398302@17@chr17:36358126-36398302@45.9@2525@3545@1.4@CNVR7083.3@RP11-1407O15.2_8, RP11-1407O15.2_7, RP11-1407O15.2_6, RP11-1407O15.2_5, RP11-1407O15.2_4, RP11-1407O15.2_3, RP11-1407O15.2_2@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
F99359@154346@154346@deletion@1@39421631@39422112@17@chr17:39421631-39422112@6.11@48@14@0.292@CNVR7096.1@KRTAP9-6_1@0@0@0@:keratin associated protein 9-6@:keratin filament@NA
F99359@155580@155581@duplication@2@44171927@44249509@17@chr17:44171927-44249509@10.5@1875@2485@1.33@CNVR7114.3, CNVR7114.2@KANSL1_3, KANSL1_2@0@0@0@:KAT8 regulatory NSL complex subunit 1@:histone acetyltransferase activity (H4-K8 specific);histone acetyltransferase activity (H4-K16 specific);histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase complex;histone H4-K5 acetylation;MLL1 complex;histone H4-K16 acetylation;protein binding;histone H4-K8 acetylation;nucleus@NA
F99359@155587@155595@deletion@9@44399689@44415089@17@chr17:44399689-44415089@22.9@145@30@0.207@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9, LRRC37A_10, LRRC37A_11, LRRC37A_12, LRRC37A_13, LRRC37A_14@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
F99359@155610@155612@duplication@3@44632519@44632945@17@chr17:44632519-44632945@6.57@133@205@1.54@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2_13, LRRC37A2_14, LRRC37A2_15@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
F99359@162017@162018@deletion@2@44542732@44550298@18@chr18:44542732-44550298@5.16@23@0@0@CNVR7319.1, CNVR7319.2@TCEB3CL2_1, TCEB3CL_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like 2:transcription elongation factor B polypeptide 3C-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
F99359@165960@165961@deletion@2@10751716@10752093@19@chr19:10751716-10752093@6.13@88@43@0.489@NA@AC011475.1_1, AC011475.1_2@0@0@0@:solute carrier family 44, member 2@:choline transmembrane transporter activity;phospholipid metabolic process;glycerophospholipid biosynthetic process;small molecule metabolic process;phosphatidylcholine biosynthetic process;signal transducer activity;transmembrane transport;positive regulation of I-kappaB kinase/NF-kappaB cascade;signal transduction;choline transport;integral to membrane;plasma membrane@NA
F99359@167047@167047@duplication@1@14877791@14877921@19@chr19:14877791-14877921@5.94@105@168@1.6@NA@EMR2_6@0@0@0@:egf-like module containing, mucin-like, hormone receptor-like 2@:transmembrane signaling receptor activity;inflammatory response;G-protein coupled receptor activity;ruffle membrane;integral to membrane;plasma membrane;cell surface receptor signaling pathway;neuropeptide signaling pathway;granulocyte chemotaxis;cell migration;leading edge membrane;G-protein coupled receptor signaling pathway;protein binding;cell adhesion;membrane;calcium ion binding;chondroitin sulfate binding@NA
F99359@168952@168952@deletion@1@35862263@35863302@19@chr19:35862263-35863302@13.3@128@44@0.344@CNVR7627.1@GPR42_2@0@0@0@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
F99359@170099@170100@deletion@2@40380120@40382826@19@chr19:40380120-40382826@6.04@28@1@0.0357@CNVR7639.2@FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F99359@170786@170802@duplication@17@43372216@43441228@19@chr19:43372216-43441228@59.7@2422@3399@1.4@CNVR7658.2@PSG1_5, PSG1_4, PSG1_3, PSG1_2, PSG1_1, PSG6_6, PSG6_5, PSG6_4, PSG6_3, PSG6_2, PSG6_1, PSG7_6, PSG7_5, PSG7_4, PSG7_3, PSG7_2, PSG7_1@0@0@0@:pregnancy specific beta-1-glycoprotein 1:pregnancy specific beta-1-glycoprotein 6:pregnancy specific beta-1-glycoprotein 7 (gene/pseudogene)@:protein binding;extracellular region;female pregnancy:protein binding;extracellular region;female pregnancy;molecular_function@NA
F99359@172989@172991@duplication@3@52146609@52147289@19@chr19:52146609-52147289@6.65@235@330@1.4@CNVR7702.1@SIGLEC14_7, SIGLEC14_6, SIGLEC14_5@0@0@0@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 14@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion;plasma membrane@NA
F99359@173296@173298@duplication@3@54724956@54726434@19@chr19:54724956-54726434@8.8@110@188@1.71@CNVR7721.3, CNVR7721.4@LILRB3_5, LILRB3_4, LILRB3_3@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F99359@173468@173469@deletion@2@55263669@55263971@19@chr19:55263669-55263971@13.6@227@112@0.493@CNVR7725.2, CNVR7725.1@KIR2DL3_7, KIR2DL3_8@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity@NA
F99359@173491@173498@deletion@8@55340817@55354373@19@chr19:55340817-55354373@10.3@856@587@0.686@CNVR7725.1, CNVR7725.6@KIR3DL1_7, KIR3DL1_8, KIR3DL1_9, KIR2DS4_1, KIR2DS4_2, KIR2DS4_3, KIR2DS4_4, KIR2DS4_5@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
F99359@174395@174395@deletion@1@1569207@1569278@20@chr20:1569207-1569278@10.6@48@0@0@CNVR7763.1@RP4-576H24.4_1@0@0@0@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
F99359@178985@178987@duplication@3@10862623@10907040@21@chr21:10862623-10907040@5.64@1719@2169@1.26@CNVR7947.10, CNVR7947.6, CNVR7947.7@IGHV1OR21-1_1, IGHV1OR21-1_2, TPTE_24@0@0@0@:transmembrane phosphatase with tensin homology@:protein binding;extracellular region:phosphatase activity;ion channel activity;protein tyrosine phosphatase activity;ion transport;protein dephosphorylation;transmembrane transport;protein binding;signal transduction;integral to membrane;protein tyrosine/serine/threonine phosphatase activity;dephosphorylation;membrane;peptidyl-tyrosine dephosphorylation@NA
F99359@179976@179978@duplication@3@40684999@40685417@21@chr21:40684999-40685417@6.81@101@165@1.63@NA@BRWD1_3, BRWD1_2, BRWD1_1@0@0@0@:bromodomain and WD repeat domain containing 1@:regulation of cell shape;regulation of transcription from RNA polymerase II promoter;cytoplasm;protein binding;nucleolus;nucleus;transcription, DNA-dependent;cytoskeleton organization;molecular_function@NA
F99359@181807@181807@deletion@1@23247056@23247205@22@chr22:23247056-23247205@6.42@239@147@0.615@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11@IGLJ3_1@0@0@0@NA@NA@NA
F99359@183631@183631@deletion@1@39357393@39357686@22@chr22:39357393-39357686@5.66@48@16@0.333@CNVR8164.1@APOBEC3A_4@0@0@0@:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A;APOBEC3A and APOBEC3B deletion hybrid@:cytidine deamination;defense response to virus;negative regulation of viral genome replication;DNA cytosine deamination;clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine;catalytic activity;DNA demethylation;cytoplasm;innate immune response;cytidine deaminase activity;nucleus;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;cellular response to xenobiotic stimulus;zinc ion binding;negative regulation of transposition@NA
F99359@184143@184151@deletion@9@42522577@42526793@22@chr22:42522577-42526793@45.3@876@471@0.538@CNVR8168.1, CNVR8168.3, CNVR8168.2@CYP2D6_9, CYP2D6_8, CYP2D6_7, CYP2D6_6, CYP2D6_5, CYP2D6_4, CYP2D6_3, CYP2D6_2, CYP2D6_1@0@0@0@:cytochrome P450, family 2, subfamily D, polypeptide 6@:oxidation-reduction process;mitochondrion;alkaloid catabolic process;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;drug catabolic process;endoplasmic reticulum membrane;response to organic substance;oxidative demethylation;endoplasmic reticulum;alkaloid metabolic process;negative regulation of binding;heme binding;xenobiotic metabolic process;dopamine metabolic process;steroid metabolic process;isoquinoline alkaloid metabolic process;arachidonic acid monooxygenase activity;arachidonic acid metabolic process;steroid 21-monooxygenase activity;negative regulation of cellular organofluorine metabolic process;oxidoreductase activity;monoterpenoid metabolic process;heterocycle metabolic process;drug binding;drug metabolic process;electron carrier activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;coumarin metabolic process@: DRUG METABOLISM, POOR, CYP2D6-RELATED
F99359@184165@184177@duplication@13@42908917@42952594@22@chr22:42908917-42952594@37.4@690@1091@1.58@CNVR8171.2, CNVR8171.3@RRP7A_7, RRP7A_6, RRP7A_5, RRP7A_4, RRP7A_3, RRP7A_2, RRP7A_1, SERHL2_1, SERHL2_2, SERHL2_3, SERHL2_4, SERHL2_5, SERHL2_6@0@0@0@:ribosomal RNA processing 7 homolog A (S. cerevisiae):serine hydrolase-like 2@:RNA binding;nucleotide binding:hydrolase activity;mitochondrion;peroxisome;cytoplasmic membrane-bounded vesicle;molecular_function;cellular_component;perinuclear region of cytoplasm;biological_process@NA
F99359@4072@4079@deletion@8@101615523@101620252@X@chrX:101615523-101620252@15.2@68@0@0@NA@NXF2B_34, NXF2B_33, NXF2B_32, NXF2B_31, NXF2B_30, NXF2B_29, NXF2B_28, NXF2B_27@0@0@0@NA@NA@NA
F99359@4884@4884@deletion@1@119210843@119211253@X@chrX:119210843-119211253@5.47@24@0@0@NA@RHOXF2B_2@0@0@0@NA@NA@NA
F99359@5719@5719@duplication@1@140336520@140336590@X@chrX:140336520-140336590@5.44@64@111@1.73@CNVR8456.1@SPANXC_1@0@0@0@NA@NA@NA
F99359@6284@6285@deletion@2@153416129@153418581@X@chrX:153416129-153418581@6.2@54@19@0.352@CNVR8489.1@OPN1LW_2, OPN1LW_3@0@0@0@NA@NA@NA
F99359@6294@6307@duplication@14@153453260@153496256@X@chrX:153453260-153496256@18.5@120@256@2.13@CNVR8489.1@OPN1MW_2, OPN1MW_3, OPN1MW_4, OPN1MW_5, OPN1MW_6, TEX28P1_4, TEX28P1_3, TEX28P1_2, TEX28P1_1, OPN1MW2_1, OPN1MW2_2, OPN1MW2_3, OPN1MW2_4, OPN1MW2_5@0@0@0@NA@NA@NA
F03450@6@6@duplication@1@69092@70008@1@chr1:69092-70008@7.35@42@100@2.38@CNVR1.1, CNVR1.2@OR4F5_1@0@0@0@:olfactory receptor, family 4, subfamily F, member 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F03450@398@399@duplication@2@1573125@1573952@1@chr1:1573125-1573952@5.64@186@266@1.43@CNVR17.1@CDK11B_14, CDK11B_13@0@0@0@:cyclin-dependent kinase 11B@:protein serine/threonine kinase activity;protein tyrosine kinase activity;protein phosphorylation;protein kinase activity;cell division;transferase activity, transferring phosphorus-containing groups;ATP binding@NA
F03450@405@409@deletion@5@1580488@1581409@1@chr1:1580488-1581409@10.5@178@89@0.5@CNVR17.1@CDK11B_7, CDK11B_6, CDK11B_5, CDK11B_4, CDK11B_3@0@0@0@:cyclin-dependent kinase 11B@:protein serine/threonine kinase activity;protein tyrosine kinase activity;protein phosphorylation;protein kinase activity;cell division;transferase activity, transferring phosphorus-containing groups;ATP binding@NA
F03450@422@422@deletion@1@1634916@1635063@1@chr1:1634916-1635063@13.9@111@29@0.261@CNVR17.1@CDK11A_18@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
F03450@426@430@deletion@5@1635990@1639684@1@chr1:1635990-1639684@24.7@461@249@0.54@CNVR17.1@CDK11A_14, CDK11A_13, CDK11A_12, CDK11A_11, CDK11A_10@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
F03450@434@434@duplication@1@1643704@1643839@1@chr1:1643704-1643839@5.9@17@58@3.41@CNVR17.1@CDK11A_6@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
F03450@3334@3339@duplication@6@25611065@25633220@1@chr1:25611065-25633220@16.4@929@1273@1.37@CNVR116.1, CNVR116.2@RHD_2, RHD_3, RHD_4, RHD_5, RHD_6, RHD_7@0@0@0@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
F03450@3357@3357@deletion@1@25735175@25735360@1@chr1:25735175-25735360@18.1@85@1@0.0118@CNVR117.1@RHCE_2@0@0@0@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
F03450@4338@4338@deletion@1@33002087@33002129@1@chr1:33002087-33002129@5.35@62@26@0.419@NA@RP1-27O5.3_6@0@0@0@@:protein binding;intracellular;zinc ion binding@NA
F03450@5196@5196@duplication@1@40235375@40236927@1@chr1:40235375-40236927@6.15@334@469@1.4@NA@OXCT2_1@0@0@0@:bone morphogenetic protein 8b:3-oxoacid CoA transferase 2@:cell differentiation;growth factor activity;extracellular space;growth;extracellular region;cytokine activity;cartilage development;skeletal system development;ossification:mitochondrion;microtubule-based flagellum;CoA-transferase activity;ketone body catabolic process;3-oxoacid CoA-transferase activity;metabolic process@NA
F03450@7378@7378@deletion@1@63307100@63307218@1@chr1:63307100-63307218@6.64@207@121@0.585@NA@ATG4C_10@0@0@0@:autophagy related 4C, cysteine peptidase@:protein targeting to membrane;autophagy;cysteine-type peptidase activity;autophagic vacuole assembly;cytoplasm;cytosol;peptidase activity;cysteine-type endopeptidase activity;proteolysis;extracellular region;protein transport@NA
F03450@8176@8177@deletion@2@84644861@84648011@1@chr1:84644861-84648011@5.78@159@95@0.597@NA@PRKACB_2, PRKACB_3@0@0@0@:protein kinase, cAMP-dependent, catalytic, beta@:nucleoplasm;fibroblast growth factor receptor signaling pathway;negative regulation of meiotic cell cycle;protein tyrosine kinase activity;energy reserve metabolic process;ATP binding;transmembrane transport;cAMP-dependent protein kinase activity;activation of protein kinase A activity;cAMP-dependent protein kinase complex;plasma membrane;glucose metabolic process;water transport;ubiquitin protein ligase binding;activation of phospholipase C activity;protein kinase activity;perinuclear region of cytoplasm;lipid metabolic process;cytosol;regulation of insulin secretion;epidermal growth factor receptor signaling pathway;gluconeogenesis;nerve growth factor receptor signaling pathway;synaptic transmission;cellular response to glucagon stimulus;intracellular protein kinase cascade;response to clozapine;magnesium ion binding;transferase activity, transferring phosphorus-containing groups;blood coagulation;triglyceride catabolic process;adenylate cyclase-modulating G-protein coupled receptor signaling pathway;small molecule metabolic process;protein serine/threonine kinase activity;protein phosphorylation;centrosome;carbohydrate metabolic process;cytoplasm;signal transduction;protein binding@NA
F03450@8507@8508@duplication@2@89476588@89477710@1@chr1:89476588-89477710@8.86@528@724@1.37@CNVR244.1@GBP3_8, GBP3_7@0@0@0@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
F03450@9373@9374@duplication@2@104233917@104234232@1@chr1:104233917-104234232@9.82@55@131@2.38@CNVR266.3, CNVR266.5@AMY1B_8, AMY1B_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
F03450@9385@9386@deletion@2@104297122@104297436@1@chr1:104297122-104297436@13.1@302@164@0.543@CNVR266.3, CNVR266.5@AMY1C_6, AMY1C_7@0@0@0@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
F03450@9436@9436@duplication@1@108769302@108769515@1@chr1:108769302-108769515@8.8@75@153@2.04@CNVR294.4@NBPF4_14@0@0@0@:neuroblastoma breakpoint family, member 4@:cytoplasm@NA
F03450@9766@9773@deletion@8@110230497@110235917@1@chr1:110230497-110235917@99.4@459@0@0@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1_1, GSTM1_2, GSTM1_3, GSTM1_4, GSTM1_5, GSTM1_6, GSTM1_7, GSTM1_8@0@0@0@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
F03450@10337@10337@deletion@1@115469123@115469184@1@chr1:115469123-115469184@4.82@105@58@0.552@CNVR306.1@SYCP1_23@0@0@0@:synaptonemal complex protein 1@:regulation of protein localization;DNA binding;central element;synaptonemal complex assembly;protein binding;spermatogenesis;male germ cell nucleus;synaptonemal complex;transverse filament;reciprocal meiotic recombination;cell division@NA
F03450@10684@10685@duplication@2@120539621@120548211@1@chr1:120539621-120548211@9.69@582@802@1.38@CNVR319.3, CNVR319.2@NOTCH2_4, NOTCH2_3@0@0@0@:notch 2@:nucleoplasm;negative regulation of apoptotic process;cell differentiation;negative regulation of cell proliferation;pulmonary valve morphogenesis;atrial septum morphogenesis;stem cell maintenance;placenta blood vessel development;placenta development;bone remodeling;induction of apoptosis;tissue regeneration;plasma membrane;nucleus;endoplasmic reticulum membrane;gene expression;cell fate determination;in utero embryonic development;Notch receptor processing;humoral immune response;inflammatory response to antigenic stimulus;embryonic limb morphogenesis;hemopoiesis;membrane;calcium ion binding;Notch signaling involved in heart development;nervous system development;Golgi membrane;morphogenesis of an epithelial sheet;integral to membrane;interleukin-4 secretion;cell cycle arrest;receptor activity;integral to plasma membrane;organ morphogenesis;determination of left/right symmetry;transcription initiation from RNA polymerase II promoter;multicellular organismal development;cell growth;regulation of transcription, DNA-dependent;positive regulation of Ras protein signal transduction;protein binding;regulation of developmental process;Notch signaling pathway;extracellular region;cell surface;positive regulation of apoptotic process@: ALAGILLE SYNDROME 2; ALGS2; HAJDU-CHENEY SYNDROME; HJCYS
F03450@12117@12118@deletion@2@152573209@152586574@1@chr1:152573209-152586574@22.9@105@0@0@CNVR358.1@LCE3C_1, LCE3B_1@0@0@0@:late cornified envelope 3C:late cornified envelope 3B@:keratinization:keratinization@NA
F03450@14056@14056@duplication@1@161599569@161599825@1@chr1:161599569-161599825@6.06@82@142@1.73@CNVR383.1@FCGR3B_3@0@0@0@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIIb, receptor (CD16b)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction:IgG binding;protein binding;extracellular region;immune response;plasma membrane;anchored to membrane@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
F03450@14061@14062@duplication@2@161641183@161643019@1@chr1:161641183-161643019@5.9@289@395@1.37@CNVR383.1@FCGR2B_3, FCGR2B_4@0@0@0@:Fc fragment of IgG, low affinity IIb, receptor (CD32)@:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
F03450@16029@16031@duplication@3@196744018@196749103@1@chr1:196744018-196749103@6.41@375@504@1.34@CNVR459.1, CNVR459.3@CFHR3_1, CFHR3_2, CFHR3_3@0@0@0@:complement factor H-related 3@:extracellular space@NA
F03450@16177@16177@deletion@1@198691546@198691605@1@chr1:198691546-198691605@5.71@65@27@0.415@NA@PTPRC_15@0@0@0@:protein tyrosine phosphatase, receptor type, C@:stem cell development;heterotypic cell-cell adhesion;negative regulation of protein autophosphorylation;response to gamma radiation;B cell proliferation;positive regulation of stem cell proliferation;activation of MAPK activity;regulation of humoral immune response mediated by circulating immunoglobulin;negative regulation of T cell mediated cytotoxicity;positive regulation of antigen receptor-mediated signaling pathway;positive regulation of B cell proliferation;regulation of S phase;protein dephosphorylation;integral to membrane;heparin binding;cell surface receptor signaling pathway;regulation of cell cycle;positive regulation of T cell mediated cytotoxicity;axon guidance;positive regulation of protein kinase activity;positive regulation of T cell mediated immunity;negative regulation of peptidyl-tyrosine phosphorylation;dephosphorylation;positive regulation of apoptotic process;defense response to virus;positive regulation of isotype switching to IgG isotypes;negative regulation of cytokine-mediated signaling pathway;T cell proliferation;bone marrow development;negative thymic T cell selection;B cell differentiation;positive thymic T cell selection;leukocyte cell-cell adhesion;plasma membrane;immunoglobulin biosynthetic process;heparan sulfate proteoglycan binding;positive regulation of T cell differentiation;B cell receptor signaling pathway;negative regulation of cell adhesion involved in substrate-bound cell migration;regulation of apoptotic process;transmembrane receptor protein tyrosine phosphatase activity;membrane raft;protein kinase binding;positive regulation of MAPK cascade;cell periphery;negative regulation of protein kinase activity;release of sequestered calcium ion into cytosol;focal adhesion;integral to plasma membrane;peptidyl-tyrosine dephosphorylation;hematopoietic progenitor cell differentiation;phosphatase activity;positive regulation of gamma-delta T cell differentiation;protein tyrosine phosphatase activity;regulation of B cell receptor signaling pathway;external side of plasma membrane;T cell differentiation;protein binding;T cell receptor signaling pathway;positive regulation of humoral immune response mediated by circulating immunoglobulin;positive regulation of alpha-beta T cell proliferation;regulation of B cell differentiation;positive regulation of T cell proliferation;positive regulation of hematopoietic stem cell migration;cell surface@: SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE,; MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO; MS
F03450@19775@19777@duplication@3@248756132@248802559@1@chr1:248756132-248802559@20.6@1426@1957@1.37@CNVR600.1@OR2T10_1, OR2T11_1, OR2T35_1@0@0@0@:olfactory receptor, family 2, subfamily T, member 10:olfactory receptor, family 2, subfamily T, member 11:olfactory receptor, family 2, subfamily T, member 35@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F03450@21793@21793@deletion@1@32417988@32418022@2@chr2:32417988-32418022@5.45@58@23@0.397@NA@SLC30A6_8@0@0@0@:solute carrier family 30 (zinc transporter), member 6@:cation transmembrane transporter activity;zinc ion transmembrane transporter activity;mitochondrion;Golgi apparatus;zinc ion transport;cation transport;Golgi membrane;transmembrane transport;integral to membrane;zinc ion transmembrane transport;Golgi to endosome transport@NA
F03450@24967@24969@deletion@3@89567759@89597316@2@chr2:89567759-89597316@10.3@125@55@0.44@CNVR866.7, CNVR866.1@IGKV1-33_2, IGKV1-33_1, IGKV1-37_2@0@0@0@@:protein binding:protein binding@NA
F03450@25004@25007@duplication@4@90192949@90199190@2@chr2:90192949-90199190@10.4@395@563@1.43@CNVR867.10, CNVR867.5, CNVR867.3, CNVR867.9, CNVR867.15@IGKV1D-13_1, IGKV1D-13_2, IGKV1D-12_1, IGKV1D-12_2@0@0@0@@:protein binding:protein binding@NA
F03450@28824@28824@deletion@1@167330310@167330398@2@chr2:167330310-167330398@4.77@81@41@0.506@NA@SCN7A_4@0@0@0@:sodium channel, voltage-gated, type VII, alpha subunit@:ion channel activity;ion transport;voltage-gated sodium channel activity;transmembrane transport;integral to membrane;sodium ion transport;muscle contraction;membrane;voltage-gated sodium channel complex@NA
F03450@34944@34945@deletion@2@10089602@10091189@3@chr3:10089602-10091189@18.6@170@55@0.324@NA@FANCD2_16, FANCD2_17@0@0@0@:Fanconi anemia, complementation group D2@:nucleoplasm;synapsis;binding;response to DNA damage stimulus;gamete generation;DNA repair;condensed chromosome;protein binding;response to gamma radiation@: FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2
F03450@39305@39305@deletion@1@57646488@57646566@3@chr3:57646488-57646566@6.73@178@101@0.567@NA@DENND6A_7@0@0@0@:DENN/MADD domain containing 6A@:Rab guanyl-nucleotide exchange factor activity;positive regulation of cell-cell adhesion mediated by cadherin;recycling endosome;cytoplasm@NA
F03450@40033@40034@deletion@2@93624629@93624987@3@chr3:93624629-93624987@5.35@382@259@0.678@NA@PROS1_6, PROS1_5@0@0@0@:protein S (alpha)@:platelet degranulation;endopeptidase inhibitor activity;Golgi membrane;post-translational protein modification;proteolysis;blood coagulation;endoplasmic reticulum membrane;platelet activation;Golgi lumen;platelet alpha granule lumen;innate immune response;peptidyl-glutamic acid carboxylation;protein binding;negative regulation of endopeptidase activity;cellular protein metabolic process;extracellular region;calcium ion binding;leukocyte migration;fibrinolysis;regulation of complement activation@: THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL DOMINANT; THPH5; THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL RECESSIVE; THPH6
F03450@43974@43974@deletion@1@169587422@169587595@3@chr3:169587422-169587595@8.8@171@87@0.509@NA@LRRC31_1@0@0@0@:leucine rich repeat containing 31@:protein binding@NA
F03450@45437@45438@duplication@2@195474048@195475935@3@chr3:195474048-195475935@10.6@398@577@1.45@CNVR1703.1, CNVR1703.2, CNVR1703.5, CNVR1703.4@MUC4_25, MUC4_24@0@0@0@:mucin 4, cell surface associated@:ErbB-2 class receptor binding;Golgi lumen;cell-matrix adhesion;post-translational protein modification;extracellular matrix structural constituent;protein binding;O-glycan processing;cellular protein metabolic process;proteinaceous extracellular matrix;integral to plasma membrane;membrane;extracellular matrix constituent, lubricant activity;biological_process@NA
F03450@45876@45881@deletion@6@996521@998181@4@chr4:996521-998181@36.4@698@359@0.514@NA@IDUA_9, IDUA_10, IDUA_11, IDUA_12, IDUA_13, IDUA_14@0@0@0@:iduronidase, alpha-L-@:chondroitin sulfate metabolic process;glycosaminoglycan metabolic process;limb morphogenesis;lysosomal lumen;glycosaminoglycan catabolic process;receptor binding;lysosome;skeletal system morphogenesis;chemical homeostasis;cation binding;small molecule metabolic process;cell morphogenesis;lysosome organization;disaccharide metabolic process;carbohydrate metabolic process;chondroitin sulfate catabolic process;protein binding;coated vesicle;L-iduronidase activity;hydrolase activity, hydrolyzing O-glycosyl compounds@: SCHEIE SYNDROME; HURLER SYNDROME; HURLER-SCHEIE SYNDROME
F03450@48556@48561@duplication@6@69403344@69434202@4@chr4:69403344-69434202@57.7@919@1647@1.79@CNVR1953.1@UGT2B17_6, UGT2B17_5, UGT2B17_4, UGT2B17_3, UGT2B17_2, UGT2B17_1@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
F03450@48592@48596@duplication@5@70146220@70156529@4@chr4:70146220-70156529@7.47@613@807@1.32@CNVR1957.2, CNVR1957.1@UGT2B28_1, UGT2B28_2, UGT2B28_3, UGT2B28_4, UGT2B28_5@0@0@0@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
F03450@48653@48654@deletion@2@70920040@70920167@4@chr4:70920040-70920167@4.95@33@8@0.242@NA@HTN1_3, HTN1_4@0@0@0@:histatin 1@:protein binding;extracellular region;defense response to fungus;defense response to bacterium;killing of cells of other organism;biomineral tissue development@NA
F03450@48699@48700@deletion@2@71468342@71468553@4@chr4:71468342-71468553@7.68@116@57@0.491@NA@AMBN_7, AMBN_8@0@0@0@:ameloblastin (enamel matrix protein)@:cell proliferation;growth factor activity;structural constituent of tooth enamel;proteinaceous extracellular matrix;cell adhesion;odontogenesis of dentin-containing tooth;bone mineralization@NA
F03450@51672@51672@deletion@1@145041644@145041741@4@chr4:145041644-145041741@5.31@102@54@0.529@NA@GYPA_2@0@0@0@:glycophorin B (MNS blood group):glycophorin A (MNS blood group)@:integral to membrane;plasma membrane;integral to plasma membrane:external side of plasma membrane;integral to membrane;cytoskeletal anchoring at plasma membrane;plasma membrane;molecular_function;protein homodimerization activity;integral to plasma membrane;cellular_component;identical protein binding;membrane;biological_process;regulation of response to osmotic stress;virus-host interaction@: BLOOD GROUP--Ss LOCUS; Ss: MALARIA, SUSCEPTIBILITY TO; BLOOD GROUP--MN LOCUS; MN
F03450@51835@51835@deletion@1@148886176@148886280@4@chr4:148886176-148886280@6.12@224@136@0.607@NA@ARHGAP10_17@0@0@0@:Rho GTPase activating protein 10@:negative regulation of apoptotic process;phospholipid binding;cytoskeletal adaptor activity;positive regulation of Rho GTPase activity;plasma membrane;apoptotic process;cytoskeleton organization;regulation of small GTPase mediated signal transduction;small GTPase mediated signal transduction;intracellular;perinuclear region of cytoplasm;filopodium assembly;cytosol;signal transduction;protein binding;Rho GTPase activator activity;SH3 domain binding;regulation of apoptotic process@NA
F03450@52493@52494@deletion@2@169183835@169188842@4@chr4:169183835-169188842@4.92@141@85@0.603@NA@DDX60_23, DDX60_22@0@0@0@:DEAD (Asp-Glu-Ala-Asp) box polypeptide 60@:double-stranded RNA binding;defense response to virus;single-stranded RNA binding;DNA binding;ATP binding;RNA binding;positive regulation of MDA-5 signaling pathway;hydrolase activity;response to virus;helicase activity;innate immune response;cytoplasm;positive regulation of RIG-I signaling pathway;protein binding;double-stranded DNA binding;nucleic acid binding;ATP-dependent helicase activity@NA
F03450@52532@52532@deletion@1@169336809@169336950@4@chr4:169336809-169336950@5.63@94@47@0.5@NA@DDX60L_21@0@0@0@:DEAD (Asp-Glu-Ala-Asp) box polypeptide 60-like@:hydrolase activity;RNA binding;helicase activity;DNA binding;ATP-dependent helicase activity;nucleic acid binding;ATP binding@NA
F03450@53188@53189@duplication@2@190946717@190947616@4@chr4:190946717-190947616@26.8@637@1100@1.73@CNVR2258.3@FRG2_4, FRG2_3@0@0@0@:FSHD region gene 2-like;FSHD region gene 2@:nucleus@NA
F03450@53220@53220@duplication@1@216845@216964@5@chr5:216845-216964@5.95@74@131@1.77@NA@CCDC127_2@0@0@0@:coiled-coil domain containing 127@NA@NA
F03450@53306@53317@deletion@12@741710@825366@5@chr5:741710-825366@70.3@1500@808@0.539@CNVR2280.3@ZDHHC11B_7, ZDHHC11B_6, ZDHHC11B_5, ZDHHC11B_4, ZDHHC11B_3, ZDHHC11B_2, ZDHHC11B_1, ZDHHC11_12, ZDHHC11_11, ZDHHC11_10, ZDHHC11_9, ZDHHC11_8@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
F03450@54849@54849@deletion@1@42629141@42629205@5@chr5:42629141-42629205@5.36@148@86@0.581@CNVR2445.1@GHR_3@0@0@0@:growth hormone receptor@:neuronal cell body;mitochondrion;proline-rich region binding;JAK-STAT cascade;growth factor binding;nucleus;succinate metabolic process;positive regulation of JAK-STAT cascade;JAK-STAT cascade involved in growth hormone signaling pathway;response to morphine;activation of MAPK activity;peptide hormone binding;response to estradiol stimulus;2-oxoglutarate metabolic process;valine metabolic process;response to cytokine stimulus;hormone-mediated signaling pathway;response to food;SH2 domain binding;oxaloacetate metabolic process;growth hormone receptor signaling pathway;allantoin metabolic process;integral to membrane;response to hormone stimulus;cartilage development involved in endochondral bone morphogenesis;positive regulation of peptidyl-tyrosine phosphorylation;receptor internalization;cytoplasm;cellular response to hormone stimulus;extracellular region;growth hormone receptor complex;positive regulation of tyrosine phosphorylation of Stat5 protein;regulation of multicellular organism growth;growth hormone receptor activity;positive regulation of tyrosine phosphorylation of Stat3 protein;response to peptide hormone stimulus;fatty acid metabolic process;creatinine metabolic process;plasma membrane;positive regulation of multicellular organism growth;receptor complex;protein phosphatase binding;protein kinase binding;creatine metabolic process;response to interleukin-1;response to cycloheximide;extracellular space;positive regulation of cell differentiation;activation of Janus kinase activity;taurine metabolic process;cellular response to insulin stimulus;integral to plasma membrane;protein homodimerization activity;negative regulation of neuron death;citrate metabolic process;endocytosis;isoleucine metabolic process;activation of JAK2 kinase activity;extrinsic to membrane;response to glucocorticoid stimulus;protein binding;insulin-like growth factor receptor signaling pathway;multicellular organismal metabolic process;cell surface@: HYPERCHOLESTEROLEMIA, FAMILIAL; LARON SYNDROME; SHORT STATURE, IDIOPATHIC, AUTOSOMAL
F03450@55494@55494@deletion@1@64023935@64024006@5@chr5:64023935-64024006@4.82@49@19@0.388@NA@SREK1IP1_4@0@0@0@:SREK1-interacting protein 1@:mRNA processing;RNA splicing;zinc ion binding;nucleic acid binding@NA
F03450@55776@55776@deletion@1@68830522@68830666@5@chr5:68830522-68830666@7.1@35@2@0.0571@CNVR2494.7, CNVR2494.4, CNVR2494.46@OCLN_5@0@0@0@:occludin@:S-adenosylmethionine metabolic process;cell-cell junction organization;cellular component disassembly involved in execution phase of apoptosis;response to testosterone stimulus;tight junction;integral to membrane;cell junction;plasma membrane;apoptotic process;thiopurine S-methyltransferase activity;S-adenosylhomocysteine metabolic process;apical plasma membrane;protein complex assembly;cytosol;cell-cell junction;protein binding;structural molecule activity;response to organic cyclic compound;apicolateral plasma membrane@: BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;
F03450@57241@57242@deletion@2@102490375@102490647@5@chr5:102490375-102490647@7.82@135@70@0.519@NA@PPIP5K2_12, PPIP5K2_13@0@0@0@:diphosphoinositol pentakisphosphate kinase 2@:inositol hexakisphosphate 3-kinase activity;inositol hexakisphosphate 1-kinase activity;inositol metabolic process;diphosphoinositol-pentakisphosphate kinase activity;acid phosphatase activity;ATP binding;cytosol;inositol hexakisphosphate 5-kinase activity;kinase activity;inositol-1,3,4,5,6-pentakisphosphate kinase activity@NA
F03450@59488@59488@deletion@1@147553798@147553933@5@chr5:147553798-147553933@34.2@164@0@0@CNVR2637.2, CNVR2637.1@SPINK14_3@0@0@0@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
F03450@59918@59918@deletion@1@150603485@150603531@5@chr5:150603485-150603531@4.62@141@84@0.596@NA@CCDC69_1@0@0@0@:coiled-coil domain containing 69:GM2 ganglioside activator@:endoplasmic reticulum:mitochondrion;phospholipid metabolic process;beta-N-acetylhexosaminidase activity;neuromuscular process controlling balance;sphingolipid catabolic process;lysosomal lumen;lipid storage;ganglioside catabolic process;glycosphingolipid metabolic process;sphingolipid activator protein activity;neurological system process;lysosome;intracellular membrane-bounded organelle;small molecule metabolic process;positive regulation of catalytic activity;sphingolipid metabolic process;learning or memory;cytoplasm;oligosaccharide catabolic process;enzyme activator activity;nucleolus;glycolipid catabolic process@: GM2-GANGLIOSIDOSIS, AB VARIANT
F03450@60876@60877@duplication@2@175388055@175388437@5@chr5:175388055-175388437@7.57@74@139@1.88@NA@THOC3_5, THOC3_4@0@0@0@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
F03450@61641@61646@duplication@6@180376905@180430876@5@chr5:180376905-180430876@9.01@1058@1366@1.29@CNVR2719.1@BTNL8_8, BTNL3_1, BTNL3_2, BTNL3_3, BTNL3_4, BTNL3_5@0@0@0@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
F03450@63282@63282@deletion@1@31237988@31238262@6@chr6:31237988-31238262@9.06@167@83@0.497@CNVR2838.1@HLA-C_4@0@0@0@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
F03450@63725@63730@duplication@6@31962023@31963571@6@chr6:31962023-31963571@10.1@189@296@1.57@CNVR2843.6, CNVR2843.3@C4A_20, C4A_21, C4A_22, C4A_23, C4A_24, C4A_25@0@0@0@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
F03450@63768@63773@deletion@6@31994761@31996309@6@chr6:31994761-31996309@14@155@63@0.406@CNVR2843.6, CNVR2843.5@C4B_20, C4B_21, C4B_22, C4B_23, C4B_24, C4B_25@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
F03450@63790@63792@deletion@3@32006201@32007025@6@chr6:32006201-32007025@5.31@175@109@0.623@CNVR2843.6, CNVR2843.5@CYP21A2_1, CYP21A2_2, CYP21A2_3@0@0@0@:cytochrome P450, family 21, subfamily A, polypeptide 2@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY
F03450@63953@63971@duplication@19@32485517@32629234@6@chr6:32485517-32629234@128@1250@2448@1.96@CNVR2845.21, CNVR2845.25, CNVR2845.24@HLA-DRB5_5, HLA-DRB5_4, HLA-DRB5_3, HLA-DRB5_2, HLA-DRB5_1, HLA-DRB1_5, HLA-DRB1_4, HLA-DRB1_3, HLA-DRB1_2, HLA-DRB1_1, HLA-DQA1_1, HLA-DQA1_2, HLA-DQA1_3, HLA-DQA1_4, HLA-DQB1_5, HLA-DQB1_4@0@0@0@:major histocompatibility complex, class II, DR beta 5:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
F03450@66313@66315@deletion@3@54034327@54067031@6@chr6:54034327-54067031@6.11@230@145@0.63@NA@MLIP_8, MLIP_9, MLIP_10@0@0@0@:muscular LMNA-interacting protein@:nuclear lumen;nuclear envelope;PML body@NA
F03450@68349@68349@deletion@1@110988638@110988777@6@chr6:110988638-110988777@5.89@227@139@0.612@NA@CDK19_4@0@0@0@:cyclin-dependent kinase 19@:protein serine/threonine kinase activity;protein tyrosine kinase activity;protein phosphorylation;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cell division;cyclin-dependent protein kinase activity@NA
F03450@71015@71015@deletion@1@167595214@167595404@6@chr6:167595214-167595404@6.07@92@44@0.478@NA@TCP10L2_8@0@0@0@:t-complex 10;t-complex 10-like 2@NA@NA
F03450@71030@71032@deletion@3@167790035@167794824@6@chr6:167790035-167794824@13.7@206@106@0.515@NA@TCP10_5, TCP10_4, TCP10_3@0@0@0@:t-complex 10@:cytosol@NA
F03450@71744@71749@deletion@6@5939916@5944900@7@chr7:5939916-5944900@25@561@306@0.545@NA@CCZ1_2, CCZ1_3, CCZ1_4, CCZ1_5, CCZ1_6, CCZ1_7@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F03450@71753@71754@deletion@2@5958499@5959597@7@chr7:5958499-5959597@6.96@153@84@0.549@NA@CCZ1_11, CCZ1_12@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F03450@71760@71766@deletion@7@5972414@5984809@7@chr7:5972414-5984809@16.7@326@176@0.54@NA@RSPH10B_18, RSPH10B_17, RSPH10B_16, RSPH10B_15, RSPH10B_14, RSPH10B_13, RSPH10B_12@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F03450@71773@71779@deletion@7@6000323@6018327@7@chr7:6000323-6018327@30.7@343@135@0.394@NA@RSPH10B_5, RSPH10B_4, RSPH10B_3, RSPH10B_2, PMS2_15, PMS2_14, PMS2_13@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas):PMS2 postmeiotic segregation increased 2 (S. cerevisiae)@:response to drug;DNA binding;MutSalpha complex binding;ATP binding;mismatch repair;DNA repair;mismatched DNA binding;ATPase activity;nucleus;mismatch repair complex;reciprocal meiotic recombination;ATP catabolic process;single-stranded DNA binding;response to DNA damage stimulus;single base insertion or deletion binding;protein binding;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;MutLalpha complex;endonuclease activity@: COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4; MISMATCH REPAIR CANCER SYNDROME
F03450@71922@71934@duplication@13@6797310@6821107@7@chr7:6797310-6821107@14.4@659@921@1.4@NA@RSPH10B2_2, RSPH10B2_3, RSPH10B2_4, RSPH10B2_5, RSPH10B2_6, RSPH10B2_7, RSPH10B2_8, RSPH10B2_9, RSPH10B2_10, RSPH10B2_11, RSPH10B2_12, RSPH10B2_13, RSPH10B2_14@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F03450@71939@71951@duplication@13@6836200@6862991@7@chr7:6836200-6862991@27@1057@1480@1.4@NA@RSPH10B2_19, RSPH10B2_20, CCZ1B_15, CCZ1B_14, CCZ1B_13, CCZ1B_12, CCZ1B_11, CCZ1B_10, CCZ1B_9, CCZ1B_8, CCZ1B_7, CCZ1B_6, CCZ1B_5@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F03450@73032@73032@deletion@1@33303903@33303986@7@chr7:33303903-33303986@6.14@33@4@0.121@NA@BBS9_7@0@0@0@:Bardet-Biedl syndrome 9@:BBSome;fat cell differentiation;microtubule organizing center;cytoplasm;protein binding;response to stimulus;visual perception;nucleus;plasma membrane;molecular_function;cilium membrane@: WILMS TUMOR 5; WT5; BARDET-BIEDL SYNDROME; BBS
F03450@74304@74304@deletion@1@72469995@72470073@7@chr7:72469995-72470073@6.47@79@34@0.43@NA@STAG3L3_6@0@0@0@@:nucleus;binding@NA
F03450@74605@74605@deletion@1@74251403@74251500@7@chr7:74251403-74251500@6.73@30@0@0@NA@GTF2IRD2_2@0@0@0@:GTF2I repeat domain containing 2@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
F03450@74663@74664@duplication@2@75054919@75055735@7@chr7:75054919-75055735@5.54@77@130@1.69@NA@POM121C_9, POM121C_8@0@0@0@:POM121 transmembrane nucleoporin C@:nuclear membrane;protein binding;protein transport;endoplasmic reticulum membrane;nuclear pore;mRNA transport@NA
F03450@74792@74793@deletion@2@76240783@76241130@7@chr7:76240783-76241130@10.8@230@125@0.543@CNVR3463.10@POMZP3_6, POMZP3_5@0@0@0@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
F03450@75219@75221@deletion@3@87339887@87370895@7@chr7:87339887-87370895@6@118@65@0.551@NA@RUNDC3B_5, RUNDC3B_6, RUNDC3B_7@0@0@0@:ATP-binding cassette, sub-family B (MDR/TAP), member 1:RUN domain containing 3B@:xenobiotic-transporting ATPase activity;ATPase activity, coupled to transmembrane movement of substances;transport;drug transmembrane transport;transporter activity;response to drug;Golgi membrane;ATP binding;transmembrane transport;intercellular canaliculus;integral to membrane;ATPase activity;plasma membrane;small molecule metabolic process;nucleoside-triphosphatase activity;apical plasma membrane;nucleotide binding;G2/M transition of mitotic cell cycle;protein binding;stem cell proliferation;membrane;cell surface@: COLCHICINE RESISTANCE; INFLAMMATORY BOWEL DISEASE 13; IBD13
F03450@76718@76718@deletion@1@102114809@102114982@7@chr7:102114809-102114982@5.54@25@0@0@CNVR3518.1@POLR2J_3@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J, 13.3kDa@:nucleoplasm;DNA binding;DNA repair;protein dimerization activity;nucleus;viral reproduction;gene expression;transcription initiation from RNA polymerase II promoter;7-methylguanosine mRNA capping;protein phosphorylation;LRR domain binding;protein kinase activity;DNA-directed RNA polymerase II, core complex;nucleotide-excision repair;transcription from RNA polymerase II promoter;DNA-directed RNA polymerase activity;protein binding;transcription-coupled nucleotide-excision repair;RNA splicing;mRNA splicing, via spliceosome;transcription, DNA-dependent;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription@NA
F03450@76731@76731@duplication@1@102136588@102136651@7@chr7:102136588-102136651@10.5@188@319@1.7@CNVR3518.1@RASA4B_11@0@0@0@:RAS p21 protein activator 4B@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction@NA
F03450@76754@76754@duplication@1@102219880@102220243@7@chr7:102219880-102220243@14@69@186@2.7@CNVR3518.1@AC093668.1_1@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
F03450@76765@76765@deletion@1@102235753@102235816@7@chr7:102235753-102235816@10.1@47@1@0.0213@CNVR3518.1@RASA4_11@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
F03450@76775@76779@duplication@5@102257073@102279646@7@chr7:102257073-102279646@6.78@158@241@1.53@CNVR3518.1@RASA4_1, UPK3BL_6, UPK3BL_6, UPK3BL_5, UPK3BL_5, UPK3BL_4, UPK3BL_4@0@0@0@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
F03450@77749@77749@deletion@1@122091429@122091529@7@chr7:122091429-122091529@5.39@75@35@0.467@NA@CADPS2_15@0@0@0@:Ca++-dependent secretion activator 2@:cytoplasmic vesicle membrane;phospholipid binding;cytoplasmic vesicle;protein binding;synaptic vesicle priming;protein transport;cell junction;cytoplasmic membrane-bounded vesicle;postsynaptic membrane;presynaptic membrane;metal ion binding;positive regulation of exocytosis@NA
F03450@79013@79013@duplication@1@141760112@141760173@7@chr7:141760112-141760173@7.04@174@270@1.55@CNVR3585.3, CNVR3585.2@MGAM_34@0@0@0@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
F03450@79058@79061@deletion@4@142099456@142104553@7@chr7:142099456-142104553@33@889@482@0.542@NA@TRBV7-8_2, TRBV7-8_1, TRBV6-9_2, TRBV6-9_1@0@0@0@@:protein binding:protein binding@NA
F03450@79310@79311@duplication@2@143884023@143929936@7@chr7:143884023-143929936@6.11@109@172@1.58@CNVR3598.4, CNVR3598.3, CNVR3598.7@ARHGEF35_2, OR2A42_1@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F03450@80368@80368@duplication@1@7274293@7274349@8@chr8:7274293-7274349@7.74@9@59@6.56@CNVR3771.8, CNVR3771.10, CNVR3771.4@DEFB4B_1@0@0@0@:defensin, beta 4B;defensin, beta 4A@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response@NA
F03450@80388@80388@deletion@1@7637545@7637611@8@chr8:7637545-7637611@6.82@31@0@0@CNVR3772.4, CNVR3772.6, CNVR3772.2, CNVR3772.8, CNVR3772.10@AC084121.16_3@0@0@0@:uncharacterized LOC100133251@NA@NA
F03450@80398@80398@deletion@1@7694008@7694064@8@chr8:7694008-7694064@7.05@57@17@0.298@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@DEFB104A_1@0@0@0@:defensin, beta 104A;defensin, beta 104B@:extracellular region;defense response to bacterium@NA
F03450@83002@83002@deletion@1@66635777@66635856@8@chr8:66635777-66635856@4.86@67@31@0.463@NA@PDE7A_12@0@0@0@:mitochondrial fission regulator 1:phosphodiesterase 7A@:mitochondrion;mitochondrial fission;plasma membrane;mitochondrion organization;aerobic respiration:cytosol;signal transduction;3',5'-cyclic-AMP phosphodiesterase activity;cAMP-mediated signaling;3',5'-cyclic-nucleotide phosphodiesterase activity;catalytic activity;cAMP catabolic process;metal ion binding@NA
F03450@86350@86352@duplication@3@145438619@145439211@8@chr8:145438619-145439211@8.7@8@64@8@NA@FAM203B_2, FAM203B_3, FAM203B_4@0@0@0@:family with sequence similarity 203, member B@:binding@NA
F03450@88584@88602@duplication@19@43624656@43885072@9@chr9:43624656-43885072@28.2@502@806@1.61@CNVR4294.1@SPATA31A6_4, SPATA31A6_3, SPATA31A6_2, SPATA31A6_1, CNTNAP3B_1, CNTNAP3B_2, CNTNAP3B_3, CNTNAP3B_4, CNTNAP3B_5, CNTNAP3B_6, CNTNAP3B_7, CNTNAP3B_8, CNTNAP3B_9, CNTNAP3B_10, CNTNAP3B_11, CNTNAP3B_12, CNTNAP3B_13, CNTNAP3B_14, CNTNAP3B_15@0@0@0@:SPATA31 subfamily A, member 6:contactin associated protein-like 3B;contactin associated protein-like 3@:integral to membrane:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
F03450@95350@95350@deletion@1@17865074@17865474@10@chr10:17865074-17865474@23.7@114@2@0.0175@NA@MRC1L1_2@0@0@0@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
F03450@95384@95385@duplication@2@18112045@18116668@10@chr10:18112045-18116668@14.8@72@195@2.71@NA@MRC1_2, MRC1_3@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F03450@95388@95393@deletion@6@18134219@18152611@10@chr10:18134219-18152611@29.7@144@4@0.0278@NA@MRC1_6, MRC1_7, MRC1_8, MRC1_9, MRC1_10, MRC1_11@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F03450@95947@95947@deletion@1@29578048@29578159@10@chr10:29578048-29578159@4.64@97@53@0.546@NA@LYZL1_1@0@0@0@:lysozyme-like 1@:extracellular region;lysozyme activity;cell wall macromolecule catabolic process@NA
F03450@96933@96939@deletion@7@51970584@51994312@10@chr10:51970584-51994312@10.9@178@96@0.539@NA@ASAH2_11, ASAH2_10, ASAH2_9, ASAH2_8, ASAH2_7, ASAH2_6, ASAH2_5@0@0@0@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
F03450@98334@98334@deletion@1@81272407@81272870@10@chr10:81272407-81272870@5.81@127@69@0.543@NA@EIF5AL1_1@0@0@0@:eukaryotic translation initiation factor 5A-like 1@:ribosome binding;translation elongation factor activity;positive regulation of translational termination;mRNA transport;RNA binding;protein transport;translational frameshifting;endoplasmic reticulum membrane;peptidyl-lysine modification to hypusine;nuclear pore;positive regulation of translational elongation@NA
F03450@98858@98858@deletion@1@93579028@93579063@10@chr10:93579028-93579063@5.58@92@46@0.5@NA@TNKS2_4@0@0@0@:tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase 2@:NAD+ ADP-ribosyltransferase activity;positive regulation of telomere maintenance via telomerase;nuclear chromosome, telomeric region;Golgi membrane;nucleus;Wnt receptor signaling pathway;protein auto-ADP-ribosylation;nuclear envelope;protein localization to chromosome, telomeric region;enzyme binding;cytoplasm;perinuclear region of cytoplasm;protein binding;protein ADP-ribosylation;multicellular organism growth;regulation of multicellular organism growth;positive regulation of canonical Wnt receptor signaling pathway;pericentriolar material;protein polyubiquitination;metal ion binding@NA
F03450@99228@99228@deletion@1@96447883@96448031@10@chr10:96447883-96448031@4.62@104@58@0.558@NA@CYP2C18_3@0@0@0@:cytochrome P450, family 2, subfamily C, polypeptide 18:cytochrome P450, family 2, subfamily C, polypeptide 19@:oxidation-reduction process;electron carrier activity;small molecule metabolic process;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;oxygen binding;heme binding;xenobiotic metabolic process;monooxygenase activity;endoplasmic reticulum membrane;iron ion binding;testosterone 16-alpha-hydroxylase activity:steroid metabolic process;oxidation-reduction process;(S)-limonene 6-monooxygenase activity;oxygen binding;(R)-limonene 6-monooxygenase activity;oxidoreductase activity;steroid hydroxylase activity;endoplasmic reticulum membrane;monoterpenoid metabolic process;heterocycle metabolic process;drug metabolic process;intracellular membrane-bounded organelle;electron carrier activity;small molecule metabolic process;exogenous drug catabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;enzyme binding;(S)-limonene 7-monooxygenase activity;heme binding;xenobiotic metabolic process;monooxygenase activity;iron ion binding@: DRUG METABOLISM, POOR, CYP2C19-RELATED
F03450@101608@101612@duplication@5@124344788@124351033@10@chr10:124344788-124351033@8.57@609@804@1.32@CNVR4912.4, CNVR4912.3, CNVR4912.2@DMBT1_15, DMBT1_16, DMBT1_17, DMBT1_18, DMBT1_19@0@0@0@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
F03450@102336@102339@deletion@4@135438604@135440246@10@chr10:135438604-135440246@83.4@490@39@0.0796@CNVR4989.11, CNVR4989.4@FRG2B_4, FRG2B_3, FRG2B_2, FRG2B_1@0@0@0@:FSHD region gene 2 family, member B@:nucleus@NA
F03450@103269@103269@duplication@1@4976003@4976943@11@chr11:4976003-4976943@9.86@552@803@1.45@CNVR5040.1@OR51A2_1@0@0@0@:matrix metallopeptidase 26:olfactory receptor, family 51, subfamily A, member 2@:metallopeptidase activity;extracellular matrix;proteolysis;proteinaceous extracellular matrix;collagen catabolic process;metalloendopeptidase activity;zinc ion binding;metabolic process:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F03450@103342@103342@duplication@1@5798891@5799864@11@chr11:5798891-5799864@10.9@661@965@1.46@CNVR5049.1@OR52N5_1@0@0@0@:tripartite motif containing 5:olfactory receptor, family 52, subfamily N, member 5@:defense response to virus;Golgi apparatus;intracellular;protein trimerization;ligase activity;cytoplasm;protein binding;nucleus;protein homodimerization activity;identical protein binding;zinc ion binding;cytoplasmic mRNA processing body;protein ubiquitination;virus-host interaction:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F03450@104917@104917@deletion@1@31811483@31811567@11@chr11:31811483-31811567@5.43@207@127@0.614@NA@PAX6_14@0@0@0@:paired box 6@:cell differentiation;negative regulation of cell proliferation;regulation of epithelial cell proliferation;histone acetyltransferase binding;sequence-specific DNA binding;neuron migration;pallium development;cornea development in camera-type eye;nucleus;blood vessel development;positive regulation of neuroblast proliferation;commitment of neuronal cell to specific neuron type in forebrain;cell fate determination;AT DNA binding;regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment;eye development;oligodendrocyte cell fate specification;transcription from RNA polymerase II promoter;positive regulation of transcription, DNA-dependent;regulation of timing of cell differentiation;visual perception;protein localization to organelle;transcription, DNA-dependent;iris morphogenesis;intracellular part;neuron fate commitment;response to wounding;signal transduction involved in regulation of gene expression;anterior/posterior pattern specification;negative regulation of neuron differentiation;embryonic camera-type eye morphogenesis;positive regulation of epithelial cell differentiation;co-SMAD binding;lens development in camera-type eye;organ morphogenesis;forebrain-midbrain boundary formation;positive regulation of transcription from RNA polymerase II promoter;astrocyte differentiation;regulation of cell migration;regulation of neuron differentiation;HMG box domain binding;pancreatic A cell development;RNA polymerase II core promoter sequence-specific DNA binding;regulation of transcription, DNA-dependent;lacrimal gland development;axon guidance;cytoplasm;forebrain dorsal/ventral pattern formation;R-SMAD binding;axonogenesis;forebrain development;negative regulation of epithelial cell proliferation;keratinocyte differentiation;ubiquitin protein ligase binding;nuclear chromatin;dorsal/ventral pattern formation;intracellular;central nervous system development;eye photoreceptor cell development;transcription factor binding;camera-type eye development;forebrain anterior/posterior pattern specification;protein kinase binding;sequence-specific DNA binding RNA polymerase II transcription factor activity;smoothened signaling pathway;DNA binding;sequence-specific DNA binding transcription factor activity;glucose homeostasis;regulation of neurogenesis;cell fate commitment;regulation of gene expression;multicellular organismal development;ubiquitin-protein ligase activity;negative regulation of neurogenesis;hindbrain development;positive regulation of gene expression;pituitary gland development;regulation of transcription from RNA polymerase II promoter;dorsal/ventral axis specification;double-stranded DNA binding;brain development;regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification;protein binding;positive regulation of cell fate specification;salivary gland morphogenesis;transcription regulatory region DNA binding;cerebral cortex regionalization;regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification;protein ubiquitination@: FOVEAL HYPOPLASIA AND PRESENILE CATARACT SYNDROME; KERATITIS, HEREDITARY; ANIRIDIA; AN; COLOBOMA, OCULAR; OPTIC NERVE HYPOPLASIA, BILATERAL; PETERS ANOMALY; COLOBOMA OF OPTIC NERVE; ANIRIDIA, CEREBELLAR ATAXIA, AND MENTAL RETARDATION
F03450@105910@105912@duplication@3@47726096@47727469@11@chr11:47726096-47727469@10.6@394@561@1.42@NA@AGBL2_7, AGBL2_6, AGBL2_5@0@0@0@:ATP/GTP binding protein-like 2@:cytosol;metallocarboxypeptidase activity;proteolysis;zinc ion binding@NA
F03450@106022@106022@deletion@1@49192748@49192829@11@chr11:49192748-49192829@6.78@166@92@0.554@NA@FOLH1_11@0@0@0@:folate hydrolase (prostate-specific membrane antigen) 1;folate hydrolase 1B@:metallopeptidase activity;carboxypeptidase activity;dipeptidase activity;cytoplasm;peptidase activity;proteolysis;integral to membrane;nucleus;folic acid-containing compound metabolic process;integral to plasma membrane;membrane;metal ion binding@NA
F03450@110885@110885@deletion@1@108002635@108002681@11@chr11:108002635-108002681@4.63@85@45@0.529@NA@ACAT1_2@0@0@0@:acetyl-CoA acetyltransferase 1@:transferase activity, transferring acyl groups other than amino-acyl groups;mitochondrion;mitochondrial inner membrane;ketone body biosynthetic process;acetyl-CoA C-acetyltransferase activity;liver development;catalytic activity;coenzyme binding;cellular ketone body metabolic process;response to hormone stimulus;ketone body catabolic process;protein homodimerization activity;adipose tissue development;mitochondrial matrix;metabolic process;metanephric proximal convoluted tubule development;small molecule metabolic process;branched-chain amino acid catabolic process;enzyme binding;cellular lipid metabolic process;response to starvation;brain development;protein homooligomerization;response to organic cyclic compound;cellular nitrogen compound metabolic process;metal ion binding@: ALPHA-METHYLACETOACETIC ACIDURIA
F03450@115537@115537@deletion@1@31249276@31249313@12@chr12:31249276-31249313@8.77@73@22@0.301@CNVR5483.1@DDX11_15@0@0@0@:DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11@:nucleoplasm;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;S phase of mitotic cell cycle;DNA binding;nucleobase-containing compound metabolic process;ATP binding;ATP-dependent DNA helicase activity;DNA helicase activity;midbody;RNA binding;DNA-dependent ATPase activity;nucleus;positive regulation of cell proliferation;virus-host interaction;nuclear chromatin;4 iron, 4 sulfur cluster binding;helicase activity;hydrolase activity, acting on acid anhydrides;DNA duplex unwinding;endoplasmic reticulum unfolded protein response;G2/M transition of mitotic cell cycle;protein binding;sister chromatid cohesion;activation of signaling protein activity involved in unfolded protein response;nucleolus;spindle pole;ATP-dependent helicase activity;metal ion binding;nucleic acid binding;mitotic sister chromatid segregation@: WARSAW BREAKAGE SYNDROME
F03450@119176@119176@deletion@1@69096517@69096564@12@chr12:69096517-69096564@5.51@76@35@0.461@NA@NUP107_8@0@0@0@:nucleoporin 107kDa@:nucleocytoplasmic transporter activity;transport;mitotic cell cycle;transmembrane transport;protein transport;M phase of mitotic cell cycle;viral reproduction;hexose transport;porin activity;kinetochore;cytokine-mediated signaling pathway;glucose transport;nuclear envelope;small molecule metabolic process;condensed chromosome kinetochore;carbohydrate metabolic process;cytosol;protein binding;regulation of glucose transport;mRNA export from nucleus;mitotic prometaphase;nuclear pore outer ring;nuclear pore@NA
F03450@119529@119530@deletion@2@75895504@75895780@12@chr12:75895504-75895780@6.66@149@85@0.57@NA@KRR1_9, KRR1_8@0@0@0@:GLI pathogenesis-related 1:KRR1, small subunit (SSU) processome component, homolog (yeast)@:extracellular region;integral to membrane;small molecule metabolic process;plasma membrane;cellular lipid metabolic process:ribonucleoprotein complex;RNA binding;nucleolus;nucleus;rRNA processing;cytoplasm@NA
F03450@123183@123183@deletion@1@123812440@123812574@12@chr12:123812440-123812574@5.22@104@56@0.538@NA@SBNO1_10@0@0@0@:strawberry notch homolog 1 (Drosophila)@:hydrolase activity;oxidation-reduction process;DNA binding;catalytic activity;ATP binding;oxidoreductase activity;molecular_function;cellular_component;biological_process@NA
F03450@124863@124863@deletion@1@35806630@35806756@13@chr13:35806630-35806756@4.68@126@73@0.579@NA@NBEA_34@0@0@0@:neurobeachin@:endomembrane system;protein kinase binding;binding;cytosol;trans-Golgi network;protein binding;protein localization;plasma membrane@NA
F03450@127333@127341@deletion@9@19553418@19574352@14@chr14:19553418-19574352@9.87@96@37@0.385@CNVR6072.1@POTEG_1, POTEG_2, POTEG_3, POTEG_4, POTEG_5, POTEG_6, POTEG_7, POTEG_8, POTEG_9@0@0@0@:POTE ankyrin domain family, member G@:protein binding@NA
F03450@127355@127356@deletion@2@20295609@20345371@14@chr14:20295609-20345371@5.64@2717@2012@0.741@CNVR6072.12, CNVR6072.4, CNVR6072.5@OR4N2_1, OR4K2_1@0@0@0@:olfactory receptor, family 4, subfamily N, member 2:olfactory receptor, family 4, subfamily K, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F03450@133343@133344@deletion@2@106053892@106054732@14@chr14:106053892-106054732@14.4@506@300@0.593@CNVR6294.46@IGHA2_2, IGHA2_1@0@0@0@@:protein binding@NA
F03450@133358@133359@duplication@2@106174123@106175002@14@chr14:106174123-106175002@14.2@581@850@1.46@CNVR6294.46, CNVR6294.43, CNVR6294.65, CNVR6294.66, CNVR6294.68@IGHA1_2, IGHA1_1@0@0@0@@:antigen binding;protein binding;immune response;protein-chromophore linkage@NA
F03450@133369@133370@deletion@2@106236631@106236862@14@chr14:106236631-106236862@10@230@128@0.557@CNVR6294.66, CNVR6294.68, CNVR6294.19, CNVR6294.35, CNVR6294.47@IGHG3_4, IGHG3_3@0@0@0@@:protein binding@NA
F03450@133409@133414@deletion@6@106373070@106380248@14@chr14:106373070-106380248@23.5@410@208@0.507@CNVR6294.27, CNVR6294.36, CNVR6294.48, CNVR6294.25, CNVR6294.57, CNVR6294.29@IGHD2-8_1, IGHD1-7_1, IGHD6-6_1, IGHD5-5_1, IGHD4-4_1, IGHD3-3_1@0@0@0@NA@NA@NA
F03450@133432@133435@deletion@4@106539080@106552729@14@chr14:106539080-106552729@83.3@393@0@0@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1@0@0@0@@:protein binding:protein binding@NA
F03450@133458@133460@deletion@3@106791006@106805516@14@chr14:106791006-106805516@19.8@768@446@0.581@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-30_2, IGHV3-30_1, IGHV4-31_2@0@0@0@@:protein binding:protein binding@NA
F03450@133468@133473@duplication@6@106866407@106926644@14@chr14:106866407-106926644@38.8@1518@2290@1.51@CNVR6294.26, CNVR6294.56, CNVR6294.18@IGHV3-38_2, IGHV3-38_1, IGHV4-39_2, IGHV4-39_1, IGHV3-43_2, IGHV3-43_1@0@0@0@@:protein binding:protein binding:protein binding@NA
F03450@133491@133492@deletion@2@107095127@107095561@14@chr14:107095127-107095561@6.45@65@25@0.385@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61_2, IGHV4-61_1@0@0@0@@:protein binding@NA
F03450@133495@133495@deletion@1@107131034@107131334@14@chr14:107131034-107131334@8.63@176@91@0.517@CNVR6294.56, CNVR6294.16@IGHV3-66_2@0@0@0@@:protein binding@NA
F03450@133869@133870@duplication@2@28629294@28629596@15@chr15:28629294-28629596@5.16@5@37@7.4@CNVR6329.4@GOLGA8F_9, GOLGA8F_10@0@0@0@@:Golgi apparatus@NA
F03450@134155@134156@deletion@2@32451771@32455536@15@chr15:32451771-32455536@5.94@28@1@0.0357@CNVR6345.2, CNVR6345.1@CHRNA7_8, CHRNA7_9@0@0@0@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
F03450@138284@138290@duplication@7@72954594@72958469@15@chr15:72954594-72958469@8.76@102@178@1.75@CNVR6443.1@GOLGA6B_11, GOLGA6B_12, GOLGA6B_13, GOLGA6B_14, GOLGA6B_15, GOLGA6B_16, GOLGA6B_17@0@0@0@:golgin A6 family, member B@:Golgi apparatus@NA
F03450@140958@140961@deletion@4@1278901@1279952@16@chr16:1278901-1279952@7.49@65@22@0.338@CNVR6591.1@TPSB2_6, TPSB2_5, TPSB2_4, TPSB2_3, TPSB2_2@0@0@0@:tryptase beta 2 (gene/pseudogene)@:proteolysis;catalytic activity;serine-type endopeptidase activity@NA
F03450@141626@141626@duplication@1@2607705@2607964@16@chr16:2607705-2607964@4.88@162@236@1.46@CNVR6601.1@PDPK1_2@0@0@0@:3-phosphoinositide dependent protein kinase-1@:3-phosphoinositide-dependent protein kinase activity;nucleoplasm;fibroblast growth factor receptor signaling pathway;protein tyrosine kinase activity;negative regulation of transforming growth factor beta receptor signaling pathway;negative regulation of toll-like receptor signaling pathway;regulation of endothelial cell migration;focal adhesion assembly;ATP binding;insulin receptor signaling pathway;plasma membrane;intracellular signal transduction;positive regulation of establishment of protein localization to plasma membrane;platelet activation;protein kinase activity;regulation of mast cell degranulation;cytosol;epidermal growth factor receptor signaling pathway;hyperosmotic response;nerve growth factor receptor signaling pathway;type B pancreatic cell development;synaptic transmission;regulation of apoptotic process;transcription, DNA-dependent;protein autophosphorylation;regulation of I-kappaB kinase/NF-kappaB cascade;protein kinase binding;T cell costimulation;insulin receptor binding;transferase activity, transferring phosphorus-containing groups;actin cytoskeleton organization;blood coagulation;negative regulation of protein kinase activity;cellular response to insulin stimulus;focal adhesion;phosphatidylinositol-mediated signaling;negative regulation of cardiac muscle cell apoptotic process;protein serine/threonine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;cytoplasm;activation of protein kinase B activity;protein binding;T cell receptor signaling pathway;cytoplasmic membrane-bounded vesicle;peptidyl-threonine phosphorylation;kinase activity@NA
F03450@143793@143793@deletion@1@24574521@24574616@16@chr16:24574521-24574616@7.01@154@83@0.539@NA@RBBP6_11@0@0@0@:retinoblastoma binding protein 6@:ubiquitin-protein ligase activity;ubiquitin ligase complex;protein ubiquitination involved in ubiquitin-dependent protein catabolic process;microtubule organizing center;protein binding;chromosome;nucleolus;nucleus;zinc ion binding;protein ubiquitination;nucleic acid binding@NA
F03450@144117@144118@duplication@2@28734486@28734872@16@chr16:28734486-28734872@9.22@702@949@1.35@CNVR6686.3, CNVR6686.2@EIF3C_9, EIF3C_10@0@0@0@:eukaryotic translation initiation factor 3, subunit C@:cytosol;protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;cellular protein metabolic process;binding;gene expression;translation;translation initiation factor activity@NA
F03450@145528@145528@deletion@1@55568356@55568389@16@chr16:55568356-55568389@4.73@53@22@0.415@NA@LPCAT2_7@0@0@0@:lysophosphatidylcholine acyltransferase 2@:phospholipid metabolic process;phosphatidylcholine acyl-chain remodeling;glycerophospholipid biosynthetic process;Golgi membrane;1-acylglycerophosphocholine O-acyltransferase activity;Golgi stack;integral to membrane;endoplasmic reticulum membrane;metabolic process;small molecule metabolic process;platelet activating factor biosynthetic process;endoplasmic reticulum;transferase activity, transferring acyl groups;cellular membrane organization;1-alkylglycerophosphocholine O-acetyltransferase activity;calcium ion binding@NA
F03450@147423@147423@deletion@1@72097156@72097159@16@chr16:72097156-72097159@6.67@70@27@0.386@CNVR6769.1@HPR_1@0@0@0@:thioredoxin-like 4B:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@NA
F03450@151422@151423@deletion@2@15539351@15546130@17@chr17:15539351-15546130@5.25@180@110@0.611@NA@TRIM16_3, TRIM16_8, TRIM16_2, TRIM16_7@0@0@0@:tripartite motif containing 16@:protein binding;intracellular;zinc ion binding;cytoplasm:histone H4 acetylation;response to growth hormone stimulus;NACHT domain binding;DNA binding;positive regulation of keratinocyte differentiation;response to organophosphorus;interleukin-1 binding;PML body;positive regulation of interleukin-1 beta secretion;intracellular;regulation of transcription, DNA-dependent;response to retinoic acid;cytoplasm;positive regulation of transcription, DNA-dependent;protein binding;positive regulation of retinoic acid receptor signaling pathway;histone H3 acetylation;zinc ion binding;nucleic acid binding@NA
F03450@151875@151876@deletion@2@18380170@18387280@17@chr17:18380170-18387280@5.01@110@62@0.564@CNVR7014.1@LGALS9C_1, LGALS9C_2@0@0@0@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
F03450@151958@151959@duplication@2@18996506@18997166@17@chr17:18996506-18997166@6.27@200@295@1.48@CNVR7018.4, CNVR7018.2, CNVR7018.6@AC007952.5_1, AC007952.5_2@0@0@0@NA@NA@NA
F03450@152089@152090@deletion@2@19753056@19768157@17@chr17:19753056-19768157@10.4@125@53@0.424@NA@ULK2_4, ULK2_3@0@0@0@:unc-51-like kinase 2 (C. elegans)@:cytoplasmic vesicle membrane;regulation of autophagy;autophagy;protein autophosphorylation;protein tyrosine kinase activity;transferase activity, transferring phosphorus-containing groups;phosphotransferase activity, alcohol group as acceptor;catalytic activity;ATP binding;negative regulation of collateral sprouting;axonogenesis;axon extension;pre-autophagosomal structure membrane;protein serine/threonine kinase activity;protein phosphorylation;lipopolysaccharide biosynthetic process;protein kinase activity;response to starvation;signal transduction;protein binding;membrane@NA
F03450@152978@152978@deletion@1@30300166@30300250@17@chr17:30300166-30300250@6.13@94@45@0.479@NA@SUZ12_6@0@0@0@:suppressor of zeste 12 homolog (Drosophila)@:sex chromatin;sequence-specific DNA binding;ESC/E(Z) complex;positive regulation of cell proliferation;nucleus;methylated histone residue binding;histone ubiquitination;negative regulation of cell differentiation;intracellular;protein binding;chromatin binding;histone methyltransferase activity;negative regulation of transcription from RNA polymerase II promoter;histone methylation;transcription, DNA-dependent;zinc ion binding@NA
F03450@152999@152999@deletion@1@30377023@30377126@17@chr17:30377023-30377126@5.94@155@88@0.568@NA@LRRC37B_11@0@0@0@:leucine rich repeat containing 37B@:protein binding;integral to membrane;cytoplasm@NA
F03450@153378@153381@duplication@4@34523998@34539971@17@chr17:34523998-34539971@18.2@62@204@3.29@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL3L3_1, CCL4L1_1, CCL4L1_2, CCL4L1_3@0@0@0@:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
F03450@153399@153400@deletion@2@34640745@34641537@17@chr17:34640745-34641537@5.61@115@62@0.539@CNVR7077.1, CNVR7077.2, CNVR7077.12@CCL4L2_2, CCL4L2_3@0@0@0@:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
F03450@153653@153657@deletion@5@36357159@36361804@17@chr17:36357159-36361804@9.17@1916@1419@0.741@CNVR7083.3@RP11-1407O15.2_9, RP11-1407O15.2_8, RP11-1407O15.2_7, RP11-1407O15.2_6, RP11-1407O15.2_5@0@0@0@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
F03450@155004@155004@deletion@1@41332813@41332834@17@chr17:41332813-41332834@7.69@126@61@0.484@NA@NBR1_5@0@0@0@:neighbor of BRCA1 gene 1@:late endosome;M band;mitogen-activated protein kinase binding;protein oligomerization;ubiquitin binding;regulation of bone mineralization;negative regulation of osteoblast differentiation;lysosome;regulation of stress-activated MAPK cascade;macroautophagy;pre-autophagosomal structure;autophagic vacuole;cytoplasmic vesicle;cytosol;protein binding;zinc ion binding@NA
F03450@155580@155581@duplication@2@44171927@44249509@17@chr17:44171927-44249509@7.37@2058@2708@1.32@CNVR7114.3, CNVR7114.2@KANSL1_3, KANSL1_2@0@0@0@:KAT8 regulatory NSL complex subunit 1@:histone acetyltransferase activity (H4-K8 specific);histone acetyltransferase activity (H4-K16 specific);histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase complex;histone H4-K5 acetylation;MLL1 complex;histone H4-K16 acetylation;protein binding;histone H4-K8 acetylation;nucleus@NA
F03450@155587@155599@deletion@13@44399689@44592687@17@chr17:44399689-44592687@30.2@197@43@0.218@CNVR7114.2, CNVR7114.1@LRRC37A_6, LRRC37A_7, LRRC37A_8, LRRC37A_9, LRRC37A_10, LRRC37A_11, LRRC37A_12, LRRC37A_13, LRRC37A_14, ARL17B_4, ARL17B_3, ARL17B_2, LRRC37A2_2@0@0@0@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane@NA
F03450@155610@155611@duplication@2@44632519@44632790@17@chr17:44632519-44632790@8.52@148@240@1.62@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2_13, LRRC37A2_14@0@0@0@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
F03450@155723@155724@deletion@2@45663515@45663764@17@chr17:45663515-45663764@10.2@190@101@0.532@CNVR7118.2@NPEPPS_7, NPEPPS_8@0@0@0@:aminopeptidase puromycin sensitive@:metallopeptidase activity;antigen processing and presentation of peptide antigen via MHC class I;aminopeptidase activity;cytosol;proteolysis;cellular response to hypoxia;nucleus;zinc ion binding;protein polyubiquitination@NA
F03450@157821@157821@deletion@1@66265238@66265487@17@chr17:66265238-66265487@9.14@99@38@0.384@NA@SLC16A6_7@0@0@0@:arylsulfatase G:solute carrier family 16, member 6 (monocarboxylic acid transporter 7)@:arylsulfatase activity;phospholipid metabolic process;sulfur compound metabolic process;small molecule metabolic process;endoplasmic reticulum;catalytic activity;endoplasmic reticulum lumen;post-translational protein modification;sphingolipid metabolic process;extracellular space;cellular protein metabolic process;sulfuric ester hydrolase activity;glycosphingolipid metabolic process;metabolic process;metal ion binding;lysosome:monocarboxylic acid transmembrane transporter activity;integral to membrane;monocarboxylic acid transport;symporter activity;integral to plasma membrane;membrane;transmembrane transport@NA
F03450@162018@162019@deletion@2@44548659@44556213@18@chr18:44548659-44556213@6.33@123@66@0.537@CNVR7319.1, CNVR7319.2@TCEB3CL_1, TCEB3C_1@0@0@0@:katanin p60 subunit A-like 2:transcription elongation factor B polypeptide 3C-like:transcription elongation factor B polypeptide 3C (elongin A3);RNA polymerase II transcription factor SIII subunit A3-like@:nucleoside-triphosphatase activity;nucleotide binding;microtubule-severing ATPase activity;cytoplasm;ATP binding;four-way junction helicase activity;DNA repair;protein binding;microtubule;DNA recombination:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent:integral to membrane;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent@NA
F03450@162790@162791@deletion@2@66365170@66367722@18@chr18:66365170-66367722@5.49@181@111@0.613@NA@TMX3_7, TMX3_6@0@0@0@:thioredoxin-related transmembrane protein 3@:isomerase activity;electron carrier activity;cell redox homeostasis;glycerol ether metabolic process;integral to membrane;protein disulfide isomerase activity;endoplasmic reticulum membrane;protein disulfide oxidoreductase activity;cell surface;calcium ion binding@NA
F03450@166916@166917@deletion@2@14508471@14508747@19@chr19:14508471-14508747@13@109@34@0.312@NA@CD97_7, CD97_8@0@0@0@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
F03450@167044@167045@duplication@2@14876337@14876616@19@chr19:14876337-14876616@7.79@423@581@1.37@NA@EMR2_9, EMR2_8@0@0@0@:egf-like module containing, mucin-like, hormone receptor-like 2@:transmembrane signaling receptor activity;inflammatory response;G-protein coupled receptor activity;ruffle membrane;integral to membrane;plasma membrane;cell surface receptor signaling pathway;neuropeptide signaling pathway;granulocyte chemotaxis;cell migration;leading edge membrane;G-protein coupled receptor signaling pathway;protein binding;cell adhesion;membrane;calcium ion binding;chondroitin sulfate binding@NA
F03450@168952@168952@deletion@1@35862263@35863302@19@chr19:35862263-35863302@11.1@156@68@0.436@CNVR7627.1@GPR42_2@0@0@0@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
F03450@170096@170100@deletion@5@40373946@40382826@19@chr19:40373946-40382826@14.5@197@92@0.467@CNVR7639.2@FCGBP_26, FCGBP_25, FCGBP_24, FCGBP_23, FCGBP_22@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F03450@170367@170367@deletion@1@41381599@41381779@19@chr19:41381599-41381779@7.31@124@61@0.492@CNVR7642.1@CYP2A7_9@0@0@0@:cytochrome P450, family 2, subfamily A, polypeptide 7@:oxidation-reduction process;electron carrier activity;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;oxygen binding;heme binding;monooxygenase activity;endoplasmic reticulum membrane;iron ion binding@NA
F03450@173294@173296@deletion@3@54724026@54725251@19@chr19:54724026-54725251@10.4@178@90@0.506@CNVR7721.3, CNVR7721.4@LILRB3_7, LILRB3_6, LILRB3_5@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F03450@173299@173308@deletion@10@54726620@54746600@19@chr19:54726620-54746600@52.5@1399@789@0.564@CNVR7721.3, CNVR7721.4, CNVR7721.1@LILRB3_2, LILRB3_1, LILRA6_8, LILRA6_7, LILRA6_6, LILRA6_5, LILRA6_4, LILRA6_3, LILRA6_2, LILRA6_1@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F03450@173478@173486@deletion@9@55315108@55329024@19@chr19:55315108-55329024@71.8@1547@805@0.52@CNVR7725.1, CNVR7725.3@KIR2DL4_1, KIR2DL4_2, KIR2DL4_3, KIR2DL4_4, KIR2DL4_5, KIR2DL4_6, KIR2DL4_7, KIR3DL1_1, KIR3DL1_2@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
F03450@173491@173503@duplication@13@55340817@55362710@19@chr19:55340817-55362710@20.2@1973@2577@1.31@CNVR7725.1, CNVR7725.6@KIR3DL1_7, KIR3DL1_8, KIR3DL1_9, KIR2DS4_1, KIR2DS4_2, KIR2DS4_3, KIR2DS4_4, KIR2DS4_5, KIR2DS4_6, KIR2DS4_7, KIR2DS4_8, KIR3DL2_1, KIR3DL2_2@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
F03450@174395@174395@deletion@1@1569207@1569278@20@chr20:1569207-1569278@9.8@44@0@0@CNVR7763.1@RP4-576H24.4_1@0@0@0@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
F03450@174403@174403@duplication@1@1895746@1896101@20@chr20:1895746-1896101@7.55@187@291@1.56@CNVR7764.2@SIRPA_2@0@0@0@:signal-regulatory protein alpha@:blood coagulation;protein binding;integral to membrane;SH3 domain binding;cell adhesion;plasma membrane;membrane;leukocyte migration@NA
F03450@175736@175737@deletion@2@26061801@26063616@20@chr20:26061801-26063616@27@196@46@0.235@CNVR7823.4, CNVR7823.3, CNVR7823.5, CNVR7823.1@FAM182A_4, FAM182A_5@0@0@0@NA@NA@NA
F03450@178195@178195@deletion@1@57266462@57266542@20@chr20:57266462-57266542@4.79@78@39@0.5@NA@STX16-NPEPL1_10@0@0@0@:uncharacterized LOC100652930;aminopeptidase-like 1@:intracellular membrane-bounded organelle;Golgi apparatus;intracellular;intracellular protein transport;protein binding;vesicle-mediated transport;nucleolus;SNAP receptor activity;membrane:manganese ion binding;proteolysis;metalloexopeptidase activity;aminopeptidase activity;intracellular;cytoplasm@NA
F03450@178280@178281@deletion@2@58440863@58441447@20@chr20:58440863-58441447@6.19@109@58@0.532@NA@SYCP2_42, SYCP2_41@0@0@0@:synaptonemal complex protein 2@:fertilization;protein heterodimerization activity;DNA binding;meiotic prophase I;male meiosis;synaptonemal complex assembly;protein binding;synaptonemal complex;female meiosis;lateral element;nucleus;apoptotic process;male genitalia morphogenesis;organ morphogenesis;cell division@NA
F03450@178990@178992@duplication@3@10914364@10920164@21@chr21:10914364-10920164@7.1@695@909@1.31@CNVR7947.10, CNVR7947.6, CNVR7947.11@TPTE_21, TPTE_20, TPTE_19@0@0@0@:transmembrane phosphatase with tensin homology@:phosphatase activity;ion channel activity;protein tyrosine phosphatase activity;ion transport;protein dephosphorylation;transmembrane transport;protein binding;signal transduction;integral to membrane;protein tyrosine/serine/threonine phosphatase activity;dephosphorylation;membrane;peptidyl-tyrosine dephosphorylation@NA
F03450@180976@180976@deletion@1@16287255@16287885@22@chr22:16287255-16287885@11.2@78@17@0.218@CNVR8071.2, CNVR8071.3, CNVR8071.9@POTEH_1@0@0@0@:POTE ankyrin domain family, member H@:protein binding@NA
F03450@181734@181734@deletion@1@22707460@22707781@22@chr22:22707460-22707781@5.48@414@274@0.662@CNVR8103.20, CNVR8103.5, CNVR8103.2, CNVR8103.12, CNVR8103.10, CNVR8103.9, CNVR8103.22@IGLV5-48_2@0@0@0@@:protein binding@NA
F03450@181807@181807@deletion@1@23247056@23247205@22@chr22:23247056-23247205@6.11@283@177@0.625@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11@IGLJ3_1@0@0@0@NA@NA@NA
F03450@181867@181867@deletion@1@23964279@23964363@22@chr22:23964279-23964363@14.5@263@122@0.464@CNVR8112.1@C22orf43_4@0@0@0@:chromosome 22 open reading frame 43@NA@NA
F03450@181936@181937@duplication@2@24300473@24300888@22@chr22:24300473-24300888@7.95@32@88@2.75@CNVR8114.6, CNVR8114.12, CNVR8114.13, CNVR8114.8@GSTT2B_4, GSTT2B_3@0@0@0@:glutathione S-transferase theta 2B (gene/pseudogene);glutathione S-transferase theta 2@:protein binding;glutathione transferase activity;nucleus;transferase activity;cytoplasm@NA
F03450@183631@183631@deletion@1@39357393@39357686@22@chr22:39357393-39357686@6.88@53@15@0.283@CNVR8164.1@APOBEC3A_4@0@0@0@:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A;APOBEC3A and APOBEC3B deletion hybrid@:cytidine deamination;defense response to virus;negative regulation of viral genome replication;DNA cytosine deamination;clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine;catalytic activity;DNA demethylation;cytoplasm;innate immune response;cytidine deaminase activity;nucleus;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;cellular response to xenobiotic stimulus;zinc ion binding;negative regulation of transposition@NA
F03450@700@700@deletion@1@18278292@18278411@X@chrX:18278292-18278411@5.28@116@66@0.569@CNVR8281.2@SCML2_9@0@0@0@NA@NA@NA
F03450@3356@3356@deletion@1@70812388@70812420@X@chrX:70812388-70812420@7.64@62@19@0.306@NA@ACRC_3@0@0@0@NA@NA@NA
F03450@4052@4071@deletion@20@101571921@101581428@X@chrX:101571921-101581428@33.5@152@0@0@NA@NXF2_15, NXF2_16, NXF2_17, NXF2_18, NXF2_19, NXF2_20, NXF2_21, NXF2_22, NXF2_23, NXF2_24, NXF2_25, NXF2_26, NXF2_27, NXF2_28, NXF2_29, NXF2_30, NXF2_31, NXF2_32, NXF2_33, NXF2_34@0@0@0@NA@NA@NA
F03450@4078@4079@duplication@2@101619967@101620252@X@chrX:101619967-101620252@5.01@28@64@2.29@NA@NXF2B_28, NXF2B_27@0@0@0@NA@NA@NA
F03450@4884@4884@deletion@1@119210843@119211253@X@chrX:119210843-119211253@20.5@95@1@0.0105@NA@RHOXF2B_2@0@0@0@NA@NA@NA
F03450@4890@4890@duplication@1@119292922@119293332@X@chrX:119292922-119293332@10.7@125@227@1.82@NA@RHOXF2_2@0@0@0@NA@NA@NA
F03450@5484@5484@duplication@1@134947908@134948155@X@chrX:134947908-134948155@7.16@198@293@1.48@CNVR8449.4, CNVR8449.2, CNVR8449.1@CT45A5_3@0@0@0@NA@NA@NA
F03450@5719@5719@deletion@1@140336520@140336590@X@chrX:140336520-140336590@24.3@138@16@0.116@CNVR8456.1@SPANXC_1@0@0@0@NA@NA@NA
F03450@5914@5914@deletion@1@151143043@151143097@X@chrX:151143043-151143097@5.72@269@174@0.647@NA@GABRE_1@0@0@0@NA@NA@NA
F03450@6297@6297@deletion@1@153458900@153459138@X@chrX:153458900-153459138@6.81@106@53@0.5@CNVR8489.1@OPN1MW_5@0@0@0@NA@NA@NA
F03450@6307@6307@duplication@1@153496018@153496256@X@chrX:153496018-153496256@9.7@48@121@2.52@CNVR8489.1@OPN1MW2_5@0@0@0@NA@NA@NA
F03450@427@428@deletion@2@1636344@1637171@1@chr1:1636344-1637171@9.36@74@20@0.27@CNVR17.1@CDK11A_13, CDK11A_12@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
F03450@437@440@duplication@4@1653036@1666274@1@chr1:1653036-1666274@7.48@270@380@1.41@CNVR17.1@CDK11A_3, CDK11A_2, SLC35E2_6, SLC35E2_5@0@0@0@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A:solute carrier family 35, member E2@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division:integral to membrane;membrane@NA
F03450@14061@14064@duplication@4@161641183@161645103@1@chr1:161641183-161645103@6.32@234@333@1.42@CNVR383.1@FCGR2B_3, FCGR2B_4, FCGR2B_5, FCGR2B_6@0@0@0@:Fc fragment of IgG, low affinity IIb, receptor (CD32)@:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
F03450@25350@25351@deletion@2@97818242@97820478@2@chr2:97818242-97820478@10.8@129@52@0.403@CNVR886.2@ANKRD36_14, ANKRD36_15@0@0@0@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
F03450@34944@34947@deletion@4@10089602@10102087@3@chr3:10089602-10102087@11.4@165@78@0.473@NA@FANCD2_16, FANCD2_17, FANCD2_18, FANCD2_19@0@0@0@:Fanconi anemia, complementation group D2@:nucleoplasm;synapsis;binding;response to DNA damage stimulus;gamete generation;DNA repair;condensed chromosome;protein binding;response to gamma radiation@: FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2
F03450@45435@45439@duplication@5@195456520@195477983@3@chr3:195456520-195477983@9.15@486@663@1.36@CNVR1703.1, CNVR1703.2, CNVR1703.5, CNVR1703.3@MUC20_3, MUC20_4, MUC4_25, MUC4_24, MUC4_23@0@0@0@:mucin 20, cell surface associated:mucin 4, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane:ErbB-2 class receptor binding;Golgi lumen;cell-matrix adhesion;post-translational protein modification;extracellular matrix structural constituent;protein binding;O-glycan processing;cellular protein metabolic process;proteinaceous extracellular matrix;integral to plasma membrane;membrane;extracellular matrix constituent, lubricant activity;biological_process@NA
F03450@48967@48969@duplication@3@75312252@75316249@4@chr4:75312252-75316249@7.77@44@104@2.36@NA@AREG_2, AREG_3, AREG_4@0@0@0@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
F03450@48972@48974@deletion@3@75482007@75486006@4@chr4:75482007-75486006@7.82@105@46@0.438@NA@AREGB_2, AREGB_3, AREGB_4@0@0@0@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
F03450@53306@53319@deletion@14@741710@837595@5@chr5:741710-837595@67.5@1217@594@0.488@CNVR2280.3@ZDHHC11B_7, ZDHHC11B_6, ZDHHC11B_5, ZDHHC11B_4, ZDHHC11B_3, ZDHHC11B_2, ZDHHC11B_1, ZDHHC11_12, ZDHHC11_11, ZDHHC11_10, ZDHHC11_9, ZDHHC11_8, ZDHHC11_7, ZDHHC11_6@0@0@0@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
F03450@59488@59489@deletion@2@147553798@147554961@5@chr5:147553798-147554961@22@115@7@0.0609@CNVR2637.1@SPINK14_3, SPINK14_4@0@0@0@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
F03450@60875@60877@duplication@3@175386973@175388437@5@chr5:175386973-175388437@7.8@84@153@1.82@NA@THOC3_6, THOC3_5, THOC3_4@0@0@0@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
F03450@61640@61645@duplication@6@180376240@180429785@5@chr5:180376240-180429785@6.49@599@772@1.29@CNVR2719.1@BTNL8_7, BTNL8_8, BTNL3_1, BTNL3_2, BTNL3_3, BTNL3_4@0@0@0@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
F03450@63768@63769@deletion@2@31994761@31995222@6@chr6:31994761-31995222@7.97@66@20@0.303@CNVR2843.6, CNVR2843.5@C4B_20, C4B_21@0@0@0@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
F03450@63973@63973@deletion@1@32632576@32632844@6@chr6:32632576-32632844@7.38@103@44@0.427@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20, CNVR2845.31@HLA-DQB1_2@0@0@0@:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
F03450@64602@64606@duplication@5@35754776@35765065@6@chr6:35754776-35765065@16.5@753@1070@1.42@CNVR2861.1@CLPSL1_2, CLPSL1_3, CLPS_3, CLPS_2, CLPS_1@0@0@0@:colipase-like 1:colipase, pancreatic@:extracellular region;enzyme activator activity;digestion;lipid catabolic process:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
F03450@71342@71343@duplication@2@1486350@1487401@7@chr7:1486350-1487401@5.32@96@153@1.59@NA@MICALL2_5, MICALL2_4@0@0@0@:MICAL-like 2@:tight junction;protein binding;endocytosis;actin filament bundle;zinc ion binding;cytoplasm@NA
F03450@71747@71749@deletion@3@5941289@5944900@7@chr7:5941289-5944900@13.5@244@123@0.504@NA@CCZ1_5, CCZ1_6, CCZ1_7@0@0@0@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
F03450@71759@71766@deletion@8@5967828@5984809@7@chr7:5967828-5984809@15.7@364@205@0.563@NA@RSPH10B_19, RSPH10B_18, RSPH10B_17, RSPH10B_16, RSPH10B_15, RSPH10B_14, RSPH10B_13, RSPH10B_12@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F03450@71776@71779@deletion@4@6006495@6018327@7@chr7:6006495-6018327@12.1@171@82@0.48@NA@RSPH10B_2, PMS2_15, PMS2_14, PMS2_13@0@0@0@:radial spoke head 10 homolog B (Chlamydomonas):PMS2 postmeiotic segregation increased 2 (S. cerevisiae)@:response to drug;DNA binding;MutSalpha complex binding;ATP binding;mismatch repair;DNA repair;mismatched DNA binding;ATPase activity;nucleus;mismatch repair complex;reciprocal meiotic recombination;ATP catabolic process;single-stranded DNA binding;response to DNA damage stimulus;single base insertion or deletion binding;protein binding;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;MutLalpha complex;endonuclease activity@: COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4; MISMATCH REPAIR CANCER SYNDROME
F03450@71933@71939@duplication@7@6820441@6836397@7@chr7:6820441-6836397@9.63@283@415@1.47@NA@RSPH10B2_13, RSPH10B2_14, RSPH10B2_15, RSPH10B2_16, RSPH10B2_17, RSPH10B2_18, RSPH10B2_19@0@0@0@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
F03450@76427@76432@duplication@6@100331793@100336236@7@chr7:100331793-100336236@28.9@467@805@1.72@CNVR3509.1@ZAN_1, ZAN_2, ZAN_3, ZAN_4, ZAN_5, ZAN_6@0@0@0@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
F03450@79056@79061@deletion@6@142045364@142104553@7@chr7:142045364-142104553@27@981@582@0.593@NA@TRBV4-2_1, TRBV4-2_2, TRBV7-8_2, TRBV7-8_1, TRBV6-9_2, TRBV6-9_1@0@0@0@@:protein binding:protein binding:protein binding@NA
F03450@88592@88602@duplication@11@43815786@43885072@9@chr9:43815786-43885072@11.8@315@466@1.48@NA@CNTNAP3B_5, CNTNAP3B_6, CNTNAP3B_7, CNTNAP3B_8, CNTNAP3B_9, CNTNAP3B_10, CNTNAP3B_11, CNTNAP3B_12, CNTNAP3B_13, CNTNAP3B_14, CNTNAP3B_15@0@0@0@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
F03450@95384@95384@duplication@1@18112045@18112445@10@chr10:18112045-18112445@6.75@47@107@2.28@NA@MRC1_2@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F03450@95389@95389@deletion@1@18138509@18138693@10@chr10:18138509-18138693@8.57@52@8@0.154@NA@MRC1_7@0@0@0@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
F03450@107400@107402@duplication@3@64108080@64108650@11@chr11:64108080-64108650@7.29@238@343@1.44@NA@CCDC88B_2, CCDC88B_3, CCDC88B_4@0@0@0@:coiled-coil domain containing 88B@:microtubule binding;microtubule cytoskeleton organization;cytoplasm@NA
F03450@111510@111511@deletion@2@117077784@117078780@11@chr11:117077784-117078780@5.01@90@46@0.511@NA@PCSK7_15, PCSK7_14@0@0@0@:proprotein convertase subtilisin/kexin type 7@:proteolysis;integral to Golgi membrane;serine-type endopeptidase activity;peptide hormone processing@NA
F03450@114483@114483@duplication@1@11243900@11244828@12@chr12:11243900-11244828@6.64@456@665@1.46@CNVR5434.1@TAS2R43_1@0@0@0@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
F03450@127354@127358@deletion@5@20248483@20404761@14@chr14:20248483-20404761@13.8@4962@3561@0.718@CNVR6072.12, CNVR6072.4, CNVR6072.5@OR4M1_1, OR4N2_1, OR4K2_1, OR4K5_1, OR4K1_1@0@0@0@:olfactory receptor, family 4, subfamily N, member 2:olfactory receptor, family 4, subfamily M, member 1:olfactory receptor, family 4, subfamily K, member 2:olfactory receptor, family 4, subfamily K, member 5:olfactory receptor, family 4, subfamily K, member 1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
F03450@133358@133362@duplication@5@106174123@106208132@14@chr14:106174123-106208132@9.87@486@692@1.42@CNVR6294.46, CNVR6294.43, CNVR6294.66, CNVR6294.68, CNVR6294.19, CNVR6294.35@IGHA1_2, IGHA1_1, IGHG1_6, IGHG1_5, IGHG1_4@0@0@0@@:antigen binding;protein binding;immune response;protein-chromophore linkage:antigen binding;complement activation;protein binding;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response@: MYELOMA, MULTIPLE
F03450@133432@133436@deletion@5@106539080@106573537@14@chr14:106539080-106573537@78.4@516@86@0.167@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8_2, IGHV1-8_1, IGHV3-9_2, IGHV3-9_1, IGHV3-11_2@0@0@0@@:protein binding:protein binding:protein binding@NA
F03450@133458@133461@deletion@4@106791006@106805644@14@chr14:106791006-106805644@7.19@436@289@0.663@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-30_2, IGHV3-30_1, IGHV4-31_2, IGHV4-31_1@0@0@0@@:protein binding:protein binding@NA
F03450@133472@133473@duplication@2@106926189@106926644@14@chr14:106926189-106926644@7.93@384@561@1.46@CNVR6294.56, CNVR6294.1@IGHV3-43_2, IGHV3-43_1@0@0@0@@:protein binding@NA
F03450@134153@134153@duplication@1@32449810@32449976@15@chr15:32449810-32449976@4.69@32@71@2.22@CNVR6345.2, CNVR6345.1@CHRNA7_6@0@0@0@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
F03450@134447@134448@deletion@2@34819834@34820278@15@chr15:34819834-34820278@5.39@30@4@0.133@CNVR6351.3@GOLGA8B_25, GOLGA8B_24@0@0@0@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
F03450@135059@135061@duplication@3@41865507@41870474@15@chr15:41865507-41870474@5.36@391@520@1.33@NA@TYRO3_17, TYRO3_18, TYRO3_19@0@0@0@:TYRO3 protein tyrosine kinase@:protein tyrosine kinase activity;platelet aggregation;negative regulation of toll-like receptor signaling pathway;ATP binding;vagina development;substrate adhesion-dependent cell spreading;nucleus;negative regulation of lymphocyte activation;endoplasmic reticulum membrane;phosphatidylinositol 3-kinase cascade;nuclear envelope;platelet activation;protein kinase activity;protein kinase B signaling cascade;neuron homeostasis;negative regulation of neuron apoptotic process;negative regulation of innate immune response;protein autophosphorylation;transmembrane receptor protein tyrosine kinase activity;apoptotic cell clearance;transferase activity, transferring phosphorus-containing groups;spermatogenesis;forebrain cell migration;integral to membrane;integral to plasma membrane;ovulation cycle;natural killer cell differentiation;phosphatidylinositol 3-kinase binding;negative regulation of inflammatory response;protein phosphorylation;receptor signaling protein tyrosine kinase activity;protein heterodimerization activity;secretion by cell;protein binding;signal transduction;cell adhesion;signal transduction by phosphorylation@NA
F03450@140852@140855@duplication@4@820533@823045@16@chr16:820533-823045@6.16@267@367@1.37@NA@MSLNL_14, MSLNL_13, MSLNL_12, MSLNL_11@0@0@0@@:integral to membrane;cell adhesion@NA
F03450@147109@147119@deletion@11@70161164@70177561@16@chr16:70161164-70177561@19.5@2167@1513@0.698@CNVR6764.1, CNVR6764.3@PDPR_4, PDPR_5, PDPR_6, PDPR_7, PDPR_8, PDPR_9, PDPR_10, PDPR_11, PDPR_12, PDPR_13, PDPR_14@0@0@0@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
F03450@151898@151898@duplication@1@18630872@18631071@17@chr17:18630872-18631071@5.11@123@195@1.59@NA@TRIM16L_4@0@0@0@:tripartite motif containing 16-like@:protein binding;cytoplasm@NA
F03450@153377@153381@duplication@5@34523198@34539971@17@chr17:34523198-34539971@14.3@25@135@5.4@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL3L3_2, CCL3L3_1, CCL4L1_1, CCL4L1_2, CCL4L1_3@0@0@0@:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
F03450@159501@159503@duplication@3@78444614@78447244@17@chr17:78444614-78447244@5.24@238@327@1.37@CNVR7225.1@NPTX1_5, NPTX1_4, NPTX1_3@0@0@0@:neuronal pentraxin I@:axonogenesis involved in innervation;transport;central nervous system development;transport vesicle;synaptic transmission;metal ion binding@NA
F03450@170104@170108@duplication@5@40389653@40398510@19@chr19:40389653-40398510@14.5@163@294@1.8@CNVR7639.2, CNVR7639.3@FCGBP_18, FCGBP_17, FCGBP_16, FCGBP_15, FCGBP_14@0@0@0@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
F03450@173297@173298@duplication@2@54725701@54726434@19@chr19:54725701-54726434@5.54@52@99@1.9@CNVR7721.3, CNVR7721.4@LILRB3_4, LILRB3_3@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F03450@173301@173302@deletion@2@54742830@54743827@19@chr19:54742830-54743827@4.94@207@129@0.623@CNVR7721.3, CNVR7721.4, CNVR7721.1, CNVR7721.6@LILRA6_8, LILRA6_7@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F03450@173305@173308@deletion@4@54745453@54746600@19@chr19:54745453-54746600@21.3@338@158@0.467@CNVR7721.3, CNVR7721.6@LILRA6_4, LILRA6_3, LILRA6_2, LILRA6_1@0@0@0@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
F03450@173339@173341@duplication@3@54803467@54804173@19@chr19:54803467-54804173@5.39@249@340@1.37@CNVR7722.1@LILRA3_3, LILRA3_2, LILRA3_1@0@0@0@:leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3@:antigen binding;signal transduction;protein binding;extracellular region;plasma membrane;receptor activity;defense response@NA
F03450@173497@173503@duplication@7@55350884@55362710@19@chr19:55350884-55362710@15.7@759@1052@1.39@CNVR7725.1, CNVR7725.6, CNVR7725.5@KIR2DS4_4, KIR2DS4_5, KIR2DS4_6, KIR2DS4_7, KIR2DS4_8, KIR3DL2_1, KIR3DL2_2@0@0@0@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
F03450@175732@175732@duplication@1@25755498@25755948@20@chr20:25755498-25755948@5.38@118@191@1.62@CNVR7821.2, CNVR7821.4@FAM182B_3@0@0@0@:family with sequence similarity 27, member B;family with sequence similarity 27, member A;family with sequence similarity 27, member C;family with sequence similarity 182, member B@NA@NA
F03450@181804@181806@duplication@3@23237556@23243475@22@chr22:23237556-23243475@5.35@170@246@1.45@CNVR8103.2, CNVR8103.1, CNVR8103.6@IGLC1_1, IGLL5_3, IGLJ2_1, IGLC2_1@0@0@0@:immunoglobulin lambda-like polypeptide 5@:regulation of immune response;complement activation;immune response;complement activation, classical pathway;innate immune response;antigen binding;protein binding;extracellular region;plasma membrane:protein binding:protein binding@NA
D050227@593@593@duplication@1@1607505@1607639@1@chr1:1607505-1607639@6.28@27@81@3@CNVR17.1@RP11-345P4-003_4@10@10@10@:solute carrier family 35, member E2B@:integral to membrane;membrane;transmembrane transport@NA
D050227@2311@2318@deletion@8@12918842@12943232@1@chr1:12918842-12943232@9.22@373@229@0.614@CNVR72.3, CNVR72.4, CNVR72.7, CNVR72.12@PRAMEF2-001_2, PRAMEF2-001_3, PRAMEF2-001_4, RP11-450I1-201_3, RP11-450I1-201_4, PRAMEF4-001_2, PRAMEF4-001_3, PRAMEF4-001_4@42.125@33@50@:PRAME family member 2:PRAME family member 4@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
D050227@2903@2919@duplication@17@16909041@16951433@1@chr1:16909041-16951433@12.8@541@755@1.4@CNVR93.3, CNVR93.6, CNVR93.12@NBPF1-201_1, NBPF1-201_2, NBPF1-201_3, NBPF1-201_4, NBPF1-201_5, NBPF1-201_6, NBPF1-201_7, NBPF1-201_8, NBPF1-201_9, NBPF1-201_10, NBPF1-201_11, NBPF1-201_12, NBPF1-201_13, NBPF1-201_14, CROCCL1-204_11, AL137798-201_1, AL137798-201_2@29.8823529411765@21@48@NA@NA@NA
D050227@2936@2946@duplication@11@16973960@16976445@1@chr1:16973960-16976445@23.8@2039@2775@1.36@CNVR93.3, CNVR93.6, CNVR93.12, CNVR93.7, CNVR93.14, CNVR93.15@RP5-1182A14-001_7, RP5-1182A14-001_8, RP5-1182A14-001_9, RP5-1182A14-001_10, RP5-1182A14-001_11, RP5-1182A14-001_12, RP5-1182A14-001_13, RP5-1182A14-001_14, RP5-1182A14-001_15, RP5-1182A14-001_16, RP5-1182A14-001_17@68.7272727272727@48@88@NA@NA@NA
D050227@2978@2988@duplication@11@17085300@17087369@1@chr1:17085300-17087369@12.2@1291@1745@1.35@CNVR93.3, CNVR93.15, CNVR93.2, CNVR93.1@MST1P9-202_3, MST1P9-202_4, MST1P9-202_5, MST1P9-202_6, MST1P9-202_7, MST1P9-202_8, MST1P9-202_9, MST1P9-202_10, MST1P9-202_11, MST1P9-202_12, MST1P9-202_13@41.1818181818182@28@56@:macrophage stimulating 1-like@:proteolysis;extracellular region;catalytic activity;serine-type endopeptidase activity@NA
D050227@3779@3779@deletion@1@21809638@21809812@1@chr1:21809638-21809812@4.83@40@11@0.275@CNVR107.2, CNVR107.1@NBPF3-003_19@111@111@111@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 3@:cytoplasm@NA
D050227@5320@5324@duplication@5@31206734@31212785@1@chr1:31206734-31212785@6.6@336@465@1.38@NA@LAPTM5-201_4, LAPTM5-201_5, LAPTM5-201_6, LAPTM5-201_7, LAPTM5-201_8@0@0@0@:lysosomal protein transmembrane 5@:transport;integral to membrane;lysosomal membrane;integral to plasma membrane;lysosome@NA
D050227@9656@9656@deletion@1@63307101@63307219@1@chr1:63307101-63307219@4.73@117@60@0.513@NA@ATG4C-001_10@5@5@5@:autophagy related 4C, cysteine peptidase@:protein targeting to membrane;autophagy;cysteine-type peptidase activity;autophagic vacuole assembly;cytoplasm;cytosol;peptidase activity;cysteine-type endopeptidase activity;proteolysis;extracellular region;protein transport@NA
D050227@11652@11653@deletion@2@93730199@93730459@1@chr1:93730199-93730459@5.09@185@110@0.595@NA@CCDC18-001_27, RP4-717I23-001_11@0@0@0@:coiled-coil domain containing 18@:nucleotide binding@NA
D050227@12416@12425@deletion@10@104202984@104234233@1@chr1:104202984-104234233@16.6@114@23@0.202@CNVR266.3, CNVR266.1, CNVR266.15@AMY1A-001_7, AMY1A-001_8, AMY1A-001_9, AMY1A-001_10, AMY1A-001_11, AMY1B-001_7, AMY1B-001_8, AMY1B-001_9, AMY1B-001_10, AMY1B-001_11@123.8@109@154@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D050227@12445@12446@duplication@2@104297123@104297437@1@chr1:104297123-104297437@14.9@229@459@2@CNVR266.3, CNVR266.5@AMY1C-201_7, AMY1C-201_8@77@75@79@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D050227@12929@12936@deletion@8@110230474@110236368@1@chr1:110230474-110236368@73.2@350@1@0.00286@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1-001_1, GSTM1-001_2, GSTM1-001_3, GSTM1-001_4, GSTM1-001_5, GSTM1-001_6, GSTM1-001_7, GSTM1-001_8@191.375@187@194@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
D050227@13716@13721@deletion@6@115469124@115520238@1@chr1:115469124-115520238@7.55@296@185@0.625@CNVR306.1@SYCP1-001_23, SYCP1-001_24, SYCP1-001_25, SYCP1-001_26, SYCP1-001_27, SYCP1-001_28@11.3333333333333@10@12@:synaptonemal complex protein 1@:regulation of protein localization;DNA binding;central element;synaptonemal complex assembly;protein binding;spermatogenesis;male germ cell nucleus;synaptonemal complex;transverse filament;reciprocal meiotic recombination;cell division@NA
D050227@15397@15403@deletion@7@149036437@149047145@1@chr1:149036437-149047145@9.44@275@163@0.593@CNVR350.3, CNVR350.1@RP11-744H18-001_1, RP11-744H18-001_2, RP11-744H18-001_3, RP11-744H18-001_4, RP11-744H18-001_5, RP11-744H18-001_6, RP11-744H18-001_7@80.1428571428571@70@86@NA@NA@NA
D050227@15456@15462@deletion@7@149375000@149400543@1@chr1:149375000-149400543@12@462@287@0.621@CNVR350.1@FCGR1C-201_4, FCGR1C-201_5, FCGR1C-201_6, ENST00000415338_1, HIST2H3PS2-001_1, HIST2H3PS2-001_2, RP5-998N21-002_1@73.7142857142857@70@76@NA@NA@NA
D050227@18687@18691@duplication@5@161641184@161643864@1@chr1:161641184-161643864@6.92@251@369@1.47@CNVR383.1@FCGR2B-207_4, FCGR2B-207_5, FCGR2B-207_6, ENST00000453111_2, ENST00000453111_3@14.8@10@19@:Fc fragment of IgG, low affinity IIb, receptor (CD32)@:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
D050227@19248@19248@deletion@1@168513144@168513236@1@chr1:168513144-168513236@8.96@75@18@0.24@NA@XCL2-001_1@7@7@7@:chemokine (C motif) ligand 2@:blood circulation;chemotaxis;extracellular space;signal transduction;extracellular region;immune response;chemokine activity@NA
D050227@21362@21374@deletion@13@196743977@196801320@1@chr1:196743977-196801320@32.9@1364@829@0.608@CNVR459.1@CFHR3-001_1, CFHR3-001_2, CFHR3-001_3, CFHR3-001_4, CFHR3-001_5, CFHR3-001_6, CFHR1-001_1, CFHR1-001_2, CFHR1-001_3, CFHR1-001_4, CFHR1-001_5, CFHR1-001_6, CFHR2-201_1@96.7692307692308@85@119@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
D050227@24160@24161@deletion@2@223727670@223727929@1@chr1:223727670-223727929@6.83@52@14@0.269@NA@CAPN8-202_23, CAPN8-202_24@0@0@0@:calpain 8@:proteolysis;Golgi apparatus;intracellular;calcium-dependent cysteine-type endopeptidase activity;calcium ion binding@NA
D050227@25585@25585@deletion@1@236388372@236388440@1@chr1:236388372-236388440@8.91@209@93@0.445@NA@ERO1LB-001_13@0@0@0@:ERO1-like beta (S. cerevisiae)@:unfolded protein binding;oxidation-reduction process;endoplasmic reticulum;electron transport chain;flavin adenine dinucleotide binding;protein folding;oxidoreductase activity;protein thiol-disulfide exchange;endoplasmic reticulum membrane;oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor@NA
D050227@30047@30049@deletion@3@39552661@39553103@2@chr2:39552661-39553103@5.88@134@73@0.545@NA@MAP4K3-001_10, MAP4K3-001_11, MAP4K3-001_12@1@1@1@:mitogen-activated protein kinase kinase kinase kinase 3@:intracellular protein kinase cascade;protein serine/threonine kinase activity;protein tyrosine kinase activity;JNK cascade;small GTPase regulator activity;protein phosphorylation;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;response to stress;protein binding;kinase activity@NA
D050227@34094@34095@deletion@2@96458183@96458295@2@chr2:96458183-96458295@5.68@47@14@0.298@NA@AC008268-201_3, ENST00000444924_2@104@104@104@NA@NA@NA
D050227@34540@34541@deletion@2@97818243@97820479@2@chr2:97818243-97820479@6.4@181@101@0.558@CNVR886.2@ENST00000461153_14, ENST00000461153_15@13@12@14@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
D050227@35975@35975@deletion@1@112551657@112551709@2@chr2:112551657-112551709@5.98@64@22@0.344@CNVR928.1@ANAPC1-001_37@0@0@0@:anaphase-promoting complex subunit 1-like;anaphase promoting complex subunit 1@:nucleoplasm;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle;anaphase-promoting complex;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle spindle assembly checkpoint;cytosol;protein K11-linked ubiquitination;protein binding;mitosis;nucleus;cell cycle checkpoint;cell division;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle@NA
D050227@40177@40179@deletion@3@175244932@175245543@2@chr2:175244932-175245543@6.84@95@43@0.453@NA@CIR1-202_4, CIR1-202_5, CIR1-202_6@0@0@0@:corepressor interacting with RBPJ, 1@:histone deacetylase complex;nuclear speck;transcription corepressor activity;negative regulation of transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity;microtubule organizing center;protein binding;RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity;mRNA processing;RNA splicing;nucleus;zinc ion binding;nucleic acid binding@NA
D050227@40930@40932@deletion@3@180835230@180835804@2@chr2:180835230-180835804@5.39@365@239@0.655@NA@CWC22-001_9, CWC22-001_10, CWC22-001_11@4@4@4@:CWC22 spliceosome-associated protein homolog (S. cerevisiae)@:binding;DNA binding;RNA metabolic process;catalytic step 2 spliceosome;spliceosomal complex;cytoplasm;protein binding;RNA binding;mRNA splicing, via spliceosome;nucleus;regulation of mRNA splicing, via spliceosome@NA
D050227@45387@45390@deletion@4@233273213@233274159@2@chr2:233273213-233274159@9.37@142@67@0.472@NA@ALPPL2-001_7, ALPPL2-001_8, ALPPL2-001_9, ALPPL2-001_10@30@16@58@:alkaline phosphatase, placental-like 2@:phosphatase activity;catalytic activity;phosphorylation;plasma membrane;metabolic process;membrane;anchored to membrane;alkaline phosphatase activity;metal ion binding@NA
D050227@59086@59088@deletion@3@160249252@160253479@3@chr3:160249252-160253479@6.54@105@52@0.495@NA@KPNA4-001_4, KPNA4-001_5, KPNA4-001_6@1@1@1@:karyopherin alpha 4 (importin alpha 3)@:nucleoplasm;binding;cytoplasm;protein transporter activity;cytosol;NLS-bearing substrate import into nucleus;protein binding;nucleus;protein import into nucleus;cytokine-mediated signaling pathway@NA
D050227@60164@60165@deletion@2@182586868@182587120@3@chr3:182586868-182587120@5.62@72@31@0.431@NA@ATP11B-001_16, ATP11B-001_17@0@0@0@:ATPase, class VI, type 11B@:cation transport;binding;magnesium ion binding;ion transport;catalytic activity;recycling endosome;ATP binding;transmembrane transport;integral to membrane;plasma membrane;metabolic process;recycling endosome membrane;phospholipid-translocating ATPase activity;endoplasmic reticulum;nuclear inner membrane;ion transmembrane transporter activity;hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances;nucleotide binding;ion transmembrane transport;phospholipid transport;early endosome;protein binding;phospholipid translocation;aminophospholipid transport;membrane;ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism;metal ion binding@NA
D050227@63768@63769@deletion@2@26614793@26616076@4@chr4:26614793-26616076@4.95@53@21@0.396@NA@TBC1D19-001_2, TBC1D19-001_3@0@0@0@:TBC1 domain family, member 19@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
D050227@65315@65320@deletion@6@69402904@69434246@4@chr4:69402904-69434246@116@690@12@0.0174@CNVR1953.1@UGT2B17-001_1, UGT2B17-001_2, UGT2B17-001_3, UGT2B17-001_4, UGT2B17-001_5, UGT2B17-001_6@124.5@118@134@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
D050227@65799@65803@deletion@5@75312253@75320727@4@chr4:75312253-75320727@9.98@119@47@0.395@NA@AREG-001_2, AREG-001_3, AREG-001_4, AREG-001_5, AREG-001_6@43@28@55@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
D050227@69501@69502@deletion@2@156274066@156274493@4@chr4:156274066-156274493@6.55@117@57@0.487@NA@MAP9-001_11, MAP9-001_12@0@0@0@:microtubule-associated protein 9@:mitosis;Golgi apparatus;microtubule;nucleus;cell division;spindle;cytoplasm@NA
D050227@70820@70822@deletion@3@741711@748675@5@chr5:741711-748675@24.2@252@83@0.329@CNVR2280.3@ZDHHC11B-201_5, ZDHHC11B-201_6, ZDHHC11B-201_7@86.6666666666667@78@96@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
D050227@73727@73727@deletion@1@69717564@69717599@5@chr5:69717564-69717599@7.9@37@0@0@CNVR2494.17, CNVR2494.3@GTF2H2B-201_4@139@139@139@NA@NA@NA
D050227@73820@73820@deletion@1@70378606@70378820@5@chr5:70378606-70378820@5.17@23@0@0@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.8, CNVR2494.1, CNVR2494.37@AC044797-201_2@138@138@138@NA@NA@NA
D050227@78044@78045@deletion@2@147553799@147554962@5@chr5:147553799-147554962@19.6@118@14@0.119@CNVR2637.1@AC116334-001_3, AC116334-001_4@43.5@9@78@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
D050227@79567@79568@deletion@2@175388056@175388438@5@chr5:175388056-175388438@13.5@81@11@0.136@NA@THOC3-001_4, THOC3-001_5@173.5@165@182@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
D050227@80022@80024@deletion@3@177166603@177168334@5@chr5:177166603-177168334@12.5@68@7@0.103@NA@FAM153A-204_7, FAM153A-204_8, FAM153A-204_9@94@86@106@:family with sequence similarity 153, member A@NA@NA
D050227@82507@82508@duplication@2@29894957@29895377@6@chr6:29894957-29895377@5.36@120@190@1.58@CNVR2829.7, CNVR2829.2, CNVR2829.3@AL645929-201_4, HLA-K-001_3@42@42@42@NA@NA@NA
D050227@83910@83946@duplication@37@32441204@32634448@6@chr6:32441204-32634448@44.3@1761@2519@1.43@CNVR2845.21, CNVR2845.25@HLA-DRB9-001_1, HLA-DRB5-001_1, HLA-DRB5-001_2, HLA-DRB5-001_3, HLA-DRB5-001_4, HLA-DRB5-001_5, HLA-DRB5-001_6, HLA-DRB6-002_1, HLA-DRB6-002_2, HLA-DRB6-002_3, HLA-DRB6-002_4, HLA-DRB6-002_5, HLA-DRB6-002_6, AL713966-201_1, AL713966-201_2, AL713966-201_3, HLA-DRB1-001_1, HLA-DRB1-001_2, HLA-DRB1-001_3, HLA-DRB1-001_4, HLA-DRB1-001_5, HLA-DRB1-001_6, HLA-DQA1-002_1, HLA-DQA1-002_2, HLA-DQA1-002_3, HLA-DQA1-002_4, HLA-DQA1-002_5, HLA-DQA1-002_6, HLA-DQB1-003_2, HLA-DQB1-003_3, HLA-DQB1-003_4, HLA-DQB1-003_5, HLA-DQB1-003_6, XXbac-BPG254F23-001_1, XXbac-BPG254F23-001_2, ENST00000443574_1, ENST00000443574_2@122.918918918919@44@189@:major histocompatibility complex, class II, DR beta 5:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
D050227@84706@84710@duplication@5@35754777@35765089@6@chr6:35754777-35765089@17.3@731@1093@1.5@CNVR2861.1@C6orf127-001_2, C6orf127-001_3, CLPS-001_1, CLPS-001_2, CLPS-001_3@39@30@43@:colipase-like 1:colipase, pancreatic@:extracellular region;enzyme activator activity;digestion;lipid catabolic process:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
D050227@87382@87383@deletion@2@70962963@70963133@6@chr6:70962963-70963133@5.69@164@92@0.561@NA@COL9A1-204_26, COL9A1-204_27@0@0@0@:collagen, type IX, alpha 1@:collagen type IX;extracellular matrix organization;endoplasmic reticulum lumen;axon guidance;tissue homeostasis;extracellular region;extracellular matrix structural constituent conferring tensile strength;growth plate cartilage development;organ morphogenesis;cartilage development;metal ion binding;chondrocyte differentiation@: STICKLER SYNDROME, TYPE IV; STL4; EPIPHYSEAL DYSPLASIA, MULTIPLE, 6; EDM6
D050227@91550@91555@deletion@6@146012076@146056635@6@chr6:146012076-146056635@8.02@202@116@0.574@NA@EPM2A-201_1, EPM2A-201_2, EPM2A-201_3, EPM2A-201_4, EPM2A-201_5, EPM2A-201_6@0@0@0@:epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)@:carbohydrate binding;glycogen metabolic process;protein dephosphorylation;protein tyrosine/serine/threonine phosphatase activity;plasma membrane;nucleus;polysome;peptidyl-tyrosine dephosphorylation;phosphatase activity;endoplasmic reticulum;protein tyrosine phosphatase activity;protein serine/threonine phosphatase activity;behavior;cytoplasm;cytosol;protein binding;starch binding;dephosphorylation;nervous system development@: MYOCLONIC EPILEPSY OF LAFORA
D050227@94171@94171@deletion@1@5886399@5887233@7@chr7:5886399-5887233@13.3@100@17@0.17@CNVR3268.1@ZNF815-201_5@5@5@5@NA@NA@NA
D050227@94183@94209@duplication@27@5941290@6000496@7@chr7:5941290-6000496@55.6@1890@2930@1.55@NA@C7orf28A-001_5, C7orf28A-001_6, C7orf28A-001_7, C7orf28A-001_8, C7orf28A-001_9, C7orf28A-001_10, C7orf28A-001_11, C7orf28A-001_12, C7orf28A-001_13, C7orf28A-001_14, C7orf28A-001_15, RSPH10B-002_6, RSPH10B-002_7, RSPH10B-002_8, RSPH10B-002_9, RSPH10B-002_10, RSPH10B-002_11, RSPH10B-002_12, RSPH10B-002_13, RSPH10B-002_14, RSPH10B-002_15, RSPH10B-002_16, RSPH10B-002_17, RSPH10B-002_18, RSPH10B-002_19, RSPH10B-002_20, RSPH10B-002_21@24.5925925925926@8@73@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae):radial spoke head 10 homolog B (Chlamydomonas)@:lysosomal membrane@NA
D050227@94422@94452@deletion@31@6799859@6863798@7@chr7:6799859-6863798@120@1584@647@0.408@NA@RSPH10B2-204_5, RSPH10B2-204_6, RSPH10B2-204_7, RSPH10B2-204_8, RSPH10B2-204_9, RSPH10B2-204_10, RSPH10B2-204_11, RSPH10B2-204_12, RSPH10B2-204_13, RSPH10B2-204_14, RSPH10B2-204_15, RSPH10B2-204_16, RSPH10B2-204_17, RSPH10B2-204_18, RSPH10B2-204_19, RSPH10B2-204_20, RSPH10B2-204_21, ENST00000429267_1, ENST00000429267_2, C7orf28B-001_4, C7orf28B-001_5, C7orf28B-001_6, C7orf28B-001_7, C7orf28B-001_8, C7orf28B-001_9, C7orf28B-001_10, C7orf28B-001_11, C7orf28B-001_12, C7orf28B-001_13, C7orf28B-001_14, C7orf28B-001_15@38.4516129032258@7@121@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D050227@96579@96584@deletion@6@38388958@38398764@7@chr7:38388958-38398764@96.5@1174@409@0.348@CNVR3354.3, CNVR3354.1@TRGV5-001_1, TRGV5-001_2, TRGV4-001_1, TRGV4-001_2, TRGV3-001_1, TRGV3-001_2@10.5@6@14@@:protein binding:protein binding:protein binding;immune response;peptide antigen binding;plasma membrane;MHC protein binding@NA
D050227@97907@97915@deletion@9@57063663@57076857@7@chr7:57063663-57076857@7.4@72@27@0.375@NA@TNRC18C-202_3, TNRC18C-202_4, TNRC18C-202_5, TNRC18C-202_6, TNRC18C-202_7, TNRC18C-202_8, TNRC18C-202_9, TNRC18C-202_10, TNRC18C-202_11@157.555555555556@139@166@NA@NA@NA
D050227@97990@97994@deletion@5@62753052@62758771@7@chr7:62753052-62758771@87.2@537@27@0.0503@NA@AC006455-201_2, AC006455-201_3, AC006455-201_4, ENST00000444809_2, ENST00000444809_3, ENST00000444809_4@137@97@171@NA@NA@NA
D050227@98172@98174@deletion@3@64533821@64534227@7@chr7:64533821-64534227@6.29@34@4@0.118@NA@RP11-460N20-001_11, RP11-460N20-001_12, ENST00000501153_3@100.666666666667@100@101@NA@NA@NA
D050227@99142@99142@deletion@1@74608620@74608703@7@chr7:74608620-74608703@11.6@65@5@0.0769@NA@GTF2IP1-001_17@12@12@12@NA@NA@NA
D050227@99233@99233@deletion@1@74991244@74991359@7@chr7:74991244-74991359@5.66@26@0@0@CNVR3456.1@STAG3L1-004_3@60@60@60@NA@NA@NA
D050227@99454@99454@deletion@1@76063357@76063473@7@chr7:76063357-76063473@8.3@66@15@0.227@CNVR3462.1@ZP3-002_6@10@10@10@:zona pellucida glycoprotein 3 (sperm receptor)@:negative regulation of transcription, DNA-dependent;manganese ion transmembrane transporter activity;intracellular protein transport;proteinaceous extracellular matrix;plasma membrane;positive regulation of acrosome reaction;outer acrosomal membrane;protein kinase C signaling cascade;manganese ion transmembrane transport;intracellular signal transduction;humoral immune response mediated by circulating immunoglobulin;negative regulation of binding of sperm to zona pellucida;positive regulation of inflammatory response;endoplasmic reticulum;signal transducer activity;perinuclear region of cytoplasm;secretory granule;positive regulation of transcription, DNA-dependent;positive regulation of ovarian follicle development;positive regulation of interferon-gamma production;carbohydrate binding;manganese ion transport;positive regulation of antral ovarian follicle growth;extracellular matrix;positive regulation of leukocyte migration;positive regulation of humoral immune response;extracellular space;blastocyst formation;integral to membrane;store-operated calcium channel activity;oocyte development;multivesicular body;phosphatidylinositol-mediated signaling;acrosomal vesicle;positive regulation of protein kinase B signaling cascade;Golgi apparatus;positive regulation of calcium ion import;positive regulation of protein kinase activity;positive regulation of acrosomal vesicle exocytosis;positive regulation of interleukin-4 production;cytoplasm;protein binding;binding of sperm to zona pellucida;positive regulation of phosphatidylinositol biosynthetic process;extracellular region;positive regulation of T cell proliferation;acrosin binding;positive regulation of type IV hypersensitivity;egg coat formation@NA
D050227@99489@99490@deletion@2@76240773@76241131@7@chr7:76240773-76241131@18.2@188@63@0.335@CNVR3463.10@POMZP3-003_6, POMZP3-003_7@43.5@41@46@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
D050227@99544@99545@duplication@2@76723321@76728269@7@chr7:76723321-76728269@7.62@74@156@2.11@NA@ENST00000398321_6, ENST00000398321_7@13.5@11@16@NA@NA@NA
D050227@102166@102166@deletion@1@102219874@102220244@7@chr7:102219874-102220244@5.38@24@0@0@CNVR3518.1@ENST00000379336_1, RASA4-001_21@63@63@63@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
D050227@103919@103919@duplication@1@128128157@128128216@7@chr7:128128157-128128216@5.59@44@99@2.25@NA@METTL2B-001_5@0@0@0@:methyltransferase like 2B@:methyltransferase activity;metabolic process@NA
D050227@105321@105338@deletion@18@141765517@141786518@7@chr7:141765517-141786518@25.4@1606@1065@0.663@CNVR3585.3, CNVR3585.2@MGAM-007_40, MGAM-007_41, MGAM-007_42, MGAM-007_43, MGAM-007_44, MGAM-007_45, MGAM-007_46, MGAM-007_47, MGAM-007_48, MGAM-007_49, MGAM-007_50, MGAM-007_51, MGAM-007_52, MGAM-007_53, MGAM-007_54, MGAM-007_55, MGAM-007_56, MGAM-007_57@120.722222222222@101@134@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
D050227@107425@107435@deletion@11@7274294@7343923@8@chr8:7274294-7343923@8.76@577@393@0.681@CNVR3771.8, CNVR3771.10, CNVR3771.4@DEFB4P-001_1, DEFB103A-001_1, DEFB103A-001_2, SPAG11-003_1, SPAG11-003_2, SPAG11-003_3, SPAG11-003_4, DEFB104B-001_1, DEFB104B-001_2, DEFB106B-001_1, DEFB106B-001_2@38.3636363636364@7@91@:defensin, beta 4B;defensin, beta 4A:defensin, beta 103B;defensin, beta 103A:sperm associated antigen 11B:defensin, beta 104A;defensin, beta 104B:defensin, beta 106B;defensin, beta 106A@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
D050227@107910@107911@deletion@2@17137750@17137953@8@chr8:17137750-17137953@5.53@79@36@0.456@NA@VPS37A-001_8, VPS37A-001_9@6@6@6@:vacuolar protein sorting 37 homolog A (S. cerevisiae)@:intracellular membrane-bounded organelle;egress of virus within host cell;late endosome membrane;centrosome;endosomal transport;cytoplasm;endosome membrane;cellular membrane organization;cell death;protein transport;viral reproduction;nucleus@NA
D050227@116854@116857@deletion@4@35662945@35664490@9@chr9:35662945-35664490@9.12@244@138@0.566@NA@C9orf100-004_4, C9orf100-004_5, C9orf100-004_6, C9orf100-004_7@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 39@:positive regulation of cell migration;phospholipid binding;protein binding;plasma membrane;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity@NA
D050227@116952@116954@duplication@3@35738751@35739417@9@chr9:35738751-35739417@5.71@384@534@1.39@NA@GBA2-003_10, GBA2-003_11, GBA2-003_12@0@0@0@:glucosidase, beta (bile acid) 2@:phospholipid metabolic process;small molecule metabolic process;catalytic activity;sphingolipid metabolic process;bile acid metabolic process;glucosylceramide catabolic process;beta-glucosidase activity;integral to membrane;plasma membrane;glycosphingolipid metabolic process;glucosylceramidase activity;smooth endoplasmic reticulum;membrane;glycoside catabolic process@NA
D050227@124047@124050@deletion@4@135957928@135960030@9@chr9:135957928-135960030@10.3@47@0@0@NA@CELP-002_1, CELP-002_2, AL162417-201_1, AL162417-201_2@82.5@66@99@NA@NA@NA
D050227@126906@126921@deletion@16@17813310@17908771@10@chr10:17813310-17908771@17.4@519@315@0.607@NA@FAM23A-201_2, FAM23A-201_3, FAM23A-201_4, FAM23A-201_5, MRC1L1-001_1, MRC1L1-001_2, MRC1L1-001_3, MRC1L1-001_4, MRC1L1-001_5, MRC1L1-001_6, MRC1L1-001_7, MRC1L1-001_8, MRC1L1-001_9, MRC1L1-001_10, MRC1L1-001_11, MRC1L1-001_12@16.375@4@108@:transmembrane protein 236;transmembrane protein 236-like:macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding@NA
D050227@126949@126956@duplication@8@18129624@18152612@10@chr10:18129624-18152612@8.35@125@211@1.69@NA@MRC1-001_5, MRC1-001_6, MRC1-001_7, MRC1-001_8, MRC1-001_9, MRC1-001_10, MRC1-001_11, RP11-457D2-001_2@19.75@16@26@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D050227@128415@128421@duplication@7@43206241@43232608@10@chr10:43206241-43232608@14@716@1012@1.41@NA@ENST00000412710_1, ENST00000412710_2, ENST00000412710_3, ENST00000453416_1, ENST00000453416_2, ENST00000453416_3, ENST00000453416_4@0@0@0@NA@NA@NA
D050227@128828@128829@duplication@2@46927785@46934899@10@chr10:46927785-46934899@8.69@47@126@2.68@CNVR4712.9, CNVR4712.2, CNVR4712.7@FAM35B-001_6, FAM35B-001_7@53@34@72@NA@NA@NA
D050227@128897@128913@deletion@17@47253597@47410082@10@chr10:47253597-47410082@28.2@205@52@0.254@CNVR4712.9, CNVR4712.1@GLUDP8-001_1, GLUDP8-001_2, GLUDP8-001_3, RP11-144G6-201_1, RP11-144G6-201_2, CTSLL7-001_1, CTSLL7-001_2, CTSLL7-001_3, ENST00000439776_1, ENST00000439776_2, ENST00000439776_3, FAM35B2-201_1, FAM35B2-201_2, FAM35B2-201_3, FAM35B2-201_4, FAM35B2-201_5, FAM35B2-201_6@23.6470588235294@8@47@NA@NA@NA
D050227@128920@128937@duplication@18@47605129@47644792@10@chr10:47605129-47644792@28.3@531@862@1.62@CNVR4713.1@ENST00000423803_1, ENST00000423803_2, ENST00000423803_3, ENST00000423803_4, ENST00000423803_5, ENST00000423803_6, ENST00000423803_7, ENST00000423803_8, ENST00000423803_9, ENST00000423803_10, ENST00000423803_11, ENST00000423803_12, ENST00000423803_13, ENST00000423803_14, ENST00000454837_1, ENST00000454837_2, ENST00000454837_3, ENST00000454837_4@23.2777777777778@20@28@NA@NA@NA
D050227@129040@129040@duplication@1@48175680@48175811@10@chr10:48175680-48175811@5.24@5@41@8.2@CNVR4716.1, CNVR4716.14@GLUDP6-001_1@125@125@125@NA@NA@NA
D050227@129460@129461@deletion@2@51361725@51361911@10@chr10:51361725-51361911@8.19@37@0@0@NA@ENST00000404618_4, ENST00000432221_4@122@121@123@NA@NA@NA
D050227@131567@131567@deletion@1@81284748@81284806@10@chr10:81284748-81284806@11.4@64@5@0.0781@NA@BX248123-201_2@2@2@2@NA@NA@NA
D050227@135726@135731@deletion@6@124348462@124354045@10@chr10:124348462-124354045@15.7@521@300@0.576@CNVR4912.4, CNVR4912.3, CNVR4912.2@DMBT1-002_17, DMBT1-002_18, DMBT1-002_19, DMBT1-002_20, DMBT1-002_21, DMBT1-002_22@43@7@51@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
D050227@136769@136779@deletion@11@135437401@135473971@10@chr10:135437401-135473971@10.6@544@346@0.636@CNVR4989.11, CNVR4989.4, CNVR4989.13@FRG2B-202_1, FRG2B-202_2, FRG2B-202_3, FRG2B-202_4, XX-2136C77-001_2, XX-2136C77-001_3, XX-2136C77-001_4, XX-2136C77-001_5, XX-2136C77-001_6, XX-2136C77-001_7, XX-2136C77-001_8@6.45454545454545@1@29@:FSHD region gene 2 family, member B@:nucleus@NA
D050227@145877@145877@deletion@1@89407257@89407338@11@chr11:89407257-89407338@6.18@159@79@0.497@NA@FOLH1B-201_6@0@0@0@NA@NA@NA
D050227@150775@150777@deletion@3@9446260@9447571@12@chr12:9446260-9447571@6.93@150@80@0.533@NA@DDX11L8-201_2, DDX11L8-201_3, DDX11L8-201_4@25.6666666666667@17@42@NA@NA@NA
D050227@150829@150841@deletion@13@9684189@9707352@12@chr12:9684189-9707352@109@607@45@0.0741@CNVR5429.1@AC006432-201_1, AC006432-201_2, AC006432-201_3, AC006432-201_4, AC006432-201_5, AC006432-201_6, AC006432-201_7, AC006432-201_8, AC006432-201_9, AC006432-201_10, AC006432-201_11, AC006432-201_12, AC006432-201_13@22.2307692307692@15@25@NA@NA@NA
D050227@152242@152249@duplication@8@31265928@31280660@12@chr12:31265928-31280660@14.3@737@1045@1.42@CNVR5483.1@ENST00000266524_25, ENST00000266524_26, ENST00000266524_27, ENST00000266524_28, ENST00000266524_29, ENST00000266524_30, ENST00000266524_31, ENST00000266524_32@2.375@1@6@NA@NA@NA
D050227@152257@152273@duplication@17@31288890@31359089@12@chr12:31288890-31359089@14.3@2169@2815@1.3@CNVR5483.1@ENST00000266524_1, ENST00000266524_2, ENST00000266524_3, ENST00000266524_4, ENST00000266524_5, ENST00000266524_6, ENST00000266524_7, ENST00000266524_8, ENST00000266524_9, ENST00000266524_10, ENST00000266524_11, ENST00000266524_12, ENST00000266524_13, ENST00000266524_14, ENST00000266524_15, ENST00000266524_16, ENST00000266524_17@0.941176470588235@0@1@NA@NA@NA
D050227@158323@158325@deletion@3@105370529@105371806@12@chr12:105370529-105371806@19.3@368@158@0.429@CNVR5653.1@AC090051-201_1, AC090051-201_2, AC090051-201_3@22@22@22@NA@NA@NA
D050227@162127@162128@deletion@2@24465240@24465671@13@chr13:24465240-24465671@13.9@659@355@0.539@NA@RP11-45B20-002_6, ENST00000382133_3@29@29@29@:C1q and tumor necrosis factor related protein 9B@:collagen;protein binding@NA
D050227@162131@162131@deletion@1@24468280@24468341@13@chr13:24468280-24468341@7.34@120@50@0.417@NA@RP11-45B20-002_4@36@36@36@:C1q and tumor necrosis factor related protein 9B@:collagen;protein binding@NA
D050227@162215@162216@deletion@2@25144700@25144871@13@chr13:25144700-25144871@11.6@107@32@0.299@NA@ENST00000455130_2, ENST00000453498_4@10@10@10@NA@NA@NA
D050227@173508@173514@deletion@7@106539081@106573538@14@chr14:106539081-106573538@106@735@109@0.148@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8-001_1, IGHV1-8-001_2, IGHV3-9-001_1, IGHV3-9-001_2, IGHV2-10-001_1, IGHV2-10-001_2, IGHV3-11-001_2@20.4285714285714@9@24@@:protein binding:protein binding:protein binding@NA
D050227@173535@173542@deletion@8@106714778@106725734@14@chr14:106714778-106725734@22.2@937@511@0.545@CNVR6294.48, CNVR6294.24, CNVR6294.40, CNVR6294.38, CNVR6294.17, CNVR6294.23@IGHV3-22-001_1, AB019439-201_1, AB019439-201_2, IGHVIII-22-2-201_1, IGHVIII-22-2-201_2, IGHVIII-22-2-201_3, IGHV3-23-001_1, IGHV3-23-001_2@6.25@3@8@@:protein binding@NA
D050227@173556@173567@duplication@12@106787370@106816254@14@chr14:106787370-106816254@42.5@995@1746@1.75@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-29-001_1, IGHV3-29-001_2, IGHV3-30-001_1, IGHV3-30-001_2, IGHV3-30-2-001_1, IGHV3-30-2-001_2, IGHV4-31-001_1, IGHV4-31-001_2, IGHV3-32-001_1, IGHV3-32-001_2, IGHV3-33-001_1, IGHV3-33-001_2@15.3333333333333@5@19@@:protein binding:protein binding:protein binding@NA
D050227@173635@173638@deletion@4@107095128@107099589@14@chr14:107095128-107099589@12.3@284@154@0.542@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61-001_1, IGHV4-61-001_2, IGHV3-62-001_1, IGHV3-62-001_2@16@15@17@@:protein binding@NA
D050227@173686@173686@duplication@1@20453920@20454038@15@chr15:20453920-20454038@5.15@81@147@1.81@CNVR6295.15, CNVR6295.7, CNVR6295.13, CNVR6295.26@ENST00000400226_11@70@70@70@NA@NA@NA
D050227@173705@173708@duplication@4@20643847@20644377@15@chr15:20643847-20644377@7.76@154@246@1.6@CNVR6295.15@HERC2P3-014_22, HERC2P3-014_23, AC026495-201_21, AC026495-201_22@111.5@111@112@NA@NA@NA
D050227@174407@174410@duplication@4@29008808@29009297@15@chr15:29008808-29009297@7.65@395@562@1.42@NA@ENST00000456510_1, ENST00000456510_2, ENST00000456510_3, ENST00000456510_4@23@18@25@NA@NA@NA
D050227@174503@174507@deletion@5@30653445@30665349@15@chr15:30653445-30665349@14.6@292@147@0.503@CNVR6337.1@CHRFAM7A-202_6, CHRFAM7A-202_7, CHRFAM7A-202_8, CHRFAM7A-202_9, CHRFAM7A-202_10@51@44@68@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
D050227@174659@174659@duplication@1@32449811@32449977@15@chr15:32449811-32449977@5@51@103@2.02@CNVR6345.2, CNVR6345.1@CHRNA7-205_6@66@66@66@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
D050227@176945@176947@deletion@3@48623715@48623993@15@chr15:48623715-48623993@6.37@134@72@0.537@NA@AC023355-201_1, DUT-201_1, DUT-201_2, DUT-201_3@0.666666666666667@0@1@:deoxyuridine triphosphatase@:nucleoplasm;hydrolase activity;mitochondrion;nucleobase-containing small molecule metabolic process;small molecule metabolic process;nucleobase-containing compound metabolic process;dUTP metabolic process;pyrimidine nucleobase metabolic process;protein binding;nucleus;dUMP biosynthetic process;DNA replication;pyrimidine nucleoside biosynthetic process;dUTP diphosphatase activity@NA
D050227@182604@182607@deletion@4@1278656@1279739@16@chr16:1278656-1279739@6.28@84@38@0.452@CNVR6591.1@TPSB2-002_3, TPSB2-002_4, TPSB2-002_5, TPSB2-002_6@68.75@46@102@:tryptase beta 2 (gene/pseudogene)@:proteolysis;catalytic activity;serine-type endopeptidase activity@NA
D050227@183384@183384@deletion@1@2692232@2693298@16@chr16:2692232-2693298@14@70@1@0.0143@CNVR6602.2@AC141586-201_1@50@50@50@NA@NA@NA
D050227@187506@187538@deletion@33@32858960@33020964@16@chr16:32858960-33020964@90.6@1220@466@0.382@CNVR6702.1@IGHV2OR16-5-001_1, IGHV2OR16-5-001_2, AC138915-201_1, AC138915-201_2, AC138915-201_3, AC138915-201_4, AC138915-201_5, AC138915-201_6, AC138915-201_7, AC138915-201_8, AC138915-201_9, AC138915-201_10, AC138915-201_11, AC138915-201_12, AC138915-201_13, AC138915-201_14, AC142086-201_1, AC142086-201_2, ENST00000423205_1, ENST00000423205_2, ENST00000423205_3, ENST00000423205_4, ENST00000423205_5, ENST00000423205_6, ENST00000423205_7, ENST00000423205_8, ENST00000423205_9, ENST00000423205_10, ENST00000423205_11, ENST00000423205_12, ENST00000423205_13, AC145350-201_1, AC145350-201_2@23.5151515151515@2@36@NA@NA@NA
D050227@187546@187548@deletion@3@33629704@33630421@16@chr16:33629704-33630421@9.51@753@483@0.641@CNVR6703.17, CNVR6703.1, CNVR6703.6, CNVR6703.21@AC136428-201_1, AC136428-201_2, AC136428-201_3@22.3333333333333@18@29@NA@NA@NA
D050227@190517@190518@duplication@2@74366308@74368885@16@chr16:74366308-74368885@5.8@359@522@1.45@CNVR6778.2, CNVR6778.1@AC009053-202_14, AC009053-202_15@15.5@15@16@NA@NA@NA
D050227@195009@195012@duplication@4@15508539@15510998@17@chr17:15508539-15510998@8.14@333@472@1.42@NA@CDRT1-201_6, CDRT1-201_7, TRIM16-202_15, TRIM16-202_16@12.5@5@20@:CMT1A duplicated region transcript 1@:protein binding;molecular_function;cellular_component;biological_process:protein binding;intracellular;zinc ion binding;cytoplasm@NA
D050227@195229@195258@deletion@30@16664741@16734608@17@chr17:16664741-16734608@36.1@2108@1341@0.636@NA@CCDC144A-202_13, CCDC144A-202_14, CCDC144A-202_15, CCDC144A-202_16, CCDC144A-202_17, CCDC144A-202_18, AC022596-003_1, AC022596-003_2, AC022596-003_3, AC022596-003_4, AC022596-003_5, AC022596-003_6, AC022596-003_7, AC022596-003_8, AC022596-003_9, AC022596-003_10, AC022596-003_11, AC022596-001_1, AC022596-001_2, AC022596-001_3, AC022596-001_4, AC022596-001_5, AC022596-001_6, AC022596-001_7, AC022596-001_8, ENST00000414673_4, ENST00000414673_5, ENST00000414673_6, ENST00000414673_7, ENST00000414673_8@76.6666666666667@45@97@:coiled-coil domain containing 144A@NA@NA
D050227@195703@195747@duplication@45@18344490@18457581@17@chr17:18344490-18457581@105@1126@2317@2.06@NA@ENST00000399124_3, ENST00000399124_4, ENST00000399124_5, ENST00000399124_6, ENST00000399124_7, ENST00000399124_8, ENST00000411877_4, LGALS9C-201_1, LGALS9C-201_2, LGALS9C-201_3, LGALS9C-201_4, LGALS9C-201_5, LGALS9C-201_6, LGALS9C-201_7, LGALS9C-201_8, LGALS9C-201_9, LGALS9C-201_10, LGALS9C-201_11, ENST00000426269_1, ENST00000426269_2, ENST00000426269_3, ENST00000426269_4, ENST00000426269_5, AC107983-001_1, AC107983-001_2, AC107983-001_3, AC107983-001_4, AC107983-001_5, AC107983-001_6, AC107983-001_7, AC107983-001_8, AC107983-001_9, AC107983-001_10, ENST00000456184_1, ENST00000456184_2, CCDC144B-201_14, CCDC144B-201_15, CCDC144B-201_16, CCDC144B-201_17, CCDC144B-201_18, ENST00000447265_11, ENST00000447265_12, ENST00000447265_13, ENST00000447265_14, ENST00000447265_15@130.2@79@153@:lectin, galactoside-binding, soluble, 9C:protein FAM106B-like@:carbohydrate binding@NA
D050227@195757@195759@deletion@3@18498037@18498176@17@chr17:18498037-18498176@5.58@184@110@0.598@NA@CCDC144B-201_8, CCDC144B-201_9, ENST00000447265_5@1@1@1@NA@NA@NA
D050227@196147@196154@duplication@8@20348266@20356381@17@chr17:20348266-20356381@10.6@175@296@1.69@CNVR7021.1, CNVR7021.3@ENST00000458685_5, ENST00000411468_5, ENST00000411468_6, LGALS9B-201_7, LGALS9B-201_8, LGALS9B-201_9, LGALS9B-201_10, LGALS9B-201_11@68.875@27@103@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
D050227@197259@197259@deletion@1@30300167@30300251@17@chr17:30300167-30300251@4.96@68@28@0.412@NA@SUZ12-001_6@1@1@1@:suppressor of zeste 12 homolog (Drosophila)@:sex chromatin;sequence-specific DNA binding;ESC/E(Z) complex;positive regulation of cell proliferation;nucleus;methylated histone residue binding;histone ubiquitination;negative regulation of cell differentiation;intracellular;protein binding;chromatin binding;histone methyltransferase activity;negative regulation of transcription from RNA polymerase II promoter;histone methylation;transcription, DNA-dependent;zinc ion binding@NA
D050227@197726@197728@duplication@3@34539180@34539966@17@chr17:34539180-34539966@6.53@49@110@2.24@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1-202_2, CCL4L1-202_3, CCL4L1-202_4@118@113@122@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
D050227@198032@198041@deletion@10@36351805@36375178@17@chr17:36351805-36375178@70.5@3991@2150@0.539@CNVR7083.3@AC183087-202_5, AC183087-202_6, AC183087-202_7, AC183087-202_8, AC183087-202_9, AC183087-202_10, AC183087-202_11, AC183087-202_12, AC183087-202_13, AC183087-202_14@55.3@42@64@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
D050227@200322@200362@deletion@41@44270942@44632791@17@chr17:44270942-44632791@66.8@2274@1210@0.532@CNVR7114.2, CNVR7114.1@AC217773-201_1, AC217773-201_2, ENST00000451529_1, ENST00000451529_3, ENST00000451529_5, LRRC37A-001_1, LRRC37A-001_2, LRRC37A-001_3, LRRC37A-001_4, LRRC37A-001_5, LRRC37A-001_6, LRRC37A-001_7, LRRC37A-001_8, LRRC37A-001_9, LRRC37A-001_10, LRRC37A-001_11, LRRC37A-001_12, LRRC37A-001_13, LRRC37A-001_14, LRRC37A-001_15, AC005829-202_1, AC005829-202_2, AC005829-202_3, AC005829-202_4, AC005829-202_5, LRRC37A2-201_1, LRRC37A2-201_2, LRRC37A2-201_3, LRRC37A2-201_4, LRRC37A2-201_5, LRRC37A2-201_6, LRRC37A2-201_7, LRRC37A2-201_8, LRRC37A2-201_9, LRRC37A2-201_10, LRRC37A2-201_11, LRRC37A2-201_12, LRRC37A2-201_13, ARL17P1-202_5@106.769230769231@46@196@:KAT8 regulatory NSL complex subunit 1:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:histone acetyltransferase activity (H4-K8 specific);histone acetyltransferase activity (H4-K16 specific);histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase complex;histone H4-K5 acetylation;MLL1 complex;histone H4-K16 acetylation;protein binding;histone H4-K8 acetylation;nucleus:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
D050227@203197@203198@deletion@2@67244405@67246126@17@chr17:67244405-67246126@5.93@89@42@0.472@NA@ABCA5-203_37, ABCA5-203_38@3@3@3@:ATP-binding cassette, sub-family A (ABC1), member 5@:late endosome;late endosome membrane;Golgi membrane;ATP binding;integral to membrane;GTP binding;ATPase activity;reverse cholesterol transport;negative regulation of macrophage derived foam cell differentiation;lysosome;cholesterol efflux;Golgi apparatus;nucleoside-triphosphatase activity;GTPase activity;lysosomal membrane;nucleotide binding;high-density lipoprotein particle remodeling@NA
D050227@213493@213494@deletion@2@14508472@14508748@19@chr19:14508472-14508748@7.32@65@20@0.308@NA@CD97-205_8, CD97-205_9@10.5@7@14@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
D050227@215928@215928@duplication@1@35862253@35863856@19@chr19:35862253-35863856@5.22@137@226@1.65@CNVR7627.1@FFAR3-001_2@102@102@102@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
D050227@217293@217297@duplication@5@40373947@40382827@19@chr19:40373947-40382827@12.7@271@436@1.61@CNVR7639.2@FCGBP-201_22, FCGBP-201_23, FCGBP-201_24, FCGBP-201_25, FCGBP-201_26@130.8@105@155@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D050227@217301@217306@deletion@6@40389654@40399856@19@chr19:40389654-40399856@30.8@229@58@0.253@CNVR7639.2, CNVR7639.3@FCGBP-201_13, FCGBP-201_14, FCGBP-201_15, FCGBP-201_16, FCGBP-201_17, FCGBP-201_18@112.333333333333@103@127@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D050227@221178@221180@deletion@3@54744152@54745755@19@chr19:54744152-54745755@8.15@415@258@0.622@CNVR7721.3, CNVR7721.6@LILRA6-002_4, LILRA6-002_5, LILRA6-002_6@55.3333333333333@50@62@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D050227@221218@221223@deletion@6@54801929@54804222@19@chr19:54801929-54804222@12.5@719@457@0.636@CNVR7722.1@LILRA3-003_5, LILRA3-003_6, LILRA3-003_7, LILRA3-003_8, LILRA3-003_9, LILRA3-003_10@108.5@107@109@:leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3@:antigen binding;signal transduction;protein binding;extracellular region;plasma membrane;receptor activity;defense response@NA
D050227@221399@221412@duplication@14@55270062@55286911@19@chr19:55270062-55286911@21.7@1585@2177@1.37@CNVR7725.2, CNVR7725.1@KIR2DL3-201_5, KIR2DL3-201_6, KIR2DL3-201_7, KIR2DL3-201_8, KIR2DP1-001_4, KIR2DP1-001_5, KIR2DP1-001_6, KIR2DP1-001_7, KIR2DP1-001_8, KIR2DP1-001_9, KIR2DL1-002_1, KIR2DL1-002_2, KIR2DL1-002_3, KIR2DL1-002_4@113.857142857143@98@126@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
D050227@221418@221434@duplication@17@55297917@55344254@19@chr19:55297917-55344254@18.7@2436@3210@1.32@CNVR7725.1, CNVR7725.3@KIR2DL4-001_1, KIR2DL4-001_2, KIR2DL4-001_3, KIR2DL4-001_4, KIR2DL4-001_5, KIR2DL4-001_6, KIR2DL4-001_7, KIR2DL4-001_8, KIR3DP1-001_1, KIR3DP1-001_2, KIR3DP1-001_3, KIR3DL1-201_1, KIR3DL1-201_2, KIR3DL1-201_3, KIR3DL1-201_4, KIR3DL1-201_5, KIR2DS4-001_1@24.9411764705882@22@38@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
D050227@221436@221437@deletion@2@55349033@55351155@19@chr19:55349033-55351155@8.74@218@113@0.518@CNVR7725.1, CNVR7725.6@KIR2DS4-001_3, KIR2DS4-001_4@67.5@67@68@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
D050227@221439@221441@duplication@3@55358641@55360024@19@chr19:55358641-55360024@16.1@999@1574@1.58@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4-001_6, KIR2DS4-001_7, KIR2DS4-001_8@96.3333333333333@85@102@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
D050227@221489@221490@duplication@2@55496417@55497684@19@chr19:55496417-55497684@4.95@184@271@1.47@NA@NLRP2-204_7, NLRP2-204_8@2@2@2@:NLR family, pyrin domain containing 2@:protein binding;Pyrin domain binding;positive regulation of interleukin-1 beta secretion;ATP binding;cytoplasm;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process@NA
D050227@221822@221824@duplication@3@56280509@56284546@19@chr19:56280509-56284546@15.8@722@1165@1.61@CNVR7734.1@ENST00000341750_1, ENST00000341750_2, ENST00000341750_3@37.6666666666667@30@47@:ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
D050227@222562@222562@deletion@1@1558986@1559341@20@chr20:1558986-1559341@7.42@248@125@0.504@CNVR7763.1, CNVR7763.2@SIRPB1-201_2@53@53@53@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
D050227@228815@228818@duplication@4@10793871@10863068@21@chr21:10793871-10863068@5.6@1126@1500@1.33@CNVR7947.10, CNVR7947.4@AF254982-201_1, AF254982-201_2, IGHV1OR15-5-001_1, IGHV1OR15-5-001_2@8.75@5@13@@:protein binding;extracellular region@NA
D050227@228848@228849@deletion@2@11012919@11012983@21@chr21:11012919-11012983@5.84@389@246@0.632@CNVR7947.1@TPTE-006_8, BAGE2-002_12@9@9@9@:transmembrane phosphatase with tensin homology@:phosphatase activity;ion channel activity;protein tyrosine phosphatase activity;ion transport;protein dephosphorylation;transmembrane transport;protein binding;signal transduction;integral to membrane;protein tyrosine/serine/threonine phosphatase activity;dephosphorylation;membrane;peptidyl-tyrosine dephosphorylation@NA
D050227@231958@231958@deletion@1@16287256@16287718@22@chr22:16287256-16287718@11.2@53@0@0@CNVR8071.2, CNVR8071.3, CNVR8071.9@POTEH-002_1@105@105@105@:POTE ankyrin domain family, member H@:protein binding@NA
D050227@232243@232246@duplication@4@18369938@18370202@22@chr22:18369938-18370202@6.12@372@510@1.37@NA@XXbac-B461K10-203_14, XXbac-B461K10-203_15, MICAL3-201_14, MICAL3-201_15@3@3@3@:microtubule associated monoxygenase, calponin and LIM domain containing 3@:oxidation-reduction process;exocytosis;cytoplasm;actin filament depolymerization;protein binding;actin binding;oxidoreductase activity;FAD binding;cytoskeleton;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NADH or NADPH as one donor, and incorporation of one atom of oxygen;zinc ion binding@NA
D050227@232769@232784@duplication@16@20383540@20402444@22@chr22:20383540-20402444@11@112@206@1.84@CNVR8094.9, CNVR8094.4, CNVR8094.10@PI4KAP1-204_1, PI4KAP1-204_2, PI4KAP1-204_3, PI4KAP1-204_4, PI4KAP1-204_5, PI4KAP1-204_6, PI4KAP1-204_7, PI4KAP1-204_8, PI4KAP1-204_9, PI4KAP1-204_10, PI4KAP1-204_11, PI4KAP1-204_12, PI4KAP1-204_13, PI4KAP1-204_14, PI4KAP1-204_15, PI4KAP1-204_16@163.9375@148@172@NA@NA@NA
D050227@236751@236757@deletion@7@42523846@42525939@22@chr22:42523846-42525939@22.3@594@322@0.542@CNVR8168.1, CNVR8168.3, CNVR8168.2@CYP2D6-203_1, CYP2D6-203_2, CYP2D6-203_3, CYP2D6-203_4, CYP2D6-203_5, CYP2D6-203_6, CYP2D6-203_7@25.2857142857143@16@28@:cytochrome P450, family 2, subfamily D, polypeptide 6@:oxidation-reduction process;mitochondrion;alkaloid catabolic process;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;drug catabolic process;endoplasmic reticulum membrane;response to organic substance;oxidative demethylation;endoplasmic reticulum;alkaloid metabolic process;negative regulation of binding;heme binding;xenobiotic metabolic process;dopamine metabolic process;steroid metabolic process;isoquinoline alkaloid metabolic process;arachidonic acid monooxygenase activity;arachidonic acid metabolic process;steroid 21-monooxygenase activity;negative regulation of cellular organofluorine metabolic process;oxidoreductase activity;monoterpenoid metabolic process;heterocycle metabolic process;drug binding;drug metabolic process;electron carrier activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;coumarin metabolic process@: DRUG METABOLISM, POOR, CYP2D6-RELATED
D050227@236814@236825@duplication@12@42905036@42950049@22@chr22:42905036-42950049@15.9@754@1068@1.42@CNVR8171.2, CNVR8171.3@SERHL-001_8, SERHL-001_9, SERHL-001_10, SERHL-001_11, RRP7A-001_1, RRP7A-001_2, RRP7A-001_3, RRP7A-001_4, RRP7A-001_5, RRP7A-001_6, RRP7A-001_7, SERHL2-203_1@37.3333333333333@26@43@:ribosomal RNA processing 7 homolog A (S. cerevisiae):serine hydrolase-like 2@:RNA binding;nucleotide binding:hydrolase activity;mitochondrion;peroxisome;cytoplasmic membrane-bounded vesicle;molecular_function;cellular_component;perinuclear region of cytoplasm;biological_process@NA
D05685@624@624@deletion@1@1670363@1670497@1@chr1:1670363-1670497@6.64@136@73@0.537@CNVR17.1@SLC35E2-002_4@28@28@28@:solute carrier family 35, member E2@:integral to membrane;membrane@NA
D05685@2888@2892@deletion@5@16890515@16893847@1@chr1:16890515-16893847@20.1@286@134@0.469@CNVR93.3, CNVR93.6, CNVR93.11@NBPF1-201_25, NBPF1-201_26, NBPF1-201_27, NBPF1-201_28, NBPF1-201_29@74.6@66@79@NA@NA@NA
D05685@2918@2921@deletion@4@16947342@16952995@1@chr1:16947342-16952995@7.86@624@429@0.688@CNVR93.3, CNVR93.6, CNVR93.12, CNVR93.7@CROCCL1-204_9, CROCCL1-204_10, CROCCL1-204_11, AL137798-201_1, AL137798-201_2@37@35@39@NA@NA@NA
D05685@2948@2969@deletion@22@17007489@17077228@1@chr1:17007489-17077228@29.4@2425@1656@0.683@CNVR93.3, CNVR93.15, CNVR93.4@RP1-163M9-001_1, RP1-163M9-001_2, RP1-163M9-001_3, RP1-163M9-001_4, RP1-163M9-001_5, ESPNP-002_1, ESPNP-002_2, ESPNP-002_3, ESPNP-002_4, ESPNP-002_5, ESPNP-002_6, ESPNP-002_7, ESPNP-002_8, ESPNP-002_9, ESPNP-002_10, ESPNP-002_11, AL021920-201_1, AL021920-201_2, AL021920-201_3, ENST00000457096_1, ENST00000457096_2, ENST00000457096_3@40.1363636363636@22@46@:UPF0627 protein ENSP00000341061/ENSP00000339743-like;UPF0627 protein ENSP00000341061/ENSP00000339743@NA@NA
D05685@2982@2983@duplication@2@17086016@17086182@1@chr1:17086016-17086182@5.52@41@83@2.02@CNVR93.3, CNVR93.15, CNVR93.2, CNVR93.1@MST1P9-202_8, MST1P9-202_9@55@54@56@:macrophage stimulating 1-like@:proteolysis;extracellular region;catalytic activity;serine-type endopeptidase activity@NA
D05685@3775@3775@deletion@1@21806546@21806717@1@chr1:21806546-21806717@8.09@38@1@0.0263@CNVR107.2, CNVR107.1@NBPF3-003_15@91@91@91@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 3@:cytoplasm@NA
D05685@4452@4461@duplication@10@25611066@25655628@1@chr1:25611066-25655628@39.3@1070@1593@1.49@CNVR116.1, CNVR116.2@RHD-202_2, RHD-202_3, RHD-202_4, RHD-202_5, RHD-202_6, RHD-202_7, RHD-202_8, RHD-202_9, RHD-202_10, RHD-202_11@123@113@128@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
D05685@4477@4477@deletion@1@25735176@25735361@1@chr1:25735176-25735361@18.6@86@0@0@CNVR117.1@RHCE-005_4@56@56@56@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
D05685@6745@6748@deletion@4@39977430@39988155@1@chr1:39977430-39988155@11.3@246@141@0.573@NA@BMP8A-001_3, BMP8A-001_4, BMP8A-001_5, RP11-69E11-006_5@32.25@25@53@:bone morphogenetic protein 8a@:cell differentiation;growth factor activity;extracellular space;growth;cytokine activity;cartilage development;ossification@NA
D05685@12416@12433@duplication@18@104202984@104257511@1@chr1:104202984-104257511@37.9@239@547@2.29@CNVR266.3, CNVR266.5@AMY1A-001_7, AMY1A-001_8, AMY1A-001_9, AMY1A-001_10, AMY1A-001_11, AMY1B-001_1, AMY1B-001_2, AMY1B-001_3, AMY1B-001_4, AMY1B-001_5, AMY1B-001_6, AMY1B-001_7, AMY1B-001_8, AMY1B-001_9, AMY1B-001_10, AMY1B-001_11, AMYP1-001_1, AMYP1-001_2@117.888888888889@107@154@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D05685@12929@12936@duplication@8@110230474@110236368@1@chr1:110230474-110236368@14.7@496@699@1.41@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1-001_1, GSTM1-001_2, GSTM1-001_3, GSTM1-001_4, GSTM1-001_5, GSTM1-001_6, GSTM1-001_7, GSTM1-001_8@191.375@187@194@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
D05685@14483@14496@deletion@14@144595837@144811958@1@chr1:144595837-144811958@15.5@408@249@0.61@NA@AL592284-001_3, AL592284-001_4, AL592284-001_5, AL592284-001_6, AL592284-001_7, AL592284-001_8, AL592284-001_9, AL592284-001_10, AL592284-001_11, AL592284-001_12, WI2-1896O14-001_1, WI2-1896O14-001_2, WI2-1896O14-001_3, NBPF9-001_1@12.7142857142857@0@49@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 24@NA@NA
D05685@15201@15217@deletion@17@148008575@148025849@1@chr1:148008575-148025849@13.9@64@1@0.0156@CNVR346.2, CNVR346.4@NBPF14-001_1, NBPF14-001_2, NBPF14-001_3, NBPF14-001_4, NBPF14-001_5, NBPF14-001_6, NBPF14-001_7, NBPF14-001_8, NBPF14-001_9, NBPF14-001_10, NBPF14-001_11, NBPF14-001_12, NBPF14-001_13, NBPF14-001_14, NBPF14-001_15, NBPF14-001_16, NBPF14-001_17@89.7058823529412@58@120@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
D05685@16280@16280@deletion@1@152573269@152573493@1@chr1:152573269-152573493@19.6@91@0@0@CNVR358.1@LCE3C-201_2@102@102@102@:late cornified envelope 3C@:keratinization@NA
D05685@18672@18684@deletion@13@161559354@161600997@1@chr1:161559354-161600997@58.4@1337@737@0.551@CNVR383.1@FCGR2C-006_3, FCGR2C-006_4, FCGR2C-006_5, FCGR2C-006_6, FCGR2C-006_7, ENST00000448848_1, ENST00000448848_2, ENST00000448848_3, FCGR3B-001_1, FCGR3B-001_2, FCGR3B-001_3, FCGR3B-001_4, FCGR3B-001_5@41.0769230769231@34@57@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene):Fc fragment of IgG, low affinity IIIb, receptor (CD16b)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction:IgG binding;protein binding;extracellular region;immune response;plasma membrane;anchored to membrane@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
D05685@21362@21374@duplication@13@196743977@196801320@1@chr1:196743977-196801320@91.4@1758@2882@1.64@CNVR459.1@CFHR3-001_1, CFHR3-001_2, CFHR3-001_3, CFHR3-001_4, CFHR3-001_5, CFHR3-001_6, CFHR1-001_1, CFHR1-001_2, CFHR1-001_3, CFHR1-001_4, CFHR1-001_5, CFHR1-001_6, CFHR2-201_1@96.7692307692308@85@119@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
D05685@24160@24164@duplication@5@223727670@223729472@1@chr1:223727670-223729472@10.6@71@154@2.17@NA@CAPN8-202_20, CAPN8-202_21, CAPN8-202_22, CAPN8-202_23, CAPN8-202_24@0@0@0@:calpain 8@:proteolysis;Golgi apparatus;intracellular;calcium-dependent cysteine-type endopeptidase activity;calcium ion binding@NA
D05685@34094@34095@deletion@2@96458183@96458295@2@chr2:96458183-96458295@8.82@60@14@0.233@NA@AC008268-201_3, ENST00000444924_2@104@104@104@NA@NA@NA
D05685@34183@34184@duplication@2@96652501@96652955@2@chr2:96652501-96652955@7.82@214@321@1.5@NA@AC073995-001_2, AC073995-001_3@4@4@4@:ankyrin repeat domain-containing protein 36A-like@:ion channel inhibitor activity;protein binding@NA
D05685@34615@34631@duplication@17@98127603@98162325@2@chr2:98127603-98162325@12.2@173@287@1.66@CNVR888.3@ANKRD36B-001_23, ANKRD36B-001_24, ANKRD36B-001_25, ANKRD36B-001_26, ANKRD36B-001_27, ANKRD36B-001_28, ANKRD36B-001_29, ANKRD36B-001_30, ANKRD36B-001_31, ANKRD36B-001_32, ANKRD36B-001_33, ANKRD36B-001_34, ANKRD36B-001_35, ANKRD36B-001_36, ANKRD36B-001_37, ANKRD36B-001_38, ANKRD36B-001_39@130.058823529412@64@154@NA@NA@NA
D05685@37202@37207@deletion@6@130895213@130897670@2@chr2:130895213-130897670@12.4@218@115@0.528@NA@AC018804-201_7, AC018804-201_8, AC068137-001_4, CCDC74B-001_6, CCDC74B-001_7, CCDC74B-001_8@34.6666666666667@22@43@:coiled-coil domain containing 74A;coiled-coil domain containing 74B@NA@NA
D05685@37242@37242@deletion@1@130955933@130956035@2@chr2:130955933-130956035@7.73@35@0@0@CNVR985.1@TUBA3E-001_1@27@27@27@:tubulin, alpha 3e@:GTPase activity;structural constituent of cytoskeleton;protein complex;GTP catabolic process;cytoplasm;microtubule cytoskeleton;protein polymerization;microtubule-based movement;structural molecule activity;cytoplasmic microtubule;GTP binding;microtubule;microtubule cytoskeleton organization;protein domain specific binding@NA
D05685@40413@40416@duplication@4@178299057@178305765@2@chr2:178299057-178305765@5.63@215@298@1.39@NA@AGPS-001_3, AGPS-001_4, AGPS-001_5, AGPS-001_6@0@0@0@:alkylglycerone phosphate synthase@:oxidation-reduction process;mitochondrion;oxidoreductase activity, acting on CH-OH group of donors;catalytic activity;oxidoreductase activity;peroxisomal membrane;ether lipid biosynthetic process;response to chemical stimulus;intracellular membrane-bounded organelle;small molecule metabolic process;peroxisome;cellular lipid metabolic process;flavin adenine dinucleotide binding;UDP-N-acetylmuramate dehydrogenase activity;lipid biosynthetic process;peroxisomal matrix;alkylglycerone-phosphate synthase activity@: RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 3; RCDP3
D05685@46349@46349@deletion@1@241622250@241622298@2@chr2:241622250-241622298@5.01@53@21@0.396@NA@AQP12B-003_1@30@30@30@:aquaporin 12B@:transport;integral to membrane;transporter activity;membrane@NA
D05685@47457@47457@deletion@1@10091060@10091190@3@chr3:10091060-10091190@10.1@125@52@0.416@NA@FANCD2-202_17@6@6@6@:Fanconi anemia, complementation group D2@:nucleoplasm;synapsis;binding;response to DNA damage stimulus;gamete generation;DNA repair;condensed chromosome;protein binding;response to gamma radiation@: FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2
D05685@47657@47657@duplication@1@11912773@11912903@3@chr3:11912773-11912903@4.99@63@110@1.75@NA@AC090958-001_4@6@6@6@NA@NA@NA
D05685@47662@47663@duplication@2@11925055@11925573@3@chr3:11925055-11925573@12.6@93@195@2.1@NA@AC090958-001_9, AC090958-001_10@9.5@9@10@NA@NA@NA
D05685@61595@61595@deletion@1@195505663@195510237@3@chr3:195505663-195510237@6.09@303@193@0.637@CNVR1704.1@MUC4-203_3@8@8@8@:mucin 4, cell surface associated@:ErbB-2 class receptor binding;Golgi lumen;cell-matrix adhesion;post-translational protein modification;extracellular matrix structural constituent;protein binding;O-glycan processing;cellular protein metabolic process;proteinaceous extracellular matrix;integral to plasma membrane;membrane;extracellular matrix constituent, lubricant activity;biological_process@NA
D05685@61897@61905@deletion@9@197349060@197351592@3@chr3:197349060-197351592@7.03@198@120@0.606@CNVR1722.1@AC024560-005_2, AC024560-005_3, AC024560-005_4, AC024560-005_5, AC024560-201_2, AC024560-201_3, AC024560-201_4, AC024560-201_5, AC024560-201_6@26.2222222222222@8@39@NA@NA@NA
D05685@70821@70822@duplication@2@745300@748675@5@chr5:745300-748675@12.6@320@485@1.52@CNVR2280.3@ZDHHC11B-201_5, ZDHHC11B-201_6@91@86@96@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
D05685@70838@70838@deletion@1@840612@840766@5@chr5:840612-840766@5.38@376@249@0.662@CNVR2280.3, CNVR2280.8@ZDHHC11-201_5@23@23@23@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
D05685@71600@71608@duplication@9@21480883@21494063@5@chr5:21480883-21494063@17.6@286@462@1.62@CNVR2395.4, CNVR2395.6, CNVR2395.2@AC138951-201_4, AC138951-202_1, AC138951-202_2, ENST00000412250_1, ENST00000412250_2, ENST00000412250_3, ENST00000412250_4, ENST00000366374_1, ENST00000366374_2@101.333333333333@86@108@NA@NA@NA
D05685@72026@72026@deletion@1@35867410@35867566@5@chr5:35867410-35867566@6.24@125@67@0.536@NA@IL7R-001_3@0@0@0@:interleukin 7 receptor@:immune response;interleukin-7-mediated signaling pathway;interleukin-7 receptor activity;homeostasis of number of cells;integral to membrane;plasma membrane;regulation of DNA recombination;cell surface receptor signaling pathway;cell morphogenesis;B cell proliferation;positive regulation of gene expression;positive regulation of T cell differentiation in thymus;cell growth;external side of plasma membrane;T cell differentiation;cytokine receptor activity;antigen binding;protein binding;negative regulation of T cell mediated cytotoxicity;signal transduction;extracellular region;immunoglobulin production;lymph node development;membrane;regulation of cell size@: SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE,; MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 3; MS3
D05685@73656@73656@duplication@1@68862418@68862453@5@chr5:68862418-68862453@5.71@45@92@2.04@CNVR2494.7, CNVR2494.46@GTF2H2C-201_5@12@12@12@:general transcription factor IIH, polypeptide 2C;general transcription factor IIH, polypeptide 2D@:regulation of transcription, DNA-dependent;nucleotide-excision repair;DNA repair;core TFIIH complex;protein binding;nucleus;transcription, DNA-dependent;zinc ion binding@NA
D05685@73727@73727@duplication@1@69717564@69717599@5@chr5:69717564-69717599@6.03@57@109@1.91@CNVR2494.17, CNVR2494.3@GTF2H2B-201_4@139@139@139@NA@NA@NA
D05685@73795@73796@deletion@2@70307104@70308746@5@chr5:70307104-70308746@31@633@292@0.461@CNVR2494.41, CNVR2494.14, CNVR2494.30, CNVR2494.20, CNVR2494.62, CNVR2494.8, CNVR2494.35@NAIP-001_4, NAIP-001_5@29.5@27@32@:baculoviral IAP repeat-containing protein 1-like;NLR family, apoptosis inhibitory protein@:negative regulation of apoptotic process;inflammatory response;basolateral plasma membrane;nucleoside-triphosphatase activity;cysteine-type endopeptidase inhibitor activity;intracellular;nucleotide binding;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;ATP binding;cytoplasm;innate immune response;protein binding;negative regulation of neuron apoptotic process;metal ion binding;nervous system development@NA
D05685@73812@73821@deletion@10@70357101@70389020@5@chr5:70357101-70389020@51.4@288@30@0.104@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.8, CNVR2494.1, CNVR2494.37@GTF2H2-202_1, GTF2H2-202_2, GTF2H2-202_3, GTF2H2-202_4, GTF2H2-202_5, AC044797-201_1, AC044797-201_2, AC044797-201_3, AC044797-201_4, AC044797-201_5@91.2@61@138@:general transcription factor IIH, polypeptide 2, 44kDa@:nucleoplasm;nucleotide-excision repair, DNA damage removal;transcription from RNA polymerase I promoter;DNA repair;RNA polymerase II carboxy-terminal domain kinase activity;nucleus;viral reproduction;translation;gene expression;transcription elongation from RNA polymerase I promoter;response to UV;holo TFIIH complex;protein kinase activity;nucleotide-excision repair;transcription from RNA polymerase II promoter;transcription-coupled nucleotide-excision repair;transcription, DNA-dependent;zinc ion binding;transcription elongation from RNA polymerase II promoter;termination of RNA polymerase I transcription;sequence-specific DNA binding transcription factor activity;G-protein coupled receptor internalization;DNA-dependent ATPase activity;protein N-terminus binding;transcription initiation from RNA polymerase I promoter;7-methylguanosine mRNA capping;transcription initiation from RNA polymerase II promoter;protein phosphorylation;translation factor activity, nucleic acid binding;regulation of transcription, DNA-dependent;core TFIIH complex;protein binding;positive regulation of viral transcription;nucleic acid binding@NA
D05685@79567@79568@duplication@2@175388056@175388438@5@chr5:175388056-175388438@12.2@87@185@2.13@NA@THOC3-001_4, THOC3-001_5@173.5@165@182@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
D05685@79583@79583@deletion@1@175528556@175528585@5@chr5:175528556-175528585@6.23@114@59@0.518@NA@FAM153B-201_12@6@6@6@:uncharacterized LOC100507387;family with sequence similarity 153, member B@NA@NA
D05685@80019@80019@duplication@1@177163582@177163611@5@chr5:177163582-177163611@4.82@60@105@1.75@NA@FAM153A-204_12@78@78@78@:family with sequence similarity 153, member A@NA@NA
D05685@80022@80024@duplication@3@177166603@177168334@5@chr5:177166603-177168334@7.61@91@158@1.74@NA@FAM153A-204_7, FAM153A-204_8, FAM153A-204_9@94@86@106@:family with sequence similarity 153, member A@NA@NA
D05685@82490@82514@deletion@25@29856246@29909097@6@chr6:29856246-29909097@54.4@1566@937@0.598@CNVR2829.7, CNVR2829.2, CNVR2829.3@HLA-H-001_3, HLA-H-001_4, HLA-H-001_5, HLA-H-001_6, HLA-H-001_7, HLA-16-001_1, HLA-16-001_2, HLA-16-001_3, HLA-16-001_4, AL645929-201_2, AL645929-201_3, AL645929-201_4, AL645929-201_5, AL645929-201_6, BAT1P1-001_1, BAT1P1-001_2, MCCD1P1-001_1, MCCD1P1-001_2, HLA-K-001_1, HLA-K-001_2, HLA-K-001_3, HLA-K-001_4, HLA-K-001_5, HLA-K-001_6, HLA-A-001_1@44@13@51@:major histocompatibility complex, class I, A@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO
D05685@83016@83017@duplication@2@31324374@31324735@6@chr6:31324374-31324735@10.5@303@448@1.48@CNVR2841.12, CNVR2841.14, CNVR2841.8@HLA-B-201_2, HLA-B-201_3@72.5@72@73@:major histocompatibility complex, class I, B@:MHC class I protein complex;regulation of immune response;regulation of interleukin-12 production;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;regulation of T cell anergy;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;receptor binding;early endosome membrane;virus-host interaction;regulation of interleukin-6 production;regulation of dendritic cell differentiation;phagocytic vesicle membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO; SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1
D05685@83026@83026@deletion@1@31379726@31380003@6@chr6:31379726-31380003@5.89@145@82@0.566@CNVR2842.1@MICA-001_6@1@1@1@:MHC class I polypeptide-related sequence A@:MHC class I protein complex;protein binding;regulation of immune response;antigen processing and presentation;immune response;plasma membrane;membrane@: PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO; PSORIASIS SUSCEPTIBILITY 1; PSORS1
D05685@83577@83582@duplication@6@31962024@31963572@6@chr6:31962024-31963572@9.35@219@328@1.5@CNVR2843.6, CNVR2843.3@C4A-001_20, C4A-001_21, C4A-001_22, C4A-001_23, C4A-001_24, C4A-001_25@13@11@17@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
D05685@83601@83603@duplication@3@31973468@31974290@6@chr6:31973468-31974290@8.15@205@303@1.48@CNVR2843.6, CNVR2843.3@CYP21A1P-001_1, CYP21A1P-001_2, CYP21A1P-001_3, AL645922-201_1@103.666666666667@98@107@NA@NA@NA
D05685@83609@83616@duplication@8@31974792@31975814@6@chr6:31974792-31975814@13.3@496@690@1.39@CNVR2843.6, CNVR2843.3@CYP21A1P-001_6, CYP21A1P-001_7, CYP21A1P-001_8, CYP21A1P-001_9, AL645922-201_4, AL645922-201_5, AL645922-201_6, AL645922-201_7@113@99@121@NA@NA@NA
D05685@83637@83642@deletion@6@31994762@31996310@6@chr6:31994762-31996310@8.95@157@83@0.529@CNVR2843.6, CNVR2843.5@C4B-001_20, C4B-001_21, C4B-001_22, C4B-001_23, C4B-001_24, C4B-001_25@12.3333333333333@10@15@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
D05685@83911@83916@duplication@6@32485122@32498065@6@chr6:32485122-32498065@56.5@224@666@2.97@CNVR2845.21, CNVR2845.25, CNVR2845.30, CNVR2845.43@HLA-DRB5-001_1, HLA-DRB5-001_2, HLA-DRB5-001_3, HLA-DRB5-001_4, HLA-DRB5-001_5, HLA-DRB5-001_6@173.833333333333@122@189@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D05685@83920@83927@duplication@8@32522469@32548048@6@chr6:32522469-32548048@15.6@256@410@1.6@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.5@HLA-DRB6-002_1, HLA-DRB6-002_2, HLA-DRB6-002_3, AL713966-201_1, AL713966-201_2, AL713966-201_3, HLA-DRB1-001_5, HLA-DRB1-001_6@125.25@85@167@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
D05685@83929@83930@duplication@2@32549336@32552156@6@chr6:32549336-32552156@15@277@448@1.62@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.5, CNVR2845.54, CNVR2845.55, CNVR2845.56, CNVR2845.34@HLA-DRB1-001_2, HLA-DRB1-001_3@80@60@100@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
D05685@83934@83934@duplication@1@32609089@32609336@6@chr6:32609089-32609336@6.57@134@212@1.58@CNVR2845.21, CNVR2845.25, CNVR2845.37, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20@HLA-DQA1-002_3@135@135@135@:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D05685@83936@83946@duplication@11@32610389@32634448@6@chr6:32610389-32634448@27.7@757@1116@1.47@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20@HLA-DQA1-002_5, HLA-DQA1-002_6, HLA-DQB1-003_2, HLA-DQB1-003_3, HLA-DQB1-003_4, HLA-DQB1-003_5, HLA-DQB1-003_6, XXbac-BPG254F23-001_1, XXbac-BPG254F23-001_2, ENST00000443574_1, ENST00000443574_2@121.090909090909@80@146@:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
D05685@93064@93064@duplication@1@167584083@167584211@6@chr6:167584083-167584211@5.03@84@137@1.63@NA@AL121935-201_1@1@1@1@:t-complex 10;t-complex 10-like 2@NA@NA
D05685@93073@93077@duplication@5@167592501@167596397@6@chr6:167592501-167596397@7.62@228@326@1.43@NA@TCP10L2-001_5, TCP10L2-001_6, AL121935-201_6, AL121935-201_7, AL121935-201_8@7.8@3@9@:t-complex 10;t-complex 10-like 2@NA@NA
D05685@93091@93092@duplication@2@167728677@167738709@6@chr6:167728677-167738709@6.42@170@253@1.49@CNVR3166.2, CNVR3166.5@UNC93A-001_8, TTLL2-001_1@0@0@0@:unc-93 homolog A (C. elegans):tubulin tyrosine ligase-like family, member 2@:integral to membrane;plasma membrane;molecular_function;biological_process:tubulin-tyrosine ligase activity;cellular protein modification process;ATP binding@NA
D05685@93097@93097@deletion@1@167787841@167787940@6@chr6:167787841-167787940@6.32@61@22@0.361@NA@TCP10-001_7@33@33@33@:t-complex 10@:cytosol@NA
D05685@93099@93099@deletion@1@167790036@167790193@6@chr6:167790036-167790193@5.62@27@1@0.037@NA@TCP10-001_5@103@103@103@:t-complex 10@:cytosol@NA
D05685@93101@93101@duplication@1@167794611@167794825@6@chr6:167794611-167794825@5.93@29@73@2.52@NA@TCP10-001_3@52@52@52@:t-complex 10@:cytosol@NA
D05685@93103@93103@deletion@1@167797871@167797999@6@chr6:167797871-167797999@8.75@62@15@0.242@NA@TCP10-001_1@5@5@5@:t-complex 10@:cytosol@NA
D05685@94059@94059@deletion@1@5172081@5172121@7@chr7:5172081-5172121@5.51@46@15@0.326@NA@AC092028-001_3@1@1@1@NA@NA@NA
D05685@94183@94186@deletion@4@5941290@5949748@7@chr7:5941290-5949748@21.5@787@494@0.628@NA@C7orf28A-001_5, C7orf28A-001_6, C7orf28A-001_7, C7orf28A-001_8@33.75@30@36@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D05685@94193@94202@duplication@10@5965265@5984810@7@chr7:5965265-5984810@10.4@910@1182@1.3@NA@C7orf28A-001_15, RSPH10B-002_13, RSPH10B-002_14, RSPH10B-002_15, RSPH10B-002_16, RSPH10B-002_17, RSPH10B-002_18, RSPH10B-002_19, RSPH10B-002_20, RSPH10B-002_21@16.5@9@46@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae):radial spoke head 10 homolog B (Chlamydomonas)@:lysosomal membrane@NA
D05685@94209@94212@duplication@4@6000324@6006833@7@chr7:6000324-6006833@15.7@179@327@1.83@NA@RSPH10B-002_3, RSPH10B-002_4, RSPH10B-002_5, RSPH10B-002_6@10@8@13@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D05685@94420@94423@deletion@4@6797226@6803733@7@chr7:6797226-6803733@17.9@341@173@0.507@NA@RSPH10B2-204_3, RSPH10B2-204_4, RSPH10B2-204_5, RSPH10B2-204_6@7@6@8@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D05685@94430@94432@deletion@3@6819243@6821108@7@chr7:6819243-6821108@26.5@304@117@0.385@NA@RSPH10B2-204_13, RSPH10B2-204_14, RSPH10B2-204_15@17@16@19@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D05685@94434@94442@deletion@9@6826511@6840707@7@chr7:6826511-6840707@66.5@407@72@0.177@NA@RSPH10B2-204_17, RSPH10B2-204_18, RSPH10B2-204_19, RSPH10B2-204_20, RSPH10B2-204_21, ENST00000429267_1, ENST00000429267_2, C7orf28B-001_14, C7orf28B-001_15@53.5555555555556@19@121@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D05685@96560@96562@duplication@3@38301774@38313241@7@chr7:38301774-38313241@26.3@924@1398@1.51@CNVR3353.1@TRGC1-001_1, TRGC1-001_2, ENST00000501456_1@6.33333333333333@3@8@:TCR gamma alternate reading frame protein@:protein binding@NA
D05685@96579@96584@duplication@6@38388958@38398764@7@chr7:38388958-38398764@33@1439@2044@1.42@CNVR3354.3, CNVR3354.1@TRGV5-001_1, TRGV5-001_2, TRGV4-001_1, TRGV4-001_2, TRGV3-001_1, TRGV3-001_2@10.5@6@14@@:protein binding:protein binding:protein binding;immune response;peptide antigen binding;plasma membrane;MHC protein binding@NA
D05685@97908@97915@deletion@8@57064289@57076857@7@chr7:57064289-57076857@10@103@42@0.408@NA@TNRC18C-202_4, TNRC18C-202_5, TNRC18C-202_6, TNRC18C-202_7, TNRC18C-202_8, TNRC18C-202_9, TNRC18C-202_10, TNRC18C-202_11@158.25@139@166@NA@NA@NA
D05685@97991@97994@duplication@4@62758072@62758771@7@chr7:62758072-62758771@60.3@667@1362@2.04@NA@AC006455-201_2, AC006455-201_3, ENST00000444809_2, ENST00000444809_3@160@151@171@NA@NA@NA
D05685@98014@98026@deletion@13@62904582@62970547@7@chr7:62904582-62970547@87.7@623@131@0.21@NA@ZNF734-201_1, ZNF734-201_2, ZNF734-201_3, ZNF734-201_4, ZNF734-201_5, ZNF734-201_6, ZNF734-201_7, ZNF734-201_8, ENST00000434048_1, ENST00000434048_2, CTD-2526L21-201_1, CTD-2526L21-201_2, CTD-2526L21-201_3@75.3846153846154@1@102@NA@NA@NA
D05685@99025@99025@duplication@1@74160678@74160751@7@chr7:74160678-74160751@8.03@6@57@9.5@NA@GTF2I-001_23@54@54@54@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
D05685@99063@99063@deletion@1@74251404@74251506@7@chr7:74251404-74251506@4.93@22@0@0@NA@GTF2IRD2-002_2@8@8@8@:GTF2I repeat domain containing 2@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
D05685@99233@99233@duplication@1@74991244@74991359@7@chr7:74991244-74991359@5.98@33@78@2.36@CNVR3456.1@STAG3L1-004_3@60@60@60@NA@NA@NA
D05685@99544@99545@duplication@2@76723321@76728269@7@chr7:76723321-76728269@9.12@112@197@1.76@NA@ENST00000398321_6, ENST00000398321_7@13.5@11@16@NA@NA@NA
D05685@101721@101726@deletion@6@100331652@100336237@7@chr7:100331652-100336237@11.5@724@486@0.671@CNVR3509.1@ZAN-001_2, ZAN-001_3, ZAN-001_4, ZAN-001_5, ZAN-001_6, ZAN-001_7@81.6666666666667@71@89@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
D05685@102144@102145@deletion@2@102180464@102180539@7@chr7:102180464-102180539@11.8@158@72@0.456@CNVR3518.1@RASA4B-007_4, POLR2J3-003_7@96@96@96@:RAS p21 protein activator 4B:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
D05685@102166@102167@deletion@2@102219874@102223340@7@chr7:102219874-102223340@8.15@46@6@0.13@CNVR3518.1@ENST00000379336_1, RASA4-001_21@56@49@63@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
D05685@102231@102231@deletion@1@102412858@102412898@7@chr7:102412858-102412898@5.71@260@164@0.631@NA@FAM185A-201_6@0@0@0@:family with sequence similarity 185, member A@:cytoplasm@NA
D05685@103007@103007@deletion@1@111958239@111958329@7@chr7:111958239-111958329@5.44@72@33@0.458@NA@ZNF277-002_5@0@0@0@:zinc finger protein 277@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;sequence-specific DNA binding transcription factor activity;nucleic acid binding@NA
D05685@104579@104579@deletion@1@134221805@134221910@7@chr7:134221805-134221910@6.96@106@51@0.481@NA@AKR1B10-001_6@2@2@2@:aldo-keto reductase family 1, member B10 (aldose reductase)@:steroid metabolic process;cellular aldehyde metabolic process;indanol dehydrogenase activity;daunorubicin metabolic process;retinal dehydrogenase activity;farnesol catabolic process;geranylgeranyl reductase activity;protein binding;extracellular region;aldo-keto reductase (NADP) activity;digestion;doxorubicin metabolic process;cellular_component;lysosome@NA
D05685@105324@105341@deletion@18@141768449@141793351@7@chr7:141768449-141793351@44.3@2363@1574@0.666@CNVR3585.3, CNVR3585.2@MGAM-007_43, MGAM-007_44, MGAM-007_45, MGAM-007_46, MGAM-007_47, MGAM-007_48, MGAM-007_49, MGAM-007_50, MGAM-007_51, MGAM-007_52, MGAM-007_53, MGAM-007_54, MGAM-007_55, MGAM-007_56, MGAM-007_57, MGAM-007_58, MGAM-007_59, MGAM-007_60@117.944444444444@79@134@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
D05685@105760@105771@duplication@12@143555919@143855253@7@chr7:143555919-143855253@19.5@623@927@1.49@NA@FAM115A-001_1, FAM115A-001_2, FAM115A-001_3, FAM115A-001_4, FAM115A-001_5, FAM115A-001_6, FAM115A-001_7, RP4-669B10-002_1, RP4-669B10-002_2, RP4-669B10-002_3, OR2A3P-201_1, OR2A3P-201_2@1.41666666666667@0@5@:family with sequence similarity 115, member A;protein FAM115A-like:olfactory receptor, family 2, subfamily F, member 2:olfactory receptor, family 2, subfamily F, member 1:olfactory receptor, family 6, subfamily B, member 1:olfactory receptor, family 2, subfamily A, member 5:olfactory receptor, family 2, subfamily A, member 25:olfactory receptor, family 2, subfamily A, member 12:olfactory receptor, family 2, subfamily A, member 2:olfactory receptor, family 2, subfamily A, member 14@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:signal transduction;integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
D05685@105785@105785@deletion@1@143969540@143969609@7@chr7:143969540-143969609@7.46@189@106@0.561@CNVR3598.4, CNVR3598.9@RP4-798C17-001_12@37@37@37@:Rho guanine nucleotide exchange factor (GEF) 35@NA@NA
D05685@105819@105822@deletion@4@144059753@144064449@7@chr7:144059753-144064449@14.3@248@126@0.508@CNVR3598.4, CNVR3598.5, CNVR3598.11@ARHGEF5-001_2, ARHGEF5-001_3, ARHGEF5-001_4, ARHGEF5-001_5@77.25@65@104@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
D05685@107428@107430@duplication@3@7308087@7320382@8@chr8:7308087-7320382@34.5@616@1069@1.74@CNVR3771.8, CNVR3771.10, CNVR3771.4@SPAG11-003_2, SPAG11-003_3, SPAG11-003_4@73.6666666666667@40@91@:sperm associated antigen 11B@:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response@NA
D05685@107504@107509@duplication@6@7680906@7698765@8@chr8:7680906-7698765@11.8@400@573@1.43@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@DEFB105A-001_1, DEFB105A-001_2, DEFB106A-001_1, DEFB106A-001_2, DEFB104A-001_1, DEFB104A-001_2@43.1666666666667@40@47@:defensin, beta 105B;defensin, beta 105A:defensin, beta 106B;defensin, beta 106A:defensin, beta 104A;defensin, beta 104B@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
D05685@107512@107513@deletion@2@7717871@7718505@8@chr8:7717871-7718505@12.5@275@151@0.549@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@SPAG11A-207_3, SPAG11A-207_4@112@111@113@:sperm associated antigen 11A;sperm associated antigen 11B@:extracellular region;defense response@NA
D05685@118852@118854@deletion@3@84545017@84549914@9@chr9:84545017-84549914@17.9@437@223@0.51@CNVR4364.1@ENST00000427387_1, RP11-383M4-201_3, RP11-383M4-201_4@16.3333333333333@11@27@NA@NA@NA
D05685@121601@121603@deletion@3@117085945@117087178@9@chr9:117085945-117087178@6.95@1238@883@0.713@CNVR4448.1@ORM1-001_2, ORM1-001_3, ORM1-001_4@89.6666666666667@89@90@:orosomucoid 1@:protein binding;extracellular space;regulation of immune system process;transport;inflammatory response;extracellular region;acute-phase response@NA
D05685@124043@124054@deletion@12@135946376@135961845@9@chr9:135946376-135961845@104@1747@812@0.465@CNVR4502.1@CEL-201_11, CEL-201_12, RP11-326L24-001_1, RP11-326L24-001_2, CELP-002_1, CELP-002_2, CELP-002_3, CELP-002_4, AL162417-201_1, AL162417-201_2, AL162417-201_3, AL162417-201_4@55.5@20@99@:carboxyl ester lipase (bile salt-stimulated lipase)@:intestinal lipid catabolic process;pancreatic juice secretion;catalytic activity;extracellular space;heparin binding;sterol esterase activity;carboxylesterase activity;metabolic process;ceramide catabolic process;hydrolase activity;small molecule metabolic process;acylglycerol lipase activity;lipid metabolic process;cytoplasm;protein esterification;cytosol;retinyl-palmitate esterase activity;fatty acid catabolic process;extracellular region;triglyceride lipase activity;lipid digestion;triglyceride metabolic process;cholesterol catabolic process;intestinal cholesterol absorption@: MATURITY-ONSET DIABETES OF THE YOUNG; MODY; MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION;
D05685@126906@126906@deletion@1@17813310@17813381@10@chr10:17813310-17813381@5.36@25@1@0.04@NA@FAM23A-201_2@17@17@17@:transmembrane protein 236;transmembrane protein 236-like@:integral to membrane@NA
D05685@126937@126937@deletion@1@17949552@17949715@10@chr10:17949552-17949715@5.66@96@49@0.51@NA@MRC1L1-001_28@7@7@7@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
D05685@126951@126974@duplication@24@18138510@18196628@10@chr10:18138510-18196628@26.4@176@385@2.19@NA@MRC1-001_7, MRC1-001_8, MRC1-001_9, MRC1-001_10, MRC1-001_11, MRC1-001_12, MRC1-001_13, MRC1-001_14, MRC1-001_15, MRC1-001_16, MRC1-001_17, MRC1-001_18, MRC1-001_19, MRC1-001_20, MRC1-001_21, MRC1-001_22, MRC1-001_23, MRC1-001_24, MRC1-001_25, MRC1-001_26, MRC1-001_27, MRC1-001_28, RP11-457D2-001_1, RP11-457D2-001_2@17.0833333333333@12@27@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D05685@127722@127722@deletion@1@29580856@29580936@10@chr10:29580856-29580936@8.53@54@10@0.185@NA@LYZL1-002_1@51@51@51@:lysozyme-like 1@:extracellular region;lysozyme activity;cell wall macromolecule catabolic process@NA
D05685@128372@128372@deletion@1@42924566@42924600@10@chr10:42924566-42924600@9.35@107@43@0.402@NA@CCNYL2-201_7@0@0@0@@:regulation of cyclin-dependent protein kinase activity;protein kinase binding@NA
D05685@128913@128913@deletion@1@47409855@47410082@10@chr10:47409855-47410082@12.9@106@30@0.283@CNVR4712.9, CNVR4712.1@FAM35B2-201_6@47@47@47@NA@NA@NA
D05685@128979@128979@deletion@1@47758848@47758905@10@chr10:47758848-47758905@5.63@25@0@0@CNVR4714.1@ANXA8L2-001_10@154@154@154@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:calcium-dependent phospholipid binding;calcium ion binding@NA
D05685@129003@129007@duplication@5@47933809@47942085@10@chr10:47933809-47942085@8.1@33@89@2.7@CNVR4715.2, CNVR4715.1@FAM21B-201_20, FAM21B-201_21, FAM21B-201_22, FAM21B-201_23, FAM21B-201_24@175@165@185@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
D05685@129021@129030@deletion@10@48020452@48055019@10@chr10:48020452-48055019@108@563@36@0.0639@CNVR4715.2@ASAH2C-201_1, ASAH2C-201_2, ASAH2C-201_3, ASAH2C-201_4, ASAH2C-201_5, ASAH2C-201_6, ASAH2C-201_7, ASAH2C-201_8, ASAH2C-201_9, ASAH2C-201_10@64.3@50@90@@:ceramidase activity;sphingolipid metabolic process@NA
D05685@129130@129131@deletion@2@48968562@48968624@10@chr10:48968562-48968624@9.41@51@6@0.118@CNVR4716.8, CNVR4716.4@RP11-508M1-002_5, GLUDP2-001_3@31@31@31@NA@NA@NA
D05685@129454@129460@duplication@7@51345755@51361911@10@chr10:51345755-51361911@13.4@12@97@8.08@NA@ENST00000404618_4, ENST00000404618_5, ENST00000404618_6, ENST00000404618_7, ENST00000432221_4, ENST00000432221_5, ENST00000432221_6, ENST00000432221_7@93.8571428571429@89@123@NA@NA@NA
D05685@129462@129463@deletion@2@51362803@51363788@10@chr10:51362803-51363788@49.5@238@4@0.0168@NA@ENST00000404618_3, ENST00000432221_3@142@142@142@NA@NA@NA
D05685@129468@129468@duplication@1@51371409@51371647@10@chr10:51371409-51371647@4.96@4@35@8.75@NA@TIMM23B-202_1@119@119@119@:translocase of inner mitochondrial membrane 23 homolog B (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process@NA
D05685@129572@129586@deletion@15@51847037@51877819@10@chr10:51847037-51877819@10.3@48@1@0.0208@NA@FAM21A-005_8, FAM21A-005_9, FAM21A-005_10, FAM21A-005_11, FAM21A-005_12, FAM21A-005_13, FAM21A-005_14, FAM21A-005_15, FAM21A-005_16, FAM21A-005_17, FAM21A-005_18, FAM21A-005_19, FAM21A-005_20, FAM21A-005_21, FAM21A-005_22@105.933333333333@93@123@:family with sequence similarity 21, member B;family with sequence similarity 21, member A@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
D05685@129604@129611@duplication@8@51965744@51994313@10@chr10:51965744-51994313@58.7@182@620@3.41@NA@ASAH2-201_5, ASAH2-201_6, ASAH2-201_7, ASAH2-201_8, ASAH2-201_9, ASAH2-201_10, ASAH2-201_11, ASAH2-201_12@147.125@53@186@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
D05685@139527@139527@duplication@1@18955060@18956211@11@chr11:18955060-18956211@17.1@994@1513@1.52@CNVR5091.2, CNVR5091.1@MRGPRX1-203_3@16@16@16@:MAS-related GPR, member X1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;acute-phase response;G-protein coupled receptor signaling pathway@NA
D05685@145944@145956@deletion@13@89701674@89718233@11@chr11:89701674-89718233@10.2@46@0@0@NA@TRIM64-202_1, TRIM64-202_2, TRIM64-202_3, TRIM64-202_4, TRIM64-202_5, TRIM64-202_6, TRIM64-202_7, TRIM64-202_8, TRIM64-202_9, ENST00000442514_6, ENST00000442514_7, ENST00000442514_8, ENST00000442514_9@140.076923076923@34@177@NA@NA@NA
D05685@150775@150775@deletion@1@9446260@9446507@12@chr12:9446260-9446507@12.7@64@4@0.0625@NA@DDX11L8-201_2@42@42@42@NA@NA@NA
D05685@150785@150786@duplication@2@9456573@9456804@12@chr12:9456573-9456804@12.3@131@249@1.9@NA@DDX11L8-201_12, DDX11L8-201_13@85@83@87@NA@NA@NA
D05685@150826@150840@duplication@15@9590609@9706679@12@chr12:9590609-9706679@39.8@656@1076@1.64@CNVR5429.1@DDX12-203_1, DDX12-203_2, DDX12-203_3, AC006432-201_1, AC006432-201_2, AC006432-201_3, AC006432-201_4, AC006432-201_5, AC006432-201_6, AC006432-201_7, AC006432-201_8, AC006432-201_9, AC006432-201_11, AC006432-201_12@20.6428571428571@7@25@NA@NA@NA
D05685@150969@150971@duplication@3@10584707@10587639@12@chr12:10584707-10587639@5.38@333@444@1.33@CNVR5430.1@KLRC2-201_3, KLRC2-201_4, KLRC2-201_5@61.3333333333333@51@67@:killer cell lectin-like receptor subfamily C, member 2@:carbohydrate binding:transmembrane signaling receptor activity;carbohydrate binding;protein binding;signal transduction;cellular defense response;integral to plasma membrane@NA
D05685@161546@161547@duplication@2@19042968@19043674@13@chr13:19042968-19043674@5.81@154@229@1.49@NA@RP11-77P19-201_5, RP11-77P19-201_6@32@27@37@NA@NA@NA
D05685@161688@161688@duplication@1@19778482@19778650@13@chr13:19778482-19778650@5.37@44@88@2@NA@RP11-408E5-201_7@4@4@4@NA@NA@NA
D05685@161811@161812@duplication@2@20425497@20426331@13@chr13:20425497-20426331@9.97@616@862@1.4@NA@ZMYM5-201_3, ZMYM5-201_4@2@2@2@:zinc finger, MYM-type 5@:nucleus;zinc ion binding@NA
D05685@162127@162128@deletion@2@24465240@24465671@13@chr13:24465240-24465671@32.5@927@492@0.531@NA@RP11-45B20-002_6, ENST00000382133_3@29@29@29@:C1q and tumor necrosis factor related protein 9B@:collagen;protein binding@NA
D05685@162131@162131@deletion@1@24468280@24468341@13@chr13:24468280-24468341@16.1@178@65@0.365@NA@RP11-45B20-002_4@36@36@36@:C1q and tumor necrosis factor related protein 9B@:collagen;protein binding@NA
D05685@162163@162164@duplication@2@24892958@24893019@13@chr13:24892958-24893019@4.93@721@930@1.29@NA@SPATA13-009_12, C1QTNF9-003_4@8.5@6@11@:spermatogenesis associated 13:C1q and tumor necrosis factor related protein 9@:lamellipodium assembly;phospholipid binding;Rac guanyl-nucleotide exchange factor activity;guanyl-nucleotide exchange factor activity;ruffle membrane;nucleus;regulation of cell migration;cell migration;regulation of Rho protein signal transduction;intracellular;Rho guanyl-nucleotide exchange factor activity;cytoplasm;filopodium assembly;filopodium;protein binding;lamellipodium:collagen;protein binding;hormone activity@NA
D05685@162167@162172@duplication@6@24895099@24982361@13@chr13:24895099-24982361@21@2780@3646@1.31@NA@SPATA13-009_13, SPATA13-009_14, C1QTNF9-003_5, C1QTNF9-003_6, ENST00000449656_1, AL359736-201_1, AL359736-201_2, RP11-556N21-001_1@58.8333333333333@2@126@:spermatogenesis associated 13:C1q and tumor necrosis factor related protein 9:C1QTNF9B antisense RNA 1@:lamellipodium assembly;phospholipid binding;Rac guanyl-nucleotide exchange factor activity;guanyl-nucleotide exchange factor activity;ruffle membrane;nucleus;regulation of cell migration;cell migration;regulation of Rho protein signal transduction;intracellular;Rho guanyl-nucleotide exchange factor activity;cytoplasm;filopodium assembly;filopodium;protein binding;lamellipodium:collagen;protein binding;hormone activity@NA
D05685@166697@166705@deletion@9@19553367@19574353@14@chr14:19553367-19574353@11.1@114@45@0.395@CNVR6072.1@POTEG-201_1, POTEG-201_2, POTEG-201_3, POTEG-201_4, POTEG-201_5, POTEG-201_6, POTEG-201_7, POTEG-201_8, POTEG-201_9@106.666666666667@76@141@:POTE ankyrin domain family, member G@:protein binding@NA
D05685@166748@166761@deletion@14@20085421@20148264@14@chr14:20085421-20148264@28@2133@1427@0.669@CNVR6072.6, CNVR6072.12, CNVR6072.14, CNVR6072.36@AL929601-201_2, AL929601-201_3, AL929601-201_4, AL512310-201_1, AL512310-201_2, AL512310-201_3, AL512310-201_4, AL512310-201_5, ENST00000398231_1, ENST00000398231_2, ENST00000398231_3, ENST00000398231_4, ENST00000398231_5, ENST00000398231_6@91.1428571428571@58@102@NA@NA@NA
D05685@173500@173503@duplication@4@106471638@106478604@14@chr14:106471638-106478604@29.6@249@508@2.04@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV3-6-210_6, IGHV1-3-001_1, IGHV4-4-001_1, IGHV4-4-001_2@10.75@4@17@@:protein binding:protein binding@NA
D05685@173508@173514@duplication@7@106539081@106573538@14@chr14:106539081-106573538@65.5@1028@1787@1.74@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8-001_1, IGHV1-8-001_2, IGHV3-9-001_1, IGHV3-9-001_2, IGHV2-10-001_1, IGHV2-10-001_2, IGHV3-11-001_2@20.4285714285714@9@24@@:protein binding:protein binding:protein binding@NA
D05685@173556@173560@deletion@5@106787370@106800618@14@chr14:106787370-106800618@14.2@690@432@0.626@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-29-001_1, IGHV3-29-001_2, IGHV3-30-001_1, IGHV3-30-001_2, IGHV3-30-2-001_2@15.4@13@19@@:protein binding@NA
D05685@173679@173684@duplication@6@20362741@20448188@15@chr15:20362741-20448188@8.79@2549@3225@1.27@CNVR6295.15@AC126603-201_1, AC126603-201_2, ENST00000400226_13, ENST00000400226_14, ENST00000400226_15, ENST00000400226_16@48.3333333333333@30@69@NA@NA@NA
D05685@173696@173734@duplication@39@20481991@20663213@15@chr15:20481991-20663213@40.6@1739@2439@1.4@CNVR6295.15, CNVR6295.7@ENST00000400226_1, HERC2P3-014_9, HERC2P3-014_10, HERC2P3-014_11, HERC2P3-014_12, HERC2P3-014_13, HERC2P3-014_14, HERC2P3-014_15, HERC2P3-014_16, HERC2P3-014_17, HERC2P3-014_18, HERC2P3-014_19, HERC2P3-014_20, HERC2P3-014_21, HERC2P3-014_22, HERC2P3-014_23, HERC2P3-014_24, HERC2P3-014_25, HERC2P3-014_26, HERC2P3-014_27, AC026495-201_8, AC026495-201_9, AC026495-201_10, AC026495-201_11, AC026495-201_12, AC026495-201_13, AC026495-201_14, AC026495-201_15, AC026495-201_16, AC026495-201_17, AC026495-201_18, AC026495-201_19, AC026495-201_20, AC026495-201_21, AC026495-201_22, AC026495-201_23, AC026495-201_24, AC026495-201_25, AC026495-201_26@98.3846153846154@57@147@NA@NA@NA
D05685@174506@174506@duplication@1@30664352@30664545@15@chr15:30664352-30664545@6.44@36@85@2.36@CNVR6337.1@CHRFAM7A-202_7@68@68@68@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
D05685@174523@174523@deletion@1@30700113@30700196@15@chr15:30700113-30700196@6.9@244@147@0.602@NA@ENST00000327271_11@54@54@54@@:Golgi apparatus@NA
D05685@174660@174662@deletion@3@32450615@32455537@15@chr15:32450615-32455537@7.56@166@94@0.566@CNVR6345.2, CNVR6345.1@CHRNA7-205_7, CHRNA7-205_8, CHRNA7-205_9@97.6666666666667@54@133@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
D05685@174997@174998@deletion@2@34848067@34849021@15@chr15:34848067-34849021@7.16@162@90@0.556@CNVR6351.3, CNVR6351.2@ENST00000427526_1, ENST00000427526_2@17@12@22@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
D05685@180187@180187@duplication@1@79065427@79065546@15@chr15:79065427-79065546@4.69@41@80@1.95@NA@ADAMTS7-201_14@10@10@10@:A disintegrin and metalloproteinase with thrombospondin motifs 7-like;ADAM metallopeptidase with thrombospondin type 1 motif, 7@:metallopeptidase activity;extracellular matrix;proteolysis;peptidase activity;proteinaceous extracellular matrix;metalloendopeptidase activity;cell surface;zinc ion binding@NA
D05685@182605@182607@deletion@3@1278902@1279739@16@chr16:1278902-1279739@7.99@53@12@0.226@CNVR6591.1@TPSB2-002_3, TPSB2-002_4, TPSB2-002_5@76.3333333333333@57@102@:tryptase beta 2 (gene/pseudogene)@:proteolysis;catalytic activity;serine-type endopeptidase activity@NA
D05685@186302@186304@deletion@3@28425026@28468348@16@chr16:28425026-28468348@5.47@124@71@0.573@NA@AC138894-201_1, AC138894-201_2, NPIPL1-202_7@43.6666666666667@22@80@NA@NA@NA
D05685@186368@186369@duplication@2@28711499@28712933@16@chr16:28711499-28712933@7.8@65@128@1.97@CNVR6686.3, CNVR6686.1, CNVR6686.2@AC145285-201_1, AC145285-201_2@60@59@61@:eukaryotic translation initiation factor 3, subunit C@:cytosol;protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;cellular protein metabolic process;binding;gene expression;translation;translation initiation factor activity@NA
D05685@186543@186545@duplication@3@29097537@29102160@16@chr16:29097537-29102160@5.35@189@268@1.42@NA@RRN3P2-201_7, RRN3P2-201_8, RRN3P2-201_9@4.66666666666667@4@5@NA@NA@NA
D05685@187506@187539@deletion@34@32858960@33021236@16@chr16:32858960-33021236@46.8@1718@1073@0.625@CNVR6702.1@IGHV2OR16-5-001_1, IGHV2OR16-5-001_2, AC138915-201_1, AC138915-201_2, AC138915-201_3, AC138915-201_4, AC138915-201_5, AC138915-201_6, AC138915-201_7, AC138915-201_8, AC138915-201_9, AC138915-201_10, AC138915-201_11, AC138915-201_12, AC138915-201_13, AC138915-201_14, AC142086-201_1, AC142086-201_2, ENST00000423205_1, ENST00000423205_2, ENST00000423205_3, ENST00000423205_4, ENST00000423205_5, ENST00000423205_6, ENST00000423205_7, ENST00000423205_8, ENST00000423205_9, ENST00000423205_10, ENST00000423205_11, ENST00000423205_12, ENST00000423205_13, AC145350-201_1, AC145350-201_2, AC145350-201_3@22.8235294117647@0@36@NA@NA@NA
D05685@188229@188235@deletion@7@55798611@55813653@16@chr16:55798611-55813653@22.3@438@241@0.55@CNVR6730.1@CES4-202_2, CES4-202_3, CES4-202_4, CES4-202_5, CES4-202_6, CES4-202_7, CES4-202_8@111@105@123@NA@NA@NA
D05685@188251@188259@duplication@9@55844431@55860208@16@chr16:55844431-55860208@14.9@1416@1839@1.3@CNVR6731.1@CES1-203_3, CES1-203_4, CES1-203_5, CES1-203_6, CES1-203_7, CES1-203_8, CES1-203_9, CES1-203_10, CES1-203_11@28.3333333333333@21@33@:carboxylesterase 1;liver carboxylesterase 1-like@:hydrolase activity;methyl salicylate esterase activity;response to toxin;methylumbelliferyl-acetate deacetylase activity;endoplasmic reticulum lumen;retinyl-palmitate esterase activity;methyl jasmonate esterase activity;metabolic process;carboxylesterase activity;methyl indole-3-acetate esterase activity@: CARBOXYLESTERASE 1; CES1
D05685@189920@189928@deletion@9@69988239@69996971@16@chr16:69988239-69996971@18@97@10@0.103@CNVR6762.3, CNVR6762.1, CNVR6762.4@CLEC18A-202_4, CLEC18A-202_5, CLEC18A-202_6, CLEC18A-202_7, CLEC18A-202_8, CLEC18A-202_9, CLEC18A-202_10, CLEC18A-202_11, CLEC18A-202_12@14.4444444444444@13@25@:C-type lectin domain family 18, member A@:carbohydrate binding;protein binding;extracellular region@NA
D05685@189989@189989@duplication@1@70219790@70219880@16@chr16:70219790-70219880@4.83@67@114@1.7@CNVR6764.1, CNVR6764.5@CLEC18C-201_11@19@19@19@:C-type lectin domain family 18, member C@:carbohydrate binding;protein binding;extracellular region@NA
D05685@192798@192800@deletion@3@4439373@4440242@17@chr17:4439373-4440242@5.39@314@216@0.688@NA@SPNS2-201_10, SPNS2-201_11, SPNS2-201_12@1@1@1@:spinster homolog 2 (Drosophila)@:integral to membrane;transmembrane transporter activity;lipid transport;transmembrane transport@NA
D05685@193078@193080@deletion@3@4890304@4890973@17@chr17:4890304-4890973@18.7@607@364@0.6@NA@CAMTA2-001_1, AC004771-201_1, AC004771-201_2@2@2@2@:calmodulin binding transcription activator 2@:cardiac muscle hypertrophy in response to stress;regulation of transcription from RNA polymerase II promoter;DNA binding;histone deacetylase binding;protein binding;chromatin binding;nucleus;transcription, DNA-dependent;transcription factor binding;positive regulation of transcription from RNA polymerase II promoter@NA
D05685@195248@195253@duplication@6@16722258@16725807@17@chr17:16722258-16725807@6.34@699@899@1.29@CNVR7008.2@AC022596-001_1, AC022596-001_2, AC022596-001_3, AC022596-001_4, AC022596-001_5, AC022596-001_6@95.5@93@97@NA@NA@NA
D05685@195691@195708@deletion@18@18331724@18345799@17@chr17:18331724-18345799@19.4@109@15@0.138@NA@ENST00000326333_2, ENST00000326333_3, ENST00000326333_4, ENST00000326333_5, ENST00000326333_6, ENST00000326333_7, ENST00000326333_8, ENST00000399124_1, ENST00000399124_2, ENST00000399124_3, ENST00000399124_4, ENST00000399124_5, ENST00000399124_6, ENST00000399124_7, ENST00000411877_1, ENST00000411877_2, ENST00000411877_3, ENST00000411877_4@140.722222222222@77@203@NA@NA@NA
D05685@195712@195747@deletion@36@18389250@18457581@17@chr17:18389250-18457581@259@1327@92@0.0693@NA@LGALS9C-201_3, LGALS9C-201_4, LGALS9C-201_5, LGALS9C-201_6, LGALS9C-201_7, LGALS9C-201_8, LGALS9C-201_9, LGALS9C-201_10, LGALS9C-201_11, ENST00000426269_1, ENST00000426269_2, ENST00000426269_3, ENST00000426269_4, ENST00000426269_5, AC107983-001_1, AC107983-001_2, AC107983-001_3, AC107983-001_4, AC107983-001_5, AC107983-001_6, AC107983-001_7, AC107983-001_8, AC107983-001_9, AC107983-001_10, ENST00000456184_1, ENST00000456184_2, CCDC144B-201_14, CCDC144B-201_15, CCDC144B-201_16, CCDC144B-201_17, CCDC144B-201_18, ENST00000447265_11, ENST00000447265_12, ENST00000447265_13, ENST00000447265_14, ENST00000447265_15@130.638888888889@123@140@:lectin, galactoside-binding, soluble, 9C:protein FAM106B-like@:carbohydrate binding@NA
D05685@196144@196154@duplication@11@20346589@20356381@17@chr17:20346589-20356381@17.8@227@390@1.72@CNVR7021.1, CNVR7021.3@ENST00000458685_4, ENST00000458685_5, ENST00000411468_3, ENST00000411468_4, ENST00000411468_5, ENST00000411468_6, LGALS9B-201_7, LGALS9B-201_8, LGALS9B-201_9, LGALS9B-201_10, LGALS9B-201_11@56.6363636363636@23@103@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
D05685@197728@197728@duplication@1@34539901@34539966@17@chr17:34539901-34539966@6.2@61@116@1.9@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1-202_4@122@122@122@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
D05685@198032@198044@duplication@13@36351805@36413071@17@chr17:36351805-36413071@195@5949@10071@1.69@CNVR7083.3@AC183087-202_2, AC183087-202_3, AC183087-202_4, AC183087-202_5, AC183087-202_6, AC183087-202_7, AC183087-202_8, AC183087-202_9, AC183087-202_10, AC183087-202_11, AC183087-202_12, AC183087-202_13, AC183087-202_14@47.4615384615385@8@64@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
D05685@199326@199326@deletion@1@40699626@40699718@17@chr17:40699626-40699718@9.85@313@180@0.575@NA@HSD17B1P1-201_4@0@0@0@NA@NA@NA
D05685@200264@200266@deletion@3@43592018@43596019@17@chr17:43592018-43596019@25@308@113@0.367@CNVR7113.4, CNVR7113.6, CNVR7113.2, CNVR7113.1@ENST00000339474_1, ENST00000339474_2, ENST00000339474_3@97.6666666666667@96@99@NA@NA@NA
D05685@200320@200328@deletion@9@44248223@44364337@17@chr17:44248223-44364337@59.7@3571@2308@0.646@CNVR7114.3, CNVR7114.2, CNVR7114.10@KIAA1267-201_1, KIAA1267-201_2, AC217773-201_1, AC217773-201_2, ENST00000451529_1, ENST00000451529_3, ENST00000451529_5@64.4285714285714@49@90@:KAT8 regulatory NSL complex subunit 1:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:histone acetyltransferase activity (H4-K8 specific);histone acetyltransferase activity (H4-K16 specific);histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase complex;histone H4-K5 acetylation;MLL1 complex;histone H4-K16 acetylation;protein binding;histone H4-K8 acetylation;nucleus:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
D05685@200337@200340@duplication@4@44399690@44409348@17@chr17:44399690-44409348@43.4@63@402@6.38@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A-001_7, LRRC37A-001_8, LRRC37A-001_9, LRRC37A-001_10@144.75@141@154@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
D05685@200343@200359@duplication@17@44414664@44627886@17@chr17:44414664-44627886@75.1@652@1379@2.12@CNVR7114.2, CNVR7114.1@LRRC37A-001_13, LRRC37A-001_14, LRRC37A-001_15, AC005829-202_1, AC005829-202_2, AC005829-202_3, LRRC37A2-201_1, LRRC37A2-201_2, LRRC37A2-201_3, LRRC37A2-201_4, LRRC37A2-201_5, LRRC37A2-201_6, LRRC37A2-201_7, LRRC37A2-201_8, LRRC37A2-201_9, LRRC37A2-201_10, ARL17P1-202_5@114.588235294118@58@196@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
D05685@200361@200363@deletion@3@44632520@44633017@17@chr17:44632520-44633017@38.8@181@0@0@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2-201_12, LRRC37A2-201_13, LRRC37A2-201_14@89.6666666666667@74@98@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
D05685@200380@200381@duplication@2@44771215@44772029@17@chr17:44771215-44772029@6.23@55@108@1.96@CNVR7114.2, CNVR7114.4@NSF-201_11, NSF-201_12@9.5@8@11@:N-ethylmaleimide-sensitive factor@:PDZ domain binding;Rab GTPase binding;regulation of exocytosis;ATP binding;Golgi stack;protein transport;protein C-terminus binding;plasma membrane;dendritic shaft;potassium ion transport;nucleoside-triphosphatase activity;exocytosis;positive regulation of receptor recycling;nucleotide binding;plasma membrane fusion;cytoplasm;cytosol;protein binding;vesicle-mediated transport;ATPase activity, coupled;protein complex binding;synaptic transmission;syntaxin binding;metal ion binding@NA
D05685@201839@201840@duplication@2@57656835@57657241@17@chr17:57656835-57657241@5.27@130@194@1.49@NA@DHX40-203_12, DHX40-203_13@7.5@3@12@:DEAH (Asp-Glu-Ala-His) box polypeptide 40@:transport;helicase activity;intracellular;ATP-dependent helicase activity;nucleic acid binding;ATP binding@NA
D05685@210511@210511@deletion@1@4294774@4294814@19@chr19:4294774-4294814@5.95@144@81@0.562@NA@TMIGD2-202_3@2@2@2@:transmembrane and immunoglobulin domain containing 2@:protein binding;integral to membrane;plasma membrane@NA
D05685@213493@213494@deletion@2@14508472@14508748@19@chr19:14508472-14508748@16.4@103@19@0.184@NA@CD97-205_8, CD97-205_9@10.5@7@14@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
D05685@215928@215928@deletion@1@35862253@35863856@19@chr19:35862253-35863856@40.3@194@0@0@CNVR7627.1@FFAR3-001_2@102@102@102@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
D05685@217305@217306@deletion@2@40397969@40399856@19@chr19:40397969-40399856@5.45@66@29@0.439@CNVR7639.2, CNVR7639.3@FCGBP-201_13, FCGBP-201_14@116.5@106@127@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D05685@217595@217595@duplication@1@41327389@41327534@19@chr19:41327389-41327534@9.91@72@156@2.17@NA@CYP2F1P-001_5@0@0@0@NA@NA@NA
D05685@220212@220214@deletion@3@50472859@50473865@19@chr19:50472859-50473865@8.59@376@239@0.636@NA@SIGLEC16-202_1, SIGLEC16-202_2, SIGLEC16-202_3@63.6666666666667@56@68@NA@NA@NA
D05685@220700@220700@duplication@1@52149512@52149894@19@chr19:52149512-52149894@8.05@77@149@1.94@CNVR7702.1@SIGLEC5-201_2@14@14@14@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 14@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion;plasma membrane@NA
D05685@220829@220830@deletion@2@53007910@53008035@19@chr19:53007910-53008035@4.93@277@184@0.664@NA@ZNF578-002_5, AC022150-201_5@2@2@2@:zinc finger protein 578@:intracellular;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
D05685@221169@221177@duplication@9@54726152@54743828@19@chr19:54726152-54743828@17.8@639@905@1.42@CNVR7721.3, CNVR7721.4, CNVR7721.1@LILRB3-008_1, LILRB3-008_2, LILRB3-008_3, AC010492-001_1, AC010492-001_2, LILRA6-002_7, LILRA6-002_8, LILRA6-002_9, LILRA6-002_10@67.4444444444444@44@119@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D05685@221397@221399@deletion@3@55267568@55270359@19@chr19:55267568-55270359@7.04@171@99@0.579@CNVR7725.2, CNVR7725.1@KIR2DP1-001_2, KIR2DP1-001_3, KIR2DP1-001_4@100.333333333333@91@107@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity@NA
D05685@221403@221409@deletion@7@55277931@55281337@19@chr19:55277931-55281337@35.7@1193@712@0.597@CNVR7725.2, CNVR7725.1@KIR2DL3-201_6, KIR2DL3-201_7, KIR2DL3-201_8, KIR2DP1-001_7, KIR2DP1-001_8, KIR2DP1-001_9, KIR2DL1-002_1@123.428571428571@110@126@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
D05685@221435@221438@deletion@4@55346536@55354374@19@chr19:55346536-55354374@5.71@396@272@0.687@CNVR7725.1, CNVR7725.6@KIR2DS4-001_2, KIR2DS4-001_3, KIR2DS4-001_4, KIR2DS4-001_5@57.75@41@68@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
D05685@221440@221441@duplication@2@55359208@55360024@19@chr19:55359208-55360024@8.09@1006@1333@1.33@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4-001_7, KIR2DS4-001_8@102@102@102@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
D05685@221819@221821@deletion@3@56270382@56274542@19@chr19:56270382-56274542@30.6@906@560@0.618@CNVR7734.1@RFPL4A-201_1, RFPL4A-201_2, RFPL4A-201_3@32.6666666666667@26@39@:ret finger protein-like 4A;ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
D05685@222067@222069@deletion@3@58002993@58003369@19@chr19:58002993-58003369@11.1@189@98@0.519@CNVR7748.1@ZNF419-202_4, ZNF419-202_5, ZNF419-202_6@0@0@0@:zinc finger protein 419@:intracellular;DNA binding;regulation of transcription, DNA-dependent;cytoplasm;nucleolus;nucleus;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding@NA
D05685@222562@222563@deletion@2@1558986@1569279@20@chr20:1558986-1569279@19.4@402@202@0.502@CNVR7763.1@SIRPB1-201_1, SIRPB1-201_2@90.5@53@128@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
D05685@222594@222594@duplication@1@1895747@1896102@20@chr20:1895747-1896102@5.8@158@237@1.5@CNVR7764.2@SIRPA-201_3@34@34@34@:signal-regulatory protein alpha@:blood coagulation;protein binding;integral to membrane;SH3 domain binding;cell adhesion;plasma membrane;membrane;leukocyte migration@NA
D05685@228887@228889@deletion@3@14468652@14469897@21@chr21:14468652-14469897@10.7@169@83@0.491@NA@ZNF355P-201_3, ZNF355P-201_4, ZNF355P-201_5@20.6666666666667@20@21@NA@NA@NA
D05685@231958@231958@deletion@1@16287256@16287718@22@chr22:16287256-16287718@5.67@81@38@0.469@CNVR8071.2, CNVR8071.3, CNVR8071.9@POTEH-002_1@105@105@105@:POTE ankyrin domain family, member H@:protein binding@NA
D05685@232771@232788@duplication@18@20385728@20475157@22@chr22:20385728-20475157@16.7@222@373@1.68@CNVR8094.4, CNVR8094.7@PI4KAP1-204_1, PI4KAP1-204_2, PI4KAP1-204_3, PI4KAP1-204_4, PI4KAP1-204_5, PI4KAP1-204_6, PI4KAP1-204_7, PI4KAP1-204_8, PI4KAP1-204_9, PI4KAP1-204_10, PI4KAP1-204_11, PI4KAP1-204_12, PI4KAP1-204_13, PI4KAP1-204_14, ENST00000434754_1, ENST00000434754_2, ENST00000434754_3, ENST00000434754_4@155.722222222222@117@172@:RIMS binding protein 3@:protein binding@NA
D05685@233473@233474@duplication@2@23247264@23248971@22@chr22:23247264-23248971@11.1@115@214@1.86@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11@BCRL4-001_6, BCRL4-001_7@0@0@0@@:protein binding@NA
D05685@233708@233708@duplication@1@24302483@24302569@22@chr22:24302483-24302569@4.91@23@59@2.57@CNVR8114.6, CNVR8114.12, CNVR8114.13, CNVR8114.8@GSTT2B-002_2@67@67@67@:glutathione S-transferase theta 2B (gene/pseudogene);glutathione S-transferase theta 2@:protein binding;glutathione transferase activity;nucleus;transferase activity;cytoplasm@NA
D05685@233721@233723@deletion@3@24323141@24325194@22@chr22:24323141-24325194@5.83@233@148@0.635@CNVR8114.6, CNVR8114.13, CNVR8114.8, CNVR8114.14@GSTT2-002_2, GSTT2-002_3, GSTT2-002_4@86@55@102@@:protein binding;glutathione transferase activity;nucleus;cytoplasm@NA
D05685@234199@234202@deletion@4@26892041@26895598@22@chr22:26892041-26895598@32.4@697@354@0.508@NA@TFIP11-001_10, TFIP11-001_11, TFIP11-001_12, TFIP11-001_13@0@0@0@:tuftelin interacting protein 11@:nuclear speck;DNA binding;regulation of transcription, DNA-dependent;catalytic step 2 spliceosome;spliceosomal complex;cytoplasm;biomineral tissue development;protein binding;proteinaceous extracellular matrix;mRNA splicing, via spliceosome;nucleus;nucleic acid binding;RNA processing@NA
D08064@593@593@duplication@1@1607505@1607639@1@chr1:1607505-1607639@5.29@41@86@2.1@CNVR17.1@RP11-345P4-003_4@10@10@10@:solute carrier family 35, member E2B@:integral to membrane;membrane;transmembrane transport@NA
D08064@2999@3000@duplication@2@17198306@17199603@1@chr1:17198306-17199603@5.14@772@1000@1.3@CNVR94.1, CNVR94.4, CNVR94.8@ENST00000356370_1, ENST00000438002_1@20.5@20@21@NA@NA@NA
D08064@4449@4461@duplication@13@25593204@25655628@1@chr1:25593204-25655628@50.7@1224@1918@1.57@CNVR116.1, CNVR116.2@C1orf63-002_1, RP11-335G20-001_1, RHD-202_1, RHD-202_2, RHD-202_3, RHD-202_4, RHD-202_5, RHD-202_6, RHD-202_7, RHD-202_8, RHD-202_9, RHD-202_10, RHD-202_11@117.692307692308@92@128@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
D08064@11245@11246@deletion@2@89476589@89477711@1@chr1:89476589-89477711@102@566@3@0.0053@CNVR244.1@GBP3-001_7, GBP3-001_8@54@54@54@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
D08064@12416@12417@deletion@2@104202984@104203299@1@chr1:104202984-104203299@9.83@124@53@0.427@CNVR266.3, CNVR266.1@AMY1A-001_7, AMY1A-001_8@123.5@118@129@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D08064@12424@12425@duplication@2@104233918@104234233@1@chr1:104233918-104234233@5.95@58@109@1.88@CNVR266.3, CNVR266.5@AMY1B-001_7, AMY1B-001_8@154@154@154@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D08064@12432@12446@deletion@15@104256347@104297437@1@chr1:104256347-104297437@36.8@428@149@0.348@CNVR266.3, CNVR266.5@AMYP1-001_1, AMYP1-001_2, AMYP1-001_3, AMYP1-001_4, AMYP1-001_5, AMYP1-001_6, AMYP1-001_7, AMY1C-201_1, AMY1C-201_2, AMY1C-201_3, AMY1C-201_4, AMY1C-201_5, AMY1C-201_6, AMY1C-201_7, AMY1C-201_8@75.6666666666667@31@145@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D08064@12525@12526@duplication@2@108769303@108771779@1@chr1:108769303-108771779@6.96@195@292@1.5@CNVR294.4@NBPF4-002_12, NBPF4-002_13@26.5@21@32@:neuroblastoma breakpoint family, member 4@:cytoplasm@NA
D08064@12929@12936@deletion@8@110230474@110236368@1@chr1:110230474-110236368@106@499@1@0.002@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1-001_1, GSTM1-001_2, GSTM1-001_3, GSTM1-001_4, GSTM1-001_5, GSTM1-001_6, GSTM1-001_7, GSTM1-001_8@191.375@187@194@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
D08064@14493@14495@duplication@3@144676872@144679973@1@chr1:144676872-144679973@11.6@328@498@1.52@CNVR337.1@WI2-1896O14-001_1, WI2-1896O14-001_2, WI2-1896O14-001_3@4.66666666666667@4@5@NA@NA@NA
D08064@21362@21367@duplication@6@196743977@196763216@1@chr1:196743977-196763216@20.2@839@1197@1.43@CNVR459.1@CFHR3-001_1, CFHR3-001_2, CFHR3-001_3, CFHR3-001_4, CFHR3-001_5, CFHR3-001_6@98@85@112@:complement factor H-related 3@:extracellular space@NA
D08064@21375@21384@deletion@10@196857217@196887764@1@chr1:196857217-196887764@81.3@2007@1046@0.521@CNVR459.5@CFHR4-201_1, CFHR4-201_2, CFHR4-201_3, CFHR4-201_4, CFHR4-201_5, CFHR4-201_6, CFHR4-201_7, CFHR4-201_8, CFHR4-201_9, CFHR4-201_10@8.2@6@15@:complement factor H-related 2:complement factor H-related 4@:extracellular region:extracellular region;lipid transporter activity;lipid transport@NA
D08064@23042@23043@deletion@2@207737211@207737580@1@chr1:207737211-207737580@5.17@56@23@0.411@CNVR485.1, CNVR485.2@CR1-201_22, CR1-201_23@11@9@13@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
D08064@33558@33564@duplication@7@87404273@87414366@2@chr2:87404273-87414366@10.1@426@590@1.38@CNVR861.2@AC083899-001_22, AC083899-001_23, AC083899-001_24, AC083899-001_25, AC083899-001_26, AC083899-001_27, AC083899-001_28@67@45@85@NA@NA@NA
D08064@34094@34095@deletion@2@96458183@96458295@2@chr2:96458183-96458295@8.6@65@18@0.277@NA@AC008268-201_3, ENST00000444924_2@104@104@104@NA@NA@NA
D08064@34183@34184@duplication@2@96652501@96652955@2@chr2:96652501-96652955@8.73@213@339@1.59@NA@AC073995-001_2, AC073995-001_3@4@4@4@:ankyrin repeat domain-containing protein 36A-like@:ion channel inhibitor activity;protein binding@NA
D08064@34212@34212@duplication@1@96697783@96697895@2@chr2:96697783-96697895@5.01@63@113@1.79@NA@GPAT2-205_4@75@75@75@:glycerol-3-phosphate acyltransferase 2, mitochondrial@:glycerol-3-phosphate O-acyltransferase activity;mitochondrion;phospholipid metabolic process;triglyceride biosynthetic process;glycerophospholipid biosynthetic process;small molecule metabolic process;transferase activity, transferring acyl groups;mitochondrial outer membrane;phosphatidic acid biosynthetic process;integral to membrane;glycerol-3-phosphate metabolic process;CDP-diacylglycerol biosynthetic process;membrane;metabolic process;phospholipid biosynthetic process@NA
D08064@35797@35798@deletion@2@110765254@110768361@2@chr2:110765254-110768361@10.2@46@0@0@NA@ENST00000262716_1, ENST00000262716_2@43@43@43@NA@NA@NA
D08064@37209@37209@deletion@1@130898733@130898870@2@chr2:130898733-130898870@4.73@92@48@0.522@NA@CCDC74B-001_4@15@15@15@:coiled-coil domain containing 74A;coiled-coil domain containing 74B@NA@NA
D08064@37359@37359@deletion@1@131414124@131415665@2@chr2:131414124-131415665@5.42@66@28@0.424@NA@POTEJ-001_15@52@52@52@:POTE ankyrin domain family, member J@:protein binding;ATP binding@NA
D08064@61532@61548@deletion@17@195377017@195393086@3@chr3:195377017-195393086@40@860@423@0.492@CNVR1703.1@AC233280-201_1, AC233280-201_2, AC233280-201_3, AC233280-201_4, AC233280-201_5, AC233280-201_6, AC233280-201_7, AC233280-201_8, AC069513-001_1, AC069513-001_2, AC069513-001_3, SDHALP2-001_1, SDHALP2-001_2, SDHALP2-001_3, SDHALP2-001_4, SDHALP2-001_5, SDHALP2-001_6@86.1176470588235@68@93@:mucin 20, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane@NA
D08064@62022@62028@deletion@7@197846588@197880281@3@chr3:197846588-197880281@7.73@121@60@0.496@CNVR1728.7, CNVR1728.8, CNVR1728.5, CNVR1728.4@ENST00000392362_1, ENST00000392362_2, ENST00000451150_1, ENST00000451150_2, ENST00000451150_3, FAM157B-201_1, FAM157B-201_2@37.1428571428571@11@53@:putative protein FAM157B-like;family with sequence similarity 157, member A;putative protein FAM157C-like;family with sequence similarity 157, member B@NA@NA
D08064@65315@65320@duplication@6@69402904@69434246@4@chr4:69402904-69434246@26.8@1171@1741@1.49@CNVR1953.1@UGT2B17-001_1, UGT2B17-001_2, UGT2B17-001_3, UGT2B17-001_4, UGT2B17-001_5, UGT2B17-001_6@124.5@118@134@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
D08064@65799@65801@deletion@3@75312253@75316250@4@chr4:75312253-75316250@15.7@163@58@0.356@NA@AREG-001_2, AREG-001_3, AREG-001_4@36.3333333333333@28@52@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
D08064@65805@65807@duplication@3@75482008@75486007@4@chr4:75482008-75486007@12.3@120@234@1.95@NA@AREGB-201_2, AREGB-201_3, AREGB-201_4@50.3333333333333@45@56@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
D08064@72026@72026@deletion@1@35867410@35867566@5@chr5:35867410-35867566@5.11@129@72@0.558@NA@IL7R-001_3@0@0@0@:interleukin 7 receptor@:immune response;interleukin-7-mediated signaling pathway;interleukin-7 receptor activity;homeostasis of number of cells;integral to membrane;plasma membrane;regulation of DNA recombination;cell surface receptor signaling pathway;cell morphogenesis;B cell proliferation;positive regulation of gene expression;positive regulation of T cell differentiation in thymus;cell growth;external side of plasma membrane;T cell differentiation;cytokine receptor activity;antigen binding;protein binding;negative regulation of T cell mediated cytotoxicity;signal transduction;extracellular region;immunoglobulin production;lymph node development;membrane;regulation of cell size@: SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE,; MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 3; MS3
D08064@73746@73747@duplication@2@69796546@69796729@5@chr5:69796546-69796729@6.42@20@64@3.2@CNVR2494.10, CNVR2494.57@AC146944-203_1, AC146944-203_2@173@173@173@NA@NA@NA
D08064@73795@73796@duplication@2@70307104@70308746@5@chr5:70307104-70308746@5.06@646@862@1.33@CNVR2494.41, CNVR2494.14, CNVR2494.30, CNVR2494.20, CNVR2494.62, CNVR2494.8, CNVR2494.35@NAIP-001_4, NAIP-001_5@29.5@27@32@:baculoviral IAP repeat-containing protein 1-like;NLR family, apoptosis inhibitory protein@:negative regulation of apoptotic process;inflammatory response;basolateral plasma membrane;nucleoside-triphosphatase activity;cysteine-type endopeptidase inhibitor activity;intracellular;nucleotide binding;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;ATP binding;cytoplasm;innate immune response;protein binding;negative regulation of neuron apoptotic process;metal ion binding;nervous system development@NA
D08064@73812@73821@duplication@10@70357101@70389020@5@chr5:70357101-70389020@15.8@310@491@1.58@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.8, CNVR2494.1, CNVR2494.37@GTF2H2-202_1, GTF2H2-202_2, GTF2H2-202_3, GTF2H2-202_4, GTF2H2-202_5, AC044797-201_1, AC044797-201_2, AC044797-201_3, AC044797-201_4, AC044797-201_5@91.2@61@138@:general transcription factor IIH, polypeptide 2, 44kDa@:nucleoplasm;nucleotide-excision repair, DNA damage removal;transcription from RNA polymerase I promoter;DNA repair;RNA polymerase II carboxy-terminal domain kinase activity;nucleus;viral reproduction;translation;gene expression;transcription elongation from RNA polymerase I promoter;response to UV;holo TFIIH complex;protein kinase activity;nucleotide-excision repair;transcription from RNA polymerase II promoter;transcription-coupled nucleotide-excision repair;transcription, DNA-dependent;zinc ion binding;transcription elongation from RNA polymerase II promoter;termination of RNA polymerase I transcription;sequence-specific DNA binding transcription factor activity;G-protein coupled receptor internalization;DNA-dependent ATPase activity;protein N-terminus binding;transcription initiation from RNA polymerase I promoter;7-methylguanosine mRNA capping;transcription initiation from RNA polymerase II promoter;protein phosphorylation;translation factor activity, nucleic acid binding;regulation of transcription, DNA-dependent;core TFIIH complex;protein binding;positive regulation of viral transcription;nucleic acid binding@NA
D08064@79566@79570@duplication@5@175386532@175394271@5@chr5:175386532-175394271@18.4@265@450@1.7@NA@THOC3-001_2, THOC3-001_3, THOC3-001_4, THOC3-001_5, THOC3-001_6@116@27@182@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
D08064@80019@80019@deletion@1@177163582@177163611@5@chr5:177163582-177163611@5.98@60@22@0.367@NA@FAM153A-204_12@78@78@78@:family with sequence similarity 153, member A@NA@NA
D08064@80022@80024@deletion@3@177166603@177168334@5@chr5:177166603-177168334@16.3@89@10@0.112@NA@FAM153A-204_7, FAM153A-204_8, FAM153A-204_9@94@86@106@:family with sequence similarity 153, member A@NA@NA
D08064@80485@80486@duplication@2@180424215@180424410@5@chr5:180424215-180424410@5.03@188@266@1.41@CNVR2719.1@BTNL3-202_3, BTNL3-202_4@53.5@4@103@:butyrophilin-like 3@:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
D08064@80560@80569@duplication@10@292099@367497@6@chr6:292099-367497@22.5@2582@3411@1.32@CNVR2728.1@DUSP22-001_1, DUSP22-001_2, DUSP22-001_3, DUSP22-001_4, DUSP22-001_5, DUSP22-001_6, DUSP22-001_7, DUSP22-001_8, AL357054-201_1, AL357054-201_2@15.2@6@20@:dual specificity phosphatase 22;dual specificity protein phosphatase 22-like@:protein dephosphorylation;transforming growth factor beta receptor signaling pathway;positive regulation of JNK cascade;protein tyrosine/serine/threonine phosphatase activity;nucleus;apoptotic process;multicellular organismal development;phosphatase activity;protein tyrosine phosphatase activity;regulation of cell proliferation;cytoplasm;cell proliferation;inactivation of MAPK activity;protein binding;negative regulation of transcription from RNA polymerase II promoter;dephosphorylation@NA
D08064@82492@82498@duplication@7@29857486@29865564@6@chr6:29857486-29865564@9.72@596@802@1.35@CNVR2829.7, CNVR2829.2, CNVR2829.8, CNVR2829.3@HLA-H-001_5, HLA-H-001_6, HLA-H-001_7, HLA-16-001_1, HLA-16-001_2, HLA-16-001_3, HLA-16-001_4@49.8571428571429@48@51@NA@NA@NA
D08064@82507@82510@duplication@4@29894957@29896034@6@chr6:29894957-29896034@8.84@314@446@1.42@CNVR2829.7, CNVR2829.2, CNVR2829.3@AL645929-201_3, AL645929-201_4, HLA-K-001_3, HLA-K-001_4@43@42@44@NA@NA@NA
D08064@82520@82523@duplication@4@29911901@29913059@6@chr6:29911901-29913059@12.1@755@1036@1.37@CNVR2829.7, CNVR2829.2, CNVR2829.3@HLA-A-001_6, HLA-A-001_7, HLA-A-001_8, HLA-A-001_9@19.25@14@22@:major histocompatibility complex, class I, A@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO
D08064@83577@83586@deletion@10@31962024@31964839@6@chr6:31962024-31964839@25.9@521@275@0.528@CNVR2843.6, CNVR2843.3@C4A-001_20, C4A-001_21, C4A-001_22, C4A-001_23, C4A-001_24, C4A-001_25, C4A-001_26, C4A-001_27, C4A-001_28, C4A-001_29@13.2@5@17@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
D08064@83602@83610@deletion@9@31973767@31974877@6@chr6:31973767-31974877@47.7@1099@589@0.536@CNVR2843.6, CNVR2843.3@CYP21A1P-001_2, CYP21A1P-001_3, CYP21A1P-001_4, CYP21A1P-001_5, CYP21A1P-001_6, AL645922-201_1, AL645922-201_2, AL645922-201_3, AL645922-201_4@107.777777777778@98@113@NA@NA@NA
D08064@83910@83915@deletion@6@32441204@32489952@6@chr6:32441204-32489952@25.2@243@91@0.374@CNVR2845.21, CNVR2845.25, CNVR2845.30@HLA-DRB9-001_1, HLA-DRB5-001_2, HLA-DRB5-001_3, HLA-DRB5-001_4, HLA-DRB5-001_5, HLA-DRB5-001_6@160.833333333333@44@189@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D08064@83919@83927@deletion@9@32521635@32548048@6@chr6:32521635-32548048@19@293@144@0.491@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.5@HLA-DRB6-002_1, HLA-DRB6-002_2, HLA-DRB6-002_3, HLA-DRB6-002_4, AL713966-201_1, AL713966-201_2, AL713966-201_3, HLA-DRB1-001_5, HLA-DRB1-001_6@126.111111111111@85@167@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
D08064@83932@83946@deletion@15@32605206@32634448@6@chr6:32605206-32634448@94@1113@471@0.423@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20@HLA-DQA1-002_1, HLA-DQA1-002_2, HLA-DQA1-002_3, HLA-DQA1-002_4, HLA-DQA1-002_5, HLA-DQA1-002_6, HLA-DQB1-003_2, HLA-DQB1-003_3, HLA-DQB1-003_4, HLA-DQB1-003_5, HLA-DQB1-003_6, XXbac-BPG254F23-001_1, XXbac-BPG254F23-001_2, ENST00000443574_1, ENST00000443574_2@120@80@146@:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
D08064@86709@86709@deletion@1@52712710@52712831@6@chr6:52712710-52712831@6.7@114@55@0.482@NA@ENST00000452866_6@1@1@1@NA@NA@NA
D08064@92591@92595@duplication@5@160132717@160133523@6@chr6:160132717-160133523@8.75@648@868@1.34@CNVR3127.2, CNVR3127.1@ENST00000442642_2, ENST00000442642_3, ENST00000442642_4, ENST00000442642_5, ENST00000442642_6@74.2@13@106@:superoxide dismutase 2, mitochondrial;uncharacterized LOC100129518@:response to reactive oxygen species;oxidation-reduction process;mitochondrion;negative regulation of cell proliferation;neuron development;negative regulation of fat cell differentiation;removal of superoxide radicals;response to gamma radiation;response to L-ascorbic acid;response to lipopolysaccharide;response to nutrient levels;response to zinc ion;protein homotetramerization;post-embryonic development;iron ion homeostasis;hemopoiesis;aging;mitochondrial inner membrane;age-dependent response to reactive oxygen species;response to drug;oxygen binding;mitochondrial nucleoid;vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure;apoptotic process;superoxide metabolic process;response to superoxide;detection of oxygen;response to silicon dioxide;cytoplasm;response to stress;respiratory electron transport chain;superoxide anion generation;protein homooligomerization;regulation of mitochondrial membrane potential;positive regulation of nitric oxide biosynthetic process;response to manganese ion;regulation of blood pressure;metal ion binding;negative regulation of apoptotic process;response to cadmium ion;response to oxidative stress;liver development;regulation of catalytic activity;negative regulation of fibroblast proliferation;response to selenium ion;age-dependent response to oxidative stress;response to electrical stimulus;mitochondrial matrix;identical protein binding;mitochondrion organization;response to hyperoxia;vasodilation;response to hydrogen peroxide;superoxide dismutase activity;heart development;negative regulation of neuron apoptotic process;erythrophore differentiation;locomotory behavior;DNA binding;release of cytochrome c from mitochondria;response to axon injury;oxygen homeostasis;response to activity;glutathione metabolic process;hydrogen peroxide metabolic process;hydrogen peroxide biosynthetic process;regulation of transcription from RNA polymerase II promoter;response to hypoxia;protein binding;manganese ion binding;cellular response to ethanol@: MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6; MVCD6
D08064@93069@93070@deletion@2@167590486@167590623@6@chr6:167590486-167590623@6.6@354@228@0.644@NA@TCP10L2-001_3, AL121935-201_4@34@34@34@:t-complex 10;t-complex 10-like 2@NA@NA
D08064@93098@93104@duplication@7@167789456@167907577@6@chr6:167789456-167907577@8.91@411@560@1.36@NA@TCP10-001_1, TCP10-001_2, TCP10-001_3, TCP10-001_4, TCP10-001_5, TCP10-001_6, AL356123-201_1@39.5714285714286@0@103@:t-complex 10@:cytosol@NA
D08064@94192@94209@deletion@18@5963468@6000496@7@chr7:5963468-6000496@39.7@1439@875@0.608@NA@C7orf28A-001_14, C7orf28A-001_15, RSPH10B-002_6, RSPH10B-002_7, RSPH10B-002_8, RSPH10B-002_9, RSPH10B-002_10, RSPH10B-002_11, RSPH10B-002_12, RSPH10B-002_13, RSPH10B-002_14, RSPH10B-002_15, RSPH10B-002_16, RSPH10B-002_17, RSPH10B-002_18, RSPH10B-002_19, RSPH10B-002_20, RSPH10B-002_21@16.6111111111111@8@73@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae):radial spoke head 10 homolog B (Chlamydomonas)@:lysosomal membrane@NA
D08064@94431@94444@duplication@14@6820442@6844687@7@chr7:6820442-6844687@48.9@938@1534@1.64@NA@RSPH10B2-204_14, RSPH10B2-204_15, RSPH10B2-204_16, RSPH10B2-204_17, RSPH10B2-204_18, RSPH10B2-204_19, RSPH10B2-204_20, RSPH10B2-204_21, ENST00000429267_1, ENST00000429267_2, C7orf28B-001_12, C7orf28B-001_13, C7orf28B-001_14, C7orf28B-001_15@54.7857142857143@16@121@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D08064@94461@94463@deletion@3@6906478@6920188@7@chr7:6906478-6920188@6.38@263@167@0.635@NA@RP11-740N7-201_1, RP11-740N7-201_2, RP11-740N7-201_3@21.3333333333333@20@22@NA@NA@NA
D08064@96205@96205@deletion@1@33195252@33195315@7@chr7:33195252-33195315@5.85@81@36@0.444@NA@BBS9-203_4@10@10@10@:Bardet-Biedl syndrome 9@:BBSome;fat cell differentiation;microtubule organizing center;cytoplasm;protein binding;response to stimulus;visual perception;nucleus;plasma membrane;molecular_function;cilium membrane@: WILMS TUMOR 5; WT5; BARDET-BIEDL SYNDROME; BBS
D08064@96579@96584@duplication@6@38388958@38398764@7@chr7:38388958-38398764@15.4@1577@2092@1.33@CNVR3354.3, CNVR3354.1@TRGV5-001_1, TRGV5-001_2, TRGV4-001_1, TRGV4-001_2, TRGV3-001_1, TRGV3-001_2@10.5@6@14@@:protein binding:protein binding:protein binding;immune response;peptide antigen binding;plasma membrane;MHC protein binding@NA
D08064@97908@97916@deletion@9@57064289@57082132@7@chr7:57064289-57082132@8.61@113@55@0.487@NA@TNRC18C-202_4, TNRC18C-202_5, TNRC18C-202_6, TNRC18C-202_7, TNRC18C-202_8, TNRC18C-202_9, TNRC18C-202_10, TNRC18C-202_11, ENST00000398760_5@157.222222222222@139@166@NA@NA@NA
D08064@97990@97996@duplication@7@62753052@62764435@7@chr7:62753052-62764435@51.5@772@1539@1.99@NA@AC006455-201_1, AC006455-201_2, AC006455-201_3, AC006455-201_4, ENST00000444809_1, ENST00000444809_2, ENST00000444809_3, ENST00000444809_4@138.285714285714@97@171@NA@NA@NA
D08064@98014@98026@deletion@13@62904582@62970547@7@chr7:62904582-62970547@71.1@599@161@0.269@NA@ZNF734-201_1, ZNF734-201_2, ZNF734-201_3, ZNF734-201_4, ZNF734-201_5, ZNF734-201_6, ZNF734-201_7, ZNF734-201_8, ENST00000434048_1, ENST00000434048_2, CTD-2526L21-201_1, CTD-2526L21-201_2, CTD-2526L21-201_3@75.3846153846154@1@102@NA@NA@NA
D08064@98192@98193@deletion@2@64646770@64646889@7@chr7:64646770-64646889@8.07@57@14@0.246@NA@INTS4L1-201_8, INTS4L1-201_9@51.5@51@52@NA@NA@NA
D08064@98688@98688@deletion@1@72613728@72613825@7@chr7:72613728-72613825@4.71@21@0@0@NA@RP11-396K3-001_18@1@1@1@NA@NA@NA
D08064@99025@99035@deletion@11@74160678@74172334@7@chr7:74160678-74172334@7.81@175@99@0.566@NA@GTF2I-001_23, GTF2I-001_24, GTF2I-001_25, GTF2I-001_26, GTF2I-001_27, GTF2I-001_28, GTF2I-001_29, GTF2I-001_30, GTF2I-001_31, GTF2I-001_32, GTF2I-001_33@32.7272727272727@14@54@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
D08064@99061@99063@deletion@3@74239464@74251506@7@chr7:74239464-74251506@6.27@30@1@0.0333@NA@GTF2IRD2-002_2, GTF2IRD2-002_3, GTF2IRD2-002_4@9@7@12@:GTF2I repeat domain containing 2@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
D08064@99272@99273@duplication@2@75054920@75055736@7@chr7:75054920-75055736@6.22@104@171@1.64@NA@POM121C-001_8, POM121C-001_9@51@30@72@:POM121 transmembrane nucleoporin C@:nuclear membrane;protein binding;protein transport;endoplasmic reticulum membrane;nuclear pore;mRNA transport@NA
D08064@101721@101726@duplication@6@100331652@100336237@7@chr7:100331652-100336237@10.9@748@1000@1.34@CNVR3509.1@ZAN-001_2, ZAN-001_3, ZAN-001_4, ZAN-001_5, ZAN-001_6, ZAN-001_7@81.6666666666667@71@89@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
D08064@102140@102145@duplication@6@102165548@102180539@7@chr7:102165548-102180539@11.2@179@297@1.66@CNVR3518.1@RASA4B-007_4, RASA4B-007_5, RASA4B-007_6, POLR2J3-003_7, POLR2J3-003_8, POLR2J3-003_9@74.5@44@96@:RAS p21 protein activator 4B:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
D08064@102166@102167@deletion@2@102219874@102223340@7@chr7:102219874-102223340@9.84@51@4@0.0784@CNVR3518.1@ENST00000379336_1, RASA4-001_21@56@49@63@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
D08064@102177@102193@duplication@17@102235754@102279647@7@chr7:102235754-102279647@18.4@433@669@1.55@CNVR3518.1@RASA4-001_1, RASA4-001_2, RASA4-001_3, RASA4-001_4, RASA4-001_5, RASA4-001_6, RASA4-001_7, RASA4-001_8, RASA4-001_9, RASA4-001_10, RASA4-001_11, ENST00000340457_4, ENST00000340457_5, ENST00000340457_6, POLR2J2-001_7, POLR2J2-001_8, POLR2J2-001_9@53.5882352941176@42@77@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
D08064@102210@102210@duplication@1@102318934@102319304@7@chr7:102318934-102319304@8.76@266@421@1.58@CNVR3518.1@ENST00000379355_1@54@54@54@NA@NA@NA
D08064@105326@105337@deletion@12@141773884@141786129@7@chr7:141773884-141786129@23.4@1970@1348@0.684@CNVR3585.3, CNVR3585.2@MGAM-007_45, MGAM-007_46, MGAM-007_47, MGAM-007_48, MGAM-007_49, MGAM-007_50, MGAM-007_51, MGAM-007_52, MGAM-007_53, MGAM-007_54, MGAM-007_55, MGAM-007_56@123.416666666667@121@127@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
D08064@105821@105822@duplication@2@144063941@144064449@7@chr7:144063941-144064449@5.28@8@42@5.25@CNVR3598.4, CNVR3598.5, CNVR3598.11@ARHGEF5-001_4, ARHGEF5-001_5@84.5@65@104@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
D08064@107428@107429@duplication@2@7308087@7308722@8@chr8:7308087-7308722@7.32@489@669@1.37@CNVR3771.8, CNVR3771.10, CNVR3771.4@SPAG11-003_3, SPAG11-003_4@90.5@90@91@:sperm associated antigen 11B@:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response@NA
D08064@107512@107513@deletion@2@7717871@7718505@8@chr8:7717871-7718505@51.9@291@20@0.0687@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@SPAG11A-207_3, SPAG11A-207_4@112@111@113@:sperm associated antigen 11A;sperm associated antigen 11B@:extracellular region;defense response@NA
D08064@114316@114317@deletion@2@145193620@145194004@8@chr8:145193620-145194004@5.56@96@48@0.5@NA@C8orf30A-201_3, C8orf30A-201_4@9.5@1@18@:family with sequence similarity 203, member B;family with sequence similarity 203, member A@:binding;molecular_function;cellular_component;biological_process@NA
D08064@114386@114388@duplication@3@145438620@145439212@8@chr8:145438620-145439212@7.69@6@55@9.17@NA@C8orf30B-201_2, C8orf30B-201_3, C8orf30B-201_4@73@7@106@:family with sequence similarity 203, member B@:binding@NA
D08064@124047@124052@deletion@6@135957928@135960431@9@chr9:135957928-135960431@16.6@101@18@0.178@NA@CELP-002_1, CELP-002_2, CELP-002_3, AL162417-201_1, AL162417-201_2, AL162417-201_3@84.3333333333333@66@99@NA@NA@NA
D08064@125889@125889@duplication@1@5202081@5202136@10@chr10:5202081-5202136@8.13@22@81@3.68@NA@AKR1CL1-202_5@4@4@4@:aldo-keto reductase family 1, member C-like 1@:oxidoreductase activity;cytoplasm@NA
D08064@126909@126915@deletion@7@17840632@17887436@10@chr10:17840632-17887436@56.2@281@8@0.0285@NA@FAM23A-201_5, MRC1L1-001_1, MRC1L1-001_2, MRC1L1-001_3, MRC1L1-001_4, MRC1L1-001_5, MRC1L1-001_6@25.8571428571429@6@108@:transmembrane protein 236;transmembrane protein 236-like:macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding@NA
D08064@126946@126949@duplication@4@18112046@18129736@10@chr10:18112046-18129736@26.1@219@487@2.22@NA@MRC1-001_2, MRC1-001_3, MRC1-001_4, MRC1-001_5@28.75@24@34@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D08064@126951@126956@deletion@6@18138510@18152612@10@chr10:18138510-18152612@21.4@104@3@0.0288@NA@MRC1-001_7, MRC1-001_8, MRC1-001_9, MRC1-001_10, MRC1-001_11, RP11-457D2-001_2@19.6666666666667@18@26@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D08064@128825@128828@deletion@4@46918171@46928012@10@chr10:46918171-46928012@6.11@117@62@0.53@CNVR4712.9, CNVR4712.2, CNVR4712.7@FAM35B-001_3, FAM35B-001_4, FAM35B-001_5, FAM35B-001_6@58.5@47@72@NA@NA@NA
D08064@128979@128979@duplication@1@47758848@47758905@10@chr10:47758848-47758905@14@21@128@6.1@CNVR4714.1@ANXA8L2-001_10@154@154@154@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:calcium-dependent phospholipid binding;calcium ion binding@NA
D08064@129460@129461@deletion@2@51361725@51361911@10@chr10:51361725-51361911@6.59@30@0@0@NA@ENST00000404618_4, ENST00000432221_4@122@121@123@NA@NA@NA
D08064@129604@129609@deletion@6@51965744@51978391@10@chr10:51965744-51978391@17.6@185@78@0.422@NA@ASAH2-201_7, ASAH2-201_8, ASAH2-201_9, ASAH2-201_10, ASAH2-201_11, ASAH2-201_12@177.833333333333@161@186@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
D08064@132335@132336@deletion@2@92678624@92679026@10@chr10:92678624-92679026@8.14@296@183@0.618@NA@ANKRD1-001_3, ANKRD1-001_4@0@0@0@:ankyrin repeat domain 1 (cardiac muscle)@:nucleoplasm;positive regulation of DNA damage response, signal transduction by p53 class mediator;response to muscle stretch;cellular response to transforming growth factor beta stimulus;R-SMAD binding;cytoplasmic part;cellular response to organic cyclic compound;cardiac muscle tissue morphogenesis;cellular response to mechanical stimulus;myofibril;nucleus;cellular response to drug;cellular response to lipopolysaccharide;p53 binding;cytosol;cellular response to interleukin-1;cellular response to hypoxia;transcription factor binding;DNA binding;transcription corepressor activity;cellular response to tumor necrosis factor;histone deacetylase binding;transcription factor complex;negative regulation of DNA biosynthetic process;positive regulation of transcription from RNA polymerase II promoter;RNA polymerase II transcription coactivator activity;RNA polymerase II transcription factor binding;small molecule metabolic process;titin binding;cellular lipid metabolic process;regulation of transcription from RNA polymerase II promoter;cytoplasm;protein binding;negative regulation of transcription from RNA polymerase II promoter;positive regulation of neuron projection development;positive regulation of protein secretion;I band;sarcomere organization;positive regulation of apoptotic process@: TOTAL ANOMALOUS PULMONARY VENOUS RETURN 1; TAPVR1
D08064@138032@138032@deletion@1@5270600@5270821@11@chr11:5270600-5270821@5.93@43@11@0.256@NA@HBG1-201_2@106@106@106@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
D08064@139384@139385@duplication@2@18288433@18290881@11@chr11:18288433-18290881@5.44@198@283@1.43@NA@SAA1-201_2, SAA1-201_3@2.5@0@5@:serum amyloid A1@:regulation of protein secretion;platelet activation;neutrophil chemotaxis;negative regulation of inflammatory response;positive regulation of cytokine secretion;macrophage chemotaxis;positive regulation of cell adhesion;positive regulation of interleukin-1 secretion;extracellular region;lymphocyte chemotaxis;high-density lipoprotein particle;elevation of cytosolic calcium ion concentration;acute-phase response;G-protein coupled receptor binding@NA
D08064@141187@141188@duplication@2@48600990@48601883@11@chr11:48600990-48601883@11.6@39@123@3.15@CNVR5165.1@AC134982-201_1, AC134982-201_2@128@128@128@NA@NA@NA
D08064@141273@141277@deletion@5@55032378@55038593@11@chr11:55032378-55038593@16.7@301@150@0.498@CNVR5178.5@TRIM48-201_2, TRIM48-201_3, TRIM48-201_4, TRIM48-201_5, TRIM48-201_6@51.2@48@61@:tripartite motif containing 48@:protein binding;intracellular;zinc ion binding@NA
D08064@145896@145917@deletion@22@89515054@89592648@11@chr11:89515054-89592648@21.2@727@431@0.593@NA@TRIM77-201_8, TRIM49-201_1, TRIM49-201_2, TRIM49-201_3, TRIM49-201_4, TRIM49-201_5, TRIM49-201_6, TRIM49-201_7, TRIM49-201_8, TRIM53L-202_1, TRIM53L-202_2, TRIM53L-202_3, TRIM53L-202_4, TRIM53L-202_5, TRIM53L-202_6, TRIM53L-202_7, AP005435-201_1, AP005435-201_2, AP005435-201_3, AP005435-201_4, AP005435-201_5, AP005435-201_6@35.8181818181818@20@52@:tripartite motif containing 49@:protein binding;intracellular;DNA binding;zinc ion binding@NA
D08064@145951@145974@duplication@24@89706480@89791264@11@chr11:89706480-89791264@15.2@205@344@1.68@NA@TRIM64-202_8, TRIM64-202_9, ENST00000442514_1, ENST00000442514_2, ENST00000442514_3, ENST00000442514_4, ENST00000442514_5, ENST00000442514_6, ENST00000442514_7, ENST00000442514_8, ENST00000442514_9, TRIM53-202_1, TRIM53-202_2, TRIM53-202_3, TRIM53-202_4, TRIM53-202_5, TRIM53-202_6, TRIM53-202_7, ENST00000432771_1, ENST00000432771_2, ENST00000432771_3, ENST00000432771_4, ENST00000432771_5, ENST00000436580_7@64.3333333333333@21@177@:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;DNA binding;zinc ion binding@NA
D08064@150504@150518@duplication@15@8025458@8088872@12@chr12:8025458-8088872@55.9@3025@4255@1.41@CNVR5421.1@SLC2A14-202_1, AC007536-201_1, AC007536-201_2, AC007536-201_3, AC007536-201_4, SLC2A3-001_1, SLC2A3-001_2, SLC2A3-001_3, SLC2A3-001_4, SLC2A3-001_5, SLC2A3-001_6, SLC2A3-001_7, SLC2A3-001_8, SLC2A3-001_9, SLC2A3-001_10@10.1333333333333@6@13@:NECAP endocytosis associated 1:solute carrier family 2 (facilitated glucose transporter), member 14:solute carrier family 2 (facilitated glucose transporter), member 3@:coated pit;protein binding;endocytosis;protein transport;clathrin vesicle coat;plasma membrane;membrane:multicellular organismal development;cell differentiation;substrate-specific transmembrane transporter activity;transport;folic acid binding;glucose transmembrane transporter activity;transmembrane transport;spermatogenesis;reduced folate carrier activity;integral to membrane;transmembrane transporter activity;membrane:sequence-specific DNA binding;nucleus;DNA binding;regulation of transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity:substrate-specific transmembrane transporter activity;transport;glucose transmembrane transporter activity;transmembrane transport;integral to membrane;transmembrane transporter activity;plasma membrane;hexose transport;glucose transport;small molecule metabolic process;folic acid binding;carbohydrate metabolic process;L-ascorbic acid metabolic process;reduced folate carrier activity;water-soluble vitamin metabolic process;vitamin metabolic process;membrane@NA
D08064@150775@150776@duplication@2@9446260@9447115@12@chr12:9446260-9447115@16.5@145@304@2.1@NA@DDX11L8-201_2, DDX11L8-201_3@30@18@42@NA@NA@NA
D08064@150778@150782@deletion@5@9450373@9453843@12@chr12:9450373-9453843@17.1@228@102@0.447@NA@DDX11L8-201_5, DDX11L8-201_6, DDX11L8-201_7, DDX11L8-201_8, DDX11L8-201_9@66.6@55@78@NA@NA@NA
D08064@150785@150786@deletion@2@9456573@9456804@12@chr12:9456573-9456804@19@147@33@0.224@NA@DDX11L8-201_12, DDX11L8-201_13@85@83@87@NA@NA@NA
D08064@150825@150841@deletion@17@9590001@9707352@12@chr12:9590001-9707352@134@796@102@0.128@CNVR5429.1@DDX12-203_1, DDX12-203_2, DDX12-203_3, DDX12-203_4, AC006432-201_1, AC006432-201_2, AC006432-201_3, AC006432-201_4, AC006432-201_5, AC006432-201_6, AC006432-201_7, AC006432-201_8, AC006432-201_9, AC006432-201_11, AC006432-201_12, AC006432-201_13@21.25@7@29@NA@NA@NA
D08064@150968@150973@deletion@6@10583212@10588593@12@chr12:10583212-10588593@14.2@777@509@0.655@CNVR5430.1@KLRC2-201_1, KLRC2-201_2, KLRC2-201_3, KLRC2-201_4, KLRC2-201_5, KLRC2-201_6@54.8333333333333@38@67@:killer cell lectin-like receptor subfamily C, member 2@:carbohydrate binding:transmembrane signaling receptor activity;carbohydrate binding;protein binding;signal transduction;cellular defense response;integral to plasma membrane@NA
D08064@151034@151034@deletion@1@11244393@11244793@12@chr12:11244393-11244793@59.7@404@22@0.0545@CNVR5434.1@TAS2R31-201_2@72@72@72@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
D08064@152013@152014@deletion@2@27648615@27655119@12@chr12:27648615-27655119@8.26@258@152@0.589@CNVR5465.1@C12orf70-202_8, C12orf70-202_9@12@12@12@:chromosome 12 open reading frame 70@:integral to membrane@NA
D08064@152251@152251@deletion@1@31283444@31283524@12@chr12:31283444-31283524@6.34@127@65@0.512@CNVR5483.1@ENST00000266524_23@1@1@1@NA@NA@NA
D08064@155297@155300@deletion@4@57345220@57351419@12@chr12:57345220-57351419@35.4@1003@520@0.518@CNVR5552.1, CNVR5552.2, CNVR5552.3@RDH16-202_1, RDH16-202_2, RDH16-202_3, RDH16-202_4@0@0@0@:retinol dehydrogenase 16 (all-trans)@:electron carrier activity;intracellular membrane-bounded organelle;nucleotide binding;lipid metabolic process;integral to membrane;oxidoreductase activity;retinol dehydrogenase activity;endoplasmic reticulum membrane;metabolic process@NA
D08064@161114@161114@deletion@1@130922912@130923062@12@chr12:130922912-130923062@7.04@72@26@0.361@NA@RIMBP2-201_9@0@0@0@:RIMS binding protein 2@:protein binding;synapse;cell junction;plasma membrane;negative regulation of phosphatase activity@NA
D08064@166691@166699@duplication@9@19412311@19559165@14@chr14:19412311-19559165@12.8@421@598@1.42@CNVR6072.1, CNVR6072.16@CR383656-201_1, CR383656-201_2, ENST00000442368_1, ENST00000442368_2, ENST00000442368_3, ENST00000442368_4, POTEG-201_1, POTEG-201_2, POTEG-201_3@65.8888888888889@30@141@:POTE ankyrin domain family, member G@:protein binding@NA
D08064@166719@166721@duplication@3@19719545@19806888@14@chr14:19719545-19806888@5.9@39@83@2.13@CNVR6072.31@ENST00000436000_1, ENST00000436000_2, ENST00000449324_3@68.6666666666667@58@82@NA@NA@NA
D08064@166746@166767@duplication@22@20019702@20337303@14@chr14:20019702-20337303@152@3620@6312@1.74@CNVR6072.6, CNVR6072.12, CNVR6072.14, CNVR6072.4@AL589182-203_1, AL929601-201_2, AL929601-201_3, AL929601-201_4, AL512310-201_1, AL512310-201_3, AL512310-201_4, AL512310-201_5, ENST00000398231_1, ENST00000398231_2, ENST00000398231_3, ENST00000398231_4, ENST00000398231_5, ENST00000398231_6, ENST00000334072_1, ENST00000334072_2, ENST00000426759_1, ENST00000426759_2, OR4K3P-201_1, OR4K3P-201_2@82.65@44@102@:POTE ankyrin domain family, member M:olfactory receptor, family 4, subfamily N, member 2:olfactory receptor, family 4, subfamily Q, member 3:olfactory receptor, family 4, subfamily M, member 1@:protein binding:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
D08064@167242@167246@duplication@5@22891474@22892038@14@chr14:22891474-22892038@13.7@1172@1570@1.34@NA@TRAC-204_1, TRAC-204_2, ENST00000390469_1, ENST00000390469_2, ENST00000499790_2@7@7@7@@:protein binding@NA
D08064@170809@170811@deletion@3@74003820@74010454@14@chr14:74003820-74010454@43.3@328@84@0.256@CNVR6188.1, CNVR6188.4@ACOT1-201_1, ACOT1-201_2, ACOT1-201_3@109.666666666667@99@116@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
D08064@173404@173432@duplication@29@106066280@106166958@14@chr14:106066280-106166958@70.9@3169@4521@1.43@CNVR6294.46, CNVR6294.20, CNVR6294.43, CNVR6294.65, CNVR6294.66@AL928742-201_1, AL928742-201_2, AL928742-201_3, AL928742-201_4, IGHE-001_1, IGHE-001_2, IGHE-001_3, IGHE-001_4, IGHG4-001_1, IGHG4-001_2, IGHG4-001_3, IGHG4-001_4, IGHG2-002_1, IGHG2-002_2, IGHG2-002_3, IGHG2-002_4, IGHG2-002_5, IGHGP-001_1, IGHGP-001_2, IGHGP-001_3, IGHGP-001_4, IGHGP-001_5, IGHGP-001_6, AL928761-201_1, AL928761-201_2, AL928761-201_3, AL928761-201_4, AL928768-201_2, AL928768-201_3@5.58620689655172@2@9@@:antigen binding;protein binding;immune response:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response@NA
D08064@173501@173502@deletion@2@106478134@106478412@14@chr14:106478134-106478412@18.7@173@55@0.318@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV3-6-210_6, IGHV4-4-001_2@17@17@17@@:protein binding@NA
D08064@173508@173513@deletion@6@106539081@106559976@14@chr14:106539081-106559976@140@708@4@0.00565@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8-001_1, IGHV1-8-001_2, IGHV3-9-001_1, IGHV3-9-001_2, IGHV2-10-001_1, IGHV2-10-001_2@22.3333333333333@17@24@@:protein binding:protein binding@NA
D08064@173559@173568@duplication@10@106791413@106825338@14@chr14:106791413-106825338@21.8@833@1219@1.46@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26@IGHV3-30-001_1, IGHV3-30-2-001_1, IGHV3-30-2-001_2, IGHV4-31-001_1, IGHV4-31-001_2, IGHV3-32-001_1, IGHV3-32-001_2, IGHV3-33-001_1, IGHV3-33-001_2, IGHV3-33-2-001_2@14.1@2@19@@:protein binding:protein binding:protein binding@NA
D08064@173590@173591@deletion@2@106899046@106899494@14@chr14:106899046-106899494@18.5@189@63@0.333@CNVR6294.26, CNVR6294.56, CNVR6294.18@IGHV3-41-001_1, IGHV3-41-001_2@10.5@10@11@NA@NA@NA
D08064@173635@173638@duplication@4@107095128@107099589@14@chr14:107095128-107099589@12.2@444@634@1.43@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61-001_1, IGHV4-61-001_2, IGHV3-62-001_1, IGHV3-62-001_2@16@15@17@@:protein binding@NA
D08064@173645@173646@duplication@2@107131035@107131561@14@chr14:107131035-107131561@9.87@399@593@1.49@CNVR6294.56, CNVR6294.16@IGHV3-66-001_1, IGHV3-66-001_2@2.5@2@3@@:protein binding@NA
D08064@173649@173652@duplication@4@107169933@107179339@14@chr14:107169933-107179339@42.8@1183@1987@1.68@CNVR6294.56, CNVR6294.6, CNVR6294.92, CNVR6294.93@IGHV1-69-001_1, IGHV1-69-001_2, IGHV2-70-001_1, IGHV2-70-001_2@4.75@4@5@@:protein binding:protein binding@NA
D08064@173819@173822@duplication@4@22466060@22473354@15@chr15:22466060-22473354@10.5@1706@2222@1.3@CNVR6297.4, CNVR6297.6@AC010760-202_1, AC010760-202_2, VSIG6-201_1, VSIG6-201_2@27@0@49@NA@NA@NA
D08064@174406@174410@duplication@5@29008591@29009297@15@chr15:29008591-29009297@14@678@939@1.38@NA@ENST00000456510_1, ENST00000456510_2, ENST00000456510_3, ENST00000456510_4, ENST00000456510_5@23.6@18@26@NA@NA@NA
D08064@174506@174507@deletion@2@30664352@30665349@15@chr15:30664352-30665349@11@220@121@0.55@CNVR6337.1@CHRFAM7A-202_6, CHRFAM7A-202_7@56@44@68@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
D08064@174658@174659@duplication@2@32446110@32449977@15@chr15:32446110-32449977@5.26@67@118@1.76@CNVR6345.2, CNVR6345.1@CHRNA7-205_5, CHRNA7-205_6@33.5@1@66@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
D08064@174964@174971@deletion@8@34701845@34812974@15@chr15:34701845-34812974@29@1239@741@0.598@CNVR6351.3@ENST00000443488_1, ENST00000443488_2, AC027139-201_1, AC027139-201_2, AC027139-201_3, AC027139-201_4, AC027139-201_5, ENST00000444260_1@39.125@21@49@:golgin A8 family, member A@:Golgi cisterna membrane;Golgi apparatus@NA
D08064@183378@183378@deletion@1@2672693@2672767@16@chr16:2672693-2672767@15.5@74@1@0.0135@CNVR6602.2@AC141586-201_6@57@57@57@NA@NA@NA
D08064@185308@185308@deletion@1@20547585@20548685@16@chr16:20547585-20548685@9.05@308@171@0.555@CNVR6667.2@ACSM2-001_14@2@2@2@:acyl-CoA synthetase medium-chain family member 2B@:mitochondrion;small molecule metabolic process;butyrate-CoA ligase activity;catalytic activity;ATP binding;xenobiotic metabolic process;fatty acid metabolic process;molecular_function;metabolic process;mitochondrial matrix;metal ion binding@NA
D08064@186367@186369@duplication@3@28634454@28712933@16@chr16:28634454-28712933@7.36@165@250@1.52@NA@SULT1A1-203_1, AC145285-201_1, AC145285-201_2@48.3333333333333@25@61@:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1:nuclear pore complex-interacting protein-like 2-like;putative NPIP-like protein LOC613037-like:eukaryotic translation initiation factor 3, subunit C@:small molecule metabolic process;sulfation;aryl sulfotransferase activity;amine metabolic process;catecholamine metabolic process;xenobiotic metabolic process;cytosol;steroid sulfotransferase activity;integral to membrane;sulfotransferase activity;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process;estrogen metabolic process:cytosol;protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;cellular protein metabolic process;binding;gene expression;translation;translation initiation factor activity@NA
D08064@187499@187507@duplication@9@32486374@32859477@16@chr16:32486374-32859477@10.4@491@698@1.42@CNVR6701.7@AC138915-202_1, AC138915-202_3, AC138915-202_4, AC138915-202_5, TP53TG3-202_1, IGHV2OR16-5-001_1, IGHV2OR16-5-001_2@35.1428571428571@18@47@:TP53 target 3B;TP53 target 3;TP53-target gene 3 protein-like;TP53 target 3C@:nucleus;cytoplasm@NA
D08064@187526@187528@duplication@3@32929000@32937067@16@chr16:32929000-32937067@5.32@63@110@1.75@CNVR6702.1@ENST00000423205_3, ENST00000423205_4, ENST00000423205_5@22.6666666666667@15@34@NA@NA@NA
D08064@187546@187548@duplication@3@33629704@33630421@16@chr16:33629704-33630421@17.6@1054@1509@1.43@CNVR6703.17, CNVR6703.1, CNVR6703.6, CNVR6703.21@AC136428-201_1, AC136428-201_2, AC136428-201_3@22.3333333333333@18@29@NA@NA@NA
D08064@188229@188241@deletion@13@55798611@55820017@16@chr16:55798611-55820017@120@568@2@0.00352@CNVR6730.1@CES4-202_2, CES4-202_3, CES4-202_4, CES4-202_5, CES4-202_6, CES4-202_7, CES4-202_8, CES4-202_9, CES4-202_10, CES4-202_11, AC147362-203_1, AC147362-203_2, AC147362-203_3@102.692307692308@83@123@NA@NA@NA
D08064@188251@188259@duplication@9@55844431@55860208@16@chr16:55844431-55860208@52.3@1498@2329@1.55@CNVR6731.1@CES1-203_3, CES1-203_4, CES1-203_5, CES1-203_6, CES1-203_7, CES1-203_8, CES1-203_9, CES1-203_10, CES1-203_11@28.3333333333333@21@33@:carboxylesterase 1;liver carboxylesterase 1-like@:hydrolase activity;methyl salicylate esterase activity;response to toxin;methylumbelliferyl-acetate deacetylase activity;endoplasmic reticulum lumen;retinyl-palmitate esterase activity;methyl jasmonate esterase activity;metabolic process;carboxylesterase activity;methyl indole-3-acetate esterase activity@: CARBOXYLESTERASE 1; CES1
D08064@188261@188261@deletion@1@55866918@55867076@16@chr16:55866918-55867076@16.7@87@5@0.0575@NA@CES1-203_1@10@10@10@:carboxylesterase 1;liver carboxylesterase 1-like@:hydrolase activity;methyl salicylate esterase activity;response to toxin;methylumbelliferyl-acetate deacetylase activity;endoplasmic reticulum lumen;retinyl-palmitate esterase activity;methyl jasmonate esterase activity;metabolic process;carboxylesterase activity;methyl indole-3-acetate esterase activity@: CARBOXYLESTERASE 1; CES1
D08064@195001@195001@duplication@1@15491980@15492542@17@chr17:15491980-15492542@6.29@245@364@1.49@NA@CDRT1-201_12@2@2@2@:CMT1A duplicated region transcript 1@:protein binding;molecular_function;cellular_component;biological_process:protein binding;intracellular;zinc ion binding;cytoplasm@NA
D08064@195757@195761@deletion@5@18498037@18498495@17@chr17:18498037-18498495@16.3@539@327@0.607@NA@CCDC144B-201_7, CCDC144B-201_8, CCDC144B-201_9, ENST00000447265_4, ENST00000447265_5@1.4@1@2@NA@NA@NA
D08064@197726@197728@deletion@3@34539180@34539966@17@chr17:34539180-34539966@13.6@64@1@0.0156@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1-202_2, CCL4L1-202_3, CCL4L1-202_4@118@113@122@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
D08064@198019@198041@duplication@23@36339578@36375178@17@chr17:36339578-36375178@255@6051@14178@2.34@CNVR7083.3@TBC1D3-202_1, TBC1D3-202_2, TBC1D3-202_3, TBC1D3-202_4, TBC1D3-202_5, TBC1D3-202_6, TBC1D3-202_7, TBC1D3-202_8, TBC1D3-202_9, TBC1D3-202_10, TBC1D3-202_11, TBC1D3-202_12, TBC1D3-202_13, AC183087-202_5, AC183087-202_6, AC183087-202_7, AC183087-202_8, AC183087-202_9, AC183087-202_10, AC183087-202_11, AC183087-202_12, AC183087-202_13, AC183087-202_14@48.0869565217391@38@64@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
D08064@200260@200265@duplication@6@43585853@43594649@17@chr17:43585853-43594649@11.6@419@637@1.52@CNVR7113.4, CNVR7113.6, CNVR7113.2, CNVR7113.1@AC091132-201_1, AC091132-201_2, AC091132-201_3, AC091132-201_4, ENST00000339474_2, ENST00000339474_3@97@81@127@NA@NA@NA
D08064@200337@200345@deletion@9@44399690@44415161@17@chr17:44399690-44415161@20.7@147@37@0.252@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A-001_7, LRRC37A-001_8, LRRC37A-001_9, LRRC37A-001_10, LRRC37A-001_11, LRRC37A-001_12, LRRC37A-001_13, LRRC37A-001_14, LRRC37A-001_15@153.666666666667@114@196@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
D08064@200497@200498@duplication@2@45668085@45669427@17@chr17:45668085-45669427@24.9@718@1229@1.71@CNVR7118.2@NPEPPS-201_10, NPEPPS-201_11@0@0@0@:aminopeptidase puromycin sensitive@:metallopeptidase activity;antigen processing and presentation of peptide antigen via MHC class I;aminopeptidase activity;cytosol;proteolysis;cellular response to hypoxia;nucleus;zinc ion binding;protein polyubiquitination@NA
D08064@205726@205726@deletion@1@117045@117305@18@chr18:117045-117305@7.74@299@173@0.579@NA@ENST00000400614_3@26@26@26@NA@NA@NA
D08064@210546@210547@duplication@2@4354948@4355171@19@chr19:4354948-4355171@5.01@167@239@1.43@NA@MPND-202_7, MPND-202_8@1.5@1@2@:MPN domain containing@:peptidase activity;protein binding;proteolysis@NA
D08064@213372@213373@deletion@2@14070581@14070882@19@chr19:14070581-14070882@5.84@382@253@0.662@NA@DCAF15-201_9, DCAF15-201_10@8.5@0@17@:DDB1 and CUL4 associated factor 15@:protein ubiquitination@NA
D08064@213493@213494@deletion@2@14508472@14508748@19@chr19:14508472-14508748@9.23@101@40@0.396@NA@CD97-205_8, CD97-205_9@10.5@7@14@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
D08064@215928@215928@duplication@1@35862253@35863856@19@chr19:35862253-35863856@4.89@194@282@1.45@CNVR7627.1@FFAR3-001_2@102@102@102@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
D08064@217296@217296@deletion@1@40380121@40380712@19@chr19:40380121-40380712@5.17@23@0@0@CNVR7639.2@FCGBP-201_23@155@155@155@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D08064@217304@217305@duplication@2@40395806@40398511@19@chr19:40395806-40398511@6.43@172@257@1.49@CNVR7639.2, CNVR7639.3@FCGBP-201_14, FCGBP-201_15@127@127@127@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D08064@218213@218214@deletion@2@43865329@43865732@19@chr19:43865329-43865732@7.8@128@66@0.516@NA@AC005392-201_1, AC005392-201_2@4.5@1@8@@:blood coagulation;plasma membrane;anchored to membrane;leukocyte migration@NA
D08064@218216@218218@duplication@3@43876896@43877758@19@chr19:43876896-43877758@9.85@311@449@1.44@NA@CD177P-201_1, CD177P-201_2, CD177P-201_3@9.66666666666667@0@18@NA@NA@NA
D08064@220201@220203@deletion@3@50452244@50455652@19@chr19:50452244-50455652@16.9@419@229@0.547@NA@SIGLEC11-001_9, SIGLEC11-001_10, SIGLEC11-001_11@0@0@0@:sialic acid binding Ig-like lectin 11@:carbohydrate binding;protein binding;integral to membrane;cell adhesion@NA
D08064@220212@220216@deletion@5@50472859@50474642@19@chr19:50472859-50474642@11.3@397@232@0.584@NA@SIGLEC16-202_1, SIGLEC16-202_2, SIGLEC16-202_3, SIGLEC16-202_4, SIGLEC16-202_5@46.6@11@68@NA@NA@NA
D08064@221166@221171@deletion@6@54724400@54726912@19@chr19:54724400-54726912@15.5@352@191@0.543@CNVR7721.3, CNVR7721.4@LILRB3-008_1, LILRB3-008_2, LILRB3-008_3, LILRB3-008_4, LILRB3-008_5, LILRB3-008_6@113.833333333333@98@136@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D08064@221393@221434@duplication@42@55250955@55344254@19@chr19:55250955-55344254@301@7476@12262@1.64@CNVR7725.2, CNVR7725.1@KIR2DL3-201_2, KIR2DL3-201_3, KIR2DL3-201_4, KIR2DL3-201_5, KIR2DL3-201_6, KIR2DL3-201_7, KIR2DL3-201_8, KIR2DL4-001_1, KIR2DL4-001_2, KIR2DL4-001_3, KIR2DL4-001_4, KIR2DL4-001_5, KIR2DL4-001_6, KIR2DL4-001_7, KIR2DL4-001_8, KIR2DP1-001_1, KIR2DP1-001_2, KIR2DP1-001_3, KIR2DP1-001_4, KIR2DP1-001_5, KIR2DP1-001_6, KIR2DP1-001_7, KIR2DP1-001_8, KIR2DP1-001_9, KIR2DL1-002_1, KIR2DL1-002_2, KIR2DL1-002_3, KIR2DL1-002_4, KIR2DL1-002_5, KIR2DL1-002_6, KIR2DL1-002_7, KIR2DL1-002_8, KIR2DL1-002_9, KIR3DP1-001_1, KIR3DP1-001_2, KIR3DP1-001_3, KIR3DL1-201_1, KIR3DL1-201_2, KIR3DL1-201_3, KIR3DL1-201_4, KIR3DL1-201_5, KIR2DS4-001_1@62.1904761904762@22@126@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
D08064@221436@221437@deletion@2@55349033@55351155@19@chr19:55349033-55351155@5.63@300@194@0.647@CNVR7725.1, CNVR7725.6@KIR2DS4-001_3, KIR2DS4-001_4@67.5@67@68@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
D08064@221439@221441@duplication@3@55358641@55360024@19@chr19:55358641-55360024@47.9@1417@2662@1.88@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4-001_6, KIR2DS4-001_7, KIR2DS4-001_8@96.3333333333333@85@102@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
D08064@221823@221824@deletion@2@56283164@56284546@19@chr19:56283164-56284546@17.8@959@576@0.601@CNVR7734.1@ENST00000341750_2, ENST00000341750_3@38.5@30@47@:ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
D08064@221873@221873@deletion@1@56531743@56531798@19@chr19:56531743-56531798@7.85@293@168@0.573@NA@NLRP5-001_6@1@1@1@:NLR family, pyrin domain containing 5@:fertilization;mitochondrion;regulation of protein stability;regulation of RNA stability;embryo implantation;in utero embryonic development;protein complex;ATP binding;apical cortex;cell cortex;cytosol;protein binding;nucleolus;cellular protein complex assembly;organ morphogenesis@NA
D08064@222563@222563@deletion@1@1569208@1569279@20@chr20:1569208-1569279@5.21@23@0@0@CNVR7763.1@SIRPB1-201_1@128@128@128@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
D08064@222594@222594@duplication@1@1895747@1896102@20@chr20:1895747-1896102@5.91@173@265@1.53@CNVR7764.2@SIRPA-201_3@34@34@34@:signal-regulatory protein alpha@:blood coagulation;protein binding;integral to membrane;SH3 domain binding;cell adhesion;plasma membrane;membrane;leukocyte migration@NA
D08064@224466@224467@deletion@2@26061802@26065122@20@chr20:26061802-26065122@6.02@237@149@0.629@CNVR7823.4, CNVR7823.3, CNVR7823.5, CNVR7823.1@C20orf91-201_4, C20orf91-201_5@46.5@33@60@NA@NA@NA
D08064@228886@228890@deletion@5@14439175@14485470@21@chr21:14439175-14485470@11.4@224@120@0.536@NA@ANKRD30B-001_11, ZNF355P-201_2, ZNF355P-201_3, ZNF355P-201_4, ZNF355P-201_5@18.8@15@21@NA@NA@NA
D08064@231958@231958@duplication@1@16287256@16287718@22@chr22:16287256-16287718@13.5@79@209@2.65@CNVR8071.2, CNVR8071.3, CNVR8071.9@POTEH-002_1@105@105@105@:POTE ankyrin domain family, member H@:protein binding@NA
D08064@231968@231971@duplication@4@16348074@16350632@22@chr22:16348074-16350632@5.88@823@1052@1.28@CNVR8071.2, CNVR8071.3, CNVR8071.10@LA16c-2F2-001_3, LA16c-2F2-001_4, LA16c-2F2-001_5, LA16c-2F2-001_6@50.25@47@54@NA@NA@NA
D08064@231978@231987@duplication@10@16373832@16415952@22@chr22:16373832-16415952@8.46@460@638@1.39@CNVR8071.2, CNVR8071.3@ENST00000428118_2, ENST00000428118_3, ENST00000412729_3, ENST00000412729_4, LA16c-60G3-201_1, LA16c-60G3-201_2, LA16c-60G3-201_3, LA16c-60G3-201_4, LA16c-60G3-201_5, LA16c-60G3-201_6@43.4@22@76@NA@NA@NA
D08064@232771@232784@deletion@14@20385728@20402444@22@chr22:20385728-20402444@13.6@134@52@0.388@CNVR8094.9, CNVR8094.4, CNVR8094.10@PI4KAP1-204_1, PI4KAP1-204_2, PI4KAP1-204_3, PI4KAP1-204_4, PI4KAP1-204_5, PI4KAP1-204_6, PI4KAP1-204_7, PI4KAP1-204_8, PI4KAP1-204_9, PI4KAP1-204_10, PI4KAP1-204_11, PI4KAP1-204_12, PI4KAP1-204_13, PI4KAP1-204_14@165.785714285714@155@172@NA@NA@NA
D08064@233731@233755@deletion@25@24345655@24396376@22@chr22:24345655-24396376@241@1156@5@0.00433@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTTP1-001_1, GSTTP1-001_2, ENST00000421902_1, ENST00000421902_2, ENST00000448902_1, ENST00000448902_2, ENST00000448902_3, ENST00000448902_4, ENST00000448902_5, ENST00000329210_1, ENST00000329210_2, ENST00000329210_3, ENST00000329210_4, ENST00000439866_1, ENST00000439866_2, GSTT1-009_1, GSTT1-009_2, GSTT1-009_3, GSTT1-009_4, GSTT1-009_5, ENST00000439996_1, ENST00000439996_2, GSTTP2-001_3, GSTTP2-001_4, GSTTP2-001_5@130.04@109@149@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
D10020@593@593@deletion@1@1607505@1607639@1@chr1:1607505-1607639@8.48@38@0@0@CNVR17.1@RP11-345P4-003_4@10@10@10@:solute carrier family 35, member E2B@:integral to membrane;membrane;transmembrane transport@NA
D10020@2296@2335@deletion@40@12853354@13036801@1@chr1:12853354-13036801@55.5@2327@1518@0.652@CNVR72.3, CNVR72.4@PRAMEF1-001_2, PRAMEF1-001_3, PRAMEF1-001_4, RP5-845O24-001_1, RP5-845O24-001_2, PRAMEF11-001_1, PRAMEF11-001_2, PRAMEF11-001_3, PRAMEF11-001_4, ENST00000438176_1, ENST00000438176_2, ENST00000438176_3, HNRNPCL1-001_1, HNRNPCL1-001_2, PRAMEF2-001_1, PRAMEF2-001_2, PRAMEF2-001_3, PRAMEF2-001_4, RP11-450I1-201_3, RP11-450I1-201_4, PRAMEF4-001_1, PRAMEF4-001_2, PRAMEF4-001_3, PRAMEF4-001_4, PRAMEF10-001_1, PRAMEF10-001_2, PRAMEF10-001_3, PRAMEF10-001_4, PRAMEF7-201_1, PRAMEF7-201_2, PRAMEF7-201_3, PRAMEF7-201_4, RP11-450I1-001_1, RP11-450I1-001_2, PRAMEF6-201_1, PRAMEF6-201_2, PRAMEF6-201_3, PRAMEF6-201_4, PRAMEF22-001_1, PRAMEF22-001_2@35.625@17@68@:PRAME family member 1:PRAME family member 11:heterogeneous nuclear ribonucleoprotein C-like 1-like;heterogeneous nuclear ribonucleoprotein C-like;heterogeneous nuclear ribonucleoprotein C-like 1:PRAME family member 2:PRAME family member 4:PRAME family member 10:PRAME family member 7:PRAME family member 6;PRAME family member 23;PRAME family member 9/15-like;PRAME family member 5:PRAME family member 22@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:ribonucleoprotein complex;RNA binding;nucleus;nucleotide binding;nucleic acid binding:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
D10020@2882@2990@duplication@109@16860923@17087580@1@chr1:16860923-17087580@445@13992@21720@1.55@CNVR93.3, CNVR93.6, CNVR93.15@ENST00000427204_1, RP5-875O13-001_1, AL355149-201_1, AL355149-201_2, ENST00000438396_1, ENST00000438396_2, ENST00000438396_3, NBPF1-201_1, NBPF1-201_2, NBPF1-201_3, NBPF1-201_4, NBPF1-201_5, NBPF1-201_6, NBPF1-201_7, NBPF1-201_8, NBPF1-201_9, NBPF1-201_10, NBPF1-201_11, NBPF1-201_12, NBPF1-201_13, NBPF1-201_14, NBPF1-201_15, NBPF1-201_16, NBPF1-201_17, NBPF1-201_18, NBPF1-201_19, NBPF1-201_20, NBPF1-201_21, NBPF1-201_22, NBPF1-201_23, NBPF1-201_24, NBPF1-201_25, NBPF1-201_26, NBPF1-201_27, NBPF1-201_28, NBPF1-201_29, CROCCL1-204_1, CROCCL1-204_2, CROCCL1-204_3, CROCCL1-204_4, CROCCL1-204_5, CROCCL1-204_6, CROCCL1-204_7, CROCCL1-204_8, CROCCL1-204_9, CROCCL1-204_10, CROCCL1-204_11, AL137798-201_1, AL137798-201_2, RP5-1182A14-001_1, RP5-1182A14-001_2, RP5-1182A14-001_3, RP5-1182A14-001_4, RP5-1182A14-001_5, RP5-1182A14-001_6, RP5-1182A14-001_7, RP5-1182A14-001_8, RP5-1182A14-001_9, RP5-1182A14-001_10, RP5-1182A14-001_11, RP5-1182A14-001_12, RP5-1182A14-001_13, RP5-1182A14-001_14, RP5-1182A14-001_15, RP5-1182A14-001_16, RP5-1182A14-001_17, RP5-1182A14-001_18, RP1-163M9-001_1, RP1-163M9-001_2, RP1-163M9-001_3, RP1-163M9-001_4, RP1-163M9-001_5, ESPNP-002_1, ESPNP-002_2, ESPNP-002_3, ESPNP-002_4, ESPNP-002_5, ESPNP-002_6, ESPNP-002_7, ESPNP-002_8, ESPNP-002_9, ESPNP-002_10, ESPNP-002_11, AL021920-201_1, AL021920-201_2, AL021920-201_3, ENST00000457096_1, ENST00000457096_2, ENST00000457096_3, ENST00000457096_4, MST1P9-202_1, MST1P9-202_2, MST1P9-202_3, MST1P9-202_4, MST1P9-202_5, MST1P9-202_6, MST1P9-202_7, MST1P9-202_8, MST1P9-202_9, MST1P9-202_10, MST1P9-202_11, MST1P9-202_12, MST1P9-202_13, MST1P9-202_14, MST1P9-202_15, MST1P9-202_16, MST1P9-202_17, MST1P9-202_18, MST1P9-202_19, MST1P9-202_20@41.4954128440367@9@88@:putative uncharacterized protein FLJ35883-like:UPF0627 protein ENSP00000364708:UPF0627 protein ENSP00000341061/ENSP00000339743-like;UPF0627 protein ENSP00000341061/ENSP00000339743:UPF0627 protein ENSP00000341061/ENSP00000339743-like;UPF0627 protein ENSP00000341061/ENSP00000339743:macrophage stimulating 1-like@:proteolysis;extracellular region;catalytic activity;serine-type endopeptidase activity@NA
D10020@2999@2999@deletion@1@17198306@17198669@1@chr1:17198306-17198669@5.33@196@118@0.602@CNVR94.1, CNVR94.4, CNVR94.8@ENST00000356370_1, ENST00000438002_1@21@21@21@NA@NA@NA
D10020@3779@3780@duplication@2@21809638@21877922@1@chr1:21809638-21877922@5@58@104@1.79@NA@NBPF3-003_19, ALPL-002_1@63.5@16@111@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 3:alkaline phosphatase, liver/bone/kidney@:cytoplasm:response to antibiotic;catalytic activity;cellular response to organic cyclic compound;extracellular space;integral to membrane;response to vitamin D;pyrophosphatase activity;plasma membrane;response to lipopolysaccharide;metabolic process;phosphatase activity;endochondral ossification;response to glucocorticoid stimulus;developmental process involved in reproduction;dephosphorylation;extracellular matrix part;alkaline phosphatase activity;anchored to membrane;metal ion binding;cementum mineralization;skeletal system development@: HYPOPHOSPHATASIA, CHILDHOOD; HYPOPHOSPHATASIA, ADULT; HYPOPHOSPHATASIA, INFANTILE
D10020@3957@3957@duplication@1@22315757@22315838@1@chr1:22315757-22315838@6.03@93@159@1.71@CNVR108.2@CELA3B-001_8@4@4@4@:chymotrypsin-like elastase family, member 3B@:peptidase activity;proteolysis;extracellular region;cholesterol metabolic process;catalytic activity;serine-type endopeptidase activity@NA
D10020@3964@3965@deletion@2@22336200@22339034@1@chr1:22336200-22339034@15.7@158@62@0.392@CNVR108.2, CNVR108.1@CELA3A-201_7, CELA3A-201_8@6.5@3@10@:chymotrypsin-like elastase family, member 3A@:proteolysis;digestion;cholesterol metabolic process;catalytic activity;serine-type endopeptidase activity@NA
D10020@4452@4460@duplication@9@25611066@25655413@1@chr1:25611066-25655413@19.8@1104@1512@1.37@CNVR116.1, CNVR116.2@RHD-202_2, RHD-202_3, RHD-202_4, RHD-202_5, RHD-202_6, RHD-202_7, RHD-202_8, RHD-202_9, RHD-202_10@124.111111111111@116@128@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
D10020@4477@4477@deletion@1@25735176@25735361@1@chr1:25735176-25735361@12@55@0@0@CNVR117.1@RHCE-005_4@56@56@56@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
D10020@11245@11246@duplication@2@89476589@89477711@1@chr1:89476589-89477711@8.63@571@790@1.38@CNVR244.1@GBP3-001_7, GBP3-001_8@54@54@54@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
D10020@12424@12432@deletion@9@104233918@104256576@1@chr1:104233918-104256576@11.8@113@42@0.372@CNVR266.3, CNVR266.5@AMY1B-001_1, AMY1B-001_2, AMY1B-001_3, AMY1B-001_4, AMY1B-001_5, AMY1B-001_6, AMY1B-001_7, AMY1B-001_8, AMYP1-001_1@119.777777777778@107@154@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D10020@12525@12525@deletion@1@108769303@108769516@1@chr1:108769303-108769516@18.1@94@5@0.0532@CNVR294.4@NBPF4-002_13@32@32@32@:neuroblastoma breakpoint family, member 4@:cytoplasm@NA
D10020@15461@15462@duplication@2@149400065@149400543@1@chr1:149400065-149400543@7.24@192@288@1.5@CNVR350.1@HIST2H3PS2-001_1, RP5-998N21-002_1@75@75@75@NA@NA@NA
D10020@16280@16280@deletion@1@152573269@152573493@1@chr1:152573269-152573493@20.7@97@0@0@CNVR358.1@LCE3C-201_2@102@102@102@:late cornified envelope 3C@:keratinization@NA
D10020@18682@18682@duplication@1@161599570@161599826@1@chr1:161599570-161599826@4.77@88@143@1.62@CNVR383.1@FCGR3B-001_3@36@36@36@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIIb, receptor (CD16b)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction:IgG binding;protein binding;extracellular region;immune response;plasma membrane;anchored to membrane@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
D10020@21359@21359@duplication@1@196712584@196712759@1@chr1:196712584-196712759@7.93@442@645@1.46@CNVR459.1@CFH-001_20@6@6@6@:complement factor H@:complement activation, alternative pathway;extracellular space;complement activation;extracellular region;regulation of complement activation;innate immune response@: HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1; MACULAR DEGENERATION, AGE-RELATED, 4; ARMD4; COMPLEMENT FACTOR H DEFICIENCY; CFHD; BASAL LAMINAR DRUSEN
D10020@21362@21371@duplication@10@196743977@196796136@1@chr1:196743977-196796136@31.3@1035@1518@1.47@CNVR459.1@CFHR3-001_1, CFHR3-001_2, CFHR3-001_3, CFHR3-001_4, CFHR3-001_5, CFHR3-001_6, CFHR1-001_1, CFHR1-001_2, CFHR1-001_3, CFHR2-201_1@94.6@85@112@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
D10020@21373@21374@duplication@2@196799632@196801320@1@chr1:196799632-196801320@18.3@534@843@1.58@CNVR459.1@CFHR1-001_5, CFHR1-001_6@96.5@96@97@:complement factor H-related 1:complement factor H-related 2@:extracellular space;complement activation:extracellular region@NA
D10020@24160@24164@deletion@5@223727670@223729472@1@chr1:223727670-223729472@10.2@62@11@0.177@NA@CAPN8-202_20, CAPN8-202_21, CAPN8-202_22, CAPN8-202_23, CAPN8-202_24@0@0@0@:calpain 8@:proteolysis;Golgi apparatus;intracellular;calcium-dependent cysteine-type endopeptidase activity;calcium ion binding@NA
D10020@25606@25607@duplication@2@236631533@236645620@1@chr1:236631533-236645620@5.4@233@326@1.4@NA@EDARADD-003_7, EDARADD-003_8@1@1@1@:EDAR-associated death domain@:cell differentiation;protein binding;signal transduction;hair follicle development;trachea gland development;odontogenesis of dentin-containing tooth;cytoplasm@: ECTODERMAL DYSPLASIA, HYPOHIDROTIC, AUTOSOMAL RECESSIVE
D10020@34092@34095@duplication@4@96457910@96458295@2@chr2:96457910-96458295@19@226@403@1.78@NA@AC008268-201_2, AC008268-201_3, ENST00000444924_1, ENST00000444924_2@102.75@101@104@NA@NA@NA
D10020@34183@34184@deletion@2@96652501@96652955@2@chr2:96652501-96652955@26.6@212@47@0.222@NA@AC073995-001_2, AC073995-001_3@4@4@4@:ankyrin repeat domain-containing protein 36A-like@:ion channel inhibitor activity;protein binding@NA
D10020@34212@34213@deletion@2@96697783@96698114@2@chr2:96697783-96698114@6.8@131@70@0.534@NA@GPAT2-205_3, GPAT2-205_4@75.5@75@76@:glycerol-3-phosphate acyltransferase 2, mitochondrial@:glycerol-3-phosphate O-acyltransferase activity;mitochondrion;phospholipid metabolic process;triglyceride biosynthetic process;glycerophospholipid biosynthetic process;small molecule metabolic process;transferase activity, transferring acyl groups;mitochondrial outer membrane;phosphatidic acid biosynthetic process;integral to membrane;glycerol-3-phosphate metabolic process;CDP-diacylglycerol biosynthetic process;membrane;metabolic process;phospholipid biosynthetic process@NA
D10020@34537@34538@deletion@2@97812225@97815099@2@chr2:97812225-97815099@5.91@106@54@0.509@CNVR886.2@ENST00000461153_11, ENST00000461153_12@6@6@6@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
D10020@34573@34582@duplication@10@97877285@97884984@2@chr2:97877285-97884984@10.1@643@866@1.35@NA@ENST00000461153_47, ENST00000461153_48, ENST00000461153_49, ENST00000461153_50, ENST00000461153_51, ENST00000461153_52, ENST00000461153_53, ENST00000461153_54, ENST00000461153_55, ENST00000461153_56@58@49@65@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
D10020@34615@34631@deletion@17@98127603@98162325@2@chr2:98127603-98162325@38.2@190@10@0.0526@CNVR888.3@ANKRD36B-001_23, ANKRD36B-001_24, ANKRD36B-001_25, ANKRD36B-001_26, ANKRD36B-001_27, ANKRD36B-001_28, ANKRD36B-001_29, ANKRD36B-001_30, ANKRD36B-001_31, ANKRD36B-001_32, ANKRD36B-001_33, ANKRD36B-001_34, ANKRD36B-001_35, ANKRD36B-001_36, ANKRD36B-001_37, ANKRD36B-001_38, ANKRD36B-001_39@130.058823529412@64@154@NA@NA@NA
D10020@35993@35997@duplication@5@112592183@112605443@2@chr2:112592183-112605443@7.68@263@382@1.45@CNVR929.1, CNVR929.2@ANAPC1-001_15, ANAPC1-001_16, ANAPC1-001_17, ANAPC1-001_18, ANAPC1-001_19@0@0@0@:anaphase-promoting complex subunit 1-like;anaphase promoting complex subunit 1@:nucleoplasm;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle;anaphase-promoting complex;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle spindle assembly checkpoint;cytosol;protein K11-linked ubiquitination;protein binding;mitosis;nucleus;cell cycle checkpoint;cell division;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle@NA
D10020@56995@56996@duplication@2@132175347@132175677@3@chr3:132175347-132175677@5.33@277@380@1.37@NA@DNAJC13-001_11, DNAJC13-001_12@1@1@1@:DnaJ (Hsp40) homolog, subfamily C, member 13@:protein binding;binding;heat shock protein binding@NA
D10020@61665@61665@deletion@1@195723611@195724526@3@chr3:195723611-195724526@5.47@207@125@0.604@CNVR1707.1@AC024937-001_1@8@8@8@NA@NA@NA
D10020@61902@61905@duplication@4@197350985@197351592@3@chr3:197350985-197351592@7.44@133@210@1.58@CNVR1722.1@AC024560-005_2, AC024560-005_3, AC024560-201_2, AC024560-201_3@19@8@23@NA@NA@NA
D10020@65315@65320@deletion@6@69402904@69434246@4@chr4:69402904-69434246@169@906@17@0.0188@CNVR1953.1@UGT2B17-001_1, UGT2B17-001_2, UGT2B17-001_3, UGT2B17-001_4, UGT2B17-001_5, UGT2B17-001_6@124.5@118@134@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
D10020@65354@65360@duplication@7@70146221@70160768@4@chr4:70146221-70160768@10.6@927@1234@1.33@CNVR1957.2, CNVR1957.1@UGT2B28-201_1, UGT2B28-201_2, UGT2B28-201_3, UGT2B28-201_4, UGT2B28-201_5, UGT2B28-201_6, UGT2B28-201_7@69.1428571428571@65@71@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
D10020@65799@65799@duplication@1@75312253@75312500@4@chr4:75312253-75312500@4.93@122@188@1.54@NA@AREG-001_2@28@28@28@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
D10020@65805@65807@deletion@3@75482008@75486007@4@chr4:75482008-75486007@21.3@99@0@0@NA@AREGB-201_2, AREGB-201_3, AREGB-201_4@50.3333333333333@45@56@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
D10020@68947@68947@duplication@1@145041645@145041742@4@chr4:145041645-145041742@10.8@110@222@2.02@NA@GYPA-205_2@8@8@8@:glycophorin B (MNS blood group):glycophorin A (MNS blood group)@:integral to membrane;plasma membrane;integral to plasma membrane:external side of plasma membrane;integral to membrane;cytoskeletal anchoring at plasma membrane;plasma membrane;molecular_function;protein homodimerization activity;integral to plasma membrane;cellular_component;identical protein binding;membrane;biological_process;regulation of response to osmotic stress;virus-host interaction@: BLOOD GROUP--Ss LOCUS; Ss: MALARIA, SUSCEPTIBILITY TO; BLOOD GROUP--MN LOCUS; MN
D10020@70823@70823@deletion@1@751250@751373@5@chr5:751250-751373@5.6@27@1@0.037@CNVR2280.3@ZDHHC11B-201_4@87@87@87@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
D10020@71601@71606@deletion@6@21482140@21491618@5@chr5:21482140-21491618@10.8@287@171@0.596@CNVR2395.4, CNVR2395.6, CNVR2395.2@AC138951-201_4, AC138951-202_2, ENST00000412250_1, ENST00000412250_2, ENST00000412250_3, ENST00000412250_4@105.833333333333@97@108@NA@NA@NA
D10020@72598@72598@deletion@1@42629142@42629206@5@chr5:42629142-42629206@4.77@125@71@0.568@CNVR2445.1@GHR-001_3@16@16@16@:growth hormone receptor@:neuronal cell body;mitochondrion;proline-rich region binding;JAK-STAT cascade;growth factor binding;nucleus;succinate metabolic process;positive regulation of JAK-STAT cascade;JAK-STAT cascade involved in growth hormone signaling pathway;response to morphine;activation of MAPK activity;peptide hormone binding;response to estradiol stimulus;2-oxoglutarate metabolic process;valine metabolic process;response to cytokine stimulus;hormone-mediated signaling pathway;response to food;SH2 domain binding;oxaloacetate metabolic process;growth hormone receptor signaling pathway;allantoin metabolic process;integral to membrane;response to hormone stimulus;cartilage development involved in endochondral bone morphogenesis;positive regulation of peptidyl-tyrosine phosphorylation;receptor internalization;cytoplasm;cellular response to hormone stimulus;extracellular region;growth hormone receptor complex;positive regulation of tyrosine phosphorylation of Stat5 protein;regulation of multicellular organism growth;growth hormone receptor activity;positive regulation of tyrosine phosphorylation of Stat3 protein;response to peptide hormone stimulus;fatty acid metabolic process;creatinine metabolic process;plasma membrane;positive regulation of multicellular organism growth;receptor complex;protein phosphatase binding;protein kinase binding;creatine metabolic process;response to interleukin-1;response to cycloheximide;extracellular space;positive regulation of cell differentiation;activation of Janus kinase activity;taurine metabolic process;cellular response to insulin stimulus;integral to plasma membrane;protein homodimerization activity;negative regulation of neuron death;citrate metabolic process;endocytosis;isoleucine metabolic process;activation of JAK2 kinase activity;extrinsic to membrane;response to glucocorticoid stimulus;protein binding;insulin-like growth factor receptor signaling pathway;multicellular organismal metabolic process;cell surface@: HYPERCHOLESTEROLEMIA, FAMILIAL; LARON SYNDROME; SHORT STATURE, IDIOPATHIC, AUTOSOMAL
D10020@73727@73727@deletion@1@69717564@69717599@5@chr5:69717564-69717599@14.3@66@0@0@CNVR2494.17, CNVR2494.3@GTF2H2B-201_4@139@139@139@NA@NA@NA
D10020@73746@73749@deletion@4@69796546@69805434@5@chr5:69796546-69805434@6.03@27@0@0@CNVR2494.10, CNVR2494.57@AC146944-203_1, AC146944-203_2, ENST00000456583_1, ENST00000456583_2@171.75@170@173@NA@NA@NA
D10020@73817@73821@deletion@5@70370032@70389020@5@chr5:70370032-70389020@32.4@151@1@0.00662@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.8, CNVR2494.1, CNVR2494.37@AC044797-201_1, AC044797-201_2, AC044797-201_3, AC044797-201_4, AC044797-201_5@120.4@100@138@NA@NA@NA
D10020@74426@74431@duplication@6@78375194@78384953@5@chr5:78375194-78384953@26.2@1022@1472@1.44@NA@BHMT2-001_3, BHMT2-001_4, BHMT2-001_5, BHMT2-001_6, BHMT2-001_7, BHMT2-001_8@0@0@0@:dimethylglycine dehydrogenase:betaine--homocysteine S-methyltransferase 2@:oxidation-reduction process;electron carrier activity;mitochondrion;folic acid binding;flavin adenine dinucleotide binding;cytoplasm;glycine catabolic process;choline metabolic process;oxidoreductase activity;glycine metabolic process;dimethylglycine dehydrogenase activity;aminomethyltransferase activity;amino-acid betaine catabolic process;mitochondrial matrix:methionine biosynthetic process;betaine-homocysteine S-methyltransferase activity;zinc ion binding;amino-acid betaine catabolic process;homocysteine S-methyltransferase activity;cytoplasm@: DIMETHYLGLYCINE DEHYDROGENASE DEFICIENCY; DMGDHD
D10020@75561@75566@deletion@6@109940812@109974057@5@chr5:109940812-109974057@54.8@1046@498@0.476@NA@TMEM232-203_5, TMEM232-203_6, TMEM232-203_7, TMEM232-203_8, TMEM232-203_9, TMEM232-203_10@4.66666666666667@4@5@:transmembrane protein 232@:integral to membrane@NA
D10020@79567@79568@deletion@2@175388056@175388438@5@chr5:175388056-175388438@12@82@19@0.232@NA@THOC3-001_4, THOC3-001_5@173.5@165@182@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
D10020@80022@80024@duplication@3@177166603@177168334@5@chr5:177166603-177168334@8.16@93@166@1.78@NA@FAM153A-204_7, FAM153A-204_8, FAM153A-204_9@94@86@106@:family with sequence similarity 153, member A@NA@NA
D10020@80560@80563@deletion@4@292099@335164@6@chr6:292099-335164@11.9@1044@726@0.695@CNVR2728.1@DUSP22-001_1, DUSP22-001_2, DUSP22-001_3, DUSP22-001_4@17.75@13@20@:dual specificity phosphatase 22;dual specificity protein phosphatase 22-like@:protein dephosphorylation;transforming growth factor beta receptor signaling pathway;positive regulation of JNK cascade;protein tyrosine/serine/threonine phosphatase activity;nucleus;apoptotic process;multicellular organismal development;phosphatase activity;protein tyrosine phosphatase activity;regulation of cell proliferation;cytoplasm;cell proliferation;inactivation of MAPK activity;protein binding;negative regulation of transcription from RNA polymerase II promoter;dephosphorylation@NA
D10020@82520@82523@deletion@4@29911901@29913059@6@chr6:29911901-29913059@8.03@699@479@0.685@CNVR2829.7, CNVR2829.2, CNVR2829.3@HLA-A-001_6, HLA-A-001_7, HLA-A-001_8, HLA-A-001_9@19.25@14@22@:major histocompatibility complex, class I, A@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO
D10020@83002@83003@deletion@2@31237745@31238263@6@chr6:31237745-31238263@17.5@323@157@0.486@CNVR2838.2, CNVR2838.1@HLA-C-006_4, HLA-C-006_5@25@25@25@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
D10020@83018@83018@deletion@1@31324865@31324990@6@chr6:31324865-31324990@5.39@70@31@0.443@CNVR2841.12, CNVR2841.14, CNVR2841.8, CNVR2841.23@HLA-B-201_1@62@62@62@:major histocompatibility complex, class I, B@:MHC class I protein complex;regulation of immune response;regulation of interleukin-12 production;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;regulation of T cell anergy;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;receptor binding;early endosome membrane;virus-host interaction;regulation of interleukin-6 production;regulation of dendritic cell differentiation;phagocytic vesicle membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO; SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1
D10020@83601@83606@duplication@6@31973468@31974499@6@chr6:31973468-31974499@8.9@503@675@1.34@CNVR2843.6, CNVR2843.3@CYP21A1P-001_1, CYP21A1P-001_2, CYP21A1P-001_3, CYP21A1P-001_4, AL645922-201_1, AL645922-201_2@101.166666666667@80@108@NA@NA@NA
D10020@83910@83915@duplication@6@32441204@32489952@6@chr6:32441204-32489952@57.2@193@651@3.37@CNVR2845.21, CNVR2845.25, CNVR2845.30@HLA-DRB9-001_1, HLA-DRB5-001_2, HLA-DRB5-001_3, HLA-DRB5-001_4, HLA-DRB5-001_5, HLA-DRB5-001_6@160.833333333333@44@189@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D10020@83920@83947@duplication@28@32522469@32636161@6@chr6:32522469-32636161@130@1745@3144@1.8@CNVR2845.21, CNVR2845.25, CNVR2845.24@HLA-DRB6-002_1, HLA-DRB6-002_2, HLA-DRB6-002_3, AL713966-201_1, AL713966-201_2, AL713966-201_3, HLA-DRB1-001_1, HLA-DRB1-001_2, HLA-DRB1-001_3, HLA-DRB1-001_4, HLA-DRB1-001_5, HLA-DRB1-001_6, HLA-DQA1-002_1, HLA-DQA1-002_2, HLA-DQA1-002_3, HLA-DQA1-002_4, HLA-DQA1-002_5, HLA-DQA1-002_6, HLA-DQB1-003_1, HLA-DQB1-003_2, HLA-DQB1-003_3, HLA-DQB1-003_4, HLA-DQB1-003_5, HLA-DQB1-003_6, XXbac-BPG254F23-001_1, XXbac-BPG254F23-001_2, ENST00000443574_1, ENST00000443574_2@110.714285714286@4@167@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
D10020@92590@92592@deletion@3@160132511@160132863@6@chr6:160132511-160132863@12.8@456@277@0.607@CNVR3127.2, CNVR3127.1@ENST00000442642_5, ENST00000442642_6, ENST00000442642_7@108@106@112@:superoxide dismutase 2, mitochondrial;uncharacterized LOC100129518@:response to reactive oxygen species;oxidation-reduction process;mitochondrion;negative regulation of cell proliferation;neuron development;negative regulation of fat cell differentiation;removal of superoxide radicals;response to gamma radiation;response to L-ascorbic acid;response to lipopolysaccharide;response to nutrient levels;response to zinc ion;protein homotetramerization;post-embryonic development;iron ion homeostasis;hemopoiesis;aging;mitochondrial inner membrane;age-dependent response to reactive oxygen species;response to drug;oxygen binding;mitochondrial nucleoid;vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure;apoptotic process;superoxide metabolic process;response to superoxide;detection of oxygen;response to silicon dioxide;cytoplasm;response to stress;respiratory electron transport chain;superoxide anion generation;protein homooligomerization;regulation of mitochondrial membrane potential;positive regulation of nitric oxide biosynthetic process;response to manganese ion;regulation of blood pressure;metal ion binding;negative regulation of apoptotic process;response to cadmium ion;response to oxidative stress;liver development;regulation of catalytic activity;negative regulation of fibroblast proliferation;response to selenium ion;age-dependent response to oxidative stress;response to electrical stimulus;mitochondrial matrix;identical protein binding;mitochondrion organization;response to hyperoxia;vasodilation;response to hydrogen peroxide;superoxide dismutase activity;heart development;negative regulation of neuron apoptotic process;erythrophore differentiation;locomotory behavior;DNA binding;release of cytochrome c from mitochondria;response to axon injury;oxygen homeostasis;response to activity;glutathione metabolic process;hydrogen peroxide metabolic process;hydrogen peroxide biosynthetic process;regulation of transcription from RNA polymerase II promoter;response to hypoxia;protein binding;manganese ion binding;cellular response to ethanol@: MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6; MVCD6
D10020@93069@93070@deletion@2@167590486@167590623@6@chr6:167590486-167590623@20.6@336@152@0.452@NA@TCP10L2-001_3, AL121935-201_4@34@34@34@:t-complex 10;t-complex 10-like 2@NA@NA
D10020@93073@93077@deletion@5@167592501@167596397@6@chr6:167592501-167596397@5.89@211@132@0.626@NA@TCP10L2-001_5, TCP10L2-001_6, AL121935-201_6, AL121935-201_7, AL121935-201_8@7.8@3@9@:t-complex 10;t-complex 10-like 2@NA@NA
D10020@93099@93101@duplication@3@167790036@167794825@6@chr6:167790036-167794825@17.1@202@370@1.83@NA@TCP10-001_3, TCP10-001_4, TCP10-001_5@77@52@103@:t-complex 10@:cytosol@NA
D10020@94038@94039@deletion@2@5023304@5023405@7@chr7:5023304-5023405@9.72@77@22@0.286@NA@RNF216L-014_3, RBAK-006_1@11.5@11@12@:RBAK-LOC389458 readthrough;uncharacterized LOC389458;RB-associated KRAB zinc finger@:nucleus;intracellular;negative regulation of transcription, DNA-dependent;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
D10020@94193@94196@deletion@4@5965265@5972507@7@chr7:5965265-5972507@13.1@585@361@0.617@NA@C7orf28A-001_15, RSPH10B-002_19, RSPH10B-002_20, RSPH10B-002_21@21.25@12@46@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae):radial spoke head 10 homolog B (Chlamydomonas)@:lysosomal membrane@NA
D10020@94212@94212@deletion@1@6006496@6006833@7@chr7:6006496-6006833@7.72@162@83@0.512@NA@RSPH10B-002_3@13@13@13@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D10020@94414@94420@duplication@7@6790882@6797563@7@chr7:6790882-6797563@6.93@284@403@1.42@NA@ENST00000338780_13, ENST00000338780_14, PMS2CL-002_13, PMS2CL-002_14, RSPH10B2-204_1, RSPH10B2-204_2, RSPH10B2-204_3@25.2857142857143@5@73@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D10020@94430@94432@duplication@3@6819243@6821108@7@chr7:6819243-6821108@26.2@239@510@2.13@NA@RSPH10B2-204_13, RSPH10B2-204_14, RSPH10B2-204_15@17@16@19@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D10020@94438@94444@duplication@7@6836201@6844687@7@chr7:6836201-6844687@53.4@329@788@2.4@NA@RSPH10B2-204_20, RSPH10B2-204_21, ENST00000429267_1, C7orf28B-001_12, C7orf28B-001_13, C7orf28B-001_14, C7orf28B-001_15@90.8571428571429@25@121@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D10020@96579@96584@duplication@6@38388958@38398764@7@chr7:38388958-38398764@18.8@1438@1938@1.35@CNVR3354.3, CNVR3354.1@TRGV5-001_1, TRGV5-001_2, TRGV4-001_1, TRGV4-001_2, TRGV3-001_1, TRGV3-001_2@10.5@6@14@@:protein binding:protein binding:protein binding;immune response;peptide antigen binding;plasma membrane;MHC protein binding@NA
D10020@97987@97996@duplication@10@62751893@62764435@7@chr7:62751893-62764435@88.3@1377@2613@1.9@NA@AC006455-201_1, AC006455-201_2, AC006455-201_3, AC006455-201_4, AC006455-201_5, AC006455-201_6, ENST00000444809_1, ENST00000444809_2, ENST00000444809_3, ENST00000444809_4@117@46@171@NA@NA@NA
D10020@98014@98026@deletion@13@62904582@62970547@7@chr7:62904582-62970547@73.4@618@174@0.282@NA@ZNF734-201_1, ZNF734-201_2, ZNF734-201_3, ZNF734-201_4, ZNF734-201_5, ZNF734-201_6, ZNF734-201_7, ZNF734-201_8, ENST00000434048_1, ENST00000434048_2, CTD-2526L21-201_1, CTD-2526L21-201_2, CTD-2526L21-201_3@75.3846153846154@1@102@NA@NA@NA
D10020@98628@98629@deletion@2@72469996@72470074@7@chr7:72469996-72470074@8.27@162@86@0.531@NA@STAG3L3-003_6, RP11-313P13-001_6@71@71@71@@:nucleus;binding@NA
D10020@99063@99063@deletion@1@74251404@74251506@7@chr7:74251404-74251506@5.97@27@0@0@NA@GTF2IRD2-002_2@8@8@8@:GTF2I repeat domain containing 2@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
D10020@99233@99233@duplication@1@74991244@74991359@7@chr7:74991244-74991359@7.36@25@79@3.16@CNVR3456.1@STAG3L1-004_3@60@60@60@NA@NA@NA
D10020@99272@99273@duplication@2@75054920@75055736@7@chr7:75054920-75055736@5.2@81@133@1.64@NA@POM121C-001_8, POM121C-001_9@51@30@72@:POM121 transmembrane nucleoporin C@:nuclear membrane;protein binding;protein transport;endoplasmic reticulum membrane;nuclear pore;mRNA transport@NA
D10020@99454@99454@duplication@1@76063357@76063473@7@chr7:76063357-76063473@7@99@174@1.76@CNVR3462.1@ZP3-002_6@10@10@10@:zona pellucida glycoprotein 3 (sperm receptor)@:negative regulation of transcription, DNA-dependent;manganese ion transmembrane transporter activity;intracellular protein transport;proteinaceous extracellular matrix;plasma membrane;positive regulation of acrosome reaction;outer acrosomal membrane;protein kinase C signaling cascade;manganese ion transmembrane transport;intracellular signal transduction;humoral immune response mediated by circulating immunoglobulin;negative regulation of binding of sperm to zona pellucida;positive regulation of inflammatory response;endoplasmic reticulum;signal transducer activity;perinuclear region of cytoplasm;secretory granule;positive regulation of transcription, DNA-dependent;positive regulation of ovarian follicle development;positive regulation of interferon-gamma production;carbohydrate binding;manganese ion transport;positive regulation of antral ovarian follicle growth;extracellular matrix;positive regulation of leukocyte migration;positive regulation of humoral immune response;extracellular space;blastocyst formation;integral to membrane;store-operated calcium channel activity;oocyte development;multivesicular body;phosphatidylinositol-mediated signaling;acrosomal vesicle;positive regulation of protein kinase B signaling cascade;Golgi apparatus;positive regulation of calcium ion import;positive regulation of protein kinase activity;positive regulation of acrosomal vesicle exocytosis;positive regulation of interleukin-4 production;cytoplasm;protein binding;binding of sperm to zona pellucida;positive regulation of phosphatidylinositol biosynthetic process;extracellular region;positive regulation of T cell proliferation;acrosin binding;positive regulation of type IV hypersensitivity;egg coat formation@NA
D10020@99489@99490@duplication@2@76240773@76241131@7@chr7:76240773-76241131@9.93@285@429@1.51@CNVR3463.10@POMZP3-003_6, POMZP3-003_7@43.5@41@46@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
D10020@102130@102131@duplication@2@102136589@102137067@7@chr7:102136589-102137067@8.65@157@266@1.69@CNVR3518.1@RASA4B-007_15, RASA4B-007_16@58@49@67@:RAS p21 protein activator 4B@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction@NA
D10020@102166@102167@duplication@2@102219874@102223340@7@chr7:102219874-102223340@10.2@37@113@3.05@CNVR3518.1@ENST00000379336_1, RASA4-001_21@56@49@63@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
D10020@102192@102193@duplication@2@102279572@102279647@7@chr7:102279572-102279647@7.2@259@372@1.44@CNVR3518.1@ENST00000340457_4, POLR2J2-001_7@76.5@76@77@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
D10020@104579@104579@duplication@1@134221805@134221910@7@chr7:134221805-134221910@7.21@97@173@1.78@NA@AKR1B10-001_6@2@2@2@:aldo-keto reductase family 1, member B10 (aldose reductase)@:steroid metabolic process;cellular aldehyde metabolic process;indanol dehydrogenase activity;daunorubicin metabolic process;retinal dehydrogenase activity;farnesol catabolic process;geranylgeranyl reductase activity;protein binding;extracellular region;aldo-keto reductase (NADP) activity;digestion;doxorubicin metabolic process;cellular_component;lysosome@NA
D10020@105321@105332@duplication@12@141765517@141782011@7@chr7:141765517-141782011@21.8@1728@2293@1.33@CNVR3585.3, CNVR3585.2@MGAM-007_40, MGAM-007_41, MGAM-007_42, MGAM-007_43, MGAM-007_44, MGAM-007_45, MGAM-007_46, MGAM-007_47, MGAM-007_48, MGAM-007_49, MGAM-007_50, MGAM-007_51@117.916666666667@101@125@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
D10020@105336@105343@duplication@8@141785635@141794455@7@chr7:141785635-141794455@14.3@697@956@1.37@CNVR3585.3, CNVR3585.2@MGAM-007_55, MGAM-007_56, MGAM-007_57, MGAM-007_58, MGAM-007_59, MGAM-007_60, MGAM-007_61, MGAM-007_62@87.5@5@134@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
D10020@105441@105442@deletion@2@142045254@142045817@7@chr7:142045254-142045817@7.35@606@406@0.67@NA@TRBV4-2-001_1, TRBV4-2-001_2@3.5@3@4@@:protein binding@NA
D10020@105521@105523@duplication@3@142481247@142482417@7@chr7:142481247-142482417@15.2@435@660@1.52@NA@PRSS1-204_4, PRSS1-204_5, PRSS1-204_6@114.333333333333@113@115@NA@NA@NA
D10020@105785@105799@duplication@15@143969540@143975569@7@chr7:143969540-143975569@16.2@620@872@1.41@CNVR3598.4, CNVR3598.9@RP4-798C17-001_5, RP4-798C17-001_6, RP4-798C17-001_7, RP4-798C17-001_8, RP4-798C17-001_9, RP4-798C17-001_10, RP4-798C17-001_11, RP4-798C17-001_12, ENST00000378112_6, ENST00000378112_7, ENST00000378112_8, ENST00000378112_9, ENST00000378112_10, ENST00000378112_11, ENST00000378112_12@92.6@37@137@:Rho guanine nucleotide exchange factor (GEF) 35@NA@NA
D10020@107434@107434@deletion@1@7340028@7340275@8@chr8:7340028-7340275@6.12@47@13@0.277@CNVR3771.8, CNVR3771.10, CNVR3771.4@DEFB106B-001_2@11@11@11@:defensin, beta 106B;defensin, beta 106A@:extracellular region;defense response to bacterium@NA
D10020@107506@107507@duplication@2@7682696@7686576@8@chr8:7682696-7686576@8.11@70@144@2.06@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10@DEFB106A-001_1, DEFB106A-001_2@42.5@41@44@:defensin, beta 106B;defensin, beta 106A@:extracellular region;defense response to bacterium@NA
D10020@117288@117288@deletion@1@38603158@38603210@9@chr9:38603158-38603210@15.6@165@54@0.327@NA@ANKRD18A-202_7@2@2@2@:ankyrin repeat domain 18A@:protein binding@NA
D10020@117587@117589@duplication@3@43313716@43314503@9@chr9:43313716-43314503@9.01@200@306@1.53@CNVR4289.2@BX649597-201_1, BX649597-201_2, BX649597-201_3@46@18@61@NA@NA@NA
D10020@121600@121606@deletion@7@117085338@117092299@9@chr9:117085338-117092299@29.7@1670@1041@0.623@CNVR4448.1@ORM1-001_1, ORM1-001_2, ORM1-001_3, ORM1-001_4, ORM1-001_5, ORM1-001_6, ORM2-001_1@71.4285714285714@10@90@:orosomucoid 1:orosomucoid 2@:protein binding;extracellular space;regulation of immune system process;transport;inflammatory response;extracellular region;acute-phase response:extracellular space;regulation of immune system process;transport;acute-phase response@NA
D10020@124047@124052@deletion@6@135957928@135960431@9@chr9:135957928-135960431@22.4@108@4@0.037@NA@CELP-002_1, CELP-002_2, CELP-002_3, AL162417-201_1, AL162417-201_2, AL162417-201_3@84.3333333333333@66@99@NA@NA@NA
D10020@125845@125845@duplication@1@5010503@5010579@10@chr10:5010503-5010579@5.5@66@120@1.82@NA@AKR1C1-202_5@2@2@2@:aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)@:trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity;bile acid and bile salt transport;oxidation-reduction process;phenanthrene 9,10-monooxygenase activity;indanol dehydrogenase activity;daunorubicin metabolic process;carboxylic acid binding;retinal metabolic process;response to organophosphorus;cholesterol homeostasis;ketosteroid monooxygenase activity;progesterone metabolic process;oxidoreductase activity;17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity;aldo-keto reductase (NADP) activity;digestion;androsterone dehydrogenase (B-specific) activity;doxorubicin metabolic process;alditol:NADP+ 1-oxidoreductase activity;bile acid binding;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;bile acid metabolic process;xenobiotic metabolic process;cytosol;protein homooligomerization;intestinal cholesterol absorption;cellular response to jasmonic acid stimulus@NA
D10020@126909@126909@deletion@1@17840632@17842868@10@chr10:17840632-17842868@10.6@48@0@0@NA@FAM23A-201_5@108@108@108@:transmembrane protein 236;transmembrane protein 236-like@:integral to membrane@NA
D10020@126911@126913@duplication@3@17865075@17875839@10@chr10:17865075-17875839@6.74@267@382@1.43@NA@MRC1L1-001_2, MRC1L1-001_3, MRC1L1-001_4@14.6666666666667@12@20@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
D10020@126918@126921@deletion@4@17898254@17908771@10@chr10:17898254-17908771@10.3@155@77@0.497@NA@MRC1L1-001_9, MRC1L1-001_10, MRC1L1-001_11, MRC1L1-001_12@4.75@4@5@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
D10020@126946@126946@deletion@1@18112046@18112446@10@chr10:18112046-18112446@11.1@51@0@0@NA@MRC1-001_2@31@31@31@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D10020@126950@126958@duplication@9@18134220@18155691@10@chr10:18134220-18155691@20.8@161@335@2.08@NA@MRC1-001_6, MRC1-001_7, MRC1-001_8, MRC1-001_9, MRC1-001_10, MRC1-001_11, MRC1-001_12, RP11-457D2-001_1, RP11-457D2-001_2@17.5555555555556@12@26@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D10020@127835@127838@duplication@4@30978170@30982598@10@chr10:30978170-30982598@6.58@303@415@1.37@NA@ENST00000422642_3, ENST00000422642_4, ENST00000422642_5, ENST00000422642_6@0@0@0@NA@NA@NA
D10020@128372@128372@duplication@1@42924566@42924600@10@chr10:42924566-42924600@8.07@97@181@1.87@NA@CCNYL2-201_7@0@0@0@@:regulation of cyclin-dependent protein kinase activity;protein kinase binding@NA
D10020@129028@129030@deletion@3@48048896@48055019@10@chr10:48048896-48055019@30@144@0@0@CNVR4715.2@ASAH2C-201_1, ASAH2C-201_2, ASAH2C-201_3@63.3333333333333@50@90@@:ceramidase activity;sphingolipid metabolic process@NA
D10020@129462@129463@duplication@2@51362803@51363788@10@chr10:51362803-51363788@9.08@211@326@1.55@NA@ENST00000404618_3, ENST00000432221_3@142@142@142@NA@NA@NA
D10020@129572@129572@deletion@1@51847037@51847083@10@chr10:51847037-51847083@5.38@24@0@0@NA@FAM21A-005_8@95@95@95@:family with sequence similarity 21, member B;family with sequence similarity 21, member A@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
D10020@129586@129609@deletion@24@51877668@51978391@10@chr10:51877668-51978391@22@197@71@0.36@NA@FAM21A-005_22, FAM21A-005_23, FAM21A-005_24, FAM21A-005_25, FAM21A-005_26, FAM21A-005_27, FAM21A-005_28, FAM21A-005_29, FAM21A-005_30, FAM21A-005_31, ASAH2-201_7, ASAH2-201_8, ASAH2-201_9, ASAH2-201_10, ASAH2-201_11, ASAH2-201_12, ASAH2-201_13, ASAH2-201_14, ASAH2-201_15, ASAH2-201_16, ASAH2-201_17, ASAH2-201_18, ASAH2-201_19, ASAH2-201_20@103.5@45@186@:family with sequence similarity 21, member B;family with sequence similarity 21, member A:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
D10020@138032@138034@duplication@3@5270600@5274636@11@chr11:5270600-5274636@7@206@299@1.45@NA@HBG1-201_1, HBG1-201_2, HBG2-001_8@66@9@106@:hemoglobin, gamma A:hemoglobin, gamma G@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@: CYANOSIS, TRANSIENT NEONATAL; TNCY
D10020@145893@145897@deletion@5@89499780@89531798@11@chr11:89499780-89531798@13.4@447@255@0.57@NA@TRIM77-201_8, ENST00000375974_1, ENST00000375974_2, ENST00000375974_3, TRIM49-201_8@52.4@49@56@:tripartite motif containing 49@:protein binding;intracellular;DNA binding;zinc ion binding@NA
D10020@145925@145929@deletion@5@89606438@89609186@11@chr11:89606438-89609186@14.4@297@157@0.529@NA@TRIM64B-202_1, TRIM64B-202_2, TRIM64B-202_3, TRIM64B-202_4, TRIM64B-202_5@21.2@18@30@:tripartite motif containing 64;tripartite motif containing 64C;tripartite motif containing 64B@:protein binding;intracellular;zinc ion binding@NA
D10020@145944@145953@duplication@10@89701674@89715285@11@chr11:89701674-89715285@24.1@38@197@5.18@NA@TRIM64-202_1, TRIM64-202_2, TRIM64-202_3, TRIM64-202_4, TRIM64-202_5, TRIM64-202_6, TRIM64-202_7, TRIM64-202_8, TRIM64-202_9, ENST00000442514_9@171.8@154@177@NA@NA@NA
D10020@150826@150841@duplication@16@9590609@9707352@12@chr12:9590609-9707352@129@829@2026@2.44@CNVR5429.1@DDX12-203_1, DDX12-203_2, DDX12-203_3, AC006432-201_1, AC006432-201_2, AC006432-201_3, AC006432-201_4, AC006432-201_5, AC006432-201_6, AC006432-201_7, AC006432-201_8, AC006432-201_9, AC006432-201_11, AC006432-201_12, AC006432-201_13@20.7333333333333@7@25@NA@NA@NA
D10020@151049@151051@duplication@3@11506726@11508488@12@chr12:11506726-11508488@15.6@634@921@1.45@CNVR5435.2, CNVR5435.1@PRB1-201_1, PRB1-201_2, PRB1-201_3@47@44@49@:proline-rich protein BstNI subfamily 1@NA@NA
D10020@152075@152075@duplication@1@28701998@28703099@12@chr12:28701998-28703099@7.99@263@403@1.53@NA@CCDC91-203_12@3@3@3@:coiled-coil domain containing 91@:protein transport;Golgi apparatus;nucleus;membrane;identical protein binding@NA
D10020@152226@152226@deletion@1@31249277@31249314@12@chr12:31249277-31249314@11.1@83@20@0.241@CNVR5483.1@DDX11-202_16@0@0@0@:DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11@:nucleoplasm;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;S phase of mitotic cell cycle;DNA binding;nucleobase-containing compound metabolic process;ATP binding;ATP-dependent DNA helicase activity;DNA helicase activity;midbody;RNA binding;DNA-dependent ATPase activity;nucleus;positive regulation of cell proliferation;virus-host interaction;nuclear chromatin;4 iron, 4 sulfur cluster binding;helicase activity;hydrolase activity, acting on acid anhydrides;DNA duplex unwinding;endoplasmic reticulum unfolded protein response;G2/M transition of mitotic cell cycle;protein binding;sister chromatid cohesion;activation of signaling protein activity involved in unfolded protein response;nucleolus;spindle pole;ATP-dependent helicase activity;metal ion binding;nucleic acid binding;mitotic sister chromatid segregation@: WARSAW BREAKAGE SYNDROME
D10020@162131@162131@deletion@1@24468280@24468341@13@chr13:24468280-24468341@19.8@183@49@0.268@NA@RP11-45B20-002_4@36@36@36@:C1q and tumor necrosis factor related protein 9B@:collagen;protein binding@NA
D10020@162163@162164@duplication@2@24892958@24893019@13@chr13:24892958-24893019@10.1@671@932@1.39@NA@SPATA13-009_12, C1QTNF9-003_4@8.5@6@11@:spermatogenesis associated 13:C1q and tumor necrosis factor related protein 9@:lamellipodium assembly;phospholipid binding;Rac guanyl-nucleotide exchange factor activity;guanyl-nucleotide exchange factor activity;ruffle membrane;nucleus;regulation of cell migration;cell migration;regulation of Rho protein signal transduction;intracellular;Rho guanyl-nucleotide exchange factor activity;cytoplasm;filopodium assembly;filopodium;protein binding;lamellipodium:collagen;protein binding;hormone activity@NA
D10020@162215@162216@deletion@2@25144700@25144871@13@chr13:25144700-25144871@11@142@62@0.437@NA@ENST00000455130_2, ENST00000453498_4@10@10@10@NA@NA@NA
D10020@164459@164476@duplication@18@52803463@52855097@13@chr13:52803463-52855097@15.6@448@642@1.43@NA@THSD1P-203_14, THSD1P-203_15, THSD1P-203_16, THSD1P-203_17, THSD1P-203_18, THSD1P-203_19, THSD1P-203_20, THSD1P-203_21, THSD1P-203_22, ENST00000403471_5, ENST00000403471_6, ENST00000403471_7, ENST00000403471_8, ENST00000403471_9, ENST00000403471_10, ENST00000403471_11, ENST00000403471_12, ENST00000403471_13@30.6666666666667@6@58@NA@NA@NA
D10020@164540@164549@deletion@10@53105738@53151312@13@chr13:53105738-53151312@25@168@38@0.226@NA@RP11-78J21-201_13, RP11-78J21-201_14, RP11-78J21-201_15, RP11-78J21-201_16, RP11-78J21-201_17, RP11-78J21-201_18, RP11-78J21-201_19, RP11-78J21-201_20, RP11-78J21-201_21, RP11-78J21-201_22@65@17@117@NA@NA@NA
D10020@166695@166705@deletion@11@19487906@19574353@14@chr14:19487906-19574353@8.47@128@65@0.508@CNVR6072.1, CNVR6072.16, CNVR6072.29@ENST00000442368_1, ENST00000442368_2, POTEG-201_1, POTEG-201_2, POTEG-201_3, POTEG-201_4, POTEG-201_5, POTEG-201_6, POTEG-201_7, POTEG-201_8, POTEG-201_9@95.4545454545455@36@141@:POTE ankyrin domain family, member G@:protein binding@NA
D10020@166751@166762@deletion@12@20137324@20182108@14@chr14:20137324-20182108@68.4@1873@1018@0.544@CNVR6072.6, CNVR6072.12, CNVR6072.14@AL512310-201_1, AL512310-201_2, AL512310-201_3, AL512310-201_4, AL512310-201_5, ENST00000398231_1, ENST00000398231_2, ENST00000398231_3, ENST00000398231_4, ENST00000398231_5, ENST00000398231_6, ENST00000334072_2@90.5@58@102@NA@NA@NA
D10020@170809@170811@deletion@3@74003820@74010454@14@chr14:74003820-74010454@46.2@361@100@0.277@CNVR6188.1, CNVR6188.4@ACOT1-201_1, ACOT1-201_2, ACOT1-201_3@109.666666666667@99@116@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
D10020@173501@173502@deletion@2@106478134@106478412@14@chr14:106478134-106478412@17.6@147@43@0.293@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV3-6-210_6, IGHV4-4-001_2@17@17@17@@:protein binding@NA
D10020@173536@173542@deletion@7@106721281@106725734@14@chr14:106721281-106725734@24.3@1255@791@0.63@CNVR6294.48, CNVR6294.24, CNVR6294.40, CNVR6294.38, CNVR6294.17, CNVR6294.23@AB019439-201_1, AB019439-201_2, IGHVIII-22-2-201_1, IGHVIII-22-2-201_2, IGHVIII-22-2-201_3, IGHV3-23-001_1, IGHV3-23-001_2@6.71428571428571@5@8@@:protein binding@NA
D10020@173556@173561@deletion@6@106787370@106800758@14@chr14:106787370-106800758@20.5@680@397@0.584@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-29-001_1, IGHV3-29-001_2, IGHV3-30-001_1, IGHV3-30-001_2, IGHV3-30-2-001_1, IGHV3-30-2-001_2@16@13@19@@:protein binding@NA
D10020@173588@173591@deletion@4@106877621@106899494@14@chr14:106877621-106899494@61.1@449@96@0.214@CNVR6294.26, CNVR6294.56, CNVR6294.18@IGHV4-39-001_1, IGHV4-39-001_2, IGHV3-41-001_1, IGHV3-41-001_2@8.75@7@11@@:protein binding@NA
D10020@173635@173638@duplication@4@107095128@107099589@14@chr14:107095128-107099589@18.8@403@638@1.58@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61-001_1, IGHV4-61-001_2, IGHV3-62-001_1, IGHV3-62-001_2@16@15@17@@:protein binding@NA
D10020@173645@173645@duplication@1@107131035@107131335@14@chr14:107131035-107131335@9.07@233@375@1.61@CNVR6294.56, CNVR6294.16@IGHV3-66-001_2@3@3@3@@:protein binding@NA
D10020@173697@173698@deletion@2@20588370@20588710@15@chr15:20588370-20588710@40.8@551@196@0.356@CNVR6295.15, CNVR6295.7, CNVR6295.3, CNVR6295.10, CNVR6295.5@HERC2P3-014_27, AC026495-201_26@70@63@77@NA@NA@NA
D10020@174409@174412@duplication@4@29008952@29034539@15@chr15:29008952-29034539@8.72@410@576@1.4@NA@ENST00000456510_1, ENST00000456510_2, ENST00000430589_1, ENST00000430589_2@12.75@0@25@NA@NA@NA
D10020@174506@174506@deletion@1@30664352@30664545@15@chr15:30664352-30664545@7.47@37@2@0.0541@CNVR6337.1@CHRFAM7A-202_7@68@68@68@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
D10020@174659@174659@deletion@1@32449811@32449977@15@chr15:32449811-32449977@13.1@60@0@0@CNVR6345.2, CNVR6345.1@CHRNA7-205_6@66@66@66@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
D10020@176432@176433@deletion@2@44002591@44002976@15@chr15:44002591-44002976@5.22@166@99@0.596@NA@AC011330-201_13, AC011330-201_14@28@16@40@:stereocilin@:detection of mechanical stimulus involved in sensory perception of sound;stereocilium bundle tip;stereocilium;cell surface;kinocilium;auditory receptor cell stereocilium organization@: DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16; DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY
D10020@181987@181987@deletion@1@102312272@102312312@15@chr15:102312272-102312312@4.81@23@1@0.0435@NA@ENST00000448387_12@0@0@0@NA@NA@NA
D10020@182605@182607@duplication@3@1278902@1279739@16@chr16:1278902-1279739@8.31@51@114@2.24@CNVR6591.1@TPSB2-002_3, TPSB2-002_4, TPSB2-002_5@76.3333333333333@57@102@:tryptase beta 2 (gene/pseudogene)@:proteolysis;catalytic activity;serine-type endopeptidase activity@NA
D10020@182613@182614@deletion@2@1291437@1291992@16@chr16:1291437-1291992@4.94@112@63@0.562@CNVR6591.1@TPSAB1-202_4, TPSAB1-202_5@12@11@13@:tryptase alpha/beta 1@:serine-type peptidase activity;extracellular matrix;extracellular matrix organization;catalytic activity;extracellular matrix disassembly;proteolysis;extracellular space;protein binding;extracellular region;defense response;serine-type endopeptidase activity@NA
D10020@185304@185305@duplication@2@20491897@20492244@16@chr16:20491897-20492244@10.3@347@515@1.48@NA@ACSM2A-201_11, ACSM2A-201_12@1@1@1@:acyl-CoA synthetase medium-chain family member 2A@:mitochondrion;butyrate-CoA ligase activity;catalytic activity;ATP binding;glucose homeostasis;medium-chain fatty-acyl-CoA metabolic process;fatty acid metabolic process;triglyceride homeostasis;metabolic process;mitochondrial matrix;metal ion binding@NA
D10020@185551@185552@duplication@2@21559236@21559328@16@chr16:21559236-21559328@6.92@829@1099@1.33@CNVR6668.3, CNVR6668.1, CNVR6668.5@ENST00000403120_2, ENST00000403120_3@9.5@9@10@NA@NA@NA
D10020@185592@185595@deletion@4@21763692@21772051@16@chr16:21763692-21772051@8.23@148@78@0.527@CNVR6668.5, CNVR6668.2, CNVR6668.7@OTOA-001_25, OTOA-001_26, OTOA-001_27, OTOA-001_28@39@15@62@:otoancorin@:proteinaceous extracellular matrix;apical plasma membrane;sensory perception of sound;anchored to membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22
D10020@186292@186293@deletion@2@28403075@28403464@16@chr16:28403075-28403464@41.5@199@1@0.00503@CNVR6684.2@EIF3CL-201_9, EIF3CL-201_10@4@3@5@:eukaryotic translation initiation factor 3, subunit C-like@:protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;translation initiation factor activity@NA
D10020@186379@186379@duplication@1@28734771@28734873@16@chr16:28734771-28734873@12.1@257@443@1.72@CNVR6686.3, CNVR6686.2@EIF3S8-202_10@4@4@4@:eukaryotic translation initiation factor 3, subunit C@:cytosol;protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;cellular protein metabolic process;binding;gene expression;translation;translation initiation factor activity@NA
D10020@187499@187507@deletion@9@32486374@32859477@16@chr16:32486374-32859477@32.9@444@173@0.39@CNVR6701.7@AC138915-202_1, AC138915-202_3, AC138915-202_4, AC138915-202_5, TP53TG3-202_1, IGHV2OR16-5-001_1, IGHV2OR16-5-001_2@35.1428571428571@18@47@:TP53 target 3B;TP53 target 3;TP53-target gene 3 protein-like;TP53 target 3C@:nucleus;cytoplasm@NA
D10020@187544@187588@deletion@45@33500509@33786535@16@chr16:33500509-33786535@181@3079@1408@0.457@CNVR6703.17, CNVR6703.1@AC142384-201_1, AC142384-201_2, AC136428-201_2, AC136428-201_3, IGHV3OR16-8-001_1, IGHV3OR16-8-001_2, AC140658-201_1, AC140658-201_2, ENST00000300901_1, ENST00000300901_2, ENST00000300901_3, ENST00000300901_4, ENST00000300901_5, ENST00000300901_6, ENST00000300901_7, ENST00000300901_8, ENST00000300901_9, ENST00000300901_10, ENST00000300901_11, ENST00000300901_12, ENST00000300901_13, ENST00000300901_14, ENST00000300901_15, ENST00000300901_17, ENST00000450856_1, ENST00000450856_2, ENST00000450856_3, ENST00000380145_1, ENST00000380145_2, AC133561-201_1, AC133561-201_2, AC133561-201_3, AC133561-201_4, AC133561-201_6, AC133561-201_7, AC133561-201_8, AC133561-201_9, AC133561-201_10, AC133561-201_11, AC133561-201_12, AC133561-201_13, AC133561-201_14@22.5238095238095@4@73@NA@NA@NA
D10020@188231@188231@deletion@1@55803876@55804008@16@chr16:55803876-55804008@4.64@21@0@0@CNVR6730.1@CES4-202_4@123@123@123@NA@NA@NA
D10020@189981@189981@duplication@1@70211146@70211384@16@chr16:70211146-70211384@4.66@53@96@1.81@CNVR6764.1@CLEC18C-201_3@34@34@34@:C-type lectin domain family 18, member C@:carbohydrate binding;protein binding;extracellular region@NA
D10020@190549@190549@deletion@1@74451959@74452197@16@chr16:74451959-74452197@4.78@60@26@0.433@CNVR6778.2, CNVR6778.3@CLEC18B-202_3@47@47@47@:C-type lectin domain family 18, member B@:carbohydrate binding;protein binding;extracellular region@NA
D10020@195229@195238@deletion@10@16664741@16703686@17@chr17:16664741-16703686@32.6@1842@1184@0.643@NA@CCDC144A-202_13, CCDC144A-202_14, CCDC144A-202_15, CCDC144A-202_16, CCDC144A-202_17, CCDC144A-202_18, AC022596-003_1, AC022596-003_2, AC022596-003_3, AC022596-003_4@59.2@45@66@:coiled-coil domain containing 144A@NA@NA
D10020@195240@195261@deletion@22@16705575@16736068@17@chr17:16705575-16736068@30.2@1230@775@0.63@NA@AC022596-003_6, AC022596-003_7, AC022596-003_8, AC022596-003_9, AC022596-003_10, AC022596-003_11, AC022596-001_1, AC022596-001_2, AC022596-001_3, AC022596-001_4, AC022596-001_5, AC022596-001_6, AC022596-001_7, AC022596-001_8, ENST00000414673_1, ENST00000414673_2, ENST00000414673_3, ENST00000414673_4, ENST00000414673_5, ENST00000414673_6, ENST00000414673_7, ENST00000414673_8@86.0454545454545@64@97@:coiled-coil domain containing 144A@NA@NA
D10020@195703@195747@duplication@45@18344490@18457581@17@chr17:18344490-18457581@224@1169@3140@2.69@NA@ENST00000399124_3, ENST00000399124_4, ENST00000399124_5, ENST00000399124_6, ENST00000399124_7, ENST00000399124_8, ENST00000411877_4, LGALS9C-201_1, LGALS9C-201_2, LGALS9C-201_3, LGALS9C-201_4, LGALS9C-201_5, LGALS9C-201_6, LGALS9C-201_7, LGALS9C-201_8, LGALS9C-201_9, LGALS9C-201_10, LGALS9C-201_11, ENST00000426269_1, ENST00000426269_2, ENST00000426269_3, ENST00000426269_4, ENST00000426269_5, AC107983-001_1, AC107983-001_2, AC107983-001_3, AC107983-001_4, AC107983-001_5, AC107983-001_6, AC107983-001_7, AC107983-001_8, AC107983-001_9, AC107983-001_10, ENST00000456184_1, ENST00000456184_2, CCDC144B-201_14, CCDC144B-201_15, CCDC144B-201_16, CCDC144B-201_17, CCDC144B-201_18, ENST00000447265_11, ENST00000447265_12, ENST00000447265_13, ENST00000447265_14, ENST00000447265_15@130.2@79@153@:lectin, galactoside-binding, soluble, 9C:protein FAM106B-like@:carbohydrate binding@NA
D10020@195757@195759@deletion@3@18498037@18498176@17@chr17:18498037-18498176@24.3@315@132@0.419@NA@CCDC144B-201_8, CCDC144B-201_9, ENST00000447265_5@1@1@1@NA@NA@NA
D10020@195870@195871@duplication@2@18996289@18996940@17@chr17:18996289-18996940@9.54@261@411@1.57@CNVR7018.4, CNVR7018.2, CNVR7018.6@AC007952-202_1, AC007952-202_2@92.5@92@93@NA@NA@NA
D10020@197726@197728@deletion@3@34539180@34539966@17@chr17:34539180-34539966@16.4@75@0@0@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1-202_2, CCL4L1-202_3, CCL4L1-202_4@118@113@122@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
D10020@198032@198043@duplication@12@36351805@36398303@17@chr17:36351805-36398303@190@5434@10179@1.87@CNVR7083.3@AC183087-202_3, AC183087-202_4, AC183087-202_5, AC183087-202_6, AC183087-202_7, AC183087-202_8, AC183087-202_9, AC183087-202_10, AC183087-202_11, AC183087-202_12, AC183087-202_13, AC183087-202_14@50.75@27@64@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
D10020@200255@200266@deletion@12@43559805@43596019@17@chr17:43559805-43596019@115@675@68@0.101@CNVR7113.4, CNVR7113.6@PLEKHM1-201_1, PLEKHM1-201_2, AC091132-201_1, AC091132-201_2, AC091132-201_3, AC091132-201_4, AC091132-201_5, AC091132-201_6, ENST00000253803_1, ENST00000339474_1, ENST00000339474_2, ENST00000339474_3@67.9166666666667@1@127@:pleckstrin homology domain containing, family M (with RUN domain) member 1@:phospholipid binding;protein binding;intracellular;metal ion binding;cytoplasm;intracellular signal transduction@: OSTEOPETROSIS, AUTOSOMAL RECESSIVE 6; OPTB6
D10020@200320@200328@duplication@9@44248223@44364337@17@chr17:44248223-44364337@125@3357@5990@1.78@CNVR7114.3, CNVR7114.2, CNVR7114.10@KIAA1267-201_1, KIAA1267-201_2, AC217773-201_1, AC217773-201_2, ENST00000451529_1, ENST00000451529_3, ENST00000451529_5@64.4285714285714@49@90@:KAT8 regulatory NSL complex subunit 1:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:histone acetyltransferase activity (H4-K8 specific);histone acetyltransferase activity (H4-K16 specific);histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase complex;histone H4-K5 acetylation;MLL1 complex;histone H4-K16 acetylation;protein binding;histone H4-K8 acetylation;nucleus:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
D10020@200337@200340@deletion@4@44399690@44409348@17@chr17:44399690-44409348@11.6@73@13@0.178@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A-001_7, LRRC37A-001_8, LRRC37A-001_9, LRRC37A-001_10@144.75@141@154@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
D10020@200343@200349@deletion@7@44414664@44592688@17@chr17:44414664-44592688@17.6@90@7@0.0778@CNVR7114.2, CNVR7114.1@LRRC37A-001_13, LRRC37A-001_14, LRRC37A-001_15, AC005829-202_1, AC005829-202_2, AC005829-202_3, LRRC37A2-201_1@161.142857142857@124@196@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane@NA
D10020@200356@200362@duplication@7@44618175@44632791@17@chr17:44618175-44632791@16.4@702@1025@1.46@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2-201_7, LRRC37A2-201_8, LRRC37A2-201_9, LRRC37A2-201_10, LRRC37A2-201_11, LRRC37A2-201_12, LRRC37A2-201_13@82@67@98@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
D10020@200497@200497@duplication@1@45668085@45668248@17@chr17:45668085-45668248@5.06@231@330@1.43@CNVR7118.2@NPEPPS-201_10@0@0@0@:aminopeptidase puromycin sensitive@:metallopeptidase activity;antigen processing and presentation of peptide antigen via MHC class I;aminopeptidase activity;cytosol;proteolysis;cellular response to hypoxia;nucleus;zinc ion binding;protein polyubiquitination@NA
D10020@205726@205726@deletion@1@117045@117305@18@chr18:117045-117305@11.4@287@147@0.512@NA@ENST00000400614_3@26@26@26@NA@NA@NA
D10020@206673@206673@duplication@1@18534746@18535006@18@chr18:18534746-18535006@5.2@519@709@1.37@NA@ROCK1-001_31@0@0@0@:Rho-associated, coiled-coil containing protein kinase 1@:protein tyrosine kinase activity;bleb;apical constriction;ATP binding;regulation of actin filament-based process;regulation of focal adhesion assembly;leukocyte cell-cell adhesion;cytokinesis;intracellular signal transduction;regulation of actin cytoskeleton organization;intracellular;protein kinase activity;Rho protein signal transduction;cytosol;negative regulation of neuron apoptotic process;regulation of keratinocyte differentiation;phospholipid binding;smooth muscle contraction;negative regulation of angiogenesis;cellular component disassembly involved in execution phase of apoptosis;transferase activity, transferring phosphorus-containing groups;Golgi membrane;actin cytoskeleton organization;leukocyte tethering or rolling;regulation of cell motility;membrane to membrane docking;apoptotic process;GTP-Rho binding;centriole;protein serine/threonine kinase activity;regulation of establishment of cell polarity;protein phosphorylation;regulation of cell adhesion;bleb assembly;axon guidance;regulation of stress fiber assembly;signal transduction;protein binding;metal ion binding;leukocyte migration@NA
D10020@209118@209119@duplication@2@77890988@77898227@18@chr18:77890988-77898227@14.6@2365@3440@1.45@NA@ADNP2-201_3, ADNP2-201_4@0@0@0@:ADNP homeobox 2@:sequence-specific DNA binding;DNA binding;sequence-specific DNA binding transcription factor activity;neuron differentiation;positive regulation of cell growth;nucleus;negative regulation of cell death;cellular response to retinoic acid;intracellular;regulation of transcription, DNA-dependent;cellular response to oxidative stress;protein binding;transcription, DNA-dependent;molecular_function;cellular_component;zinc ion binding@NA
D10020@212729@212731@duplication@3@11632785@11633314@19@chr19:11632785-11633314@5.52@51@96@1.88@NA@CTC-398G3-201_1, CTC-398G3-201_2, CTC-398G3-201_3@1.66666666666667@1@2@:ECSIT homolog (Drosophila)@:mitochondrion;regulation of oxidoreductase activity;regulation of transcription from RNA polymerase II promoter;sequence-specific DNA binding transcription factor activity;signal transducer activity;cytoplasm;innate immune response;protein binding;transmembrane receptor protein serine/threonine kinase signaling pathway;transcription factor complex;BMP signaling pathway;nucleus;mesoderm formation;oxidoreductase activity, acting on NADH or NADPH@NA
D10020@213493@213494@duplication@2@14508472@14508748@19@chr19:14508472-14508748@21.1@75@240@3.2@NA@CD97-205_8, CD97-205_9@10.5@7@14@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
D10020@213632@213633@deletion@2@14876338@14876617@19@chr19:14876338-14876617@11.2@557@347@0.623@NA@EMR2-209_8, EMR2-209_9@3@3@3@:egf-like module containing, mucin-like, hormone receptor-like 2@:transmembrane signaling receptor activity;inflammatory response;G-protein coupled receptor activity;ruffle membrane;integral to membrane;plasma membrane;cell surface receptor signaling pathway;neuropeptide signaling pathway;granulocyte chemotaxis;cell migration;leading edge membrane;G-protein coupled receptor signaling pathway;protein binding;cell adhesion;membrane;calcium ion binding;chondroitin sulfate binding@NA
D10020@213635@213635@deletion@1@14877792@14877922@19@chr19:14877792-14877922@7.07@69@24@0.348@NA@EMR2-209_6@4@4@4@:egf-like module containing, mucin-like, hormone receptor-like 2@:transmembrane signaling receptor activity;inflammatory response;G-protein coupled receptor activity;ruffle membrane;integral to membrane;plasma membrane;cell surface receptor signaling pathway;neuropeptide signaling pathway;granulocyte chemotaxis;cell migration;leading edge membrane;G-protein coupled receptor signaling pathway;protein binding;cell adhesion;membrane;calcium ion binding;chondroitin sulfate binding@NA
D10020@215372@215372@deletion@1@29703814@29704137@19@chr19:29703814-29704137@4.61@49@19@0.388@NA@UQCRFS1-201_1@2@2@2@:ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1@:oxidation-reduction process;mitochondrion;response to antibiotic;small molecule metabolic process;ubiquinol-cytochrome-c reductase activity;mitochondrial inner membrane;response to drug;respiratory electron transport chain;protein binding;oxidoreductase activity;integral to membrane;response to hormone stimulus;protein complex binding;mitochondrial membrane;2 iron, 2 sulfur cluster binding;mitochondrial respiratory chain complex III;metal ion binding@NA
D10020@217290@217297@deletion@8@40367300@40382827@19@chr19:40367300-40382827@25.1@568@329@0.579@CNVR7639.2@FCGBP-201_22, FCGBP-201_23, FCGBP-201_24, FCGBP-201_25, FCGBP-201_26, FCGBP-201_27, FCGBP-201_28, FCGBP-201_29@88.875@13@155@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D10020@217301@217305@duplication@5@40389654@40398511@19@chr19:40389654-40398511@10@303@438@1.45@CNVR7639.2, CNVR7639.3@FCGBP-201_14, FCGBP-201_15, FCGBP-201_16, FCGBP-201_17, FCGBP-201_18@113.6@103@127@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D10020@217309@217309@deletion@1@40405921@40406061@19@chr19:40405921-40406061@5.06@30@5@0.167@CNVR7639.2@FCGBP-201_10@16@16@16@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D10020@220493@220494@deletion@2@51330920@51334780@19@chr19:51330920-51334780@8.55@131@62@0.473@NA@KLK15-202_1, KLK15-202_2@0@0@0@:kallikrein-related peptidase 15@:serine-type peptidase activity;proteolysis;extracellular region;catalytic activity;serine-type endopeptidase activity@NA
D10020@221177@221177@deletion@1@54743779@54743828@19@chr19:54743779-54743828@5.37@80@38@0.475@CNVR7721.3, CNVR7721.6@LILRA6-002_7@48@48@48@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D10020@221218@221222@deletion@5@54801929@54803979@19@chr19:54801929-54803979@11.1@854@577@0.676@CNVR7722.1@LILRA3-003_6, LILRA3-003_7, LILRA3-003_8, LILRA3-003_9, LILRA3-003_10@108.4@107@109@:leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3@:antigen binding;signal transduction;protein binding;extracellular region;plasma membrane;receptor activity;defense response@NA
D10020@221403@221408@duplication@6@55277931@55279337@19@chr19:55277931-55279337@25.4@906@1331@1.47@CNVR7725.2, CNVR7725.1@KIR2DL3-201_6, KIR2DL3-201_7, KIR2DL3-201_8, KIR2DP1-001_7, KIR2DP1-001_8, KIR2DP1-001_9@125.666666666667@125@126@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity@NA
D10020@221436@221437@duplication@2@55349033@55351155@19@chr19:55349033-55351155@5.03@290@396@1.37@CNVR7725.1, CNVR7725.6@KIR2DS4-001_3, KIR2DS4-001_4@67.5@67@68@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
D10020@221439@221441@deletion@3@55358641@55360024@19@chr19:55358641-55360024@24.1@1193@702@0.588@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4-001_6, KIR2DS4-001_7, KIR2DS4-001_8@96.3333333333333@85@102@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
D10020@221447@221448@duplication@2@55370536@55370585@19@chr19:55370536-55370585@6.66@223@322@1.44@CNVR7725.1, CNVR7725.6, CNVR7725.5@KIR3DL1-201_6, KIR3DL2-001_6@2@2@2@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
D10020@221819@221820@deletion@2@56270382@56273453@19@chr19:56270382-56273453@29.6@173@22@0.127@CNVR7734.1@RFPL4A-201_1, RFPL4A-201_2@32.5@26@39@:ret finger protein-like 4A;ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
D10020@221822@221824@duplication@3@56280509@56284546@19@chr19:56280509-56284546@24.7@948@1481@1.56@CNVR7734.1@ENST00000341750_1, ENST00000341750_2, ENST00000341750_3@37.6666666666667@30@47@:ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
D10020@222068@222069@deletion@2@58003184@58003369@19@chr19:58003184-58003369@6.46@71@29@0.408@CNVR7748.1@ZNF419-202_5, ZNF419-202_6@0@0@0@:zinc finger protein 419@:intracellular;DNA binding;regulation of transcription, DNA-dependent;cytoplasm;nucleolus;nucleus;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding@NA
D10020@222563@222563@duplication@1@1569208@1569279@20@chr20:1569208-1569279@4.77@26@63@2.42@CNVR7763.1@SIRPB1-201_1@128@128@128@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
D10020@222594@222594@duplication@1@1895747@1896102@20@chr20:1895747-1896102@7.22@154@250@1.62@CNVR7764.2@SIRPA-201_3@34@34@34@:signal-regulatory protein alpha@:blood coagulation;protein binding;integral to membrane;SH3 domain binding;cell adhesion;plasma membrane;membrane;leukocyte migration@NA
D10020@224466@224467@deletion@2@26061802@26065122@20@chr20:26061802-26065122@29.8@213@46@0.216@CNVR7823.4, CNVR7823.3, CNVR7823.5, CNVR7823.1@C20orf91-201_4, C20orf91-201_5@46.5@33@60@NA@NA@NA
D10020@228815@228833@duplication@19@10793871@10944788@21@chr21:10793871-10944788@37.3@6096@7924@1.3@CNVR7947.10, CNVR7947.6@AF254982-201_1, AF254982-201_2, IGHV1OR15-5-001_1, IGHV1OR15-5-001_2, ENST00000456889_1, ENST00000456889_2, TPTE-006_20, TPTE-006_21, TPTE-006_22, TPTE-006_23, TPTE-006_24, TPTE-006_25, TPTE-006_26, TPTE-006_27, TPTE-006_28, TPTE-006_29, TPTE-006_30, TPTE-006_31, TPTE-006_32@24.0526315789474@5@33@:transmembrane phosphatase with tensin homology@:protein binding;extracellular region:phosphatase activity;ion channel activity;protein tyrosine phosphatase activity;ion transport;protein dephosphorylation;transmembrane transport;protein binding;signal transduction;integral to membrane;protein tyrosine/serine/threonine phosphatase activity;dephosphorylation;membrane;peptidyl-tyrosine dephosphorylation@NA
D10020@231958@231958@deletion@1@16287256@16287718@22@chr22:16287256-16287718@6.11@80@35@0.438@CNVR8071.2, CNVR8071.3, CNVR8071.9@POTEH-002_1@105@105@105@:POTE ankyrin domain family, member H@:protein binding@NA
D10020@232762@232781@duplication@20@20378428@20397986@22@chr22:20378428-20397986@13.2@169@286@1.69@CNVR8094.9, CNVR8094.4, CNVR8094.10@AC023490-001_2, AC023490-005_1, AC023490-005_2, AC023490-005_3, AC023490-005_4, AC023490-005_5, AC023490-005_6, PI4KAP1-204_4, PI4KAP1-204_5, PI4KAP1-204_6, PI4KAP1-204_7, PI4KAP1-204_8, PI4KAP1-204_9, PI4KAP1-204_10, PI4KAP1-204_11, PI4KAP1-204_12, PI4KAP1-204_13, PI4KAP1-204_14, PI4KAP1-204_15, PI4KAP1-204_16@160.8@122@172@NA@NA@NA
D10020@233707@233708@deletion@2@24300740@24302569@22@chr22:24300740-24302569@5.1@31@6@0.194@CNVR8114.6, CNVR8114.12, CNVR8114.13, CNVR8114.8@GSTT2B-002_2, GSTT2B-002_3@63.5@60@67@:glutathione S-transferase theta 2B (gene/pseudogene);glutathione S-transferase theta 2@:protein binding;glutathione transferase activity;nucleus;transferase activity;cytoplasm@NA
D10020@233731@233754@deletion@24@24345655@24394850@22@chr22:24345655-24394850@219@1034@1@0.000967@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTTP1-001_1, GSTTP1-001_2, ENST00000421902_1, ENST00000421902_2, ENST00000448902_1, ENST00000448902_2, ENST00000448902_3, ENST00000448902_4, ENST00000448902_5, ENST00000329210_1, ENST00000329210_2, ENST00000329210_3, ENST00000329210_4, ENST00000439866_1, ENST00000439866_2, GSTT1-009_1, GSTT1-009_2, GSTT1-009_3, GSTT1-009_4, GSTT1-009_5, ENST00000439996_1, ENST00000439996_2, GSTTP2-001_4, GSTTP2-001_5@130.833333333333@109@149@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
D10020@236823@236824@deletion@2@42914013@42915809@22@chr22:42914013-42915809@5.73@158@93@0.589@CNVR8171.2, CNVR8171.3@RRP7A-001_1, RRP7A-001_2@32.5@30@35@:ribosomal RNA processing 7 homolog A (S. cerevisiae)@:RNA binding;nucleotide binding@NA
D100563@608@608@duplication@1@1643705@1643840@1@chr1:1643705-1643840@8.17@22@79@3.59@CNVR17.1@CDC2L2-208_7@25@25@25@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
D100563@1577@1577@duplication@1@9107671@9107794@1@chr1:9107671-9107794@7.56@336@486@1.45@NA@SLC2A5-001_4@0@0@0@:solute carrier family 2 (facilitated glucose/fructose transporter), member 5@:glucose transport;substrate-specific transmembrane transporter activity;small molecule metabolic process;glucose transmembrane transporter activity;fructose transport;carbohydrate metabolic process;transmembrane transport;integral to membrane;transmembrane transporter activity;plasma membrane;hexose transport;fructose transmembrane transporter activity;membrane@NA
D100563@2944@2946@duplication@3@16975876@16976445@1@chr1:16975876-16976445@16.1@782@1104@1.41@CNVR93.3, CNVR93.6, CNVR93.12, CNVR93.7, CNVR93.14, CNVR93.15@RP5-1182A14-001_15, RP5-1182A14-001_16, RP5-1182A14-001_17@80.6666666666667@69@88@NA@NA@NA
D100563@2956@2956@duplication@1@17025923@17026117@1@chr1:17025923-17026117@4.95@85@138@1.62@CNVR93.3, CNVR93.15, CNVR93.4@ESPNP-002_8@46@46@46@NA@NA@NA
D100563@3775@3779@duplication@5@21806546@21809812@1@chr1:21806546-21809812@9.71@250@371@1.48@CNVR107.2, CNVR107.1@NBPF3-003_15, NBPF3-003_16, NBPF3-003_17, NBPF3-003_18, NBPF3-003_19@86.4@62@111@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 3@:cytoplasm@NA
D100563@4448@4461@deletion@14@25579800@25655628@1@chr1:25579800-25655628@265@1345@45@0.0335@CNVR116.1@C1orf63-002_1, RP11-335G20-001_1, RP11-335G20-001_2, RHD-202_1, RHD-202_2, RHD-202_3, RHD-202_4, RHD-202_5, RHD-202_6, RHD-202_7, RHD-202_8, RHD-202_9, RHD-202_10, RHD-202_11@109.714285714286@6@128@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
D100563@4477@4477@duplication@1@25735176@25735361@1@chr1:25735176-25735361@13.7@95@219@2.31@CNVR117.1@RHCE-005_4@56@56@56@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
D100563@12424@12432@deletion@9@104233918@104256576@1@chr1:104233918-104256576@17.2@128@34@0.266@CNVR266.3, CNVR266.5@AMY1B-001_1, AMY1B-001_2, AMY1B-001_3, AMY1B-001_4, AMY1B-001_5, AMY1B-001_6, AMY1B-001_7, AMY1B-001_8, AMYP1-001_1@119.777777777778@107@154@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D100563@12929@12936@deletion@8@110230474@110236368@1@chr1:110230474-110236368@110@519@5@0.00963@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1-001_1, GSTM1-001_2, GSTM1-001_3, GSTM1-001_4, GSTM1-001_5, GSTM1-001_6, GSTM1-001_7, GSTM1-001_8@191.375@187@194@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
D100563@14487@14496@deletion@10@144615098@144811958@1@chr1:144615098-144811958@22.7@439@233@0.531@NA@AL592284-001_7, AL592284-001_8, AL592284-001_9, AL592284-001_10, AL592284-001_11, AL592284-001_12, WI2-1896O14-001_1, WI2-1896O14-001_2, WI2-1896O14-001_3, NBPF9-001_1@16.5@2@49@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 24@NA@NA
D100563@15397@15431@deletion@35@149036437@149115189@1@chr1:149036437-149115189@45.9@1020@582@0.571@CNVR350.3, CNVR350.1@RP11-744H18-001_1, RP11-744H18-001_2, RP11-744H18-001_3, RP11-744H18-001_4, RP11-744H18-001_5, RP11-744H18-001_6, RP11-744H18-001_7, RP11-744H18-001_8, RP11-744H18-001_9, RP11-744H18-001_10, RP11-744H18-001_11, RP11-744H18-001_12, RP11-744H18-001_13, RP11-744H18-001_14, RP11-744H18-001_15, RP11-744H18-001_16, RP11-744H18-001_17, ENST00000401087_2, ENST00000401087_3, ENST00000401087_4, ENST00000401087_5, ENST00000401087_6, ENST00000401087_7, ENST00000401087_8, ENST00000401087_9, ENST00000401087_10, ENST00000401087_11, ENST00000401087_12, ENST00000401087_13, ENST00000401087_14, ENST00000401087_15, ENST00000401087_16, RP11-403I13-201_1, RP11-403I13-201_2, RP11-403I13-201_3@79.7428571428571@11@87@NA@NA@NA
D100563@15456@15462@deletion@7@149375000@149400543@1@chr1:149375000-149400543@31.6@751@415@0.553@CNVR350.1@FCGR1C-201_4, FCGR1C-201_5, FCGR1C-201_6, ENST00000415338_1, HIST2H3PS2-001_1, HIST2H3PS2-001_2, RP5-998N21-002_1@73.7142857142857@70@76@NA@NA@NA
D100563@18653@18663@duplication@11@161487767@161519571@1@chr1:161487767-161519571@38.9@2690@3731@1.39@CNVR383.3, CNVR383.1@FCGR2A-001_7, AL590385-201_1, AL590385-201_2, RP11-5K23-001_1, RP11-5K23-001_2, RP11-5K23-001_3, FCGR3A-003_2, FCGR3A-003_3, FCGR3A-003_4, FCGR3A-003_5, FCGR3A-003_6@7.72727272727273@7@9@:Fc fragment of IgG, low affinity IIa, receptor (CD32):heat shock 70kDa protein 6 (HSP70B'):Fc fragment of IgG, low affinity IIIa, receptor (CD16a)@:IgG binding;protein binding;integral to membrane;plasma membrane:signalosome;cell morphogenesis;response to unfolded protein;ATP binding:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane@NA
D100563@18676@18684@deletion@9@161569422@161600997@1@chr1:161569422-161600997@95.8@1144@436@0.381@CNVR383.1@FCGR2C-006_7, ENST00000448848_1, ENST00000448848_2, ENST00000448848_3, FCGR3B-001_1, FCGR3B-001_2, FCGR3B-001_3, FCGR3B-001_4, FCGR3B-001_5@38.1111111111111@34@40@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene):Fc fragment of IgG, low affinity IIIb, receptor (CD16b)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction:IgG binding;protein binding;extracellular region;immune response;plasma membrane;anchored to membrane@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
D100563@21522@21531@deletion@10@198608172@198668834@1@chr1:198608172-198668834@9.69@812@570@0.702@NA@PTPRC-001_1, PTPRC-001_2, PTPRC-001_3, PTPRC-001_4, PTPRC-001_5, ENST00000413577_1, ENST00000413577_2, ENST00000413577_3, ENST00000455475_1, ENST00000455475_2@1.4@1@3@:protein tyrosine phosphatase, receptor type, C@:stem cell development;heterotypic cell-cell adhesion;negative regulation of protein autophosphorylation;response to gamma radiation;B cell proliferation;positive regulation of stem cell proliferation;activation of MAPK activity;regulation of humoral immune response mediated by circulating immunoglobulin;negative regulation of T cell mediated cytotoxicity;positive regulation of antigen receptor-mediated signaling pathway;positive regulation of B cell proliferation;regulation of S phase;protein dephosphorylation;integral to membrane;heparin binding;cell surface receptor signaling pathway;regulation of cell cycle;positive regulation of T cell mediated cytotoxicity;axon guidance;positive regulation of protein kinase activity;positive regulation of T cell mediated immunity;negative regulation of peptidyl-tyrosine phosphorylation;dephosphorylation;positive regulation of apoptotic process;defense response to virus;positive regulation of isotype switching to IgG isotypes;negative regulation of cytokine-mediated signaling pathway;T cell proliferation;bone marrow development;negative thymic T cell selection;B cell differentiation;positive thymic T cell selection;leukocyte cell-cell adhesion;plasma membrane;immunoglobulin biosynthetic process;heparan sulfate proteoglycan binding;positive regulation of T cell differentiation;B cell receptor signaling pathway;negative regulation of cell adhesion involved in substrate-bound cell migration;regulation of apoptotic process;transmembrane receptor protein tyrosine phosphatase activity;membrane raft;protein kinase binding;positive regulation of MAPK cascade;cell periphery;negative regulation of protein kinase activity;release of sequestered calcium ion into cytosol;focal adhesion;integral to plasma membrane;peptidyl-tyrosine dephosphorylation;hematopoietic progenitor cell differentiation;phosphatase activity;positive regulation of gamma-delta T cell differentiation;protein tyrosine phosphatase activity;regulation of B cell receptor signaling pathway;external side of plasma membrane;T cell differentiation;protein binding;T cell receptor signaling pathway;positive regulation of humoral immune response mediated by circulating immunoglobulin;positive regulation of alpha-beta T cell proliferation;regulation of B cell differentiation;positive regulation of T cell proliferation;positive regulation of hematopoietic stem cell migration;cell surface@: SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE,; MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO; MS
D100563@22991@22991@deletion@1@207498969@207499067@1@chr1:207498969-207499067@4.76@115@65@0.565@NA@CD55-201_4@0@0@0@:CD55 molecule, decay accelerating factor for complement (Cromer blood group)@:membrane raft;complement activation, classical pathway;maternal process involved in parturition;spermatogenesis;negative regulation of complement activation;response to peptide hormone stimulus;plasma membrane;negative regulation of catalytic activity;integral to plasma membrane;enzyme inhibitor activity;apical plasma membrane;respiratory burst;innate immune response;extracellular region;elevation of cytosolic calcium ion concentration;cell surface;anchored to membrane;regulation of complement activation@: BLOOD GROUP, CROMER SYSTEM; CROM
D100563@23032@23044@deletion@13@207718655@207739269@1@chr1:207718655-207739269@21.6@375@179@0.477@CNVR485.1@CR1-201_14, CR1-201_15, CR1-201_16, CR1-201_17, CR1-201_18, CR1-201_19, CR1-201_20, CR1-201_21, CR1-201_22, CR1-201_23, CR1-201_24, RP11-78B10-001_1, RP11-78B10-001_2@48.2307692307692@9@98@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
D100563@24160@24164@deletion@5@223727670@223729472@1@chr1:223727670-223729472@18.7@87@1@0.0115@NA@CAPN8-202_20, CAPN8-202_21, CAPN8-202_22, CAPN8-202_23, CAPN8-202_24@0@0@0@:calpain 8@:proteolysis;Golgi apparatus;intracellular;calcium-dependent cysteine-type endopeptidase activity;calcium ion binding@NA
D100563@34094@34095@deletion@2@96458183@96458295@2@chr2:96458183-96458295@8.44@67@20@0.299@NA@AC008268-201_3, ENST00000444924_2@104@104@104@NA@NA@NA
D100563@34620@34635@duplication@16@98152765@98166078@2@chr2:98152765-98166078@12.8@227@356@1.57@NA@ANKRD36B-001_19, ANKRD36B-001_20, ANKRD36B-001_21, ANKRD36B-001_22, ANKRD36B-001_23, ANKRD36B-001_24, ANKRD36B-001_25, ANKRD36B-001_26, ANKRD36B-001_27, ANKRD36B-001_28, ANKRD36B-001_29, ANKRD36B-001_30, ANKRD36B-001_31, ANKRD36B-001_32, ANKRD36B-001_33, ANKRD36B-001_34@113.3125@14@154@NA@NA@NA
D100563@38877@38878@deletion@2@160634451@160634476@2@chr2:160634451-160634476@11.1@129@54@0.419@NA@CD302-002_6, LY75-002_38@1@1@1@:CD302 molecule:LY75-CD302 readthrough:lymphocyte antigen 75;LY75-CD302 readthrough@:carbohydrate binding;filopodium;cell cortex;integral to membrane;phagocytosis;microvillus:carbohydrate binding:carbohydrate binding;inflammatory response;endocytosis;immune response;receptor activity;integral to plasma membrane@NA
D100563@40385@40391@deletion@7@178081233@178084814@2@chr2:178081233-178084814@17.2@928@610@0.657@NA@HNRNPA3-001_5, HNRNPA3-001_6, HNRNPA3-001_7, HNRNPA3-001_8, HNRNPA3-001_9, HNRNPA3-001_10, HNRNPA3-001_11@0@0@0@:heterogeneous nuclear ribonucleoprotein A3@:nucleoplasm;ribonucleoprotein complex;nucleotide binding;catalytic step 2 spliceosome;RNA binding;nucleolus;RNA splicing;mRNA splicing, via spliceosome;nucleus;gene expression;nucleic acid binding@NA
D100563@45386@45389@deletion@4@233272979@233273823@2@chr2:233272979-233273823@12.4@308@176@0.571@NA@ALPPL2-001_6, ALPPL2-001_7, ALPPL2-001_8, ALPPL2-001_9@39.75@19@58@:alkaline phosphatase, placental-like 2@:phosphatase activity;catalytic activity;phosphorylation;plasma membrane;metabolic process;membrane;anchored to membrane;alkaline phosphatase activity;metal ion binding@NA
D100563@47953@47953@duplication@1@14551330@14551473@3@chr3:14551330-14551473@5.26@132@201@1.52@NA@GRIP2-202_18@0@0@0@NA@NA@NA
D100563@61551@61552@duplication@2@195399357@195400859@3@chr3:195399357-195400859@10.3@246@376@1.53@CNVR1703.1@SDHALP2-001_9, SDHALP2-001_10@71.5@71@72@:mucin 20, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane@NA
D100563@61568@61570@deletion@3@195451553@195456611@3@chr3:195451553-195456611@7.6@1716@1257@0.733@CNVR1703.1, CNVR1703.2, CNVR1703.5@MUC20-201_2, MUC20-201_3, MUC20-201_4@41.6666666666667@38@44@:mucin 20, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane@NA
D100563@61572@61573@deletion@2@195473642@195475936@3@chr3:195473642-195475936@5.88@483@329@0.681@CNVR1703.1, CNVR1703.2, CNVR1703.5, CNVR1703.4@MUC4-203_25, MUC4-203_26@32@30@34@:mucin 4, cell surface associated@:ErbB-2 class receptor binding;Golgi lumen;cell-matrix adhesion;post-translational protein modification;extracellular matrix structural constituent;protein binding;O-glycan processing;cellular protein metabolic process;proteinaceous extracellular matrix;integral to plasma membrane;membrane;extracellular matrix constituent, lubricant activity;biological_process@NA
D100563@61643@61647@deletion@5@195701270@195702772@3@chr3:195701270-195702772@27.7@941@563@0.598@CNVR1707.1, CNVR1707.2@SDHALP1-002_9, SDHALP1-002_10, ENST00000354937_10, ENST00000354937_11, ENST00000354937_12@40@39@41@NA@NA@NA
D100563@65315@65320@deletion@6@69402904@69434246@4@chr4:69402904-69434246@211@1094@3@0.00274@CNVR1953.1@UGT2B17-001_1, UGT2B17-001_2, UGT2B17-001_3, UGT2B17-001_4, UGT2B17-001_5, UGT2B17-001_6@124.5@118@134@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
D100563@65354@65359@duplication@6@70146221@70156530@4@chr4:70146221-70156530@12.5@644@885@1.37@CNVR1957.2, CNVR1957.1@UGT2B28-201_1, UGT2B28-201_2, UGT2B28-201_3, UGT2B28-201_4, UGT2B28-201_5, UGT2B28-201_6@68.8333333333333@65@71@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
D100563@68947@68947@deletion@1@145041645@145041742@4@chr4:145041645-145041742@9.45@125@54@0.432@NA@GYPA-205_2@8@8@8@:glycophorin B (MNS blood group):glycophorin A (MNS blood group)@:integral to membrane;plasma membrane;integral to plasma membrane:external side of plasma membrane;integral to membrane;cytoskeletal anchoring at plasma membrane;plasma membrane;molecular_function;protein homodimerization activity;integral to plasma membrane;cellular_component;identical protein binding;membrane;biological_process;regulation of response to osmotic stress;virus-host interaction@: BLOOD GROUP--Ss LOCUS; Ss: MALARIA, SUSCEPTIBILITY TO; BLOOD GROUP--MN LOCUS; MN
D100563@70816@70821@duplication@6@712144@745414@5@chr5:712144-745414@18.8@1326@1779@1.34@CNVR2280.3@ZDHHC11-201_13, ZDHHC11B-201_6, ZDHHC11B-201_7, ZDHHC11B-201_8, ZDHHC11B-201_9, ZDHHC11B-201_10@62.6666666666667@34@86@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
D100563@70823@70838@duplication@16@751250@840766@5@chr5:751250-840766@145@3420@5590@1.63@CNVR2280.3@ZDHHC11-201_5, ZDHHC11-201_6, ZDHHC11-201_7, ZDHHC11-201_8, ZDHHC11-201_9, ZDHHC11-201_10, ZDHHC11-201_11, ZDHHC11-201_12, ZDHHC11B-201_1, ZDHHC11B-201_2, ZDHHC11B-201_3, ZDHHC11B-201_4, AC026740-202_1, AC026740-202_2, AC026740-202_3, AC026740-202_4@51.125@23@87@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
D100563@71600@71606@duplication@7@21480883@21491618@5@chr5:21480883-21491618@7.44@308@425@1.38@CNVR2395.4, CNVR2395.6, CNVR2395.2@AC138951-201_4, AC138951-202_1, AC138951-202_2, ENST00000412250_1, ENST00000412250_2, ENST00000412250_3, ENST00000412250_4@105.714285714286@97@108@NA@NA@NA
D100563@73655@73656@duplication@2@68861960@68862453@5@chr5:68861960-68862453@10.4@49@130@2.65@CNVR2494.7, CNVR2494.46@GTF2H2C-201_4, GTF2H2C-201_5@10@8@12@:general transcription factor IIH, polypeptide 2C;general transcription factor IIH, polypeptide 2D@:regulation of transcription, DNA-dependent;nucleotide-excision repair;DNA repair;core TFIIH complex;protein binding;nucleus;transcription, DNA-dependent;zinc ion binding@NA
D100563@73746@73754@deletion@9@69796546@69807068@5@chr5:69796546-69807068@7.23@34@1@0.0294@CNVR2494.10, CNVR2494.57@AC146944-203_1, AC146944-203_2, ENST00000456583_1, ENST00000456583_2, ENST00000456583_3, ENST00000456583_4, ENST00000456583_5, AC146944-202_1, AC146944-202_2@152.666666666667@85@173@NA@NA@NA
D100563@76559@76563@deletion@5@131805734@131820190@5@chr5:131805734-131820190@11.9@350@210@0.6@NA@C5orf56-005_4, AC116366-001_1, AC116366-001_2, IRF1-008_9, IRF1-008_10@0@0@0@:interferon regulatory factor 1@:nucleoplasm;defense response to virus;negative regulation of cell proliferation;sequence-specific DNA binding;cellular response to dsRNA;negative regulation of transcription, DNA-dependent;induction of apoptosis;cellular response to mechanical stimulus;nucleus;positive regulation of interferon-beta production;type I interferon-mediated signaling pathway;positive regulation of type I interferon production;I-kappaB kinase/NF-kappaB cascade;transcription from RNA polymerase II promoter;cytosol;cellular response to interleukin-1;CD8-positive, alpha-beta T cell differentiation;positive regulation of interleukin-12 biosynthetic process;positive regulation of transcription, DNA-dependent;regulatory region DNA binding;regulation of CD8-positive, alpha-beta T cell proliferation;transcription, DNA-dependent;response to growth hormone stimulus;DNA binding;sequence-specific DNA binding transcription factor activity;cellular response to tumor necrosis factor;positive regulation of cell death;negative regulation of tyrosine phosphorylation of Stat1 protein;blood coagulation;interferon-gamma-mediated signaling pathway;cell cycle arrest;cytokine-mediated signaling pathway;positive regulation of transcription from RNA polymerase II promoter;regulation of gene expression;regulation of innate immune response;regulation of cell cycle;cellular response to retinoic acid;protein phosphorylation;regulation of MyD88-dependent toll-like receptor signaling pathway;cytoplasm;protein binding;regulation of adaptive immune response;protein acetylation;female pregnancy;response to heat;cellular response to peptide hormone stimulus;negative regulation of regulatory T cell differentiation@: GASTRIC CANCER
D100563@78044@78045@deletion@2@147553799@147554962@5@chr5:147553799-147554962@28.9@171@25@0.146@CNVR2637.1@AC116334-001_3, AC116334-001_4@43.5@9@78@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
D100563@78367@78381@deletion@15@149771109@149786524@5@chr5:149771109-149786524@41.8@2020@1306@0.647@NA@TCOF1-208_21, TCOF1-208_22, TCOF1-208_23, TCOF1-208_24, TCOF1-208_25, TCOF1-208_26, TCOF1-208_27, TCOF1-208_28, CD74-201_3, CD74-201_4, CD74-201_5, CD74-201_6, CD74-201_7, CD74-201_8, CD74-201_9@0@0@0@:Treacher Collins-Franceschetti syndrome 1:CD74 molecule, major histocompatibility complex, class II invariant chain@:protein binding;transcription of nuclear large rRNA transcript from RNA polymerase I promoter;nucleolus;transporter activity;nucleus;cytoplasm;skeletal system development:transport vesicle membrane;positive regulation of ERK1 and ERK2 cascade;intracellular protein transport;lysosomal lumen;positive regulation of fibroblast proliferation;negative regulation of mature B cell apoptotic process;negative regulation of DNA damage response, signal transduction by p53 class mediator;positive regulation of neutrophil chemotaxis;activation of MAPK activity;vacuole;positive regulation of macrophage cytokine production;negative regulation of peptide secretion;positive regulation of type 2 immune response;positive regulation of B cell proliferation;membrane;integral to lumenal side of endoplasmic reticulum membrane;nitric-oxide synthase binding;Golgi membrane;integral to membrane;macrophage migration inhibitory factor binding;endocytic vesicle membrane;multivesicular body;positive regulation of peptidyl-tyrosine phosphorylation;lysosomal membrane;cytokine receptor activity;cell proliferation;signal transduction;positive regulation of chemokine (C-X-C motif) ligand 2 production;negative regulation of apoptotic process;positive regulation of dendritic cell antigen processing and presentation;cytokine binding;late endosome;immune response;immunoglobulin mediated immune response;beta-amyloid binding;negative regulation of T cell differentiation;antigen processing and presentation of endogenous antigen;negative thymic T cell selection;macrophage migration inhibitory factor signaling pathway;positive thymic T cell selection;plasma membrane;regulation of macrophage activation;defense response;identical protein binding;antigen processing and presentation of exogenous peptide antigen via MHC class II;endoplasmic reticulum;positive regulation of T cell differentiation;intracellular;MHC class II protein complex;macrophage migration inhibitory factor receptor complex;NOS2-CD74 complex;antigen processing and presentation;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;MHC class II protein binding;positive regulation of cytokine-mediated signaling pathway;prostaglandin biosynthetic process;chaperone mediated protein folding requiring cofactor;lysosome;T cell selection;Golgi apparatus;protein complex assembly;external side of plasma membrane;protein binding;cell surface;trans-Golgi network membrane@: TREACHER COLLINS SYNDROME 1; TCS1
D100563@79566@79568@deletion@3@175386532@175388438@5@chr5:175386532-175388438@18.1@178@67@0.376@NA@THOC3-001_4, THOC3-001_5, THOC3-001_6@169@160@182@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
D100563@80479@80482@duplication@4@180375357@180376325@5@chr5:180375357-180376325@10.1@351@500@1.42@CNVR2719.1@BTNL8-202_5, BTNL8-202_6, BTNL8-202_7, BTNL8-202_8@103.25@93@108@:butyrophilin-like 8@:protein binding;integral to membrane@NA
D100563@81695@81696@duplication@2@20212320@20212631@6@chr6:20212320-20212631@4.96@123@183@1.49@NA@LPCAT3-001_1, RP11-239H6-001_1@2@2@2@:membrane bound O-acyltransferase domain containing 1@:transferase activity, transferring acyl groups other than amino-acyl groups;phospholipid metabolic process;glycerophospholipid biosynthetic process;small molecule metabolic process;phosphatidylserine acyl-chain remodeling;integral to membrane;phosphatidylethanolamine acyl-chain remodeling;endoplasmic reticulum membrane@NA
D100563@82487@82513@deletion@27@29798547@29897010@6@chr6:29798547-29897010@70.1@2012@1186@0.589@CNVR2829.7, CNVR2829.2, CNVR2829.8@HLA-G-202_8, HLA-H-001_1, HLA-H-001_2, HLA-H-001_3, HLA-H-001_4, HLA-H-001_5, HLA-H-001_6, HLA-H-001_7, HLA-16-001_1, HLA-16-001_2, HLA-16-001_3, HLA-16-001_4, AL645929-201_2, AL645929-201_3, AL645929-201_4, AL645929-201_5, AL645929-201_6, BAT1P1-001_1, BAT1P1-001_2, MCCD1P1-001_1, MCCD1P1-001_2, HLA-K-001_1, HLA-K-001_2, HLA-K-001_3, HLA-K-001_4, HLA-K-001_5, HLA-K-001_6@43.9259259259259@10@51@:major histocompatibility complex, class I, G@:MHC class I protein complex;regulation of immune response;positive regulation of T cell tolerance induction;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;negative regulation of dendritic cell differentiation;positive regulation of regulatory T cell differentiation;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;positive regulation of interleukin-12 production;Golgi membrane;interferon-gamma-mediated signaling pathway;plasma membrane;protein homodimerization activity;cytokine-mediated signaling pathway;receptor binding;early endosome membrane;phagocytic vesicle membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;cellular defense response;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane;negative regulation of T cell proliferation;immune response-inhibiting cell surface receptor signaling pathway@NA
D100563@83002@83003@deletion@2@31237745@31238263@6@chr6:31237745-31238263@23.3@382@178@0.466@CNVR2838.2, CNVR2838.1@HLA-C-006_4, HLA-C-006_5@25@25@25@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
D100563@83015@83018@deletion@4@31324252@31324990@6@chr6:31324252-31324990@12.5@607@400@0.659@CNVR2841.12, CNVR2841.14, CNVR2841.8@HLA-B-201_1, HLA-B-201_2, HLA-B-201_3, HLA-B-201_4@69.25@62@73@:major histocompatibility complex, class I, B@:MHC class I protein complex;regulation of immune response;regulation of interleukin-12 production;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;regulation of T cell anergy;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;receptor binding;early endosome membrane;virus-host interaction;regulation of interleukin-6 production;regulation of dendritic cell differentiation;phagocytic vesicle membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO; SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1
D100563@83026@83027@deletion@2@31379726@31380238@6@chr6:31379726-31380238@11.9@246@131@0.533@CNVR2842.1@MICA-001_6, MICA-001_7@1@1@1@:MHC class I polypeptide-related sequence A@:MHC class I protein complex;protein binding;regulation of immune response;antigen processing and presentation;immune response;plasma membrane;membrane@: PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO; PSORIASIS SUSCEPTIBILITY 1; PSORS1
D100563@83577@83577@deletion@1@31962024@31962162@6@chr6:31962024-31962162@10.9@51@1@0.0196@CNVR2843.6, CNVR2843.3@C4A-001_20@12@12@12@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
D100563@83601@83617@deletion@17@31973468@31976177@6@chr6:31973468-31976177@50.1@1560@948@0.608@CNVR2843.6, CNVR2843.3@CYP21A1P-001_1, CYP21A1P-001_2, CYP21A1P-001_3, CYP21A1P-001_4, CYP21A1P-001_5, CYP21A1P-001_6, CYP21A1P-001_7, CYP21A1P-001_8, CYP21A1P-001_9, CYP21A1P-001_10, AL645922-201_1, AL645922-201_2, AL645922-201_3, AL645922-201_4, AL645922-201_5, AL645922-201_6, AL645922-201_7@106.529411764706@80@121@NA@NA@NA
D100563@83910@83915@deletion@6@32441204@32489952@6@chr6:32441204-32489952@23.6@230@91@0.396@CNVR2845.21, CNVR2845.25, CNVR2845.30@HLA-DRB9-001_1, HLA-DRB5-001_2, HLA-DRB5-001_3, HLA-DRB5-001_4, HLA-DRB5-001_5, HLA-DRB5-001_6@160.833333333333@44@189@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D100563@83920@83928@deletion@9@32522469@32548634@6@chr6:32522469-32548634@56.1@369@73@0.198@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.5@HLA-DRB6-002_1, HLA-DRB6-002_2, HLA-DRB6-002_3, AL713966-201_1, AL713966-201_2, AL713966-201_3, HLA-DRB1-001_4, HLA-DRB1-001_5, HLA-DRB1-001_6@117.555555555556@56@167@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
D100563@83930@83946@deletion@17@32551888@32634448@6@chr6:32551888-32634448@122@1421@585@0.412@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.34@HLA-DRB1-001_1, HLA-DRB1-001_2, HLA-DQA1-002_1, HLA-DQA1-002_2, HLA-DQA1-002_3, HLA-DQA1-002_4, HLA-DQA1-002_5, HLA-DQA1-002_6, HLA-DQB1-003_2, HLA-DQB1-003_3, HLA-DQB1-003_4, HLA-DQB1-003_5, HLA-DQB1-003_6, XXbac-BPG254F23-001_1, XXbac-BPG254F23-001_2, ENST00000443574_1, ENST00000443574_2@116.352941176471@78@146@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
D100563@84054@84056@deletion@3@33037420@33043919@6@chr6:33037420-33043919@6.34@587@404@0.688@CNVR2846.4@HLA-DPA1-001_2, HLA-DPA1-001_3, HLA-DPB1-201_1@0@0@0@:major histocompatibility complex, class II, DP alpha 1:major histocompatibility complex, class II, DP beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;cellular response to interferon-gamma;membrane;trans-Golgi network membrane:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D100563@84061@84063@deletion@3@33053998@33059681@6@chr6:33053998-33059681@7.33@265@165@0.623@NA@HLA-DPB1-201_5, HLA-DPB1-201_6, HLA-DPA2-001_4@15@3@24@:major histocompatibility complex, class II, DP beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D100563@93097@93097@deletion@1@167787841@167787940@6@chr6:167787841-167787940@4.76@66@31@0.47@NA@TCP10-001_7@33@33@33@:t-complex 10@:cytosol@NA
D100563@93099@93099@duplication@1@167790036@167790193@6@chr6:167790036-167790193@5.97@28@72@2.57@NA@TCP10-001_5@103@103@103@:t-complex 10@:cytosol@NA
D100563@93101@93101@deletion@1@167794611@167794825@6@chr6:167794611-167794825@5.01@31@6@0.194@NA@TCP10-001_3@52@52@52@:t-complex 10@:cytosol@NA
D100563@94180@94181@deletion@2@5939917@5940198@7@chr7:5939917-5940198@11.2@90@26@0.289@NA@C7orf28A-001_2, C7orf28A-001_3@13.5@10@17@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D100563@94200@94208@duplication@9@5982957@5998710@7@chr7:5982957-5998710@22.9@625@983@1.57@NA@RSPH10B-002_7, RSPH10B-002_8, RSPH10B-002_9, RSPH10B-002_10, RSPH10B-002_11, RSPH10B-002_12, RSPH10B-002_13, RSPH10B-002_14, RSPH10B-002_15@9.33333333333333@8@14@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D100563@94215@94216@deletion@2@6012872@6017389@7@chr7:6012872-6017389@4.91@91@51@0.56@NA@PMS2-001_14, PMS2-001_15@43@35@51@:PMS2 postmeiotic segregation increased 2 (S. cerevisiae)@:response to drug;DNA binding;MutSalpha complex binding;ATP binding;mismatch repair;DNA repair;mismatched DNA binding;ATPase activity;nucleus;mismatch repair complex;reciprocal meiotic recombination;ATP catabolic process;single-stranded DNA binding;response to DNA damage stimulus;single base insertion or deletion binding;protein binding;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;MutLalpha complex;endonuclease activity@: COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4; MISMATCH REPAIR CANCER SYNDROME
D100563@94414@94415@duplication@2@6790882@6791233@7@chr7:6790882-6791233@6.52@49@100@2.04@NA@ENST00000338780_13, PMS2CL-002_13@73@73@73@NA@NA@NA
D100563@94424@94432@deletion@9@6805339@6821108@7@chr7:6805339-6821108@33.2@563@271@0.481@NA@RSPH10B2-204_7, RSPH10B2-204_8, RSPH10B2-204_9, RSPH10B2-204_10, RSPH10B2-204_11, RSPH10B2-204_12, RSPH10B2-204_13, RSPH10B2-204_14, RSPH10B2-204_15@13.2222222222222@11@19@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D100563@95542@95546@deletion@5@26233197@26236638@7@chr7:26233197-26236638@7.7@1343@967@0.72@NA@HNRNPA2B1-006_5, HNRNPA2B1-006_6, HNRNPA2B1-006_7, HNRNPA2B1-006_8, HNRNPA2B1-006_9@1@1@1@:heterogeneous nuclear ribonucleoprotein A2/B1@:nucleoplasm;negative regulation of mRNA splicing, via spliceosome;ribonucleoprotein complex;nucleotide binding;catalytic step 2 spliceosome;spliceosomal complex;cytoplasm;protein binding;single-stranded telomeric DNA binding;RNA binding;mRNA processing;nucleolus;RNA splicing;mRNA splicing, via spliceosome;RNA transport;nucleus;gene expression;pre-mRNA intronic binding;nucleic acid binding@NA
D100563@96581@96581@duplication@1@38393318@38393627@7@chr7:38393318-38393627@4.85@292@402@1.38@CNVR3354.3, CNVR3354.1@TRGV4-001_2@14@14@14@@:protein binding@NA
D100563@97912@97917@deletion@6@57071006@57084498@7@chr7:57071006-57084498@9.86@71@19@0.268@NA@TNRC18C-202_8, TNRC18C-202_9, TNRC18C-202_10, TNRC18C-202_11, ENST00000398760_4, ENST00000398760_5@155.5@144@166@NA@NA@NA
D100563@97991@97994@duplication@4@62758072@62758771@7@chr7:62758072-62758771@25@734@1120@1.53@NA@AC006455-201_2, AC006455-201_3, ENST00000444809_2, ENST00000444809_3@160@151@171@NA@NA@NA
D100563@98015@98016@deletion@2@62910199@62910898@7@chr7:62910199-62910898@20.6@371@171@0.461@NA@ZNF734-201_2, ZNF734-201_3@102@102@102@NA@NA@NA
D100563@98173@98174@deletion@2@64533487@64534227@7@chr7:64533487-64534227@5.97@35@6@0.171@NA@RP11-460N20-001_11, RP11-460N20-001_12, ENST00000501153_3@101@101@101@NA@NA@NA
D100563@98215@98215@deletion@1@65150574@65150717@7@chr7:65150574-65150717@9.26@48@4@0.0833@NA@INTS4L2-001_5@56@56@56@NA@NA@NA
D100563@98730@98730@deletion@1@72707499@72707589@7@chr7:72707499-72707589@4.97@109@60@0.55@NA@POM121B-201_2@8@8@8@NA@NA@NA
D100563@99035@99035@deletion@1@74172294@74172334@7@chr7:74172294-74172334@5.51@83@40@0.482@NA@GTF2I-001_33@25@25@25@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
D100563@99545@99545@duplication@1@76728229@76728269@7@chr7:76728229-76728269@6.73@100@170@1.7@NA@ENST00000398321_6@11@11@11@NA@NA@NA
D100563@99550@99551@deletion@2@76748836@76749023@7@chr7:76748836-76749023@5.2@288@191@0.663@NA@ENST00000398321_2, ENST00000398321_3@2@1@3@NA@NA@NA
D100563@101721@101726@deletion@6@100331652@100336237@7@chr7:100331652-100336237@14.6@805@530@0.658@CNVR3509.1@ZAN-001_2, ZAN-001_3, ZAN-001_4, ZAN-001_5, ZAN-001_6, ZAN-001_7@81.6666666666667@71@89@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
D100563@102615@102623@deletion@9@105894812@105925639@7@chr7:105894812-105925639@41.5@1755@1082@0.617@NA@PBEF1-001_1, PBEF1-001_2, PBEF1-001_3, PBEF1-001_4, PBEF1-001_5, PBEF1-001_6, PBEF1-001_7, PBEF1-001_8, PBEF1-001_9@1.22222222222222@0@3@:nicotinamide phosphoribosyltransferase@:nicotinate phosphoribosyltransferase activity;small molecule metabolic process;positive regulation of nitric-oxide synthase biosynthetic process;NAD metabolic process;cytoplasm;cell-cell signaling;NAD biosynthetic process;cytosol;signal transduction;cytokine activity;positive regulation of cell proliferation;water-soluble vitamin metabolic process;nicotinate-nucleotide diphosphorylase (carboxylating) activity;nicotinamide metabolic process;vitamin metabolic process;nicotinamide phosphoribosyltransferase activity@NA
D100563@104579@104579@duplication@1@134221805@134221910@7@chr7:134221805-134221910@6.14@114@184@1.61@NA@AKR1B10-001_6@2@2@2@:aldo-keto reductase family 1, member B10 (aldose reductase)@:steroid metabolic process;cellular aldehyde metabolic process;indanol dehydrogenase activity;daunorubicin metabolic process;retinal dehydrogenase activity;farnesol catabolic process;geranylgeranyl reductase activity;protein binding;extracellular region;aldo-keto reductase (NADP) activity;digestion;doxorubicin metabolic process;cellular_component;lysosome@NA
D100563@105322@105342@duplication@21@141766375@141794298@7@chr7:141766375-141794298@50.6@2819@3821@1.36@CNVR3585.3, CNVR3585.2@MGAM-007_41, MGAM-007_42, MGAM-007_43, MGAM-007_44, MGAM-007_45, MGAM-007_46, MGAM-007_47, MGAM-007_48, MGAM-007_49, MGAM-007_50, MGAM-007_51, MGAM-007_52, MGAM-007_53, MGAM-007_54, MGAM-007_55, MGAM-007_56, MGAM-007_57, MGAM-007_58, MGAM-007_59, MGAM-007_60, MGAM-007_61@113.333333333333@35@134@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
D100563@105785@105795@duplication@11@143969540@143974431@7@chr7:143969540-143974431@8.82@691@911@1.32@CNVR3598.4, CNVR3598.9@RP4-798C17-001_7, RP4-798C17-001_8, RP4-798C17-001_9, RP4-798C17-001_10, RP4-798C17-001_11, RP4-798C17-001_12, ENST00000378112_8, ENST00000378112_9, ENST00000378112_10, ENST00000378112_11, ENST00000378112_12@92.0909090909091@37@137@:Rho guanine nucleotide exchange factor (GEF) 35@NA@NA
D100563@107425@107425@deletion@1@7274294@7274386@8@chr8:7274294-7274386@4.67@22@1@0.0455@CNVR3771.8, CNVR3771.10, CNVR3771.4@DEFB4P-001_1@57@57@57@:defensin, beta 4B;defensin, beta 4A@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response@NA
D100563@107428@107429@duplication@2@7308087@7308722@8@chr8:7308087-7308722@8.18@549@743@1.35@CNVR3771.8, CNVR3771.10, CNVR3771.4@SPAG11-003_3, SPAG11-003_4@90.5@90@91@:sperm associated antigen 11B@:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response@NA
D100563@107512@107513@deletion@2@7717871@7718505@8@chr8:7717871-7718505@5.88@296@193@0.652@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@SPAG11A-207_3, SPAG11A-207_4@112@111@113@:sperm associated antigen 11A;sperm associated antigen 11B@:extracellular region;defense response@NA
D100563@109572@109585@deletion@14@39311571@39349528@8@chr8:39311571-39349528@90@414@0@0@CNVR3859.1@ADAM3A-005_11, ADAM3A-005_12, ADAM3A-005_13, ADAM3A-005_14, ADAM3A-005_15, ADAM3A-005_16, ADAM3A-005_17, ADAM3A-005_18, ADAM3A-005_19, ADAM3A-005_20, ADAM3A-005_21, ADAM3A-009_7, ADAM3A-009_8, ADAM3A-009_9@120.5@98@136@NA@NA@NA
D100563@112156@112161@deletion@6@101930806@101964354@8@chr8:101930806-101964354@8.62@607@417@0.687@NA@YWHAZ-001_2, YWHAZ-001_3, YWHAZ-001_4, YWHAZ-001_5, YWHAZ-001_6, YWHAZ-001_7@0@0@0@:tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide@:nucleoplasm;negative regulation of apoptotic process;mitochondrion;response to drug;histamine secretion by mast cell;RNA metabolic process;blood coagulation;mRNA metabolic process;protein targeting;nucleus;protein targeting to mitochondrion;melanosome;gene expression;cell leading edge;platelet activation;regulation of cell death;postsynaptic density;protein complex;cytoplasm;perinuclear region of cytoplasm;cytosol;protein binding;signal transduction;protein complex binding;transcription factor binding;kinase activity;protein domain specific binding@NA
D100563@117587@117589@duplication@3@43313716@43314503@9@chr9:43313716-43314503@10.6@258@387@1.5@CNVR4289.2@BX649597-201_1, BX649597-201_2, BX649597-201_3@46@18@61@NA@NA@NA
D100563@118854@118854@duplication@1@84545372@84549914@9@chr9:84545372-84549914@10.1@482@710@1.47@CNVR4364.1@ENST00000427387_1, RP11-383M4-201_4@27@27@27@NA@NA@NA
D100563@121599@121605@duplication@7@117072831@117088756@9@chr9:117072831-117088756@162@1641@4541@2.77@NA@COL27A1-001_61, ORM1-001_1, ORM1-001_2, ORM1-001_3, ORM1-001_4, ORM1-001_5, ORM1-001_6@70.7142857142857@5@90@:collagen, type XXVII, alpha 1:orosomucoid 1@:extracellular matrix structural constituent;collagen;extracellular region;extracellular matrix organization;endoplasmic reticulum lumen;fibrillar collagen:protein binding;extracellular space;regulation of immune system process;transport;inflammatory response;extracellular region;acute-phase response@NA
D100563@125859@125861@deletion@3@5037950@5038339@10@chr10:5037950-5038339@5.61@315@209@0.663@NA@AKR1C2-201_7, RP11-499O7-001_1, RP11-499O7-001_2@2.66666666666667@0@6@:aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III);aldo-keto reductase family 1 member C2-like@:trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity;steroid metabolic process;oxidation-reduction process;phenanthrene 9,10-monooxygenase activity;prostaglandin F receptor activity;daunorubicin metabolic process;carboxylic acid binding;ketosteroid monooxygenase activity;progesterone metabolic process;oxidoreductase activity;digestion;positive regulation of cell proliferation;prostaglandin metabolic process;doxorubicin metabolic process;response to prostaglandin stimulus;positive regulation of protein kinase B signaling cascade;alditol:NADP+ 1-oxidoreductase activity;androsterone dehydrogenase (A-specific) activity;bile acid binding;G-protein coupled receptor signaling pathway;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;cytoplasm;cellular response to jasmonic acid stimulus@: 46,XY SEX REVERSAL 8; SRXY8
D100563@126269@126269@deletion@1@9449789@9449825@10@chr10:9449789-9449825@7.68@42@5@0.119@NA@AL355591-202_3@0@0@0@NA@NA@NA
D100563@126909@126909@deletion@1@17840632@17842868@10@chr10:17840632-17842868@10.7@49@0@0@NA@FAM23A-201_5@108@108@108@:transmembrane protein 236;transmembrane protein 236-like@:integral to membrane@NA
D100563@126911@126911@duplication@1@17865075@17865475@10@chr10:17865075-17865475@7.11@150@238@1.59@NA@MRC1L1-001_2@12@12@12@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
D100563@126915@126918@deletion@4@17887291@17898363@10@chr10:17887291-17898363@7.92@347@218@0.628@NA@MRC1L1-001_6, MRC1L1-001_7, MRC1L1-001_8, MRC1L1-001_9@5.75@5@7@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
D100563@126938@126948@deletion@11@17951324@18122793@10@chr10:17951324-18122793@27.6@232@74@0.319@NA@MRC1L1-001_29, MRC1L1-001_30, FAM23B-202_1, FAM23B-202_2, FAM23B-202_3, FAM23B-202_4, FAM23B-202_5, MRC1-001_1, MRC1-001_2, MRC1-001_3, MRC1-001_4@43@5@107@:macrophage mannose receptor 1-like:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D100563@126951@126953@duplication@3@18138510@18145282@10@chr10:18138510-18145282@14.9@107@240@2.24@NA@MRC1-001_7, MRC1-001_8, MRC1-001_9@20.6666666666667@18@26@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D100563@126956@126974@deletion@19@18152465@18196628@10@chr10:18152465-18196628@10.7@86@27@0.314@NA@MRC1-001_11, MRC1-001_12, MRC1-001_13, MRC1-001_14, MRC1-001_15, MRC1-001_16, MRC1-001_17, MRC1-001_18, MRC1-001_19, MRC1-001_20, MRC1-001_21, MRC1-001_22, MRC1-001_23, MRC1-001_24, MRC1-001_25, MRC1-001_26, MRC1-001_27, MRC1-001_28, RP11-457D2-001_1@16.4210526315789@12@27@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D100563@128372@128372@deletion@1@42924566@42924600@10@chr10:42924566-42924600@11.7@118@41@0.347@NA@CCNYL2-201_7@0@0@0@@:regulation of cyclin-dependent protein kinase activity;protein kinase binding@NA
D100563@128979@128979@deletion@1@47758848@47758905@10@chr10:47758848-47758905@5.88@26@0@0@CNVR4714.1@ANXA8L2-001_10@154@154@154@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:calcium-dependent phospholipid binding;calcium ion binding@NA
D100563@129003@129007@deletion@5@47933809@47942085@10@chr10:47933809-47942085@7.31@34@1@0.0294@CNVR4715.2, CNVR4715.1@FAM21B-201_20, FAM21B-201_21, FAM21B-201_22, FAM21B-201_23, FAM21B-201_24@175@165@185@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
D100563@129021@129040@duplication@20@48020452@48175811@10@chr10:48020452-48175811@23.2@599@893@1.49@NA@ASAH2C-201_1, ASAH2C-201_2, ASAH2C-201_3, ASAH2C-201_4, ASAH2C-201_5, ASAH2C-201_6, ASAH2C-201_7, ASAH2C-201_8, ASAH2C-201_9, ASAH2C-201_10, CTD-2173J9-001_1, CTD-2173J9-001_2, CTSLL2-001_1, CTSLL2-001_2, CTSLL2-001_3, GLUDP6-001_1, GLUDP6-001_2, GLUDP6-001_3, CTD-2173J9-201_1, CTD-2173J9-201_2@74.2@50@143@@:ceramidase activity;sphingolipid metabolic process@NA
D100563@129460@129461@deletion@2@51361725@51361911@10@chr10:51361725-51361911@5.32@27@2@0.0741@NA@ENST00000404618_4, ENST00000432221_4@122@121@123@NA@NA@NA
D100563@129605@129611@deletion@7@51970585@51994313@10@chr10:51970585-51994313@26.3@215@65@0.302@NA@ASAH2-201_5, ASAH2-201_6, ASAH2-201_7, ASAH2-201_8, ASAH2-201_9, ASAH2-201_10, ASAH2-201_11@145.142857142857@53@186@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
D100563@132335@132335@deletion@1@92678624@92678730@10@chr10:92678624-92678730@5.21@139@80@0.576@NA@ANKRD1-001_4@0@0@0@:ankyrin repeat domain 1 (cardiac muscle)@:nucleoplasm;positive regulation of DNA damage response, signal transduction by p53 class mediator;response to muscle stretch;cellular response to transforming growth factor beta stimulus;R-SMAD binding;cytoplasmic part;cellular response to organic cyclic compound;cardiac muscle tissue morphogenesis;cellular response to mechanical stimulus;myofibril;nucleus;cellular response to drug;cellular response to lipopolysaccharide;p53 binding;cytosol;cellular response to interleukin-1;cellular response to hypoxia;transcription factor binding;DNA binding;transcription corepressor activity;cellular response to tumor necrosis factor;histone deacetylase binding;transcription factor complex;negative regulation of DNA biosynthetic process;positive regulation of transcription from RNA polymerase II promoter;RNA polymerase II transcription coactivator activity;RNA polymerase II transcription factor binding;small molecule metabolic process;titin binding;cellular lipid metabolic process;regulation of transcription from RNA polymerase II promoter;cytoplasm;protein binding;negative regulation of transcription from RNA polymerase II promoter;positive regulation of neuron projection development;positive regulation of protein secretion;I band;sarcomere organization;positive regulation of apoptotic process@: TOTAL ANOMALOUS PULMONARY VENOUS RETURN 1; TAPVR1
D100563@135724@135730@deletion@7@124344789@124353115@10@chr10:124344789-124353115@47.1@1169@649@0.555@CNVR4912.4, CNVR4912.3, CNVR4912.2@DMBT1-002_15, DMBT1-002_16, DMBT1-002_17, DMBT1-002_18, DMBT1-002_19, DMBT1-002_20, DMBT1-002_21@49.4285714285714@47@51@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
D100563@138032@138033@deletion@2@5270600@5271118@11@chr11:5270600-5271118@6.92@49@12@0.245@NA@HBG1-201_1, HBG1-201_2@94.5@83@106@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
D100563@141187@141188@deletion@2@48600990@48601883@11@chr11:48600990-48601883@11.5@52@0@0@CNVR5165.1@AC134982-201_1, AC134982-201_2@128@128@128@NA@NA@NA
D100563@145896@145897@duplication@2@89515054@89531798@11@chr11:89515054-89531798@13.4@461@688@1.49@NA@TRIM77-201_8, TRIM49-201_8@50@49@51@:tripartite motif containing 49@:protein binding;intracellular;DNA binding;zinc ion binding@NA
D100563@145952@145953@duplication@2@89706559@89715285@11@chr11:89706559-89715285@5.39@23@60@2.61@NA@TRIM64-202_9, ENST00000442514_9@165@154@176@NA@NA@NA
D100563@145974@145976@deletion@3@89789147@89793440@11@chr11:89789147-89793440@13.5@98@25@0.255@NA@ENST00000436580_5, ENST00000436580_6, ENST00000436580_7@85.6666666666667@82@93@:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;DNA binding;zinc ion binding@NA
D100563@150776@150783@deletion@8@9447030@9454871@12@chr12:9447030-9454871@36.2@413@175@0.424@NA@DDX11L8-201_3, DDX11L8-201_4, DDX11L8-201_5, DDX11L8-201_6, DDX11L8-201_7, DDX11L8-201_8, DDX11L8-201_9, DDX11L8-201_10@55.25@17@78@NA@NA@NA
D100563@150785@150786@deletion@2@9456573@9456804@12@chr12:9456573-9456804@30.5@144@0@0@NA@DDX11L8-201_12, DDX11L8-201_13@85@83@87@NA@NA@NA
D100563@150789@150789@duplication@1@9458835@9458965@12@chr12:9458835-9458965@5.65@192@281@1.46@NA@DDX11L8-201_16@42@42@42@NA@NA@NA
D100563@150803@150804@deletion@2@9571373@9571787@12@chr12:9571373-9571787@12.1@131@51@0.389@NA@DDX12-203_25, DDX12-203_26@2@1@3@NA@NA@NA
D100563@150815@150815@duplication@1@9580231@9580297@12@chr12:9580231-9580297@7.07@285@415@1.46@NA@DDX12-203_14@3@3@3@NA@NA@NA
D100563@150821@150825@duplication@5@9585567@9590086@12@chr12:9585567-9590086@18.3@251@433@1.73@NA@DDX12-203_4, DDX12-203_5, DDX12-203_6, DDX12-203_7, DDX12-203_8@16@6@29@NA@NA@NA
D100563@150828@150841@deletion@14@9600580@9707352@12@chr12:9600580-9707352@120@613@40@0.0653@CNVR5429.1@DDX12-203_1, AC006432-201_1, AC006432-201_2, AC006432-201_3, AC006432-201_4, AC006432-201_5, AC006432-201_6, AC006432-201_7, AC006432-201_8, AC006432-201_9, AC006432-201_11, AC006432-201_12, AC006432-201_13@21.6153846153846@7@25@NA@NA@NA
D100563@150968@150971@deletion@4@10583212@10587639@12@chr12:10583212-10587639@17.1@442@253@0.572@CNVR5430.1@KLRC2-201_3, KLRC2-201_4, KLRC2-201_5, KLRC2-201_6@62@51@67@:killer cell lectin-like receptor subfamily C, member 2@:carbohydrate binding:transmembrane signaling receptor activity;carbohydrate binding;protein binding;signal transduction;cellular defense response;integral to plasma membrane@NA
D100563@151034@151034@duplication@1@11244393@11244793@12@chr12:11244393-11244793@12@422@652@1.55@CNVR5434.1@TAS2R31-201_2@72@72@72@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
D100563@153363@153366@duplication@4@49521571@49525305@12@chr12:49521571-49525305@16.9@877@1221@1.39@NA@TUBA1B-201_1, TUBA1B-201_2, TUBA1B-201_3, TUBA1B-201_4@0@0@0@:tubulin, alpha 1b@:microtubule-based process;structural constituent of cytoskeleton;protein folding;protein polymerization;cytoplasmic microtubule;GTP binding;microtubule cytoskeleton organization;cell division;GTPase activity;GTP catabolic process;cytoskeleton-dependent intracellular transport;protein complex;microtubule cytoskeleton;protein binding;'de novo' posttranslational protein folding;cellular protein metabolic process;microtubule-based movement;structural molecule activity;microtubule;protein domain specific binding@NA
D100563@162181@162181@deletion@1@25015986@25016107@13@chr13:25015986-25016107@7.53@128@63@0.492@NA@PARP4-001_30@5@5@5@:poly (ADP-ribose) polymerase family, member 4@:NAD+ ADP-ribosyltransferase activity;transport;inflammatory response;response to drug;DNA binding;DNA repair;cellular protein modification process;cell death;nucleus;spindle microtubule;ribonucleoprotein complex;enzyme binding;response to DNA damage stimulus;cytoplasm;protein ADP-ribosylation;protein binding@NA
D100563@162316@162316@deletion@1@25535889@25535993@13@chr13:25535889-25535993@4.87@22@0@0@NA@TPTE2P1-001_3@0@0@0@NA@NA@NA
D100563@166697@166707@deletion@11@19553367@19589683@14@chr14:19553367-19589683@18.6@160@52@0.325@CNVR6072.1@POTEG-201_1, POTEG-201_2, POTEG-201_3, POTEG-201_4, POTEG-201_5, POTEG-201_6, POTEG-201_7, POTEG-201_8, POTEG-201_9, POTEG-201_10, POTEG-201_11@98@55@141@:POTE ankyrin domain family, member G@:protein binding@NA
D100563@170809@170810@deletion@2@74003820@74008400@14@chr14:74003820-74008400@48.7@234@1@0.00427@CNVR6188.1, CNVR6188.4@ACOT1-201_1, ACOT1-201_2@115@114@116@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
D100563@171734@171734@deletion@1@90458263@90458328@14@chr14:90458263-90458328@4.65@88@47@0.534@NA@TDP1-203_13@0@0@0@:tyrosyl-DNA phosphodiesterase 1@:3'-tyrosyl-DNA phosphodiesterase activity;double-strand break repair;single strand break repair;single-stranded DNA binding;exonuclease activity;cytoplasm;DNA repair;protein binding;double-stranded DNA binding;cell death;nucleus;phosphoric diester hydrolase activity@: SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY;
D100563@173501@173502@deletion@2@106478134@106478412@14@chr14:106478134-106478412@13.1@152@63@0.414@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV3-6-210_6, IGHV4-4-001_2@17@17@17@@:protein binding@NA
D100563@173561@173567@deletion@7@106800714@106816254@14@chr14:106800714-106816254@21.1@735@443@0.603@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.41@IGHV3-30-2-001_1, IGHV4-31-001_1, IGHV4-31-001_2, IGHV3-32-001_1, IGHV3-32-001_2, IGHV3-33-001_1, IGHV3-33-001_2@15.2857142857143@5@19@@:protein binding:protein binding@NA
D100563@173586@173595@duplication@10@106866408@106934400@14@chr14:106866408-106934400@62.6@2283@3476@1.52@CNVR6294.26, CNVR6294.56, CNVR6294.18@IGHV3-38-001_1, IGHV3-38-001_2, IGHV4-39-001_1, IGHV4-39-001_2, IGHV3-41-001_1, IGHV3-41-001_2, IGHV3-43-001_1, IGHV3-43-001_2, IGHVIII-44-001_1, IGHVIII-44-001_2@9@4@12@@:protein binding:protein binding:protein binding@NA
D100563@173645@173645@deletion@1@107131035@107131335@14@chr14:107131035-107131335@5.94@280@176@0.629@CNVR6294.56, CNVR6294.16@IGHV3-66-001_2@3@3@3@@:protein binding@NA
D100563@173681@173681@duplication@1@20433872@20434131@15@chr15:20433872-20434131@15.8@1016@1548@1.52@CNVR6295.15, CNVR6295.7@ENST00000400226_16@48@48@48@NA@NA@NA
D100563@173697@173734@duplication@38@20588370@20663213@15@chr15:20588370-20663213@110@1543@2759@1.79@CNVR6295.15, CNVR6295.7, CNVR6295.3, CNVR6295.5@HERC2P3-014_9, HERC2P3-014_10, HERC2P3-014_11, HERC2P3-014_12, HERC2P3-014_13, HERC2P3-014_14, HERC2P3-014_15, HERC2P3-014_16, HERC2P3-014_17, HERC2P3-014_18, HERC2P3-014_19, HERC2P3-014_20, HERC2P3-014_21, HERC2P3-014_22, HERC2P3-014_23, HERC2P3-014_24, HERC2P3-014_25, HERC2P3-014_26, HERC2P3-014_27, AC026495-201_8, AC026495-201_9, AC026495-201_10, AC026495-201_11, AC026495-201_12, AC026495-201_13, AC026495-201_14, AC026495-201_15, AC026495-201_16, AC026495-201_17, AC026495-201_18, AC026495-201_19, AC026495-201_20, AC026495-201_21, AC026495-201_22, AC026495-201_23, AC026495-201_24, AC026495-201_25, AC026495-201_26@99.1578947368421@57@147@NA@NA@NA
D100563@173799@173800@duplication@2@21369348@21369733@15@chr15:21369348-21369733@10.2@53@132@2.49@CNVR6296.1@ENST00000450252_1, ENST00000450252_2@87.5@74@101@NA@NA@NA
D100563@173814@173823@deletion@10@22297500@22494464@15@chr15:22297500-22494464@59.5@2624@1509@0.575@CNVR6297.4, CNVR6297.17, CNVR6297.6@AC134980-201_1, AC134980-201_2, ENST00000438898_1, ENST00000438898_2, AC025884-201_1, AC025884-201_2, AC010760-202_2, VSIG6-201_1, VSIG6-201_2@54.1111111111111@5@87@:olfactory receptor, family 4, subfamily M, member 2:olfactory receptor, family 4, subfamily N, member 4@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
D100563@174002@174003@duplication@2@23572081@23573019@15@chr15:23572081-23573019@5.32@22@59@2.68@CNVR6301.3@ENST00000357842_9, ENST00000357842_10@98.5@93@104@NA@NA@NA
D100563@174966@174974@duplication@9@34781208@34820036@15@chr15:34781208-34820036@7.71@1335@1700@1.27@CNVR6351.3@AC027139-201_1, AC027139-201_2, AC027139-201_3, AC027139-201_4, AC027139-201_5, ENST00000444260_1, ENST00000444260_2, ENST00000444260_3, GOLGA8B-201_24@44.6666666666667@38@49@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
D100563@176671@176673@deletion@3@45003677@45008555@15@chr15:45003677-45008555@6.82@569@395@0.694@NA@B2M-001_1, B2M-001_2, B2M-001_3@0@0@0@:beta-2-microglobulin@:response to cadmium ion;MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;response to drug;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;T cell differentiation in thymus;antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent;extracellular space;interferon-gamma-mediated signaling pathway;plasma membrane;viral reproduction;early endosome lumen;cytokine-mediated signaling pathway;early endosome membrane;regulation of defense response to virus by virus;phagocytic vesicle membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;Golgi apparatus;response to molecule of bacterial origin;external side of plasma membrane;positive regulation of T cell mediated cytotoxicity;endoplasmic reticulum lumen;cytoplasm;protein binding;protein refolding;extracellular region;antigen processing and presentation of exogenous peptide antigen via MHC class I@: HYPOPROTEINEMIA, HYPERCATABOLIC
D100563@180187@180187@deletion@1@79065427@79065546@15@chr15:79065427-79065546@8.89@45@3@0.0667@NA@ADAMTS7-201_14@10@10@10@:A disintegrin and metalloproteinase with thrombospondin motifs 7-like;ADAM metallopeptidase with thrombospondin type 1 motif, 7@:metallopeptidase activity;extracellular matrix;proteolysis;peptidase activity;proteinaceous extracellular matrix;metalloendopeptidase activity;cell surface;zinc ion binding@NA
D100563@183378@183384@duplication@7@2672693@2693298@16@chr16:2672693-2693298@14@217@368@1.7@CNVR6602.2@AC141586-001_4, AC141586-201_1, AC141586-201_2, AC141586-201_3, AC141586-201_4, AC141586-201_5, AC141586-201_6@34.4285714285714@19@57@NA@NA@NA
D100563@185265@185265@deletion@1@20361095@20361192@16@chr16:20361095-20361192@5.69@180@107@0.594@NA@UMOD-204_3@0@0@0@:uromodulin@:negative regulation of cell proliferation;basolateral plasma membrane;membrane raft;apical part of cell;regulation of ion homeostasis;extracellular space;excretion;cilium membrane;response to organic substance;metanephric ascending thin limb development;metanephric distal convoluted tubule development;chemical homeostasis;apical plasma membrane;Golgi apparatus;extrinsic to membrane;cytoplasmic vesicle;protein binding;cellular defense response;extracellular region;metanephric thick ascending limb development;primary cilium;anchored to membrane;spindle pole;calcium ion binding@: MEDULLARY CYSTIC KIDNEY DISEASE 2; MCKD2; GLOMERULOCYSTIC KIDNEY DISEASE WITH HYPERURICEMIA AND ISOSTHENURIA; HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 1; HNFJ1
D100563@186292@186293@duplication@2@28403075@28403464@16@chr16:28403075-28403464@19.2@223@422@1.89@CNVR6684.2@EIF3CL-201_9, EIF3CL-201_10@4@3@5@:eukaryotic translation initiation factor 3, subunit C-like@:protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;translation initiation factor activity@NA
D100563@186379@186379@deletion@1@28734771@28734873@16@chr16:28734771-28734873@12.8@291@148@0.509@CNVR6686.3, CNVR6686.2@EIF3S8-202_10@4@4@4@:eukaryotic translation initiation factor 3, subunit C@:cytosol;protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;cellular protein metabolic process;binding;gene expression;translation;translation initiation factor activity@NA
D100563@186584@186585@duplication@2@29469251@29469337@16@chr16:29469251-29469337@7.65@75@140@1.87@CNVR6690.2, CNVR6690.3, CNVR6690.4@GIYD1-001_5, SULT1A4-201_3@12@12@12@:structure-specific endonuclease subunit SLX1-like;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae);SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae):sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3;sulfotransferase 1A3/1A4-like@:Slx1-Slx4 complex;5'-flap endonuclease activity;DNA repair;protein binding;DNA double-strand break processing involved in repair via single-strand annealing;double-strand break repair via homologous recombination;metal ion binding;crossover junction endodeoxyribonuclease activity:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;cytoplasm;catecholamine metabolic process;cytosol;endoplasmic reticulum unfolded protein response;xenobiotic metabolic process;sulfotransferase activity;activation of signaling protein activity involved in unfolded protein response;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process@NA
D100563@186862@186865@deletion@4@30208297@30208883@16@chr16:30208297-30208883@13.2@60@0@0@CNVR6694.1, CNVR6694.2, CNVR6694.3@GIYD2-001_4, GIYD2-001_5, GIYD2-001_6, SULT1A3-001_2@4.75@0@7@:structure-specific endonuclease subunit SLX1-like;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae);SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae):sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3;sulfotransferase 1A3/1A4-like@:Slx1-Slx4 complex;5'-flap endonuclease activity;DNA repair;protein binding;DNA double-strand break processing involved in repair via single-strand annealing;double-strand break repair via homologous recombination;metal ion binding;crossover junction endodeoxyribonuclease activity:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;cytoplasm;catecholamine metabolic process;cytosol;endoplasmic reticulum unfolded protein response;xenobiotic metabolic process;sulfotransferase activity;activation of signaling protein activity involved in unfolded protein response;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process@NA
D100563@187527@187528@deletion@2@32936755@32937067@16@chr16:32936755-32937067@5.24@58@24@0.414@CNVR6702.1@ENST00000423205_4, ENST00000423205_5@26.5@19@34@NA@NA@NA
D100563@189959@189968@duplication@10@70162689@70177562@16@chr16:70162689-70177562@94.6@3027@4663@1.54@CNVR6764.1, CNVR6764.3@AC009060-202_5, AC009060-202_6, AC009060-202_7, AC009060-202_8, AC009060-202_9, AC009060-202_10, AC009060-202_11, AC009060-202_12, AC009060-202_13, AC009060-202_14@72@61@77@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
D100563@190515@190518@duplication@4@74346509@74368885@16@chr16:74346509-74368885@10.7@529@750@1.42@CNVR6778.2@AC009120-001_1, AC009120-001_2, AC009053-202_14, AC009053-202_15@8.75@0@16@NA@NA@NA
D100563@190520@190529@deletion@10@74371375@74387809@16@chr16:74371375-74387809@74@1897@1056@0.557@CNVR6778.2, CNVR6778.1@AC009053-202_3, AC009053-202_4, AC009053-202_5, AC009053-202_6, AC009053-202_7, AC009053-202_8, AC009053-202_9, AC009053-202_10, AC009053-202_11, AC009053-202_12@16@13@26@NA@NA@NA
D100563@190539@190549@duplication@11@74442533@74452197@16@chr16:74442533-74452197@12@373@540@1.45@CNVR6778.2, CNVR6778.3, CNVR6778.5@CLEC18B-202_3, CLEC18B-202_4, CLEC18B-202_5, CLEC18B-202_6, CLEC18B-202_7, CLEC18B-202_8, CLEC18B-202_9, CLEC18B-202_10, CLEC18B-202_11, CLEC18B-202_12, CLEC18B-202_13@57.3636363636364@47@63@:C-type lectin domain family 18, member B@:carbohydrate binding;protein binding;extracellular region@NA
D100563@195017@195018@duplication@2@15517149@15517348@17@chr17:15517149-15517348@5.96@385@518@1.35@NA@CDRT1-201_3, TRIM16-202_12@38@38@38@:CMT1A duplicated region transcript 1@:protein binding;molecular_function;cellular_component;biological_process:protein binding;intracellular;zinc ion binding;cytoplasm@NA
D100563@195230@195231@duplication@2@16665629@16667490@17@chr17:16665629-16667490@5.01@899@1162@1.29@NA@CCDC144A-202_14, CCDC144A-202_15@54.5@53@56@:coiled-coil domain containing 144A@NA@NA
D100563@195237@195238@duplication@2@16701558@16703686@17@chr17:16701558-16703686@5.84@306@420@1.37@NA@AC022596-003_3, AC022596-003_4@66@66@66@:coiled-coil domain containing 144A@NA@NA
D100563@195711@195716@deletion@6@18387191@18394638@17@chr17:18387191-18394638@12.9@204@104@0.51@CNVR7014.1@LGALS9C-201_2, LGALS9C-201_3, LGALS9C-201_4, LGALS9C-201_5, LGALS9C-201_6, LGALS9C-201_7@131@125@135@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
D100563@195726@195726@deletion@1@18414537@18416773@17@chr17:18414537-18416773@8.73@39@0@0@NA@AC107983-001_10@129@129@129@NA@NA@NA
D100563@195728@195747@deletion@20@18418662@18457581@17@chr17:18418662-18457581@197@927@4@0.00431@NA@AC107983-001_1, AC107983-001_2, AC107983-001_3, AC107983-001_4, AC107983-001_5, AC107983-001_6, AC107983-001_7, AC107983-001_8, ENST00000456184_1, ENST00000456184_2, CCDC144B-201_14, CCDC144B-201_15, CCDC144B-201_16, CCDC144B-201_17, CCDC144B-201_18, ENST00000447265_11, ENST00000447265_12, ENST00000447265_13, ENST00000447265_14, ENST00000447265_15@129.8@126@133@:protein FAM106B-like@NA@NA
D100563@195785@195785@duplication@1@18585519@18585573@17@chr17:18585519-18585573@4.96@49@92@1.88@NA@FOXO3B-201_1@30@30@30@:zinc finger protein 286B@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding@NA
D100563@196150@196151@duplication@2@20353178@20354957@17@chr17:20353178-20354957@5.45@52@97@1.87@CNVR7021.1, CNVR7021.3@LGALS9B-201_10, LGALS9B-201_11@84.5@75@94@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
D100563@196154@196168@duplication@15@20356332@20407737@17@chr17:20356332-20407737@11.9@436@608@1.39@CNVR7021.1, CNVR7021.3@LGALS9B-201_1, LGALS9B-201_2, LGALS9B-201_3, LGALS9B-201_4, LGALS9B-201_5, LGALS9B-201_6, LGALS9B-201_7, ENST00000439127_1, ENST00000439127_2, ENST00000439127_3, ENST00000439127_4, ENST00000439127_5, ENST00000439127_6, ENST00000439127_7, ENST00000439127_8@36.5333333333333@7@103@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
D100563@197726@197728@duplication@3@34539180@34539966@17@chr17:34539180-34539966@19.5@77@239@3.1@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1-202_2, CCL4L1-202_3, CCL4L1-202_4@118@113@122@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
D100563@198037@198038@deletion@2@36358301@36359043@17@chr17:36358301-36359043@5.45@1368@996@0.728@CNVR7083.3@AC183087-202_8, AC183087-202_9@57@56@58@:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
D100563@200320@200363@deletion@44@44248223@44633017@17@chr17:44248223-44633017@133@4959@2988@0.603@CNVR7114.2@KIAA1267-201_1, KIAA1267-201_2, AC217773-201_1, AC217773-201_2, ENST00000451529_1, ENST00000451529_3, ENST00000451529_5, LRRC37A-001_1, LRRC37A-001_2, LRRC37A-001_3, LRRC37A-001_4, LRRC37A-001_5, LRRC37A-001_6, LRRC37A-001_7, LRRC37A-001_8, LRRC37A-001_9, LRRC37A-001_10, LRRC37A-001_11, LRRC37A-001_12, LRRC37A-001_13, LRRC37A-001_14, LRRC37A-001_15, AC005829-202_1, AC005829-202_2, AC005829-202_3, AC005829-202_4, AC005829-202_5, LRRC37A2-201_1, LRRC37A2-201_2, LRRC37A2-201_3, LRRC37A2-201_4, LRRC37A2-201_5, LRRC37A2-201_6, LRRC37A2-201_7, LRRC37A2-201_8, LRRC37A2-201_9, LRRC37A2-201_10, LRRC37A2-201_11, LRRC37A2-201_12, LRRC37A2-201_13, LRRC37A2-201_14, ARL17P1-202_5@103.333333333333@46@196@:KAT8 regulatory NSL complex subunit 1:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:histone acetyltransferase activity (H4-K8 specific);histone acetyltransferase activity (H4-K16 specific);histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase complex;histone H4-K5 acetylation;MLL1 complex;histone H4-K16 acetylation;protein binding;histone H4-K8 acetylation;nucleus:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
D100563@206637@206638@deletion@2@14796222@14796415@18@chr18:14796222-14796415@5.29@106@58@0.547@NA@AP006565-201_17, AP006565-201_18@3.5@3@4@:ankyrin repeat domain 30B@:protein binding;molecular_function;cellular_component;biological_process@NA
D100563@215259@215260@deletion@2@22939009@22939581@19@chr19:22939009-22939581@6.27@380@251@0.661@NA@ZNF99-201_7, ZNF99-201_8@6.5@6@7@:zinc finger protein 99@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
D100563@216277@216279@deletion@3@36387630@36388759@19@chr19:36387630-36388759@5.71@522@360@0.69@NA@NFKBID-203_4, NFKBID-203_5, NFKBID-203_6@0@0@0@:nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, delta@:inflammatory response;negative regulation of NF-kappaB transcription factor activity;NF-kappaB binding;positive regulation of thymocyte apoptotic process;negative regulation of I-kappaB kinase/NF-kappaB cascade;protein binding;nucleus;negative regulation of T cell differentiation in thymus@NA
D100563@217293@217297@deletion@5@40373947@40382827@19@chr19:40373947-40382827@38.1@390@142@0.364@CNVR7639.2@FCGBP-201_22, FCGBP-201_23, FCGBP-201_24, FCGBP-201_25, FCGBP-201_26@130.8@105@155@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D100563@217301@217306@duplication@6@40389654@40399856@19@chr19:40389654-40399856@16.3@381@573@1.5@CNVR7639.2, CNVR7639.3@FCGBP-201_13, FCGBP-201_14, FCGBP-201_15, FCGBP-201_16, FCGBP-201_17, FCGBP-201_18@112.333333333333@103@127@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D100563@217607@217608@deletion@2@41355725@41356242@19@chr19:41355725-41356242@13.3@282@148@0.525@CNVR7642.1@CYP2A6-204_2, CYP2A6-204_3@17@17@17@:cytochrome P450, family 2, subfamily A, polypeptide 6@:coumarin 7-hydroxylase activity;steroid metabolic process;oxidation-reduction process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;endoplasmic reticulum membrane;drug metabolic process;electron carrier activity;small molecule metabolic process;exogenous drug catabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;enzyme binding;heme binding;xenobiotic metabolic process;iron ion binding;coumarin catabolic process;coumarin metabolic process@: CYTOCHROME P450, SUBFAMILY IIA, POLYPEPTIDE 6; CYP2A6
D100563@217640@217640@deletion@1@41515126@41515301@19@chr19:41515126-41515301@8.24@113@50@0.442@CNVR7643.1@CYP2B6-201_5@0@0@0@:cytochrome P450, family 2, subfamily B, polypeptide 6@:steroid metabolic process;oxidation-reduction process;electron carrier activity;intracellular membrane-bounded organelle;drug metabolic process;exogenous drug catabolic process;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;endoplasmic reticulum;heme binding;xenobiotic metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;monooxygenase activity;iron ion binding;cellular ketone metabolic process;endoplasmic reticulum membrane@: EFAVIRENZ, POOR METABOLISM OF
D100563@218217@218218@duplication@2@43877355@43877758@19@chr19:43877355-43877758@8.74@116@199@1.72@NA@CD177P-201_1, CD177P-201_2@14.5@11@18@NA@NA@NA
D100563@220213@220214@deletion@2@50473071@50473865@19@chr19:50473071-50473865@10.6@408@249@0.61@NA@SIGLEC16-202_2, SIGLEC16-202_3@61.5@56@67@NA@NA@NA
D100563@221218@221224@deletion@7@54801929@54804722@19@chr19:54801929-54804722@49@1281@712@0.556@CNVR7722.1@LILRA3-003_4, LILRA3-003_5, LILRA3-003_6, LILRA3-003_7, LILRA3-003_8, LILRA3-003_9, LILRA3-003_10@105.857142857143@90@109@:leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3@:antigen binding;signal transduction;protein binding;extracellular region;plasma membrane;receptor activity;defense response@NA
D100563@221407@221412@duplication@6@55278649@55286911@19@chr19:55278649-55286911@10@1523@1964@1.29@CNVR7725.2, CNVR7725.1, CNVR7725.7@KIR2DL3-201_8, KIR2DP1-001_9, KIR2DL1-002_1, KIR2DL1-002_2, KIR2DL1-002_3, KIR2DL1-002_4@112.5@103@126@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
D100563@221435@221438@deletion@4@55346536@55354374@19@chr19:55346536-55354374@5.53@438@303@0.692@CNVR7725.1, CNVR7725.6@KIR2DS4-001_2, KIR2DS4-001_3, KIR2DS4-001_4, KIR2DS4-001_5@57.75@41@68@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
D100563@221819@221820@deletion@2@56270382@56273453@19@chr19:56270382-56273453@23.7@201@57@0.284@CNVR7734.1@RFPL4A-201_1, RFPL4A-201_2@32.5@26@39@:ret finger protein-like 4A;ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
D100563@222068@222069@duplication@2@58003184@58003369@19@chr19:58003184-58003369@11.8@71@164@2.31@CNVR7748.1@ZNF419-202_5, ZNF419-202_6@0@0@0@:zinc finger protein 419@:intracellular;DNA binding;regulation of transcription, DNA-dependent;cytoplasm;nucleolus;nucleus;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding@NA
D100563@222563@222563@duplication@1@1569208@1569279@20@chr20:1569208-1569279@8.66@25@86@3.44@CNVR7763.1@SIRPB1-201_1@128@128@128@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
D100563@227604@227604@deletion@1@55099948@55100114@20@chr20:55099948-55100114@6.42@239@145@0.607@NA@C20orf106-002_3@0@0@0@:glucosaminyl (N-acetyl) transferase family member 7:family with sequence similarity 209, member A@:integral to membrane;protein glycosylation;acetylglucosaminyltransferase activity;Golgi membrane;membrane:integral to membrane@NA
D100563@228815@228818@duplication@4@10793871@10863068@21@chr21:10793871-10863068@7.14@1767@2252@1.27@CNVR7947.10, CNVR7947.4@AF254982-201_1, AF254982-201_2, IGHV1OR15-5-001_1, IGHV1OR15-5-001_2@8.75@5@13@@:protein binding;extracellular region@NA
D100563@231972@231972@deletion@1@16352064@16352492@22@chr22:16352064-16352492@4.67@25@3@0.12@CNVR8071.2, CNVR8071.3@LA16c-2F2-001_7@43@43@43@NA@NA@NA
D100563@232771@232784@deletion@14@20385728@20402444@22@chr22:20385728-20402444@20@154@45@0.292@CNVR8094.9, CNVR8094.4, CNVR8094.10@PI4KAP1-204_1, PI4KAP1-204_2, PI4KAP1-204_3, PI4KAP1-204_4, PI4KAP1-204_5, PI4KAP1-204_6, PI4KAP1-204_7, PI4KAP1-204_8, PI4KAP1-204_9, PI4KAP1-204_10, PI4KAP1-204_11, PI4KAP1-204_12, PI4KAP1-204_13, PI4KAP1-204_14@165.785714285714@155@172@NA@NA@NA
D100563@233414@233414@deletion@1@22989226@22989352@22@chr22:22989226-22989352@5.51@92@46@0.5@CNVR8103.5, CNVR8103.2, CNVR8103.13@GGTLC2-203_3@3@3@3@:gamma-glutamyltransferase light chain 2@:leukotriene biosynthetic process;glutathione metabolic process;gamma-glutamyltransferase activity;anchored to external side of plasma membrane@NA
D100563@233700@233708@deletion@9@24283261@24302569@22@chr22:24283261-24302569@27@183@43@0.235@CNVR8114.6, CNVR8114.10, CNVR8114.12, CNVR8114.13@ENST00000443377_2, ENST00000443377_3, ENST00000440099_1, ENST00000440099_2, ENST00000440099_3, GSTT2B-002_2, GSTT2B-002_3, GSTT2B-002_4, GSTT2B-002_5@74.6666666666667@56@125@:glutathione S-transferase theta 2B (gene/pseudogene);glutathione S-transferase theta 2@:protein binding;glutathione transferase activity;nucleus;transferase activity;cytoplasm@NA
D100563@233731@233755@duplication@25@24345655@24396376@22@chr22:24345655-24396376@82.1@1236@2099@1.7@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTTP1-001_1, GSTTP1-001_2, ENST00000421902_1, ENST00000421902_2, ENST00000448902_1, ENST00000448902_2, ENST00000448902_3, ENST00000448902_4, ENST00000448902_5, ENST00000329210_1, ENST00000329210_2, ENST00000329210_3, ENST00000329210_4, ENST00000439866_1, ENST00000439866_2, GSTT1-009_1, GSTT1-009_2, GSTT1-009_3, GSTT1-009_4, GSTT1-009_5, ENST00000439996_1, ENST00000439996_2, GSTTP2-001_3, GSTTP2-001_4, GSTTP2-001_5@130.04@109@149@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
D100563@235184@235184@deletion@1@32827336@32827402@22@chr22:32827336-32827402@8.68@145@70@0.483@NA@BPIL2-010_12@8@8@8@:BPI fold containing family C@:lipid binding;phospholipid binding;extracellular region;lipopolysaccharide binding@NA
D100563@236123@236123@deletion@1@39357394@39357687@22@chr22:39357394-39357687@12.1@63@5@0.0794@CNVR8164.1@APOBEC3A-001_4@23@23@23@:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A;APOBEC3A and APOBEC3B deletion hybrid@:cytidine deamination;defense response to virus;negative regulation of viral genome replication;DNA cytosine deamination;clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine;catalytic activity;DNA demethylation;cytoplasm;innate immune response;cytidine deaminase activity;nucleus;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;cellular response to xenobiotic stimulus;zinc ion binding;negative regulation of transposition@NA
D11016@611@613@duplication@3@1653037@1654269@1@chr1:1653037-1654269@14.4@508@746@1.47@CNVR17.1@CDC2L2-208_2, CDC2L2-208_3, CDC2L2-208_4@23.3333333333333@20@25@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
D11016@2952@2971@deletion@20@17014873@17083889@1@chr1:17014873-17083889@26.7@2365@1637@0.692@CNVR93.3, CNVR93.15, CNVR93.4@RP1-163M9-001_1, ESPNP-002_1, ESPNP-002_2, ESPNP-002_3, ESPNP-002_4, ESPNP-002_5, ESPNP-002_6, ESPNP-002_7, ESPNP-002_8, ESPNP-002_9, ESPNP-002_10, ESPNP-002_11, AL021920-201_1, AL021920-201_2, AL021920-201_3, ENST00000457096_1, ENST00000457096_2, ENST00000457096_3, ENST00000457096_4, MST1P9-202_20@41.05@30@46@:UPF0627 protein ENSP00000341061/ENSP00000339743-like;UPF0627 protein ENSP00000341061/ENSP00000339743:macrophage stimulating 1-like@:proteolysis;extracellular region;catalytic activity;serine-type endopeptidase activity@NA
D11016@2974@2975@deletion@2@17084439@17084789@1@chr1:17084439-17084789@15.5@439@248@0.565@CNVR93.3, CNVR93.15, CNVR93.2, CNVR93.1@MST1P9-202_16, MST1P9-202_17@36@35@37@:macrophage stimulating 1-like@:proteolysis;extracellular region;catalytic activity;serine-type endopeptidase activity@NA
D11016@2979@2986@deletion@8@17085384@17086986@1@chr1:17085384-17086986@17.4@824@538@0.653@CNVR93.3, CNVR93.15, CNVR93.2, CNVR93.1@MST1P9-202_5, MST1P9-202_6, MST1P9-202_7, MST1P9-202_8, MST1P9-202_9, MST1P9-202_10, MST1P9-202_11, MST1P9-202_12@44.75@31@56@:macrophage stimulating 1-like@:proteolysis;extracellular region;catalytic activity;serine-type endopeptidase activity@NA
D11016@2999@2999@duplication@1@17198306@17198669@1@chr1:17198306-17198669@4.67@226@323@1.43@CNVR94.1, CNVR94.4, CNVR94.8@ENST00000356370_1, ENST00000438002_1@21@21@21@NA@NA@NA
D11016@3003@3020@deletion@18@17216045@17273487@1@chr1:17216045-17273487@29.6@1589@1029@0.648@CNVR94.4, CNVR94.5, CNVR94.6@ENST00000457075_1, CROCC-201_1, CROCC-201_2, CROCC-201_3, CROCC-201_4, CROCC-201_5, CROCC-201_6, CROCC-201_7, CROCC-201_8, CROCC-201_9, CROCC-201_10, CROCC-201_11, CROCC-201_12, CROCC-201_13, CROCC-201_14, CROCC-201_15, CROCC-201_16, CROCC-201_17@75.7222222222222@62@85@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
D11016@3777@3777@deletion@1@21808092@21808263@1@chr1:21808092-21808263@7.22@113@52@0.46@CNVR107.2, CNVR107.1@NBPF3-003_17@83@83@83@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 3@:cytoplasm@NA
D11016@4452@4461@duplication@10@25611066@25655628@1@chr1:25611066-25655628@25.6@1237@1738@1.41@CNVR116.1, CNVR116.2@RHD-202_2, RHD-202_3, RHD-202_4, RHD-202_5, RHD-202_6, RHD-202_7, RHD-202_8, RHD-202_9, RHD-202_10, RHD-202_11@123@113@128@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
D11016@4477@4477@deletion@1@25735176@25735361@1@chr1:25735176-25735361@16.4@77@0@0@CNVR117.1@RHCE-005_4@56@56@56@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
D11016@6813@6814@duplication@2@40229386@40229587@1@chr1:40229386-40229587@5.51@171@249@1.46@NA@PPIE-003_11, BMP8B-001_5@34@34@34@:peptidylprolyl isomerase E (cyclophilin E):bone morphogenetic protein 8b@:regulation of transcription, DNA-dependent;nucleotide binding;catalytic step 2 spliceosome;protein folding;protein binding;protein peptidyl-prolyl isomerization;peptidyl-prolyl cis-trans isomerase activity;cyclosporin A binding;RNA binding;mRNA splicing, via spliceosome;nucleus;nucleic acid binding:cell differentiation;growth factor activity;extracellular space;growth;extracellular region;cytokine activity;cartilage development;skeletal system development;ossification@NA
D11016@10378@10378@deletion@1@75184895@75185057@1@chr1:75184895-75185057@9.86@145@62@0.428@NA@CRYZ-202_5@1@1@1@:crystallin, zeta (quinone reductase)@:oxidation-reduction process;transferase activity, transferring acyl groups other than amino-acyl groups;intracellular membrane-bounded organelle;protein homotetramerization;mRNA 3'-UTR binding;Golgi apparatus;nucleotide binding;NADPH binding;cytoplasm;cytosol;NADPH:quinone reductase activity;oxidoreductase activity;visual perception;zinc ion binding;xenobiotic catabolic process@NA
D11016@11245@11246@deletion@2@89476589@89477711@1@chr1:89476589-89477711@12@659@409@0.621@CNVR244.1@GBP3-001_7, GBP3-001_8@54@54@54@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
D11016@12416@12425@deletion@10@104202984@104234233@1@chr1:104202984-104234233@42.1@198@1@0.00505@CNVR266.3, CNVR266.1, CNVR266.15@AMY1A-001_7, AMY1A-001_8, AMY1A-001_9, AMY1A-001_10, AMY1A-001_11, AMY1B-001_7, AMY1B-001_8, AMY1B-001_9, AMY1B-001_10, AMY1B-001_11@123.8@109@154@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D11016@12445@12446@duplication@2@104297123@104297437@1@chr1:104297123-104297437@11.4@348@540@1.55@CNVR266.3, CNVR266.5@AMY1C-201_7, AMY1C-201_8@77@75@79@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D11016@12525@12525@duplication@1@108769303@108769516@1@chr1:108769303-108769516@4.93@103@165@1.6@CNVR294.4@NBPF4-002_13@32@32@32@:neuroblastoma breakpoint family, member 4@:cytoplasm@NA
D11016@12582@12582@deletion@1@109007812@109008047@1@chr1:109007812-109008047@4.92@22@0@0@CNVR294.4@NBPF6-202_14@43@43@43@:neuroblastoma breakpoint family, member 6@:cytoplasm@NA
D11016@12928@12936@deletion@9@110225831@110236368@1@chr1:110225831-110236368@127@600@0@0@CNVR299.6, CNVR299.4, CNVR299.5@GSTM2-203_9, GSTM1-001_1, GSTM1-001_2, GSTM1-001_3, GSTM1-001_4, GSTM1-001_5, GSTM1-001_6, GSTM1-001_7, GSTM1-001_8@173.555555555556@31@194@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
D11016@14295@14299@deletion@5@143189436@143195894@1@chr1:143189436-143195894@10.6@88@28@0.318@CNVR327.1@BX571672-002_2, BX571672-002_3, BX571672-002_4, BX571672-002_5, ENST00000425124_2@12.8@10@17@NA@NA@NA
D11016@14487@14495@duplication@9@144615098@144679973@1@chr1:144615098-144679973@19.7@391@661@1.69@NA@AL592284-001_7, AL592284-001_8, AL592284-001_9, AL592284-001_10, AL592284-001_11, AL592284-001_12, WI2-1896O14-001_1, WI2-1896O14-001_2, WI2-1896O14-001_3@17.7777777777778@2@49@NA@NA@NA
D11016@15201@15203@duplication@3@148008575@148010165@1@chr1:148008575-148010165@9.44@34@101@2.97@CNVR346.2, CNVR346.4@NBPF14-001_15, NBPF14-001_16, NBPF14-001_17@116.666666666667@111@120@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
D11016@15397@15430@deletion@34@149036437@149115112@1@chr1:149036437-149115112@26.3@944@593@0.628@CNVR350.3, CNVR350.1@RP11-744H18-001_1, RP11-744H18-001_2, RP11-744H18-001_3, RP11-744H18-001_4, RP11-744H18-001_5, RP11-744H18-001_6, RP11-744H18-001_7, RP11-744H18-001_8, RP11-744H18-001_9, RP11-744H18-001_10, RP11-744H18-001_11, RP11-744H18-001_12, RP11-744H18-001_13, RP11-744H18-001_14, RP11-744H18-001_15, RP11-744H18-001_16, RP11-744H18-001_17, ENST00000401087_2, ENST00000401087_3, ENST00000401087_4, ENST00000401087_5, ENST00000401087_6, ENST00000401087_7, ENST00000401087_8, ENST00000401087_9, ENST00000401087_10, ENST00000401087_11, ENST00000401087_12, ENST00000401087_13, ENST00000401087_14, ENST00000401087_15, ENST00000401087_16, RP11-403I13-201_1, RP11-403I13-201_2@79.7647058823529@11@87@NA@NA@NA
D11016@15456@15462@deletion@7@149375000@149400543@1@chr1:149375000-149400543@13.4@696@460@0.661@CNVR350.1@FCGR1C-201_4, FCGR1C-201_5, FCGR1C-201_6, ENST00000415338_1, HIST2H3PS2-001_1, HIST2H3PS2-001_2, RP5-998N21-002_1@73.7142857142857@70@76@NA@NA@NA
D11016@15723@15723@deletion@1@150551895@150552007@1@chr1:150551895-150552007@4.99@336@216@0.643@NA@MCL1-201_1@0@0@0@:myeloid cell leukemia sequence 1 (BCL2-related)@:nucleoplasm;negative regulation of apoptotic process;mitochondrion;mitochondrial outer membrane;integral to membrane;negative regulation of extrinsic apoptotic signaling pathway in absence of ligand;apoptotic process;negative regulation of anoikis;BH3 domain binding;mitochondrial matrix;Bcl-2 family protein complex;multicellular organismal development;cell fate determination;protein channel activity;protein heterodimerization activity;cytoplasm;protein binding;cellular homeostasis;regulation of apoptotic process;response to cytokine stimulus;membrane@NA
D11016@24160@24164@deletion@5@223727670@223729472@1@chr1:223727670-223729472@16@84@7@0.0833@NA@CAPN8-202_20, CAPN8-202_21, CAPN8-202_22, CAPN8-202_23, CAPN8-202_24@0@0@0@:calpain 8@:proteolysis;Golgi apparatus;intracellular;calcium-dependent cysteine-type endopeptidase activity;calcium ion binding@NA
D11016@33520@33520@duplication@1@87239638@87241105@2@chr2:87239638-87241105@6.9@48@107@2.23@NA@RGPD1-001_23@110@110@110@:RANBP2-like and GRIP domain containing 1:plasminogen-like B1;plasminogen-like B2@:protein binding;intracellular;intracellular transport;protein targeting to Golgi:extracellular region@NA
D11016@34092@34095@deletion@4@96457910@96458295@2@chr2:96457910-96458295@15.2@269@144@0.535@NA@AC008268-201_2, AC008268-201_3, ENST00000444924_1, ENST00000444924_2@102.75@101@104@NA@NA@NA
D11016@34183@34184@duplication@2@96652501@96652955@2@chr2:96652501-96652955@10.3@221@362@1.64@NA@AC073995-001_2, AC073995-001_3@4@4@4@:ankyrin repeat domain-containing protein 36A-like@:ion channel inhibitor activity;protein binding@NA
D11016@34630@34632@duplication@3@98162131@98164072@2@chr2:98162131-98164072@6.06@135@210@1.56@NA@ANKRD36B-001_22, ANKRD36B-001_23, ANKRD36B-001_24@91@15@137@NA@NA@NA
D11016@37492@37495@deletion@4@132288154@132290511@2@chr2:132288154-132290511@13.9@364@212@0.582@NA@CCDC74A-201_3, CCDC74A-201_4, CCDC74A-201_5, CCDC74A-201_6@8.25@4@13@:coiled-coil domain containing 74A@NA@NA
D11016@37995@37996@deletion@2@142301867@142356645@2@chr2:142301867-142356645@7.36@69@23@0.333@NA@AC093859-201_1, AC093859-201_2@0@0@0@:low density lipoprotein receptor-related protein 1B@:low-density lipoprotein receptor activity;protein binding;integral to membrane;protein transport;receptor-mediated endocytosis;membrane;calcium ion binding@NA
D11016@46353@46354@deletion@2@241631264@241631939@2@chr2:241631264-241631939@4.91@86@45@0.523@NA@AQP12A-201_1, AQP12A-201_2@27@25@29@:aquaporin 12A@:transport;integral to membrane;transporter activity;membrane@NA
D11016@47656@47657@duplication@2@11901951@11912903@3@chr3:11901951-11912903@4.97@144@211@1.47@NA@AC090958-001_3, AC090958-001_4@3@0@6@NA@NA@NA
D11016@61544@61548@deletion@5@195388629@195393086@3@chr3:195388629-195393086@7.85@171@97@0.567@CNVR1703.1@SDHALP2-001_2, SDHALP2-001_3, SDHALP2-001_4, SDHALP2-001_5, SDHALP2-001_6@88.6@85@92@:mucin 20, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane@NA
D11016@61551@61552@deletion@2@195399357@195400859@3@chr3:195399357-195400859@12.2@239@121@0.506@CNVR1703.1@SDHALP2-001_9, SDHALP2-001_10@71.5@71@72@:mucin 20, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane@NA
D11016@61643@61647@duplication@5@195701270@195702772@3@chr3:195701270-195702772@13.5@917@1243@1.36@CNVR1707.1, CNVR1707.2@SDHALP1-002_9, SDHALP1-002_10, ENST00000354937_10, ENST00000354937_11, ENST00000354937_12@40@39@41@NA@NA@NA
D11016@64681@64686@duplication@6@49513172@49559427@4@chr4:49513172-49559427@8.22@107@184@1.72@CNVR1911.5@AC119752-201_1, AC119751-202_1, AC119751-202_2, AC119751-202_3, AC119751-202_4, AC119751-202_5@25.5@8@34@NA@NA@NA
D11016@65354@65360@deletion@7@70146221@70160768@4@chr4:70146221-70160768@20.7@921@575@0.624@CNVR1957.2, CNVR1957.1@UGT2B28-201_1, UGT2B28-201_2, UGT2B28-201_3, UGT2B28-201_4, UGT2B28-201_5, UGT2B28-201_6, UGT2B28-201_7@69.1428571428571@65@71@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
D11016@68947@68947@deletion@1@145041645@145041742@4@chr4:145041645-145041742@9.47@117@46@0.393@NA@GYPA-205_2@8@8@8@:glycophorin B (MNS blood group):glycophorin A (MNS blood group)@:integral to membrane;plasma membrane;integral to plasma membrane:external side of plasma membrane;integral to membrane;cytoskeletal anchoring at plasma membrane;plasma membrane;molecular_function;protein homodimerization activity;integral to plasma membrane;cellular_component;identical protein binding;membrane;biological_process;regulation of response to osmotic stress;virus-host interaction@: BLOOD GROUP--Ss LOCUS; Ss: MALARIA, SUSCEPTIBILITY TO; BLOOD GROUP--MN LOCUS; MN
D11016@73651@73652@duplication@2@68849399@68856231@5@chr5:68849399-68856231@5.85@166@253@1.52@CNVR2494.7, CNVR2494.46@OCLN-202_9, GTF2H2C-201_1@8.5@7@10@:occludin:general transcription factor IIH, polypeptide 2C;general transcription factor IIH, polypeptide 2D@:S-adenosylmethionine metabolic process;cell-cell junction organization;cellular component disassembly involved in execution phase of apoptosis;response to testosterone stimulus;tight junction;integral to membrane;cell junction;plasma membrane;apoptotic process;thiopurine S-methyltransferase activity;S-adenosylhomocysteine metabolic process;apical plasma membrane;protein complex assembly;cytosol;cell-cell junction;protein binding;structural molecule activity;response to organic cyclic compound;apicolateral plasma membrane:regulation of transcription, DNA-dependent;nucleotide-excision repair;DNA repair;core TFIIH complex;protein binding;nucleus;transcription, DNA-dependent;zinc ion binding@: BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;
D11016@73817@73817@deletion@1@70370032@70370154@5@chr5:70370032-70370154@15.8@74@0@0@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.8, CNVR2494.1, CNVR2494.37@AC044797-201_5@124@124@124@NA@NA@NA
D11016@79567@79568@deletion@2@175388056@175388438@5@chr5:175388056-175388438@10.2@78@22@0.282@NA@THOC3-001_4, THOC3-001_5@173.5@165@182@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
D11016@79579@79581@duplication@3@175524360@175526049@5@chr5:175524360-175526049@7.2@388@540@1.39@NA@FAM153B-201_8, FAM153B-201_9, FAM153B-201_10@12.6666666666667@4@17@:uncharacterized LOC100507387;family with sequence similarity 153, member B@NA@NA
D11016@80019@80024@deletion@6@177163582@177168334@5@chr5:177163582-177168334@28.7@327@132@0.404@NA@FAM153A-204_7, FAM153A-204_8, FAM153A-204_9, FAM153A-204_10, FAM153A-204_11, FAM153A-204_12@86.1666666666667@76@106@:family with sequence similarity 153, member A@NA@NA
D11016@80479@80487@deletion@9@180375357@180429786@5@chr5:180375357-180429786@19.6@870@559@0.643@CNVR2719.1@BTNL8-202_5, BTNL8-202_6, BTNL8-202_7, BTNL8-202_8, BTNL3-202_1, BTNL3-202_2, BTNL3-202_3, BTNL3-202_5@102.375@90@108@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
D11016@82489@82492@duplication@4@29855734@29857601@6@chr6:29855734-29857601@5.92@663@859@1.3@CNVR2829.7, CNVR2829.2, CNVR2829.8, CNVR2829.3@HLA-H-001_2, HLA-H-001_3, HLA-H-001_4, HLA-H-001_5@46.5@45@48@NA@NA@NA
D11016@83003@83003@duplication@1@31237989@31238263@6@chr6:31237989-31238263@5.88@208@312@1.5@CNVR2838.1@HLA-C-006_4@25@25@25@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
D11016@83371@83371@deletion@1@31795730@31795884@6@chr6:31795730-31795884@10.6@161@69@0.429@NA@HSPA1B-201_1@3@3@3@:heat shock 70kDa protein 1A;heat shock 70kDa protein 1B@:negative regulation of apoptotic process;protein binding involved in protein folding;mitochondrion;negative regulation of cell proliferation;nuclear speck;aggresome;positive regulation of erythrocyte differentiation;RNA metabolic process;negative regulation of inclusion body assembly;ATP binding;negative regulation of cell growth;mRNA metabolic process;nucleus;response to unfolded protein;gene expression;protein N-terminus binding;ubiquitin protein ligase binding;unfolded protein binding;signalosome;mRNA catabolic process;ribonucleoprotein complex;cell morphogenesis;endoplasmic reticulum;inclusion body;perinuclear region of cytoplasm;cytoplasm;cytosol;protein binding;protein refolding@NA
D11016@83601@83613@deletion@13@31973468@31975248@6@chr6:31973468-31975248@60.6@1303@689@0.529@CNVR2843.6, CNVR2843.3@CYP21A1P-001_1, CYP21A1P-001_2, CYP21A1P-001_3, CYP21A1P-001_4, CYP21A1P-001_5, CYP21A1P-001_6, CYP21A1P-001_7, AL645922-201_1, AL645922-201_2, AL645922-201_3, AL645922-201_4, AL645922-201_5, AL645922-201_6@107.615384615385@80@121@NA@NA@NA
D11016@83642@83646@deletion@5@31996236@31997576@6@chr6:31996236-31997576@16.2@332@177@0.533@CNVR2843.6, CNVR2843.5@C4B-001_25, C4B-001_26, C4B-001_27, C4B-001_28, C4B-001_29@14.8@8@19@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
D11016@83669@83675@deletion@7@32008447@32010384@6@chr6:32008447-32010384@16@312@167@0.535@CNVR2843.6, CNVR2843.5@TNXB-201_40, TNXB-201_41, TNXB-201_42, TNXB-201_43, TNXB-201_44, CYP21A2-002_9, CYP21A2-002_10@40.8571428571429@33@46@:cytochrome P450, family 21, subfamily A, polypeptide 2:tenascin-X-like;tenascin XB@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
D11016@83683@83683@deletion@1@32012785@32013104@6@chr6:32012785-32013104@7.17@110@50@0.455@CNVR2843.6, CNVR2843.5@TNXB-201_32@13@13@13@:tenascin-X-like;tenascin XB@:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
D11016@83911@83915@deletion@5@32485122@32489952@6@chr6:32485122-32489952@20.9@191@73@0.382@CNVR2845.21, CNVR2845.25, CNVR2845.30@HLA-DRB5-001_2, HLA-DRB5-001_3, HLA-DRB5-001_4, HLA-DRB5-001_5, HLA-DRB5-001_6@184.2@177@189@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D11016@83918@83925@duplication@8@32521155@32527800@6@chr6:32521155-32527800@12.1@288@436@1.51@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.5@HLA-DRB6-002_1, HLA-DRB6-002_2, HLA-DRB6-002_3, HLA-DRB6-002_4, HLA-DRB6-002_5, AL713966-201_1, AL713966-201_2, AL713966-201_3@132.375@95@167@NA@NA@NA
D11016@83928@83930@deletion@3@32548525@32552156@6@chr6:32548525-32552156@5.7@384@259@0.674@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.5, CNVR2845.54@HLA-DRB1-001_2, HLA-DRB1-001_3, HLA-DRB1-001_4@72@56@100@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
D11016@83932@83942@duplication@11@32605206@32629235@6@chr6:32605206-32629235@12.3@827@1109@1.34@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20@HLA-DQA1-002_1, HLA-DQA1-002_2, HLA-DQA1-002_3, HLA-DQA1-002_4, HLA-DQA1-002_5, HLA-DQA1-002_6, HLA-DQB1-003_5, HLA-DQB1-003_6, XXbac-BPG254F23-001_1, XXbac-BPG254F23-001_2, ENST00000443574_2@126.727272727273@83@146@:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
D11016@83944@83945@deletion@2@32630133@32632845@6@chr6:32630133-32632845@12.3@127@45@0.354@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20, CNVR2845.31, CNVR2845.64@HLA-DQB1-003_3, ENST00000443574_1@106.5@101@112@:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
D11016@84061@84062@duplication@2@33053998@33054977@6@chr6:33053998-33054977@5.46@264@367@1.39@CNVR2846.3, CNVR2846.5@HLA-DPB1-201_5, HLA-DPB1-201_6@21@18@24@:major histocompatibility complex, class II, DP beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D11016@92589@92595@deletion@7@160132299@160133523@6@chr6:160132299-160133523@24.1@856@527@0.616@CNVR3127.2, CNVR3127.1@ENST00000442642_2, ENST00000442642_3, ENST00000442642_4, ENST00000442642_5, ENST00000442642_6, ENST00000442642_7, ENST00000442642_8@83.8571428571429@13@112@:superoxide dismutase 2, mitochondrial;uncharacterized LOC100129518@:response to reactive oxygen species;oxidation-reduction process;mitochondrion;negative regulation of cell proliferation;neuron development;negative regulation of fat cell differentiation;removal of superoxide radicals;response to gamma radiation;response to L-ascorbic acid;response to lipopolysaccharide;response to nutrient levels;response to zinc ion;protein homotetramerization;post-embryonic development;iron ion homeostasis;hemopoiesis;aging;mitochondrial inner membrane;age-dependent response to reactive oxygen species;response to drug;oxygen binding;mitochondrial nucleoid;vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure;apoptotic process;superoxide metabolic process;response to superoxide;detection of oxygen;response to silicon dioxide;cytoplasm;response to stress;respiratory electron transport chain;superoxide anion generation;protein homooligomerization;regulation of mitochondrial membrane potential;positive regulation of nitric oxide biosynthetic process;response to manganese ion;regulation of blood pressure;metal ion binding;negative regulation of apoptotic process;response to cadmium ion;response to oxidative stress;liver development;regulation of catalytic activity;negative regulation of fibroblast proliferation;response to selenium ion;age-dependent response to oxidative stress;response to electrical stimulus;mitochondrial matrix;identical protein binding;mitochondrion organization;response to hyperoxia;vasodilation;response to hydrogen peroxide;superoxide dismutase activity;heart development;negative regulation of neuron apoptotic process;erythrophore differentiation;locomotory behavior;DNA binding;release of cytochrome c from mitochondria;response to axon injury;oxygen homeostasis;response to activity;glutathione metabolic process;hydrogen peroxide metabolic process;hydrogen peroxide biosynthetic process;regulation of transcription from RNA polymerase II promoter;response to hypoxia;protein binding;manganese ion binding;cellular response to ethanol@: MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6; MVCD6
D11016@93099@93099@deletion@1@167790036@167790193@6@chr6:167790036-167790193@4.67@24@2@0.0833@NA@TCP10-001_5@103@103@103@:t-complex 10@:cytosol@NA
D11016@94059@94059@deletion@1@5172081@5172121@7@chr7:5172081-5172121@6.6@50@13@0.26@NA@AC092028-001_3@1@1@1@NA@NA@NA
D11016@94198@94212@deletion@15@5977391@6006833@7@chr7:5977391-6006833@47.8@899@439@0.488@NA@RSPH10B-002_3, RSPH10B-002_4, RSPH10B-002_5, RSPH10B-002_6, RSPH10B-002_7, RSPH10B-002_8, RSPH10B-002_9, RSPH10B-002_10, RSPH10B-002_11, RSPH10B-002_12, RSPH10B-002_13, RSPH10B-002_14, RSPH10B-002_15, RSPH10B-002_16, RSPH10B-002_17@10.6@8@18@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D11016@94424@94439@duplication@16@6805339@6836574@7@chr7:6805339-6836574@28@756@1167@1.54@NA@RSPH10B2-204_7, RSPH10B2-204_8, RSPH10B2-204_9, RSPH10B2-204_10, RSPH10B2-204_11, RSPH10B2-204_12, RSPH10B2-204_13, RSPH10B2-204_14, RSPH10B2-204_15, RSPH10B2-204_16, RSPH10B2-204_17, RSPH10B2-204_18, RSPH10B2-204_19, RSPH10B2-204_20, ENST00000429267_1, ENST00000429267_2@16.625@11@26@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D11016@94442@94444@duplication@3@6840581@6844687@7@chr7:6840581-6844687@7.75@128@211@1.65@NA@C7orf28B-001_12, C7orf28B-001_13, C7orf28B-001_14@117.666666666667@114@121@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D11016@97907@97916@duplication@10@57063663@57082132@7@chr7:57063663-57082132@11.7@125@222@1.78@NA@TNRC18C-202_3, TNRC18C-202_4, TNRC18C-202_5, TNRC18C-202_6, TNRC18C-202_7, TNRC18C-202_8, TNRC18C-202_9, TNRC18C-202_10, TNRC18C-202_11, ENST00000398760_5@156.7@139@166@NA@NA@NA
D11016@97991@97994@deletion@4@62758072@62758771@7@chr7:62758072-62758771@127@663@2@0.00302@NA@AC006455-201_2, AC006455-201_3, ENST00000444809_2, ENST00000444809_3@160@151@171@NA@NA@NA
D11016@98015@98016@duplication@2@62910199@62910898@7@chr7:62910199-62910898@22@406@752@1.85@NA@ZNF734-201_2, ZNF734-201_3@102@102@102@NA@NA@NA
D11016@98688@98701@deletion@14@72613728@72640087@7@chr7:72613728-72640087@16.7@129@35@0.271@NA@RP11-396K3-001_18, RP11-396K3-001_19, RP11-396K3-001_20, RP11-396K3-001_21, RP11-396K3-001_22, RP11-396K3-001_23, ENST00000338578_1, ENST00000338578_2, ENST00000338578_3, ENST00000338578_4, NCF1B-001_1, NCF1B-001_2, NCF1B-001_3, NCF1B-001_4@8.42857142857143@1@27@NA@NA@NA
D11016@99031@99035@duplication@5@74167428@74172334@7@chr7:74167428-74172334@20.7@204@421@2.06@NA@GTF2I-001_29, GTF2I-001_30, GTF2I-001_31, GTF2I-001_32, GTF2I-001_33@22.8@14@35@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
D11016@99091@99091@duplication@1@74422162@74422231@7@chr7:74422162-74422231@8.27@5@60@12@NA@AC118138-001_2@6@6@6@:GATS protein-like 1@NA@NA
D11016@99133@99142@deletion@10@74582344@74608703@7@chr7:74582344-74608703@10.7@157@72@0.459@NA@NCF1C-001_1, NCF1C-001_2, NCF1C-001_3, NCF1C-001_4, GTF2IP1-001_17, GTF2IP1-001_18, GTF2IP1-001_19, GTF2IP1-001_20, GTF2IP1-001_21, GTF2IP1-001_22@15.3@11@49@NA@NA@NA
D11016@99185@99185@deletion@1@74824185@74824254@7@chr7:74824185-74824254@7.1@109@50@0.459@NA@GATSL1-001_2@11@11@11@:GATS protein-like 2@NA@NA
D11016@99233@99233@deletion@1@74991244@74991359@7@chr7:74991244-74991359@6.16@29@1@0.0345@CNVR3456.1@STAG3L1-004_3@60@60@60@NA@NA@NA
D11016@99272@99273@deletion@2@75054920@75055736@7@chr7:75054920-75055736@5.16@95@51@0.537@NA@POM121C-001_8, POM121C-001_9@51@30@72@:POM121 transmembrane nucleoporin C@:nuclear membrane;protein binding;protein transport;endoplasmic reticulum membrane;nuclear pore;mRNA transport@NA
D11016@99454@99454@duplication@1@76063357@76063473@7@chr7:76063357-76063473@8.7@117@216@1.85@CNVR3462.1@ZP3-002_6@10@10@10@:zona pellucida glycoprotein 3 (sperm receptor)@:negative regulation of transcription, DNA-dependent;manganese ion transmembrane transporter activity;intracellular protein transport;proteinaceous extracellular matrix;plasma membrane;positive regulation of acrosome reaction;outer acrosomal membrane;protein kinase C signaling cascade;manganese ion transmembrane transport;intracellular signal transduction;humoral immune response mediated by circulating immunoglobulin;negative regulation of binding of sperm to zona pellucida;positive regulation of inflammatory response;endoplasmic reticulum;signal transducer activity;perinuclear region of cytoplasm;secretory granule;positive regulation of transcription, DNA-dependent;positive regulation of ovarian follicle development;positive regulation of interferon-gamma production;carbohydrate binding;manganese ion transport;positive regulation of antral ovarian follicle growth;extracellular matrix;positive regulation of leukocyte migration;positive regulation of humoral immune response;extracellular space;blastocyst formation;integral to membrane;store-operated calcium channel activity;oocyte development;multivesicular body;phosphatidylinositol-mediated signaling;acrosomal vesicle;positive regulation of protein kinase B signaling cascade;Golgi apparatus;positive regulation of calcium ion import;positive regulation of protein kinase activity;positive regulation of acrosomal vesicle exocytosis;positive regulation of interleukin-4 production;cytoplasm;protein binding;binding of sperm to zona pellucida;positive regulation of phosphatidylinositol biosynthetic process;extracellular region;positive regulation of T cell proliferation;acrosin binding;positive regulation of type IV hypersensitivity;egg coat formation@NA
D11016@102130@102130@duplication@1@102136589@102136652@7@chr7:102136589-102136652@4.77@178@261@1.47@CNVR3518.1@RASA4B-007_16@49@49@49@:RAS p21 protein activator 4B@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction@NA
D11016@102144@102145@deletion@2@102180464@102180539@7@chr7:102180464-102180539@37.7@178@0@0@CNVR3518.1@RASA4B-007_4, POLR2J3-003_7@96@96@96@:RAS p21 protein activator 4B:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
D11016@102177@102177@deletion@1@102235754@102235817@7@chr7:102235754-102235817@4.76@84@42@0.5@CNVR3518.1@RASA4-001_11@55@55@55@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
D11016@102192@102193@duplication@2@102279572@102279647@7@chr7:102279572-102279647@19@308@550@1.79@CNVR3518.1@ENST00000340457_4, POLR2J2-001_7@76.5@76@77@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
D11016@102614@102623@deletion@10@105893465@105925639@7@chr7:105893465-105925639@75.5@1866@971@0.52@NA@PBEF1-001_1, PBEF1-001_2, PBEF1-001_3, PBEF1-001_4, PBEF1-001_5, PBEF1-001_6, PBEF1-001_7, PBEF1-001_8, PBEF1-001_9, PBEF1-001_10@1.3@0@3@:nicotinamide phosphoribosyltransferase@:nicotinate phosphoribosyltransferase activity;small molecule metabolic process;positive regulation of nitric-oxide synthase biosynthetic process;NAD metabolic process;cytoplasm;cell-cell signaling;NAD biosynthetic process;cytosol;signal transduction;cytokine activity;positive regulation of cell proliferation;water-soluble vitamin metabolic process;nicotinate-nucleotide diphosphorylase (carboxylating) activity;nicotinamide metabolic process;vitamin metabolic process;nicotinamide phosphoribosyltransferase activity@NA
D11016@103919@103919@duplication@1@128128157@128128216@7@chr7:128128157-128128216@5.04@68@119@1.75@NA@METTL2B-001_5@0@0@0@:methyltransferase like 2B@:methyltransferase activity;metabolic process@NA
D11016@105316@105339@duplication@24@141762370@141791848@7@chr7:141762370-141791848@155@3372@5604@1.66@CNVR3585.3, CNVR3585.2@MGAM-007_35, MGAM-007_36, MGAM-007_37, MGAM-007_38, MGAM-007_39, MGAM-007_40, MGAM-007_41, MGAM-007_42, MGAM-007_43, MGAM-007_44, MGAM-007_45, MGAM-007_46, MGAM-007_47, MGAM-007_48, MGAM-007_49, MGAM-007_50, MGAM-007_51, MGAM-007_52, MGAM-007_53, MGAM-007_54, MGAM-007_55, MGAM-007_56, MGAM-007_57, MGAM-007_58@100.833333333333@4@134@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
D11016@105521@105527@duplication@7@142481247@142494348@7@chr7:142481247-142494348@34.5@564@1012@1.79@NA@AC231380-201_1, TRBC1-210_1, TRBC1-210_2, TRBC1-210_3, PRSS1-204_4, PRSS1-204_5, PRSS1-204_6@56.5714285714286@10@115@NA@NA@NA
D11016@105784@105787@duplication@4@143953276@143971215@7@chr7:143953276-143971215@6.74@229@336@1.47@CNVR3598.4, CNVR3598.7, CNVR3598.6@OR2A20P-003_1, RP4-798C17-001_11, RP4-798C17-001_12, ENST00000378112_12@61.5@16@97@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor, family 2, subfamily A, member 7:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane@NA
D11016@105806@105807@duplication@2@143980908@143984072@7@chr7:143980908-143984072@7.88@407@572@1.41@CNVR3598.4, CNVR3598.9@RP4-798C17-001_1, ENST00000378112_2@66@65@67@:Rho guanine nucleotide exchange factor (GEF) 35@NA@NA
D11016@105820@105828@duplication@9@144063450@144071983@7@chr7:144063450-144071983@14@646@916@1.42@CNVR3598.4, CNVR3598.5, CNVR3598.11@ARHGEF5-001_3, ARHGEF5-001_4, ARHGEF5-001_5, ARHGEF5-001_6, ARHGEF5-001_7, ARHGEF5-001_8, ARHGEF5-001_9, ARHGEF5-001_10, ARHGEF5-001_11@76.1111111111111@48@104@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
D11016@107425@107429@deletion@5@7274294@7308722@8@chr8:7274294-7308722@8.7@555@372@0.67@CNVR3771.8, CNVR3771.10, CNVR3771.4@DEFB4P-001_1, DEFB103A-001_1, DEFB103A-001_2, SPAG11-003_3, SPAG11-003_4@68@51@91@:defensin, beta 4B;defensin, beta 4A:defensin, beta 103B;defensin, beta 103A:sperm associated antigen 11B@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response@NA
D11016@117601@117602@duplication@2@43816639@43818185@9@chr9:43816639-43818185@5.27@378@512@1.35@CNVR4294.1@CNTNAP3B-001_6, CNTNAP3B-001_7@88.5@86@91@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
D11016@121600@121604@deletion@5@117085338@117087433@9@chr9:117085338-117087433@19.9@1689@1097@0.649@CNVR4448.1@ORM1-001_1, ORM1-001_2, ORM1-001_3, ORM1-001_4, ORM1-001_5@87.6@84@90@:orosomucoid 1@:protein binding;extracellular space;regulation of immune system process;transport;inflammatory response;extracellular region;acute-phase response@NA
D11016@124049@124050@deletion@2@135959845@135960030@9@chr9:135959845-135960030@10.9@59@6@0.102@NA@CELP-002_2, AL162417-201_2@99@99@99@NA@NA@NA
D11016@126906@126906@deletion@1@17813310@17813381@10@chr10:17813310-17813381@5.49@28@2@0.0714@NA@FAM23A-201_2@17@17@17@:transmembrane protein 236;transmembrane protein 236-like@:integral to membrane@NA
D11016@126909@126909@duplication@1@17840632@17842868@10@chr10:17840632-17842868@18.1@44@204@4.64@NA@FAM23A-201_5@108@108@108@:transmembrane protein 236;transmembrane protein 236-like@:integral to membrane@NA
D11016@126937@126946@duplication@10@17949552@18112446@10@chr10:17949552-18112446@16.8@201@357@1.78@NA@MRC1L1-001_28, MRC1L1-001_29, MRC1L1-001_30, FAM23B-202_1, FAM23B-202_2, FAM23B-202_3, FAM23B-202_4, FAM23B-202_5, MRC1-001_1, MRC1-001_2@42@5@107@:macrophage mannose receptor 1-like:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D11016@126950@126951@deletion@2@18134220@18138694@10@chr10:18134220-18138694@21.1@113@7@0.0619@NA@MRC1-001_6, MRC1-001_7@21@16@26@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D11016@126956@126956@deletion@1@18152465@18152612@10@chr10:18152465-18152612@4.74@21@0@0@NA@MRC1-001_11@20@20@20@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D11016@126974@126975@deletion@2@18196465@18198277@10@chr10:18196465-18198277@15.1@71@1@0.0141@NA@MRC1-001_28, MRC1-001_29@15@3@27@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D11016@127722@127722@deletion@1@29580856@29580936@10@chr10:29580856-29580936@8.57@63@15@0.238@NA@LYZL1-002_1@51@51@51@:lysozyme-like 1@:extracellular region;lysozyme activity;cell wall macromolecule catabolic process@NA
D11016@128372@128372@duplication@1@42924566@42924600@10@chr10:42924566-42924600@7.09@113@196@1.73@NA@CCNYL2-201_7@0@0@0@@:regulation of cyclin-dependent protein kinase activity;protein kinase binding@NA
D11016@128828@128829@deletion@2@46927785@46934899@10@chr10:46927785-46934899@18.1@85@0@0@CNVR4712.9, CNVR4712.2, CNVR4712.7@FAM35B-001_6, FAM35B-001_7@53@34@72@NA@NA@NA
D11016@128912@128913@duplication@2@47405673@47410082@10@chr10:47405673-47410082@8.86@138@240@1.74@CNVR4712.9, CNVR4712.1@FAM35B2-201_5, FAM35B2-201_6@39@31@47@NA@NA@NA
D11016@128979@128979@deletion@1@47758848@47758905@10@chr10:47758848-47758905@5.94@27@0@0@CNVR4714.1@ANXA8L2-001_10@154@154@154@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:calcium-dependent phospholipid binding;calcium ion binding@NA
D11016@129003@129007@deletion@5@47933809@47942085@10@chr10:47933809-47942085@7.03@32@0@0@CNVR4715.2, CNVR4715.1@FAM21B-201_20, FAM21B-201_21, FAM21B-201_22, FAM21B-201_23, FAM21B-201_24@175@165@185@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
D11016@129030@129030@duplication@1@48054985@48055019@10@chr10:48054985-48055019@6.44@152@242@1.59@CNVR4715.2@ASAH2C-201_1@50@50@50@@:ceramidase activity;sphingolipid metabolic process@NA
D11016@129460@129461@deletion@2@51361725@51361911@10@chr10:51361725-51361911@8.94@40@0@0@NA@ENST00000404618_4, ENST00000432221_4@122@121@123@NA@NA@NA
D11016@129605@129609@deletion@5@51970585@51978391@10@chr10:51970585-51978391@18.9@205@89@0.434@NA@ASAH2-201_7, ASAH2-201_8, ASAH2-201_9, ASAH2-201_10, ASAH2-201_11@181.2@176@186@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
D11016@135724@135731@deletion@8@124344789@124354045@10@chr10:124344789-124354045@36.7@1151@666@0.579@CNVR4912.4, CNVR4912.3, CNVR4912.2@DMBT1-002_15, DMBT1-002_16, DMBT1-002_17, DMBT1-002_18, DMBT1-002_19, DMBT1-002_20, DMBT1-002_21, DMBT1-002_22@44.125@7@51@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
D11016@137396@137399@deletion@4@1266331@1272974@11@chr11:1266331-1272974@11.3@1964@1408@0.717@CNVR5008.1@MUC5B-203_49, MUC5B-203_50, MUC5B-203_51, MUC5B-203_52@4@4@4@:mucin 5B, oligomeric mucus/gel-forming@:extracellular matrix structural constituent;protein binding;O-glycan processing;extracellular region;cellular protein metabolic process;cell adhesion;Golgi lumen;post-translational protein modification@: PULMONARY FIBROSIS, IDIOPATHIC; IPF
D11016@138032@138033@deletion@2@5270600@5271118@11@chr11:5270600-5271118@5.23@56@22@0.393@NA@HBG1-201_1, HBG1-201_2@94.5@83@106@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
D11016@141187@141188@duplication@2@48600990@48601883@11@chr11:48600990-48601883@14.1@45@148@3.29@CNVR5165.1@AC134982-201_1, AC134982-201_2@128@128@128@NA@NA@NA
D11016@145896@145897@deletion@2@89515054@89531798@11@chr11:89515054-89531798@7.65@459@289@0.63@NA@TRIM77-201_8, TRIM49-201_8@50@49@51@:tripartite motif containing 49@:protein binding;intracellular;DNA binding;zinc ion binding@NA
D11016@145944@145953@deletion@10@89701674@89715285@11@chr11:89701674-89715285@7.77@35@0@0@NA@TRIM64-202_1, TRIM64-202_2, TRIM64-202_3, TRIM64-202_4, TRIM64-202_5, TRIM64-202_6, TRIM64-202_7, TRIM64-202_8, TRIM64-202_9, ENST00000442514_9@171.8@154@177@NA@NA@NA
D11016@145974@145983@duplication@10@89789147@89806559@11@chr11:89789147-89806559@9.4@178@278@1.56@NA@ENST00000432771_6, ENST00000432771_7, ENST00000432771_8, ENST00000436580_1, ENST00000436580_2, ENST00000436580_3, ENST00000436580_4, ENST00000436580_5, ENST00000436580_6, ENST00000436580_7@86@82@93@:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;DNA binding;zinc ion binding@NA
D11016@150826@150840@duplication@15@9590609@9706679@12@chr12:9590609-9706679@12.9@832@1110@1.33@CNVR5429.1@DDX12-203_1, DDX12-203_2, DDX12-203_3, AC006432-201_1, AC006432-201_2, AC006432-201_3, AC006432-201_4, AC006432-201_5, AC006432-201_6, AC006432-201_7, AC006432-201_8, AC006432-201_9, AC006432-201_11, AC006432-201_12@20.6428571428571@7@25@NA@NA@NA
D11016@151034@151034@duplication@1@11244393@11244793@12@chr12:11244393-11244793@11.5@417@673@1.61@CNVR5434.1@TAS2R31-201_2@72@72@72@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
D11016@154154@154155@deletion@2@53086207@53086665@12@chr12:53086207-53086665@16.2@460@248@0.539@CNVR5537.1@KRT77-201_6, KRT77-201_7@8@8@8@:keratin 77@:structural molecule activity;keratin filament;molecular_function;cellular_component;biological_process@NA
D11016@162127@162128@duplication@2@24465240@24465671@13@chr13:24465240-24465671@6.69@985@1305@1.32@NA@RP11-45B20-002_6, ENST00000382133_3@29@29@29@:C1q and tumor necrosis factor related protein 9B@:collagen;protein binding@NA
D11016@162131@162131@duplication@1@24468280@24468341@13@chr13:24468280-24468341@5.92@197@297@1.51@NA@RP11-45B20-002_4@36@36@36@:C1q and tumor necrosis factor related protein 9B@:collagen;protein binding@NA
D11016@162181@162181@deletion@1@25015986@25016107@13@chr13:25015986-25016107@5.74@129@69@0.535@NA@PARP4-001_30@5@5@5@:poly (ADP-ribose) polymerase family, member 4@:NAD+ ADP-ribosyltransferase activity;transport;inflammatory response;response to drug;DNA binding;DNA repair;cellular protein modification process;cell death;nucleus;spindle microtubule;ribonucleoprotein complex;enzyme binding;response to DNA damage stimulus;cytoplasm;protein ADP-ribosylation;protein binding@NA
D11016@164471@164478@duplication@8@52853978@52857493@13@chr13:52853978-52857493@14.4@336@508@1.51@NA@THSD1P-203_13, THSD1P-203_14, THSD1P-203_15, THSD1P-203_16, ENST00000403471_4, ENST00000403471_5, ENST00000403471_6, ENST00000403471_7@53@48@58@NA@NA@NA
D11016@164539@164543@deletion@5@53103402@53106857@13@chr13:53103402-53106857@31.5@146@0@0@NA@RP11-78J21-201_12, RP11-78J21-201_13, RP11-78J21-201_14, RP11-78J21-201_15, RP11-78J21-201_16@113.8@107@117@NA@NA@NA
D11016@166687@166692@deletion@6@19411434@19413781@14@chr14:19411434-19413781@31.2@547@253@0.463@CNVR6072.1, CNVR6072.16@CR383656-201_1, CR383656-201_2, CR383656-201_3, CR383656-201_4, CR383656-201_5, CR383656-201_6@35@30@37@NA@NA@NA
D11016@166751@166767@duplication@17@20137324@20337303@14@chr14:20137324-20337303@95.8@3625@5936@1.64@CNVR6072.12, CNVR6072.4, CNVR6072.37@AL512310-201_1, AL512310-201_2, AL512310-201_3, AL512310-201_4, AL512310-201_5, ENST00000398231_1, ENST00000398231_2, ENST00000398231_3, ENST00000398231_4, ENST00000398231_5, ENST00000398231_6, ENST00000334072_1, ENST00000334072_2, ENST00000426759_1, ENST00000426759_2, OR4K3P-201_1, OR4K3P-201_2@79.1176470588235@44@102@:olfactory receptor, family 4, subfamily N, member 2:olfactory receptor, family 4, subfamily Q, member 3:olfactory receptor, family 4, subfamily M, member 1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
D11016@167659@167666@deletion@8@24437968@24473602@14@chr14:24437968-24473602@70.7@1393@677@0.486@NA@DHRS4-201_8, DHRS4L2-001_1, DHRS4L2-001_2, DHRS4L2-001_3, DHRS4L2-001_4, DHRS4L2-001_5, DHRS4L2-001_6, DHRS4L2-001_7@7.375@7@9@:dehydrogenase/reductase (SDR family) member 4:dehydrogenase/reductase (SDR family) member 4 like 2@:steroid metabolic process;oxidation-reduction process;mitochondrion;protein tetramerization;oxidoreductase activity;peroxisomal membrane;nucleus;cellular ketone metabolic process;metabolic process;receptor binding;alcohol dehydrogenase [NAD(P)+] activity;peroxisome;nucleotide binding;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;3-keto sterol reductase activity;alcohol metabolic process;carbonyl reductase (NADPH) activity:extracellular region;oxidoreductase activity;nucleotide binding;metabolic process@NA
D11016@168238@168241@duplication@4@31787432@31795549@14@chr14:31787432-31795549@22.3@800@1192@1.49@NA@HEATR5A-202_22, HEATR5A-202_23, HEATR5A-202_24, HEATR5A-202_25@0@0@0@:HEAT repeat containing 5A@:binding@NA
D11016@168260@168269@deletion@10@31867881@32068586@14@chr14:31867881-32068586@72.3@2107@1139@0.541@NA@HEATR5A-202_1, HEATR5A-202_2, HEATR5A-202_3, C14orf126-001_1, C14orf126-001_2, C14orf126-001_3, NUBPL-202_1, NUBPL-202_2, NUBPL-202_3, NUBPL-202_4@0.3@0@1@:HEAT repeat containing 5A:D-tyrosyl-tRNA deacylase 2 (putative):G protein-coupled receptor 33 (gene/pseudogene):nucleotide binding protein-like@:binding:hydrolase activity, acting on ester bonds;D-amino acid catabolic process;cytoplasm:hydrolase activity, acting on ester bonds;D-amino acid catabolic process;molecular_function;cellular_component;cytoplasm;biological_process:4 iron, 4 sulfur cluster binding;mitochondrion;mitochondrion morphogenesis;metal ion binding;ATP binding;mitochondrial respiratory chain complex I assembly@: MITOCHONDRIAL COMPLEX I DEFICIENCY
D11016@170809@170811@deletion@3@74003820@74010454@14@chr14:74003820-74010454@54.5@411@99@0.241@CNVR6188.1, CNVR6188.4@ACOT1-201_1, ACOT1-201_2, ACOT1-201_3@109.666666666667@99@116@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
D11016@170815@170815@deletion@1@74041614@74042360@14@chr14:74041614-74042360@7.44@119@55@0.462@CNVR6188.1, CNVR6188.6@ACOT2-201_3@5@5@5@:acyl-CoA thioesterase 2@:acyl-CoA metabolic process;mitochondrion;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity;receptor binding@NA
D11016@173413@173414@deletion@2@106091235@106091717@14@chr14:106091235-106091717@5.21@387@260@0.672@CNVR6294.46, CNVR6294.20, CNVR6294.54, CNVR6294.43, CNVR6294.50, CNVR6294.61@IGHG4-001_2, IGHG4-001_3@6@6@6@@:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response@NA
D11016@173501@173502@deletion@2@106478134@106478412@14@chr14:106478134-106478412@23.4@161@32@0.199@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV3-6-210_6, IGHV4-4-001_2@17@17@17@@:protein binding@NA
D11016@173635@173636@deletion@2@107095128@107095663@14@chr14:107095128-107095663@19.1@95@4@0.0421@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61-001_1, IGHV4-61-001_2@17@17@17@@:protein binding@NA
D11016@173645@173645@deletion@1@107131035@107131335@14@chr14:107131035-107131335@9.01@253@135@0.534@CNVR6294.56, CNVR6294.16@IGHV3-66-001_2@3@3@3@@:protein binding@NA
D11016@173697@173698@duplication@2@20588370@20588710@15@chr15:20588370-20588710@21.3@670@1087@1.62@CNVR6295.15, CNVR6295.7, CNVR6295.3, CNVR6295.10, CNVR6295.5@HERC2P3-014_27, AC026495-201_26@70@63@77@NA@NA@NA
D11016@173814@173822@duplication@9@22297500@22473354@15@chr15:22297500-22473354@24.3@2501@3402@1.36@CNVR6297.4, CNVR6297.17, CNVR6297.6@AC134980-201_1, AC134980-201_2, ENST00000438898_1, ENST00000438898_2, AC025884-201_1, AC010760-202_2, VSIG6-201_1, VSIG6-201_2@60.25@15@87@:olfactory receptor, family 4, subfamily M, member 2:olfactory receptor, family 4, subfamily N, member 4@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
D11016@174406@174410@duplication@5@29008591@29009297@15@chr15:29008591-29009297@30.5@682@1108@1.62@NA@ENST00000456510_1, ENST00000456510_2, ENST00000456510_3, ENST00000456510_4, ENST00000456510_5@23.6@18@26@NA@NA@NA
D11016@174506@174507@duplication@2@30664352@30665349@15@chr15:30664352-30665349@7.65@236@347@1.47@CNVR6337.1@CHRFAM7A-202_6, CHRFAM7A-202_7@56@44@68@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
D11016@174523@174523@deletion@1@30700113@30700196@15@chr15:30700113-30700196@5.08@249@155@0.622@NA@ENST00000327271_11@54@54@54@@:Golgi apparatus@NA
D11016@174659@174660@deletion@2@32449811@32450808@15@chr15:32449811-32450808@14.3@198@95@0.48@CNVR6345.2, CNVR6345.1@CHRNA7-205_6, CHRNA7-205_7@60@54@66@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
D11016@174966@174973@deletion@8@34781208@34813824@15@chr15:34781208-34813824@21.9@1248@800@0.641@CNVR6351.3@AC027139-201_1, AC027139-201_2, AC027139-201_3, AC027139-201_4, AC027139-201_5, ENST00000444260_1, ENST00000444260_2, ENST00000444260_3@44.5@38@49@:golgin A8 family, member A@:Golgi cisterna membrane;Golgi apparatus@NA
D11016@179305@179310@duplication@6@72953607@72956853@15@chr15:72953607-72956853@7.02@85@147@1.73@CNVR6443.1@GOLGA6-001_8, GOLGA6-001_9, GOLGA6-001_10, GOLGA6-001_11, GOLGA6-001_12, GOLGA6-001_13@75.5@45@99@:golgin A6 family, member B@:Golgi apparatus@NA
D11016@183384@183384@duplication@1@2692232@2693298@16@chr16:2692232-2693298@9.58@122@232@1.9@CNVR6602.2@AC141586-201_1@50@50@50@NA@NA@NA
D11016@184850@184853@deletion@4@16349579@16357073@16@chr16:16349579-16357073@25.8@628@327@0.521@NA@NOMO3-201_10, NOMO3-201_11, NOMO3-201_12, NOMO3-201_13@29.75@27@31@:NODAL modulator 3@:carbohydrate binding;integral to membrane;carboxypeptidase activity@NA
D11016@185021@185024@duplication@4@18542790@18550287@16@chr16:18542790-18550287@8.99@569@780@1.37@NA@NOMO2-201_10, NOMO2-201_11, NOMO2-201_12, NOMO2-201_13@21.5@20@23@:NODAL modulator 2@:carbohydrate binding;protein binding;integral to membrane;carboxypeptidase activity;endoplasmic reticulum membrane@NA
D11016@185292@185293@deletion@2@20451124@20452659@16@chr16:20451124-20452659@6.87@169@94@0.556@NA@ACSM5-001_13, ACSM5-001_14@3@3@3@:acyl-CoA synthetase medium-chain family member 5@:butyrate-CoA ligase activity;catalytic activity;ATP binding;fatty acid metabolic process;GTP binding;metabolic process;mitochondrial matrix;metal ion binding@NA
D11016@186359@186365@duplication@7@28617379@28621513@16@chr16:28617379-28621513@12.2@924@1233@1.33@CNVR6685.1, CNVR6685.2@SULT1A1-203_3, SULT1A1-203_4, SULT1A1-203_5, SULT1A1-203_6, SULT1A1-203_7, SULT1A1-203_8, SULT1A1-203_9@66.7142857142857@49@73@:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1@:small molecule metabolic process;sulfation;aryl sulfotransferase activity;amine metabolic process;catecholamine metabolic process;xenobiotic metabolic process;cytosol;steroid sulfotransferase activity;integral to membrane;sulfotransferase activity;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process;estrogen metabolic process@NA
D11016@187488@187507@duplication@20@32190709@32859477@16@chr16:32190709-32859477@14.3@610@872@1.43@CNVR6701.10@AC133485-201_1, AC133485-201_2, AC133485-201_3, AC133485-201_4, AC133485-201_5, AC133485-201_6, AC133485-201_7, AC133485-001_1, AC133485-001_2, AC133485-001_3, AC133485-001_4, AC138915-202_1, AC138915-202_3, AC138915-202_4, AC138915-202_5, TP53TG3-202_1, IGHV2OR16-5-001_1, IGHV2OR16-5-001_2@34.7222222222222@18@47@:TP53 target 3B;TP53 target 3;TP53-target gene 3 protein-like;TP53 target 3C:TP53 target 3B;TP53 target 3;TP53-target gene 3 protein-like;TP53 target 3C@:nucleus;cytoplasm:nucleus;cytoplasm@NA
D11016@187515@187517@deletion@3@32891801@32892340@16@chr16:32891801-32892340@8.54@80@28@0.35@CNVR6702.2, CNVR6702.1, CNVR6702.3@AC138915-201_5, AC138915-201_6, AC138915-201_7@35.6666666666667@35@36@NA@NA@NA
D11016@187546@187548@duplication@3@33629704@33630421@16@chr16:33629704-33630421@13.8@1107@1524@1.38@CNVR6703.17, CNVR6703.1, CNVR6703.6, CNVR6703.21@AC136428-201_1, AC136428-201_2, AC136428-201_3@22.3333333333333@18@29@NA@NA@NA
D11016@187553@187558@duplication@6@33709889@33718308@16@chr16:33709889-33718308@6.82@57@111@1.95@CNVR6703.17, CNVR6703.1, CNVR6703.21@ENST00000300901_12, ENST00000300901_13, ENST00000300901_14, ENST00000300901_15, ENST00000300901_16, ENST00000300901_17@40.5@13@73@NA@NA@NA
D11016@187578@187582@duplication@5@33781918@33783526@16@chr16:33781918-33783526@9.49@115@203@1.77@CNVR6703.17, CNVR6703.1, CNVR6703.23, CNVR6703.4, CNVR6703.9@AC133561-201_4, AC133561-201_5, AC133561-201_6, AC133561-201_7, AC133561-201_8@45@38@52@NA@NA@NA
D11016@188229@188239@duplication@11@55798611@55819606@16@chr16:55798611-55819606@17@583@824@1.41@CNVR6730.1@CES4-202_2, CES4-202_3, CES4-202_4, CES4-202_5, CES4-202_6, CES4-202_7, CES4-202_8, CES4-202_9, CES4-202_10, AC147362-203_1, AC147362-203_2@106.272727272727@92@123@NA@NA@NA
D11016@190152@190153@deletion@2@70714699@70714929@16@chr16:70714699-70714929@7.59@175@99@0.566@NA@MTSS1L-202_2, MTSS1L-202_3@13.5@9@18@:metastasis suppressor 1-like@:filopodium assembly;actin binding;signal transduction;SH3 domain binding;cytoskeletal adaptor activity@NA
D11016@190549@190549@deletion@1@74451959@74452197@16@chr16:74451959-74452197@7.4@69@23@0.333@CNVR6778.2, CNVR6778.3@CLEC18B-202_3@47@47@47@:C-type lectin domain family 18, member B@:carbohydrate binding;protein binding;extracellular region@NA
D11016@194777@194778@deletion@2@11607522@11608503@17@chr17:11607522-11608503@9.29@255@147@0.576@NA@DNAH9-201_25, DNAH9-201_26@0@0@0@:dynein, axonemal, heavy chain 9@:microtubule motor activity;ATP binding;motor activity;spermatogenesis;ATPase activity;cellular component movement;cilium axoneme;nucleoside-triphosphatase activity;nucleotide binding;cytoplasm;dynein complex;microtubule-based movement;axonemal dynein complex;microtubule;cytoskeleton;cell projection organization@NA
D11016@195744@195747@duplication@4@18456469@18457581@17@chr17:18456469-18457581@7.75@333@462@1.39@NA@CCDC144B-201_14, CCDC144B-201_15, ENST00000447265_11, ENST00000447265_12@128@126@130@NA@NA@NA
D11016@195870@195871@duplication@2@18996289@18996940@17@chr17:18996289-18996940@9.94@268@436@1.63@CNVR7018.4, CNVR7018.2, CNVR7018.6@AC007952-202_1, AC007952-202_2@92.5@92@93@NA@NA@NA
D11016@200259@200266@duplication@8@43585590@43596019@17@chr17:43585590-43596019@15@579@863@1.49@CNVR7113.4, CNVR7113.6, CNVR7113.2, CNVR7113.1@AC091132-201_1, AC091132-201_2, AC091132-201_3, AC091132-201_4, AC091132-201_5, ENST00000339474_1, ENST00000339474_2, ENST00000339474_3@94.875@81@127@NA@NA@NA
D11016@200320@200328@deletion@9@44248223@44364337@17@chr17:44248223-44364337@59.2@4069@2563@0.63@CNVR7114.3, CNVR7114.2, CNVR7114.10@KIAA1267-201_1, KIAA1267-201_2, AC217773-201_1, AC217773-201_2, ENST00000451529_1, ENST00000451529_3, ENST00000451529_5@64.4285714285714@49@90@:KAT8 regulatory NSL complex subunit 1:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:histone acetyltransferase activity (H4-K8 specific);histone acetyltransferase activity (H4-K16 specific);histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase complex;histone H4-K5 acetylation;MLL1 complex;histone H4-K16 acetylation;protein binding;histone H4-K8 acetylation;nucleus:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
D11016@200340@200340@duplication@1@44407818@44409348@17@chr17:44407818-44409348@12.9@64@180@2.81@CNVR7114.3, CNVR7114.2, CNVR7114.1, CNVR7114.7@LRRC37A-001_10@154@154@154@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
D11016@200343@200349@duplication@7@44414664@44592688@17@chr17:44414664-44592688@15.8@93@223@2.4@CNVR7114.2, CNVR7114.1@LRRC37A-001_13, LRRC37A-001_14, LRRC37A-001_15, AC005829-202_1, AC005829-202_2, AC005829-202_3, LRRC37A2-201_1@161.142857142857@124@196@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane@NA
D11016@200361@200363@deletion@3@44632520@44633017@17@chr17:44632520-44633017@14.5@211@92@0.436@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2-201_12, LRRC37A2-201_13, LRRC37A2-201_14@89.6666666666667@74@98@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
D11016@202163@202165@duplication@3@60129900@60140458@17@chr17:60129900-60140458@5.85@487@648@1.33@NA@MED13-201_3, MED13-201_4, MED13-201_5@0@0@0@:mediator complex subunit 13@:nucleoplasm;intracellular steroid hormone receptor signaling pathway;mediator complex;transcription coactivator activity;nucleus;receptor activity;gene expression;androgen receptor signaling pathway;positive regulation of transcription from RNA polymerase II promoter;transcription initiation from RNA polymerase II promoter;RNA polymerase II transcription cofactor activity;transcription cofactor activity;regulation of transcription from RNA polymerase II promoter;vitamin D receptor binding;positive regulation of transcription, DNA-dependent;thyroid hormone receptor binding;ligand-dependent nuclear receptor transcription coactivator activity@NA
D11016@203680@203680@duplication@1@73201599@73201890@17@chr17:73201599-73201890@6.91@209@324@1.55@NA@NUP85-201_1@0@0@0@:nucleoporin 85kDa@:lamellipodium assembly;mitotic cell cycle;macrophage chemotaxis;mRNA transport;transmembrane transport;chemotaxis;protein transport;M phase of mitotic cell cycle;viral reproduction;hexose transport;kinetochore;cytokine-mediated signaling pathway;spindle;glucose transport;nuclear envelope;small molecule metabolic process;condensed chromosome kinetochore;carbohydrate metabolic process;nuclear membrane;cytosol;protein binding;regulation of glucose transport;mitotic prometaphase;nuclear pore outer ring@NA
D11016@213493@213494@deletion@2@14508472@14508748@19@chr19:14508472-14508748@11.3@106@36@0.34@NA@CD97-205_8, CD97-205_9@10.5@7@14@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
D11016@215138@215138@deletion@1@20607594@20607776@19@chr19:20607594-20607776@4.72@104@56@0.538@CNVR7571.1@ENST00000440763_1@6@6@6@NA@NA@NA
D11016@215926@215926@deletion@1@35849784@35851388@19@chr19:35849784-35851388@4.76@530@355@0.67@CNVR7627.1@AC002511-201_2@12@12@12@:free fatty acid receptor 3@:lipid binding;integral to membrane;G-protein coupled receptor activity;plasma membrane;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
D11016@215928@215928@duplication@1@35862253@35863856@19@chr19:35862253-35863856@11.8@212@383@1.81@CNVR7627.1@FFAR3-001_2@102@102@102@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
D11016@217293@217297@duplication@5@40373947@40382827@19@chr19:40373947-40382827@23.5@375@637@1.7@CNVR7639.2@FCGBP-201_22, FCGBP-201_23, FCGBP-201_24, FCGBP-201_25, FCGBP-201_26@130.8@105@155@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D11016@217301@217306@deletion@6@40389654@40399856@19@chr19:40389654-40399856@54.3@374@82@0.219@CNVR7639.2, CNVR7639.3@FCGBP-201_13, FCGBP-201_14, FCGBP-201_15, FCGBP-201_16, FCGBP-201_17, FCGBP-201_18@112.333333333333@103@127@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D11016@217595@217595@deletion@1@41327389@41327534@19@chr19:41327389-41327534@5.47@79@36@0.456@NA@CYP2F1P-001_5@0@0@0@NA@NA@NA
D11016@221165@221170@deletion@6@54723740@54726655@19@chr19:54723740-54726655@21.3@398@200@0.503@CNVR7721.3, CNVR7721.4@LILRB3-008_2, LILRB3-008_3, LILRB3-008_4, LILRB3-008_5, LILRB3-008_6, LILRB3-008_7@107.833333333333@62@136@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D11016@221397@221408@duplication@12@55267568@55279337@19@chr19:55267568-55279337@20@1585@2106@1.33@CNVR7725.2, CNVR7725.1@KIR2DL3-201_5, KIR2DL3-201_6, KIR2DL3-201_7, KIR2DL3-201_8, KIR2DP1-001_2, KIR2DP1-001_3, KIR2DP1-001_4, KIR2DP1-001_5, KIR2DP1-001_6, KIR2DP1-001_7, KIR2DP1-001_8, KIR2DP1-001_9@113.75@91@126@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity@NA
D11016@221413@221417@duplication@5@55290066@55295318@19@chr19:55290066-55295318@11.2@913@1235@1.35@CNVR7725.2, CNVR7725.1@KIR2DL1-002_5, KIR2DL1-002_6, KIR2DL1-002_7, KIR2DL1-002_8, KIR2DL1-002_9@45.6@34@76@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
D11016@222563@222563@duplication@1@1569208@1569279@20@chr20:1569208-1569279@6.54@24@73@3.04@CNVR7763.1@SIRPB1-201_1@128@128@128@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
D11016@232350@232351@deletion@2@18775046@18775393@22@chr22:18775046-18775393@6.07@120@65@0.542@CNVR8087.5, CNVR8087.2, CNVR8087.7@AC008132-201_3, AC008132-201_4@103.5@103@104@NA@NA@NA
D11016@232771@232784@deletion@14@20385728@20402444@22@chr22:20385728-20402444@17.9@151@50@0.331@CNVR8094.9, CNVR8094.4, CNVR8094.10@PI4KAP1-204_1, PI4KAP1-204_2, PI4KAP1-204_3, PI4KAP1-204_4, PI4KAP1-204_5, PI4KAP1-204_6, PI4KAP1-204_7, PI4KAP1-204_8, PI4KAP1-204_9, PI4KAP1-204_10, PI4KAP1-204_11, PI4KAP1-204_12, PI4KAP1-204_13, PI4KAP1-204_14@165.785714285714@155@172@NA@NA@NA
D11016@232927@232927@deletion@1@21065631@21065750@22@chr22:21065631-21065750@6.4@30@1@0.0333@CNVR8099.6, CNVR8099.2@PI4KA-001_51@4@4@4@:phosphatidylinositol 4-kinase, catalytic, alpha@:phospholipid metabolic process;1-phosphatidylinositol 4-kinase activity;small molecule metabolic process;phosphatidylinositol phosphorylation;binding;transferase activity, transferring phosphorus-containing groups;phosphotransferase activity, alcohol group as acceptor;ATP binding;Golgi-associated vesicle;phosphatidylinositol biosynthetic process;cytosol;protein binding;signal transduction;synaptic transmission;kinase activity;phosphatidylinositol-mediated signaling@NA
D11016@233706@233707@duplication@2@24300516@24300889@22@chr22:24300516-24300889@5.57@42@86@2.05@CNVR8114.6, CNVR8114.12, CNVR8114.13, CNVR8114.8@GSTT2B-002_3, GSTT2B-002_4@62@60@64@:glutathione S-transferase theta 2B (gene/pseudogene);glutathione S-transferase theta 2@:protein binding;glutathione transferase activity;nucleus;transferase activity;cytoplasm@NA
D11016@235915@235916@deletion@2@38482251@38482457@22@chr22:38482251-38482457@9.8@97@35@0.361@NA@BAIAP2L2-003_12, BAIAP2L2-003_13@14@14@14@:BAI1-associated protein 2-like 2@:cytoplasmic vesicle membrane;phospholipid binding;cytoskeletal adaptor activity;clathrin complex;vesicle membrane;filopodium assembly;signal transduction;cellular membrane organization;protein binding;SH3 domain binding;plasma membrane;cell-cell contact zone@NA
D11016@236125@236132@deletion@8@39358502@39388155@22@chr22:39358502-39388155@44.2@894@459@0.513@CNVR8164.1@APOBEC3A-001_6, APOBEC3B-003_1, APOBEC3B-003_2, APOBEC3B-003_3, APOBEC3B-003_4, APOBEC3B-003_5, APOBEC3B-003_6, APOBEC3B-003_7@33.5@18@37@:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A;APOBEC3A and APOBEC3B deletion hybrid:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B@:cytidine deamination;defense response to virus;negative regulation of viral genome replication;DNA cytosine deamination;clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine;catalytic activity;DNA demethylation;cytoplasm;innate immune response;cytidine deaminase activity;nucleus;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;cellular response to xenobiotic stimulus;zinc ion binding;negative regulation of transposition:RNA binding;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;negative regulation of transposition;catalytic activity;zinc ion binding@NA
D11016@236821@236821@deletion@1@42911159@42911275@22@chr22:42911159-42911275@5.42@36@8@0.222@CNVR8171.2, CNVR8171.3@RRP7A-001_4@35@35@35@:ribosomal RNA processing 7 homolog A (S. cerevisiae)@:RNA binding;nucleotide binding@NA
D114041@608@608@deletion@1@1643705@1643840@1@chr1:1643705-1643840@5.31@24@0@0@CNVR17.1@CDC2L2-208_7@25@25@25@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
D114041@2338@2353@duplication@16@13109020@13165444@1@chr1:13109020-13165444@10.2@23@87@3.78@CNVR73.1, CNVR73.2@RP11-450I1-201_1, RP11-450I1-201_2, PRAMEF23-202_1, PRAMEF23-202_2, PRAMEF23-202_3, PRAMEF23-202_4, RP13-221M14-201_1, RP13-221M14-201_2, RP13-221M14-201_3, RP13-221M14-201_4, RP13-221M14-201_5, RP13-221M14-001_1, RP13-221M14-001_2, ENST00000448180_1, ENST00000448180_2, ENST00000448180_3@137.875@111@178@:PRAME family member 6;PRAME family member 23;PRAME family member 9/15-like;PRAME family member 5@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
D114041@2738@2738@deletion@1@16362733@16362842@1@chr1:16362733-16362842@9.81@197@105@0.533@CNVR92.1@ENST00000447882_4@9@9@9@NA@NA@NA
D114041@2950@2965@deletion@16@17013136@17034574@1@chr1:17013136-17034574@20.5@2509@1779@0.709@CNVR93.3, CNVR93.15, CNVR93.4@RP1-163M9-001_1, RP1-163M9-001_2, RP1-163M9-001_3, ESPNP-002_2, ESPNP-002_3, ESPNP-002_4, ESPNP-002_5, ESPNP-002_6, ESPNP-002_7, ESPNP-002_8, ESPNP-002_9, ESPNP-002_10, ESPNP-002_11, AL021920-201_1, AL021920-201_2, AL021920-201_3@43@37@46@NA@NA@NA
D114041@2999@3000@deletion@2@17198306@17199603@1@chr1:17198306-17199603@20.3@842@536@0.637@CNVR94.1, CNVR94.4, CNVR94.8@ENST00000356370_1, ENST00000438002_1@20.5@20@21@NA@NA@NA
D114041@11245@11246@duplication@2@89476589@89477711@1@chr1:89476589-89477711@9.43@629@841@1.34@CNVR244.1@GBP3-001_7, GBP3-001_8@54@54@54@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
D114041@12416@12433@deletion@18@104202984@104257511@1@chr1:104202984-104257511@30.5@297@113@0.38@CNVR266.3, CNVR266.5@AMY1A-001_7, AMY1A-001_8, AMY1A-001_9, AMY1A-001_10, AMY1A-001_11, AMY1B-001_1, AMY1B-001_2, AMY1B-001_3, AMY1B-001_4, AMY1B-001_5, AMY1B-001_6, AMY1B-001_7, AMY1B-001_8, AMY1B-001_9, AMY1B-001_10, AMY1B-001_11, AMYP1-001_1, AMYP1-001_2@117.888888888889@107@154@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D114041@12525@12526@duplication@2@108769303@108771779@1@chr1:108769303-108771779@7.48@221@318@1.44@CNVR294.4@NBPF4-002_12, NBPF4-002_13@26.5@21@32@:neuroblastoma breakpoint family, member 4@:cytoplasm@NA
D114041@12582@12582@deletion@1@109007812@109008047@1@chr1:109007812-109008047@5.95@27@0@0@CNVR294.4@NBPF6-202_14@43@43@43@:neuroblastoma breakpoint family, member 6@:cytoplasm@NA
D114041@12927@12927@deletion@1@110224433@110224457@1@chr1:110224433-110224457@5.28@89@46@0.517@CNVR299.6, CNVR299.4, CNVR299.5@GSTM2-203_8@23@23@23@:glutathione S-transferase mu 2 (muscle)@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process@NA
D114041@12929@12936@duplication@8@110230474@110236368@1@chr1:110230474-110236368@123@622@1596@2.57@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1-001_1, GSTM1-001_2, GSTM1-001_3, GSTM1-001_4, GSTM1-001_5, GSTM1-001_6, GSTM1-001_7, GSTM1-001_8@191.375@187@194@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
D114041@14492@14493@deletion@2@144621449@144677050@1@chr1:144621449-144677050@10.4@68@15@0.221@NA@AL592284-001_12, WI2-1896O14-001_3@3.5@2@5@NA@NA@NA
D114041@16301@16302@duplication@2@152769219@152771397@1@chr1:152769219-152771397@6.51@78@137@1.76@CNVR360.1@LCE1D-001_1, LCE1D-001_2@23.5@22@25@:late cornified envelope 1D@:cytoplasmic part;cornified envelope;cellular response to calcium ion;keratinization;perinuclear region of cytoplasm;cytoplasm@NA
D114041@21362@21374@deletion@13@196743977@196801320@1@chr1:196743977-196801320@434@2075@12@0.00578@CNVR459.1@CFHR3-001_1, CFHR3-001_2, CFHR3-001_3, CFHR3-001_4, CFHR3-001_5, CFHR3-001_6, CFHR1-001_1, CFHR1-001_2, CFHR1-001_3, CFHR1-001_4, CFHR1-001_5, CFHR1-001_6, CFHR2-201_1@96.7692307692308@85@119@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
D114041@23612@23612@duplication@1@214656364@214656731@1@chr1:214656364-214656731@6.03@85@142@1.67@NA@RP11-365D23-201_1@0@0@0@:protein tyrosine phosphatase, non-receptor type 14@:phosphatase activity;protein tyrosine phosphatase activity;receptor tyrosine kinase binding;protein dephosphorylation;cytoplasm;lymphangiogenesis;cytoskeleton;protein tyrosine/serine/threonine phosphatase activity;dephosphorylation;peptidyl-tyrosine dephosphorylation@: CHOANAL ATRESIA AND LYMPHEDEMA
D114041@24160@24161@deletion@2@223727670@223727929@1@chr1:223727670-223727929@5.91@73@34@0.466@NA@CAPN8-202_23, CAPN8-202_24@0@0@0@:calpain 8@:proteolysis;Golgi apparatus;intracellular;calcium-dependent cysteine-type endopeptidase activity;calcium ion binding@NA
D114041@33520@33520@deletion@1@87239638@87241105@2@chr2:87239638-87241105@12.4@56@0@0@NA@RGPD1-001_23@110@110@110@:RANBP2-like and GRIP domain containing 1:plasminogen-like B1;plasminogen-like B2@:protein binding;intracellular;intracellular transport;protein targeting to Golgi:extracellular region@NA
D114041@33542@33542@deletion@1@87365381@87365416@2@chr2:87365381-87365416@11.6@64@8@0.125@CNVR861.2@AC083899-001_6@11@11@11@NA@NA@NA
D114041@33558@33565@deletion@8@87404273@87416182@2@chr2:87404273-87416182@48.3@513@202@0.394@CNVR861.2@AC083899-001_22, AC083899-001_23, AC083899-001_24, AC083899-001_25, AC083899-001_26, AC083899-001_27, AC083899-001_28, AC083899-001_29@61.25@21@85@NA@NA@NA
D114041@33599@33600@duplication@2@88055476@88056454@2@chr2:88055476-88056454@10.3@243@365@1.5@NA@PLGLB2-003_4, RGPD2-001_23@26@26@26@:plasminogen-like B1;plasminogen-like B2:RANBP2-like and GRIP domain containing 2@:extracellular region:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
D114041@33832@33832@deletion@1@90192770@90193003@2@chr2:90192770-90193003@7.16@139@75@0.54@CNVR867.10, CNVR867.5, CNVR867.3, CNVR867.9, CNVR867.15@IGKV1D-13-001_1@7@7@7@@:protein binding@NA
D114041@34540@34541@deletion@2@97818243@97820479@2@chr2:97818243-97820479@8.86@286@176@0.615@CNVR886.2@ENST00000461153_14, ENST00000461153_15@13@12@14@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
D114041@34571@34581@duplication@11@97875420@97884816@2@chr2:97875420-97884816@8.97@740@964@1.3@NA@ENST00000461153_45, ENST00000461153_46, ENST00000461153_47, ENST00000461153_48, ENST00000461153_49, ENST00000461153_50, ENST00000461153_51, ENST00000461153_52, ENST00000461153_53, ENST00000461153_54, ENST00000461153_55@59.9090909090909@49@65@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
D114041@34615@34631@deletion@17@98127603@98162325@2@chr2:98127603-98162325@56.5@287@19@0.0662@CNVR888.3@ANKRD36B-001_23, ANKRD36B-001_24, ANKRD36B-001_25, ANKRD36B-001_26, ANKRD36B-001_27, ANKRD36B-001_28, ANKRD36B-001_29, ANKRD36B-001_30, ANKRD36B-001_31, ANKRD36B-001_32, ANKRD36B-001_33, ANKRD36B-001_34, ANKRD36B-001_35, ANKRD36B-001_36, ANKRD36B-001_37, ANKRD36B-001_38, ANKRD36B-001_39@130.058823529412@64@154@NA@NA@NA
D114041@35970@35973@duplication@4@112541476@112545898@2@chr2:112541476-112545898@7.76@434@581@1.34@CNVR928.1@ANAPC1-001_39, ANAPC1-001_40, ANAPC1-001_41, ANAPC1-001_42@4.25@1@11@:anaphase-promoting complex subunit 1-like;anaphase promoting complex subunit 1@:nucleoplasm;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle;anaphase-promoting complex;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle spindle assembly checkpoint;cytosol;protein K11-linked ubiquitination;protein binding;mitosis;nucleus;cell cycle checkpoint;cell division;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle@NA
D114041@37136@37136@deletion@1@130737612@130737743@2@chr2:130737612-130737743@6@109@58@0.532@CNVR982.2@AC079776-002_2@0@0@0@:RAB6C-like;RAB6C, member RAS oncogene family@:regulation of centrosome duplication;centrosome;intracellular;response to drug;small GTPase mediated signal transduction;GTPase activity;GTP catabolic process;intracellular protein transport;signal transduction;nucleocytoplasmic transport;cell cycle process;protein transport;GTP binding;nucleus;membrane@NA
D114041@40502@40502@duplication@1@179296383@179296982@2@chr2:179296383-179296982@5.31@257@354@1.38@CNVR1065.1@PRKRA-002_9@2@2@2@:protein kinase, interferon-inducible double stranded RNA dependent activator@:double-stranded RNA binding;negative regulation of cell proliferation;immune response;pyridoxal phosphate binding;middle ear morphogenesis;production of siRNA involved in RNA interference;induction of apoptosis;protein homodimerization activity;skeletal system morphogenesis;response to virus;positive regulation of catalytic activity;protein phosphorylation;intracellular;response to stress;cytoplasm;perinuclear region of cytoplasm;outer ear morphogenesis;protein binding;enzyme activator activity;kinase activity@: DYSTONIA 16; DYT16
D114041@53169@53169@deletion@1@62267240@62267385@3@chr3:62267240-62267385@6.66@182@107@0.588@NA@PTPRG-001_27@3@3@3@:protein tyrosine phosphatase, receptor type, G@:phosphatase activity;protein tyrosine phosphatase activity;protein dephosphorylation;protein binding;transmembrane receptor protein tyrosine kinase signaling pathway;dephosphorylation;integral to plasma membrane;identical protein binding;transmembrane receptor protein tyrosine phosphatase activity;peptidyl-tyrosine dephosphorylation@NA
D114041@56605@56606@deletion@2@128864606@128864717@3@chr3:128864606-128864717@6.54@205@126@0.615@NA@RAB43-201_6, ISY1-201_6@0@0@0@:ISY1-RAB43 readthrough:ISY1 splicing factor homolog (S. cerevisiae)@:nucleus;mRNA splicing, via spliceosome;catalytic step 2 spliceosome@NA
D114041@57670@57672@deletion@3@140621038@140621327@3@chr3:140621038-140621327@5.22@54@22@0.407@NA@RP11-4H14-201_1, RP11-4H14-201_2, RP11-4H14-201_3@1@1@1@NA@NA@NA
D114041@61532@61543@deletion@12@195377017@195385037@3@chr3:195377017-195385037@69.4@789@292@0.37@CNVR1703.1@AC233280-201_1, AC233280-201_2, AC233280-201_3, AC233280-201_4, AC233280-201_5, AC233280-201_6, AC233280-201_7, AC233280-201_8, AC069513-001_1, AC069513-001_2, AC069513-001_3, SDHALP2-001_1@85.0833333333333@68@93@:mucin 20, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane@NA
D114041@61547@61552@deletion@6@195390959@195400859@3@chr3:195390959-195400859@22.4@881@562@0.638@CNVR1703.1@SDHALP2-001_5, SDHALP2-001_6, SDHALP2-001_7, SDHALP2-001_8, SDHALP2-001_9, SDHALP2-001_10@78.3333333333333@71@92@:mucin 20, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane@NA
D114041@65315@65320@duplication@6@69402904@69434246@4@chr4:69402904-69434246@64.9@1226@2035@1.66@CNVR1953.1@UGT2B17-001_1, UGT2B17-001_2, UGT2B17-001_3, UGT2B17-001_4, UGT2B17-001_5, UGT2B17-001_6@124.5@118@134@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
D114041@70816@70823@deletion@8@712144@751373@5@chr5:712144-751373@39.3@1615@1052@0.651@CNVR2280.3@ZDHHC11-201_13, ZDHHC11B-201_4, ZDHHC11B-201_5, ZDHHC11B-201_6, ZDHHC11B-201_7, ZDHHC11B-201_8, ZDHHC11B-201_9, ZDHHC11B-201_10@69.875@34@96@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
D114041@71600@71608@deletion@9@21480883@21494063@5@chr5:21480883-21494063@20.4@366@191@0.522@CNVR2395.4, CNVR2395.6, CNVR2395.2@AC138951-201_4, AC138951-202_1, AC138951-202_2, ENST00000412250_1, ENST00000412250_2, ENST00000412250_3, ENST00000412250_4, ENST00000366374_1, ENST00000366374_2@101.333333333333@86@108@NA@NA@NA
D114041@73727@73727@duplication@1@69717564@69717599@5@chr5:69717564-69717599@5.63@75@127@1.69@CNVR2494.17, CNVR2494.3@GTF2H2B-201_4@139@139@139@NA@NA@NA
D114041@76566@76567@deletion@2@131822251@131822537@5@chr5:131822251-131822537@6.17@479@329@0.687@NA@IRF1-008_5, IRF1-008_6@0@0@0@:interferon regulatory factor 1@:nucleoplasm;defense response to virus;negative regulation of cell proliferation;sequence-specific DNA binding;cellular response to dsRNA;negative regulation of transcription, DNA-dependent;induction of apoptosis;cellular response to mechanical stimulus;nucleus;positive regulation of interferon-beta production;type I interferon-mediated signaling pathway;positive regulation of type I interferon production;I-kappaB kinase/NF-kappaB cascade;transcription from RNA polymerase II promoter;cytosol;cellular response to interleukin-1;CD8-positive, alpha-beta T cell differentiation;positive regulation of interleukin-12 biosynthetic process;positive regulation of transcription, DNA-dependent;regulatory region DNA binding;regulation of CD8-positive, alpha-beta T cell proliferation;transcription, DNA-dependent;response to growth hormone stimulus;DNA binding;sequence-specific DNA binding transcription factor activity;cellular response to tumor necrosis factor;positive regulation of cell death;negative regulation of tyrosine phosphorylation of Stat1 protein;blood coagulation;interferon-gamma-mediated signaling pathway;cell cycle arrest;cytokine-mediated signaling pathway;positive regulation of transcription from RNA polymerase II promoter;regulation of gene expression;regulation of innate immune response;regulation of cell cycle;cellular response to retinoic acid;protein phosphorylation;regulation of MyD88-dependent toll-like receptor signaling pathway;cytoplasm;protein binding;regulation of adaptive immune response;protein acetylation;female pregnancy;response to heat;cellular response to peptide hormone stimulus;negative regulation of regulatory T cell differentiation@: GASTRIC CANCER
D114041@79566@79568@deletion@3@175386532@175388438@5@chr5:175386532-175388438@17.5@182@74@0.407@NA@THOC3-001_4, THOC3-001_5, THOC3-001_6@169@160@182@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
D114041@80019@80019@duplication@1@177163582@177163611@5@chr5:177163582-177163611@7.4@71@134@1.89@NA@FAM153A-204_12@78@78@78@:family with sequence similarity 153, member A@NA@NA
D114041@80022@80024@duplication@3@177166603@177168334@5@chr5:177166603-177168334@8.29@106@180@1.7@NA@FAM153A-204_7, FAM153A-204_8, FAM153A-204_9@94@86@106@:family with sequence similarity 153, member A@NA@NA
D114041@80479@80484@duplication@6@180375357@180420161@5@chr5:180375357-180420161@7.82@664@863@1.3@CNVR2719.1@BTNL8-202_5, BTNL8-202_6, BTNL8-202_7, BTNL8-202_8, BTNL3-202_1, BTNL3-202_2@104.333333333333@93@108@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
D114041@83577@83584@duplication@8@31962024@31964101@6@chr6:31962024-31964101@23.3@421@662@1.57@CNVR2843.6, CNVR2843.3@C4A-001_20, C4A-001_21, C4A-001_22, C4A-001_23, C4A-001_24, C4A-001_25, C4A-001_26, C4A-001_27@13.875@11@17@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
D114041@83601@83604@deletion@4@31973468@31974290@6@chr6:31973468-31974290@13.6@296@170@0.574@CNVR2843.6, CNVR2843.3@CYP21A1P-001_1, CYP21A1P-001_2, CYP21A1P-001_3, AL645922-201_1@97.75@80@107@NA@NA@NA
D114041@83607@83610@duplication@4@31974589@31974877@6@chr6:31974589-31974877@6.78@529@692@1.31@CNVR2843.6, CNVR2843.3@CYP21A1P-001_5, CYP21A1P-001_6, AL645922-201_3, AL645922-201_4@110.75@109@113@NA@NA@NA
D114041@83637@83645@deletion@9@31994762@31997116@6@chr6:31994762-31997116@33.5@425@194@0.456@CNVR2843.6, CNVR2843.5@C4B-001_20, C4B-001_21, C4B-001_22, C4B-001_23, C4B-001_24, C4B-001_25, C4B-001_26, C4B-001_27, C4B-001_28@13.8888888888889@10@19@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
D114041@83661@83662@duplication@2@32006044@32006589@6@chr6:32006044-32006589@5.5@133@197@1.48@CNVR2843.6, CNVR2843.5@CYP21A2-002_1, CYP21A2-002_2@15@12@18@:cytochrome P450, family 21, subfamily A, polypeptide 2@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY
D114041@83911@83913@deletion@3@32485122@32486444@6@chr6:32485122-32486444@12.3@61@4@0.0656@CNVR2845.21, CNVR2845.25, CNVR2845.30@HLA-DRB5-001_4, HLA-DRB5-001_5, HLA-DRB5-001_6@187.333333333333@186@189@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D114041@83915@83915@deletion@1@32489684@32489952@6@chr6:32489684-32489952@15.3@77@5@0.0649@CNVR2845.21, CNVR2845.25, CNVR2845.30, CNVR2845.43@HLA-DRB5-001_2@177@177@177@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D114041@83920@83928@deletion@9@32522469@32548634@6@chr6:32522469-32548634@56.7@415@109@0.263@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.5@HLA-DRB6-002_1, HLA-DRB6-002_2, HLA-DRB6-002_3, AL713966-201_1, AL713966-201_2, AL713966-201_3, HLA-DRB1-001_4, HLA-DRB1-001_5, HLA-DRB1-001_6@117.555555555556@56@167@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
D114041@83934@83934@deletion@1@32609089@32609336@6@chr6:32609089-32609336@29.4@156@12@0.0769@CNVR2845.21, CNVR2845.25, CNVR2845.37, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20@HLA-DQA1-002_3@135@135@135@:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D114041@83936@83937@deletion@2@32610389@32611050@6@chr6:32610389-32611050@49.3@285@35@0.123@CNVR2845.21, CNVR2845.25, CNVR2845.37, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20@HLA-DQA1-002_5, HLA-DQA1-002_6@145.5@145@146@:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D114041@83942@83945@deletion@4@32629126@32632845@6@chr6:32629126-32632845@23.9@348@174@0.5@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20, CNVR2845.31@HLA-DQB1-003_3, HLA-DQB1-003_4, HLA-DQB1-003_5, ENST00000443574_1@113.5@101@128@:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
D114041@84706@84710@duplication@5@35754777@35765089@6@chr6:35754777-35765089@17.9@1189@1591@1.34@CNVR2861.1@C6orf127-001_2, C6orf127-001_3, CLPS-001_1, CLPS-001_2, CLPS-001_3@39@30@43@:colipase-like 1:colipase, pancreatic@:extracellular region;enzyme activator activity;digestion;lipid catabolic process:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
D114041@92589@92594@deletion@6@160132299@160133143@6@chr6:160132299-160133143@139@773@80@0.103@CNVR3127.2, CNVR3127.1@ENST00000442642_3, ENST00000442642_4, ENST00000442642_5, ENST00000442642_6, ENST00000442642_7, ENST00000442642_8@95.6666666666667@56@112@:superoxide dismutase 2, mitochondrial;uncharacterized LOC100129518@:response to reactive oxygen species;oxidation-reduction process;mitochondrion;negative regulation of cell proliferation;neuron development;negative regulation of fat cell differentiation;removal of superoxide radicals;response to gamma radiation;response to L-ascorbic acid;response to lipopolysaccharide;response to nutrient levels;response to zinc ion;protein homotetramerization;post-embryonic development;iron ion homeostasis;hemopoiesis;aging;mitochondrial inner membrane;age-dependent response to reactive oxygen species;response to drug;oxygen binding;mitochondrial nucleoid;vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure;apoptotic process;superoxide metabolic process;response to superoxide;detection of oxygen;response to silicon dioxide;cytoplasm;response to stress;respiratory electron transport chain;superoxide anion generation;protein homooligomerization;regulation of mitochondrial membrane potential;positive regulation of nitric oxide biosynthetic process;response to manganese ion;regulation of blood pressure;metal ion binding;negative regulation of apoptotic process;response to cadmium ion;response to oxidative stress;liver development;regulation of catalytic activity;negative regulation of fibroblast proliferation;response to selenium ion;age-dependent response to oxidative stress;response to electrical stimulus;mitochondrial matrix;identical protein binding;mitochondrion organization;response to hyperoxia;vasodilation;response to hydrogen peroxide;superoxide dismutase activity;heart development;negative regulation of neuron apoptotic process;erythrophore differentiation;locomotory behavior;DNA binding;release of cytochrome c from mitochondria;response to axon injury;oxygen homeostasis;response to activity;glutathione metabolic process;hydrogen peroxide metabolic process;hydrogen peroxide biosynthetic process;regulation of transcription from RNA polymerase II promoter;response to hypoxia;protein binding;manganese ion binding;cellular response to ethanol@: MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6; MVCD6
D114041@93099@93101@deletion@3@167790036@167794825@6@chr6:167790036-167794825@6.54@250@168@0.672@NA@TCP10-001_3, TCP10-001_4, TCP10-001_5@77@52@103@:t-complex 10@:cytosol@NA
D114041@94194@94201@duplication@8@5965779@5983622@7@chr7:5965779-5983622@17.6@890@1221@1.37@NA@RSPH10B-002_14, RSPH10B-002_15, RSPH10B-002_16, RSPH10B-002_17, RSPH10B-002_18, RSPH10B-002_19, RSPH10B-002_20, RSPH10B-002_21@13.75@10@18@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D114041@94208@94208@deletion@1@5998626@5998710@7@chr7:5998626-5998710@13.4@260@134@0.515@NA@RSPH10B-002_7@11@11@11@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D114041@94412@94415@deletion@4@6786669@6791233@7@chr7:6786669-6791233@14.7@182@82@0.451@NA@ENST00000338780_12, ENST00000338780_13, PMS2CL-002_12, PMS2CL-002_13@81.5@73@90@NA@NA@NA
D114041@94421@94423@deletion@3@6798717@6803733@7@chr7:6798717-6803733@12.8@87@20@0.23@NA@RSPH10B2-204_4, RSPH10B2-204_5, RSPH10B2-204_6@7@6@8@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D114041@94430@94432@deletion@3@6819243@6821108@7@chr7:6819243-6821108@27.4@335@141@0.421@NA@RSPH10B2-204_13, RSPH10B2-204_14, RSPH10B2-204_15@17@16@19@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D114041@94438@94444@deletion@7@6836201@6844687@7@chr7:6836201-6844687@65.9@467@120@0.257@NA@RSPH10B2-204_20, RSPH10B2-204_21, ENST00000429267_1, C7orf28B-001_12, C7orf28B-001_13, C7orf28B-001_14, C7orf28B-001_15@90.8571428571429@25@121@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D114041@96205@96205@deletion@1@33195252@33195315@7@chr7:33195252-33195315@5.64@93@48@0.516@NA@BBS9-203_4@10@10@10@:Bardet-Biedl syndrome 9@:BBSome;fat cell differentiation;microtubule organizing center;cytoplasm;protein binding;response to stimulus;visual perception;nucleus;plasma membrane;molecular_function;cilium membrane@: WILMS TUMOR 5; WT5; BARDET-BIEDL SYNDROME; BBS
D114041@96579@96584@deletion@6@38388958@38398764@7@chr7:38388958-38398764@173@1754@660@0.376@CNVR3354.3, CNVR3354.1@TRGV5-001_1, TRGV5-001_2, TRGV4-001_1, TRGV4-001_2, TRGV3-001_1, TRGV3-001_2@10.5@6@14@@:protein binding:protein binding:protein binding;immune response;peptide antigen binding;plasma membrane;MHC protein binding@NA
D114041@97907@97915@deletion@9@57063663@57076857@7@chr7:57063663-57076857@11.9@125@52@0.416@NA@TNRC18C-202_3, TNRC18C-202_4, TNRC18C-202_5, TNRC18C-202_6, TNRC18C-202_7, TNRC18C-202_8, TNRC18C-202_9, TNRC18C-202_10, TNRC18C-202_11@157.555555555556@139@166@NA@NA@NA
D114041@97990@97994@deletion@5@62753052@62758771@7@chr7:62753052-62758771@175@838@1@0.00119@NA@AC006455-201_2, AC006455-201_3, AC006455-201_4, ENST00000444809_2, ENST00000444809_3, ENST00000444809_4@137@97@171@NA@NA@NA
D114041@98015@98018@duplication@4@62910199@62917064@7@chr7:62910199-62917064@40.8@656@1137@1.73@NA@ZNF734-201_2, ZNF734-201_3, ZNF734-201_4, ZNF734-201_5@95.5@80@102@NA@NA@NA
D114041@98192@98195@deletion@4@64646770@64661024@7@chr7:64646770-64661024@10.3@182@98@0.538@NA@INTS4L1-201_8, INTS4L1-201_9, INTS4L1-201_10, INTS4L1-201_11@29@5@52@NA@NA@NA
D114041@98213@98219@duplication@7@65139336@65160139@7@chr7:65139336-65160139@13.5@272@415@1.53@NA@INTS4L2-001_3, INTS4L2-001_4, INTS4L2-001_5, INTS4L2-001_6, INTS4L2-001_7, INTS4L2-001_8, INTS4L2-001_9@13.4285714285714@0@56@NA@NA@NA
D114041@98688@98688@duplication@1@72613728@72613825@7@chr7:72613728-72613825@7.99@25@79@3.16@NA@RP11-396K3-001_18@1@1@1@NA@NA@NA
D114041@99063@99063@deletion@1@74251404@74251506@7@chr7:74251404-74251506@6.68@30@0@0@NA@GTF2IRD2-002_2@8@8@8@:GTF2I repeat domain containing 2@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
D114041@99233@99233@deletion@1@74991244@74991359@7@chr7:74991244-74991359@7.23@34@1@0.0294@CNVR3456.1@STAG3L1-004_3@60@60@60@NA@NA@NA
D114041@99454@99454@deletion@1@76063357@76063473@7@chr7:76063357-76063473@20.5@118@15@0.127@CNVR3462.1@ZP3-002_6@10@10@10@:zona pellucida glycoprotein 3 (sperm receptor)@:negative regulation of transcription, DNA-dependent;manganese ion transmembrane transporter activity;intracellular protein transport;proteinaceous extracellular matrix;plasma membrane;positive regulation of acrosome reaction;outer acrosomal membrane;protein kinase C signaling cascade;manganese ion transmembrane transport;intracellular signal transduction;humoral immune response mediated by circulating immunoglobulin;negative regulation of binding of sperm to zona pellucida;positive regulation of inflammatory response;endoplasmic reticulum;signal transducer activity;perinuclear region of cytoplasm;secretory granule;positive regulation of transcription, DNA-dependent;positive regulation of ovarian follicle development;positive regulation of interferon-gamma production;carbohydrate binding;manganese ion transport;positive regulation of antral ovarian follicle growth;extracellular matrix;positive regulation of leukocyte migration;positive regulation of humoral immune response;extracellular space;blastocyst formation;integral to membrane;store-operated calcium channel activity;oocyte development;multivesicular body;phosphatidylinositol-mediated signaling;acrosomal vesicle;positive regulation of protein kinase B signaling cascade;Golgi apparatus;positive regulation of calcium ion import;positive regulation of protein kinase activity;positive regulation of acrosomal vesicle exocytosis;positive regulation of interleukin-4 production;cytoplasm;protein binding;binding of sperm to zona pellucida;positive regulation of phosphatidylinositol biosynthetic process;extracellular region;positive regulation of T cell proliferation;acrosin binding;positive regulation of type IV hypersensitivity;egg coat formation@NA
D114041@99463@99465@deletion@3@76121472@76129838@7@chr7:76121472-76129838@5.86@96@51@0.531@CNVR3462.1@DTX2-001_6, DTX2-001_7, DTX2-001_8@51.3333333333333@22@69@:deltex homolog 2 (Drosophila)@:ligase activity;cytoplasm;nuclear membrane;Notch signaling pathway;protein binding;nucleus;zinc ion binding;protein ubiquitination@NA
D114041@99489@99490@deletion@2@76240773@76241131@7@chr7:76240773-76241131@44.7@320@73@0.228@CNVR3463.10@POMZP3-003_6, POMZP3-003_7@43.5@41@46@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
D114041@101967@101969@deletion@3@100932972@100944552@7@chr7:100932972-100944552@6.05@73@33@0.452@NA@RP11-132A1-001_1, ENST00000429254_1, ENST00000429254_2@0.666666666666667@0@2@NA@NA@NA
D114041@102116@102116@deletion@1@102114810@102114983@7@chr7:102114810-102114983@5.14@27@3@0.111@CNVR3518.1@POLR2J-001_3@91@91@91@:polymerase (RNA) II (DNA directed) polypeptide J, 13.3kDa@:nucleoplasm;DNA binding;DNA repair;protein dimerization activity;nucleus;viral reproduction;gene expression;transcription initiation from RNA polymerase II promoter;7-methylguanosine mRNA capping;protein phosphorylation;LRR domain binding;protein kinase activity;DNA-directed RNA polymerase II, core complex;nucleotide-excision repair;transcription from RNA polymerase II promoter;DNA-directed RNA polymerase activity;protein binding;transcription-coupled nucleotide-excision repair;RNA splicing;mRNA splicing, via spliceosome;transcription, DNA-dependent;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription@NA
D114041@102130@102132@deletion@3@102136589@102137412@7@chr7:102136589-102137412@12@194@95@0.49@CNVR3518.1@RASA4B-007_14, RASA4B-007_15, RASA4B-007_16@58.3333333333333@49@67@:RAS p21 protein activator 4B@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction@NA
D114041@102166@102167@deletion@2@102219874@102223340@7@chr7:102219874-102223340@10.1@48@2@0.0417@CNVR3518.1@ENST00000379336_1, RASA4-001_21@56@49@63@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
D114041@105322@105338@duplication@17@141766375@141786518@7@chr7:141766375-141786518@22.3@2905@3707@1.28@CNVR3585.3, CNVR3585.2@MGAM-007_41, MGAM-007_42, MGAM-007_43, MGAM-007_44, MGAM-007_45, MGAM-007_46, MGAM-007_47, MGAM-007_48, MGAM-007_49, MGAM-007_50, MGAM-007_51, MGAM-007_52, MGAM-007_53, MGAM-007_54, MGAM-007_55, MGAM-007_56, MGAM-007_57@121.882352941176@108@134@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
D114041@105785@105785@deletion@1@143969540@143969609@7@chr7:143969540-143969609@13.4@238@119@0.5@CNVR3598.4, CNVR3598.9@RP4-798C17-001_12@37@37@37@:Rho guanine nucleotide exchange factor (GEF) 35@NA@NA
D114041@105792@105795@duplication@4@143973974@143974431@7@chr7:143973974-143974431@5.63@38@80@2.11@CNVR3598.4, CNVR3598.9@RP4-798C17-001_7, RP4-798C17-001_8, ENST00000378112_8, ENST00000378112_9@97@57@137@:Rho guanine nucleotide exchange factor (GEF) 35@NA@NA
D114041@105798@105799@deletion@2@143975408@143975569@7@chr7:143975408-143975569@6.59@30@0@0@CNVR3598.4, CNVR3598.9@RP4-798C17-001_5, ENST00000378112_6@135@135@135@:Rho guanine nucleotide exchange factor (GEF) 35@NA@NA
D114041@105819@105828@deletion@10@144059753@144071983@7@chr7:144059753-144071983@46.5@899@487@0.542@CNVR3598.4, CNVR3598.5, CNVR3598.11@ARHGEF5-001_2, ARHGEF5-001_3, ARHGEF5-001_4, ARHGEF5-001_5, ARHGEF5-001_6, ARHGEF5-001_7, ARHGEF5-001_8, ARHGEF5-001_9, ARHGEF5-001_10, ARHGEF5-001_11@75.4@48@104@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
D114041@107424@107434@deletion@11@7272384@7340275@8@chr8:7272384-7340275@28.5@815@482@0.591@CNVR3771.8, CNVR3771.10, CNVR3771.4@DEFB4P-001_1, DEFB4P-001_2, DEFB103A-001_1, DEFB103A-001_2, SPAG11-003_1, SPAG11-003_2, SPAG11-003_3, SPAG11-003_4, DEFB104B-001_1, DEFB104B-001_2, DEFB106B-001_2@42.2727272727273@7@91@:defensin, beta 4B;defensin, beta 4A:defensin, beta 103B;defensin, beta 103A:sperm associated antigen 11B:defensin, beta 104A;defensin, beta 104B:defensin, beta 106B;defensin, beta 106A@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
D114041@107512@107513@deletion@2@7717871@7718505@8@chr8:7717871-7718505@10.2@301@181@0.601@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@SPAG11A-207_3, SPAG11A-207_4@112@111@113@:sperm associated antigen 11A;sperm associated antigen 11B@:extracellular region;defense response@NA
D114041@109572@109585@duplication@14@39311571@39349528@8@chr8:39311571-39349528@40.1@495@855@1.73@CNVR3859.1@ADAM3A-005_11, ADAM3A-005_12, ADAM3A-005_13, ADAM3A-005_14, ADAM3A-005_15, ADAM3A-005_16, ADAM3A-005_17, ADAM3A-005_18, ADAM3A-005_19, ADAM3A-005_20, ADAM3A-005_21, ADAM3A-009_7, ADAM3A-009_8, ADAM3A-009_9@120.5@98@136@NA@NA@NA
D114041@114387@114387@duplication@1@145438828@145438925@8@chr8:145438828-145438925@8.07@5@54@10.8@NA@C8orf30B-201_3@106@106@106@:family with sequence similarity 203, member B@:binding@NA
D114041@118852@118854@deletion@3@84545017@84549914@9@chr9:84545017-84549914@28.2@501@230@0.459@CNVR4364.1@ENST00000427387_1, RP11-383M4-201_3, RP11-383M4-201_4@16.3333333333333@11@27@NA@NA@NA
D114041@121602@121603@deletion@2@117086300@117087178@9@chr9:117086300-117087178@4.94@528@370@0.701@CNVR4448.1@ORM1-001_3, ORM1-001_4@89.5@89@90@:orosomucoid 1@:protein binding;extracellular space;regulation of immune system process;transport;inflammatory response;extracellular region;acute-phase response@NA
D114041@124047@124052@duplication@6@135957928@135960431@9@chr9:135957928-135960431@22.5@117@276@2.36@NA@CELP-002_1, CELP-002_2, CELP-002_3, AL162417-201_1, AL162417-201_2, AL162417-201_3@84.3333333333333@66@99@NA@NA@NA
D114041@124517@124517@duplication@1@138441156@138441178@9@chr9:138441156-138441178@6.27@98@161@1.64@CNVR4529.1@OBP2A-001_6@18@18@18@:odorant binding protein 2A@:odorant binding;sensory perception of chemical stimulus;response to stimulus;transport;extracellular region;sensory perception of smell;cellular_component@NA
D114041@124532@124533@deletion@2@138479850@138480579@9@chr9:138479850-138480579@4.95@76@39@0.513@NA@RP11-98L5-001_1, RP11-98L5-001_2@1@0@2@NA@NA@NA
D114041@125889@125889@deletion@1@5202081@5202136@10@chr10:5202081-5202136@4.64@21@0@0@NA@AKR1CL1-202_5@4@4@4@:aldo-keto reductase family 1, member C-like 1@:oxidoreductase activity;cytoplasm@NA
D114041@126269@126269@duplication@1@9449789@9449825@10@chr10:9449789-9449825@7.36@46@102@2.22@NA@AL355591-202_3@0@0@0@NA@NA@NA
D114041@126909@126913@deletion@5@17840632@17875839@10@chr10:17840632-17875839@31.5@320@131@0.409@NA@FAM23A-201_5, MRC1L1-001_1, MRC1L1-001_2, MRC1L1-001_3, MRC1L1-001_4@32.6@11@108@:transmembrane protein 236;transmembrane protein 236-like:macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding@NA
D114041@126946@126948@duplication@3@18112046@18122793@10@chr10:18112046-18122793@23.5@220@430@1.95@NA@MRC1-001_2, MRC1-001_3, MRC1-001_4@30.3333333333333@26@34@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D114041@126951@126956@deletion@6@18138510@18152612@10@chr10:18138510-18152612@28@137@6@0.0438@NA@MRC1-001_7, MRC1-001_8, MRC1-001_9, MRC1-001_10, MRC1-001_11, RP11-457D2-001_2@19.6666666666667@18@26@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D114041@128372@128372@deletion@1@42924566@42924600@10@chr10:42924566-42924600@13.4@124@42@0.339@NA@CCNYL2-201_7@0@0@0@@:regulation of cyclin-dependent protein kinase activity;protein kinase binding@NA
D114041@128828@128829@duplication@2@46927785@46934899@10@chr10:46927785-46934899@6.47@94@154@1.64@CNVR4712.9, CNVR4712.2, CNVR4712.7@FAM35B-001_6, FAM35B-001_7@53@34@72@NA@NA@NA
D114041@128901@128913@deletion@13@47259622@47410082@10@chr10:47259622-47410082@12.5@286@164@0.573@CNVR4712.9, CNVR4712.1@GLUDP8-001_3, CTSLL7-001_1, CTSLL7-001_2, CTSLL7-001_3, ENST00000439776_1, ENST00000439776_2, ENST00000439776_3, FAM35B2-201_1, FAM35B2-201_2, FAM35B2-201_3, FAM35B2-201_4, FAM35B2-201_5, FAM35B2-201_6@26.7692307692308@16@47@NA@NA@NA
D114041@128979@128979@deletion@1@47758848@47758905@10@chr10:47758848-47758905@7.3@33@0@0@CNVR4714.1@ANXA8L2-001_10@154@154@154@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:calcium-dependent phospholipid binding;calcium ion binding@NA
D114041@129021@129028@duplication@8@48020452@48049022@10@chr10:48020452-48049022@11.8@446@618@1.39@CNVR4715.2@ASAH2C-201_3, ASAH2C-201_4, ASAH2C-201_5, ASAH2C-201_6, ASAH2C-201_7, ASAH2C-201_8, ASAH2C-201_9, ASAH2C-201_10@67.875@57@90@@:ceramidase activity;sphingolipid metabolic process@NA
D114041@129460@129477@deletion@18@51361725@51391568@10@chr10:51361725-51391568@103@491@12@0.0244@NA@ENST00000404618_1, ENST00000404618_2, ENST00000404618_3, ENST00000404618_4, ENST00000432221_1, ENST00000432221_2, ENST00000432221_3, ENST00000432221_4, TIMM23B-202_1, TIMM23B-202_2, TIMM23B-202_3, TIMM23B-202_4, TIMM23B-202_5, TIMM23B-202_6, TIMM23B-202_7, TIMM23B-202_8, TIMM23B-202_9, TIMM23B-202_10@68.7222222222222@0@142@:translocase of inner mitochondrial membrane 23 homolog B (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process@NA
D114041@129509@129511@duplication@3@51603186@51603447@10@chr10:51603186-51603447@9.12@84@158@1.88@NA@TIMM23-202_8, TIMM23-202_9, TIMM23-202_10@0@0@0@:translocase of inner mitochondrial membrane 23 homolog B (yeast):translocase of inner mitochondrial membrane 23 homolog B (yeast);translocase of inner mitochondrial membrane 23 homolog (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:mitochondrion;mitochondrial inner membrane;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;mitochondrial intermembrane space;integral to mitochondrial inner membrane;intracellular protein transport;protein binding;integral to membrane;cellular protein metabolic process;protein targeting to mitochondrion@NA
D114041@129604@129611@deletion@8@51965744@51994313@10@chr10:51965744-51994313@27.4@247@88@0.356@NA@ASAH2-201_5, ASAH2-201_6, ASAH2-201_7, ASAH2-201_8, ASAH2-201_9, ASAH2-201_10, ASAH2-201_11, ASAH2-201_12@147.125@53@186@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
D114041@131595@131601@deletion@7@81462985@81472508@10@chr10:81462985-81472508@8.76@52@9@0.173@CNVR4815.2, CNVR4815.4@FAM22B-201_1, FAM22B-201_2, FAM22B-201_3, FAM22B-201_4, FAM22B-201_5, FAM22B-201_6, FAM22B-201_7@87.2857142857143@84@90@NA@NA@NA
D114041@137792@137794@deletion@3@3239564@3244362@11@chr11:3239564-3244362@23@521@279@0.536@CNVR5028.1@C11orf36-202_1, C11orf36-202_2, C11orf36-202_3@13@13@13@:MAS-related GPR, member G@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway@NA
D114041@145944@145953@duplication@10@89701674@89715285@11@chr11:89701674-89715285@9.44@31@93@3@NA@TRIM64-202_1, TRIM64-202_2, TRIM64-202_3, TRIM64-202_4, TRIM64-202_5, TRIM64-202_6, TRIM64-202_7, TRIM64-202_8, TRIM64-202_9, ENST00000442514_9@171.8@154@177@NA@NA@NA
D114041@150829@150841@deletion@13@9684189@9707352@12@chr12:9684189-9707352@168@847@51@0.0602@CNVR5429.1@AC006432-201_1, AC006432-201_2, AC006432-201_3, AC006432-201_4, AC006432-201_5, AC006432-201_6, AC006432-201_7, AC006432-201_8, AC006432-201_9, AC006432-201_10, AC006432-201_11, AC006432-201_12, AC006432-201_13@22.2307692307692@15@25@NA@NA@NA
D114041@151048@151052@deletion@5@11506043@11544583@12@chr12:11506043-11544583@52.2@819@384@0.469@CNVR5435.2, CNVR5435.1@PRB1-201_1, PRB1-201_2, PRB1-201_3, PRB1-201_4, PRB2-001_4@44@35@49@:proline-rich protein BstNI subfamily 1:proline-rich protein BstNI subfamily 2@:extracellular region;molecular_function;cellular_component;biological_process@NA
D114041@154075@154077@deletion@3@52865852@52867522@12@chr12:52865852-52867522@25.8@216@66@0.306@NA@KRT6C-202_1, KRT6C-202_2, KRT6C-202_3@27.3333333333333@10@45@:keratin 6C@:intermediate filament;structural molecule activity;keratin filament;cytoskeleton organization@NA
D114041@162314@162316@deletion@3@25528913@25535993@13@chr13:25528913-25535993@10.3@145@70@0.483@NA@TPTE2P1-001_3, TPTE2P1-001_4, TPTE2P1-001_5@0.666666666666667@0@2@NA@NA@NA
D114041@164539@164543@deletion@5@53103402@53106857@13@chr13:53103402-53106857@30.5@139@0@0@NA@RP11-78J21-201_12, RP11-78J21-201_13, RP11-78J21-201_14, RP11-78J21-201_15, RP11-78J21-201_16@113.8@107@117@NA@NA@NA
D114041@166922@166924@duplication@3@21359843@21388336@14@chr14:21359843-21388336@31@1395@2035@1.46@CNVR6076.1@RNASE3-001_2, AL355922-201_1, AL355922-201_2@1@1@1@:ribonuclease, RNase A family, 3@:ribonuclease activity;extracellular region;defense response to bacterium;pancreatic ribonuclease activity;RNA catabolic process;nucleic acid binding@NA
D114041@170809@170812@duplication@4@74003820@74025652@14@chr14:74003820-74025652@33.8@403@738@1.83@CNVR6188.1, CNVR6188.4@HEATR4-201_1, ACOT1-201_1, ACOT1-201_2, ACOT1-201_3@87@19@116@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
D114041@173412@173413@deletion@2@106090689@106091563@14@chr14:106090689-106091563@6.21@331@222@0.671@CNVR6294.46, CNVR6294.20, CNVR6294.54, CNVR6294.43, CNVR6294.50, CNVR6294.61@IGHG4-001_3, IGHG4-001_4@6@6@6@@:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response@NA
D114041@173556@173559@duplication@4@106787370@106791537@14@chr14:106787370-106791537@19.2@758@1121@1.48@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-29-001_1, IGHV3-29-001_2, IGHV3-30-001_1, IGHV3-30-001_2@15.25@13@19@@:protein binding@NA
D114041@173562@173568@deletion@7@106805211@106825338@14@chr14:106805211-106825338@40@787@402@0.511@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.41, CNVR6294.56, CNVR6294.51@IGHV4-31-001_1, IGHV4-31-001_2, IGHV3-32-001_1, IGHV3-32-001_2, IGHV3-33-001_1, IGHV3-33-001_2, IGHV3-33-2-001_2@12.8571428571429@2@18@@:protein binding:protein binding@NA
D114041@173586@173589@duplication@4@106866408@106878127@14@chr14:106866408-106878127@32.2@1236@1789@1.45@CNVR6294.38, CNVR6294.26, CNVR6294.56, CNVR6294.51, CNVR6294.2, CNVR6294.44@IGHV3-38-001_1, IGHV3-38-001_2, IGHV4-39-001_1, IGHV4-39-001_2@5.75@4@7@@:protein binding:protein binding@NA
D114041@173592@173595@duplication@4@106926190@106934400@14@chr14:106926190-106934400@47.2@984@1627@1.65@CNVR6294.56, CNVR6294.1@IGHV3-43-001_1, IGHV3-43-001_2, IGHVIII-44-001_1, IGHVIII-44-001_2@11.5@11@12@@:protein binding@NA
D114041@173645@173645@deletion@1@107131035@107131335@14@chr14:107131035-107131335@8.35@281@170@0.605@CNVR6294.56, CNVR6294.16@IGHV3-66-001_2@3@3@3@@:protein binding@NA
D114041@173697@173698@deletion@2@20588370@20588710@15@chr15:20588370-20588710@15.6@692@438@0.633@CNVR6295.15, CNVR6295.7, CNVR6295.3, CNVR6295.10, CNVR6295.5@HERC2P3-014_27, AC026495-201_26@70@63@77@NA@NA@NA
D114041@173814@173822@duplication@9@22297500@22473354@15@chr15:22297500-22473354@39.9@2685@3650@1.36@CNVR6297.4, CNVR6297.17, CNVR6297.6@AC134980-201_1, AC134980-201_2, ENST00000438898_1, ENST00000438898_2, AC025884-201_1, AC010760-202_2, VSIG6-201_1, VSIG6-201_2@60.25@15@87@:olfactory receptor, family 4, subfamily M, member 2:olfactory receptor, family 4, subfamily N, member 4@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
D114041@173932@173932@deletion@1@23191836@23191921@15@chr15:23191836-23191921@5.28@124@71@0.573@NA@WHAMML1-202_9@7@7@7@NA@NA@NA
D114041@174406@174410@deletion@5@29008591@29009297@15@chr15:29008591-29009297@42.6@737@377@0.512@NA@ENST00000456510_1, ENST00000456510_2, ENST00000456510_3, ENST00000456510_4, ENST00000456510_5@23.6@18@26@NA@NA@NA
D114041@174552@174559@deletion@8@30918405@30936906@15@chr15:30918405-30936906@73.3@1476@775@0.525@CNVR6339.3, CNVR6339.4@ARHGAP11B-201_1, ARHGAP11B-201_2, ARHGAP11B-201_3, ARHGAP11B-201_4, ARHGAP11B-201_5, ARHGAP11B-201_6, ARHGAP11B-201_7, ARHGAP11B-201_8@8.125@7@9@:Rho GTPase activating protein 11B;OTU domain containing 7A pseudogene@:cytosol;signal transduction;intracellular;small GTPase mediated signal transduction;GTPase activator activity;regulation of small GTPase mediated signal transduction@NA
D114041@174658@174659@deletion@2@32446110@32449977@15@chr15:32446110-32449977@15.3@74@3@0.0405@CNVR6345.2, CNVR6345.1@CHRNA7-205_5, CHRNA7-205_6@33.5@1@66@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
D114041@174941@174942@duplication@2@34671271@34674058@15@chr15:34671271-34674058@5.57@42@84@2@CNVR6351.4, CNVR6351.3@GOLGA8A-201_22, GOLGA8A-201_23@0.5@0@1@:golgin A8 family, member A@:Golgi cisterna membrane;Golgi apparatus@NA
D114041@176366@176368@deletion@3@43900063@43901533@15@chr15:43900063-43901533@26.1@401@194@0.484@CNVR6365.1@STRC-001_16, STRC-001_17, STRC-001_18@16.3333333333333@15@18@:diphosphoinositol pentakisphosphate kinase 1:stereocilin@:inositol hexakisphosphate 3-kinase activity;inositol hexakisphosphate 1-kinase activity;inositol metabolic process;diphosphoinositol-pentakisphosphate kinase activity;ATP binding;acid phosphatase activity;cytoplasm;cytosol;inositol hexakisphosphate 5-kinase activity;nucleus;kinase activity;inositol-1,3,4,5,6-pentakisphosphate kinase activity:detection of mechanical stimulus involved in sensory perception of sound;stereocilium bundle tip;stereocilium;cell surface;kinocilium;auditory receptor cell stereocilium organization@: DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16; DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY
D114041@176428@176430@duplication@3@43999537@44001005@15@chr15:43999537-44001005@15.8@408@608@1.49@NA@AC011330-201_16, AC011330-201_17, AC011330-201_18@16@15@18@:stereocilin@:detection of mechanical stimulus involved in sensory perception of sound;stereocilium bundle tip;stereocilium;cell surface;kinocilium;auditory receptor cell stereocilium organization@: DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16; DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY
D114041@179450@179455@duplication@6@74362200@74365159@15@chr15:74362200-74365159@12.3@110@207@1.88@CNVR6448.1@ENST00000290438_13, ENST00000290438_14, ENST00000290438_15, ENST00000290438_16, ENST00000290438_17, ENST00000290438_18@26.8333333333333@20@51@:golgin A6 family, member C;golgin A6 family, member A;golgin A6 family, member D;golgin A6 family, member B@:Golgi apparatus@NA
D114041@180187@180187@deletion@1@79065427@79065546@15@chr15:79065427-79065546@8.98@46@4@0.087@NA@ADAMTS7-201_14@10@10@10@:A disintegrin and metalloproteinase with thrombospondin motifs 7-like;ADAM metallopeptidase with thrombospondin type 1 motif, 7@:metallopeptidase activity;extracellular matrix;proteolysis;peptidase activity;proteinaceous extracellular matrix;metalloendopeptidase activity;cell surface;zinc ion binding@NA
D114041@183359@183359@deletion@1@2607706@2607965@16@chr16:2607706-2607965@8.38@263@157@0.597@CNVR6601.1@PDPK1-003_2@3@3@3@:3-phosphoinositide dependent protein kinase-1@:3-phosphoinositide-dependent protein kinase activity;nucleoplasm;fibroblast growth factor receptor signaling pathway;protein tyrosine kinase activity;negative regulation of transforming growth factor beta receptor signaling pathway;negative regulation of toll-like receptor signaling pathway;regulation of endothelial cell migration;focal adhesion assembly;ATP binding;insulin receptor signaling pathway;plasma membrane;intracellular signal transduction;positive regulation of establishment of protein localization to plasma membrane;platelet activation;protein kinase activity;regulation of mast cell degranulation;cytosol;epidermal growth factor receptor signaling pathway;hyperosmotic response;nerve growth factor receptor signaling pathway;type B pancreatic cell development;synaptic transmission;regulation of apoptotic process;transcription, DNA-dependent;protein autophosphorylation;regulation of I-kappaB kinase/NF-kappaB cascade;protein kinase binding;T cell costimulation;insulin receptor binding;transferase activity, transferring phosphorus-containing groups;actin cytoskeleton organization;blood coagulation;negative regulation of protein kinase activity;cellular response to insulin stimulus;focal adhesion;phosphatidylinositol-mediated signaling;negative regulation of cardiac muscle cell apoptotic process;protein serine/threonine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;cytoplasm;activation of protein kinase B activity;protein binding;T cell receptor signaling pathway;cytoplasmic membrane-bounded vesicle;peptidyl-threonine phosphorylation;kinase activity@NA
D114041@183378@183384@duplication@7@2672693@2693298@16@chr16:2672693-2693298@18.9@218@391@1.79@CNVR6602.2@AC141586-001_4, AC141586-201_1, AC141586-201_2, AC141586-201_3, AC141586-201_4, AC141586-201_5, AC141586-201_6@34.4285714285714@19@57@NA@NA@NA
D114041@185592@185593@duplication@2@21763692@21764446@16@chr16:21763692-21764446@11@108@202@1.87@CNVR6668.5, CNVR6668.2, CNVR6668.7@OTOA-001_25, OTOA-001_26@61.5@61@62@:otoancorin@:proteinaceous extracellular matrix;apical plasma membrane;sensory perception of sound;anchored to membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22
D114041@186368@186369@deletion@2@28711499@28712933@16@chr16:28711499-28712933@16.9@78@1@0.0128@CNVR6686.3, CNVR6686.1, CNVR6686.2@AC145285-201_1, AC145285-201_2@60@59@61@:eukaryotic translation initiation factor 3, subunit C@:cytosol;protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;cellular protein metabolic process;binding;gene expression;translation;translation initiation factor activity@NA
D114041@186379@186379@deletion@1@28734771@28734873@16@chr16:28734771-28734873@14.3@302@159@0.526@CNVR6686.3, CNVR6686.2@EIF3S8-202_10@4@4@4@:eukaryotic translation initiation factor 3, subunit C@:cytosol;protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;cellular protein metabolic process;binding;gene expression;translation;translation initiation factor activity@NA
D114041@186543@186545@duplication@3@29097537@29102160@16@chr16:29097537-29102160@7.96@206@306@1.49@NA@RRN3P2-201_7, RRN3P2-201_8, RRN3P2-201_9@4.66666666666667@4@5@NA@NA@NA
D114041@186582@186586@duplication@5@29468955@29469541@16@chr16:29468955-29469541@10.3@97@180@1.86@CNVR6690.2, CNVR6690.3, CNVR6690.4@GIYD1-001_4, GIYD1-001_5, GIYD1-001_6, SULT1A4-201_2, SULT1A4-201_3@10.4@2@13@:structure-specific endonuclease subunit SLX1-like;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae);SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae):sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3;sulfotransferase 1A3/1A4-like@:Slx1-Slx4 complex;5'-flap endonuclease activity;DNA repair;protein binding;DNA double-strand break processing involved in repair via single-strand annealing;double-strand break repair via homologous recombination;metal ion binding;crossover junction endodeoxyribonuclease activity:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;cytoplasm;catecholamine metabolic process;cytosol;endoplasmic reticulum unfolded protein response;xenobiotic metabolic process;sulfotransferase activity;activation of signaling protein activity involved in unfolded protein response;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process@NA
D114041@186862@186865@deletion@4@30208297@30208883@16@chr16:30208297-30208883@14.1@64@0@0@CNVR6694.1, CNVR6694.2, CNVR6694.3@GIYD2-001_4, GIYD2-001_5, GIYD2-001_6, SULT1A3-001_2@4.75@0@7@:structure-specific endonuclease subunit SLX1-like;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae);SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae):sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3;sulfotransferase 1A3/1A4-like@:Slx1-Slx4 complex;5'-flap endonuclease activity;DNA repair;protein binding;DNA double-strand break processing involved in repair via single-strand annealing;double-strand break repair via homologous recombination;metal ion binding;crossover junction endodeoxyribonuclease activity:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;cytoplasm;catecholamine metabolic process;cytosol;endoplasmic reticulum unfolded protein response;xenobiotic metabolic process;sulfotransferase activity;activation of signaling protein activity involved in unfolded protein response;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process@NA
D114041@188231@188231@deletion@1@55803876@55804008@16@chr16:55803876-55804008@5.15@24@1@0.0417@CNVR6730.1@CES4-202_4@123@123@123@NA@NA@NA
D114041@188261@188261@duplication@1@55866918@55867076@16@chr16:55866918-55867076@4.73@101@154@1.52@NA@CES1-203_1@10@10@10@:carboxylesterase 1;liver carboxylesterase 1-like@:hydrolase activity;methyl salicylate esterase activity;response to toxin;methylumbelliferyl-acetate deacetylase activity;endoplasmic reticulum lumen;retinyl-palmitate esterase activity;methyl jasmonate esterase activity;metabolic process;carboxylesterase activity;methyl indole-3-acetate esterase activity@: CARBOXYLESTERASE 1; CES1
D114041@189930@189930@deletion@1@70010214@70010636@16@chr16:70010214-70010636@17.1@78@0@0@CNVR6762.3, CNVR6762.2@AC026468-201_8@10@10@10@NA@NA@NA
D114041@189959@189969@deletion@11@70162689@70178437@16@chr16:70162689-70178437@68.7@3276@2091@0.638@CNVR6764.1, CNVR6764.3@AC009060-202_5, AC009060-202_6, AC009060-202_7, AC009060-202_8, AC009060-202_9, AC009060-202_10, AC009060-202_11, AC009060-202_12, AC009060-202_13, AC009060-202_14, AC009060-202_15@72@61@77@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
D114041@189972@189973@deletion@2@70187296@70195206@16@chr16:70187296-70195206@22.9@1667@1078@0.647@CNVR6764.1, CNVR6764.3@AC009060-202_18, AC009060-202_19, AC009060-201_3, AC009060-201_4, AC009060-201_5@70@69@71@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
D114041@189989@189989@deletion@1@70219790@70219880@16@chr16:70219790-70219880@10.5@76@19@0.25@CNVR6764.1, CNVR6764.5@CLEC18C-201_11@19@19@19@:C-type lectin domain family 18, member C@:carbohydrate binding;protein binding;extracellular region@NA
D114041@190530@190533@deletion@4@74394533@74415597@16@chr16:74394533-74415597@5.65@452@310@0.686@CNVR6778.2, CNVR6778.1@AC009053-202_1, AC009053-202_2, NPIPL2-202_1, NPIPL2-202_2@52.5@46@57@@:extracellular region@NA
D114041@190549@190549@deletion@1@74451959@74452197@16@chr16:74451959-74452197@5.2@71@34@0.479@CNVR6778.2, CNVR6778.3@CLEC18B-202_3@47@47@47@:C-type lectin domain family 18, member B@:carbohydrate binding;protein binding;extracellular region@NA
D114041@191081@191082@duplication@2@83983868@83984131@16@chr16:83983868-83984131@7.36@166@249@1.5@NA@AC009063-201_2, AC009063-201_3@2@2@2@:oxidative stress induced growth inhibitor 1@:oxidation-reduction process;multicellular organismal development;cell differentiation;growth factor activity;negative regulation of cell growth;oxidoreductase activity;cellular_component@NA
D114041@191748@191764@deletion@17@89642178@89663655@16@chr16:89642178-89663655@109@2164@1164@0.538@NA@CPNE7-002_1, CPNE7-002_2, CPNE7-002_3, CPNE7-002_4, CPNE7-002_5, CPNE7-002_6, CPNE7-002_7, CPNE7-002_8, CPNE7-002_9, CPNE7-002_10, CPNE7-002_11, CPNE7-002_12, CPNE7-002_13, CPNE7-002_14, CPNE7-002_15, CPNE7-002_16, CPNE7-002_17@0.0588235294117647@0@1@:copine VII@:protein binding;transport;transporter activity;lipid metabolic process@NA
D114041@194345@194346@duplication@2@8656426@8656808@17@chr17:8656426-8656808@7.16@185@272@1.47@NA@SPDYE4-201_5, SPDYE4-201_6@2@1@3@:speedy homolog E4 (Xenopus laevis)@NA@NA
D114041@195017@195018@duplication@2@15517149@15517348@17@chr17:15517149-15517348@12.2@408@586@1.44@NA@CDRT1-201_3, TRIM16-202_12@38@38@38@:CMT1A duplicated region transcript 1@:protein binding;molecular_function;cellular_component;biological_process:protein binding;intracellular;zinc ion binding;cytoplasm@NA
D114041@195757@195759@duplication@3@18498037@18498176@17@chr17:18498037-18498176@8.83@325@453@1.39@NA@CCDC144B-201_8, CCDC144B-201_9, ENST00000447265_5@1@1@1@NA@NA@NA
D114041@196144@196150@deletion@7@20346589@20353433@17@chr17:20346589-20353433@7.26@63@22@0.349@CNVR7021.1, CNVR7021.3@ENST00000458685_4, ENST00000458685_5, ENST00000411468_3, ENST00000411468_4, ENST00000411468_5, ENST00000411468_6, LGALS9B-201_11@32.5714285714286@23@75@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
D114041@197728@197728@deletion@1@34539901@34539966@17@chr17:34539901-34539966@15.4@71@1@0.0141@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1-202_4@122@122@122@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
D114041@197748@197748@duplication@1@34641334@34641345@17@chr17:34641334-34641345@11.3@100@197@1.97@CNVR7077.1, CNVR7077.2, CNVR7077.12@CCL4L2-202_3@39@39@39@:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
D114041@198032@198041@deletion@10@36351805@36375178@17@chr17:36351805-36375178@101@6229@4015@0.645@CNVR7083.3@AC183087-202_5, AC183087-202_6, AC183087-202_7, AC183087-202_8, AC183087-202_9, AC183087-202_10, AC183087-202_11, AC183087-202_12, AC183087-202_13, AC183087-202_14@55.3@42@64@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
D114041@199069@199069@duplication@1@39991842@39991935@17@chr17:39991842-39991935@4.73@121@179@1.48@NA@NT5C3L-007_3@5@5@5@:5'-nucleotidase, cytosolic III-like@:protein binding;5'-nucleotidase activity;magnesium ion binding;transferase activity;nucleotide binding;nucleotide metabolic process;cytoplasm@NA
D114041@200259@200265@deletion@7@43585590@43594649@17@chr17:43585590-43594649@19@641@391@0.61@CNVR7113.4, CNVR7113.6, CNVR7113.2, CNVR7113.1@AC091132-201_1, AC091132-201_2, AC091132-201_3, AC091132-201_4, AC091132-201_5, ENST00000339474_2, ENST00000339474_3@94.7142857142857@81@127@NA@NA@NA
D114041@200325@200328@duplication@4@44363251@44364337@17@chr17:44363251-44364337@14.5@1686@2184@1.3@CNVR7114.3, CNVR7114.2, CNVR7114.10@ENST00000451529_1, ENST00000451529_2, ENST00000451529_3, ENST00000451529_4@46.5@11@90@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
D114041@200337@200340@deletion@4@44399690@44409348@17@chr17:44399690-44409348@15.1@76@5@0.0658@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A-001_7, LRRC37A-001_8, LRRC37A-001_9, LRRC37A-001_10@144.75@141@154@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
D114041@200343@200345@deletion@3@44414664@44415161@17@chr17:44414664-44415161@16.1@73@0@0@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A-001_13, LRRC37A-001_14, LRRC37A-001_15@190.333333333333@181@196@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
D114041@201839@201840@deletion@2@57656835@57657241@17@chr17:57656835-57657241@6.97@145@81@0.559@NA@DHX40-203_12, DHX40-203_13@7.5@3@12@:DEAH (Asp-Glu-Ala-His) box polypeptide 40@:transport;helicase activity;intracellular;ATP-dependent helicase activity;nucleic acid binding;ATP binding@NA
D114041@206352@206355@deletion@4@11629647@11751706@18@chr18:11629647-11751706@16.9@254@117@0.461@NA@AMAC1L1-201_2, AP001120-201_1, AP001120-201_2, GNAL-201_1@26.5@8@61@:guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type@:adenylate cyclase-activating dopamine receptor signaling pathway;adenylate cyclase-activating G-protein coupled receptor signaling pathway;response to caffeine;activation of adenylate cyclase activity;response to amphetamine;guanyl nucleotide binding;extrinsic to internal side of plasma membrane;GTP binding;plasma membrane;sensory perception of smell;adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway;GTPase activity;G-protein coupled receptor signaling pathway;GTP catabolic process;G-protein beta/gamma-subunit complex binding;heterotrimeric G-protein complex;signal transducer activity;signal transduction;synaptic transmission;G-protein coupled receptor binding;metal ion binding@NA
D114041@213493@213494@deletion@2@14508472@14508748@19@chr19:14508472-14508748@16.3@113@27@0.239@NA@CD97-205_8, CD97-205_9@10.5@7@14@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
D114041@215926@215927@deletion@2@35849784@35862021@19@chr19:35849784-35862021@6.18@571@392@0.687@CNVR7627.1@AC002511-201_2, FFAR3-001_1@56@12@100@:free fatty acid receptor 3@:lipid binding;integral to membrane;G-protein coupled receptor activity;plasma membrane;integral to plasma membrane;G-protein coupled receptor signaling pathway:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
D114041@217595@217595@duplication@1@41327389@41327534@19@chr19:41327389-41327534@4.73@83@132@1.59@NA@CYP2F1P-001_5@0@0@0@NA@NA@NA
D114041@217598@217598@duplication@1@41331994@41332193@19@chr19:41331994-41332193@8.76@189@294@1.56@NA@CYP2F1P-001_2@0@0@0@NA@NA@NA
D114041@217611@217612@duplication@2@41397898@41398058@19@chr19:41397898-41398058@16.1@282@454@1.61@NA@AC008537-203_2, AC008537-203_3@0@0@0@NA@NA@NA
D114041@217667@217667@deletion@1@41627864@41628039@19@chr19:41627864-41628039@5.93@178@107@0.601@CNVR7644.1@CYP2F1-201_6@10@10@10@:cytochrome P450, family 2, subfamily F, polypeptide 1@:trichloroethylene metabolic process;oxidation-reduction process;aromatase activity;response to toxin;oxygen binding;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;endoplasmic reticulum membrane;naphthalene metabolic process;intracellular membrane-bounded organelle;electron carrier activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;heme binding;xenobiotic metabolic process;monooxygenase activity;iron ion binding@NA
D114041@220700@220700@deletion@1@52149512@52149894@19@chr19:52149512-52149894@5.7@95@49@0.516@CNVR7702.1@SIGLEC5-201_2@14@14@14@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 14@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion;plasma membrane@NA
D114041@221166@221166@duplication@1@54724400@54724701@19@chr19:54724400-54724701@8.77@215@327@1.52@CNVR7721.3, CNVR7721.4@LILRB3-008_6@106@106@106@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D114041@221178@221183@deletion@6@54744152@54746618@19@chr19:54744152-54746618@32.4@1241@783@0.631@CNVR7721.3, CNVR7721.6@LILRA6-002_1, LILRA6-002_2, LILRA6-002_3, LILRA6-002_4, LILRA6-002_5, LILRA6-002_6@63.6666666666667@50@77@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D114041@221396@221412@deletion@17@55266477@55286911@19@chr19:55266477-55286911@73.1@2711@1694@0.625@CNVR7725.2, CNVR7725.1@KIR2DL3-201_5, KIR2DL3-201_6, KIR2DL3-201_7, KIR2DL3-201_8, KIR2DP1-001_1, KIR2DP1-001_2, KIR2DP1-001_3, KIR2DP1-001_4, KIR2DP1-001_5, KIR2DP1-001_6, KIR2DP1-001_7, KIR2DP1-001_8, KIR2DP1-001_9, KIR2DL1-002_1, KIR2DL1-002_2, KIR2DL1-002_3, KIR2DL1-002_4@110.176470588235@85@126@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
D114041@221441@221441@deletion@1@55359359@55360024@19@chr19:55359359-55360024@5.27@965@689@0.714@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4-001_8@102@102@102@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
D114041@221821@221821@deletion@1@56273966@56274542@19@chr19:56273966-56274542@6.61@832@580@0.697@CNVR7734.1@RFPL4A-201_3@33@33@33@:ret finger protein-like 4A;ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
D114041@222068@222069@deletion@2@58003184@58003369@19@chr19:58003184-58003369@5.95@74@34@0.459@CNVR7748.1@ZNF419-202_5, ZNF419-202_6@0@0@0@:zinc finger protein 419@:intracellular;DNA binding;regulation of transcription, DNA-dependent;cytoplasm;nucleolus;nucleus;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding@NA
D114041@222563@222564@duplication@2@1569208@1610283@20@chr20:1569208-1610283@10.4@33@104@3.15@CNVR7763.1@SIRPB1-201_1, SIRPG-005_6@64@0@128@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like:signal-regulatory protein gamma@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway:negative regulation of cell proliferation;positive regulation of T cell activation;positive regulation of cell-cell adhesion;intracellular;cell-cell signaling;protein binding;blood coagulation;integral to membrane;cell adhesion;plasma membrane;positive regulation of cell proliferation;membrane;intracellular signal transduction;leukocyte migration@NA
D114041@222594@222594@deletion@1@1895747@1896102@20@chr20:1895747-1896102@15.7@195@81@0.415@CNVR7764.2@SIRPA-201_3@34@34@34@:signal-regulatory protein alpha@:blood coagulation;protein binding;integral to membrane;SH3 domain binding;cell adhesion;plasma membrane;membrane;leukocyte migration@NA
D114041@232350@232351@deletion@2@18775046@18775393@22@chr22:18775046-18775393@7.5@127@66@0.52@CNVR8087.5, CNVR8087.2, CNVR8087.7@AC008132-201_3, AC008132-201_4@103.5@103@104@NA@NA@NA
D114041@232772@232783@duplication@12@20386519@20398724@22@chr22:20386519-20398724@10.4@84@163@1.94@CNVR8094.9, CNVR8094.4, CNVR8094.10@PI4KAP1-204_2, PI4KAP1-204_3, PI4KAP1-204_4, PI4KAP1-204_5, PI4KAP1-204_6, PI4KAP1-204_7, PI4KAP1-204_8, PI4KAP1-204_9, PI4KAP1-204_10, PI4KAP1-204_11, PI4KAP1-204_12, PI4KAP1-204_13@167.5@156@172@NA@NA@NA
D114041@233183@233188@deletion@6@21834050@21841962@22@chr22:21834050-21841962@7.54@161@92@0.571@CNVR8101.1@PI1KAP2-201_5, PI1KAP2-201_6, PI1KAP2-201_7, PI1KAP2-201_8, PI1KAP2-201_9, PI1KAP2-201_10@36.3333333333333@34@38@NA@NA@NA
D114041@233586@233586@deletion@1@23964280@23964364@22@chr22:23964280-23964364@19.7@281@123@0.438@CNVR8112.1@C22orf43-001_4@3@3@3@:chromosome 22 open reading frame 43@NA@NA
D114041@233722@233723@duplication@2@24324821@24325194@22@chr22:24324821-24325194@5.61@46@90@1.96@CNVR8114.6, CNVR8114.13, CNVR8114.8, CNVR8114.14@GSTT2-002_3, GSTT2-002_4@101.5@101@102@@:protein binding;glutathione transferase activity;nucleus;cytoplasm@NA
D114041@236768@236774@duplication@7@42537546@42539610@22@chr22:42537546-42539610@27.4@864@1236@1.43@CNVR8168.1, CNVR8168.3, CNVR8168.4@CYP2D7P1-202_1, CYP2D7P1-202_2, CYP2D7P1-202_3, CYP2D7P1-202_4, CYP2D7P1-202_5, CYP2D7P1-202_6, CYP2D7P1-202_7@18.7142857142857@12@22@@:oxidation-reduction process;electron carrier activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;heme binding@NA
D115022@608@608@duplication@1@1643705@1643840@1@chr1:1643705-1643840@6.06@23@67@2.91@CNVR17.1@CDC2L2-208_7@25@25@25@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
D115022@2736@2736@duplication@1@16360108@16360546@1@chr1:16360108-16360546@6.79@173@268@1.55@CNVR92.1, CNVR92.2@CLCNKA-003_24@31@31@31@:chloride channel, voltage-sensitive Ka@:ion channel activity;transport;chloride channel complex;transmembrane transport;protein binding;chloride transport;integral to membrane;excretion;integral to plasma membrane;membrane;voltage-gated chloride channel activity@: BARTTER SYNDROME, TYPE 4B
D115022@2738@2738@deletion@1@16362733@16362842@1@chr1:16362733-16362842@6.09@183@106@0.579@CNVR92.1@ENST00000447882_4@9@9@9@NA@NA@NA
D115022@4452@4453@deletion@2@25611066@25617283@1@chr1:25611066-25617283@10.6@364@214@0.588@CNVR116.1, CNVR116.2@RHD-202_2, RHD-202_3@127@126@128@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
D115022@4477@4477@duplication@1@25735176@25735361@1@chr1:25735176-25735361@11.4@109@223@2.05@CNVR117.1@RHCE-005_4@56@56@56@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
D115022@6745@6746@deletion@2@39977430@39987243@1@chr1:39977430-39987243@5.67@92@49@0.533@NA@BMP8A-001_3, BMP8A-001_4@39.5@26@53@:bone morphogenetic protein 8a@:cell differentiation;growth factor activity;extracellular space;growth;cytokine activity;cartilage development;ossification@NA
D115022@6813@6816@duplication@4@40229386@40240129@1@chr1:40229386-40240129@11.2@272@408@1.5@NA@PPIE-003_11, BMP8B-001_3, BMP8B-001_4, BMP8B-001_5@44.75@34@70@:peptidylprolyl isomerase E (cyclophilin E):bone morphogenetic protein 8b:3-oxoacid CoA transferase 2@:regulation of transcription, DNA-dependent;nucleotide binding;catalytic step 2 spliceosome;protein folding;protein binding;protein peptidyl-prolyl isomerization;peptidyl-prolyl cis-trans isomerase activity;cyclosporin A binding;RNA binding;mRNA splicing, via spliceosome;nucleus;nucleic acid binding:cell differentiation;growth factor activity;extracellular space;growth;extracellular region;cytokine activity;cartilage development;skeletal system development;ossification:mitochondrion;microtubule-based flagellum;CoA-transferase activity;ketone body catabolic process;3-oxoacid CoA-transferase activity;metabolic process@NA
D115022@11245@11246@duplication@2@89476589@89477711@1@chr1:89476589-89477711@5.3@593@779@1.31@CNVR244.1@GBP3-001_7, GBP3-001_8@54@54@54@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
D115022@12928@12936@duplication@9@110225831@110236368@1@chr1:110225831-110236368@120@508@1568@3.09@CNVR299.6, CNVR299.4, CNVR299.5@GSTM2-203_9, GSTM1-001_1, GSTM1-001_2, GSTM1-001_3, GSTM1-001_4, GSTM1-001_5, GSTM1-001_6, GSTM1-001_7, GSTM1-001_8@173.555555555556@31@194@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
D115022@14370@14370@deletion@1@144053508@144053669@1@chr1:144053508-144053669@4.82@86@44@0.512@CNVR332.5@SRGAP2P2-002_4@2@2@2@NA@NA@NA
D115022@18672@18675@duplication@4@161559354@161562033@1@chr1:161559354-161562033@15@365@568@1.56@CNVR383.1@FCGR2C-006_3, FCGR2C-006_4, FCGR2C-006_5, FCGR2C-006_6@47.75@37@57@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
D115022@18680@18684@duplication@5@161592988@161600997@1@chr1:161592988-161600997@16.5@943@1298@1.38@CNVR383.1@FCGR3B-001_1, FCGR3B-001_2, FCGR3B-001_3, FCGR3B-001_4, FCGR3B-001_5@36.6@34@40@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIIb, receptor (CD16b)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction:IgG binding;protein binding;extracellular region;immune response;plasma membrane;anchored to membrane@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
D115022@21362@21374@deletion@13@196743977@196801320@1@chr1:196743977-196801320@68.3@2007@1177@0.586@CNVR459.1@CFHR3-001_1, CFHR3-001_2, CFHR3-001_3, CFHR3-001_4, CFHR3-001_5, CFHR3-001_6, CFHR1-001_1, CFHR1-001_2, CFHR1-001_3, CFHR1-001_4, CFHR1-001_5, CFHR1-001_6, CFHR2-201_1@96.7692307692308@85@119@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
D115022@24160@24161@deletion@2@223727670@223727929@1@chr1:223727670-223727929@6.18@76@35@0.461@NA@CAPN8-202_23, CAPN8-202_24@0@0@0@:calpain 8@:proteolysis;Golgi apparatus;intracellular;calcium-dependent cysteine-type endopeptidase activity;calcium ion binding@NA
D115022@33542@33543@duplication@2@87365381@87365581@2@chr2:87365381-87365581@10.5@146@251@1.72@CNVR861.2@AC083899-001_6, AC083899-001_7@13@11@15@NA@NA@NA
D115022@33560@33565@duplication@6@87408191@87416182@2@chr2:87408191-87416182@8.08@346@479@1.38@CNVR861.2@AC083899-001_24, AC083899-001_25, AC083899-001_26, AC083899-001_27, AC083899-001_28, AC083899-001_29@66.5@21@85@NA@NA@NA
D115022@33585@33589@deletion@5@88012880@88019541@2@chr2:88012880-88019541@15.2@439@257@0.585@CNVR861.3@AC093616-001_5, AC093616-001_6, AC093616-001_7, AC093616-001_8, AC093616-001_9@35.2@32@38@NA@NA@NA
D115022@34092@34095@duplication@4@96457910@96458295@2@chr2:96457910-96458295@6.91@247@346@1.4@NA@AC008268-201_2, AC008268-201_3, ENST00000444924_1, ENST00000444924_2@102.75@101@104@NA@NA@NA
D115022@34965@34965@duplication@1@100065800@100065967@2@chr2:100065800-100065967@4.97@75@126@1.68@NA@REV1-003_5@0@0@0@:REV1, polymerase (DNA directed)@:deoxycytidyl transferase activity;damaged DNA binding;nucleoplasm;response to UV;magnesium ion binding;error-prone translesion synthesis;DNA repair;protein binding;DNA-directed DNA polymerase activity;DNA replication;nucleotidyltransferase activity@NA
D115022@35461@35463@duplication@3@106992909@106994704@2@chr2:106992909-106994704@6.18@107@173@1.62@NA@ENST00000447760_4, ENST00000447760_5, ENST00000447760_6@20@11@27@NA@NA@NA
D115022@35993@35997@duplication@5@112592183@112605443@2@chr2:112592183-112605443@7.34@289@411@1.42@CNVR929.1, CNVR929.2@ANAPC1-001_15, ANAPC1-001_16, ANAPC1-001_17, ANAPC1-001_18, ANAPC1-001_19@0@0@0@:anaphase-promoting complex subunit 1-like;anaphase promoting complex subunit 1@:nucleoplasm;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle;anaphase-promoting complex;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle spindle assembly checkpoint;cytosol;protein K11-linked ubiquitination;protein binding;mitosis;nucleus;cell cycle checkpoint;cell division;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle@NA
D115022@37242@37242@deletion@1@130955933@130956035@2@chr2:130955933-130956035@8.39@38@0@0@CNVR985.1@TUBA3E-001_1@27@27@27@:tubulin, alpha 3e@:GTPase activity;structural constituent of cytoskeleton;protein complex;GTP catabolic process;cytoplasm;microtubule cytoskeleton;protein polymerization;microtubule-based movement;structural molecule activity;cytoplasmic microtubule;GTP binding;microtubule;microtubule cytoskeleton organization;protein domain specific binding@NA
D115022@37492@37496@duplication@5@132288154@132290643@2@chr2:132288154-132290643@8.15@500@668@1.34@NA@CCDC74A-201_3, CCDC74A-201_4, CCDC74A-201_5, CCDC74A-201_6, CCDC74A-201_7@7.6@4@13@:coiled-coil domain containing 74A@NA@NA
D115022@45386@45390@deletion@5@233272979@233274159@2@chr2:233272979-233274159@13@367@216@0.589@NA@ALPPL2-001_6, ALPPL2-001_7, ALPPL2-001_8, ALPPL2-001_9, ALPPL2-001_10@35@16@58@:alkaline phosphatase, placental-like 2@:phosphatase activity;catalytic activity;phosphorylation;plasma membrane;metabolic process;membrane;anchored to membrane;alkaline phosphatase activity;metal ion binding@NA
D115022@46353@46354@deletion@2@241631264@241631939@2@chr2:241631264-241631939@7.66@88@37@0.42@NA@AQP12A-201_1, AQP12A-201_2@27@25@29@:aquaporin 12A@:transport;integral to membrane;transporter activity;membrane@NA
D115022@61549@61550@deletion@2@195395392@195398172@3@chr3:195395392-195398172@7.89@415@268@0.646@CNVR1703.1@SDHALP2-001_7, SDHALP2-001_8@74@73@75@:mucin 20, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane@NA
D115022@61564@61567@deletion@4@195435007@195447955@3@chr3:195435007-195447955@8.72@77@25@0.325@CNVR1703.1, CNVR1703.2, CNVR1703.6@AC069513-013_3, AC069513-013_4, AC069513-013_5, MUC20-201_1@42.25@39@45@:mucin 20, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane@NA
D115022@61569@61573@deletion@5@195452546@195475936@3@chr3:195452546-195475936@8.26@1955@1432@0.732@CNVR1703.1, CNVR1703.2, CNVR1703.5, CNVR1703.3@MUC20-201_3, MUC20-201_4, MUC20-201_5, MUC4-203_25, MUC4-203_26@37@30@44@:mucin 20, cell surface associated:mucin 4, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane:ErbB-2 class receptor binding;Golgi lumen;cell-matrix adhesion;post-translational protein modification;extracellular matrix structural constituent;protein binding;O-glycan processing;cellular protein metabolic process;proteinaceous extracellular matrix;integral to plasma membrane;membrane;extracellular matrix constituent, lubricant activity;biological_process@NA
D115022@61646@61647@deletion@2@195702578@195702772@3@chr3:195702578-195702772@8.16@423@272@0.643@CNVR1707.1, CNVR1707.2@SDHALP1-002_9, ENST00000354937_10@39.5@39@40@NA@NA@NA
D115022@61895@61896@deletion@2@197348577@197348740@3@chr3:197348577-197348740@5.47@149@88@0.591@CNVR1722.1@AC024560-005_6, AC024560-201_7@10@10@10@NA@NA@NA
D115022@62022@62024@duplication@3@197846588@197848413@3@chr3:197846588-197848413@5.99@104@167@1.61@CNVR1728.7, CNVR1728.8, CNVR1728.3@ENST00000392362_1, ENST00000392362_2, ENST00000451150_3@50.3333333333333@45@53@NA@NA@NA
D115022@64024@64024@duplication@1@39241899@39241955@4@chr4:39241899-39241955@5.67@71@126@1.77@NA@WDR19-201_21@0@0@0@:WD repeat domain 19@:nonmotile primary cilium;smoothened signaling pathway;digestive system development;myotome development;motile cilium;cilium assembly;neurological system process;photoreceptor connecting cilium;smoothened signaling pathway involved in dorsal/ventral neural tube patterning;ear morphogenesis;cell morphogenesis;cilium;microtubule basal body;in utero embryonic development;embryonic cranial skeleton morphogenesis;embryonic camera-type eye development;protein binding;cilium morphogenesis;ciliary receptor clustering involved in smoothened signaling pathway;embryonic limb morphogenesis;cell projection organization@: NEPHRONOPHTHISIS 13; NPHP13; ASPHYXIATING THORACIC DYSTROPHY 5; ATD5; CRANIOECTODERMAL DYSPLASIA 4; CED4
D115022@65354@65360@deletion@7@70146221@70160768@4@chr4:70146221-70160768@193@969@5@0.00516@CNVR1957.2, CNVR1957.1@UGT2B28-201_1, UGT2B28-201_2, UGT2B28-201_3, UGT2B28-201_4, UGT2B28-201_5, UGT2B28-201_6, UGT2B28-201_7@69.1428571428571@65@71@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
D115022@67916@67917@duplication@2@113606213@113606660@4@chr4:113606213-113606660@5.3@159@230@1.45@NA@ENST00000407499_1, ENST00000407499_2@0@0@0@NA@NA@NA
D115022@68947@68947@duplication@1@145041645@145041742@4@chr4:145041645-145041742@5.26@114@179@1.57@NA@GYPA-205_2@8@8@8@:glycophorin B (MNS blood group):glycophorin A (MNS blood group)@:integral to membrane;plasma membrane;integral to plasma membrane:external side of plasma membrane;integral to membrane;cytoskeletal anchoring at plasma membrane;plasma membrane;molecular_function;protein homodimerization activity;integral to plasma membrane;cellular_component;identical protein binding;membrane;biological_process;regulation of response to osmotic stress;virus-host interaction@: BLOOD GROUP--Ss LOCUS; Ss: MALARIA, SUSCEPTIBILITY TO; BLOOD GROUP--MN LOCUS; MN
D115022@70688@70690@deletion@3@190947541@190948413@4@chr4:190947541-190948413@12@329@176@0.535@CNVR2258.3@FRG2-201_1, FRG2-201_2, FRG2-201_3@39.3333333333333@26@58@:FSHD region gene 2-like;FSHD region gene 2@:nucleus@NA
D115022@70816@70822@deletion@7@712144@748675@5@chr5:712144-748675@34.9@1557@1037@0.666@CNVR2280.3@ZDHHC11-201_13, ZDHHC11B-201_5, ZDHHC11B-201_6, ZDHHC11B-201_7, ZDHHC11B-201_8, ZDHHC11B-201_9, ZDHHC11B-201_10@67.4285714285714@34@96@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
D115022@71604@71605@deletion@2@21483325@21484666@5@chr5:21483325-21484666@5.58@58@23@0.397@CNVR2395.4, CNVR2395.6, CNVR2395.2@AC138951-202_2, ENST00000412250_1@108@108@108@NA@NA@NA
D115022@71895@71898@duplication@4@34182208@34191311@5@chr5:34182208-34191311@8.93@412@580@1.41@CNVR2430.2, CNVR2430.1@AC138409-202_6, ENST00000380721_1, ENST00000502234_2, AC138409-201_1@38.75@22@49@NA@NA@NA
D115022@73817@73821@deletion@5@70370032@70389020@5@chr5:70370032-70389020@32.6@152@1@0.00658@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.8, CNVR2494.1, CNVR2494.37@AC044797-201_1, AC044797-201_2, AC044797-201_3, AC044797-201_4, AC044797-201_5@120.4@100@138@NA@NA@NA
D115022@75483@75485@deletion@3@104434371@104435800@5@chr5:104434371-104435800@16.2@285@142@0.498@CNVR2549.1@AC091987-201_7, RAB9P1-201_1, RAB9P1-201_2@0@0@0@NA@NA@NA
D115022@78044@78044@duplication@1@147553799@147553934@5@chr5:147553799-147553934@18.6@140@341@2.44@CNVR2637.2, CNVR2637.1@AC116334-001_3@78@78@78@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
D115022@79567@79570@deletion@4@175388056@175394271@5@chr5:175388056-175394271@22.7@226@85@0.376@NA@THOC3-001_2, THOC3-001_3, THOC3-001_4, THOC3-001_5@105@27@182@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
D115022@82492@82513@deletion@22@29857486@29897010@6@chr6:29857486-29897010@32.1@1305@833@0.638@CNVR2829.7, CNVR2829.2, CNVR2829.3@HLA-H-001_5, HLA-H-001_6, HLA-H-001_7, HLA-16-001_1, HLA-16-001_2, HLA-16-001_3, HLA-16-001_4, AL645929-201_2, AL645929-201_3, AL645929-201_4, AL645929-201_5, AL645929-201_6, BAT1P1-001_1, BAT1P1-001_2, MCCD1P1-001_1, MCCD1P1-001_2, HLA-K-001_1, HLA-K-001_2, HLA-K-001_3, HLA-K-001_4, HLA-K-001_5, HLA-K-001_6@45.1818181818182@41@51@NA@NA@NA
D115022@83583@83584@deletion@2@31963734@31964101@6@chr6:31963734-31964101@7.56@165@89@0.539@CNVR2843.6, CNVR2843.3@C4A-001_26, C4A-001_27@16.5@16@17@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
D115022@83601@83606@duplication@6@31973468@31974499@6@chr6:31973468-31974499@8.94@569@759@1.33@CNVR2843.6, CNVR2843.3@CYP21A1P-001_1, CYP21A1P-001_2, CYP21A1P-001_3, CYP21A1P-001_4, AL645922-201_1, AL645922-201_2@101.166666666667@80@108@NA@NA@NA
D115022@83614@83617@duplication@4@31975450@31976177@6@chr6:31975450-31976177@14.7@159@291@1.83@CNVR2843.6, CNVR2843.3@CYP21A1P-001_8, CYP21A1P-001_9, CYP21A1P-001_10, AL645922-201_7@103@82@116@NA@NA@NA
D115022@83637@83645@duplication@9@31994762@31997116@6@chr6:31994762-31997116@14.5@390@580@1.49@CNVR2843.6, CNVR2843.5@C4B-001_20, C4B-001_21, C4B-001_22, C4B-001_23, C4B-001_24, C4B-001_25, C4B-001_26, C4B-001_27, C4B-001_28@13.8888888888889@10@19@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
D115022@83910@83927@duplication@18@32441204@32548048@6@chr6:32441204-32548048@81.7@666@1393@2.09@CNVR2845.21, CNVR2845.25@HLA-DRB9-001_1, HLA-DRB5-001_1, HLA-DRB5-001_2, HLA-DRB5-001_3, HLA-DRB5-001_4, HLA-DRB5-001_5, HLA-DRB5-001_6, HLA-DRB6-002_1, HLA-DRB6-002_2, HLA-DRB6-002_3, HLA-DRB6-002_4, HLA-DRB6-002_5, HLA-DRB6-002_6, AL713966-201_1, AL713966-201_2, AL713966-201_3, HLA-DRB1-001_5, HLA-DRB1-001_6@136.333333333333@44@189@:major histocompatibility complex, class II, DR beta 5:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
D115022@83930@83930@duplication@1@32551888@32552156@6@chr6:32551888-32552156@12.6@107@232@2.17@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.54, CNVR2845.56, CNVR2845.34@HLA-DRB1-001_2@100@100@100@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
D115022@83936@83946@duplication@11@32610389@32634448@6@chr6:32610389-32634448@31.1@770@1166@1.51@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20@HLA-DQA1-002_5, HLA-DQA1-002_6, HLA-DQB1-003_2, HLA-DQB1-003_3, HLA-DQB1-003_4, HLA-DQB1-003_5, HLA-DQB1-003_6, XXbac-BPG254F23-001_1, XXbac-BPG254F23-001_2, ENST00000443574_1, ENST00000443574_2@121.090909090909@80@146@:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
D115022@93071@93072@deletion@2@167591874@167592031@6@chr6:167591874-167592031@11.8@312@176@0.564@NA@TCP10L2-001_4, AL121935-201_5@29@29@29@:t-complex 10;t-complex 10-like 2@NA@NA
D115022@93099@93099@duplication@1@167790036@167790193@6@chr6:167790036-167790193@15.9@27@146@5.41@NA@TCP10-001_5@103@103@103@:t-complex 10@:cytosol@NA
D115022@93748@93748@duplication@1@2309196@2309275@7@chr7:2309196-2309275@9.81@198@330@1.67@NA@SNX8-001_5@0@0@0@:sorting nexin 8@:intracellular protein transport;protein binding;early endosome to Golgi transport;phosphatidylinositol binding;retromer complex;early endosome membrane;cell communication@NA
D115022@94189@94196@duplication@8@5958500@5972507@7@chr7:5958500-5972507@11.8@1054@1391@1.32@NA@C7orf28A-001_11, C7orf28A-001_12, C7orf28A-001_13, C7orf28A-001_14, C7orf28A-001_15, RSPH10B-002_19, RSPH10B-002_20, RSPH10B-002_21@41.75@12@73@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae):radial spoke head 10 homolog B (Chlamydomonas)@:lysosomal membrane@NA
D115022@94212@94212@deletion@1@6006496@6006833@7@chr7:6006496-6006833@35@170@0@0@NA@RSPH10B-002_3@13@13@13@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D115022@94410@94421@duplication@12@6785721@6798791@7@chr7:6785721-6798791@20.3@593@915@1.54@NA@ENST00000338780_11, ENST00000338780_12, ENST00000338780_13, ENST00000338780_14, PMS2CL-002_11, PMS2CL-002_12, PMS2CL-002_13, PMS2CL-002_14, RSPH10B2-204_1, RSPH10B2-204_2, RSPH10B2-204_3, RSPH10B2-204_4@43.25@5@90@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D115022@94438@94444@deletion@7@6836201@6844687@7@chr7:6836201-6844687@67.9@457@99@0.217@NA@RSPH10B2-204_20, RSPH10B2-204_21, ENST00000429267_1, C7orf28B-001_12, C7orf28B-001_13, C7orf28B-001_14, C7orf28B-001_15@90.8571428571429@25@121@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D115022@95259@95259@deletion@1@22532945@22533456@7@chr7:22532945-22533456@4.75@924@645@0.698@NA@AC099759-202_4@0@0@0@:STEAP family member 1B@:integral to membrane@NA
D115022@97907@97917@duplication@11@57063663@57084498@7@chr7:57063663-57084498@16.8@129@259@2.01@NA@TNRC18C-202_3, TNRC18C-202_4, TNRC18C-202_5, TNRC18C-202_6, TNRC18C-202_7, TNRC18C-202_8, TNRC18C-202_9, TNRC18C-202_10, TNRC18C-202_11, ENST00000398760_4, ENST00000398760_5@155.545454545455@139@166@NA@NA@NA
D115022@98173@98174@deletion@2@64533487@64534227@7@chr7:64533487-64534227@7.3@43@7@0.163@NA@RP11-460N20-001_11, RP11-460N20-001_12, ENST00000501153_3@101@101@101@NA@NA@NA
D115022@98192@98193@duplication@2@64646770@64646889@7@chr7:64646770-64646889@5.11@55@99@1.8@NA@INTS4L1-201_8, INTS4L1-201_9@51.5@51@52@NA@NA@NA
D115022@98735@98735@deletion@1@72710751@72712438@7@chr7:72710751-72712438@5.62@80@37@0.462@NA@POM121B-201_7@2@2@2@NA@NA@NA
D115022@99332@99333@duplication@2@75368121@75399108@7@chr7:75368121-75399108@9.53@278@417@1.5@NA@HIP1-001_1, CCL26-002_4@2@1@3@:huntingtin interacting protein 1:chemokine (C-C motif) ligand 26@:cell differentiation;phospholipid binding;binding;phosphatidylinositol binding;structural constituent of cytoskeleton;clathrin-coated vesicle;positive regulation of receptor-mediated endocytosis;induction of apoptosis;activation of cysteine-type endopeptidase activity involved in apoptotic process;nucleus;apoptotic process;clathrin-coated vesicle membrane;intracellular membrane-bounded organelle;endocytosis;Golgi apparatus;clathrin coat assembly;regulation of transcription, DNA-dependent;cytoplasm;actin binding;protein binding;clathrin binding;cytoskeleton;regulation of apoptotic process;transcription, DNA-dependent;membrane:inflammatory response;immune response;cell-cell signaling;positive regulation of actin filament polymerization;chemotaxis;extracellular space;signal transduction;positive regulation of cell migration;extracellular region;positive regulation of Rac GTPase activity;positive regulation of endothelial cell proliferation;chemokine activity@NA
D115022@99455@99456@duplication@2@76069569@76069929@7@chr7:76069569-76069929@12.6@456@672@1.47@CNVR3462.1@ZP3-002_7, ZP3-002_8@9@8@10@:zona pellucida glycoprotein 3 (sperm receptor)@:negative regulation of transcription, DNA-dependent;manganese ion transmembrane transporter activity;intracellular protein transport;proteinaceous extracellular matrix;plasma membrane;positive regulation of acrosome reaction;outer acrosomal membrane;protein kinase C signaling cascade;manganese ion transmembrane transport;intracellular signal transduction;humoral immune response mediated by circulating immunoglobulin;negative regulation of binding of sperm to zona pellucida;positive regulation of inflammatory response;endoplasmic reticulum;signal transducer activity;perinuclear region of cytoplasm;secretory granule;positive regulation of transcription, DNA-dependent;positive regulation of ovarian follicle development;positive regulation of interferon-gamma production;carbohydrate binding;manganese ion transport;positive regulation of antral ovarian follicle growth;extracellular matrix;positive regulation of leukocyte migration;positive regulation of humoral immune response;extracellular space;blastocyst formation;integral to membrane;store-operated calcium channel activity;oocyte development;multivesicular body;phosphatidylinositol-mediated signaling;acrosomal vesicle;positive regulation of protein kinase B signaling cascade;Golgi apparatus;positive regulation of calcium ion import;positive regulation of protein kinase activity;positive regulation of acrosomal vesicle exocytosis;positive regulation of interleukin-4 production;cytoplasm;protein binding;binding of sperm to zona pellucida;positive regulation of phosphatidylinositol biosynthetic process;extracellular region;positive regulation of T cell proliferation;acrosin binding;positive regulation of type IV hypersensitivity;egg coat formation@NA
D115022@99465@99465@deletion@1@76129760@76129838@7@chr7:76129760-76129838@5.8@27@1@0.037@CNVR3462.1@DTX2-001_8@22@22@22@:deltex homolog 2 (Drosophila)@:ligase activity;cytoplasm;nuclear membrane;Notch signaling pathway;protein binding;nucleus;zinc ion binding;protein ubiquitination@NA
D115022@99489@99490@deletion@2@76240773@76241131@7@chr7:76240773-76241131@48.9@293@32@0.109@CNVR3463.10@POMZP3-003_6, POMZP3-003_7@43.5@41@46@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
D115022@99545@99545@duplication@1@76728229@76728269@7@chr7:76728229-76728269@5.77@104@170@1.63@NA@ENST00000398321_6@11@11@11@NA@NA@NA
D115022@99550@99551@deletion@2@76748836@76749023@7@chr7:76748836-76749023@5.41@269@172@0.639@NA@ENST00000398321_2, ENST00000398321_3@2@1@3@NA@NA@NA
D115022@101722@101726@duplication@5@100333345@100336237@7@chr7:100333345-100336237@16@779@1087@1.4@CNVR3509.1@ZAN-001_3, ZAN-001_4, ZAN-001_5, ZAN-001_6, ZAN-001_7@82.4@71@89@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
D115022@102144@102145@deletion@2@102180464@102180539@7@chr7:102180464-102180539@18.1@179@62@0.346@CNVR3518.1@RASA4B-007_4, POLR2J3-003_7@96@96@96@:RAS p21 protein activator 4B:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
D115022@102192@102193@duplication@2@102279572@102279647@7@chr7:102279572-102279647@24.8@285@558@1.96@CNVR3518.1@ENST00000340457_4, POLR2J2-001_7@76.5@76@77@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
D115022@102210@102210@duplication@1@102318934@102319304@7@chr7:102318934-102319304@5.51@260@370@1.42@CNVR3518.1@ENST00000379355_1@54@54@54@NA@NA@NA
D115022@102613@102623@deletion@11@105888733@105925639@7@chr7:105888733-105925639@18.7@1942@1351@0.696@NA@PBEF1-001_1, PBEF1-001_2, PBEF1-001_3, PBEF1-001_4, PBEF1-001_5, PBEF1-001_6, PBEF1-001_7, PBEF1-001_8, PBEF1-001_9, PBEF1-001_10, PBEF1-001_11@1.36363636363636@0@3@:nicotinamide phosphoribosyltransferase@:nicotinate phosphoribosyltransferase activity;small molecule metabolic process;positive regulation of nitric-oxide synthase biosynthetic process;NAD metabolic process;cytoplasm;cell-cell signaling;NAD biosynthetic process;cytosol;signal transduction;cytokine activity;positive regulation of cell proliferation;water-soluble vitamin metabolic process;nicotinate-nucleotide diphosphorylase (carboxylating) activity;nicotinamide metabolic process;vitamin metabolic process;nicotinamide phosphoribosyltransferase activity@NA
D115022@105326@105340@duplication@15@141773884@141792409@7@chr7:141773884-141792409@28.8@2282@3014@1.32@CNVR3585.3, CNVR3585.2@MGAM-007_45, MGAM-007_46, MGAM-007_47, MGAM-007_48, MGAM-007_49, MGAM-007_50, MGAM-007_51, MGAM-007_52, MGAM-007_53, MGAM-007_54, MGAM-007_55, MGAM-007_56, MGAM-007_57, MGAM-007_58, MGAM-007_59@120.6@93@134@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
D115022@105772@105772@deletion@1@143883178@143885489@7@chr7:143883178-143885489@7.15@84@34@0.405@CNVR3598.4, CNVR3598.3, CNVR3598.7@ARHGEF5L-001_2@58@58@58@:Rho guanine nucleotide exchange factor (GEF) 35@NA@NA
D115022@105783@105791@duplication@9@143952604@143973535@7@chr7:143952604-143973535@42@669@1232@1.84@CNVR3598.4, CNVR3598.6@OR2A20P-003_1, OR2A20P-003_2, RP4-798C17-001_9, RP4-798C17-001_10, RP4-798C17-001_11, RP4-798C17-001_12, ENST00000378112_10, ENST00000378112_11, ENST00000378112_12@73@16@127@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor, family 2, subfamily A, member 7:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane@NA
D115022@105793@105799@deletion@7@143973974@143975569@7@chr7:143973974-143975569@10.3@53@5@0.0943@CNVR3598.4, CNVR3598.9@RP4-798C17-001_5, RP4-798C17-001_6, RP4-798C17-001_7, RP4-798C17-001_8, ENST00000378112_6, ENST00000378112_7, ENST00000378112_8, ENST00000378112_9@89.8571428571429@53@137@:Rho guanine nucleotide exchange factor (GEF) 35@NA@NA
D115022@105801@105828@duplication@28@143979376@144071983@7@chr7:143979376-144071983@122@1543@2961@1.92@CNVR3598.4@RP4-798C17-004_1, RP4-798C17-004_2, RP4-798C17-004_3, RP4-798C17-004_4, RP4-798C17-004_5, RP4-798C17-004_6, RP4-798C17-001_1, RP4-798C17-001_2, RP4-798C17-001_3, RP4-798C17-001_4, ENST00000378112_1, ENST00000378112_2, ENST00000378112_3, ENST00000378112_4, ENST00000378112_5, OR2A9P-002_1, OR2A9P-002_2, OR2A9P-002_3, ARHGEF5-001_1, ARHGEF5-001_2, ARHGEF5-001_3, ARHGEF5-001_4, ARHGEF5-001_5, ARHGEF5-001_6, ARHGEF5-001_7, ARHGEF5-001_8, ARHGEF5-001_9, ARHGEF5-001_10, ARHGEF5-001_11@52.8214285714286@14@104@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
D115022@107425@107425@duplication@1@7274294@7274386@8@chr8:7274294-7274386@4.67@22@56@2.55@CNVR3771.8, CNVR3771.10, CNVR3771.4@DEFB4P-001_1@57@57@57@:defensin, beta 4B;defensin, beta 4A@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response@NA
D115022@107428@107434@deletion@7@7308087@7340275@8@chr8:7308087-7340275@46.7@719@304@0.423@CNVR3771.8, CNVR3771.10, CNVR3771.4@SPAG11-003_1, SPAG11-003_2, SPAG11-003_3, SPAG11-003_4, DEFB104B-001_1, DEFB104B-001_2, DEFB106B-001_2@36.4285714285714@7@91@:sperm associated antigen 11B:defensin, beta 104A;defensin, beta 104B:defensin, beta 106B;defensin, beta 106A@:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
D115022@107502@107509@deletion@8@7673083@7698765@8@chr8:7673083-7698765@7.06@445@300@0.674@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@DEFB107A-001_1, DEFB105A-001_1, DEFB105A-001_2, DEFB105A-001_3, DEFB106A-001_1, DEFB106A-001_2, DEFB104A-001_1, DEFB104A-001_2@42.875@40@47@:defensin, beta 107B;defensin, beta 107A:defensin, beta 105B;defensin, beta 105A:defensin, beta 106B;defensin, beta 106A:defensin, beta 104A;defensin, beta 104B@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
D115022@107516@107516@deletion@1@7752153@7752293@8@chr8:7752153-7752293@9.84@181@88@0.486@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@DEFB4-001_1@65@65@65@:defensin, beta 4B;defensin, beta 4A@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response@NA
D115022@109572@109585@duplication@14@39311571@39349528@8@chr8:39311571-39349528@39.7@419@767@1.83@CNVR3859.1@ADAM3A-005_11, ADAM3A-005_12, ADAM3A-005_13, ADAM3A-005_14, ADAM3A-005_15, ADAM3A-005_16, ADAM3A-005_17, ADAM3A-005_18, ADAM3A-005_19, ADAM3A-005_20, ADAM3A-005_21, ADAM3A-009_7, ADAM3A-009_8, ADAM3A-009_9@120.5@98@136@NA@NA@NA
D115022@124033@124046@duplication@14@135937367@135947248@9@chr9:135937367-135947248@61.3@2626@3768@1.43@NA@CEL-201_1, CEL-201_2, CEL-201_3, CEL-201_4, CEL-201_5, CEL-201_6, CEL-201_7, CEL-201_8, CEL-201_9, CEL-201_10, CEL-201_11, CEL-201_12, RP11-326L24-001_1, RP11-326L24-001_2@16.7142857142857@4@38@:carboxyl ester lipase (bile salt-stimulated lipase)@:intestinal lipid catabolic process;pancreatic juice secretion;catalytic activity;extracellular space;heparin binding;sterol esterase activity;carboxylesterase activity;metabolic process;ceramide catabolic process;hydrolase activity;small molecule metabolic process;acylglycerol lipase activity;lipid metabolic process;cytoplasm;protein esterification;cytosol;retinyl-palmitate esterase activity;fatty acid catabolic process;extracellular region;triglyceride lipase activity;lipid digestion;triglyceride metabolic process;cholesterol catabolic process;intestinal cholesterol absorption@: MATURITY-ONSET DIABETES OF THE YOUNG; MODY; MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION;
D115022@124517@124517@deletion@1@138441156@138441178@9@chr9:138441156-138441178@16.3@87@7@0.0805@CNVR4529.1@OBP2A-001_6@18@18@18@:odorant binding protein 2A@:odorant binding;sensory perception of chemical stimulus;response to stimulus;transport;extracellular region;sensory perception of smell;cellular_component@NA
D115022@126909@126909@deletion@1@17840632@17842868@10@chr10:17840632-17842868@8.66@39@0@0@NA@FAM23A-201_5@108@108@108@:transmembrane protein 236;transmembrane protein 236-like@:integral to membrane@NA
D115022@126938@126941@deletion@4@17951324@18060365@10@chr10:17951324-18060365@5.71@26@0@0@NA@MRC1L1-001_29, MRC1L1-001_30, FAM23B-202_1, FAM23B-202_2@29@5@101@:macrophage mannose receptor 1-like:transmembrane protein 236;transmembrane protein 236-like@:carbohydrate binding:integral to membrane@NA
D115022@126951@126956@deletion@6@18138510@18152612@10@chr10:18138510-18152612@19.6@93@2@0.0215@NA@MRC1-001_7, MRC1-001_8, MRC1-001_9, MRC1-001_10, MRC1-001_11, RP11-457D2-001_2@19.6666666666667@18@26@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D115022@127722@127722@deletion@1@29580856@29580936@10@chr10:29580856-29580936@9.75@60@10@0.167@NA@LYZL1-002_1@51@51@51@:lysozyme-like 1@:extracellular region;lysozyme activity;cell wall macromolecule catabolic process@NA
D115022@128731@128745@deletion@15@46242050@46272874@10@chr10:46242050-46272874@18.8@553@308@0.557@NA@FAM21C-203_8, FAM21C-203_9, FAM21C-203_10, FAM21C-203_11, FAM21C-203_12, FAM21C-203_13, FAM21C-203_14, FAM21C-203_15, FAM21C-203_16, FAM21C-203_17, FAM21C-203_18, FAM21C-203_19, FAM21C-203_20, FAM21C-203_21, FAM21C-203_22@3.2@0@25@:family with sequence similarity 21, member C@:endosome;protein binding;plasma membrane;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
D115022@128805@128807@duplication@3@46754681@46760099@10@chr10:46754681-46760099@5.57@2@36@18@CNVR4712.9, CNVR4712.2@BMS1P1-201_3, BMS1P1-201_4, BMS1P1-201_5@40@40@40@NA@NA@NA
D115022@128828@128829@duplication@2@46927785@46934899@10@chr10:46927785-46934899@6.51@92@158@1.72@CNVR4712.9, CNVR4712.2, CNVR4712.7@FAM35B-001_6, FAM35B-001_7@53@34@72@NA@NA@NA
D115022@128979@128979@deletion@1@47758848@47758905@10@chr10:47758848-47758905@7.54@36@1@0.0278@CNVR4714.1@ANXA8L2-001_10@154@154@154@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:calcium-dependent phospholipid binding;calcium ion binding@NA
D115022@129022@129040@duplication@19@48025302@48175811@10@chr10:48025302-48175811@22.6@570@856@1.5@NA@ASAH2C-201_1, ASAH2C-201_2, ASAH2C-201_3, ASAH2C-201_4, ASAH2C-201_5, ASAH2C-201_6, ASAH2C-201_7, ASAH2C-201_8, ASAH2C-201_9, CTD-2173J9-001_1, CTD-2173J9-001_2, CTSLL2-001_1, CTSLL2-001_2, CTSLL2-001_3, GLUDP6-001_1, GLUDP6-001_2, GLUDP6-001_3, CTD-2173J9-201_1, CTD-2173J9-201_2@75.1052631578947@50@143@@:ceramidase activity;sphingolipid metabolic process@NA
D115022@129460@129478@deletion@19@51361725@51465940@10@chr10:51361725-51465940@82.2@507@85@0.168@NA@ENST00000404618_1, ENST00000404618_2, ENST00000404618_3, ENST00000404618_4, ENST00000432221_1, ENST00000432221_2, ENST00000432221_3, ENST00000432221_4, TIMM23B-202_1, TIMM23B-202_2, TIMM23B-202_3, TIMM23B-202_4, TIMM23B-202_5, TIMM23B-202_6, TIMM23B-202_7, TIMM23B-202_10, AGAP7-201_9@73.3529411764706@8@142@:translocase of inner mitochondrial membrane 23 homolog B (yeast):ArfGAP with GTPase domain, ankyrin repeat and PH domain 7@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
D115022@129509@129510@duplication@2@51603186@51603348@10@chr10:51603186-51603348@7.09@73@135@1.85@NA@TIMM23-202_9, TIMM23-202_10@0@0@0@:translocase of inner mitochondrial membrane 23 homolog B (yeast):translocase of inner mitochondrial membrane 23 homolog B (yeast);translocase of inner mitochondrial membrane 23 homolog (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:mitochondrion;mitochondrial inner membrane;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;mitochondrial intermembrane space;integral to mitochondrial inner membrane;intracellular protein transport;protein binding;integral to membrane;cellular protein metabolic process;protein targeting to mitochondrion@NA
D115022@129604@129611@deletion@8@51965744@51994313@10@chr10:51965744-51994313@33.6@231@50@0.216@NA@ASAH2-201_5, ASAH2-201_6, ASAH2-201_7, ASAH2-201_8, ASAH2-201_9, ASAH2-201_10, ASAH2-201_11, ASAH2-201_12@147.125@53@186@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
D115022@135969@135970@duplication@2@126463246@126463352@10@chr10:126463246-126463352@5.47@100@158@1.58@NA@FAM53B-002_4, METTL10-202_5@1@1@1@:methyltransferase like 10@:protein methyltransferase activity;tRNA (guanine-N7-)-methyltransferase activity;protein methylation;methyltransferase activity;metabolic process;cytoplasm;tRNA modification:protein methyltransferase activity;tRNA (guanine-N7-)-methyltransferase activity;protein methylation;methyltransferase activity;metabolic process;cytoplasm;tRNA modification@NA
D115022@136770@136770@duplication@1@135439428@135439504@10@chr10:135439428-135439504@10.6@284@457@1.61@CNVR4989.11, CNVR4989.4@FRG2B-202_3@29@29@29@:FSHD region gene 2 family, member B@:nucleus@NA
D115022@144637@144641@deletion@5@71709960@71711604@11@chr11:71709960-71711604@22@366@178@0.486@NA@IL18BP-005_1, IL18BP-005_2, IL18BP-005_3, IL18BP-005_4, IL18BP-005_5@0@0@0@:interleukin 18 binding protein@:T-helper 1 type immune response;interleukin-18 binding;cellular response to hydrogen peroxide;cellular response to tumor necrosis factor;extracellular negative regulation of signal transduction;extracellular space;protein binding;receptor antagonist activity;extracellular region;response to lipopolysaccharide@NA
D115022@145893@145897@deletion@5@89499780@89531798@11@chr11:89499780-89531798@19.7@510@263@0.516@NA@TRIM77-201_8, ENST00000375974_1, ENST00000375974_2, ENST00000375974_3, TRIM49-201_8@52.4@49@56@:tripartite motif containing 49@:protein binding;intracellular;DNA binding;zinc ion binding@NA
D115022@145911@145916@duplication@6@89583465@89591641@11@chr11:89583465-89591641@9.04@157@257@1.64@NA@TRIM53L-202_7, AP005435-201_1, AP005435-201_2, AP005435-201_3, AP005435-201_4, AP005435-201_5@24.8333333333333@20@46@NA@NA@NA
D115022@145952@145964@deletion@13@89706559@89729449@11@chr11:89706559-89729449@19.3@129@28@0.217@NA@TRIM64-202_9, ENST00000442514_1, ENST00000442514_2, ENST00000442514_3, ENST00000442514_4, ENST00000442514_5, ENST00000442514_6, ENST00000442514_7, ENST00000442514_8, ENST00000442514_9, TRIM53-202_5, TRIM53-202_6, TRIM53-202_7@47.0769230769231@21@176@NA@NA@NA
D115022@145971@145983@duplication@13@89768378@89806559@11@chr11:89768378-89806559@11.1@201@313@1.56@NA@ENST00000432771_3, ENST00000432771_4, ENST00000432771_5, ENST00000432771_6, ENST00000432771_7, ENST00000432771_8, ENST00000436580_1, ENST00000436580_2, ENST00000436580_3, ENST00000436580_4, ENST00000436580_5, ENST00000436580_6, ENST00000436580_7@88.2307692307692@82@104@:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;DNA binding;zinc ion binding@NA
D115022@147532@147532@duplication@1@117075812@117077073@11@chr11:117075812-117077073@6.19@177@268@1.51@NA@PCSK7-201_17@1@1@1@:proprotein convertase subtilisin/kexin type 7@:proteolysis;integral to Golgi membrane;serine-type endopeptidase activity;peptide hormone processing@NA
D115022@150775@150775@deletion@1@9446260@9446507@12@chr12:9446260-9446507@16.9@80@1@0.0125@NA@DDX11L8-201_2@42@42@42@NA@NA@NA
D115022@150778@150782@duplication@5@9450373@9453843@12@chr12:9450373-9453843@9.65@218@330@1.51@NA@DDX11L8-201_5, DDX11L8-201_6, DDX11L8-201_7, DDX11L8-201_8, DDX11L8-201_9@66.6@55@78@NA@NA@NA
D115022@150786@150786@duplication@1@9456738@9456804@12@chr12:9456738-9456804@12@116@239@2.06@NA@DDX11L8-201_13@83@83@83@NA@NA@NA
D115022@150826@150841@duplication@16@9590609@9707352@12@chr12:9590609-9707352@21.8@826@1166@1.41@CNVR5429.1@DDX12-203_1, DDX12-203_2, DDX12-203_3, AC006432-201_1, AC006432-201_2, AC006432-201_3, AC006432-201_4, AC006432-201_5, AC006432-201_6, AC006432-201_7, AC006432-201_8, AC006432-201_9, AC006432-201_11, AC006432-201_12, AC006432-201_13@20.7333333333333@7@25@NA@NA@NA
D115022@150968@150973@deletion@6@10583212@10588593@12@chr12:10583212-10588593@122@792@125@0.158@CNVR5430.1@KLRC2-201_1, KLRC2-201_2, KLRC2-201_3, KLRC2-201_4, KLRC2-201_5, KLRC2-201_6@54.8333333333333@38@67@:killer cell lectin-like receptor subfamily C, member 2@:carbohydrate binding:transmembrane signaling receptor activity;carbohydrate binding;protein binding;signal transduction;cellular defense response;integral to plasma membrane@NA
D115022@152242@152273@duplication@32@31265928@31359089@12@chr12:31265928-31359089@116@5236@7406@1.41@CNVR5483.1@ENST00000266524_1, ENST00000266524_2, ENST00000266524_3, ENST00000266524_4, ENST00000266524_5, ENST00000266524_6, ENST00000266524_7, ENST00000266524_8, ENST00000266524_9, ENST00000266524_10, ENST00000266524_11, ENST00000266524_12, ENST00000266524_13, ENST00000266524_14, ENST00000266524_15, ENST00000266524_16, ENST00000266524_17, ENST00000266524_18, ENST00000266524_19, ENST00000266524_20, ENST00000266524_21, ENST00000266524_22, ENST00000266524_23, ENST00000266524_24, ENST00000266524_25, ENST00000266524_26, ENST00000266524_27, ENST00000266524_28, ENST00000266524_29, ENST00000266524_30, ENST00000266524_31, ENST00000266524_32@1.3125@0@6@NA@NA@NA
D115022@160888@160889@duplication@2@124496095@124773917@12@chr12:124496095-124773917@7.76@607@853@1.41@NA@ZNF664-201_5, FAM101A-202_1@2.5@0@5@:zinc finger protein 664:family with sequence similarity 101, member A;protein FAM101A@:intracellular;nucleus;DNA binding;molecular_function;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;biological_process@NA
D115022@162127@162128@deletion@2@24465240@24465671@13@chr13:24465240-24465671@11.3@985@651@0.661@NA@RP11-45B20-002_6, ENST00000382133_3@29@29@29@:C1q and tumor necrosis factor related protein 9B@:collagen;protein binding@NA
D115022@166687@166690@duplication@4@19411434@19412308@14@chr14:19411434-19412308@10.6@241@365@1.51@CNVR6072.1, CNVR6072.16@CR383656-201_3, CR383656-201_4, CR383656-201_5, CR383656-201_6@36@34@37@NA@NA@NA
D115022@166751@166767@deletion@17@20137324@20337303@14@chr14:20137324-20337303@51.2@3802@2548@0.67@CNVR6072.12, CNVR6072.4, CNVR6072.37@AL512310-201_1, AL512310-201_2, AL512310-201_3, AL512310-201_4, AL512310-201_5, ENST00000398231_1, ENST00000398231_2, ENST00000398231_3, ENST00000398231_4, ENST00000398231_5, ENST00000398231_6, ENST00000334072_1, ENST00000334072_2, ENST00000426759_1, ENST00000426759_2, OR4K3P-201_1, OR4K3P-201_2@79.1176470588235@44@102@:olfactory receptor, family 4, subfamily N, member 2:olfactory receptor, family 4, subfamily Q, member 3:olfactory receptor, family 4, subfamily M, member 1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
D115022@170809@170811@deletion@3@74003820@74010454@14@chr14:74003820-74010454@51.5@387@99@0.256@CNVR6188.1, CNVR6188.4@ACOT1-201_1, ACOT1-201_2, ACOT1-201_3@109.666666666667@99@116@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
D115022@170815@170815@deletion@1@74041614@74042360@14@chr14:74041614-74042360@4.97@117@65@0.556@CNVR6188.1, CNVR6188.6@ACOT2-201_3@5@5@5@:acyl-CoA thioesterase 2@:acyl-CoA metabolic process;mitochondrion;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity;receptor binding@NA
D115022@173397@173400@duplication@4@106015853@106053669@14@chr14:106015853-106053669@7.76@127@207@1.63@CNVR6294.46@AL928742-001_1, IGHA2-004_2, IGHA2-004_3, IGHA2-004_4@1.5@1@2@@:protein binding@NA
D115022@173415@173431@duplication@17@106092111@106166399@14@chr14:106092111-106166399@22@1002@1377@1.37@CNVR6294.46, CNVR6294.20, CNVR6294.43, CNVR6294.65, CNVR6294.66@IGHG4-001_1, IGHG2-002_1, IGHG2-002_2, IGHG2-002_3, IGHG2-002_4, IGHG2-002_5, IGHGP-001_1, IGHGP-001_2, IGHGP-001_3, IGHGP-001_4, IGHGP-001_5, IGHGP-001_6, AL928761-201_1, AL928761-201_2, AL928761-201_3, AL928761-201_4, AL928768-201_3@6.58823529411765@4@9@@:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response@NA
D115022@173440@173443@duplication@4@106174124@106204183@14@chr14:106174124-106204183@19.4@579@872@1.51@CNVR6294.46, CNVR6294.43, CNVR6294.66, CNVR6294.68, CNVR6294.69, CNVR6294.19@IGHA1-002_1, IGHEP1-001_1, IGHEP1-001_2, IGHG1-002_6@1.25@1@2@@:antigen binding;protein binding;immune response;protein-chromophore linkage:antigen binding;complement activation;protein binding;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response@: MYELOMA, MULTIPLE
D115022@173556@173563@duplication@8@106787370@106805717@14@chr14:106787370-106805717@12.3@984@1333@1.35@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-29-001_1, IGHV3-29-001_2, IGHV3-30-001_1, IGHV3-30-001_2, IGHV3-30-2-001_1, IGHV3-30-2-001_2, IGHV4-31-001_1, IGHV4-31-001_2@16.5@13@19@@:protein binding:protein binding@NA
D115022@173590@173591@duplication@2@106899046@106899494@14@chr14:106899046-106899494@11.1@212@341@1.61@CNVR6294.26, CNVR6294.56, CNVR6294.18@IGHV3-41-001_1, IGHV3-41-001_2@10.5@10@11@NA@NA@NA
D115022@173635@173638@duplication@4@107095128@107099589@14@chr14:107095128-107099589@17.8@468@708@1.51@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61-001_1, IGHV4-61-001_2, IGHV3-62-001_1, IGHV3-62-001_2@16@15@17@@:protein binding@NA
D115022@173645@173645@duplication@1@107131035@107131335@14@chr14:107131035-107131335@5.21@277@390@1.41@CNVR6294.56, CNVR6294.16@IGHV3-66-001_2@3@3@3@@:protein binding@NA
D115022@173681@173708@duplication@28@20433872@20644377@15@chr15:20433872-20644377@84@7826@10551@1.35@CNVR6295.15, CNVR6295.7@ENST00000400226_1, ENST00000400226_2, ENST00000400226_3, ENST00000400226_4, ENST00000400226_8, ENST00000400226_9, ENST00000400226_10, ENST00000400226_11, ENST00000400226_12, ENST00000400226_14, ENST00000400226_15, ENST00000400226_16, HERC2P3-014_22, HERC2P3-014_23, HERC2P3-014_24, HERC2P3-014_25, HERC2P3-014_26, HERC2P3-014_27, AC026495-201_21, AC026495-201_22, AC026495-201_23, AC026495-201_24, AC026495-201_25, AC026495-201_26@77.5833333333333@48@112@NA@NA@NA
D115022@173819@173822@duplication@4@22466060@22473354@15@chr15:22466060-22473354@19.6@1683@2370@1.41@CNVR6297.4, CNVR6297.6@AC010760-202_1, AC010760-202_2, VSIG6-201_1, VSIG6-201_2@27@0@49@NA@NA@NA
D115022@174406@174410@duplication@5@29008591@29009297@15@chr15:29008591-29009297@13.4@665@922@1.39@NA@ENST00000456510_1, ENST00000456510_2, ENST00000456510_3, ENST00000456510_4, ENST00000456510_5@23.6@18@26@NA@NA@NA
D115022@174659@174659@deletion@1@32449811@32449977@15@chr15:32449811-32449977@14.2@65@0@0@CNVR6345.2, CNVR6345.1@CHRNA7-205_6@66@66@66@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
D115022@174661@174663@deletion@3@32451772@32461234@15@chr15:32451772-32461234@5.89@110@60@0.545@CNVR6345.2, CNVR6345.1@CHRNA7-205_8, CHRNA7-205_9, CHRNA7-205_10@91.3333333333333@35@133@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
D115022@180187@180187@duplication@1@79065427@79065546@15@chr15:79065427-79065546@5.97@44@93@2.11@NA@ADAMTS7-201_14@10@10@10@:A disintegrin and metalloproteinase with thrombospondin motifs 7-like;ADAM metallopeptidase with thrombospondin type 1 motif, 7@:metallopeptidase activity;extracellular matrix;proteolysis;peptidase activity;proteinaceous extracellular matrix;metalloendopeptidase activity;cell surface;zinc ion binding@NA
D115022@181790@181791@deletion@2@100341182@100345135@15@chr15:100341182-100345135@5.65@268@175@0.653@CNVR6545.2@C15orf51-202_2, C15orf51-202_3@11@11@11@NA@NA@NA
D115022@183378@183378@deletion@1@2672693@2672767@16@chr16:2672693-2672767@17.8@83@0@0@CNVR6602.2@AC141586-201_6@57@57@57@NA@NA@NA
D115022@185304@185304@duplication@1@20491897@20492023@16@chr16:20491897-20492023@6.82@206@312@1.51@NA@ACSM2A-201_11@1@1@1@:acyl-CoA synthetase medium-chain family member 2A@:mitochondrion;butyrate-CoA ligase activity;catalytic activity;ATP binding;glucose homeostasis;medium-chain fatty-acyl-CoA metabolic process;fatty acid metabolic process;triglyceride homeostasis;metabolic process;mitochondrial matrix;metal ion binding@NA
D115022@185592@185598@duplication@7@21763692@21809180@16@chr16:21763692-21809180@7.71@355@487@1.37@CNVR6668.5, CNVR6668.2, CNVR6668.7@OTOA-001_25, OTOA-001_26, OTOA-001_27, OTOA-001_28, AC092375-201_5, AC092375-201_6, AC092375-201_7@23.7142857142857@3@62@:otoancorin@:proteinaceous extracellular matrix;apical plasma membrane;sensory perception of sound;anchored to membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22
D115022@186358@186369@duplication@12@28616920@28712933@16@chr16:28616920-28712933@39@1088@1619@1.49@NA@SULT1A1-203_1, SULT1A1-203_2, SULT1A1-203_3, SULT1A1-203_4, SULT1A1-203_5, SULT1A1-203_6, SULT1A1-203_7, SULT1A1-203_8, SULT1A1-203_9, SULT1A1-203_10, AC145285-201_1, AC145285-201_2@58.25@17@73@:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1:nuclear pore complex-interacting protein-like 2-like;putative NPIP-like protein LOC613037-like:eukaryotic translation initiation factor 3, subunit C@:small molecule metabolic process;sulfation;aryl sulfotransferase activity;amine metabolic process;catecholamine metabolic process;xenobiotic metabolic process;cytosol;steroid sulfotransferase activity;integral to membrane;sulfotransferase activity;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process;estrogen metabolic process:cytosol;protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;cellular protein metabolic process;binding;gene expression;translation;translation initiation factor activity@NA
D115022@188232@188233@deletion@2@55806283@55807424@16@chr16:55806283-55807424@5.53@192@117@0.609@CNVR6730.1@CES4-202_5, CES4-202_6@110.5@110@111@NA@NA@NA
D115022@188252@188254@duplication@3@55844841@55850875@16@chr16:55844841-55850875@8.7@365@510@1.4@CNVR6731.1@CES1-203_8, CES1-203_9, CES1-203_10@29.3333333333333@25@32@:carboxylesterase 1;liver carboxylesterase 1-like@:hydrolase activity;methyl salicylate esterase activity;response to toxin;methylumbelliferyl-acetate deacetylase activity;endoplasmic reticulum lumen;retinyl-palmitate esterase activity;methyl jasmonate esterase activity;metabolic process;carboxylesterase activity;methyl indole-3-acetate esterase activity@: CARBOXYLESTERASE 1; CES1
D115022@189930@189930@duplication@1@70010214@70010636@16@chr16:70010214-70010636@8.19@69@142@2.06@CNVR6762.3, CNVR6762.2@AC026468-201_8@10@10@10@NA@NA@NA
D115022@189989@189989@duplication@1@70219790@70219880@16@chr16:70219790-70219880@6.54@70@131@1.87@CNVR6764.1, CNVR6764.5@CLEC18C-201_11@19@19@19@:C-type lectin domain family 18, member C@:carbohydrate binding;protein binding;extracellular region@NA
D115022@190577@190577@duplication@1@74566021@74566052@16@chr16:74566021-74566052@5.31@49@96@1.96@NA@GLG1-201_2@1@1@1@:golgi glycoprotein 1@:extracellular matrix;Golgi apparatus;negative regulation of protein processing;negative regulation of transforming growth factor beta receptor signaling pathway;bone morphogenesis;Golgi membrane;Golgi medial cisterna;regulation of chondrocyte differentiation;integral to membrane;membrane;receptor binding@NA
D115022@192611@192611@duplication@1@3687652@3687678@17@chr17:3687652-3687678@4.86@91@146@1.6@NA@ITGAE-202_1@0@0@0@:integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)@:protein binding;integrin complex;cell adhesion;plasma membrane;integrin-mediated signaling pathway;external side of plasma membrane@NA
D115022@195229@195238@deletion@10@16664741@16703686@17@chr17:16664741-16703686@23.8@1853@1229@0.663@NA@CCDC144A-202_13, CCDC144A-202_14, CCDC144A-202_15, CCDC144A-202_16, CCDC144A-202_17, CCDC144A-202_18, AC022596-003_1, AC022596-003_2, AC022596-003_3, AC022596-003_4@59.2@45@66@:coiled-coil domain containing 144A@NA@NA
D115022@195240@195257@deletion@18@16705575@16734358@17@chr17:16705575-16734358@15.2@1096@749@0.683@NA@AC022596-003_6, AC022596-003_7, AC022596-003_8, AC022596-003_9, AC022596-003_10, AC022596-003_11, AC022596-001_1, AC022596-001_2, AC022596-001_3, AC022596-001_4, AC022596-001_5, AC022596-001_6, AC022596-001_7, AC022596-001_8, ENST00000414673_5, ENST00000414673_6, ENST00000414673_7, ENST00000414673_8@86.1666666666667@64@97@:coiled-coil domain containing 144A@NA@NA
D115022@195703@195747@duplication@45@18344490@18457581@17@chr17:18344490-18457581@220@1751@3837@2.19@NA@ENST00000399124_3, ENST00000399124_4, ENST00000399124_5, ENST00000399124_6, ENST00000399124_7, ENST00000399124_8, ENST00000411877_4, LGALS9C-201_1, LGALS9C-201_2, LGALS9C-201_3, LGALS9C-201_4, LGALS9C-201_5, LGALS9C-201_6, LGALS9C-201_7, LGALS9C-201_8, LGALS9C-201_9, LGALS9C-201_10, LGALS9C-201_11, ENST00000426269_1, ENST00000426269_2, ENST00000426269_3, ENST00000426269_4, ENST00000426269_5, AC107983-001_1, AC107983-001_2, AC107983-001_3, AC107983-001_4, AC107983-001_5, AC107983-001_6, AC107983-001_7, AC107983-001_8, AC107983-001_9, AC107983-001_10, ENST00000456184_1, ENST00000456184_2, CCDC144B-201_14, CCDC144B-201_15, CCDC144B-201_16, CCDC144B-201_17, CCDC144B-201_18, ENST00000447265_11, ENST00000447265_12, ENST00000447265_13, ENST00000447265_14, ENST00000447265_15@130.2@79@153@:lectin, galactoside-binding, soluble, 9C:protein FAM106B-like@:carbohydrate binding@NA
D115022@195757@195759@deletion@3@18498037@18498176@17@chr17:18498037-18498176@26.5@306@120@0.392@NA@CCDC144B-201_8, CCDC144B-201_9, ENST00000447265_5@1@1@1@NA@NA@NA
D115022@196150@196150@deletion@1@20353178@20353433@17@chr17:20353178-20353433@5.41@24@0@0@CNVR7021.1, CNVR7021.3@LGALS9B-201_11@75@75@75@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
D115022@197726@197728@deletion@3@34539180@34539966@17@chr17:34539180-34539966@19.4@89@0@0@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1-202_2, CCL4L1-202_3, CCL4L1-202_4@118@113@122@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
D115022@198034@198034@duplication@1@36353603@36353766@17@chr17:36353603-36353766@8.23@382@562@1.47@CNVR7083.3@AC183087-202_12@59@59@59@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
D115022@200259@200265@deletion@7@43585590@43594649@17@chr17:43585590-43594649@10.2@601@400@0.666@CNVR7113.4, CNVR7113.6, CNVR7113.2, CNVR7113.1@AC091132-201_1, AC091132-201_2, AC091132-201_3, AC091132-201_4, AC091132-201_5, ENST00000339474_2, ENST00000339474_3@94.7142857142857@81@127@NA@NA@NA
D115022@200326@200328@duplication@3@44363278@44364337@17@chr17:44363278-44364337@7.97@1298@1693@1.3@CNVR7114.3, CNVR7114.2, CNVR7114.10@ENST00000451529_1, ENST00000451529_2, ENST00000451529_3@52@11@90@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
D115022@200337@200340@deletion@4@44399690@44409348@17@chr17:44399690-44409348@12.9@79@13@0.165@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A-001_7, LRRC37A-001_8, LRRC37A-001_9, LRRC37A-001_10@144.75@141@154@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
D115022@200343@200349@deletion@7@44414664@44592688@17@chr17:44414664-44592688@19.2@96@6@0.0625@CNVR7114.2, CNVR7114.1@LRRC37A-001_13, LRRC37A-001_14, LRRC37A-001_15, AC005829-202_1, AC005829-202_2, AC005829-202_3, LRRC37A2-201_1@161.142857142857@124@196@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane@NA
D115022@205726@205726@deletion@1@117045@117305@18@chr18:117045-117305@13.1@323@164@0.508@NA@ENST00000400614_3@26@26@26@NA@NA@NA
D115022@213372@213373@duplication@2@14070581@14070882@19@chr19:14070581-14070882@7@392@539@1.38@NA@DCAF15-201_9, DCAF15-201_10@8.5@0@17@:DDB1 and CUL4 associated factor 15@:protein ubiquitination@NA
D115022@213441@213442@duplication@2@14201157@14201300@19@chr19:14201157-14201300@5.23@56@101@1.8@CNVR7546.1@ENST00000269724_1, ENST00000269724_2@0@0@0@@:protein binding;sequence-specific DNA binding;nucleus@NA
D115022@213493@213494@duplication@2@14508472@14508748@19@chr19:14508472-14508748@22.2@105@286@2.72@NA@CD97-205_8, CD97-205_9@10.5@7@14@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
D115022@213632@213633@deletion@2@14876338@14876617@19@chr19:14876338-14876617@9.29@604@395@0.654@NA@EMR2-209_8, EMR2-209_9@3@3@3@:egf-like module containing, mucin-like, hormone receptor-like 2@:transmembrane signaling receptor activity;inflammatory response;G-protein coupled receptor activity;ruffle membrane;integral to membrane;plasma membrane;cell surface receptor signaling pathway;neuropeptide signaling pathway;granulocyte chemotaxis;cell migration;leading edge membrane;G-protein coupled receptor signaling pathway;protein binding;cell adhesion;membrane;calcium ion binding;chondroitin sulfate binding@NA
D115022@213635@213635@deletion@1@14877792@14877922@19@chr19:14877792-14877922@8.66@73@22@0.301@NA@EMR2-209_6@4@4@4@:egf-like module containing, mucin-like, hormone receptor-like 2@:transmembrane signaling receptor activity;inflammatory response;G-protein coupled receptor activity;ruffle membrane;integral to membrane;plasma membrane;cell surface receptor signaling pathway;neuropeptide signaling pathway;granulocyte chemotaxis;cell migration;leading edge membrane;G-protein coupled receptor signaling pathway;protein binding;cell adhesion;membrane;calcium ion binding;chondroitin sulfate binding@NA
D115022@215927@215928@duplication@2@35861833@35863856@19@chr19:35861833-35863856@10.5@198@336@1.7@CNVR7627.1@FFAR3-001_1, FFAR3-001_2@101@100@102@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
D115022@217295@217297@deletion@3@40376633@40382827@19@chr19:40376633-40382827@12.3@201@105@0.522@CNVR7639.2@FCGBP-201_22, FCGBP-201_23, FCGBP-201_24@145@131@155@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D115022@217302@217305@duplication@4@40392000@40398511@19@chr19:40392000-40398511@8.17@355@491@1.38@CNVR7639.2, CNVR7639.3@FCGBP-201_14, FCGBP-201_15, FCGBP-201_16, FCGBP-201_17@116@103@127@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D115022@217595@217595@deletion@1@41327389@41327534@19@chr19:41327389-41327534@8.82@77@24@0.312@NA@CYP2F1P-001_5@0@0@0@NA@NA@NA
D115022@217601@217604@deletion@4@41350538@41352957@19@chr19:41350538-41352957@33.5@679@344@0.507@CNVR7642.1@CYP2A6-204_6, CYP2A6-204_7, CYP2A6-204_8, CYP2A6-204_9@9@9@9@:cytochrome P450, family 2, subfamily A, polypeptide 6@:coumarin 7-hydroxylase activity;steroid metabolic process;oxidation-reduction process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;endoplasmic reticulum membrane;drug metabolic process;electron carrier activity;small molecule metabolic process;exogenous drug catabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;enzyme binding;heme binding;xenobiotic metabolic process;iron ion binding;coumarin catabolic process;coumarin metabolic process@: CYTOCHROME P450, SUBFAMILY IIA, POLYPEPTIDE 6; CYP2A6
D115022@221203@221204@duplication@2@54780120@54780311@19@chr19:54780120-54780311@7.97@190@289@1.52@NA@LILRB2-001_11, LILRB2-001_12@0@0@0@:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2@:regulation of immune response;positive regulation of T cell tolerance induction;immune response;cell adhesion molecule binding;heterotypic cell-cell adhesion;eukaryotic cell surface binding;plasma membrane;negative regulation of calcium ion transport;inhibitory MHC class I receptor activity;cellular response to lipopolysaccharide;cell-cell signaling;membrane;negative regulation of T cell proliferation;Fc receptor mediated inhibitory signaling pathway;immune response-inhibiting cell surface receptor signaling pathway;positive regulation of regulatory T cell differentiation;negative regulation of antigen processing and presentation;extracellular space;integral to plasma membrane;receptor activity;MHC class I protein binding;cell surface receptor signaling pathway;regulation of dendritic cell differentiation;positive regulation of interleukin-6 production;protein phosphatase 1 binding;MHC class Ib protein binding;cytoplasm;signal transduction;protein binding;cellular defense response;positive regulation of T cell proliferation;cell surface@NA
D115022@221340@221341@deletion@2@55146557@55146748@19@chr19:55146557-55146748@11.3@168@79@0.47@NA@LILRB1-002_12, LILRB1-002_13@1@1@1@:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1@:interferon-gamma secretion;defense response to virus;dendritic cell differentiation;negative regulation of interferon-gamma production;regulation of immune response;negative regulation of dendritic cell differentiation;HLA-A specific inhibitory MHC class I receptor activity;negative regulation of alpha-beta T cell activation;negative regulation of transforming growth factor-beta secretion;negative regulation of interleukin-10 secretion;T cell proliferation involved in immune response;plasma membrane;negative regulation of mononuclear cell proliferation;positive regulation of gamma-delta T cell activation involved in immune response;negative regulation of interferon-beta secretion;negative regulation of calcium ion transport;response to virus;negative regulation of serotonin secretion;negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell;cellular response to lipopolysaccharide;negative regulation of cell cycle;positive regulation of cytolysis;negative regulation of T cell mediated cytotoxicity;positive regulation of defense response to virus by host;MHC class I receptor activity;negative regulation of natural killer cell mediated cytotoxicity;negative regulation of dendritic cell apoptotic process;negative regulation of T cell proliferation;negative regulation of CD8-positive, alpha-beta T cell activation;immune response-inhibiting cell surface receptor signaling pathway;Fc receptor mediated inhibitory signaling pathway;negative regulation of cytokine secretion involved in immune response;SH2 domain binding;negative regulation of interleukin-12 secretion;HLA-B specific inhibitory MHC class I receptor activity;negative regulation of osteoclast development;integral to membrane;interferon-gamma production;MHC class I protein binding;protein homodimerization activity;positive regulation of transcription from RNA polymerase II promoter;protein phosphatase 1 binding;positive regulation of gene expression;external side of plasma membrane;receptor internalization;cytoplasm;negative regulation of tumor necrosis factor biosynthetic process;protein binding;signal transduction;negative regulation of interferon-gamma biosynthetic process;negative regulation of endocytosis;positive regulation of apoptotic process@NA
D115022@221403@221413@duplication@11@55277931@55290115@19@chr19:55277931-55290115@22.6@1906@2509@1.32@CNVR7725.2, CNVR7725.1@KIR2DL3-201_6, KIR2DL3-201_7, KIR2DL3-201_8, KIR2DP1-001_7, KIR2DP1-001_8, KIR2DP1-001_9, KIR2DL1-002_1, KIR2DL1-002_2, KIR2DL1-002_3, KIR2DL1-002_4, KIR2DL1-002_5@113.909090909091@76@126@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
D115022@222067@222069@deletion@3@58002993@58003369@19@chr19:58002993-58003369@9.05@201@116@0.577@CNVR7748.1@ZNF419-202_4, ZNF419-202_5, ZNF419-202_6@0@0@0@:zinc finger protein 419@:intracellular;DNA binding;regulation of transcription, DNA-dependent;cytoplasm;nucleolus;nucleus;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding@NA
D115022@222594@222594@deletion@1@1895747@1896102@20@chr20:1895747-1896102@8.21@168@86@0.512@CNVR7764.2@SIRPA-201_3@34@34@34@:signal-regulatory protein alpha@:blood coagulation;protein binding;integral to membrane;SH3 domain binding;cell adhesion;plasma membrane;membrane;leukocyte migration@NA
D115022@224467@224467@deletion@1@26063532@26065122@20@chr20:26063532-26065122@7.58@113@52@0.46@CNVR7823.4, CNVR7823.3, CNVR7823.5, CNVR7823.1@C20orf91-201_5@60@60@60@NA@NA@NA
D115022@228225@228226@duplication@2@60991818@60992376@20@chr20:60991818-60992376@4.99@147@213@1.45@NA@C20orf151-001_4, C20orf151-001_5@0@0@0@:RBBP8 N-terminal like@NA@NA
D115022@231958@231958@duplication@1@16287256@16287718@22@chr22:16287256-16287718@9.65@91@184@2.02@CNVR8071.2, CNVR8071.3, CNVR8071.9@POTEH-002_1@105@105@105@:POTE ankyrin domain family, member H@:protein binding@NA
D115022@232772@232784@deletion@13@20386519@20402444@22@chr22:20386519-20402444@13@82@17@0.207@CNVR8094.9, CNVR8094.4, CNVR8094.10@PI4KAP1-204_1, PI4KAP1-204_2, PI4KAP1-204_3, PI4KAP1-204_4, PI4KAP1-204_5, PI4KAP1-204_6, PI4KAP1-204_7, PI4KAP1-204_8, PI4KAP1-204_9, PI4KAP1-204_10, PI4KAP1-204_11, PI4KAP1-204_12, PI4KAP1-204_13@166.615384615385@156@172@NA@NA@NA
D115022@233257@233257@duplication@1@22312273@22312385@22@chr22:22312273-22312385@6.38@71@132@1.86@CNVR8102.1@ENST00000449517_5@1@1@1@:topoisomerase (DNA) III beta@:chromosome segregation;DNA topoisomerase type I activity;DNA binding;ATP binding;condensed chromosome;DNA topoisomerase activity;DNA topological change;chromosome;nucleus@NA
D115022@233740@233754@duplication@15@24368973@24394850@22@chr22:24368973-24394850@53@1215@1872@1.54@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTTP1-001_1, ENST00000329210_2, ENST00000329210_3, ENST00000329210_4, ENST00000439866_1, ENST00000439866_2, GSTT1-009_1, GSTT1-009_2, GSTT1-009_3, GSTT1-009_4, GSTT1-009_5, ENST00000439996_1, ENST00000439996_2, GSTTP2-001_4, GSTTP2-001_5@137.666666666667@122@149@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
D115022@236145@236146@duplication@2@39436611@39436983@22@chr22:39436611-39436983@5.19@173@247@1.43@CNVR8165.1@APOBEC3F-001_1, APOBEC3G-201_1@1@1@1@:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G@:cytidine deamination;defense response to virus;catalytic activity;cytidine deaminase activity;RNA binding;negative regulation of viral reproduction;negative regulation of transposition;negative regulation of viral genome replication;DNA demethylation;innate immune response;cytoplasm;base conversion or substitution editing;apolipoprotein B mRNA editing enzyme complex;positive regulation of defense response to virus by host;negative regulation of retroviral genome replication;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;zinc ion binding:cytidine deamination;defense response to virus;mitochondrion;catalytic activity;cytidine deaminase activity;RNA binding;negative regulation of viral reproduction;viral reproduction;protein homodimerization activity;negative regulation of transposition;virus-host interaction;negative regulation of viral genome replication;DNA cytosine deamination;deoxycytidine deaminase activity;innate immune response;cytoplasm;base conversion or substitution editing;cytosol;apolipoprotein B mRNA editing enzyme complex;positive regulation of defense response to virus by host;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;negative regulation of retroviral genome replication;zinc ion binding@NA
D122641@575@592@duplication@18@1569583@1607030@1@chr1:1569583-1607030@113@1511@2740@1.81@CNVR17.1@MMP23B-202_8, MMP23B-202_9, CDC2L2-208_12, CDC2L2-208_13, CDC2L2-208_14, CDC2L2-208_15, CDC2L2-208_16, CDC2L2-208_17, CDC2L2-208_18, CDC2L2-208_19, CDC2L2-208_20, CDC2L2-208_21, RP11-345P4-003_5, RP11-345P4-003_6, RP11-345P4-003_7, RP11-345P4-003_8, RP11-345P4-003_9, RP11-345P4-003_10@5.72222222222222@0@28@:matrix metallopeptidase 23B:cyclin-dependent kinase 11B:solute carrier family 35, member E2B@:metallopeptidase activity;extracellular matrix;reproduction;intracellular;protein binding;proteolysis;integral to membrane;proteinaceous extracellular matrix;endoplasmic reticulum membrane;metalloendopeptidase activity;zinc ion binding:protein serine/threonine kinase activity;protein tyrosine kinase activity;protein phosphorylation;protein kinase activity;cell division;transferase activity, transferring phosphorus-containing groups;ATP binding:integral to membrane;membrane;transmembrane transport@NA
D122641@2329@2335@deletion@7@12987525@13036801@1@chr1:12987525-13036801@8.6@106@47@0.443@CNVR72.3, CNVR72.4, CNVR72.9@RP11-450I1-001_2, PRAMEF6-201_1, PRAMEF6-201_2, PRAMEF6-201_3, PRAMEF6-201_4, PRAMEF22-001_1, PRAMEF22-001_2@35.8571428571429@25@54@:PRAME family member 6;PRAME family member 23;PRAME family member 9/15-like;PRAME family member 5:PRAME family member 22@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
D122641@2364@2373@duplication@10@13330416@13379722@1@chr1:13330416-13379722@7.73@7@54@7.71@CNVR74.8, CNVR74.4, CNVR74.2@PRAMEF3-201_1, PRAMEF3-201_2, RP11-248D7-001_1, RP11-248D7-001_2, RP11-248D7-001_3, PRAMEF5-001_1, PRAMEF5-001_2, PRAMEF5-001_3, PRAMEF5-001_4, RP11-219C24-008_2@119.1@82@159@:PRAME family member 3:PRAME family member 5@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
D122641@2756@2756@deletion@1@16378695@16378907@1@chr1:16378695-16378907@4.87@95@50@0.526@CNVR92.1@CLCNKB-001_15@9@9@9@:chloride channel, voltage-sensitive Kb@:ion channel activity;transport;chloride channel complex;transmembrane transport;protein binding;integral to membrane;chloride transport;excretion;integral to plasma membrane;voltage-gated chloride channel activity;membrane@: BARTTER SYNDROME, TYPE 3; BARTTER SYNDROME, TYPE 4B
D122641@2888@2892@duplication@5@16890515@16893847@1@chr1:16890515-16893847@7.34@265@373@1.41@CNVR93.3, CNVR93.6, CNVR93.11@NBPF1-201_25, NBPF1-201_26, NBPF1-201_27, NBPF1-201_28, NBPF1-201_29@74.6@66@79@NA@NA@NA
D122641@2931@2948@duplication@18@16972895@17007723@1@chr1:16972895-17007723@101@3752@5514@1.47@CNVR93.3, CNVR93.6, CNVR93.12, CNVR93.7, CNVR93.15@RP5-1182A14-001_2, RP5-1182A14-001_3, RP5-1182A14-001_4, RP5-1182A14-001_5, RP5-1182A14-001_6, RP5-1182A14-001_7, RP5-1182A14-001_8, RP5-1182A14-001_9, RP5-1182A14-001_10, RP5-1182A14-001_11, RP5-1182A14-001_12, RP5-1182A14-001_13, RP5-1182A14-001_14, RP5-1182A14-001_15, RP5-1182A14-001_16, RP5-1182A14-001_17, RP5-1182A14-001_18, RP1-163M9-001_5@57.8333333333333@22@88@:UPF0627 protein ENSP00000341061/ENSP00000339743-like;UPF0627 protein ENSP00000341061/ENSP00000339743@NA@NA
D122641@3004@3020@deletion@17@17248447@17273487@1@chr1:17248447-17273487@22.5@1275@855@0.671@CNVR94.4, CNVR94.5@CROCC-201_1, CROCC-201_2, CROCC-201_3, CROCC-201_4, CROCC-201_5, CROCC-201_6, CROCC-201_7, CROCC-201_8, CROCC-201_9, CROCC-201_10, CROCC-201_11, CROCC-201_12, CROCC-201_13, CROCC-201_14, CROCC-201_15, CROCC-201_16, CROCC-201_17@76.2941176470588@62@85@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
D122641@3775@3775@deletion@1@21806546@21806717@1@chr1:21806546-21806717@7.58@36@1@0.0278@CNVR107.2, CNVR107.1@NBPF3-003_15@91@91@91@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 3@:cytoplasm@NA
D122641@4451@4461@duplication@11@25599041@25655628@1@chr1:25599041-25655628@22.3@1181@1608@1.36@CNVR116.1, CNVR116.2@RHD-202_1, RHD-202_2, RHD-202_3, RHD-202_4, RHD-202_5, RHD-202_6, RHD-202_7, RHD-202_8, RHD-202_9, RHD-202_10, RHD-202_11@122.181818181818@113@128@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
D122641@4477@4477@deletion@1@25735176@25735361@1@chr1:25735176-25735361@11.1@51@0@0@CNVR117.1@RHCE-005_4@56@56@56@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
D122641@12445@12446@duplication@2@104297123@104297437@1@chr1:104297123-104297437@9.75@287@430@1.5@CNVR266.3, CNVR266.5@AMY1C-201_7, AMY1C-201_8@77@75@79@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D122641@14493@14496@duplication@4@144676872@144811958@1@chr1:144676872-144811958@15.9@272@453@1.67@NA@WI2-1896O14-001_1, WI2-1896O14-001_2, WI2-1896O14-001_3, NBPF9-001_1@4.75@4@5@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 24@NA@NA
D122641@15456@15462@duplication@7@149375000@149400543@1@chr1:149375000-149400543@12.1@554@760@1.37@CNVR350.1@FCGR1C-201_4, FCGR1C-201_5, FCGR1C-201_6, ENST00000415338_1, HIST2H3PS2-001_1, HIST2H3PS2-001_2, RP5-998N21-002_1@73.7142857142857@70@76@NA@NA@NA
D122641@18672@18682@deletion@11@161559354@161599826@1@chr1:161559354-161599826@40.7@873@474@0.543@CNVR383.1@FCGR2C-006_3, FCGR2C-006_4, FCGR2C-006_5, FCGR2C-006_6, FCGR2C-006_7, ENST00000448848_1, ENST00000448848_2, ENST00000448848_3, FCGR3B-001_3, FCGR3B-001_4, FCGR3B-001_5@42.3636363636364@36@57@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene):Fc fragment of IgG, low affinity IIIb, receptor (CD16b)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction:IgG binding;protein binding;extracellular region;immune response;plasma membrane;anchored to membrane@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
D122641@18684@18684@deletion@1@161600847@161600997@1@chr1:161600847-161600997@10.5@133@54@0.406@CNVR383.1@FCGR3B-001_1@34@34@34@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIIb, receptor (CD16b)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction:IgG binding;protein binding;extracellular region;immune response;plasma membrane;anchored to membrane@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
D122641@21372@21372@deletion@1@196797202@196797377@1@chr1:196797202-196797377@15@133@38@0.286@CNVR459.1@CFHR1-001_4@119@119@119@:complement factor H-related 1:complement factor H-related 2@:extracellular space;complement activation:extracellular region@NA
D122641@23024@23025@deletion@2@207700100@207700469@1@chr1:207700100-207700469@5.58@26@1@0.0385@CNVR485.1@CR1-201_6, CR1-201_7@17@7@27@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
D122641@24160@24164@duplication@5@223727670@223729472@1@chr1:223727670-223729472@28.4@52@252@4.85@NA@CAPN8-202_20, CAPN8-202_21, CAPN8-202_22, CAPN8-202_23, CAPN8-202_24@0@0@0@:calpain 8@:proteolysis;Golgi apparatus;intracellular;calcium-dependent cysteine-type endopeptidase activity;calcium ion binding@NA
D122641@24169@24169@deletion@1@223740182@223740201@1@chr1:223740182-223740201@5.9@26@0@0@NA@CAPN8-202_15@0@0@0@:calpain 8@:proteolysis;Golgi apparatus;intracellular;calcium-dependent cysteine-type endopeptidase activity;calcium ion binding@NA
D122641@32943@32943@deletion@1@79253841@79253958@2@chr2:79253841-79253958@5.41@68@30@0.441@NA@REG3G-001_3@0@0@0@:regenerating islet-derived 3 gamma@:carbohydrate binding;extracellular region;acute-phase response@NA
D122641@33520@33520@deletion@1@87239638@87241105@2@chr2:87239638-87241105@8.18@39@1@0.0256@NA@RGPD1-001_23@110@110@110@:RANBP2-like and GRIP domain containing 1:plasminogen-like B1;plasminogen-like B2@:protein binding;intracellular;intracellular transport;protein targeting to Golgi:extracellular region@NA
D122641@33542@33543@deletion@2@87365381@87365581@2@chr2:87365381-87365581@9.45@114@51@0.447@CNVR861.2@AC083899-001_6, AC083899-001_7@13@11@15@NA@NA@NA
D122641@33558@33564@deletion@7@87404273@87414366@2@chr2:87404273-87414366@27.6@366@165@0.451@CNVR861.2@AC083899-001_22, AC083899-001_23, AC083899-001_24, AC083899-001_25, AC083899-001_26, AC083899-001_27, AC083899-001_28@67@45@85@NA@NA@NA
D122641@33599@33600@duplication@2@88055476@88056454@2@chr2:88055476-88056454@5.01@195@273@1.4@NA@PLGLB2-003_4, RGPD2-001_23@26@26@26@:plasminogen-like B1;plasminogen-like B2:RANBP2-like and GRIP domain containing 2@:extracellular region:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
D122641@33778@33782@deletion@5@89567760@89597317@2@chr2:89567760-89597317@5.9@149@87@0.584@CNVR866.7, CNVR866.1@IGKV1-33-001_1, IGKV1-33-001_2, IGKV3-34-001_1, IGKV3-34-001_2, IGKV1-37-001_2@4@3@5@@:protein binding:protein binding@NA
D122641@33802@33803@duplication@2@89998791@89999559@2@chr2:89998791-89999559@5.32@97@154@1.59@CNVR867.10, CNVR867.7, CNVR867.1@IGKV2D-28-001_1, IGKV2D-28-001_2@5@5@5@@:protein binding@NA
D122641@33832@33833@duplication@2@90192770@90193425@2@chr2:90192770-90193425@8.82@425@596@1.4@CNVR867.10, CNVR867.5, CNVR867.3, CNVR867.9, CNVR867.15@IGKV1D-13-001_1, IGKV1D-13-001_2@7@7@7@@:protein binding@NA
D122641@33879@33879@duplication@1@91885972@91886023@2@chr2:91885972-91886023@5.08@194@280@1.44@CNVR870.6, CNVR870.7@AC027612-002_8@1@1@1@NA@NA@NA
D122641@34615@34631@deletion@17@98127603@98162325@2@chr2:98127603-98162325@31.4@171@18@0.105@CNVR888.3@ANKRD36B-001_23, ANKRD36B-001_24, ANKRD36B-001_25, ANKRD36B-001_26, ANKRD36B-001_27, ANKRD36B-001_28, ANKRD36B-001_29, ANKRD36B-001_30, ANKRD36B-001_31, ANKRD36B-001_32, ANKRD36B-001_33, ANKRD36B-001_34, ANKRD36B-001_35, ANKRD36B-001_36, ANKRD36B-001_37, ANKRD36B-001_38, ANKRD36B-001_39@130.058823529412@64@154@NA@NA@NA
D122641@35470@35471@deletion@2@107007364@107008168@2@chr2:107007364-107008168@17.3@258@117@0.453@NA@AC114755-201_4, PLGLA-001_4@0@0@0@NA@NA@NA
D122641@45364@45405@duplication@42@233214466@233309690@2@chr2:233214466-233309690@125@3662@5400@1.47@NA@ECEL1P3-001_1, ECEL1P3-001_2, ECEL1P3-001_3, ALPP-001_1, ALPP-001_2, ALPP-001_3, ALPP-001_4, ALPP-001_5, ALPP-001_6, ALPP-001_7, ALPP-001_8, ALPP-001_9, ALPP-001_10, ALPP-001_11, AC068134-001_1, AC068134-001_2, AC068134-001_3, ALPPL2-001_1, ALPPL2-001_2, ALPPL2-001_3, ALPPL2-001_4, ALPPL2-001_5, ALPPL2-001_6, ALPPL2-001_7, ALPPL2-001_8, ALPPL2-001_9, ALPPL2-001_10, ALPPL2-001_11, ENST00000373592_1, ENST00000373592_2, ENST00000373592_3, ENST00000373592_4, ENST00000373592_5, ENST00000373592_6, ENST00000373592_7, ENST00000373592_8, ENST00000373592_9, ENST00000437095_1, ENST00000437095_2, ENST00000431466_1, ENST00000431466_2, ENST00000431466_3@7.71428571428571@1@58@:alkaline phosphatase, placental:alkaline phosphatase, placental-like 2@:phosphatase activity;catalytic activity;integral to membrane;plasma membrane;metabolic process;cell surface;anchored to membrane;alkaline phosphatase activity;metal ion binding:phosphatase activity;catalytic activity;phosphorylation;plasma membrane;metabolic process;membrane;anchored to membrane;alkaline phosphatase activity;metal ion binding@NA
D122641@45713@45721@duplication@9@234676868@234677086@2@chr2:234676868-234677086@11.2@1098@1422@1.3@NA@UGT1A8-001_4, UGT1A10-001_4, UGT1A9-001_4, UGT1A7-201_5, UGT1A6-004_5, UGT1A5-001_4, UGT1A4-002_4, UGT1A3-001_4, UGT1A1-001_4@0@0@0@:UDP glucuronosyltransferase 1 family, polypeptide A8:UDP glucuronosyltransferase 1 family, polypeptide A10:UDP glucuronosyltransferase 1 family, polypeptide A9:UDP glucuronosyltransferase 1 family, polypeptide A7:UDP glucuronosyltransferase 1 family, polypeptide A6:UDP glucuronosyltransferase 1 family, polypeptide A5:UDP glucuronosyltransferase 1 family, polypeptide A4:UDP glucuronosyltransferase 1 family, polypeptide A3:UDP glucuronosyltransferase 1 family, polypeptide A1@:carbohydrate binding;xenobiotic glucuronidation;steroid metabolic process;negative regulation of cellular metabolic process;glucuronosyltransferase activity;fatty acid binding;negative regulation of steroid metabolic process;integral to membrane;fatty acid metabolic process;protein homodimerization activity;endoplasmic reticulum membrane;negative regulation of catalytic activity;metabolic process;negative regulation of fatty acid metabolic process;enzyme inhibitor activity;drug binding;transferase activity, transferring hexosyl groups;intracellular membrane-bounded organelle;drug metabolic process;retinoic acid binding;enzyme binding;protein heterodimerization activity;carbohydrate metabolic process;retinoic acid metabolic process;flavone metabolic process;flavonoid glucuronidation;lipid glycosylation;steroid binding;coumarin metabolic process:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;enzyme binding;protein heterodimerization activity;flavone metabolic process;carbohydrate metabolic process;cellular glucuronidation;protein kinase C binding;integral to membrane;lipid glycosylation;protein homodimerization activity;endoplasmic reticulum membrane;metabolic process:carbohydrate binding;xenobiotic glucuronidation;glucuronosyltransferase activity;integral to membrane;protein homodimerization activity;endoplasmic reticulum membrane;negative regulation of catalytic activity;metabolic process;negative regulation of fatty acid metabolic process;enzyme inhibitor activity;transferase activity, transferring hexosyl groups;drug metabolic process;intracellular membrane-bounded organelle;retinoic acid binding;small molecule metabolic process;enzyme binding;protein heterodimerization activity;cellular lipid metabolic process;carbohydrate metabolic process;retinoic acid metabolic process;flavone metabolic process;flavonoid glucuronidation;xenobiotic metabolic process;lipid glycosylation:carbohydrate binding;xenobiotic glucuronidation;glucuronosyltransferase activity;protein kinase C binding;integral to membrane;excretion;protein homodimerization activity;endoplasmic reticulum membrane;negative regulation of catalytic activity;metabolic process;negative regulation of fatty acid metabolic process;enzyme inhibitor activity;drug binding;transferase activity, transferring hexosyl groups;drug metabolic process;retinoic acid binding;endoplasmic reticulum;enzyme binding;protein heterodimerization activity;carbohydrate metabolic process;retinoic acid metabolic process;flavone metabolic process;flavonoid glucuronidation;lipid glycosylation;coumarin metabolic process:carbohydrate binding;transferase activity, transferring hexosyl groups;intracellular membrane-bounded organelle;small molecule metabolic process;glucuronosyltransferase activity;enzyme binding;protein heterodimerization activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;protein homodimerization activity;endoplasmic reticulum membrane;metabolic process:carbohydrate binding;transferase activity, transferring hexosyl groups;intracellular membrane-bounded organelle;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process:carbohydrate binding;transferase activity, transferring hexosyl groups;small molecule metabolic process;endoplasmic reticulum;glucuronosyltransferase activity;enzyme binding;protein heterodimerization activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;protein homodimerization activity;endoplasmic reticulum membrane;metabolic process:carbohydrate binding;transferase activity, transferring hexosyl groups;xenobiotic glucuronidation;UDP-glycosyltransferase activity;retinoic acid binding;glucuronosyltransferase activity;enzyme binding;protein heterodimerization activity;retinoic acid metabolic process;carbohydrate metabolic process;flavonoid glucuronidation;integral to membrane;lipid glycosylation;protein homodimerization activity;endoplasmic reticulum membrane;metabolic process:xenobiotic glucuronidation;porphyrin-containing compound metabolic process;cellular response to glucocorticoid stimulus;liver development;endoplasmic reticulum membrane;negative regulation of catalytic activity;response to lipopolysaccharide;response to organic substance;estrogen metabolic process;enzyme inhibitor activity;endoplasmic reticulum;heme catabolic process;enzyme binding;flavone metabolic process;response to starvation;xenobiotic metabolic process;lipid glycosylation;response to steroid hormone stimulus;organ regeneration;response to organic cyclic compound;carbohydrate binding;steroid metabolic process;response to drug;glucuronosyltransferase activity;negative regulation of steroid metabolic process;digestion;biphenyl catabolic process;protein homodimerization activity;integral to plasma membrane;response to ethanol;metabolic process;response to nutrient;heterocycle metabolic process;bilirubin conjugation;transferase activity, transferring hexosyl groups;intracellular membrane-bounded organelle;drug metabolic process;retinoic acid binding;small molecule metabolic process;protein heterodimerization activity;carbohydrate metabolic process;retinoic acid metabolic process;flavonoid glucuronidation;cellular response to hormone stimulus;response to glucocorticoid stimulus;steroid binding;cellular response to ethanol;cytochrome complex;acute-phase response@: GILBERT SYNDROME; CRIGLER-NAJJAR SYNDROME, TYPE II; CRIGLER-NAJJAR SYNDROME, TYPE I: BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1; GILBERT SYNDROME; CRIGLER-NAJJAR SYNDROME, TYPE II; CRIGLER-NAJJAR SYNDROME, TYPE I; HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN
D122641@47662@47663@deletion@2@11925055@11925573@3@chr3:11925055-11925573@8.26@82@31@0.378@NA@AC090958-001_9, AC090958-001_10@9.5@9@10@NA@NA@NA
D122641@61532@61534@deletion@3@195377017@195377877@3@chr3:195377017-195377877@15.2@578@349@0.604@NA@AC233280-201_6, AC233280-201_7, AC233280-201_8@88.3333333333333@82@92@:mucin 20, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane@NA
D122641@61545@61552@duplication@8@195389444@195400859@3@chr3:195389444-195400859@13.2@703@945@1.34@CNVR1703.1@SDHALP2-001_3, SDHALP2-001_4, SDHALP2-001_5, SDHALP2-001_6, SDHALP2-001_7, SDHALP2-001_8, SDHALP2-001_9, SDHALP2-001_10@81.125@71@92@:mucin 20, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane@NA
D122641@61567@61568@deletion@2@195447755@195452031@3@chr3:195447755-195452031@10.1@339@196@0.578@CNVR1703.1, CNVR1703.2, CNVR1703.5@MUC20-201_1, MUC20-201_2@41@38@44@:mucin 20, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane@NA
D122641@61648@61653@deletion@6@195703956@195709182@3@chr3:195703956-195709182@31.4@413@182@0.441@CNVR1707.1, CNVR1707.2@SDHALP1-002_6, SDHALP1-002_7, SDHALP1-002_8, ENST00000354937_7, ENST00000354937_8, ENST00000354937_9@28.8333333333333@18@44@NA@NA@NA
D122641@61902@61904@duplication@3@197350985@197351069@3@chr3:197350985-197351069@9.36@118@204@1.73@CNVR1722.1@AC024560-005_3, AC024560-201_2, AC024560-201_3@22.6666666666667@22@23@NA@NA@NA
D122641@62022@62023@deletion@2@197846588@197847650@3@chr3:197846588-197847650@6.56@82@37@0.451@CNVR1728.7, CNVR1728.8, CNVR1728.3@ENST00000392362_1, ENST00000392362_2@53@53@53@NA@NA@NA
D122641@62724@62726@deletion@3@4128371@4158898@4@chr4:4128371-4158898@5.46@120@68@0.567@CNVR1776.1@AC011744-201_2, AC011744-201_3, AC011744-201_4@62.3333333333333@30@82@NA@NA@NA
D122641@68947@68947@deletion@1@145041645@145041742@4@chr4:145041645-145041742@5.13@95@49@0.516@NA@GYPA-205_2@8@8@8@:glycophorin B (MNS blood group):glycophorin A (MNS blood group)@:integral to membrane;plasma membrane;integral to plasma membrane:external side of plasma membrane;integral to membrane;cytoskeletal anchoring at plasma membrane;plasma membrane;molecular_function;protein homodimerization activity;integral to plasma membrane;cellular_component;identical protein binding;membrane;biological_process;regulation of response to osmotic stress;virus-host interaction@: BLOOD GROUP--Ss LOCUS; Ss: MALARIA, SUSCEPTIBILITY TO; BLOOD GROUP--MN LOCUS; MN
D122641@70688@70690@duplication@3@190947541@190948413@4@chr4:190947541-190948413@6.36@286@407@1.42@CNVR2258.3@FRG2-201_1, FRG2-201_2, FRG2-201_3@39.3333333333333@26@58@:FSHD region gene 2-like;FSHD region gene 2@:nucleus@NA
D122641@70822@70839@deletion@18@748521@843840@5@chr5:748521-843840@123@2993@1603@0.536@CNVR2280.3@ZDHHC11-201_4, ZDHHC11-201_5, ZDHHC11-201_6, ZDHHC11-201_7, ZDHHC11-201_8, ZDHHC11-201_9, ZDHHC11-201_10, ZDHHC11-201_11, ZDHHC11-201_12, ZDHHC11B-201_1, ZDHHC11B-201_2, ZDHHC11B-201_3, ZDHHC11B-201_4, ZDHHC11B-201_5, AC026740-202_1, AC026740-202_2, AC026740-202_3, AC026740-202_4@51.7777777777778@18@96@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
D122641@71600@71610@deletion@11@21480883@21497350@5@chr5:21480883-21497350@26.6@290@108@0.372@CNVR2395.4, CNVR2395.2@AC138951-201_4, AC138951-201_5, AC138951-201_6, AC138951-202_1, AC138951-202_2, ENST00000412250_1, ENST00000412250_2, ENST00000412250_3, ENST00000412250_4, ENST00000366374_1, ENST00000366374_2@94.3636363636364@40@108@NA@NA@NA
D122641@73727@73727@deletion@1@69717564@69717599@5@chr5:69717564-69717599@13@61@1@0.0164@CNVR2494.17, CNVR2494.3@GTF2H2B-201_4@139@139@139@NA@NA@NA
D122641@73819@73820@deletion@2@70375626@70378820@5@chr5:70375626-70378820@11.5@57@3@0.0526@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.8, CNVR2494.1, CNVR2494.37@AC044797-201_2, AC044797-201_3@129.5@121@138@NA@NA@NA
D122641@78044@78044@deletion@1@147553799@147553934@5@chr5:147553799-147553934@23.6@111@0@0@CNVR2637.2, CNVR2637.1@AC116334-001_3@78@78@78@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
D122641@79567@79569@duplication@3@175388056@175392159@5@chr5:175388056-175392159@12.6@145@259@1.79@NA@THOC3-001_3, THOC3-001_4, THOC3-001_5@131@46@182@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
D122641@79580@79581@duplication@2@175525493@175526049@5@chr5:175525493-175526049@7.9@253@369@1.46@NA@FAM153B-201_9, FAM153B-201_10@10.5@4@17@:uncharacterized LOC100507387;family with sequence similarity 153, member B@NA@NA
D122641@80019@80024@deletion@6@177163582@177168334@5@chr5:177163582-177168334@23.3@275@119@0.433@NA@FAM153A-204_7, FAM153A-204_8, FAM153A-204_9, FAM153A-204_10, FAM153A-204_11, FAM153A-204_12@86.1666666666667@76@106@:family with sequence similarity 153, member A@NA@NA
D122641@80481@80487@deletion@7@180376241@180429786@5@chr5:180376241-180429786@13.2@540@344@0.637@CNVR2719.1@BTNL8-202_7, BTNL8-202_8, BTNL3-202_1, BTNL3-202_2, BTNL3-202_3, BTNL3-202_5@103.333333333333@90@108@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
D122641@82505@82507@duplication@3@29894238@29895230@6@chr6:29894238-29895230@5.92@139@207@1.49@CNVR2829.7, CNVR2829.2, CNVR2829.3@AL645929-201_4, HLA-K-001_1, HLA-K-001_2, HLA-K-001_3@41.6666666666667@41@42@NA@NA@NA
D122641@82520@82520@deletion@1@29911901@29912175@6@chr6:29911901-29912175@7.99@206@113@0.549@CNVR2829.7, CNVR2829.2, CNVR2829.3@HLA-A-001_6@22@22@22@:major histocompatibility complex, class I, A@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO
D122641@83003@83003@deletion@1@31237989@31238263@6@chr6:31237989-31238263@11.9@163@68@0.417@CNVR2838.1@HLA-C-006_4@25@25@25@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
D122641@83582@83584@deletion@3@31963498@31964101@6@chr6:31963498-31964101@15.2@204@98@0.48@CNVR2843.6, CNVR2843.3@C4A-001_25, C4A-001_26, C4A-001_27@16.6666666666667@16@17@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
D122641@83614@83615@duplication@2@31975450@31975627@6@chr6:31975450-31975627@7.37@124@201@1.62@CNVR2843.6, CNVR2843.3@CYP21A1P-001_8, AL645922-201_7@115.5@115@116@NA@NA@NA
D122641@83642@83644@duplication@3@31996236@31996839@6@chr6:31996236-31996839@16.7@161@311@1.93@CNVR2843.6, CNVR2843.5@C4B-001_25, C4B-001_26, C4B-001_27@17@15@19@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
D122641@83661@83665@duplication@5@32006044@32007425@6@chr6:32006044-32007425@15.7@473@703@1.49@CNVR2843.6, CNVR2843.5@CYP21A2-002_1, CYP21A2-002_2, CYP21A2-002_3, CYP21A2-002_4, CYP21A2-002_5@14.8@12@18@:cytochrome P450, family 21, subfamily A, polypeptide 2@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY
D122641@83669@83675@duplication@7@32008447@32010384@6@chr6:32008447-32010384@10.4@249@370@1.49@CNVR2843.6, CNVR2843.5@TNXB-201_40, TNXB-201_41, TNXB-201_42, TNXB-201_43, TNXB-201_44, CYP21A2-002_9, CYP21A2-002_10@40.8571428571429@33@46@:cytochrome P450, family 21, subfamily A, polypeptide 2:tenascin-X-like;tenascin XB@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
D122641@83911@83916@deletion@6@32485122@32498065@6@chr6:32485122-32498065@23.3@187@56@0.299@CNVR2845.21, CNVR2845.25, CNVR2845.30, CNVR2845.43@HLA-DRB5-001_1, HLA-DRB5-001_2, HLA-DRB5-001_3, HLA-DRB5-001_4, HLA-DRB5-001_5, HLA-DRB5-001_6@173.833333333333@122@189@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D122641@83922@83923@deletion@2@32525695@32525964@6@chr6:32525695-32525964@5.34@24@0@0@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.5@HLA-DRB6-002_2, AL713966-201_2@166.5@166@167@NA@NA@NA
D122641@83944@83945@duplication@2@32630133@32632845@6@chr6:32630133-32632845@8.78@109@195@1.79@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20, CNVR2845.31, CNVR2845.64@HLA-DQB1-003_3, ENST00000443574_1@106.5@101@112@:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
D122641@84706@84710@duplication@5@35754777@35765089@6@chr6:35754777-35765089@7.93@915@1181@1.29@CNVR2861.1@C6orf127-001_2, C6orf127-001_3, CLPS-001_1, CLPS-001_2, CLPS-001_3@39@30@43@:colipase-like 1:colipase, pancreatic@:extracellular region;enzyme activator activity;digestion;lipid catabolic process:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
D122641@92592@92594@duplication@3@160132858@160133143@6@chr6:160132858-160133143@5.73@310@420@1.35@CNVR3127.2, CNVR3127.1@ENST00000442642_3, ENST00000442642_4, ENST00000442642_5@84@56@106@:superoxide dismutase 2, mitochondrial;uncharacterized LOC100129518@:response to reactive oxygen species;oxidation-reduction process;mitochondrion;negative regulation of cell proliferation;neuron development;negative regulation of fat cell differentiation;removal of superoxide radicals;response to gamma radiation;response to L-ascorbic acid;response to lipopolysaccharide;response to nutrient levels;response to zinc ion;protein homotetramerization;post-embryonic development;iron ion homeostasis;hemopoiesis;aging;mitochondrial inner membrane;age-dependent response to reactive oxygen species;response to drug;oxygen binding;mitochondrial nucleoid;vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure;apoptotic process;superoxide metabolic process;response to superoxide;detection of oxygen;response to silicon dioxide;cytoplasm;response to stress;respiratory electron transport chain;superoxide anion generation;protein homooligomerization;regulation of mitochondrial membrane potential;positive regulation of nitric oxide biosynthetic process;response to manganese ion;regulation of blood pressure;metal ion binding;negative regulation of apoptotic process;response to cadmium ion;response to oxidative stress;liver development;regulation of catalytic activity;negative regulation of fibroblast proliferation;response to selenium ion;age-dependent response to oxidative stress;response to electrical stimulus;mitochondrial matrix;identical protein binding;mitochondrion organization;response to hyperoxia;vasodilation;response to hydrogen peroxide;superoxide dismutase activity;heart development;negative regulation of neuron apoptotic process;erythrophore differentiation;locomotory behavior;DNA binding;release of cytochrome c from mitochondria;response to axon injury;oxygen homeostasis;response to activity;glutathione metabolic process;hydrogen peroxide metabolic process;hydrogen peroxide biosynthetic process;regulation of transcription from RNA polymerase II promoter;response to hypoxia;protein binding;manganese ion binding;cellular response to ethanol@: MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6; MVCD6
D122641@93099@93099@duplication@1@167790036@167790193@6@chr6:167790036-167790193@6.06@16@58@3.62@NA@TCP10-001_5@103@103@103@:t-complex 10@:cytosol@NA
D122641@93101@93101@duplication@1@167794611@167794825@6@chr6:167794611-167794825@4.88@20@55@2.75@NA@TCP10-001_3@52@52@52@:t-complex 10@:cytosol@NA
D122641@94190@94192@duplication@3@5959482@5963594@7@chr7:5959482-5963594@7.11@393@542@1.38@NA@C7orf28A-001_12, C7orf28A-001_13, C7orf28A-001_14@72.3333333333333@71@73@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D122641@94208@94212@duplication@5@5998626@6006833@7@chr7:5998626-6006833@16@398@619@1.56@NA@RSPH10B-002_3, RSPH10B-002_4, RSPH10B-002_5, RSPH10B-002_6, RSPH10B-002_7@10.2@8@13@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D122641@94410@94432@deletion@23@6785721@6821108@7@chr7:6785721-6821108@32.7@961@571@0.594@NA@ENST00000338780_11, ENST00000338780_12, ENST00000338780_13, ENST00000338780_14, PMS2CL-002_11, PMS2CL-002_12, PMS2CL-002_13, PMS2CL-002_14, RSPH10B2-204_1, RSPH10B2-204_2, RSPH10B2-204_3, RSPH10B2-204_4, RSPH10B2-204_5, RSPH10B2-204_6, RSPH10B2-204_7, RSPH10B2-204_8, RSPH10B2-204_9, RSPH10B2-204_10, RSPH10B2-204_11, RSPH10B2-204_12, RSPH10B2-204_13, RSPH10B2-204_14, RSPH10B2-204_15@28.3913043478261@5@90@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D122641@94438@94444@deletion@7@6836201@6844687@7@chr7:6836201-6844687@37.4@318@110@0.346@NA@RSPH10B2-204_20, RSPH10B2-204_21, ENST00000429267_1, C7orf28B-001_12, C7orf28B-001_13, C7orf28B-001_14, C7orf28B-001_15@90.8571428571429@25@121@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D122641@96560@96567@deletion@8@38301774@38356938@7@chr7:38301774-38356938@43.3@1414@800@0.566@NA@TRGC1-001_1, TRGC1-001_2, ENST00000501456_1, ENST00000501456_2, ENST00000499120_1, ENST00000499120_2, ENST00000499120_3, TRGV9-001_2@2.375@0@8@:TCR gamma alternate reading frame protein@:protein binding:protein binding:protein binding@NA
D122641@97912@97915@duplication@4@57071006@57076857@7@chr7:57071006-57076857@6.09@42@88@2.1@NA@TNRC18C-202_8, TNRC18C-202_9, TNRC18C-202_10, TNRC18C-202_11@160@154@166@NA@NA@NA
D122641@97945@97965@duplication@21@57528432@57896753@7@chr7:57528432-57896753@34.2@1333@2052@1.54@NA@ZNF716-201_4, ZNF716-201_5, RP11-368M16-001_1, RP11-368M16-001_2, ENST00000436522_1, AC064862-201_1, AC064862-201_2, ENST00000421221_1, ENST00000421221_2, ENST00000445460_1, ENST00000445460_2, ENST00000436698_1, ENST00000436698_2, ENST00000415634_1, ENST00000415634_2, ENST00000430646_1, ENST00000430646_2, ENST00000430646_3@3.55555555555556@0@18@:zinc finger protein 716@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
D122641@97991@97994@deletion@4@62758072@62758771@7@chr7:62758072-62758771@113@558@2@0.00358@NA@AC006455-201_2, AC006455-201_3, ENST00000444809_2, ENST00000444809_3@160@151@171@NA@NA@NA
D122641@98015@98026@duplication@12@62910199@62970547@7@chr7:62910199-62970547@30.9@602@1025@1.7@NA@ZNF734-201_2, ZNF734-201_3, ZNF734-201_4, ZNF734-201_5, ZNF734-201_6, ZNF734-201_7, ZNF734-201_8, ENST00000434048_1, ENST00000434048_2, CTD-2526L21-201_1, CTD-2526L21-201_2, CTD-2526L21-201_3@81.5833333333333@66@102@NA@NA@NA
D122641@98173@98174@duplication@2@64533487@64534227@7@chr7:64533487-64534227@7.95@21@74@3.52@NA@RP11-460N20-001_11, RP11-460N20-001_12, ENST00000501153_3@101@101@101@NA@NA@NA
D122641@99063@99065@duplication@3@74251404@74299148@7@chr7:74251404-74299148@5.5@32@74@2.31@NA@STAG3L2-202_8, GTF2IRD2-002_1, GTF2IRD2-002_2@5.33333333333333@2@8@:GTF2I repeat domain containing 2@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
D122641@99133@99134@deletion@2@74582344@74582683@7@chr7:74582344-74582683@5.59@47@15@0.319@NA@NCF1C-001_3, NCF1C-001_4@32@15@49@NA@NA@NA
D122641@99233@99233@deletion@1@74991244@74991359@7@chr7:74991244-74991359@5.21@23@0@0@CNVR3456.1@STAG3L1-004_3@60@60@60@NA@NA@NA
D122641@102130@102130@duplication@1@102136589@102136652@7@chr7:102136589-102136652@6.26@140@220@1.57@CNVR3518.1@RASA4B-007_16@49@49@49@:RAS p21 protein activator 4B@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction@NA
D122641@102166@102166@duplication@1@102219874@102220244@7@chr7:102219874-102220244@6.34@28@75@2.68@CNVR3518.1@ENST00000379336_1, RASA4-001_21@63@63@63@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
D122641@102187@102193@duplication@7@102257074@102279647@7@chr7:102257074-102279647@10.7@268@404@1.51@CNVR3518.1@RASA4-001_1, ENST00000340457_4, ENST00000340457_5, ENST00000340457_6, POLR2J2-001_7, POLR2J2-001_8, POLR2J2-001_9@59.7142857142857@45@77@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
D122641@103919@103919@duplication@1@128128157@128128216@7@chr7:128128157-128128216@4.73@57@102@1.79@NA@METTL2B-001_5@0@0@0@:methyltransferase like 2B@:methyltransferase activity;metabolic process@NA
D122641@105321@105342@deletion@22@141765517@141794298@7@chr7:141765517-141794298@61.6@2570@1614@0.628@CNVR3585.3, CNVR3585.2@MGAM-007_40, MGAM-007_41, MGAM-007_42, MGAM-007_43, MGAM-007_44, MGAM-007_45, MGAM-007_46, MGAM-007_47, MGAM-007_48, MGAM-007_49, MGAM-007_50, MGAM-007_51, MGAM-007_52, MGAM-007_53, MGAM-007_54, MGAM-007_55, MGAM-007_56, MGAM-007_57, MGAM-007_58, MGAM-007_59, MGAM-007_60, MGAM-007_61@112.772727272727@35@134@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
D122641@105512@105527@deletion@16@142423175@142494348@7@chr7:142423175-142494348@18.6@1970@1387@0.704@NA@AC231380-201_1, TRBC1-210_1, TRBC1-210_2, TRBC1-210_3, TRBV27-001_1, TRBV27-001_2, TRBV28-001_1, TRBV28-001_2, TRBV29-1-001_1, TRBV29-1-001_2, PRSS1-204_1, PRSS1-204_2, PRSS1-204_3, PRSS1-204_4, PRSS1-204_5, PRSS1-204_6@25.75@0@115@:protease, serine, 1 (trypsin 1)@:protein binding:protein binding:protein binding:extracellular matrix organization;catalytic activity;extracellular matrix disassembly;proteolysis;extracellular space;extracellular region;digestion;metal ion binding;serine-type endopeptidase activity@: PANCREATITIS, HEREDITARY; PCTT
D122641@105785@105785@deletion@1@143969540@143969609@7@chr7:143969540-143969609@13.5@170@66@0.388@CNVR3598.4, CNVR3598.9@RP4-798C17-001_12@37@37@37@:Rho guanine nucleotide exchange factor (GEF) 35@NA@NA
D122641@105794@105803@deletion@10@143974303@143979884@7@chr7:143974303-143979884@14.4@271@144@0.531@CNVR3598.4, CNVR3598.9@RP4-798C17-001_3, RP4-798C17-001_4, RP4-798C17-001_5, RP4-798C17-001_6, RP4-798C17-001_7, ENST00000378112_4, ENST00000378112_5, ENST00000378112_6, ENST00000378112_7, ENST00000378112_8@71.9@53@135@:Rho guanine nucleotide exchange factor (GEF) 35@NA@NA
D122641@105819@105829@deletion@11@144059753@144072769@7@chr7:144059753-144072769@54.3@662@278@0.42@CNVR3598.4, CNVR3598.5, CNVR3598.11@ARHGEF5-001_2, ARHGEF5-001_3, ARHGEF5-001_4, ARHGEF5-001_5, ARHGEF5-001_6, ARHGEF5-001_7, ARHGEF5-001_8, ARHGEF5-001_9, ARHGEF5-001_10, ARHGEF5-001_11, ARHGEF5-001_12@72.0909090909091@39@104@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
D122641@107512@107513@deletion@2@7717871@7718505@8@chr8:7717871-7718505@11@244@133@0.545@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@SPAG11A-207_3, SPAG11A-207_4@112@111@113@:sperm associated antigen 11A;sperm associated antigen 11B@:extracellular region;defense response@NA
D122641@109572@109585@deletion@14@39311571@39349528@8@chr8:39311571-39349528@69.2@321@2@0.00623@CNVR3859.1@ADAM3A-005_11, ADAM3A-005_12, ADAM3A-005_13, ADAM3A-005_14, ADAM3A-005_15, ADAM3A-005_16, ADAM3A-005_17, ADAM3A-005_18, ADAM3A-005_19, ADAM3A-005_20, ADAM3A-005_21, ADAM3A-009_7, ADAM3A-009_8, ADAM3A-009_9@120.5@98@136@NA@NA@NA
D122641@117587@117589@deletion@3@43313716@43314503@9@chr9:43313716-43314503@12.2@181@87@0.481@CNVR4289.2@BX649597-201_1, BX649597-201_2, BX649597-201_3@46@18@61@NA@NA@NA
D122641@117601@117602@duplication@2@43816639@43818185@9@chr9:43816639-43818185@11.1@309@466@1.51@CNVR4294.1@CNTNAP3B-001_6, CNTNAP3B-001_7@88.5@86@91@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
D122641@121600@121604@deletion@5@117085338@117087433@9@chr9:117085338-117087433@16.5@1496@1005@0.672@CNVR4448.1@ORM1-001_1, ORM1-001_2, ORM1-001_3, ORM1-001_4, ORM1-001_5@87.6@84@90@:orosomucoid 1@:protein binding;extracellular space;regulation of immune system process;transport;inflammatory response;extracellular region;acute-phase response@NA
D122641@124531@124532@duplication@2@138476897@138479944@9@chr9:138476897-138479944@5.92@20@61@3.05@NA@RP11-98L5-002_6, RP11-98L5-001_1@1@0@2@NA@NA@NA
D122641@126909@126909@deletion@1@17840632@17842868@10@chr10:17840632-17842868@9.84@45@0@0@NA@FAM23A-201_5@108@108@108@:transmembrane protein 236;transmembrane protein 236-like@:integral to membrane@NA
D122641@126928@126948@deletion@21@17921735@18122793@10@chr10:17921735-18122793@42.9@278@56@0.201@NA@MRC1L1-001_19, MRC1L1-001_20, MRC1L1-001_21, MRC1L1-001_22, MRC1L1-001_23, MRC1L1-001_24, MRC1L1-001_25, MRC1L1-001_26, MRC1L1-001_27, MRC1L1-001_28, MRC1L1-001_29, MRC1L1-001_30, FAM23B-202_1, FAM23B-202_2, FAM23B-202_3, FAM23B-202_4, FAM23B-202_5, MRC1-001_1, MRC1-001_2, MRC1-001_3, MRC1-001_4@26.7142857142857@5@107@:macrophage mannose receptor 1-like:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D122641@126951@126951@duplication@1@18138510@18138694@10@chr10:18138510-18138694@7.95@98@179@1.83@NA@MRC1-001_7@26@26@26@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D122641@126974@126975@duplication@2@18196465@18198277@10@chr10:18196465-18198277@15.2@58@174@3@NA@MRC1-001_28, MRC1-001_29@15@3@27@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D122641@128353@128359@duplication@7@42383281@42396475@10@chr10:42383281-42396475@11.2@88@176@2@CNVR4697.1@BX322613-201_1, BX322613-201_2, BX322613-201_3, ENST00000439345_1, ENST00000439345_2, ENST00000439345_3, ENST00000439345_4@56.2857142857143@50@62@NA@NA@NA
D122641@128372@128372@deletion@1@42924566@42924600@10@chr10:42924566-42924600@12.4@94@23@0.245@NA@CCNYL2-201_7@0@0@0@@:regulation of cyclin-dependent protein kinase activity;protein kinase binding@NA
D122641@128828@128829@deletion@2@46927785@46934899@10@chr10:46927785-46934899@14.4@66@0@0@CNVR4712.9, CNVR4712.2, CNVR4712.7@FAM35B-001_6, FAM35B-001_7@53@34@72@NA@NA@NA
D122641@128897@128914@duplication@18@47253597@47416977@10@chr10:47253597-47416977@22.4@833@1200@1.44@CNVR4712.9, CNVR4712.1@GLUDP8-001_1, GLUDP8-001_2, GLUDP8-001_3, RP11-144G6-201_1, RP11-144G6-201_2, CTSLL7-001_1, CTSLL7-001_2, CTSLL7-001_3, ENST00000439776_1, ENST00000439776_2, ENST00000439776_3, FAM35B2-201_1, FAM35B2-201_2, FAM35B2-201_3, FAM35B2-201_4, FAM35B2-201_5, FAM35B2-201_6, FAM35B2-201_7@23.5@8@47@NA@NA@NA
D122641@129030@129030@duplication@1@48054985@48055019@10@chr10:48054985-48055019@10.4@124@235@1.9@CNVR4715.2@ASAH2C-201_1@50@50@50@@:ceramidase activity;sphingolipid metabolic process@NA
D122641@129130@129131@duplication@2@48968562@48968624@10@chr10:48968562-48968624@4.91@44@84@1.91@CNVR4716.8, CNVR4716.4@RP11-508M1-002_5, GLUDP2-001_3@31@31@31@NA@NA@NA
D122641@129460@129477@deletion@18@51361725@51391568@10@chr10:51361725-51391568@69.8@340@10@0.0294@NA@ENST00000404618_1, ENST00000404618_2, ENST00000404618_3, ENST00000404618_4, ENST00000432221_1, ENST00000432221_2, ENST00000432221_3, ENST00000432221_4, TIMM23B-202_1, TIMM23B-202_2, TIMM23B-202_3, TIMM23B-202_4, TIMM23B-202_5, TIMM23B-202_6, TIMM23B-202_7, TIMM23B-202_8, TIMM23B-202_9, TIMM23B-202_10@68.7222222222222@0@142@:translocase of inner mitochondrial membrane 23 homolog B (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process@NA
D122641@129519@129521@duplication@3@51623585@51631957@10@chr10:51623585-51631957@7.56@479@665@1.39@NA@ENST00000456092_1, ENST00000456092_2, ENST00000456092_3@26.6666666666667@26@28@:translocase of inner mitochondrial membrane 23 homolog B (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process@NA
D122641@129605@129609@deletion@5@51970585@51978391@10@chr10:51970585-51978391@11.2@160@85@0.531@NA@ASAH2-201_7, ASAH2-201_8, ASAH2-201_9, ASAH2-201_10, ASAH2-201_11@181.2@176@186@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
D122641@131567@131568@deletion@2@81284748@81286392@10@chr10:81284748-81286392@23.7@153@29@0.19@NA@BX248123-201_1, BX248123-201_2@2.5@2@3@NA@NA@NA
D122641@131601@131601@deletion@1@81471458@81472508@10@chr10:81471458-81472508@5.21@25@1@0.04@CNVR4815.2, CNVR4815.4@FAM22B-201_7@84@84@84@NA@NA@NA
D122641@131687@131688@duplication@2@81993422@81995118@10@chr10:81993422-81995118@10.9@250@386@1.54@NA@ENST00000423182_1, ENST00000423182_2@1@1@1@NA@NA@NA
D122641@136731@136768@duplication@38@135269743@135383463@10@chr10:135269743-135383463@124@4349@6284@1.44@CNVR4989.7@RP11-108K14-006_2, RP11-108K14-006_3, RP11-108K14-006_4, RP11-108K14-006_5, RP11-108K14-006_6, RP11-108K14-006_7, RP11-108K14-006_8, RP11-108K14-006_9, RP11-108K14-006_10, RP11-108K14-006_11, RP11-108K14-006_12, RP11-108K14-006_13, RP11-108K14-006_14, RP11-108K14-006_15, CYP2E1-001_1, CYP2E1-001_2, CYP2E1-001_3, CYP2E1-001_4, CYP2E1-001_5, CYP2E1-001_6, CYP2E1-001_7, CYP2E1-001_8, CYP2E1-001_9, SYCE1-001_1, SYCE1-001_2, SYCE1-001_3, SYCE1-001_4, SYCE1-001_5, SYCE1-001_6, SYCE1-001_7, SYCE1-001_8, SYCE1-001_9, SYCE1-001_10, SYCE1-001_11, SYCE1-001_12, SYCE1-001_13, AL161645-201_1, AL161645-201_2@8.63157894736842@6@13@:shadow of prion protein homolog (zebrafish):scavenger receptor protein family member:cytochrome P450, family 2, subfamily E, polypeptide 1:synaptonemal complex central element protein 1@:plasma membrane;membrane;anchored to membrane:gamma-delta T cell lineage commitment;integral to membrane;scavenger receptor activity;interleukin-17 production;external side of plasma membrane;membrane:steroid metabolic process;oxidation-reduction process;mitochondrion;response to drug;oxygen binding;Golgi membrane;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;response to organic nitrogen;oxidoreductase activity;endoplasmic reticulum membrane;heterocycle metabolic process;monoterpenoid metabolic process;response to ethanol;electron carrier activity;drug metabolic process;intracellular membrane-bounded organelle;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;endoplasmic reticulum;enzyme binding;heme binding;response to ozone;intrinsic to endoplasmic reticulum membrane;xenobiotic metabolic process;monooxygenase activity;triglyceride metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NADH or NADPH as one donor, and incorporation of one atom of oxygen;iron ion binding:protein binding;synaptonemal complex;meiotic prophase I;cell division;central element@NA
D122641@136770@136770@deletion@1@135439428@135439504@10@chr10:135439428-135439504@5@221@138@0.624@CNVR4989.11, CNVR4989.4@FRG2B-202_3@29@29@29@:FSHD region gene 2 family, member B@:nucleus@NA
D122641@145899@145917@deletion@19@89534136@89592648@11@chr11:89534136-89592648@24.8@245@90@0.367@NA@TRIM49-201_1, TRIM49-201_2, TRIM49-201_3, TRIM49-201_4, TRIM49-201_5, TRIM49-201_6, TRIM53L-202_1, TRIM53L-202_2, TRIM53L-202_3, TRIM53L-202_4, TRIM53L-202_5, TRIM53L-202_6, TRIM53L-202_7, AP005435-201_1, AP005435-201_2, AP005435-201_3, AP005435-201_4, AP005435-201_5, AP005435-201_6@34@20@52@:tripartite motif containing 49@:protein binding;intracellular;DNA binding;zinc ion binding@NA
D122641@145944@145964@duplication@21@89701674@89729449@11@chr11:89701674-89729449@35.1@153@404@2.64@NA@TRIM64-202_1, TRIM64-202_2, TRIM64-202_3, TRIM64-202_4, TRIM64-202_5, TRIM64-202_6, TRIM64-202_7, TRIM64-202_8, TRIM64-202_9, ENST00000442514_1, ENST00000442514_2, ENST00000442514_3, ENST00000442514_4, ENST00000442514_5, ENST00000442514_6, ENST00000442514_7, ENST00000442514_8, ENST00000442514_9, TRIM53-202_5, TRIM53-202_6, TRIM53-202_7@95.2380952380952@21@177@NA@NA@NA
D122641@150493@150493@duplication@1@7966399@7967131@12@chr12:7966399-7967131@7.09@189@292@1.54@NA@SLC2A14-202_12@11@11@11@:NECAP endocytosis associated 1:solute carrier family 2 (facilitated glucose transporter), member 14@:coated pit;protein binding;endocytosis;protein transport;clathrin vesicle coat;plasma membrane;membrane:multicellular organismal development;cell differentiation;substrate-specific transmembrane transporter activity;transport;folic acid binding;glucose transmembrane transporter activity;transmembrane transport;spermatogenesis;reduced folate carrier activity;integral to membrane;transmembrane transporter activity;membrane@NA
D122641@150563@150571@duplication@9@8370271@8389669@12@chr12:8370271-8389669@7.74@55@114@2.07@CNVR5422.5, CNVR5422.6@ENST00000456135_7, FAM90A1-201_1, FAM90A1-201_2, FAM90A1-201_3, FAM90A1-201_4, AC092111-202_4, AC092111-202_5, AC092111-202_6, AC092111-202_7@45@37@48@:family with sequence similarity 90, member A1@:zinc ion binding;nucleic acid binding@NA
D122641@150829@150841@deletion@13@9684189@9707352@12@chr12:9684189-9707352@129@652@35@0.0537@CNVR5429.1@AC006432-201_1, AC006432-201_2, AC006432-201_3, AC006432-201_4, AC006432-201_5, AC006432-201_6, AC006432-201_7, AC006432-201_8, AC006432-201_9, AC006432-201_10, AC006432-201_11, AC006432-201_12, AC006432-201_13@22.2307692307692@15@25@NA@NA@NA
D122641@150968@150971@deletion@4@10583212@10587639@12@chr12:10583212-10587639@8.58@412@266@0.646@CNVR5430.1@KLRC2-201_3, KLRC2-201_4, KLRC2-201_5, KLRC2-201_6@62@51@67@:killer cell lectin-like receptor subfamily C, member 2@:carbohydrate binding:transmembrane signaling receptor activity;carbohydrate binding;protein binding;signal transduction;cellular defense response;integral to plasma membrane@NA
D122641@151022@151022@duplication@1@11035136@11035298@12@chr12:11035136-11035298@4.6@85@137@1.61@NA@PRH1-201_3@10@10@10@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):proline-rich protein HaeIII subfamily 1@:extracellular space;visual perception:protein binding;extracellular space@NA
D122641@151027@151027@deletion@1@11083263@11083680@12@chr12:11083263-11083680@6.07@151@84@0.556@NA@PRH2-201_3@1@1@1@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):proline-rich protein HaeIII subfamily 2;proline-rich protein HaeIII subfamily 1@:extracellular space;visual perception:protein binding;extracellular space@NA
D122641@151034@151034@deletion@1@11244393@11244793@12@chr12:11244393-11244793@52.8@337@26@0.0772@CNVR5434.1@TAS2R31-201_2@72@72@72@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
D122641@162127@162128@deletion@2@24465240@24465671@13@chr13:24465240-24465671@17.8@860@519@0.603@NA@RP11-45B20-002_6, ENST00000382133_3@29@29@29@:C1q and tumor necrosis factor related protein 9B@:collagen;protein binding@NA
D122641@162168@162171@duplication@4@24895666@24896098@13@chr13:24895666-24896098@6.12@2119@2677@1.26@NA@SPATA13-009_14, C1QTNF9-003_6, ENST00000449656_1, AL359736-201_1@31.5@27@33@:spermatogenesis associated 13:C1q and tumor necrosis factor related protein 9@:lamellipodium assembly;phospholipid binding;Rac guanyl-nucleotide exchange factor activity;guanyl-nucleotide exchange factor activity;ruffle membrane;nucleus;regulation of cell migration;cell migration;regulation of Rho protein signal transduction;intracellular;Rho guanyl-nucleotide exchange factor activity;cytoplasm;filopodium assembly;filopodium;protein binding;lamellipodium:collagen;protein binding;hormone activity@NA
D122641@162215@162216@deletion@2@25144700@25144871@13@chr13:25144700-25144871@15.4@131@40@0.305@NA@ENST00000455130_2, ENST00000453498_4@10@10@10@NA@NA@NA
D122641@164539@164544@duplication@6@53103402@53122079@13@chr13:53103402-53122079@18.3@129@279@2.16@NA@RP11-78J21-201_12, RP11-78J21-201_13, RP11-78J21-201_14, RP11-78J21-201_15, RP11-78J21-201_16, RP11-78J21-201_17@102.166666666667@44@117@NA@NA@NA
D122641@166748@166752@duplication@5@20085421@20137506@14@chr14:20085421-20137506@10.6@328@473@1.44@CNVR6072.6, CNVR6072.12, CNVR6072.14, CNVR6072.36@AL929601-201_2, AL929601-201_3, AL929601-201_4, AL512310-201_1, AL512310-201_2@84@58@95@NA@NA@NA
D122641@167201@167215@deletion@15@22520782@22600561@14@chr14:22520782-22600561@25.9@2573@1786@0.694@NA@ENST00000390449_1, ENST00000390449_2, ENST00000390450_1, ENST00000390450_2, ENST00000390451_1, ENST00000390451_2, ENST00000390452_1, ENST00000390452_2, ENST00000390453_1, ENST00000390453_2, ENST00000390454_1, ENST00000390454_2, ENST00000390455_1, ENST00000390455_2, ENST00000390456_1@1.06666666666667@0@2@@:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding@NA
D122641@167220@167227@deletion@8@22631463@22689838@14@chr14:22631463-22689838@16.6@1012@675@0.667@NA@ENST00000390458_2, ENST00000390459_1, ENST00000390459_2, ENST00000390460_1, ENST00000390460_2, ENST00000390461_1, ENST00000390461_2, ENST00000390462_1@3@3@3@@:protein binding:protein binding:protein binding:protein binding:protein binding@NA
D122641@167233@167252@deletion@20@22740148@22938607@14@chr14:22740148-22938607@87.4@3764@2329@0.619@NA@TRAC-204_1, TRAC-204_2, AE000661-201_2, ENST00000390465_1, ENST00000390465_2, ENST00000390466_1, ENST00000390466_2, ENST00000390467_1, ENST00000390467_2, ENST00000390468_1, ENST00000390468_2, ENST00000390469_1, ENST00000390469_2, ENST00000499790_1, ENST00000499790_2, ENST00000390477_1, ENST00000390477_2, ENST00000390477_3, ENST00000390478_1, ENST00000390478_2@5.4@4@7@@:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:integral to membrane:protein binding@NA
D122641@170809@170811@duplication@3@74003820@74010454@14@chr14:74003820-74010454@20@349@590@1.69@CNVR6188.1, CNVR6188.4@ACOT1-201_1, ACOT1-201_2, ACOT1-201_3@109.666666666667@99@116@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
D122641@173508@173514@duplication@7@106539081@106573538@14@chr14:106539081-106573538@45.2@1025@1637@1.6@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8-001_1, IGHV1-8-001_2, IGHV3-9-001_1, IGHV3-9-001_2, IGHV2-10-001_1, IGHV2-10-001_2, IGHV3-11-001_2@20.4285714285714@9@24@@:protein binding:protein binding:protein binding@NA
D122641@173535@173540@duplication@6@106714778@106721477@14@chr14:106714778-106721477@7.85@306@423@1.38@CNVR6294.48, CNVR6294.24, CNVR6294.40, CNVR6294.38, CNVR6294.17, CNVR6294.23@IGHV3-22-001_1, AB019439-201_1, AB019439-201_2, IGHVIII-22-2-201_1, IGHVIII-22-2-201_2, IGHVIII-22-2-201_3@5.83333333333333@3@8@NA@NA@NA
D122641@173561@173566@deletion@6@106800714@106816027@14@chr14:106800714-106816027@29.7@560@270@0.482@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.41@IGHV3-30-2-001_1, IGHV4-31-001_1, IGHV4-31-001_2, IGHV3-32-001_1, IGHV3-32-001_2, IGHV3-33-001_2@17@14@19@@:protein binding:protein binding@NA
D122641@173586@173587@duplication@2@106866408@106866935@14@chr14:106866408-106866935@22.7@710@1127@1.59@CNVR6294.38, CNVR6294.21, CNVR6294.26, CNVR6294.56, CNVR6294.51, CNVR6294.2, CNVR6294.44@IGHV3-38-001_1, IGHV3-38-001_2@4.5@4@5@@:protein binding@NA
D122641@173590@173590@deletion@1@106899046@106899346@14@chr14:106899046-106899346@5.17@138@79@0.572@CNVR6294.26, CNVR6294.56, CNVR6294.18@IGHV3-41-001_2@11@11@11@NA@NA@NA
D122641@173592@173595@duplication@4@106926190@106934400@14@chr14:106926190-106934400@38.6@789@1349@1.71@CNVR6294.56, CNVR6294.1@IGHV3-43-001_1, IGHV3-43-001_2, IGHVIII-44-001_1, IGHVIII-44-001_2@11.5@11@12@@:protein binding@NA
D122641@173645@173645@duplication@1@107131035@107131335@14@chr14:107131035-107131335@11.6@210@364@1.73@CNVR6294.56, CNVR6294.16@IGHV3-66-001_2@3@3@3@@:protein binding@NA
D122641@173649@173652@duplication@4@107169933@107179339@14@chr14:107169933-107179339@12.2@966@1296@1.34@CNVR6294.56, CNVR6294.6, CNVR6294.92, CNVR6294.93@IGHV1-69-001_1, IGHV1-69-001_2, IGHV2-70-001_1, IGHV2-70-001_2@4.75@4@5@@:protein binding:protein binding@NA
D122641@179305@179310@duplication@6@72953607@72956853@15@chr15:72953607-72956853@7.82@73@136@1.86@CNVR6443.1@GOLGA6-001_8, GOLGA6-001_9, GOLGA6-001_10, GOLGA6-001_11, GOLGA6-001_12, GOLGA6-001_13@75.5@45@99@:golgin A6 family, member B@:Golgi apparatus@NA
D122641@184122@184134@duplication@13@8868749@8906964@16@chr16:8868749-8906964@46.5@2079@2924@1.41@NA@ABAT-202_13, ABAT-202_14, ABAT-202_15, ABAT-202_16, TMEM186-001_1, TMEM186-001_2, PMM2-001_1, PMM2-001_2, PMM2-001_3, PMM2-001_4, PMM2-001_5, PMM2-001_6, PMM2-001_7@0@0@0@:4-aminobutyrate aminotransferase:transmembrane protein 186:phosphomannomutase 2@:mitochondrion;locomotory behavior;pyridoxal phosphate binding;negative regulation of blood pressure;behavioral response to cocaine;response to drug;neuron projection;transaminase activity;gamma-aminobutyric acid catabolic process;protein homodimerization activity;succinate-semialdehyde dehydrogenase binding;mitochondrial matrix;response to ethanol;neurotransmitter secretion;(S)-3-amino-2-methylpropionate transaminase activity;copulation;response to hypoxia;response to nicotine;4-aminobutyrate transaminase activity;behavior;4-aminobutyrate transaminase complex;neurotransmitter catabolic process;response to cocaine;synaptic transmission;response to iron ion;gamma-aminobutyric acid metabolic process:mitochondrion;integral to membrane:neuronal cell body;mannose biosynthetic process;post-translational protein modification;phosphomannomutase activity;catalytic activity;cytoplasm;cytosol;dolichol-linked oligosaccharide biosynthetic process;protein glycosylation;cellular protein metabolic process;protein N-linked glycosylation via asparagine;GDP-mannose biosynthetic process;metabolic process@: GABA-TRANSAMINASE DEFICIENCY: CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A
D122641@186358@186365@duplication@8@28616920@28621513@16@chr16:28616920-28621513@15.8@757@1038@1.37@CNVR6685.1, CNVR6685.2@SULT1A1-203_3, SULT1A1-203_4, SULT1A1-203_5, SULT1A1-203_6, SULT1A1-203_7, SULT1A1-203_8, SULT1A1-203_9, SULT1A1-203_10@67.125@49@73@:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1@:small molecule metabolic process;sulfation;aryl sulfotransferase activity;amine metabolic process;catecholamine metabolic process;xenobiotic metabolic process;cytosol;steroid sulfotransferase activity;integral to membrane;sulfotransferase activity;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process;estrogen metabolic process@NA
D122641@186862@186865@deletion@4@30208297@30208883@16@chr16:30208297-30208883@10.4@47@0@0@CNVR6694.1, CNVR6694.2, CNVR6694.3@GIYD2-001_4, GIYD2-001_5, GIYD2-001_6, SULT1A3-001_2@4.75@0@7@:structure-specific endonuclease subunit SLX1-like;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae);SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae):sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3;sulfotransferase 1A3/1A4-like@:Slx1-Slx4 complex;5'-flap endonuclease activity;DNA repair;protein binding;DNA double-strand break processing involved in repair via single-strand annealing;double-strand break repair via homologous recombination;metal ion binding;crossover junction endodeoxyribonuclease activity:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;cytoplasm;catecholamine metabolic process;cytosol;endoplasmic reticulum unfolded protein response;xenobiotic metabolic process;sulfotransferase activity;activation of signaling protein activity involved in unfolded protein response;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process@NA
D122641@188229@188229@duplication@1@55798611@55798817@16@chr16:55798611-55798817@7.29@44@102@2.32@CNVR6730.1@CES4-202_2@108@108@108@NA@NA@NA
D122641@188232@188241@deletion@10@55806283@55820017@16@chr16:55806283-55820017@18.4@408@232@0.569@CNVR6730.1@CES4-202_5, CES4-202_6, CES4-202_7, CES4-202_8, CES4-202_9, CES4-202_10, CES4-202_11, AC147362-203_1, AC147362-203_2, AC147362-203_3@99.1@83@111@NA@NA@NA
D122641@188251@188257@duplication@7@55844431@55855434@16@chr16:55844431-55855434@9.29@878@1141@1.3@CNVR6731.1@CES1-203_5, CES1-203_6, CES1-203_7, CES1-203_8, CES1-203_9, CES1-203_10, CES1-203_11@30.1428571428571@24@33@:carboxylesterase 1;liver carboxylesterase 1-like@:hydrolase activity;methyl salicylate esterase activity;response to toxin;methylumbelliferyl-acetate deacetylase activity;endoplasmic reticulum lumen;retinyl-palmitate esterase activity;methyl jasmonate esterase activity;metabolic process;carboxylesterase activity;methyl indole-3-acetate esterase activity@: CARBOXYLESTERASE 1; CES1
D122641@189930@189930@deletion@1@70010214@70010636@16@chr16:70010214-70010636@11@53@2@0.0377@CNVR6762.3, CNVR6762.2@AC026468-201_8@10@10@10@NA@NA@NA
D122641@189959@189969@deletion@11@70162689@70178437@16@chr16:70162689-70178437@58.5@2502@1533@0.613@CNVR6764.1, CNVR6764.3@AC009060-202_5, AC009060-202_6, AC009060-202_7, AC009060-202_8, AC009060-202_9, AC009060-202_10, AC009060-202_11, AC009060-202_12, AC009060-202_13, AC009060-202_14, AC009060-202_15@72@61@77@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
D122641@189972@189973@deletion@2@70187296@70195206@16@chr16:70187296-70195206@25.5@1267@727@0.574@CNVR6764.1, CNVR6764.3@AC009060-202_18, AC009060-202_19, AC009060-201_3, AC009060-201_4, AC009060-201_5@70@69@71@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
D122641@189989@189989@deletion@1@70219790@70219880@16@chr16:70219790-70219880@7.96@54@12@0.222@CNVR6764.1, CNVR6764.5@CLEC18C-201_11@19@19@19@:C-type lectin domain family 18, member C@:carbohydrate binding;protein binding;extracellular region@NA
D122641@190518@190518@deletion@1@74368792@74368885@16@chr16:74368792-74368885@5.82@324@206@0.636@CNVR6778.2, CNVR6778.1@AC009053-202_14@16@16@16@NA@NA@NA
D122641@190540@190543@deletion@4@74443450@74444933@16@chr16:74443450-74444933@11@145@62@0.428@CNVR6778.2, CNVR6778.3, CNVR6778.5@CLEC18B-202_9, CLEC18B-202_10, CLEC18B-202_11, CLEC18B-202_12@60.75@57@63@:C-type lectin domain family 18, member B@:carbohydrate binding;protein binding;extracellular region@NA
D122641@195232@195235@duplication@4@16675293@16691450@17@chr17:16675293-16691450@6.95@334@459@1.37@NA@CCDC144A-202_16, CCDC144A-202_17, CCDC144A-202_18, AC022596-003_1@60@57@65@:coiled-coil domain containing 144A@NA@NA
D122641@195703@195747@deletion@45@18344490@18457581@17@chr17:18344490-18457581@153@1078@269@0.25@NA@ENST00000399124_3, ENST00000399124_4, ENST00000399124_5, ENST00000399124_6, ENST00000399124_7, ENST00000399124_8, ENST00000411877_4, LGALS9C-201_1, LGALS9C-201_2, LGALS9C-201_3, LGALS9C-201_4, LGALS9C-201_5, LGALS9C-201_6, LGALS9C-201_7, LGALS9C-201_8, LGALS9C-201_9, LGALS9C-201_10, LGALS9C-201_11, ENST00000426269_1, ENST00000426269_2, ENST00000426269_3, ENST00000426269_4, ENST00000426269_5, AC107983-001_1, AC107983-001_2, AC107983-001_3, AC107983-001_4, AC107983-001_5, AC107983-001_6, AC107983-001_7, AC107983-001_8, AC107983-001_9, AC107983-001_10, ENST00000456184_1, ENST00000456184_2, CCDC144B-201_14, CCDC144B-201_15, CCDC144B-201_16, CCDC144B-201_17, CCDC144B-201_18, ENST00000447265_11, ENST00000447265_12, ENST00000447265_13, ENST00000447265_14, ENST00000447265_15@130.2@79@153@:lectin, galactoside-binding, soluble, 9C:protein FAM106B-like@:carbohydrate binding@NA
D122641@195757@195759@duplication@3@18498037@18498176@17@chr17:18498037-18498176@29.1@299@585@1.96@NA@CCDC144B-201_8, CCDC144B-201_9, ENST00000447265_5@1@1@1@NA@NA@NA
D122641@196353@196355@deletion@3@25969266@25972376@17@chr17:25969266-25972376@10.4@188@97@0.516@CNVR7045.1, CNVR7045.2@LGALS9-001_4, LGALS9-001_5, LGALS9-001_6@8.66666666666667@5@16@:lectin, galactoside-binding, soluble, 9@:carbohydrate binding;positive regulation of I-kappaB kinase/NF-kappaB cascade;signal transduction;extracellular region;galactose binding;signal transducer activity;cytoplasm@NA
D122641@197277@197277@duplication@1@30372721@30372838@17@chr17:30372721-30372838@5.64@63@115@1.83@NA@LRRC37B-001_8@1@1@1@:leucine rich repeat containing 37B@:protein binding;integral to membrane;cytoplasm@NA
D122641@197547@197560@deletion@14@33680357@33769306@17@chr17:33680357-33769306@103@4285@2329@0.544@NA@SLFN11-001_1, SLFN11-001_2, SLFN11-001_3, SLFN11-001_4, SLFN11-001_5, SLFN11-001_6, SLFN12-002_1, SLFN12-002_2, SLFN12-002_3, SLFN12-002_4, SLFN12-002_5, SLFN12-002_6, SLFN13-201_5, SLFN13-201_6@0.928571428571429@0@1@:schlafen family member 11:schlafen family member 12:schlafen family member 13@:defense response to virus;tRNA binding;nucleus;ATP binding:ATP binding:intracellular;ATP binding@NA
D122641@197726@197728@deletion@3@34539180@34539966@17@chr17:34539180-34539966@15.1@69@0@0@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1-202_2, CCL4L1-202_3, CCL4L1-202_4@118@113@122@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
D122641@200259@200265@deletion@7@43585590@43594649@17@chr17:43585590-43594649@17.2@502@287@0.572@CNVR7113.4, CNVR7113.6, CNVR7113.2, CNVR7113.1@AC091132-201_1, AC091132-201_2, AC091132-201_3, AC091132-201_4, AC091132-201_5, ENST00000339474_2, ENST00000339474_3@94.7142857142857@81@127@NA@NA@NA
D122641@200324@200328@duplication@5@44360679@44364337@17@chr17:44360679-44364337@21.7@1426@1972@1.38@CNVR7114.3, CNVR7114.2, CNVR7114.10@ENST00000451529_1, ENST00000451529_2, ENST00000451529_3, ENST00000451529_4, ENST00000451529_5@54@11@90@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
D122641@200337@200340@deletion@4@44399690@44409348@17@chr17:44399690-44409348@13.1@68@5@0.0735@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A-001_7, LRRC37A-001_8, LRRC37A-001_9, LRRC37A-001_10@144.75@141@154@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
D122641@200343@200349@deletion@7@44414664@44592688@17@chr17:44414664-44592688@15.9@84@8@0.0952@CNVR7114.2, CNVR7114.1@LRRC37A-001_13, LRRC37A-001_14, LRRC37A-001_15, AC005829-202_1, AC005829-202_2, AC005829-202_3, LRRC37A2-201_1@161.142857142857@124@196@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane@NA
D122641@200362@200362@duplication@1@44632653@44632791@17@chr17:44632653-44632791@4.89@120@184@1.53@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2-201_13@97@97@97@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
D122641@209136@209136@duplication@1@107475@107556@19@chr19:107475-107556@5.84@71@128@1.8@CNVR7451.1, CNVR7451.3@OR4F17-202_2@18@18@18@:olfactory receptor, family 4, subfamily F, member 17@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
D122641@212892@212893@duplication@2@12543193@12544012@19@chr19:12543193-12544012@5.42@205@291@1.42@CNVR7541.1@ZNF443-201_2, ZNF443-201_3@9@2@16@:zinc finger protein 443@:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding:intracellular;DNA binding;regulation of transcription, DNA-dependent;response to stress;induction of apoptosis;nucleus;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding@NA
D122641@213493@213494@deletion@2@14508472@14508748@19@chr19:14508472-14508748@5.43@74@35@0.473@NA@CD97-205_8, CD97-205_9@10.5@7@14@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
D122641@213635@213635@duplication@1@14877792@14877922@19@chr19:14877792-14877922@8.56@63@137@2.17@NA@EMR2-209_6@4@4@4@:egf-like module containing, mucin-like, hormone receptor-like 2@:transmembrane signaling receptor activity;inflammatory response;G-protein coupled receptor activity;ruffle membrane;integral to membrane;plasma membrane;cell surface receptor signaling pathway;neuropeptide signaling pathway;granulocyte chemotaxis;cell migration;leading edge membrane;G-protein coupled receptor signaling pathway;protein binding;cell adhesion;membrane;calcium ion binding;chondroitin sulfate binding@NA
D122641@215242@215242@duplication@1@22586190@22586315@19@chr19:22586190-22586315@6.43@259@378@1.46@NA@ZNF98-201_2@1@1@1@:zinc finger protein 98@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
D122641@215259@215260@deletion@2@22939009@22939581@19@chr19:22939009-22939581@41.4@298@57@0.191@NA@ZNF99-201_7, ZNF99-201_8@6.5@6@7@:zinc finger protein 99@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
D122641@215928@215928@duplication@1@35862253@35863856@19@chr19:35862253-35863856@6.84@170@264@1.55@CNVR7627.1@FFAR3-001_2@102@102@102@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
D122641@217595@217595@deletion@1@41327389@41327534@19@chr19:41327389-41327534@4.79@68@32@0.471@NA@CYP2F1P-001_5@0@0@0@NA@NA@NA
D122641@217666@217667@deletion@2@41627365@41628039@19@chr19:41627365-41628039@15.4@277@137@0.495@CNVR7644.1@CYP2F1-201_5, CYP2F1-201_6@5@0@10@:cytochrome P450, family 2, subfamily F, polypeptide 1@:trichloroethylene metabolic process;oxidation-reduction process;aromatase activity;response to toxin;oxygen binding;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;endoplasmic reticulum membrane;naphthalene metabolic process;intracellular membrane-bounded organelle;electron carrier activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;heme binding;xenobiotic metabolic process;monooxygenase activity;iron ion binding@NA
D122641@218185@218185@deletion@1@43715945@43716628@19@chr19:43715945-43716628@5.36@58@23@0.397@CNVR7658.5, CNVR7658.1@CEACAMP10-001_9@41@41@41@:pregnancy specific beta-1-glycoprotein 9@:protein binding;extracellular region;female pregnancy;defense response@NA
D122641@218555@218556@deletion@2@45394669@45395718@19@chr19:45394669-45395718@5.03@51@20@0.392@NA@TOMM40-201_2, TOMM40-201_3@0@0@0@:translocase of outer mitochondrial membrane 40 homolog (yeast)@:integral to mitochondrial membrane;mitochondrion;voltage-gated anion channel activity;protein transmembrane transporter activity;mitochondrial outer membrane translocase complex;regulation of anion transport;transmembrane transport;pore complex;mitochondrial outer membrane;cellular protein metabolic process;integral to membrane;integral to mitochondrial outer membrane;protein targeting to mitochondrion;porin activity;anion transport@NA
D122641@220212@220214@deletion@3@50472859@50473865@19@chr19:50472859-50473865@6.17@342@226@0.661@NA@SIGLEC16-202_1, SIGLEC16-202_2, SIGLEC16-202_3@63.6666666666667@56@68@NA@NA@NA
D122641@221166@221171@deletion@6@54724400@54726912@19@chr19:54724400-54726912@51.7@328@60@0.183@CNVR7721.3, CNVR7721.4@LILRB3-008_1, LILRB3-008_2, LILRB3-008_3, LILRB3-008_4, LILRB3-008_5, LILRB3-008_6@113.833333333333@98@136@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D122641@221393@221394@deletion@2@55250955@55253726@19@chr19:55250955-55253726@5.01@238@154@0.647@CNVR7725.2, CNVR7725.4, CNVR7725.1@KIR2DL3-201_2, KIR2DL3-201_3@30@29@31@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity@NA
D122641@221403@221408@duplication@6@55277931@55279337@19@chr19:55277931-55279337@9.53@833@1091@1.31@CNVR7725.2, CNVR7725.1@KIR2DL3-201_6, KIR2DL3-201_7, KIR2DL3-201_8, KIR2DP1-001_7, KIR2DP1-001_8, KIR2DP1-001_9@125.666666666667@125@126@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity@NA
D122641@221439@221441@deletion@3@55358641@55360024@19@chr19:55358641-55360024@20.5@1063@648@0.61@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4-001_6, KIR2DS4-001_7, KIR2DS4-001_8@96.3333333333333@85@102@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
D122641@221822@221823@duplication@2@56280509@56283457@19@chr19:56280509-56283457@17.7@374@648@1.73@CNVR7734.1@ENST00000341750_1, ENST00000341750_2@41.5@36@47@:ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
D122641@222068@222069@duplication@2@58003184@58003369@19@chr19:58003184-58003369@7.63@64@126@1.97@CNVR7748.1@ZNF419-202_5, ZNF419-202_6@0@0@0@:zinc finger protein 419@:intracellular;DNA binding;regulation of transcription, DNA-dependent;cytoplasm;nucleolus;nucleus;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding@NA
D122641@222563@222564@deletion@2@1569208@1610283@20@chr20:1569208-1610283@5.78@29@2@0.069@CNVR7763.1@SIRPB1-201_1, SIRPG-005_6@64@0@128@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like:signal-regulatory protein gamma@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway:negative regulation of cell proliferation;positive regulation of T cell activation;positive regulation of cell-cell adhesion;intracellular;cell-cell signaling;protein binding;blood coagulation;integral to membrane;cell adhesion;plasma membrane;positive regulation of cell proliferation;membrane;intracellular signal transduction;leukocyte migration@NA
D122641@222594@222594@deletion@1@1895747@1896102@20@chr20:1895747-1896102@11.8@143@56@0.392@CNVR7764.2@SIRPA-201_3@34@34@34@:signal-regulatory protein alpha@:blood coagulation;protein binding;integral to membrane;SH3 domain binding;cell adhesion;plasma membrane;membrane;leukocyte migration@NA
D122641@227607@227607@deletion@1@55108304@55108647@20@chr20:55108304-55108647@7.97@221@123@0.557@NA@C20orf107-001_1@0@0@0@:family with sequence similarity 209, member B@:integral to membrane@NA
D122641@231958@231958@duplication@1@16287256@16287718@22@chr22:16287256-16287718@9.97@78@168@2.15@CNVR8071.2, CNVR8071.3, CNVR8071.9@POTEH-002_1@105@105@105@:POTE ankyrin domain family, member H@:protein binding@NA
D122641@232350@232351@deletion@2@18775046@18775393@22@chr22:18775046-18775393@5.86@99@51@0.515@CNVR8087.5, CNVR8087.2, CNVR8087.7@AC008132-201_3, AC008132-201_4@103.5@103@104@NA@NA@NA
D122641@232927@232929@deletion@3@21065631@21067086@22@chr22:21065631-21067086@5.44@53@21@0.396@CNVR8099.6, CNVR8099.2@PI4KA-001_49, PI4KA-001_50, PI4KA-001_51@3@2@4@:phosphatidylinositol 4-kinase, catalytic, alpha@:phospholipid metabolic process;1-phosphatidylinositol 4-kinase activity;small molecule metabolic process;phosphatidylinositol phosphorylation;binding;transferase activity, transferring phosphorus-containing groups;phosphotransferase activity, alcohol group as acceptor;ATP binding;Golgi-associated vesicle;phosphatidylinositol biosynthetic process;cytosol;protein binding;signal transduction;synaptic transmission;kinase activity;phosphatidylinositol-mediated signaling@NA
D122641@233177@233178@duplication@2@21830293@21830450@22@chr22:21830293-21830450@5.15@1@32@32@CNVR8101.1@PI1KAP2-201_15, PI1KAP2-201_16@81@81@81@NA@NA@NA
D122641@233731@233754@duplication@24@24345655@24394850@22@chr22:24345655-24394850@56.8@955@1556@1.63@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTTP1-001_1, GSTTP1-001_2, ENST00000421902_1, ENST00000421902_2, ENST00000448902_1, ENST00000448902_2, ENST00000448902_3, ENST00000448902_4, ENST00000448902_5, ENST00000329210_1, ENST00000329210_2, ENST00000329210_3, ENST00000329210_4, ENST00000439866_1, ENST00000439866_2, GSTT1-009_1, GSTT1-009_2, GSTT1-009_3, GSTT1-009_4, GSTT1-009_5, ENST00000439996_1, ENST00000439996_2, GSTTP2-001_4, GSTTP2-001_5@130.833333333333@109@149@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
D122641@236770@236771@deletion@2@42538482@42538641@22@chr22:42538482-42538641@8.32@87@34@0.391@CNVR8168.1, CNVR8168.3, CNVR8168.4@CYP2D7P1-202_4, CYP2D7P1-202_5@21.5@21@22@@:oxidation-reduction process;electron carrier activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;heme binding@NA
D122836@2736@2740@duplication@5@16360108@16366192@1@chr1:16360108-16366192@7.24@338@459@1.36@CNVR92.1@CLCNKA-003_24, ENST00000447882_2, ENST00000447882_3, ENST00000447882_4, ENST00000447882_5@20@9@40@:chloride channel, voltage-sensitive Ka@:ion channel activity;transport;chloride channel complex;transmembrane transport;protein binding;chloride transport;integral to membrane;excretion;integral to plasma membrane;membrane;voltage-gated chloride channel activity@: BARTTER SYNDROME, TYPE 4B
D122836@2885@2887@duplication@3@16875148@16879027@1@chr1:16875148-16879027@6.19@96@154@1.6@CNVR93.3, CNVR93.6, CNVR93.10@ENST00000438396_1, ENST00000438396_2, ENST00000438396_3@51@44@61@NA@NA@NA
D122836@2931@2933@duplication@3@16972895@16973397@1@chr1:16972895-16973397@6.35@505@661@1.31@CNVR93.3, CNVR93.6, CNVR93.12, CNVR93.7, CNVR93.14, CNVR93.15@RP5-1182A14-001_2, RP5-1182A14-001_3, RP5-1182A14-001_4@40.3333333333333@39@42@NA@NA@NA
D122836@2943@2946@duplication@4@16975671@16976445@1@chr1:16975671-16976445@18.1@681@964@1.42@CNVR93.3, CNVR93.6, CNVR93.12, CNVR93.7, CNVR93.14, CNVR93.15@RP5-1182A14-001_14, RP5-1182A14-001_15, RP5-1182A14-001_16, RP5-1182A14-001_17@81@69@88@NA@NA@NA
D122836@2950@2966@deletion@17@17013136@17046653@1@chr1:17013136-17046653@115@1861@897@0.482@CNVR93.3, CNVR93.15, CNVR93.4@RP1-163M9-001_1, RP1-163M9-001_2, RP1-163M9-001_3, ESPNP-002_1, ESPNP-002_2, ESPNP-002_3, ESPNP-002_4, ESPNP-002_5, ESPNP-002_6, ESPNP-002_7, ESPNP-002_8, ESPNP-002_9, ESPNP-002_10, ESPNP-002_11, AL021920-201_1, AL021920-201_2, AL021920-201_3@42.8235294117647@37@46@NA@NA@NA
D122836@3957@3957@duplication@1@22315757@22315838@1@chr1:22315757-22315838@5.43@89@145@1.63@CNVR108.2@CELA3B-001_8@4@4@4@:chymotrypsin-like elastase family, member 3B@:peptidase activity;proteolysis;extracellular region;cholesterol metabolic process;catalytic activity;serine-type endopeptidase activity@NA
D122836@3965@3965@deletion@1@22338945@22339034@1@chr1:22338945-22339034@11.9@54@0@0@CNVR108.2, CNVR108.1@CELA3A-201_8@3@3@3@:chymotrypsin-like elastase family, member 3A@:proteolysis;digestion;cholesterol metabolic process;catalytic activity;serine-type endopeptidase activity@NA
D122836@11245@11245@duplication@1@89476589@89476800@1@chr1:89476589-89476800@6.54@306@428@1.4@CNVR244.1@GBP3-001_8@54@54@54@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
D122836@12525@12525@deletion@1@108769303@108769516@1@chr1:108769303-108769516@18.4@89@3@0.0337@CNVR294.4@NBPF4-002_13@32@32@32@:neuroblastoma breakpoint family, member 4@:cytoplasm@NA
D122836@12929@12936@deletion@8@110230474@110236368@1@chr1:110230474-110236368@105@488@4@0.0082@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1-001_1, GSTM1-001_2, GSTM1-001_3, GSTM1-001_4, GSTM1-001_5, GSTM1-001_6, GSTM1-001_7, GSTM1-001_8@191.375@187@194@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
D122836@14493@14495@duplication@3@144676872@144679973@1@chr1:144676872-144679973@12@264@405@1.53@CNVR337.1@WI2-1896O14-001_1, WI2-1896O14-001_2, WI2-1896O14-001_3@4.66666666666667@4@5@NA@NA@NA
D122836@15201@15205@duplication@5@148008575@148011789@1@chr1:148008575-148011789@10.2@35@104@2.97@CNVR346.2, CNVR346.4@NBPF14-001_13, NBPF14-001_14, NBPF14-001_15, NBPF14-001_16, NBPF14-001_17@112@105@120@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
D122836@17734@17779@duplication@46@156890706@156933387@1@chr1:156890706-156933387@158@4825@6949@1.44@NA@C1orf92-002_1, C1orf92-002_2, C1orf92-002_3, C1orf92-002_4, C1orf92-002_5, C1orf92-002_6, C1orf92-002_7, C1orf92-002_8, C1orf92-002_9, C1orf92-002_10, C1orf92-002_11, C1orf92-002_12, C1orf92-002_13, C1orf92-002_14, C1orf92-002_15, C1orf92-002_16, ARHGEF11-001_12, ARHGEF11-001_13, ARHGEF11-001_14, ARHGEF11-001_15, ARHGEF11-001_16, ARHGEF11-001_17, ARHGEF11-001_18, ARHGEF11-001_19, ARHGEF11-001_20, ARHGEF11-001_21, ARHGEF11-001_22, ARHGEF11-001_23, ARHGEF11-001_24, ARHGEF11-001_25, ARHGEF11-001_26, ARHGEF11-001_27, ARHGEF11-001_28, ARHGEF11-001_29, ARHGEF11-001_30, ARHGEF11-001_31, ARHGEF11-001_32, ARHGEF11-001_33, ARHGEF11-001_34, ARHGEF11-001_35, ARHGEF11-001_36, ARHGEF11-001_37, ARHGEF11-001_38, ARHGEF11-001_39, ARHGEF11-001_40, ARHGEF11-001_41@0.0217391304347826@0@1@:leucine rich repeat containing 71:Rho guanine nucleotide exchange factor (GEF) 11@:phospholipid binding;regulation of cell growth;GTPase activator activity;striated muscle contraction;actin cytoskeleton organization;establishment of cell polarity;apoptotic process;regulation of small GTPase mediated signal transduction;cytokinesis;cellular component movement;intracellular;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;G-protein coupled receptor signaling pathway;Rho guanyl-nucleotide exchange factor activity;axon guidance;Rho protein signal transduction;cytoplasm;termination of G-protein coupled receptor signaling pathway;cytosol;protein binding;positive regulation of transcription, DNA-dependent;nerve growth factor receptor signaling pathway;membrane;G-protein coupled receptor binding@NA
D122836@18676@18679@duplication@4@161569422@161589376@1@chr1:161569422-161589376@11.2@213@343@1.61@CNVR383.1@FCGR2C-006_7, ENST00000448848_1, ENST00000448848_2, ENST00000448848_3@40@40@40@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
D122836@21366@21366@deletion@1@196759177@196759358@1@chr1:196759177-196759358@11@58@5@0.0862@CNVR459.1@CFHR3-001_5@112@112@112@:complement factor H-related 3@:extracellular space@NA
D122836@23045@23045@duplication@1@207741171@207741388@1@chr1:207741171-207741388@9.05@214@331@1.55@CNVR485.1, CNVR485.2@CR1-201_25@16@16@16@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
D122836@33559@33564@duplication@6@87407114@87414366@2@chr2:87407114-87414366@13@315@467@1.48@CNVR861.2@AC083899-001_23, AC083899-001_24, AC083899-001_25, AC083899-001_26, AC083899-001_27, AC083899-001_28@70.6666666666667@46@85@NA@NA@NA
D122836@33585@33585@deletion@1@88012880@88012957@2@chr2:88012880-88012957@4.83@105@59@0.562@CNVR861.3@AC093616-001_5@35@35@35@NA@NA@NA
D122836@34183@34184@deletion@2@96652501@96652955@2@chr2:96652501-96652955@27.3@179@33@0.184@NA@AC073995-001_2, AC073995-001_3@4@4@4@:ankyrin repeat domain-containing protein 36A-like@:ion channel inhibitor activity;protein binding@NA
D122836@34212@34212@deletion@1@96697783@96697895@2@chr2:96697783-96697895@6.24@48@14@0.292@NA@GPAT2-205_4@75@75@75@:glycerol-3-phosphate acyltransferase 2, mitochondrial@:glycerol-3-phosphate O-acyltransferase activity;mitochondrion;phospholipid metabolic process;triglyceride biosynthetic process;glycerophospholipid biosynthetic process;small molecule metabolic process;transferase activity, transferring acyl groups;mitochondrial outer membrane;phosphatidic acid biosynthetic process;integral to membrane;glycerol-3-phosphate metabolic process;CDP-diacylglycerol biosynthetic process;membrane;metabolic process;phospholipid biosynthetic process@NA
D122836@34652@34652@duplication@1@98201749@98201862@2@chr2:98201749-98201862@5.03@263@361@1.37@NA@ANKRD36B-001_2@0@0@0@NA@NA@NA
D122836@37174@37174@duplication@1@130831605@130833146@2@chr2:130831605-130833146@4.71@62@106@1.71@NA@A26C1B-001_17@44@44@44@:POTE ankyrin domain family, member F@:cell cortex;protein binding;ATP binding@NA
D122836@37995@37996@deletion@2@142301867@142356645@2@chr2:142301867-142356645@5.46@51@19@0.373@NA@AC093859-201_1, AC093859-201_2@0@0@0@:low density lipoprotein receptor-related protein 1B@:low-density lipoprotein receptor activity;protein binding;integral to membrane;protein transport;receptor-mediated endocytosis;membrane;calcium ion binding@NA
D122836@40522@40524@duplication@3@179337758@179337866@2@chr2:179337758-179337866@7.94@127@203@1.6@NA@FKBP7-201_3, FKBP7-201_4, FKBP7-201_5@0@0@0@:FK506 binding protein 7@:FK506 binding;endoplasmic reticulum;endoplasmic reticulum lumen;peptidyl-proline modification;protein folding;protein binding;protein peptidyl-prolyl isomerization;peptidyl-prolyl cis-trans isomerase activity;membrane;calcium ion binding@NA
D122836@47457@47457@deletion@1@10091060@10091190@3@chr3:10091060-10091190@6.97@106@52@0.491@NA@FANCD2-202_17@6@6@6@:Fanconi anemia, complementation group D2@:nucleoplasm;synapsis;binding;response to DNA damage stimulus;gamete generation;DNA repair;condensed chromosome;protein binding;response to gamma radiation@: FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2
D122836@47662@47663@deletion@2@11925055@11925573@3@chr3:11925055-11925573@5.75@90@46@0.511@NA@AC090958-001_9, AC090958-001_10@9.5@9@10@NA@NA@NA
D122836@61532@61539@duplication@8@195377017@195378510@3@chr3:195377017-195378510@31@571@927@1.62@NA@AC233280-201_1, AC233280-201_2, AC233280-201_3, AC233280-201_4, AC233280-201_5, AC233280-201_6, AC233280-201_7, AC233280-201_8@89.125@82@93@:mucin 20, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane@NA
D122836@61569@61573@deletion@5@195452546@195475936@3@chr3:195452546-195475936@12.2@1556@1088@0.699@CNVR1703.1, CNVR1703.2, CNVR1703.5, CNVR1703.3@MUC20-201_3, MUC20-201_4, MUC20-201_5, MUC4-203_25, MUC4-203_26@37@30@44@:mucin 20, cell surface associated:mucin 4, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane:ErbB-2 class receptor binding;Golgi lumen;cell-matrix adhesion;post-translational protein modification;extracellular matrix structural constituent;protein binding;O-glycan processing;cellular protein metabolic process;proteinaceous extracellular matrix;integral to plasma membrane;membrane;extracellular matrix constituent, lubricant activity;biological_process@NA
D122836@61643@61645@duplication@3@195701270@195701438@3@chr3:195701270-195701438@5.48@366@483@1.32@CNVR1707.1, CNVR1707.2@SDHALP1-002_10, ENST00000354937_11, ENST00000354937_12@40.3333333333333@39@41@NA@NA@NA
D122836@61648@61649@deletion@2@195703956@195704123@3@chr3:195703956-195704123@9.62@191@104@0.545@CNVR1707.1, CNVR1707.2@SDHALP1-002_8, ENST00000354937_9@32.5@32@33@NA@NA@NA
D122836@65315@65320@duplication@6@69402904@69434246@4@chr4:69402904-69434246@46.8@922@1495@1.62@CNVR1953.1@UGT2B17-001_1, UGT2B17-001_2, UGT2B17-001_3, UGT2B17-001_4, UGT2B17-001_5, UGT2B17-001_6@124.5@118@134@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
D122836@65355@65360@duplication@6@70146890@70160768@4@chr4:70146890-70160768@6.4@552@716@1.3@CNVR1957.2, CNVR1957.1@UGT2B28-201_2, UGT2B28-201_3, UGT2B28-201_4, UGT2B28-201_5, UGT2B28-201_6, UGT2B28-201_7@68.8333333333333@65@71@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
D122836@68065@68066@duplication@2@119465473@119472328@4@chr4:119465473-119472328@5.43@149@216@1.45@NA@CEP170L-201_5, CEP170L-201_6@27@4@50@NA@NA@NA
D122836@68947@68947@deletion@1@145041645@145041742@4@chr4:145041645-145041742@8.19@104@46@0.442@NA@GYPA-205_2@8@8@8@:glycophorin B (MNS blood group):glycophorin A (MNS blood group)@:integral to membrane;plasma membrane;integral to plasma membrane:external side of plasma membrane;integral to membrane;cytoskeletal anchoring at plasma membrane;plasma membrane;molecular_function;protein homodimerization activity;integral to plasma membrane;cellular_component;identical protein binding;membrane;biological_process;regulation of response to osmotic stress;virus-host interaction@: BLOOD GROUP--Ss LOCUS; Ss: MALARIA, SUSCEPTIBILITY TO; BLOOD GROUP--MN LOCUS; MN
D122836@73705@73705@duplication@1@69372350@69372402@5@chr5:69372350-69372402@13.3@87@197@2.26@CNVR2494.48, CNVR2494.39, CNVR2494.15, CNVR2494.18, CNVR2494.26, CNVR2494.43, CNVR2494.52, CNVR2494.28, CNVR2494.2, CNVR2494.36@SMN2-001_8@8@8@8@:survival of motor neuron 2, centromeric;survival of motor neuron 1, telomeric@:nucleoplasm;ncRNA metabolic process;Cajal body;RNA metabolic process;spliceosomal complex;cytoplasm;cytosol;protein binding;cell death;spliceosomal complex assembly;RNA binding;mRNA processing;nucleus;gene expression;spliceosomal snRNP assembly@: SPINAL MUSCULAR ATROPHY, TYPE II; SMA2; SPINAL MUSCULAR ATROPHY, TYPE I; SMA1; SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4; SPINAL MUSCULAR ATROPHY, TYPE III; SMA3
D122836@73727@73727@deletion@1@69717564@69717599@5@chr5:69717564-69717599@10.9@49@0@0@CNVR2494.17, CNVR2494.3@GTF2H2B-201_4@139@139@139@NA@NA@NA
D122836@73781@73782@deletion@2@70247770@70248840@5@chr5:70247770-70248840@6.48@131@72@0.55@CNVR2494.41, CNVR2494.14, CNVR2494.30, CNVR2494.25, CNVR2494.20, CNVR2494.61, CNVR2494.22, CNVR2494.21, CNVR2494.62, CNVR2494.63@SMN1-001_8, SMN1-001_9@0@0@0@:survival of motor neuron 2, centromeric;survival of motor neuron 1, telomeric@:nucleoplasm;ncRNA metabolic process;Cajal body;RNA metabolic process;spliceosomal complex;cytoplasm;cytosol;protein binding;cell death;spliceosomal complex assembly;RNA binding;mRNA processing;nucleus;gene expression;spliceosomal snRNP assembly@: SPINAL MUSCULAR ATROPHY, TYPE II; SMA2; SPINAL MUSCULAR ATROPHY, TYPE I; SMA1; SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4; SPINAL MUSCULAR ATROPHY, TYPE III; SMA3
D122836@73795@73796@duplication@2@70307104@70308746@5@chr5:70307104-70308746@7.52@573@770@1.34@CNVR2494.41, CNVR2494.14, CNVR2494.30, CNVR2494.20, CNVR2494.62, CNVR2494.8, CNVR2494.35@NAIP-001_4, NAIP-001_5@29.5@27@32@:baculoviral IAP repeat-containing protein 1-like;NLR family, apoptosis inhibitory protein@:negative regulation of apoptotic process;inflammatory response;basolateral plasma membrane;nucleoside-triphosphatase activity;cysteine-type endopeptidase inhibitor activity;intracellular;nucleotide binding;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;ATP binding;cytoplasm;innate immune response;protein binding;negative regulation of neuron apoptotic process;metal ion binding;nervous system development@NA
D122836@78044@78044@deletion@1@147553799@147553934@5@chr5:147553799-147553934@23.3@107@0@0@CNVR2637.2, CNVR2637.1@AC116334-001_3@78@78@78@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
D122836@79568@79568@deletion@1@175388278@175388438@5@chr5:175388278-175388438@6.97@33@1@0.0303@NA@THOC3-001_4@165@165@165@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
D122836@80228@80231@deletion@4@179022907@179023683@5@chr5:179022907-179023683@5.73@217@139@0.641@NA@RUFY1-201_13, RUFY1-201_14, RUFY1-201_15, AC136604-201_9@3.75@3@4@:RUN and FYVE domain containing 1@:endocytosis;cytoplasm;protein transporter activity;lipid binding;regulation of endocytosis;protein binding;protein transport;zinc ion binding;early endosome membrane;metal ion binding@NA
D122836@82109@82109@deletion@1@26422319@26422426@6@chr6:26422319-26422426@6.86@156@87@0.558@NA@BTN2A3-205_2@0@0@0@NA@NA@NA
D122836@82488@82513@deletion@26@29855352@29897010@6@chr6:29855352-29897010@45.1@1521@950@0.625@CNVR2829.7, CNVR2829.2, CNVR2829.3@HLA-H-001_1, HLA-H-001_2, HLA-H-001_3, HLA-H-001_4, HLA-H-001_5, HLA-H-001_6, HLA-H-001_7, HLA-16-001_1, HLA-16-001_2, HLA-16-001_3, HLA-16-001_4, AL645929-201_2, AL645929-201_3, AL645929-201_4, AL645929-201_5, AL645929-201_6, BAT1P1-001_1, BAT1P1-001_2, MCCD1P1-001_1, MCCD1P1-001_2, HLA-K-001_1, HLA-K-001_2, HLA-K-001_3, HLA-K-001_4, HLA-K-001_5, HLA-K-001_6@45.2307692307692@41@51@NA@NA@NA
D122836@83002@83003@deletion@2@31237745@31238263@6@chr6:31237745-31238263@26.8@304@119@0.391@CNVR2838.2, CNVR2838.1@HLA-C-006_4, HLA-C-006_5@25@25@25@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
D122836@83577@83582@duplication@6@31962024@31963572@6@chr6:31962024-31963572@8.29@188@282@1.5@CNVR2843.6, CNVR2843.3@C4A-001_20, C4A-001_21, C4A-001_22, C4A-001_23, C4A-001_24, C4A-001_25@13@11@17@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
D122836@83637@83642@deletion@6@31994762@31996310@6@chr6:31994762-31996310@12.4@146@64@0.438@CNVR2843.6, CNVR2843.5@C4B-001_20, C4B-001_21, C4B-001_22, C4B-001_23, C4B-001_24, C4B-001_25@12.3333333333333@10@15@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
D122836@83911@83914@deletion@4@32485122@32487429@6@chr6:32485122-32487429@14@81@12@0.148@CNVR2845.21, CNVR2845.25, CNVR2845.30@HLA-DRB5-001_3, HLA-DRB5-001_4, HLA-DRB5-001_5, HLA-DRB5-001_6@186@182@189@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D122836@83920@83927@duplication@8@32522469@32548048@6@chr6:32522469-32548048@17@213@365@1.71@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.5@HLA-DRB6-002_1, HLA-DRB6-002_2, HLA-DRB6-002_3, AL713966-201_1, AL713966-201_2, AL713966-201_3, HLA-DRB1-001_5, HLA-DRB1-001_6@125.25@85@167@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
D122836@83929@83932@deletion@4@32549336@32605318@6@chr6:32549336-32605318@11.8@317@189@0.596@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.34@HLA-DRB1-001_1, HLA-DRB1-001_2, HLA-DRB1-001_3, HLA-DQA1-002_1@80.25@60@100@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
D122836@83936@83937@duplication@2@32610389@32611050@6@chr6:32610389-32611050@5.94@199@283@1.42@CNVR2845.21, CNVR2845.25, CNVR2845.37, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20@HLA-DQA1-002_5, HLA-DQA1-002_6@145.5@145@146@:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D122836@92590@92593@deletion@4@160132511@160133097@6@chr6:160132511-160133097@10.2@442@286@0.647@CNVR3127.2, CNVR3127.1@ENST00000442642_4, ENST00000442642_5, ENST00000442642_6, ENST00000442642_7@103.5@90@112@:superoxide dismutase 2, mitochondrial;uncharacterized LOC100129518@:response to reactive oxygen species;oxidation-reduction process;mitochondrion;negative regulation of cell proliferation;neuron development;negative regulation of fat cell differentiation;removal of superoxide radicals;response to gamma radiation;response to L-ascorbic acid;response to lipopolysaccharide;response to nutrient levels;response to zinc ion;protein homotetramerization;post-embryonic development;iron ion homeostasis;hemopoiesis;aging;mitochondrial inner membrane;age-dependent response to reactive oxygen species;response to drug;oxygen binding;mitochondrial nucleoid;vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure;apoptotic process;superoxide metabolic process;response to superoxide;detection of oxygen;response to silicon dioxide;cytoplasm;response to stress;respiratory electron transport chain;superoxide anion generation;protein homooligomerization;regulation of mitochondrial membrane potential;positive regulation of nitric oxide biosynthetic process;response to manganese ion;regulation of blood pressure;metal ion binding;negative regulation of apoptotic process;response to cadmium ion;response to oxidative stress;liver development;regulation of catalytic activity;negative regulation of fibroblast proliferation;response to selenium ion;age-dependent response to oxidative stress;response to electrical stimulus;mitochondrial matrix;identical protein binding;mitochondrion organization;response to hyperoxia;vasodilation;response to hydrogen peroxide;superoxide dismutase activity;heart development;negative regulation of neuron apoptotic process;erythrophore differentiation;locomotory behavior;DNA binding;release of cytochrome c from mitochondria;response to axon injury;oxygen homeostasis;response to activity;glutathione metabolic process;hydrogen peroxide metabolic process;hydrogen peroxide biosynthetic process;regulation of transcription from RNA polymerase II promoter;response to hypoxia;protein binding;manganese ion binding;cellular response to ethanol@: MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6; MVCD6
D122836@94190@94193@deletion@4@5959482@5965606@7@chr7:5959482-5965606@35@487@218@0.448@NA@C7orf28A-001_12, C7orf28A-001_13, C7orf28A-001_14, C7orf28A-001_15@65.75@46@73@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae):radial spoke head 10 homolog B (Chlamydomonas)@:lysosomal membrane@NA
D122836@94198@94201@deletion@4@5977391@5983622@7@chr7:5977391-5983622@9.86@291@178@0.612@NA@RSPH10B-002_14, RSPH10B-002_15, RSPH10B-002_16, RSPH10B-002_17@14.75@10@18@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D122836@94212@94212@deletion@1@6006496@6006833@7@chr7:6006496-6006833@10@134@60@0.448@NA@RSPH10B-002_3@13@13@13@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D122836@94410@94415@duplication@6@6785721@6791233@7@chr7:6785721-6791233@8.96@251@360@1.43@NA@ENST00000338780_11, ENST00000338780_12, ENST00000338780_13, PMS2CL-002_11, PMS2CL-002_12, PMS2CL-002_13@80.3333333333333@73@90@NA@NA@NA
D122836@94424@94444@duplication@21@6805339@6844687@7@chr7:6805339-6844687@65.8@891@1517@1.7@NA@RSPH10B2-204_7, RSPH10B2-204_8, RSPH10B2-204_9, RSPH10B2-204_10, RSPH10B2-204_11, RSPH10B2-204_12, RSPH10B2-204_13, RSPH10B2-204_14, RSPH10B2-204_15, RSPH10B2-204_16, RSPH10B2-204_17, RSPH10B2-204_18, RSPH10B2-204_19, RSPH10B2-204_20, RSPH10B2-204_21, ENST00000429267_1, ENST00000429267_2, C7orf28B-001_12, C7orf28B-001_13, C7orf28B-001_14, C7orf28B-001_15@40.5238095238095@11@121@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D122836@94452@94454@duplication@3@6863722@6864369@7@chr7:6863722-6864369@5.85@179@257@1.44@NA@C7orf28B-001_2, C7orf28B-001_3, C7orf28B-001_4@25.6666666666667@20@33@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D122836@94462@94463@deletion@2@6906510@6920188@7@chr7:6906510-6920188@5.94@205@129@0.629@NA@RP11-740N7-201_1, RP11-740N7-201_2@21@20@22@NA@NA@NA
D122836@97907@97917@duplication@11@57063663@57084498@7@chr7:57063663-57084498@32.3@109@325@2.98@NA@TNRC18C-202_3, TNRC18C-202_4, TNRC18C-202_5, TNRC18C-202_6, TNRC18C-202_7, TNRC18C-202_8, TNRC18C-202_9, TNRC18C-202_10, TNRC18C-202_11, ENST00000398760_4, ENST00000398760_5@155.545454545455@139@166@NA@NA@NA
D122836@97991@97994@deletion@4@62758072@62758771@7@chr7:62758072-62758771@96.1@453@2@0.00442@NA@AC006455-201_2, AC006455-201_3, ENST00000444809_2, ENST00000444809_3@160@151@171@NA@NA@NA
D122836@98015@98018@duplication@4@62910199@62917064@7@chr7:62910199-62917064@24.3@549@868@1.58@NA@ZNF734-201_2, ZNF734-201_3, ZNF734-201_4, ZNF734-201_5@95.5@80@102@NA@NA@NA
D122836@98032@98039@deletion@8@63028123@63040747@7@chr7:63028123-63040747@16@376@217@0.577@NA@ENST00000417666_4, ENST00000417666_5, ENST00000417666_6, ENST00000417666_7, ENST00000417666_8, ENST00000417666_9, ENST00000417666_10, ENST00000417666_11@32.5@29@37@NA@NA@NA
D122836@99063@99063@duplication@1@74251404@74251506@7@chr7:74251404-74251506@5.96@25@67@2.68@NA@GTF2IRD2-002_2@8@8@8@:GTF2I repeat domain containing 2@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
D122836@99545@99545@duplication@1@76728229@76728269@7@chr7:76728229-76728269@7.31@71@134@1.89@NA@ENST00000398321_6@11@11@11@NA@NA@NA
D122836@101721@101726@duplication@6@100331652@100336237@7@chr7:100331652-100336237@18.5@601@855@1.42@CNVR3509.1@ZAN-001_2, ZAN-001_3, ZAN-001_4, ZAN-001_5, ZAN-001_6, ZAN-001_7@81.6666666666667@71@89@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
D122836@102116@102119@deletion@4@102114810@102121393@7@chr7:102114810-102121393@6.03@76@35@0.461@CNVR3518.1@POLR2J-001_1, POLR2J-001_2, POLR2J-001_3, AC093668-201_2@43@14@91@:polymerase (RNA) II (DNA directed) polypeptide J, 13.3kDa@:nucleoplasm;DNA binding;DNA repair;protein dimerization activity;nucleus;viral reproduction;gene expression;transcription initiation from RNA polymerase II promoter;7-methylguanosine mRNA capping;protein phosphorylation;LRR domain binding;protein kinase activity;DNA-directed RNA polymerase II, core complex;nucleotide-excision repair;transcription from RNA polymerase II promoter;DNA-directed RNA polymerase activity;protein binding;transcription-coupled nucleotide-excision repair;RNA splicing;mRNA splicing, via spliceosome;transcription, DNA-dependent;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription@NA
D122836@102166@102166@deletion@1@102219874@102220244@7@chr7:102219874-102220244@6.55@29@0@0@CNVR3518.1@ENST00000379336_1, RASA4-001_21@63@63@63@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
D122836@102187@102193@deletion@7@102257074@102279647@7@chr7:102257074-102279647@17.7@277@136@0.491@CNVR3518.1@RASA4-001_1, ENST00000340457_4, ENST00000340457_5, ENST00000340457_6, POLR2J2-001_7, POLR2J2-001_8, POLR2J2-001_9@59.7142857142857@45@77@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
D122836@103919@103919@duplication@1@128128157@128128216@7@chr7:128128157-128128216@4.62@48@88@1.83@NA@METTL2B-001_5@0@0@0@:methyltransferase like 2B@:methyltransferase activity;metabolic process@NA
D122836@105330@105337@duplication@8@141778610@141786129@7@chr7:141778610-141786129@15.3@1081@1426@1.32@CNVR3585.3, CNVR3585.2@MGAM-007_49, MGAM-007_50, MGAM-007_51, MGAM-007_52, MGAM-007_53, MGAM-007_54, MGAM-007_55, MGAM-007_56@124.25@122@127@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
D122836@105521@105523@duplication@3@142481247@142482417@7@chr7:142481247-142482417@16.5@384@585@1.52@NA@PRSS1-204_4, PRSS1-204_5, PRSS1-204_6@114.333333333333@113@115@NA@NA@NA
D122836@105798@105799@duplication@2@143975408@143975569@7@chr7:143975408-143975569@5.04@7@38@5.43@CNVR3598.4, CNVR3598.9@RP4-798C17-001_5, ENST00000378112_6@135@135@135@:Rho guanine nucleotide exchange factor (GEF) 35@NA@NA
D122836@107430@107437@deletion@8@7320231@7345700@8@chr8:7320231-7345700@8.8@206@120@0.583@CNVR3771.8, CNVR3771.10, CNVR3771.4@SPAG11-003_1, SPAG11-003_2, DEFB104B-001_1, DEFB104B-001_2, DEFB106B-001_1, DEFB106B-001_2, DEFB105B-001_1, DEFB105B-001_2@11.25@4@40@:sperm associated antigen 11B:defensin, beta 104A;defensin, beta 104B:defensin, beta 106B;defensin, beta 106A:defensin, beta 105B;defensin, beta 105A@:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
D122836@107503@107513@deletion@11@7679532@7718505@8@chr8:7679532-7718505@55.7@606@248@0.409@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@DEFB105A-001_1, DEFB105A-001_2, DEFB105A-001_3, DEFB106A-001_1, DEFB106A-001_2, DEFB104A-001_1, DEFB104A-001_2, SPAG11A-207_1, SPAG11A-207_2, SPAG11A-207_3, SPAG11A-207_4@56.0909090909091@40@113@:defensin, beta 105B;defensin, beta 105A:defensin, beta 106B;defensin, beta 106A:defensin, beta 104A;defensin, beta 104B:sperm associated antigen 11A;sperm associated antigen 11B@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response@NA
D122836@107738@107746@deletion@9@12003180@12043035@8@chr8:12003180-12043035@10.9@56@5@0.0893@CNVR3785.8, CNVR3785.5, CNVR3785.2, CNVR3785.3, CNVR3785.7@ENST00000438689_1, ENST00000438689_2, ENST00000438689_3, ENST00000382200_1, ENST00000382200_2, ENST00000382200_3, ENST00000382200_4, FAM86B1-202_6, FAM86B1-202_7@87.2222222222222@63@121@:family with sequence similarity 86, member B2;family with sequence similarity 86, member B1@NA@NA
D122836@116854@116857@deletion@4@35662945@35664490@9@chr9:35662945-35664490@23@283@124@0.438@NA@C9orf100-004_4, C9orf100-004_5, C9orf100-004_6, C9orf100-004_7@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 39@:positive regulation of cell migration;phospholipid binding;protein binding;plasma membrane;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity@NA
D122836@117587@117589@deletion@3@43313716@43314503@9@chr9:43313716-43314503@10.8@202@109@0.54@CNVR4289.2@BX649597-201_1, BX649597-201_2, BX649597-201_3@46@18@61@NA@NA@NA
D122836@121600@121604@deletion@5@117085338@117087433@9@chr9:117085338-117087433@24.6@1449@930@0.642@CNVR4448.1@ORM1-001_1, ORM1-001_2, ORM1-001_3, ORM1-001_4, ORM1-001_5@87.6@84@90@:orosomucoid 1@:protein binding;extracellular space;regulation of immune system process;transport;inflammatory response;extracellular region;acute-phase response@NA
D122836@124047@124052@deletion@6@135957928@135960431@9@chr9:135957928-135960431@23.3@106@0@0@NA@CELP-002_1, CELP-002_2, CELP-002_3, AL162417-201_1, AL162417-201_2, AL162417-201_3@84.3333333333333@66@99@NA@NA@NA
D122836@124517@124517@deletion@1@138441156@138441178@9@chr9:138441156-138441178@13.5@69@5@0.0725@CNVR4529.1@OBP2A-001_6@18@18@18@:odorant binding protein 2A@:odorant binding;sensory perception of chemical stimulus;response to stimulus;transport;extracellular region;sensory perception of smell;cellular_component@NA
D122836@126909@126915@deletion@7@17840632@17887436@10@chr10:17840632-17887436@51@242@5@0.0207@NA@FAM23A-201_5, MRC1L1-001_1, MRC1L1-001_2, MRC1L1-001_3, MRC1L1-001_4, MRC1L1-001_5, MRC1L1-001_6@25.8571428571429@6@108@:transmembrane protein 236;transmembrane protein 236-like:macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding@NA
D122836@126937@126938@deletion@2@17949552@17951364@10@chr10:17949552-17951364@6.43@98@49@0.5@NA@MRC1L1-001_28, MRC1L1-001_29@6@5@7@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
D122836@126946@126948@duplication@3@18112046@18122793@10@chr10:18112046-18122793@25.7@156@363@2.33@NA@MRC1-001_2, MRC1-001_3, MRC1-001_4@30.3333333333333@26@34@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D122836@126951@126951@deletion@1@18138510@18138694@10@chr10:18138510-18138694@16@73@0@0@NA@MRC1-001_7@26@26@26@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D122836@126974@126975@duplication@2@18196465@18198277@10@chr10:18196465-18198277@8.17@50@111@2.22@NA@MRC1-001_28, MRC1-001_29@15@3@27@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D122836@128372@128372@duplication@1@42924566@42924600@10@chr10:42924566-42924600@8.19@83@155@1.87@NA@CCNYL2-201_7@0@0@0@@:regulation of cyclin-dependent protein kinase activity;protein kinase binding@NA
D122836@128979@128979@duplication@1@47758848@47758905@10@chr10:47758848-47758905@11.6@19@96@5.05@CNVR4714.1@ANXA8L2-001_10@154@154@154@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:calcium-dependent phospholipid binding;calcium ion binding@NA
D122836@129025@129028@deletion@4@48029222@48049022@10@chr10:48029222-48049022@9.2@192@107@0.557@CNVR4715.2@ASAH2C-201_3, ASAH2C-201_4, ASAH2C-201_5, ASAH2C-201_6@72.5@58@90@@:ceramidase activity;sphingolipid metabolic process@NA
D122836@129462@129477@duplication@16@51362803@51391568@10@chr10:51362803-51391568@33.2@361@665@1.84@NA@ENST00000404618_1, ENST00000404618_2, ENST00000404618_3, ENST00000432221_1, ENST00000432221_2, ENST00000432221_3, TIMM23B-202_1, TIMM23B-202_2, TIMM23B-202_3, TIMM23B-202_4, TIMM23B-202_5, TIMM23B-202_6, TIMM23B-202_7, TIMM23B-202_8, TIMM23B-202_9, TIMM23B-202_10@62.0625@0@142@:translocase of inner mitochondrial membrane 23 homolog B (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process@NA
D122836@129509@129517@deletion@9@51603186@51620383@10@chr10:51603186-51620383@11.6@117@46@0.393@NA@TIMM23-202_2, TIMM23-202_3, TIMM23-202_4, TIMM23-202_5, TIMM23-202_6, TIMM23-202_7, TIMM23-202_8, TIMM23-202_9, TIMM23-202_10@3.22222222222222@0@29@:translocase of inner mitochondrial membrane 23 homolog B (yeast):translocase of inner mitochondrial membrane 23 homolog B (yeast);translocase of inner mitochondrial membrane 23 homolog (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:mitochondrion;mitochondrial inner membrane;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;mitochondrial intermembrane space;integral to mitochondrial inner membrane;intracellular protein transport;protein binding;integral to membrane;cellular protein metabolic process;protein targeting to mitochondrion@NA
D122836@129519@129521@deletion@3@51623585@51631957@10@chr10:51623585-51631957@8.24@419@269@0.642@NA@ENST00000456092_1, ENST00000456092_2, ENST00000456092_3@26.6666666666667@26@28@:translocase of inner mitochondrial membrane 23 homolog B (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process@NA
D122836@129586@129586@deletion@1@51877668@51877819@10@chr10:51877668-51877819@4.76@23@1@0.0435@CNVR4734.2@FAM21A-005_22@113@113@113@:family with sequence similarity 21, member B;family with sequence similarity 21, member A@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
D122836@129605@129609@duplication@5@51970585@51978391@10@chr10:51970585-51978391@15.9@144@272@1.89@NA@ASAH2-201_7, ASAH2-201_8, ASAH2-201_9, ASAH2-201_10, ASAH2-201_11@181.2@176@186@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
D122836@137792@137794@deletion@3@3239564@3244362@11@chr11:3239564-3244362@17@388@213@0.549@CNVR5028.1@C11orf36-202_1, C11orf36-202_2, C11orf36-202_3@13@13@13@:MAS-related GPR, member G@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway@NA
D122836@138526@138526@deletion@1@8959121@8959721@11@chr11:8959121-8959721@19.2@370@179@0.484@NA@ASCL3-201_2@0@0@0@:achaete-scute complex homolog 3 (Drosophila)@:intracellular membrane-bounded organelle;DNA binding;regulation of transcription from RNA polymerase II promoter;protein binding;transcription factor complex;nucleolus;nucleus;protein dimerization activity;transcription, DNA-dependent@NA
D122836@139527@139527@deletion@1@18955060@18956211@11@chr11:18955060-18956211@43.2@773@305@0.395@CNVR5091.2, CNVR5091.1@MRGPRX1-203_3@16@16@16@:MAS-related GPR, member X1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;acute-phase response;G-protein coupled receptor signaling pathway@NA
D122836@141187@141188@deletion@2@48600990@48601883@11@chr11:48600990-48601883@5.35@24@0@0@CNVR5165.1@AC134982-201_1, AC134982-201_2@128@128@128@NA@NA@NA
D122836@145893@145897@deletion@5@89499780@89531798@11@chr11:89499780-89531798@23.4@402@190@0.473@NA@TRIM77-201_8, ENST00000375974_1, ENST00000375974_2, ENST00000375974_3, TRIM49-201_8@52.4@49@56@:tripartite motif containing 49@:protein binding;intracellular;DNA binding;zinc ion binding@NA
D122836@149648@149648@deletion@1@3039416@3039512@12@chr12:3039416-3039512@6.97@121@62@0.512@NA@TULP3-202_6@0@0@0@:tubby like protein 3@:embryonic digit morphogenesis;phosphatidylinositol-4,5-bisphosphate binding;bronchus morphogenesis;regulation of smoothened signaling pathway;limb development;central nervous system neuron differentiation;plasma membrane;nucleus;cilium axoneme;smoothened signaling pathway involved in dorsal/ventral neural tube patterning;multicellular organismal development;negative regulation of smoothened signaling pathway;negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning;cilium;in utero embryonic development;G-protein coupled receptor signaling pathway;regulation of transcription, DNA-dependent;neural tube closure;cytoplasm;dorsal/ventral neural tube patterning;embryonic camera-type eye development;protein binding;brain development;extracellular region;neural tube development;embryonic neurocranium morphogenesis@NA
D122836@150776@150786@duplication@11@9447030@9456804@12@chr12:9447030-9456804@20.2@536@782@1.46@NA@DDX11L8-201_3, DDX11L8-201_4, DDX11L8-201_5, DDX11L8-201_6, DDX11L8-201_7, DDX11L8-201_8, DDX11L8-201_9, DDX11L8-201_10, DDX11L8-201_11, DDX11L8-201_12, DDX11L8-201_13@61.5454545454545@17@87@NA@NA@NA
D122836@150826@150841@duplication@16@9590609@9707352@12@chr12:9590609-9707352@25.8@615@910@1.48@CNVR5429.1@DDX12-203_1, DDX12-203_2, DDX12-203_3, AC006432-201_1, AC006432-201_2, AC006432-201_3, AC006432-201_4, AC006432-201_5, AC006432-201_6, AC006432-201_7, AC006432-201_8, AC006432-201_9, AC006432-201_11, AC006432-201_12, AC006432-201_13@20.7333333333333@7@25@NA@NA@NA
D122836@150968@150971@duplication@4@10583212@10587639@12@chr12:10583212-10587639@9.65@339@477@1.41@CNVR5430.1@KLRC2-201_3, KLRC2-201_4, KLRC2-201_5, KLRC2-201_6@62@51@67@:killer cell lectin-like receptor subfamily C, member 2@:carbohydrate binding:transmembrane signaling receptor activity;carbohydrate binding;protein binding;signal transduction;cellular defense response;integral to plasma membrane@NA
D122836@155520@155521@duplication@2@57682642@57682824@12@chr12:57682642-57682824@5.99@231@322@1.39@NA@R3HDM2-007_11, R3HDM2-007_12@0@0@0@:R3H domain containing 2@:nucleus;nucleic acid binding@NA
D122836@157282@157283@deletion@2@92534076@92539674@12@chr12:92534076-92539674@5.38@166@102@0.614@NA@BTG1-201_1, BTG1-201_2@0@0@0@:uncharacterized LOC256021:B-cell translocation gene 1, anti-proliferative@:response to oxidative stress;negative regulation of cell proliferation;kinase binding;spermatogenesis;negative regulation of cell growth;protein methylation;response to peptide hormone stimulus;nucleus;transcription cofactor activity;cell migration;enzyme binding;regulation of transcription, DNA-dependent;positive regulation of myoblast differentiation;cytoplasm;positive regulation of angiogenesis;protein binding;positive regulation of endothelial cell differentiation;regulation of apoptotic process@NA
D122836@162127@162128@duplication@2@24465240@24465671@13@chr13:24465240-24465671@5.02@822@1052@1.28@NA@RP11-45B20-002_6, ENST00000382133_3@29@29@29@:C1q and tumor necrosis factor related protein 9B@:collagen;protein binding@NA
D122836@164540@164544@duplication@5@53105738@53122079@13@chr13:53105738-53122079@14.7@135@257@1.9@NA@RP11-78J21-201_13, RP11-78J21-201_14, RP11-78J21-201_15, RP11-78J21-201_16, RP11-78J21-201_17@101.2@44@117@NA@NA@NA
D122836@166754@166758@duplication@5@20137803@20147556@14@chr14:20137803-20147556@9.49@776@1016@1.31@CNVR6072.6, CNVR6072.12, CNVR6072.14@AL512310-201_4, AL512310-201_5, ENST00000398231_1, ENST00000398231_2, ENST00000398231_3@95.8@92@102@NA@NA@NA
D122836@170809@170809@duplication@1@74003820@74004583@14@chr14:74003820-74004583@5.42@51@97@1.9@CNVR6188.1, CNVR6188.3, CNVR6188.4@ACOT1-201_1@114@114@114@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
D122836@170814@170815@duplication@2@74040094@74042360@14@chr14:74040094-74042360@15.8@452@671@1.48@CNVR6188.1, CNVR6188.5, CNVR6188.6@ACOT2-201_2, ACOT2-201_3@6.5@5@8@:acyl-CoA thioesterase 2@:acyl-CoA metabolic process;mitochondrion;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity;receptor binding@NA
D122836@173501@173503@duplication@3@106478134@106478604@14@chr14:106478134-106478604@8.46@151@237@1.57@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV3-6-210_6, IGHV4-4-001_1, IGHV4-4-001_2@13@5@17@@:protein binding@NA
D122836@173556@173562@deletion@7@106787370@106805517@14@chr14:106787370-106805517@69.6@884@332@0.376@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-29-001_1, IGHV3-29-001_2, IGHV3-30-001_1, IGHV3-30-001_2, IGHV3-30-2-001_1, IGHV3-30-2-001_2, IGHV4-31-001_2@16.2857142857143@13@19@@:protein binding:protein binding@NA
D122836@173566@173567@duplication@2@106815724@106816254@14@chr14:106815724-106816254@15.4@299@489@1.64@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.56, CNVR6294.51@IGHV3-33-001_1, IGHV3-33-001_2@10@5@15@@:protein binding@NA
D122836@173635@173638@deletion@4@107095128@107099589@14@chr14:107095128-107099589@18.2@329@178@0.541@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61-001_1, IGHV4-61-001_2, IGHV3-62-001_1, IGHV3-62-001_2@16@15@17@@:protein binding@NA
D122836@173645@173645@deletion@1@107131035@107131335@14@chr14:107131035-107131335@5.32@200@125@0.625@CNVR6294.56, CNVR6294.16@IGHV3-66-001_2@3@3@3@@:protein binding@NA
D122836@173679@173734@deletion@56@20362741@20663213@15@chr15:20362741-20663213@260@6581@3637@0.553@CNVR6295.15, CNVR6295.7@AC126603-201_1, AC126603-201_2, ENST00000400226_1, ENST00000400226_2, ENST00000400226_3, ENST00000400226_4, ENST00000400226_8, ENST00000400226_9, ENST00000400226_10, ENST00000400226_11, ENST00000400226_12, ENST00000400226_14, ENST00000400226_15, ENST00000400226_16, HERC2P3-014_9, HERC2P3-014_10, HERC2P3-014_11, HERC2P3-014_12, HERC2P3-014_13, HERC2P3-014_14, HERC2P3-014_15, HERC2P3-014_16, HERC2P3-014_17, HERC2P3-014_18, HERC2P3-014_19, HERC2P3-014_20, HERC2P3-014_21, HERC2P3-014_22, HERC2P3-014_23, HERC2P3-014_24, HERC2P3-014_25, HERC2P3-014_26, HERC2P3-014_27, AC026495-201_8, AC026495-201_9, AC026495-201_10, AC026495-201_11, AC026495-201_12, AC026495-201_13, AC026495-201_14, AC026495-201_15, AC026495-201_16, AC026495-201_17, AC026495-201_18, AC026495-201_19, AC026495-201_20, AC026495-201_21, AC026495-201_22, AC026495-201_23, AC026495-201_24, AC026495-201_25, AC026495-201_26@90.3076923076923@33@147@NA@NA@NA
D122836@173799@173821@deletion@23@21369348@22473225@15@chr15:21369348-22473225@79.9@1886@979@0.519@NA@ENST00000450252_1, ENST00000450252_2, ENST00000500487_1, ENST00000500487_2, POTEB-202_1, POTEB-202_2, POTEB-202_3, POTEB-202_5, POTEB-202_9, POTEB-202_10, POTEB-202_11, AC134980-201_1, AC134980-201_2, ENST00000438898_1, ENST00000438898_2, AC010760-202_2, VSIG6-201_2@68.5294117647059@34@101@:POTE ankyrin domain family member B-like:olfactory receptor, family 4, subfamily M, member 2:olfactory receptor, family 4, subfamily N, member 4@:protein binding:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
D122836@173993@174003@deletion@11@23441084@23573019@15@chr15:23441084-23573019@8.14@55@13@0.236@CNVR6300.8@GOLGA8E-201_10, GOLGA8E-201_11, GOLGA8E-201_12, GOLGA8E-201_13, GOLGA8E-201_14, GOLGA8E-201_15, GOLGA8E-201_16, GOLGA8E-201_17, GOLGA8E-201_18, ENST00000357842_9, ENST00000357842_10@77@54@104@NA@NA@NA
D122836@174406@174407@duplication@2@29008591@29008896@15@chr15:29008591-29008896@4.97@107@161@1.5@NA@ENST00000456510_4, ENST00000456510_5@25.5@25@26@NA@NA@NA
D122836@174659@174659@deletion@1@32449811@32449977@15@chr15:32449811-32449977@11.1@50@0@0@CNVR6345.2, CNVR6345.1@CHRNA7-205_6@66@66@66@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
D122836@174661@174662@deletion@2@32451772@32455537@15@chr15:32451772-32455537@5.1@32@7@0.219@CNVR6345.2, CNVR6345.1@CHRNA7-205_8, CHRNA7-205_9@119.5@106@133@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
D122836@176432@176433@deletion@2@44002591@44002976@15@chr15:44002591-44002976@8.02@150@79@0.527@NA@AC011330-201_13, AC011330-201_14@28@16@40@:stereocilin@:detection of mechanical stimulus involved in sensory perception of sound;stereocilium bundle tip;stereocilium;cell surface;kinocilium;auditory receptor cell stereocilium organization@: DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16; DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY
D122836@180187@180187@deletion@1@79065427@79065546@15@chr15:79065427-79065546@5.5@29@3@0.103@NA@ADAMTS7-201_14@10@10@10@:A disintegrin and metalloproteinase with thrombospondin motifs 7-like;ADAM metallopeptidase with thrombospondin type 1 motif, 7@:metallopeptidase activity;extracellular matrix;proteolysis;peptidase activity;proteinaceous extracellular matrix;metalloendopeptidase activity;cell surface;zinc ion binding@NA
D122836@186292@186293@deletion@2@28403075@28403464@16@chr16:28403075-28403464@39.8@185@1@0.00541@CNVR6684.2@EIF3CL-201_9, EIF3CL-201_10@4@3@5@:eukaryotic translation initiation factor 3, subunit C-like@:protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;translation initiation factor activity@NA
D122836@186379@186379@duplication@1@28734771@28734873@16@chr16:28734771-28734873@14.1@219@378@1.73@CNVR6686.3, CNVR6686.2@EIF3S8-202_10@4@4@4@:eukaryotic translation initiation factor 3, subunit C@:cytosol;protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;cellular protein metabolic process;binding;gene expression;translation;translation initiation factor activity@NA
D122836@186584@186586@deletion@3@29469251@29469541@16@chr16:29469251-29469541@5.45@59@25@0.424@CNVR6690.2, CNVR6690.3, CNVR6690.4@GIYD1-001_5, GIYD1-001_6, SULT1A4-201_3@8.66666666666667@2@12@:structure-specific endonuclease subunit SLX1-like;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae);SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae):sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3;sulfotransferase 1A3/1A4-like@:Slx1-Slx4 complex;5'-flap endonuclease activity;DNA repair;protein binding;DNA double-strand break processing involved in repair via single-strand annealing;double-strand break repair via homologous recombination;metal ion binding;crossover junction endodeoxyribonuclease activity:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;cytoplasm;catecholamine metabolic process;cytosol;endoplasmic reticulum unfolded protein response;xenobiotic metabolic process;sulfotransferase activity;activation of signaling protein activity involved in unfolded protein response;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process@NA
D122836@189959@189960@duplication@2@70162689@70163026@16@chr16:70162689-70163026@5.3@561@728@1.3@CNVR6764.1, CNVR6764.3@AC009060-202_5, AC009060-202_6@63@61@65@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
D122836@189989@189989@duplication@1@70219790@70219880@16@chr16:70219790-70219880@4.72@56@98@1.75@CNVR6764.1, CNVR6764.5@CLEC18C-201_11@19@19@19@:C-type lectin domain family 18, member C@:carbohydrate binding;protein binding;extracellular region@NA
D122836@190430@190432@deletion@3@72091293@72093088@16@chr16:72091293-72093088@12.2@254@139@0.547@CNVR6769.1, CNVR6769.2@HP-201_4, HP-201_5, HP-201_6@24.6666666666667@17@31@:thioredoxin-like 4B:haptoglobin:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:cellular iron ion homeostasis;negative regulation of oxidoreductase activity;catalytic activity;negative regulation of hydrogen peroxide catabolic process;positive regulation of cell death;haptoglobin-hemoglobin complex;extracellular space;proteolysis;response to hydrogen peroxide;extracellular region;hemoglobin binding;defense response;serine-type endopeptidase activity:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@: ANHAPTOGLOBINEMIA; AHP
D122836@192798@192799@duplication@2@4439373@4439722@17@chr17:4439373-4439722@5.01@228@311@1.36@NA@SPNS2-201_10, SPNS2-201_11@1@1@1@:spinster homolog 2 (Drosophila)@:integral to membrane;transmembrane transporter activity;lipid transport;transmembrane transport@NA
D122836@195742@195747@duplication@6@18454822@18457581@17@chr17:18454822-18457581@8.93@486@650@1.34@NA@CCDC144B-201_14, CCDC144B-201_15, CCDC144B-201_16, ENST00000447265_11, ENST00000447265_12, ENST00000447265_13@129.166666666667@126@132@NA@NA@NA
D122836@195870@195871@deletion@2@18996289@18996940@17@chr17:18996289-18996940@13.8@184@80@0.435@CNVR7018.4, CNVR7018.2, CNVR7018.6@AC007952-202_1, AC007952-202_2@92.5@92@93@NA@NA@NA
D122836@197728@197728@duplication@1@34539901@34539966@17@chr17:34539901-34539966@4.95@51@94@1.84@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1-202_4@122@122@122@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
D122836@200259@200266@deletion@8@43585590@43596019@17@chr17:43585590-43596019@24.6@479@250@0.522@CNVR7113.4, CNVR7113.6, CNVR7113.2, CNVR7113.1@AC091132-201_1, AC091132-201_2, AC091132-201_3, AC091132-201_4, AC091132-201_5, ENST00000339474_1, ENST00000339474_2, ENST00000339474_3@94.875@81@127@NA@NA@NA
D122836@200320@200328@duplication@9@44248223@44364337@17@chr17:44248223-44364337@55.2@3248@4494@1.38@CNVR7114.3, CNVR7114.2, CNVR7114.10@KIAA1267-201_1, KIAA1267-201_2, AC217773-201_1, AC217773-201_2, ENST00000451529_1, ENST00000451529_3, ENST00000451529_5@64.4285714285714@49@90@:KAT8 regulatory NSL complex subunit 1:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:histone acetyltransferase activity (H4-K8 specific);histone acetyltransferase activity (H4-K16 specific);histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase complex;histone H4-K5 acetylation;MLL1 complex;histone H4-K16 acetylation;protein binding;histone H4-K8 acetylation;nucleus:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
D122836@200337@200344@deletion@8@44399690@44414935@17@chr17:44399690-44414935@7.54@82@36@0.439@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A-001_7, LRRC37A-001_8, LRRC37A-001_9, LRRC37A-001_10, LRRC37A-001_11, LRRC37A-001_12, LRRC37A-001_13, LRRC37A-001_14@150.25@114@196@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
D122836@200355@200362@duplication@8@44617544@44632791@17@chr17:44617544-44632791@15.8@680@959@1.41@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2-201_6, LRRC37A2-201_7, LRRC37A2-201_8, LRRC37A2-201_9, LRRC37A2-201_10, LRRC37A2-201_11, LRRC37A2-201_12, LRRC37A2-201_13@81.125@67@98@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
D122836@208288@208288@duplication@1@55278871@55278940@18@chr18:55278871-55278940@4.82@120@179@1.49@NA@NARS-201_6@0@0@0@:asparaginyl-tRNA synthetase@:mitochondrion;asparaginyl-tRNA aminoacylation;asparagine-tRNA ligase activity;nucleotide binding;tRNA aminoacylation for protein translation;ATP binding;cytoplasm;cytosol;gene expression;aminoacyl-tRNA ligase activity;nucleic acid binding@NA
D122836@210486@210489@duplication@4@4219590@4224812@19@chr19:4219590-4224812@42.2@520@940@1.81@NA@ANKRD24-203_18, ANKRD24-203_19, ANKRD24-203_20, ANKRD24-203_21@13@12@14@:ankyrin repeat domain 24@:protein binding@NA
D122836@217296@217297@deletion@2@40380121@40382827@19@chr19:40380121-40382827@9.29@46@3@0.0652@CNVR7639.2@FCGBP-201_22, FCGBP-201_23@152@149@155@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D122836@217595@217595@deletion@1@41327389@41327534@19@chr19:41327389-41327534@7.6@56@15@0.268@NA@CYP2F1P-001_5@0@0@0@NA@NA@NA
D122836@217607@217608@deletion@2@41355725@41356242@19@chr19:41355725-41356242@11@209@111@0.531@CNVR7642.1@CYP2A6-204_2, CYP2A6-204_3@17@17@17@:cytochrome P450, family 2, subfamily A, polypeptide 6@:coumarin 7-hydroxylase activity;steroid metabolic process;oxidation-reduction process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;endoplasmic reticulum membrane;drug metabolic process;electron carrier activity;small molecule metabolic process;exogenous drug catabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;enzyme binding;heme binding;xenobiotic metabolic process;iron ion binding;coumarin catabolic process;coumarin metabolic process@: CYTOCHROME P450, SUBFAMILY IIA, POLYPEPTIDE 6; CYP2A6
D122836@220563@220571@duplication@9@51559465@51582960@19@chr19:51559465-51582960@23.4@1061@1460@1.38@NA@KLK13-201_1, KLK13-201_2, KLK13-201_3, KLK13-201_4, KLK13-201_5, KLK14-001_5, KLK14-001_6, KLK14-001_7, KLK14-001_8@0@0@0@:kallikrein-related peptidase 13:kallikrein-related peptidase 14@:hydrolase activity;endopeptidase activity;protein processing;catalytic activity;cytoplasm;secretory granule;proteolysis;extracellular space;protein binding;extracellular region;serine-type endopeptidase activity:fertilization;epidermis morphogenesis;catalytic activity;seminal clot liquefaction;proteolysis;extracellular space;negative regulation of G-protein coupled receptor protein signaling pathway;positive regulation of G-protein coupled receptor protein signaling pathway;serine-type endopeptidase activity@NA
D122836@220709@220709@duplication@1@52227180@52227222@19@chr19:52227180-52227222@6.99@33@84@2.55@NA@HAS1-201_1@1@1@1@:hyaluronan synthase 1@:hyaluronan synthase activity;transferase activity, transferring hexosyl groups;hyaluronan biosynthetic process;small molecule metabolic process;hyaluronan metabolic process;carbohydrate metabolic process;glycosaminoglycan metabolic process;glycosaminoglycan biosynthetic process;cellular response to platelet-derived growth factor stimulus;cell adhesion;plasma membrane;integral to plasma membrane;membrane;negative regulation of fibroblast migration@NA
D122836@221166@221171@deletion@6@54724400@54726912@19@chr19:54724400-54726912@51.7@326@63@0.193@CNVR7721.3, CNVR7721.4@LILRB3-008_1, LILRB3-008_2, LILRB3-008_3, LILRB3-008_4, LILRB3-008_5, LILRB3-008_6@113.833333333333@98@136@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D122836@221178@221178@duplication@1@54744152@54744453@19@chr19:54744152-54744453@13.5@310@495@1.6@CNVR7721.3, CNVR7721.6@LILRA6-002_6@54@54@54@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D122836@221180@221183@duplication@4@54745540@54746618@19@chr19:54745540-54746618@8.1@452@606@1.34@CNVR7721.3, CNVR7721.6@LILRA6-002_1, LILRA6-002_2, LILRA6-002_3, LILRA6-002_4@69.5@62@77@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D122836@221396@221417@duplication@22@55266477@55295318@19@chr19:55266477-55295318@87.1@2655@3869@1.46@CNVR7725.2, CNVR7725.1@KIR2DL3-201_5, KIR2DL3-201_6, KIR2DL3-201_7, KIR2DL3-201_8, KIR2DP1-001_1, KIR2DP1-001_2, KIR2DP1-001_3, KIR2DP1-001_4, KIR2DP1-001_5, KIR2DP1-001_6, KIR2DP1-001_7, KIR2DP1-001_8, KIR2DP1-001_9, KIR2DL1-002_1, KIR2DL1-002_2, KIR2DL1-002_3, KIR2DL1-002_4, KIR2DL1-002_5, KIR2DL1-002_6, KIR2DL1-002_7, KIR2DL1-002_8, KIR2DL1-002_9@95.5@34@126@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
D122836@221439@221441@duplication@3@55358641@55360024@19@chr19:55358641-55360024@36.5@1083@1675@1.55@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4-001_6, KIR2DS4-001_7, KIR2DS4-001_8@96.3333333333333@85@102@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
D122836@222068@222069@deletion@2@58003184@58003369@19@chr19:58003184-58003369@6.01@49@16@0.327@CNVR7748.1@ZNF419-202_5, ZNF419-202_6@0@0@0@:zinc finger protein 419@:intracellular;DNA binding;regulation of transcription, DNA-dependent;cytoplasm;nucleolus;nucleus;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding@NA
D122836@222561@222563@deletion@3@1552368@1569279@20@chr20:1552368-1569279@11.2@530@345@0.651@CNVR7763.1@SIRPB1-201_1, SIRPB1-201_2, SIRPB1-201_3@61@2@128@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
D122836@226338@226338@deletion@1@42831603@42831715@20@chr20:42831603-42831715@8.14@180@99@0.55@NA@C20orf111-002_5@0@0@0@:chromosome 20 open reading frame 111@NA@NA
D122836@228848@228849@duplication@2@11012919@11012983@21@chr21:11012919-11012983@5.14@467@610@1.31@CNVR7947.1@TPTE-006_8, BAGE2-002_12@9@9@9@:transmembrane phosphatase with tensin homology@:phosphatase activity;ion channel activity;protein tyrosine phosphatase activity;ion transport;protein dephosphorylation;transmembrane transport;protein binding;signal transduction;integral to membrane;protein tyrosine/serine/threonine phosphatase activity;dephosphorylation;membrane;peptidyl-tyrosine dephosphorylation@NA
D122836@231128@231129@duplication@2@44834397@44837655@21@chr21:44834397-44837655@14.7@292@460@1.58@CNVR8029.1@SIK1-001_13, SIK1-001_14@1@1@1@:salt-inducible kinase 1@:intracellular protein kinase cascade;regulation of mitotic cell cycle;anoikis by p53 class mediator;negative regulation of gluconeogenesis;protein autophosphorylation;regulation of cell differentiation;protein kinase binding;protein tyrosine kinase activity;magnesium ion binding;transferase activity, transferring phosphorus-containing groups;anoikis;ATP binding;negative regulation of triglyceride biosynthetic process;histone deacetylase binding;negative regulation of CREB transcription factor activity;regulation of myotube differentiation;nucleus;cardiac muscle cell differentiation;protein serine/threonine kinase activity;protein phosphorylation;protein kinase activity;cytoplasm;cytosol;protein binding;negative regulation of transcription from RNA polymerase II promoter;regulation of sodium ion transport;cAMP response element binding protein binding;cell cycle;14-3-3 protein binding@NA
D122836@231968@231969@duplication@2@16348074@16349582@22@chr22:16348074-16349582@10.2@563@775@1.38@CNVR8071.2, CNVR8071.3, CNVR8071.10@LA16c-2F2-001_3, LA16c-2F2-001_4@52@50@54@NA@NA@NA
D122836@232769@232783@deletion@15@20383540@20398724@22@chr22:20383540-20398724@11.4@118@49@0.415@CNVR8094.9, CNVR8094.4, CNVR8094.10@PI4KAP1-204_2, PI4KAP1-204_3, PI4KAP1-204_4, PI4KAP1-204_5, PI4KAP1-204_6, PI4KAP1-204_7, PI4KAP1-204_8, PI4KAP1-204_9, PI4KAP1-204_10, PI4KAP1-204_11, PI4KAP1-204_12, PI4KAP1-204_13, PI4KAP1-204_14, PI4KAP1-204_15, PI4KAP1-204_16@164.466666666667@148@172@NA@NA@NA
D122836@232899@232935@duplication@37@20970599@21075707@22@chr22:20970599-21075707@48.7@1054@1588@1.51@NA@ENST00000416717_1, ENST00000416717_2, ENST00000416717_3, ENST00000416717_4, ENST00000416717_5, ENST00000416717_6, ENST00000416717_7, ENST00000416717_8, FAM108A5-001_1, FAM108A5-001_2, ENST00000437860_1, ENST00000437860_2, ENST00000422529_1, ENST00000422529_2, ENST00000422529_3, ENST00000422529_4, TMEM191A-001_1, TMEM191A-001_2, TMEM191A-001_3, TMEM191A-001_4, TMEM191A-001_5, TMEM191A-001_6, TMEM191A-001_7, TMEM191A-001_8, PI4KA-001_43, PI4KA-001_44, PI4KA-001_45, PI4KA-001_46, PI4KA-001_47, PI4KA-001_48, PI4KA-001_49, PI4KA-001_50, PI4KA-001_51, PI4KA-001_52, PI4KA-001_53, PI4KA-001_54, PI4KA-001_55@2.83783783783784@0@20@:phosphatidylinositol 4-kinase, catalytic, alpha@:phospholipid metabolic process;1-phosphatidylinositol 4-kinase activity;small molecule metabolic process;phosphatidylinositol phosphorylation;binding;transferase activity, transferring phosphorus-containing groups;phosphotransferase activity, alcohol group as acceptor;ATP binding;Golgi-associated vesicle;phosphatidylinositol biosynthetic process;cytosol;protein binding;signal transduction;synaptic transmission;kinase activity;phosphatidylinositol-mediated signaling@NA
D122836@233739@233752@duplication@14@24366754@24384272@22@chr22:24366754-24384272@35.1@964@1403@1.46@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTTP1-001_1, ENST00000329210_1, ENST00000329210_2, ENST00000329210_3, ENST00000329210_4, ENST00000439866_1, ENST00000439866_2, GSTT1-009_1, GSTT1-009_2, GSTT1-009_3, GSTT1-009_4, GSTT1-009_5, ENST00000439996_1, ENST00000439996_2@139.214285714286@128@149@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
D122836@236811@236826@duplication@16@42898757@42951094@22@chr22:42898757-42951094@31.5@974@1397@1.43@CNVR8171.2, CNVR8171.3@SERHL-001_5, SERHL-001_6, SERHL-001_7, SERHL-001_8, SERHL-001_9, SERHL-001_10, SERHL-001_11, RRP7A-001_1, RRP7A-001_2, RRP7A-001_3, RRP7A-001_4, RRP7A-001_5, RRP7A-001_6, RRP7A-001_7, SERHL2-203_1, SERHL2-203_2@36.375@22@44@:ribosomal RNA processing 7 homolog A (S. cerevisiae):serine hydrolase-like 2@:RNA binding;nucleotide binding:hydrolase activity;mitochondrion;peroxisome;cytoplasmic membrane-bounded vesicle;molecular_function;cellular_component;perinuclear region of cytoplasm;biological_process@NA
D13415@593@593@deletion@1@1607505@1607639@1@chr1:1607505-1607639@7.44@36@1@0.0278@CNVR17.1@RP11-345P4-003_4@10@10@10@:solute carrier family 35, member E2B@:integral to membrane;membrane;transmembrane transport@NA
D13415@2949@2968@deletion@20@17008209@17077090@1@chr1:17008209-17077090@101@2460@1171@0.476@CNVR93.3, CNVR93.15, CNVR93.4@RP1-163M9-001_1, RP1-163M9-001_2, RP1-163M9-001_3, RP1-163M9-001_4, ESPNP-002_1, ESPNP-002_2, ESPNP-002_3, ESPNP-002_4, ESPNP-002_5, ESPNP-002_6, ESPNP-002_7, ESPNP-002_8, ESPNP-002_9, ESPNP-002_10, ESPNP-002_11, AL021920-201_1, AL021920-201_2, AL021920-201_3, ENST00000457096_1, ENST00000457096_2@41.35@22@46@:UPF0627 protein ENSP00000341061/ENSP00000339743-like;UPF0627 protein ENSP00000341061/ENSP00000339743@NA@NA
D13415@2972@2976@deletion@5@17084015@17085082@1@chr1:17084015-17085082@20.8@1745@1092@0.626@CNVR93.3, CNVR93.15, CNVR93.2, CNVR93.1@MST1P9-202_15, MST1P9-202_16, MST1P9-202_17, MST1P9-202_18, MST1P9-202_19@35.8@34@37@:macrophage stimulating 1-like@:proteolysis;extracellular region;catalytic activity;serine-type endopeptidase activity@NA
D13415@3004@3019@deletion@16@17248447@17272901@1@chr1:17248447-17272901@22.3@1414@902@0.638@CNVR94.4, CNVR94.5@CROCC-201_1, CROCC-201_2, CROCC-201_3, CROCC-201_4, CROCC-201_5, CROCC-201_6, CROCC-201_7, CROCC-201_8, CROCC-201_9, CROCC-201_10, CROCC-201_11, CROCC-201_12, CROCC-201_13, CROCC-201_14, CROCC-201_15, CROCC-201_16@77.1875@67@85@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
D13415@3750@3750@deletion@1@21752734@21752904@1@chr1:21752734-21752904@5.84@89@39@0.438@CNVR107.2, CNVR107.1, CNVR107.3@ENST00000453025_3@9@9@9@NA@NA@NA
D13415@4451@4461@duplication@11@25599041@25655628@1@chr1:25599041-25655628@22.2@1352@1876@1.39@CNVR116.1, CNVR116.2@RHD-202_1, RHD-202_2, RHD-202_3, RHD-202_4, RHD-202_5, RHD-202_6, RHD-202_7, RHD-202_8, RHD-202_9, RHD-202_10, RHD-202_11@122.181818181818@113@128@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
D13415@4477@4477@deletion@1@25735176@25735361@1@chr1:25735176-25735361@14.4@71@1@0.0141@CNVR117.1@RHCE-005_4@56@56@56@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
D13415@6746@6746@deletion@1@39987050@39987243@1@chr1:39987050-39987243@5.78@26@0@0@NA@BMP8A-001_4@53@53@53@:bone morphogenetic protein 8a@:cell differentiation;growth factor activity;extracellular space;growth;cytokine activity;cartilage development;ossification@NA
D13415@11245@11246@deletion@2@89476589@89477711@1@chr1:89476589-89477711@9.49@612@370@0.605@CNVR244.1@GBP3-001_7, GBP3-001_8@54@54@54@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
D13415@12391@12395@duplication@5@104115687@104118163@1@chr1:104115687-104118163@26.1@755@1244@1.65@CNVR266.8, CNVR266.10@AMY2B-001_5, AMY2B-001_6, AMY2B-001_7, AMY2B-001_8, AMY2B-001_9@27.6@27@28@:actin, gamma 1 pseudogene 4;amylase, alpha 2B (pancreatic)@:extracellular region;cation binding;digestion;carbohydrate metabolic process;catalytic activity;alpha-amylase activity;metal ion binding@NA
D13415@12424@12446@deletion@23@104233918@104297437@1@chr1:104233918-104297437@27.8@468@225@0.481@CNVR266.3, CNVR266.5@AMY1B-001_1, AMY1B-001_2, AMY1B-001_3, AMY1B-001_4, AMY1B-001_5, AMY1B-001_6, AMY1B-001_7, AMY1B-001_8, AMYP1-001_1, AMYP1-001_2, AMYP1-001_3, AMYP1-001_4, AMYP1-001_5, AMYP1-001_6, AMYP1-001_7, AMY1C-201_1, AMY1C-201_2, AMY1C-201_3, AMY1C-201_4, AMY1C-201_5, AMY1C-201_6, AMY1C-201_7, AMY1C-201_8@90.6521739130435@31@154@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D13415@12927@12936@duplication@10@110224433@110236368@1@chr1:110224433-110236368@74.7@722@1654@2.29@CNVR299.6, CNVR299.4, CNVR299.5@GSTM2-203_8, GSTM2-203_9, GSTM1-001_1, GSTM1-001_2, GSTM1-001_3, GSTM1-001_4, GSTM1-001_5, GSTM1-001_6, GSTM1-001_7, GSTM1-001_8@158.5@23@194@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
D13415@14493@14500@deletion@8@144676872@144816679@1@chr1:144676872-144816679@14.5@377@216@0.573@NA@WI2-1896O14-001_1, WI2-1896O14-001_2, WI2-1896O14-001_3, NBPF9-001_1, NBPF9-001_2, NBPF9-001_3, NBPF9-001_4, NBPF9-001_5@3.125@0@5@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 24@NA@NA
D13415@15397@15430@deletion@34@149036437@149115112@1@chr1:149036437-149115112@29.8@907@545@0.601@CNVR350.3, CNVR350.1@RP11-744H18-001_1, RP11-744H18-001_2, RP11-744H18-001_3, RP11-744H18-001_4, RP11-744H18-001_5, RP11-744H18-001_6, RP11-744H18-001_7, RP11-744H18-001_8, RP11-744H18-001_9, RP11-744H18-001_10, RP11-744H18-001_11, RP11-744H18-001_12, RP11-744H18-001_13, RP11-744H18-001_14, RP11-744H18-001_15, RP11-744H18-001_16, RP11-744H18-001_17, ENST00000401087_2, ENST00000401087_3, ENST00000401087_4, ENST00000401087_5, ENST00000401087_6, ENST00000401087_7, ENST00000401087_8, ENST00000401087_9, ENST00000401087_10, ENST00000401087_11, ENST00000401087_12, ENST00000401087_13, ENST00000401087_14, ENST00000401087_15, ENST00000401087_16, RP11-403I13-201_1, RP11-403I13-201_2@79.7647058823529@11@87@NA@NA@NA
D13415@15456@15462@deletion@7@149375000@149400543@1@chr1:149375000-149400543@12.7@665@418@0.629@CNVR350.1@FCGR1C-201_4, FCGR1C-201_5, FCGR1C-201_6, ENST00000415338_1, HIST2H3PS2-001_1, HIST2H3PS2-001_2, RP5-998N21-002_1@73.7142857142857@70@76@NA@NA@NA
D13415@17200@17201@duplication@2@155581342@155581619@1@chr1:155581342-155581619@5.03@144@220@1.53@NA@MSTO1-001_5, MSTO1-001_6@2.5@2@3@:misato homolog 1 (Drosophila)@:mitochondrial outer membrane;protein polymerization;mitochondrion distribution;mitochondrion organization;molecular_function;protein complex;cytoplasm@NA
D13415@17245@17245@deletion@1@155716922@155716975@1@chr1:155716922-155716975@11.4@110@30@0.273@NA@ENST00000314835_5@0@0@0@:misato homolog 1 (Drosophila)@:mitochondrial outer membrane;protein polymerization;mitochondrion distribution;mitochondrion organization;molecular_function;protein complex;cytoplasm@NA
D13415@18676@18676@duplication@1@161569422@161569486@1@chr1:161569422-161569486@5.45@235@360@1.53@CNVR383.1@FCGR2C-006_7@40@40@40@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
D13415@33556@33564@duplication@9@87398460@87414366@2@chr2:87398460-87414366@9.03@708@939@1.33@CNVR861.2@AC083899-001_20, AC083899-001_21, AC083899-001_22, AC083899-001_23, AC083899-001_24, AC083899-001_25, AC083899-001_26, AC083899-001_27, AC083899-001_28@54.2222222222222@7@85@NA@NA@NA
D13415@33832@33833@deletion@2@90192770@90193425@2@chr2:90192770-90193425@11.2@484@303@0.626@CNVR867.10, CNVR867.5, CNVR867.3, CNVR867.9, CNVR867.15@IGKV1D-13-001_1, IGKV1D-13-001_2@7@7@7@@:protein binding@NA
D13415@34092@34095@duplication@4@96457910@96458295@2@chr2:96457910-96458295@11.5@267@414@1.55@NA@AC008268-201_2, AC008268-201_3, ENST00000444924_1, ENST00000444924_2@102.75@101@104@NA@NA@NA
D13415@34212@34213@deletion@2@96697783@96698114@2@chr2:96697783-96698114@5.08@130@74@0.569@NA@GPAT2-205_3, GPAT2-205_4@75.5@75@76@:glycerol-3-phosphate acyltransferase 2, mitochondrial@:glycerol-3-phosphate O-acyltransferase activity;mitochondrion;phospholipid metabolic process;triglyceride biosynthetic process;glycerophospholipid biosynthetic process;small molecule metabolic process;transferase activity, transferring acyl groups;mitochondrial outer membrane;phosphatidic acid biosynthetic process;integral to membrane;glycerol-3-phosphate metabolic process;CDP-diacylglycerol biosynthetic process;membrane;metabolic process;phospholipid biosynthetic process@NA
D13415@35975@35975@deletion@1@112551657@112551709@2@chr2:112551657-112551709@6.02@97@43@0.443@CNVR928.1@ANAPC1-001_37@0@0@0@:anaphase-promoting complex subunit 1-like;anaphase promoting complex subunit 1@:nucleoplasm;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle;anaphase-promoting complex;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle spindle assembly checkpoint;cytosol;protein K11-linked ubiquitination;protein binding;mitosis;nucleus;cell cycle checkpoint;cell division;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle@NA
D13415@36586@36587@duplication@2@120319592@120319691@2@chr2:120319592-120319691@5.43@141@216@1.53@NA@AC069154-001_6, AC013275-201_6@0@0@0@:primary ciliary dyskinesia protein 1@:cilium movement;flagellum;cilium morphogenesis;calmodulin binding;cilium@NA
D13415@40502@40502@duplication@1@179296383@179296982@2@chr2:179296383-179296982@5.79@231@360@1.56@CNVR1065.1@PRKRA-002_9@2@2@2@:protein kinase, interferon-inducible double stranded RNA dependent activator@:double-stranded RNA binding;negative regulation of cell proliferation;immune response;pyridoxal phosphate binding;middle ear morphogenesis;production of siRNA involved in RNA interference;induction of apoptosis;protein homodimerization activity;skeletal system morphogenesis;response to virus;positive regulation of catalytic activity;protein phosphorylation;intracellular;response to stress;cytoplasm;perinuclear region of cytoplasm;outer ear morphogenesis;protein binding;enzyme activator activity;kinase activity@: DYSTONIA 16; DYT16
D13415@47657@47657@duplication@1@11912773@11912903@3@chr3:11912773-11912903@6.09@72@140@1.94@NA@AC090958-001_4@6@6@6@NA@NA@NA
D13415@47662@47663@duplication@2@11925055@11925573@3@chr3:11925055-11925573@10.5@87@186@2.14@NA@AC090958-001_9, AC090958-001_10@9.5@9@10@NA@NA@NA
D13415@61530@61562@deletion@33@195341820@195415669@3@chr3:195341820-195415669@130@3470@1804@0.52@NA@ENST00000457750_1, ENST00000457750_2, AC233280-201_1, AC233280-201_2, AC233280-201_3, AC233280-201_4, AC233280-201_5, AC233280-201_6, AC233280-201_7, AC233280-201_8, AC069513-001_1, AC069513-001_2, AC069513-001_3, SDHALP2-001_1, SDHALP2-001_2, SDHALP2-001_3, SDHALP2-001_4, SDHALP2-001_5, SDHALP2-001_6, SDHALP2-001_7, SDHALP2-001_8, SDHALP2-001_9, SDHALP2-001_10, SDHALP2-001_11, SDHALP2-001_12, SDHALP2-001_13, SDHALP2-001_14, SDHALP2-001_15, ENST00000430928_1, ENST00000430928_2, ENST00000430928_4, AC069513-013_1@72.3125@20@93@:mucin 20, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane@NA
D13415@63143@63148@duplication@6@9176933@9204999@4@chr4:9176933-9204999@7.83@4@55@13.8@NA@AC108519-201_4, ENST00000429096_3, ENST00000429096_4, ENST00000429096_5, ENST00000429096_6, ENST00000429096_7@129@122@133@@:zinc ion binding;nucleic acid binding@NA
D13415@65356@65360@deletion@5@70148234@70160768@4@chr4:70148234-70160768@11.8@665@421@0.633@CNVR1957.2, CNVR1957.1@UGT2B28-201_3, UGT2B28-201_4, UGT2B28-201_5, UGT2B28-201_6, UGT2B28-201_7@69.6@68@71@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
D13415@65799@65801@duplication@3@75312253@75316250@4@chr4:75312253-75316250@5.85@173@267@1.54@NA@AREG-001_2, AREG-001_3, AREG-001_4@36.3333333333333@28@52@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
D13415@65805@65807@deletion@3@75482008@75486007@4@chr4:75482008-75486007@23.4@114@0@0@NA@AREGB-201_2, AREGB-201_3, AREGB-201_4@50.3333333333333@45@56@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
D13415@71604@71606@duplication@3@21483325@21491618@5@chr5:21483325-21491618@5.88@259@381@1.47@CNVR2395.4, CNVR2395.6, CNVR2395.2@AC138951-201_4, AC138951-202_2, ENST00000412250_1@104.333333333333@97@108@NA@NA@NA
D13415@73705@73706@duplication@2@69372350@69373420@5@chr5:69372350-69373420@5.85@111@188@1.69@CNVR2494.48, CNVR2494.39, CNVR2494.15, CNVR2494.18, CNVR2494.26, CNVR2494.43, CNVR2494.52, CNVR2494.28, CNVR2494.2, CNVR2494.36, CNVR2494.53@SMN2-001_8, SMN2-001_9@10@8@12@:survival of motor neuron 2, centromeric;survival of motor neuron 1, telomeric@:nucleoplasm;ncRNA metabolic process;Cajal body;RNA metabolic process;spliceosomal complex;cytoplasm;cytosol;protein binding;cell death;spliceosomal complex assembly;RNA binding;mRNA processing;nucleus;gene expression;spliceosomal snRNP assembly@: SPINAL MUSCULAR ATROPHY, TYPE II; SMA2; SPINAL MUSCULAR ATROPHY, TYPE I; SMA1; SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4; SPINAL MUSCULAR ATROPHY, TYPE III; SMA3
D13415@73727@73727@duplication@1@69717564@69717599@5@chr5:69717564-69717599@4.65@59@110@1.86@CNVR2494.17, CNVR2494.3@GTF2H2B-201_4@139@139@139@NA@NA@NA
D13415@73812@73821@duplication@10@70357101@70389020@5@chr5:70357101-70389020@17.3@318@543@1.71@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.8, CNVR2494.1, CNVR2494.37@GTF2H2-202_1, GTF2H2-202_2, GTF2H2-202_3, GTF2H2-202_4, GTF2H2-202_5, AC044797-201_1, AC044797-201_2, AC044797-201_3, AC044797-201_4, AC044797-201_5@91.2@61@138@:general transcription factor IIH, polypeptide 2, 44kDa@:nucleoplasm;nucleotide-excision repair, DNA damage removal;transcription from RNA polymerase I promoter;DNA repair;RNA polymerase II carboxy-terminal domain kinase activity;nucleus;viral reproduction;translation;gene expression;transcription elongation from RNA polymerase I promoter;response to UV;holo TFIIH complex;protein kinase activity;nucleotide-excision repair;transcription from RNA polymerase II promoter;transcription-coupled nucleotide-excision repair;transcription, DNA-dependent;zinc ion binding;transcription elongation from RNA polymerase II promoter;termination of RNA polymerase I transcription;sequence-specific DNA binding transcription factor activity;G-protein coupled receptor internalization;DNA-dependent ATPase activity;protein N-terminus binding;transcription initiation from RNA polymerase I promoter;7-methylguanosine mRNA capping;transcription initiation from RNA polymerase II promoter;protein phosphorylation;translation factor activity, nucleic acid binding;regulation of transcription, DNA-dependent;core TFIIH complex;protein binding;positive regulation of viral transcription;nucleic acid binding@NA
D13415@78044@78044@deletion@1@147553799@147553934@5@chr5:147553799-147553934@27.8@145@0@0@CNVR2637.2, CNVR2637.1@AC116334-001_3@78@78@78@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
D13415@79567@79568@deletion@2@175388056@175388438@5@chr5:175388056-175388438@12.3@76@13@0.171@NA@THOC3-001_4, THOC3-001_5@173.5@165@182@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
D13415@80022@80023@duplication@2@177166603@177167803@5@chr5:177166603-177167803@7.32@78@148@1.9@NA@FAM153A-204_8, FAM153A-204_9@88@86@90@:family with sequence similarity 153, member A@NA@NA
D13415@80481@80487@deletion@7@180376241@180429786@5@chr5:180376241-180429786@18.1@668@405@0.606@CNVR2719.1@BTNL8-202_7, BTNL8-202_8, BTNL3-202_1, BTNL3-202_2, BTNL3-202_3, BTNL3-202_5@103.333333333333@90@108@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
D13415@83002@83003@deletion@2@31237745@31238263@6@chr6:31237745-31238263@11.7@352@189@0.537@CNVR2838.2, CNVR2838.1@HLA-C-006_4, HLA-C-006_5@25@25@25@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
D13415@83014@83018@deletion@5@31323946@31324990@6@chr6:31323946-31324990@12.7@699@462@0.661@CNVR2841.12, CNVR2841.14, CNVR2841.8@HLA-B-201_1, HLA-B-201_2, HLA-B-201_3, HLA-B-201_4, HLA-B-201_5@67.2@59@73@:major histocompatibility complex, class I, B@:MHC class I protein complex;regulation of immune response;regulation of interleukin-12 production;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;regulation of T cell anergy;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;receptor binding;early endosome membrane;virus-host interaction;regulation of interleukin-6 production;regulation of dendritic cell differentiation;phagocytic vesicle membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO; SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1
D13415@83577@83577@deletion@1@31962024@31962162@6@chr6:31962024-31962162@8.19@38@0@0@CNVR2843.6, CNVR2843.3@C4A-001_20@12@12@12@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
D13415@83670@83679@deletion@10@32008648@32011334@6@chr6:32008648-32011334@28@235@67@0.285@CNVR2843.6, CNVR2843.5@TNXB-201_36, TNXB-201_37, TNXB-201_38, TNXB-201_39, TNXB-201_40, TNXB-201_41, TNXB-201_42, TNXB-201_43, TNXB-201_44, CYP21A2-002_10@32.9@17@46@:cytochrome P450, family 21, subfamily A, polypeptide 2:tenascin-X-like;tenascin XB@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
D13415@83911@83915@deletion@5@32485122@32489952@6@chr6:32485122-32489952@28@201@47@0.234@CNVR2845.21, CNVR2845.25, CNVR2845.30@HLA-DRB5-001_2, HLA-DRB5-001_3, HLA-DRB5-001_4, HLA-DRB5-001_5, HLA-DRB5-001_6@184.2@177@189@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D13415@83920@83928@deletion@9@32522469@32548634@6@chr6:32522469-32548634@52.8@397@84@0.212@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.5@HLA-DRB6-002_1, HLA-DRB6-002_2, HLA-DRB6-002_3, AL713966-201_1, AL713966-201_2, AL713966-201_3, HLA-DRB1-001_4, HLA-DRB1-001_5, HLA-DRB1-001_6@117.555555555556@56@167@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
D13415@83930@83930@deletion@1@32551888@32552156@6@chr6:32551888-32552156@11.6@100@24@0.24@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.54, CNVR2845.56, CNVR2845.34@HLA-DRB1-001_2@100@100@100@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
D13415@83933@83946@deletion@14@32606691@32634448@6@chr6:32606691-32634448@84.4@1150@492@0.428@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20@HLA-DQA1-002_2, HLA-DQA1-002_3, HLA-DQA1-002_4, HLA-DQA1-002_5, HLA-DQA1-002_6, HLA-DQB1-003_2, HLA-DQB1-003_3, HLA-DQB1-003_4, HLA-DQB1-003_5, HLA-DQB1-003_6, XXbac-BPG254F23-001_1, XXbac-BPG254F23-001_2, ENST00000443574_1, ENST00000443574_2@122.642857142857@80@146@:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
D13415@84706@84710@deletion@5@35754777@35765089@6@chr6:35754777-35765089@13.8@1086@703@0.647@CNVR2861.1@C6orf127-001_2, C6orf127-001_3, CLPS-001_1, CLPS-001_2, CLPS-001_3@39@30@43@:colipase-like 1:colipase, pancreatic@:extracellular region;enzyme activator activity;digestion;lipid catabolic process:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
D13415@92589@92595@deletion@7@160132299@160133523@6@chr6:160132299-160133523@93.1@856@213@0.249@CNVR3127.2, CNVR3127.1@ENST00000442642_2, ENST00000442642_3, ENST00000442642_4, ENST00000442642_5, ENST00000442642_6, ENST00000442642_7, ENST00000442642_8@83.8571428571429@13@112@:superoxide dismutase 2, mitochondrial;uncharacterized LOC100129518@:response to reactive oxygen species;oxidation-reduction process;mitochondrion;negative regulation of cell proliferation;neuron development;negative regulation of fat cell differentiation;removal of superoxide radicals;response to gamma radiation;response to L-ascorbic acid;response to lipopolysaccharide;response to nutrient levels;response to zinc ion;protein homotetramerization;post-embryonic development;iron ion homeostasis;hemopoiesis;aging;mitochondrial inner membrane;age-dependent response to reactive oxygen species;response to drug;oxygen binding;mitochondrial nucleoid;vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure;apoptotic process;superoxide metabolic process;response to superoxide;detection of oxygen;response to silicon dioxide;cytoplasm;response to stress;respiratory electron transport chain;superoxide anion generation;protein homooligomerization;regulation of mitochondrial membrane potential;positive regulation of nitric oxide biosynthetic process;response to manganese ion;regulation of blood pressure;metal ion binding;negative regulation of apoptotic process;response to cadmium ion;response to oxidative stress;liver development;regulation of catalytic activity;negative regulation of fibroblast proliferation;response to selenium ion;age-dependent response to oxidative stress;response to electrical stimulus;mitochondrial matrix;identical protein binding;mitochondrion organization;response to hyperoxia;vasodilation;response to hydrogen peroxide;superoxide dismutase activity;heart development;negative regulation of neuron apoptotic process;erythrophore differentiation;locomotory behavior;DNA binding;release of cytochrome c from mitochondria;response to axon injury;oxygen homeostasis;response to activity;glutathione metabolic process;hydrogen peroxide metabolic process;hydrogen peroxide biosynthetic process;regulation of transcription from RNA polymerase II promoter;response to hypoxia;protein binding;manganese ion binding;cellular response to ethanol@: MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6; MVCD6
D13415@93099@93101@deletion@3@167790036@167794825@6@chr6:167790036-167794825@6.46@228@159@0.697@NA@TCP10-001_3, TCP10-001_4, TCP10-001_5@77@52@103@:t-complex 10@:cytosol@NA
D13415@94190@94202@duplication@13@5959482@5984810@7@chr7:5959482-5984810@20.5@1442@1986@1.38@NA@C7orf28A-001_12, C7orf28A-001_13, C7orf28A-001_14, C7orf28A-001_15, RSPH10B-002_13, RSPH10B-002_14, RSPH10B-002_15, RSPH10B-002_16, RSPH10B-002_17, RSPH10B-002_18, RSPH10B-002_19, RSPH10B-002_20, RSPH10B-002_21@29.3846153846154@9@73@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae):radial spoke head 10 homolog B (Chlamydomonas)@:lysosomal membrane@NA
D13415@94209@94217@duplication@9@6000324@6018328@7@chr7:6000324-6018328@15.9@404@646@1.6@NA@RSPH10B-002_1, RSPH10B-002_2, RSPH10B-002_3, RSPH10B-002_4, RSPH10B-002_5, RSPH10B-002_6, PMS2-001_13, PMS2-001_14, PMS2-001_15@20@8@51@:radial spoke head 10 homolog B (Chlamydomonas):PMS2 postmeiotic segregation increased 2 (S. cerevisiae)@:response to drug;DNA binding;MutSalpha complex binding;ATP binding;mismatch repair;DNA repair;mismatched DNA binding;ATPase activity;nucleus;mismatch repair complex;reciprocal meiotic recombination;ATP catabolic process;single-stranded DNA binding;response to DNA damage stimulus;single base insertion or deletion binding;protein binding;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;MutLalpha complex;endonuclease activity@: COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4; MISMATCH REPAIR CANCER SYNDROME
D13415@94410@94421@deletion@12@6785721@6798791@7@chr7:6785721-6798791@15.6@600@346@0.577@NA@ENST00000338780_11, ENST00000338780_12, ENST00000338780_13, ENST00000338780_14, PMS2CL-002_11, PMS2CL-002_12, PMS2CL-002_13, PMS2CL-002_14, RSPH10B2-204_1, RSPH10B2-204_2, RSPH10B2-204_3, RSPH10B2-204_4@43.25@5@90@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D13415@94430@94444@deletion@15@6819243@6844687@7@chr7:6819243-6844687@107@865@231@0.267@NA@RSPH10B2-204_13, RSPH10B2-204_14, RSPH10B2-204_15, RSPH10B2-204_16, RSPH10B2-204_17, RSPH10B2-204_18, RSPH10B2-204_19, RSPH10B2-204_20, RSPH10B2-204_21, ENST00000429267_1, ENST00000429267_2, C7orf28B-001_12, C7orf28B-001_13, C7orf28B-001_14, C7orf28B-001_15@52.2@16@121@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D13415@96197@96203@duplication@7@33136107@33185977@7@chr7:33136107-33185977@22.7@883@1324@1.5@NA@RP9-004_1, RP9-004_2, RP9-004_3, RP9-004_4, RP9-004_5, BBS9-203_1, BBS9-203_2@1@1@1@:retinitis pigmentosa 9 (autosomal dominant):Bardet-Biedl syndrome 9@:protein binding;nucleus;RNA splicing;zinc ion binding;nucleic acid binding;signal recognition particle receptor complex:BBSome;fat cell differentiation;microtubule organizing center;cytoplasm;protein binding;response to stimulus;visual perception;nucleus;plasma membrane;molecular_function;cilium membrane@: RETINITIS PIGMENTOSA; RP; RETINITIS PIGMENTOSA 9; RP9: WILMS TUMOR 5; WT5; BARDET-BIEDL SYNDROME; BBS
D13415@96560@96561@duplication@2@38301774@38305280@7@chr7:38301774-38305280@10.4@776@1133@1.46@CNVR3353.1@TRGC1-001_1, TRGC1-001_2@8@8@8@:TCR gamma alternate reading frame protein@:protein binding@NA
D13415@96579@96584@duplication@6@38388958@38398764@7@chr7:38388958-38398764@22.8@1469@2098@1.43@CNVR3354.3, CNVR3354.1@TRGV5-001_1, TRGV5-001_2, TRGV4-001_1, TRGV4-001_2, TRGV3-001_1, TRGV3-001_2@10.5@6@14@@:protein binding:protein binding:protein binding;immune response;peptide antigen binding;plasma membrane;MHC protein binding@NA
D13415@97990@97994@deletion@5@62753052@62758771@7@chr7:62753052-62758771@112@617@2@0.00324@NA@AC006455-201_2, AC006455-201_3, AC006455-201_4, ENST00000444809_2, ENST00000444809_3, ENST00000444809_4@137@97@171@NA@NA@NA
D13415@98015@98026@duplication@12@62910199@62970547@7@chr7:62910199-62970547@25.9@751@1234@1.64@NA@ZNF734-201_2, ZNF734-201_3, ZNF734-201_4, ZNF734-201_5, ZNF734-201_6, ZNF734-201_7, ZNF734-201_8, ENST00000434048_1, ENST00000434048_2, CTD-2526L21-201_1, CTD-2526L21-201_2, CTD-2526L21-201_3@81.5833333333333@66@102@NA@NA@NA
D13415@98173@98174@deletion@2@64533487@64534227@7@chr7:64533487-64534227@5.76@35@6@0.171@NA@RP11-460N20-001_11, RP11-460N20-001_12, ENST00000501153_3@101@101@101@NA@NA@NA
D13415@98215@98215@deletion@1@65150574@65150717@7@chr7:65150574-65150717@8.26@50@7@0.14@NA@INTS4L2-001_5@56@56@56@NA@NA@NA
D13415@98628@98629@duplication@2@72469996@72470074@7@chr7:72469996-72470074@5.77@170@256@1.51@NA@STAG3L3-003_6, RP11-313P13-001_6@71@71@71@@:nucleus;binding@NA
D13415@98735@98735@duplication@1@72710751@72712438@7@chr7:72710751-72712438@8.34@75@169@2.25@NA@POM121B-201_7@2@2@2@NA@NA@NA
D13415@99063@99063@duplication@1@74251404@74251506@7@chr7:74251404-74251506@10.5@30@124@4.13@NA@GTF2IRD2-002_2@8@8@8@:GTF2I repeat domain containing 2@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
D13415@99069@99074@deletion@6@74300542@74312350@7@chr7:74300542-74312350@21.1@104@0@0@CNVR3452.1@STAG3L2-202_1, STAG3L2-202_2, STAG3L2-202_3, STAG3L2-202_4, PMS2L5-203_1, PMS2L5-203_2@35.6666666666667@20@53@NA@NA@NA
D13415@99111@99113@deletion@3@74524754@74536812@7@chr7:74524754-74536812@7.27@71@24@0.338@NA@GTF2IRD2B-004_2, GTF2IRD2B-004_3, GTF2IRD2B-004_4@15.6666666666667@15@16@:GTF2I repeat domain containing 2B@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
D13415@99133@99134@deletion@2@74582344@74582683@7@chr7:74582344-74582683@8.74@59@11@0.186@NA@NCF1C-001_3, NCF1C-001_4@32@15@49@NA@NA@NA
D13415@99233@99233@deletion@1@74991244@74991359@7@chr7:74991244-74991359@5.64@25@0@0@CNVR3456.1@STAG3L1-004_3@60@60@60@NA@NA@NA
D13415@99272@99273@deletion@2@75054920@75055736@7@chr7:75054920-75055736@4.9@89@46@0.517@NA@POM121C-001_8, POM121C-001_9@51@30@72@:POM121 transmembrane nucleoporin C@:nuclear membrane;protein binding;protein transport;endoplasmic reticulum membrane;nuclear pore;mRNA transport@NA
D13415@99544@99545@deletion@2@76723321@76728269@7@chr7:76723321-76728269@14.7@120@29@0.242@NA@ENST00000398321_6, ENST00000398321_7@13.5@11@16@NA@NA@NA
D13415@102078@102080@deletion@3@102020914@102021081@7@chr7:102020914-102021081@15.8@709@410@0.578@NA@CTA-313A17-201_2, RP11-163E9-003_5, RP11-163E9-001_3@3@3@3@:PRKR interacting protein 1 (IL11 inducible);LOC100289561-PRKRIP1 readthrough@:double-stranded RNA binding;protein binding;protein kinase inhibitor activity;negative regulation of protein kinase activity;protein kinase binding;nucleolus;negative regulation of phosphorylation@NA
D13415@102144@102145@deletion@2@102180464@102180539@7@chr7:102180464-102180539@35.9@176@0@0@CNVR3518.1@RASA4B-007_4, POLR2J3-003_7@96@96@96@:RAS p21 protein activator 4B:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
D13415@102166@102167@deletion@2@102219874@102223340@7@chr7:102219874-102223340@10.1@46@0@0@CNVR3518.1@ENST00000379336_1, RASA4-001_21@56@49@63@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
D13415@102192@102193@duplication@2@102279572@102279647@7@chr7:102279572-102279647@5.79@300@426@1.42@CNVR3518.1@ENST00000340457_4, POLR2J2-001_7@76.5@76@77@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
D13415@104579@104579@deletion@1@134221805@134221910@7@chr7:134221805-134221910@7.79@114@46@0.404@NA@AKR1B10-001_6@2@2@2@:aldo-keto reductase family 1, member B10 (aldose reductase)@:steroid metabolic process;cellular aldehyde metabolic process;indanol dehydrogenase activity;daunorubicin metabolic process;retinal dehydrogenase activity;farnesol catabolic process;geranylgeranyl reductase activity;protein binding;extracellular region;aldo-keto reductase (NADP) activity;digestion;doxorubicin metabolic process;cellular_component;lysosome@NA
D13415@105323@105325@duplication@3@141767143@141770919@7@chr7:141767143-141770919@6.33@216@315@1.46@CNVR3585.3, CNVR3585.2@MGAM-007_42, MGAM-007_43, MGAM-007_44@116.333333333333@114@119@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
D13415@105338@105342@duplication@5@141786457@141794298@7@chr7:141786457-141794298@8.94@388@545@1.4@CNVR3585.3, CNVR3585.2@MGAM-007_57, MGAM-007_58, MGAM-007_59, MGAM-007_60, MGAM-007_61@88.4@35@134@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
D13415@105798@105799@deletion@2@143975408@143975569@7@chr7:143975408-143975569@6.68@30@0@0@CNVR3598.4, CNVR3598.9@RP4-798C17-001_5, ENST00000378112_6@135@135@135@:Rho guanine nucleotide exchange factor (GEF) 35@NA@NA
D13415@105827@105829@duplication@3@144070290@144072769@7@chr7:144070290-144072769@8.56@182@305@1.68@CNVR3598.4, CNVR3598.5, CNVR3598.11@ARHGEF5-001_10, ARHGEF5-001_11, ARHGEF5-001_12@56.6666666666667@39@83@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
D13415@109572@109585@duplication@14@39311571@39349528@8@chr8:39311571-39349528@41.9@434@851@1.96@CNVR3859.1@ADAM3A-005_11, ADAM3A-005_12, ADAM3A-005_13, ADAM3A-005_14, ADAM3A-005_15, ADAM3A-005_16, ADAM3A-005_17, ADAM3A-005_18, ADAM3A-005_19, ADAM3A-005_20, ADAM3A-005_21, ADAM3A-009_7, ADAM3A-009_8, ADAM3A-009_9@120.5@98@136@NA@NA@NA
D13415@114793@114844@deletion@52@214867@465256@9@chr9:214867-465256@284@7871@4095@0.52@NA@DOCK8-001_1, DOCK8-001_2, DOCK8-001_3, DOCK8-001_4, DOCK8-001_5, DOCK8-001_6, DOCK8-001_7, DOCK8-001_8, DOCK8-001_9, DOCK8-001_10, DOCK8-001_11, DOCK8-001_12, DOCK8-001_13, DOCK8-001_14, DOCK8-001_15, DOCK8-001_16, DOCK8-001_17, DOCK8-001_18, DOCK8-001_19, DOCK8-001_20, DOCK8-001_21, DOCK8-001_22, DOCK8-001_23, DOCK8-001_24, DOCK8-001_25, DOCK8-001_26, DOCK8-001_27, DOCK8-001_28, DOCK8-001_29, DOCK8-001_30, DOCK8-001_31, DOCK8-001_32, DOCK8-001_33, DOCK8-001_34, DOCK8-001_35, DOCK8-001_36, DOCK8-001_37, DOCK8-001_38, DOCK8-001_39, DOCK8-001_40, DOCK8-001_41, DOCK8-001_42, DOCK8-001_43, DOCK8-001_44, DOCK8-001_45, DOCK8-001_46, DOCK8-001_47, DOCK8-001_48, RP11-59O6-001_1, RP11-59O6-001_2, RP11-165F24-001_1, RP11-165F24-001_2@2.01923076923077@2@3@:chromosome 9 open reading frame 66:dedicator of cytokinesis 8@:cytosol;GTPase binding;blood coagulation;binding;GTP binding;guanyl-nucleotide exchange factor activity@: MENTAL RETARDATION, AUTOSOMAL DOMINANT 2; MRD2; HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL RECESSIVE
D13415@114855@114867@deletion@13@676892@746106@9@chr9:676892-746106@80.3@3841@1945@0.506@NA@KANK1-001_6, KANK1-001_7, KANK1-001_8, KANK1-001_9, KANK1-001_10, KANK1-001_11, KANK1-001_12, KANK1-001_13, KANK1-001_14, KANK1-001_15, KANK1-001_16, ENST00000421645_1, ENST00000421645_2@0@0@0@:KN motif and ankyrin repeat domains 1@:positive regulation of catenin import into nucleus;positive regulation of Wnt receptor signaling pathway;negative regulation of ruffle assembly;ruffle membrane;negative regulation of substrate adhesion-dependent cell spreading;negative regulation of cell migration;nucleus;negative regulation of neuron projection development;negative regulation of actin filament polymerization;negative regulation of insulin receptor signaling pathway;negative regulation of lamellipodium morphogenesis;beta-catenin binding;regulation of establishment of cell polarity;regulation of transcription, DNA-dependent;cytoplasm;negative regulation of Rho protein signal transduction;protein binding;transcription, DNA-dependent;positive regulation of wound healing@: CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 2; CPSQ2
D13415@118852@118854@deletion@3@84545017@84549914@9@chr9:84545017-84549914@6.12@435@269@0.618@CNVR4364.1@ENST00000427387_1, RP11-383M4-201_3, RP11-383M4-201_4@16.3333333333333@11@27@NA@NA@NA
D13415@121600@121605@duplication@6@117085338@117088756@9@chr9:117085338-117088756@88@1532@4505@2.94@CNVR4448.1@ORM1-001_1, ORM1-001_2, ORM1-001_3, ORM1-001_4, ORM1-001_5, ORM1-001_6@81.6666666666667@52@90@:orosomucoid 1@:protein binding;extracellular space;regulation of immune system process;transport;inflammatory response;extracellular region;acute-phase response@NA
D13415@126269@126269@deletion@1@9449789@9449825@10@chr10:9449789-9449825@8.19@46@5@0.109@NA@AL355591-202_3@0@0@0@NA@NA@NA
D13415@126909@126909@deletion@1@17840632@17842868@10@chr10:17840632-17842868@9.34@43@0@0@NA@FAM23A-201_5@108@108@108@:transmembrane protein 236;transmembrane protein 236-like@:integral to membrane@NA
D13415@126911@126911@duplication@1@17865075@17865475@10@chr10:17865075-17865475@6.08@149@248@1.66@NA@MRC1L1-001_2@12@12@12@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
D13415@126913@126918@deletion@6@17875676@17898363@10@chr10:17875676-17898363@57.4@438@59@0.135@NA@MRC1L1-001_4, MRC1L1-001_5, MRC1L1-001_6, MRC1L1-001_7, MRC1L1-001_8, MRC1L1-001_9@9.16666666666667@5@20@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
D13415@126938@126947@deletion@10@17951324@18116669@10@chr10:17951324-18116669@21.7@107@3@0.028@NA@MRC1L1-001_29, MRC1L1-001_30, FAM23B-202_1, FAM23B-202_2, FAM23B-202_3, FAM23B-202_4, FAM23B-202_5, MRC1-001_1, MRC1-001_2, MRC1-001_3@43.9@5@107@:macrophage mannose receptor 1-like:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D13415@126949@126953@duplication@5@18129624@18145282@10@chr10:18129624-18145282@26@126@482@3.83@NA@MRC1-001_5, MRC1-001_6, MRC1-001_7, MRC1-001_8, MRC1-001_9@20.4@16@26@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D13415@127722@127722@deletion@1@29580856@29580936@10@chr10:29580856-29580936@9.27@61@10@0.164@NA@LYZL1-002_1@51@51@51@:lysozyme-like 1@:extracellular region;lysozyme activity;cell wall macromolecule catabolic process@NA
D13415@128372@128372@deletion@1@42924566@42924600@10@chr10:42924566-42924600@8.2@113@44@0.389@NA@CCNYL2-201_7@0@0@0@@:regulation of cyclin-dependent protein kinase activity;protein kinase binding@NA
D13415@128779@128779@duplication@1@46552471@46552532@10@chr10:46552471-46552532@6.27@3@46@15.3@CNVR4712.3@PTPN20A-202_9@0@0@0@:protein tyrosine phosphatase, non-receptor type 20B;protein tyrosine phosphatase, non-receptor type 20A@:phosphatase activity;protein tyrosine phosphatase activity;microtubule;nucleus;dephosphorylation;protein dephosphorylation;microtubule organizing center@NA
D13415@128979@128979@deletion@1@47758848@47758905@10@chr10:47758848-47758905@6.34@29@0@0@CNVR4714.1@ANXA8L2-001_10@154@154@154@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:calcium-dependent phospholipid binding;calcium ion binding@NA
D13415@129130@129131@duplication@2@48968562@48968624@10@chr10:48968562-48968624@5.16@52@98@1.88@CNVR4716.8, CNVR4716.4@RP11-508M1-002_5, GLUDP2-001_3@31@31@31@NA@NA@NA
D13415@129454@129477@duplication@24@51345755@51391568@10@chr10:51345755-51391568@57@408@1050@2.57@NA@ENST00000404618_1, ENST00000404618_2, ENST00000404618_3, ENST00000404618_4, ENST00000404618_5, ENST00000404618_6, ENST00000404618_7, ENST00000432221_1, ENST00000432221_2, ENST00000432221_3, ENST00000432221_4, ENST00000432221_5, ENST00000432221_6, ENST00000432221_7, TIMM23B-202_1, TIMM23B-202_2, TIMM23B-202_3, TIMM23B-202_4, TIMM23B-202_5, TIMM23B-202_6, TIMM23B-202_7, TIMM23B-202_8, TIMM23B-202_10@77@0@142@:translocase of inner mitochondrial membrane 23 homolog B (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process@NA
D13415@129509@129521@deletion@13@51603186@51631957@10@chr10:51603186-51631957@22@874@540@0.618@NA@TIMM23-202_1, TIMM23-202_2, TIMM23-202_3, TIMM23-202_4, TIMM23-202_5, TIMM23-202_6, TIMM23-202_7, TIMM23-202_8, TIMM23-202_9, TIMM23-202_10, ENST00000456092_1, ENST00000456092_2, ENST00000456092_3@10.5384615384615@0@29@:translocase of inner mitochondrial membrane 23 homolog B (yeast):translocase of inner mitochondrial membrane 23 homolog B (yeast);translocase of inner mitochondrial membrane 23 homolog (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:mitochondrion;mitochondrial inner membrane;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;mitochondrial intermembrane space;integral to mitochondrial inner membrane;intracellular protein transport;protein binding;integral to membrane;cellular protein metabolic process;protein targeting to mitochondrion@NA
D13415@129605@129609@deletion@5@51970585@51978391@10@chr10:51970585-51978391@16@177@75@0.424@NA@ASAH2-201_7, ASAH2-201_8, ASAH2-201_9, ASAH2-201_10, ASAH2-201_11@181.2@176@186@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
D13415@135724@135730@deletion@7@124344789@124353115@10@chr10:124344789-124353115@41.3@1140@593@0.52@CNVR4912.4, CNVR4912.3, CNVR4912.2@DMBT1-002_15, DMBT1-002_16, DMBT1-002_17, DMBT1-002_18, DMBT1-002_19, DMBT1-002_20, DMBT1-002_21@49.4285714285714@47@51@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
D13415@135736@135736@deletion@1@124359582@124359610@10@chr10:124359582-124359610@7.23@254@135@0.531@CNVR4912.4, CNVR4912.3@DMBT1-002_27@7@7@7@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
D13415@136769@136770@deletion@2@135437401@135439504@10@chr10:135437401-135439504@7.66@667@427@0.64@CNVR4989.11, CNVR4989.4@FRG2B-202_3, FRG2B-202_4@23.5@18@29@:FSHD region gene 2 family, member B@:nucleus@NA
D13415@139526@139527@deletion@2@18813074@18956211@11@chr11:18813074-18956211@21.5@995@393@0.395@NA@PTPN5-201_1, MRGPRX1-203_3@9.5@3@16@:protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched):MAS-related GPR, member X1@:phosphatase activity;protein tyrosine phosphatase activity;protein dephosphorylation;integral to membrane;phosphotyrosine binding;dephosphorylation;endoplasmic reticulum membrane;peptidyl-tyrosine dephosphorylation:integral to membrane;G-protein coupled receptor activity;plasma membrane;acute-phase response;G-protein coupled receptor signaling pathway@NA
D13415@141187@141188@deletion@2@48600990@48601883@11@chr11:48600990-48601883@9.56@45@1@0.0222@CNVR5165.1@AC134982-201_1, AC134982-201_2@128@128@128@NA@NA@NA
D13415@145899@145902@deletion@4@89534136@89537642@11@chr11:89534136-89537642@7.78@111@51@0.459@NA@TRIM49-201_3, TRIM49-201_4, TRIM49-201_5, TRIM49-201_6@36.5@34@40@:tripartite motif containing 49@:protein binding;intracellular;DNA binding;zinc ion binding@NA
D13415@145978@145983@duplication@6@89795133@89806559@11@chr11:89795133-89806559@9.81@76@157@2.07@CNVR5268.1@ENST00000432771_6, ENST00000432771_7, ENST00000432771_8, ENST00000436580_1, ENST00000436580_2, ENST00000436580_3@86.8333333333333@84@92@:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;DNA binding;zinc ion binding@NA
D13415@150968@150971@deletion@4@10583212@10587639@12@chr12:10583212-10587639@5.59@460@313@0.68@CNVR5430.1@KLRC2-201_3, KLRC2-201_4, KLRC2-201_5, KLRC2-201_6@62@51@67@:killer cell lectin-like receptor subfamily C, member 2@:carbohydrate binding:transmembrane signaling receptor activity;carbohydrate binding;protein binding;signal transduction;cellular defense response;integral to plasma membrane@NA
D13415@164471@164478@duplication@8@52853978@52857493@13@chr13:52853978-52857493@9.8@338@486@1.44@NA@THSD1P-203_13, THSD1P-203_14, THSD1P-203_15, THSD1P-203_16, ENST00000403471_4, ENST00000403471_5, ENST00000403471_6, ENST00000403471_7@53@48@58@NA@NA@NA
D13415@164539@164543@deletion@5@53103402@53106857@13@chr13:53103402-53106857@28.4@133@0@0@NA@RP11-78J21-201_12, RP11-78J21-201_13, RP11-78J21-201_14, RP11-78J21-201_15, RP11-78J21-201_16@113.8@107@117@NA@NA@NA
D13415@166697@166704@deletion@8@19553367@19573145@14@chr14:19553367-19573145@12.7@102@27@0.265@CNVR6072.1@POTEG-201_1, POTEG-201_2, POTEG-201_3, POTEG-201_4, POTEG-201_5, POTEG-201_6, POTEG-201_7, POTEG-201_8@110.5@84@141@:POTE ankyrin domain family, member G@:protein binding@NA
D13415@170815@170815@deletion@1@74041614@74042360@14@chr14:74041614-74042360@5.63@116@57@0.491@CNVR6188.1, CNVR6188.6@ACOT2-201_3@5@5@5@:acyl-CoA thioesterase 2@:acyl-CoA metabolic process;mitochondrion;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity;receptor binding@NA
D13415@173501@173502@deletion@2@106478134@106478412@14@chr14:106478134-106478412@23.1@167@31@0.186@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV3-6-210_6, IGHV4-4-001_2@17@17@17@@:protein binding@NA
D13415@173536@173540@deletion@5@106721281@106721477@14@chr14:106721281-106721477@8.66@309@189@0.612@CNVR6294.48, CNVR6294.24, CNVR6294.40, CNVR6294.38, CNVR6294.17, CNVR6294.23@AB019439-201_1, AB019439-201_2, IGHVIII-22-2-201_1, IGHVIII-22-2-201_2, IGHVIII-22-2-201_3@6.4@5@8@NA@NA@NA
D13415@173556@173563@duplication@8@106787370@106805717@14@chr14:106787370-106805717@28.8@1028@1721@1.67@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-29-001_1, IGHV3-29-001_2, IGHV3-30-001_1, IGHV3-30-001_2, IGHV3-30-2-001_1, IGHV3-30-2-001_2, IGHV4-31-001_1, IGHV4-31-001_2@16.5@13@19@@:protein binding:protein binding@NA
D13415@173635@173638@deletion@4@107095128@107099589@14@chr14:107095128-107099589@20.1@435@247@0.568@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61-001_1, IGHV4-61-001_2, IGHV3-62-001_1, IGHV3-62-001_2@16@15@17@@:protein binding@NA
D13415@173645@173646@deletion@2@107131035@107131561@14@chr14:107131035-107131561@15.7@402@193@0.48@CNVR6294.56, CNVR6294.16@IGHV3-66-001_1, IGHV3-66-001_2@2.5@2@3@@:protein binding@NA
D13415@173682@173696@deletion@15@20444657@20482048@15@chr15:20444657-20482048@48.8@5616@3747@0.667@CNVR6295.15, CNVR6295.7, CNVR6295.13, CNVR6295.26@ENST00000400226_1, ENST00000400226_2, ENST00000400226_3, ENST00000400226_4, ENST00000400226_5, ENST00000400226_6, ENST00000400226_7, ENST00000400226_8, ENST00000400226_9, ENST00000400226_10, ENST00000400226_11, ENST00000400226_12, ENST00000400226_13, ENST00000400226_14, ENST00000400226_15@61.6@20@80@NA@NA@NA
D13415@173814@173822@deletion@9@22297500@22473354@15@chr15:22297500-22473354@46.9@2449@1328@0.542@CNVR6297.4, CNVR6297.17, CNVR6297.6@AC134980-201_1, AC134980-201_2, ENST00000438898_1, ENST00000438898_2, AC025884-201_1, AC010760-202_2, VSIG6-201_1, VSIG6-201_2@60.25@15@87@:olfactory receptor, family 4, subfamily M, member 2:olfactory receptor, family 4, subfamily N, member 4@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
D13415@174406@174410@deletion@5@29008591@29009297@15@chr15:29008591-29009297@36.6@648@282@0.435@NA@ENST00000456510_1, ENST00000456510_2, ENST00000456510_3, ENST00000456510_4, ENST00000456510_5@23.6@18@26@NA@NA@NA
D13415@174506@174506@deletion@1@30664352@30664545@15@chr15:30664352-30664545@8.73@40@0@0@CNVR6337.1@CHRFAM7A-202_7@68@68@68@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
D13415@174966@174971@deletion@6@34781208@34812974@15@chr15:34781208-34812974@19.9@1224@734@0.6@CNVR6351.3@AC027139-201_1, AC027139-201_2, AC027139-201_3, AC027139-201_4, AC027139-201_5, ENST00000444260_1@45@40@49@:golgin A8 family, member A@:Golgi cisterna membrane;Golgi apparatus@NA
D13415@176340@176340@duplication@1@43873202@43873322@15@chr15:43873202-43873322@5.9@150@248@1.65@CNVR6365.1@HISPPD2A-201_10@10@10@10@:diphosphoinositol pentakisphosphate kinase 1@:inositol hexakisphosphate 3-kinase activity;inositol hexakisphosphate 1-kinase activity;inositol metabolic process;diphosphoinositol-pentakisphosphate kinase activity;ATP binding;acid phosphatase activity;cytoplasm;cytosol;inositol hexakisphosphate 5-kinase activity;nucleus;kinase activity;inositol-1,3,4,5,6-pentakisphosphate kinase activity@NA
D13415@176387@176388@duplication@2@43927560@43928025@15@chr15:43927560-43928025@5.3@468@659@1.41@CNVR6365.1@CATSPER2-001_10, CATSPER2-001_11@4@4@4@:diphosphoinositol pentakisphosphate kinase 1:stereocilin:cation channel, sperm associated 2@:inositol hexakisphosphate 3-kinase activity;inositol hexakisphosphate 1-kinase activity;inositol metabolic process;diphosphoinositol-pentakisphosphate kinase activity;ATP binding;acid phosphatase activity;cytoplasm;cytosol;inositol hexakisphosphate 5-kinase activity;nucleus;kinase activity;inositol-1,3,4,5,6-pentakisphosphate kinase activity:detection of mechanical stimulus involved in sensory perception of sound;stereocilium bundle tip;stereocilium;cell surface;kinocilium;auditory receptor cell stereocilium organization:cell differentiation;CatSper complex;ion transport;transmembrane transport;voltage-gated ion channel activity;flagellar membrane;spermatogenesis;integral to membrane;multicellular organismal development;fertilization;sperm motility;ion channel activity;ciliary or flagellar motility;calcium channel activity;cilium;protein binding;microtubule-based flagellum;membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16; DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY: DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY
D13415@176449@176450@deletion@2@44024017@44024501@15@chr15:44024017-44024501@5.83@247@144@0.583@NA@CATSPER2P1-001_8, CATSPER2P1-001_9@4@4@4@NA@NA@NA
D13415@179308@179310@deletion@3@72954595@72956853@15@chr15:72954595-72956853@7.34@33@0@0@CNVR6443.1@GOLGA6-001_11, GOLGA6-001_12, GOLGA6-001_13@96.6666666666667@95@99@:golgin A6 family, member B@:Golgi apparatus@NA
D13415@180031@180034@deletion@4@78208171@78211599@15@chr15:78208171-78211599@6.75@151@82@0.543@CNVR6464.1@AC104758-201_1, ENST00000331447_1, ENST00000331447_2, ENST00000331447_3@5.5@0@14@NA@NA@NA
D13415@180187@180187@deletion@1@79065427@79065546@15@chr15:79065427-79065546@8.08@42@3@0.0714@NA@ADAMTS7-201_14@10@10@10@:A disintegrin and metalloproteinase with thrombospondin motifs 7-like;ADAM metallopeptidase with thrombospondin type 1 motif, 7@:metallopeptidase activity;extracellular matrix;proteolysis;peptidase activity;proteinaceous extracellular matrix;metalloendopeptidase activity;cell surface;zinc ion binding@NA
D13415@182604@182607@deletion@4@1278656@1279739@16@chr16:1278656-1279739@8.61@135@64@0.474@CNVR6591.1@TPSB2-002_3, TPSB2-002_4, TPSB2-002_5, TPSB2-002_6@68.75@46@102@:tryptase beta 2 (gene/pseudogene)@:proteolysis;catalytic activity;serine-type endopeptidase activity@NA
D13415@185021@185021@deletion@1@18542790@18542930@16@chr16:18542790-18542930@8.38@237@117@0.494@NA@NOMO2-201_13@23@23@23@:NODAL modulator 2@:carbohydrate binding;protein binding;integral to membrane;carboxypeptidase activity;endoplasmic reticulum membrane@NA
D13415@186582@186586@deletion@5@29468955@29469541@16@chr16:29468955-29469541@7.62@86@35@0.407@CNVR6690.2, CNVR6690.3, CNVR6690.4@GIYD1-001_4, GIYD1-001_5, GIYD1-001_6, SULT1A4-201_2, SULT1A4-201_3@10.4@2@13@:structure-specific endonuclease subunit SLX1-like;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae);SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae):sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3;sulfotransferase 1A3/1A4-like@:Slx1-Slx4 complex;5'-flap endonuclease activity;DNA repair;protein binding;DNA double-strand break processing involved in repair via single-strand annealing;double-strand break repair via homologous recombination;metal ion binding;crossover junction endodeoxyribonuclease activity:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;cytoplasm;catecholamine metabolic process;cytosol;endoplasmic reticulum unfolded protein response;xenobiotic metabolic process;sulfotransferase activity;activation of signaling protein activity involved in unfolded protein response;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process@NA
D13415@186863@186864@duplication@2@30208593@30208679@16@chr16:30208593-30208679@6.93@54@114@2.11@CNVR6694.1, CNVR6694.2, CNVR6694.3@GIYD2-001_5, SULT1A3-001_2@6@6@6@:structure-specific endonuclease subunit SLX1-like;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae);SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae):sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3;sulfotransferase 1A3/1A4-like@:Slx1-Slx4 complex;5'-flap endonuclease activity;DNA repair;protein binding;DNA double-strand break processing involved in repair via single-strand annealing;double-strand break repair via homologous recombination;metal ion binding;crossover junction endodeoxyribonuclease activity:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;cytoplasm;catecholamine metabolic process;cytosol;endoplasmic reticulum unfolded protein response;xenobiotic metabolic process;sulfotransferase activity;activation of signaling protein activity involved in unfolded protein response;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process@NA
D13415@187604@187609@duplication@6@34578529@34682257@16@chr16:34578529-34682257@12.4@1154@1572@1.36@CNVR6708.1@ENST00000425453_1, ENST00000425453_2, ENST00000425453_3, ENST00000425453_4, AC018558-202_1, AC018558-202_2@13@2@20@NA@NA@NA
D13415@188229@188231@duplication@3@55798611@55804008@16@chr16:55798611-55804008@8.23@186@288@1.55@CNVR6730.1@CES4-202_2, CES4-202_3, CES4-202_4@114.666666666667@108@123@NA@NA@NA
D13415@189960@189961@duplication@2@70162864@70164448@16@chr16:70162864-70164448@6.24@743@1019@1.37@CNVR6764.1, CNVR6764.3@AC009060-202_6, AC009060-202_7@67.5@65@70@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
D13415@190430@190431@duplication@2@72091293@72092255@16@chr16:72091293-72092255@4.91@56@101@1.8@CNVR6769.1, CNVR6769.2@HP-201_4, HP-201_5@28.5@26@31@:thioredoxin-like 4B:haptoglobin:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:cellular iron ion homeostasis;negative regulation of oxidoreductase activity;catalytic activity;negative regulation of hydrogen peroxide catabolic process;positive regulation of cell death;haptoglobin-hemoglobin complex;extracellular space;proteolysis;response to hydrogen peroxide;extracellular region;hemoglobin binding;defense response;serine-type endopeptidase activity:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@: ANHAPTOGLOBINEMIA; AHP
D13415@190518@190518@duplication@1@74368792@74368885@16@chr16:74368792-74368885@4.62@376@540@1.44@CNVR6778.2, CNVR6778.1@AC009053-202_14@16@16@16@NA@NA@NA
D13415@190527@190528@deletion@2@74385940@74386277@16@chr16:74385940-74386277@18.5@348@146@0.42@CNVR6778.2, CNVR6778.1@AC009053-202_4, AC009053-202_5@23.5@21@26@NA@NA@NA
D13415@195229@195240@duplication@12@16664741@16705831@17@chr17:16664741-16705831@19.2@2011@2754@1.37@NA@CCDC144A-202_13, CCDC144A-202_14, CCDC144A-202_15, CCDC144A-202_16, CCDC144A-202_17, CCDC144A-202_18, AC022596-003_1, AC022596-003_2, AC022596-003_3, AC022596-003_4, AC022596-003_5, AC022596-003_6@60.5833333333333@45@68@:coiled-coil domain containing 144A@NA@NA
D13415@195691@195726@deletion@36@18331724@18416773@17@chr17:18331724-18416773@80@701@209@0.298@CNVR7014.1@ENST00000326333_2, ENST00000326333_3, ENST00000326333_4, ENST00000326333_5, ENST00000326333_6, ENST00000326333_7, ENST00000326333_8, ENST00000399124_1, ENST00000399124_2, ENST00000399124_3, ENST00000399124_4, ENST00000399124_5, ENST00000399124_6, ENST00000399124_7, ENST00000399124_8, ENST00000411877_1, ENST00000411877_2, ENST00000411877_4, LGALS9C-201_1, LGALS9C-201_2, LGALS9C-201_3, LGALS9C-201_4, LGALS9C-201_5, LGALS9C-201_6, LGALS9C-201_7, LGALS9C-201_8, LGALS9C-201_9, LGALS9C-201_10, LGALS9C-201_11, ENST00000426269_1, ENST00000426269_2, ENST00000426269_3, ENST00000426269_4, ENST00000426269_5, AC107983-001_10@136.628571428571@79@203@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
D13415@195728@195747@deletion@20@18418662@18457581@17@chr17:18418662-18457581@187@940@2@0.00213@NA@AC107983-001_1, AC107983-001_2, AC107983-001_3, AC107983-001_4, AC107983-001_5, AC107983-001_6, AC107983-001_7, AC107983-001_8, ENST00000456184_1, ENST00000456184_2, CCDC144B-201_14, CCDC144B-201_15, CCDC144B-201_16, CCDC144B-201_17, CCDC144B-201_18, ENST00000447265_11, ENST00000447265_12, ENST00000447265_13, ENST00000447265_14, ENST00000447265_15@129.8@126@133@:protein FAM106B-like@NA@NA
D13415@195870@195874@duplication@5@18996289@19036053@17@chr17:18996289-19036053@9.54@292@467@1.6@CNVR7018.2, CNVR7018.3, CNVR7018.1@AC007952-202_1, AC007952-202_2, AC007952-202_3, GRAPL-203_1, GRAPL-203_2@39.4@4@93@:GRB2-related adaptor protein-like@:protein binding@NA
D13415@197728@197728@duplication@1@34539901@34539966@17@chr17:34539901-34539966@4.96@55@106@1.93@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1-202_4@122@122@122@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
D13415@197745@197748@deletion@4@34625573@34641345@17@chr17:34625573-34641345@28@135@0@0@CNVR7077.1, CNVR7077.2, CNVR7077.12@CCL3L1-205_1, CCL4L2-202_1, CCL4L2-202_2, CCL4L2-202_3@60.25@39@71@:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
D13415@198033@198034@deletion@2@36352424@36353766@17@chr17:36352424-36353766@10.1@760@466@0.613@CNVR7083.3@AC183087-202_12, AC183087-202_13@61.5@59@64@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
D13415@200259@200266@deletion@8@43585590@43596019@17@chr17:43585590-43596019@11.6@572@349@0.61@CNVR7113.4, CNVR7113.6, CNVR7113.2, CNVR7113.1@AC091132-201_1, AC091132-201_2, AC091132-201_3, AC091132-201_4, AC091132-201_5, ENST00000339474_1, ENST00000339474_2, ENST00000339474_3@94.875@81@127@NA@NA@NA
D13415@200320@200328@duplication@9@44248223@44364337@17@chr17:44248223-44364337@24.1@4156@5638@1.36@CNVR7114.3, CNVR7114.2, CNVR7114.10@KIAA1267-201_1, KIAA1267-201_2, AC217773-201_1, AC217773-201_2, ENST00000451529_1, ENST00000451529_3, ENST00000451529_5@64.4285714285714@49@90@:KAT8 regulatory NSL complex subunit 1:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:histone acetyltransferase activity (H4-K8 specific);histone acetyltransferase activity (H4-K16 specific);histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase complex;histone H4-K5 acetylation;MLL1 complex;histone H4-K16 acetylation;protein binding;histone H4-K8 acetylation;nucleus:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
D13415@200337@200345@deletion@9@44399690@44415161@17@chr17:44399690-44415161@17.4@148@52@0.351@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A-001_7, LRRC37A-001_8, LRRC37A-001_9, LRRC37A-001_10, LRRC37A-001_11, LRRC37A-001_12, LRRC37A-001_13, LRRC37A-001_14, LRRC37A-001_15@153.666666666667@114@196@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
D13415@200361@200363@duplication@3@44632520@44633017@17@chr17:44632520-44633017@6.94@218@333@1.53@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2-201_12, LRRC37A2-201_13, LRRC37A2-201_14@89.6666666666667@74@98@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
D13415@213493@213494@deletion@2@14508472@14508748@19@chr19:14508472-14508748@14.2@111@27@0.243@NA@CD97-205_8, CD97-205_9@10.5@7@14@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
D13415@213635@213635@deletion@1@14877792@14877922@19@chr19:14877792-14877922@8.16@70@19@0.271@NA@EMR2-209_6@4@4@4@:egf-like module containing, mucin-like, hormone receptor-like 2@:transmembrane signaling receptor activity;inflammatory response;G-protein coupled receptor activity;ruffle membrane;integral to membrane;plasma membrane;cell surface receptor signaling pathway;neuropeptide signaling pathway;granulocyte chemotaxis;cell migration;leading edge membrane;G-protein coupled receptor signaling pathway;protein binding;cell adhesion;membrane;calcium ion binding;chondroitin sulfate binding@NA
D13415@217293@217297@deletion@5@40373947@40382827@19@chr19:40373947-40382827@18.7@393@214@0.545@CNVR7639.2@FCGBP-201_22, FCGBP-201_23, FCGBP-201_24, FCGBP-201_25, FCGBP-201_26@130.8@105@155@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D13415@217304@217305@duplication@2@40395806@40398511@19@chr19:40395806-40398511@6.12@136@215@1.58@CNVR7639.2, CNVR7639.3@FCGBP-201_14, FCGBP-201_15@127@127@127@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D13415@217595@217596@deletion@2@41327389@41328318@19@chr19:41327389-41328318@8.26@100@40@0.4@NA@CYP2F1P-001_4, CYP2F1P-001_5@0@0@0@NA@NA@NA
D13415@218131@218186@duplication@56@43348413@43719532@19@chr19:43348413-43719532@189@8593@12936@1.51@CNVR7658.2@PSG1-202_1, PSG1-202_2, PSG1-202_3, PSG1-202_4, PSG1-202_5, PSG1-202_6, PSG1-202_7, PSG6-001_1, PSG6-001_2, PSG6-001_3, PSG6-001_4, PSG6-001_5, PSG6-001_6, PSG7-001_1, PSG7-001_2, PSG7-001_3, PSG7-001_4, PSG7-001_5, PSG7-001_6, CEACAMP7-001_1, CEACAMP7-001_2, PSG11-001_1, PSG11-001_2, PSG11-001_3, PSG11-001_4, PSG11-001_5, PSG11-001_6, CEACAMP8-001_1, CEACAMP8-001_2, CEACAMP8-001_3, PSG2-001_1, PSG2-001_2, PSG2-001_3, PSG2-001_4, PSG2-001_5, PSG2-001_6, CEACAMP9-001_1, CEACAMP9-001_2, AC005392-001_1, AC005392-001_2, PSG5-201_1, PSG5-201_2, PSG5-201_3, PSG5-201_4, PSG5-201_5, PSG5-201_6, PSG5-201_7, PSG4-001_1, PSG4-001_2, PSG4-001_3, PSG4-001_4, PSG4-001_5, PSG4-001_6, CEACAMP10-001_8, CEACAMP10-001_9@12.7090909090909@1@41@:pregnancy specific beta-1-glycoprotein 8:pregnancy specific beta-1-glycoprotein 1:pregnancy specific beta-1-glycoprotein 6:pregnancy specific beta-1-glycoprotein 7 (gene/pseudogene):pregnancy specific beta-1-glycoprotein 11:pregnancy specific beta-1-glycoprotein 2:pregnancy specific beta-1-glycoprotein 5:pregnancy specific beta-1-glycoprotein 4:pregnancy specific beta-1-glycoprotein 9@:protein binding;extracellular region:protein binding;extracellular region;female pregnancy:protein binding;extracellular region;female pregnancy;molecular_function:protein binding;extracellular region;female pregnancy:protein binding;extracellular region;female pregnancy;cell migration;molecular_function;cellular_component:protein binding;extracellular region;female pregnancy:protein binding;extracellular region;female pregnancy;defense response:protein binding;extracellular region;female pregnancy;defense response@NA
D13415@220942@220945@deletion@4@53785379@53788201@19@chr19:53785379-53788201@8.44@771@519@0.673@NA@AC092070-202_2, AC092070-202_3, AC092070-202_4, AC092070-202_5@0.25@0@1@NA@NA@NA
D13415@221177@221177@deletion@1@54743779@54743828@19@chr19:54743779-54743828@6.45@79@30@0.38@CNVR7721.3, CNVR7721.6@LILRA6-002_7@48@48@48@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D13415@221218@221224@deletion@7@54801929@54804722@19@chr19:54801929-54804722@205@1177@1@0.00085@CNVR7722.1@LILRA3-003_4, LILRA3-003_5, LILRA3-003_6, LILRA3-003_7, LILRA3-003_8, LILRA3-003_9, LILRA3-003_10@105.857142857143@90@109@:leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3@:antigen binding;signal transduction;protein binding;extracellular region;plasma membrane;receptor activity;defense response@NA
D13415@221317@221319@deletion@3@55105115@55105942@19@chr19:55105115-55105942@6.38@225@135@0.6@NA@LILRA1-001_1, LILRA1-001_2, LILRA1-001_3@1@1@1@:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1@:interferon-gamma secretion;defense response to virus;dendritic cell differentiation;negative regulation of interferon-gamma production;regulation of immune response;negative regulation of dendritic cell differentiation;HLA-A specific inhibitory MHC class I receptor activity;negative regulation of alpha-beta T cell activation;negative regulation of transforming growth factor-beta secretion;negative regulation of interleukin-10 secretion;T cell proliferation involved in immune response;plasma membrane;negative regulation of mononuclear cell proliferation;positive regulation of gamma-delta T cell activation involved in immune response;negative regulation of interferon-beta secretion;negative regulation of calcium ion transport;response to virus;negative regulation of serotonin secretion;negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell;cellular response to lipopolysaccharide;negative regulation of cell cycle;positive regulation of cytolysis;negative regulation of T cell mediated cytotoxicity;positive regulation of defense response to virus by host;MHC class I receptor activity;negative regulation of natural killer cell mediated cytotoxicity;negative regulation of dendritic cell apoptotic process;negative regulation of T cell proliferation;negative regulation of CD8-positive, alpha-beta T cell activation;immune response-inhibiting cell surface receptor signaling pathway;Fc receptor mediated inhibitory signaling pathway;negative regulation of cytokine secretion involved in immune response;SH2 domain binding;negative regulation of interleukin-12 secretion;HLA-B specific inhibitory MHC class I receptor activity;negative regulation of osteoclast development;integral to membrane;interferon-gamma production;MHC class I protein binding;protein homodimerization activity;positive regulation of transcription from RNA polymerase II promoter;protein phosphatase 1 binding;positive regulation of gene expression;external side of plasma membrane;receptor internalization;cytoplasm;negative regulation of tumor necrosis factor biosynthetic process;protein binding;signal transduction;negative regulation of interferon-gamma biosynthetic process;negative regulation of endocytosis;positive regulation of apoptotic process:transmembrane signaling receptor activity;regulation of immune response;antigen binding;protein binding;integral to membrane;plasma membrane;defense response;cell surface receptor signaling pathway@NA
D13415@221396@221413@deletion@18@55266477@55290115@19@chr19:55266477-55290115@56.4@2241@1314@0.586@CNVR7725.2, CNVR7725.1@KIR2DL3-201_5, KIR2DL3-201_6, KIR2DL3-201_7, KIR2DL3-201_8, KIR2DP1-001_1, KIR2DP1-001_2, KIR2DP1-001_3, KIR2DP1-001_4, KIR2DP1-001_5, KIR2DP1-001_6, KIR2DP1-001_7, KIR2DP1-001_8, KIR2DP1-001_9, KIR2DL1-002_1, KIR2DL1-002_2, KIR2DL1-002_3, KIR2DL1-002_4, KIR2DL1-002_5@108.277777777778@76@126@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
D13415@221872@221872@duplication@1@56530710@56530765@19@chr19:56530710-56530765@6.34@311@481@1.55@NA@NLRP5-001_5@1@1@1@:NLR family, pyrin domain containing 5@:fertilization;mitochondrion;regulation of protein stability;regulation of RNA stability;embryo implantation;in utero embryonic development;protein complex;ATP binding;apical cortex;cell cortex;cytosol;protein binding;nucleolus;cellular protein complex assembly;organ morphogenesis@NA
D13415@222068@222069@deletion@2@58003184@58003369@19@chr19:58003184-58003369@7.17@69@24@0.348@CNVR7748.1@ZNF419-202_5, ZNF419-202_6@0@0@0@:zinc finger protein 419@:intracellular;DNA binding;regulation of transcription, DNA-dependent;cytoplasm;nucleolus;nucleus;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding@NA
D13415@222563@222563@deletion@1@1569208@1569279@20@chr20:1569208-1569279@5.57@25@0@0@CNVR7763.1@SIRPB1-201_1@128@128@128@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
D13415@223373@223374@duplication@2@9424630@9424891@20@chr20:9424630-9424891@4.98@132@200@1.52@NA@PLCB4-204_30, PLCB4-204_31@0@0@0@:phospholipase C, beta 4@:mitogen-activated protein kinase binding;phospholipase C activity;nucleus;phosphoric diester hydrolase activity;dendrite;smooth endoplasmic reticulum;intracellular signal transduction;intracellular;negative regulation of potassium ion transport;postsynaptic density;phosphatidylinositol phospholipase C activity;lipid metabolic process;signal transducer activity;cytosol;signal transduction;protein binding;lipid catabolic process;calcium ion binding@: AURICULOCONDYLAR SYNDROME 2; ARCND2
D13415@227604@227604@deletion@1@55099948@55100114@20@chr20:55099948-55100114@7.29@226@117@0.518@NA@C20orf106-002_3@0@0@0@:glucosaminyl (N-acetyl) transferase family member 7:family with sequence similarity 209, member A@:integral to membrane;protein glycosylation;acetylglucosaminyltransferase activity;Golgi membrane;membrane:integral to membrane@NA
D13415@228630@228633@duplication@4@62369176@62369414@20@chr20:62369176-62369414@11.3@288@448@1.56@CNVR7933.1@ZGPAT-012_9, ZGPAT-012_10, LIME1-201_3, LIME1-201_4@32@30@34@:zinc finger, CCCH-type with G patch domain:Lck interacting transmembrane adaptor 1@:sequence-specific DNA binding;negative regulation of transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity;protein binding;nucleus;transcription, DNA-dependent;negative regulation of epidermal growth factor-activated receptor activity;zinc ion binding;nucleic acid binding:regulation of I-kappaB kinase/NF-kappaB cascade;regulation of NF-kappaB import into nucleus;protein kinase binding;regulation of transcription from RNA polymerase II promoter;B cell receptor complex;growth factor receptor binding;T cell receptor signaling pathway;B cell receptor signaling pathway;regulation of MAP kinase activity;integral to membrane;regulation of release of sequestered calcium ion into cytosol;regulation of phosphatidylinositol 3-kinase cascade@NA
D13415@228876@228880@duplication@5@14417486@14421351@21@chr21:14417486-14421351@5.94@330@448@1.36@NA@ANKRD30B-001_4, ANKRD30B-001_5, ANKRD30B-001_6, AP001464-201_2, AP001464-201_3@1.4@1@2@NA@NA@NA
D13415@232771@232783@deletion@13@20385728@20398724@22@chr22:20385728-20398724@14.9@134@48@0.358@CNVR8094.9, CNVR8094.4, CNVR8094.10@PI4KAP1-204_2, PI4KAP1-204_3, PI4KAP1-204_4, PI4KAP1-204_5, PI4KAP1-204_6, PI4KAP1-204_7, PI4KAP1-204_8, PI4KAP1-204_9, PI4KAP1-204_10, PI4KAP1-204_11, PI4KAP1-204_12, PI4KAP1-204_13, PI4KAP1-204_14@166.538461538462@155@172@NA@NA@NA
D13415@233701@233701@duplication@1@24284790@24284986@22@chr22:24284790-24284986@9.19@89@199@2.24@CNVR8114.6, CNVR8114.10, CNVR8114.12, CNVR8114.13@ENST00000443377_3@125@125@125@NA@NA@NA
D13415@233729@233754@deletion@26@24342271@24394850@22@chr22:24342271-24394850@226@1151@14@0.0122@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTTP1-001_1, GSTTP1-001_2, GSTTP1-001_3, GSTTP1-001_4, ENST00000421902_1, ENST00000421902_2, ENST00000448902_1, ENST00000448902_2, ENST00000448902_3, ENST00000448902_4, ENST00000448902_5, ENST00000329210_1, ENST00000329210_2, ENST00000329210_3, ENST00000329210_4, ENST00000439866_1, ENST00000439866_2, GSTT1-009_1, GSTT1-009_2, GSTT1-009_3, GSTT1-009_4, GSTT1-009_5, ENST00000439996_1, ENST00000439996_2, GSTTP2-001_4, GSTTP2-001_5@123.730769230769@35@149@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
D13415@236124@236130@deletion@7@39358105@39385616@22@chr22:39358105-39385616@28.6@761@407@0.535@CNVR8164.1@APOBEC3A-001_5, APOBEC3A-001_6, APOBEC3B-003_1, APOBEC3B-003_2, APOBEC3B-003_3, APOBEC3B-003_4, APOBEC3B-003_5@34.2857142857143@19@37@:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A;APOBEC3A and APOBEC3B deletion hybrid:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B@:cytidine deamination;defense response to virus;negative regulation of viral genome replication;DNA cytosine deamination;clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine;catalytic activity;DNA demethylation;cytoplasm;innate immune response;cytidine deaminase activity;nucleus;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;cellular response to xenobiotic stimulus;zinc ion binding;negative regulation of transposition:RNA binding;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;negative regulation of transposition;catalytic activity;zinc ion binding@NA
D13415@236814@236820@duplication@7@42905036@42910786@22@chr22:42905036-42910786@26.3@671@1089@1.62@CNVR8171.2, CNVR8171.3@SERHL-001_8, SERHL-001_9, SERHL-001_10, SERHL-001_11, RRP7A-001_5, RRP7A-001_6, RRP7A-001_7@41.1428571428571@38@43@:ribosomal RNA processing 7 homolog A (S. cerevisiae)@:RNA binding;nucleotide binding@NA
D13415@236822@236825@duplication@4@42912019@42950049@22@chr22:42912019-42950049@14.6@397@623@1.57@CNVR8171.2, CNVR8171.3@RRP7A-001_1, RRP7A-001_2, RRP7A-001_3, SERHL2-203_1@31.25@26@35@:ribosomal RNA processing 7 homolog A (S. cerevisiae):serine hydrolase-like 2@:RNA binding;nucleotide binding:hydrolase activity;mitochondrion;peroxisome;cytoplasmic membrane-bounded vesicle;molecular_function;cellular_component;perinuclear region of cytoplasm;biological_process@NA
D13415@236832@236840@deletion@9@42956194@42972616@22@chr22:42956194-42972616@31.3@609@304@0.499@CNVR8171.3, CNVR8171.1@SERHL2-203_8, SERHL2-203_9, SERHL2-203_10, SERHL2-203_11, SERHL2-203_12, RRP7B-203_5, RRP7B-203_6, RRP7B-203_7, RRP7B-203_8@10.1111111111111@7@12@:serine hydrolase-like 2@:hydrolase activity;mitochondrion;peroxisome;cytoplasmic membrane-bounded vesicle;molecular_function;cellular_component;perinuclear region of cytoplasm;biological_process@NA
D146989@593@593@deletion@1@1607505@1607639@1@chr1:1607505-1607639@7.09@37@3@0.0811@CNVR17.1@RP11-345P4-003_4@10@10@10@:solute carrier family 35, member E2B@:integral to membrane;membrane;transmembrane transport@NA
D146989@2889@2892@deletion@4@16891304@16893847@1@chr1:16891304-16893847@8.05@227@135@0.595@CNVR93.3, CNVR93.6, CNVR93.11@NBPF1-201_25, NBPF1-201_26, NBPF1-201_27, NBPF1-201_28@76.75@74@79@NA@NA@NA
D146989@2952@2958@deletion@7@17014873@17028191@1@chr1:17014873-17028191@8.08@1208@869@0.719@CNVR93.3, CNVR93.15, CNVR93.4@RP1-163M9-001_1, ESPNP-002_7, ESPNP-002_8, ESPNP-002_9, ESPNP-002_10, ESPNP-002_11, AL021920-201_1@45@43@46@NA@NA@NA
D146989@2999@3021@duplication@23@17198306@17275020@1@chr1:17198306-17275020@36.6@2181@2987@1.37@CNVR94.4, CNVR94.5@ENST00000356370_1, ENST00000438002_1, ENST00000438002_2, ENST00000457075_1, ENST00000457075_2, CROCC-201_1, CROCC-201_2, CROCC-201_3, CROCC-201_4, CROCC-201_5, CROCC-201_6, CROCC-201_7, CROCC-201_8, CROCC-201_9, CROCC-201_10, CROCC-201_11, CROCC-201_12, CROCC-201_13, CROCC-201_14, CROCC-201_15, CROCC-201_16, CROCC-201_17, CROCC-201_18@66.8260869565217@20@85@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
D146989@3779@3779@deletion@1@21809638@21809812@1@chr1:21809638-21809812@6.31@49@14@0.286@CNVR107.2, CNVR107.1@NBPF3-003_19@111@111@111@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 3@:cytoplasm@NA
D146989@6746@6746@duplication@1@39987050@39987243@1@chr1:39987050-39987243@8.85@21@83@3.95@NA@BMP8A-001_4@53@53@53@:bone morphogenetic protein 8a@:cell differentiation;growth factor activity;extracellular space;growth;cytokine activity;cartilage development;ossification@NA
D146989@11245@11246@deletion@2@89476589@89477711@1@chr1:89476589-89477711@8.02@528@350@0.663@CNVR244.1@GBP3-001_7, GBP3-001_8@54@54@54@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
D146989@12416@12425@deletion@10@104202984@104234233@1@chr1:104202984-104234233@22.8@158@36@0.228@CNVR266.3, CNVR266.1, CNVR266.15@AMY1A-001_7, AMY1A-001_8, AMY1A-001_9, AMY1A-001_10, AMY1A-001_11, AMY1B-001_7, AMY1B-001_8, AMY1B-001_9, AMY1B-001_10, AMY1B-001_11@123.8@109@154@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D146989@12929@12936@deletion@8@110230474@110236368@1@chr1:110230474-110236368@100@469@3@0.0064@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1-001_1, GSTM1-001_2, GSTM1-001_3, GSTM1-001_4, GSTM1-001_5, GSTM1-001_6, GSTM1-001_7, GSTM1-001_8@191.375@187@194@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
D146989@16280@16280@deletion@1@152573269@152573493@1@chr1:152573269-152573493@20.3@95@0@0@CNVR358.1@LCE3C-201_2@102@102@102@:late cornified envelope 3C@:keratinization@NA
D146989@21362@21374@duplication@13@196743977@196801320@1@chr1:196743977-196801320@56.8@1728@2584@1.5@CNVR459.1@CFHR3-001_1, CFHR3-001_2, CFHR3-001_3, CFHR3-001_4, CFHR3-001_5, CFHR3-001_6, CFHR1-001_1, CFHR1-001_2, CFHR1-001_3, CFHR1-001_4, CFHR1-001_5, CFHR1-001_6, CFHR2-201_1@96.7692307692308@85@119@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
D146989@23512@23513@deletion@2@213003485@213009530@1@chr1:213003485-213009530@12.7@218@103@0.472@CNVR498.1@C1orf227-001_2, C1orf227-001_3@7.5@7@8@:chromosome 1 open reading frame 227@NA@NA
D146989@24160@24164@duplication@5@223727670@223729472@1@chr1:223727670-223729472@6.85@75@134@1.79@NA@CAPN8-202_20, CAPN8-202_21, CAPN8-202_22, CAPN8-202_23, CAPN8-202_24@0@0@0@:calpain 8@:proteolysis;Golgi apparatus;intracellular;calcium-dependent cysteine-type endopeptidase activity;calcium ion binding@NA
D146989@24169@24169@deletion@1@223740182@223740201@1@chr1:223740182-223740201@6.32@28@0@0@NA@CAPN8-202_15@0@0@0@:calpain 8@:proteolysis;Golgi apparatus;intracellular;calcium-dependent cysteine-type endopeptidase activity;calcium ion binding@NA
D146989@26211@26211@deletion@1@245006345@245006555@1@chr1:245006345-245006555@15.5@250@107@0.428@NA@FAM36A-005_5@0@0@0@:COX20 Cox2 chaperone homolog (S. cerevisiae)@:mitochondrion;integral to membrane;mitochondrial membrane@NA
D146989@33560@33560@deletion@1@87408191@87408267@2@chr2:87408191-87408267@9.47@76@21@0.276@CNVR861.2@AC083899-001_24@85@85@85@NA@NA@NA
D146989@33582@33582@deletion@1@88003854@88004120@2@chr2:88003854-88004120@6.51@142@76@0.535@CNVR861.3@AC093616-001_2@45@45@45@NA@NA@NA
D146989@34210@34213@deletion@4@96696494@96698114@2@chr2:96696494-96698114@9.26@133@63@0.474@NA@GPAT2-205_3, GPAT2-205_4, GPAT2-205_5, GPAT2-205_6@75.75@69@83@:glycerol-3-phosphate acyltransferase 2, mitochondrial@:glycerol-3-phosphate O-acyltransferase activity;mitochondrion;phospholipid metabolic process;triglyceride biosynthetic process;glycerophospholipid biosynthetic process;small molecule metabolic process;transferase activity, transferring acyl groups;mitochondrial outer membrane;phosphatidic acid biosynthetic process;integral to membrane;glycerol-3-phosphate metabolic process;CDP-diacylglycerol biosynthetic process;membrane;metabolic process;phospholipid biosynthetic process@NA
D146989@37242@37242@deletion@1@130955933@130956035@2@chr2:130955933-130956035@8.05@36@0@0@CNVR985.1@TUBA3E-001_1@27@27@27@:tubulin, alpha 3e@:GTPase activity;structural constituent of cytoskeleton;protein complex;GTP catabolic process;cytoplasm;microtubule cytoskeleton;protein polymerization;microtubule-based movement;structural molecule activity;cytoplasmic microtubule;GTP binding;microtubule;microtubule cytoskeleton organization;protein domain specific binding@NA
D146989@47427@47427@deletion@1@10030398@10030433@3@chr3:10030398-10030433@10.3@64@11@0.172@NA@AC034193-002_3@8@8@8@:ER membrane protein complex subunit 3@:ER membrane protein complex;integral to membrane;molecular_function;membrane;cellular_component;biological_process@NA
D146989@61657@61659@deletion@3@195712500@195712661@3@chr3:195712500-195712661@8.87@56@11@0.196@CNVR1707.1, CNVR1707.2@SDHALP1-002_3, ENST00000354937_4, ENST00000354937_5@63.6666666666667@63@64@NA@NA@NA
D146989@65315@65320@duplication@6@69402904@69434246@4@chr4:69402904-69434246@27.4@1080@1581@1.46@CNVR1953.1@UGT2B17-001_1, UGT2B17-001_2, UGT2B17-001_3, UGT2B17-001_4, UGT2B17-001_5, UGT2B17-001_6@124.5@118@134@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
D146989@65799@65799@deletion@1@75312253@75312500@4@chr4:75312253-75312500@6.57@106@51@0.481@NA@AREG-001_2@28@28@28@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
D146989@69769@69769@duplication@1@165890632@165891492@4@chr4:165890632-165891492@4.85@211@300@1.42@NA@TRIM61-201_3@0@0@0@:tripartite motif containing 61@:protein binding;intracellular;zinc ion binding@NA
D146989@70687@70688@duplication@2@190945524@190947617@4@chr4:190945524-190947617@9.17@712@975@1.37@CNVR2258.3@FRG2-201_3, FRG2-201_4@20.5@15@26@:FSHD region gene 2-like;FSHD region gene 2@:nucleus@NA
D146989@70817@70822@duplication@6@716925@748675@5@chr5:716925-748675@59.5@1412@2357@1.67@CNVR2280.3@ZDHHC11B-201_5, ZDHHC11B-201_6, ZDHHC11B-201_7, ZDHHC11B-201_8, ZDHHC11B-201_9, ZDHHC11B-201_10@73@52@96@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
D146989@70827@70837@deletion@11@795876@837596@5@chr5:795876-837596@367@2545@355@0.139@CNVR2280.3@ZDHHC11-201_6, ZDHHC11-201_7, ZDHHC11-201_8, ZDHHC11-201_9, ZDHHC11-201_10, ZDHHC11-201_11, ZDHHC11-201_12, AC026740-202_1, AC026740-202_2, AC026740-202_3, AC026740-202_4@42.3636363636364@29@57@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
D146989@71895@71901@deletion@7@34182208@34194311@5@chr5:34182208-34194311@42.6@485@169@0.348@CNVR2430.2, CNVR2430.1, CNVR2430.3@AC138409-202_6, ENST00000380721_1, ENST00000502234_1, ENST00000502234_2, AC138409-201_1, AC138409-201_2, AC138409-201_3@42@22@49@NA@NA@NA
D146989@73705@73706@deletion@2@69372350@69373420@5@chr5:69372350-69373420@23.2@109@0@0@CNVR2494.48, CNVR2494.39, CNVR2494.15, CNVR2494.18, CNVR2494.26, CNVR2494.43, CNVR2494.52, CNVR2494.28, CNVR2494.2, CNVR2494.36, CNVR2494.53@SMN2-001_8, SMN2-001_9@10@8@12@:survival of motor neuron 2, centromeric;survival of motor neuron 1, telomeric@:nucleoplasm;ncRNA metabolic process;Cajal body;RNA metabolic process;spliceosomal complex;cytoplasm;cytosol;protein binding;cell death;spliceosomal complex assembly;RNA binding;mRNA processing;nucleus;gene expression;spliceosomal snRNP assembly@: SPINAL MUSCULAR ATROPHY, TYPE II; SMA2; SPINAL MUSCULAR ATROPHY, TYPE I; SMA1; SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4; SPINAL MUSCULAR ATROPHY, TYPE III; SMA3
D146989@73727@73727@deletion@1@69717564@69717599@5@chr5:69717564-69717599@13.6@63@0@0@CNVR2494.17, CNVR2494.3@GTF2H2B-201_4@139@139@139@NA@NA@NA
D146989@73817@73821@deletion@5@70370032@70389020@5@chr5:70370032-70389020@33@154@1@0.00649@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.8, CNVR2494.1, CNVR2494.37@AC044797-201_1, AC044797-201_2, AC044797-201_3, AC044797-201_4, AC044797-201_5@120.4@100@138@NA@NA@NA
D146989@78044@78044@deletion@1@147553799@147553934@5@chr5:147553799-147553934@25.3@121@1@0.00826@CNVR2637.2, CNVR2637.1@AC116334-001_3@78@78@78@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
D146989@79567@79570@deletion@4@175388056@175394271@5@chr5:175388056-175394271@8.82@199@116@0.583@NA@THOC3-001_2, THOC3-001_3, THOC3-001_4, THOC3-001_5@105@27@182@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
D146989@79583@79583@deletion@1@175528556@175528585@5@chr5:175528556-175528585@8.23@120@54@0.45@NA@FAM153B-201_12@6@6@6@:uncharacterized LOC100507387;family with sequence similarity 153, member B@NA@NA
D146989@80022@80024@duplication@3@177166603@177168334@5@chr5:177166603-177168334@9.09@89@165@1.85@NA@FAM153A-204_7, FAM153A-204_8, FAM153A-204_9@94@86@106@:family with sequence similarity 153, member A@NA@NA
D146989@80564@80569@deletion@6@345856@367497@6@chr6:345856-367497@8.35@1447@1036@0.716@CNVR2728.1@DUSP22-001_5, DUSP22-001_6, DUSP22-001_7, DUSP22-001_8, AL357054-201_1, AL357054-201_2@13.5@6@19@:dual specificity phosphatase 22;dual specificity protein phosphatase 22-like@:protein dephosphorylation;transforming growth factor beta receptor signaling pathway;positive regulation of JNK cascade;protein tyrosine/serine/threonine phosphatase activity;nucleus;apoptotic process;multicellular organismal development;phosphatase activity;protein tyrosine phosphatase activity;regulation of cell proliferation;cytoplasm;cell proliferation;inactivation of MAPK activity;protein binding;negative regulation of transcription from RNA polymerase II promoter;dephosphorylation@NA
D146989@83002@83003@duplication@2@31237745@31238263@6@chr6:31237745-31238263@15.3@353@562@1.59@CNVR2838.2, CNVR2838.1@HLA-C-006_4, HLA-C-006_5@25@25@25@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
D146989@83026@83026@duplication@1@31379726@31380003@6@chr6:31379726-31380003@4.85@145@215@1.48@CNVR2842.1@MICA-001_6@1@1@1@:MHC class I polypeptide-related sequence A@:MHC class I protein complex;protein binding;regulation of immune response;antigen processing and presentation;immune response;plasma membrane;membrane@: PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO; PSORIASIS SUSCEPTIBILITY 1; PSORS1
D146989@83577@83617@deletion@41@31962024@31976177@6@chr6:31962024-31976177@388@1855@23@0.0124@CNVR2843.6, CNVR2843.3@C4A-001_20, C4A-001_21, C4A-001_22, C4A-001_23, C4A-001_24, C4A-001_25, C4A-001_26, C4A-001_27, C4A-001_28, C4A-001_29, C4A-001_30, C4A-001_31, C4A-001_32, C4A-001_33, C4A-001_34, C4A-001_35, C4A-001_36, C4A-001_37, C4A-001_38, C4A-001_39, C4A-001_40, C4A-001_41, ENST00000458633_1, ENST00000458633_2, CYP21A1P-001_1, CYP21A1P-001_2, CYP21A1P-001_3, CYP21A1P-001_4, CYP21A1P-001_5, CYP21A1P-001_6, CYP21A1P-001_7, CYP21A1P-001_8, CYP21A1P-001_9, CYP21A1P-001_10, AL645922-201_1, AL645922-201_2, AL645922-201_3, AL645922-201_4, AL645922-201_5, AL645922-201_6, AL645922-201_7@48.1463414634146@2@121@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
D146989@83638@83645@duplication@8@31995015@31997116@6@chr6:31995015-31997116@7.3@298@410@1.38@CNVR2843.6, CNVR2843.5@C4B-001_21, C4B-001_22, C4B-001_23, C4B-001_24, C4B-001_25, C4B-001_26, C4B-001_27, C4B-001_28@14@10@19@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
D146989@83911@83923@deletion@13@32485122@32525964@6@chr6:32485122-32525964@45.8@477@185@0.388@CNVR2845.21, CNVR2845.25, CNVR2845.43, CNVR2845.24@HLA-DRB5-001_1, HLA-DRB5-001_2, HLA-DRB5-001_3, HLA-DRB5-001_4, HLA-DRB5-001_5, HLA-DRB5-001_6, HLA-DRB6-002_2, HLA-DRB6-002_3, HLA-DRB6-002_4, HLA-DRB6-002_5, HLA-DRB6-002_6, AL713966-201_2, AL713966-201_3@156.076923076923@114@189@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D146989@83928@83928@duplication@1@32548525@32548634@6@chr6:32548525-32548634@6.5@78@142@1.82@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.5, CNVR2845.4@HLA-DRB1-001_4@56@56@56@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
D146989@83932@83946@deletion@15@32605206@32634448@6@chr6:32605206-32634448@123@1080@349@0.323@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20@HLA-DQA1-002_1, HLA-DQA1-002_2, HLA-DQA1-002_3, HLA-DQA1-002_4, HLA-DQA1-002_5, HLA-DQA1-002_6, HLA-DQB1-003_2, HLA-DQB1-003_3, HLA-DQB1-003_4, HLA-DQB1-003_5, HLA-DQB1-003_6, XXbac-BPG254F23-001_1, XXbac-BPG254F23-001_2, ENST00000443574_1, ENST00000443574_2@120@80@146@:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
D146989@84706@84710@duplication@5@35754777@35765089@6@chr6:35754777-35765089@7.11@1030@1315@1.28@CNVR2861.1@C6orf127-001_2, C6orf127-001_3, CLPS-001_1, CLPS-001_2, CLPS-001_3@39@30@43@:colipase-like 1:colipase, pancreatic@:extracellular region;enzyme activator activity;digestion;lipid catabolic process:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
D146989@92589@92594@deletion@6@160132299@160133143@6@chr6:160132299-160133143@47.6@608@253@0.416@CNVR3127.2, CNVR3127.1@ENST00000442642_3, ENST00000442642_4, ENST00000442642_5, ENST00000442642_6, ENST00000442642_7, ENST00000442642_8@95.6666666666667@56@112@:superoxide dismutase 2, mitochondrial;uncharacterized LOC100129518@:response to reactive oxygen species;oxidation-reduction process;mitochondrion;negative regulation of cell proliferation;neuron development;negative regulation of fat cell differentiation;removal of superoxide radicals;response to gamma radiation;response to L-ascorbic acid;response to lipopolysaccharide;response to nutrient levels;response to zinc ion;protein homotetramerization;post-embryonic development;iron ion homeostasis;hemopoiesis;aging;mitochondrial inner membrane;age-dependent response to reactive oxygen species;response to drug;oxygen binding;mitochondrial nucleoid;vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure;apoptotic process;superoxide metabolic process;response to superoxide;detection of oxygen;response to silicon dioxide;cytoplasm;response to stress;respiratory electron transport chain;superoxide anion generation;protein homooligomerization;regulation of mitochondrial membrane potential;positive regulation of nitric oxide biosynthetic process;response to manganese ion;regulation of blood pressure;metal ion binding;negative regulation of apoptotic process;response to cadmium ion;response to oxidative stress;liver development;regulation of catalytic activity;negative regulation of fibroblast proliferation;response to selenium ion;age-dependent response to oxidative stress;response to electrical stimulus;mitochondrial matrix;identical protein binding;mitochondrion organization;response to hyperoxia;vasodilation;response to hydrogen peroxide;superoxide dismutase activity;heart development;negative regulation of neuron apoptotic process;erythrophore differentiation;locomotory behavior;DNA binding;release of cytochrome c from mitochondria;response to axon injury;oxygen homeostasis;response to activity;glutathione metabolic process;hydrogen peroxide metabolic process;hydrogen peroxide biosynthetic process;regulation of transcription from RNA polymerase II promoter;response to hypoxia;protein binding;manganese ion binding;cellular response to ethanol@: MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6; MVCD6
D146989@93099@93099@deletion@1@167790036@167790193@6@chr6:167790036-167790193@5.2@25@1@0.04@NA@TCP10-001_5@103@103@103@:t-complex 10@:cytosol@NA
D146989@94200@94202@deletion@3@5982957@5984810@7@chr7:5982957-5984810@7.8@320@201@0.628@NA@RSPH10B-002_13, RSPH10B-002_14, RSPH10B-002_15@11@9@14@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D146989@94208@94208@duplication@1@5998626@5998710@7@chr7:5998626-5998710@6.48@195@294@1.51@NA@RSPH10B-002_7@11@11@11@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D146989@94431@94432@duplication@2@6820442@6821108@7@chr7:6820442-6821108@11.5@302@461@1.53@NA@RSPH10B2-204_14, RSPH10B2-204_15@17.5@16@19@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D146989@94438@94438@deletion@1@6836201@6836398@7@chr7:6836201-6836398@7.36@79@30@0.38@NA@RSPH10B2-204_20@26@26@26@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D146989@94440@94444@duplication@5@6837996@6844687@7@chr7:6837996-6844687@21.7@327@559@1.71@NA@RSPH10B2-204_21, C7orf28B-001_12, C7orf28B-001_13, C7orf28B-001_14, C7orf28B-001_15@117@114@121@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D146989@94462@94463@deletion@2@6906510@6920188@7@chr7:6906510-6920188@8.07@228@133@0.583@NA@RP11-740N7-201_1, RP11-740N7-201_2@21@20@22@NA@NA@NA
D146989@97912@97917@deletion@6@57071006@57084498@7@chr7:57071006-57084498@7.56@70@26@0.371@NA@TNRC18C-202_8, TNRC18C-202_9, TNRC18C-202_10, TNRC18C-202_11, ENST00000398760_4, ENST00000398760_5@155.5@144@166@NA@NA@NA
D146989@98173@98174@deletion@2@64533487@64534227@7@chr7:64533487-64534227@7.13@41@6@0.146@NA@RP11-460N20-001_11, RP11-460N20-001_12, ENST00000501153_3@101@101@101@NA@NA@NA
D146989@99063@99063@deletion@1@74251404@74251506@7@chr7:74251404-74251506@6.52@29@0@0@NA@GTF2IRD2-002_2@8@8@8@:GTF2I repeat domain containing 2@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
D146989@99332@99332@duplication@1@75368121@75368266@7@chr7:75368121-75368266@5.69@126@198@1.57@NA@HIP1-001_1@3@3@3@:huntingtin interacting protein 1@:cell differentiation;phospholipid binding;binding;phosphatidylinositol binding;structural constituent of cytoskeleton;clathrin-coated vesicle;positive regulation of receptor-mediated endocytosis;induction of apoptosis;activation of cysteine-type endopeptidase activity involved in apoptotic process;nucleus;apoptotic process;clathrin-coated vesicle membrane;intracellular membrane-bounded organelle;endocytosis;Golgi apparatus;clathrin coat assembly;regulation of transcription, DNA-dependent;cytoplasm;actin binding;protein binding;clathrin binding;cytoskeleton;regulation of apoptotic process;transcription, DNA-dependent;membrane@NA
D146989@99465@99465@deletion@1@76129760@76129838@7@chr7:76129760-76129838@5.04@25@2@0.08@CNVR3462.1@DTX2-001_8@22@22@22@:deltex homolog 2 (Drosophila)@:ligase activity;cytoplasm;nuclear membrane;Notch signaling pathway;protein binding;nucleus;zinc ion binding;protein ubiquitination@NA
D146989@99489@99490@deletion@2@76240773@76241131@7@chr7:76240773-76241131@12.8@250@129@0.516@CNVR3463.10@POMZP3-003_6, POMZP3-003_7@43.5@41@46@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
D146989@99505@99512@duplication@8@76610141@76635093@7@chr7:76610141-76635093@10.3@352@502@1.43@CNVR3463.10@PMS2L11-203_1, PMS2L11-203_2, PMS2L11-203_3, PMS2L11-203_4, PMS2L11-203_5, PMS2L11-203_6, ENST00000428678_1, ENST00000428678_2@10.75@6@17@:uroplakin 3B@:negative regulation of gene expression;integral to membrane;plasma membrane@NA
D146989@99544@99545@duplication@2@76723321@76728269@7@chr7:76723321-76728269@12.5@106@215@2.03@NA@ENST00000398321_6, ENST00000398321_7@13.5@11@16@NA@NA@NA
D146989@101721@101726@deletion@6@100331652@100336237@7@chr7:100331652-100336237@16.1@773@495@0.64@CNVR3509.1@ZAN-001_2, ZAN-001_3, ZAN-001_4, ZAN-001_5, ZAN-001_6, ZAN-001_7@81.6666666666667@71@89@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
D146989@104579@104579@deletion@1@134221805@134221910@7@chr7:134221805-134221910@6.7@105@50@0.476@NA@AKR1B10-001_6@2@2@2@:aldo-keto reductase family 1, member B10 (aldose reductase)@:steroid metabolic process;cellular aldehyde metabolic process;indanol dehydrogenase activity;daunorubicin metabolic process;retinal dehydrogenase activity;farnesol catabolic process;geranylgeranyl reductase activity;protein binding;extracellular region;aldo-keto reductase (NADP) activity;digestion;doxorubicin metabolic process;cellular_component;lysosome@NA
D146989@105321@105342@deletion@22@141765517@141794298@7@chr7:141765517-141794298@59.3@2854@1829@0.641@CNVR3585.3, CNVR3585.2@MGAM-007_40, MGAM-007_41, MGAM-007_42, MGAM-007_43, MGAM-007_44, MGAM-007_45, MGAM-007_46, MGAM-007_47, MGAM-007_48, MGAM-007_49, MGAM-007_50, MGAM-007_51, MGAM-007_52, MGAM-007_53, MGAM-007_54, MGAM-007_55, MGAM-007_56, MGAM-007_57, MGAM-007_58, MGAM-007_59, MGAM-007_60, MGAM-007_61@112.772727272727@35@134@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
D146989@105798@105799@deletion@2@143975408@143975569@7@chr7:143975408-143975569@5.46@24@0@0@CNVR3598.4, CNVR3598.9@RP4-798C17-001_5, ENST00000378112_6@135@135@135@:Rho guanine nucleotide exchange factor (GEF) 35@NA@NA
D146989@107424@107437@deletion@14@7272384@7345700@8@chr8:7272384-7345700@30.8@742@433@0.584@CNVR3771.8, CNVR3771.10, CNVR3771.4@DEFB4P-001_1, DEFB4P-001_2, DEFB103A-001_1, DEFB103A-001_2, SPAG11-003_1, SPAG11-003_2, SPAG11-003_3, SPAG11-003_4, DEFB104B-001_1, DEFB104B-001_2, DEFB106B-001_1, DEFB106B-001_2, DEFB105B-001_1, DEFB105B-001_2@34.3571428571429@4@91@:defensin, beta 4B;defensin, beta 4A:defensin, beta 103B;defensin, beta 103A:sperm associated antigen 11B:defensin, beta 104A;defensin, beta 104B:defensin, beta 106B;defensin, beta 106A:defensin, beta 105B;defensin, beta 105A@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
D146989@107502@107516@deletion@15@7673083@7752293@8@chr8:7673083-7752293@91.1@821@260@0.317@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@DEFB107A-001_1, DEFB105A-001_1, DEFB105A-001_2, DEFB105A-001_3, DEFB106A-001_1, DEFB106A-001_2, DEFB104A-001_1, DEFB104A-001_2, SPAG11A-207_1, SPAG11A-207_2, SPAG11A-207_3, SPAG11A-207_4, DEFB103B-001_1, DEFB103B-001_2, DEFB4-001_1@56.5333333333333@40@113@:defensin, beta 107B;defensin, beta 107A:defensin, beta 105B;defensin, beta 105A:defensin, beta 106B;defensin, beta 106A:defensin, beta 104A;defensin, beta 104B:sperm associated antigen 11A;sperm associated antigen 11B:defensin, beta 103B;defensin, beta 103A:defensin, beta 4B;defensin, beta 4A@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response@NA
D146989@117601@117611@deletion@11@43816639@43876146@9@chr9:43816639-43876146@19.9@526@303@0.576@NA@CNTNAP3B-001_6, CNTNAP3B-001_7, CNTNAP3B-001_8, CNTNAP3B-001_9, CNTNAP3B-001_10, CNTNAP3B-001_11, CNTNAP3B-001_12, CNTNAP3B-001_13, CNTNAP3B-001_14, RP11-24B13-001_1, RP11-24B13-001_2@81.6363636363636@49@123@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
D146989@118854@118857@deletion@4@84545372@84560148@9@chr9:84545372-84560148@11.6@453@262@0.578@CNVR4364.1@ENST00000427387_1, RP11-383M4-201_4, ENST00000334208_1, ENST00000334208_2, ENST00000334208_3@20@17@27@NA@NA@NA
D146989@121600@121603@deletion@4@117085338@117087178@9@chr9:117085338-117087178@22.5@1456@946@0.65@CNVR4448.1@ORM1-001_1, ORM1-001_2, ORM1-001_3, ORM1-001_4@88.5@85@90@:orosomucoid 1@:protein binding;extracellular space;regulation of immune system process;transport;inflammatory response;extracellular region;acute-phase response@NA
D146989@124517@124517@duplication@1@138441156@138441178@9@chr9:138441156-138441178@5.34@77@132@1.71@CNVR4529.1@OBP2A-001_6@18@18@18@:odorant binding protein 2A@:odorant binding;sensory perception of chemical stimulus;response to stimulus;transport;extracellular region;sensory perception of smell;cellular_component@NA
D146989@126909@126916@deletion@8@17840632@17891769@10@chr10:17840632-17891769@24.5@573@326@0.569@NA@FAM23A-201_5, MRC1L1-001_1, MRC1L1-001_2, MRC1L1-001_3, MRC1L1-001_4, MRC1L1-001_5, MRC1L1-001_6, MRC1L1-001_7@23.5@6@108@:transmembrane protein 236;transmembrane protein 236-like:macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding@NA
D146989@126948@126953@duplication@6@18122630@18145282@10@chr10:18122630-18145282@17.9@213@392@1.84@NA@MRC1-001_4, MRC1-001_5, MRC1-001_6, MRC1-001_7, MRC1-001_8, MRC1-001_9@22.6666666666667@16@34@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D146989@127722@127722@deletion@1@29580856@29580936@10@chr10:29580856-29580936@4.61@50@20@0.4@NA@LYZL1-002_1@51@51@51@:lysozyme-like 1@:extracellular region;lysozyme activity;cell wall macromolecule catabolic process@NA
D146989@128913@128913@duplication@1@47409855@47410082@10@chr10:47409855-47410082@5.81@98@162@1.65@CNVR4712.9, CNVR4712.1@FAM35B2-201_6@47@47@47@NA@NA@NA
D146989@128979@128979@duplication@1@47758848@47758905@10@chr10:47758848-47758905@14.8@25@135@5.4@CNVR4714.1@ANXA8L2-001_10@154@154@154@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:calcium-dependent phospholipid binding;calcium ion binding@NA
D146989@129003@129007@duplication@5@47933809@47942085@10@chr10:47933809-47942085@7.94@26@80@3.08@CNVR4715.2, CNVR4715.1@FAM21B-201_20, FAM21B-201_21, FAM21B-201_22, FAM21B-201_23, FAM21B-201_24@175@165@185@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
D146989@129021@129028@deletion@8@48020452@48049022@10@chr10:48020452-48049022@21.9@413@215@0.521@CNVR4715.2@ASAH2C-201_3, ASAH2C-201_4, ASAH2C-201_5, ASAH2C-201_6, ASAH2C-201_7, ASAH2C-201_8, ASAH2C-201_9, ASAH2C-201_10@67.875@57@90@@:ceramidase activity;sphingolipid metabolic process@NA
D146989@129454@129461@duplication@8@51345755@51361911@10@chr10:51345755-51361911@9.73@34@100@2.94@NA@ENST00000404618_4, ENST00000404618_5, ENST00000404618_6, ENST00000404618_7, ENST00000432221_4, ENST00000432221_5, ENST00000432221_6, ENST00000432221_7@97.25@89@123@NA@NA@NA
D146989@129572@129586@deletion@15@51847037@51877819@10@chr10:51847037-51877819@11.9@55@1@0.0182@NA@FAM21A-005_8, FAM21A-005_9, FAM21A-005_10, FAM21A-005_11, FAM21A-005_12, FAM21A-005_13, FAM21A-005_14, FAM21A-005_15, FAM21A-005_16, FAM21A-005_17, FAM21A-005_18, FAM21A-005_19, FAM21A-005_20, FAM21A-005_21, FAM21A-005_22@105.933333333333@93@123@:family with sequence similarity 21, member B;family with sequence similarity 21, member A@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
D146989@129604@129609@duplication@6@51965744@51978391@10@chr10:51965744-51978391@19.4@151@309@2.05@NA@ASAH2-201_7, ASAH2-201_8, ASAH2-201_9, ASAH2-201_10, ASAH2-201_11, ASAH2-201_12@177.833333333333@161@186@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
D146989@136769@136770@deletion@2@135437401@135439504@10@chr10:135437401-135439504@8.53@657@443@0.674@CNVR4989.11, CNVR4989.4@FRG2B-202_3, FRG2B-202_4@23.5@18@29@:FSHD region gene 2 family, member B@:nucleus@NA
D146989@138032@138034@deletion@3@5270600@5274636@11@chr11:5270600-5274636@11.7@206@111@0.539@NA@HBG1-201_1, HBG1-201_2, HBG2-001_8@66@9@106@:hemoglobin, gamma A:hemoglobin, gamma G@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@: CYANOSIS, TRANSIENT NEONATAL; TNCY
D146989@150775@150775@deletion@1@9446260@9446507@12@chr12:9446260-9446507@16.8@78@0@0@NA@DDX11L8-201_2@42@42@42@NA@NA@NA
D146989@150778@150783@duplication@6@9450373@9454871@12@chr12:9450373-9454871@8.23@234@340@1.45@NA@DDX11L8-201_5, DDX11L8-201_6, DDX11L8-201_7, DDX11L8-201_8, DDX11L8-201_9, DDX11L8-201_10@67.8333333333333@55@78@NA@NA@NA
D146989@150785@150786@duplication@2@9456573@9456804@12@chr12:9456573-9456804@13.7@112@238@2.12@NA@DDX11L8-201_12, DDX11L8-201_13@85@83@87@NA@NA@NA
D146989@150818@150824@deletion@7@9582158@9589701@12@chr12:9582158-9589701@6.78@265@171@0.645@NA@DDX12-203_5, DDX12-203_6, DDX12-203_7, DDX12-203_8, DDX12-203_9, DDX12-203_10, DDX12-203_11@9.14285714285714@2@25@NA@NA@NA
D146989@150828@150841@deletion@14@9600580@9707352@12@chr12:9600580-9707352@115@612@53@0.0866@CNVR5429.1@DDX12-203_1, AC006432-201_1, AC006432-201_2, AC006432-201_3, AC006432-201_4, AC006432-201_5, AC006432-201_6, AC006432-201_7, AC006432-201_8, AC006432-201_9, AC006432-201_11, AC006432-201_12, AC006432-201_13@21.6153846153846@7@25@NA@NA@NA
D146989@151034@151034@duplication@1@11244393@11244793@12@chr12:11244393-11244793@5.56@410@566@1.38@CNVR5434.1@TAS2R31-201_2@72@72@72@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
D146989@152242@152273@duplication@32@31265928@31359089@12@chr12:31265928-31359089@62.3@4865@6463@1.33@CNVR5483.1@ENST00000266524_1, ENST00000266524_2, ENST00000266524_3, ENST00000266524_4, ENST00000266524_5, ENST00000266524_6, ENST00000266524_7, ENST00000266524_8, ENST00000266524_9, ENST00000266524_10, ENST00000266524_11, ENST00000266524_12, ENST00000266524_13, ENST00000266524_14, ENST00000266524_15, ENST00000266524_16, ENST00000266524_17, ENST00000266524_18, ENST00000266524_19, ENST00000266524_20, ENST00000266524_21, ENST00000266524_22, ENST00000266524_23, ENST00000266524_24, ENST00000266524_25, ENST00000266524_26, ENST00000266524_27, ENST00000266524_28, ENST00000266524_29, ENST00000266524_30, ENST00000266524_31, ENST00000266524_32@1.3125@0@6@NA@NA@NA
D146989@160888@160888@duplication@1@124496095@124499952@12@chr12:124496095-124499952@7.66@555@784@1.41@CNVR5712.1@ZNF664-201_5@5@5@5@:zinc finger protein 664@:intracellular;nucleus;DNA binding;molecular_function;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;biological_process@NA
D146989@161352@161352@duplication@1@133067390@133067448@12@chr12:133067390-133067448@4.7@72@120@1.67@NA@FBRSL1-201_2@0@0@0@:fibrosin-like 1@NA@NA
D146989@162127@162128@deletion@2@24465240@24465671@13@chr13:24465240-24465671@33.6@946@474@0.501@NA@RP11-45B20-002_6, ENST00000382133_3@29@29@29@:C1q and tumor necrosis factor related protein 9B@:collagen;protein binding@NA
D146989@162131@162131@deletion@1@24468280@24468341@13@chr13:24468280-24468341@17.6@193@65@0.337@NA@RP11-45B20-002_4@36@36@36@:C1q and tumor necrosis factor related protein 9B@:collagen;protein binding@NA
D146989@162163@162164@duplication@2@24892958@24893019@13@chr13:24892958-24893019@7.89@690@928@1.34@NA@SPATA13-009_12, C1QTNF9-003_4@8.5@6@11@:spermatogenesis associated 13:C1q and tumor necrosis factor related protein 9@:lamellipodium assembly;phospholipid binding;Rac guanyl-nucleotide exchange factor activity;guanyl-nucleotide exchange factor activity;ruffle membrane;nucleus;regulation of cell migration;cell migration;regulation of Rho protein signal transduction;intracellular;Rho guanyl-nucleotide exchange factor activity;cytoplasm;filopodium assembly;filopodium;protein binding;lamellipodium:collagen;protein binding;hormone activity@NA
D146989@164473@164476@deletion@4@52854789@52855097@13@chr13:52854789-52855097@16.6@290@144@0.497@NA@THSD1P-203_14, THSD1P-203_15, ENST00000403471_5, ENST00000403471_6@57@56@58@NA@NA@NA
D146989@164539@164543@duplication@5@53103402@53106857@13@chr13:53103402-53106857@20.6@121@285@2.36@NA@RP11-78J21-201_12, RP11-78J21-201_13, RP11-78J21-201_14, RP11-78J21-201_15, RP11-78J21-201_16@113.8@107@117@NA@NA@NA
D146989@166697@166699@deletion@3@19553367@19559165@14@chr14:19553367-19559165@6.01@90@44@0.489@CNVR6072.1@POTEG-201_1, POTEG-201_2, POTEG-201_3@122.333333333333@91@141@:POTE ankyrin domain family, member G@:protein binding@NA
D146989@166748@166750@deletion@3@20085421@20087779@14@chr14:20085421-20087779@13.6@127@44@0.346@CNVR6072.6, CNVR6072.12, CNVR6072.14@AL929601-201_2, AL929601-201_3, AL929601-201_4@90@87@95@NA@NA@NA
D146989@166764@166765@deletion@2@20201537@20202426@14@chr14:20201537-20202426@9.57@1544@1067@0.691@CNVR6072.6, CNVR6072.12, CNVR6072.4, CNVR6072.11, CNVR6072.37@ENST00000426759_1, ENST00000426759_2@59.5@56@63@:olfactory receptor, family 4, subfamily N, member 2@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
D146989@170809@170810@duplication@2@74003820@74008400@14@chr14:74003820-74008400@19@203@406@2@CNVR6188.1, CNVR6188.4@ACOT1-201_1, ACOT1-201_2@115@114@116@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
D146989@173415@173426@duplication@12@106092111@106135330@14@chr14:106092111-106135330@18.6@743@1036@1.39@CNVR6294.46, CNVR6294.20, CNVR6294.43, CNVR6294.50, CNVR6294.64, CNVR6294.65, CNVR6294.66@IGHG4-001_1, IGHG2-002_1, IGHG2-002_2, IGHG2-002_3, IGHG2-002_4, IGHG2-002_5, IGHGP-001_3, IGHGP-001_4, IGHGP-001_5, IGHGP-001_6, AL928761-201_3, AL928761-201_4@6.33333333333333@4@9@@:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response@NA
D146989@173440@173447@duplication@8@106174124@106208723@14@chr14:106174124-106208723@21.7@847@1204@1.42@CNVR6294.46, CNVR6294.43, CNVR6294.66, CNVR6294.68, CNVR6294.19, CNVR6294.35@IGHA1-002_1, IGHEP1-001_1, IGHEP1-001_2, IGHG1-002_2, IGHG1-002_3, IGHG1-002_4, IGHG1-002_5, IGHG1-002_6@1.125@1@2@@:antigen binding;protein binding;immune response;protein-chromophore linkage:antigen binding;complement activation;protein binding;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response@: MYELOMA, MULTIPLE
D146989@173592@173594@deletion@3@106926190@106934274@14@chr14:106926190-106934274@6.51@788@555@0.704@CNVR6294.56, CNVR6294.1@IGHV3-43-001_1, IGHV3-43-001_2, IGHVIII-44-001_2@11.6666666666667@11@12@@:protein binding@NA
D146989@173635@173638@deletion@4@107095128@107099589@14@chr14:107095128-107099589@25.2@411@206@0.501@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61-001_1, IGHV4-61-001_2, IGHV3-62-001_1, IGHV3-62-001_2@16@15@17@@:protein binding@NA
D146989@173645@173646@deletion@2@107131035@107131561@14@chr14:107131035-107131561@11.2@378@222@0.587@CNVR6294.56, CNVR6294.16@IGHV3-66-001_1, IGHV3-66-001_2@2.5@2@3@@:protein binding@NA
D146989@173681@173766@duplication@86@20433872@20772165@15@chr15:20433872-20772165@266@7861@12485@1.59@CNVR6295.15, CNVR6295.7@ENST00000400226_1, ENST00000400226_2, ENST00000400226_3, ENST00000400226_4, ENST00000400226_8, ENST00000400226_9, ENST00000400226_10, ENST00000400226_11, ENST00000400226_12, ENST00000400226_14, ENST00000400226_15, ENST00000400226_16, HERC2P3-014_1, HERC2P3-014_2, HERC2P3-014_3, HERC2P3-014_4, HERC2P3-014_5, HERC2P3-014_6, HERC2P3-014_7, HERC2P3-014_8, HERC2P3-014_9, HERC2P3-014_10, HERC2P3-014_11, HERC2P3-014_12, HERC2P3-014_13, HERC2P3-014_14, HERC2P3-014_15, HERC2P3-014_16, HERC2P3-014_17, HERC2P3-014_18, HERC2P3-014_19, HERC2P3-014_20, HERC2P3-014_21, HERC2P3-014_22, HERC2P3-014_23, HERC2P3-014_24, HERC2P3-014_25, HERC2P3-014_26, HERC2P3-014_27, AC026495-201_1, AC026495-201_2, AC026495-201_3, AC026495-201_4, AC026495-201_5, AC026495-201_6, AC026495-201_7, AC026495-201_8, AC026495-201_9, AC026495-201_10, AC026495-201_11, AC026495-201_12, AC026495-201_13, AC026495-201_14, AC026495-201_15, AC026495-201_16, AC026495-201_17, AC026495-201_18, AC026495-201_19, AC026495-201_20, AC026495-201_21, AC026495-201_22, AC026495-201_23, AC026495-201_24, AC026495-201_25, AC026495-201_26, GOLGA6L6-201_1, GOLGA6L6-201_2, GOLGA6L6-201_3, GOLGA6L6-201_4, GOLGA6L6-201_5, GOLGA6L6-201_6, GOLGA6L6-201_7, GOLGA6L6-201_8, GOLGA6L6-201_9, GOLGA6L6-201_10, AC131280-203_1, AC131280-203_2, AC131280-203_3, AC131280-203_4, AC131280-203_5, AC131280-203_6, AC131280-203_7@86.4390243902439@48@147@:putative transmembrane protein FLJ36131-like;putative transmembrane protein ENSP00000320207-like;golgin A6 family-like 6@NA@NA
D146989@173799@173817@duplication@19@21369348@22333196@15@chr15:21369348-22333196@14.2@791@1088@1.38@NA@ENST00000450252_1, ENST00000450252_2, ENST00000500487_1, ENST00000500487_2, POTEB-202_1, POTEB-202_2, POTEB-202_3, POTEB-202_4, POTEB-202_5, POTEB-202_9, POTEB-202_10, POTEB-202_11, AC134980-201_1, AC134980-201_2, ENST00000438898_1, ENST00000438898_2@70.25@34@101@:POTE ankyrin domain family member B-like@:protein binding@NA
D146989@173855@173979@deletion@125@22742398@23330614@15@chr15:22742398-23330614@602@11519@5729@0.497@NA@GOLGA6L1-201_8, GOLGA6L1-201_9, GOLGA6L1-201_10, TUBGCP5-001_1, TUBGCP5-001_3, TUBGCP5-001_4, TUBGCP5-001_5, TUBGCP5-001_6, TUBGCP5-001_7, TUBGCP5-001_8, TUBGCP5-001_9, TUBGCP5-001_10, TUBGCP5-001_11, TUBGCP5-001_12, TUBGCP5-001_13, TUBGCP5-001_14, TUBGCP5-001_15, TUBGCP5-001_16, TUBGCP5-001_17, TUBGCP5-001_18, TUBGCP5-001_19, TUBGCP5-001_20, TUBGCP5-001_21, TUBGCP5-001_22, TUBGCP5-001_23, CYFIP1-001_1, CYFIP1-001_2, CYFIP1-001_3, CYFIP1-001_4, CYFIP1-001_5, CYFIP1-001_6, CYFIP1-001_7, CYFIP1-001_8, CYFIP1-001_9, CYFIP1-001_10, CYFIP1-001_11, CYFIP1-001_12, CYFIP1-001_13, CYFIP1-001_14, CYFIP1-001_15, CYFIP1-001_16, CYFIP1-001_17, CYFIP1-001_18, CYFIP1-001_19, CYFIP1-001_20, CYFIP1-001_21, CYFIP1-001_22, CYFIP1-001_23, CYFIP1-001_24, CYFIP1-001_25, CYFIP1-001_26, CYFIP1-001_27, CYFIP1-001_28, CYFIP1-001_29, CYFIP1-001_30, CYFIP1-001_31, NIPA2-001_1, NIPA2-001_2, NIPA2-001_3, NIPA2-001_4, NIPA2-001_6, NIPA2-001_7, NIPA2-001_8, NIPA1-201_3, NIPA1-201_4, NIPA1-201_5, AC011767-201_1, AC011767-201_2, AC011767-201_3, AC011767-201_4, AC011767-201_5, WHAMML1-202_1, WHAMML1-202_2, WHAMML1-202_3, WHAMML1-202_4, WHAMML1-202_5, WHAMML1-202_6, WHAMML1-202_7, WHAMML1-202_8, WHAMML1-202_9, WHAMML1-202_10, WHAMML1-202_11, GOLGA9P-001_1, GOLGA9P-001_2, GOLGA9P-001_3, GOLGA9P-001_4, GOLGA9P-001_7, GOLGA9P-001_8, GOLGA9P-001_9, GOLGA9P-001_10, GOLGA9P-001_11, GOLGA9P-001_12, GOLGA9P-001_13, GOLGA9P-001_14, GOLGA9P-001_15, GOLGA9P-001_16, GOLGA9P-001_17, GOLGA9P-001_18, GOLGA9P-001_19, ENST00000454333_1, ENST00000454333_2, ENST00000454333_3, ENST00000454333_4, ENST00000454333_5, ENST00000454333_6, ENST00000454333_7, ENST00000454333_8, ENST00000454333_9, ENST00000454333_11, ENST00000454333_12, ENST00000422607_3, ENST00000422607_4, ENST00000422607_5, ENST00000422607_6, ENST00000422607_7, ENST00000422607_8, ENST00000422607_9@12.2222222222222@2@99@:golgin A6 family-like 1;putative transmembrane protein FLJ36131-like;putative transmembrane protein ENSP00000320207-like;putative golgin subfamily A member 6-like:tubulin, gamma complex associated protein 5:cytoplasmic FMR1 interacting protein 1:non imprinted in Prader-Willi/Angelman syndrome 2:non imprinted in Prader-Willi/Angelman syndrome 1:golgin A8 family, member I@:microtubule binding;mitotic cell cycle;centrosome;microtubule organizing center;G2/M transition of mitotic cell cycle;microtubule nucleation;cytosol;microtubule;gamma-tubulin ring complex;microtubule cytoskeleton organization;spindle pole:lamellipodium assembly;regulation of cell shape;Rac GTPase binding;cytoplasm;perinuclear region of cytoplasm;neuron projection;ruffle organization;protein binding;actin filament binding;synapse;axon extension;cell junction;mRNA cap binding complex;lamellipodium;ruffle:protein binding;magnesium ion transmembrane transporter activity;integral to membrane;magnesium ion transport;plasma membrane;membrane;early endosome:magnesium ion transmembrane transporter activity;integral to membrane;magnesium ion transport;cell death;plasma membrane;membrane;early endosome:Golgi cisterna membrane@: SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT; SPG6
D146989@174505@174506@duplication@2@30663303@30664545@15@chr15:30663303-30664545@11@160@279@1.74@CNVR6337.1@CHRFAM7A-202_7, CHRFAM7A-202_8@58.5@49@68@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
D146989@174661@174662@deletion@2@32451772@32455537@15@chr15:32451772-32455537@8.47@44@4@0.0909@CNVR6345.2, CNVR6345.1@CHRNA7-205_8, CHRNA7-205_9@119.5@106@133@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
D146989@179305@179311@deletion@7@72953607@72957377@15@chr15:72953607-72957377@11.2@87@26@0.299@CNVR6443.1@GOLGA6-001_8, GOLGA6-001_9, GOLGA6-001_10, GOLGA6-001_11, GOLGA6-001_12, GOLGA6-001_13, GOLGA6-001_14@72.2857142857143@45@99@:golgin A6 family, member B@:Golgi apparatus@NA
D146989@180187@180187@duplication@1@79065427@79065546@15@chr15:79065427-79065546@8.64@36@102@2.83@NA@ADAMTS7-201_14@10@10@10@:A disintegrin and metalloproteinase with thrombospondin motifs 7-like;ADAM metallopeptidase with thrombospondin type 1 motif, 7@:metallopeptidase activity;extracellular matrix;proteolysis;peptidase activity;proteinaceous extracellular matrix;metalloendopeptidase activity;cell surface;zinc ion binding@NA
D146989@183378@183378@duplication@1@2672693@2672767@16@chr16:2672693-2672767@5.25@72@124@1.72@CNVR6602.2@AC141586-201_6@57@57@57@NA@NA@NA
D146989@186292@186293@duplication@2@28403075@28403464@16@chr16:28403075-28403464@8.94@222@339@1.53@CNVR6684.2@EIF3CL-201_9, EIF3CL-201_10@4@3@5@:eukaryotic translation initiation factor 3, subunit C-like@:protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;translation initiation factor activity@NA
D146989@186302@186304@deletion@3@28425026@28468348@16@chr16:28425026-28468348@27.6@128@0@0@NA@AC138894-201_1, AC138894-201_2, NPIPL1-202_7@43.6666666666667@22@80@NA@NA@NA
D146989@186367@186369@duplication@3@28634454@28712933@16@chr16:28634454-28712933@23.2@142@333@2.35@NA@SULT1A1-203_1, AC145285-201_1, AC145285-201_2@48.3333333333333@25@61@:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1:nuclear pore complex-interacting protein-like 2-like;putative NPIP-like protein LOC613037-like:eukaryotic translation initiation factor 3, subunit C@:small molecule metabolic process;sulfation;aryl sulfotransferase activity;amine metabolic process;catecholamine metabolic process;xenobiotic metabolic process;cytosol;steroid sulfotransferase activity;integral to membrane;sulfotransferase activity;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process;estrogen metabolic process:cytosol;protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;cellular protein metabolic process;binding;gene expression;translation;translation initiation factor activity@NA
D146989@186379@186379@deletion@1@28734771@28734873@16@chr16:28734771-28734873@6.16@247@150@0.607@CNVR6686.3, CNVR6686.2@EIF3S8-202_10@4@4@4@:eukaryotic translation initiation factor 3, subunit C@:cytosol;protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;cellular protein metabolic process;binding;gene expression;translation;translation initiation factor activity@NA
D146989@188229@188233@duplication@5@55798611@55807424@16@chr16:55798611-55807424@10.2@343@486@1.42@CNVR6730.1@CES4-202_2, CES4-202_3, CES4-202_4, CES4-202_5, CES4-202_6@113@108@123@NA@NA@NA
D146989@189920@189928@deletion@9@69988239@69996971@16@chr16:69988239-69996971@8.33@108@49@0.454@CNVR6762.3, CNVR6762.1, CNVR6762.4@CLEC18A-202_4, CLEC18A-202_5, CLEC18A-202_6, CLEC18A-202_7, CLEC18A-202_8, CLEC18A-202_9, CLEC18A-202_10, CLEC18A-202_11, CLEC18A-202_12@14.4444444444444@13@25@:C-type lectin domain family 18, member A@:carbohydrate binding;protein binding;extracellular region@NA
D146989@189930@189930@duplication@1@70010214@70010636@16@chr16:70010214-70010636@5.02@60@108@1.8@CNVR6762.3, CNVR6762.2@AC026468-201_8@10@10@10@NA@NA@NA
D146989@189959@189969@duplication@11@70162689@70178437@16@chr16:70162689-70178437@59.1@2868@4123@1.44@CNVR6764.1, CNVR6764.3@AC009060-202_5, AC009060-202_6, AC009060-202_7, AC009060-202_8, AC009060-202_9, AC009060-202_10, AC009060-202_11, AC009060-202_12, AC009060-202_13, AC009060-202_14, AC009060-202_15@72@61@77@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
D146989@189972@189973@duplication@2@70187296@70195206@16@chr16:70187296-70195206@29.5@1455@2315@1.59@CNVR6764.1, CNVR6764.3@AC009060-202_18, AC009060-202_19, AC009060-201_3, AC009060-201_4, AC009060-201_5@70@69@71@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
D146989@190431@190432@deletion@2@72092155@72093088@16@chr16:72092155-72093088@9.57@240@135@0.562@CNVR6769.1, CNVR6769.2@HP-201_5, HP-201_6@21.5@17@26@:thioredoxin-like 4B:haptoglobin:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:cellular iron ion homeostasis;negative regulation of oxidoreductase activity;catalytic activity;negative regulation of hydrogen peroxide catabolic process;positive regulation of cell death;haptoglobin-hemoglobin complex;extracellular space;proteolysis;response to hydrogen peroxide;extracellular region;hemoglobin binding;defense response;serine-type endopeptidase activity:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@: ANHAPTOGLOBINEMIA; AHP
D146989@190517@190518@duplication@2@74366308@74368885@16@chr16:74366308-74368885@15.3@486@769@1.58@CNVR6778.2, CNVR6778.1@AC009053-202_14, AC009053-202_15@15.5@15@16@NA@NA@NA
D146989@190539@190549@duplication@11@74442533@74452197@16@chr16:74442533-74452197@13.7@342@517@1.51@CNVR6778.2, CNVR6778.3, CNVR6778.5@CLEC18B-202_3, CLEC18B-202_4, CLEC18B-202_5, CLEC18B-202_6, CLEC18B-202_7, CLEC18B-202_8, CLEC18B-202_9, CLEC18B-202_10, CLEC18B-202_11, CLEC18B-202_12, CLEC18B-202_13@57.3636363636364@47@63@:C-type lectin domain family 18, member B@:carbohydrate binding;protein binding;extracellular region@NA
D146989@195229@195258@deletion@30@16664741@16734608@17@chr17:16664741-16734608@61.6@2867@1812@0.632@NA@CCDC144A-202_13, CCDC144A-202_14, CCDC144A-202_15, CCDC144A-202_16, CCDC144A-202_17, CCDC144A-202_18, AC022596-003_1, AC022596-003_2, AC022596-003_3, AC022596-003_4, AC022596-003_5, AC022596-003_6, AC022596-003_7, AC022596-003_8, AC022596-003_9, AC022596-003_10, AC022596-003_11, AC022596-001_1, AC022596-001_2, AC022596-001_3, AC022596-001_4, AC022596-001_5, AC022596-001_6, AC022596-001_7, AC022596-001_8, ENST00000414673_4, ENST00000414673_5, ENST00000414673_6, ENST00000414673_7, ENST00000414673_8@76.6666666666667@45@97@:coiled-coil domain containing 144A@NA@NA
D146989@195688@195747@duplication@60@18328110@18457581@17@chr17:18328110-18457581@168@1665@3254@1.95@NA@ENST00000445433_8, ENST00000332088_6, ENST00000326333_1, ENST00000326333_2, ENST00000326333_3, ENST00000326333_4, ENST00000326333_5, ENST00000326333_6, ENST00000326333_7, ENST00000326333_8, ENST00000399124_1, ENST00000399124_2, ENST00000399124_3, ENST00000399124_4, ENST00000399124_5, ENST00000399124_6, ENST00000399124_7, ENST00000399124_8, ENST00000411877_1, ENST00000411877_2, ENST00000411877_4, LGALS9C-201_1, LGALS9C-201_2, LGALS9C-201_3, LGALS9C-201_4, LGALS9C-201_5, LGALS9C-201_6, LGALS9C-201_7, LGALS9C-201_8, LGALS9C-201_9, LGALS9C-201_10, LGALS9C-201_11, ENST00000426269_1, ENST00000426269_2, ENST00000426269_3, ENST00000426269_4, ENST00000426269_5, AC107983-001_1, AC107983-001_2, AC107983-001_3, AC107983-001_4, AC107983-001_5, AC107983-001_6, AC107983-001_7, AC107983-001_8, AC107983-001_9, AC107983-001_10, ENST00000456184_1, ENST00000456184_2, CCDC144B-201_14, CCDC144B-201_15, CCDC144B-201_16, CCDC144B-201_17, CCDC144B-201_18, ENST00000447265_11, ENST00000447265_12, ENST00000447265_13, ENST00000447265_14, ENST00000447265_15@129.135593220339@11@203@:lectin, galactoside-binding, soluble, 9C:protein FAM106B-like@:carbohydrate binding@NA
D146989@195757@195759@deletion@3@18498037@18498176@17@chr17:18498037-18498176@20.9@286@127@0.444@NA@CCDC144B-201_8, CCDC144B-201_9, ENST00000447265_5@1@1@1@NA@NA@NA
D146989@196151@196155@duplication@5@20354796@20356921@17@chr17:20354796-20356921@15.8@177@327@1.85@CNVR7021.1, CNVR7021.3@LGALS9B-201_6, LGALS9B-201_7, LGALS9B-201_8, LGALS9B-201_9, LGALS9B-201_10@99.6@94@103@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
D146989@198032@198043@deletion@12@36351805@36398303@17@chr17:36351805-36398303@300@5226@1853@0.355@CNVR7083.3@AC183087-202_3, AC183087-202_4, AC183087-202_5, AC183087-202_6, AC183087-202_7, AC183087-202_8, AC183087-202_9, AC183087-202_10, AC183087-202_11, AC183087-202_12, AC183087-202_13, AC183087-202_14@50.75@27@64@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
D146989@200259@200266@deletion@8@43585590@43596019@17@chr17:43585590-43596019@32.1@566@264@0.466@CNVR7113.4, CNVR7113.6, CNVR7113.2, CNVR7113.1@AC091132-201_1, AC091132-201_2, AC091132-201_3, AC091132-201_4, AC091132-201_5, ENST00000339474_1, ENST00000339474_2, ENST00000339474_3@94.875@81@127@NA@NA@NA
D146989@200319@200328@duplication@10@44171928@44364337@17@chr17:44171928-44364337@125@3784@6358@1.68@CNVR7114.3, CNVR7114.2@KIAA1267-201_1, KIAA1267-201_2, KIAA1267-201_3, AC217773-201_1, AC217773-201_2, ENST00000451529_1, ENST00000451529_3, ENST00000451529_5@60.25@31@90@:KAT8 regulatory NSL complex subunit 1:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:histone acetyltransferase activity (H4-K8 specific);histone acetyltransferase activity (H4-K16 specific);histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase complex;histone H4-K5 acetylation;MLL1 complex;histone H4-K16 acetylation;protein binding;histone H4-K8 acetylation;nucleus:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
D146989@200337@200340@deletion@4@44399690@44409348@17@chr17:44399690-44409348@7.9@51@10@0.196@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A-001_7, LRRC37A-001_8, LRRC37A-001_9, LRRC37A-001_10@144.75@141@154@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
D146989@200343@200345@deletion@3@44414664@44415161@17@chr17:44414664-44415161@9.37@44@1@0.0227@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A-001_13, LRRC37A-001_14, LRRC37A-001_15@190.333333333333@181@196@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
D146989@200355@200363@duplication@9@44617544@44633017@17@chr17:44617544-44633017@32.2@803@1286@1.6@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2-201_6, LRRC37A2-201_7, LRRC37A2-201_8, LRRC37A2-201_9, LRRC37A2-201_10, LRRC37A2-201_11, LRRC37A2-201_12, LRRC37A2-201_13, LRRC37A2-201_14@80.3333333333333@67@98@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
D146989@201839@201840@deletion@2@57656835@57657241@17@chr17:57656835-57657241@24.9@116@0@0@NA@DHX40-203_12, DHX40-203_13@7.5@3@12@:DEAH (Asp-Glu-Ala-His) box polypeptide 40@:transport;helicase activity;intracellular;ATP-dependent helicase activity;nucleic acid binding;ATP binding@NA
D146989@213493@213494@duplication@2@14508472@14508748@19@chr19:14508472-14508748@24.6@98@295@3.01@NA@CD97-205_8, CD97-205_9@10.5@7@14@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
D146989@213632@213633@deletion@2@14876338@14876617@19@chr19:14876338-14876617@8.89@557@364@0.654@NA@EMR2-209_8, EMR2-209_9@3@3@3@:egf-like module containing, mucin-like, hormone receptor-like 2@:transmembrane signaling receptor activity;inflammatory response;G-protein coupled receptor activity;ruffle membrane;integral to membrane;plasma membrane;cell surface receptor signaling pathway;neuropeptide signaling pathway;granulocyte chemotaxis;cell migration;leading edge membrane;G-protein coupled receptor signaling pathway;protein binding;cell adhesion;membrane;calcium ion binding;chondroitin sulfate binding@NA
D146989@217293@217293@deletion@1@40373947@40374087@19@chr19:40373947-40374087@7.16@66@22@0.333@CNVR7639.2@FCGBP-201_26@105@105@105@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D146989@217296@217297@deletion@2@40380121@40382827@19@chr19:40380121-40382827@7.67@53@13@0.245@CNVR7639.2@FCGBP-201_22, FCGBP-201_23@152@149@155@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D146989@217301@217306@duplication@6@40389654@40399856@19@chr19:40389654-40399856@13.6@369@542@1.47@CNVR7639.2, CNVR7639.3@FCGBP-201_13, FCGBP-201_14, FCGBP-201_15, FCGBP-201_16, FCGBP-201_17, FCGBP-201_18@112.333333333333@103@127@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D146989@221166@221170@deletion@5@54724400@54726655@19@chr19:54724400-54726655@21.5@311@145@0.466@CNVR7721.3, CNVR7721.4@LILRB3-008_2, LILRB3-008_3, LILRB3-008_4, LILRB3-008_5, LILRB3-008_6@117@101@136@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D146989@221180@221182@duplication@3@54745540@54746407@19@chr19:54745540-54746407@8.32@420@581@1.38@CNVR7721.3, CNVR7721.6@LILRA6-002_2, LILRA6-002_3, LILRA6-002_4@68.3333333333333@62@77@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D146989@221396@221413@deletion@18@55266477@55290115@19@chr19:55266477-55290115@115@2510@1297@0.517@CNVR7725.2, CNVR7725.1@KIR2DL3-201_5, KIR2DL3-201_6, KIR2DL3-201_7, KIR2DL3-201_8, KIR2DP1-001_1, KIR2DP1-001_2, KIR2DP1-001_3, KIR2DP1-001_4, KIR2DP1-001_5, KIR2DP1-001_6, KIR2DP1-001_7, KIR2DP1-001_8, KIR2DP1-001_9, KIR2DL1-002_1, KIR2DL1-002_2, KIR2DL1-002_3, KIR2DL1-002_4, KIR2DL1-002_5@108.277777777778@76@126@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
D146989@221822@221824@duplication@3@56280509@56284546@19@chr19:56280509-56284546@43.2@907@1633@1.8@CNVR7734.1@ENST00000341750_1, ENST00000341750_2, ENST00000341750_3@37.6666666666667@30@47@:ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
D146989@222068@222069@deletion@2@58003184@58003369@19@chr19:58003184-58003369@8.13@63@18@0.286@CNVR7748.1@ZNF419-202_5, ZNF419-202_6@0@0@0@:zinc finger protein 419@:intracellular;DNA binding;regulation of transcription, DNA-dependent;cytoplasm;nucleolus;nucleus;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding@NA
D146989@222562@222563@deletion@2@1558986@1569279@20@chr20:1558986-1569279@18.8@393@189@0.481@CNVR7763.1@SIRPB1-201_1, SIRPB1-201_2@90.5@53@128@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
D146989@228837@228845@duplication@9@10970011@10998336@21@chr21:10970011-10998336@7.39@1433@1820@1.27@CNVR7947.11, CNVR7947.12@TPTE-006_10, TPTE-006_11, TPTE-006_12, TPTE-006_13, TPTE-006_14, TPTE-006_15, TPTE-006_16, BAGE2-002_14, BAGE2-002_15@10.6666666666667@8@14@:transmembrane phosphatase with tensin homology@:phosphatase activity;ion channel activity;protein tyrosine phosphatase activity;ion transport;protein dephosphorylation;transmembrane transport;protein binding;signal transduction;integral to membrane;protein tyrosine/serine/threonine phosphatase activity;dephosphorylation;membrane;peptidyl-tyrosine dephosphorylation@NA
D146989@229003@229005@duplication@3@15386956@15387164@21@chr21:15386956-15387164@5.5@24@62@2.58@NA@ENST00000447719_17, ENST00000447719_18, ENST00000447719_19@16@16@16@NA@NA@NA
D146989@232771@232783@deletion@13@20385728@20398724@22@chr22:20385728-20398724@13.2@116@41@0.353@CNVR8094.9, CNVR8094.4, CNVR8094.10@PI4KAP1-204_2, PI4KAP1-204_3, PI4KAP1-204_4, PI4KAP1-204_5, PI4KAP1-204_6, PI4KAP1-204_7, PI4KAP1-204_8, PI4KAP1-204_9, PI4KAP1-204_10, PI4KAP1-204_11, PI4KAP1-204_12, PI4KAP1-204_13, PI4KAP1-204_14@166.538461538462@155@172@NA@NA@NA
D146989@233473@233473@duplication@1@23247264@23247821@22@chr22:23247264-23247821@7.19@65@130@2@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11@BCRL4-001_6@0@0@0@NA@NA@NA
D146989@236767@236767@duplication@1@42537164@42537350@22@chr22:42537164-42537350@8.9@105@196@1.87@CNVR8168.1, CNVR8168.3, CNVR8168.4@CYP2D7P1-202_8@12@12@12@@:oxidation-reduction process;electron carrier activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;heme binding@NA
D163417@2296@2307@deletion@12@12853354@12901211@1@chr1:12853354-12901211@9.69@420@272@0.648@CNVR72.3, CNVR72.10@PRAMEF1-001_2, PRAMEF1-001_3, PRAMEF1-001_4, RP5-845O24-001_1, RP5-845O24-001_2, PRAMEF11-001_1, PRAMEF11-001_2, PRAMEF11-001_3, PRAMEF11-001_4, ENST00000438176_1, ENST00000438176_2, ENST00000438176_3@20@17@30@:PRAME family member 1:PRAME family member 11@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
D163417@2885@2887@deletion@3@16875148@16879027@1@chr1:16875148-16879027@5.37@102@58@0.569@CNVR93.3, CNVR93.6, CNVR93.10@ENST00000438396_1, ENST00000438396_2, ENST00000438396_3@51@44@61@NA@NA@NA
D163417@2961@2966@duplication@6@17030440@17046653@1@chr1:17030440-17046653@6.74@521@685@1.31@CNVR93.3, CNVR93.15, CNVR93.4@ESPNP-002_1, ESPNP-002_2, ESPNP-002_3, ESPNP-002_4, ESPNP-002_5, AL021920-201_3@41.1666666666667@38@43@NA@NA@NA
D163417@2973@2978@duplication@6@17084251@17085380@1@chr1:17084251-17085380@9.98@1323@1719@1.3@CNVR93.3, CNVR93.15, CNVR93.2, CNVR93.1@MST1P9-202_13, MST1P9-202_14, MST1P9-202_15, MST1P9-202_16, MST1P9-202_17, MST1P9-202_18@36.1666666666667@35@37@:macrophage stimulating 1-like@:proteolysis;extracellular region;catalytic activity;serine-type endopeptidase activity@NA
D163417@2981@2990@duplication@10@17085766@17087580@1@chr1:17085766-17087580@10.5@1307@1682@1.29@CNVR93.3, CNVR93.15, CNVR93.2, CNVR93.1@MST1P9-202_1, MST1P9-202_2, MST1P9-202_3, MST1P9-202_4, MST1P9-202_5, MST1P9-202_6, MST1P9-202_7, MST1P9-202_8, MST1P9-202_9, MST1P9-202_10@39.5@28@56@:macrophage stimulating 1-like@:proteolysis;extracellular region;catalytic activity;serine-type endopeptidase activity@NA
D163417@3775@3775@deletion@1@21806546@21806717@1@chr1:21806546-21806717@6.28@33@3@0.0909@CNVR107.2, CNVR107.1@NBPF3-003_15@91@91@91@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 3@:cytoplasm@NA
D163417@4449@4461@deletion@13@25593204@25655628@1@chr1:25593204-25655628@200@1031@35@0.0339@CNVR116.1, CNVR116.2@C1orf63-002_1, RP11-335G20-001_1, RHD-202_1, RHD-202_2, RHD-202_3, RHD-202_4, RHD-202_5, RHD-202_6, RHD-202_7, RHD-202_8, RHD-202_9, RHD-202_10, RHD-202_11@117.692307692308@92@128@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
D163417@4477@4477@duplication@1@25735176@25735361@1@chr1:25735176-25735361@10.2@83@184@2.22@CNVR117.1@RHCE-005_4@56@56@56@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
D163417@6812@6815@duplication@4@40228766@40230490@1@chr1:40228766-40230490@8.16@269@384@1.43@NA@PPIE-003_11, BMP8B-001_4, BMP8B-001_5, BMP8B-001_6@29.25@8@41@:peptidylprolyl isomerase E (cyclophilin E):bone morphogenetic protein 8b@:regulation of transcription, DNA-dependent;nucleotide binding;catalytic step 2 spliceosome;protein folding;protein binding;protein peptidyl-prolyl isomerization;peptidyl-prolyl cis-trans isomerase activity;cyclosporin A binding;RNA binding;mRNA splicing, via spliceosome;nucleus;nucleic acid binding:cell differentiation;growth factor activity;extracellular space;growth;extracellular region;cytokine activity;cartilage development;skeletal system development;ossification@NA
D163417@11245@11246@deletion@2@89476589@89477711@1@chr1:89476589-89477711@81@425@0@0@CNVR244.1@GBP3-001_7, GBP3-001_8@54@54@54@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
D163417@12416@12425@deletion@10@104202984@104234233@1@chr1:104202984-104234233@19.3@150@42@0.28@CNVR266.3, CNVR266.1, CNVR266.15@AMY1A-001_7, AMY1A-001_8, AMY1A-001_9, AMY1A-001_10, AMY1A-001_11, AMY1B-001_7, AMY1B-001_8, AMY1B-001_9, AMY1B-001_10, AMY1B-001_11@123.8@109@154@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D163417@12525@12525@deletion@1@108769303@108769516@1@chr1:108769303-108769516@17.5@90@4@0.0444@CNVR294.4@NBPF4-002_13@32@32@32@:neuroblastoma breakpoint family, member 4@:cytoplasm@NA
D163417@12929@12936@deletion@8@110230474@110236368@1@chr1:110230474-110236368@86.7@410@4@0.00976@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1-001_1, GSTM1-001_2, GSTM1-001_3, GSTM1-001_4, GSTM1-001_5, GSTM1-001_6, GSTM1-001_7, GSTM1-001_8@191.375@187@194@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
D163417@16280@16280@deletion@1@152573269@152573493@1@chr1:152573269-152573493@16@75@0@0@CNVR358.1@LCE3C-201_2@102@102@102@:late cornified envelope 3C@:keratinization@NA
D163417@16302@16302@deletion@1@152770251@152771397@1@chr1:152770251-152771397@9.34@49@4@0.0816@CNVR360.1@LCE1D-001_2@25@25@25@:late cornified envelope 1D@:cytoplasmic part;cornified envelope;cellular response to calcium ion;keratinization;perinuclear region of cytoplasm;cytoplasm@NA
D163417@21362@21374@duplication@13@196743977@196801320@1@chr1:196743977-196801320@30@1477@2072@1.4@CNVR459.1@CFHR3-001_1, CFHR3-001_2, CFHR3-001_3, CFHR3-001_4, CFHR3-001_5, CFHR3-001_6, CFHR1-001_1, CFHR1-001_2, CFHR1-001_3, CFHR1-001_4, CFHR1-001_5, CFHR1-001_6, CFHR2-201_1@96.7692307692308@85@119@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
D163417@22772@22781@deletion@10@206306071@206332105@1@chr1:206306071-206332105@59@1068@516@0.483@NA@ENST00000436158_1, CTSE-001_1, CTSE-001_2, CTSE-001_3, CTSE-001_4, CTSE-001_5, CTSE-001_6, CTSE-001_7, CTSE-001_8, CTSE-001_9@4.4@1@5@:cathepsin E@:endosome;proteolysis;digestion;aspartic-type endopeptidase activity;protein homodimerization activity;protein autoprocessing;antigen processing and presentation of exogenous peptide antigen via MHC class II@NA
D163417@24160@24164@deletion@5@223727670@223729472@1@chr1:223727670-223729472@12.6@68@7@0.103@NA@CAPN8-202_20, CAPN8-202_21, CAPN8-202_22, CAPN8-202_23, CAPN8-202_24@0@0@0@:calpain 8@:proteolysis;Golgi apparatus;intracellular;calcium-dependent cysteine-type endopeptidase activity;calcium ion binding@NA
D163417@34615@34635@deletion@21@98127603@98166078@2@chr2:98127603-98166078@29.4@189@37@0.196@CNVR888.3@ANKRD36B-001_19, ANKRD36B-001_20, ANKRD36B-001_21, ANKRD36B-001_22, ANKRD36B-001_23, ANKRD36B-001_24, ANKRD36B-001_25, ANKRD36B-001_26, ANKRD36B-001_27, ANKRD36B-001_28, ANKRD36B-001_29, ANKRD36B-001_30, ANKRD36B-001_31, ANKRD36B-001_32, ANKRD36B-001_33, ANKRD36B-001_34, ANKRD36B-001_35, ANKRD36B-001_36, ANKRD36B-001_37, ANKRD36B-001_38, ANKRD36B-001_39@109.142857142857@14@154@NA@NA@NA
D163417@37996@37996@deletion@1@142356616@142356645@2@chr2:142356616-142356645@5.1@47@16@0.34@NA@AC093859-201_1@0@0@0@:low density lipoprotein receptor-related protein 1B@:low-density lipoprotein receptor activity;protein binding;integral to membrane;protein transport;receptor-mediated endocytosis;membrane;calcium ion binding@NA
D163417@40522@40524@deletion@3@179337758@179337866@2@chr2:179337758-179337866@5.45@129@74@0.574@NA@FKBP7-201_3, FKBP7-201_4, FKBP7-201_5@0@0@0@:FK506 binding protein 7@:FK506 binding;endoplasmic reticulum;endoplasmic reticulum lumen;peptidyl-proline modification;protein folding;protein binding;protein peptidyl-prolyl isomerization;peptidyl-prolyl cis-trans isomerase activity;membrane;calcium ion binding@NA
D163417@61531@61539@deletion@9@195345501@195378510@3@chr3:195345501-195378510@27.7@1883@1272@0.676@NA@ENST00000457750_2, AC233280-201_1, AC233280-201_2, AC233280-201_3, AC233280-201_4, AC233280-201_5, AC233280-201_6, AC233280-201_7, AC233280-201_8@85.4444444444444@56@93@:mucin 20, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane@NA
D163417@61547@61561@deletion@15@195390959@195412776@3@chr3:195390959-195412776@25.1@806@483@0.599@CNVR1703.1@SDHALP2-001_5, SDHALP2-001_6, SDHALP2-001_7, SDHALP2-001_8, SDHALP2-001_9, SDHALP2-001_10, SDHALP2-001_11, SDHALP2-001_12, SDHALP2-001_13, SDHALP2-001_14, SDHALP2-001_15, ENST00000430928_1, ENST00000430928_2, ENST00000430928_3, ENST00000430928_4@62.0666666666667@16@92@:mucin 20, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane@NA
D163417@65315@65320@deletion@6@69402904@69434246@4@chr4:69402904-69434246@177@1043@34@0.0326@CNVR1953.1@UGT2B17-001_1, UGT2B17-001_2, UGT2B17-001_3, UGT2B17-001_4, UGT2B17-001_5, UGT2B17-001_6@124.5@118@134@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
D163417@70817@70830@duplication@14@716925@796593@5@chr5:716925-796593@68.1@2481@3818@1.54@CNVR2280.3@ZDHHC11B-201_1, ZDHHC11B-201_2, ZDHHC11B-201_3, ZDHHC11B-201_4, ZDHHC11B-201_5, ZDHHC11B-201_6, ZDHHC11B-201_7, ZDHHC11B-201_8, ZDHHC11B-201_9, ZDHHC11B-201_10, AC026740-202_1, AC026740-202_2, AC026740-202_3, AC026740-202_4@70.3571428571429@52@96@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
D163417@70837@70841@duplication@5@837482@848776@5@chr5:837482-848776@13.2@742@1026@1.38@CNVR2280.3, CNVR2280.8@ZDHHC11-201_2, ZDHHC11-201_3, ZDHHC11-201_4, ZDHHC11-201_5, ZDHHC11-201_6@18@5@29@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
D163417@71601@71605@deletion@5@21482140@21484666@5@chr5:21482140-21484666@7.66@77@30@0.39@CNVR2395.4, CNVR2395.6, CNVR2395.2@AC138951-202_2, ENST00000412250_1, ENST00000412250_2, ENST00000412250_3, ENST00000412250_4@107.6@107@108@NA@NA@NA
D163417@73727@73727@deletion@1@69717564@69717599@5@chr5:69717564-69717599@12.4@57@0@0@CNVR2494.17, CNVR2494.3@GTF2H2B-201_4@139@139@139@NA@NA@NA
D163417@73820@73820@deletion@1@70378606@70378820@5@chr5:70378606-70378820@9.18@42@0@0@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.8, CNVR2494.1, CNVR2494.37@AC044797-201_2@138@138@138@NA@NA@NA
D163417@78044@78045@deletion@2@147553799@147554962@5@chr5:147553799-147554962@21.1@125@18@0.144@CNVR2637.1@AC116334-001_3, AC116334-001_4@43.5@9@78@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
D163417@79567@79568@deletion@2@175388056@175388438@5@chr5:175388056-175388438@8.89@62@15@0.242@NA@THOC3-001_4, THOC3-001_5@173.5@165@182@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
D163417@83577@83578@duplication@2@31962024@31962485@6@chr6:31962024-31962485@12.9@139@264@1.9@CNVR2843.6, CNVR2843.3@C4A-001_20, C4A-001_21@12@12@12@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
D163417@83601@83604@duplication@4@31973468@31974290@6@chr6:31973468-31974290@7.11@231@330@1.43@CNVR2843.6, CNVR2843.3@CYP21A1P-001_1, CYP21A1P-001_2, CYP21A1P-001_3, AL645922-201_1@97.75@80@107@NA@NA@NA
D163417@83932@83945@deletion@14@32605206@32632845@6@chr6:32605206-32632845@43.6@705@362@0.513@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20@HLA-DQA1-002_1, HLA-DQA1-002_2, HLA-DQA1-002_3, HLA-DQA1-002_4, HLA-DQA1-002_5, HLA-DQA1-002_6, HLA-DQB1-003_3, HLA-DQB1-003_4, HLA-DQB1-003_5, HLA-DQB1-003_6, XXbac-BPG254F23-001_1, XXbac-BPG254F23-001_2, ENST00000443574_1, ENST00000443574_2@122.857142857143@83@146@:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
D163417@84707@84710@duplication@4@35755646@35765089@6@chr6:35755646-35765089@6.76@859@1112@1.29@CNVR2861.1@C6orf127-001_3, CLPS-001_1, CLPS-001_2, CLPS-001_3@38.75@30@43@:colipase-like 1:colipase, pancreatic@:extracellular region;enzyme activator activity;digestion;lipid catabolic process:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
D163417@92594@92595@deletion@2@160133141@160133523@6@chr6:160133141-160133523@8.14@184@101@0.549@CNVR3127.2, CNVR3127.1@ENST00000442642_2, ENST00000442642_3@34.5@13@56@:superoxide dismutase 2, mitochondrial;uncharacterized LOC100129518@:response to reactive oxygen species;oxidation-reduction process;mitochondrion;negative regulation of cell proliferation;neuron development;negative regulation of fat cell differentiation;removal of superoxide radicals;response to gamma radiation;response to L-ascorbic acid;response to lipopolysaccharide;response to nutrient levels;response to zinc ion;protein homotetramerization;post-embryonic development;iron ion homeostasis;hemopoiesis;aging;mitochondrial inner membrane;age-dependent response to reactive oxygen species;response to drug;oxygen binding;mitochondrial nucleoid;vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure;apoptotic process;superoxide metabolic process;response to superoxide;detection of oxygen;response to silicon dioxide;cytoplasm;response to stress;respiratory electron transport chain;superoxide anion generation;protein homooligomerization;regulation of mitochondrial membrane potential;positive regulation of nitric oxide biosynthetic process;response to manganese ion;regulation of blood pressure;metal ion binding;negative regulation of apoptotic process;response to cadmium ion;response to oxidative stress;liver development;regulation of catalytic activity;negative regulation of fibroblast proliferation;response to selenium ion;age-dependent response to oxidative stress;response to electrical stimulus;mitochondrial matrix;identical protein binding;mitochondrion organization;response to hyperoxia;vasodilation;response to hydrogen peroxide;superoxide dismutase activity;heart development;negative regulation of neuron apoptotic process;erythrophore differentiation;locomotory behavior;DNA binding;release of cytochrome c from mitochondria;response to axon injury;oxygen homeostasis;response to activity;glutathione metabolic process;hydrogen peroxide metabolic process;hydrogen peroxide biosynthetic process;regulation of transcription from RNA polymerase II promoter;response to hypoxia;protein binding;manganese ion binding;cellular response to ethanol@: MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6; MVCD6
D163417@94190@94202@deletion@13@5959482@5984810@7@chr7:5959482-5984810@37.4@1119@638@0.57@NA@C7orf28A-001_12, C7orf28A-001_13, C7orf28A-001_14, C7orf28A-001_15, RSPH10B-002_13, RSPH10B-002_14, RSPH10B-002_15, RSPH10B-002_16, RSPH10B-002_17, RSPH10B-002_18, RSPH10B-002_19, RSPH10B-002_20, RSPH10B-002_21@29.3846153846154@9@73@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae):radial spoke head 10 homolog B (Chlamydomonas)@:lysosomal membrane@NA
D163417@94430@94432@duplication@3@6819243@6821108@7@chr7:6819243-6821108@7.49@261@380@1.46@NA@RSPH10B2-204_13, RSPH10B2-204_14, RSPH10B2-204_15@17@16@19@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D163417@94438@94444@duplication@7@6836201@6844687@7@chr7:6836201-6844687@41.3@389@780@2.01@NA@RSPH10B2-204_20, RSPH10B2-204_21, ENST00000429267_1, C7orf28B-001_12, C7orf28B-001_13, C7orf28B-001_14, C7orf28B-001_15@90.8571428571429@25@121@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D163417@96560@96561@duplication@2@38301774@38305280@7@chr7:38301774-38305280@5.42@663@879@1.33@CNVR3353.1@TRGC1-001_1, TRGC1-001_2@8@8@8@:TCR gamma alternate reading frame protein@:protein binding@NA
D163417@96579@96582@duplication@4@38388958@38394119@7@chr7:38388958-38394119@25.4@693@1101@1.59@CNVR3354.3, CNVR3354.1@TRGV5-001_1, TRGV5-001_2, TRGV4-001_1, TRGV4-001_2@12.75@11@14@@:protein binding:protein binding@NA
D163417@99039@99041@duplication@3@74191615@74193769@7@chr7:74191615-74193769@7.2@136@220@1.62@NA@NCF1-001_2, NCF1-001_3, NCF1-001_4@22.6666666666667@14@27@:neutrophil cytosolic factor 1@:inflammatory response;antigen processing and presentation of peptide antigen via MHC class I;phagosome maturation;NADPH oxidase complex;neutrophil mediated killing of gram-positive bacterium;cell communication;interaction with host;leukotriene metabolic process;response to yeast;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;respiratory burst;GTPase activity;negative regulation of smooth muscle contraction;GTP catabolic process;cytosol;defense response to fungus;defense response to bacterium;antigen processing and presentation of exogenous peptide antigen via MHC class I;leukocyte mediated cytotoxicity;neutrophil mediated killing of fungus;phosphatidylinositol binding;defense response to Gram-positive bacterium;GTP binding;respiratory burst involved in defense response;superoxide-generating NADPH oxidase activity;hydrogen peroxide biosynthetic process;protein targeting to membrane;electron carrier activity;superoxide metabolic process;innate immune response;phagolysosome;cytoplasm;cell proliferation;superoxide anion generation;protein binding;SH3 domain binding;cellular defense response;response to bacterium@: GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE,
D163417@99091@99091@duplication@1@74422162@74422231@7@chr7:74422162-74422231@7.46@3@51@17@NA@AC118138-001_2@6@6@6@:GATS protein-like 1@NA@NA
D163417@101721@101726@deletion@6@100331652@100336237@7@chr7:100331652-100336237@121@592@2@0.00338@CNVR3509.1@ZAN-001_2, ZAN-001_3, ZAN-001_4, ZAN-001_5, ZAN-001_6, ZAN-001_7@81.6666666666667@71@89@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
D163417@102166@102167@duplication@2@102219874@102223340@7@chr7:102219874-102223340@10.5@36@119@3.31@CNVR3518.1@ENST00000379336_1, RASA4-001_21@56@49@63@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
D163417@102620@102621@deletion@2@105912978@105915496@7@chr7:105912978-105915496@8.97@216@117@0.542@NA@PBEF1-001_3, PBEF1-001_4@1@1@1@:nicotinamide phosphoribosyltransferase@:nicotinate phosphoribosyltransferase activity;small molecule metabolic process;positive regulation of nitric-oxide synthase biosynthetic process;NAD metabolic process;cytoplasm;cell-cell signaling;NAD biosynthetic process;cytosol;signal transduction;cytokine activity;positive regulation of cell proliferation;water-soluble vitamin metabolic process;nicotinate-nucleotide diphosphorylase (carboxylating) activity;nicotinamide metabolic process;vitamin metabolic process;nicotinamide phosphoribosyltransferase activity@NA
D163417@105322@105335@deletion@14@141766375@141784445@7@chr7:141766375-141784445@22.1@1604@1087@0.678@CNVR3585.3, CNVR3585.2@MGAM-007_41, MGAM-007_42, MGAM-007_43, MGAM-007_44, MGAM-007_45, MGAM-007_46, MGAM-007_47, MGAM-007_48, MGAM-007_49, MGAM-007_50, MGAM-007_51, MGAM-007_52, MGAM-007_53, MGAM-007_54@120.357142857143@108@125@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
D163417@105341@105341@deletion@1@141793214@141793351@7@chr7:141793214-141793351@5.99@125@65@0.52@CNVR3585.3, CNVR3585.2@MGAM-007_60@79@79@79@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
D163417@105726@105728@duplication@3@143298483@143301929@7@chr7:143298483-143301929@6.99@8@53@6.62@CNVR3594.2, CNVR3594.1@AC106862-004_4, AC106862-004_5, AC106862-004_6@60.6666666666667@15@87@NA@NA@NA
D163417@105786@105795@deletion@10@143970528@143974431@7@chr7:143970528-143974431@8.07@399@276@0.692@CNVR3598.4, CNVR3598.9@RP4-798C17-001_7, RP4-798C17-001_8, RP4-798C17-001_9, RP4-798C17-001_10, RP4-798C17-001_11, ENST00000378112_8, ENST00000378112_9, ENST00000378112_10, ENST00000378112_11, ENST00000378112_12@97.6@57@137@:Rho guanine nucleotide exchange factor (GEF) 35@NA@NA
D163417@105798@105799@duplication@2@143975408@143975569@7@chr7:143975408-143975569@6.95@17@64@3.76@CNVR3598.4, CNVR3598.9@RP4-798C17-001_5, ENST00000378112_6@135@135@135@:Rho guanine nucleotide exchange factor (GEF) 35@NA@NA
D163417@107424@107430@duplication@7@7272384@7320382@8@chr8:7272384-7320382@8.9@541@725@1.34@CNVR3771.8, CNVR3771.10, CNVR3771.4@DEFB4P-001_1, DEFB4P-001_2, DEFB103A-001_1, DEFB103A-001_2, SPAG11-003_2, SPAG11-003_3, SPAG11-003_4@61.5714285714286@40@91@:defensin, beta 4B;defensin, beta 4A:defensin, beta 103B;defensin, beta 103A:sperm associated antigen 11B@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response@NA
D163417@107502@107513@duplication@12@7673083@7718505@8@chr8:7673083-7718505@21.6@595@903@1.52@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@DEFB107A-001_1, DEFB105A-001_1, DEFB105A-001_2, DEFB105A-001_3, DEFB106A-001_1, DEFB106A-001_2, DEFB104A-001_1, DEFB104A-001_2, SPAG11A-207_1, SPAG11A-207_2, SPAG11A-207_3, SPAG11A-207_4@54.9166666666667@40@113@:defensin, beta 107B;defensin, beta 107A:defensin, beta 105B;defensin, beta 105A:defensin, beta 106B;defensin, beta 106A:defensin, beta 104A;defensin, beta 104B:sperm associated antigen 11A;sperm associated antigen 11B@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response@NA
D163417@126951@126956@deletion@6@18138510@18152612@10@chr10:18138510-18152612@17.2@84@3@0.0357@NA@MRC1-001_7, MRC1-001_8, MRC1-001_9, MRC1-001_10, MRC1-001_11, RP11-457D2-001_2@19.6666666666667@18@26@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D163417@128372@128372@deletion@1@42924566@42924600@10@chr10:42924566-42924600@7.61@85@32@0.376@NA@CCNYL2-201_7@0@0@0@@:regulation of cyclin-dependent protein kinase activity;protein kinase binding@NA
D163417@128828@128829@deletion@2@46927785@46934899@10@chr10:46927785-46934899@14.8@68@0@0@CNVR4712.9, CNVR4712.2, CNVR4712.7@FAM35B-001_6, FAM35B-001_7@53@34@72@NA@NA@NA
D163417@128979@128979@deletion@1@47758848@47758905@10@chr10:47758848-47758905@4.94@22@0@0@CNVR4714.1@ANXA8L2-001_10@154@154@154@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:calcium-dependent phospholipid binding;calcium ion binding@NA
D163417@129462@129477@duplication@16@51362803@51391568@10@chr10:51362803-51391568@41.8@279@694@2.49@NA@ENST00000404618_1, ENST00000404618_2, ENST00000404618_3, ENST00000432221_1, ENST00000432221_2, ENST00000432221_3, TIMM23B-202_1, TIMM23B-202_2, TIMM23B-202_3, TIMM23B-202_4, TIMM23B-202_5, TIMM23B-202_6, TIMM23B-202_7, TIMM23B-202_8, TIMM23B-202_9, TIMM23B-202_10@62.0625@0@142@:translocase of inner mitochondrial membrane 23 homolog B (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process@NA
D163417@129509@129517@deletion@9@51603186@51620383@10@chr10:51603186-51620383@12.6@124@46@0.371@NA@TIMM23-202_2, TIMM23-202_3, TIMM23-202_4, TIMM23-202_5, TIMM23-202_6, TIMM23-202_7, TIMM23-202_8, TIMM23-202_9, TIMM23-202_10@3.22222222222222@0@29@:translocase of inner mitochondrial membrane 23 homolog B (yeast):translocase of inner mitochondrial membrane 23 homolog B (yeast);translocase of inner mitochondrial membrane 23 homolog (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:mitochondrion;mitochondrial inner membrane;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;mitochondrial intermembrane space;integral to mitochondrial inner membrane;intracellular protein transport;protein binding;integral to membrane;cellular protein metabolic process;protein targeting to mitochondrion@NA
D163417@129521@129521@deletion@1@51630972@51631957@10@chr10:51630972-51631957@8.24@406@239@0.589@NA@ENST00000456092_3@26@26@26@:translocase of inner mitochondrial membrane 23 homolog B (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process@NA
D163417@129605@129609@deletion@5@51970585@51978391@10@chr10:51970585-51978391@11.6@137@63@0.46@NA@ASAH2-201_7, ASAH2-201_8, ASAH2-201_9, ASAH2-201_10, ASAH2-201_11@181.2@176@186@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
D163417@133139@133141@duplication@3@98799747@98803271@10@chr10:98799747-98803271@6@256@357@1.39@NA@SLIT1-001_19, SLIT1-001_20, SLIT1-001_21@0@0@0@:slit homolog 1 (Drosophila):Rho GTPase activating protein 19@:axon extension involved in axon guidance;telencephalon cell migration;Roundabout binding;forebrain morphogenesis;negative regulation of synapse assembly;extracellular space;axonogenesis;olfactory bulb development;retinal ganglion cell axon guidance;tangential migration from the subventricular zone to the olfactory bulb;heparan sulfate proteoglycan binding;spinal cord development;axon guidance;cytoplasm;establishment of nucleus localization;protein binding;negative regulation of axon extension involved in axon guidance;brain development;neuron projection morphogenesis;motor neuron axon guidance;calcium ion binding;negative chemotaxis;dorsal/ventral axon guidance:cytosol;signal transduction;intracellular;nucleus;small GTPase mediated signal transduction;GTPase activator activity;regulation of small GTPase mediated signal transduction@NA
D163417@135724@135730@deletion@7@124344789@124353115@10@chr10:124344789-124353115@39.1@918@490@0.534@CNVR4912.4, CNVR4912.3, CNVR4912.2@DMBT1-002_15, DMBT1-002_16, DMBT1-002_17, DMBT1-002_18, DMBT1-002_19, DMBT1-002_20, DMBT1-002_21@49.4285714285714@47@51@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
D163417@138029@138031@deletion@3@5264682@5269718@11@chr11:5264682-5269718@5.24@311@205@0.659@NA@HBBP1-001_1, HBG1-201_3, HBG1-201_4@17@0@39@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
D163417@141187@141188@deletion@2@48600990@48601883@11@chr11:48600990-48601883@7.49@34@0@0@CNVR5165.1@AC134982-201_1, AC134982-201_2@128@128@128@NA@NA@NA
D163417@149009@149009@duplication@1@130029684@130029956@11@chr11:130029684-130029956@4.75@61@108@1.77@NA@ST14-201_1@0@0@0@:suppression of tumorigenicity 14 (colon carcinoma)@:serine-type peptidase activity;basolateral plasma membrane;extrinsic to plasma membrane;catalytic activity;protein binding;proteolysis;extracellular space;extracellular region;plasma membrane;integral to plasma membrane;membrane;serine-type endopeptidase activity@: ICHTHYOSIS WITH HYPOTRICHOSIS, AUTOSOMAL RECESSIVE
D163417@150775@150775@deletion@1@9446260@9446507@12@chr12:9446260-9446507@10.5@48@0@0@NA@DDX11L8-201_2@42@42@42@NA@NA@NA
D163417@150778@150783@duplication@6@9450373@9454871@12@chr12:9450373-9454871@9.66@233@350@1.5@NA@DDX11L8-201_5, DDX11L8-201_6, DDX11L8-201_7, DDX11L8-201_8, DDX11L8-201_9, DDX11L8-201_10@67.8333333333333@55@78@NA@NA@NA
D163417@150829@150841@deletion@13@9684189@9707352@12@chr12:9684189-9707352@66.5@336@20@0.0595@CNVR5429.1@AC006432-201_1, AC006432-201_2, AC006432-201_3, AC006432-201_4, AC006432-201_5, AC006432-201_6, AC006432-201_7, AC006432-201_8, AC006432-201_9, AC006432-201_10, AC006432-201_11, AC006432-201_12, AC006432-201_13@22.2307692307692@15@25@NA@NA@NA
D163417@150970@150972@deletion@3@10586392@10588010@12@chr12:10586392-10588010@6.98@318@202@0.635@CNVR5430.1@KLRC2-201_2, KLRC2-201_3, KLRC2-201_4@53.6666666666667@43@67@:killer cell lectin-like receptor subfamily C, member 2@:carbohydrate binding:transmembrane signaling receptor activity;carbohydrate binding;protein binding;signal transduction;cellular defense response;integral to plasma membrane@NA
D163417@151034@151034@duplication@1@11244393@11244793@12@chr12:11244393-11244793@10.3@322@524@1.63@CNVR5434.1@TAS2R31-201_2@72@72@72@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
D163417@155980@155980@duplication@1@64041027@64041146@12@chr12:64041027-64041146@4.82@78@131@1.68@CNVR5566.1@AC027667-201_5@5@5@5@:dpy-19-like 2 (C. elegans)@:spermatid development;multicellular organismal development;integral to membrane@: SPERMATOGENIC FAILURE 9; SPGF9
D163417@166748@166749@deletion@2@20085421@20086381@14@chr14:20085421-20086381@9.6@102@39@0.382@CNVR6072.6, CNVR6072.12, CNVR6072.14@AL929601-201_2, AL929601-201_3@91@87@95@NA@NA@NA
D163417@166754@166761@deletion@8@20137803@20148264@14@chr14:20137803-20148264@20@1241@816@0.658@CNVR6072.6, CNVR6072.12, CNVR6072.14@AL512310-201_4, AL512310-201_5, ENST00000398231_1, ENST00000398231_2, ENST00000398231_3, ENST00000398231_4, ENST00000398231_5, ENST00000398231_6@94.75@92@102@NA@NA@NA
D163417@170815@170815@deletion@1@74041614@74042360@14@chr14:74041614-74042360@4.72@94@49@0.521@CNVR6188.1, CNVR6188.6@ACOT2-201_3@5@5@5@:acyl-CoA thioesterase 2@:acyl-CoA metabolic process;mitochondrion;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity;receptor binding@NA
D163417@173538@173541@deletion@4@106721384@106725506@14@chr14:106721384-106725506@5.89@841@606@0.721@CNVR6294.48, CNVR6294.24, CNVR6294.40, CNVR6294.38, CNVR6294.17, CNVR6294.23@AB019439-201_1, IGHVIII-22-2-201_1, IGHVIII-22-2-201_2, IGHV3-23-001_2@7@5@8@@:protein binding@NA
D163417@173559@173567@duplication@9@106791413@106816254@14@chr14:106791413-106816254@19.3@712@1054@1.48@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-30-001_1, IGHV3-30-2-001_1, IGHV3-30-2-001_2, IGHV4-31-001_1, IGHV4-31-001_2, IGHV3-32-001_1, IGHV3-32-001_2, IGHV3-33-001_1, IGHV3-33-001_2@15.4444444444444@5@19@@:protein binding:protein binding:protein binding@NA
D163417@173645@173645@duplication@1@107131035@107131335@14@chr14:107131035-107131335@6.56@212@325@1.53@CNVR6294.56, CNVR6294.16@IGHV3-66-001_2@3@3@3@@:protein binding@NA
D163417@173682@173698@deletion@17@20444657@20588710@15@chr15:20444657-20588710@110@5654@3406@0.602@CNVR6295.15, CNVR6295.7, CNVR6295.26@ENST00000400226_1, ENST00000400226_2, ENST00000400226_3, ENST00000400226_4, ENST00000400226_5, ENST00000400226_6, ENST00000400226_8, ENST00000400226_9, ENST00000400226_10, ENST00000400226_11, ENST00000400226_12, ENST00000400226_13, ENST00000400226_14, ENST00000400226_15, HERC2P3-014_27, AC026495-201_26@65.25@30@80@NA@NA@NA
D163417@173814@173823@deletion@10@22297500@22494464@15@chr15:22297500-22494464@69.1@2136@1051@0.492@CNVR6297.4, CNVR6297.17, CNVR6297.6@AC134980-201_1, AC134980-201_2, ENST00000438898_1, ENST00000438898_2, AC025884-201_1, AC025884-201_2, AC010760-202_2, VSIG6-201_1, VSIG6-201_2@54.1111111111111@5@87@:olfactory receptor, family 4, subfamily M, member 2:olfactory receptor, family 4, subfamily N, member 4@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
D163417@174503@174505@duplication@3@30653445@30663388@15@chr15:30653445-30663388@7.4@209@311@1.49@CNVR6337.1@CHRFAM7A-202_8, CHRFAM7A-202_9, CHRFAM7A-202_10@47.6666666666667@44@50@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
D163417@174661@174662@deletion@2@32451772@32455537@15@chr15:32451772-32455537@6.24@31@2@0.0645@CNVR6345.2, CNVR6345.1@CHRNA7-205_8, CHRNA7-205_9@119.5@106@133@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
D163417@182017@182024@deletion@8@61557@64094@16@chr16:61557-64094@7.63@34@0@0@CNVR6565.1@DDX11L10-203_1, DDX11L10-203_2, DDX11L10-203_3, Z84812-001_1, Z84812-001_2, Z84812-001_3, Z84812-001_4, Z84812-001_5, Z84812-001_6, WASH4P-004_10@109.375@98@116@@:intracellular membrane-bounded organelle;endosomal transport;recycling endosome;early endosome;Arp2/3 complex-mediated actin nucleation;actin binding;alpha-tubulin binding;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;recycling endosome membrane@NA
D163417@183378@183378@duplication@1@2672693@2672767@16@chr16:2672693-2672767@6.95@69@137@1.99@CNVR6602.2@AC141586-201_6@57@57@57@NA@NA@NA
D163417@185592@185598@deletion@7@21763692@21809180@16@chr16:21763692-21809180@12.9@286@155@0.542@CNVR6668.5, CNVR6668.2, CNVR6668.7@OTOA-001_25, OTOA-001_26, OTOA-001_27, OTOA-001_28, AC092375-201_5, AC092375-201_6, AC092375-201_7@23.7142857142857@3@62@:otoancorin@:proteinaceous extracellular matrix;apical plasma membrane;sensory perception of sound;anchored to membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22
D163417@186368@186369@deletion@2@28711499@28712933@16@chr16:28711499-28712933@14.5@68@1@0.0147@CNVR6686.3, CNVR6686.1, CNVR6686.2@AC145285-201_1, AC145285-201_2@60@59@61@:eukaryotic translation initiation factor 3, subunit C@:cytosol;protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;cellular protein metabolic process;binding;gene expression;translation;translation initiation factor activity@NA
D163417@186863@186864@duplication@2@30208593@30208679@16@chr16:30208593-30208679@6.18@37@84@2.27@CNVR6694.1, CNVR6694.2, CNVR6694.3@GIYD2-001_5, SULT1A3-001_2@6@6@6@:structure-specific endonuclease subunit SLX1-like;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae);SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae):sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3;sulfotransferase 1A3/1A4-like@:Slx1-Slx4 complex;5'-flap endonuclease activity;DNA repair;protein binding;DNA double-strand break processing involved in repair via single-strand annealing;double-strand break repair via homologous recombination;metal ion binding;crossover junction endodeoxyribonuclease activity:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;cytoplasm;catecholamine metabolic process;cytosol;endoplasmic reticulum unfolded protein response;xenobiotic metabolic process;sulfotransferase activity;activation of signaling protein activity involved in unfolded protein response;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process@NA
D163417@195017@195018@duplication@2@15517149@15517348@17@chr17:15517149-15517348@5.21@311@424@1.36@NA@CDRT1-201_3, TRIM16-202_12@38@38@38@:CMT1A duplicated region transcript 1@:protein binding;molecular_function;cellular_component;biological_process:protein binding;intracellular;zinc ion binding;cytoplasm@NA
D163417@195232@195238@duplication@7@16675293@16703686@17@chr17:16675293-16703686@11.5@530@732@1.38@NA@CCDC144A-202_16, CCDC144A-202_17, CCDC144A-202_18, AC022596-003_1, AC022596-003_2, AC022596-003_3, AC022596-003_4@62.5714285714286@57@66@:coiled-coil domain containing 144A@NA@NA
D163417@195247@195257@duplication@11@16722117@16734358@17@chr17:16722117-16734358@14.5@689@952@1.38@NA@AC022596-001_1, AC022596-001_2, AC022596-001_3, AC022596-001_4, AC022596-001_5, AC022596-001_6, AC022596-001_7, ENST00000414673_5, ENST00000414673_6, ENST00000414673_7, ENST00000414673_8@94.5454545454545@89@97@NA@NA@NA
D163417@195698@195747@deletion@50@18343301@18457581@17@chr17:18343301-18457581@227@1417@240@0.169@NA@ENST00000399124_1, ENST00000399124_2, ENST00000399124_3, ENST00000399124_4, ENST00000399124_5, ENST00000399124_6, ENST00000399124_7, ENST00000399124_8, ENST00000411877_1, ENST00000411877_2, ENST00000411877_4, LGALS9C-201_1, LGALS9C-201_2, LGALS9C-201_3, LGALS9C-201_4, LGALS9C-201_5, LGALS9C-201_6, LGALS9C-201_7, LGALS9C-201_8, LGALS9C-201_9, LGALS9C-201_10, LGALS9C-201_11, ENST00000426269_1, ENST00000426269_2, ENST00000426269_3, ENST00000426269_4, ENST00000426269_5, AC107983-001_1, AC107983-001_2, AC107983-001_3, AC107983-001_4, AC107983-001_5, AC107983-001_6, AC107983-001_7, AC107983-001_8, AC107983-001_9, AC107983-001_10, ENST00000456184_1, ENST00000456184_2, CCDC144B-201_14, CCDC144B-201_15, CCDC144B-201_16, CCDC144B-201_17, CCDC144B-201_18, ENST00000447265_11, ENST00000447265_12, ENST00000447265_13, ENST00000447265_14, ENST00000447265_15@133.877551020408@79@203@:lectin, galactoside-binding, soluble, 9C:protein FAM106B-like@:carbohydrate binding@NA
D163417@195757@195759@duplication@3@18498037@18498176@17@chr17:18498037-18498176@12.1@246@389@1.58@NA@CCDC144B-201_8, CCDC144B-201_9, ENST00000447265_5@1@1@1@NA@NA@NA
D163417@195870@195871@duplication@2@18996289@18996940@17@chr17:18996289-18996940@11.2@199@354@1.78@CNVR7018.4, CNVR7018.2, CNVR7018.6@AC007952-202_1, AC007952-202_2@92.5@92@93@NA@NA@NA
D163417@197726@197728@duplication@3@34539180@34539966@17@chr17:34539180-34539966@13.5@67@186@2.78@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1-202_2, CCL4L1-202_3, CCL4L1-202_4@118@113@122@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
D163417@197747@197748@deletion@2@34640746@34641345@17@chr17:34640746-34641345@18.7@88@0@0@CNVR7077.1, CNVR7077.2, CNVR7077.12@CCL4L2-202_2, CCL4L2-202_3@55@39@71@:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
D163417@198032@198044@deletion@13@36351805@36413071@17@chr17:36351805-36413071@90.6@5201@3071@0.59@CNVR7083.3@AC183087-202_2, AC183087-202_3, AC183087-202_4, AC183087-202_5, AC183087-202_6, AC183087-202_7, AC183087-202_8, AC183087-202_9, AC183087-202_10, AC183087-202_11, AC183087-202_12, AC183087-202_13, AC183087-202_14@47.4615384615385@8@64@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
D163417@200319@200328@deletion@10@44171928@44364337@17@chr17:44171928-44364337@32@3088@2027@0.656@CNVR7114.3, CNVR7114.2@KIAA1267-201_1, KIAA1267-201_2, KIAA1267-201_3, AC217773-201_1, AC217773-201_2, ENST00000451529_1, ENST00000451529_3, ENST00000451529_5@60.25@31@90@:KAT8 regulatory NSL complex subunit 1:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:histone acetyltransferase activity (H4-K8 specific);histone acetyltransferase activity (H4-K16 specific);histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase complex;histone H4-K5 acetylation;MLL1 complex;histone H4-K16 acetylation;protein binding;histone H4-K8 acetylation;nucleus:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
D163417@200337@200349@duplication@13@44399690@44592688@17@chr17:44399690-44592688@25.4@138@342@2.48@CNVR7114.2, CNVR7114.1@LRRC37A-001_7, LRRC37A-001_8, LRRC37A-001_9, LRRC37A-001_10, LRRC37A-001_11, LRRC37A-001_12, LRRC37A-001_13, LRRC37A-001_14, LRRC37A-001_15, AC005829-202_1, AC005829-202_2, AC005829-202_3, LRRC37A2-201_1@149.230769230769@114@196@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane@NA
D163417@200361@200362@deletion@2@44632520@44632791@17@chr17:44632520-44632791@12.7@153@60@0.392@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2-201_12, LRRC37A2-201_13@97.5@97@98@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
D163417@201839@201840@duplication@2@57656835@57657241@17@chr17:57656835-57657241@7.67@100@178@1.78@NA@DHX40-203_12, DHX40-203_13@7.5@3@12@:DEAH (Asp-Glu-Ala-His) box polypeptide 40@:transport;helicase activity;intracellular;ATP-dependent helicase activity;nucleic acid binding;ATP binding@NA
D163417@213493@213494@deletion@2@14508472@14508748@19@chr19:14508472-14508748@8.73@86@32@0.372@NA@CD97-205_8, CD97-205_9@10.5@7@14@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
D163417@215928@215929@deletion@2@35862253@35896584@19@chr19:35862253-35896584@32.8@163@0@0@NA@FFAR3-001_2, ENST00000379093_1@58.5@15@102@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
D163417@217293@217297@deletion@5@40373947@40382827@19@chr19:40373947-40382827@26.8@272@96@0.353@CNVR7639.2@FCGBP-201_22, FCGBP-201_23, FCGBP-201_24, FCGBP-201_25, FCGBP-201_26@130.8@105@155@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D163417@217599@217600@duplication@2@41332509@41349883@19@chr19:41332509-41349883@8.36@351@519@1.48@CNVR7642.1@CYP2F1P-001_1, CYP2A6-204_10@3.5@0@7@:cytochrome P450, family 2, subfamily A, polypeptide 6@:coumarin 7-hydroxylase activity;steroid metabolic process;oxidation-reduction process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;endoplasmic reticulum membrane;drug metabolic process;electron carrier activity;small molecule metabolic process;exogenous drug catabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;enzyme binding;heme binding;xenobiotic metabolic process;iron ion binding;coumarin catabolic process;coumarin metabolic process@: CYTOCHROME P450, SUBFAMILY IIA, POLYPEPTIDE 6; CYP2A6
D163417@218218@218218@deletion@1@43877606@43877758@19@chr19:43877606-43877758@6.47@34@3@0.0882@NA@CD177P-201_1@11@11@11@NA@NA@NA
D163417@220212@220214@deletion@3@50472859@50473865@19@chr19:50472859-50473865@8.09@329@201@0.611@NA@SIGLEC16-202_1, SIGLEC16-202_2, SIGLEC16-202_3@63.6666666666667@56@68@NA@NA@NA
D163417@221165@221165@deletion@1@54723740@54723786@19@chr19:54723740-54723786@5.04@50@18@0.36@NA@LILRB3-008_7@62@62@62@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D163417@221169@221180@duplication@12@54726152@54745755@19@chr19:54726152-54745755@13.3@1126@1483@1.32@CNVR7721.3, CNVR7721.4, CNVR7721.1@LILRB3-008_1, LILRB3-008_2, LILRB3-008_3, AC010492-001_1, AC010492-001_2, LILRA6-002_4, LILRA6-002_5, LILRA6-002_6, LILRA6-002_7, LILRA6-002_8, LILRA6-002_9, LILRA6-002_10@64.4166666666667@44@119@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D163417@221203@221204@duplication@2@54780120@54780311@19@chr19:54780120-54780311@5.23@156@228@1.46@NA@LILRB2-001_11, LILRB2-001_12@0@0@0@:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2@:regulation of immune response;positive regulation of T cell tolerance induction;immune response;cell adhesion molecule binding;heterotypic cell-cell adhesion;eukaryotic cell surface binding;plasma membrane;negative regulation of calcium ion transport;inhibitory MHC class I receptor activity;cellular response to lipopolysaccharide;cell-cell signaling;membrane;negative regulation of T cell proliferation;Fc receptor mediated inhibitory signaling pathway;immune response-inhibiting cell surface receptor signaling pathway;positive regulation of regulatory T cell differentiation;negative regulation of antigen processing and presentation;extracellular space;integral to plasma membrane;receptor activity;MHC class I protein binding;cell surface receptor signaling pathway;regulation of dendritic cell differentiation;positive regulation of interleukin-6 production;protein phosphatase 1 binding;MHC class Ib protein binding;cytoplasm;signal transduction;protein binding;cellular defense response;positive regulation of T cell proliferation;cell surface@NA
D163417@221340@221341@deletion@2@55146557@55146748@19@chr19:55146557-55146748@6.13@129@71@0.55@NA@LILRB1-002_12, LILRB1-002_13@1@1@1@:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1@:interferon-gamma secretion;defense response to virus;dendritic cell differentiation;negative regulation of interferon-gamma production;regulation of immune response;negative regulation of dendritic cell differentiation;HLA-A specific inhibitory MHC class I receptor activity;negative regulation of alpha-beta T cell activation;negative regulation of transforming growth factor-beta secretion;negative regulation of interleukin-10 secretion;T cell proliferation involved in immune response;plasma membrane;negative regulation of mononuclear cell proliferation;positive regulation of gamma-delta T cell activation involved in immune response;negative regulation of interferon-beta secretion;negative regulation of calcium ion transport;response to virus;negative regulation of serotonin secretion;negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell;cellular response to lipopolysaccharide;negative regulation of cell cycle;positive regulation of cytolysis;negative regulation of T cell mediated cytotoxicity;positive regulation of defense response to virus by host;MHC class I receptor activity;negative regulation of natural killer cell mediated cytotoxicity;negative regulation of dendritic cell apoptotic process;negative regulation of T cell proliferation;negative regulation of CD8-positive, alpha-beta T cell activation;immune response-inhibiting cell surface receptor signaling pathway;Fc receptor mediated inhibitory signaling pathway;negative regulation of cytokine secretion involved in immune response;SH2 domain binding;negative regulation of interleukin-12 secretion;HLA-B specific inhibitory MHC class I receptor activity;negative regulation of osteoclast development;integral to membrane;interferon-gamma production;MHC class I protein binding;protein homodimerization activity;positive regulation of transcription from RNA polymerase II promoter;protein phosphatase 1 binding;positive regulation of gene expression;external side of plasma membrane;receptor internalization;cytoplasm;negative regulation of tumor necrosis factor biosynthetic process;protein binding;signal transduction;negative regulation of interferon-gamma biosynthetic process;negative regulation of endocytosis;positive regulation of apoptotic process@NA
D163417@221407@221413@duplication@7@55278649@55290115@19@chr19:55278649-55290115@9.26@1304@1674@1.28@CNVR7725.2, CNVR7725.1@KIR2DL3-201_8, KIR2DP1-001_9, KIR2DL1-002_1, KIR2DL1-002_2, KIR2DL1-002_3, KIR2DL1-002_4, KIR2DL1-002_5@107.285714285714@76@126@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
D163417@221819@221820@duplication@2@56270382@56273453@19@chr19:56270382-56273453@6.08@160@244@1.52@CNVR7734.1@RFPL4A-201_1, RFPL4A-201_2@32.5@26@39@:ret finger protein-like 4A;ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
D163417@221822@221824@deletion@3@56280509@56284546@19@chr19:56280509-56284546@27.2@827@435@0.526@CNVR7734.1@ENST00000341750_1, ENST00000341750_2, ENST00000341750_3@37.6666666666667@30@47@:ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
D163417@222594@222594@deletion@1@1895747@1896102@20@chr20:1895747-1896102@4.74@136@78@0.574@CNVR7764.2@SIRPA-201_3@34@34@34@:signal-regulatory protein alpha@:blood coagulation;protein binding;integral to membrane;SH3 domain binding;cell adhesion;plasma membrane;membrane;leukocyte migration@NA
D163417@227560@227560@deletion@1@54941129@54943720@20@chr20:54941129-54943720@4.98@190@114@0.6@NA@C20orf108-001_3@0@0@0@:family with sequence similarity 210, member B@:integral to membrane@NA
D163417@231958@231962@deletion@5@16287256@16341164@22@chr22:16287256-16341164@17.3@97@12@0.124@CNVR8071.2, CNVR8071.3@POTEH-002_1, LA16c-59E1-001_1, LA16c-59E1-001_2, LA16c-59E1-001_3, LA16c-59E1-001_4@52.8@36@105@:POTE ankyrin domain family, member H@:protein binding@NA
D163417@232772@232783@deletion@12@20386519@20398724@22@chr22:20386519-20398724@10.5@60@9@0.15@CNVR8094.9, CNVR8094.4, CNVR8094.10@PI4KAP1-204_2, PI4KAP1-204_3, PI4KAP1-204_4, PI4KAP1-204_5, PI4KAP1-204_6, PI4KAP1-204_7, PI4KAP1-204_8, PI4KAP1-204_9, PI4KAP1-204_10, PI4KAP1-204_11, PI4KAP1-204_12, PI4KAP1-204_13@167.5@156@172@NA@NA@NA
D163417@233743@233755@duplication@13@24373119@24396376@22@chr22:24373119-24396376@29.2@1055@1509@1.43@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTTP1-001_1, ENST00000439866_1, ENST00000439866_2, GSTT1-009_1, GSTT1-009_2, GSTT1-009_3, GSTT1-009_4, GSTT1-009_5, ENST00000439996_1, ENST00000439996_2, GSTTP2-001_3, GSTTP2-001_4, GSTTP2-001_5@135.846153846154@111@149@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
D163417@236131@236133@duplication@3@39387414@39388552@22@chr22:39387414-39388552@7.92@250@364@1.46@CNVR8164.1@APOBEC3B-003_6, APOBEC3B-003_7, APOBEC3B-003_8@16@1@29@:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B@:RNA binding;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;negative regulation of transposition;catalytic activity;zinc ion binding@NA
D163417@236770@236771@deletion@2@42538482@42538641@22@chr22:42538482-42538641@6.65@91@42@0.462@CNVR8168.1, CNVR8168.3, CNVR8168.4@CYP2D7P1-202_4, CYP2D7P1-202_5@21.5@21@22@@:oxidation-reduction process;electron carrier activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;heme binding@NA
D163417@237742@237743@duplication@2@50706251@50708823@22@chr22:50706251-50708823@5.57@168@247@1.47@NA@MAPK11-003_1, MAPK11-003_2@15@13@17@:mitogen-activated protein kinase 11@:nucleoplasm;MAPK cascade;MAP kinase activity;protein tyrosine kinase activity;toll-like receptor 4 signaling pathway;Ras protein signal transduction;ATP binding;regulation of sequence-specific DNA binding transcription factor activity;mRNA metabolic process;toll-like receptor 2 signaling pathway;MyD88-dependent toll-like receptor signaling pathway;gene expression;MyD88-independent toll-like receptor signaling pathway;activation of MAPK activity;protein kinase activity;TRIF-dependent toll-like receptor signaling pathway;cytosol;toll-like receptor signaling pathway;nerve growth factor receptor signaling pathway;transcription, DNA-dependent;membrane;muscle cell differentiation;toll-like receptor 1 signaling pathway;intracellular protein kinase cascade;RNA metabolic process;transferase activity, transferring phosphorus-containing groups;phosphotransferase activity, alcohol group as acceptor;Toll signaling pathway;stress-activated MAPK cascade;toll-like receptor 3 signaling pathway;protein serine/threonine kinase activity;positive regulation of muscle cell differentiation;protein phosphorylation;lipopolysaccharide biosynthetic process;response to stress;innate immune response;signal transduction;protein binding@NA
D164942@593@593@deletion@1@1607505@1607639@1@chr1:1607505-1607639@7.24@35@1@0.0286@CNVR17.1@RP11-345P4-003_4@10@10@10@:solute carrier family 35, member E2B@:integral to membrane;membrane;transmembrane transport@NA
D164942@608@608@deletion@1@1643705@1643840@1@chr1:1643705-1643840@4.78@21@0@0@CNVR17.1@CDC2L2-208_7@25@25@25@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
D164942@2932@2934@deletion@3@16973094@16973612@1@chr1:16973094-16973612@14.1@729@452@0.62@CNVR93.3, CNVR93.6, CNVR93.12, CNVR93.7, CNVR93.14, CNVR93.15@RP5-1182A14-001_3, RP5-1182A14-001_4, RP5-1182A14-001_5@40.6666666666667@39@42@NA@NA@NA
D164942@2943@2946@deletion@4@16975671@16976445@1@chr1:16975671-16976445@26@796@434@0.545@CNVR93.3, CNVR93.6, CNVR93.12, CNVR93.7, CNVR93.14, CNVR93.15@RP5-1182A14-001_14, RP5-1182A14-001_15, RP5-1182A14-001_16, RP5-1182A14-001_17@81@69@88@NA@NA@NA
D164942@2949@2966@duplication@18@17008209@17046653@1@chr1:17008209-17046653@44.8@2077@3051@1.47@CNVR93.3, CNVR93.15, CNVR93.4@RP1-163M9-001_1, RP1-163M9-001_2, RP1-163M9-001_3, RP1-163M9-001_4, ESPNP-002_1, ESPNP-002_2, ESPNP-002_3, ESPNP-002_4, ESPNP-002_5, ESPNP-002_6, ESPNP-002_7, ESPNP-002_8, ESPNP-002_9, ESPNP-002_10, ESPNP-002_11, AL021920-201_1, AL021920-201_2, AL021920-201_3@41.6666666666667@22@46@NA@NA@NA
D164942@3001@3021@duplication@21@17200220@17275020@1@chr1:17200220-17275020@21.8@1450@1980@1.37@CNVR94.4, CNVR94.5@ENST00000438002_2, ENST00000457075_1, ENST00000457075_2, CROCC-201_1, CROCC-201_2, CROCC-201_3, CROCC-201_4, CROCC-201_5, CROCC-201_6, CROCC-201_7, CROCC-201_8, CROCC-201_9, CROCC-201_10, CROCC-201_11, CROCC-201_12, CROCC-201_13, CROCC-201_14, CROCC-201_15, CROCC-201_16, CROCC-201_17, CROCC-201_18@71.2380952380952@23@85@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
D164942@3776@3779@duplication@4@21807425@21809812@1@chr1:21807425-21809812@7.28@189@284@1.5@CNVR107.2, CNVR107.1@NBPF3-003_16, NBPF3-003_17, NBPF3-003_18, NBPF3-003_19@85.25@62@111@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 3@:cytoplasm@NA
D164942@3965@3965@deletion@1@22338945@22339034@1@chr1:22338945-22339034@11.8@57@1@0.0175@CNVR108.2, CNVR108.1@CELA3A-201_8@3@3@3@:chymotrypsin-like elastase family, member 3A@:proteolysis;digestion;cholesterol metabolic process;catalytic activity;serine-type endopeptidase activity@NA
D164942@11245@11246@deletion@2@89476589@89477711@1@chr1:89476589-89477711@95.4@566@0@0@CNVR244.1@GBP3-001_7, GBP3-001_8@54@54@54@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
D164942@12416@12417@deletion@2@104202984@104203299@1@chr1:104202984-104203299@9.61@118@48@0.407@CNVR266.3, CNVR266.1@AMY1A-001_7, AMY1A-001_8@123.5@118@129@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D164942@14256@14257@duplication@2@142620647@142621060@1@chr1:142620647-142621060@4.92@252@351@1.39@NA@ENST00000411746_2, ENST00000369381_9@7.5@7@8@NA@NA@NA
D164942@14491@14495@duplication@5@144619885@144679973@1@chr1:144619885-144679973@16@350@600@1.71@NA@AL592284-001_11, AL592284-001_12, WI2-1896O14-001_1, WI2-1896O14-001_2, WI2-1896O14-001_3@7.6@2@22@NA@NA@NA
D164942@15397@15431@deletion@35@149036437@149115189@1@chr1:149036437-149115189@26.1@857@530@0.618@CNVR350.3, CNVR350.1@RP11-744H18-001_1, RP11-744H18-001_2, RP11-744H18-001_3, RP11-744H18-001_4, RP11-744H18-001_5, RP11-744H18-001_6, RP11-744H18-001_7, RP11-744H18-001_8, RP11-744H18-001_9, RP11-744H18-001_10, RP11-744H18-001_11, RP11-744H18-001_12, RP11-744H18-001_13, RP11-744H18-001_14, RP11-744H18-001_15, RP11-744H18-001_16, RP11-744H18-001_17, ENST00000401087_2, ENST00000401087_3, ENST00000401087_4, ENST00000401087_5, ENST00000401087_6, ENST00000401087_7, ENST00000401087_8, ENST00000401087_9, ENST00000401087_10, ENST00000401087_11, ENST00000401087_12, ENST00000401087_13, ENST00000401087_14, ENST00000401087_15, ENST00000401087_16, RP11-403I13-201_1, RP11-403I13-201_2, RP11-403I13-201_3@79.7428571428571@11@87@NA@NA@NA
D164942@15456@15462@deletion@7@149375000@149400543@1@chr1:149375000-149400543@19.8@613@351@0.573@CNVR350.1@FCGR1C-201_4, FCGR1C-201_5, FCGR1C-201_6, ENST00000415338_1, HIST2H3PS2-001_1, HIST2H3PS2-001_2, RP5-998N21-002_1@73.7142857142857@70@76@NA@NA@NA
D164942@18672@18684@duplication@13@161559354@161600997@1@chr1:161559354-161600997@36.3@1421@2094@1.47@CNVR383.1@FCGR2C-006_3, FCGR2C-006_4, FCGR2C-006_5, FCGR2C-006_6, FCGR2C-006_7, ENST00000448848_1, ENST00000448848_2, ENST00000448848_3, FCGR3B-001_1, FCGR3B-001_2, FCGR3B-001_3, FCGR3B-001_4, FCGR3B-001_5@41.0769230769231@34@57@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene):Fc fragment of IgG, low affinity IIIb, receptor (CD16b)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction:IgG binding;protein binding;extracellular region;immune response;plasma membrane;anchored to membrane@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
D164942@21362@21374@duplication@13@196743977@196801320@1@chr1:196743977-196801320@72.5@1708@2892@1.69@CNVR459.1@CFHR3-001_1, CFHR3-001_2, CFHR3-001_3, CFHR3-001_4, CFHR3-001_5, CFHR3-001_6, CFHR1-001_1, CFHR1-001_2, CFHR1-001_3, CFHR1-001_4, CFHR1-001_5, CFHR1-001_6, CFHR2-201_1@96.7692307692308@85@119@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
D164942@23042@23045@duplication@4@207737211@207741388@1@chr1:207737211-207741388@19.1@574@927@1.61@CNVR485.1, CNVR485.2@CR1-201_22, CR1-201_23, CR1-201_24, CR1-201_25@11.75@9@16@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
D164942@24160@24164@deletion@5@223727670@223729472@1@chr1:223727670-223729472@13.1@68@5@0.0735@NA@CAPN8-202_20, CAPN8-202_21, CAPN8-202_22, CAPN8-202_23, CAPN8-202_24@0@0@0@:calpain 8@:proteolysis;Golgi apparatus;intracellular;calcium-dependent cysteine-type endopeptidase activity;calcium ion binding@NA
D164942@25609@25665@duplication@57@236687272@236767428@1@chr1:236687272-236767428@227@9306@13896@1.49@NA@LGALS8-001_2, LGALS8-001_3, LGALS8-001_4, LGALS8-001_5, LGALS8-001_6, LGALS8-001_7, LGALS8-001_8, LGALS8-001_9, LGALS8-001_10, LGALS8-001_11, LGALS8-001_12, ENST00000433131_1, ENST00000433131_2, HEATR1-001_2, HEATR1-001_3, HEATR1-001_4, HEATR1-001_5, HEATR1-001_6, HEATR1-001_7, HEATR1-001_8, HEATR1-001_9, HEATR1-001_10, HEATR1-001_11, HEATR1-001_12, HEATR1-001_13, HEATR1-001_14, HEATR1-001_15, HEATR1-001_16, HEATR1-001_17, HEATR1-001_18, HEATR1-001_19, HEATR1-001_20, HEATR1-001_21, HEATR1-001_22, HEATR1-001_23, HEATR1-001_24, HEATR1-001_25, HEATR1-001_26, HEATR1-001_27, HEATR1-001_28, HEATR1-001_29, HEATR1-001_30, HEATR1-001_31, HEATR1-001_32, HEATR1-001_33, HEATR1-001_34, HEATR1-001_35, HEATR1-001_36, HEATR1-001_37, HEATR1-001_38, HEATR1-001_39, HEATR1-001_40, HEATR1-001_41, HEATR1-001_42, HEATR1-001_43, HEATR1-001_44, HEATR1-001_45@0.666666666666667@0@1@:lectin, galactoside-binding, soluble, 8:HEAT repeat containing 1@:carbohydrate binding;extracellular space;plasma cell differentiation;T cell costimulation;cytoplasm:protein binding;mitochondrion;ribonucleoprotein complex;nucleolus;binding;nucleus;rRNA processing@NA
D164942@33560@33560@deletion@1@87408191@87408267@2@chr2:87408191-87408267@6.56@72@26@0.361@CNVR861.2@AC083899-001_24@85@85@85@NA@NA@NA
D164942@33739@33739@duplication@1@89339723@89340017@2@chr2:89339723-89340017@8.49@185@323@1.75@CNVR866.7, CNVR866.6, CNVR866.10, CNVR866.9, CNVR866.11@IGKV1-12-001_2@0@0@0@@:protein binding@NA
D164942@33747@33747@deletion@1@89416835@89417129@2@chr2:89416835-89417129@7.77@283@154@0.544@CNVR866.7, CNVR866.10, CNVR866.11@IGKV1-17-001_2@2@2@2@@:protein binding@NA
D164942@33822@33823@duplication@2@90121479@90122134@2@chr2:90121479-90122134@6.63@413@603@1.46@CNVR867.10, CNVR867.5, CNVR867.3, CNVR867.9, CNVR867.14@IGKV1D-17-001_1, IGKV1D-17-001_2@8@8@8@@:protein binding@NA
D164942@33832@33835@deletion@4@90192770@90199191@2@chr2:90192770-90199191@52.1@536@194@0.362@CNVR867.10, CNVR867.5, CNVR867.3, CNVR867.9, CNVR867.15@IGKV1D-13-001_1, IGKV1D-13-001_2, IGKV1D-12-001_1, IGKV1D-12-001_2@8.25@7@10@@:protein binding:protein binding@NA
D164942@34573@34574@deletion@2@97877285@97877479@2@chr2:97877285-97877479@7.38@420@266@0.633@CNVR886.1@ENST00000461153_47, ENST00000461153_48@63.5@63@64@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
D164942@34615@34631@duplication@17@98127603@98162325@2@chr2:98127603-98162325@35@241@580@2.41@CNVR888.3@ANKRD36B-001_23, ANKRD36B-001_24, ANKRD36B-001_25, ANKRD36B-001_26, ANKRD36B-001_27, ANKRD36B-001_28, ANKRD36B-001_29, ANKRD36B-001_30, ANKRD36B-001_31, ANKRD36B-001_32, ANKRD36B-001_33, ANKRD36B-001_34, ANKRD36B-001_35, ANKRD36B-001_36, ANKRD36B-001_37, ANKRD36B-001_38, ANKRD36B-001_39@130.058823529412@64@154@NA@NA@NA
D164942@37212@37212@deletion@1@130902322@130902708@2@chr2:130902322-130902708@5.38@106@53@0.5@NA@CCDC74B-001_1@0@0@0@:coiled-coil domain containing 74A;coiled-coil domain containing 74B@NA@NA
D164942@47662@47663@deletion@2@11925055@11925573@3@chr3:11925055-11925573@7.9@103@45@0.437@NA@AC090958-001_9, AC090958-001_10@9.5@9@10@NA@NA@NA
D164942@58011@58011@deletion@1@143212497@143212607@3@chr3:143212497-143212607@6.12@151@79@0.523@NA@SLC9A9-001_11@0@0@0@:solute carrier family 9, subfamily A (NHE9, cation proton antiporter 9), member 9@:solute:hydrogen antiporter activity;sodium:hydrogen antiporter activity;cation transport;late endosome membrane;ion transport;recycling endosome;transmembrane transport;integral to membrane;sodium ion transport;regulation of pH@: AUTISM, SUSCEPTIBILITY TO, 16; AUTS16
D164942@61117@61118@deletion@2@189689681@189690814@3@chr3:189689681-189690814@15.4@377@189@0.501@NA@LEPREL1-001_11, LEPREL1-001_12@0@0@0@:leprecan-like 1@:oxidation-reduction process;negative regulation of cell proliferation;oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen;peptidyl-proline hydroxylation;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors;oxidoreductase activity;basement membrane;procollagen-proline 3-dioxygenase activity;L-ascorbic acid binding;endoplasmic reticulum;Golgi apparatus;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;extracellular matrix organization;endoplasmic reticulum lumen;iron ion binding;collagen metabolic process@: MYOPIA, HIGH, WITH CATARACT AND VITREORETINAL DEGENERATION; MCVD
D164942@61638@61647@deletion@10@195698196@195702772@3@chr3:195698196-195702772@9.33@844@581@0.688@CNVR1707.1, CNVR1707.2@SDHALP1-002_9, SDHALP1-002_10, SDHALP1-002_11, ENST00000354937_10, ENST00000354937_11, ENST00000354937_12, ENST00000354937_13, ENST00000366437_1, ENST00000366437_2, ENST00000366437_3@38.1@31@43@NA@NA@NA
D164942@61897@61898@deletion@2@197349060@197349202@3@chr3:197349060-197349202@5.02@57@24@0.421@CNVR1722.1@AC024560-005_5, AC024560-201_6@22@22@22@NA@NA@NA
D164942@62040@62053@duplication@14@59325@289945@4@chr4:59325-289945@37.2@5652@7733@1.37@NA@ZNF595-201_2, ZNF595-201_3, ZNF595-201_4, ZNF876P-202_1, ZNF876P-202_2, ZNF876P-202_3, ZNF732-202_3, ZNF732-202_4, ZNF732-202_5, ZNF732-202_6, ZNF732-202_7, ZNF732-202_8, ZNF732-202_9, ZNF732-202_10@1.42857142857143@0@4@:zinc finger protein 732@:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
D164942@65357@65360@duplication@4@70152472@70160768@4@chr4:70152472-70160768@11.2@494@709@1.44@CNVR1957.2, CNVR1957.1@UGT2B28-201_4, UGT2B28-201_5, UGT2B28-201_6, UGT2B28-201_7@69.75@68@71@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
D164942@68823@68823@deletion@1@141677072@141677472@4@chr4:141677072-141677472@4.71@147@83@0.565@NA@TBC1D9-201_1@0@0@0@:TBC1 domain family, member 9 (with GRAM domain)@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular;calcium ion binding@NA
D164942@70670@70675@duplication@6@190426460@190864428@4@chr4:190426460-190864428@7.15@369@515@1.4@NA@AC020698-201_2, AF250324-201_1, AF250324-201_2, AF250324-201_3, FRG1-201_1, FRG1-201_2@0@0@0@:protein FRG1-like;FSHD region gene 1@:actin filament binding;nuclear speck;nucleolus;Cajal body;mRNA splicing, via spliceosome;protein binding, bridging;catalytic step 2 spliceosome;rRNA processing@NA
D164942@70681@70683@duplication@3@190882979@190904706@4@chr4:190882979-190904706@6.93@377@522@1.38@CNVR2256.1@FRG1-201_8, FRG1-201_9, AF146191-201_4@9.66666666666667@1@25@:protein FRG1-like;FSHD region gene 1@:actin filament binding;nuclear speck;nucleolus;Cajal body;mRNA splicing, via spliceosome;protein binding, bridging;catalytic step 2 spliceosome;rRNA processing@NA
D164942@70817@70830@duplication@14@716925@796593@5@chr5:716925-796593@105@2793@5020@1.8@CNVR2280.3@ZDHHC11B-201_1, ZDHHC11B-201_2, ZDHHC11B-201_3, ZDHHC11B-201_4, ZDHHC11B-201_5, ZDHHC11B-201_6, ZDHHC11B-201_7, ZDHHC11B-201_8, ZDHHC11B-201_9, ZDHHC11B-201_10, AC026740-202_1, AC026740-202_2, AC026740-202_3, AC026740-202_4@70.3571428571429@52@96@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
D164942@70837@70840@duplication@4@837482@847731@5@chr5:837482-847731@12.8@808@1167@1.44@CNVR2280.3, CNVR2280.8@ZDHHC11-201_3, ZDHHC11-201_4, ZDHHC11-201_5, ZDHHC11-201_6@21.25@15@29@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
D164942@73727@73727@deletion@1@69717564@69717599@5@chr5:69717564-69717599@14.3@68@0@0@CNVR2494.17, CNVR2494.3@GTF2H2B-201_4@139@139@139@NA@NA@NA
D164942@73746@73754@deletion@9@69796546@69807068@5@chr5:69796546-69807068@7.56@35@1@0.0286@CNVR2494.10, CNVR2494.57@AC146944-203_1, AC146944-203_2, ENST00000456583_1, ENST00000456583_2, ENST00000456583_3, ENST00000456583_4, ENST00000456583_5, AC146944-202_1, AC146944-202_2@152.666666666667@85@173@NA@NA@NA
D164942@73781@73796@duplication@16@70247770@70308746@5@chr5:70247770-70308746@13.1@804@1154@1.44@CNVR2494.41, CNVR2494.14, CNVR2494.30, CNVR2494.20, CNVR2494.62@SMN1-001_8, SMN1-001_9, NAIP-001_4, NAIP-001_5, NAIP-001_6, NAIP-001_7, NAIP-001_8, NAIP-001_9, NAIP-001_10, NAIP-001_11, NAIP-001_12, NAIP-001_13, NAIP-001_14, NAIP-001_15, NAIP-001_16, NAIP-001_17@5.8125@0@32@:survival of motor neuron 2, centromeric;survival of motor neuron 1, telomeric:baculoviral IAP repeat-containing protein 1-like;NLR family, apoptosis inhibitory protein@:nucleoplasm;ncRNA metabolic process;Cajal body;RNA metabolic process;spliceosomal complex;cytoplasm;cytosol;protein binding;cell death;spliceosomal complex assembly;RNA binding;mRNA processing;nucleus;gene expression;spliceosomal snRNP assembly:negative regulation of apoptotic process;inflammatory response;basolateral plasma membrane;nucleoside-triphosphatase activity;cysteine-type endopeptidase inhibitor activity;intracellular;nucleotide binding;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;ATP binding;cytoplasm;innate immune response;protein binding;negative regulation of neuron apoptotic process;metal ion binding;nervous system development@: SPINAL MUSCULAR ATROPHY, TYPE II; SMA2; SPINAL MUSCULAR ATROPHY, TYPE I; SMA1; SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4; SPINAL MUSCULAR ATROPHY, TYPE III; SMA3
D164942@73817@73820@deletion@4@70370032@70378820@5@chr5:70370032-70378820@26.6@125@0@0@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.8, CNVR2494.1, CNVR2494.37@AC044797-201_2, AC044797-201_3, AC044797-201_4, AC044797-201_5@125.5@119@138@NA@NA@NA
D164942@79566@79570@duplication@5@175386532@175394271@5@chr5:175386532-175394271@17.1@252@437@1.73@NA@THOC3-001_2, THOC3-001_3, THOC3-001_4, THOC3-001_5, THOC3-001_6@116@27@182@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
D164942@80485@80489@duplication@5@180424215@180431444@5@chr5:180424215-180431444@6.58@477@636@1.33@CNVR2719.1@BTNL3-202_3, BTNL3-202_4, BTNL3-202_5, BTNL3-202_6, BTNL3-202_7@46.2@4@103@:butyrophilin-like 3@:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
D164942@80503@80510@deletion@8@180526142@180527658@5@chr5:180526142-180527658@22.5@368@178@0.484@NA@AC008620-201_1, AC008620-201_2, AC008620-201_3, AC008620-201_4, AC008620-201_5, AC008620-201_6, AC008620-201_7, AC008620-201_8@0.875@0@1@NA@NA@NA
D164942@82518@82519@deletion@2@29911030@29911321@6@chr6:29911030-29911321@4.93@217@139@0.641@CNVR2829.7, CNVR2829.2, CNVR2829.3@AL645929-201_1, HLA-A-001_5@20@20@20@:major histocompatibility complex, class I, A@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO
D164942@83002@83004@deletion@3@31237745@31239109@6@chr6:31237745-31239109@21.8@502@255@0.508@CNVR2838.1@HLA-C-006_3, HLA-C-006_4, HLA-C-006_5@21@13@25@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
D164942@83014@83018@deletion@5@31323946@31324990@6@chr6:31323946-31324990@25.5@650@357@0.549@CNVR2841.12, CNVR2841.14, CNVR2841.8@HLA-B-201_1, HLA-B-201_2, HLA-B-201_3, HLA-B-201_4, HLA-B-201_5@67.2@59@73@:major histocompatibility complex, class I, B@:MHC class I protein complex;regulation of immune response;regulation of interleukin-12 production;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;regulation of T cell anergy;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;receptor binding;early endosome membrane;virus-host interaction;regulation of interleukin-6 production;regulation of dendritic cell differentiation;phagocytic vesicle membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO; SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1
D164942@83601@83614@deletion@14@31973468@31975476@6@chr6:31973468-31975476@33.5@1243@772@0.621@CNVR2843.6, CNVR2843.3@CYP21A1P-001_1, CYP21A1P-001_2, CYP21A1P-001_3, CYP21A1P-001_4, CYP21A1P-001_5, CYP21A1P-001_6, CYP21A1P-001_7, CYP21A1P-001_8, AL645922-201_1, AL645922-201_2, AL645922-201_3, AL645922-201_4, AL645922-201_5, AL645922-201_6, AL645922-201_7@110.714285714286@98@121@NA@NA@NA
D164942@83642@83647@deletion@6@31996236@31997826@6@chr6:31996236-31997826@14.3@307@164@0.534@CNVR2843.6, CNVR2843.5@C4B-001_25, C4B-001_26, C4B-001_27, C4B-001_28, C4B-001_29, C4B-001_30@13.1666666666667@5@19@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
D164942@83910@83930@duplication@21@32441204@32552156@6@chr6:32441204-32552156@77@1024@1869@1.83@CNVR2845.21, CNVR2845.25@HLA-DRB9-001_1, HLA-DRB5-001_1, HLA-DRB5-001_2, HLA-DRB5-001_3, HLA-DRB5-001_4, HLA-DRB5-001_5, HLA-DRB5-001_6, HLA-DRB6-002_1, HLA-DRB6-002_2, HLA-DRB6-002_3, HLA-DRB6-002_4, HLA-DRB6-002_5, HLA-DRB6-002_6, AL713966-201_1, AL713966-201_2, AL713966-201_3, HLA-DRB1-001_2, HLA-DRB1-001_3, HLA-DRB1-001_4, HLA-DRB1-001_5, HLA-DRB1-001_6@127.142857142857@44@189@:major histocompatibility complex, class II, DR beta 5:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
D164942@83943@83945@duplication@3@32629746@32632845@6@chr6:32629746-32632845@5.56@287@393@1.37@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20, CNVR2845.31, CNVR2845.64@HLA-DQB1-003_3, HLA-DQB1-003_4, ENST00000443574_1@108.666666666667@101@113@:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
D164942@92589@92595@duplication@7@160132299@160133523@6@chr6:160132299-160133523@13.8@694@962@1.39@CNVR3127.2, CNVR3127.1@ENST00000442642_2, ENST00000442642_3, ENST00000442642_4, ENST00000442642_5, ENST00000442642_6, ENST00000442642_7, ENST00000442642_8@83.8571428571429@13@112@:superoxide dismutase 2, mitochondrial;uncharacterized LOC100129518@:response to reactive oxygen species;oxidation-reduction process;mitochondrion;negative regulation of cell proliferation;neuron development;negative regulation of fat cell differentiation;removal of superoxide radicals;response to gamma radiation;response to L-ascorbic acid;response to lipopolysaccharide;response to nutrient levels;response to zinc ion;protein homotetramerization;post-embryonic development;iron ion homeostasis;hemopoiesis;aging;mitochondrial inner membrane;age-dependent response to reactive oxygen species;response to drug;oxygen binding;mitochondrial nucleoid;vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure;apoptotic process;superoxide metabolic process;response to superoxide;detection of oxygen;response to silicon dioxide;cytoplasm;response to stress;respiratory electron transport chain;superoxide anion generation;protein homooligomerization;regulation of mitochondrial membrane potential;positive regulation of nitric oxide biosynthetic process;response to manganese ion;regulation of blood pressure;metal ion binding;negative regulation of apoptotic process;response to cadmium ion;response to oxidative stress;liver development;regulation of catalytic activity;negative regulation of fibroblast proliferation;response to selenium ion;age-dependent response to oxidative stress;response to electrical stimulus;mitochondrial matrix;identical protein binding;mitochondrion organization;response to hyperoxia;vasodilation;response to hydrogen peroxide;superoxide dismutase activity;heart development;negative regulation of neuron apoptotic process;erythrophore differentiation;locomotory behavior;DNA binding;release of cytochrome c from mitochondria;response to axon injury;oxygen homeostasis;response to activity;glutathione metabolic process;hydrogen peroxide metabolic process;hydrogen peroxide biosynthetic process;regulation of transcription from RNA polymerase II promoter;response to hypoxia;protein binding;manganese ion binding;cellular response to ethanol@: MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6; MVCD6
D164942@93099@93101@duplication@3@167790036@167794825@6@chr6:167790036-167794825@8.3@201@299@1.49@NA@TCP10-001_3, TCP10-001_4, TCP10-001_5@77@52@103@:t-complex 10@:cytosol@NA
D164942@93379@93400@duplication@22@170713853@170892836@6@chr6:170713853-170892836@19.7@2582@3352@1.3@NA@FAM120B-001_11, PSMB1-201_1, PSMB1-201_2, PSMB1-201_3, PSMB1-201_4, PSMB1-201_5, PSMB1-201_6, TBP-201_1, TBP-201_2, TBP-201_3, TBP-201_4, TBP-201_5, TBP-201_6, TBP-201_7, TBP-201_8, TBP-201_9, PDCD2-201_3, PDCD2-201_4, PDCD2-201_5, PDCD2-201_6, PDCD2-201_7@0@0@0@:family with sequence similarity 120B:proteasome (prosome, macropain) subunit, beta type, 1:TATA box binding protein:programmed cell death 2@:cell differentiation;nucleus;regulation of transcription, DNA-dependent;transcription, DNA-dependent:nucleoplasm;proteasome core complex;proteasome complex;S phase of mitotic cell cycle;mitotic cell cycle;antigen processing and presentation of peptide antigen via MHC class I;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;RNA metabolic process;G1/S transition of mitotic cell cycle;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;mRNA metabolic process;regulation of cellular amino acid metabolic process;apoptotic process;viral reproduction;gene expression;cell cycle checkpoint;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;virus-host interaction;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;small molecule metabolic process;threonine-type endopeptidase activity;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;M/G1 transition of mitotic cell cycle;cytosol;protein binding;antigen processing and presentation of exogenous peptide antigen via MHC class I;proteolysis involved in cellular protein catabolic process;regulation of apoptotic process;cellular nitrogen compound metabolic process;protein polyubiquitination:nucleoplasm;repressing transcription factor binding;DNA binding;sequence-specific DNA binding transcription factor activity;transcription from RNA polymerase III promoter;transcription factor TFIID complex;nuclear euchromatin;spermatogenesis;cell death;nucleus;viral reproduction;gene expression;pronucleus;transcription factor TFIIA complex;virus-host interaction;transcription initiation from RNA polymerase II promoter;male pronucleus;female pronucleus;transcription from RNA polymerase II promoter;cytoplasm;DNA-dependent transcription, initiation;RNA polymerase II repressing transcription factor binding;protein binding;positive regulation of transcription, DNA-dependent;transcription regulatory region DNA binding;transcription factor binding;transcription elongation from RNA polymerase II promoter:nucleus;apoptotic process;DNA binding;zinc ion binding;programmed cell death;cytoplasm@: SPINOCEREBELLAR ATAXIA 17; SCA17
D164942@94190@94192@deletion@3@5959482@5963594@7@chr7:5959482-5963594@19.1@392@178@0.454@NA@C7orf28A-001_12, C7orf28A-001_13, C7orf28A-001_14@72.3333333333333@71@73@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D164942@94196@94212@deletion@17@5972415@6006833@7@chr7:5972415-6006833@32.3@751@397@0.529@NA@RSPH10B-002_3, RSPH10B-002_4, RSPH10B-002_5, RSPH10B-002_6, RSPH10B-002_7, RSPH10B-002_8, RSPH10B-002_9, RSPH10B-002_10, RSPH10B-002_11, RSPH10B-002_12, RSPH10B-002_13, RSPH10B-002_14, RSPH10B-002_15, RSPH10B-002_16, RSPH10B-002_17, RSPH10B-002_18, RSPH10B-002_19@10.7647058823529@8@18@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D164942@94420@94444@duplication@25@6797226@6844687@7@chr7:6797226-6844687@33.6@1344@1963@1.46@NA@RSPH10B2-204_3, RSPH10B2-204_4, RSPH10B2-204_5, RSPH10B2-204_6, RSPH10B2-204_7, RSPH10B2-204_8, RSPH10B2-204_9, RSPH10B2-204_10, RSPH10B2-204_11, RSPH10B2-204_12, RSPH10B2-204_13, RSPH10B2-204_14, RSPH10B2-204_15, RSPH10B2-204_16, RSPH10B2-204_17, RSPH10B2-204_18, RSPH10B2-204_19, RSPH10B2-204_20, RSPH10B2-204_21, ENST00000429267_1, ENST00000429267_2, C7orf28B-001_12, C7orf28B-001_13, C7orf28B-001_14, C7orf28B-001_15@35.16@6@121@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D164942@94461@94463@deletion@3@6906478@6920188@7@chr7:6906478-6920188@10.1@245@132@0.539@NA@RP11-740N7-201_1, RP11-740N7-201_2, RP11-740N7-201_3@21.3333333333333@20@22@NA@NA@NA
D164942@96584@96584@deletion@1@38398540@38398764@7@chr7:38398540-38398764@9.73@136@53@0.39@CNVR3354.1@TRGV3-001_1@6@6@6@@:protein binding;immune response;peptide antigen binding;plasma membrane;MHC protein binding@NA
D164942@97990@97996@duplication@7@62753052@62764435@7@chr7:62753052-62764435@16.4@550@814@1.48@NA@AC006455-201_1, AC006455-201_2, AC006455-201_3, AC006455-201_4, ENST00000444809_1, ENST00000444809_2, ENST00000444809_3, ENST00000444809_4@138.285714285714@97@171@NA@NA@NA
D164942@98172@98174@duplication@3@64533821@64534227@7@chr7:64533821-64534227@12.2@39@129@3.31@NA@RP11-460N20-001_11, RP11-460N20-001_12, ENST00000501153_3@100.666666666667@100@101@NA@NA@NA
D164942@98192@98193@deletion@2@64646770@64646889@7@chr7:64646770-64646889@7.78@53@12@0.226@NA@INTS4L1-201_8, INTS4L1-201_9@51.5@51@52@NA@NA@NA
D164942@98601@98623@deletion@23@72412378@72440606@7@chr7:72412378-72440606@69.6@2443@1345@0.551@NA@POM121-003_14, POM121-003_15, POM121-003_16, NSUN5C-006_1, NSUN5C-006_2, NSUN5C-006_3, NSUN5C-006_4, NSUN5C-006_5, NSUN5C-006_6, NSUN5C-006_7, NSUN5C-006_8, NSUN5C-006_9, NSUN5C-006_10, NSUN5C-006_11, NSUN5C-006_12, TRIM74-002_1, TRIM74-002_2, TRIM74-002_3, TRIM74-002_4, TRIM74-002_5, ENST00000380778_1, ENST00000380778_2, STAG3L3-003_8@6.30434782608696@0@15@:POM121 transmembrane nucleoporin:tripartite motif containing 74@:glucose transport;nuclear envelope;small molecule metabolic process;carbohydrate metabolic process;mRNA transport;transmembrane transport;nuclear membrane;regulation of glucose transport;protein transport;viral reproduction;endoplasmic reticulum membrane;hexose transport;nuclear pore;cytokine-mediated signaling pathway:protein binding;intracellular;zinc ion binding:nucleus;binding@NA
D164942@98688@98701@deletion@14@72613728@72640087@7@chr7:72613728-72640087@15.7@115@28@0.243@NA@RP11-396K3-001_18, RP11-396K3-001_19, RP11-396K3-001_20, RP11-396K3-001_21, RP11-396K3-001_22, RP11-396K3-001_23, ENST00000338578_1, ENST00000338578_2, ENST00000338578_3, ENST00000338578_4, NCF1B-001_1, NCF1B-001_2, NCF1B-001_3, NCF1B-001_4@8.42857142857143@1@27@NA@NA@NA
D164942@99233@99233@deletion@1@74991244@74991359@7@chr7:74991244-74991359@5.61@25@0@0@CNVR3456.1@STAG3L1-004_3@60@60@60@NA@NA@NA
D164942@99272@99273@deletion@2@75054920@75055736@7@chr7:75054920-75055736@5.24@88@45@0.511@NA@POM121C-001_8, POM121C-001_9@51@30@72@:POM121 transmembrane nucleoporin C@:nuclear membrane;protein binding;protein transport;endoplasmic reticulum membrane;nuclear pore;mRNA transport@NA
D164942@99454@99454@deletion@1@76063357@76063473@7@chr7:76063357-76063473@14.7@97@14@0.144@CNVR3462.1@ZP3-002_6@10@10@10@:zona pellucida glycoprotein 3 (sperm receptor)@:negative regulation of transcription, DNA-dependent;manganese ion transmembrane transporter activity;intracellular protein transport;proteinaceous extracellular matrix;plasma membrane;positive regulation of acrosome reaction;outer acrosomal membrane;protein kinase C signaling cascade;manganese ion transmembrane transport;intracellular signal transduction;humoral immune response mediated by circulating immunoglobulin;negative regulation of binding of sperm to zona pellucida;positive regulation of inflammatory response;endoplasmic reticulum;signal transducer activity;perinuclear region of cytoplasm;secretory granule;positive regulation of transcription, DNA-dependent;positive regulation of ovarian follicle development;positive regulation of interferon-gamma production;carbohydrate binding;manganese ion transport;positive regulation of antral ovarian follicle growth;extracellular matrix;positive regulation of leukocyte migration;positive regulation of humoral immune response;extracellular space;blastocyst formation;integral to membrane;store-operated calcium channel activity;oocyte development;multivesicular body;phosphatidylinositol-mediated signaling;acrosomal vesicle;positive regulation of protein kinase B signaling cascade;Golgi apparatus;positive regulation of calcium ion import;positive regulation of protein kinase activity;positive regulation of acrosomal vesicle exocytosis;positive regulation of interleukin-4 production;cytoplasm;protein binding;binding of sperm to zona pellucida;positive regulation of phosphatidylinositol biosynthetic process;extracellular region;positive regulation of T cell proliferation;acrosin binding;positive regulation of type IV hypersensitivity;egg coat formation@NA
D164942@99463@99465@deletion@3@76121472@76129838@7@chr7:76121472-76129838@9.24@73@21@0.288@CNVR3462.1@DTX2-001_6, DTX2-001_7, DTX2-001_8@51.3333333333333@22@69@:deltex homolog 2 (Drosophila)@:ligase activity;cytoplasm;nuclear membrane;Notch signaling pathway;protein binding;nucleus;zinc ion binding;protein ubiquitination@NA
D164942@99489@99490@deletion@2@76240773@76241131@7@chr7:76240773-76241131@5.25@236@147@0.623@CNVR3463.10@POMZP3-003_6, POMZP3-003_7@43.5@41@46@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
D164942@101721@101726@deletion@6@100331652@100336237@7@chr7:100331652-100336237@16.5@770@476@0.618@CNVR3509.1@ZAN-001_2, ZAN-001_3, ZAN-001_4, ZAN-001_5, ZAN-001_6, ZAN-001_7@81.6666666666667@71@89@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
D164942@102166@102166@duplication@1@102219874@102220244@7@chr7:102219874-102220244@6.23@33@85@2.58@CNVR3518.1@ENST00000379336_1, RASA4-001_21@63@63@63@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
D164942@105521@105523@duplication@3@142481247@142482417@7@chr7:142481247-142482417@18.3@493@793@1.61@NA@PRSS1-204_4, PRSS1-204_5, PRSS1-204_6@114.333333333333@113@115@NA@NA@NA
D164942@105772@105807@duplication@36@143883178@143984072@7@chr7:143883178-143984072@85@1408@2503@1.78@CNVR3598.4, CNVR3598.7@ARHGEF5L-001_1, ARHGEF5L-001_2, RP4-545C24-003_1, RP4-545C24-003_2, RP4-545C24-003_3, RP4-545C24-003_4, RP4-545C24-003_5, RP4-545C24-003_6, OR2A20P-003_1, OR2A20P-003_2, OR2A20P-003_3, OR2A20P-003_4, OR2A20P-003_5, RP4-798C17-001_1, RP4-798C17-001_2, RP4-798C17-001_3, RP4-798C17-001_4, RP4-798C17-001_5, RP4-798C17-001_6, RP4-798C17-001_7, RP4-798C17-001_8, RP4-798C17-001_9, RP4-798C17-001_10, RP4-798C17-001_11, RP4-798C17-001_12, ENST00000378112_2, ENST00000378112_3, ENST00000378112_4, ENST00000378112_5, ENST00000378112_6, ENST00000378112_7, ENST00000378112_8, ENST00000378112_9, ENST00000378112_10, ENST00000378112_11, ENST00000378112_12@61.1666666666667@14@137@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:olfactory receptor, family 2, subfamily A, member 7:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane@NA
D164942@107097@107105@duplication@9@158835728@159026068@7@chr7:158835728-159026068@8.09@1335@1704@1.28@NA@VIPR2-001_1, VIPR2-001_2, VIPR2-001_3, VIPR2-001_4, VIPR2-001_5, VIPR2-001_6, AF027390-001_1, AF027390-001_2, AF027390-001_3@0@0@0@:vasoactive intestinal peptide receptor 2@:transmembrane signaling receptor activity;activation of adenylate cyclase activity;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;vasoactive intestinal polypeptide receptor activity;negative regulation of smooth muscle cell proliferation;cell-cell signaling;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;membrane;cell surface receptor signaling pathway@NA
D164942@107112@107127@duplication@16@190826@401454@8@chr8:190826-401454@15.3@1767@2354@1.33@NA@ZNF596-202_2, ZNF596-202_3, ZNF596-202_4, ZNF596-202_5, ZNF596-202_6, FAM87A-201_1, FAM87A-201_2, FAM87A-201_3, FAM87A-201_4, FBXO25-202_1, FBXO25-202_2, FBXO25-202_3, FBXO25-202_4, FBXO25-202_5, FBXO25-202_6, FBXO25-202_7@0.375@0@4@:zinc finger protein 596:F-box protein 25@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding:ubiquitin-protein ligase activity;actin binding;protein binding;SCF ubiquitin ligase complex;ubiquitin ligase complex;nucleus;protein ubiquitination@NA
D164942@107508@107513@deletion@6@7693995@7718505@8@chr8:7693995-7718505@48.8@352@73@0.207@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@DEFB104A-001_1, DEFB104A-001_2, SPAG11A-207_1, SPAG11A-207_2, SPAG11A-207_3, SPAG11A-207_4@68@45@113@:defensin, beta 104A;defensin, beta 104B:sperm associated antigen 11A;sperm associated antigen 11B@:extracellular region;defense response to bacterium:extracellular region;defense response@NA
D164942@107738@107738@deletion@1@12003180@12003210@8@chr8:12003180-12003210@6.5@29@0@0@CNVR3785.8, CNVR3785.5, CNVR3785.6, CNVR3785.2, CNVR3785.3@ENST00000438689_1@119@119@119@NA@NA@NA
D164942@109584@109585@deletion@2@39349346@39349528@8@chr8:39349346-39349528@9@50@6@0.12@CNVR3859.1@ADAM3A-005_11, ADAM3A-009_7@118@118@118@NA@NA@NA
D164942@114726@114734@duplication@9@146155748@146228282@8@chr8:146155748-146228282@12.5@2269@3040@1.34@NA@ZNF16-201_1, ZNF16-201_2, ZNF16-201_3, ZNF16-201_4, AF235103-203_1, AF235103-203_2, AF235103-203_3, AF235103-203_4, AF235103-203_5@0@0@0@:zinc finger protein 16@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding@NA
D164942@114795@114814@duplication@20@271629@377212@9@chr9:271629-377212@14.9@2771@3517@1.27@NA@DOCK8-001_2, DOCK8-001_3, DOCK8-001_4, DOCK8-001_5, DOCK8-001_6, DOCK8-001_7, DOCK8-001_8, DOCK8-001_9, DOCK8-001_10, DOCK8-001_11, DOCK8-001_12, DOCK8-001_13, DOCK8-001_14, DOCK8-001_15, DOCK8-001_16, DOCK8-001_17, DOCK8-001_18, DOCK8-001_19, DOCK8-001_20, RP11-59O6-001_1@2@2@2@:dedicator of cytokinesis 8@:cytosol;GTPase binding;blood coagulation;binding;GTP binding;guanyl-nucleotide exchange factor activity@: MENTAL RETARDATION, AUTOSOMAL DOMINANT 2; MRD2; HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL RECESSIVE
D164942@121600@121604@deletion@5@117085338@117087433@9@chr9:117085338-117087433@25.8@1639@1047@0.639@CNVR4448.1@ORM1-001_1, ORM1-001_2, ORM1-001_3, ORM1-001_4, ORM1-001_5@87.6@84@90@:orosomucoid 1@:protein binding;extracellular space;regulation of immune system process;transport;inflammatory response;extracellular region;acute-phase response@NA
D164942@124047@124052@deletion@6@135957928@135960431@9@chr9:135957928-135960431@23.3@109@2@0.0183@NA@CELP-002_1, CELP-002_2, CELP-002_3, AL162417-201_1, AL162417-201_2, AL162417-201_3@84.3333333333333@66@99@NA@NA@NA
D164942@125529@125546@duplication@18@225936@329387@10@chr10:225936-329387@29.9@3386@4468@1.32@NA@ZMYND11-204_2, ZMYND11-204_3, ZMYND11-204_4, ZMYND11-204_5, ZMYND11-204_6, ZMYND11-204_7, ZMYND11-204_8, ZMYND11-204_9, ZMYND11-204_10, ZMYND11-204_11, ZMYND11-204_12, ZMYND11-204_13, ZMYND11-204_14, ZMYND11-204_15, ZMYND11-204_16, DIP2C-001_35, DIP2C-001_36, DIP2C-001_37@0@0@0@:zinc finger, MYND-type containing 11:zinc finger, MYND-type containing 11:DIP2 disco-interacting protein 2 homolog C (Drosophila)@:DNA binding;negative regulation of I-kappaB kinase/NF-kappaB cascade;cytoplasm;cell proliferation;negative regulation of JNK cascade;protein binding;negative regulation of transcription from RNA polymerase II promoter;negative regulation of extrinsic apoptotic signaling pathway;nucleus;transcription, DNA-dependent;cell cycle;zinc ion binding;virus-host interaction:protein binding;nucleus;zinc ion binding;cytoplasm:nucleus;transcription factor binding;catalytic activity;metabolic process@NA
D164942@126909@126915@deletion@7@17840632@17887436@10@chr10:17840632-17887436@20.4@281@135@0.48@NA@FAM23A-201_5, MRC1L1-001_1, MRC1L1-001_2, MRC1L1-001_3, MRC1L1-001_4, MRC1L1-001_5, MRC1L1-001_6@25.8571428571429@6@108@:transmembrane protein 236;transmembrane protein 236-like:macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding@NA
D164942@126937@126949@duplication@13@17949552@18129736@10@chr10:17949552-18129736@16.1@326@522@1.6@NA@MRC1L1-001_28, MRC1L1-001_29, MRC1L1-001_30, FAM23B-202_1, FAM23B-202_2, FAM23B-202_3, FAM23B-202_4, FAM23B-202_5, MRC1-001_1, MRC1-001_2, MRC1-001_3, MRC1-001_4, MRC1-001_5@38.7692307692308@5@107@:macrophage mannose receptor 1-like:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D164942@126951@126975@deletion@25@18138510@18198277@10@chr10:18138510-18198277@37.5@198@15@0.0758@NA@MRC1-001_7, MRC1-001_8, MRC1-001_9, MRC1-001_10, MRC1-001_11, MRC1-001_12, MRC1-001_13, MRC1-001_14, MRC1-001_15, MRC1-001_16, MRC1-001_17, MRC1-001_18, MRC1-001_19, MRC1-001_20, MRC1-001_21, MRC1-001_22, MRC1-001_23, MRC1-001_24, MRC1-001_25, MRC1-001_26, MRC1-001_27, MRC1-001_28, MRC1-001_29, RP11-457D2-001_1, RP11-457D2-001_2@16.52@3@27@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D164942@127722@127722@deletion@1@29580856@29580936@10@chr10:29580856-29580936@5.56@44@12@0.273@NA@LYZL1-002_1@51@51@51@:lysozyme-like 1@:extracellular region;lysozyme activity;cell wall macromolecule catabolic process@NA
D164942@128372@128372@deletion@1@42924566@42924600@10@chr10:42924566-42924600@7.39@92@36@0.391@NA@CCNYL2-201_7@0@0@0@@:regulation of cyclin-dependent protein kinase activity;protein kinase binding@NA
D164942@128825@128828@duplication@4@46918171@46928012@10@chr10:46918171-46928012@7.23@119@199@1.67@CNVR4712.9, CNVR4712.2, CNVR4712.7@FAM35B-001_3, FAM35B-001_4, FAM35B-001_5, FAM35B-001_6@58.5@47@72@NA@NA@NA
D164942@128914@128914@duplication@1@47416863@47416977@10@chr10:47416863-47416977@4.85@612@854@1.4@CNVR4712.9, CNVR4712.1@FAM35B2-201_7@21@21@21@NA@NA@NA
D164942@128920@128937@deletion@18@47605129@47644792@10@chr10:47605129-47644792@32.9@713@360@0.505@CNVR4713.1@ENST00000423803_1, ENST00000423803_2, ENST00000423803_3, ENST00000423803_4, ENST00000423803_5, ENST00000423803_6, ENST00000423803_7, ENST00000423803_8, ENST00000423803_9, ENST00000423803_10, ENST00000423803_11, ENST00000423803_12, ENST00000423803_13, ENST00000423803_14, ENST00000454837_1, ENST00000454837_2, ENST00000454837_3, ENST00000454837_4@23.2777777777778@20@28@NA@NA@NA
D164942@128979@129007@deletion@29@47758848@47942085@10@chr10:47758848-47942085@14.5@96@22@0.229@NA@ANXA8L2-001_10, ANXA8L2-001_11, ANXA8L2-001_12, AL603965-201_1, AL603965-201_2, FAM21B-201_1, FAM21B-201_2, FAM21B-201_3, FAM21B-201_4, FAM21B-201_5, FAM21B-201_6, FAM21B-201_7, FAM21B-201_8, FAM21B-201_9, FAM21B-201_10, FAM21B-201_11, FAM21B-201_12, FAM21B-201_13, FAM21B-201_14, FAM21B-201_15, FAM21B-201_16, FAM21B-201_17, FAM21B-201_18, FAM21B-201_19, FAM21B-201_20, FAM21B-201_21, FAM21B-201_22, FAM21B-201_23, FAM21B-201_24@137.034482758621@64@185@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760:family with sequence similarity 21, member B@:calcium-dependent phospholipid binding;calcium ion binding:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
D164942@129023@129028@deletion@6@48025509@48049022@10@chr10:48025509-48049022@8.72@272@163@0.599@CNVR4715.2@ASAH2C-201_3, ASAH2C-201_4, ASAH2C-201_5, ASAH2C-201_6, ASAH2C-201_7, ASAH2C-201_8@69.6666666666667@58@90@@:ceramidase activity;sphingolipid metabolic process@NA
D164942@129130@129131@deletion@2@48968562@48968624@10@chr10:48968562-48968624@7.79@44@6@0.136@CNVR4716.8, CNVR4716.4@RP11-508M1-002_5, GLUDP2-001_3@31@31@31@NA@NA@NA
D164942@129454@129477@duplication@24@51345755@51391568@10@chr10:51345755-51391568@51.9@451@973@2.16@NA@ENST00000404618_1, ENST00000404618_2, ENST00000404618_3, ENST00000404618_4, ENST00000404618_5, ENST00000404618_6, ENST00000404618_7, ENST00000432221_1, ENST00000432221_2, ENST00000432221_3, ENST00000432221_4, ENST00000432221_5, ENST00000432221_6, ENST00000432221_7, TIMM23B-202_1, TIMM23B-202_2, TIMM23B-202_3, TIMM23B-202_4, TIMM23B-202_5, TIMM23B-202_6, TIMM23B-202_7, TIMM23B-202_8, TIMM23B-202_10@77@0@142@:translocase of inner mitochondrial membrane 23 homolog B (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process@NA
D164942@129509@129521@deletion@13@51603186@51631957@10@chr10:51603186-51631957@17.9@775@511@0.659@NA@TIMM23-202_1, TIMM23-202_2, TIMM23-202_3, TIMM23-202_4, TIMM23-202_5, TIMM23-202_6, TIMM23-202_7, TIMM23-202_8, TIMM23-202_9, TIMM23-202_10, ENST00000456092_1, ENST00000456092_2, ENST00000456092_3@10.5384615384615@0@29@:translocase of inner mitochondrial membrane 23 homolog B (yeast):translocase of inner mitochondrial membrane 23 homolog B (yeast);translocase of inner mitochondrial membrane 23 homolog (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:mitochondrion;mitochondrial inner membrane;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;mitochondrial intermembrane space;integral to mitochondrial inner membrane;intracellular protein transport;protein binding;integral to membrane;cellular protein metabolic process;protein targeting to mitochondrion@NA
D164942@129605@129611@duplication@7@51970585@51994313@10@chr10:51970585-51994313@12.1@213@343@1.61@NA@ASAH2-201_5, ASAH2-201_6, ASAH2-201_7, ASAH2-201_8, ASAH2-201_9, ASAH2-201_10, ASAH2-201_11@145.142857142857@53@186@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
D164942@136770@136772@duplication@3@135439428@135440297@10@chr10:135439428-135440297@5.7@288@413@1.43@CNVR4989.11, CNVR4989.4@FRG2B-202_1, FRG2B-202_2, FRG2B-202_3@13@3@29@:FSHD region gene 2 family, member B@:nucleus@NA
D164942@136869@136874@duplication@6@308240@309335@11@chr11:308240-309335@6.65@903@1164@1.29@NA@IFITM2-203_1, IFITM2-203_2, IFITM2-203_3, IFITM2-203_4, IFITM2-203_5, IFITM2-203_6@0.5@0@1@:interferon induced transmembrane protein 2@:defense response to virus;response to interferon-alpha;negative regulation of viral genome replication;immune response;response to virus;response to biotic stimulus;negative regulation of viral entry into host cell;type I interferon-mediated signaling pathway;integral to membrane;response to interferon-gamma;plasma membrane;cytokine-mediated signaling pathway;response to interferon-beta@NA
D164942@137792@137794@deletion@3@3239564@3244362@11@chr11:3239564-3244362@18.3@422@199@0.472@CNVR5028.1@C11orf36-202_1, C11orf36-202_2, C11orf36-202_3@13@13@13@:MAS-related GPR, member G@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway@NA
D164942@138032@138032@duplication@1@5270600@5270821@11@chr11:5270600-5270821@5.02@45@92@2.04@NA@HBG1-201_2@106@106@106@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
D164942@141187@141188@deletion@2@48600990@48601883@11@chr11:48600990-48601883@8.04@36@0@0@CNVR5165.1@AC134982-201_1, AC134982-201_2@128@128@128@NA@NA@NA
D164942@144365@144366@deletion@2@68671193@68671507@11@chr11:68671193-68671507@6.62@398@254@0.638@NA@MRPL21-201_1, IGHMBP2-201_1@5@5@5@:mitochondrial ribosomal protein L21:immunoglobulin mu binding protein 2@:structural constituent of ribosome;mitochondrion;ribosome;RNA binding;intracellular;translation:ribosome binding;ATP-dependent 5'-3' RNA helicase activity;ATP binding;DNA repair;cell death;nucleus;SMN complex;translation;axon;ribonucleoprotein complex;tRNA binding;DNA duplex unwinding;transcription, DNA-dependent;transcription factor binding;zinc ion binding;DNA replication;DNA binding;DNA helicase activity;RNA binding;DNA-dependent ATPase activity;DNA recombination;ATP-dependent 5'-3' DNA helicase activity;hydrolase activity;single-stranded DNA binding;nucleoside-triphosphatase activity;RNA-dependent ATPase activity;nucleotide binding;cytoplasm;growth cone;protein binding;negative regulation of transcription from RNA polymerase II promoter;protein homooligomerization;nucleic acid binding@: SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1
D164942@149335@149361@duplication@27@369164@475271@12@chr12:369164-475271@29.2@5992@7657@1.28@NA@SLC6A13-201_1, KDM5A-203_4, KDM5A-203_5, KDM5A-203_6, KDM5A-203_7, KDM5A-203_8, KDM5A-203_9, KDM5A-203_10, KDM5A-203_11, KDM5A-203_12, KDM5A-203_13, KDM5A-203_14, KDM5A-203_15, KDM5A-203_16, KDM5A-203_17, KDM5A-203_18, KDM5A-203_19, KDM5A-203_20, KDM5A-203_21, KDM5A-203_22, KDM5A-203_23, KDM5A-203_24, KDM5A-203_25, KDM5A-203_26, KDM5A-203_27, KDM5A-203_28, KDM5A-203_29@1.25925925925926@1@2@:solute carrier family 6 (neurotransmitter transporter, GABA), member 13:lysine (K)-specific demethylase 5A@:neurotransmitter:sodium symporter activity;neurotransmitter binding;gamma-aminobutyric acid:sodium symporter activity;transmembrane transport;neurotransmitter transport;integral to membrane;plasma membrane;synaptic transmission;integral to plasma membrane;neurotransmitter secretion:oxidation-reduction process;oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen;cyclin-dependent protein kinase activating kinase holoenzyme complex;DNA binding;sequence-specific DNA binding transcription factor activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors;nucleus;multicellular organismal development;intracellular;transcription from RNA polymerase II promoter;cytoplasm;positive regulation of transcription, DNA-dependent;protein binding;chromatin binding;nucleolus;chromatin modification;zinc ion binding@NA
D164942@150776@150783@deletion@8@9447030@9454871@12@chr12:9447030-9454871@15.5@356@204@0.573@NA@DDX11L8-201_3, DDX11L8-201_4, DDX11L8-201_5, DDX11L8-201_6, DDX11L8-201_7, DDX11L8-201_8, DDX11L8-201_9, DDX11L8-201_10@55.25@17@78@NA@NA@NA
D164942@150785@150787@deletion@3@9456573@9458354@12@chr12:9456573-9458354@21.7@131@15@0.115@NA@DDX11L8-201_12, DDX11L8-201_13, DDX11L8-201_14@57@1@87@NA@NA@NA
D164942@150815@150816@duplication@2@9580231@9580462@12@chr12:9580231-9580462@6.65@287@432@1.51@NA@DDX12-203_13, DDX12-203_14@3@3@3@NA@NA@NA
D164942@150829@150841@duplication@13@9684189@9707352@12@chr12:9684189-9707352@108@700@1846@2.64@CNVR5429.1@AC006432-201_1, AC006432-201_2, AC006432-201_3, AC006432-201_4, AC006432-201_5, AC006432-201_6, AC006432-201_7, AC006432-201_8, AC006432-201_9, AC006432-201_10, AC006432-201_11, AC006432-201_12, AC006432-201_13@22.2307692307692@15@25@NA@NA@NA
D164942@150968@150971@deletion@4@10583212@10587639@12@chr12:10583212-10587639@9.21@417@272@0.652@CNVR5430.1@KLRC2-201_3, KLRC2-201_4, KLRC2-201_5, KLRC2-201_6@62@51@67@:killer cell lectin-like receptor subfamily C, member 2@:carbohydrate binding:transmembrane signaling receptor activity;carbohydrate binding;protein binding;signal transduction;cellular defense response;integral to plasma membrane@NA
D164942@161513@161534@duplication@22@133617873@133795954@12@chr12:133617873-133795954@30.3@5193@6981@1.34@CNVR5791.1@ZNF84-202_2, ZNF84-202_3, ZNF84-202_4, ZNF84-202_5, ZNF140-201_1, ZNF140-201_2, ZNF140-201_3, ZNF140-201_4, ZNF140-201_5, ZNF10-204_1, ZNF10-204_2, ZNF10-204_3, ZNF10-204_4, ZNF10-204_5, ZNF10-204_6, ZNF10-204_7, ZNF10-204_8, ZNF10-204_9, ZNF10-204_10, ZNF10-204_11, AC226150-201_8, AC226150-201_9@0.318181818181818@0@2@:zinc finger protein 84-like;zinc finger protein 84:zinc finger protein 140:zinc finger protein 891-like:zinc finger protein 10:zinc finger protein 268:zinc finger protein 268:anomalous homeobox@:intracellular;nucleus;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;sequence-specific DNA binding transcription factor activity;nucleic acid binding:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;sequence-specific DNA binding transcription factor activity;nucleic acid binding:sequence-specific DNA binding;nucleus;DNA binding;regulation of transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity@NA
D164942@162314@162314@duplication@1@25528913@25529008@13@chr13:25528913-25529008@4.73@78@134@1.72@NA@TPTE2P1-001_5@2@2@2@NA@NA@NA
D164942@164471@164476@duplication@6@52853978@52855097@13@chr13:52853978-52855097@6.86@303@422@1.39@NA@THSD1P-203_14, THSD1P-203_15, THSD1P-203_16, ENST00000403471_5, ENST00000403471_6, ENST00000403471_7@54@48@58@NA@NA@NA
D164942@164539@164543@deletion@5@53103402@53106857@13@chr13:53103402-53106857@25.8@123@2@0.0163@NA@RP11-78J21-201_12, RP11-78J21-201_13, RP11-78J21-201_14, RP11-78J21-201_15, RP11-78J21-201_16@113.8@107@117@NA@NA@NA
D164942@166648@166665@duplication@18@115002122@115038151@13@chr13:115002122-115038151@18.7@2638@3425@1.3@CNVR6071.3@CDC16-201_2, CDC16-201_3, CDC16-201_4, CDC16-201_5, CDC16-201_6, CDC16-201_7, CDC16-201_8, CDC16-201_9, CDC16-201_10, CDC16-201_11, CDC16-201_12, CDC16-201_13, CDC16-201_14, CDC16-201_15, CDC16-201_16, CDC16-201_17, CDC16-201_18, CDC16-201_19@0@0@0@:cell division cycle 16 homolog (S. cerevisiae)@:nucleoplasm;mitotic cell cycle;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;mitotic cell cycle spindle assembly checkpoint;protein K11-linked ubiquitination;nucleus;cell cycle checkpoint;cell division;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;spindle;spindle microtubule;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;anaphase-promoting complex;centrosome;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;cytoplasm;cell proliferation;cytosol;protein binding;mitosis;regulation of mitosis@NA
D164942@166688@166691@duplication@4@19411745@19412531@14@chr14:19411745-19412531@9.68@162@266@1.64@CNVR6072.1, CNVR6072.16@CR383656-201_2, CR383656-201_3, CR383656-201_4, CR383656-201_5@36.5@36@37@NA@NA@NA
D164942@166697@166707@duplication@11@19553367@19589683@14@chr14:19553367-19589683@11.5@131@237@1.81@CNVR6072.1@POTEG-201_1, POTEG-201_2, POTEG-201_3, POTEG-201_4, POTEG-201_5, POTEG-201_6, POTEG-201_7, POTEG-201_8, POTEG-201_9, POTEG-201_10, POTEG-201_11@98@55@141@:POTE ankyrin domain family, member G@:protein binding@NA
D164942@166746@166765@duplication@20@20019702@20202426@14@chr14:20019702-20202426@50.9@3577@5005@1.4@CNVR6072.6, CNVR6072.12, CNVR6072.14@AL589182-203_1, AL929601-201_1, AL929601-201_2, AL929601-201_3, AL929601-201_4, AL512310-201_1, AL512310-201_2, AL512310-201_3, AL512310-201_4, AL512310-201_5, ENST00000398231_1, ENST00000398231_2, ENST00000398231_3, ENST00000398231_4, ENST00000398231_5, ENST00000398231_6, ENST00000334072_1, ENST00000334072_2, ENST00000426759_1, ENST00000426759_2@83.85@44@102@:POTE ankyrin domain family, member M:olfactory receptor, family 4, subfamily N, member 2@:protein binding:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
D164942@173311@173312@deletion@2@105715357@105715585@14@chr14:105715357-105715585@10.6@130@51@0.392@NA@BTBD6-201_2, BTBD6-201_3@0@0@0@:BRF1 homolog, subunit of RNA polymerase III transcription initiation factor IIIB (S. cerevisiae):BTB (POZ) domain containing 6@:TBP-class protein binding;nucleoplasm;transcription initiation from RNA polymerase III promoter;regulation of transcription, DNA-dependent;transcription from RNA polymerase III promoter;regulation of mRNA stability;DNA-dependent transcription, initiation;transcription factor TFIIIB complex;positive regulation of transcription, DNA-dependent;nucleus;tRNA transcription;gene expression;rRNA transcription;zinc ion binding:protein binding;cytoplasmic mRNA processing body@NA
D164942@173412@173421@deletion@10@106090689@106131047@14@chr14:106090689-106131047@8.85@820@563@0.687@CNVR6294.46, CNVR6294.20, CNVR6294.43, CNVR6294.50, CNVR6294.64@IGHG4-001_1, IGHG4-001_2, IGHG4-001_3, IGHG4-001_4, IGHG2-002_1, IGHG2-002_2, IGHG2-002_3, IGHG2-002_4, IGHG2-002_5, IGHGP-001_6@5.5@4@7@@:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response@NA
D164942@173500@173502@duplication@3@106471638@106478412@14@chr14:106471638-106478412@21.3@230@462@2.01@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV3-6-210_6, IGHV1-3-001_1, IGHV4-4-001_2@12.6666666666667@4@17@@:protein binding:protein binding@NA
D164942@173536@173542@duplication@7@106721281@106725734@14@chr14:106721281-106725734@12.5@1275@1712@1.34@CNVR6294.48, CNVR6294.24, CNVR6294.40, CNVR6294.38, CNVR6294.17, CNVR6294.23@AB019439-201_1, AB019439-201_2, IGHVIII-22-2-201_1, IGHVIII-22-2-201_2, IGHVIII-22-2-201_3, IGHV3-23-001_1, IGHV3-23-001_2@6.71428571428571@5@8@@:protein binding@NA
D164942@173558@173567@deletion@10@106791007@106816254@14@chr14:106791007-106816254@34.8@1280@746@0.583@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-30-001_1, IGHV3-30-001_2, IGHV3-30-2-001_1, IGHV3-30-2-001_2, IGHV4-31-001_1, IGHV4-31-001_2, IGHV3-32-001_1, IGHV3-32-001_2, IGHV3-33-001_1, IGHV3-33-001_2@15.8@5@19@@:protein binding:protein binding:protein binding@NA
D164942@173586@173668@duplication@83@106866408@107276305@14@chr14:106866408-107276305@236@15165@21573@1.42@CNVR6294.56, CNVR6294.16@IGHV3-38-001_1, IGHV3-38-001_2, IGHV4-39-001_1, IGHV4-39-001_2, IGHV3-41-001_1, IGHV3-41-001_2, IGHV3-43-001_1, IGHV3-43-001_2, IGHVIII-44-001_1, IGHVIII-44-001_2, ENST00000433371_1, ENST00000433371_2, ENST00000433371_3, ENST00000433371_4, IGHVIV-44-1-001_2, IGHV1-45-001_1, IGHV1-45-001_2, IGHV1-46-001_1, IGHV1-46-001_2, AB019438-201_1, AB019438-201_2, IGHV3-47-201_1, IGHV3-47-201_2, IGHV3-48-001_1, IGHV3-48-001_2, IGHV3-49-001_1, IGHV3-49-001_2, IGHV3-50-001_1, IGHV3-50-001_2, IGHV5-51-001_1, IGHV5-51-001_2, IGHV3-52-001_1, IGHV3-52-001_2, IGHV3-53-001_1, IGHV3-53-001_2, IGHV3-54-001_1, IGHV3-54-001_2, IGHV4-55-001_1, IGHV4-55-001_2, IGHV7-56-001_1, IGHV7-56-001_2, IGHV1-58-001_1, IGHV1-58-001_2, IGHV4-59-002_1, IGHV4-59-002_2, IGHV4-59-002_3, IGHV3-60-001_1, IGHV3-60-001_2, IGHV4-61-001_1, IGHV4-61-001_2, IGHV3-62-001_1, IGHV3-62-001_2, IGHV3-63-001_1, IGHV3-63-001_2, IGHV3-64-001_1, IGHV3-64-001_2, IGHV3-65-001_1, IGHV3-65-001_2, IGHV3-66-001_1, IGHV3-66-001_2, IGHV1-67-001_1, IGHV1-67-001_2, IGHV1-69-001_1, IGHV1-69-001_2, IGHV2-70-001_1, IGHV2-70-001_2, IGHV3-71-001_1, IGHV3-71-001_2, IGHV3-72-001_1, IGHV3-72-001_2, IGHV3-73-001_1, IGHV3-73-001_2, IGHV3-74-001_1, IGHV3-74-001_2, IGHV3-75-001_1, IGHV3-75-001_2, IGHV5-78-201_1, IGHV5-78-201_2, AB019437-201_1, AB019437-201_2, IGHV3-79-001_1, IGHV3-79-001_2@2.36585365853659@0@17@@:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding@NA
D164942@173685@173692@deletion@8@20450159@20466520@15@chr15:20450159-20466520@17.6@2065@1443@0.699@CNVR6295.15, CNVR6295.7, CNVR6295.13, CNVR6295.26@ENST00000400226_5, ENST00000400226_6, ENST00000400226_7, ENST00000400226_8, ENST00000400226_9, ENST00000400226_10, ENST00000400226_11, ENST00000400226_12@58.5@20@80@NA@NA@NA
D164942@173697@173706@deletion@10@20588370@20644076@15@chr15:20588370-20644076@13.9@809@500@0.618@CNVR6295.15, CNVR6295.7, CNVR6295.3, CNVR6295.5@HERC2P3-014_23, HERC2P3-014_24, HERC2P3-014_25, HERC2P3-014_26, HERC2P3-014_27, AC026495-201_22, AC026495-201_23, AC026495-201_24, AC026495-201_25, AC026495-201_26@78.6@57@112@NA@NA@NA
D164942@173855@173856@duplication@2@22742398@22743599@15@chr15:22742398-22743599@5.06@41@85@2.07@CNVR6298.5@GOLGA6L1-201_8, GOLGA6L1-201_9@32@31@33@:golgin A6 family-like 1;putative transmembrane protein FLJ36131-like;putative transmembrane protein ENSP00000320207-like;putative golgin subfamily A member 6-like@NA@NA
D164942@174503@174507@deletion@5@30653445@30665349@15@chr15:30653445-30665349@25.4@440@217@0.493@CNVR6337.1@CHRFAM7A-202_6, CHRFAM7A-202_7, CHRFAM7A-202_8, CHRFAM7A-202_9, CHRFAM7A-202_10@51@44@68@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
D164942@176411@176412@deletion@2@43988239@43988562@15@chr15:43988239-43988562@5.42@190@110@0.579@CNVR6365.1@CKMT1A-203_7, CKMT1A-203_8@12@12@12@:stereocilin:creatine kinase, mitochondrial 1A;creatine kinase, mitochondrial 1B@:detection of mechanical stimulus involved in sensory perception of sound;stereocilium bundle tip;stereocilium;cell surface;kinocilium;auditory receptor cell stereocilium organization:mitochondrion;small molecule metabolic process;mitochondrial inner membrane;creatine metabolic process;creatine kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cellular nitrogen compound metabolic process;kinase activity@: DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16; DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY
D164942@176432@176433@duplication@2@44002591@44002976@15@chr15:44002591-44002976@6.8@178@285@1.6@NA@AC011330-201_13, AC011330-201_14@28@16@40@:stereocilin@:detection of mechanical stimulus involved in sensory perception of sound;stereocilium bundle tip;stereocilium;cell surface;kinocilium;auditory receptor cell stereocilium organization@: DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16; DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY
D164942@182122@182128@duplication@7@240123@258664@16@chr16:240123-258664@7.05@989@1283@1.3@NA@LUC7L-009_5, LUC7L-009_6, LUC7L-009_7, LUC7L-009_8, LUC7L-009_9, LUC7L-009_10, LUC7L-009_11@0.142857142857143@0@1@:LUC7-like (S. cerevisiae)@:protein binding;RS domain binding;negative regulation of striated muscle tissue development;nucleus;metal ion binding@NA
D164942@183378@183378@deletion@1@2672693@2672767@16@chr16:2672693-2672767@14.3@69@1@0.0145@CNVR6602.2@AC141586-201_6@57@57@57@NA@NA@NA
D164942@186378@186379@deletion@2@28734487@28734873@16@chr16:28734487-28734873@7.65@806@546@0.677@CNVR6686.3, CNVR6686.2@EIF3S8-202_9, EIF3S8-202_10@3.5@3@4@:eukaryotic translation initiation factor 3, subunit C@:cytosol;protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;cellular protein metabolic process;binding;gene expression;translation;translation initiation factor activity@NA
D164942@187551@187552@deletion@2@33661367@33661655@16@chr16:33661367-33661655@8.35@215@117@0.544@CNVR6703.17, CNVR6703.1, CNVR6703.21@AC140658-201_1, AC140658-201_2@26.5@23@30@NA@NA@NA
D164942@187603@187610@duplication@8@34490054@46505841@16@chr16:34490054-46505841@10.9@1108@1482@1.34@NA@ANKRD26P1-201_17@2@2@2@NA@NA@NA
D164942@190431@190432@deletion@2@72092155@72093088@16@chr16:72092155-72093088@42.1@232@2@0.00862@CNVR6769.1, CNVR6769.2@HP-201_5, HP-201_6@21.5@17@26@:thioredoxin-like 4B:haptoglobin:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:cellular iron ion homeostasis;negative regulation of oxidoreductase activity;catalytic activity;negative regulation of hydrogen peroxide catabolic process;positive regulation of cell death;haptoglobin-hemoglobin complex;extracellular space;proteolysis;response to hydrogen peroxide;extracellular region;hemoglobin binding;defense response;serine-type endopeptidase activity:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@: ANHAPTOGLOBINEMIA; AHP
D164942@190434@190434@deletion@1@72097113@72097160@16@chr16:72097113-72097160@7.89@100@39@0.39@CNVR6769.1@HPR-202_1@26@26@26@:thioredoxin-like 4B:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@NA
D164942@190549@190549@deletion@1@74451959@74452197@16@chr16:74451959-74452197@4.85@62@26@0.419@CNVR6778.2, CNVR6778.3@CLEC18B-202_3@47@47@47@:C-type lectin domain family 18, member B@:carbohydrate binding;protein binding;extracellular region@NA
D164942@191958@191966@duplication@9@90122978@90141883@16@chr16:90122978-90141883@9.67@2652@3425@1.29@NA@PRDM7-203_2, PRDM7-203_3, PRDM7-203_4, PRDM7-203_5, PRDM7-203_6, PRDM7-203_7, PRDM7-203_8, PRDM7-203_9, PRDM7-203_10@0@0@0@:PR domain containing 7@:protein binding;chromosome;intracellular;nucleus;regulation of transcription, DNA-dependent;histone-lysine N-methyltransferase activity;nucleic acid binding@NA
D164942@195716@195718@duplication@3@18394589@18395860@17@chr17:18394589-18395860@6.04@269@382@1.42@CNVR7014.1@LGALS9C-201_7, LGALS9C-201_8, LGALS9C-201_9@138@135@140@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
D164942@195742@195747@duplication@6@18454822@18457581@17@chr17:18454822-18457581@11.8@611@852@1.39@NA@CCDC144B-201_14, CCDC144B-201_15, CCDC144B-201_16, ENST00000447265_11, ENST00000447265_12, ENST00000447265_13@129.166666666667@126@132@NA@NA@NA
D164942@196144@196155@deletion@12@20346589@20356921@17@chr17:20346589-20356921@40@229@27@0.118@CNVR7021.1, CNVR7021.3@ENST00000458685_4, ENST00000458685_5, ENST00000411468_3, ENST00000411468_4, ENST00000411468_5, ENST00000411468_6, LGALS9B-201_6, LGALS9B-201_7, LGALS9B-201_8, LGALS9B-201_9, LGALS9B-201_10, LGALS9B-201_11@60.5@23@103@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
D164942@197728@197728@duplication@1@34539901@34539966@17@chr17:34539901-34539966@4.79@63@114@1.81@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1-202_4@122@122@122@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
D164942@198032@198041@deletion@10@36351805@36375178@17@chr17:36351805-36375178@53.5@4553@2845@0.625@CNVR7083.3@AC183087-202_5, AC183087-202_6, AC183087-202_7, AC183087-202_8, AC183087-202_9, AC183087-202_10, AC183087-202_11, AC183087-202_12, AC183087-202_13, AC183087-202_14@55.3@42@64@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
D164942@200325@200328@duplication@4@44363251@44364337@17@chr17:44363251-44364337@10.2@1467@1954@1.33@CNVR7114.3, CNVR7114.2, CNVR7114.10@ENST00000451529_1, ENST00000451529_2, ENST00000451529_3, ENST00000451529_4@46.5@11@90@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
D164942@200337@200349@deletion@13@44399690@44592688@17@chr17:44399690-44592688@22@163@46@0.282@CNVR7114.2, CNVR7114.1@LRRC37A-001_7, LRRC37A-001_8, LRRC37A-001_9, LRRC37A-001_10, LRRC37A-001_11, LRRC37A-001_12, LRRC37A-001_13, LRRC37A-001_14, LRRC37A-001_15, AC005829-202_1, AC005829-202_2, AC005829-202_3, LRRC37A2-201_1@149.230769230769@114@196@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane@NA
D164942@205721@205728@duplication@8@48942@122218@18@chr18:48942-122218@21.3@840@1279@1.52@CNVR7228.2@AP001005-201_1, AP001005-201_2, AP001005-201_3, ENST00000400614_1, ENST00000400614_2, ENST00000400614_3, ENST00000400614_4, ENST00000400614_5@24.75@0@40@@:GTPase activity;protein complex;GTP catabolic process;cytoplasm;microtubule cytoskeleton;protein polymerization;microtubule-based movement;structural molecule activity;microtubule;GTP binding;plasma membrane@NA
D164942@205730@205761@duplication@32@163310@260305@18@chr18:163310-260305@58.9@4253@5741@1.35@NA@USP14-201_2, USP14-201_3, USP14-201_4, USP14-201_5, USP14-201_6, USP14-201_7, USP14-201_8, USP14-201_9, USP14-201_10, USP14-201_11, USP14-201_12, USP14-201_13, USP14-201_14, USP14-201_15, USP14-201_16, THOC1-201_5, THOC1-201_6, THOC1-201_7, THOC1-201_8, THOC1-201_9, THOC1-201_10, THOC1-201_11, THOC1-201_12, THOC1-201_13, THOC1-201_14, THOC1-201_15, THOC1-201_16, THOC1-201_17, THOC1-201_18, THOC1-201_19, THOC1-201_20, THOC1-201_21@0@0@0@:ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase):THO complex 1@:ubiquitin-specific protease activity;proteasome complex;cysteine-type peptidase activity;endopeptidase inhibitor activity;regulation of proteasomal protein catabolic process;plasma membrane;proteasome binding;ubiquitin thiolesterase activity;regulation of chemotaxis;ubiquitin-dependent protein catabolic process;cytoplasm;negative regulation of endopeptidase activity;protein binding;cysteine-type endopeptidase activity;synapse;cytoplasmic membrane-bounded vesicle;tRNA guanylyltransferase activity;synaptic transmission;cell surface:THO complex part of transcription export complex;nuclear speck;DNA binding;transcription export complex;nuclear matrix;RNA binding;nucleus;apoptotic process;RNA processing;intronless viral mRNA export from host nucleus;THO complex;cytoplasm;protein binding;regulation of DNA-dependent transcription, elongation;mRNA export from nucleus;signal transduction;mRNA processing;RNA splicing;transcription, DNA-dependent@NA
D164942@215927@215928@duplication@2@35861833@35863856@19@chr19:35861833-35863856@7.48@202@331@1.64@CNVR7627.1@FFAR3-001_1, FFAR3-001_2@101@100@102@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
D164942@217595@217595@deletion@1@41327389@41327534@19@chr19:41327389-41327534@12.4@60@1@0.0167@NA@CYP2F1P-001_5@0@0@0@NA@NA@NA
D164942@217670@217670@duplication@1@41631400@41631540@19@chr19:41631400-41631540@7.71@202@337@1.67@NA@CYP2F1-201_9@2@2@2@:cytochrome P450, family 2, subfamily F, polypeptide 1@:trichloroethylene metabolic process;oxidation-reduction process;aromatase activity;response to toxin;oxygen binding;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;endoplasmic reticulum membrane;naphthalene metabolic process;intracellular membrane-bounded organelle;electron carrier activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;heme binding;xenobiotic metabolic process;monooxygenase activity;iron ion binding@NA
D164942@221177@221183@deletion@7@54743779@54746618@19@chr19:54743779-54746618@8.27@1034@750@0.725@CNVR7721.3, CNVR7721.6@LILRA6-002_1, LILRA6-002_2, LILRA6-002_3, LILRA6-002_4, LILRA6-002_5, LILRA6-002_6, LILRA6-002_7@61.4285714285714@48@77@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D164942@221218@221224@deletion@7@54801929@54804722@19@chr19:54801929-54804722@19.4@1078@692@0.642@CNVR7722.1@LILRA3-003_4, LILRA3-003_5, LILRA3-003_6, LILRA3-003_7, LILRA3-003_8, LILRA3-003_9, LILRA3-003_10@105.857142857143@90@109@:leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3@:antigen binding;signal transduction;protein binding;extracellular region;plasma membrane;receptor activity;defense response@NA
D164942@221397@221417@duplication@21@55267568@55295318@19@chr19:55267568-55295318@37.7@2915@3975@1.36@CNVR7725.2, CNVR7725.1@KIR2DL3-201_5, KIR2DL3-201_6, KIR2DL3-201_7, KIR2DL3-201_8, KIR2DP1-001_2, KIR2DP1-001_3, KIR2DP1-001_4, KIR2DP1-001_5, KIR2DP1-001_6, KIR2DP1-001_7, KIR2DP1-001_8, KIR2DP1-001_9, KIR2DL1-002_1, KIR2DL1-002_2, KIR2DL1-002_3, KIR2DL1-002_4, KIR2DL1-002_5, KIR2DL1-002_6, KIR2DL1-002_7, KIR2DL1-002_8, KIR2DL1-002_9@96@34@126@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
D164942@222068@222069@duplication@2@58003184@58003369@19@chr19:58003184-58003369@10.1@55@138@2.51@CNVR7748.1@ZNF419-202_5, ZNF419-202_6@0@0@0@:zinc finger protein 419@:intracellular;DNA binding;regulation of transcription, DNA-dependent;cytoplasm;nucleolus;nucleus;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding@NA
D164942@222334@222335@duplication@2@59063275@59063553@19@chr19:59063275-59063553@5.44@596@801@1.34@NA@CHMP2A-201_4, CHMP2A-201_5@0@0@0@:charged multivesicular body protein 2A@:cytosol;protein binding;cellular membrane organization;protein transport;late endosome membrane;endosomal transport;protein domain specific binding@NA
D164942@222360@222368@duplication@9@76648@210528@20@chr20:76648-210528@31.9@2883@4047@1.4@NA@DEFB125-001_2, DEFB126-001_1, DEFB126-001_2, DEFB127-001_1, DEFB127-001_2, DEFB128-001_1, DEFB128-001_2, DEFB129-001_1, DEFB129-001_2@0.666666666666667@0@1@:defensin, beta 125:defensin, beta 126:defensin, beta 127:defensin, beta 128:defensin, beta 129@:extracellular region;defense response to bacterium:glycocalyx;extracellular region;defense response to bacterium;cell surface:extracellular region;defense response to bacterium;cellular_component;innate immune response:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
D164942@222563@222563@duplication@1@1569208@1569279@20@chr20:1569208-1569279@5.92@23@69@3@CNVR7763.1@SIRPB1-201_1@128@128@128@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
D164942@222594@222594@duplication@1@1895747@1896102@20@chr20:1895747-1896102@5.85@143@232@1.62@CNVR7764.2@SIRPA-201_3@34@34@34@:signal-regulatory protein alpha@:blood coagulation;protein binding;integral to membrane;SH3 domain binding;cell adhesion;plasma membrane;membrane;leukocyte migration@NA
D164942@228792@228793@duplication@2@62891297@62895885@20@chr20:62891297-62895885@5.64@575@774@1.35@NA@PCMTD2-202_2, PCMTD2-202_3@0@0@0@:protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2@:protein-L-isoaspartate (D-aspartate) O-methyltransferase activity;cellular protein modification process;cytoplasm@NA
D164942@229384@229386@duplication@3@24762581@24763318@21@chr21:24762581-24763318@5.46@46@90@1.96@NA@EEF1A1P-201_1, EEF1A1P-201_2, EEF1A1P-201_3@0@0@0@NA@NA@NA
D164942@231759@231760@duplication@2@47660727@47660934@21@chr21:47660727-47660934@6.06@226@328@1.45@NA@MCM3APAS-001_3, MCM3AP-001_27@0@0@0@:minichromosome maintenance complex component 3 associated protein@:cytosol;nucleus;DNA binding;protein import into nucleus;nucleotide binding;DNA replication;cytoplasm@NA
D164942@231848@231852@duplication@5@47860770@47865683@21@chr21:47860770-47865683@9.55@699@946@1.35@NA@PCNT-002_43, PCNT-002_44, PCNT-002_45, PCNT-002_46, PCNT-002_47@0@0@0@:pericentrin@:mitotic cell cycle;calmodulin binding;neuron migration;microtubule organizing center;limb morphogenesis;intercellular bridge;olfactory bulb development;apoptotic process;neural precursor cell proliferation;cilium assembly;microtubule cytoskeleton organization;centriole;spindle organization;centrosome;in utero embryonic development;cytoplasm;G2/M transition of mitotic cell cycle;cytosol;protein binding;multicellular organism growth;brain morphogenesis;microtubule;cerebellar cortex morphogenesis@: MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2
D164942@231860@231876@duplication@17@47904672@47961809@21@chr21:47904672-47961809@23.6@3081@4034@1.31@NA@DIP2A-201_2, DIP2A-201_3, DIP2A-201_4, DIP2A-201_5, DIP2A-201_6, DIP2A-201_7, DIP2A-201_8, DIP2A-201_9, DIP2A-201_10, DIP2A-201_11, DIP2A-201_12, DIP2A-201_13, DIP2A-201_14, DIP2A-201_15, DIP2A-201_16, DIP2A-201_17, DIP2A-201_18@0@0@0@:DIP2 disco-interacting protein 2 homolog A (Drosophila)@:multicellular organismal development;protein binding;nucleus;transcription factor binding;catalytic activity;metabolic process@NA
D164942@231887@231909@duplication@23@47975897@48080875@21@chr21:47975897-48080875@19.9@2627@3398@1.29@NA@DIP2A-201_29, DIP2A-201_30, DIP2A-201_31, DIP2A-201_32, DIP2A-201_33, DIP2A-201_34, DIP2A-201_35, DIP2A-201_36, DIP2A-201_37, DIP2A-201_38, S100B-002_1, S100B-002_2, S100B-002_3, S100B-002_4, PRMT2-001_1, PRMT2-001_2, PRMT2-001_3, PRMT2-001_4, PRMT2-001_5, PRMT2-001_6, PRMT2-001_7, PRMT2-001_8, PRMT2-001_9@0@0@0@:DIP2 disco-interacting protein 2 homolog A (Drosophila):S100 calcium binding protein B:protein arginine methyltransferase 2@:multicellular organismal development;protein binding;nucleus;transcription factor binding;catalytic activity;metabolic process:neuronal cell body;axonogenesis;nucleus;identical protein binding;receptor binding;regulation of cell shape;response to methylmercury;perinuclear region of cytoplasm;S100 protein binding;memory;cellular response to hypoxia;central nervous system development;zinc ion binding;calcium ion binding;long-term synaptic potentiation;calcium-dependent protein binding;positive regulation of I-kappaB kinase/NF-kappaB cascade;negative regulation of skeletal muscle cell differentiation;positive regulation of synaptic transmission;extracellular space;positive regulation of cell proliferation;protein homodimerization activity;astrocyte differentiation;regulation of neuronal synaptic plasticity;learning or memory;innate immune response;cytoplasm;tau protein binding;cell proliferation;response to glucocorticoid stimulus;protein binding;extracellular region;RAGE receptor binding;positive regulation of apoptotic process;ruffle:negative regulation of NF-kappaB transcription factor activity;transferase activity;negative regulation of transcription, DNA-dependent;induction of apoptosis;protein methyltransferase activity;transcription coactivator activity;protein methylation;nucleus;androgen receptor binding;progesterone receptor binding;histone arginine methylation;signal transducer activity;cytosol;histone methyltransferase activity;positive regulation of transcription, DNA-dependent;histone methylation;developmental cell growth;estrogen receptor binding;negative regulation of G1/S transition of mitotic cell cycle;histone-arginine N-methyltransferase activity;protein homodimerization activity;retinoic acid receptor binding;Rb-E2F complex;cytoplasm;protein-arginine N-methyltransferase activity;signal transduction;peptidyl-arginine N-methylation;protein binding;methyltransferase activity;thyroid hormone receptor binding;regulation of androgen receptor signaling pathway;peroxisome proliferator activated receptor binding@NA
D164942@232771@232784@deletion@14@20385728@20402444@22@chr22:20385728-20402444@15.5@129@41@0.318@CNVR8094.9, CNVR8094.4, CNVR8094.10@PI4KAP1-204_1, PI4KAP1-204_2, PI4KAP1-204_3, PI4KAP1-204_4, PI4KAP1-204_5, PI4KAP1-204_6, PI4KAP1-204_7, PI4KAP1-204_8, PI4KAP1-204_9, PI4KAP1-204_10, PI4KAP1-204_11, PI4KAP1-204_12, PI4KAP1-204_13, PI4KAP1-204_14@165.785714285714@155@172@NA@NA@NA
D164942@233414@233414@deletion@1@22989226@22989352@22@chr22:22989226-22989352@7.09@78@28@0.359@CNVR8103.5, CNVR8103.2, CNVR8103.13@GGTLC2-203_3@3@3@3@:gamma-glutamyltransferase light chain 2@:leukotriene biosynthetic process;glutathione metabolic process;gamma-glutamyltransferase activity;anchored to external side of plasma membrane@NA
D164942@233706@233708@deletion@3@24300516@24302569@22@chr22:24300516-24302569@6.83@61@22@0.361@CNVR8114.6, CNVR8114.12, CNVR8114.13, CNVR8114.8@GSTT2B-002_2, GSTT2B-002_3, GSTT2B-002_4@63.6666666666667@60@67@:glutathione S-transferase theta 2B (gene/pseudogene);glutathione S-transferase theta 2@:protein binding;glutathione transferase activity;nucleus;transferase activity;cytoplasm@NA
D164942@236748@236767@deletion@20@42522505@42537350@22@chr22:42522505-42537350@60.2@1325@685@0.517@CNVR8168.1, CNVR8168.3, CNVR8168.2, CNVR8168.4@RP4-669P10-201_4, RP4-669P10-201_5, RP4-669P10-201_6, RP4-669P10-201_7, CYP2D6-203_1, CYP2D6-203_2, CYP2D6-203_3, CYP2D6-203_4, CYP2D6-203_5, CYP2D6-203_6, CYP2D6-203_7, CYP2D6-203_8, CYP2D6-203_9, CYP2D6-203_10, ENST00000428786_1, ENST00000428786_2, ENST00000428786_3, CYP2D7P1-202_8, CYP2D7P1-202_9, CYP2D7P1-202_10@16.15@2@30@:cytochrome P450, family 2, subfamily D, polypeptide 6@:oxidation-reduction process;mitochondrion;alkaloid catabolic process;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;drug catabolic process;endoplasmic reticulum membrane;response to organic substance;oxidative demethylation;endoplasmic reticulum;alkaloid metabolic process;negative regulation of binding;heme binding;xenobiotic metabolic process;dopamine metabolic process;steroid metabolic process;isoquinoline alkaloid metabolic process;arachidonic acid monooxygenase activity;arachidonic acid metabolic process;steroid 21-monooxygenase activity;negative regulation of cellular organofluorine metabolic process;oxidoreductase activity;monoterpenoid metabolic process;heterocycle metabolic process;drug binding;drug metabolic process;electron carrier activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;coumarin metabolic process:oxidation-reduction process;electron carrier activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;heme binding@: DRUG METABOLISM, POOR, CYP2D6-RELATED
D164942@238039@238042@duplication@4@51207885@51215178@22@chr22:51207885-51215178@6.41@535@711@1.33@NA@RABL2B-203_4, RABL2B-203_5, RABL2B-203_6, RABL2B-203_7@0@0@0@:RAB, member of RAS oncogene family-like 2B@:intracellular;small GTPase mediated signal transduction;GTPase activity;GTP catabolic process;cytoplasm;intracellular protein transport;signal transduction;nucleocytoplasmic transport;protein transport;GTP binding;nucleus;membrane@NA
D16618@499@500@deletion@2@1414431@1416317@1@chr1:1414431-1416317@6.32@128@69@0.539@CNVR15.1@ATAD3B-001_4, ATAD3B-001_5@24.5@23@26@:ATPase family, AAA domain containing 3B@:nucleoside-triphosphatase activity;mitochondrial inner membrane;nucleotide binding;ATP binding@NA
D16618@619@619@deletion@1@1666131@1666275@1@chr1:1666131-1666275@5.03@74@36@0.486@CNVR17.1@SLC35E2-002_6@32@32@32@:solute carrier family 35, member E2@:integral to membrane;membrane@NA
D16618@2884@2887@deletion@4@16863297@16879027@1@chr1:16863297-16879027@8.85@486@331@0.681@CNVR93.3, CNVR93.6, CNVR93.10@AL355149-201_2, ENST00000438396_1, ENST00000438396_2, ENST00000438396_3@41@11@61@:putative uncharacterized protein FLJ35883-like:UPF0627 protein ENSP00000364708@NA@NA
D16618@2909@2910@deletion@2@16916396@16918552@1@chr1:16916396-16918552@6.07@228@142@0.623@CNVR93.3, CNVR93.6@NBPF1-201_7, NBPF1-201_8@22@21@23@NA@NA@NA
D16618@2931@2947@deletion@17@16972895@16976731@1@chr1:16972895-16976731@186@4227@2304@0.545@CNVR93.3, CNVR93.6, CNVR93.12, CNVR93.7, CNVR93.14, CNVR93.15@RP5-1182A14-001_2, RP5-1182A14-001_3, RP5-1182A14-001_4, RP5-1182A14-001_5, RP5-1182A14-001_6, RP5-1182A14-001_7, RP5-1182A14-001_8, RP5-1182A14-001_9, RP5-1182A14-001_10, RP5-1182A14-001_11, RP5-1182A14-001_12, RP5-1182A14-001_13, RP5-1182A14-001_14, RP5-1182A14-001_15, RP5-1182A14-001_16, RP5-1182A14-001_17, RP5-1182A14-001_18@59.9411764705882@39@88@NA@NA@NA
D16618@2977@2979@deletion@3@17085173@17085434@1@chr1:17085173-17085434@15.9@660@415@0.629@CNVR93.3, CNVR93.15, CNVR93.2, CNVR93.1@MST1P9-202_12, MST1P9-202_13, MST1P9-202_14@36.6666666666667@35@38@:macrophage stimulating 1-like@:proteolysis;extracellular region;catalytic activity;serine-type endopeptidase activity@NA
D16618@2987@2990@deletion@4@17087066@17087580@1@chr1:17087066-17087580@17.4@1166@773@0.663@CNVR93.3, CNVR93.15, CNVR93.2, CNVR93.1@MST1P9-202_1, MST1P9-202_2, MST1P9-202_3, MST1P9-202_4@28.75@28@30@:macrophage stimulating 1-like@:proteolysis;extracellular region;catalytic activity;serine-type endopeptidase activity@NA
D16618@3005@3020@duplication@16@17249160@17273487@1@chr1:17249160-17273487@23.1@1590@2131@1.34@CNVR94.4, CNVR94.5@CROCC-201_2, CROCC-201_3, CROCC-201_4, CROCC-201_5, CROCC-201_6, CROCC-201_7, CROCC-201_8, CROCC-201_9, CROCC-201_10, CROCC-201_11, CROCC-201_12, CROCC-201_13, CROCC-201_14, CROCC-201_15, CROCC-201_16, CROCC-201_17@76.875@62@85@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
D16618@3761@3764@duplication@4@21786157@21786568@1@chr1:21786157-21786568@6.62@64@117@1.83@CNVR107.2, CNVR107.1@NBPF3-003_4, RP11-293F5-201_1, RP11-293F5-201_2, RP11-293F5-201_3@62.25@49@73@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 3@:cytoplasm@NA
D16618@4451@4461@duplication@11@25599041@25655628@1@chr1:25599041-25655628@47.3@1280@1905@1.49@CNVR116.1, CNVR116.2@RHD-202_1, RHD-202_2, RHD-202_3, RHD-202_4, RHD-202_5, RHD-202_6, RHD-202_7, RHD-202_8, RHD-202_9, RHD-202_10, RHD-202_11@122.181818181818@113@128@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
D16618@6746@6746@deletion@1@39987050@39987243@1@chr1:39987050-39987243@5.44@24@0@0@NA@BMP8A-001_4@53@53@53@:bone morphogenetic protein 8a@:cell differentiation;growth factor activity;extracellular space;growth;cytokine activity;cartilage development;ossification@NA
D16618@11245@11246@duplication@2@89476589@89477711@1@chr1:89476589-89477711@13.5@596@861@1.44@CNVR244.1@GBP3-001_7, GBP3-001_8@54@54@54@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
D16618@12416@12446@duplication@31@104202984@104297437@1@chr1:104202984-104297437@35.5@648@1043@1.61@CNVR266.3, CNVR266.5@AMY1A-001_7, AMY1A-001_8, AMY1A-001_9, AMY1A-001_10, AMY1A-001_11, AMY1B-001_1, AMY1B-001_2, AMY1B-001_3, AMY1B-001_4, AMY1B-001_5, AMY1B-001_6, AMY1B-001_7, AMY1B-001_8, AMY1B-001_9, AMY1B-001_10, AMY1B-001_11, AMYP1-001_1, AMYP1-001_2, AMYP1-001_3, AMYP1-001_4, AMYP1-001_5, AMYP1-001_6, AMYP1-001_7, AMY1C-201_1, AMY1C-201_2, AMY1C-201_3, AMY1C-201_4, AMY1C-201_5, AMY1C-201_6, AMY1C-201_7, AMY1C-201_8@97.258064516129@31@154@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D16618@12927@12927@duplication@1@110224433@110224457@1@chr1:110224433-110224457@6.36@84@146@1.74@CNVR299.6, CNVR299.4, CNVR299.5@GSTM2-203_8@23@23@23@:glutathione S-transferase mu 2 (muscle)@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process@NA
D16618@15450@15460@duplication@11@149307425@149399167@1@chr1:149307425-149399167@12.8@491@687@1.4@CNVR350.1@ENST00000449024_1, ENST00000449024_2, FCGR1C-201_1, FCGR1C-201_2, FCGR1C-201_3, FCGR1C-201_4, FCGR1C-201_5, FCGR1C-201_6, ENST00000415338_1, ENST00000415338_2, HIST2H3PS2-001_2@59.6363636363636@27@76@NA@NA@NA
D16618@15499@15500@deletion@2@149762795@149764577@1@chr1:149762795-149764577@6.77@95@44@0.463@CNVR351.3, CNVR351.5@FCGR1A-001_6, ENST00000428289_1@1.5@0@3@:Fc fragment of IgG, high affinity Ib, receptor (CD64);Fc fragment of IgG, high affinity Ia, receptor (CD64):histone cluster 2, H2bf@:IgG receptor activity;phagocytosis, recognition;antibody-dependent cellular cytotoxicity;regulation of immune response;phagocytosis, engulfment;antigen processing and presentation of peptide antigen via MHC class I;immune response;clathrin-coated endocytic vesicle membrane;interferon-gamma-mediated signaling pathway;integral to membrane;Fc-gamma receptor signaling pathway;positive regulation of type III hypersensitivity;plasma membrane;receptor-mediated endocytosis;positive regulation of phagocytosis;cytokine-mediated signaling pathway;early endosome membrane;cell surface receptor signaling pathway;IgG binding;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;positive regulation of type IIa hypersensitivity;antigen processing and presentation of exogenous antigen;external side of plasma membrane;signal transduction;protein binding;defense response to bacterium;antigen processing and presentation of exogenous peptide antigen via MHC class I;receptor signaling protein activity;response to bacterium:sequence-specific DNA binding;intracellular;nucleus;protein heterodimerization activity;DNA binding;nucleosome assembly;nucleosome@NA
D16618@16280@16280@deletion@1@152573269@152573493@1@chr1:152573269-152573493@20.3@94@0@0@CNVR358.1@LCE3C-201_2@102@102@102@:late cornified envelope 3C@:keratinization@NA
D16618@21363@21366@deletion@4@196748294@196759358@1@chr1:196748294-196759358@21.9@487@280@0.575@CNVR459.1@CFHR3-001_2, CFHR3-001_3, CFHR3-001_4, CFHR3-001_5@100.75@95@112@:complement factor H-related 3@:extracellular space@NA
D16618@24160@24164@deletion@5@223727670@223729472@1@chr1:223727670-223729472@13.1@68@6@0.0882@NA@CAPN8-202_20, CAPN8-202_21, CAPN8-202_22, CAPN8-202_23, CAPN8-202_24@0@0@0@:calpain 8@:proteolysis;Golgi apparatus;intracellular;calcium-dependent cysteine-type endopeptidase activity;calcium ion binding@NA
D16618@32513@32514@duplication@2@73912090@73912704@2@chr2:73912090-73912704@9.12@231@346@1.5@NA@AC092653-201_8, ALMS1P-002_7@1@1@1@NA@NA@NA
D16618@33832@33835@deletion@4@90192770@90199191@2@chr2:90192770-90199191@6.74@621@437@0.704@CNVR867.10, CNVR867.5, CNVR867.3, CNVR867.9, CNVR867.15@IGKV1D-13-001_1, IGKV1D-13-001_2, IGKV1D-12-001_1, IGKV1D-12-001_2@8.25@7@10@@:protein binding:protein binding@NA
D16618@34053@34053@duplication@1@96146055@96146284@2@chr2:96146055-96146284@5.46@133@203@1.53@NA@TRIM43B-203_4@4@4@4@NA@NA@NA
D16618@34082@34082@deletion@1@96261952@96262181@2@chr2:96261952-96262181@4.76@86@45@0.523@NA@TRIM43-001_4@2@2@2@:tripartite motif containing 43B;tripartite motif containing 43@:protein binding;intracellular;zinc ion binding@NA
D16618@34183@34184@duplication@2@96652501@96652955@2@chr2:96652501-96652955@12.1@230@375@1.63@NA@AC073995-001_2, AC073995-001_3@4@4@4@:ankyrin repeat domain-containing protein 36A-like@:ion channel inhibitor activity;protein binding@NA
D16618@35461@35467@duplication@7@106992909@107002872@2@chr2:106992909-107002872@9.88@166@265@1.6@NA@ENST00000447760_4, ENST00000447760_5, ENST00000447760_6, AC114755-201_1, AC114755-201_2, PLGLA-001_1, PLGLA-001_2@9.71428571428571@0@27@NA@NA@NA
D16618@35993@35997@duplication@5@112592183@112605443@2@chr2:112592183-112605443@6.18@308@423@1.37@CNVR929.1, CNVR929.2@ANAPC1-001_15, ANAPC1-001_16, ANAPC1-001_17, ANAPC1-001_18, ANAPC1-001_19@0@0@0@:anaphase-promoting complex subunit 1-like;anaphase promoting complex subunit 1@:nucleoplasm;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle;anaphase-promoting complex;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle spindle assembly checkpoint;cytosol;protein K11-linked ubiquitination;protein binding;mitosis;nucleus;cell cycle checkpoint;cell division;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle@NA
D16618@45386@45390@deletion@5@233272979@233274159@2@chr2:233272979-233274159@16.3@376@212@0.564@NA@ALPPL2-001_6, ALPPL2-001_7, ALPPL2-001_8, ALPPL2-001_9, ALPPL2-001_10@35@16@58@:alkaline phosphatase, placental-like 2@:phosphatase activity;catalytic activity;phosphorylation;plasma membrane;metabolic process;membrane;anchored to membrane;alkaline phosphatase activity;metal ion binding@NA
D16618@47457@47457@duplication@1@10091060@10091190@3@chr3:10091060-10091190@5.84@135@208@1.54@NA@FANCD2-202_17@6@6@6@:Fanconi anemia, complementation group D2@:nucleoplasm;synapsis;binding;response to DNA damage stimulus;gamete generation;DNA repair;condensed chromosome;protein binding;response to gamma radiation@: FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2
D16618@51972@51976@duplication@5@52089868@52159198@3@chr3:52089868-52159198@17.3@890@1227@1.38@NA@DUSP7-001_1, WDR51A-001_8, WDR51A-001_9, WDR51A-001_10, WDR51A-001_11@0.2@0@1@:dual specificity phosphatase 7:POC1 centriolar protein homolog A (Chlamydomonas)@:nucleoplasm;toll-like receptor 4 signaling pathway;protein dephosphorylation;negative regulation of MAP kinase activity;Toll signaling pathway;stress-activated MAPK cascade;protein tyrosine/serine/threonine phosphatase activity;toll-like receptor 2 signaling pathway;MyD88-dependent toll-like receptor signaling pathway;peptidyl-tyrosine dephosphorylation;phosphatase activity;toll-like receptor 3 signaling pathway;MyD88-independent toll-like receptor signaling pathway;protein tyrosine phosphatase activity;TRIF-dependent toll-like receptor signaling pathway;innate immune response;cytosol;protein binding;inactivation of MAPK activity;MAP kinase tyrosine/serine/threonine phosphatase activity;toll-like receptor signaling pathway;nerve growth factor receptor signaling pathway;dephosphorylation;toll-like receptor 1 signaling pathway:centriole;protein binding;centrosome;microtubule basal body;cytoplasm@NA
D16618@61569@61573@deletion@5@195452546@195475936@3@chr3:195452546-195475936@37.2@2010@1208@0.601@CNVR1703.1, CNVR1703.2, CNVR1703.5, CNVR1703.3@MUC20-201_3, MUC20-201_4, MUC20-201_5, MUC4-203_25, MUC4-203_26@37@30@44@:mucin 20, cell surface associated:mucin 4, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane:ErbB-2 class receptor binding;Golgi lumen;cell-matrix adhesion;post-translational protein modification;extracellular matrix structural constituent;protein binding;O-glycan processing;cellular protein metabolic process;proteinaceous extracellular matrix;integral to plasma membrane;membrane;extracellular matrix constituent, lubricant activity;biological_process@NA
D16618@62022@62023@duplication@2@197846588@197847650@3@chr3:197846588-197847650@6.05@99@161@1.63@CNVR1728.7, CNVR1728.8, CNVR1728.3@ENST00000392362_1, ENST00000392362_2@53@53@53@NA@NA@NA
D16618@65315@65320@duplication@6@69402904@69434246@4@chr4:69402904-69434246@70.7@1058@1994@1.88@CNVR1953.1@UGT2B17-001_1, UGT2B17-001_2, UGT2B17-001_3, UGT2B17-001_4, UGT2B17-001_5, UGT2B17-001_6@124.5@118@134@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
D16618@65799@65799@deletion@1@75312253@75312500@4@chr4:75312253-75312500@12.7@124@42@0.339@NA@AREG-001_2@28@28@28@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
D16618@65805@65805@duplication@1@75482008@75482255@4@chr4:75482008-75482255@11.4@105@212@2.02@NA@AREGB-201_2@56@56@56@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
D16618@68947@68947@duplication@1@145041645@145041742@4@chr4:145041645-145041742@9.56@127@226@1.78@NA@GYPA-205_2@8@8@8@:glycophorin B (MNS blood group):glycophorin A (MNS blood group)@:integral to membrane;plasma membrane;integral to plasma membrane:external side of plasma membrane;integral to membrane;cytoskeletal anchoring at plasma membrane;plasma membrane;molecular_function;protein homodimerization activity;integral to plasma membrane;cellular_component;identical protein binding;membrane;biological_process;regulation of response to osmotic stress;virus-host interaction@: BLOOD GROUP--Ss LOCUS; Ss: MALARIA, SUSCEPTIBILITY TO; BLOOD GROUP--MN LOCUS; MN
D16618@70822@70824@duplication@3@748521@755215@5@chr5:748521-755215@10.8@171@283@1.65@CNVR2280.3@ZDHHC11B-201_3, ZDHHC11B-201_4, ZDHHC11B-201_5@89@84@96@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
D16618@70836@70840@deletion@5@833890@847731@5@chr5:833890-847731@14.1@924@613@0.663@CNVR2280.3, CNVR2280.8@ZDHHC11-201_3, ZDHHC11-201_4, ZDHHC11-201_5, ZDHHC11-201_6, ZDHHC11-201_7@23@15@30@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
D16618@71896@71900@duplication@5@34182787@34193054@5@chr5:34182787-34193054@37.1@532@979@1.84@CNVR2430.2, CNVR2430.1@ENST00000380721_1, ENST00000502234_2, AC138409-201_1, AC138409-201_2, AC138409-201_3@45.2@35@49@NA@NA@NA
D16618@72598@72598@deletion@1@42629142@42629206@5@chr5:42629142-42629206@27@129@1@0.00775@CNVR2445.1@GHR-001_3@16@16@16@:growth hormone receptor@:neuronal cell body;mitochondrion;proline-rich region binding;JAK-STAT cascade;growth factor binding;nucleus;succinate metabolic process;positive regulation of JAK-STAT cascade;JAK-STAT cascade involved in growth hormone signaling pathway;response to morphine;activation of MAPK activity;peptide hormone binding;response to estradiol stimulus;2-oxoglutarate metabolic process;valine metabolic process;response to cytokine stimulus;hormone-mediated signaling pathway;response to food;SH2 domain binding;oxaloacetate metabolic process;growth hormone receptor signaling pathway;allantoin metabolic process;integral to membrane;response to hormone stimulus;cartilage development involved in endochondral bone morphogenesis;positive regulation of peptidyl-tyrosine phosphorylation;receptor internalization;cytoplasm;cellular response to hormone stimulus;extracellular region;growth hormone receptor complex;positive regulation of tyrosine phosphorylation of Stat5 protein;regulation of multicellular organism growth;growth hormone receptor activity;positive regulation of tyrosine phosphorylation of Stat3 protein;response to peptide hormone stimulus;fatty acid metabolic process;creatinine metabolic process;plasma membrane;positive regulation of multicellular organism growth;receptor complex;protein phosphatase binding;protein kinase binding;creatine metabolic process;response to interleukin-1;response to cycloheximide;extracellular space;positive regulation of cell differentiation;activation of Janus kinase activity;taurine metabolic process;cellular response to insulin stimulus;integral to plasma membrane;protein homodimerization activity;negative regulation of neuron death;citrate metabolic process;endocytosis;isoleucine metabolic process;activation of JAK2 kinase activity;extrinsic to membrane;response to glucocorticoid stimulus;protein binding;insulin-like growth factor receptor signaling pathway;multicellular organismal metabolic process;cell surface@: HYPERCHOLESTEROLEMIA, FAMILIAL; LARON SYNDROME; SHORT STATURE, IDIOPATHIC, AUTOSOMAL
D16618@73656@73656@duplication@1@68862418@68862453@5@chr5:68862418-68862453@8.78@59@131@2.22@CNVR2494.7, CNVR2494.46@GTF2H2C-201_5@12@12@12@:general transcription factor IIH, polypeptide 2C;general transcription factor IIH, polypeptide 2D@:regulation of transcription, DNA-dependent;nucleotide-excision repair;DNA repair;core TFIIH complex;protein binding;nucleus;transcription, DNA-dependent;zinc ion binding@NA
D16618@73727@73727@duplication@1@69717564@69717599@5@chr5:69717564-69717599@7.45@57@119@2.09@CNVR2494.17, CNVR2494.3@GTF2H2B-201_4@139@139@139@NA@NA@NA
D16618@73817@73821@duplication@5@70370032@70389020@5@chr5:70370032-70389020@17.3@146@291@1.99@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.8, CNVR2494.1, CNVR2494.37@AC044797-201_1, AC044797-201_2, AC044797-201_3, AC044797-201_4, AC044797-201_5@120.4@100@138@NA@NA@NA
D16618@80560@80560@duplication@1@292099@292561@6@chr6:292099-292561@5.67@272@383@1.41@CNVR2728.1, CNVR2728.2@DUSP22-001_1@13@13@13@:dual specificity phosphatase 22;dual specificity protein phosphatase 22-like@:protein dephosphorylation;transforming growth factor beta receptor signaling pathway;positive regulation of JNK cascade;protein tyrosine/serine/threonine phosphatase activity;nucleus;apoptotic process;multicellular organismal development;phosphatase activity;protein tyrosine phosphatase activity;regulation of cell proliferation;cytoplasm;cell proliferation;inactivation of MAPK activity;protein binding;negative regulation of transcription from RNA polymerase II promoter;dephosphorylation@NA
D16618@82488@82513@duplication@26@29855352@29897010@6@chr6:29855352-29897010@31.1@1910@2549@1.33@CNVR2829.7, CNVR2829.2, CNVR2829.3@HLA-H-001_1, HLA-H-001_2, HLA-H-001_3, HLA-H-001_4, HLA-H-001_5, HLA-H-001_6, HLA-H-001_7, HLA-16-001_1, HLA-16-001_2, HLA-16-001_3, HLA-16-001_4, AL645929-201_2, AL645929-201_3, AL645929-201_4, AL645929-201_5, AL645929-201_6, BAT1P1-001_1, BAT1P1-001_2, MCCD1P1-001_1, MCCD1P1-001_2, HLA-K-001_1, HLA-K-001_2, HLA-K-001_3, HLA-K-001_4, HLA-K-001_5, HLA-K-001_6@45.2307692307692@41@51@NA@NA@NA
D16618@82520@82523@duplication@4@29911901@29913059@6@chr6:29911901-29913059@13.8@793@1083@1.37@CNVR2829.7, CNVR2829.2, CNVR2829.3@HLA-A-001_6, HLA-A-001_7, HLA-A-001_8, HLA-A-001_9@19.25@14@22@:major histocompatibility complex, class I, A@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO
D16618@83003@83003@deletion@1@31237989@31238263@6@chr6:31237989-31238263@14@197@84@0.426@CNVR2838.1@HLA-C-006_4@25@25@25@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
D16618@83026@83026@deletion@1@31379726@31380003@6@chr6:31379726-31380003@5.68@142@81@0.57@CNVR2842.1@MICA-001_6@1@1@1@:MHC class I polypeptide-related sequence A@:MHC class I protein complex;protein binding;regulation of immune response;antigen processing and presentation;immune response;plasma membrane;membrane@: PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO; PSORIASIS SUSCEPTIBILITY 1; PSORS1
D16618@83603@83617@deletion@15@31973923@31976177@6@chr6:31973923-31976177@62.9@1322@722@0.546@CNVR2843.6, CNVR2843.3@CYP21A1P-001_3, CYP21A1P-001_4, CYP21A1P-001_5, CYP21A1P-001_6, CYP21A1P-001_7, CYP21A1P-001_8, CYP21A1P-001_9, CYP21A1P-001_10, AL645922-201_1, AL645922-201_2, AL645922-201_3, AL645922-201_4, AL645922-201_5, AL645922-201_6, AL645922-201_7@108.866666666667@82@121@NA@NA@NA
D16618@83642@83644@deletion@3@31996236@31996839@6@chr6:31996236-31996839@8.1@204@119@0.583@CNVR2843.6, CNVR2843.5@C4B-001_25, C4B-001_26, C4B-001_27@17@15@19@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
D16618@83669@83675@deletion@7@32008447@32010384@6@chr6:32008447-32010384@7.09@313@204@0.652@CNVR2843.6, CNVR2843.5@TNXB-201_40, TNXB-201_41, TNXB-201_42, TNXB-201_43, TNXB-201_44, CYP21A2-002_9, CYP21A2-002_10@40.8571428571429@33@46@:cytochrome P450, family 21, subfamily A, polypeptide 2:tenascin-X-like;tenascin XB@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
D16618@83911@83915@deletion@5@32485122@32489952@6@chr6:32485122-32489952@36.6@221@36@0.163@CNVR2845.21, CNVR2845.25, CNVR2845.30@HLA-DRB5-001_2, HLA-DRB5-001_3, HLA-DRB5-001_4, HLA-DRB5-001_5, HLA-DRB5-001_6@184.2@177@189@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D16618@83918@83923@duplication@6@32521155@32525964@6@chr6:32521155-32525964@13.5@280@431@1.54@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.5@HLA-DRB6-002_2, HLA-DRB6-002_3, HLA-DRB6-002_4, HLA-DRB6-002_5, AL713966-201_2, AL713966-201_3@144.666666666667@114@167@NA@NA@NA
D16618@83928@83930@deletion@3@32548525@32552156@6@chr6:32548525-32552156@16.6@398@229@0.575@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.5, CNVR2845.54@HLA-DRB1-001_2, HLA-DRB1-001_3, HLA-DRB1-001_4@72@56@100@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
D16618@84061@84062@deletion@2@33053998@33054977@6@chr6:33053998-33054977@24.3@256@100@0.391@CNVR2846.3, CNVR2846.5@HLA-DPB1-201_5, HLA-DPB1-201_6@21@18@24@:major histocompatibility complex, class II, DP beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D16618@93075@93077@duplication@3@167594123@167596397@6@chr6:167594123-167596397@8.47@117@200@1.71@NA@TCP10L2-001_6, AL121935-201_7, AL121935-201_8@7@3@9@:t-complex 10;t-complex 10-like 2@NA@NA
D16618@93097@93101@deletion@5@167787841@167794825@6@chr6:167787841-167794825@12.1@370@230@0.622@NA@TCP10-001_3, TCP10-001_4, TCP10-001_5, TCP10-001_6, TCP10-001_7@59.4@33@103@:t-complex 10@:cytosol@NA
D16618@94190@94194@deletion@5@5959482@5966180@7@chr7:5959482-5966180@5.88@736@520@0.707@NA@C7orf28A-001_12, C7orf28A-001_13, C7orf28A-001_14, C7orf28A-001_15, RSPH10B-002_21@55.4@14@73@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae):radial spoke head 10 homolog B (Chlamydomonas)@:lysosomal membrane@NA
D16618@94207@94208@deletion@2@5997540@5998710@7@chr7:5997540-5998710@21.4@268@101@0.377@NA@RSPH10B-002_7, RSPH10B-002_8@9.5@8@11@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D16618@94410@94415@deletion@6@6785721@6791233@7@chr7:6785721-6791233@18.8@307@156@0.508@NA@ENST00000338780_11, ENST00000338780_12, ENST00000338780_13, PMS2CL-002_11, PMS2CL-002_12, PMS2CL-002_13@80.3333333333333@73@90@NA@NA@NA
D16618@94424@94424@duplication@1@6805339@6805423@7@chr7:6805339-6805423@6.37@220@321@1.46@NA@RSPH10B2-204_7@12@12@12@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D16618@94440@94444@duplication@5@6837996@6844687@7@chr7:6837996-6844687@21.3@327@542@1.66@NA@RSPH10B2-204_21, C7orf28B-001_12, C7orf28B-001_13, C7orf28B-001_14, C7orf28B-001_15@117@114@121@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D16618@96557@96557@duplication@1@38284786@38284832@7@chr7:38284786-38284832@11@293@461@1.57@NA@TRGC2-001_2@3@3@3@@:protein binding@NA
D16618@96579@96579@duplication@1@38388958@38389267@7@chr7:38388958-38389267@5.81@401@550@1.37@CNVR3354.3, CNVR3354.1@TRGV5-001_2@13@13@13@@:protein binding@NA
D16618@96581@96584@duplication@4@38393318@38398764@7@chr7:38393318-38398764@12.1@1097@1441@1.31@CNVR3354.3, CNVR3354.1@TRGV4-001_1, TRGV4-001_2, TRGV3-001_1, TRGV3-001_2@9.25@6@14@@:protein binding:protein binding;immune response;peptide antigen binding;plasma membrane;MHC protein binding@NA
D16618@97912@97916@duplication@5@57071006@57082132@7@chr7:57071006-57082132@6.57@65@119@1.83@NA@TNRC18C-202_8, TNRC18C-202_9, TNRC18C-202_10, TNRC18C-202_11, ENST00000398760_5@157.8@149@166@NA@NA@NA
D16618@97990@97994@deletion@5@62753052@62758771@7@chr7:62753052-62758771@149@728@0@0@NA@AC006455-201_2, AC006455-201_3, AC006455-201_4, ENST00000444809_2, ENST00000444809_3, ENST00000444809_4@137@97@171@NA@NA@NA
D16618@98015@98026@duplication@12@62910199@62970547@7@chr7:62910199-62970547@41.3@688@1206@1.75@NA@ZNF734-201_2, ZNF734-201_3, ZNF734-201_4, ZNF734-201_5, ZNF734-201_6, ZNF734-201_7, ZNF734-201_8, ENST00000434048_1, ENST00000434048_2, CTD-2526L21-201_1, CTD-2526L21-201_2, CTD-2526L21-201_3@81.5833333333333@66@102@NA@NA@NA
D16618@98192@98193@deletion@2@64646770@64646889@7@chr7:64646770-64646889@8.96@63@16@0.254@NA@INTS4L1-201_8, INTS4L1-201_9@51.5@51@52@NA@NA@NA
D16618@98213@98215@duplication@3@65139336@65150717@7@chr7:65139336-65150717@9.14@57@129@2.26@CNVR3430.2@INTS4L2-001_3, INTS4L2-001_4, INTS4L2-001_5@30.3333333333333@2@56@NA@NA@NA
D16618@98688@98688@deletion@1@72613728@72613825@7@chr7:72613728-72613825@5.26@23@0@0@NA@RP11-396K3-001_18@1@1@1@NA@NA@NA
D16618@99031@99035@duplication@5@74167428@74172334@7@chr7:74167428-74172334@13.8@205@348@1.7@NA@GTF2I-001_29, GTF2I-001_30, GTF2I-001_31, GTF2I-001_32, GTF2I-001_33@22.8@14@35@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
D16618@99100@99100@deletion@1@74466820@74466904@7@chr7:74466820-74466904@6.99@31@0@0@NA@WBSCR16-001_10@37@37@37@:RCC1-like G exchanging factor-like;Williams-Beuren syndrome chromosome region 16@:mitochondrion;cellular_component;biological_process@: WILLIAMS-BEUREN SYNDROME; WBS
D16618@99133@99134@deletion@2@74582344@74582683@7@chr7:74582344-74582683@12@54@0@0@NA@NCF1C-001_3, NCF1C-001_4@32@15@49@NA@NA@NA
D16618@99454@99454@deletion@1@76063357@76063473@7@chr7:76063357-76063473@15.2@95@16@0.168@CNVR3462.1@ZP3-002_6@10@10@10@:zona pellucida glycoprotein 3 (sperm receptor)@:negative regulation of transcription, DNA-dependent;manganese ion transmembrane transporter activity;intracellular protein transport;proteinaceous extracellular matrix;plasma membrane;positive regulation of acrosome reaction;outer acrosomal membrane;protein kinase C signaling cascade;manganese ion transmembrane transport;intracellular signal transduction;humoral immune response mediated by circulating immunoglobulin;negative regulation of binding of sperm to zona pellucida;positive regulation of inflammatory response;endoplasmic reticulum;signal transducer activity;perinuclear region of cytoplasm;secretory granule;positive regulation of transcription, DNA-dependent;positive regulation of ovarian follicle development;positive regulation of interferon-gamma production;carbohydrate binding;manganese ion transport;positive regulation of antral ovarian follicle growth;extracellular matrix;positive regulation of leukocyte migration;positive regulation of humoral immune response;extracellular space;blastocyst formation;integral to membrane;store-operated calcium channel activity;oocyte development;multivesicular body;phosphatidylinositol-mediated signaling;acrosomal vesicle;positive regulation of protein kinase B signaling cascade;Golgi apparatus;positive regulation of calcium ion import;positive regulation of protein kinase activity;positive regulation of acrosomal vesicle exocytosis;positive regulation of interleukin-4 production;cytoplasm;protein binding;binding of sperm to zona pellucida;positive regulation of phosphatidylinositol biosynthetic process;extracellular region;positive regulation of T cell proliferation;acrosin binding;positive regulation of type IV hypersensitivity;egg coat formation@NA
D16618@99489@99490@deletion@2@76240773@76241131@7@chr7:76240773-76241131@35.5@270@66@0.244@CNVR3463.10@POMZP3-003_6, POMZP3-003_7@43.5@41@46@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
D16618@99544@99545@duplication@2@76723321@76728269@7@chr7:76723321-76728269@14@134@257@1.92@NA@ENST00000398321_6, ENST00000398321_7@13.5@11@16@NA@NA@NA
D16618@101721@101726@duplication@6@100331652@100336237@7@chr7:100331652-100336237@17.3@770@1070@1.39@CNVR3509.1@ZAN-001_2, ZAN-001_3, ZAN-001_4, ZAN-001_5, ZAN-001_6, ZAN-001_7@81.6666666666667@71@89@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
D16618@102116@102116@deletion@1@102114810@102114983@7@chr7:102114810-102114983@4.86@23@1@0.0435@CNVR3518.1@POLR2J-001_3@91@91@91@:polymerase (RNA) II (DNA directed) polypeptide J, 13.3kDa@:nucleoplasm;DNA binding;DNA repair;protein dimerization activity;nucleus;viral reproduction;gene expression;transcription initiation from RNA polymerase II promoter;7-methylguanosine mRNA capping;protein phosphorylation;LRR domain binding;protein kinase activity;DNA-directed RNA polymerase II, core complex;nucleotide-excision repair;transcription from RNA polymerase II promoter;DNA-directed RNA polymerase activity;protein binding;transcription-coupled nucleotide-excision repair;RNA splicing;mRNA splicing, via spliceosome;transcription, DNA-dependent;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription@NA
D16618@102616@102617@duplication@2@105902036@105904064@7@chr7:105902036-105904064@6.66@622@819@1.32@NA@PBEF1-001_7, PBEF1-001_8@2.5@2@3@:nicotinamide phosphoribosyltransferase@:nicotinate phosphoribosyltransferase activity;small molecule metabolic process;positive regulation of nitric-oxide synthase biosynthetic process;NAD metabolic process;cytoplasm;cell-cell signaling;NAD biosynthetic process;cytosol;signal transduction;cytokine activity;positive regulation of cell proliferation;water-soluble vitamin metabolic process;nicotinate-nucleotide diphosphorylase (carboxylating) activity;nicotinamide metabolic process;vitamin metabolic process;nicotinamide phosphoribosyltransferase activity@NA
D16618@105321@105336@deletion@16@141765517@141785762@7@chr7:141765517-141785762@23.2@2262@1577@0.697@CNVR3585.3, CNVR3585.2@MGAM-007_40, MGAM-007_41, MGAM-007_42, MGAM-007_43, MGAM-007_44, MGAM-007_45, MGAM-007_46, MGAM-007_47, MGAM-007_48, MGAM-007_49, MGAM-007_50, MGAM-007_51, MGAM-007_52, MGAM-007_53, MGAM-007_54, MGAM-007_55@119.5@101@126@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
D16618@105441@105442@deletion@2@142045254@142045817@7@chr7:142045254-142045817@17.7@671@404@0.602@NA@TRBV4-2-001_1, TRBV4-2-001_2@3.5@3@4@@:protein binding@NA
D16618@105521@105523@deletion@3@142481247@142482417@7@chr7:142481247-142482417@97.9@479@6@0.0125@NA@PRSS1-204_4, PRSS1-204_5, PRSS1-204_6@114.333333333333@113@115@NA@NA@NA
D16618@105784@105791@duplication@8@143953276@143973535@7@chr7:143953276-143973535@18@671@962@1.43@CNVR3598.4@OR2A20P-003_1, RP4-798C17-001_9, RP4-798C17-001_10, RP4-798C17-001_11, RP4-798C17-001_12, ENST00000378112_10, ENST00000378112_11, ENST00000378112_12@80.125@16@127@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor, family 2, subfamily A, member 7:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane@NA
D16618@105800@105803@duplication@4@143979376@143979884@7@chr7:143979376-143979884@11.2@312@458@1.47@CNVR3598.4, CNVR3598.9@RP4-798C17-001_3, RP4-798C17-001_4, ENST00000378112_4, ENST00000378112_5@57.25@55@58@:Rho guanine nucleotide exchange factor (GEF) 35@NA@NA
D16618@107428@107429@deletion@2@7308087@7308722@8@chr8:7308087-7308722@25.3@512@264@0.516@CNVR3771.8, CNVR3771.10, CNVR3771.4@SPAG11-003_3, SPAG11-003_4@90.5@90@91@:sperm associated antigen 11B@:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response@NA
D16618@107507@107507@deletion@1@7686329@7686576@8@chr8:7686329-7686576@4.67@70@34@0.486@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@DEFB106A-001_2@44@44@44@:defensin, beta 106B;defensin, beta 106A@:extracellular region;defense response to bacterium@NA
D16618@107512@107513@duplication@2@7717871@7718505@8@chr8:7717871-7718505@25@301@564@1.87@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@SPAG11A-207_3, SPAG11A-207_4@112@111@113@:sperm associated antigen 11A;sperm associated antigen 11B@:extracellular region;defense response@NA
D16618@109572@109585@duplication@14@39311571@39349528@8@chr8:39311571-39349528@51@456@882@1.93@CNVR3859.1@ADAM3A-005_11, ADAM3A-005_12, ADAM3A-005_13, ADAM3A-005_14, ADAM3A-005_15, ADAM3A-005_16, ADAM3A-005_17, ADAM3A-005_18, ADAM3A-005_19, ADAM3A-005_20, ADAM3A-005_21, ADAM3A-009_7, ADAM3A-009_8, ADAM3A-009_9@120.5@98@136@NA@NA@NA
D16618@117602@117602@duplication@1@43818043@43818185@9@chr9:43818043-43818185@5.68@170@251@1.48@CNVR4294.1@CNTNAP3B-001_7@91@91@91@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
D16618@118854@118854@duplication@1@84545372@84549914@9@chr9:84545372-84549914@5.48@449@608@1.35@CNVR4364.1@ENST00000427387_1, RP11-383M4-201_4@27@27@27@NA@NA@NA
D16618@121601@121603@deletion@3@117085945@117087178@9@chr9:117085945-117087178@7.49@1331@958@0.72@CNVR4448.1@ORM1-001_2, ORM1-001_3, ORM1-001_4@89.6666666666667@89@90@:orosomucoid 1@:protein binding;extracellular space;regulation of immune system process;transport;inflammatory response;extracellular region;acute-phase response@NA
D16618@126909@126909@deletion@1@17840632@17842868@10@chr10:17840632-17842868@5.12@23@0@0@NA@FAM23A-201_5@108@108@108@:transmembrane protein 236;transmembrane protein 236-like@:integral to membrane@NA
D16618@126911@126921@duplication@11@17865075@17908771@10@chr10:17865075-17908771@24.5@781@1141@1.46@NA@MRC1L1-001_2, MRC1L1-001_3, MRC1L1-001_4, MRC1L1-001_5, MRC1L1-001_6, MRC1L1-001_7, MRC1L1-001_8, MRC1L1-001_9, MRC1L1-001_10, MRC1L1-001_11, MRC1L1-001_12@8.45454545454546@4@20@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
D16618@126938@126974@deletion@37@17951324@18196628@10@chr10:17951324-18196628@80.6@405@22@0.0543@NA@MRC1L1-001_29, MRC1L1-001_30, FAM23B-202_1, FAM23B-202_2, FAM23B-202_3, FAM23B-202_4, FAM23B-202_5, MRC1-001_1, MRC1-001_2, MRC1-001_3, MRC1-001_4, MRC1-001_5, MRC1-001_6, MRC1-001_7, MRC1-001_8, MRC1-001_9, MRC1-001_10, MRC1-001_11, MRC1-001_12, MRC1-001_13, MRC1-001_14, MRC1-001_15, MRC1-001_16, MRC1-001_17, MRC1-001_18, MRC1-001_19, MRC1-001_20, MRC1-001_21, MRC1-001_22, MRC1-001_23, MRC1-001_24, MRC1-001_25, MRC1-001_26, MRC1-001_27, MRC1-001_28, RP11-457D2-001_1, RP11-457D2-001_2@24.9459459459459@5@107@:macrophage mannose receptor 1-like:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D16618@127722@127722@deletion@1@29580856@29580936@10@chr10:29580856-29580936@9.89@56@7@0.125@NA@LYZL1-002_1@51@51@51@:lysozyme-like 1@:extracellular region;lysozyme activity;cell wall macromolecule catabolic process@NA
D16618@128349@128359@deletion@11@39149222@42396475@10@chr10:39149222-42396475@11.6@111@42@0.378@NA@BX322613-201_1, BX322613-201_2, ENST00000439345_2, ENST00000439345_3@59.75@58@62@NA@NA@NA
D16618@128731@128745@deletion@15@46242050@46272874@10@chr10:46242050-46272874@22.1@564@308@0.546@NA@FAM21C-203_8, FAM21C-203_9, FAM21C-203_10, FAM21C-203_11, FAM21C-203_12, FAM21C-203_13, FAM21C-203_14, FAM21C-203_15, FAM21C-203_16, FAM21C-203_17, FAM21C-203_18, FAM21C-203_19, FAM21C-203_20, FAM21C-203_21, FAM21C-203_22@3.2@0@25@:family with sequence similarity 21, member C@:endosome;protein binding;plasma membrane;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
D16618@128979@128979@deletion@1@47758848@47758905@10@chr10:47758848-47758905@5.94@27@0@0@CNVR4714.1@ANXA8L2-001_10@154@154@154@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:calcium-dependent phospholipid binding;calcium ion binding@NA
D16618@129021@129030@duplication@10@48020452@48055019@10@chr10:48020452-48055019@25.2@553@844@1.53@CNVR4715.2@ASAH2C-201_1, ASAH2C-201_2, ASAH2C-201_3, ASAH2C-201_4, ASAH2C-201_5, ASAH2C-201_6, ASAH2C-201_7, ASAH2C-201_8, ASAH2C-201_9, ASAH2C-201_10@64.3@50@90@@:ceramidase activity;sphingolipid metabolic process@NA
D16618@129130@129131@duplication@2@48968562@48968624@10@chr10:48968562-48968624@6.98@57@112@1.96@CNVR4716.8, CNVR4716.4@RP11-508M1-002_5, GLUDP2-001_3@31@31@31@NA@NA@NA
D16618@129460@129463@deletion@4@51361725@51363788@10@chr10:51361725-51363788@72.2@347@4@0.0115@NA@ENST00000404618_3, ENST00000404618_4, ENST00000432221_3, ENST00000432221_4@132@121@142@NA@NA@NA
D16618@129468@129477@deletion@10@51371409@51391568@10@chr10:51371409-51391568@18.4@106@15@0.142@NA@TIMM23B-202_1, TIMM23B-202_2, TIMM23B-202_3, TIMM23B-202_4, TIMM23B-202_5, TIMM23B-202_6, TIMM23B-202_7, TIMM23B-202_8, TIMM23B-202_9, TIMM23B-202_10@24.8@0@119@:translocase of inner mitochondrial membrane 23 homolog B (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process@NA
D16618@129521@129521@duplication@1@51630972@51631957@10@chr10:51630972-51631957@4.89@496@662@1.33@NA@ENST00000456092_3@26@26@26@:translocase of inner mitochondrial membrane 23 homolog B (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process@NA
D16618@129604@129611@deletion@8@51965744@51994313@10@chr10:51965744-51994313@30.4@239@71@0.297@NA@ASAH2-201_5, ASAH2-201_6, ASAH2-201_7, ASAH2-201_8, ASAH2-201_9, ASAH2-201_10, ASAH2-201_11, ASAH2-201_12@147.125@53@186@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
D16618@132335@132336@deletion@2@92678624@92679026@10@chr10:92678624-92679026@8.24@321@201@0.626@NA@ANKRD1-001_3, ANKRD1-001_4@0@0@0@:ankyrin repeat domain 1 (cardiac muscle)@:nucleoplasm;positive regulation of DNA damage response, signal transduction by p53 class mediator;response to muscle stretch;cellular response to transforming growth factor beta stimulus;R-SMAD binding;cytoplasmic part;cellular response to organic cyclic compound;cardiac muscle tissue morphogenesis;cellular response to mechanical stimulus;myofibril;nucleus;cellular response to drug;cellular response to lipopolysaccharide;p53 binding;cytosol;cellular response to interleukin-1;cellular response to hypoxia;transcription factor binding;DNA binding;transcription corepressor activity;cellular response to tumor necrosis factor;histone deacetylase binding;transcription factor complex;negative regulation of DNA biosynthetic process;positive regulation of transcription from RNA polymerase II promoter;RNA polymerase II transcription coactivator activity;RNA polymerase II transcription factor binding;small molecule metabolic process;titin binding;cellular lipid metabolic process;regulation of transcription from RNA polymerase II promoter;cytoplasm;protein binding;negative regulation of transcription from RNA polymerase II promoter;positive regulation of neuron projection development;positive regulation of protein secretion;I band;sarcomere organization;positive regulation of apoptotic process@: TOTAL ANOMALOUS PULMONARY VENOUS RETURN 1; TAPVR1
D16618@137792@137794@deletion@3@3239564@3244362@11@chr11:3239564-3244362@14.7@468@276@0.59@CNVR5028.1@C11orf36-202_1, C11orf36-202_2, C11orf36-202_3@13@13@13@:MAS-related GPR, member G@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway@NA
D16618@145899@145902@duplication@4@89534136@89537642@11@chr11:89534136-89537642@5.56@115@175@1.52@NA@TRIM49-201_3, TRIM49-201_4, TRIM49-201_5, TRIM49-201_6@36.5@34@40@:tripartite motif containing 49@:protein binding;intracellular;DNA binding;zinc ion binding@NA
D16618@145944@145962@duplication@19@89701674@89727385@11@chr11:89701674-89727385@11.2@149@249@1.67@NA@TRIM64-202_1, TRIM64-202_2, TRIM64-202_3, TRIM64-202_4, TRIM64-202_5, TRIM64-202_6, TRIM64-202_7, TRIM64-202_8, TRIM64-202_9, ENST00000442514_1, ENST00000442514_2, ENST00000442514_3, ENST00000442514_4, ENST00000442514_5, ENST00000442514_6, ENST00000442514_7, ENST00000442514_8, ENST00000442514_9, TRIM53-202_7@102.789473684211@21@177@NA@NA@NA
D16618@150775@150775@duplication@1@9446260@9446507@12@chr12:9446260-9446507@5.64@71@125@1.76@NA@DDX11L8-201_2@42@42@42@NA@NA@NA
D16618@150778@150783@deletion@6@9450373@9454871@12@chr12:9450373-9454871@13@270@153@0.567@NA@DDX11L8-201_5, DDX11L8-201_6, DDX11L8-201_7, DDX11L8-201_8, DDX11L8-201_9, DDX11L8-201_10@67.8333333333333@55@78@NA@NA@NA
D16618@150785@150786@deletion@2@9456573@9456804@12@chr12:9456573-9456804@23.2@138@18@0.13@NA@DDX11L8-201_12, DDX11L8-201_13@85@83@87@NA@NA@NA
D16618@150829@150840@duplication@12@9684189@9706679@12@chr12:9684189-9706679@14.4@591@817@1.38@CNVR5429.1@AC006432-201_1, AC006432-201_2, AC006432-201_3, AC006432-201_4, AC006432-201_5, AC006432-201_6, AC006432-201_7, AC006432-201_8, AC006432-201_9, AC006432-201_10, AC006432-201_11, AC006432-201_12@22.25@15@25@NA@NA@NA
D16618@151034@151034@deletion@1@11244393@11244793@12@chr12:11244393-11244793@65.5@399@25@0.0627@CNVR5434.1@TAS2R31-201_2@72@72@72@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
D16618@152221@152221@duplication@1@31244655@31244806@12@chr12:31244655-31244806@5.6@130@200@1.54@CNVR5483.1@DDX11-202_11@0@0@0@:DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11@:nucleoplasm;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;S phase of mitotic cell cycle;DNA binding;nucleobase-containing compound metabolic process;ATP binding;ATP-dependent DNA helicase activity;DNA helicase activity;midbody;RNA binding;DNA-dependent ATPase activity;nucleus;positive regulation of cell proliferation;virus-host interaction;nuclear chromatin;4 iron, 4 sulfur cluster binding;helicase activity;hydrolase activity, acting on acid anhydrides;DNA duplex unwinding;endoplasmic reticulum unfolded protein response;G2/M transition of mitotic cell cycle;protein binding;sister chromatid cohesion;activation of signaling protein activity involved in unfolded protein response;nucleolus;spindle pole;ATP-dependent helicase activity;metal ion binding;nucleic acid binding;mitotic sister chromatid segregation@: WARSAW BREAKAGE SYNDROME
D16618@152226@152226@deletion@1@31249277@31249314@12@chr12:31249277-31249314@14.8@98@19@0.194@CNVR5483.1@DDX11-202_16@0@0@0@:DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11@:nucleoplasm;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;S phase of mitotic cell cycle;DNA binding;nucleobase-containing compound metabolic process;ATP binding;ATP-dependent DNA helicase activity;DNA helicase activity;midbody;RNA binding;DNA-dependent ATPase activity;nucleus;positive regulation of cell proliferation;virus-host interaction;nuclear chromatin;4 iron, 4 sulfur cluster binding;helicase activity;hydrolase activity, acting on acid anhydrides;DNA duplex unwinding;endoplasmic reticulum unfolded protein response;G2/M transition of mitotic cell cycle;protein binding;sister chromatid cohesion;activation of signaling protein activity involved in unfolded protein response;nucleolus;spindle pole;ATP-dependent helicase activity;metal ion binding;nucleic acid binding;mitotic sister chromatid segregation@: WARSAW BREAKAGE SYNDROME
D16618@152246@152246@deletion@1@31269977@31270151@12@chr12:31269977-31270151@7.44@77@29@0.377@CNVR5483.1@ENST00000266524_28@6@6@6@NA@NA@NA
D16618@162127@162128@deletion@2@24465240@24465671@13@chr13:24465240-24465671@12.3@1010@672@0.665@NA@RP11-45B20-002_6, ENST00000382133_3@29@29@29@:C1q and tumor necrosis factor related protein 9B@:collagen;protein binding@NA
D16618@162167@162170@duplication@4@24895099@24896097@13@chr13:24895099-24896097@6.66@2306@2910@1.26@NA@SPATA13-009_13, SPATA13-009_14, C1QTNF9-003_5, C1QTNF9-003_6, ENST00000449656_1, AL359736-201_1, AL359736-201_2@56.25@33@126@:spermatogenesis associated 13:C1q and tumor necrosis factor related protein 9:C1QTNF9B antisense RNA 1@:lamellipodium assembly;phospholipid binding;Rac guanyl-nucleotide exchange factor activity;guanyl-nucleotide exchange factor activity;ruffle membrane;nucleus;regulation of cell migration;cell migration;regulation of Rho protein signal transduction;intracellular;Rho guanyl-nucleotide exchange factor activity;cytoplasm;filopodium assembly;filopodium;protein binding;lamellipodium:collagen;protein binding;hormone activity@NA
D16618@162228@162229@deletion@2@25169929@25169998@13@chr13:25169929-25169998@5.72@60@24@0.4@CNVR5826.1@RP11-556N21-001_9, ENST00000453498_11@65@65@65@NA@NA@NA
D16618@162314@162314@duplication@1@25528913@25529008@13@chr13:25528913-25529008@4.74@97@151@1.56@NA@TPTE2P1-001_5@2@2@2@NA@NA@NA
D16618@164539@164543@deletion@5@53103402@53106857@13@chr13:53103402-53106857@27.9@130@2@0.0154@NA@RP11-78J21-201_12, RP11-78J21-201_13, RP11-78J21-201_14, RP11-78J21-201_15, RP11-78J21-201_16@113.8@107@117@NA@NA@NA
D16618@165776@165776@deletion@1@100622707@100622826@13@chr13:100622707-100622826@6.47@85@38@0.447@NA@ZIC5-201_2@2@2@2@:Zic family member 5@:cell differentiation;intracellular;DNA binding;sequence-specific DNA binding transcription factor activity;neural tube closure;forebrain development;nucleus;zinc ion binding@NA
D16618@166697@166704@deletion@8@19553367@19573145@14@chr14:19553367-19573145@7.24@85@37@0.435@CNVR6072.1@POTEG-201_1, POTEG-201_2, POTEG-201_3, POTEG-201_4, POTEG-201_5, POTEG-201_6, POTEG-201_7, POTEG-201_8@110.5@84@141@:POTE ankyrin domain family, member G@:protein binding@NA
D16618@166748@166761@deletion@14@20085421@20148264@14@chr14:20085421-20148264@39.3@2146@1380@0.643@CNVR6072.6, CNVR6072.12, CNVR6072.14, CNVR6072.36@AL929601-201_2, AL929601-201_3, AL929601-201_4, AL512310-201_1, AL512310-201_2, AL512310-201_3, AL512310-201_4, AL512310-201_5, ENST00000398231_1, ENST00000398231_2, ENST00000398231_3, ENST00000398231_4, ENST00000398231_5, ENST00000398231_6@91.1428571428571@58@102@NA@NA@NA
D16618@167271@167275@deletion@5@23072297@23078817@14@chr14:23072297-23078817@36.7@775@411@0.53@NA@ABHD4-202_3, ABHD4-202_4, ABHD4-202_5, ABHD4-202_6, ABHD4-202_7@0@0@0@:abhydrolase domain containing 4@:hydrolase activity;lipid catabolic process@NA
D16618@173500@173502@duplication@3@106471638@106478412@14@chr14:106471638-106478412@7.57@299@416@1.39@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV3-6-210_6, IGHV1-3-001_1, IGHV4-4-001_2@12.6666666666667@4@17@@:protein binding:protein binding@NA
D16618@173508@173514@duplication@7@106539081@106573538@14@chr14:106539081-106573538@63.5@1246@2067@1.66@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8-001_1, IGHV1-8-001_2, IGHV3-9-001_1, IGHV3-9-001_2, IGHV2-10-001_1, IGHV2-10-001_2, IGHV3-11-001_2@20.4285714285714@9@24@@:protein binding:protein binding:protein binding@NA
D16618@173556@173563@deletion@8@106787370@106805717@14@chr14:106787370-106805717@27.9@1047@641@0.612@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-29-001_1, IGHV3-29-001_2, IGHV3-30-001_1, IGHV3-30-001_2, IGHV3-30-2-001_1, IGHV3-30-2-001_2, IGHV4-31-001_1, IGHV4-31-001_2@16.5@13@19@@:protein binding:protein binding@NA
D16618@173635@173636@deletion@2@107095128@107095663@14@chr14:107095128-107095663@16.6@96@13@0.135@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61-001_1, IGHV4-61-001_2@17@17@17@@:protein binding@NA
D16618@173645@173645@deletion@1@107131035@107131335@14@chr14:107131035-107131335@5.12@266@171@0.643@CNVR6294.56, CNVR6294.16@IGHV3-66-001_2@3@3@3@@:protein binding@NA
D16618@174506@174507@deletion@2@30664352@30665349@15@chr15:30664352-30665349@11.7@212@113@0.533@CNVR6337.1@CHRFAM7A-202_6, CHRFAM7A-202_7@56@44@68@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
D16618@174972@174975@duplication@4@34813602@34820279@15@chr15:34813602-34820279@6.11@68@120@1.76@CNVR6351.3@ENST00000444260_2, ENST00000444260_3, GOLGA8B-201_23, GOLGA8B-201_24@40.75@31@48@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
D16618@176432@176433@deletion@2@44002591@44002976@15@chr15:44002591-44002976@5.26@176@107@0.608@NA@AC011330-201_13, AC011330-201_14@28@16@40@:stereocilin@:detection of mechanical stimulus involved in sensory perception of sound;stereocilium bundle tip;stereocilium;cell surface;kinocilium;auditory receptor cell stereocilium organization@: DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16; DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY
D16618@180187@180187@duplication@1@79065427@79065546@15@chr15:79065427-79065546@6.61@47@100@2.13@NA@ADAMTS7-201_14@10@10@10@:A disintegrin and metalloproteinase with thrombospondin motifs 7-like;ADAM metallopeptidase with thrombospondin type 1 motif, 7@:metallopeptidase activity;extracellular matrix;proteolysis;peptidase activity;proteinaceous extracellular matrix;metalloendopeptidase activity;cell surface;zinc ion binding@NA
D16618@180949@180949@deletion@1@86768147@86768183@15@chr15:86768147-86768183@10.1@186@93@0.5@NA@AGBL1-203_5@1@1@1@:ATP/GTP binding protein-like 1@:binding;protein side chain deglutamylation;cytosol;protein binding;proteolysis;metallocarboxypeptidase activity;C-terminal protein deglutamylation;tubulin binding;zinc ion binding@NA
D16618@186292@186293@duplication@2@28403075@28403464@16@chr16:28403075-28403464@13.1@231@379@1.64@CNVR6684.2@EIF3CL-201_9, EIF3CL-201_10@4@3@5@:eukaryotic translation initiation factor 3, subunit C-like@:protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;translation initiation factor activity@NA
D16618@186368@186369@duplication@2@28711499@28712933@16@chr16:28711499-28712933@9.3@68@141@2.07@CNVR6686.3, CNVR6686.1, CNVR6686.2@AC145285-201_1, AC145285-201_2@60@59@61@:eukaryotic translation initiation factor 3, subunit C@:cytosol;protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;cellular protein metabolic process;binding;gene expression;translation;translation initiation factor activity@NA
D16618@186379@186379@deletion@1@28734771@28734873@16@chr16:28734771-28734873@9.42@269@152@0.565@CNVR6686.3, CNVR6686.2@EIF3S8-202_10@4@4@4@:eukaryotic translation initiation factor 3, subunit C@:cytosol;protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;cellular protein metabolic process;binding;gene expression;translation;translation initiation factor activity@NA
D16618@187515@187524@deletion@10@32891801@32928451@16@chr16:32891801-32928451@13.3@305@176@0.577@CNVR6702.1@AC138915-201_1, AC138915-201_2, AC138915-201_3, AC138915-201_4, AC138915-201_5, AC138915-201_6, AC138915-201_7, AC142086-201_1, AC142086-201_2, ENST00000423205_1@30@24@36@NA@NA@NA
D16618@187546@187548@duplication@3@33629704@33630421@16@chr16:33629704-33630421@22@1112@1576@1.42@CNVR6703.17, CNVR6703.1, CNVR6703.6, CNVR6703.21@AC136428-201_1, AC136428-201_2, AC136428-201_3@22.3333333333333@18@29@NA@NA@NA
D16618@187553@187558@duplication@6@33709889@33718308@16@chr16:33709889-33718308@6.69@56@109@1.95@CNVR6703.17, CNVR6703.1, CNVR6703.21@ENST00000300901_12, ENST00000300901_13, ENST00000300901_14, ENST00000300901_15, ENST00000300901_16, ENST00000300901_17@40.5@13@73@NA@NA@NA
D16618@187569@187582@duplication@14@33739212@33783526@16@chr16:33739212-33783526@11.8@777@1047@1.35@CNVR6703.17, CNVR6703.1, CNVR6703.23@ENST00000300901_1, ENST00000450856_1, ENST00000450856_2, ENST00000450856_3, ENST00000380145_1, ENST00000380145_2, AC133561-201_1, AC133561-201_2, AC133561-201_3, AC133561-201_4, AC133561-201_5, AC133561-201_6, AC133561-201_7, AC133561-201_8@23.5@8@52@NA@NA@NA
D16618@190434@190434@deletion@1@72097113@72097160@16@chr16:72097113-72097160@9.8@102@38@0.373@CNVR6769.1@HPR-202_1@26@26@26@:thioredoxin-like 4B:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@NA
D16618@192798@192799@duplication@2@4439373@4439722@17@chr17:4439373-4439722@9.09@279@406@1.46@NA@SPNS2-201_10, SPNS2-201_11@1@1@1@:spinster homolog 2 (Drosophila)@:integral to membrane;transmembrane transporter activity;lipid transport;transmembrane transport@NA
D16618@195229@195238@deletion@10@16664741@16703686@17@chr17:16664741-16703686@34.3@1931@1264@0.655@NA@CCDC144A-202_13, CCDC144A-202_14, CCDC144A-202_15, CCDC144A-202_16, CCDC144A-202_17, CCDC144A-202_18, AC022596-003_1, AC022596-003_2, AC022596-003_3, AC022596-003_4@59.2@45@66@:coiled-coil domain containing 144A@NA@NA
D16618@195246@195258@deletion@13@16721458@16734608@17@chr17:16721458-16734608@22.7@1061@689@0.649@NA@AC022596-001_1, AC022596-001_2, AC022596-001_3, AC022596-001_4, AC022596-001_5, AC022596-001_6, AC022596-001_7, AC022596-001_8, ENST00000414673_4, ENST00000414673_5, ENST00000414673_6, ENST00000414673_7, ENST00000414673_8@93.5384615384615@87@97@NA@NA@NA
D16618@195703@195712@duplication@10@18344490@18389450@17@chr17:18344490-18389450@28.2@226@453@2@CNVR7014.1@ENST00000399124_3, ENST00000399124_4, ENST00000399124_5, ENST00000399124_6, ENST00000399124_7, ENST00000399124_8, ENST00000411877_4, LGALS9C-201_1, LGALS9C-201_2, LGALS9C-201_3@128.7@79@153@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
D16618@195719@195747@duplication@29@18396013@18457581@17@chr17:18396013-18457581@177@1174@2737@2.33@NA@LGALS9C-201_10, LGALS9C-201_11, ENST00000426269_1, ENST00000426269_2, ENST00000426269_3, ENST00000426269_4, ENST00000426269_5, AC107983-001_1, AC107983-001_2, AC107983-001_3, AC107983-001_4, AC107983-001_5, AC107983-001_6, AC107983-001_7, AC107983-001_8, AC107983-001_9, AC107983-001_10, ENST00000456184_1, ENST00000456184_2, CCDC144B-201_14, CCDC144B-201_15, CCDC144B-201_16, CCDC144B-201_17, CCDC144B-201_18, ENST00000447265_11, ENST00000447265_12, ENST00000447265_13, ENST00000447265_14, ENST00000447265_15@130.068965517241@123@139@:lectin, galactoside-binding, soluble, 9C:protein FAM106B-like@:carbohydrate binding@NA
D16618@195757@195759@deletion@3@18498037@18498176@17@chr17:18498037-18498176@23.2@310@138@0.445@NA@CCDC144B-201_8, CCDC144B-201_9, ENST00000447265_5@1@1@1@NA@NA@NA
D16618@195785@195785@deletion@1@18585519@18585573@17@chr17:18585519-18585573@6.63@49@13@0.265@NA@FOXO3B-201_1@30@30@30@:zinc finger protein 286B@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding@NA
D16618@196151@196154@duplication@4@20354796@20356381@17@chr17:20354796-20356381@12.6@203@333@1.64@CNVR7021.1, CNVR7021.3@LGALS9B-201_7, LGALS9B-201_8, LGALS9B-201_9, LGALS9B-201_10@98.75@94@103@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
D16618@198032@198034@deletion@3@36351805@36353766@17@chr17:36351805-36353766@25.1@1291@814@0.631@CNVR7083.3@AC183087-202_12, AC183087-202_13, AC183087-202_14@60.3333333333333@58@64@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
D16618@200259@200260@duplication@2@43585590@43585906@17@chr17:43585590-43585906@11.1@266@405@1.52@CNVR7113.4, CNVR7113.6, CNVR7113.8, CNVR7113.2@AC091132-201_4, AC091132-201_5@81@81@81@NA@NA@NA
D16618@200319@200323@duplication@5@44171928@44274081@17@chr17:44171928-44274081@12.9@2382@3202@1.34@CNVR7114.3, CNVR7114.2, CNVR7114.8@KIAA1267-201_1, KIAA1267-201_2, KIAA1267-201_3, AC217773-201_1, AC217773-201_2@50.6@31@61@:KAT8 regulatory NSL complex subunit 1@:histone acetyltransferase activity (H4-K8 specific);histone acetyltransferase activity (H4-K16 specific);histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase complex;histone H4-K5 acetylation;MLL1 complex;histone H4-K16 acetylation;protein binding;histone H4-K8 acetylation;nucleus@NA
D16618@200337@200340@deletion@4@44399690@44409348@17@chr17:44399690-44409348@9.42@57@10@0.175@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A-001_7, LRRC37A-001_8, LRRC37A-001_9, LRRC37A-001_10@144.75@141@154@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
D16618@200343@200345@deletion@3@44414664@44415161@17@chr17:44414664-44415161@11.6@54@1@0.0185@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A-001_13, LRRC37A-001_14, LRRC37A-001_15@190.333333333333@181@196@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
D16618@210546@210547@duplication@2@4354948@4355171@19@chr19:4354948-4355171@9.29@173@274@1.58@NA@MPND-202_7, MPND-202_8@1.5@1@2@:MPN domain containing@:peptidase activity;protein binding;proteolysis@NA
D16618@213493@213494@duplication@2@14508472@14508748@19@chr19:14508472-14508748@6.2@113@178@1.58@NA@CD97-205_8, CD97-205_9@10.5@7@14@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
D16618@215145@215150@duplication@6@20829087@20989523@19@chr19:20829087-20989523@62.6@2190@3377@1.54@NA@ZNF626-203_1, ZNF626-203_2, AC010329-201_1, AC010329-201_2, AC010329-201_3, AC010329-201_4@0@0@0@:zinc finger protein 626@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
D16618@215927@215928@deletion@2@35861833@35863856@19@chr19:35861833-35863856@17.4@220@86@0.391@CNVR7627.1@FFAR3-001_1, FFAR3-001_2@101@100@102@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
D16618@217091@217091@deletion@1@39734195@39734371@19@chr19:39734195-39734371@5.72@113@60@0.531@NA@IL28B-201_6@0@0@0@:interleukin 28B (interferon, lambda 3)@:defense response to virus;extracellular space;cytokine activity@NA
D16618@217290@217290@deletion@1@40367300@40367915@19@chr19:40367300-40367915@5.32@24@0@0@CNVR7639.2@FCGBP-201_29@30@30@30@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D16618@217295@217297@deletion@3@40376633@40382827@19@chr19:40376633-40382827@18.1@204@84@0.412@CNVR7639.2@FCGBP-201_22, FCGBP-201_23, FCGBP-201_24@145@131@155@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D16618@217309@217309@deletion@1@40405921@40406061@19@chr19:40405921-40406061@5.65@33@5@0.152@CNVR7639.2@FCGBP-201_10@16@16@16@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D16618@217595@217595@deletion@1@41327389@41327534@19@chr19:41327389-41327534@5.95@65@26@0.4@NA@CYP2F1P-001_5@0@0@0@NA@NA@NA
D16618@217667@217667@deletion@1@41627864@41628039@19@chr19:41627864-41628039@9.41@156@75@0.481@CNVR7644.1@CYP2F1-201_6@10@10@10@:cytochrome P450, family 2, subfamily F, polypeptide 1@:trichloroethylene metabolic process;oxidation-reduction process;aromatase activity;response to toxin;oxygen binding;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;endoplasmic reticulum membrane;naphthalene metabolic process;intracellular membrane-bounded organelle;electron carrier activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;heme binding;xenobiotic metabolic process;monooxygenase activity;iron ion binding@NA
D16618@218217@218218@deletion@2@43877355@43877758@19@chr19:43877355-43877758@9.51@112@50@0.446@NA@CD177P-201_1, CD177P-201_2@14.5@11@18@NA@NA@NA
D16618@220700@220700@deletion@1@52149512@52149894@19@chr19:52149512-52149894@5.45@88@44@0.5@CNVR7702.1@SIGLEC5-201_2@14@14@14@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 14@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion;plasma membrane@NA
D16618@221165@221165@deletion@1@54723740@54723786@19@chr19:54723740-54723786@7.54@62@19@0.306@NA@LILRB3-008_7@62@62@62@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D16618@221169@221169@duplication@1@54726152@54726435@19@chr19:54726152-54726435@5.09@83@136@1.64@CNVR7721.3, CNVR7721.4@LILRB3-008_3@119@119@119@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D16618@221178@221178@deletion@1@54744152@54744453@19@chr19:54744152-54744453@6.96@391@250@0.639@CNVR7721.3, CNVR7721.6@LILRA6-002_6@54@54@54@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D16618@221181@221181@deletion@1@54745904@54746187@19@chr19:54745904-54746187@11.9@368@206@0.56@CNVR7721.3, CNVR7721.6@LILRA6-002_3@66@66@66@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D16618@221403@221404@duplication@2@55277931@55278034@19@chr19:55277931-55278034@7.12@201@294@1.46@CNVR7725.2, CNVR7725.1@KIR2DL3-201_6, KIR2DP1-001_7@125@125@125@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity@NA
D16618@221407@221408@duplication@2@55278649@55279337@19@chr19:55278649-55279337@5.71@676@881@1.3@CNVR7725.2, CNVR7725.1@KIR2DL3-201_8, KIR2DP1-001_9@126@126@126@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity@NA
D16618@221435@221437@duplication@3@55346536@55351155@19@chr19:55346536-55351155@5.5@362@480@1.33@CNVR7725.1, CNVR7725.6@KIR2DS4-001_2, KIR2DS4-001_3, KIR2DS4-001_4@63.3333333333333@55@68@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
D16618@221439@221441@deletion@3@55358641@55360024@19@chr19:55358641-55360024@41.1@1386@757@0.546@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4-001_6, KIR2DS4-001_7, KIR2DS4-001_8@96.3333333333333@85@102@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
D16618@221823@221823@deletion@1@56283164@56283457@19@chr19:56283164-56283457@7.04@379@241@0.636@CNVR7734.1@ENST00000341750_2@47@47@47@:ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
D16618@222068@222069@deletion@2@58003184@58003369@19@chr19:58003184-58003369@7.31@64@22@0.344@CNVR7748.1@ZNF419-202_5, ZNF419-202_6@0@0@0@:zinc finger protein 419@:intracellular;DNA binding;regulation of transcription, DNA-dependent;cytoplasm;nucleolus;nucleus;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding@NA
D16618@222562@222564@deletion@3@1558986@1610283@20@chr20:1558986-1610283@17.4@426@230@0.54@CNVR7763.1@SIRPB1-201_1, SIRPB1-201_2, SIRPG-005_6@60.3333333333333@0@128@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like:signal-regulatory protein gamma@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway:negative regulation of cell proliferation;positive regulation of T cell activation;positive regulation of cell-cell adhesion;intracellular;cell-cell signaling;protein binding;blood coagulation;integral to membrane;cell adhesion;plasma membrane;positive regulation of cell proliferation;membrane;intracellular signal transduction;leukocyte migration@NA
D16618@222594@222594@duplication@1@1895747@1896102@20@chr20:1895747-1896102@5.89@169@252@1.49@CNVR7764.2@SIRPA-201_3@34@34@34@:signal-regulatory protein alpha@:blood coagulation;protein binding;integral to membrane;SH3 domain binding;cell adhesion;plasma membrane;membrane;leukocyte migration@NA
D16618@225911@225911@deletion@1@36989360@36989422@20@chr20:36989360-36989422@7.13@109@52@0.477@NA@LBP-001_6@0@0@0@:lipopolysaccharide binding protein@:positive regulation of tumor necrosis factor production;positive regulation of chemokine production;lipopolysaccharide transport;lipid binding;Gram-negative bacterial cell surface binding;response to lipopolysaccharide;receptor binding;positive regulation of neutrophil chemotaxis;negative regulation of tumor necrosis factor production;cellular response to lipopolysaccharide;positive regulation of respiratory burst involved in inflammatory response;positive regulation of interleukin-8 production;macrophage activation involved in immune response;opsonization;detection of molecule of bacterial origin;defense response to Gram-negative bacterium;lipopolysaccharide binding;leukocyte chemotaxis involved in inflammatory response;defense response to Gram-positive bacterium;Toll signaling pathway;positive regulation of macrophage activation;extracellular space;lipoteichoic acid binding;negative regulation of growth of symbiont in host;positive regulation of interleukin-6 production;Gram-positive bacterial cell surface binding;cell surface binding;innate immune response;lipopolysaccharide-mediated signaling pathway;protein binding;positive regulation of tumor necrosis factor biosynthetic process;cellular defense response;extracellular region;positive regulation of toll-like receptor 4 signaling pathway;cellular response to lipoteichoic acid;acute-phase response@NA
D16618@228838@228845@deletion@8@10971294@10998336@21@chr21:10971294-10998336@12.1@1388@978@0.705@CNVR7947.11, CNVR7947.12@TPTE-006_10, TPTE-006_11, TPTE-006_12, TPTE-006_13, TPTE-006_14, TPTE-006_15, BAGE2-002_14, BAGE2-002_15@10.25@8@14@:transmembrane phosphatase with tensin homology@:phosphatase activity;ion channel activity;protein tyrosine phosphatase activity;ion transport;protein dephosphorylation;transmembrane transport;protein binding;signal transduction;integral to membrane;protein tyrosine/serine/threonine phosphatase activity;dephosphorylation;membrane;peptidyl-tyrosine dephosphorylation@NA
D16618@231958@231958@deletion@1@16287256@16287718@22@chr22:16287256-16287718@5.6@90@45@0.5@CNVR8071.2, CNVR8071.3, CNVR8071.9@POTEH-002_1@105@105@105@:POTE ankyrin domain family, member H@:protein binding@NA
D16618@232369@232371@duplication@3@18843775@18848563@22@chr22:18843775-18848563@5.4@55@101@1.84@CNVR8087.2, CNVR8087.7, CNVR8087.12, CNVR8087.10@AC008103-001_5, AC008103-001_6, AC008103-201_1@97.3333333333333@75@130@NA@NA@NA
D16618@232761@232783@deletion@23@20377671@20398724@22@chr22:20377671-20398724@17.9@170@64@0.376@CNVR8094.9, CNVR8094.4, CNVR8094.10@AC023490-001_1, AC023490-001_2, AC023490-005_1, AC023490-005_2, AC023490-005_3, AC023490-005_4, AC023490-005_5, AC023490-005_6, PI4KAP1-204_2, PI4KAP1-204_3, PI4KAP1-204_4, PI4KAP1-204_5, PI4KAP1-204_6, PI4KAP1-204_7, PI4KAP1-204_8, PI4KAP1-204_9, PI4KAP1-204_10, PI4KAP1-204_11, PI4KAP1-204_12, PI4KAP1-204_13, PI4KAP1-204_14, PI4KAP1-204_15, PI4KAP1-204_16@161.260869565217@122@172@NA@NA@NA
D16618@233701@233708@duplication@8@24284790@24302569@22@chr22:24284790-24302569@7.73@176@263@1.49@CNVR8114.6, CNVR8114.10, CNVR8114.12, CNVR8114.13@ENST00000443377_3, ENST00000440099_1, ENST00000440099_2, ENST00000440099_3, GSTT2B-002_2, GSTT2B-002_3, GSTT2B-002_4, GSTT2B-002_5@68.375@56@125@:glutathione S-transferase theta 2B (gene/pseudogene);glutathione S-transferase theta 2@:protein binding;glutathione transferase activity;nucleus;transferase activity;cytoplasm@NA
D169918@608@608@deletion@1@1643705@1643840@1@chr1:1643705-1643840@5.18@23@0@0@CNVR17.1@CDC2L2-208_7@25@25@25@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
D169918@2923@2928@deletion@6@16954965@16969641@1@chr1:16954965-16969641@6.51@508@350@0.689@CNVR93.3, CNVR93.6, CNVR93.12, CNVR93.7@CROCCL1-204_2, CROCCL1-204_3, CROCCL1-204_4, CROCCL1-204_5, CROCCL1-204_6, CROCCL1-204_7@44.1666666666667@43@46@NA@NA@NA
D169918@2933@2947@deletion@15@16973284@16976731@1@chr1:16973284-16976731@130@4071@2490@0.612@CNVR93.3, CNVR93.6, CNVR93.12, CNVR93.7, CNVR93.14, CNVR93.15@RP5-1182A14-001_4, RP5-1182A14-001_5, RP5-1182A14-001_6, RP5-1182A14-001_7, RP5-1182A14-001_8, RP5-1182A14-001_9, RP5-1182A14-001_10, RP5-1182A14-001_11, RP5-1182A14-001_12, RP5-1182A14-001_13, RP5-1182A14-001_14, RP5-1182A14-001_15, RP5-1182A14-001_16, RP5-1182A14-001_17, RP5-1182A14-001_18@62.6666666666667@41@88@NA@NA@NA
D169918@2971@2971@duplication@1@17081407@17083889@1@chr1:17081407-17083889@5.4@72@122@1.69@CNVR93.3, CNVR93.15, CNVR93.2, CNVR93.16@MST1P9-202_20@30@30@30@:macrophage stimulating 1-like@:proteolysis;extracellular region;catalytic activity;serine-type endopeptidase activity@NA
D169918@2998@3022@duplication@25@17196256@17275422@1@chr1:17196256-17275422@117@2774@4293@1.55@CNVR94.4, CNVR94.5@ENST00000356370_1, ENST00000356370_2, ENST00000438002_1, ENST00000438002_2, ENST00000457075_1, ENST00000457075_2, CROCC-201_1, CROCC-201_2, CROCC-201_3, CROCC-201_4, CROCC-201_5, CROCC-201_6, CROCC-201_7, CROCC-201_8, CROCC-201_9, CROCC-201_10, CROCC-201_11, CROCC-201_12, CROCC-201_13, CROCC-201_14, CROCC-201_15, CROCC-201_16, CROCC-201_17, CROCC-201_18, CROCC-201_19@63.68@18@85@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
D169918@4450@4459@duplication@10@25594233@25648454@1@chr1:25594233-25648454@32@1271@1777@1.4@CNVR116.1, CNVR116.2@C1orf63-002_1, RP11-335G20-001_1, RHD-202_1, RHD-202_2, RHD-202_3, RHD-202_4, RHD-202_5, RHD-202_6, RHD-202_7, RHD-202_8, RHD-202_9@120.9@94@128@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
D169918@4471@4471@duplication@1@25701842@25701920@1@chr1:25701842-25701920@4.87@184@259@1.41@CNVR117.1@RHCE-005_10@2@2@2@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
D169918@4477@4477@deletion@1@25735176@25735361@1@chr1:25735176-25735361@18.4@84@0@0@CNVR117.1@RHCE-005_4@56@56@56@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
D169918@11245@11246@deletion@2@89476589@89477711@1@chr1:89476589-89477711@121@591@2@0.00338@CNVR244.1@GBP3-001_7, GBP3-001_8@54@54@54@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
D169918@12424@12432@deletion@9@104233918@104256576@1@chr1:104233918-104256576@18.1@127@31@0.244@CNVR266.3, CNVR266.5@AMY1B-001_1, AMY1B-001_2, AMY1B-001_3, AMY1B-001_4, AMY1B-001_5, AMY1B-001_6, AMY1B-001_7, AMY1B-001_8, AMYP1-001_1@119.777777777778@107@154@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D169918@12445@12446@deletion@2@104297123@104297437@1@chr1:104297123-104297437@19.4@359@184@0.513@CNVR266.3, CNVR266.5@AMY1C-201_7, AMY1C-201_8@77@75@79@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D169918@12582@12582@deletion@1@109007812@109008047@1@chr1:109007812-109008047@5.63@25@0@0@CNVR294.4@NBPF6-202_14@43@43@43@:neuroblastoma breakpoint family, member 6@:cytoplasm@NA
D169918@12932@12936@duplication@5@110231672@110236368@1@chr1:110231672-110236368@8.99@461@620@1.34@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1-001_4, GSTM1-001_5, GSTM1-001_6, GSTM1-001_7, GSTM1-001_8@192.2@187@194@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
D169918@14493@14496@deletion@4@144676872@144811958@1@chr1:144676872-144811958@15.2@356@207@0.581@NA@WI2-1896O14-001_1, WI2-1896O14-001_2, WI2-1896O14-001_3, NBPF9-001_1@4.75@4@5@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 24@NA@NA
D169918@14567@14574@deletion@8@145273187@145296572@1@chr1:145273187-145296572@14@2036@1442@0.708@CNVR341.2, CNVR341.1@NOTCH2NL-001_3, NOTCH2NL-001_4, NOTCH2NL-001_5, NOTCH2NL-001_6, AL592307-201_1, AL592307-201_2, AL592307-201_3, AL592307-201_4@17@1@67@:notch 2 N-terminal like:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family member 21-like;neuroblastoma breakpoint family, member 10@:multicellular organismal development;cell differentiation;protein binding;Notch signaling pathway;extracellular region;calcium ion binding;cytoplasm:protein binding;calcium ion binding@NA
D169918@15201@15217@deletion@17@148008575@148025849@1@chr1:148008575-148025849@14.8@70@2@0.0286@CNVR346.2, CNVR346.4@NBPF14-001_1, NBPF14-001_2, NBPF14-001_3, NBPF14-001_4, NBPF14-001_5, NBPF14-001_6, NBPF14-001_7, NBPF14-001_8, NBPF14-001_9, NBPF14-001_10, NBPF14-001_11, NBPF14-001_12, NBPF14-001_13, NBPF14-001_14, NBPF14-001_15, NBPF14-001_16, NBPF14-001_17@89.7058823529412@58@120@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
D169918@15395@15405@deletion@11@148933293@149049613@1@chr1:148933293-149049613@16.4@511@316@0.618@NA@ENST00000431263_3, ENST00000431263_4, RP11-744H18-001_1, RP11-744H18-001_2, RP11-744H18-001_3, RP11-744H18-001_4, RP11-744H18-001_5, RP11-744H18-001_6, RP11-744H18-001_7, RP11-744H18-001_8, RP11-744H18-001_9@69.8181818181818@13@87@NA@NA@NA
D169918@15428@15430@deletion@3@149105896@149115112@1@chr1:149105896-149115112@6.55@105@54@0.514@CNVR350.3, CNVR350.1@ENST00000401087_2, RP11-403I13-201_1, RP11-403I13-201_2@79@79@79@NA@NA@NA
D169918@15456@15462@deletion@7@149375000@149400543@1@chr1:149375000-149400543@27@717@419@0.584@CNVR350.1@FCGR1C-201_4, FCGR1C-201_5, FCGR1C-201_6, ENST00000415338_1, HIST2H3PS2-001_1, HIST2H3PS2-001_2, RP5-998N21-002_1@73.7142857142857@70@76@NA@NA@NA
D169918@21364@21384@deletion@21@196748929@196887764@1@chr1:196748929-196887764@340@3830@1532@0.4@CNVR459.1@CFHR3-001_3, CFHR3-001_4, CFHR3-001_5, CFHR3-001_6, CFHR1-001_1, CFHR1-001_2, CFHR1-001_3, CFHR1-001_4, CFHR1-001_5, CFHR1-001_6, CFHR2-201_1, CFHR4-201_1, CFHR4-201_2, CFHR4-201_3, CFHR4-201_4, CFHR4-201_5, CFHR4-201_6, CFHR4-201_7, CFHR4-201_8, CFHR4-201_9, CFHR4-201_10@55.2380952380952@6@119@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2:complement factor H-related 4@:extracellular space:extracellular space;complement activation:extracellular region:extracellular region;lipid transporter activity;lipid transport@NA
D169918@23674@23675@deletion@2@215914719@215916678@1@chr1:215914719-215916678@8.18@395@257@0.651@NA@USH2A-201_59, USH2A-201_60@0@0@0@:Usher syndrome 2A (autosomal recessive, mild)@:stereocilium membrane;photoreceptor cell maintenance;inner ear receptor cell differentiation;integral to membrane;basement membrane;myosin binding;apical plasma membrane;sensory perception of sound;stereocilia ankle link complex;cytoplasm;response to stimulus;stereocilium bundle;protein binding;sensory perception of light stimulus;collagen binding;maintenance of organ identity;hair cell differentiation@: USHER SYNDROME, TYPE IIA; USH2A; RETINITIS PIGMENTOSA 39; RP39
D169918@24160@24164@deletion@5@223727670@223729472@1@chr1:223727670-223729472@12.5@72@11@0.153@NA@CAPN8-202_20, CAPN8-202_21, CAPN8-202_22, CAPN8-202_23, CAPN8-202_24@0@0@0@:calpain 8@:proteolysis;Golgi apparatus;intracellular;calcium-dependent cysteine-type endopeptidase activity;calcium ion binding@NA
D169918@33164@33166@duplication@3@85555042@85570922@2@chr2:85555042-85570922@9.01@306@433@1.42@NA@TGOLN2-201_1, RETSAT-001_10, RETSAT-001_11@0@0@0@:trans-golgi network protein 2:retinol saturase (all-trans-retinol 13,14-reductase)@:trans-Golgi network;protein binding;integral to membrane;transport vesicle;Golgi apparatus;plasma membrane;nucleus:all-trans-retinol 13,14-reductase activity;nuclear membrane;oxidation-reduction process;oxidoreductase activity;retinol metabolic process;endoplasmic reticulum membrane;nuclear outer membrane@NA
D169918@33542@33542@duplication@1@87365381@87365416@2@chr2:87365381-87365416@4.68@61@104@1.7@CNVR861.2@AC083899-001_6@11@11@11@NA@NA@NA
D169918@33561@33564@duplication@4@87408627@87414366@2@chr2:87408627-87414366@8.32@271@385@1.42@CNVR861.2@AC083899-001_25, AC083899-001_26, AC083899-001_27, AC083899-001_28@73.25@70@82@NA@NA@NA
D169918@34094@34095@duplication@2@96458183@96458295@2@chr2:96458183-96458295@5.07@68@114@1.68@NA@AC008268-201_3, ENST00000444924_2@104@104@104@NA@NA@NA
D169918@34183@34184@deletion@2@96652501@96652955@2@chr2:96652501-96652955@35.4@230@40@0.174@NA@AC073995-001_2, AC073995-001_3@4@4@4@:ankyrin repeat domain-containing protein 36A-like@:ion channel inhibitor activity;protein binding@NA
D169918@34615@34631@deletion@17@98127603@98162325@2@chr2:98127603-98162325@43.3@219@15@0.0685@CNVR888.3@ANKRD36B-001_23, ANKRD36B-001_24, ANKRD36B-001_25, ANKRD36B-001_26, ANKRD36B-001_27, ANKRD36B-001_28, ANKRD36B-001_29, ANKRD36B-001_30, ANKRD36B-001_31, ANKRD36B-001_32, ANKRD36B-001_33, ANKRD36B-001_34, ANKRD36B-001_35, ANKRD36B-001_36, ANKRD36B-001_37, ANKRD36B-001_38, ANKRD36B-001_39@130.058823529412@64@154@NA@NA@NA
D169918@35970@35970@deletion@1@112541476@112541542@2@chr2:112541476-112541542@6.02@31@3@0.0968@CNVR928.1@ANAPC1-001_42@11@11@11@:anaphase-promoting complex subunit 1-like;anaphase promoting complex subunit 1@:nucleoplasm;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle;anaphase-promoting complex;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle spindle assembly checkpoint;cytosol;protein K11-linked ubiquitination;protein binding;mitosis;nucleus;cell cycle checkpoint;cell division;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle@NA
D169918@35975@35975@deletion@1@112551657@112551709@2@chr2:112551657-112551709@11.6@105@35@0.333@CNVR928.1@ANAPC1-001_37@0@0@0@:anaphase-promoting complex subunit 1-like;anaphase promoting complex subunit 1@:nucleoplasm;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle;anaphase-promoting complex;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle spindle assembly checkpoint;cytosol;protein K11-linked ubiquitination;protein binding;mitosis;nucleus;cell cycle checkpoint;cell division;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle@NA
D169918@38680@38682@duplication@3@158287374@158291260@2@chr2:158287374-158291260@5.39@281@379@1.35@NA@CYTIP-003_3, CYTIP-003_4, CYTIP-003_5@0@0@0@:cytohesin 1 interacting protein@:cell cortex;protein binding;regulation of cell adhesion;early endosome;cytoplasm@NA
D169918@45387@45390@deletion@4@233273213@233274159@2@chr2:233273213-233274159@9.36@238@141@0.592@NA@ALPPL2-001_7, ALPPL2-001_8, ALPPL2-001_9, ALPPL2-001_10@30@16@58@:alkaline phosphatase, placental-like 2@:phosphatase activity;catalytic activity;phosphorylation;plasma membrane;metabolic process;membrane;anchored to membrane;alkaline phosphatase activity;metal ion binding@NA
D169918@61532@61535@duplication@4@195377017@195378241@3@chr3:195377017-195378241@11.7@673@911@1.35@NA@AC233280-201_5, AC233280-201_6, AC233280-201_7, AC233280-201_8@89.5@82@93@:mucin 20, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane@NA
D169918@61550@61552@duplication@3@195398005@195400859@3@chr3:195398005-195400859@6.3@440@581@1.32@CNVR1703.1@SDHALP2-001_8, SDHALP2-001_9, SDHALP2-001_10@72@71@73@:mucin 20, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane@NA
D169918@61648@61649@deletion@2@195703956@195704123@3@chr3:195703956-195704123@9.57@243@142@0.584@CNVR1707.1, CNVR1707.2@SDHALP1-002_8, ENST00000354937_9@32.5@32@33@NA@NA@NA
D169918@65354@65360@deletion@7@70146221@70160768@4@chr4:70146221-70160768@32.2@1003@606@0.604@CNVR1957.2, CNVR1957.1@UGT2B28-201_1, UGT2B28-201_2, UGT2B28-201_3, UGT2B28-201_4, UGT2B28-201_5, UGT2B28-201_6, UGT2B28-201_7@69.1428571428571@65@71@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
D169918@68947@68947@duplication@1@145041645@145041742@4@chr4:145041645-145041742@10.8@124@225@1.81@NA@GYPA-205_2@8@8@8@:glycophorin B (MNS blood group):glycophorin A (MNS blood group)@:integral to membrane;plasma membrane;integral to plasma membrane:external side of plasma membrane;integral to membrane;cytoskeletal anchoring at plasma membrane;plasma membrane;molecular_function;protein homodimerization activity;integral to plasma membrane;cellular_component;identical protein binding;membrane;biological_process;regulation of response to osmotic stress;virus-host interaction@: BLOOD GROUP--Ss LOCUS; Ss: MALARIA, SUSCEPTIBILITY TO; BLOOD GROUP--MN LOCUS; MN
D169918@70821@70822@deletion@2@745300@748675@5@chr5:745300-748675@29.8@341@148@0.434@CNVR2280.3@ZDHHC11B-201_5, ZDHHC11B-201_6@91@86@96@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
D169918@73727@73754@deletion@28@69717564@69807068@5@chr5:69717564-69807068@23.8@112@3@0.0268@CNVR2494.17, CNVR2494.3@GTF2H2B-201_4, GTF2H2B-201_5, GTF2H2B-201_6, GTF2H2B-201_7, GTF2H2B-201_8, GTF2H2B-201_9, GTF2H2B-201_10, GTF2H2B-201_11, GTF2H2B-201_12, GTF2H2B-201_13, GTF2H2B-201_14, GTF2H2B-201_15, GTF2H2B-201_16, AC146944-201_1, AC146944-201_2, AC146944-201_3, AC146944-201_4, AC146944-203_1, AC146944-203_2, AC146944-203_3, AC146944-203_4, ENST00000456583_1, ENST00000456583_2, ENST00000456583_3, ENST00000456583_5, AC146944-202_1, AC146944-202_2@135.925925925926@83@173@NA@NA@NA
D169918@73820@73820@deletion@1@70378606@70378820@5@chr5:70378606-70378820@11.5@52@0@0@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.8, CNVR2494.1, CNVR2494.37@AC044797-201_2@138@138@138@NA@NA@NA
D169918@77450@77450@duplication@1@139931569@139931770@5@chr5:139931569-139931770@4.76@135@197@1.46@NA@SRA1-201_3@0@0@0@:steroid receptor RNA activator 1@:cell differentiation;cell leading edge;ribonucleoprotein complex;DNA binding;cytoplasm;thyroid hormone receptor activator activity;cell proliferation;transcription coactivator activity;ligand-dependent nuclear receptor binding;transcription factor complex;apoptotic process;nucleus;transcription, DNA-dependent;ligand-dependent nuclear receptor transcription coactivator activity;positive regulation of transcription from RNA polymerase II promoter@NA
D169918@79567@79568@deletion@2@175388056@175388438@5@chr5:175388056-175388438@13.9@87@17@0.195@NA@THOC3-001_4, THOC3-001_5@173.5@165@182@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
D169918@79578@79580@duplication@3@175523829@175525562@5@chr5:175523829-175525562@9.06@256@370@1.45@NA@FAM153B-201_7, FAM153B-201_8, FAM153B-201_9@18@17@20@:uncharacterized LOC100507387;family with sequence similarity 153, member B@NA@NA
D169918@80019@80019@deletion@1@177163582@177163611@5@chr5:177163582-177163611@6.88@68@26@0.382@NA@FAM153A-204_12@78@78@78@:family with sequence similarity 153, member A@NA@NA
D169918@80022@80024@deletion@3@177166603@177168334@5@chr5:177166603-177168334@19.2@103@11@0.107@NA@FAM153A-204_7, FAM153A-204_8, FAM153A-204_9@94@86@106@:family with sequence similarity 153, member A@NA@NA
D169918@80479@80487@deletion@9@180375357@180429786@5@chr5:180375357-180429786@23.3@895@570@0.637@CNVR2719.1@BTNL8-202_5, BTNL8-202_6, BTNL8-202_7, BTNL8-202_8, BTNL3-202_1, BTNL3-202_2, BTNL3-202_3, BTNL3-202_5@102.375@90@108@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
D169918@82520@82521@deletion@2@29911901@29912394@6@chr6:29911901-29912394@12@484@305@0.63@CNVR2829.7, CNVR2829.2, CNVR2829.3@HLA-A-001_6, HLA-A-001_7@21@20@22@:major histocompatibility complex, class I, A@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO
D169918@83002@83003@deletion@2@31237745@31238263@6@chr6:31237745-31238263@20.3@376@193@0.513@CNVR2838.2, CNVR2838.1@HLA-C-006_4, HLA-C-006_5@25@25@25@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
D169918@83017@83017@deletion@1@31324480@31324735@6@chr6:31324480-31324735@5.51@142@83@0.585@CNVR2841.12, CNVR2841.14, CNVR2841.8@HLA-B-201_2@72@72@72@:major histocompatibility complex, class I, B@:MHC class I protein complex;regulation of immune response;regulation of interleukin-12 production;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;regulation of T cell anergy;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;receptor binding;early endosome membrane;virus-host interaction;regulation of interleukin-6 production;regulation of dendritic cell differentiation;phagocytic vesicle membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO; SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1
D169918@83577@83577@deletion@1@31962024@31962162@6@chr6:31962024-31962162@9.23@46@3@0.0652@CNVR2843.6, CNVR2843.3@C4A-001_20@12@12@12@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
D169918@83601@83608@duplication@8@31973468@31974689@6@chr6:31973468-31974689@20@887@1213@1.37@CNVR2843.6, CNVR2843.3@CYP21A1P-001_1, CYP21A1P-001_2, CYP21A1P-001_3, CYP21A1P-001_4, CYP21A1P-001_5, AL645922-201_1, AL645922-201_2, AL645922-201_3@103.125@80@109@NA@NA@NA
D169918@83637@83638@duplication@2@31994762@31995223@6@chr6:31994762-31995223@8.42@112@190@1.7@CNVR2843.6, CNVR2843.5@C4B-001_20, C4B-001_21@13@13@13@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
D169918@83670@83675@deletion@6@32008648@32010384@6@chr6:32008648-32010384@22.3@233@93@0.399@CNVR2843.6, CNVR2843.5@TNXB-201_40, TNXB-201_41, TNXB-201_42, TNXB-201_43, TNXB-201_44, CYP21A2-002_10@42.1666666666667@34@46@:cytochrome P450, family 21, subfamily A, polypeptide 2:tenascin-X-like;tenascin XB@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
D169918@83911@83915@deletion@5@32485122@32489952@6@chr6:32485122-32489952@19.4@191@73@0.382@CNVR2845.21, CNVR2845.25, CNVR2845.30@HLA-DRB5-001_2, HLA-DRB5-001_3, HLA-DRB5-001_4, HLA-DRB5-001_5, HLA-DRB5-001_6@184.2@177@189@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D169918@83920@83923@deletion@4@32522469@32525964@6@chr6:32522469-32525964@8.6@186@107@0.575@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.5@HLA-DRB6-002_2, HLA-DRB6-002_3, AL713966-201_2, AL713966-201_3@155.25@144@167@NA@NA@NA
D169918@83930@83930@deletion@1@32551888@32552156@6@chr6:32551888-32552156@5.22@103@56@0.544@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.54, CNVR2845.56, CNVR2845.34@HLA-DRB1-001_2@100@100@100@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
D169918@83932@83947@deletion@16@32605206@32636161@6@chr6:32605206-32636161@95.7@1187@529@0.446@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20@HLA-DQA1-002_1, HLA-DQA1-002_2, HLA-DQA1-002_3, HLA-DQA1-002_4, HLA-DQA1-002_5, HLA-DQA1-002_6, HLA-DQB1-003_1, HLA-DQB1-003_2, HLA-DQB1-003_3, HLA-DQB1-003_4, HLA-DQB1-003_5, HLA-DQB1-003_6, XXbac-BPG254F23-001_1, XXbac-BPG254F23-001_2, ENST00000443574_1, ENST00000443574_2@112.75@4@146@:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
D169918@84707@84709@duplication@3@35755646@35763631@6@chr6:35755646-35763631@14@850@1156@1.36@CNVR2861.1@C6orf127-001_3, CLPS-001_2, CLPS-001_3@41.6666666666667@40@43@:colipase-like 1:colipase, pancreatic@:extracellular region;enzyme activator activity;digestion;lipid catabolic process:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
D169918@86709@86709@deletion@1@52712710@52712831@6@chr6:52712710-52712831@6.45@130@71@0.546@NA@ENST00000452866_6@1@1@1@NA@NA@NA
D169918@91874@91874@deletion@1@150343118@150343380@6@chr6:150343118-150343380@6.15@153@88@0.575@NA@RAET1L-001_2@10@10@10@:retinoic acid early transcript 1L@:MHC class I protein complex;antigen processing and presentation;immune response;anchored to membrane;membrane@NA
D169918@92588@92596@duplication@9@160131986@160133803@6@chr6:160131986-160133803@43.9@1210@1779@1.47@CNVR3127.2, CNVR3127.1@ENST00000442642_1, ENST00000442642_2, ENST00000442642_3, ENST00000442642_4, ENST00000442642_5, ENST00000442642_6, ENST00000442642_7, ENST00000442642_8, ENST00000442642_9@74.7777777777778@1@112@:superoxide dismutase 2, mitochondrial;uncharacterized LOC100129518@:response to reactive oxygen species;oxidation-reduction process;mitochondrion;negative regulation of cell proliferation;neuron development;negative regulation of fat cell differentiation;removal of superoxide radicals;response to gamma radiation;response to L-ascorbic acid;response to lipopolysaccharide;response to nutrient levels;response to zinc ion;protein homotetramerization;post-embryonic development;iron ion homeostasis;hemopoiesis;aging;mitochondrial inner membrane;age-dependent response to reactive oxygen species;response to drug;oxygen binding;mitochondrial nucleoid;vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure;apoptotic process;superoxide metabolic process;response to superoxide;detection of oxygen;response to silicon dioxide;cytoplasm;response to stress;respiratory electron transport chain;superoxide anion generation;protein homooligomerization;regulation of mitochondrial membrane potential;positive regulation of nitric oxide biosynthetic process;response to manganese ion;regulation of blood pressure;metal ion binding;negative regulation of apoptotic process;response to cadmium ion;response to oxidative stress;liver development;regulation of catalytic activity;negative regulation of fibroblast proliferation;response to selenium ion;age-dependent response to oxidative stress;response to electrical stimulus;mitochondrial matrix;identical protein binding;mitochondrion organization;response to hyperoxia;vasodilation;response to hydrogen peroxide;superoxide dismutase activity;heart development;negative regulation of neuron apoptotic process;erythrophore differentiation;locomotory behavior;DNA binding;release of cytochrome c from mitochondria;response to axon injury;oxygen homeostasis;response to activity;glutathione metabolic process;hydrogen peroxide metabolic process;hydrogen peroxide biosynthetic process;regulation of transcription from RNA polymerase II promoter;response to hypoxia;protein binding;manganese ion binding;cellular response to ethanol@: MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6; MVCD6
D169918@93099@93099@deletion@1@167790036@167790193@6@chr6:167790036-167790193@5.23@26@2@0.0769@NA@TCP10-001_5@103@103@103@:t-complex 10@:cytosol@NA
D169918@94190@94193@duplication@4@5959482@5965606@7@chr7:5959482-5965606@13.1@621@856@1.38@NA@C7orf28A-001_12, C7orf28A-001_13, C7orf28A-001_14, C7orf28A-001_15@65.75@46@73@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae):radial spoke head 10 homolog B (Chlamydomonas)@:lysosomal membrane@NA
D169918@94209@94217@deletion@9@6000324@6018328@7@chr7:6000324-6018328@19.9@414@231@0.558@NA@RSPH10B-002_1, RSPH10B-002_2, RSPH10B-002_3, RSPH10B-002_4, RSPH10B-002_5, RSPH10B-002_6, PMS2-001_13, PMS2-001_14, PMS2-001_15@20@8@51@:radial spoke head 10 homolog B (Chlamydomonas):PMS2 postmeiotic segregation increased 2 (S. cerevisiae)@:response to drug;DNA binding;MutSalpha complex binding;ATP binding;mismatch repair;DNA repair;mismatched DNA binding;ATPase activity;nucleus;mismatch repair complex;reciprocal meiotic recombination;ATP catabolic process;single-stranded DNA binding;response to DNA damage stimulus;single base insertion or deletion binding;protein binding;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;MutLalpha complex;endonuclease activity@: COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4; MISMATCH REPAIR CANCER SYNDROME
D169918@94410@94420@duplication@11@6785721@6797563@7@chr7:6785721-6797563@21.1@602@870@1.45@NA@ENST00000338780_11, ENST00000338780_12, ENST00000338780_13, ENST00000338780_14, PMS2CL-002_11, PMS2CL-002_12, PMS2CL-002_13, PMS2CL-002_14, RSPH10B2-204_1, RSPH10B2-204_2, RSPH10B2-204_3@46.6363636363636@5@90@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D169918@94430@94432@deletion@3@6819243@6821108@7@chr7:6819243-6821108@26.2@312@128@0.41@NA@RSPH10B2-204_13, RSPH10B2-204_14, RSPH10B2-204_15@17@16@19@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D169918@94438@94438@deletion@1@6836201@6836398@7@chr7:6836201-6836398@7.54@79@31@0.392@NA@RSPH10B2-204_20@26@26@26@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D169918@94440@94440@duplication@1@6837996@6838397@7@chr7:6837996-6838397@7.17@73@135@1.85@NA@RSPH10B2-204_21, C7orf28B-001_15@117@117@117@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D169918@94442@94444@deletion@3@6840581@6844687@7@chr7:6840581-6844687@31.8@149@2@0.0134@NA@C7orf28B-001_12, C7orf28B-001_13, C7orf28B-001_14@117.666666666667@114@121@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D169918@97907@97915@deletion@9@57063663@57076857@7@chr7:57063663-57076857@10.7@115@49@0.426@NA@TNRC18C-202_3, TNRC18C-202_4, TNRC18C-202_5, TNRC18C-202_6, TNRC18C-202_7, TNRC18C-202_8, TNRC18C-202_9, TNRC18C-202_10, TNRC18C-202_11@157.555555555556@139@166@NA@NA@NA
D169918@97964@97965@deletion@2@57894966@57896753@7@chr7:57894966-57896753@8.29@37@0@0@CNVR3409.1@ENST00000430646_2, ENST00000430646_3@14@14@14@NA@NA@NA
D169918@98189@98193@duplication@5@64639672@64646889@7@chr7:64639672-64646889@6.95@341@461@1.35@NA@INTS4L1-201_5, INTS4L1-201_6, INTS4L1-201_7, INTS4L1-201_8, INTS4L1-201_9@24.6@5@52@NA@NA@NA
D169918@98215@98215@deletion@1@65150574@65150717@7@chr7:65150574-65150717@9.82@49@3@0.0612@NA@INTS4L2-001_5@56@56@56@NA@NA@NA
D169918@98688@98688@deletion@1@72613728@72613825@7@chr7:72613728-72613825@4.72@21@0@0@NA@RP11-396K3-001_18@1@1@1@NA@NA@NA
D169918@99025@99025@duplication@1@74160678@74160751@7@chr7:74160678-74160751@10.9@6@74@12.3@NA@GTF2I-001_23@54@54@54@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
D169918@99041@99041@deletion@1@74193605@74193769@7@chr7:74193605-74193769@5.55@59@24@0.407@NA@NCF1-001_4@27@27@27@:neutrophil cytosolic factor 1@:inflammatory response;antigen processing and presentation of peptide antigen via MHC class I;phagosome maturation;NADPH oxidase complex;neutrophil mediated killing of gram-positive bacterium;cell communication;interaction with host;leukotriene metabolic process;response to yeast;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;respiratory burst;GTPase activity;negative regulation of smooth muscle contraction;GTP catabolic process;cytosol;defense response to fungus;defense response to bacterium;antigen processing and presentation of exogenous peptide antigen via MHC class I;leukocyte mediated cytotoxicity;neutrophil mediated killing of fungus;phosphatidylinositol binding;defense response to Gram-positive bacterium;GTP binding;respiratory burst involved in defense response;superoxide-generating NADPH oxidase activity;hydrogen peroxide biosynthetic process;protein targeting to membrane;electron carrier activity;superoxide metabolic process;innate immune response;phagolysosome;cytoplasm;cell proliferation;superoxide anion generation;protein binding;SH3 domain binding;cellular defense response;response to bacterium@: GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE,
D169918@99063@99063@deletion@1@74251404@74251506@7@chr7:74251404-74251506@6.88@31@0@0@NA@GTF2IRD2-002_2@8@8@8@:GTF2I repeat domain containing 2@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
D169918@99133@99142@duplication@10@74582344@74608703@7@chr7:74582344-74608703@8.49@159@248@1.56@NA@NCF1C-001_1, NCF1C-001_2, NCF1C-001_3, NCF1C-001_4, GTF2IP1-001_17, GTF2IP1-001_18, GTF2IP1-001_19, GTF2IP1-001_20, GTF2IP1-001_21, GTF2IP1-001_22@15.3@11@49@NA@NA@NA
D169918@101721@101726@deletion@6@100331652@100336237@7@chr7:100331652-100336237@173@821@6@0.00731@CNVR3509.1@ZAN-001_2, ZAN-001_3, ZAN-001_4, ZAN-001_5, ZAN-001_6, ZAN-001_7@81.6666666666667@71@89@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
D169918@101995@101996@deletion@2@101200653@101202305@7@chr7:101200653-101202305@7.4@391@258@0.66@NA@EMID2-001_13, EMID2-001_14@0@0@0@:EMI domain containing 2@:collagen;protein binding;extracellular region;plasma membrane;extracellular matrix organization;endoplasmic reticulum lumen@NA
D169918@102116@102116@deletion@1@102114810@102114983@7@chr7:102114810-102114983@4.67@25@3@0.12@CNVR3518.1@POLR2J-001_3@91@91@91@:polymerase (RNA) II (DNA directed) polypeptide J, 13.3kDa@:nucleoplasm;DNA binding;DNA repair;protein dimerization activity;nucleus;viral reproduction;gene expression;transcription initiation from RNA polymerase II promoter;7-methylguanosine mRNA capping;protein phosphorylation;LRR domain binding;protein kinase activity;DNA-directed RNA polymerase II, core complex;nucleotide-excision repair;transcription from RNA polymerase II promoter;DNA-directed RNA polymerase activity;protein binding;transcription-coupled nucleotide-excision repair;RNA splicing;mRNA splicing, via spliceosome;transcription, DNA-dependent;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription@NA
D169918@102140@102145@duplication@6@102165548@102180539@7@chr7:102165548-102180539@43.8@199@548@2.75@CNVR3518.1@RASA4B-007_4, RASA4B-007_5, RASA4B-007_6, POLR2J3-003_7, POLR2J3-003_8, POLR2J3-003_9@74.5@44@96@:RAS p21 protein activator 4B:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
D169918@102166@102166@deletion@1@102219874@102220244@7@chr7:102219874-102220244@8.92@40@0@0@CNVR3518.1@ENST00000379336_1, RASA4-001_21@63@63@63@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
D169918@102177@102187@duplication@11@102235754@102257205@7@chr7:102235754-102257205@25.5@131@332@2.53@CNVR3518.1@RASA4-001_1, RASA4-001_2, RASA4-001_3, RASA4-001_4, RASA4-001_5, RASA4-001_6, RASA4-001_7, RASA4-001_8, RASA4-001_9, RASA4-001_10, RASA4-001_11@48.9090909090909@42@60@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
D169918@102209@102210@duplication@2@102313328@102319304@7@chr7:102313328-102319304@24@315@590@1.87@CNVR3518.1@ENST00000379355_1, ENST00000379355_2@53@52@54@NA@NA@NA
D169918@105320@105325@deletion@6@141765390@141770919@7@chr7:141765390-141770919@15.9@453@273@0.603@CNVR3585.3, CNVR3585.2@MGAM-007_39, MGAM-007_40, MGAM-007_41, MGAM-007_42, MGAM-007_43, MGAM-007_44@108.666666666667@94@119@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
D169918@105330@105342@deletion@13@141778610@141794298@7@chr7:141778610-141794298@57.7@1813@1112@0.613@CNVR3585.3, CNVR3585.2@MGAM-007_49, MGAM-007_50, MGAM-007_51, MGAM-007_52, MGAM-007_53, MGAM-007_54, MGAM-007_55, MGAM-007_56, MGAM-007_57, MGAM-007_58, MGAM-007_59, MGAM-007_60, MGAM-007_61@110.461538461538@35@134@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
D169918@105620@105623@deletion@4@142829172@142836840@7@chr7:142829172-142836840@50.9@841@408@0.485@NA@PIP-001_1, PIP-001_2, PIP-001_3, PIP-001_4@3@3@3@:prolactin-induced protein@:protein binding;actin binding;extracellular region;apical plasma membrane;biological_process@NA
D169918@105798@105799@deletion@2@143975408@143975569@7@chr7:143975408-143975569@4.98@22@0@0@CNVR3598.4, CNVR3598.9@RP4-798C17-001_5, ENST00000378112_6@135@135@135@:Rho guanine nucleotide exchange factor (GEF) 35@NA@NA
D169918@107425@107429@deletion@5@7274294@7308722@8@chr8:7274294-7308722@6.37@591@421@0.712@CNVR3771.8, CNVR3771.10, CNVR3771.4@DEFB4P-001_1, DEFB103A-001_1, DEFB103A-001_2, SPAG11-003_3, SPAG11-003_4@68@51@91@:defensin, beta 4B;defensin, beta 4A:defensin, beta 103B;defensin, beta 103A:sperm associated antigen 11B@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response@NA
D169918@107502@107516@duplication@15@7673083@7752293@8@chr8:7673083-7752293@66.8@965@1662@1.72@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@DEFB107A-001_1, DEFB105A-001_1, DEFB105A-001_2, DEFB105A-001_3, DEFB106A-001_1, DEFB106A-001_2, DEFB104A-001_1, DEFB104A-001_2, SPAG11A-207_1, SPAG11A-207_2, SPAG11A-207_3, SPAG11A-207_4, DEFB103B-001_1, DEFB103B-001_2, DEFB4-001_1@56.5333333333333@40@113@:defensin, beta 107B;defensin, beta 107A:defensin, beta 105B;defensin, beta 105A:defensin, beta 106B;defensin, beta 106A:defensin, beta 104A;defensin, beta 104B:sperm associated antigen 11A;sperm associated antigen 11B:defensin, beta 103B;defensin, beta 103A:defensin, beta 4B;defensin, beta 4A@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response@NA
D169918@109572@109585@duplication@14@39311571@39349528@8@chr8:39311571-39349528@46.6@425@808@1.9@CNVR3859.1@ADAM3A-005_11, ADAM3A-005_12, ADAM3A-005_13, ADAM3A-005_14, ADAM3A-005_15, ADAM3A-005_16, ADAM3A-005_17, ADAM3A-005_18, ADAM3A-005_19, ADAM3A-005_20, ADAM3A-005_21, ADAM3A-009_7, ADAM3A-009_8, ADAM3A-009_9@120.5@98@136@NA@NA@NA
D169918@121600@121604@deletion@5@117085338@117087433@9@chr9:117085338-117087433@24.8@1691@1113@0.658@CNVR4448.1@ORM1-001_1, ORM1-001_2, ORM1-001_3, ORM1-001_4, ORM1-001_5@87.6@84@90@:orosomucoid 1@:protein binding;extracellular space;regulation of immune system process;transport;inflammatory response;extracellular region;acute-phase response@NA
D169918@126269@126269@deletion@1@9449789@9449825@10@chr10:9449789-9449825@6.81@42@8@0.19@NA@AL355591-202_3@0@0@0@NA@NA@NA
D169918@126909@126918@deletion@10@17840632@17898363@10@chr10:17840632-17898363@35.4@659@355@0.539@NA@FAM23A-201_5, MRC1L1-001_1, MRC1L1-001_2, MRC1L1-001_3, MRC1L1-001_4, MRC1L1-001_5, MRC1L1-001_6, MRC1L1-001_7, MRC1L1-001_8, MRC1L1-001_9@19.8@5@108@:transmembrane protein 236;transmembrane protein 236-like:macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding@NA
D169918@126948@126951@duplication@4@18122630@18138694@10@chr10:18122630-18138694@22.2@236@438@1.86@NA@MRC1-001_4, MRC1-001_5, MRC1-001_6, MRC1-001_7@25@16@34@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D169918@128372@128372@duplication@1@42924566@42924600@10@chr10:42924566-42924600@6.13@113@179@1.58@NA@CCNYL2-201_7@0@0@0@@:regulation of cyclin-dependent protein kinase activity;protein kinase binding@NA
D169918@128828@128829@deletion@2@46927785@46934899@10@chr10:46927785-46934899@16.9@77@0@0@CNVR4712.9, CNVR4712.2, CNVR4712.7@FAM35B-001_6, FAM35B-001_7@53@34@72@NA@NA@NA
D169918@128979@128979@deletion@1@47758848@47758905@10@chr10:47758848-47758905@7.13@32@0@0@CNVR4714.1@ANXA8L2-001_10@154@154@154@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:calcium-dependent phospholipid binding;calcium ion binding@NA
D169918@129022@129030@deletion@9@48025302@48055019@10@chr10:48025302-48055019@39.1@599@306@0.511@CNVR4715.2@ASAH2C-201_1, ASAH2C-201_2, ASAH2C-201_3, ASAH2C-201_4, ASAH2C-201_5, ASAH2C-201_6, ASAH2C-201_7, ASAH2C-201_8, ASAH2C-201_9@65.1111111111111@50@90@@:ceramidase activity;sphingolipid metabolic process@NA
D169918@129460@129461@deletion@2@51361725@51361911@10@chr10:51361725-51361911@6.77@33@2@0.0606@NA@ENST00000404618_4, ENST00000432221_4@122@121@123@NA@NA@NA
D169918@129604@129611@duplication@8@51965744@51994313@10@chr10:51965744-51994313@24.9@205@403@1.97@NA@ASAH2-201_5, ASAH2-201_6, ASAH2-201_7, ASAH2-201_8, ASAH2-201_9, ASAH2-201_10, ASAH2-201_11, ASAH2-201_12@147.125@53@186@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
D169918@138032@138032@duplication@1@5270600@5270821@11@chr11:5270600-5270821@6.18@49@99@2.02@NA@HBG1-201_2@106@106@106@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
D169918@141187@141188@deletion@2@48600990@48601883@11@chr11:48600990-48601883@11.5@52@0@0@CNVR5165.1@AC134982-201_1, AC134982-201_2@128@128@128@NA@NA@NA
D169918@145897@145897@deletion@1@89530825@89531798@11@chr11:89530825-89531798@10.3@390@237@0.608@NA@TRIM49-201_8@51@51@51@:tripartite motif containing 49@:protein binding;intracellular;DNA binding;zinc ion binding@NA
D169918@145909@145911@deletion@3@89581401@89584144@11@chr11:89581401-89584144@8.52@38@0@0@NA@TRIM53L-202_5, TRIM53L-202_6, TRIM53L-202_7@47.6666666666667@45@52@NA@NA@NA
D169918@145956@145964@duplication@9@89718200@89729449@11@chr11:89718200-89729449@15.2@132@255@1.93@NA@ENST00000442514_1, ENST00000442514_2, ENST00000442514_3, ENST00000442514_4, ENST00000442514_5, ENST00000442514_6, TRIM53-202_5, TRIM53-202_6, TRIM53-202_7@23.6666666666667@21@34@NA@NA@NA
D169918@150493@150493@deletion@1@7966399@7967131@12@chr12:7966399-7967131@7.7@229@136@0.594@NA@SLC2A14-202_12@11@11@11@:NECAP endocytosis associated 1:solute carrier family 2 (facilitated glucose transporter), member 14@:coated pit;protein binding;endocytosis;protein transport;clathrin vesicle coat;plasma membrane;membrane:multicellular organismal development;cell differentiation;substrate-specific transmembrane transporter activity;transport;folic acid binding;glucose transmembrane transporter activity;transmembrane transport;spermatogenesis;reduced folate carrier activity;integral to membrane;transmembrane transporter activity;membrane@NA
D169918@150775@150775@deletion@1@9446260@9446507@12@chr12:9446260-9446507@15.3@71@1@0.0141@NA@DDX11L8-201_2@42@42@42@NA@NA@NA
D169918@150778@150783@duplication@6@9450373@9454871@12@chr12:9450373-9454871@6.89@276@379@1.37@NA@DDX11L8-201_5, DDX11L8-201_6, DDX11L8-201_7, DDX11L8-201_8, DDX11L8-201_9, DDX11L8-201_10@67.8333333333333@55@78@NA@NA@NA
D169918@150785@150786@duplication@2@9456573@9456804@12@chr12:9456573-9456804@11.2@144@251@1.74@NA@DDX11L8-201_12, DDX11L8-201_13@85@83@87@NA@NA@NA
D169918@150826@150841@duplication@16@9590609@9707352@12@chr12:9590609-9707352@33.4@858@1259@1.47@CNVR5429.1@DDX12-203_1, DDX12-203_2, DDX12-203_3, AC006432-201_1, AC006432-201_2, AC006432-201_3, AC006432-201_4, AC006432-201_5, AC006432-201_6, AC006432-201_7, AC006432-201_8, AC006432-201_9, AC006432-201_11, AC006432-201_12, AC006432-201_13@20.7333333333333@7@25@NA@NA@NA
D169918@151049@151052@duplication@4@11506726@11544583@12@chr12:11506726-11544583@25@716@1074@1.5@CNVR5435.2, CNVR5435.1@PRB1-201_1, PRB1-201_2, PRB1-201_3, PRB2-001_4@44@35@49@:proline-rich protein BstNI subfamily 1:proline-rich protein BstNI subfamily 2@:extracellular region;molecular_function;cellular_component;biological_process@NA
D169918@154154@154155@deletion@2@53086207@53086665@12@chr12:53086207-53086665@18.2@457@257@0.562@CNVR5537.1@KRT77-201_6, KRT77-201_7@8@8@8@:keratin 77@:structural molecule activity;keratin filament;molecular_function;cellular_component;biological_process@NA
D169918@160888@160888@duplication@1@124496095@124499952@12@chr12:124496095-124499952@31.5@648@1164@1.8@CNVR5712.1@ZNF664-201_5@5@5@5@:zinc finger protein 664@:intracellular;nucleus;DNA binding;molecular_function;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;biological_process@NA
D169918@162127@162128@duplication@2@24465240@24465671@13@chr13:24465240-24465671@13.4@1035@1394@1.35@NA@RP11-45B20-002_6, ENST00000382133_3@29@29@29@:C1q and tumor necrosis factor related protein 9B@:collagen;protein binding@NA
D169918@162226@162227@duplication@2@25168411@25168502@13@chr13:25168411-25168502@5.13@334@444@1.33@CNVR5826.1@RP11-556N21-001_8, ENST00000453498_10@9@9@9@NA@NA@NA
D169918@164473@164474@deletion@2@52854789@52854851@13@chr13:52854789-52854851@8.01@263@162@0.616@NA@THSD1P-203_15, ENST00000403471_6@58@58@58@NA@NA@NA
D169918@164539@164543@duplication@5@53103402@53106857@13@chr13:53103402-53106857@25.2@142@333@2.35@NA@RP11-78J21-201_12, RP11-78J21-201_13, RP11-78J21-201_14, RP11-78J21-201_15, RP11-78J21-201_16@113.8@107@117@NA@NA@NA
D169918@164719@164720@duplication@2@64320936@64321324@13@chr13:64320936-64321324@5.32@119@178@1.5@NA@AL445989-201_1, AL445989-201_2@0@0@0@NA@NA@NA
D169918@166758@166761@deletion@4@20147390@20148264@14@chr14:20147390-20148264@10@615@415@0.675@CNVR6072.6, CNVR6072.12, CNVR6072.14@ENST00000398231_3, ENST00000398231_4, ENST00000398231_5, ENST00000398231_6@92.75@92@94@NA@NA@NA
D169918@170809@170810@duplication@2@74003820@74008400@14@chr14:74003820-74008400@23.1@235@461@1.96@CNVR6188.1, CNVR6188.4@ACOT1-201_1, ACOT1-201_2@115@114@116@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
D169918@173500@173502@duplication@3@106471638@106478412@14@chr14:106471638-106478412@19.6@261@446@1.71@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV3-6-210_6, IGHV1-3-001_1, IGHV4-4-001_2@12.6666666666667@4@17@@:protein binding:protein binding@NA
D169918@173508@173514@duplication@7@106539081@106573538@14@chr14:106539081-106573538@80.3@1160@2031@1.75@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8-001_1, IGHV1-8-001_2, IGHV3-9-001_1, IGHV3-9-001_2, IGHV2-10-001_1, IGHV2-10-001_2, IGHV3-11-001_2@20.4285714285714@9@24@@:protein binding:protein binding:protein binding@NA
D169918@173556@173567@duplication@12@106787370@106816254@14@chr14:106787370-106816254@74.5@1520@2488@1.64@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-29-001_1, IGHV3-29-001_2, IGHV3-30-001_1, IGHV3-30-001_2, IGHV3-30-2-001_1, IGHV3-30-2-001_2, IGHV4-31-001_1, IGHV4-31-001_2, IGHV3-32-001_1, IGHV3-32-001_2, IGHV3-33-001_1, IGHV3-33-001_2@15.3333333333333@5@19@@:protein binding:protein binding:protein binding@NA
D169918@173635@173638@deletion@4@107095128@107099589@14@chr14:107095128-107099589@23.6@457@253@0.554@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61-001_1, IGHV4-61-001_2, IGHV3-62-001_1, IGHV3-62-001_2@16@15@17@@:protein binding@NA
D169918@173705@173708@deletion@4@20643847@20644377@15@chr15:20643847-20644377@5.8@249@162@0.651@CNVR6295.15@HERC2P3-014_22, HERC2P3-014_23, AC026495-201_21, AC026495-201_22@111.5@111@112@NA@NA@NA
D169918@174506@174507@deletion@2@30664352@30665349@15@chr15:30664352-30665349@11.5@227@127@0.559@CNVR6337.1@CHRFAM7A-202_6, CHRFAM7A-202_7@56@44@68@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
D169918@174523@174523@duplication@1@30700113@30700196@15@chr15:30700113-30700196@6.35@266@374@1.41@NA@ENST00000327271_11@54@54@54@@:Golgi apparatus@NA
D169918@174659@174660@duplication@2@32449811@32450808@15@chr15:32449811-32450808@14.4@207@347@1.68@CNVR6345.2, CNVR6345.1@CHRNA7-205_6, CHRNA7-205_7@60@54@66@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
D169918@175657@175657@duplication@1@41870086@41871537@15@chr15:41870086-41871537@9.58@192@305@1.59@NA@TYRO3-001_19@2@2@2@:TYRO3 protein tyrosine kinase@:protein tyrosine kinase activity;platelet aggregation;negative regulation of toll-like receptor signaling pathway;ATP binding;vagina development;substrate adhesion-dependent cell spreading;nucleus;negative regulation of lymphocyte activation;endoplasmic reticulum membrane;phosphatidylinositol 3-kinase cascade;nuclear envelope;platelet activation;protein kinase activity;protein kinase B signaling cascade;neuron homeostasis;negative regulation of neuron apoptotic process;negative regulation of innate immune response;protein autophosphorylation;transmembrane receptor protein tyrosine kinase activity;apoptotic cell clearance;transferase activity, transferring phosphorus-containing groups;spermatogenesis;forebrain cell migration;integral to membrane;integral to plasma membrane;ovulation cycle;natural killer cell differentiation;phosphatidylinositol 3-kinase binding;negative regulation of inflammatory response;protein phosphorylation;receptor signaling protein tyrosine kinase activity;protein heterodimerization activity;secretion by cell;protein binding;signal transduction;cell adhesion;signal transduction by phosphorylation@NA
D169918@176340@176340@deletion@1@43873202@43873322@15@chr15:43873202-43873322@9.45@155@77@0.497@CNVR6365.1@HISPPD2A-201_10@10@10@10@:diphosphoinositol pentakisphosphate kinase 1@:inositol hexakisphosphate 3-kinase activity;inositol hexakisphosphate 1-kinase activity;inositol metabolic process;diphosphoinositol-pentakisphosphate kinase activity;ATP binding;acid phosphatase activity;cytoplasm;cytosol;inositol hexakisphosphate 5-kinase activity;nucleus;kinase activity;inositol-1,3,4,5,6-pentakisphosphate kinase activity@NA
D169918@182605@182607@duplication@3@1278902@1279739@16@chr16:1278902-1279739@11.5@56@138@2.46@CNVR6591.1@TPSB2-002_3, TPSB2-002_4, TPSB2-002_5@76.3333333333333@57@102@:tryptase beta 2 (gene/pseudogene)@:proteolysis;catalytic activity;serine-type endopeptidase activity@NA
D169918@183384@183384@duplication@1@2692232@2693298@16@chr16:2692232-2693298@10.6@125@225@1.8@CNVR6602.2@AC141586-201_1@50@50@50@NA@NA@NA
D169918@185304@185304@duplication@1@20491897@20492023@16@chr16:20491897-20492023@6.82@215@313@1.46@NA@ACSM2A-201_11@1@1@1@:acyl-CoA synthetase medium-chain family member 2A@:mitochondrion;butyrate-CoA ligase activity;catalytic activity;ATP binding;glucose homeostasis;medium-chain fatty-acyl-CoA metabolic process;fatty acid metabolic process;triglyceride homeostasis;metabolic process;mitochondrial matrix;metal ion binding@NA
D169918@186292@186292@deletion@1@28403075@28403177@16@chr16:28403075-28403177@5.28@152@91@0.599@CNVR6684.2@EIF3CL-201_10@5@5@5@:eukaryotic translation initiation factor 3, subunit C-like@:protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;translation initiation factor activity@NA
D169918@186359@186363@duplication@5@28617379@28619925@16@chr16:28617379-28619925@17.2@826@1132@1.37@CNVR6685.1, CNVR6685.2@SULT1A1-203_5, SULT1A1-203_6, SULT1A1-203_7, SULT1A1-203_8, SULT1A1-203_9@71@69@73@:sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1@:small molecule metabolic process;sulfation;aryl sulfotransferase activity;amine metabolic process;catecholamine metabolic process;xenobiotic metabolic process;cytosol;steroid sulfotransferase activity;integral to membrane;sulfotransferase activity;flavonol 3-sulfotransferase activity;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process;estrogen metabolic process@NA
D169918@186368@186369@duplication@2@28711499@28712933@16@chr16:28711499-28712933@11@71@155@2.18@CNVR6686.3, CNVR6686.1, CNVR6686.2@AC145285-201_1, AC145285-201_2@60@59@61@:eukaryotic translation initiation factor 3, subunit C@:cytosol;protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;cellular protein metabolic process;binding;gene expression;translation;translation initiation factor activity@NA
D169918@186582@186585@duplication@4@29468955@29469337@16@chr16:29468955-29469337@10.1@85@164@1.93@CNVR6690.2, CNVR6690.3, CNVR6690.4@GIYD1-001_4, GIYD1-001_5, SULT1A4-201_2, SULT1A4-201_3@12.5@12@13@:structure-specific endonuclease subunit SLX1-like;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae);SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae):sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3;sulfotransferase 1A3/1A4-like@:Slx1-Slx4 complex;5'-flap endonuclease activity;DNA repair;protein binding;DNA double-strand break processing involved in repair via single-strand annealing;double-strand break repair via homologous recombination;metal ion binding;crossover junction endodeoxyribonuclease activity:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;cytoplasm;catecholamine metabolic process;cytosol;endoplasmic reticulum unfolded protein response;xenobiotic metabolic process;sulfotransferase activity;activation of signaling protein activity involved in unfolded protein response;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process@NA
D169918@187527@187528@deletion@2@32936755@32937067@16@chr16:32936755-32937067@6.83@56@18@0.321@CNVR6702.1@ENST00000423205_4, ENST00000423205_5@26.5@19@34@NA@NA@NA
D169918@187548@187548@deletion@1@33630379@33630421@16@chr16:33630379-33630421@8.32@332@206@0.62@CNVR6703.17, CNVR6703.1, CNVR6703.6, CNVR6703.21@AC136428-201_3@20@20@20@NA@NA@NA
D169918@188261@188261@deletion@1@55866918@55867076@16@chr16:55866918-55867076@21@99@2@0.0202@NA@CES1-203_1@10@10@10@:carboxylesterase 1;liver carboxylesterase 1-like@:hydrolase activity;methyl salicylate esterase activity;response to toxin;methylumbelliferyl-acetate deacetylase activity;endoplasmic reticulum lumen;retinyl-palmitate esterase activity;methyl jasmonate esterase activity;metabolic process;carboxylesterase activity;methyl indole-3-acetate esterase activity@: CARBOXYLESTERASE 1; CES1
D169918@189920@189928@deletion@9@69988239@69996971@16@chr16:69988239-69996971@21.4@112@10@0.0893@CNVR6762.3, CNVR6762.1, CNVR6762.4@CLEC18A-202_4, CLEC18A-202_5, CLEC18A-202_6, CLEC18A-202_7, CLEC18A-202_8, CLEC18A-202_9, CLEC18A-202_10, CLEC18A-202_11, CLEC18A-202_12@14.4444444444444@13@25@:C-type lectin domain family 18, member A@:carbohydrate binding;protein binding;extracellular region@NA
D169918@189930@189930@duplication@1@70010214@70010636@16@chr16:70010214-70010636@8.2@71@140@1.97@CNVR6762.3, CNVR6762.2@AC026468-201_8@10@10@10@NA@NA@NA
D169918@189958@189958@deletion@1@70161165@70161297@16@chr16:70161165-70161297@7.71@161@88@0.547@CNVR6764.1, CNVR6764.3@AC009060-202_4@44@44@44@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
D169918@189989@189989@duplication@1@70219790@70219880@16@chr16:70219790-70219880@8.27@72@141@1.96@CNVR6764.1, CNVR6764.5@CLEC18C-201_11@19@19@19@:C-type lectin domain family 18, member C@:carbohydrate binding;protein binding;extracellular region@NA
D169918@190431@190432@duplication@2@72092155@72093088@16@chr16:72092155-72093088@17.9@297@507@1.71@CNVR6769.1, CNVR6769.2@HP-201_5, HP-201_6@21.5@17@26@:thioredoxin-like 4B:haptoglobin:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:cellular iron ion homeostasis;negative regulation of oxidoreductase activity;catalytic activity;negative regulation of hydrogen peroxide catabolic process;positive regulation of cell death;haptoglobin-hemoglobin complex;extracellular space;proteolysis;response to hydrogen peroxide;extracellular region;hemoglobin binding;defense response;serine-type endopeptidase activity:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@: ANHAPTOGLOBINEMIA; AHP
D169918@195242@195253@duplication@12@16712159@16725807@17@chr17:16712159-16725807@8.97@973@1243@1.28@CNVR7008.2@AC022596-003_8, AC022596-003_9, AC022596-003_10, AC022596-003_11, AC022596-001_1, AC022596-001_2, AC022596-001_3, AC022596-001_4, AC022596-001_5, AC022596-001_6, AC022596-001_7, AC022596-001_8@87.4166666666667@65@97@NA@NA@NA
D169918@195691@195726@deletion@36@18331724@18416773@17@chr17:18331724-18416773@59.9@676@290@0.429@CNVR7014.1@ENST00000326333_2, ENST00000326333_3, ENST00000326333_4, ENST00000326333_5, ENST00000326333_6, ENST00000326333_7, ENST00000326333_8, ENST00000399124_1, ENST00000399124_2, ENST00000399124_3, ENST00000399124_4, ENST00000399124_5, ENST00000399124_6, ENST00000399124_7, ENST00000399124_8, ENST00000411877_1, ENST00000411877_2, ENST00000411877_4, LGALS9C-201_1, LGALS9C-201_2, LGALS9C-201_3, LGALS9C-201_4, LGALS9C-201_5, LGALS9C-201_6, LGALS9C-201_7, LGALS9C-201_8, LGALS9C-201_9, LGALS9C-201_10, LGALS9C-201_11, ENST00000426269_1, ENST00000426269_2, ENST00000426269_3, ENST00000426269_4, ENST00000426269_5, AC107983-001_10@136.628571428571@79@203@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
D169918@195728@195747@deletion@20@18418662@18457581@17@chr17:18418662-18457581@179@843@12@0.0142@NA@AC107983-001_1, AC107983-001_2, AC107983-001_3, AC107983-001_4, AC107983-001_5, AC107983-001_6, AC107983-001_7, AC107983-001_8, ENST00000456184_1, ENST00000456184_2, CCDC144B-201_14, CCDC144B-201_15, CCDC144B-201_16, CCDC144B-201_17, CCDC144B-201_18, ENST00000447265_11, ENST00000447265_12, ENST00000447265_13, ENST00000447265_14, ENST00000447265_15@129.8@126@133@:protein FAM106B-like@NA@NA
D169918@197726@197728@deletion@3@34539180@34539966@17@chr17:34539180-34539966@18.9@86@0@0@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1-202_2, CCL4L1-202_3, CCL4L1-202_4@118@113@122@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
D169918@198032@198032@deletion@1@36351805@36351997@17@chr17:36351805-36351997@15@595@354@0.595@CNVR7083.3@AC183087-202_14@58@58@58@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
D169918@198035@198044@deletion@10@36357160@36413071@17@chr17:36357160-36413071@57.7@4720@3139@0.665@CNVR7083.3@AC183087-202_2, AC183087-202_3, AC183087-202_4, AC183087-202_5, AC183087-202_6, AC183087-202_7, AC183087-202_8, AC183087-202_9, AC183087-202_10, AC183087-202_11@43.6@8@59@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
D169918@200255@200266@duplication@12@43559805@43596019@17@chr17:43559805-43596019@32.3@732@1165@1.59@CNVR7113.4, CNVR7113.6@PLEKHM1-201_1, PLEKHM1-201_2, AC091132-201_1, AC091132-201_2, AC091132-201_3, AC091132-201_4, AC091132-201_5, AC091132-201_6, ENST00000253803_1, ENST00000339474_1, ENST00000339474_2, ENST00000339474_3@67.9166666666667@1@127@:pleckstrin homology domain containing, family M (with RUN domain) member 1@:phospholipid binding;protein binding;intracellular;metal ion binding;cytoplasm;intracellular signal transduction@: OSTEOPETROSIS, AUTOSOMAL RECESSIVE 6; OPTB6
D169918@200324@200360@deletion@37@44360679@44630816@17@chr17:44360679-44630816@117@2650@1412@0.533@CNVR7114.2, CNVR7114.1@ENST00000451529_1, ENST00000451529_3, ENST00000451529_5, LRRC37A-001_1, LRRC37A-001_2, LRRC37A-001_3, LRRC37A-001_4, LRRC37A-001_5, LRRC37A-001_6, LRRC37A-001_7, LRRC37A-001_8, LRRC37A-001_9, LRRC37A-001_10, LRRC37A-001_11, LRRC37A-001_12, LRRC37A-001_13, LRRC37A-001_14, LRRC37A-001_15, AC005829-202_1, AC005829-202_2, AC005829-202_3, AC005829-202_4, AC005829-202_5, LRRC37A2-201_1, LRRC37A2-201_2, LRRC37A2-201_3, LRRC37A2-201_4, LRRC37A2-201_5, LRRC37A2-201_6, LRRC37A2-201_7, LRRC37A2-201_8, LRRC37A2-201_9, LRRC37A2-201_10, LRRC37A2-201_11, ARL17P1-202_5@109.971428571429@46@196@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
D169918@205726@205726@duplication@1@117045@117305@18@chr18:117045-117305@8.1@320@458@1.43@NA@ENST00000400614_3@26@26@26@NA@NA@NA
D169918@208951@208951@deletion@1@72672144@72672711@18@chr18:72672144-72672711@6.54@269@169@0.628@NA@AC100783-201_2@0@0@0@:zinc finger protein 407@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
D169918@210398@210398@deletion@1@3939900@3939970@19@chr19:3939900-3939970@4.62@105@60@0.571@NA@ITGB1BP3-201_6@4@4@4@:nicotinamide riboside kinase 2@:protein binding;intracellular;negative regulation of myoblast differentiation;ribosylnicotinamide kinase activity;metal ion binding;ATP binding;NAD biosynthetic process@NA
D169918@213493@213494@deletion@2@14508472@14508748@19@chr19:14508472-14508748@9.63@105@43@0.41@NA@CD97-205_8, CD97-205_9@10.5@7@14@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
D169918@217293@217297@duplication@5@40373947@40382827@19@chr19:40373947-40382827@35.5@385@701@1.82@CNVR7639.2@FCGBP-201_22, FCGBP-201_23, FCGBP-201_24, FCGBP-201_25, FCGBP-201_26@130.8@105@155@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D169918@217301@217306@deletion@6@40389654@40399856@19@chr19:40389654-40399856@57@392@94@0.24@CNVR7639.2, CNVR7639.3@FCGBP-201_13, FCGBP-201_14, FCGBP-201_15, FCGBP-201_16, FCGBP-201_17, FCGBP-201_18@112.333333333333@103@127@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D169918@217595@217595@duplication@1@41327389@41327534@19@chr19:41327389-41327534@4.64@78@125@1.6@NA@CYP2F1P-001_5@0@0@0@NA@NA@NA
D169918@218183@218185@deletion@3@43709627@43716628@19@chr19:43709627-43716628@6.02@224@143@0.638@CNVR7658.5, CNVR7658.1@PSG1-202_1, PSG4-001_1, CEACAMP10-001_9@39@38@41@:pregnancy specific beta-1-glycoprotein 4:pregnancy specific beta-1-glycoprotein 9@:protein binding;extracellular region;female pregnancy;defense response:protein binding;extracellular region;female pregnancy;defense response@NA
D169918@218213@218214@deletion@2@43865329@43865732@19@chr19:43865329-43865732@6.12@131@75@0.573@NA@AC005392-201_1, AC005392-201_2@4.5@1@8@@:blood coagulation;plasma membrane;anchored to membrane;leukocyte migration@NA
D169918@218217@218218@duplication@2@43877355@43877758@19@chr19:43877355-43877758@5.39@119@178@1.5@NA@CD177P-201_1, CD177P-201_2@14.5@11@18@NA@NA@NA
D169918@220541@220541@deletion@1@51509716@51509980@19@chr19:51509716-51509980@6.33@223@137@0.614@CNVR7699.1@KLK9-201_3@1@1@1@:kallikrein-related peptidase 9:kallikrein-related peptidase 9@:proteolysis;extracellular region;catalytic activity;serine-type endopeptidase activity:proteolysis;extracellular region;catalytic activity;serine-type endopeptidase activity@NA
D169918@220946@220947@deletion@2@53818392@53819154@19@chr19:53818392-53819154@30.3@655@341@0.521@NA@VN1R6P-201_1, VN1R6P-201_2@1@0@2@NA@NA@NA
D169918@221171@221181@duplication@11@54726817@54746187@19@chr19:54726817-54746187@70.4@1715@2647@1.54@CNVR7721.3, CNVR7721.4, CNVR7721.1@LILRB3-008_1, AC010492-001_1, AC010492-001_2, LILRA6-002_3, LILRA6-002_4, LILRA6-002_5, LILRA6-002_6, LILRA6-002_7, LILRA6-002_8, LILRA6-002_9, LILRA6-002_10@56.2727272727273@44@98@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D169918@221218@221224@duplication@7@54801929@54804722@19@chr19:54801929-54804722@8.42@1229@1561@1.27@CNVR7722.1@LILRA3-003_4, LILRA3-003_5, LILRA3-003_6, LILRA3-003_7, LILRA3-003_8, LILRA3-003_9, LILRA3-003_10@105.857142857143@90@109@:leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3@:antigen binding;signal transduction;protein binding;extracellular region;plasma membrane;receptor activity;defense response@NA
D169918@221396@221399@deletion@4@55266477@55270359@19@chr19:55266477-55270359@6.15@272@178@0.654@CNVR7725.2, CNVR7725.1@KIR2DP1-001_1, KIR2DP1-001_2, KIR2DP1-001_3, KIR2DP1-001_4@96.5@85@107@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity@NA
D169918@221403@221408@deletion@6@55277931@55279337@19@chr19:55277931-55279337@46.1@1112@622@0.559@CNVR7725.2, CNVR7725.1@KIR2DL3-201_6, KIR2DL3-201_7, KIR2DL3-201_8, KIR2DP1-001_7, KIR2DP1-001_8, KIR2DP1-001_9@125.666666666667@125@126@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity@NA
D169918@221436@221438@deletion@3@55349033@55354374@19@chr19:55349033-55354374@6.28@368@246@0.668@CNVR7725.1, CNVR7725.6@KIR2DS4-001_3, KIR2DS4-001_4, KIR2DS4-001_5@58.6666666666667@41@68@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
D169918@221440@221441@duplication@2@55359208@55360024@19@chr19:55359208-55360024@8.8@1118@1476@1.32@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4-001_7, KIR2DS4-001_8@102@102@102@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
D169918@222068@222069@duplication@2@58003184@58003369@19@chr19:58003184-58003369@7.25@72@132@1.83@CNVR7748.1@ZNF419-202_5, ZNF419-202_6@0@0@0@:zinc finger protein 419@:intracellular;DNA binding;regulation of transcription, DNA-dependent;cytoplasm;nucleolus;nucleus;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding@NA
D169918@222563@222563@duplication@1@1569208@1569279@20@chr20:1569208-1569279@9.52@23@87@3.78@CNVR7763.1@SIRPB1-201_1@128@128@128@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
D169918@222594@222594@duplication@1@1895747@1896102@20@chr20:1895747-1896102@9.13@173@277@1.6@CNVR7764.2@SIRPA-201_3@34@34@34@:signal-regulatory protein alpha@:blood coagulation;protein binding;integral to membrane;SH3 domain binding;cell adhesion;plasma membrane;membrane;leukocyte migration@NA
D169918@228815@228817@deletion@3@10793871@10862668@21@chr21:10793871-10862668@7.29@728@506@0.695@CNVR7947.10, CNVR7947.4@AF254982-201_1, AF254982-201_2, IGHV1OR15-5-001_1@7.33333333333333@5@9@@:protein binding;extracellular region@NA
D169918@232771@232784@deletion@14@20385728@20402444@22@chr22:20385728-20402444@14@139@55@0.396@CNVR8094.9, CNVR8094.4, CNVR8094.10@PI4KAP1-204_1, PI4KAP1-204_2, PI4KAP1-204_3, PI4KAP1-204_4, PI4KAP1-204_5, PI4KAP1-204_6, PI4KAP1-204_7, PI4KAP1-204_8, PI4KAP1-204_9, PI4KAP1-204_10, PI4KAP1-204_11, PI4KAP1-204_12, PI4KAP1-204_13, PI4KAP1-204_14@165.785714285714@155@172@NA@NA@NA
D169918@233708@233708@deletion@1@24302483@24302569@22@chr22:24302483-24302569@6@27@0@0@CNVR8114.6, CNVR8114.12, CNVR8114.13, CNVR8114.8@GSTT2B-002_2@67@67@67@:glutathione S-transferase theta 2B (gene/pseudogene);glutathione S-transferase theta 2@:protein binding;glutathione transferase activity;nucleus;transferase activity;cytoplasm@NA
D169918@236123@236123@duplication@1@39357394@39357687@22@chr22:39357394-39357687@6.01@61@113@1.85@CNVR8164.1@APOBEC3A-001_4@23@23@23@:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A;APOBEC3A and APOBEC3B deletion hybrid@:cytidine deamination;defense response to virus;negative regulation of viral genome replication;DNA cytosine deamination;clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine;catalytic activity;DNA demethylation;cytoplasm;innate immune response;cytidine deaminase activity;nucleus;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;cellular response to xenobiotic stimulus;zinc ion binding;negative regulation of transposition@NA
D169918@236125@236131@deletion@7@39358502@39387632@22@chr22:39358502-39387632@41.7@848@462@0.545@CNVR8164.1@APOBEC3A-001_6, APOBEC3B-003_1, APOBEC3B-003_2, APOBEC3B-003_3, APOBEC3B-003_4, APOBEC3B-003_5, APOBEC3B-003_6@35.7142857142857@29@37@:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A;APOBEC3A and APOBEC3B deletion hybrid:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B@:cytidine deamination;defense response to virus;negative regulation of viral genome replication;DNA cytosine deamination;clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine;catalytic activity;DNA demethylation;cytoplasm;innate immune response;cytidine deaminase activity;nucleus;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;cellular response to xenobiotic stimulus;zinc ion binding;negative regulation of transposition:RNA binding;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;negative regulation of transposition;catalytic activity;zinc ion binding@NA
D169918@236749@236750@duplication@2@42522855@42523637@22@chr22:42522855-42523637@6.46@256@356@1.39@CNVR8168.1, CNVR8168.3@CYP2D6-203_8, CYP2D6-203_9@30@30@30@:cytochrome P450, family 2, subfamily D, polypeptide 6@:oxidation-reduction process;mitochondrion;alkaloid catabolic process;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;drug catabolic process;endoplasmic reticulum membrane;response to organic substance;oxidative demethylation;endoplasmic reticulum;alkaloid metabolic process;negative regulation of binding;heme binding;xenobiotic metabolic process;dopamine metabolic process;steroid metabolic process;isoquinoline alkaloid metabolic process;arachidonic acid monooxygenase activity;arachidonic acid metabolic process;steroid 21-monooxygenase activity;negative regulation of cellular organofluorine metabolic process;oxidoreductase activity;monoterpenoid metabolic process;heterocycle metabolic process;drug binding;drug metabolic process;electron carrier activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;coumarin metabolic process@: DRUG METABOLISM, POOR, CYP2D6-RELATED
D169918@236768@236774@duplication@7@42537546@42539610@22@chr22:42537546-42539610@46.7@811@1303@1.61@CNVR8168.1, CNVR8168.3, CNVR8168.4@CYP2D7P1-202_1, CYP2D7P1-202_2, CYP2D7P1-202_3, CYP2D7P1-202_4, CYP2D7P1-202_5, CYP2D7P1-202_6, CYP2D7P1-202_7@18.7142857142857@12@22@@:oxidation-reduction process;electron carrier activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;heme binding@NA
D170484@515@516@duplication@2@1453098@1454371@1@chr1:1453098-1454371@9.42@224@344@1.54@NA@ATAD3A-201_4, ATAD3A-201_5@8.5@8@9@:ATPase family, AAA domain containing 3A@:negative regulation of apoptotic process;mitochondrion;nucleoside-triphosphatase activity;mitochondrial inner membrane;cell growth;nucleotide binding;ATP binding;mitochondrial nucleoid;integral to membrane@NA
D170484@608@613@duplication@6@1643705@1654269@1@chr1:1643705-1654269@31@922@1343@1.46@CNVR17.1@CDC2L2-208_2, CDC2L2-208_3, CDC2L2-208_4, CDC2L2-208_5, CDC2L2-208_6, CDC2L2-208_7@22.5@19@25@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
D170484@2888@2892@deletion@5@16890515@16893847@1@chr1:16890515-16893847@11.3@237@133@0.561@CNVR93.3, CNVR93.6, CNVR93.11@NBPF1-201_25, NBPF1-201_26, NBPF1-201_27, NBPF1-201_28, NBPF1-201_29@74.6@66@79@NA@NA@NA
D170484@2971@2986@deletion@16@17081407@17086986@1@chr1:17081407-17086986@45@2498@1671@0.669@CNVR93.3, CNVR93.15, CNVR93.2, CNVR93.1@MST1P9-202_5, MST1P9-202_6, MST1P9-202_7, MST1P9-202_8, MST1P9-202_9, MST1P9-202_10, MST1P9-202_11, MST1P9-202_12, MST1P9-202_13, MST1P9-202_14, MST1P9-202_15, MST1P9-202_16, MST1P9-202_17, MST1P9-202_18, MST1P9-202_19, MST1P9-202_20@39.9375@30@56@:macrophage stimulating 1-like@:proteolysis;extracellular region;catalytic activity;serine-type endopeptidase activity@NA
D170484@3005@3019@deletion@15@17249160@17272901@1@chr1:17249160-17272901@27.9@1143@732@0.64@CNVR94.4, CNVR94.5@CROCC-201_2, CROCC-201_3, CROCC-201_4, CROCC-201_5, CROCC-201_6, CROCC-201_7, CROCC-201_8, CROCC-201_9, CROCC-201_10, CROCC-201_11, CROCC-201_12, CROCC-201_13, CROCC-201_14, CROCC-201_15, CROCC-201_16@77.8666666666667@67@85@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
D170484@3775@3775@duplication@1@21806546@21806717@1@chr1:21806546-21806717@5.98@31@75@2.42@CNVR107.2, CNVR107.1@NBPF3-003_15@91@91@91@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 3@:cytoplasm@NA
D170484@6813@6814@deletion@2@40229386@40229587@1@chr1:40229386-40229587@8.9@129@63@0.488@NA@PPIE-003_11, BMP8B-001_5@34@34@34@:peptidylprolyl isomerase E (cyclophilin E):bone morphogenetic protein 8b@:regulation of transcription, DNA-dependent;nucleotide binding;catalytic step 2 spliceosome;protein folding;protein binding;protein peptidyl-prolyl isomerization;peptidyl-prolyl cis-trans isomerase activity;cyclosporin A binding;RNA binding;mRNA splicing, via spliceosome;nucleus;nucleic acid binding:cell differentiation;growth factor activity;extracellular space;growth;extracellular region;cytokine activity;cartilage development;skeletal system development;ossification@NA
D170484@11245@11246@duplication@2@89476589@89477711@1@chr1:89476589-89477711@14@463@675@1.46@CNVR244.1@GBP3-001_7, GBP3-001_8@54@54@54@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
D170484@12416@12433@duplication@18@104202984@104257511@1@chr1:104202984-104257511@45.6@226@566@2.5@CNVR266.3, CNVR266.5@AMY1A-001_7, AMY1A-001_8, AMY1A-001_9, AMY1A-001_10, AMY1A-001_11, AMY1B-001_1, AMY1B-001_2, AMY1B-001_3, AMY1B-001_4, AMY1B-001_5, AMY1B-001_6, AMY1B-001_7, AMY1B-001_8, AMY1B-001_9, AMY1B-001_10, AMY1B-001_11, AMYP1-001_1, AMYP1-001_2@117.888888888889@107@154@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D170484@12929@12936@duplication@8@110230474@110236368@1@chr1:110230474-110236368@11.7@429@596@1.39@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1-001_1, GSTM1-001_2, GSTM1-001_3, GSTM1-001_4, GSTM1-001_5, GSTM1-001_6, GSTM1-001_7, GSTM1-001_8@191.375@187@194@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
D170484@15397@15448@duplication@52@149036437@149291744@1@chr1:149036437-149291744@79.9@1233@1996@1.62@CNVR350.3, CNVR350.1@RP11-744H18-001_1, RP11-744H18-001_2, RP11-744H18-001_3, RP11-744H18-001_4, RP11-744H18-001_5, RP11-744H18-001_6, RP11-744H18-001_7, RP11-744H18-001_8, RP11-744H18-001_9, RP11-744H18-001_10, RP11-744H18-001_11, RP11-744H18-001_12, RP11-744H18-001_13, RP11-744H18-001_14, RP11-744H18-001_15, RP11-744H18-001_16, ENST00000401087_1, ENST00000401087_2, ENST00000401087_3, ENST00000401087_4, ENST00000401087_5, ENST00000401087_6, ENST00000401087_7, ENST00000401087_8, ENST00000401087_9, ENST00000401087_10, ENST00000401087_11, ENST00000401087_12, ENST00000401087_13, ENST00000401087_14, ENST00000401087_15, ENST00000401087_16, RP11-403I13-201_1, RP11-403I13-201_2, RP11-403I13-201_3, RP11-403I13-001_1, RP11-403I13-001_2, ENST00000443018_1, ENST00000443018_2, RP11-403I13-002_1, RP11-403I13-002_2, RP11-403I13-002_3, RP11-403I13-002_4, RP11-403I13-002_5, RP11-403I13-002_6, RP11-403I13-002_7, ENST00000452637_1, ENST00000452637_2, ENST00000452637_3, ENST00000433084_1, ENST00000433084_2@67.8627450980392@20@87@NA@NA@NA
D170484@18672@18675@deletion@4@161559354@161562033@1@chr1:161559354-161562033@20.5@287@134@0.467@CNVR383.1@FCGR2C-006_3, FCGR2C-006_4, FCGR2C-006_5, FCGR2C-006_6@47.75@37@57@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
D170484@21359@21359@duplication@1@196712584@196712759@1@chr1:196712584-196712759@10.9@371@550@1.48@CNVR459.1@CFH-001_20@6@6@6@:complement factor H@:complement activation, alternative pathway;extracellular space;complement activation;extracellular region;regulation of complement activation;innate immune response@: HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1; MACULAR DEGENERATION, AGE-RELATED, 4; ARMD4; COMPLEMENT FACTOR H DEFICIENCY; CFHD; BASAL LAMINAR DRUSEN
D170484@21362@21371@duplication@10@196743977@196796136@1@chr1:196743977-196796136@49.4@865@1391@1.61@CNVR459.1@CFHR3-001_1, CFHR3-001_2, CFHR3-001_3, CFHR3-001_4, CFHR3-001_5, CFHR3-001_6, CFHR1-001_1, CFHR1-001_2, CFHR1-001_3, CFHR2-201_1@94.6@85@112@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
D170484@21373@21374@duplication@2@196799632@196801320@1@chr1:196799632-196801320@24.7@455@747@1.64@CNVR459.1@CFHR1-001_5, CFHR1-001_6@96.5@96@97@:complement factor H-related 1:complement factor H-related 2@:extracellular space;complement activation:extracellular region@NA
D170484@24160@24164@deletion@5@223727670@223729472@1@chr1:223727670-223729472@14.3@70@4@0.0571@NA@CAPN8-202_20, CAPN8-202_21, CAPN8-202_22, CAPN8-202_23, CAPN8-202_24@0@0@0@:calpain 8@:proteolysis;Golgi apparatus;intracellular;calcium-dependent cysteine-type endopeptidase activity;calcium ion binding@NA
D170484@33558@33564@duplication@7@87404273@87414366@2@chr2:87404273-87414366@11.9@381@540@1.42@CNVR861.2@AC083899-001_22, AC083899-001_23, AC083899-001_24, AC083899-001_25, AC083899-001_26, AC083899-001_27, AC083899-001_28@67@45@85@NA@NA@NA
D170484@34183@34184@duplication@2@96652501@96652955@2@chr2:96652501-96652955@11.8@196@323@1.65@NA@AC073995-001_2, AC073995-001_3@4@4@4@:ankyrin repeat domain-containing protein 36A-like@:ion channel inhibitor activity;protein binding@NA
D170484@34615@34631@deletion@17@98127603@98162325@2@chr2:98127603-98162325@31.5@174@21@0.121@CNVR888.3@ANKRD36B-001_23, ANKRD36B-001_24, ANKRD36B-001_25, ANKRD36B-001_26, ANKRD36B-001_27, ANKRD36B-001_28, ANKRD36B-001_29, ANKRD36B-001_30, ANKRD36B-001_31, ANKRD36B-001_32, ANKRD36B-001_33, ANKRD36B-001_34, ANKRD36B-001_35, ANKRD36B-001_36, ANKRD36B-001_37, ANKRD36B-001_38, ANKRD36B-001_39@130.058823529412@64@154@NA@NA@NA
D170484@37206@37207@deletion@2@130897466@130897670@2@chr2:130897466-130897670@5.91@95@49@0.516@NA@CCDC74B-001_6, CCDC74B-001_7@25.5@22@29@:coiled-coil domain containing 74A;coiled-coil domain containing 74B@NA@NA
D170484@37242@37242@deletion@1@130955933@130956035@2@chr2:130955933-130956035@5.84@26@0@0@CNVR985.1@TUBA3E-001_1@27@27@27@:tubulin, alpha 3e@:GTPase activity;structural constituent of cytoskeleton;protein complex;GTP catabolic process;cytoplasm;microtubule cytoskeleton;protein polymerization;microtubule-based movement;structural molecule activity;cytoplasmic microtubule;GTP binding;microtubule;microtubule cytoskeleton organization;protein domain specific binding@NA
D170484@37495@37497@duplication@3@132290439@132291240@2@chr2:132290439-132291240@6.32@251@348@1.39@NA@CCDC74A-201_6, CCDC74A-201_7, CCDC74A-201_8@4.66666666666667@4@5@:coiled-coil domain containing 74A@NA@NA
D170484@45374@45375@deletion@2@233245132@233245468@2@chr2:233245132-233245468@5.11@198@126@0.636@NA@ALPP-001_7, ALPP-001_8@15.5@12@19@:alkaline phosphatase, placental@:phosphatase activity;catalytic activity;integral to membrane;plasma membrane;metabolic process;cell surface;anchored to membrane;alkaline phosphatase activity;metal ion binding@NA
D170484@47662@47662@deletion@1@11925055@11925127@3@chr3:11925055-11925127@4.93@31@6@0.194@NA@AC090958-001_9@10@10@10@NA@NA@NA
D170484@61902@61904@deletion@3@197350985@197351069@3@chr3:197350985-197351069@6.43@110@58@0.527@CNVR1722.1@AC024560-005_3, AC024560-201_2, AC024560-201_3@22.6666666666667@22@23@NA@NA@NA
D170484@65315@65320@duplication@6@69402904@69434246@4@chr4:69402904-69434246@43.5@977@1544@1.58@CNVR1953.1@UGT2B17-001_1, UGT2B17-001_2, UGT2B17-001_3, UGT2B17-001_4, UGT2B17-001_5, UGT2B17-001_6@124.5@118@134@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
D170484@65799@65800@duplication@2@75312253@75314966@4@chr4:75312253-75314966@12.6@117@227@1.94@NA@AREG-001_2, AREG-001_3@28.5@28@29@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
D170484@65805@65807@deletion@3@75482008@75486007@4@chr4:75482008-75486007@22.5@120@12@0.1@NA@AREGB-201_2, AREGB-201_3, AREGB-201_4@50.3333333333333@45@56@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
D170484@68947@68947@deletion@1@145041645@145041742@4@chr4:145041645-145041742@10.3@106@40@0.377@NA@GYPA-205_2@8@8@8@:glycophorin B (MNS blood group):glycophorin A (MNS blood group)@:integral to membrane;plasma membrane;integral to plasma membrane:external side of plasma membrane;integral to membrane;cytoskeletal anchoring at plasma membrane;plasma membrane;molecular_function;protein homodimerization activity;integral to plasma membrane;cellular_component;identical protein binding;membrane;biological_process;regulation of response to osmotic stress;virus-host interaction@: BLOOD GROUP--Ss LOCUS; Ss: MALARIA, SUSCEPTIBILITY TO; BLOOD GROUP--MN LOCUS; MN
D170484@70821@70825@duplication@5@745300@756260@5@chr5:745300-756260@24.1@331@564@1.7@CNVR2280.3@ZDHHC11B-201_2, ZDHHC11B-201_3, ZDHHC11B-201_4, ZDHHC11B-201_5, ZDHHC11B-201_6@87.4@84@96@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
D170484@70838@70838@deletion@1@840612@840766@5@chr5:840612-840766@9.63@344@207@0.602@CNVR2280.3, CNVR2280.8@ZDHHC11-201_5@23@23@23@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
D170484@71604@71610@deletion@7@21483325@21497350@5@chr5:21483325-21497350@13.1@254@137@0.539@CNVR2395.4, CNVR2395.2@AC138951-201_4, AC138951-201_5, AC138951-201_6, AC138951-202_2, ENST00000412250_1, ENST00000366374_1, ENST00000366374_2@87.2857142857143@40@108@NA@NA@NA
D170484@73656@73656@duplication@1@68862418@68862453@5@chr5:68862418-68862453@9.01@40@106@2.65@CNVR2494.7, CNVR2494.46@GTF2H2C-201_5@12@12@12@:general transcription factor IIH, polypeptide 2C;general transcription factor IIH, polypeptide 2D@:regulation of transcription, DNA-dependent;nucleotide-excision repair;DNA repair;core TFIIH complex;protein binding;nucleus;transcription, DNA-dependent;zinc ion binding@NA
D170484@73727@73727@duplication@1@69717564@69717599@5@chr5:69717564-69717599@5.69@53@100@1.89@CNVR2494.17, CNVR2494.3@GTF2H2B-201_4@139@139@139@NA@NA@NA
D170484@73795@73796@duplication@2@70307104@70308746@5@chr5:70307104-70308746@11.1@567@783@1.38@CNVR2494.41, CNVR2494.14, CNVR2494.30, CNVR2494.20, CNVR2494.62, CNVR2494.8, CNVR2494.35@NAIP-001_4, NAIP-001_5@29.5@27@32@:baculoviral IAP repeat-containing protein 1-like;NLR family, apoptosis inhibitory protein@:negative regulation of apoptotic process;inflammatory response;basolateral plasma membrane;nucleoside-triphosphatase activity;cysteine-type endopeptidase inhibitor activity;intracellular;nucleotide binding;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;ATP binding;cytoplasm;innate immune response;protein binding;negative regulation of neuron apoptotic process;metal ion binding;nervous system development@NA
D170484@73817@73821@duplication@5@70370032@70389020@5@chr5:70370032-70389020@43.9@127@443@3.49@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.8, CNVR2494.1, CNVR2494.37@AC044797-201_1, AC044797-201_2, AC044797-201_3, AC044797-201_4, AC044797-201_5@120.4@100@138@NA@NA@NA
D170484@78044@78044@duplication@1@147553799@147553934@5@chr5:147553799-147553934@22.3@120@311@2.59@CNVR2637.2, CNVR2637.1@AC116334-001_3@78@78@78@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
D170484@79567@79568@deletion@2@175388056@175388438@5@chr5:175388056-175388438@11@74@17@0.23@NA@THOC3-001_4, THOC3-001_5@173.5@165@182@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
D170484@82488@82508@duplication@21@29855352@29895377@6@chr6:29855352-29895377@25.8@1178@1604@1.36@CNVR2829.7, CNVR2829.2, CNVR2829.3@HLA-H-001_1, HLA-H-001_2, HLA-H-001_3, HLA-H-001_4, HLA-H-001_5, HLA-H-001_6, HLA-H-001_7, HLA-16-001_1, HLA-16-001_2, HLA-16-001_3, HLA-16-001_4, AL645929-201_4, AL645929-201_5, AL645929-201_6, BAT1P1-001_1, BAT1P1-001_2, MCCD1P1-001_1, MCCD1P1-001_2, HLA-K-001_1, HLA-K-001_2, HLA-K-001_3@45.6190476190476@41@51@NA@NA@NA
D170484@82879@82880@deletion@2@30876813@30876951@6@chr6:30876813-30876951@6.06@128@72@0.562@NA@GTF2H4-002_2, VARS2-002_2@0@0@0@:general transcription factor IIH, polypeptide 4, 52kDa:valyl-tRNA synthetase 2, mitochondrial@:nucleoplasm;termination of RNA polymerase I transcription;nucleotide-excision repair, DNA damage removal;transcription from RNA polymerase I promoter;sequence-specific DNA binding transcription factor activity;ATP-dependent DNA helicase activity;DNA repair;RNA polymerase II carboxy-terminal domain kinase activity;DNA-dependent ATPase activity;nucleus;viral reproduction;gene expression;transcription initiation from RNA polymerase II promoter;7-methylguanosine mRNA capping;transcription initiation from RNA polymerase I promoter;transcription elongation from RNA polymerase I promoter;holo TFIIH complex;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;nucleotide-excision repair;transcription from RNA polymerase II promoter;protein binding;core TFIIH complex;transcription-coupled nucleotide-excision repair;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription:mitochondrion;aminoacyl-tRNA editing activity;nucleotide binding;tRNA aminoacylation for protein translation;valyl-tRNA aminoacylation;ATP binding;cytoplasm;valine-tRNA ligase activity;gene expression;aminoacyl-tRNA ligase activity@NA
D170484@83002@83004@duplication@3@31237745@31239109@6@chr6:31237745-31239109@16@459@676@1.47@CNVR2838.1@HLA-C-006_3, HLA-C-006_4, HLA-C-006_5@21@13@25@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
D170484@83026@83028@deletion@3@31379726@31383093@6@chr6:31379726-31383093@9.06@429@281@0.655@CNVR2842.1@MICA-001_6, MICA-001_7, MICA-001_8@1@1@1@:MHC class I polypeptide-related sequence A@:MHC class I protein complex;protein binding;regulation of immune response;antigen processing and presentation;immune response;plasma membrane;membrane@: PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO; PSORIASIS SUSCEPTIBILITY 1; PSORS1
D170484@83583@83585@duplication@3@31963734@31964378@6@chr6:31963734-31964378@8.19@218@319@1.46@CNVR2843.6, CNVR2843.3@C4A-001_26, C4A-001_27, C4A-001_28@16.3333333333333@16@17@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
D170484@83643@83645@deletion@3@31996472@31997116@6@chr6:31996472-31997116@8.73@193@110@0.57@CNVR2843.6, CNVR2843.5@C4B-001_26, C4B-001_27, C4B-001_28@17@15@19@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
D170484@83911@83915@deletion@5@32485122@32489952@6@chr6:32485122-32489952@22.1@152@37@0.243@CNVR2845.21, CNVR2845.25, CNVR2845.30@HLA-DRB5-001_2, HLA-DRB5-001_3, HLA-DRB5-001_4, HLA-DRB5-001_5, HLA-DRB5-001_6@184.2@177@189@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D170484@83917@83921@duplication@5@32520492@32522749@6@chr6:32520492-32522749@10.5@220@333@1.51@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.29@HLA-DRB6-002_3, HLA-DRB6-002_4, HLA-DRB6-002_5, HLA-DRB6-002_6, AL713966-201_3@130.6@114@144@NA@NA@NA
D170484@83932@83935@duplication@4@32605206@32610031@6@chr6:32605206-32610031@10.3@330@468@1.42@CNVR2845.21, CNVR2845.25, CNVR2845.37, CNVR2845.63, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20@HLA-DQA1-002_1, HLA-DQA1-002_2, HLA-DQA1-002_3, HLA-DQA1-002_4@117@83@141@:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D170484@83938@83940@deletion@3@32627246@32627875@6@chr6:32627246-32627875@6.66@61@22@0.361@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20, CNVR2845.31, CNVR2845.40@HLA-DQB1-003_6, XXbac-BPG254F23-001_1, ENST00000443574_2@127@127@127@:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
D170484@83944@83945@deletion@2@32630133@32632845@6@chr6:32630133-32632845@9.05@108@47@0.435@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20, CNVR2845.31, CNVR2845.64@HLA-DQB1-003_3, ENST00000443574_1@106.5@101@112@:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
D170484@84059@84062@deletion@4@33052729@33054977@6@chr6:33052729-33054977@21.3@503@290@0.577@CNVR2846.4, CNVR2846.3, CNVR2846.5@HLA-DPB1-201_3, HLA-DPB1-201_4, HLA-DPB1-201_5, HLA-DPB1-201_6@13.5@3@24@:major histocompatibility complex, class II, DP beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D170484@86709@86709@deletion@1@52712710@52712831@6@chr6:52712710-52712831@5.7@97@50@0.515@NA@ENST00000452866_6@1@1@1@NA@NA@NA
D170484@93077@93077@duplication@1@167595215@167596397@6@chr6:167595215-167596397@5.16@97@152@1.57@NA@AL121935-201_8@3@3@3@:t-complex 10;t-complex 10-like 2@NA@NA
D170484@93098@93101@deletion@4@167789456@167794825@6@chr6:167789456-167794825@9.29@252@153@0.607@NA@TCP10-001_3, TCP10-001_4, TCP10-001_5, TCP10-001_6@66@33@103@:t-complex 10@:cytosol@NA
D170484@94192@94192@deletion@1@5963468@5963594@7@chr7:5963468-5963594@4.9@210@134@0.638@NA@C7orf28A-001_14@73@73@73@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D170484@94211@94212@deletion@2@6005270@6006833@7@chr7:6005270-6006833@5.37@148@88@0.595@NA@RSPH10B-002_3, RSPH10B-002_4@10.5@8@13@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D170484@94420@94432@duplication@13@6797226@6821108@7@chr7:6797226-6821108@17.7@743@1030@1.39@NA@RSPH10B2-204_3, RSPH10B2-204_4, RSPH10B2-204_5, RSPH10B2-204_6, RSPH10B2-204_7, RSPH10B2-204_8, RSPH10B2-204_9, RSPH10B2-204_10, RSPH10B2-204_11, RSPH10B2-204_12, RSPH10B2-204_13, RSPH10B2-204_14, RSPH10B2-204_15@11.3076923076923@6@19@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D170484@96559@96559@duplication@1@38297482@38299832@7@chr7:38297482-38299832@5.07@51@94@1.84@CNVR3353.1@TRGC1-001_3@7@7@7@:TCR gamma alternate reading frame protein@:protein binding@NA
D170484@97902@97923@deletion@22@57008632@57129009@7@chr7:57008632-57129009@25.7@217@72@0.332@NA@RP11-220H4-001_1, RP11-220H4-001_2, RP11-220H4-001_3, TNRC18C-202_1, TNRC18C-202_2, TNRC18C-202_3, TNRC18C-202_4, TNRC18C-202_5, TNRC18C-202_6, TNRC18C-202_7, TNRC18C-202_8, TNRC18C-202_9, TNRC18C-202_10, TNRC18C-202_11, ENST00000398760_1, ENST00000398760_2, ENST00000398760_3, ENST00000398760_4, ENST00000398760_5, RP11-220H4-201_1, RP11-220H4-201_2, RP11-220H4-201_3@90.0909090909091@15@166@NA@NA@NA
D170484@97990@97994@deletion@5@62753052@62758771@7@chr7:62753052-62758771@126@614@10@0.0163@NA@AC006455-201_2, AC006455-201_3, AC006455-201_4, ENST00000444809_2, ENST00000444809_3, ENST00000444809_4@137@97@171@NA@NA@NA
D170484@98014@98026@duplication@13@62904582@62970547@7@chr7:62904582-62970547@38.5@524@920@1.76@NA@ZNF734-201_1, ZNF734-201_2, ZNF734-201_3, ZNF734-201_4, ZNF734-201_5, ZNF734-201_6, ZNF734-201_7, ZNF734-201_8, ENST00000434048_1, ENST00000434048_2, CTD-2526L21-201_1, CTD-2526L21-201_2, CTD-2526L21-201_3@75.3846153846154@1@102@NA@NA@NA
D170484@99035@99035@duplication@1@74172294@74172334@7@chr7:74172294-74172334@7.93@60@124@2.07@NA@GTF2I-001_33@25@25@25@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
D170484@99454@99454@duplication@1@76063357@76063473@7@chr7:76063357-76063473@8.7@82@158@1.93@CNVR3462.1@ZP3-002_6@10@10@10@:zona pellucida glycoprotein 3 (sperm receptor)@:negative regulation of transcription, DNA-dependent;manganese ion transmembrane transporter activity;intracellular protein transport;proteinaceous extracellular matrix;plasma membrane;positive regulation of acrosome reaction;outer acrosomal membrane;protein kinase C signaling cascade;manganese ion transmembrane transport;intracellular signal transduction;humoral immune response mediated by circulating immunoglobulin;negative regulation of binding of sperm to zona pellucida;positive regulation of inflammatory response;endoplasmic reticulum;signal transducer activity;perinuclear region of cytoplasm;secretory granule;positive regulation of transcription, DNA-dependent;positive regulation of ovarian follicle development;positive regulation of interferon-gamma production;carbohydrate binding;manganese ion transport;positive regulation of antral ovarian follicle growth;extracellular matrix;positive regulation of leukocyte migration;positive regulation of humoral immune response;extracellular space;blastocyst formation;integral to membrane;store-operated calcium channel activity;oocyte development;multivesicular body;phosphatidylinositol-mediated signaling;acrosomal vesicle;positive regulation of protein kinase B signaling cascade;Golgi apparatus;positive regulation of calcium ion import;positive regulation of protein kinase activity;positive regulation of acrosomal vesicle exocytosis;positive regulation of interleukin-4 production;cytoplasm;protein binding;binding of sperm to zona pellucida;positive regulation of phosphatidylinositol biosynthetic process;extracellular region;positive regulation of T cell proliferation;acrosin binding;positive regulation of type IV hypersensitivity;egg coat formation@NA
D170484@99489@99490@duplication@2@76240773@76241131@7@chr7:76240773-76241131@13.3@217@354@1.63@CNVR3463.10@POMZP3-003_6, POMZP3-003_7@43.5@41@46@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
D170484@99506@99507@deletion@2@76619588@76629706@7@chr7:76619588-76629706@7.43@90@40@0.444@CNVR3463.10@PMS2L11-203_2, PMS2L11-203_3@8.5@7@10@:uroplakin 3B@:negative regulation of gene expression;integral to membrane;plasma membrane@NA
D170484@101723@101726@deletion@4@100334108@100336237@7@chr7:100334108-100336237@8.92@474@313@0.66@CNVR3509.1@ZAN-001_4, ZAN-001_5, ZAN-001_6, ZAN-001_7@82@71@89@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
D170484@102078@102080@deletion@3@102020914@102021081@7@chr7:102020914-102021081@19.5@608@365@0.6@NA@CTA-313A17-201_2, RP11-163E9-003_5, RP11-163E9-001_3@3@3@3@:PRKR interacting protein 1 (IL11 inducible);LOC100289561-PRKRIP1 readthrough@:double-stranded RNA binding;protein binding;protein kinase inhibitor activity;negative regulation of protein kinase activity;protein kinase binding;nucleolus;negative regulation of phosphorylation@NA
D170484@102144@102145@deletion@2@102180464@102180539@7@chr7:102180464-102180539@16.2@149@52@0.349@CNVR3518.1@RASA4B-007_4, POLR2J3-003_7@96@96@96@:RAS p21 protein activator 4B:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
D170484@102177@102210@deletion@34@102235754@102319304@7@chr7:102235754-102319304@46.8@613@273@0.445@CNVR3518.1@RASA4-001_1, RASA4-001_2, RASA4-001_3, RASA4-001_4, RASA4-001_5, RASA4-001_6, RASA4-001_7, RASA4-001_8, RASA4-001_9, RASA4-001_10, RASA4-001_11, ENST00000340457_1, ENST00000340457_2, ENST00000340457_3, ENST00000340457_4, ENST00000340457_5, ENST00000340457_6, POLR2J2-001_1, POLR2J2-001_2, POLR2J2-001_3, POLR2J2-001_4, POLR2J2-001_5, POLR2J2-001_6, POLR2J2-001_7, POLR2J2-001_8, POLR2J2-001_9, RP11-577H5-001_1, RP11-577H5-001_2, RP11-577H5-001_3, RP11-577H5-001_4, RP11-577H5-001_5, RP11-577H5-001_6, ENST00000379355_1, ENST00000379355_2@59.9117647058824@42@140@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2:WBSCR19-like protein 3;speedy homolog E6 (Xenopus laevis)@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
D170484@104579@104579@duplication@1@134221805@134221910@7@chr7:134221805-134221910@5.84@89@147@1.65@NA@AKR1B10-001_6@2@2@2@:aldo-keto reductase family 1, member B10 (aldose reductase)@:steroid metabolic process;cellular aldehyde metabolic process;indanol dehydrogenase activity;daunorubicin metabolic process;retinal dehydrogenase activity;farnesol catabolic process;geranylgeranyl reductase activity;protein binding;extracellular region;aldo-keto reductase (NADP) activity;digestion;doxorubicin metabolic process;cellular_component;lysosome@NA
D170484@105324@105330@deletion@7@141768449@141778809@7@chr7:141768449-141778809@10.2@926@645@0.697@CNVR3585.3, CNVR3585.2@MGAM-007_43, MGAM-007_44, MGAM-007_45, MGAM-007_46, MGAM-007_47, MGAM-007_48, MGAM-007_49@120.571428571429@116@123@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
D170484@105337@105343@deletion@7@141786020@141794455@7@chr7:141786020-141794455@17.6@424@251@0.592@CNVR3585.3, CNVR3585.2@MGAM-007_56, MGAM-007_57, MGAM-007_58, MGAM-007_59, MGAM-007_60, MGAM-007_61, MGAM-007_62@82@5@134@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
D170484@105521@105523@duplication@3@142481247@142482417@7@chr7:142481247-142482417@32@399@715@1.79@NA@PRSS1-204_4, PRSS1-204_5, PRSS1-204_6@114.333333333333@113@115@NA@NA@NA
D170484@107428@107429@deletion@2@7308087@7308722@8@chr8:7308087-7308722@62.1@421@78@0.185@CNVR3771.8, CNVR3771.10, CNVR3771.4@SPAG11-003_3, SPAG11-003_4@90.5@90@91@:sperm associated antigen 11B@:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response@NA
D170484@107437@107439@duplication@3@7345660@7353526@8@chr8:7345660-7353526@6.13@8@46@5.75@CNVR3771.8, CNVR3771.10, CNVR3771.4, CNVR3771.6@DEFB105B-001_2, DEFB105B-001_3, DEFB107B-001_1@2.33333333333333@1@4@:defensin, beta 105B;defensin, beta 105A:defensin, beta 107B;defensin, beta 107A@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
D170484@107504@107504@deletion@1@7680906@7680946@8@chr8:7680906-7680946@4.81@189@119@0.63@CNVR3772.4, CNVR3772.6, CNVR3772.2, CNVR3772.8, CNVR3772.10@DEFB105A-001_2@40@40@40@:defensin, beta 105B;defensin, beta 105A@:extracellular region;defense response to bacterium@NA
D170484@107512@107513@duplication@2@7717871@7718505@8@chr8:7717871-7718505@35.4@255@570@2.24@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@SPAG11A-207_3, SPAG11A-207_4@112@111@113@:sperm associated antigen 11A;sperm associated antigen 11B@:extracellular region;defense response@NA
D170484@109572@109585@deletion@14@39311571@39349528@8@chr8:39311571-39349528@79.7@367@2@0.00545@CNVR3859.1@ADAM3A-005_11, ADAM3A-005_12, ADAM3A-005_13, ADAM3A-005_14, ADAM3A-005_15, ADAM3A-005_16, ADAM3A-005_17, ADAM3A-005_18, ADAM3A-005_19, ADAM3A-005_20, ADAM3A-005_21, ADAM3A-009_7, ADAM3A-009_8, ADAM3A-009_9@120.5@98@136@NA@NA@NA
D170484@117587@117602@deletion@16@43313716@43818185@9@chr9:43313716-43818185@33.4@584@308@0.527@NA@BX649597-201_1, BX649597-201_3, RP11-186G6-001_1, RP11-186G6-001_2, FAM75A6-201_1, FAM75A6-201_2, FAM75A6-201_3, FAM75A6-201_4, CNTNAP3B-001_1, CNTNAP3B-001_2, CNTNAP3B-001_3, CNTNAP3B-001_4, CNTNAP3B-001_5, CNTNAP3B-001_6, CNTNAP3B-001_7@89.8@52@132@:SPATA31 subfamily A, member 6:contactin associated protein-like 3B;contactin associated protein-like 3@:integral to membrane:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
D170484@117972@117982@deletion@11@69084844@69120919@9@chr9:69084844-69120919@14.3@398@237@0.595@NA@RP11-87H9-001_5, ENST00000412376_1, ENST00000412376_2, ENST00000412376_3, ENST00000412376_4, ENST00000412376_5, ENST00000412376_6, ENST00000426020_3, ENST00000426020_4, ENST00000426020_5, ENST00000426020_6@16.7272727272727@10@29@NA@NA@NA
D170484@118852@118854@deletion@3@84545017@84549914@9@chr9:84545017-84549914@7.28@367@237@0.646@CNVR4364.1@ENST00000427387_1, RP11-383M4-201_3, RP11-383M4-201_4@16.3333333333333@11@27@NA@NA@NA
D170484@126906@126909@deletion@4@17813310@17842868@10@chr10:17813310-17842868@10.6@58@7@0.121@NA@FAM23A-201_2, FAM23A-201_3, FAM23A-201_4, FAM23A-201_5@39.5@15@108@:transmembrane protein 236;transmembrane protein 236-like@:integral to membrane@NA
D170484@126916@126916@duplication@1@17891585@17891769@10@chr10:17891585-17891769@7.29@263@379@1.44@NA@MRC1L1-001_7@7@7@7@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
D170484@126950@126951@deletion@2@18134220@18138694@10@chr10:18134220-18138694@13@64@3@0.0469@NA@MRC1-001_6, MRC1-001_7@21@16@26@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D170484@126956@126956@duplication@1@18152465@18152612@10@chr10:18152465-18152612@8.99@13@71@5.46@NA@MRC1-001_11@20@20@20@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D170484@128921@128922@deletion@2@47620120@47620208@10@chr10:47620120-47620208@6.84@107@54@0.505@CNVR4713.1@ENST00000423803_13, ENST00000454837_4@22@22@22@NA@NA@NA
D170484@128979@128979@deletion@1@47758848@47758905@10@chr10:47758848-47758905@5.63@25@0@0@CNVR4714.1@ANXA8L2-001_10@154@154@154@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:calcium-dependent phospholipid binding;calcium ion binding@NA
D170484@129022@129030@duplication@9@48025302@48055019@10@chr10:48025302-48055019@13.7@450@637@1.42@CNVR4715.2@ASAH2C-201_1, ASAH2C-201_2, ASAH2C-201_3, ASAH2C-201_4, ASAH2C-201_5, ASAH2C-201_6, ASAH2C-201_7, ASAH2C-201_8, ASAH2C-201_9@65.1111111111111@50@90@@:ceramidase activity;sphingolipid metabolic process@NA
D170484@129460@129461@deletion@2@51361725@51361911@10@chr10:51361725-51361911@5.64@25@0@0@NA@ENST00000404618_4, ENST00000432221_4@122@121@123@NA@NA@NA
D170484@129605@129611@deletion@7@51970585@51994313@10@chr10:51970585-51994313@18.3@188@77@0.41@NA@ASAH2-201_5, ASAH2-201_6, ASAH2-201_7, ASAH2-201_8, ASAH2-201_9, ASAH2-201_10, ASAH2-201_11@145.142857142857@53@186@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
D170484@137395@137395@deletion@1@1264660@1266164@11@chr11:1264660-1266164@5.87@99@51@0.515@CNVR5008.1@MUC5B-203_48@2@2@2@:mucin 5B, oligomeric mucus/gel-forming@:extracellular matrix structural constituent;protein binding;O-glycan processing;extracellular region;cellular protein metabolic process;cell adhesion;Golgi lumen;post-translational protein modification@: PULMONARY FIBROSIS, IDIOPATHIC; IPF
D170484@138032@138033@duplication@2@5270600@5271118@11@chr11:5270600-5271118@6.11@40@87@2.17@NA@HBG1-201_1, HBG1-201_2@94.5@83@106@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
D170484@139526@139527@duplication@2@18813074@18956211@11@chr11:18813074-18956211@46.3@850@1757@2.07@NA@PTPN5-201_1, MRGPRX1-203_3@9.5@3@16@:protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched):MAS-related GPR, member X1@:phosphatase activity;protein tyrosine phosphatase activity;protein dephosphorylation;integral to membrane;phosphotyrosine binding;dephosphorylation;endoplasmic reticulum membrane;peptidyl-tyrosine dephosphorylation:integral to membrane;G-protein coupled receptor activity;plasma membrane;acute-phase response;G-protein coupled receptor signaling pathway@NA
D170484@141187@141188@deletion@2@48600990@48601883@11@chr11:48600990-48601883@7.22@32@0@0@CNVR5165.1@AC134982-201_1, AC134982-201_2@128@128@128@NA@NA@NA
D170484@145897@145897@duplication@1@89530825@89531798@11@chr11:89530825-89531798@11.7@336@511@1.52@NA@TRIM49-201_8@51@51@51@:tripartite motif containing 49@:protein binding;intracellular;DNA binding;zinc ion binding@NA
D170484@150829@150841@deletion@13@9684189@9707352@12@chr12:9684189-9707352@93.5@461@23@0.0499@CNVR5429.1@AC006432-201_1, AC006432-201_2, AC006432-201_3, AC006432-201_4, AC006432-201_5, AC006432-201_6, AC006432-201_7, AC006432-201_8, AC006432-201_9, AC006432-201_10, AC006432-201_11, AC006432-201_12, AC006432-201_13@22.2307692307692@15@25@NA@NA@NA
D170484@150968@150973@duplication@6@10583212@10588593@12@chr12:10583212-10588593@15.9@649@898@1.38@CNVR5430.1@KLRC2-201_1, KLRC2-201_2, KLRC2-201_3, KLRC2-201_4, KLRC2-201_5, KLRC2-201_6@54.8333333333333@38@67@:killer cell lectin-like receptor subfamily C, member 2@:carbohydrate binding:transmembrane signaling receptor activity;carbohydrate binding;protein binding;signal transduction;cellular defense response;integral to plasma membrane@NA
D170484@151034@151034@duplication@1@11244393@11244793@12@chr12:11244393-11244793@12.3@355@542@1.53@CNVR5434.1@TAS2R31-201_2@72@72@72@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
D170484@158322@158325@deletion@4@105352370@105371806@12@chr12:105352370-105371806@23@458@240@0.524@NA@SLC41A2-001_1, AC090051-201_1, AC090051-201_2, AC090051-201_3@16.5@0@22@:solute carrier family 41, member 2@:cation transmembrane transporter activity;integral to membrane;cation transport;plasma membrane;transmembrane transport@NA
D170484@162131@162131@deletion@1@24468280@24468341@13@chr13:24468280-24468341@13.1@161@67@0.416@NA@RP11-45B20-002_4@36@36@36@:C1q and tumor necrosis factor related protein 9B@:collagen;protein binding@NA
D170484@162163@162164@duplication@2@24892958@24893019@13@chr13:24892958-24893019@23.2@626@960@1.53@NA@SPATA13-009_12, C1QTNF9-003_4@8.5@6@11@:spermatogenesis associated 13:C1q and tumor necrosis factor related protein 9@:lamellipodium assembly;phospholipid binding;Rac guanyl-nucleotide exchange factor activity;guanyl-nucleotide exchange factor activity;ruffle membrane;nucleus;regulation of cell migration;cell migration;regulation of Rho protein signal transduction;intracellular;Rho guanyl-nucleotide exchange factor activity;cytoplasm;filopodium assembly;filopodium;protein binding;lamellipodium:collagen;protein binding;hormone activity@NA
D170484@162314@162316@duplication@3@25528913@25535993@13@chr13:25528913-25535993@6.05@105@166@1.58@NA@TPTE2P1-001_3, TPTE2P1-001_4, TPTE2P1-001_5@0.666666666666667@0@2@NA@NA@NA
D170484@172497@172498@deletion@2@99182456@99184098@14@chr14:99182456-99184098@22.9@390@190@0.487@NA@C14orf177-201_3, C14orf177-201_4@0@0@0@:chromosome 14 open reading frame 177@NA@NA
D170484@173500@173503@duplication@4@106471638@106478604@14@chr14:106471638-106478604@24.4@243@454@1.87@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV3-6-210_6, IGHV1-3-001_1, IGHV4-4-001_1, IGHV4-4-001_2@10.75@4@17@@:protein binding:protein binding@NA
D170484@173556@173560@deletion@5@106787370@106800618@14@chr14:106787370-106800618@23.4@628@347@0.553@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-29-001_1, IGHV3-29-001_2, IGHV3-30-001_1, IGHV3-30-001_2, IGHV3-30-2-001_2@15.4@13@19@@:protein binding@NA
D170484@173635@173638@duplication@4@107095128@107099589@14@chr14:107095128-107099589@22@361@584@1.62@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61-001_1, IGHV4-61-001_2, IGHV3-62-001_1, IGHV3-62-001_2@16@15@17@@:protein binding@NA
D170484@173645@173645@duplication@1@107131035@107131335@14@chr14:107131035-107131335@7.67@222@329@1.48@CNVR6294.56, CNVR6294.16@IGHV3-66-001_2@3@3@3@@:protein binding@NA
D170484@173685@173694@duplication@10@20450159@20468164@15@chr15:20450159-20468164@22.4@2441@3153@1.29@CNVR6295.15, CNVR6295.7, CNVR6295.13, CNVR6295.26@ENST00000400226_3, ENST00000400226_4, ENST00000400226_5, ENST00000400226_6, ENST00000400226_7, ENST00000400226_8, ENST00000400226_9, ENST00000400226_10, ENST00000400226_11, ENST00000400226_12@61.2@20@80@NA@NA@NA
D170484@173696@173698@duplication@3@20481991@20588710@15@chr15:20481991-20588710@28.7@817@1231@1.51@CNVR6295.15, CNVR6295.7, CNVR6295.26@ENST00000400226_1, HERC2P3-014_27, AC026495-201_26@69.6666666666667@63@77@NA@NA@NA
D170484@173814@173820@duplication@7@22297500@22466378@15@chr15:22297500-22466378@19.5@1721@2296@1.33@CNVR6297.4, CNVR6297.17@AC134980-201_1, AC134980-201_2, ENST00000438898_1, ENST00000438898_2, AC025884-201_1, AC010760-202_2@70.5@32@87@:olfactory receptor, family 4, subfamily M, member 2:olfactory receptor, family 4, subfamily N, member 4@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
D170484@174406@174409@duplication@4@29008591@29009049@15@chr15:29008591-29009049@6.7@324@438@1.35@NA@ENST00000456510_2, ENST00000456510_3, ENST00000456510_4, ENST00000456510_5@23.5@18@26@NA@NA@NA
D170484@174966@174970@deletion@5@34781208@34782684@15@chr15:34781208-34782684@19.3@953@614@0.644@CNVR6351.3@AC027139-201_1, AC027139-201_2, AC027139-201_3, AC027139-201_4, AC027139-201_5@44.2@40@46@:golgin A8 family, member A@:Golgi cisterna membrane;Golgi apparatus@NA
D170484@181790@181791@deletion@2@100341182@100345135@15@chr15:100341182-100345135@13.6@214@109@0.509@CNVR6545.2@C15orf51-202_2, C15orf51-202_3@11@11@11@NA@NA@NA
D170484@185292@185293@deletion@2@20451124@20452659@16@chr16:20451124-20452659@7.76@140@74@0.529@NA@ACSM5-001_13, ACSM5-001_14@3@3@3@:acyl-CoA synthetase medium-chain family member 5@:butyrate-CoA ligase activity;catalytic activity;ATP binding;fatty acid metabolic process;GTP binding;metabolic process;mitochondrial matrix;metal ion binding@NA
D170484@185592@185595@deletion@4@21763692@21772051@16@chr16:21763692-21772051@12.7@148@64@0.432@CNVR6668.5, CNVR6668.2, CNVR6668.7@OTOA-001_25, OTOA-001_26, OTOA-001_27, OTOA-001_28@39@15@62@:otoancorin@:proteinaceous extracellular matrix;apical plasma membrane;sensory perception of sound;anchored to membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22
D170484@187526@187533@deletion@8@32929000@32945317@16@chr16:32929000-32945317@9.48@155@81@0.523@CNVR6702.1@ENST00000423205_3, ENST00000423205_4, ENST00000423205_5, ENST00000423205_6, ENST00000423205_7, ENST00000423205_8, ENST00000423205_9, ENST00000423205_10@19.5@14@34@NA@NA@NA
D170484@187546@187548@deletion@3@33629704@33630421@16@chr16:33629704-33630421@6.69@926@660@0.713@CNVR6703.17, CNVR6703.1, CNVR6703.6, CNVR6703.21@AC136428-201_1, AC136428-201_2, AC136428-201_3@22.3333333333333@18@29@NA@NA@NA
D170484@188228@188237@duplication@10@55794462@55817652@16@chr16:55794462-55817652@41.7@466@829@1.78@CNVR6730.1@CES4-202_1, CES4-202_2, CES4-202_3, CES4-202_4, CES4-202_5, CES4-202_6, CES4-202_7, CES4-202_8, CES4-202_9, AC147362-203_1@99.3@8@123@NA@NA@NA
D170484@188258@188261@deletion@4@55857464@55867076@16@chr16:55857464-55867076@26.2@810@494@0.61@CNVR6731.1@CES1-203_1, CES1-203_2, CES1-203_3, CES1-203_4@16.5@10@23@:carboxylesterase 1;liver carboxylesterase 1-like@:hydrolase activity;methyl salicylate esterase activity;response to toxin;methylumbelliferyl-acetate deacetylase activity;endoplasmic reticulum lumen;retinyl-palmitate esterase activity;methyl jasmonate esterase activity;metabolic process;carboxylesterase activity;methyl indole-3-acetate esterase activity@: CARBOXYLESTERASE 1; CES1
D170484@189920@189928@duplication@9@69988239@69996971@16@chr16:69988239-69996971@7.63@84@149@1.77@CNVR6762.3, CNVR6762.1, CNVR6762.4@CLEC18A-202_4, CLEC18A-202_5, CLEC18A-202_6, CLEC18A-202_7, CLEC18A-202_8, CLEC18A-202_9, CLEC18A-202_10, CLEC18A-202_11, CLEC18A-202_12@14.4444444444444@13@25@:C-type lectin domain family 18, member A@:carbohydrate binding;protein binding;extracellular region@NA
D170484@189967@189970@duplication@4@70176458@70180132@16@chr16:70176458-70180132@18.7@806@1138@1.41@CNVR6764.1, CNVR6764.3@AC009060-202_13, AC009060-202_14, AC009060-202_15, AC009060-202_16@72.5@66@76@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
D170484@190518@190518@deletion@1@74368792@74368885@16@chr16:74368792-74368885@8.65@325@199@0.612@CNVR6778.2, CNVR6778.1@AC009053-202_14@16@16@16@NA@NA@NA
D170484@192798@192799@deletion@2@4439373@4439722@17@chr17:4439373-4439722@5.69@237@154@0.65@NA@SPNS2-201_10, SPNS2-201_11@1@1@1@:spinster homolog 2 (Drosophila)@:integral to membrane;transmembrane transporter activity;lipid transport;transmembrane transport@NA
D170484@195712@195720@duplication@9@18389250@18397792@17@chr17:18389250-18397792@15.1@353@528@1.5@CNVR7014.1@LGALS9C-201_3, LGALS9C-201_4, LGALS9C-201_5, LGALS9C-201_6, LGALS9C-201_7, LGALS9C-201_8, LGALS9C-201_9, LGALS9C-201_10, LGALS9C-201_11@134.333333333333@125@140@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
D170484@195737@195747@duplication@11@18441119@18457581@17@chr17:18441119-18457581@17.6@634@883@1.39@NA@AC107983-001_1, CCDC144B-201_14, CCDC144B-201_15, CCDC144B-201_16, CCDC144B-201_17, CCDC144B-201_18, ENST00000447265_11, ENST00000447265_12, ENST00000447265_13, ENST00000447265_14, ENST00000447265_15@130.181818181818@126@133@NA@NA@NA
D170484@196147@196154@deletion@8@20348266@20356381@17@chr17:20348266-20356381@37.3@199@20@0.101@CNVR7021.1, CNVR7021.3@ENST00000458685_5, ENST00000411468_5, ENST00000411468_6, LGALS9B-201_7, LGALS9B-201_8, LGALS9B-201_9, LGALS9B-201_10, LGALS9B-201_11@68.875@27@103@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
D170484@197726@197728@deletion@3@34539180@34539966@17@chr17:34539180-34539966@13.2@60@0@0@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1-202_2, CCL4L1-202_3, CCL4L1-202_4@118@113@122@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
D170484@198032@198035@duplication@4@36351805@36357273@17@chr17:36351805-36357273@12.1@1798@2313@1.29@CNVR7083.3@AC183087-202_11, AC183087-202_12, AC183087-202_13, AC183087-202_14@59.75@58@64@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
D170484@198043@198043@duplication@1@36398220@36398303@17@chr17:36398220-36398303@4.89@205@287@1.4@CNVR7083.3, CNVR7083.7@AC183087-202_3@29@29@29@:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
D170484@200337@200345@deletion@9@44399690@44415161@17@chr17:44399690-44415161@17.2@123@33@0.268@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A-001_7, LRRC37A-001_8, LRRC37A-001_9, LRRC37A-001_10, LRRC37A-001_11, LRRC37A-001_12, LRRC37A-001_13, LRRC37A-001_14, LRRC37A-001_15@153.666666666667@114@196@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
D170484@201839@201840@duplication@2@57656835@57657241@17@chr17:57656835-57657241@9.82@105@193@1.84@NA@DHX40-203_12, DHX40-203_13@7.5@3@12@:DEAH (Asp-Glu-Ala-His) box polypeptide 40@:transport;helicase activity;intracellular;ATP-dependent helicase activity;nucleic acid binding;ATP binding@NA
D170484@202979@202980@deletion@2@66264340@66265040@17@chr17:66264340-66265040@6.3@224@140@0.625@NA@AMZ2-204_8, SLC16A6-202_8@1@1@1@:arylsulfatase G:solute carrier family 16, member 6 (monocarboxylic acid transporter 7)@:arylsulfatase activity;phospholipid metabolic process;sulfur compound metabolic process;small molecule metabolic process;endoplasmic reticulum;catalytic activity;endoplasmic reticulum lumen;post-translational protein modification;sphingolipid metabolic process;extracellular space;cellular protein metabolic process;sulfuric ester hydrolase activity;glycosphingolipid metabolic process;metabolic process;metal ion binding;lysosome:monocarboxylic acid transmembrane transporter activity;integral to membrane;monocarboxylic acid transport;symporter activity;integral to plasma membrane;membrane;transmembrane transport@NA
D170484@213493@213494@deletion@2@14508472@14508748@19@chr19:14508472-14508748@9.36@82@28@0.341@NA@CD97-205_8, CD97-205_9@10.5@7@14@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
D170484@215259@215260@deletion@2@22939009@22939581@19@chr19:22939009-22939581@8.73@315@196@0.622@NA@ZNF99-201_7, ZNF99-201_8@6.5@6@7@:zinc finger protein 99@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
D170484@217293@217297@deletion@5@40373947@40382827@19@chr19:40373947-40382827@29.8@293@109@0.372@CNVR7639.2@FCGBP-201_22, FCGBP-201_23, FCGBP-201_24, FCGBP-201_25, FCGBP-201_26@130.8@105@155@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D170484@217301@217305@duplication@5@40389654@40398511@19@chr19:40389654-40398511@6.71@325@438@1.35@CNVR7639.2, CNVR7639.3@FCGBP-201_14, FCGBP-201_15, FCGBP-201_16, FCGBP-201_17, FCGBP-201_18@113.6@103@127@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D170484@217595@217595@deletion@1@41327389@41327534@19@chr19:41327389-41327534@9.86@65@14@0.215@NA@CYP2F1P-001_5@0@0@0@NA@NA@NA
D170484@218131@218156@deletion@26@43348413@43540113@19@chr19:43348413-43540113@179@3461@1813@0.524@CNVR7658.2@PSG1-202_3, PSG1-202_4, PSG1-202_5, PSG1-202_6, PSG1-202_7, PSG6-001_1, PSG6-001_2, PSG6-001_3, PSG6-001_4, PSG6-001_5, PSG6-001_6, PSG7-001_1, PSG7-001_2, PSG7-001_3, PSG7-001_4, PSG7-001_5, PSG7-001_6, CEACAMP7-001_1, CEACAMP7-001_2, PSG11-001_1, PSG11-001_2, PSG11-001_3, PSG11-001_4, PSG11-001_5, PSG11-001_6, CEACAMP8-001_3@12.8076923076923@12@17@:pregnancy specific beta-1-glycoprotein 8:pregnancy specific beta-1-glycoprotein 1:pregnancy specific beta-1-glycoprotein 6:pregnancy specific beta-1-glycoprotein 7 (gene/pseudogene):pregnancy specific beta-1-glycoprotein 11@:protein binding;extracellular region:protein binding;extracellular region;female pregnancy:protein binding;extracellular region;female pregnancy;molecular_function:protein binding;extracellular region;female pregnancy@NA
D170484@220942@220943@deletion@2@53785379@53786171@19@chr19:53785379-53786171@16.5@160@58@0.362@NA@AC092070-202_2, AC092070-202_3@0.5@0@1@NA@NA@NA
D170484@221166@221171@duplication@6@54724400@54726912@19@chr19:54724400-54726912@29.3@331@596@1.8@CNVR7721.3, CNVR7721.4@LILRB3-008_1, LILRB3-008_2, LILRB3-008_3, LILRB3-008_4, LILRB3-008_5, LILRB3-008_6@113.833333333333@98@136@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D170484@221178@221181@deletion@4@54744152@54746187@19@chr19:54744152-54746187@26@855@509@0.595@CNVR7721.3, CNVR7721.6@LILRA6-002_3, LILRA6-002_4, LILRA6-002_5, LILRA6-002_6@58@50@66@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D170484@221416@221417@duplication@2@55294940@55295318@19@chr19:55294940-55295318@6.16@571@748@1.31@CNVR7725.2, CNVR7725.1@KIR2DL1-002_8, KIR2DL1-002_9@39.5@38@41@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
D170484@221435@221438@duplication@4@55346536@55354374@19@chr19:55346536-55354374@13.3@333@494@1.48@CNVR7725.1, CNVR7725.6@KIR2DS4-001_2, KIR2DS4-001_3, KIR2DS4-001_4, KIR2DS4-001_5@57.75@41@68@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
D170484@221447@221448@duplication@2@55370536@55370585@19@chr19:55370536-55370585@6.42@190@274@1.44@CNVR7725.1, CNVR7725.6, CNVR7725.5@KIR3DL1-201_6, KIR3DL2-001_6@2@2@2@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
D170484@221819@221820@duplication@2@56270382@56273453@19@chr19:56270382-56273453@6.93@166@247@1.49@CNVR7734.1@RFPL4A-201_1, RFPL4A-201_2@32.5@26@39@:ret finger protein-like 4A;ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
D170484@222075@222075@deletion@1@58016027@58016155@19@chr19:58016027-58016155@5.09@113@64@0.566@NA@ZNF773-202_2@3@3@3@:zinc finger protein 773@:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
D170484@222562@222563@duplication@2@1558986@1569279@20@chr20:1558986-1569279@12.5@335@496@1.48@CNVR7763.1@SIRPB1-201_1, SIRPB1-201_2@90.5@53@128@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
D170484@232770@232788@duplication@19@20385114@20475157@22@chr22:20385114-20475157@15.5@189@321@1.7@CNVR8094.4, CNVR8094.7@PI4KAP1-204_1, PI4KAP1-204_2, PI4KAP1-204_3, PI4KAP1-204_4, PI4KAP1-204_5, PI4KAP1-204_6, PI4KAP1-204_7, PI4KAP1-204_8, PI4KAP1-204_9, PI4KAP1-204_10, PI4KAP1-204_11, PI4KAP1-204_12, PI4KAP1-204_13, PI4KAP1-204_14, PI4KAP1-204_15, ENST00000434754_1, ENST00000434754_2, ENST00000434754_3, ENST00000434754_4@155.631578947368@117@172@:RIMS binding protein 3@:protein binding@NA
D170484@233473@233474@deletion@2@23247264@23248971@22@chr22:23247264-23248971@6.81@105@53@0.505@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11@BCRL4-001_6, BCRL4-001_7@0@0@0@@:protein binding@NA
D170484@233700@233701@deletion@2@24283261@24284986@22@chr22:24283261-24284986@15.6@71@0@0@CNVR8114.6, CNVR8114.10, CNVR8114.12, CNVR8114.13@ENST00000443377_2, ENST00000443377_3@125@125@125@NA@NA@NA
D170484@233706@233708@deletion@3@24300516@24302569@22@chr22:24300516-24302569@6.27@50@16@0.32@CNVR8114.6, CNVR8114.12, CNVR8114.13, CNVR8114.8@GSTT2B-002_2, GSTT2B-002_3, GSTT2B-002_4@63.6666666666667@60@67@:glutathione S-transferase theta 2B (gene/pseudogene);glutathione S-transferase theta 2@:protein binding;glutathione transferase activity;nucleus;transferase activity;cytoplasm@NA
D170484@233731@233754@duplication@24@24345655@24394850@22@chr22:24345655-24394850@55.5@1076@1670@1.55@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTTP1-001_1, GSTTP1-001_2, ENST00000421902_1, ENST00000421902_2, ENST00000448902_1, ENST00000448902_2, ENST00000448902_3, ENST00000448902_4, ENST00000448902_5, ENST00000329210_1, ENST00000329210_2, ENST00000329210_3, ENST00000329210_4, ENST00000439866_1, ENST00000439866_2, GSTT1-009_1, GSTT1-009_2, GSTT1-009_3, GSTT1-009_4, GSTT1-009_5, ENST00000439996_1, ENST00000439996_2, GSTTP2-001_4, GSTTP2-001_5@130.833333333333@109@149@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
D170484@235915@235916@deletion@2@38482251@38482457@22@chr22:38482251-38482457@7.72@80@32@0.4@NA@BAIAP2L2-003_12, BAIAP2L2-003_13@14@14@14@:BAI1-associated protein 2-like 2@:cytoplasmic vesicle membrane;phospholipid binding;cytoskeletal adaptor activity;clathrin complex;vesicle membrane;filopodium assembly;signal transduction;cellular membrane organization;protein binding;SH3 domain binding;plasma membrane;cell-cell contact zone@NA
D171748@611@619@duplication@9@1653037@1666275@1@chr1:1653037-1666275@12.1@855@1180@1.38@CNVR17.1@CDC2L2-208_1, CDC2L2-208_2, CDC2L2-208_3, CDC2L2-208_4, RP1-283E3-001_1, RP1-283E3-001_2, SLC35E2-002_6, SLC35E2-002_7, ENST00000424604_1@25.1111111111111@20@32@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A:solute carrier family 35, member E2@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division:integral to membrane;membrane@NA
D171748@2739@2764@duplication@26@16363109@16386547@1@chr1:16363109-16386547@167@3394@6461@1.9@CNVR92.1@ENST00000447882_1, ENST00000447882_2, ENST00000447882_3, CLCNKB-001_1, CLCNKB-001_2, CLCNKB-001_3, CLCNKB-001_4, CLCNKB-001_5, CLCNKB-001_6, CLCNKB-001_7, CLCNKB-001_8, CLCNKB-001_9, CLCNKB-001_10, CLCNKB-001_11, CLCNKB-001_12, CLCNKB-001_13, CLCNKB-001_14, CLCNKB-001_15, CLCNKB-001_16, CLCNKB-001_17, CLCNKB-001_18, CLCNKB-001_19, CLCNKB-001_20, FAM131C-001_5, FAM131C-001_6, FAM131C-001_7@10.1153846153846@7@20@:chloride channel, voltage-sensitive Kb:family with sequence similarity 131, member C@:ion channel activity;transport;chloride channel complex;transmembrane transport;protein binding;integral to membrane;chloride transport;excretion;integral to plasma membrane;voltage-gated chloride channel activity;membrane@: BARTTER SYNDROME, TYPE 3; BARTTER SYNDROME, TYPE 4B
D171748@2885@2885@deletion@1@16875148@16875382@1@chr1:16875148-16875382@4.64@27@4@0.148@CNVR93.3, CNVR93.6, CNVR93.10@ENST00000438396_3@44@44@44@NA@NA@NA
D171748@2904@2906@deletion@3@16910091@16913757@1@chr1:16910091-16913757@6.01@76@32@0.421@CNVR93.3, CNVR93.6@NBPF1-201_11, NBPF1-201_12, NBPF1-201_13@44.3333333333333@42@48@NA@NA@NA
D171748@2933@2933@deletion@1@16973284@16973397@1@chr1:16973284-16973397@10.7@280@122@0.436@CNVR93.3, CNVR93.6, CNVR93.12, CNVR93.7, CNVR93.14, CNVR93.15@RP5-1182A14-001_4@42@42@42@NA@NA@NA
D171748@2938@2939@deletion@2@16974565@16974897@1@chr1:16974565-16974897@9.54@327@203@0.621@CNVR93.3, CNVR93.6, CNVR93.12, CNVR93.7, CNVR93.14, CNVR93.15@RP5-1182A14-001_9, RP5-1182A14-001_10@56.5@56@57@NA@NA@NA
D171748@2942@2946@deletion@5@16975378@16976445@1@chr1:16975378-16976445@71.7@1309@518@0.396@CNVR93.3, CNVR93.6, CNVR93.12, CNVR93.7, CNVR93.14, CNVR93.15@RP5-1182A14-001_13, RP5-1182A14-001_14, RP5-1182A14-001_15, RP5-1182A14-001_16, RP5-1182A14-001_17@80.2@69@88@NA@NA@NA
D171748@2950@2966@duplication@17@17013136@17046653@1@chr1:17013136-17046653@52.6@2768@4106@1.48@CNVR93.3, CNVR93.15, CNVR93.4@RP1-163M9-001_1, RP1-163M9-001_2, RP1-163M9-001_3, ESPNP-002_1, ESPNP-002_2, ESPNP-002_3, ESPNP-002_4, ESPNP-002_5, ESPNP-002_6, ESPNP-002_7, ESPNP-002_8, ESPNP-002_9, ESPNP-002_10, ESPNP-002_11, AL021920-201_1, AL021920-201_2, AL021920-201_3@42.8235294117647@37@46@NA@NA@NA
D171748@2977@2978@deletion@2@17085173@17085380@1@chr1:17085173-17085380@6.96@469@300@0.64@CNVR93.3, CNVR93.15, CNVR93.2, CNVR93.1@MST1P9-202_13, MST1P9-202_14@36@35@37@:macrophage stimulating 1-like@:proteolysis;extracellular region;catalytic activity;serine-type endopeptidase activity@NA
D171748@2996@2998@duplication@3@17183209@17197629@1@chr1:17183209-17197629@7.48@580@808@1.39@CNVR94.2, CNVR94.1, CNVR94.4@ENST00000414128_2, ENST00000414128_3, ENST00000356370_2, ENST00000438002_1@16@9@21@NA@NA@NA
D171748@3004@3022@duplication@19@17248447@17275422@1@chr1:17248447-17275422@47@1861@2785@1.5@CNVR94.4, CNVR94.5@CROCC-201_1, CROCC-201_2, CROCC-201_3, CROCC-201_4, CROCC-201_5, CROCC-201_6, CROCC-201_7, CROCC-201_8, CROCC-201_9, CROCC-201_10, CROCC-201_11, CROCC-201_12, CROCC-201_13, CROCC-201_14, CROCC-201_15, CROCC-201_16, CROCC-201_17, CROCC-201_18, CROCC-201_19@72.8421052631579@37@85@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
D171748@3779@3780@deletion@2@21809638@21877922@1@chr1:21809638-21877922@5.04@65@27@0.415@NA@NBPF3-003_19, ALPL-002_1@63.5@16@111@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 3:alkaline phosphatase, liver/bone/kidney@:cytoplasm:response to antibiotic;catalytic activity;cellular response to organic cyclic compound;extracellular space;integral to membrane;response to vitamin D;pyrophosphatase activity;plasma membrane;response to lipopolysaccharide;metabolic process;phosphatase activity;endochondral ossification;response to glucocorticoid stimulus;developmental process involved in reproduction;dephosphorylation;extracellular matrix part;alkaline phosphatase activity;anchored to membrane;metal ion binding;cementum mineralization;skeletal system development@: HYPOPHOSPHATASIA, CHILDHOOD; HYPOPHOSPHATASIA, ADULT; HYPOPHOSPHATASIA, INFANTILE
D171748@4449@4461@duplication@13@25593204@25655628@1@chr1:25593204-25655628@43.3@1527@2434@1.59@CNVR116.1, CNVR116.2@C1orf63-002_1, RP11-335G20-001_1, RHD-202_1, RHD-202_2, RHD-202_3, RHD-202_4, RHD-202_5, RHD-202_6, RHD-202_7, RHD-202_8, RHD-202_9, RHD-202_10, RHD-202_11@117.692307692308@92@128@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
D171748@4477@4477@deletion@1@25735176@25735361@1@chr1:25735176-25735361@18.4@94@1@0.0106@CNVR117.1@RHCE-005_4@56@56@56@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
D171748@9414@9414@deletion@1@60106954@60107024@1@chr1:60106954-60107024@8.79@329@163@0.495@CNVR197.1@FGGY-005_12@2@2@2@:FGGY carbohydrate kinase domain containing@:cell death;neuron homeostasis;molecular_function;carbohydrate metabolic process;kinase activity;cellular_component;phosphotransferase activity, alcohol group as acceptor@: AMYOTROPHIC LATERAL SCLEROSIS 1; ALS1
D171748@12416@12417@duplication@2@104202984@104203299@1@chr1:104202984-104203299@13.8@156@330@2.12@CNVR266.3, CNVR266.1@AMY1A-001_7, AMY1A-001_8@123.5@118@129@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D171748@12432@12432@duplication@1@104256347@104256576@1@chr1:104256347-104256576@5.8@87@162@1.86@CNVR266.3, CNVR266.5@AMYP1-001_1@128@128@128@NA@NA@NA
D171748@12525@12525@deletion@1@108769303@108769516@1@chr1:108769303-108769516@20.9@115@3@0.0261@CNVR294.4@NBPF4-002_13@32@32@32@:neuroblastoma breakpoint family, member 4@:cytoplasm@NA
D171748@12928@12936@duplication@9@110225831@110236368@1@chr1:110225831-110236368@8.2@658@872@1.33@CNVR299.6, CNVR299.4, CNVR299.5@GSTM2-203_9, GSTM1-001_1, GSTM1-001_2, GSTM1-001_3, GSTM1-001_4, GSTM1-001_5, GSTM1-001_6, GSTM1-001_7, GSTM1-001_8@173.555555555556@31@194@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
D171748@14487@14495@deletion@9@144615098@144679973@1@chr1:144615098-144679973@16.1@449@270@0.601@NA@AL592284-001_7, AL592284-001_8, AL592284-001_9, AL592284-001_10, AL592284-001_11, AL592284-001_12, WI2-1896O14-001_1, WI2-1896O14-001_2, WI2-1896O14-001_3@17.7777777777778@2@49@NA@NA@NA
D171748@14565@14565@duplication@1@145209121@145209437@1@chr1:145209121-145209437@5.16@122@205@1.68@CNVR341.2, CNVR341.1@NOTCH2NL-001_1@5@5@5@:notch 2 N-terminal like@:multicellular organismal development;cell differentiation;protein binding;Notch signaling pathway;extracellular region;calcium ion binding;cytoplasm:protein binding;calcium ion binding@NA
D171748@15396@15434@deletion@39@148952339@149187374@1@chr1:148952339-149187374@35.5@1096@654@0.597@CNVR350.3, CNVR350.1@ENST00000431263_4, RP11-744H18-001_1, RP11-744H18-001_2, RP11-744H18-001_3, RP11-744H18-001_4, RP11-744H18-001_5, RP11-744H18-001_6, RP11-744H18-001_7, RP11-744H18-001_8, RP11-744H18-001_9, RP11-744H18-001_10, RP11-744H18-001_11, RP11-744H18-001_12, RP11-744H18-001_13, RP11-744H18-001_14, RP11-744H18-001_15, RP11-744H18-001_16, ENST00000401087_1, ENST00000401087_2, ENST00000401087_3, ENST00000401087_4, ENST00000401087_5, ENST00000401087_6, ENST00000401087_7, ENST00000401087_8, ENST00000401087_9, ENST00000401087_10, ENST00000401087_11, ENST00000401087_12, ENST00000401087_13, ENST00000401087_14, ENST00000401087_15, ENST00000401087_16, RP11-403I13-201_1, RP11-403I13-201_2, RP11-403I13-201_3, RP11-403I13-001_1, RP11-403I13-001_2@79.7631578947368@20@87@NA@NA@NA
D171748@15456@15462@deletion@7@149375000@149400543@1@chr1:149375000-149400543@13.1@793@507@0.639@CNVR350.1@FCGR1C-201_4, FCGR1C-201_5, FCGR1C-201_6, ENST00000415338_1, HIST2H3PS2-001_1, HIST2H3PS2-001_2, RP5-998N21-002_1@73.7142857142857@70@76@NA@NA@NA
D171748@16299@16303@duplication@5@152748828@152777975@1@chr1:152748828-152777975@14.7@433@674@1.56@NA@LCE1E-201_2, LCE1E-201_3, LCE1D-001_1, LCE1D-001_2, LCE1C-001_2@13.4@2@25@:late cornified envelope 1F:late cornified envelope 1E:late cornified envelope 1D:late cornified envelope 1C@:keratinization:keratinization:cytoplasmic part;cornified envelope;cellular response to calcium ion;keratinization;perinuclear region of cytoplasm;cytoplasm:keratinization@NA
D171748@21362@21374@duplication@13@196743977@196801320@1@chr1:196743977-196801320@33.9@2098@2994@1.43@CNVR459.1@CFHR3-001_1, CFHR3-001_2, CFHR3-001_3, CFHR3-001_4, CFHR3-001_5, CFHR3-001_6, CFHR1-001_1, CFHR1-001_2, CFHR1-001_3, CFHR1-001_4, CFHR1-001_5, CFHR1-001_6, CFHR2-201_1@96.7692307692308@85@119@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
D171748@23024@23025@deletion@2@207700100@207700469@1@chr1:207700100-207700469@7.31@36@2@0.0556@CNVR485.1@CR1-201_6, CR1-201_7@17@7@27@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
D171748@23032@23033@duplication@2@207718655@207719024@1@chr1:207718655-207719024@5.26@12@50@4.17@CNVR485.1@CR1-201_14, CR1-201_15@75@52@98@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
D171748@23042@23043@deletion@2@207737211@207737580@1@chr1:207737211-207737580@10.8@61@7@0.115@CNVR485.1, CNVR485.2@CR1-201_22, CR1-201_23@11@9@13@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
D171748@24160@24164@deletion@5@223727670@223729472@1@chr1:223727670-223729472@17.8@95@7@0.0737@NA@CAPN8-202_20, CAPN8-202_21, CAPN8-202_22, CAPN8-202_23, CAPN8-202_24@0@0@0@:calpain 8@:proteolysis;Golgi apparatus;intracellular;calcium-dependent cysteine-type endopeptidase activity;calcium ion binding@NA
D171748@33747@33748@deletion@2@89416835@89417336@2@chr2:89416835-89417336@17.5@404@162@0.401@CNVR866.7, CNVR866.10, CNVR866.11@IGKV1-17-001_1, IGKV1-17-001_2@1@0@2@@:protein binding@NA
D171748@33754@33754@deletion@1@89459237@89459531@2@chr2:89459237-89459531@5.06@365@218@0.597@CNVR866.7, CNVR866.10, CNVR866.11, CNVR866.4, CNVR866.22@IGKV6-21-001_2@0@0@0@@:protein binding@NA
D171748@33772@33773@deletion@2@89545003@89545080@2@chr2:89545003-89545080@5.13@92@46@0.5@CNVR866.7, CNVR866.1, CNVR866.23@AC096579-209_1, IGKV2-30-001_1@1@1@1@@:protein binding@NA
D171748@33778@33782@deletion@5@89567760@89597317@2@chr2:89567760-89597317@35.7@208@20@0.0962@CNVR866.7, CNVR866.1@IGKV1-33-001_1, IGKV1-33-001_2, IGKV3-34-001_1, IGKV3-34-001_2, IGKV1-37-001_2@4@3@5@@:protein binding:protein binding@NA
D171748@33789@33789@duplication@1@89923731@89924028@2@chr2:89923731-89924028@5.24@46@99@2.15@NA@ENST00000442736_2@4@4@4@@:protein binding@NA
D171748@33792@33795@deletion@4@89952794@89967678@2@chr2:89952794-89967678@10.4@163@78@0.479@CNVR867.4, CNVR867.10, CNVR867.11@IGKV1D-33-001_1, IGKV1D-33-001_2, IGKV1D-32-001_1, IGKV1D-32-001_2@7.75@7@8@@:protein binding@NA
D171748@33832@33835@duplication@4@90192770@90199191@2@chr2:90192770-90199191@18.5@745@1229@1.65@CNVR867.10, CNVR867.5, CNVR867.3, CNVR867.9, CNVR867.15@IGKV1D-13-001_1, IGKV1D-13-001_2, IGKV1D-12-001_1, IGKV1D-12-001_2@8.25@7@10@@:protein binding:protein binding@NA
D171748@34538@34540@duplication@3@97815034@97818272@2@chr2:97815034-97818272@8.28@397@570@1.44@CNVR886.2@ENST00000461153_12, ENST00000461153_13, ENST00000461153_14@8@6@12@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
D171748@34560@34587@deletion@28@97856848@97911809@2@chr2:97856848-97911809@25.6@1256@785@0.625@NA@ENST00000461153_34, ENST00000461153_35, ENST00000461153_36, ENST00000461153_37, ENST00000461153_38, ENST00000461153_39, ENST00000461153_40, ENST00000461153_41, ENST00000461153_42, ENST00000461153_43, ENST00000461153_44, ENST00000461153_45, ENST00000461153_46, ENST00000461153_47, ENST00000461153_48, ENST00000461153_49, ENST00000461153_50, ENST00000461153_51, ENST00000461153_52, ENST00000461153_53, ENST00000461153_54, ENST00000461153_55, ENST00000461153_56, ENST00000461153_57, ENST00000461153_58, ENST00000461153_59, ENST00000461153_60, ENST00000461153_61@44.7142857142857@13@65@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
D171748@34615@34631@duplication@17@98127603@98162325@2@chr2:98127603-98162325@36.2@258@662@2.57@CNVR888.3@ANKRD36B-001_23, ANKRD36B-001_24, ANKRD36B-001_25, ANKRD36B-001_26, ANKRD36B-001_27, ANKRD36B-001_28, ANKRD36B-001_29, ANKRD36B-001_30, ANKRD36B-001_31, ANKRD36B-001_32, ANKRD36B-001_33, ANKRD36B-001_34, ANKRD36B-001_35, ANKRD36B-001_36, ANKRD36B-001_37, ANKRD36B-001_38, ANKRD36B-001_39@130.058823529412@64@154@NA@NA@NA
D171748@36919@36920@duplication@2@128180495@128180748@2@chr2:128180495-128180748@5.05@386@538@1.39@NA@PROC-001_4, PROC-001_5@0@0@0@:protein C (inactivator of coagulation factors Va and VIIIa)@:negative regulation of blood coagulation;negative regulation of apoptotic process;catalytic activity;post-translational protein modification;peptidase activity;extracellular space;proteolysis;blood coagulation;plasma membrane;Golgi lumen;endoplasmic reticulum lumen;peptidyl-glutamic acid carboxylation;protein binding;extracellular region;cellular protein metabolic process;leukocyte migration;calcium ion binding;serine-type endopeptidase activity@: THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4; THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT; THPH3
D171748@39853@39855@deletion@3@171636299@171641344@2@chr2:171636299-171641344@15@423@217@0.513@NA@AC007405-201_8, AC007405-201_9, AC007405-201_10@0@0@0@:glutamate-rich 2@NA@NA
D171748@45386@45390@deletion@5@233272979@233274159@2@chr2:233272979-233274159@19.5@432@214@0.495@NA@ALPPL2-001_6, ALPPL2-001_7, ALPPL2-001_8, ALPPL2-001_9, ALPPL2-001_10@35@16@58@:alkaline phosphatase, placental-like 2@:phosphatase activity;catalytic activity;phosphorylation;plasma membrane;metabolic process;membrane;anchored to membrane;alkaline phosphatase activity;metal ion binding@NA
D171748@47662@47663@deletion@2@11925055@11925573@3@chr3:11925055-11925573@12.4@118@36@0.305@NA@AC090958-001_9, AC090958-001_10@9.5@9@10@NA@NA@NA
D171748@61666@61666@deletion@1@195724782@195725105@3@chr3:195724782-195725105@7.26@109@44@0.404@CNVR1707.1@AC024937-001_2@3@3@3@NA@NA@NA
D171748@61902@61904@deletion@3@197350985@197351069@3@chr3:197350985-197351069@8.49@157@79@0.503@CNVR1722.1@AC024560-005_3, AC024560-201_2, AC024560-201_3@22.6666666666667@22@23@NA@NA@NA
D171748@64677@64686@deletion@10@49241265@49559427@4@chr4:49241265-49559427@19.4@319@167@0.524@NA@ENST00000428211_1, ENST00000428211_2, ENST00000428211_3, AC119752-201_1, AC119752-201_2, AC119751-202_1, AC119751-202_3, AC119751-202_4, AC119751-202_5@28.8888888888889@18@43@NA@NA@NA
D171748@68947@68947@deletion@1@145041645@145041742@4@chr4:145041645-145041742@14@135@32@0.237@NA@GYPA-205_2@8@8@8@:glycophorin B (MNS blood group):glycophorin A (MNS blood group)@:integral to membrane;plasma membrane;integral to plasma membrane:external side of plasma membrane;integral to membrane;cytoskeletal anchoring at plasma membrane;plasma membrane;molecular_function;protein homodimerization activity;integral to plasma membrane;cellular_component;identical protein binding;membrane;biological_process;regulation of response to osmotic stress;virus-host interaction@: BLOOD GROUP--Ss LOCUS; Ss: MALARIA, SUSCEPTIBILITY TO; BLOOD GROUP--MN LOCUS; MN
D171748@70823@70825@deletion@3@751250@756260@5@chr5:751250-756260@8.23@58@13@0.224@CNVR2280.3@ZDHHC11B-201_2, ZDHHC11B-201_3, ZDHHC11B-201_4@85@84@87@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
D171748@73656@73656@duplication@1@68862418@68862453@5@chr5:68862418-68862453@7.59@59@141@2.39@CNVR2494.7, CNVR2494.46@GTF2H2C-201_5@12@12@12@:general transcription factor IIH, polypeptide 2C;general transcription factor IIH, polypeptide 2D@:regulation of transcription, DNA-dependent;nucleotide-excision repair;DNA repair;core TFIIH complex;protein binding;nucleus;transcription, DNA-dependent;zinc ion binding@NA
D171748@73727@73727@duplication@1@69717564@69717599@5@chr5:69717564-69717599@4.79@74@133@1.8@CNVR2494.17, CNVR2494.3@GTF2H2B-201_4@139@139@139@NA@NA@NA
D171748@73746@73747@duplication@2@69796546@69796729@5@chr5:69796546-69796729@6.24@25@71@2.84@CNVR2494.10, CNVR2494.57@AC146944-203_1, AC146944-203_2@173@173@173@NA@NA@NA
D171748@73781@73781@duplication@1@70247770@70247822@5@chr5:70247770-70247822@6.3@189@316@1.67@CNVR2494.41, CNVR2494.14, CNVR2494.30, CNVR2494.25, CNVR2494.20, CNVR2494.61, CNVR2494.22, CNVR2494.21, CNVR2494.62, CNVR2494.63@SMN1-001_8@0@0@0@:survival of motor neuron 2, centromeric;survival of motor neuron 1, telomeric@:nucleoplasm;ncRNA metabolic process;Cajal body;RNA metabolic process;spliceosomal complex;cytoplasm;cytosol;protein binding;cell death;spliceosomal complex assembly;RNA binding;mRNA processing;nucleus;gene expression;spliceosomal snRNP assembly@: SPINAL MUSCULAR ATROPHY, TYPE II; SMA2; SPINAL MUSCULAR ATROPHY, TYPE I; SMA1; SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4; SPINAL MUSCULAR ATROPHY, TYPE III; SMA3
D171748@79567@79568@deletion@2@175388056@175388438@5@chr5:175388056-175388438@15.5@91@11@0.121@NA@THOC3-001_4, THOC3-001_5@173.5@165@182@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
D171748@80483@80487@deletion@5@180415903@180429786@5@chr5:180415903-180429786@13@622@389@0.625@CNVR2719.1@BTNL3-202_1, BTNL3-202_2, BTNL3-202_3, BTNL3-202_4, BTNL3-202_5@82@4@108@:butyrophilin-like 3@:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
D171748@82492@82494@deletion@3@29857486@29858260@6@chr6:29857486-29858260@8.93@542@346@0.638@CNVR2829.7, CNVR2829.2, CNVR2829.8, CNVR2829.3@HLA-H-001_5, HLA-H-001_6, HLA-H-001_7@50@48@51@NA@NA@NA
D171748@83601@83617@deletion@17@31973468@31976177@6@chr6:31973468-31976177@265@1682@145@0.0862@CNVR2843.6, CNVR2843.3@CYP21A1P-001_1, CYP21A1P-001_2, CYP21A1P-001_3, CYP21A1P-001_4, CYP21A1P-001_5, CYP21A1P-001_6, CYP21A1P-001_7, CYP21A1P-001_8, CYP21A1P-001_9, CYP21A1P-001_10, AL645922-201_1, AL645922-201_2, AL645922-201_3, AL645922-201_4, AL645922-201_5, AL645922-201_6, AL645922-201_7@106.529411764706@80@121@NA@NA@NA
D171748@83638@83645@deletion@8@31995015@31997116@6@chr6:31995015-31997116@11.3@369@216@0.585@CNVR2843.6, CNVR2843.5@C4B-001_21, C4B-001_22, C4B-001_23, C4B-001_24, C4B-001_25, C4B-001_26, C4B-001_27, C4B-001_28@14@10@19@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
D171748@83661@83663@duplication@3@32006044@32007026@6@chr6:32006044-32007026@5.58@207@299@1.44@CNVR2843.6, CNVR2843.5@CYP21A2-002_1, CYP21A2-002_2, CYP21A2-002_3@15@12@18@:cytochrome P450, family 21, subfamily A, polypeptide 2@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY
D171748@83670@83680@duplication@11@32008648@32011670@6@chr6:32008648-32011670@16.2@495@771@1.56@CNVR2843.6, CNVR2843.5@TNXB-201_35, TNXB-201_36, TNXB-201_37, TNXB-201_38, TNXB-201_39, TNXB-201_40, TNXB-201_41, TNXB-201_42, TNXB-201_43, TNXB-201_44, CYP21A2-002_10@31.3636363636364@16@46@:cytochrome P450, family 21, subfamily A, polypeptide 2:tenascin-X-like;tenascin XB@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
D171748@83911@83919@deletion@9@32485122@32521744@6@chr6:32485122-32521744@34@367@136@0.371@CNVR2845.21, CNVR2845.25, CNVR2845.43@HLA-DRB5-001_1, HLA-DRB5-001_2, HLA-DRB5-001_3, HLA-DRB5-001_4, HLA-DRB5-001_5, HLA-DRB5-001_6, HLA-DRB6-002_4, HLA-DRB6-002_5, HLA-DRB6-002_6@156.444444444444@114@189@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D171748@83931@83942@deletion@12@32557422@32629235@6@chr6:32557422-32629235@97.3@971@300@0.309@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.34@HLA-DRB1-001_1, HLA-DQA1-002_1, HLA-DQA1-002_2, HLA-DQA1-002_3, HLA-DQA1-002_4, HLA-DQA1-002_5, HLA-DQA1-002_6, HLA-DQB1-003_5, HLA-DQB1-003_6, XXbac-BPG254F23-001_1, XXbac-BPG254F23-001_2, ENST00000443574_2@122.666666666667@78@146@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
D171748@83944@83946@deletion@3@32630133@32634448@6@chr6:32630133-32634448@34@256@52@0.203@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20, CNVR2845.31@HLA-DQB1-003_2, HLA-DQB1-003_3, ENST00000443574_1@97.6666666666667@80@112@:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
D171748@84706@84710@deletion@5@35754777@35765089@6@chr6:35754777-35765089@9.18@1262@863@0.684@CNVR2861.1@C6orf127-001_2, C6orf127-001_3, CLPS-001_1, CLPS-001_2, CLPS-001_3@39@30@43@:colipase-like 1:colipase, pancreatic@:extracellular region;enzyme activator activity;digestion;lipid catabolic process:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
D171748@92590@92592@duplication@3@160132511@160132863@6@chr6:160132511-160132863@28.4@529@1064@2.01@CNVR3127.2, CNVR3127.1@ENST00000442642_5, ENST00000442642_6, ENST00000442642_7@108@106@112@:superoxide dismutase 2, mitochondrial;uncharacterized LOC100129518@:response to reactive oxygen species;oxidation-reduction process;mitochondrion;negative regulation of cell proliferation;neuron development;negative regulation of fat cell differentiation;removal of superoxide radicals;response to gamma radiation;response to L-ascorbic acid;response to lipopolysaccharide;response to nutrient levels;response to zinc ion;protein homotetramerization;post-embryonic development;iron ion homeostasis;hemopoiesis;aging;mitochondrial inner membrane;age-dependent response to reactive oxygen species;response to drug;oxygen binding;mitochondrial nucleoid;vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure;apoptotic process;superoxide metabolic process;response to superoxide;detection of oxygen;response to silicon dioxide;cytoplasm;response to stress;respiratory electron transport chain;superoxide anion generation;protein homooligomerization;regulation of mitochondrial membrane potential;positive regulation of nitric oxide biosynthetic process;response to manganese ion;regulation of blood pressure;metal ion binding;negative regulation of apoptotic process;response to cadmium ion;response to oxidative stress;liver development;regulation of catalytic activity;negative regulation of fibroblast proliferation;response to selenium ion;age-dependent response to oxidative stress;response to electrical stimulus;mitochondrial matrix;identical protein binding;mitochondrion organization;response to hyperoxia;vasodilation;response to hydrogen peroxide;superoxide dismutase activity;heart development;negative regulation of neuron apoptotic process;erythrophore differentiation;locomotory behavior;DNA binding;release of cytochrome c from mitochondria;response to axon injury;oxygen homeostasis;response to activity;glutathione metabolic process;hydrogen peroxide metabolic process;hydrogen peroxide biosynthetic process;regulation of transcription from RNA polymerase II promoter;response to hypoxia;protein binding;manganese ion binding;cellular response to ethanol@: MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6; MVCD6
D171748@92795@92796@deletion@2@161054787@161056337@6@chr6:161054787-161056337@5.01@33@7@0.212@CNVR3133.1@LPA-201_8, LPA-201_9@111@99@123@:lipoprotein, Lp(a)@:blood circulation;endopeptidase inhibitor activity;catalytic activity;lipoprotein metabolic process;proteolysis;heparin binding;receptor-mediated endocytosis;fibronectin binding;small molecule metabolic process;apolipoprotein binding;lipid metabolic process;negative regulation of endopeptidase activity;extracellular region;plasma lipoprotein particle;lipid transport;serine-type endopeptidase activity@: APOLIPOPROTEIN(a); LPA
D171748@93099@93099@deletion@1@167790036@167790193@6@chr6:167790036-167790193@5.5@25@0@0@NA@TCP10-001_5@103@103@103@:t-complex 10@:cytosol@NA
D171748@94208@94208@duplication@1@5998626@5998710@7@chr7:5998626-5998710@12.9@289@632@2.19@NA@RSPH10B-002_7@11@11@11@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D171748@94424@94444@deletion@21@6805339@6844687@7@chr7:6805339-6844687@161@1216@236@0.194@NA@RSPH10B2-204_7, RSPH10B2-204_8, RSPH10B2-204_9, RSPH10B2-204_10, RSPH10B2-204_11, RSPH10B2-204_12, RSPH10B2-204_13, RSPH10B2-204_14, RSPH10B2-204_15, RSPH10B2-204_16, RSPH10B2-204_17, RSPH10B2-204_18, RSPH10B2-204_19, RSPH10B2-204_20, RSPH10B2-204_21, ENST00000429267_1, ENST00000429267_2, C7orf28B-001_12, C7orf28B-001_13, C7orf28B-001_14, C7orf28B-001_15@40.5238095238095@11@121@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D171748@96579@96582@duplication@4@38388958@38394119@7@chr7:38388958-38394119@13.1@1084@1558@1.44@CNVR3354.3, CNVR3354.1@TRGV5-001_1, TRGV5-001_2, TRGV4-001_1, TRGV4-001_2@12.75@11@14@@:protein binding:protein binding@NA
D171748@97912@97915@deletion@4@57071006@57076857@7@chr7:57071006-57076857@6.48@61@22@0.361@NA@TNRC18C-202_8, TNRC18C-202_9, TNRC18C-202_10, TNRC18C-202_11@160@154@166@NA@NA@NA
D171748@97990@97996@duplication@7@62753052@62764435@7@chr7:62753052-62764435@44.7@796@1715@2.15@NA@AC006455-201_1, AC006455-201_2, AC006455-201_3, AC006455-201_4, ENST00000444809_1, ENST00000444809_2, ENST00000444809_3, ENST00000444809_4@138.285714285714@97@171@NA@NA@NA
D171748@98014@98026@deletion@13@62904582@62970547@7@chr7:62904582-62970547@82.1@787@168@0.213@NA@ZNF734-201_1, ZNF734-201_2, ZNF734-201_3, ZNF734-201_4, ZNF734-201_5, ZNF734-201_6, ZNF734-201_7, ZNF734-201_8, ENST00000434048_1, ENST00000434048_2, CTD-2526L21-201_1, CTD-2526L21-201_2, CTD-2526L21-201_3@75.3846153846154@1@102@NA@NA@NA
D171748@98173@98174@deletion@2@64533487@64534227@7@chr7:64533487-64534227@7.14@40@5@0.125@NA@RP11-460N20-001_11, RP11-460N20-001_12, ENST00000501153_3@101@101@101@NA@NA@NA
D171748@99031@99041@duplication@11@74167428@74193769@7@chr7:74167428-74193769@15@424@671@1.58@NA@GTF2I-001_29, GTF2I-001_30, GTF2I-001_31, GTF2I-001_32, GTF2I-001_33, GTF2I-001_34, GTF2I-001_35, NCF1-001_1, NCF1-001_2, NCF1-001_3, NCF1-001_4@20.6363636363636@12@35@:general transcription factor IIi:neutrophil cytosolic factor 1@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration:inflammatory response;antigen processing and presentation of peptide antigen via MHC class I;phagosome maturation;NADPH oxidase complex;neutrophil mediated killing of gram-positive bacterium;cell communication;interaction with host;leukotriene metabolic process;response to yeast;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;respiratory burst;GTPase activity;negative regulation of smooth muscle contraction;GTP catabolic process;cytosol;defense response to fungus;defense response to bacterium;antigen processing and presentation of exogenous peptide antigen via MHC class I;leukocyte mediated cytotoxicity;neutrophil mediated killing of fungus;phosphatidylinositol binding;defense response to Gram-positive bacterium;GTP binding;respiratory burst involved in defense response;superoxide-generating NADPH oxidase activity;hydrogen peroxide biosynthetic process;protein targeting to membrane;electron carrier activity;superoxide metabolic process;innate immune response;phagolysosome;cytoplasm;cell proliferation;superoxide anion generation;protein binding;SH3 domain binding;cellular defense response;response to bacterium@: GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE,
D171748@99100@99106@deletion@7@74466820@74480462@7@chr7:74466820-74480462@7.39@274@168@0.613@NA@WBSCR16-001_4, WBSCR16-001_5, WBSCR16-001_6, WBSCR16-001_7, WBSCR16-001_8, WBSCR16-001_9, WBSCR16-001_10@31.7142857142857@7@40@:RCC1-like G exchanging factor-like;Williams-Beuren syndrome chromosome region 16@:mitochondrion;cellular_component;biological_process@: WILLIAMS-BEUREN SYNDROME; WBS
D171748@99133@99142@deletion@10@74582344@74608703@7@chr7:74582344-74608703@10.1@176@82@0.466@NA@NCF1C-001_1, NCF1C-001_2, NCF1C-001_3, NCF1C-001_4, GTF2IP1-001_17, GTF2IP1-001_18, GTF2IP1-001_19, GTF2IP1-001_20, GTF2IP1-001_21, GTF2IP1-001_22@15.3@11@49@NA@NA@NA
D171748@99233@99233@deletion@1@74991244@74991359@7@chr7:74991244-74991359@7.35@34@0@0@CNVR3456.1@STAG3L1-004_3@60@60@60@NA@NA@NA
D171748@99272@99273@deletion@2@75054920@75055736@7@chr7:75054920-75055736@5.68@105@54@0.514@NA@POM121C-001_8, POM121C-001_9@51@30@72@:POM121 transmembrane nucleoporin C@:nuclear membrane;protein binding;protein transport;endoplasmic reticulum membrane;nuclear pore;mRNA transport@NA
D171748@99455@99455@deletion@1@76069569@76069659@7@chr7:76069569-76069659@8.65@235@110@0.468@CNVR3462.1@ZP3-002_7@10@10@10@:zona pellucida glycoprotein 3 (sperm receptor)@:negative regulation of transcription, DNA-dependent;manganese ion transmembrane transporter activity;intracellular protein transport;proteinaceous extracellular matrix;plasma membrane;positive regulation of acrosome reaction;outer acrosomal membrane;protein kinase C signaling cascade;manganese ion transmembrane transport;intracellular signal transduction;humoral immune response mediated by circulating immunoglobulin;negative regulation of binding of sperm to zona pellucida;positive regulation of inflammatory response;endoplasmic reticulum;signal transducer activity;perinuclear region of cytoplasm;secretory granule;positive regulation of transcription, DNA-dependent;positive regulation of ovarian follicle development;positive regulation of interferon-gamma production;carbohydrate binding;manganese ion transport;positive regulation of antral ovarian follicle growth;extracellular matrix;positive regulation of leukocyte migration;positive regulation of humoral immune response;extracellular space;blastocyst formation;integral to membrane;store-operated calcium channel activity;oocyte development;multivesicular body;phosphatidylinositol-mediated signaling;acrosomal vesicle;positive regulation of protein kinase B signaling cascade;Golgi apparatus;positive regulation of calcium ion import;positive regulation of protein kinase activity;positive regulation of acrosomal vesicle exocytosis;positive regulation of interleukin-4 production;cytoplasm;protein binding;binding of sperm to zona pellucida;positive regulation of phosphatidylinositol biosynthetic process;extracellular region;positive regulation of T cell proliferation;acrosin binding;positive regulation of type IV hypersensitivity;egg coat formation@NA
D171748@99489@99490@duplication@2@76240773@76241131@7@chr7:76240773-76241131@16.1@341@631@1.85@CNVR3463.10@POMZP3-003_6, POMZP3-003_7@43.5@41@46@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
D171748@99545@99545@duplication@1@76728229@76728269@7@chr7:76728229-76728269@4.7@112@185@1.65@NA@ENST00000398321_6@11@11@11@NA@NA@NA
D171748@99550@99551@deletion@2@76748836@76749023@7@chr7:76748836-76749023@21.4@313@101@0.323@NA@ENST00000398321_2, ENST00000398321_3@2@1@3@NA@NA@NA
D171748@101289@101289@duplication@1@99578391@99578472@7@chr7:99578391-99578472@5.54@116@200@1.72@CNVR3507.1@AZGP1P1-201_1@0@0@0@NA@NA@NA
D171748@101721@101726@duplication@6@100331652@100336237@7@chr7:100331652-100336237@9.31@924@1251@1.35@CNVR3509.1@ZAN-001_2, ZAN-001_3, ZAN-001_4, ZAN-001_5, ZAN-001_6, ZAN-001_7@81.6666666666667@71@89@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
D171748@101967@101967@deletion@1@100932972@100933057@7@chr7:100932972-100933057@8.31@48@5@0.104@NA@RP11-132A1-001_1@2@2@2@NA@NA@NA
D171748@102116@102116@deletion@1@102114810@102114983@7@chr7:102114810-102114983@5.95@29@1@0.0345@CNVR3518.1@POLR2J-001_3@91@91@91@:polymerase (RNA) II (DNA directed) polypeptide J, 13.3kDa@:nucleoplasm;DNA binding;DNA repair;protein dimerization activity;nucleus;viral reproduction;gene expression;transcription initiation from RNA polymerase II promoter;7-methylguanosine mRNA capping;protein phosphorylation;LRR domain binding;protein kinase activity;DNA-directed RNA polymerase II, core complex;nucleotide-excision repair;transcription from RNA polymerase II promoter;DNA-directed RNA polymerase activity;protein binding;transcription-coupled nucleotide-excision repair;RNA splicing;mRNA splicing, via spliceosome;transcription, DNA-dependent;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription@NA
D171748@102130@102130@deletion@1@102136589@102136652@7@chr7:102136589-102136652@7.01@206@103@0.5@CNVR3518.1@RASA4B-007_16@49@49@49@:RAS p21 protein activator 4B@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction@NA
D171748@102144@102145@duplication@2@102180464@102180539@7@chr7:102180464-102180539@25.4@198@570@2.88@CNVR3518.1@RASA4B-007_4, POLR2J3-003_7@96@96@96@:RAS p21 protein activator 4B:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
D171748@102166@102166@deletion@1@102219874@102220244@7@chr7:102219874-102220244@10.9@51@0@0@CNVR3518.1@ENST00000379336_1, RASA4-001_21@63@63@63@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
D171748@102192@102193@deletion@2@102279572@102279647@7@chr7:102279572-102279647@49.8@349@30@0.086@CNVR3518.1@ENST00000340457_4, POLR2J2-001_7@76.5@76@77@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
D171748@105332@105335@duplication@4@141781844@141784445@7@chr7:141781844-141784445@6.88@542@738@1.36@CNVR3585.3, CNVR3585.2@MGAM-007_51, MGAM-007_52, MGAM-007_53, MGAM-007_54@124@123@125@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
D171748@105339@105342@duplication@4@141791715@141794298@7@chr7:141791715-141794298@6.77@354@501@1.42@CNVR3585.3, CNVR3585.2@MGAM-007_58, MGAM-007_59, MGAM-007_60, MGAM-007_61@77@35@101@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
D171748@105443@105446@deletion@4@142099457@142104554@7@chr7:142099457-142104554@24.7@1109@588@0.53@NA@TRBV7-8-001_1, TRBV7-8-001_2, TRBV6-9-001_1, TRBV6-9-001_2@4.75@4@5@@:protein binding:protein binding@NA
D171748@105521@105524@deletion@4@142481247@142486594@7@chr7:142481247-142486594@88.7@547@16@0.0293@NA@TRBC1-210_1, PRSS1-204_4, PRSS1-204_5, PRSS1-204_6@90.25@18@115@NA@NA@NA
D171748@105792@105795@deletion@4@143973974@143974431@7@chr7:143973974-143974431@8.33@38@0@0@CNVR3598.4, CNVR3598.9@RP4-798C17-001_7, RP4-798C17-001_8, ENST00000378112_8, ENST00000378112_9@97@57@137@:Rho guanine nucleotide exchange factor (GEF) 35@NA@NA
D171748@105798@105828@duplication@31@143975408@144071983@7@chr7:143975408-144071983@37.3@1781@2551@1.43@CNVR3598.4@RP4-798C17-004_1, RP4-798C17-004_2, RP4-798C17-004_3, RP4-798C17-004_4, RP4-798C17-004_5, RP4-798C17-004_6, RP4-798C17-001_1, RP4-798C17-001_2, RP4-798C17-001_3, RP4-798C17-001_4, RP4-798C17-001_5, ENST00000378112_1, ENST00000378112_2, ENST00000378112_3, ENST00000378112_4, ENST00000378112_5, ENST00000378112_6, OR2A9P-002_1, OR2A9P-002_2, OR2A9P-002_3, ARHGEF5-001_1, ARHGEF5-001_2, ARHGEF5-001_3, ARHGEF5-001_4, ARHGEF5-001_5, ARHGEF5-001_6, ARHGEF5-001_7, ARHGEF5-001_8, ARHGEF5-001_9, ARHGEF5-001_10, ARHGEF5-001_11@56.9032258064516@14@135@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
D171748@107425@107430@duplication@6@7274294@7320382@8@chr8:7274294-7320382@6.98@760@991@1.3@CNVR3771.8, CNVR3771.10, CNVR3771.4@DEFB4P-001_1, DEFB103A-001_1, DEFB103A-001_2, SPAG11-003_2, SPAG11-003_3, SPAG11-003_4@63.3333333333333@40@91@:defensin, beta 4B;defensin, beta 4A:defensin, beta 103B;defensin, beta 103A:sperm associated antigen 11B@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response@NA
D171748@107511@107513@deletion@3@7706215@7718505@8@chr8:7706215-7718505@11.8@357@188@0.527@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@SPAG11A-207_2, SPAG11A-207_3, SPAG11A-207_4@90@46@113@:sperm associated antigen 11A;sperm associated antigen 11B@:extracellular region;defense response@NA
D171748@117587@117589@deletion@3@43313716@43314503@9@chr9:43313716-43314503@22.2@271@96@0.354@CNVR4289.2@BX649597-201_1, BX649597-201_2, BX649597-201_3@46@18@61@NA@NA@NA
D171748@117601@117602@deletion@2@43816639@43818185@9@chr9:43816639-43818185@14.1@428@214@0.5@CNVR4294.1@CNTNAP3B-001_6, CNTNAP3B-001_7@88.5@86@91@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
D171748@119446@119446@duplication@1@94123912@94124196@9@chr9:94123912-94124196@5.2@187@296@1.58@NA@AUH-001_1@0@0@0@:AU RNA binding protein/enoyl-CoA hydratase@:mitochondrion;mRNA catabolic process;mRNA 3'-UTR binding;small molecule metabolic process;branched-chain amino acid catabolic process;enoyl-CoA hydratase activity;catalytic activity;leucine catabolic process;RNA binding;methylglutaconyl-CoA hydratase activity;cellular nitrogen compound metabolic process;metabolic process;mitochondrial matrix@: 3-@METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1
D171748@125888@125889@deletion@2@5200800@5202136@10@chr10:5200800-5202136@5.21@74@34@0.459@NA@AKR1CL1-202_5, AKR1CL1-202_6@2@0@4@:aldo-keto reductase family 1, member C-like 1@:oxidoreductase activity;cytoplasm@NA
D171748@126909@126909@deletion@1@17840632@17842868@10@chr10:17840632-17842868@10.5@49@0@0@NA@FAM23A-201_5@108@108@108@:transmembrane protein 236;transmembrane protein 236-like@:integral to membrane@NA
D171748@126911@126918@duplication@8@17865075@17898363@10@chr10:17865075-17898363@13.5@699@1011@1.45@NA@MRC1L1-001_2, MRC1L1-001_3, MRC1L1-001_4, MRC1L1-001_5, MRC1L1-001_6, MRC1L1-001_7, MRC1L1-001_8, MRC1L1-001_9@9.875@5@20@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
D171748@126946@126956@deletion@11@18112046@18152612@10@chr10:18112046-18152612@70.5@375@11@0.0293@NA@MRC1-001_2, MRC1-001_3, MRC1-001_4, MRC1-001_5, MRC1-001_6, MRC1-001_7, MRC1-001_8, MRC1-001_9, MRC1-001_10, MRC1-001_11, RP11-457D2-001_2@22.6363636363636@16@34@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D171748@127614@127616@deletion@3@27638643@27639220@10@chr10:27638643-27639220@11.6@195@87@0.446@CNVR4670.1@ENST00000396262_1, ENST00000396262_2, ENST00000396262_3@13.6666666666667@11@15@NA@NA@NA
D171748@127722@127722@duplication@1@29580856@29580936@10@chr10:29580856-29580936@5@70@130@1.86@NA@LYZL1-002_1@51@51@51@:lysozyme-like 1@:extracellular region;lysozyme activity;cell wall macromolecule catabolic process@NA
D171748@127838@127838@deletion@1@30982427@30982598@10@chr10:30982427-30982598@6.22@110@49@0.445@NA@ENST00000422642_6@0@0@0@NA@NA@NA
D171748@128828@128828@duplication@1@46927785@46928012@10@chr10:46927785-46928012@5.96@83@159@1.92@CNVR4712.9, CNVR4712.2, CNVR4712.7@FAM35B-001_6@72@72@72@NA@NA@NA
D171748@128897@128901@deletion@5@47253597@47259684@10@chr10:47253597-47259684@5.96@131@71@0.542@CNVR4712.9, CNVR4712.1@GLUDP8-001_1, GLUDP8-001_2, GLUDP8-001_3, RP11-144G6-201_1, RP11-144G6-201_2@14.8@8@20@NA@NA@NA
D171748@128912@128913@deletion@2@47405673@47410082@10@chr10:47405673-47410082@8.73@158@74@0.468@CNVR4712.9, CNVR4712.1@FAM35B2-201_5, FAM35B2-201_6@39@31@47@NA@NA@NA
D171748@128920@128947@duplication@28@47605129@47669299@10@chr10:47605129-47669299@49.4@2450@3576@1.46@CNVR4713.1@ENST00000423803_1, ENST00000423803_2, ENST00000423803_3, ENST00000423803_4, ENST00000423803_5, ENST00000423803_6, ENST00000423803_7, ENST00000423803_8, ENST00000423803_9, ENST00000423803_10, ENST00000423803_11, ENST00000423803_12, ENST00000423803_13, ENST00000423803_14, ENST00000454837_1, ENST00000454837_2, ENST00000454837_3, ENST00000454837_4, ANTXRL-001_1, ANTXRL-001_2, ANTXRL-001_3, ANTXRL-001_4, ANTXRL-001_5, ANTXRL-001_6, ANTXRL-001_7, ANTXRL-001_8, ANTXRL-001_9, ANTXRL-001_10@23.3214285714286@17@30@@:protein binding;integral to membrane;receptor activity;metal ion binding@NA
D171748@128976@128979@duplication@4@47756035@47758905@10@chr10:47756035-47758905@14.1@87@235@2.7@CNVR4714.1@ANXA8L2-001_7, ANXA8L2-001_8, ANXA8L2-001_9, ANXA8L2-001_10@135.75@88@154@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:calcium-dependent phospholipid binding;calcium ion binding@NA
D171748@129003@129007@deletion@5@47933809@47942085@10@chr10:47933809-47942085@7.86@36@0@0@CNVR4715.2, CNVR4715.1@FAM21B-201_20, FAM21B-201_21, FAM21B-201_22, FAM21B-201_23, FAM21B-201_24@175@165@185@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
D171748@129021@129026@deletion@6@48020452@48033106@10@chr10:48020452-48033106@11@467@283@0.606@CNVR4715.2@ASAH2C-201_5, ASAH2C-201_6, ASAH2C-201_7, ASAH2C-201_8, ASAH2C-201_9, ASAH2C-201_10@65.8333333333333@57@73@@:ceramidase activity;sphingolipid metabolic process@NA
D171748@129130@129131@deletion@2@48968562@48968624@10@chr10:48968562-48968624@9.22@61@12@0.197@CNVR4716.8, CNVR4716.4@RP11-508M1-002_5, GLUDP2-001_3@31@31@31@NA@NA@NA
D171748@129454@129460@duplication@7@51345755@51361911@10@chr10:51345755-51361911@9.04@26@97@3.73@NA@ENST00000404618_4, ENST00000404618_5, ENST00000404618_6, ENST00000404618_7, ENST00000432221_4, ENST00000432221_5, ENST00000432221_6, ENST00000432221_7@93.8571428571429@89@123@NA@NA@NA
D171748@129462@129463@deletion@2@51362803@51363788@10@chr10:51362803-51363788@55.3@300@0@0@NA@ENST00000404618_3, ENST00000432221_3@142@142@142@NA@NA@NA
D171748@129468@129468@duplication@1@51371409@51371647@10@chr10:51371409-51371647@4.69@10@44@4.4@NA@TIMM23B-202_1@119@119@119@:translocase of inner mitochondrial membrane 23 homolog B (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process@NA
D171748@129605@129609@duplication@5@51970585@51978391@10@chr10:51970585-51978391@18.6@219@420@1.92@NA@ASAH2-201_7, ASAH2-201_8, ASAH2-201_9, ASAH2-201_10, ASAH2-201_11@181.2@176@186@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
D171748@131567@131568@deletion@2@81284748@81286392@10@chr10:81284748-81286392@22.5@210@66@0.314@NA@BX248123-201_1, BX248123-201_2@2.5@2@3@NA@NA@NA
D171748@131687@131688@duplication@2@81993422@81995118@10@chr10:81993422-81995118@8.39@335@515@1.54@NA@ENST00000423182_1, ENST00000423182_2@1@1@1@NA@NA@NA
D171748@136769@136771@deletion@3@135437401@135439811@10@chr10:135437401-135439811@13.3@782@441@0.564@CNVR4989.11, CNVR4989.4@FRG2B-202_2, FRG2B-202_3, FRG2B-202_4@18@7@29@:FSHD region gene 2 family, member B@:nucleus@NA
D171748@139115@139116@duplication@2@16812347@16812747@11@chr11:16812347-16812747@4.92@416@575@1.38@NA@PLEKHA7-202_20, PLEKHA7-202_21@0@0@0@:pleckstrin homology domain containing, family A member 7@:phospholipid binding;epithelial cell-cell adhesion;centrosome;cytoplasm;zonula adherens;protein binding;zonula adherens maintenance;cell junction;nucleus;delta-catenin binding@NA
D171748@141263@141263@deletion@1@50368320@50368360@11@chr11:50368320-50368360@5.4@51@16@0.314@CNVR5173.1@AC024405-201_1@3@3@3@NA@NA@NA
D171748@141274@141277@deletion@4@55033078@55038593@11@chr11:55033078-55038593@13.7@319@160@0.502@CNVR5178.5@TRIM48-201_3, TRIM48-201_4, TRIM48-201_5, TRIM48-201_6@51.25@48@61@:tripartite motif containing 48@:protein binding;intracellular;zinc ion binding@NA
D171748@145944@145953@deletion@10@89701674@89715285@11@chr11:89701674-89715285@8.19@37@0@0@NA@TRIM64-202_1, TRIM64-202_2, TRIM64-202_3, TRIM64-202_4, TRIM64-202_5, TRIM64-202_6, TRIM64-202_7, TRIM64-202_8, TRIM64-202_9, ENST00000442514_9@171.8@154@177@NA@NA@NA
D171748@150833@150840@duplication@8@9693796@9706679@12@chr12:9693796-9706679@7.93@475@649@1.37@CNVR5429.1@AC006432-201_5, AC006432-201_6, AC006432-201_7, AC006432-201_8, AC006432-201_9, AC006432-201_10, AC006432-201_11, AC006432-201_12@22@15@23@NA@NA@NA
D171748@150969@150969@duplication@1@10584707@10584806@12@chr12:10584707-10584806@5.03@118@197@1.67@CNVR5430.1@KLRC2-201_5@66@66@66@:killer cell lectin-like receptor subfamily C, member 2@:carbohydrate binding:transmembrane signaling receptor activity;carbohydrate binding;protein binding;signal transduction;cellular defense response;integral to plasma membrane@NA
D171748@151048@151051@duplication@4@11506043@11508488@12@chr12:11506043-11508488@8.71@837@1141@1.36@CNVR5435.2, CNVR5435.1@PRB1-201_1, PRB1-201_2, PRB1-201_3, PRB1-201_4@46.25@44@49@:proline-rich protein BstNI subfamily 1@NA@NA
D171748@152013@152014@deletion@2@27648615@27655119@12@chr12:27648615-27655119@13.8@304@141@0.464@CNVR5465.1@C12orf70-202_8, C12orf70-202_9@12@12@12@:chromosome 12 open reading frame 70@:integral to membrane@NA
D171748@160704@160705@duplication@2@123915057@123921044@12@chr12:123915057-123921044@5.15@466@646@1.39@NA@RILPL2-201_1, RILPL2-201_2@0@0@0@:Rab interacting lysosomal protein-like 2@:cytosol;plasma membrane;identical protein binding;cytoplasm@NA
D171748@161687@161687@duplication@1@19775779@19775963@13@chr13:19775779-19775963@5.22@115@196@1.7@NA@RP11-408E5-201_8@4@4@4@NA@NA@NA
D171748@164259@164260@duplication@2@51417326@51417886@13@chr13:51417326-51417886@6.04@171@263@1.54@NA@DLEU7-201_1, ENST00000335465_1@6@6@6@:deleted in lymphocytic leukemia, 7@NA@NA
D171748@164475@164478@deletion@4@52854999@52857493@13@chr13:52854999-52857493@5.81@67@28@0.418@NA@THSD1P-203_13, THSD1P-203_14, ENST00000403471_4, ENST00000403471_5@53@50@56@NA@NA@NA
D171748@164539@164543@deletion@5@53103402@53106857@13@chr13:53103402-53106857@32@157@2@0.0127@NA@RP11-78J21-201_12, RP11-78J21-201_13, RP11-78J21-201_14, RP11-78J21-201_15, RP11-78J21-201_16@113.8@107@117@NA@NA@NA
D171748@166697@166699@deletion@3@19553367@19559165@14@chr14:19553367-19559165@10.4@93@27@0.29@CNVR6072.1@POTEG-201_1, POTEG-201_2, POTEG-201_3@122.333333333333@91@141@:POTE ankyrin domain family, member G@:protein binding@NA
D171748@168604@168605@duplication@2@39680998@39681460@14@chr14:39680998-39681460@5.04@127@196@1.54@NA@AL132639-201_1, AL132639-201_2@0@0@0@NA@NA@NA
D171748@173423@173426@deletion@4@106134588@106135330@14@chr14:106134588-106135330@8.46@368@236@0.641@CNVR6294.46, CNVR6294.20, CNVR6294.43, CNVR6294.65, CNVR6294.66@IGHGP-001_3, IGHGP-001_4, AL928761-201_3, AL928761-201_4@8@7@9@NA@NA@NA
D171748@173500@173503@duplication@4@106471638@106478604@14@chr14:106471638-106478604@22.5@323@643@1.99@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV3-6-210_6, IGHV1-3-001_1, IGHV4-4-001_1, IGHV4-4-001_2@10.75@4@17@@:protein binding:protein binding@NA
D171748@173508@173514@duplication@7@106539081@106573538@14@chr14:106539081-106573538@33.1@1322@2111@1.6@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8-001_1, IGHV1-8-001_2, IGHV3-9-001_1, IGHV3-9-001_2, IGHV2-10-001_1, IGHV2-10-001_2, IGHV3-11-001_2@20.4285714285714@9@24@@:protein binding:protein binding:protein binding@NA
D171748@173558@173559@deletion@2@106791007@106791537@14@chr14:106791007-106791537@6.84@742@499@0.673@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-30-001_1, IGHV3-30-001_2@17.5@16@19@@:protein binding@NA
D171748@173682@173685@deletion@4@20444657@20450352@15@chr15:20444657-20450352@7.45@2432@1742@0.716@CNVR6295.15, CNVR6295.7, CNVR6295.13, CNVR6295.26@ENST00000400226_12, ENST00000400226_13, ENST00000400226_14, ENST00000400226_15@60.75@30@75@NA@NA@NA
D171748@173689@173690@deletion@2@20462540@20464834@15@chr15:20462540-20464834@6.97@829@529@0.638@CNVR6295.15, CNVR6295.7, CNVR6295.13, CNVR6295.26@ENST00000400226_7, ENST00000400226_8@50@20@80@NA@NA@NA
D171748@173692@173698@deletion@7@20466501@20588710@15@chr15:20466501-20588710@19@3108@2120@0.682@CNVR6295.15, CNVR6295.7, CNVR6295.26@ENST00000400226_1, ENST00000400226_2, ENST00000400226_3, ENST00000400226_4, ENST00000400226_5, HERC2P3-014_27, AC026495-201_26@66@34@77@NA@NA@NA
D171748@173729@173734@deletion@6@20662560@20663213@15@chr15:20662560-20663213@8.26@601@394@0.656@CNVR6295.15@HERC2P3-014_9, HERC2P3-014_10, HERC2P3-014_11, AC026495-201_8, AC026495-201_9, AC026495-201_10@97.1666666666667@91@106@NA@NA@NA
D171748@173814@173822@deletion@9@22297500@22473354@15@chr15:22297500-22473354@36.2@2737@1533@0.56@CNVR6297.4, CNVR6297.17, CNVR6297.6@AC134980-201_1, AC134980-201_2, ENST00000438898_1, ENST00000438898_2, AC025884-201_1, AC010760-202_2, VSIG6-201_1, VSIG6-201_2@60.25@15@87@:olfactory receptor, family 4, subfamily M, member 2:olfactory receptor, family 4, subfamily N, member 4@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
D171748@174386@174388@deletion@3@28912344@28913502@15@chr15:28912344-28913502@9.56@128@55@0.43@CNVR6330.9@AC055876-201_21, AC055876-201_22, AC055876-201_23@20.3333333333333@19@23@NA@NA@NA
D171748@174504@174506@duplication@3@30659623@30664545@15@chr15:30659623-30664545@7.28@328@463@1.41@CNVR6337.1@CHRFAM7A-202_7, CHRFAM7A-202_8, CHRFAM7A-202_9@53.6666666666667@44@68@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
D171748@174661@174662@deletion@2@32451772@32455537@15@chr15:32451772-32455537@9.4@45@1@0.0222@CNVR6345.2, CNVR6345.1@CHRNA7-205_8, CHRNA7-205_9@119.5@106@133@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
D171748@174966@174974@deletion@9@34781208@34820036@15@chr15:34781208-34820036@26.8@1459@863@0.592@CNVR6351.3@AC027139-201_1, AC027139-201_2, AC027139-201_3, AC027139-201_4, AC027139-201_5, ENST00000444260_1, ENST00000444260_2, ENST00000444260_3, GOLGA8B-201_24@44.6666666666667@38@49@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
D171748@176432@176433@deletion@2@44002591@44002976@15@chr15:44002591-44002976@34.9@192@0@0@NA@AC011330-201_13, AC011330-201_14@28@16@40@:stereocilin@:detection of mechanical stimulus involved in sensory perception of sound;stereocilium bundle tip;stereocilium;cell surface;kinocilium;auditory receptor cell stereocilium organization@: DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16; DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY
D171748@176607@176608@duplication@2@44829257@44829626@15@chr15:44829257-44829626@5.87@302@438@1.45@NA@EIF3J-001_1, EIF3J-001_2@8.5@7@10@:eukaryotic translation initiation factor 3, subunit J@:cytosol;protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;cellular protein metabolic process;gene expression;translation;translation initiation factor activity@NA
D171748@179308@179312@deletion@5@72954595@72958040@15@chr15:72954595-72958040@11@52@1@0.0192@CNVR6443.1@GOLGA6-001_11, GOLGA6-001_12, GOLGA6-001_13, GOLGA6-001_14, GOLGA6-001_15@73.4@24@99@:golgin A6 family, member B@:Golgi apparatus@NA
D171748@181965@181987@duplication@23@102292670@102312312@15@chr15:102292670-102312312@12.8@83@185@2.23@CNVR6563.1@AC107977-201_1, AC107977-201_2, ENST00000417911_1, ENST00000417911_2, AC107977-204_1, AC107977-204_2, AC107977-203_1, AC107977-203_2, ENST00000446640_1, ENST00000446640_2, AC107977-202_1, AC107977-202_2, AC107977-202_3, ENST00000425127_1, ENST00000425127_2, AC107977-205_1, AC107977-205_2, AC107977-205_3, ENST00000415800_1, ENST00000415800_2, ENST00000423393_1, ENST00000423393_2, ENST00000448387_12@96.4782608695652@0@148@NA@NA@NA
D171748@185021@185024@duplication@4@18542790@18550287@16@chr16:18542790-18550287@6.93@638@889@1.39@NA@NOMO2-201_10, NOMO2-201_11, NOMO2-201_12, NOMO2-201_13@21.5@20@23@:NODAL modulator 2@:carbohydrate binding;protein binding;integral to membrane;carboxypeptidase activity;endoplasmic reticulum membrane@NA
D171748@185587@185598@deletion@12@21742160@21809180@16@chr16:21742160-21809180@17@727@448@0.616@CNVR6668.5, CNVR6668.2, CNVR6668.7@OTOA-001_20, OTOA-001_21, OTOA-001_22, OTOA-001_23, OTOA-001_24, OTOA-001_25, OTOA-001_26, OTOA-001_27, OTOA-001_28, AC092375-201_5, AC092375-201_6, AC092375-201_7@22.0833333333333@3@62@:otoancorin@:proteinaceous extracellular matrix;apical plasma membrane;sensory perception of sound;anchored to membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22
D171748@186543@186543@deletion@1@29097537@29097597@16@chr16:29097537-29097597@19.2@196@41@0.209@NA@RRN3P2-201_7@4@4@4@NA@NA@NA
D171748@186862@186865@deletion@4@30208297@30208883@16@chr16:30208297-30208883@14.5@67@0@0@CNVR6694.1, CNVR6694.2, CNVR6694.3@GIYD2-001_4, GIYD2-001_5, GIYD2-001_6, SULT1A3-001_2@4.75@0@7@:structure-specific endonuclease subunit SLX1-like;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae);SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae):sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3;sulfotransferase 1A3/1A4-like@:Slx1-Slx4 complex;5'-flap endonuclease activity;DNA repair;protein binding;DNA double-strand break processing involved in repair via single-strand annealing;double-strand break repair via homologous recombination;metal ion binding;crossover junction endodeoxyribonuclease activity:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;cytoplasm;catecholamine metabolic process;cytosol;endoplasmic reticulum unfolded protein response;xenobiotic metabolic process;sulfotransferase activity;activation of signaling protein activity involved in unfolded protein response;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process@NA
D171748@187143@187146@duplication@4@30953698@30960839@16@chr16:30953698-30960839@8.21@789@1070@1.36@NA@FBXL19-201_9, FBXL19-201_10, FBXL19-201_11, ORAI3-201_1@0@0@0@:F-box and leucine-rich repeat protein 19:ORAI calcium release-activated calcium modulator 3@:protein binding;DNA binding;zinc ion binding:protein binding;integral to membrane@NA
D171748@188229@188235@deletion@7@55798611@55813653@16@chr16:55798611-55813653@15.3@540@323@0.598@CNVR6730.1@CES4-202_2, CES4-202_3, CES4-202_4, CES4-202_5, CES4-202_6, CES4-202_7, CES4-202_8@111@105@123@NA@NA@NA
D171748@189959@189969@deletion@11@70162689@70178437@16@chr16:70162689-70178437@49.2@3350@1963@0.586@CNVR6764.1, CNVR6764.3@AC009060-202_5, AC009060-202_6, AC009060-202_7, AC009060-202_8, AC009060-202_9, AC009060-202_10, AC009060-202_11, AC009060-202_12, AC009060-202_13, AC009060-202_14, AC009060-202_15@72@61@77@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
D171748@189972@189974@deletion@3@70187296@70193984@16@chr16:70187296-70193984@10.3@1710@1074@0.628@CNVR6764.1, CNVR6764.3@AC009060-202_18, AC009060-202_19, AC009060-201_5@71.3333333333333@71@72@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
D171748@195871@195871@duplication@1@18996780@18996940@17@chr17:18996780-18996940@8.53@300@526@1.75@CNVR7018.4, CNVR7018.2, CNVR7018.6@AC007952-202_2@92@92@92@NA@NA@NA
D171748@196150@196156@duplication@7@20353178@20358712@17@chr17:20353178-20358712@12.9@264@442@1.67@CNVR7021.1, CNVR7021.3@LGALS9B-201_5, LGALS9B-201_6, LGALS9B-201_7, LGALS9B-201_8, LGALS9B-201_9, LGALS9B-201_10, LGALS9B-201_11@95.1428571428571@75@103@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
D171748@197277@197277@duplication@1@30372721@30372838@17@chr17:30372721-30372838@5.96@85@161@1.89@NA@LRRC37B-001_8@1@1@1@:leucine rich repeat containing 37B@:protein binding;integral to membrane;cytoplasm@NA
D171748@197726@197745@duplication@20@34539180@34625732@17@chr17:34539180-34625732@12.3@139@261@1.88@CNVR7077.1, CNVR7077.13, CNVR7077.19, CNVR7077.2@CCL3L1-205_1, CCL3L1-205_2, CCL3L1-205_3, CCL4L1-202_2, CCL4L1-202_3, CCL4L1-202_4, TBC1D3C-002_1, TBC1D3C-002_2, TBC1D3C-002_3, TBC1D3C-002_4, TBC1D3C-002_5, TBC1D3C-002_6, TBC1D3C-002_7, TBC1D3C-002_8, TBC1D3C-002_9, TBC1D3C-002_10, TBC1D3C-002_11, TBC1D3C-002_12, TBC1D3C-002_13, TBC1D3C-002_14@102.1@34@136@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity@NA
D171748@198032@198041@deletion@10@36351805@36375178@17@chr17:36351805-36375178@36.2@6040@3966@0.657@CNVR7083.3@AC183087-202_5, AC183087-202_6, AC183087-202_7, AC183087-202_8, AC183087-202_9, AC183087-202_10, AC183087-202_11, AC183087-202_12, AC183087-202_13, AC183087-202_14@55.3@42@64@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
D171748@200337@200349@duplication@13@44399690@44592688@17@chr17:44399690-44592688@31.5@230@589@2.56@CNVR7114.2, CNVR7114.1@LRRC37A-001_7, LRRC37A-001_8, LRRC37A-001_9, LRRC37A-001_10, LRRC37A-001_11, LRRC37A-001_12, LRRC37A-001_13, LRRC37A-001_14, LRRC37A-001_15, AC005829-202_1, AC005829-202_2, AC005829-202_3, LRRC37A2-201_1@149.230769230769@114@196@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane@NA
D171748@205726@205726@deletion@1@117045@117305@18@chr18:117045-117305@11.5@360@159@0.442@NA@ENST00000400614_3@26@26@26@NA@NA@NA
D171748@209136@209136@deletion@1@107475@107556@19@chr19:107475-107556@6.11@95@40@0.421@CNVR7451.1, CNVR7451.3@OR4F17-202_2@18@18@18@:olfactory receptor, family 4, subfamily F, member 17@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
D171748@209807@209807@deletion@1@1923071@1923187@19@chr19:1923071-1923187@7.81@260@130@0.5@NA@SCAMP4-001_6@0@0@0@:secretory carrier membrane protein 4@:integral to membrane;transport vesicle;protein transport@NA
D171748@210849@210850@duplication@2@5719717@5720144@19@chr19:5719717-5720144@5.05@257@368@1.43@NA@LONP1-201_1, LONP1-201_2@5@5@5@:lon peptidase 1, mitochondrial@:ADP binding;mitochondrial heavy strand promoter anti-sense binding;mitochondrion;single-stranded RNA binding;sequence-specific DNA binding;ATP binding;four-way junction helicase activity;DNA repair;proteolysis;ATPase activity;mitochondrial matrix;mitochondrion organization;misfolded or incompletely synthesized protein catabolic process;mitochondrial genome maintenance;proteolysis involved in cellular protein catabolic process;serine-type endopeptidase activity;response to aluminum ion;aging;mitochondrial light strand promoter anti-sense binding;oxidation-dependent protein catabolic process;mitochondrial nucleoid;cellular protein complex assembly;response to hormone stimulus;DNA recombination;ATP catabolic process;single-stranded DNA binding;nucleoside-triphosphatase activity;ATP-dependent peptidase activity;response to hypoxia;nucleotide binding;cytoplasm;cellular response to oxidative stress;protein binding;protein homooligomerization;mitochondrial DNA metabolic process;DNA polymerase binding;G-quadruplex DNA binding@NA
D171748@213493@213494@deletion@2@14508472@14508748@19@chr19:14508472-14508748@11.3@113@37@0.327@NA@CD97-205_8, CD97-205_9@10.5@7@14@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
D171748@215926@215926@duplication@1@35849784@35851388@19@chr19:35849784-35851388@5.5@593@878@1.48@CNVR7627.1@AC002511-201_2@12@12@12@:free fatty acid receptor 3@:lipid binding;integral to membrane;G-protein coupled receptor activity;plasma membrane;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
D171748@217290@217291@duplication@2@40367300@40368877@19@chr19:40367300-40368877@6.27@243@383@1.58@CNVR7639.2@FCGBP-201_28, FCGBP-201_29@21.5@13@30@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D171748@217295@217297@deletion@3@40376633@40382827@19@chr19:40376633-40382827@21.3@245@88@0.359@CNVR7639.2@FCGBP-201_22, FCGBP-201_23, FCGBP-201_24@145@131@155@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D171748@217301@217305@duplication@5@40389654@40398511@19@chr19:40389654-40398511@24@435@769@1.77@CNVR7639.2, CNVR7639.3@FCGBP-201_14, FCGBP-201_15, FCGBP-201_16, FCGBP-201_17, FCGBP-201_18@113.6@103@127@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D171748@219545@219545@deletion@1@49206214@49209192@19@chr19:49206214-49209192@11.7@890@439@0.493@NA@FUT2-202_2@1@1@1@:fucosyltransferase 2 (secretor status included)@:Golgi apparatus;galactoside 2-alpha-L-fucosyltransferase activity;carbohydrate metabolic process;Golgi cisterna membrane;protein glycosylation;integral to Golgi membrane;fucosyltransferase activity;membrane;L-fucose catabolic process@: FUCOSYLTRANSFERASE 2; FUT2; VITAMIN B12 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1; B12QTL1
D171748@221167@221168@deletion@2@54724957@54726003@19@chr19:54724957-54726003@12.7@63@2@0.0317@CNVR7721.3, CNVR7721.4@LILRB3-008_4, LILRB3-008_5@129.5@123@136@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D171748@221176@221180@duplication@5@54742700@54745755@19@chr19:54742700-54745755@19.1@1206@1748@1.45@CNVR7721.3, CNVR7721.6@LILRA6-002_4, LILRA6-002_5, LILRA6-002_6, LILRA6-002_7, LILRA6-002_8@52.4@48@62@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D171748@221218@221226@duplication@9@54801929@54809228@19@chr19:54801929-54809228@10.1@1420@1865@1.31@CNVR7722.1@LILRA3-003_2, LILRA3-003_3, LILRA3-003_4, LILRA3-003_5, LILRA3-003_6, LILRA3-003_7, LILRA3-003_8, LILRA3-003_9, LILRA3-003_10@83.8888888888889@3@109@:leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3@:antigen binding;signal transduction;protein binding;extracellular region;plasma membrane;receptor activity;defense response@NA
D171748@221393@221395@duplication@3@55250955@55255537@19@chr19:55250955-55255537@12.1@636@930@1.46@CNVR7725.2, CNVR7725.4, CNVR7725.1@KIR2DL3-201_2, KIR2DL3-201_3, KIR2DL3-201_4@29@27@31@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity@NA
D171748@221397@221400@deletion@4@55267568@55272178@19@chr19:55267568-55272178@41.1@439@140@0.319@CNVR7725.2, CNVR7725.1@KIR2DP1-001_2, KIR2DP1-001_3, KIR2DP1-001_4, KIR2DP1-001_5@99.75@91@107@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity@NA
D171748@221403@221409@deletion@7@55277931@55281337@19@chr19:55277931-55281337@190@1286@50@0.0389@CNVR7725.2, CNVR7725.1@KIR2DL3-201_6, KIR2DL3-201_7, KIR2DL3-201_8, KIR2DP1-001_7, KIR2DP1-001_8, KIR2DP1-001_9, KIR2DL1-002_1@123.428571428571@110@126@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
D171748@221418@221438@deletion@21@55297917@55354374@19@chr19:55297917-55354374@636@4151@159@0.0383@CNVR7725.1, CNVR7725.3@KIR2DL4-001_1, KIR2DL4-001_2, KIR2DL4-001_3, KIR2DL4-001_4, KIR2DL4-001_5, KIR2DL4-001_6, KIR2DL4-001_7, KIR2DL4-001_8, KIR3DP1-001_1, KIR3DP1-001_2, KIR3DP1-001_3, KIR3DL1-201_1, KIR3DL1-201_2, KIR3DL1-201_3, KIR3DL1-201_4, KIR3DL1-201_5, KIR2DS4-001_1, KIR2DS4-001_2, KIR2DS4-001_3, KIR2DS4-001_4, KIR2DS4-001_5@31.1904761904762@22@68@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
D171748@221440@221441@duplication@2@55359208@55360024@19@chr19:55359208-55360024@13.3@1179@1854@1.57@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4-001_7, KIR2DS4-001_8@102@102@102@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
D171748@222563@222563@deletion@1@1569208@1569279@20@chr20:1569208-1569279@5.53@25@0@0@CNVR7763.1@SIRPB1-201_1@128@128@128@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
D171748@231958@231963@duplication@6@16287256@16341418@22@chr22:16287256-16341418@17.1@169@381@2.25@CNVR8071.2, CNVR8071.3@POTEH-002_1, LA16c-59E1-001_1, LA16c-59E1-001_2, LA16c-59E1-001_3, LA16c-59E1-001_4, LA16c-59E1-001_5@50.6666666666667@36@105@:POTE ankyrin domain family, member H@:protein binding@NA
D171748@231966@231968@deletion@3@16345914@16348226@22@chr22:16345914-16348226@5.21@200@119@0.595@CNVR8071.2, CNVR8071.3, CNVR8071.10@LA16c-2F2-001_1, LA16c-2F2-001_2, LA16c-2F2-001_3@54.3333333333333@54@55@NA@NA@NA
D171748@232350@232353@duplication@4@18775046@18778743@22@chr22:18775046-18778743@7.38@155@249@1.61@CNVR8087.5, CNVR8087.2, CNVR8087.7@GGT3P-201_6, AC008132-201_2, AC008132-201_3, AC008132-201_4@96.25@89@104@NA@NA@NA
D171748@232771@232789@deletion@19@20385728@20486673@22@chr22:20385728-20486673@23.3@263@108@0.411@CNVR8094.4, CNVR8094.7@PI4KAP1-204_1, PI4KAP1-204_2, PI4KAP1-204_3, PI4KAP1-204_4, PI4KAP1-204_5, PI4KAP1-204_6, PI4KAP1-204_7, PI4KAP1-204_8, PI4KAP1-204_9, PI4KAP1-204_10, PI4KAP1-204_11, PI4KAP1-204_12, PI4KAP1-204_13, PI4KAP1-204_14, ENST00000434754_1, ENST00000434754_2, ENST00000434754_3, ENST00000434754_4, ENST00000424817_6@150.789473684211@62@172@:RIMS binding protein 3@:protein binding@NA
D171748@233305@233307@deletion@3@22458837@22472375@22@chr22:22458837-22472375@7.89@180@97@0.539@CNVR8103.3, CNVR8103.20, CNVR8103.4, CNVR8103.16, CNVR8103.5, CNVR8103.2@LL22NC03-88E1-001_2, FAM108A6-001_1, FAM108A6-001_2@15.3333333333333@5@22@NA@NA@NA
D171748@234471@234471@duplication@1@29763198@29763260@22@chr22:29763198-29763260@4.74@240@363@1.51@NA@AP1B1-202_2@38@38@38@:adaptor-related protein complex 1, beta 1 subunit@:cytoplasmic vesicle membrane;post-Golgi vesicle-mediated transport;binding;transporter activity;Golgi membrane;intracellular protein transport;protein transport;viral reproduction;clathrin-coated vesicle membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;regulation of defense response to virus by virus;membrane coat;endocytosis;lysosomal membrane;clathrin adaptor complex;protein transporter activity;cytosol;protein binding;cellular membrane organization;vesicle-mediated transport;trans-Golgi network membrane@NA
D171748@234474@234474@deletion@1@29819116@29819183@22@chr22:29819116-29819183@7.97@213@101@0.474@NA@AC000041-001_1@0@0@0@:adaptor-related protein complex 1, beta 1 subunit@:cytoplasmic vesicle membrane;post-Golgi vesicle-mediated transport;binding;transporter activity;Golgi membrane;intracellular protein transport;protein transport;viral reproduction;clathrin-coated vesicle membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;regulation of defense response to virus by virus;membrane coat;endocytosis;lysosomal membrane;clathrin adaptor complex;protein transporter activity;cytosol;protein binding;cellular membrane organization;vesicle-mediated transport;trans-Golgi network membrane@NA
D171748@236819@236838@duplication@20@42910114@42970825@22@chr22:42910114-42970825@41.5@1339@2024@1.51@CNVR8171.2, CNVR8171.3@RRP7A-001_1, RRP7A-001_2, RRP7A-001_3, RRP7A-001_4, RRP7A-001_5, RRP7A-001_6, SERHL2-203_1, SERHL2-203_2, SERHL2-203_3, SERHL2-203_4, SERHL2-203_5, SERHL2-203_6, SERHL2-203_7, SERHL2-203_8, SERHL2-203_9, SERHL2-203_10, SERHL2-203_11, SERHL2-203_12, RRP7B-203_7, RRP7B-203_8@20.05@2@42@:ribosomal RNA processing 7 homolog A (S. cerevisiae):serine hydrolase-like 2@:RNA binding;nucleotide binding:hydrolase activity;mitochondrion;peroxisome;cytoplasmic membrane-bounded vesicle;molecular_function;cellular_component;perinuclear region of cytoplasm;biological_process@NA
D171987@612@612@duplication@1@1654029@1654074@1@chr1:1654029-1654074@6.52@98@164@1.67@CNVR17.1@CDC2L2-208_3@25@25@25@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division@NA
D171987@616@616@deletion@1@1656279@1656862@1@chr1:1656279-1656862@5.62@136@78@0.574@CNVR17.1@SLC35E2-002_7@24@24@24@:solute carrier family 35, member E2@:integral to membrane;membrane@NA
D171987@624@624@deletion@1@1670363@1670497@1@chr1:1670363-1670497@7.47@144@76@0.528@CNVR17.1@SLC35E2-002_4@28@28@28@:solute carrier family 35, member E2@:integral to membrane;membrane@NA
D171987@2303@2318@deletion@16@12888359@12943232@1@chr1:12888359-12943232@38.5@1801@1136@0.631@CNVR72.3, CNVR72.4, CNVR72.7, CNVR72.12@PRAMEF11-001_1, PRAMEF11-001_2, ENST00000438176_1, ENST00000438176_2, ENST00000438176_3, HNRNPCL1-001_1, HNRNPCL1-001_2, PRAMEF2-001_1, PRAMEF2-001_2, PRAMEF2-001_3, PRAMEF2-001_4, RP11-450I1-201_3, RP11-450I1-201_4, PRAMEF4-001_2, PRAMEF4-001_3, PRAMEF4-001_4@34.0625@18@50@:PRAME family member 11:heterogeneous nuclear ribonucleoprotein C-like 1-like;heterogeneous nuclear ribonucleoprotein C-like;heterogeneous nuclear ribonucleoprotein C-like 1:PRAME family member 2:PRAME family member 4@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:ribonucleoprotein complex;RNA binding;nucleus;nucleotide binding;nucleic acid binding:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
D171987@2328@2331@deletion@4@12985992@13001396@1@chr1:12985992-13001396@9.86@132@62@0.47@CNVR72.3, CNVR72.4, CNVR72.2, CNVR72.9@RP11-450I1-001_1, RP11-450I1-001_2, PRAMEF6-201_3, PRAMEF6-201_4@44@33@54@:PRAME family member 6;PRAME family member 23;PRAME family member 9/15-like;PRAME family member 5@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
D171987@2737@2740@deletion@4@16361675@16366192@1@chr1:16361675-16366192@7@235@146@0.621@CNVR92.1@ENST00000447882_2, ENST00000447882_3, ENST00000447882_4, ENST00000447882_5@17.25@9@40@NA@NA@NA
D171987@2931@2936@duplication@6@16972895@16974077@1@chr1:16972895-16974077@11.1@1114@1446@1.3@CNVR93.3, CNVR93.6, CNVR93.12, CNVR93.7, CNVR93.14, CNVR93.15@RP5-1182A14-001_2, RP5-1182A14-001_3, RP5-1182A14-001_4, RP5-1182A14-001_5, RP5-1182A14-001_6, RP5-1182A14-001_7@42.1666666666667@39@48@NA@NA@NA
D171987@2942@2951@duplication@10@16975378@17014018@1@chr1:16975378-17014018@18.5@1507@1982@1.32@CNVR93.3, CNVR93.6, CNVR93.12, CNVR93.7, CNVR93.15@RP5-1182A14-001_13, RP5-1182A14-001_14, RP5-1182A14-001_15, RP5-1182A14-001_16, RP5-1182A14-001_17, RP5-1182A14-001_18, RP1-163M9-001_2, RP1-163M9-001_3, RP1-163M9-001_4, RP1-163M9-001_5@58.1@22@88@:UPF0627 protein ENSP00000341061/ENSP00000339743-like;UPF0627 protein ENSP00000341061/ENSP00000339743@NA@NA
D171987@2999@3021@deletion@23@17198306@17275020@1@chr1:17198306-17275020@20@2297@1626@0.708@CNVR94.4, CNVR94.5@ENST00000356370_1, ENST00000438002_1, ENST00000438002_2, ENST00000457075_1, ENST00000457075_2, CROCC-201_1, CROCC-201_2, CROCC-201_3, CROCC-201_4, CROCC-201_5, CROCC-201_6, CROCC-201_7, CROCC-201_8, CROCC-201_9, CROCC-201_10, CROCC-201_11, CROCC-201_12, CROCC-201_13, CROCC-201_14, CROCC-201_15, CROCC-201_16, CROCC-201_17, CROCC-201_18@66.8260869565217@20@85@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
D171987@4452@4459@deletion@8@25611066@25648454@1@chr1:25611066-25648454@23.4@1102@716@0.65@CNVR116.1, CNVR116.2@RHD-202_2, RHD-202_3, RHD-202_4, RHD-202_5, RHD-202_6, RHD-202_7, RHD-202_8, RHD-202_9@125.125@121@128@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
D171987@11245@11246@duplication@2@89476589@89477711@1@chr1:89476589-89477711@7.15@594@787@1.32@CNVR244.1@GBP3-001_7, GBP3-001_8@54@54@54@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
D171987@12416@12417@duplication@2@104202984@104203299@1@chr1:104202984-104203299@6.16@132@201@1.52@CNVR266.3, CNVR266.1@AMY1A-001_7, AMY1A-001_8@123.5@118@129@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D171987@12424@12446@deletion@23@104233918@104297437@1@chr1:104233918-104297437@42.2@472@186@0.394@CNVR266.3, CNVR266.5@AMY1B-001_1, AMY1B-001_2, AMY1B-001_3, AMY1B-001_4, AMY1B-001_5, AMY1B-001_6, AMY1B-001_7, AMY1B-001_8, AMYP1-001_1, AMYP1-001_2, AMYP1-001_3, AMYP1-001_4, AMYP1-001_5, AMYP1-001_6, AMYP1-001_7, AMY1C-201_1, AMY1C-201_2, AMY1C-201_3, AMY1C-201_4, AMY1C-201_5, AMY1C-201_6, AMY1C-201_7, AMY1C-201_8@90.6521739130435@31@154@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D171987@14493@14493@deletion@1@144676872@144677050@1@chr1:144676872-144677050@9.12@41@0@0@CNVR337.1@WI2-1896O14-001_3@5@5@5@NA@NA@NA
D171987@15397@15430@deletion@34@149036437@149115112@1@chr1:149036437-149115112@27.1@899@563@0.626@CNVR350.3, CNVR350.1@RP11-744H18-001_1, RP11-744H18-001_2, RP11-744H18-001_3, RP11-744H18-001_4, RP11-744H18-001_5, RP11-744H18-001_6, RP11-744H18-001_7, RP11-744H18-001_8, RP11-744H18-001_9, RP11-744H18-001_10, RP11-744H18-001_11, RP11-744H18-001_12, RP11-744H18-001_13, RP11-744H18-001_14, RP11-744H18-001_15, RP11-744H18-001_16, RP11-744H18-001_17, ENST00000401087_2, ENST00000401087_3, ENST00000401087_4, ENST00000401087_5, ENST00000401087_6, ENST00000401087_7, ENST00000401087_8, ENST00000401087_9, ENST00000401087_10, ENST00000401087_11, ENST00000401087_12, ENST00000401087_13, ENST00000401087_14, ENST00000401087_15, ENST00000401087_16, RP11-403I13-201_1, RP11-403I13-201_2@79.7647058823529@11@87@NA@NA@NA
D171987@15456@15462@deletion@7@149375000@149400543@1@chr1:149375000-149400543@23.2@662@396@0.598@CNVR350.1@FCGR1C-201_4, FCGR1C-201_5, FCGR1C-201_6, ENST00000415338_1, HIST2H3PS2-001_1, HIST2H3PS2-001_2, RP5-998N21-002_1@73.7142857142857@70@76@NA@NA@NA
D171987@18672@18675@deletion@4@161559354@161562033@1@chr1:161559354-161562033@19.8@337@170@0.504@CNVR383.1@FCGR2C-006_3, FCGR2C-006_4, FCGR2C-006_5, FCGR2C-006_6@47.75@37@57@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
D171987@18687@18690@duplication@4@161641184@161643020@1@chr1:161641184-161643020@10.6@333@482@1.45@CNVR383.1@FCGR2B-207_4, FCGR2B-207_5, ENST00000453111_2, ENST00000453111_3@16@14@19@:Fc fragment of IgG, low affinity IIb, receptor (CD32)@:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
D171987@21362@21365@deletion@4@196743977@196757529@1@chr1:196743977-196757529@10.3@506@334@0.66@CNVR459.1@CFHR3-001_1, CFHR3-001_2, CFHR3-001_3, CFHR3-001_4@94@85@100@:complement factor H-related 3@:extracellular space@NA
D171987@21372@21374@deletion@3@196797202@196801320@1@chr1:196797202-196801320@28@752@444@0.59@CNVR459.1@CFHR1-001_4, CFHR1-001_5, CFHR1-001_6@104@96@119@:complement factor H-related 1:complement factor H-related 2@:extracellular space;complement activation:extracellular region@NA
D171987@23024@23025@deletion@2@207700100@207700469@1@chr1:207700100-207700469@6.65@30@0@0@CNVR485.1@CR1-201_6, CR1-201_7@17@7@27@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
D171987@23032@23039@duplication@8@207718655@207726325@1@chr1:207718655-207726325@7.07@36@86@2.39@CNVR485.1@CR1-201_14, CR1-201_15, CR1-201_16, CR1-201_17, CR1-201_18, CR1-201_19, RP11-78B10-001_1, RP11-78B10-001_2@61@52@98@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
D171987@23042@23043@deletion@2@207737211@207737580@1@chr1:207737211-207737580@8.92@54@10@0.185@CNVR485.1, CNVR485.2@CR1-201_22, CR1-201_23@11@9@13@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
D171987@23045@23045@deletion@1@207741171@207741388@1@chr1:207741171-207741388@5.2@278@181@0.651@CNVR485.1, CNVR485.2@CR1-201_25@16@16@16@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
D171987@24160@24170@deletion@11@223727670@223797884@1@chr1:223727670-223797884@8.91@142@74@0.521@NA@CAPN8-202_14, CAPN8-202_15, CAPN8-202_16, CAPN8-202_17, CAPN8-202_19, CAPN8-202_20, CAPN8-202_21, CAPN8-202_22, CAPN8-202_23, CAPN8-202_24@0@0@0@:calpain 8@:proteolysis;Golgi apparatus;intracellular;calcium-dependent cysteine-type endopeptidase activity;calcium ion binding@NA
D171987@30719@30724@duplication@6@48844979@48860261@2@chr2:48844979-48860261@16.3@527@749@1.42@NA@STON1-GTF2A1L-003_4, STON1-GTF2A1L-003_5, GTF2A1L-001_1, GTF2A1L-001_2, GTF2A1L-001_3, LHCGR-002_13@0@0@0@:STON1-GTF2A1L readthrough:general transcription factor IIA, 1-like:luteinizing hormone/choriogonadotropin receptor@:transcription initiation from RNA polymerase II promoter;intracellular protein transport;protein binding;endocytosis;vesicle-mediated transport;clathrin adaptor complex;transcription factor TFIIA complex:transcription initiation from RNA polymerase II promoter;transcription coactivator activity;DNA binding;regulation of transcription, DNA-dependent;transcription from RNA polymerase II promoter;transcription factor TFIIA complex:ATPase binding;positive regulation of calcium-mediated signaling;ovarian follicle development;positive regulation of release of sequestered calcium ion into cytosol;plasma membrane;nucleus;endosome;G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger;endoplasmic reticulum;seminiferous tubule development;choriogonadotropin hormone binding;receptor complex;male genitalia development;peptide hormone binding;uterus development;arachidonic acid secretion;positive regulation of hormone biosynthetic process;central nervous system development;choriogonadotropin hormone receptor activity;positive regulation of inositol trisphosphate biosynthetic process;hormone-mediated signaling pathway;male gonad development;phospholipase C-activating G-protein coupled receptor signaling pathway;activation of adenylate cyclase activity;response to drug;positive regulation of cAMP-mediated signaling;spermatogenesis;extracellular space;integral to membrane;protein targeting to lysosome;adenylate cyclase-modulating G-protein coupled receptor signaling pathway;protein homodimerization activity;integral to plasma membrane;lysosome;development of secondary male sexual characteristics;G-protein coupled receptor signaling pathway;G-protein coupled peptide receptor activity;intrinsic to external side of plasma membrane;female gonad development;cellular response to gonadotropin stimulus;luteinizing hormone receptor activity;regulation of steroid hormone biosynthetic process;ovulation cycle process@: LEYDIG CELL HYPOPLASIA, TYPE I; PRECOCIOUS PUBERTY, MALE-LIMITED
D171987@33560@33564@duplication@5@87408191@87414366@2@chr2:87408191-87414366@14.1@317@480@1.51@CNVR861.2@AC083899-001_24, AC083899-001_25, AC083899-001_26, AC083899-001_27, AC083899-001_28@75.6@70@85@NA@NA@NA
D171987@33778@33779@deletion@2@89567760@89568264@2@chr2:89567760-89568264@5.95@102@54@0.529@CNVR866.7, CNVR866.1@IGKV1-33-001_1, IGKV1-33-001_2@4.5@4@5@@:protein binding@NA
D171987@33832@33836@deletion@5@90192770@90211789@2@chr2:90192770-90211789@6.82@626@442@0.706@CNVR867.10, CNVR867.3, CNVR867.9, CNVR867.2@IGKV1D-13-001_1, IGKV1D-13-001_2, IGKV1D-12-001_1, IGKV1D-12-001_2, IGKV3D-11-001_1@8.2@7@10@@:protein binding:protein binding:protein binding@NA
D171987@34092@34099@duplication@8@96457910@96459584@2@chr2:96457910-96459584@8.3@275@386@1.4@NA@AC008268-201_2, AC008268-201_3, AC008268-201_4, AC008268-201_5, ENST00000444924_1, ENST00000444924_2, ENST00000444924_3, ENST00000444924_4@68.875@26@104@NA@NA@NA
D171987@34212@34213@deletion@2@96697783@96698114@2@chr2:96697783-96698114@8.17@128@65@0.508@NA@GPAT2-205_3, GPAT2-205_4@75.5@75@76@:glycerol-3-phosphate acyltransferase 2, mitochondrial@:glycerol-3-phosphate O-acyltransferase activity;mitochondrion;phospholipid metabolic process;triglyceride biosynthetic process;glycerophospholipid biosynthetic process;small molecule metabolic process;transferase activity, transferring acyl groups;mitochondrial outer membrane;phosphatidic acid biosynthetic process;integral to membrane;glycerol-3-phosphate metabolic process;CDP-diacylglycerol biosynthetic process;membrane;metabolic process;phospholipid biosynthetic process@NA
D171987@35461@35463@duplication@3@106992909@106994704@2@chr2:106992909-106994704@9.88@104@189@1.82@NA@ENST00000447760_4, ENST00000447760_5, ENST00000447760_6@20@11@27@NA@NA@NA
D171987@37465@37466@deletion@2@132236883@132238089@2@chr2:132236883-132238089@10.3@375@233@0.621@NA@TUBA3D-002_3, TUBA3D-002_4@1.5@1@2@:microRNA 4784;mitotic spindle organizing protein 2A:tubulin, alpha 3c;tubulin, alpha 3d@:gamma-tubulin ring complex;centrosome;spindle:microtubule-based process;structural constituent of cytoskeleton;protein folding;protein polymerization;cytoplasmic microtubule;GTP binding;microtubule cytoskeleton organization;GTPase activity;GTP catabolic process;protein complex;cytoplasm;microtubule cytoskeleton;protein binding;'de novo' posttranslational protein folding;cellular protein metabolic process;microtubule-based movement;structural molecule activity;microtubule;protein domain specific binding@NA
D171987@46353@46353@deletion@1@241631264@241631338@2@chr2:241631264-241631338@5.37@51@19@0.373@NA@AQP12A-201_1@25@25@25@:aquaporin 12A@:transport;integral to membrane;transporter activity;membrane@NA
D171987@46750@46751@duplication@2@243037040@243037179@2@chr2:243037040-243037179@13.3@411@604@1.47@CNVR1236.5@AC093642-002_2, AC134873-201_2@3@3@3@NA@NA@NA
D171987@49555@49555@deletion@1@39685539@39686197@3@chr3:39685539-39686197@5.97@74@33@0.446@NA@RP11-420K5-001_2@0@0@0@NA@NA@NA
D171987@61595@61595@deletion@1@195505663@195510237@3@chr3:195505663-195510237@5.42@308@202@0.656@CNVR1704.1@MUC4-203_3@8@8@8@:mucin 4, cell surface associated@:ErbB-2 class receptor binding;Golgi lumen;cell-matrix adhesion;post-translational protein modification;extracellular matrix structural constituent;protein binding;O-glycan processing;cellular protein metabolic process;proteinaceous extracellular matrix;integral to plasma membrane;membrane;extracellular matrix constituent, lubricant activity;biological_process@NA
D171987@61657@61659@deletion@3@195712500@195712661@3@chr3:195712500-195712661@6.12@57@21@0.368@CNVR1707.1, CNVR1707.2@SDHALP1-002_3, ENST00000354937_4, ENST00000354937_5@63.6666666666667@63@64@NA@NA@NA
D171987@65315@65319@deletion@5@69402904@69431439@4@chr4:69402904-69431439@119@595@23@0.0387@CNVR1953.1@UGT2B17-001_2, UGT2B17-001_3, UGT2B17-001_4, UGT2B17-001_5, UGT2B17-001_6@125.8@118@134@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
D171987@65321@65325@duplication@5@69512318@69533907@4@chr4:69512318-69533907@31.6@1126@1668@1.48@CNVR1953.1@UGT2B15-201_2, UGT2B15-201_3, UGT2B15-201_4, UGT2B15-201_5, UGT2B15-201_6@11.4@6@16@:UDP glucuronosyltransferase 2 family, polypeptide B15@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;cellular glucuronidation;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
D171987@65799@65801@deletion@3@75312253@75316250@4@chr4:75312253-75316250@17.6@165@57@0.345@NA@AREG-001_2, AREG-001_3, AREG-001_4@36.3333333333333@28@52@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
D171987@65805@65807@duplication@3@75482008@75486007@4@chr4:75482008-75486007@16.6@118@258@2.19@NA@AREGB-201_2, AREGB-201_3, AREGB-201_4@50.3333333333333@45@56@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
D171987@68947@68947@deletion@1@145041645@145041742@4@chr4:145041645-145041742@5.56@115@63@0.548@NA@GYPA-205_2@8@8@8@:glycophorin B (MNS blood group):glycophorin A (MNS blood group)@:integral to membrane;plasma membrane;integral to plasma membrane:external side of plasma membrane;integral to membrane;cytoskeletal anchoring at plasma membrane;plasma membrane;molecular_function;protein homodimerization activity;integral to plasma membrane;cellular_component;identical protein binding;membrane;biological_process;regulation of response to osmotic stress;virus-host interaction@: BLOOD GROUP--Ss LOCUS; Ss: MALARIA, SUSCEPTIBILITY TO; BLOOD GROUP--MN LOCUS; MN
D171987@69769@69769@duplication@1@165890632@165891492@4@chr4:165890632-165891492@8.35@225@341@1.52@NA@TRIM61-201_3@0@0@0@:tripartite motif containing 61@:protein binding;intracellular;zinc ion binding@NA
D171987@70687@70688@duplication@2@190945524@190947617@4@chr4:190945524-190947617@9.12@751@1000@1.33@CNVR2258.3@FRG2-201_3, FRG2-201_4@20.5@15@26@:FSHD region gene 2-like;FSHD region gene 2@:nucleus@NA
D171987@70821@70823@deletion@3@745300@751373@5@chr5:745300-751373@17.9@360@195@0.542@CNVR2280.3@ZDHHC11B-201_4, ZDHHC11B-201_5, ZDHHC11B-201_6@89.6666666666667@86@96@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
D171987@71600@71605@duplication@6@21480883@21484666@5@chr5:21480883-21484666@7.85@100@168@1.68@CNVR2395.4, CNVR2395.6, CNVR2395.2@AC138951-202_1, AC138951-202_2, ENST00000412250_1, ENST00000412250_2, ENST00000412250_3, ENST00000412250_4@107.166666666667@105@108@NA@NA@NA
D171987@71895@71898@deletion@4@34182208@34191311@5@chr5:34182208-34191311@10.2@413@268@0.649@CNVR2430.2, CNVR2430.1@AC138409-202_6, ENST00000380721_1, ENST00000502234_2, AC138409-201_1@38.75@22@49@NA@NA@NA
D171987@73727@73727@deletion@1@69717564@69717599@5@chr5:69717564-69717599@13.9@63@0@0@CNVR2494.17, CNVR2494.3@GTF2H2B-201_4@139@139@139@NA@NA@NA
D171987@73746@73754@deletion@9@69796546@69807068@5@chr5:69796546-69807068@7.4@36@2@0.0556@CNVR2494.10, CNVR2494.57@AC146944-203_1, AC146944-203_2, ENST00000456583_1, ENST00000456583_2, ENST00000456583_3, ENST00000456583_4, ENST00000456583_5, AC146944-202_1, AC146944-202_2@152.666666666667@85@173@NA@NA@NA
D171987@73819@73820@deletion@2@70375626@70378820@5@chr5:70375626-70378820@10.9@53@3@0.0566@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.8, CNVR2494.1, CNVR2494.37@AC044797-201_2, AC044797-201_3@129.5@121@138@NA@NA@NA
D171987@78044@78045@duplication@2@147553799@147554962@5@chr5:147553799-147554962@22.1@171@379@2.22@CNVR2637.1@AC116334-001_3, AC116334-001_4@43.5@9@78@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
D171987@79566@79568@duplication@3@175386532@175388438@5@chr5:175386532-175388438@18.6@158@311@1.97@NA@THOC3-001_4, THOC3-001_5, THOC3-001_6@169@160@182@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
D171987@80019@80019@duplication@1@177163582@177163611@5@chr5:177163582-177163611@5.15@64@111@1.73@NA@FAM153A-204_12@78@78@78@:family with sequence similarity 153, member A@NA@NA
D171987@80022@80024@duplication@3@177166603@177168334@5@chr5:177166603-177168334@13.8@93@198@2.13@NA@FAM153A-204_7, FAM153A-204_8, FAM153A-204_9@94@86@106@:family with sequence similarity 153, member A@NA@NA
D171987@80479@80487@deletion@9@180375357@180429786@5@chr5:180375357-180429786@14.6@823@550@0.668@CNVR2719.1@BTNL8-202_5, BTNL8-202_6, BTNL8-202_7, BTNL8-202_8, BTNL3-202_1, BTNL3-202_2, BTNL3-202_3, BTNL3-202_5@102.375@90@108@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
D171987@82488@82513@deletion@26@29855352@29897010@6@chr6:29855352-29897010@77.9@1854@1057@0.57@CNVR2829.7, CNVR2829.2, CNVR2829.3@HLA-H-001_1, HLA-H-001_2, HLA-H-001_3, HLA-H-001_4, HLA-H-001_5, HLA-H-001_6, HLA-H-001_7, HLA-16-001_1, HLA-16-001_2, HLA-16-001_3, HLA-16-001_4, AL645929-201_2, AL645929-201_3, AL645929-201_4, AL645929-201_5, AL645929-201_6, BAT1P1-001_1, BAT1P1-001_2, MCCD1P1-001_1, MCCD1P1-001_2, HLA-K-001_1, HLA-K-001_2, HLA-K-001_3, HLA-K-001_4, HLA-K-001_5, HLA-K-001_6@45.2307692307692@41@51@NA@NA@NA
D171987@83002@83003@deletion@2@31237745@31238263@6@chr6:31237745-31238263@21.8@350@169@0.483@CNVR2838.2, CNVR2838.1@HLA-C-006_4, HLA-C-006_5@25@25@25@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
D171987@83017@83018@deletion@2@31324480@31324990@6@chr6:31324480-31324990@6.42@204@125@0.613@CNVR2841.12, CNVR2841.14, CNVR2841.8@HLA-B-201_1, HLA-B-201_2@67@62@72@:major histocompatibility complex, class I, B@:MHC class I protein complex;regulation of immune response;regulation of interleukin-12 production;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;regulation of T cell anergy;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;receptor binding;early endosome membrane;virus-host interaction;regulation of interleukin-6 production;regulation of dendritic cell differentiation;phagocytic vesicle membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO; SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1
D171987@83577@83577@deletion@1@31962024@31962162@6@chr6:31962024-31962162@8.92@42@1@0.0238@CNVR2843.6, CNVR2843.3@C4A-001_20@12@12@12@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
D171987@83910@83923@deletion@14@32441204@32525964@6@chr6:32441204-32525964@58.5@596@233@0.391@CNVR2845.21, CNVR2845.25@HLA-DRB9-001_1, HLA-DRB5-001_1, HLA-DRB5-001_2, HLA-DRB5-001_3, HLA-DRB5-001_4, HLA-DRB5-001_5, HLA-DRB5-001_6, HLA-DRB6-002_2, HLA-DRB6-002_3, HLA-DRB6-002_4, HLA-DRB6-002_5, HLA-DRB6-002_6, AL713966-201_2, AL713966-201_3@148.071428571429@44@189@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D171987@83928@83928@duplication@1@32548525@32548634@6@chr6:32548525-32548634@6.24@87@148@1.7@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.5, CNVR2845.4@HLA-DRB1-001_4@56@56@56@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
D171987@83932@83947@duplication@16@32605206@32636161@6@chr6:32605206-32636161@166@1221@2715@2.22@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20@HLA-DQA1-002_1, HLA-DQA1-002_2, HLA-DQA1-002_3, HLA-DQA1-002_4, HLA-DQA1-002_5, HLA-DQA1-002_6, HLA-DQB1-003_1, HLA-DQB1-003_2, HLA-DQB1-003_3, HLA-DQB1-003_4, HLA-DQB1-003_5, HLA-DQB1-003_6, XXbac-BPG254F23-001_1, XXbac-BPG254F23-001_2, ENST00000443574_1, ENST00000443574_2@112.75@4@146@:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
D171987@84706@84710@deletion@5@35754777@35765089@6@chr6:35754777-35765089@19.1@1045@684@0.655@CNVR2861.1@C6orf127-001_2, C6orf127-001_3, CLPS-001_1, CLPS-001_2, CLPS-001_3@39@30@43@:colipase-like 1:colipase, pancreatic@:extracellular region;enzyme activator activity;digestion;lipid catabolic process:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
D171987@92590@92593@duplication@4@160132511@160133097@6@chr6:160132511-160133097@25.2@577@889@1.54@CNVR3127.2, CNVR3127.1@ENST00000442642_4, ENST00000442642_5, ENST00000442642_6, ENST00000442642_7@103.5@90@112@:superoxide dismutase 2, mitochondrial;uncharacterized LOC100129518@:response to reactive oxygen species;oxidation-reduction process;mitochondrion;negative regulation of cell proliferation;neuron development;negative regulation of fat cell differentiation;removal of superoxide radicals;response to gamma radiation;response to L-ascorbic acid;response to lipopolysaccharide;response to nutrient levels;response to zinc ion;protein homotetramerization;post-embryonic development;iron ion homeostasis;hemopoiesis;aging;mitochondrial inner membrane;age-dependent response to reactive oxygen species;response to drug;oxygen binding;mitochondrial nucleoid;vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure;apoptotic process;superoxide metabolic process;response to superoxide;detection of oxygen;response to silicon dioxide;cytoplasm;response to stress;respiratory electron transport chain;superoxide anion generation;protein homooligomerization;regulation of mitochondrial membrane potential;positive regulation of nitric oxide biosynthetic process;response to manganese ion;regulation of blood pressure;metal ion binding;negative regulation of apoptotic process;response to cadmium ion;response to oxidative stress;liver development;regulation of catalytic activity;negative regulation of fibroblast proliferation;response to selenium ion;age-dependent response to oxidative stress;response to electrical stimulus;mitochondrial matrix;identical protein binding;mitochondrion organization;response to hyperoxia;vasodilation;response to hydrogen peroxide;superoxide dismutase activity;heart development;negative regulation of neuron apoptotic process;erythrophore differentiation;locomotory behavior;DNA binding;release of cytochrome c from mitochondria;response to axon injury;oxygen homeostasis;response to activity;glutathione metabolic process;hydrogen peroxide metabolic process;hydrogen peroxide biosynthetic process;regulation of transcription from RNA polymerase II promoter;response to hypoxia;protein binding;manganese ion binding;cellular response to ethanol@: MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6; MVCD6
D171987@92795@92795@duplication@1@161054787@161054945@6@chr6:161054787-161054945@4.93@20@55@2.75@CNVR3133.1@LPA-201_9@123@123@123@:lipoprotein, Lp(a)@:blood circulation;endopeptidase inhibitor activity;catalytic activity;lipoprotein metabolic process;proteolysis;heparin binding;receptor-mediated endocytosis;fibronectin binding;small molecule metabolic process;apolipoprotein binding;lipid metabolic process;negative regulation of endopeptidase activity;extracellular region;plasma lipoprotein particle;lipid transport;serine-type endopeptidase activity@: APOLIPOPROTEIN(a); LPA
D171987@93100@93100@duplication@1@167791445@167791581@6@chr6:167791445-167791581@6.92@166@253@1.52@NA@TCP10-001_4@76@76@76@:t-complex 10@:cytosol@NA
D171987@94200@94201@duplication@2@5982957@5983622@7@chr7:5982957-5983622@5.4@328@440@1.34@NA@RSPH10B-002_14, RSPH10B-002_15@12@10@14@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D171987@94209@94212@duplication@4@6000324@6006833@7@chr7:6000324-6006833@5.54@201@283@1.41@NA@RSPH10B-002_3, RSPH10B-002_4, RSPH10B-002_5, RSPH10B-002_6@10@8@13@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D171987@94425@94432@deletion@8@6806390@6821108@7@chr7:6806390-6821108@24.6@296@124@0.419@NA@RSPH10B2-204_8, RSPH10B2-204_9, RSPH10B2-204_10, RSPH10B2-204_11, RSPH10B2-204_12, RSPH10B2-204_13, RSPH10B2-204_14, RSPH10B2-204_15@13.375@11@19@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D171987@94438@94444@deletion@7@6836201@6844687@7@chr7:6836201-6844687@15.1@369@217@0.588@NA@RSPH10B2-204_20, RSPH10B2-204_21, ENST00000429267_1, C7orf28B-001_12, C7orf28B-001_13, C7orf28B-001_14, C7orf28B-001_15@90.8571428571429@25@121@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D171987@97912@97917@deletion@6@57071006@57084498@7@chr7:57071006-57084498@11.2@70@14@0.2@NA@TNRC18C-202_8, TNRC18C-202_9, TNRC18C-202_10, TNRC18C-202_11, ENST00000398760_4, ENST00000398760_5@155.5@144@166@NA@NA@NA
D171987@97993@97994@duplication@2@62758644@62758771@7@chr7:62758644-62758771@5.71@495@650@1.31@NA@AC006455-201_2, ENST00000444809_2@161@151@171@NA@NA@NA
D171987@98192@98193@deletion@2@64646770@64646889@7@chr7:64646770-64646889@5.23@60@26@0.433@NA@INTS4L1-201_8, INTS4L1-201_9@51.5@51@52@NA@NA@NA
D171987@99063@99063@deletion@1@74251404@74251506@7@chr7:74251404-74251506@6.4@29@0@0@NA@GTF2IRD2-002_2@8@8@8@:GTF2I repeat domain containing 2@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
D171987@99091@99091@duplication@1@74422162@74422231@7@chr7:74422162-74422231@7.56@5@52@10.4@NA@AC118138-001_2@6@6@6@:GATS protein-like 1@NA@NA
D171987@99185@99185@deletion@1@74824185@74824254@7@chr7:74824185-74824254@6.72@104@51@0.49@NA@GATSL1-001_2@11@11@11@:GATS protein-like 2@NA@NA
D171987@99544@99545@deletion@2@76723321@76728269@7@chr7:76723321-76728269@20.6@123@19@0.154@NA@ENST00000398321_6, ENST00000398321_7@13.5@11@16@NA@NA@NA
D171987@101492@101494@duplication@3@99936398@99936513@7@chr7:99936398-99936513@11.5@443@621@1.4@CNVR3508.2@PILRB-001_3, CTB-161A2-201_3, CTB-161A2-001_3@1@1@1@:paired immunoglobin-like type 2 receptor beta@:protein binding;transmembrane receptor protein tyrosine kinase signaling pathway;activation of transmembrane receptor protein tyrosine kinase activity;integral to plasma membrane@NA
D171987@101724@101726@duplication@3@100334434@100336237@7@chr7:100334434-100336237@6.68@440@587@1.33@CNVR3509.1@ZAN-001_5, ZAN-001_6, ZAN-001_7@79.6666666666667@71@87@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
D171987@104579@104579@duplication@1@134221805@134221910@7@chr7:134221805-134221910@6.95@106@177@1.67@NA@AKR1B10-001_6@2@2@2@:aldo-keto reductase family 1, member B10 (aldose reductase)@:steroid metabolic process;cellular aldehyde metabolic process;indanol dehydrogenase activity;daunorubicin metabolic process;retinal dehydrogenase activity;farnesol catabolic process;geranylgeranyl reductase activity;protein binding;extracellular region;aldo-keto reductase (NADP) activity;digestion;doxorubicin metabolic process;cellular_component;lysosome@NA
D171987@105315@105315@duplication@1@141760113@141760174@7@chr7:141760113-141760174@6.37@174@259@1.49@CNVR3585.3, CNVR3585.2@MGAM-007_34@8@8@8@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
D171987@105331@105335@duplication@5@141780593@141784445@7@chr7:141780593-141784445@9.68@717@944@1.32@CNVR3585.3, CNVR3585.2@MGAM-007_50, MGAM-007_51, MGAM-007_52, MGAM-007_53, MGAM-007_54@123.8@123@125@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
D171987@105338@105338@deletion@1@141786457@141786518@7@chr7:141786457-141786518@14@64@0@0@CNVR3585.3, CNVR3585.2, CNVR3585.1, CNVR3585.4@MGAM-007_57@134@134@134@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
D171987@105521@105523@deletion@3@142481247@142482417@7@chr7:142481247-142482417@98.7@479@8@0.0167@NA@PRSS1-204_4, PRSS1-204_5, PRSS1-204_6@114.333333333333@113@115@NA@NA@NA
D171987@105785@105803@deletion@19@143969540@143979884@7@chr7:143969540-143979884@70.1@1022@470@0.46@CNVR3598.4, CNVR3598.9@RP4-798C17-001_3, RP4-798C17-001_4, RP4-798C17-001_5, RP4-798C17-001_6, RP4-798C17-001_7, RP4-798C17-001_8, RP4-798C17-001_9, RP4-798C17-001_10, RP4-798C17-001_11, RP4-798C17-001_12, ENST00000378112_4, ENST00000378112_5, ENST00000378112_6, ENST00000378112_7, ENST00000378112_8, ENST00000378112_9, ENST00000378112_10, ENST00000378112_11, ENST00000378112_12@85.1578947368421@37@137@:Rho guanine nucleotide exchange factor (GEF) 35@NA@NA
D171987@105806@105807@deletion@2@143980908@143984072@7@chr7:143980908-143984072@35.1@390@144@0.369@CNVR3598.4, CNVR3598.9@RP4-798C17-001_1, ENST00000378112_2@66@65@67@:Rho guanine nucleotide exchange factor (GEF) 35@NA@NA
D171987@105821@105822@duplication@2@144063941@144064449@7@chr7:144063941-144064449@9.14@10@67@6.7@CNVR3598.4, CNVR3598.5, CNVR3598.11@ARHGEF5-001_4, ARHGEF5-001_5@84.5@65@104@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
D171987@107424@107435@duplication@12@7272384@7343923@8@chr8:7272384-7343923@40.6@788@1254@1.59@CNVR3771.8, CNVR3771.10, CNVR3771.4@DEFB4P-001_1, DEFB4P-001_2, DEFB103A-001_1, DEFB103A-001_2, SPAG11-003_1, SPAG11-003_2, SPAG11-003_3, SPAG11-003_4, DEFB104B-001_1, DEFB104B-001_2, DEFB106B-001_1, DEFB106B-001_2@39.4166666666667@7@91@:defensin, beta 4B;defensin, beta 4A:defensin, beta 103B;defensin, beta 103A:sperm associated antigen 11B:defensin, beta 104A;defensin, beta 104B:defensin, beta 106B;defensin, beta 106A@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
D171987@107502@107512@duplication@11@7673083@7717945@8@chr8:7673083-7717945@12.7@562@775@1.38@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@DEFB107A-001_1, DEFB105A-001_1, DEFB105A-001_2, DEFB105A-001_3, DEFB106A-001_1, DEFB106A-001_2, DEFB104A-001_1, DEFB104A-001_2, SPAG11A-207_1, SPAG11A-207_2, SPAG11A-207_3@49.8181818181818@40@113@:defensin, beta 107B;defensin, beta 107A:defensin, beta 105B;defensin, beta 105A:defensin, beta 106B;defensin, beta 106A:defensin, beta 104A;defensin, beta 104B:sperm associated antigen 11A;sperm associated antigen 11B@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response@NA
D171987@109572@109580@duplication@9@39311571@39335463@8@chr8:39311571-39335463@25.2@375@619@1.65@CNVR3859.1@ADAM3A-005_13, ADAM3A-005_14, ADAM3A-005_15, ADAM3A-005_16, ADAM3A-005_17, ADAM3A-005_18, ADAM3A-005_19, ADAM3A-005_20, ADAM3A-005_21@128.555555555556@104@136@NA@NA@NA
D171987@117388@117388@deletion@1@40501668@40501810@9@chr9:40501668-40501810@13.2@205@95@0.463@CNVR4272.1@ENST00000399669_7@13@13@13@NA@NA@NA
D171987@117587@117589@deletion@3@43313716@43314503@9@chr9:43313716-43314503@25.1@222@73@0.329@CNVR4289.2@BX649597-201_1, BX649597-201_2, BX649597-201_3@46@18@61@NA@NA@NA
D171987@117601@117602@deletion@2@43816639@43818185@9@chr9:43816639-43818185@12@361@216@0.598@CNVR4294.1@CNTNAP3B-001_6, CNTNAP3B-001_7@88.5@86@91@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
D171987@117792@117792@deletion@1@65595070@65595188@9@chr9:65595070-65595188@4.96@91@48@0.527@CNVR4312.5@RP11-203I2-001_3@34@34@34@NA@NA@NA
D171987@121600@121601@deletion@2@117085338@117086086@9@chr9:117085338-117086086@9.8@892@597@0.669@CNVR4448.1@ORM1-001_1, ORM1-001_2@87.5@85@90@:orosomucoid 1@:protein binding;extracellular space;regulation of immune system process;transport;inflammatory response;extracellular region;acute-phase response@NA
D171987@124036@124039@duplication@4@135940429@135942593@9@chr9:135940429-135942593@15.8@638@897@1.41@NA@CEL-201_4, CEL-201_5, CEL-201_6, CEL-201_7@9.25@9@10@:carboxyl ester lipase (bile salt-stimulated lipase)@:intestinal lipid catabolic process;pancreatic juice secretion;catalytic activity;extracellular space;heparin binding;sterol esterase activity;carboxylesterase activity;metabolic process;ceramide catabolic process;hydrolase activity;small molecule metabolic process;acylglycerol lipase activity;lipid metabolic process;cytoplasm;protein esterification;cytosol;retinyl-palmitate esterase activity;fatty acid catabolic process;extracellular region;triglyceride lipase activity;lipid digestion;triglyceride metabolic process;cholesterol catabolic process;intestinal cholesterol absorption@: MATURITY-ONSET DIABETES OF THE YOUNG; MODY; MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION;
D171987@124042@124052@duplication@11@135945850@135960431@9@chr9:135945850-135960431@50.6@1512@2236@1.48@CNVR4502.1@CEL-201_10, CEL-201_11, CEL-201_12, RP11-326L24-001_1, RP11-326L24-001_2, CELP-002_1, CELP-002_2, CELP-002_3, AL162417-201_1, AL162417-201_2, AL162417-201_3@58.2727272727273@15@99@:carboxyl ester lipase (bile salt-stimulated lipase)@:intestinal lipid catabolic process;pancreatic juice secretion;catalytic activity;extracellular space;heparin binding;sterol esterase activity;carboxylesterase activity;metabolic process;ceramide catabolic process;hydrolase activity;small molecule metabolic process;acylglycerol lipase activity;lipid metabolic process;cytoplasm;protein esterification;cytosol;retinyl-palmitate esterase activity;fatty acid catabolic process;extracellular region;triglyceride lipase activity;lipid digestion;triglyceride metabolic process;cholesterol catabolic process;intestinal cholesterol absorption@: MATURITY-ONSET DIABETES OF THE YOUNG; MODY; MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION;
D171987@124517@124518@deletion@2@138441156@138441803@9@chr9:138441156-138441803@6.23@125@69@0.552@NA@OBP2A-001_6, OBP2A-001_7@10@2@18@:odorant binding protein 2A@:odorant binding;sensory perception of chemical stimulus;response to stimulus;transport;extracellular region;sensory perception of smell;cellular_component@NA
D171987@125858@125859@deletion@2@5037666@5038058@10@chr10:5037666-5038058@5.45@181@111@0.613@NA@AKR1C2-201_7, AKR1C2-201_8@14.5@6@23@:aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III);aldo-keto reductase family 1 member C2-like@:trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity;steroid metabolic process;oxidation-reduction process;phenanthrene 9,10-monooxygenase activity;prostaglandin F receptor activity;daunorubicin metabolic process;carboxylic acid binding;ketosteroid monooxygenase activity;progesterone metabolic process;oxidoreductase activity;digestion;positive regulation of cell proliferation;prostaglandin metabolic process;doxorubicin metabolic process;response to prostaglandin stimulus;positive regulation of protein kinase B signaling cascade;alditol:NADP+ 1-oxidoreductase activity;androsterone dehydrogenase (A-specific) activity;bile acid binding;G-protein coupled receptor signaling pathway;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;cytoplasm;cellular response to jasmonic acid stimulus@: 46,XY SEX REVERSAL 8; SRXY8
D171987@126906@126911@deletion@6@17813310@17865475@10@chr10:17813310-17865475@19.9@217@89@0.41@NA@FAM23A-201_2, FAM23A-201_3, FAM23A-201_4, FAM23A-201_5, MRC1L1-001_1, MRC1L1-001_2@30.1666666666667@11@108@:transmembrane protein 236;transmembrane protein 236-like:macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding@NA
D171987@126916@126938@deletion@23@17891585@17951364@10@chr10:17891585-17951364@26.7@591@328@0.555@NA@MRC1L1-001_7, MRC1L1-001_8, MRC1L1-001_9, MRC1L1-001_10, MRC1L1-001_11, MRC1L1-001_12, MRC1L1-001_13, MRC1L1-001_14, MRC1L1-001_15, MRC1L1-001_16, MRC1L1-001_17, MRC1L1-001_18, MRC1L1-001_19, MRC1L1-001_20, MRC1L1-001_21, MRC1L1-001_22, MRC1L1-001_23, MRC1L1-001_24, MRC1L1-001_25, MRC1L1-001_26, MRC1L1-001_27, MRC1L1-001_28, MRC1L1-001_29@6.43478260869565@4@18@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
D171987@126941@126947@duplication@7@18060294@18116669@10@chr10:18060294-18116669@9.16@87@162@1.86@NA@FAM23B-202_2, FAM23B-202_3, FAM23B-202_4, FAM23B-202_5, MRC1-001_1, MRC1-001_2, MRC1-001_3@60.5714285714286@10@107@:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D171987@126951@126958@duplication@8@18138510@18155691@10@chr10:18138510-18155691@22.7@148@330@2.23@NA@MRC1-001_7, MRC1-001_8, MRC1-001_9, MRC1-001_10, MRC1-001_11, MRC1-001_12, RP11-457D2-001_1, RP11-457D2-001_2@17.75@12@26@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D171987@126974@126975@duplication@2@18196465@18198277@10@chr10:18196465-18198277@7.7@64@126@1.97@NA@MRC1-001_28, MRC1-001_29@15@3@27@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D171987@128372@128372@duplication@1@42924566@42924600@10@chr10:42924566-42924600@6.37@108@175@1.62@NA@CCNYL2-201_7@0@0@0@@:regulation of cyclin-dependent protein kinase activity;protein kinase binding@NA
D171987@128910@128911@deletion@2@47400243@47400737@10@chr10:47400243-47400737@6.62@62@22@0.355@CNVR4712.9, CNVR4712.1@FAM35B2-201_3, FAM35B2-201_4@36.5@36@37@NA@NA@NA
D171987@128979@128979@duplication@1@47758848@47758905@10@chr10:47758848-47758905@16.9@26@142@5.46@CNVR4714.1@ANXA8L2-001_10@154@154@154@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:calcium-dependent phospholipid binding;calcium ion binding@NA
D171987@129021@129030@duplication@10@48020452@48055019@10@chr10:48020452-48055019@15.1@519@738@1.42@CNVR4715.2@ASAH2C-201_1, ASAH2C-201_2, ASAH2C-201_3, ASAH2C-201_4, ASAH2C-201_5, ASAH2C-201_6, ASAH2C-201_7, ASAH2C-201_8, ASAH2C-201_9, ASAH2C-201_10@64.3@50@90@@:ceramidase activity;sphingolipid metabolic process@NA
D171987@129460@129461@deletion@2@51361725@51361911@10@chr10:51361725-51361911@9.21@44@2@0.0455@NA@ENST00000404618_4, ENST00000432221_4@122@121@123@NA@NA@NA
D171987@129604@129609@deletion@6@51965744@51978391@10@chr10:51965744-51978391@20.2@210@88@0.419@NA@ASAH2-201_7, ASAH2-201_8, ASAH2-201_9, ASAH2-201_10, ASAH2-201_11, ASAH2-201_12@177.833333333333@161@186@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
D171987@136769@136770@deletion@2@135437401@135439504@10@chr10:135437401-135439504@20.7@659@384@0.583@CNVR4989.11, CNVR4989.4@FRG2B-202_3, FRG2B-202_4@23.5@18@29@:FSHD region gene 2 family, member B@:nucleus@NA
D171987@138032@138033@duplication@2@5270600@5271118@11@chr11:5270600-5271118@12.3@58@151@2.6@NA@HBG1-201_1, HBG1-201_2@94.5@83@106@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
D171987@139527@139527@deletion@1@18955060@18956211@11@chr11:18955060-18956211@47.4@989@392@0.396@CNVR5091.2, CNVR5091.1@MRGPRX1-203_3@16@16@16@:MAS-related GPR, member X1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;acute-phase response;G-protein coupled receptor signaling pathway@NA
D171987@145464@145465@deletion@2@77635798@77639594@11@chr11:77635798-77639594@6.56@249@157@0.631@NA@INTS4-201_11, INTS4-201_12@0.5@0@1@:integrator complex subunit 4@:protein binding;integrator complex;binding;snRNA processing@NA
D171987@150775@150776@duplication@2@9446260@9447115@12@chr12:9446260-9447115@10.7@149@252@1.69@NA@DDX11L8-201_2, DDX11L8-201_3@30@18@42@NA@NA@NA
D171987@150778@150783@deletion@6@9450373@9454871@12@chr12:9450373-9454871@10.2@260@156@0.6@NA@DDX11L8-201_5, DDX11L8-201_6, DDX11L8-201_7, DDX11L8-201_8, DDX11L8-201_9, DDX11L8-201_10@67.8333333333333@55@78@NA@NA@NA
D171987@150785@150786@deletion@2@9456573@9456804@12@chr12:9456573-9456804@21.3@138@25@0.181@NA@DDX11L8-201_12, DDX11L8-201_13@85@83@87@NA@NA@NA
D171987@150825@150826@deletion@2@9590001@9590856@12@chr12:9590001-9590856@13.5@236@119@0.504@NA@DDX12-203_3, DDX12-203_4@25@21@29@NA@NA@NA
D171987@151048@151052@deletion@5@11506043@11544583@12@chr12:11506043-11544583@35.8@730@377@0.516@CNVR5435.2, CNVR5435.1@PRB1-201_1, PRB1-201_2, PRB1-201_3, PRB1-201_4, PRB2-001_4@44@35@49@:proline-rich protein BstNI subfamily 1:proline-rich protein BstNI subfamily 2@:extracellular region;molecular_function;cellular_component;biological_process@NA
D171987@162131@162131@duplication@1@24468280@24468341@13@chr13:24468280-24468341@5.15@189@269@1.42@NA@RP11-45B20-002_4@36@36@36@:C1q and tumor necrosis factor related protein 9B@:collagen;protein binding@NA
D171987@164539@164544@deletion@6@53103402@53122079@13@chr13:53103402-53122079@29.1@150@13@0.0867@NA@RP11-78J21-201_12, RP11-78J21-201_13, RP11-78J21-201_14, RP11-78J21-201_15, RP11-78J21-201_16, RP11-78J21-201_17@102.166666666667@44@117@NA@NA@NA
D171987@166751@166761@duplication@11@20137324@20148264@14@chr14:20137324-20148264@51.7@1992@2813@1.41@CNVR6072.6, CNVR6072.12, CNVR6072.14@AL512310-201_1, AL512310-201_2, AL512310-201_3, AL512310-201_4, AL512310-201_5, ENST00000398231_1, ENST00000398231_2, ENST00000398231_3, ENST00000398231_4, ENST00000398231_5, ENST00000398231_6@91.4545454545455@58@102@NA@NA@NA
D171987@168933@168934@deletion@2@50825748@50829113@14@chr14:50825748-50829113@9.75@147@70@0.476@CNVR6152.2@CDKL1-002_13, CDKL1-002_14@0@0@0@:cyclin-dependent kinase-like 1 (CDC2-related kinase)@:protein serine/threonine kinase activity;protein tyrosine kinase activity;protein phosphorylation;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;nucleus;cell cycle;heart development;cyclin-dependent protein kinase activity@NA
D171987@170809@170811@duplication@3@74003820@74010454@14@chr14:74003820-74010454@59.8@405@984@2.43@CNVR6188.1, CNVR6188.4@ACOT1-201_1, ACOT1-201_2, ACOT1-201_3@109.666666666667@99@116@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
D171987@173412@173414@duplication@3@106090689@106091717@14@chr14:106090689-106091717@23.7@440@708@1.61@CNVR6294.46, CNVR6294.20, CNVR6294.54, CNVR6294.43, CNVR6294.50, CNVR6294.61@IGHG4-001_2, IGHG4-001_3, IGHG4-001_4@6@6@6@@:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response@NA
D171987@173501@173503@deletion@3@106478134@106478604@14@chr14:106478134-106478604@27@189@44@0.233@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV3-6-210_6, IGHV4-4-001_1, IGHV4-4-001_2@13@5@17@@:protein binding@NA
D171987@173555@173567@deletion@13@106780902@106816254@14@chr14:106780902-106816254@57.6@1411@768@0.544@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV4-28-001_1, IGHV3-29-001_1, IGHV3-29-001_2, IGHV3-30-001_1, IGHV3-30-001_2, IGHV3-30-2-001_1, IGHV3-30-2-001_2, IGHV4-31-001_1, IGHV4-31-001_2, IGHV3-32-001_1, IGHV3-32-001_2, IGHV3-33-001_1, IGHV3-33-001_2@14.5384615384615@5@19@:uncharacterized LOC100653243;uncharacterized LOC642131@:protein binding:protein binding:protein binding:protein binding@NA
D171987@173592@173593@duplication@2@106926190@106926725@14@chr14:106926190-106926725@5.77@757@983@1.3@CNVR6294.56, CNVR6294.1@IGHV3-43-001_1, IGHV3-43-001_2@12@12@12@@:protein binding@NA
D171987@173620@173620@deletion@1@107048674@107048974@14@chr14:107048674-107048974@5.36@439@297@0.677@CNVR6294.56, CNVR6294.16, CNVR6294.89@IGHV3-53-001_2@0@0@0@@:protein binding@NA
D171987@173645@173645@duplication@1@107131035@107131335@14@chr14:107131035-107131335@17.5@250@454@1.82@CNVR6294.56, CNVR6294.16@IGHV3-66-001_2@3@3@3@@:protein binding@NA
D171987@173649@173651@duplication@3@107169933@107179131@14@chr14:107169933-107179131@10.7@943@1246@1.32@CNVR6294.56, CNVR6294.6, CNVR6294.92, CNVR6294.93@IGHV1-69-001_1, IGHV1-69-001_2, IGHV2-70-001_2@5@5@5@@:protein binding:protein binding@NA
D171987@173681@173766@deletion@86@20433872@20772165@15@chr15:20433872-20772165@218@7951@4869@0.612@CNVR6295.15, CNVR6295.7@ENST00000400226_1, ENST00000400226_2, ENST00000400226_3, ENST00000400226_4, ENST00000400226_8, ENST00000400226_9, ENST00000400226_10, ENST00000400226_11, ENST00000400226_12, ENST00000400226_14, ENST00000400226_15, ENST00000400226_16, HERC2P3-014_1, HERC2P3-014_2, HERC2P3-014_3, HERC2P3-014_4, HERC2P3-014_5, HERC2P3-014_6, HERC2P3-014_7, HERC2P3-014_8, HERC2P3-014_9, HERC2P3-014_10, HERC2P3-014_11, HERC2P3-014_12, HERC2P3-014_13, HERC2P3-014_14, HERC2P3-014_15, HERC2P3-014_16, HERC2P3-014_17, HERC2P3-014_18, HERC2P3-014_19, HERC2P3-014_20, HERC2P3-014_21, HERC2P3-014_22, HERC2P3-014_23, HERC2P3-014_24, HERC2P3-014_25, HERC2P3-014_26, HERC2P3-014_27, AC026495-201_1, AC026495-201_2, AC026495-201_3, AC026495-201_4, AC026495-201_5, AC026495-201_6, AC026495-201_7, AC026495-201_8, AC026495-201_9, AC026495-201_10, AC026495-201_11, AC026495-201_12, AC026495-201_13, AC026495-201_14, AC026495-201_15, AC026495-201_16, AC026495-201_17, AC026495-201_18, AC026495-201_19, AC026495-201_20, AC026495-201_21, AC026495-201_22, AC026495-201_23, AC026495-201_24, AC026495-201_25, AC026495-201_26, GOLGA6L6-201_1, GOLGA6L6-201_2, GOLGA6L6-201_3, GOLGA6L6-201_4, GOLGA6L6-201_5, GOLGA6L6-201_6, GOLGA6L6-201_7, GOLGA6L6-201_8, GOLGA6L6-201_9, GOLGA6L6-201_10, AC131280-203_1, AC131280-203_2, AC131280-203_3, AC131280-203_4, AC131280-203_5, AC131280-203_6, AC131280-203_7@86.4390243902439@48@147@:putative transmembrane protein FLJ36131-like;putative transmembrane protein ENSP00000320207-like;golgin A6 family-like 6@NA@NA
D171987@174406@174410@deletion@5@29008591@29009297@15@chr15:29008591-29009297@28.2@648@367@0.566@NA@ENST00000456510_1, ENST00000456510_2, ENST00000456510_3, ENST00000456510_4, ENST00000456510_5@23.6@18@26@NA@NA@NA
D171987@174535@174536@deletion@2@30772947@30776821@15@chr15:30772947-30776821@5.3@32@6@0.188@NA@AC127502-201_2, AC127502-201_3@44@37@51@NA@NA@NA
D171987@176387@176388@duplication@2@43927560@43928025@15@chr15:43927560-43928025@14@455@683@1.5@CNVR6365.1@CATSPER2-001_10, CATSPER2-001_11@4@4@4@:diphosphoinositol pentakisphosphate kinase 1:stereocilin:cation channel, sperm associated 2@:inositol hexakisphosphate 3-kinase activity;inositol hexakisphosphate 1-kinase activity;inositol metabolic process;diphosphoinositol-pentakisphosphate kinase activity;ATP binding;acid phosphatase activity;cytoplasm;cytosol;inositol hexakisphosphate 5-kinase activity;nucleus;kinase activity;inositol-1,3,4,5,6-pentakisphosphate kinase activity:detection of mechanical stimulus involved in sensory perception of sound;stereocilium bundle tip;stereocilium;cell surface;kinocilium;auditory receptor cell stereocilium organization:cell differentiation;CatSper complex;ion transport;transmembrane transport;voltage-gated ion channel activity;flagellar membrane;spermatogenesis;integral to membrane;multicellular organismal development;fertilization;sperm motility;ion channel activity;ciliary or flagellar motility;calcium channel activity;cilium;protein binding;microtubule-based flagellum;membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16; DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY: DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY
D171987@176432@176433@duplication@2@44002591@44002976@15@chr15:44002591-44002976@6.22@169@248@1.47@NA@AC011330-201_13, AC011330-201_14@28@16@40@:stereocilin@:detection of mechanical stimulus involved in sensory perception of sound;stereocilium bundle tip;stereocilium;cell surface;kinocilium;auditory receptor cell stereocilium organization@: DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16; DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY
D171987@176449@176450@deletion@2@44024017@44024501@15@chr15:44024017-44024501@14.1@243@119@0.49@NA@CATSPER2P1-001_8, CATSPER2P1-001_9@4@4@4@NA@NA@NA
D171987@179451@179460@deletion@10@74363467@74368327@15@chr15:74363467-74368327@8.58@114@54@0.474@CNVR6448.1@ENST00000290438_8, ENST00000290438_9, ENST00000290438_10, ENST00000290438_11, ENST00000290438_12, ENST00000290438_13, ENST00000290438_14, ENST00000290438_15, ENST00000290438_16, ENST00000290438_17@29.3@16@51@:golgin A6 family, member C;golgin A6 family, member A;golgin A6 family, member D;golgin A6 family, member B@:Golgi apparatus@NA
D171987@180187@180187@deletion@1@79065427@79065546@15@chr15:79065427-79065546@9.25@43@1@0.0233@NA@ADAMTS7-201_14@10@10@10@:A disintegrin and metalloproteinase with thrombospondin motifs 7-like;ADAM metallopeptidase with thrombospondin type 1 motif, 7@:metallopeptidase activity;extracellular matrix;proteolysis;peptidase activity;proteinaceous extracellular matrix;metalloendopeptidase activity;cell surface;zinc ion binding@NA
D171987@181169@181170@duplication@2@90176053@90176498@15@chr15:90176053-90176498@5.87@140@209@1.49@NA@KIF7-201_13, KIF7-201_14@0.5@0@1@:kinesin family member 7@:negative regulation of smoothened signaling pathway;microtubule motor activity;microtubule associated complex;cilium;ATP binding;positive regulation of smoothened signaling pathway;protein binding;microtubule-based movement;microtubule@: PALLISTER-HALL SYNDROME; PHS; ACROCALLOSAL SYNDROME; ACLS; BARDET-BIEDL SYNDROME; BBS; HYDROLETHALUS SYNDROME 2; HLS2
D171987@183378@183384@duplication@7@2672693@2693298@16@chr16:2672693-2693298@8.81@193@295@1.53@CNVR6602.2@AC141586-001_4, AC141586-201_1, AC141586-201_2, AC141586-201_3, AC141586-201_4, AC141586-201_5, AC141586-201_6@34.4285714285714@19@57@NA@NA@NA
D171987@186292@186293@deletion@2@28403075@28403464@16@chr16:28403075-28403464@7.65@204@120@0.588@CNVR6684.2@EIF3CL-201_9, EIF3CL-201_10@4@3@5@:eukaryotic translation initiation factor 3, subunit C-like@:protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;translation initiation factor activity@NA
D171987@186368@186369@deletion@2@28711499@28712933@16@chr16:28711499-28712933@15@68@0@0@CNVR6686.3, CNVR6686.1, CNVR6686.2@AC145285-201_1, AC145285-201_2@60@59@61@:eukaryotic translation initiation factor 3, subunit C@:cytosol;protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;cellular protein metabolic process;binding;gene expression;translation;translation initiation factor activity@NA
D171987@186582@186586@deletion@5@29468955@29469541@16@chr16:29468955-29469541@13@83@17@0.205@CNVR6690.2, CNVR6690.3, CNVR6690.4@GIYD1-001_4, GIYD1-001_5, GIYD1-001_6, SULT1A4-201_2, SULT1A4-201_3@10.4@2@13@:structure-specific endonuclease subunit SLX1-like;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae);SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae):sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3;sulfotransferase 1A3/1A4-like@:Slx1-Slx4 complex;5'-flap endonuclease activity;DNA repair;protein binding;DNA double-strand break processing involved in repair via single-strand annealing;double-strand break repair via homologous recombination;metal ion binding;crossover junction endodeoxyribonuclease activity:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;cytoplasm;catecholamine metabolic process;cytosol;endoplasmic reticulum unfolded protein response;xenobiotic metabolic process;sulfotransferase activity;activation of signaling protein activity involved in unfolded protein response;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process@NA
D171987@186863@186864@duplication@2@30208593@30208679@16@chr16:30208593-30208679@7.4@52@108@2.08@CNVR6694.1, CNVR6694.2, CNVR6694.3@GIYD2-001_5, SULT1A3-001_2@6@6@6@:structure-specific endonuclease subunit SLX1-like;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae);SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae):sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3;sulfotransferase 1A3/1A4-like@:Slx1-Slx4 complex;5'-flap endonuclease activity;DNA repair;protein binding;DNA double-strand break processing involved in repair via single-strand annealing;double-strand break repair via homologous recombination;metal ion binding;crossover junction endodeoxyribonuclease activity:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;cytoplasm;catecholamine metabolic process;cytosol;endoplasmic reticulum unfolded protein response;xenobiotic metabolic process;sulfotransferase activity;activation of signaling protein activity involved in unfolded protein response;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process@NA
D171987@187474@187474@deletion@1@31993195@31993511@16@chr16:31993195-31993511@4.76@50@20@0.4@CNVR6700.1@ENST00000398685_4@1@1@1@NA@NA@NA
D171987@188229@188234@duplication@6@55798611@55810808@16@chr16:55798611-55810808@14.2@411@589@1.43@CNVR6730.1@CES4-202_2, CES4-202_3, CES4-202_4, CES4-202_5, CES4-202_6, CES4-202_7@112@107@123@NA@NA@NA
D171987@189961@189969@deletion@9@70164328@70178437@16@chr16:70164328-70178437@57.6@2175@1338@0.615@CNVR6764.1, CNVR6764.3@AC009060-202_7, AC009060-202_8, AC009060-202_9, AC009060-202_10, AC009060-202_11, AC009060-202_12, AC009060-202_13, AC009060-202_14, AC009060-202_15@74@70@77@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
D171987@189972@189973@deletion@2@70187296@70195206@16@chr16:70187296-70195206@27.8@1458@879@0.603@CNVR6764.1, CNVR6764.3@AC009060-202_18, AC009060-202_19, AC009060-201_3, AC009060-201_4, AC009060-201_5@70@69@71@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
D171987@190530@190549@deletion@20@74394533@74452197@16@chr16:74394533-74452197@25.8@919@572@0.622@CNVR6778.2@AC009053-202_1, AC009053-202_2, NPIPL2-202_1, NPIPL2-202_2, NPIPL2-202_3, NPIPL2-202_4, NPIPL2-202_5, NPIPL2-202_6, NPIPL2-202_7, CLEC18B-202_3, CLEC18B-202_4, CLEC18B-202_5, CLEC18B-202_6, CLEC18B-202_7, CLEC18B-202_8, CLEC18B-202_9, CLEC18B-202_10, CLEC18B-202_11, CLEC18B-202_12, CLEC18B-202_13@57.3@46@63@:C-type lectin domain family 18, member B@:extracellular region:carbohydrate binding;protein binding;extracellular region@NA
D171987@195228@195234@duplication@7@16649609@16678314@17@chr17:16649609-16678314@15.1@1532@2003@1.31@NA@CCDC144A-202_13, CCDC144A-202_14, CCDC144A-202_15, CCDC144A-202_16, CCDC144A-202_17, CCDC144A-202_18, ENST00000441471_1@47.5714285714286@4@60@:coiled-coil domain containing 144A@NA@NA
D171987@195239@195257@duplication@19@16704352@16734358@17@chr17:16704352-16734358@11.7@1108@1429@1.29@NA@AC022596-003_5, AC022596-003_6, AC022596-003_7, AC022596-003_8, AC022596-003_9, AC022596-003_10, AC022596-003_11, AC022596-001_1, AC022596-001_2, AC022596-001_3, AC022596-001_4, AC022596-001_5, AC022596-001_6, AC022596-001_7, AC022596-001_8, ENST00000414673_5, ENST00000414673_6, ENST00000414673_7, ENST00000414673_8@85.2105263157895@64@97@:coiled-coil domain containing 144A@NA@NA
D171987@195691@195747@deletion@57@18331724@18457581@17@chr17:18331724-18457581@325@1678@125@0.0745@NA@ENST00000326333_2, ENST00000326333_3, ENST00000326333_4, ENST00000326333_5, ENST00000326333_6, ENST00000326333_7, ENST00000326333_8, ENST00000399124_1, ENST00000399124_2, ENST00000399124_3, ENST00000399124_4, ENST00000399124_5, ENST00000399124_6, ENST00000399124_7, ENST00000399124_8, ENST00000411877_1, ENST00000411877_2, ENST00000411877_4, LGALS9C-201_1, LGALS9C-201_2, LGALS9C-201_3, LGALS9C-201_4, LGALS9C-201_5, LGALS9C-201_6, LGALS9C-201_7, LGALS9C-201_8, LGALS9C-201_9, LGALS9C-201_10, LGALS9C-201_11, ENST00000426269_1, ENST00000426269_2, ENST00000426269_3, ENST00000426269_4, ENST00000426269_5, AC107983-001_1, AC107983-001_2, AC107983-001_3, AC107983-001_4, AC107983-001_5, AC107983-001_6, AC107983-001_7, AC107983-001_8, AC107983-001_9, AC107983-001_10, ENST00000456184_1, ENST00000456184_2, CCDC144B-201_14, CCDC144B-201_15, CCDC144B-201_16, CCDC144B-201_17, CCDC144B-201_18, ENST00000447265_11, ENST00000447265_12, ENST00000447265_13, ENST00000447265_14, ENST00000447265_15@134.017857142857@79@203@:lectin, galactoside-binding, soluble, 9C:protein FAM106B-like@:carbohydrate binding@NA
D171987@195870@195874@deletion@5@18996289@19036053@17@chr17:18996289-19036053@56.7@274@1@0.00365@CNVR7018.2, CNVR7018.3, CNVR7018.1@AC007952-202_1, AC007952-202_2, AC007952-202_3, GRAPL-203_1, GRAPL-203_2@39.4@4@93@:GRB2-related adaptor protein-like@:protein binding@NA
D171987@196151@196157@duplication@7@20354796@20359985@17@chr17:20354796-20359985@14@192@324@1.69@CNVR7021.1, CNVR7021.3@LGALS9B-201_4, LGALS9B-201_5, LGALS9B-201_6, LGALS9B-201_7, LGALS9B-201_8, LGALS9B-201_9, LGALS9B-201_10@92.2857142857143@55@103@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
D171987@197726@197745@duplication@20@34539180@34625732@17@chr17:34539180-34625732@33.2@102@341@3.34@CNVR7077.1, CNVR7077.13, CNVR7077.19, CNVR7077.2@CCL3L1-205_1, CCL3L1-205_2, CCL3L1-205_3, CCL4L1-202_2, CCL4L1-202_3, CCL4L1-202_4, TBC1D3C-002_1, TBC1D3C-002_2, TBC1D3C-002_3, TBC1D3C-002_4, TBC1D3C-002_5, TBC1D3C-002_6, TBC1D3C-002_7, TBC1D3C-002_8, TBC1D3C-002_9, TBC1D3C-002_10, TBC1D3C-002_11, TBC1D3C-002_12, TBC1D3C-002_13, TBC1D3C-002_14@102.1@34@136@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity@NA
D171987@198033@198033@deletion@1@36352424@36352527@17@chr17:36352424-36352527@7.13@434@283@0.652@CNVR7083.3@AC183087-202_13@64@64@64@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
D171987@200259@200265@duplication@7@43585590@43594649@17@chr17:43585590-43594649@21.5@530@814@1.54@CNVR7113.4, CNVR7113.6, CNVR7113.2, CNVR7113.1@AC091132-201_1, AC091132-201_2, AC091132-201_3, AC091132-201_4, AC091132-201_5, ENST00000339474_2, ENST00000339474_3@94.7142857142857@81@127@NA@NA@NA
D171987@200320@200328@deletion@9@44248223@44364337@17@chr17:44248223-44364337@83.5@3981@2516@0.632@CNVR7114.3, CNVR7114.2, CNVR7114.10@KIAA1267-201_1, KIAA1267-201_2, AC217773-201_1, AC217773-201_2, ENST00000451529_1, ENST00000451529_3, ENST00000451529_5@64.4285714285714@49@90@:KAT8 regulatory NSL complex subunit 1:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:histone acetyltransferase activity (H4-K8 specific);histone acetyltransferase activity (H4-K16 specific);histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase complex;histone H4-K5 acetylation;MLL1 complex;histone H4-K16 acetylation;protein binding;histone H4-K8 acetylation;nucleus:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
D171987@200337@200340@duplication@4@44399690@44409348@17@chr17:44399690-44409348@15.2@73@186@2.55@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A-001_7, LRRC37A-001_8, LRRC37A-001_9, LRRC37A-001_10@144.75@141@154@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
D171987@200343@200345@duplication@3@44414664@44415161@17@chr17:44414664-44415161@16.4@71@192@2.7@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A-001_13, LRRC37A-001_14, LRRC37A-001_15@190.333333333333@181@196@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
D171987@200360@200363@deletion@4@44630768@44633017@17@chr17:44630768-44633017@20.8@213@77@0.362@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2-201_11, LRRC37A2-201_12, LRRC37A2-201_13, LRRC37A2-201_14@84@67@98@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
D171987@213493@213494@deletion@2@14508472@14508748@19@chr19:14508472-14508748@13.6@101@27@0.267@NA@CD97-205_8, CD97-205_9@10.5@7@14@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
D171987@215926@215926@duplication@1@35849784@35851388@19@chr19:35849784-35851388@6.47@502@680@1.35@CNVR7627.1@AC002511-201_2@12@12@12@:free fatty acid receptor 3@:lipid binding;integral to membrane;G-protein coupled receptor activity;plasma membrane;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
D171987@215928@215928@deletion@1@35862253@35863856@19@chr19:35862253-35863856@15.7@204@85@0.417@CNVR7627.1@FFAR3-001_2@102@102@102@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
D171987@217293@217297@duplication@5@40373947@40382827@19@chr19:40373947-40382827@14.6@370@545@1.47@CNVR7639.2@FCGBP-201_22, FCGBP-201_23, FCGBP-201_24, FCGBP-201_25, FCGBP-201_26@130.8@105@155@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D171987@217301@217306@deletion@6@40389654@40399856@19@chr19:40389654-40399856@47.3@341@90@0.264@CNVR7639.2, CNVR7639.3@FCGBP-201_13, FCGBP-201_14, FCGBP-201_15, FCGBP-201_16, FCGBP-201_17, FCGBP-201_18@112.333333333333@103@127@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D171987@218183@218185@deletion@3@43709627@43716628@19@chr19:43709627-43716628@6.87@205@126@0.615@CNVR7658.5, CNVR7658.1@PSG1-202_1, PSG4-001_1, CEACAMP10-001_9@39@38@41@:pregnancy specific beta-1-glycoprotein 4:pregnancy specific beta-1-glycoprotein 9@:protein binding;extracellular region;female pregnancy;defense response:protein binding;extracellular region;female pregnancy;defense response@NA
D171987@221172@221174@duplication@3@54732913@54741070@19@chr19:54732913-54741070@5.58@140@206@1.47@CNVR7721.3, CNVR7721.4, CNVR7721.1@AC010492-001_1, AC010492-001_2, LILRA6-002_10@49.3333333333333@44@55@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D171987@221393@221394@deletion@2@55250955@55253726@19@chr19:55250955-55253726@6.06@276@179@0.649@CNVR7725.2, CNVR7725.4, CNVR7725.1@KIR2DL3-201_2, KIR2DL3-201_3@30@29@31@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity@NA
D171987@221396@221399@duplication@4@55266477@55270359@19@chr19:55266477-55270359@14.9@226@369@1.63@CNVR7725.2, CNVR7725.1@KIR2DP1-001_1, KIR2DP1-001_2, KIR2DP1-001_3, KIR2DP1-001_4@96.5@85@107@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity@NA
D171987@221403@221408@duplication@6@55277931@55279337@19@chr19:55277931-55279337@33.1@967@1439@1.49@CNVR7725.2, CNVR7725.1@KIR2DL3-201_6, KIR2DL3-201_7, KIR2DL3-201_8, KIR2DP1-001_7, KIR2DP1-001_8, KIR2DP1-001_9@125.666666666667@125@126@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity@NA
D171987@221439@221441@deletion@3@55358641@55360024@19@chr19:55358641-55360024@38.3@1223@687@0.562@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4-001_6, KIR2DS4-001_7, KIR2DS4-001_8@96.3333333333333@85@102@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
D171987@221820@221820@duplication@1@56273160@56273453@19@chr19:56273160-56273453@8.08@149@240@1.61@CNVR7734.1@RFPL4A-201_2@39@39@39@:ret finger protein-like 4A;ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
D171987@222016@222016@duplication@1@57742379@57742483@19@chr19:57742379-57742483@5.32@72@122@1.69@NA@AURKC-202_1@3@3@3@:aurora kinase C@:spindle midzone;protein tyrosine kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;positive regulation of cell cycle cytokinesis;condensed chromosome;protein serine/threonine/tyrosine kinase activity;midbody;chromosome, centromeric region;attachment of spindle microtubules to kinetochore;nucleus;spindle;cytokinesis;protein serine/threonine kinase activity;chromosome passenger complex;protein phosphorylation;protein kinase activity;cytoplasm;meiosis;spindle midzone assembly involved in mitosis;histone modification@: SPERMATOGENIC FAILURE 5; SPGF5
D171987@222068@222069@deletion@2@58003184@58003369@19@chr19:58003184-58003369@5.43@64@28@0.438@CNVR7748.1@ZNF419-202_5, ZNF419-202_6@0@0@0@:zinc finger protein 419@:intracellular;DNA binding;regulation of transcription, DNA-dependent;cytoplasm;nucleolus;nucleus;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding@NA
D171987@222563@222563@deletion@1@1569208@1569279@20@chr20:1569208-1569279@4.99@22@0@0@CNVR7763.1@SIRPB1-201_1@128@128@128@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
D171987@222594@222594@deletion@1@1895747@1896102@20@chr20:1895747-1896102@10.5@164@78@0.476@CNVR7764.2@SIRPA-201_3@34@34@34@:signal-regulatory protein alpha@:blood coagulation;protein binding;integral to membrane;SH3 domain binding;cell adhesion;plasma membrane;membrane;leukocyte migration@NA
D171987@224466@224467@deletion@2@26061802@26065122@20@chr20:26061802-26065122@6.47@227@142@0.626@CNVR7823.4, CNVR7823.3, CNVR7823.5, CNVR7823.1@C20orf91-201_4, C20orf91-201_5@46.5@33@60@NA@NA@NA
D171987@228897@228898@duplication@2@14765869@14766067@21@chr21:14765869-14766067@12@48@132@2.75@NA@AL050302-001_14, AL050302-001_15@4.5@1@8@NA@NA@NA
D171987@231982@231994@deletion@13@16413614@16427060@22@chr22:16413614-16427060@13.4@513@332@0.647@CNVR8071.2, CNVR8071.3@ENST00000412729_2, LA16c-60G3-201_1, LA16c-60G3-201_2, LA16c-60G3-201_3, LA16c-60G3-201_4, LA16c-60G3-201_5, LA16c-60G3-201_6, LA16c-23H5-004_1, LA16c-23H5-004_2, LA16c-23H5-004_3, LA16c-23H5-001_1, LA16c-23H5-001_2, LA16c-23H5-001_3@48.6153846153846@25@76@NA@NA@NA
D171987@232348@232351@duplication@4@18769654@18775393@22@chr22:18769654-18775393@13.8@122@237@1.94@CNVR8087.5, CNVR8087.2, CNVR8087.7@GGT3P-201_7, AC008132-201_3, AC008132-201_4, AC008132-201_5@103.25@103@104@NA@NA@NA
D171987@232758@232789@duplication@32@20367231@20486673@22@chr22:20367231-20486673@56.2@272@667@2.45@CNVR8094.4@GGTLC3-001_1, GGTLC3-001_2, GGTLC3-001_3, AC023490-001_1, AC023490-001_2, AC023490-005_1, AC023490-005_2, AC023490-005_3, AC023490-005_4, AC023490-005_5, AC023490-005_6, PI4KAP1-204_1, PI4KAP1-204_2, PI4KAP1-204_3, PI4KAP1-204_4, PI4KAP1-204_5, PI4KAP1-204_6, PI4KAP1-204_7, PI4KAP1-204_8, PI4KAP1-204_9, PI4KAP1-204_10, PI4KAP1-204_11, PI4KAP1-204_12, PI4KAP1-204_13, PI4KAP1-204_14, PI4KAP1-204_15, PI4KAP1-204_16, ENST00000434754_1, ENST00000434754_2, ENST00000434754_3, ENST00000434754_4, ENST00000424817_6@152.25@62@172@:RIMS binding protein 3@:leukotriene biosynthetic process;glutathione metabolic process;gamma-glutamyltransferase activity;anchored to external side of plasma membrane:protein binding@NA
D171987@233470@233472@deletion@3@23241801@23241987@22@chr22:23241801-23241987@14@191@89@0.466@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11@D87015-202_1, BCRL4-001_4, BCRL4-001_5@0@0@0@NA@NA@NA
D171987@233700@233708@deletion@9@24283261@24302569@22@chr22:24283261-24302569@28.4@182@38@0.209@CNVR8114.6, CNVR8114.10, CNVR8114.12, CNVR8114.13@ENST00000443377_2, ENST00000443377_3, ENST00000440099_1, ENST00000440099_2, ENST00000440099_3, GSTT2B-002_2, GSTT2B-002_3, GSTT2B-002_4, GSTT2B-002_5@74.6666666666667@56@125@:glutathione S-transferase theta 2B (gene/pseudogene);glutathione S-transferase theta 2@:protein binding;glutathione transferase activity;nucleus;transferase activity;cytoplasm@NA
D171987@233731@233754@duplication@24@24345655@24394850@22@chr22:24345655-24394850@81.2@1061@1837@1.73@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTTP1-001_1, GSTTP1-001_2, ENST00000421902_1, ENST00000421902_2, ENST00000448902_1, ENST00000448902_2, ENST00000448902_3, ENST00000448902_4, ENST00000448902_5, ENST00000329210_1, ENST00000329210_2, ENST00000329210_3, ENST00000329210_4, ENST00000439866_1, ENST00000439866_2, GSTT1-009_1, GSTT1-009_2, GSTT1-009_3, GSTT1-009_4, GSTT1-009_5, ENST00000439996_1, ENST00000439996_2, GSTTP2-001_4, GSTTP2-001_5@130.833333333333@109@149@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
D171987@235184@235184@deletion@1@32827336@32827402@22@chr22:32827336-32827402@7.15@145@78@0.538@NA@BPIL2-010_12@8@8@8@:BPI fold containing family C@:lipid binding;phospholipid binding;extracellular region;lipopolysaccharide binding@NA
D174381@2314@2315@deletion@2@12939035@12939927@1@chr1:12939035-12939927@5.58@39@10@0.256@CNVR72.3, CNVR72.4, CNVR72.12, CNVR72.13@RP11-450I1-201_4, PRAMEF4-001_4@50@50@50@:PRAME family member 4@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
D174381@2889@2890@deletion@2@16891304@16892301@1@chr1:16891304-16892301@6.78@59@20@0.339@CNVR93.3, CNVR93.6, CNVR93.11@NBPF1-201_27, NBPF1-201_28@77.5@76@79@NA@NA@NA
D174381@2943@2943@deletion@1@16975671@16975747@1@chr1:16975671-16975747@5.22@103@56@0.544@CNVR93.3, CNVR93.6, CNVR93.12, CNVR93.7, CNVR93.14, CNVR93.15@RP5-1182A14-001_14@82@82@82@NA@NA@NA
D174381@2974@2975@duplication@2@17084439@17084789@1@chr1:17084439-17084789@10.1@281@411@1.46@CNVR93.3, CNVR93.15, CNVR93.2, CNVR93.1@MST1P9-202_16, MST1P9-202_17@36@35@37@:macrophage stimulating 1-like@:proteolysis;extracellular region;catalytic activity;serine-type endopeptidase activity@NA
D174381@3775@3775@deletion@1@21806546@21806717@1@chr1:21806546-21806717@5.72@27@1@0.037@CNVR107.2, CNVR107.1@NBPF3-003_15@91@91@91@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 3@:cytoplasm@NA
D174381@6747@6748@duplication@2@39987954@39988155@1@chr1:39987954-39988155@8.11@116@192@1.66@NA@BMP8A-001_5, RP11-69E11-006_5@25@25@25@:bone morphogenetic protein 8a@:cell differentiation;growth factor activity;extracellular space;growth;cytokine activity;cartilage development;ossification@NA
D174381@6813@6814@deletion@2@40229386@40229587@1@chr1:40229386-40229587@5.77@120@67@0.558@NA@PPIE-003_11, BMP8B-001_5@34@34@34@:peptidylprolyl isomerase E (cyclophilin E):bone morphogenetic protein 8b@:regulation of transcription, DNA-dependent;nucleotide binding;catalytic step 2 spliceosome;protein folding;protein binding;protein peptidyl-prolyl isomerization;peptidyl-prolyl cis-trans isomerase activity;cyclosporin A binding;RNA binding;mRNA splicing, via spliceosome;nucleus;nucleic acid binding:cell differentiation;growth factor activity;extracellular space;growth;extracellular region;cytokine activity;cartilage development;skeletal system development;ossification@NA
D174381@12416@12417@deletion@2@104202984@104203299@1@chr1:104202984-104203299@7.32@87@38@0.437@CNVR266.3, CNVR266.1@AMY1A-001_7, AMY1A-001_8@123.5@118@129@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D174381@12424@12425@duplication@2@104233918@104234233@1@chr1:104233918-104234233@11@40@117@2.92@CNVR266.3, CNVR266.5@AMY1B-001_7, AMY1B-001_8@154@154@154@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D174381@12445@12446@deletion@2@104297123@104297437@1@chr1:104297123-104297437@6.07@244@156@0.639@CNVR266.3, CNVR266.5@AMY1C-201_7, AMY1C-201_8@77@75@79@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D174381@12929@12936@deletion@8@110230474@110236368@1@chr1:110230474-110236368@95.6@442@3@0.00679@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1-001_1, GSTM1-001_2, GSTM1-001_3, GSTM1-001_4, GSTM1-001_5, GSTM1-001_6, GSTM1-001_7, GSTM1-001_8@191.375@187@194@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
D174381@24160@24164@duplication@5@223727670@223729472@1@chr1:223727670-223729472@24.6@52@216@4.15@NA@CAPN8-202_20, CAPN8-202_21, CAPN8-202_22, CAPN8-202_23, CAPN8-202_24@0@0@0@:calpain 8@:proteolysis;Golgi apparatus;intracellular;calcium-dependent cysteine-type endopeptidase activity;calcium ion binding@NA
D174381@32513@32514@deletion@2@73912090@73912704@2@chr2:73912090-73912704@5.08@159@98@0.616@NA@AC092653-201_8, ALMS1P-002_7@1@1@1@NA@NA@NA
D174381@34183@34184@duplication@2@96652501@96652955@2@chr2:96652501-96652955@5.48@171@247@1.44@NA@AC073995-001_2, AC073995-001_3@4@4@4@:ankyrin repeat domain-containing protein 36A-like@:ion channel inhibitor activity;protein binding@NA
D174381@45387@45389@deletion@3@233273213@233273823@2@chr2:233273213-233273823@8.29@105@48@0.457@NA@ALPPL2-001_7, ALPPL2-001_8, ALPPL2-001_9@34.6666666666667@19@58@:alkaline phosphatase, placental-like 2@:phosphatase activity;catalytic activity;phosphorylation;plasma membrane;metabolic process;membrane;anchored to membrane;alkaline phosphatase activity;metal ion binding@NA
D174381@61638@61647@deletion@10@195698196@195702772@3@chr3:195698196-195702772@12.2@667@445@0.667@CNVR1707.1, CNVR1707.2@SDHALP1-002_9, SDHALP1-002_10, SDHALP1-002_11, ENST00000354937_10, ENST00000354937_11, ENST00000354937_12, ENST00000354937_13, ENST00000366437_1, ENST00000366437_2, ENST00000366437_3@38.1@31@43@NA@NA@NA
D174381@65315@65320@duplication@6@69402904@69434246@4@chr4:69402904-69434246@37.6@877@1365@1.56@CNVR1953.1@UGT2B17-001_1, UGT2B17-001_2, UGT2B17-001_3, UGT2B17-001_4, UGT2B17-001_5, UGT2B17-001_6@124.5@118@134@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
D174381@65356@65359@deletion@4@70148234@70156530@4@chr4:70148234-70156530@10.9@222@123@0.554@CNVR1957.2, CNVR1957.1@UGT2B28-201_3, UGT2B28-201_4, UGT2B28-201_5, UGT2B28-201_6@69.25@68@71@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
D174381@65799@65799@deletion@1@75312253@75312500@4@chr4:75312253-75312500@9.96@82@25@0.305@NA@AREG-001_2@28@28@28@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
D174381@65805@65807@duplication@3@75482008@75486007@4@chr4:75482008-75486007@7.45@94@163@1.73@NA@AREGB-201_2, AREGB-201_3, AREGB-201_4@50.3333333333333@45@56@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
D174381@70822@70822@deletion@1@748521@748675@5@chr5:748521-748675@20.8@96@0@0@CNVR2280.3@ZDHHC11B-201_5@96@96@96@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
D174381@70838@70838@duplication@1@840612@840766@5@chr5:840612-840766@10.4@278@425@1.53@CNVR2280.3, CNVR2280.8@ZDHHC11-201_5@23@23@23@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
D174381@71600@71606@duplication@7@21480883@21491618@5@chr5:21480883-21491618@8.04@223@323@1.45@CNVR2395.4, CNVR2395.6, CNVR2395.2@AC138951-201_4, AC138951-202_1, AC138951-202_2, ENST00000412250_1, ENST00000412250_2, ENST00000412250_3, ENST00000412250_4@105.714285714286@97@108@NA@NA@NA
D174381@73727@73727@deletion@1@69717564@69717599@5@chr5:69717564-69717599@10.8@49@0@0@CNVR2494.17, CNVR2494.3@GTF2H2B-201_4@139@139@139@NA@NA@NA
D174381@73817@73820@deletion@4@70370032@70378820@5@chr5:70370032-70378820@21.8@101@1@0.0099@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.8, CNVR2494.1, CNVR2494.37@AC044797-201_2, AC044797-201_3, AC044797-201_4, AC044797-201_5@125.5@119@138@NA@NA@NA
D174381@79567@79568@deletion@2@175388056@175388438@5@chr5:175388056-175388438@10.1@57@8@0.14@NA@THOC3-001_4, THOC3-001_5@173.5@165@182@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
D174381@79578@79580@duplication@3@175523829@175525562@5@chr5:175523829-175525562@6.42@173@251@1.45@NA@FAM153B-201_7, FAM153B-201_8, FAM153B-201_9@18@17@20@:uncharacterized LOC100507387;family with sequence similarity 153, member B@NA@NA
D174381@80022@80024@deletion@3@177166603@177168334@5@chr5:177166603-177168334@13.1@73@10@0.137@NA@FAM153A-204_7, FAM153A-204_8, FAM153A-204_9@94@86@106@:family with sequence similarity 153, member A@NA@NA
D174381@80033@80036@deletion@4@177302598@177305850@5@chr5:177302598-177305850@12.5@57@0@0@NA@AC106795-201_1, AC106795-201_2, AC106795-201_3, AC106795-201_4@88.5@85@92@NA@NA@NA
D174381@80561@80569@duplication@9@304630@367497@6@chr6:304630-367497@60.8@1780@2640@1.48@CNVR2728.1@DUSP22-001_2, DUSP22-001_3, DUSP22-001_4, DUSP22-001_5, DUSP22-001_6, DUSP22-001_7, DUSP22-001_8, AL357054-201_1, AL357054-201_2@15.4444444444444@6@20@:dual specificity phosphatase 22;dual specificity protein phosphatase 22-like@:protein dephosphorylation;transforming growth factor beta receptor signaling pathway;positive regulation of JNK cascade;protein tyrosine/serine/threonine phosphatase activity;nucleus;apoptotic process;multicellular organismal development;phosphatase activity;protein tyrosine phosphatase activity;regulation of cell proliferation;cytoplasm;cell proliferation;inactivation of MAPK activity;protein binding;negative regulation of transcription from RNA polymerase II promoter;dephosphorylation@NA
D174381@82491@82491@duplication@1@29857107@29857382@6@chr6:29857107-29857382@7.75@101@175@1.73@CNVR2829.7, CNVR2829.2, CNVR2829.8, CNVR2829.3@HLA-H-001_4@47@47@47@NA@NA@NA
D174381@83577@83585@deletion@9@31962024@31964378@6@chr6:31962024-31964378@20.3@342@179@0.523@CNVR2843.6, CNVR2843.3@C4A-001_20, C4A-001_21, C4A-001_22, C4A-001_23, C4A-001_24, C4A-001_25, C4A-001_26, C4A-001_27, C4A-001_28@14.1111111111111@11@17@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
D174381@83614@83616@deletion@3@31975450@31975814@6@chr6:31975450-31975814@9.58@114@50@0.439@CNVR2843.6, CNVR2843.3@CYP21A1P-001_8, CYP21A1P-001_9, AL645922-201_7@110@99@116@NA@NA@NA
D174381@83637@83645@duplication@9@31994762@31997116@6@chr6:31994762-31997116@24.3@283@497@1.76@CNVR2843.6, CNVR2843.5@C4B-001_20, C4B-001_21, C4B-001_22, C4B-001_23, C4B-001_24, C4B-001_25, C4B-001_26, C4B-001_27, C4B-001_28@13.8888888888889@10@19@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
D174381@83668@83672@duplication@5@32008185@32009712@6@chr6:32008185-32009712@8.14@227@329@1.45@CNVR2843.6, CNVR2843.5@TNXB-201_43, TNXB-201_44, CYP21A2-002_8, CYP21A2-002_9, CYP21A2-002_10@39.2@29@46@:cytochrome P450, family 21, subfamily A, polypeptide 2:tenascin-X-like;tenascin XB@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
D174381@83911@83916@deletion@6@32485122@32498065@6@chr6:32485122-32498065@26.8@169@33@0.195@CNVR2845.21, CNVR2845.25, CNVR2845.30, CNVR2845.43@HLA-DRB5-001_1, HLA-DRB5-001_2, HLA-DRB5-001_3, HLA-DRB5-001_4, HLA-DRB5-001_5, HLA-DRB5-001_6@173.833333333333@122@189@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D174381@83920@83921@duplication@2@32522469@32522749@6@chr6:32522469-32522749@11.5@141@246@1.74@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.29, CNVR2845.5, CNVR2845.53@HLA-DRB6-002_3, AL713966-201_3@144@144@144@NA@NA@NA
D174381@83929@83930@deletion@2@32549336@32552156@6@chr6:32549336-32552156@8.43@203@118@0.581@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.5, CNVR2845.54, CNVR2845.55, CNVR2845.56, CNVR2845.34@HLA-DRB1-001_2, HLA-DRB1-001_3@80@60@100@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
D174381@83944@83945@deletion@2@32630133@32632845@6@chr6:32630133-32632845@9.9@95@35@0.368@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20, CNVR2845.31, CNVR2845.64@HLA-DQB1-003_3, ENST00000443574_1@106.5@101@112@:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
D174381@92590@92593@duplication@4@160132511@160133097@6@chr6:160132511-160133097@39.8@352@696@1.98@CNVR3127.2, CNVR3127.1@ENST00000442642_4, ENST00000442642_5, ENST00000442642_6, ENST00000442642_7@103.5@90@112@:superoxide dismutase 2, mitochondrial;uncharacterized LOC100129518@:response to reactive oxygen species;oxidation-reduction process;mitochondrion;negative regulation of cell proliferation;neuron development;negative regulation of fat cell differentiation;removal of superoxide radicals;response to gamma radiation;response to L-ascorbic acid;response to lipopolysaccharide;response to nutrient levels;response to zinc ion;protein homotetramerization;post-embryonic development;iron ion homeostasis;hemopoiesis;aging;mitochondrial inner membrane;age-dependent response to reactive oxygen species;response to drug;oxygen binding;mitochondrial nucleoid;vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure;apoptotic process;superoxide metabolic process;response to superoxide;detection of oxygen;response to silicon dioxide;cytoplasm;response to stress;respiratory electron transport chain;superoxide anion generation;protein homooligomerization;regulation of mitochondrial membrane potential;positive regulation of nitric oxide biosynthetic process;response to manganese ion;regulation of blood pressure;metal ion binding;negative regulation of apoptotic process;response to cadmium ion;response to oxidative stress;liver development;regulation of catalytic activity;negative regulation of fibroblast proliferation;response to selenium ion;age-dependent response to oxidative stress;response to electrical stimulus;mitochondrial matrix;identical protein binding;mitochondrion organization;response to hyperoxia;vasodilation;response to hydrogen peroxide;superoxide dismutase activity;heart development;negative regulation of neuron apoptotic process;erythrophore differentiation;locomotory behavior;DNA binding;release of cytochrome c from mitochondria;response to axon injury;oxygen homeostasis;response to activity;glutathione metabolic process;hydrogen peroxide metabolic process;hydrogen peroxide biosynthetic process;regulation of transcription from RNA polymerase II promoter;response to hypoxia;protein binding;manganese ion binding;cellular response to ethanol@: MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6; MVCD6
D174381@93101@93101@duplication@1@167794611@167794825@6@chr6:167794611-167794825@6.52@16@59@3.69@NA@TCP10-001_3@52@52@52@:t-complex 10@:cytosol@NA
D174381@93103@93103@deletion@1@167797871@167797999@6@chr6:167797871-167797999@7.07@46@10@0.217@NA@TCP10-001_1@5@5@5@:t-complex 10@:cytosol@NA
D174381@94208@94208@deletion@1@5998626@5998710@7@chr7:5998626-5998710@5.94@132@74@0.561@NA@RSPH10B-002_7@11@11@11@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D174381@94442@94444@duplication@3@6840581@6844687@7@chr7:6840581-6844687@5.56@109@168@1.54@NA@C7orf28B-001_12, C7orf28B-001_13, C7orf28B-001_14@117.666666666667@114@121@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D174381@96579@96584@duplication@6@38388958@38398764@7@chr7:38388958-38398764@51.9@994@1598@1.61@CNVR3354.3, CNVR3354.1@TRGV5-001_1, TRGV5-001_2, TRGV4-001_1, TRGV4-001_2, TRGV3-001_1, TRGV3-001_2@10.5@6@14@@:protein binding:protein binding:protein binding;immune response;peptide antigen binding;plasma membrane;MHC protein binding@NA
D174381@97907@97917@deletion@11@57063663@57084498@7@chr7:57063663-57084498@13.1@110@37@0.336@NA@TNRC18C-202_3, TNRC18C-202_4, TNRC18C-202_5, TNRC18C-202_6, TNRC18C-202_7, TNRC18C-202_8, TNRC18C-202_9, TNRC18C-202_10, TNRC18C-202_11, ENST00000398760_4, ENST00000398760_5@155.545454545455@139@166@NA@NA@NA
D174381@97991@97994@deletion@4@62758072@62758771@7@chr7:62758072-62758771@70.3@325@0@0@NA@AC006455-201_2, AC006455-201_3, ENST00000444809_2, ENST00000444809_3@160@151@171@NA@NA@NA
D174381@98015@98016@duplication@2@62910199@62910898@7@chr7:62910199-62910898@11@340@502@1.48@NA@ZNF734-201_2, ZNF734-201_3@102@102@102@NA@NA@NA
D174381@98173@98174@duplication@2@64533487@64534227@7@chr7:64533487-64534227@13@27@112@4.15@NA@RP11-460N20-001_11, RP11-460N20-001_12, ENST00000501153_3@101@101@101@NA@NA@NA
D174381@98192@98193@deletion@2@64646770@64646889@7@chr7:64646770-64646889@6.83@39@6@0.154@NA@INTS4L1-201_8, INTS4L1-201_9@51.5@51@52@NA@NA@NA
D174381@98733@98735@deletion@3@72709324@72712438@7@chr7:72709324-72712438@9.03@63@15@0.238@NA@POM121B-201_5, POM121B-201_6, POM121B-201_7@2.66666666666667@2@3@NA@NA@NA
D174381@99025@99025@duplication@1@74160678@74160751@7@chr7:74160678-74160751@5.74@1@36@36@NA@GTF2I-001_23@54@54@54@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
D174381@99063@99063@deletion@1@74251404@74251506@7@chr7:74251404-74251506@4.84@22@0@0@NA@GTF2IRD2-002_2@8@8@8@:GTF2I repeat domain containing 2@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
D174381@99455@99455@deletion@1@76069569@76069659@7@chr7:76069569-76069659@15.8@158@55@0.348@CNVR3462.1@ZP3-002_7@10@10@10@:zona pellucida glycoprotein 3 (sperm receptor)@:negative regulation of transcription, DNA-dependent;manganese ion transmembrane transporter activity;intracellular protein transport;proteinaceous extracellular matrix;plasma membrane;positive regulation of acrosome reaction;outer acrosomal membrane;protein kinase C signaling cascade;manganese ion transmembrane transport;intracellular signal transduction;humoral immune response mediated by circulating immunoglobulin;negative regulation of binding of sperm to zona pellucida;positive regulation of inflammatory response;endoplasmic reticulum;signal transducer activity;perinuclear region of cytoplasm;secretory granule;positive regulation of transcription, DNA-dependent;positive regulation of ovarian follicle development;positive regulation of interferon-gamma production;carbohydrate binding;manganese ion transport;positive regulation of antral ovarian follicle growth;extracellular matrix;positive regulation of leukocyte migration;positive regulation of humoral immune response;extracellular space;blastocyst formation;integral to membrane;store-operated calcium channel activity;oocyte development;multivesicular body;phosphatidylinositol-mediated signaling;acrosomal vesicle;positive regulation of protein kinase B signaling cascade;Golgi apparatus;positive regulation of calcium ion import;positive regulation of protein kinase activity;positive regulation of acrosomal vesicle exocytosis;positive regulation of interleukin-4 production;cytoplasm;protein binding;binding of sperm to zona pellucida;positive regulation of phosphatidylinositol biosynthetic process;extracellular region;positive regulation of T cell proliferation;acrosin binding;positive regulation of type IV hypersensitivity;egg coat formation@NA
D174381@99489@99490@duplication@2@76240773@76241131@7@chr7:76240773-76241131@11.7@177@293@1.66@CNVR3463.10@POMZP3-003_6, POMZP3-003_7@43.5@41@46@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
D174381@102166@102177@duplication@12@102219874@102235817@7@chr7:102219874-102235817@11@81@167@2.06@CNVR3518.1@ENST00000379336_1, RASA4-001_11, RASA4-001_12, RASA4-001_13, RASA4-001_14, RASA4-001_15, RASA4-001_16, RASA4-001_17, RASA4-001_18, RASA4-001_19, RASA4-001_20, RASA4-001_21@35.5@28@63@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
D174381@102209@102210@duplication@2@102313328@102319304@7@chr7:102313328-102319304@5.06@201@280@1.39@CNVR3518.1@ENST00000379355_1, ENST00000379355_2@53@52@54@NA@NA@NA
D174381@102617@102619@duplication@3@105903840@105909759@7@chr7:105903840-105909759@8.03@572@758@1.33@NA@PBEF1-001_5, PBEF1-001_6, PBEF1-001_7@1.66666666666667@1@3@:nicotinamide phosphoribosyltransferase@:nicotinate phosphoribosyltransferase activity;small molecule metabolic process;positive regulation of nitric-oxide synthase biosynthetic process;NAD metabolic process;cytoplasm;cell-cell signaling;NAD biosynthetic process;cytosol;signal transduction;cytokine activity;positive regulation of cell proliferation;water-soluble vitamin metabolic process;nicotinate-nucleotide diphosphorylase (carboxylating) activity;nicotinamide metabolic process;vitamin metabolic process;nicotinamide phosphoribosyltransferase activity@NA
D174381@105521@105523@deletion@3@142481247@142482417@7@chr7:142481247-142482417@82.1@387@2@0.00517@NA@PRSS1-204_4, PRSS1-204_5, PRSS1-204_6@114.333333333333@113@115@NA@NA@NA
D174381@105819@105822@deletion@4@144059753@144064449@7@chr7:144059753-144064449@6.17@192@120@0.625@CNVR3598.4, CNVR3598.5, CNVR3598.11@ARHGEF5-001_2, ARHGEF5-001_3, ARHGEF5-001_4, ARHGEF5-001_5@77.25@65@104@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
D174381@105827@105829@deletion@3@144070290@144072769@7@chr7:144070290-144072769@7.72@128@66@0.516@CNVR3598.4, CNVR3598.5, CNVR3598.11@ARHGEF5-001_10, ARHGEF5-001_11, ARHGEF5-001_12@56.6666666666667@39@83@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
D174381@107429@107429@deletion@1@7308648@7308722@8@chr8:7308648-7308722@6.42@118@62@0.525@CNVR3771.8, CNVR3771.10, CNVR3771.4@SPAG11-003_3@90@90@90@:sperm associated antigen 11B@:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response@NA
D174381@107507@107516@duplication@10@7686329@7752293@8@chr8:7686329-7752293@36.4@434@783@1.8@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@DEFB106A-001_2, DEFB104A-001_1, DEFB104A-001_2, SPAG11A-207_1, SPAG11A-207_2, SPAG11A-207_3, SPAG11A-207_4, DEFB103B-001_1, DEFB103B-001_2, DEFB4-001_1@64.1@44@113@:defensin, beta 106B;defensin, beta 106A:defensin, beta 104A;defensin, beta 104B:sperm associated antigen 11A;sperm associated antigen 11B:defensin, beta 103B;defensin, beta 103A:defensin, beta 4B;defensin, beta 4A@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response@NA
D174381@109572@109585@duplication@14@39311571@39349528@8@chr8:39311571-39349528@28.4@331@575@1.74@CNVR3859.1@ADAM3A-005_11, ADAM3A-005_12, ADAM3A-005_13, ADAM3A-005_14, ADAM3A-005_15, ADAM3A-005_16, ADAM3A-005_17, ADAM3A-005_18, ADAM3A-005_19, ADAM3A-005_20, ADAM3A-005_21, ADAM3A-009_7, ADAM3A-009_8, ADAM3A-009_9@120.5@98@136@NA@NA@NA
D174381@117288@117288@deletion@1@38603158@38603210@9@chr9:38603158-38603210@11.3@128@51@0.398@NA@ANKRD18A-202_7@2@2@2@:ankyrin repeat domain 18A@:protein binding@NA
D174381@117601@117602@deletion@2@43816639@43818185@9@chr9:43816639-43818185@13.6@265@141@0.532@CNVR4294.1@CNTNAP3B-001_6, CNTNAP3B-001_7@88.5@86@91@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
D174381@121600@121604@deletion@5@117085338@117087433@9@chr9:117085338-117087433@14.2@1160@791@0.682@CNVR4448.1@ORM1-001_1, ORM1-001_2, ORM1-001_3, ORM1-001_4, ORM1-001_5@87.6@84@90@:orosomucoid 1@:protein binding;extracellular space;regulation of immune system process;transport;inflammatory response;extracellular region;acute-phase response@NA
D174381@125349@125349@deletion@1@140379041@140379189@9@chr9:140379041-140379189@4.8@64@30@0.469@NA@PNPLA7-204_21@0@0@0@:patatin-like phospholipase domain containing 7@:hydrolase activity;endoplasmic reticulum;lysosomal membrane;lipid metabolic process;nuclear membrane;integral to membrane;mitochondrial membrane;metabolic process@NA
D174381@126909@126913@deletion@5@17840632@17875839@10@chr10:17840632-17875839@21.1@203@80@0.394@NA@FAM23A-201_5, MRC1L1-001_1, MRC1L1-001_2, MRC1L1-001_3, MRC1L1-001_4@32.6@11@108@:transmembrane protein 236;transmembrane protein 236-like:macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding@NA
D174381@126938@126948@duplication@11@17951324@18122793@10@chr10:17951324-18122793@10.2@175@278@1.59@NA@MRC1L1-001_29, MRC1L1-001_30, FAM23B-202_1, FAM23B-202_2, FAM23B-202_3, FAM23B-202_4, FAM23B-202_5, MRC1-001_1, MRC1-001_2, MRC1-001_3, MRC1-001_4@43@5@107@:macrophage mannose receptor 1-like:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D174381@126951@126956@deletion@6@18138510@18152612@10@chr10:18138510-18152612@15.2@72@2@0.0278@NA@MRC1-001_7, MRC1-001_8, MRC1-001_9, MRC1-001_10, MRC1-001_11, RP11-457D2-001_2@19.6666666666667@18@26@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D174381@126974@126975@deletion@2@18196465@18198277@10@chr10:18196465-18198277@9.1@41@0@0@NA@MRC1-001_28, MRC1-001_29@15@3@27@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D174381@127722@127722@duplication@1@29580856@29580936@10@chr10:29580856-29580936@6.75@35@85@2.43@NA@LYZL1-002_1@51@51@51@:lysozyme-like 1@:extracellular region;lysozyme activity;cell wall macromolecule catabolic process@NA
D174381@128913@128913@deletion@1@47409855@47410082@10@chr10:47409855-47410082@7.4@71@26@0.366@CNVR4712.9, CNVR4712.1@FAM35B2-201_6@47@47@47@NA@NA@NA
D174381@128998@129007@deletion@10@47915880@47942085@10@chr10:47915880-47942085@7.8@46@8@0.174@CNVR4715.2, CNVR4715.1@FAM21B-201_15, FAM21B-201_16, FAM21B-201_17, FAM21B-201_18, FAM21B-201_19, FAM21B-201_20, FAM21B-201_21, FAM21B-201_22, FAM21B-201_23, FAM21B-201_24@176.7@165@185@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
D174381@129023@129030@duplication@8@48025509@48055019@10@chr10:48025509-48055019@8.04@328@450@1.37@CNVR4715.2@ASAH2C-201_1, ASAH2C-201_2, ASAH2C-201_3, ASAH2C-201_4, ASAH2C-201_5, ASAH2C-201_6, ASAH2C-201_7, ASAH2C-201_8@64.75@50@90@@:ceramidase activity;sphingolipid metabolic process@NA
D174381@129460@129477@deletion@18@51361725@51391568@10@chr10:51361725-51391568@72.5@354@14@0.0395@NA@ENST00000404618_1, ENST00000404618_2, ENST00000404618_3, ENST00000404618_4, ENST00000432221_1, ENST00000432221_2, ENST00000432221_3, ENST00000432221_4, TIMM23B-202_1, TIMM23B-202_2, TIMM23B-202_3, TIMM23B-202_4, TIMM23B-202_5, TIMM23B-202_6, TIMM23B-202_7, TIMM23B-202_8, TIMM23B-202_9, TIMM23B-202_10@68.7222222222222@0@142@:translocase of inner mitochondrial membrane 23 homolog B (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process@NA
D174381@129509@129521@duplication@13@51603186@51631957@10@chr10:51603186-51631957@17.2@588@837@1.42@NA@TIMM23-202_1, TIMM23-202_2, TIMM23-202_3, TIMM23-202_4, TIMM23-202_5, TIMM23-202_6, TIMM23-202_7, TIMM23-202_8, TIMM23-202_9, TIMM23-202_10, ENST00000456092_1, ENST00000456092_2, ENST00000456092_3@10.5384615384615@0@29@:translocase of inner mitochondrial membrane 23 homolog B (yeast):translocase of inner mitochondrial membrane 23 homolog B (yeast);translocase of inner mitochondrial membrane 23 homolog (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:mitochondrion;mitochondrial inner membrane;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;mitochondrial intermembrane space;integral to mitochondrial inner membrane;intracellular protein transport;protein binding;integral to membrane;cellular protein metabolic process;protein targeting to mitochondrion@NA
D174381@129605@129611@deletion@7@51970585@51994313@10@chr10:51970585-51994313@13.6@152@68@0.447@NA@ASAH2-201_5, ASAH2-201_6, ASAH2-201_7, ASAH2-201_8, ASAH2-201_9, ASAH2-201_10, ASAH2-201_11@145.142857142857@53@186@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
D174381@131567@131568@deletion@2@81284748@81286392@10@chr10:81284748-81286392@15.6@139@50@0.36@NA@BX248123-201_1, BX248123-201_2@2.5@2@3@NA@NA@NA
D174381@139253@139253@duplication@1@17542419@17542542@11@chr11:17542419-17542542@4.92@106@163@1.54@NA@USH1C-201_14@0@0@0@:Usher syndrome 1C (autosomal recessive, severe)@:photoreceptor cell maintenance;parallel actin filament bundle assembly;apical part of cell;neuromuscular process controlling balance;actin filament bundle assembly;plasma membrane;inner ear morphogenesis;auditory receptor cell differentiation;photoreceptor outer segment;photoreceptor inner segment;sensory perception of sound;stereocilium;cytoplasm;equilibrioception;G2/M transition of mitotic cell cycle;cytosol;protein binding;synapse;sensory perception of light stimulus;cytoskeleton@: USHER SYNDROME, TYPE I; USH1; USHER SYNDROME, TYPE IC; USH1C; DEAFNESS, AUTOSOMAL RECESSIVE 18; DFNB18
D174381@141187@141188@deletion@2@48600990@48601883@11@chr11:48600990-48601883@6.43@29@0@0@CNVR5165.1@AC134982-201_1, AC134982-201_2@128@128@128@NA@NA@NA
D174381@150826@150841@duplication@16@9590609@9707352@12@chr12:9590609-9707352@99.9@685@1488@2.17@CNVR5429.1@DDX12-203_1, DDX12-203_2, DDX12-203_3, AC006432-201_1, AC006432-201_2, AC006432-201_3, AC006432-201_4, AC006432-201_5, AC006432-201_6, AC006432-201_7, AC006432-201_8, AC006432-201_9, AC006432-201_11, AC006432-201_12, AC006432-201_13@20.7333333333333@7@25@NA@NA@NA
D174381@151034@151034@duplication@1@11244393@11244793@12@chr12:11244393-11244793@6.83@309@435@1.41@CNVR5434.1@TAS2R31-201_2@72@72@72@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
D174381@161688@161688@duplication@1@19778482@19778650@13@chr13:19778482-19778650@5.08@28@65@2.32@NA@RP11-408E5-201_7@4@4@4@NA@NA@NA
D174381@162125@162128@deletion@4@24463273@24465671@13@chr13:24463273-24465671@24.9@753@432@0.574@NA@MIPEP-001_1, RP11-45B20-002_6, ENST00000382133_2, ENST00000382133_3@16.25@3@29@:mitochondrial intermediate peptidase:C1q and tumor necrosis factor related protein 9B@:mitochondrion;proteolysis;protein processing involved in protein targeting to mitochondrion;metalloendopeptidase activity;mitochondrial matrix;metal ion binding:collagen;protein binding@NA
D174381@162131@162131@deletion@1@24468280@24468341@13@chr13:24468280-24468341@16.8@147@45@0.306@NA@RP11-45B20-002_4@36@36@36@:C1q and tumor necrosis factor related protein 9B@:collagen;protein binding@NA
D174381@162163@162164@duplication@2@24892958@24893019@13@chr13:24892958-24893019@11@525@728@1.39@NA@SPATA13-009_12, C1QTNF9-003_4@8.5@6@11@:spermatogenesis associated 13:C1q and tumor necrosis factor related protein 9@:lamellipodium assembly;phospholipid binding;Rac guanyl-nucleotide exchange factor activity;guanyl-nucleotide exchange factor activity;ruffle membrane;nucleus;regulation of cell migration;cell migration;regulation of Rho protein signal transduction;intracellular;Rho guanyl-nucleotide exchange factor activity;cytoplasm;filopodium assembly;filopodium;protein binding;lamellipodium:collagen;protein binding;hormone activity@NA
D174381@166922@166924@deletion@3@21359843@21388336@14@chr14:21359843-21388336@33.7@897@482@0.537@CNVR6076.1@RNASE3-001_2, AL355922-201_1, AL355922-201_2@1@1@1@:ribonuclease, RNase A family, 3@:ribonuclease activity;extracellular region;defense response to bacterium;pancreatic ribonuclease activity;RNA catabolic process;nucleic acid binding@NA
D174381@167663@167664@duplication@2@24470074@24470294@14@chr14:24470074-24470294@9.07@230@342@1.49@NA@DHRS4L2-001_4, DHRS4L2-001_5@7.5@7@8@:dehydrogenase/reductase (SDR family) member 4 like 2@:extracellular region;oxidoreductase activity;nucleotide binding;metabolic process@NA
D174381@173501@173503@duplication@3@106478134@106478604@14@chr14:106478134-106478604@20@123@278@2.26@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV3-6-210_6, IGHV4-4-001_1, IGHV4-4-001_2@13@5@17@@:protein binding@NA
D174381@173508@173513@duplication@6@106539081@106559976@14@chr14:106539081-106559976@56@545@1062@1.95@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8-001_1, IGHV1-8-001_2, IGHV3-9-001_1, IGHV3-9-001_2, IGHV2-10-001_1, IGHV2-10-001_2@22.3333333333333@17@24@@:protein binding:protein binding@NA
D174381@173556@173561@deletion@6@106787370@106800758@14@chr14:106787370-106800758@20.7@561@316@0.563@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-29-001_1, IGHV3-29-001_2, IGHV3-30-001_1, IGHV3-30-001_2, IGHV3-30-2-001_1, IGHV3-30-2-001_2@16@13@19@@:protein binding@NA
D174381@173566@173566@duplication@1@106815724@106816027@14@chr14:106815724-106816027@11.2@231@370@1.6@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.56, CNVR6294.51@IGHV3-33-001_2@15@15@15@@:protein binding@NA
D174381@173588@173591@deletion@4@106877621@106899494@14@chr14:106877621-106899494@15.6@379@220@0.58@CNVR6294.26, CNVR6294.56, CNVR6294.18@IGHV4-39-001_1, IGHV4-39-001_2, IGHV3-41-001_1, IGHV3-41-001_2@8.75@7@11@@:protein binding@NA
D174381@173690@173690@duplication@1@20464830@20464834@15@chr15:20464830-20464834@4.94@415@553@1.33@CNVR6295.15, CNVR6295.7, CNVR6295.13, CNVR6295.26@ENST00000400226_7@20@20@20@NA@NA@NA
D174381@174037@174037@duplication@1@23690459@23690586@15@chr15:23690459-23690586@5.17@7@40@5.71@NA@ENST00000312015_2@5@5@5@:golgin A6 family-like 2@NA@NA
D174381@174503@174507@duplication@5@30653445@30665349@15@chr15:30653445-30665349@24.4@336@569@1.69@CNVR6337.1@CHRFAM7A-202_6, CHRFAM7A-202_7, CHRFAM7A-202_8, CHRFAM7A-202_9, CHRFAM7A-202_10@51@44@68@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
D174381@174659@174660@deletion@2@32449811@32450808@15@chr15:32449811-32450808@8.32@136@72@0.529@CNVR6345.2, CNVR6345.1@CHRNA7-205_6, CHRNA7-205_7@60@54@66@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
D174381@174967@174975@duplication@9@34781267@34820279@15@chr15:34781267-34820279@11.8@738@981@1.33@CNVR6351.3@AC027139-201_1, AC027139-201_2, AC027139-201_3, AC027139-201_4, ENST00000444260_1, ENST00000444260_2, ENST00000444260_3, GOLGA8B-201_23, GOLGA8B-201_24@43.6666666666667@31@49@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
D174381@176432@176433@deletion@2@44002591@44002976@15@chr15:44002591-44002976@28.8@133@0@0@NA@AC011330-201_13, AC011330-201_14@28@16@40@:stereocilin@:detection of mechanical stimulus involved in sensory perception of sound;stereocilium bundle tip;stereocilium;cell surface;kinocilium;auditory receptor cell stereocilium organization@: DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16; DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY
D174381@179008@179009@deletion@2@69708295@69708403@15@chr15:69708295-69708403@5.82@218@138@0.633@NA@KIF23-203_1, KIF23-203_2@0@0@0@:kinesin family member 23@:microtubule binding;nucleoplasm;kinesin complex;microtubule motor activity;mitotic cell cycle;microtubule associated complex;centralspindlin complex;mitotic spindle elongation;ATP binding;positive regulation of cell cycle cytokinesis;intercellular bridge;midbody;blood coagulation;nucleus;M phase of mitotic cell cycle;spindle;cytokinesis;antigen processing and presentation of exogenous peptide antigen via MHC class II;centrosome;cell cycle cytokinesis;mitotic spindle;cytosol;protein binding;microtubule-based movement;microtubule;spindle midzone assembly involved in mitosis@NA
D174381@183378@183378@deletion@1@2672693@2672767@16@chr16:2672693-2672767@11.3@51@0@0@CNVR6602.2@AC141586-201_6@57@57@57@NA@NA@NA
D174381@184851@184851@deletion@1@16349867@16350016@16@chr16:16349867-16350016@6.25@176@104@0.591@NA@NOMO3-201_11@31@31@31@:NODAL modulator 3@:carbohydrate binding;integral to membrane;carboxypeptidase activity@NA
D174381@185304@185304@duplication@1@20491897@20492023@16@chr16:20491897-20492023@6.45@136@211@1.55@NA@ACSM2A-201_11@1@1@1@:acyl-CoA synthetase medium-chain family member 2A@:mitochondrion;butyrate-CoA ligase activity;catalytic activity;ATP binding;glucose homeostasis;medium-chain fatty-acyl-CoA metabolic process;fatty acid metabolic process;triglyceride homeostasis;metabolic process;mitochondrial matrix;metal ion binding@NA
D174381@187527@187528@duplication@2@32936755@32937067@16@chr16:32936755-32937067@5.82@44@89@2.02@CNVR6702.1@ENST00000423205_4, ENST00000423205_5@26.5@19@34@NA@NA@NA
D174381@187546@187548@duplication@3@33629704@33630421@16@chr16:33629704-33630421@17.7@817@1142@1.4@CNVR6703.17, CNVR6703.1, CNVR6703.6, CNVR6703.21@AC136428-201_1, AC136428-201_2, AC136428-201_3@22.3333333333333@18@29@NA@NA@NA
D174381@187570@187570@duplication@1@33740805@33741079@16@chr16:33740805-33741079@4.9@272@372@1.37@CNVR6703.17, CNVR6703.1, CNVR6703.23@ENST00000450856_3@10@10@10@NA@NA@NA
D174381@187602@187609@duplication@8@34489564@34682257@16@chr16:34489564-34682257@12.7@906@1192@1.32@CNVR6708.1@ENST00000425453_1, ENST00000425453_2, ENST00000425453_3, ENST00000425453_4, ENST00000425453_6, AC018558-202_1, AC018558-202_2@13.4285714285714@2@20@NA@NA@NA
D174381@188229@188233@duplication@5@55798611@55807424@16@chr16:55798611-55807424@6.64@282@385@1.37@CNVR6730.1@CES4-202_2, CES4-202_3, CES4-202_4, CES4-202_5, CES4-202_6@113@108@123@NA@NA@NA
D174381@189930@189931@duplication@2@70010214@70012016@16@chr16:70010214-70012016@5.3@49@93@1.9@CNVR6762.3, CNVR6762.2@AC026468-201_7, AC026468-201_8@6.5@3@10@NA@NA@NA
D174381@190403@190404@deletion@2@72001038@72001907@16@chr16:72001038-72001907@8.37@165@90@0.545@NA@PKD1L3-201_14, PKD1L3-201_15@0@0@0@NA@NA@NA
D174381@190430@190431@deletion@2@72091293@72092255@16@chr16:72091293-72092255@9.13@41@0@0@CNVR6769.1, CNVR6769.2@HP-201_4, HP-201_5@28.5@26@31@:thioredoxin-like 4B:haptoglobin:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:cellular iron ion homeostasis;negative regulation of oxidoreductase activity;catalytic activity;negative regulation of hydrogen peroxide catabolic process;positive regulation of cell death;haptoglobin-hemoglobin complex;extracellular space;proteolysis;response to hydrogen peroxide;extracellular region;hemoglobin binding;defense response;serine-type endopeptidase activity:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@: ANHAPTOGLOBINEMIA; AHP
D174381@195009@195010@deletion@2@15508539@15508738@17@chr17:15508539-15508738@7.7@83@34@0.41@NA@CDRT1-201_7, TRIM16-202_16@20@20@20@:CMT1A duplicated region transcript 1@:protein binding;molecular_function;cellular_component;biological_process:protein binding;intracellular;zinc ion binding;cytoplasm@NA
D174381@195017@195018@deletion@2@15517149@15517348@17@chr17:15517149-15517348@6.26@245@156@0.637@NA@CDRT1-201_3, TRIM16-202_12@38@38@38@:CMT1A duplicated region transcript 1@:protein binding;molecular_function;cellular_component;biological_process:protein binding;intracellular;zinc ion binding;cytoplasm@NA
D174381@195871@195871@deletion@1@18996780@18996940@17@chr17:18996780-18996940@4.84@161@99@0.615@CNVR7018.4, CNVR7018.2, CNVR7018.6@AC007952-202_2@92@92@92@NA@NA@NA
D174381@197726@197728@deletion@3@34539180@34539966@17@chr17:34539180-34539966@10.1@46@0@0@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1-202_2, CCL4L1-202_3, CCL4L1-202_4@118@113@122@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
D174381@200337@200349@duplication@13@44399690@44592688@17@chr17:44399690-44592688@37.7@94@347@3.69@CNVR7114.2, CNVR7114.1@LRRC37A-001_7, LRRC37A-001_8, LRRC37A-001_9, LRRC37A-001_10, LRRC37A-001_11, LRRC37A-001_12, LRRC37A-001_13, LRRC37A-001_14, LRRC37A-001_15, AC005829-202_1, AC005829-202_2, AC005829-202_3, LRRC37A2-201_1@149.230769230769@114@196@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane@NA
D174381@213493@213494@deletion@2@14508472@14508748@19@chr19:14508472-14508748@10.7@78@21@0.269@NA@CD97-205_8, CD97-205_9@10.5@7@14@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
D174381@215928@215928@deletion@1@35862253@35863856@19@chr19:35862253-35863856@22.9@162@34@0.21@CNVR7627.1@FFAR3-001_2@102@102@102@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
D174381@217293@217298@deletion@6@40373947@40384168@19@chr19:40373947-40384168@31.8@313@117@0.374@CNVR7639.2@FCGBP-201_21, FCGBP-201_22, FCGBP-201_23, FCGBP-201_24, FCGBP-201_25, FCGBP-201_26@121.5@75@155@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D174381@217304@217306@duplication@3@40395806@40399856@19@chr19:40395806-40399856@5.26@101@155@1.53@CNVR7639.2, CNVR7639.3@FCGBP-201_13, FCGBP-201_14, FCGBP-201_15@120@106@127@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D174381@217595@217595@duplication@1@41327389@41327534@19@chr19:41327389-41327534@13.5@42@139@3.31@NA@CYP2F1P-001_5@0@0@0@NA@NA@NA
D174381@218183@218185@deletion@3@43709627@43716628@19@chr19:43709627-43716628@9.3@156@82@0.526@CNVR7658.5, CNVR7658.1@PSG1-202_1, PSG4-001_1, CEACAMP10-001_9@39@38@41@:pregnancy specific beta-1-glycoprotein 4:pregnancy specific beta-1-glycoprotein 9@:protein binding;extracellular region;female pregnancy;defense response:protein binding;extracellular region;female pregnancy;defense response@NA
D174381@218872@218874@deletion@3@46274231@46274319@19@chr19:46274231-46274319@5.27@111@63@0.568@NA@DMPK-206_14, DMPK-206_15, DMPK-206_16@3.66666666666667@3@4@:dystrophia myotonica-protein kinase@:cellular calcium ion homeostasis;protein tyrosine kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;sarcoplasmic reticulum membrane;regulation of myotube differentiation;plasma membrane;nuclear envelope organization;endoplasmic reticulum membrane;muscle cell apoptotic process;protein serine/threonine kinase activity;regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction;protein phosphorylation;regulation of heart contraction;protein kinase activity;myosin phosphatase regulator activity;regulation of skeletal muscle contraction by calcium ion signaling;cytosol;nuclear membrane;protein binding;regulation of synapse structural plasticity;regulation of sodium ion transport;integral to mitochondrial outer membrane;metal ion binding;nuclear outer membrane@: MYOTONIC DYSTROPHY 1; DM1
D174381@221169@221171@deletion@3@54726152@54726912@19@chr19:54726152-54726912@9.09@94@37@0.394@CNVR7721.3, CNVR7721.4@LILRB3-008_1, LILRB3-008_2, LILRB3-008_3@106@98@119@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D174381@221396@221413@deletion@18@55266477@55290115@19@chr19:55266477-55290115@39.3@1634@1053@0.644@CNVR7725.2, CNVR7725.1@KIR2DL3-201_5, KIR2DL3-201_6, KIR2DL3-201_7, KIR2DL3-201_8, KIR2DP1-001_1, KIR2DP1-001_2, KIR2DP1-001_3, KIR2DP1-001_4, KIR2DP1-001_5, KIR2DP1-001_6, KIR2DP1-001_7, KIR2DP1-001_8, KIR2DP1-001_9, KIR2DL1-002_1, KIR2DL1-002_2, KIR2DL1-002_3, KIR2DL1-002_4, KIR2DL1-002_5@108.277777777778@76@126@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
D174381@221819@221821@deletion@3@56270382@56274542@19@chr19:56270382-56274542@25.9@688@415@0.603@CNVR7734.1@RFPL4A-201_1, RFPL4A-201_2, RFPL4A-201_3@32.6666666666667@26@39@:ret finger protein-like 4A;ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
D174381@222562@222563@deletion@2@1558986@1569279@20@chr20:1558986-1569279@12.8@284@155@0.546@CNVR7763.1@SIRPB1-201_1, SIRPB1-201_2@90.5@53@128@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
D174381@222594@222594@duplication@1@1895747@1896102@20@chr20:1895747-1896102@7.73@105@180@1.71@CNVR7764.2@SIRPA-201_3@34@34@34@:signal-regulatory protein alpha@:blood coagulation;protein binding;integral to membrane;SH3 domain binding;cell adhesion;plasma membrane;membrane;leukocyte migration@NA
D174381@224444@224444@deletion@1@25755748@25755949@20@chr20:25755748-25755949@6.81@114@58@0.509@CNVR7821.2, CNVR7821.4@FAM182B-005_3@1@1@1@:family with sequence similarity 27, member B;family with sequence similarity 27, member A;family with sequence similarity 27, member C;family with sequence similarity 182, member B@NA@NA
D174381@224466@224467@duplication@2@26061802@26065122@20@chr20:26061802-26065122@15.7@174@317@1.82@CNVR7823.4, CNVR7823.3, CNVR7823.5, CNVR7823.1@C20orf91-201_4, C20orf91-201_5@46.5@33@60@NA@NA@NA
D174381@229275@229275@deletion@1@20230099@20230330@21@chr21:20230099-20230330@6.54@94@45@0.479@NA@PPIAL3-201_1@0@0@0@NA@NA@NA
D174381@231968@231969@duplication@2@16348074@16349582@22@chr22:16348074-16349582@9.03@493@681@1.38@CNVR8071.2, CNVR8071.3, CNVR8071.10@LA16c-2F2-001_3, LA16c-2F2-001_4@52@50@54@NA@NA@NA
D174381@232771@232783@deletion@13@20385728@20398724@22@chr22:20385728-20398724@11.2@96@33@0.344@CNVR8094.9, CNVR8094.4, CNVR8094.10@PI4KAP1-204_2, PI4KAP1-204_3, PI4KAP1-204_4, PI4KAP1-204_5, PI4KAP1-204_6, PI4KAP1-204_7, PI4KAP1-204_8, PI4KAP1-204_9, PI4KAP1-204_10, PI4KAP1-204_11, PI4KAP1-204_12, PI4KAP1-204_13, PI4KAP1-204_14@166.538461538462@155@172@NA@NA@NA
D174381@233700@233708@deletion@9@24283261@24302569@22@chr22:24283261-24302569@20.3@129@27@0.209@CNVR8114.6, CNVR8114.10, CNVR8114.12, CNVR8114.13@ENST00000443377_2, ENST00000443377_3, ENST00000440099_1, ENST00000440099_2, ENST00000440099_3, GSTT2B-002_2, GSTT2B-002_3, GSTT2B-002_4, GSTT2B-002_5@74.6666666666667@56@125@:glutathione S-transferase theta 2B (gene/pseudogene);glutathione S-transferase theta 2@:protein binding;glutathione transferase activity;nucleus;transferase activity;cytoplasm@NA
D174381@233743@233754@duplication@12@24373119@24394850@22@chr22:24373119-24394850@58.5@776@1321@1.7@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTTP1-001_1, ENST00000439866_1, ENST00000439866_2, GSTT1-009_1, GSTT1-009_2, GSTT1-009_3, GSTT1-009_4, GSTT1-009_5, ENST00000439996_1, ENST00000439996_2, GSTTP2-001_4, GSTTP2-001_5@137.916666666667@122@149@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
D174381@236751@236766@deletion@16@42523846@42536708@22@chr22:42523846-42536708@45.3@716@357@0.499@CNVR8168.1, CNVR8168.3, CNVR8168.2, CNVR8168.4@RP4-669P10-201_4, RP4-669P10-201_5, RP4-669P10-201_6, RP4-669P10-201_7, CYP2D6-203_1, CYP2D6-203_2, CYP2D6-203_3, CYP2D6-203_4, CYP2D6-203_5, CYP2D6-203_6, CYP2D6-203_7, ENST00000428786_1, ENST00000428786_2, ENST00000428786_3, CYP2D7P1-202_9, CYP2D7P1-202_10@13.875@2@28@:cytochrome P450, family 2, subfamily D, polypeptide 6@:oxidation-reduction process;mitochondrion;alkaloid catabolic process;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;drug catabolic process;endoplasmic reticulum membrane;response to organic substance;oxidative demethylation;endoplasmic reticulum;alkaloid metabolic process;negative regulation of binding;heme binding;xenobiotic metabolic process;dopamine metabolic process;steroid metabolic process;isoquinoline alkaloid metabolic process;arachidonic acid monooxygenase activity;arachidonic acid metabolic process;steroid 21-monooxygenase activity;negative regulation of cellular organofluorine metabolic process;oxidoreductase activity;monoterpenoid metabolic process;heterocycle metabolic process;drug binding;drug metabolic process;electron carrier activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;coumarin metabolic process:oxidation-reduction process;electron carrier activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;heme binding@: DRUG METABOLISM, POOR, CYP2D6-RELATED
D36421@619@619@deletion@1@1666131@1666275@1@chr1:1666131-1666275@5.22@61@25@0.41@CNVR17.1@SLC35E2-002_6@32@32@32@:solute carrier family 35, member E2@:integral to membrane;membrane@NA
D36421@2296@2302@deletion@7@12853354@12887690@1@chr1:12853354-12887690@6.8@369@241@0.653@CNVR72.3, CNVR72.10@PRAMEF1-001_2, PRAMEF1-001_3, PRAMEF1-001_4, RP5-845O24-001_1, RP5-845O24-001_2, PRAMEF11-001_3, PRAMEF11-001_4@17.2857142857143@17@18@:PRAME family member 1:PRAME family member 11@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
D36421@2311@2313@deletion@3@12918842@12921765@1@chr1:12918842-12921765@15.2@327@169@0.517@CNVR72.3, CNVR72.4, CNVR72.7, CNVR72.12@PRAMEF2-001_2, PRAMEF2-001_3, PRAMEF2-001_4@33.3333333333333@33@34@:PRAME family member 2@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
D36421@2953@2957@duplication@5@17017715@17026516@1@chr1:17017715-17026516@9.49@642@863@1.34@CNVR93.3, CNVR93.15, CNVR93.4@ESPNP-002_7, ESPNP-002_8, ESPNP-002_9, ESPNP-002_10, ESPNP-002_11@45.6@45@46@NA@NA@NA
D36421@2977@2978@duplication@2@17085173@17085380@1@chr1:17085173-17085380@8.14@316@455@1.44@CNVR93.3, CNVR93.15, CNVR93.2, CNVR93.1@MST1P9-202_13, MST1P9-202_14@36@35@37@:macrophage stimulating 1-like@:proteolysis;extracellular region;catalytic activity;serine-type endopeptidase activity@NA
D36421@2996@2997@duplication@2@17183209@17185780@1@chr1:17183209-17185780@9.38@172@281@1.63@CNVR94.2, CNVR94.1, CNVR94.4@ENST00000414128_2, ENST00000414128_3@10@9@11@NA@NA@NA
D36421@3777@3779@deletion@3@21808092@21809812@1@chr1:21808092-21809812@8.64@131@62@0.473@CNVR107.2, CNVR107.1@NBPF3-003_17, NBPF3-003_18, NBPF3-003_19@93@83@111@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 3@:cytoplasm@NA
D36421@3965@3965@deletion@1@22338945@22339034@1@chr1:22338945-22339034@10.6@49@0@0@CNVR108.2, CNVR108.1@CELA3A-201_8@3@3@3@:chymotrypsin-like elastase family, member 3A@:proteolysis;digestion;cholesterol metabolic process;catalytic activity;serine-type endopeptidase activity@NA
D36421@4449@4459@duplication@11@25593204@25648454@1@chr1:25593204-25648454@44.4@870@1406@1.62@CNVR116.1, CNVR116.2@C1orf63-002_1, RP11-335G20-001_1, RHD-202_1, RHD-202_2, RHD-202_3, RHD-202_4, RHD-202_5, RHD-202_6, RHD-202_7, RHD-202_8, RHD-202_9@118.272727272727@92@128@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
D36421@12416@12417@duplication@2@104202984@104203299@1@chr1:104202984-104203299@15.6@101@235@2.33@CNVR266.3, CNVR266.1@AMY1A-001_7, AMY1A-001_8@123.5@118@129@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D36421@12929@12936@deletion@8@110230474@110236368@1@chr1:110230474-110236368@94.9@449@4@0.00891@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1-001_1, GSTM1-001_2, GSTM1-001_3, GSTM1-001_4, GSTM1-001_5, GSTM1-001_6, GSTM1-001_7, GSTM1-001_8@191.375@187@194@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
D36421@16280@16280@deletion@1@152573269@152573493@1@chr1:152573269-152573493@18.2@85@0@0@CNVR358.1@LCE3C-201_2@102@102@102@:late cornified envelope 3C@:keratinization@NA
D36421@18673@18688@duplication@16@161560936@161641940@1@chr1:161560936-161641940@39@1330@1986@1.49@CNVR383.1@FCGR2B-207_4, FCGR2C-006_4, FCGR2C-006_5, FCGR2C-006_6, FCGR2C-006_7, ENST00000448848_1, ENST00000448848_2, ENST00000448848_3, FCGR3B-001_1, FCGR3B-001_2, FCGR3B-001_3, FCGR3B-001_4, FCGR3B-001_5, RP11-474I16-001_1, RP11-474I16-001_2, ENST00000453111_3@33.5@10@57@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene):Fc fragment of IgG, low affinity IIIb, receptor (CD16b)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction:IgG binding;protein binding;extracellular region;immune response;plasma membrane;anchored to membrane@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
D36421@21362@21371@deletion@10@196743977@196796136@1@chr1:196743977-196796136@144@873@123@0.141@CNVR459.1@CFHR3-001_1, CFHR3-001_2, CFHR3-001_3, CFHR3-001_4, CFHR3-001_5, CFHR3-001_6, CFHR1-001_1, CFHR1-001_2, CFHR1-001_3, CFHR2-201_1@94.6@85@112@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
D36421@21375@21384@duplication@10@196857217@196887764@1@chr1:196857217-196887764@29.9@1836@2510@1.37@CNVR459.5@CFHR4-201_1, CFHR4-201_2, CFHR4-201_3, CFHR4-201_4, CFHR4-201_5, CFHR4-201_6, CFHR4-201_7, CFHR4-201_8, CFHR4-201_9, CFHR4-201_10@8.2@6@15@:complement factor H-related 2:complement factor H-related 4@:extracellular region:extracellular region;lipid transporter activity;lipid transport@NA
D36421@21389@21390@deletion@2@196946688@196952210@1@chr1:196946688-196952210@20@372@174@0.468@NA@CFHR5-001_1, CFHR5-001_2@3@3@3@:complement factor H-related 5@:complement activation, alternative pathway;extracellular region@NA
D36421@23045@23045@duplication@1@207741171@207741388@1@chr1:207741171-207741388@6.71@240@363@1.51@CNVR485.1, CNVR485.2@CR1-201_25@16@16@16@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
D36421@24160@24164@duplication@5@223727670@223729472@1@chr1:223727670-223729472@21.8@63@224@3.56@NA@CAPN8-202_20, CAPN8-202_21, CAPN8-202_22, CAPN8-202_23, CAPN8-202_24@0@0@0@:calpain 8@:proteolysis;Golgi apparatus;intracellular;calcium-dependent cysteine-type endopeptidase activity;calcium ion binding@NA
D36421@32943@32943@deletion@1@79253841@79253958@2@chr2:79253841-79253958@5.82@70@29@0.414@NA@REG3G-001_3@0@0@0@:regenerating islet-derived 3 gamma@:carbohydrate binding;extracellular region;acute-phase response@NA
D36421@33542@33543@deletion@2@87365381@87365581@2@chr2:87365381-87365581@10.1@118@50@0.424@CNVR861.2@AC083899-001_6, AC083899-001_7@13@11@15@NA@NA@NA
D36421@33558@33560@deletion@3@87404273@87408267@2@chr2:87404273-87408267@9.05@154@80@0.519@CNVR861.2@AC083899-001_22, AC083899-001_23, AC083899-001_24@58.6666666666667@45@85@NA@NA@NA
D36421@33831@33832@deletion@2@90161107@90193003@2@chr2:90161107-90193003@7.79@116@53@0.457@CNVR867.10, CNVR867.5, CNVR867.3, CNVR867.9@IGKV2D-14-001_2, IGKV1D-13-001_1@7@7@7@@:protein binding@NA
D36421@34053@34055@deletion@3@96146055@96148467@2@chr2:96146055-96148467@11.9@250@134@0.536@NA@TRIM43B-203_2, TRIM43B-203_3, TRIM43B-203_4@4@4@4@NA@NA@NA
D36421@34080@34082@duplication@3@96259770@96262181@2@chr2:96259770-96262181@7.21@292@410@1.4@NA@TRIM43-001_2, TRIM43-001_3, TRIM43-001_4@2.66666666666667@2@3@:tripartite motif containing 43B;tripartite motif containing 43@:protein binding;intracellular;zinc ion binding@NA
D36421@34620@34635@duplication@16@98152765@98166078@2@chr2:98152765-98166078@36.1@231@536@2.32@NA@ANKRD36B-001_19, ANKRD36B-001_20, ANKRD36B-001_21, ANKRD36B-001_22, ANKRD36B-001_23, ANKRD36B-001_24, ANKRD36B-001_25, ANKRD36B-001_26, ANKRD36B-001_27, ANKRD36B-001_28, ANKRD36B-001_29, ANKRD36B-001_30, ANKRD36B-001_31, ANKRD36B-001_32, ANKRD36B-001_33, ANKRD36B-001_34@113.3125@14@154@NA@NA@NA
D36421@37206@37207@deletion@2@130897466@130897670@2@chr2:130897466-130897670@8.31@101@43@0.426@NA@CCDC74B-001_6, CCDC74B-001_7@25.5@22@29@:coiled-coil domain containing 74A;coiled-coil domain containing 74B@NA@NA
D36421@37209@37210@duplication@2@130898733@130899955@2@chr2:130898733-130899955@8.88@184@292@1.59@NA@CCDC74B-001_3, CCDC74B-001_4@12.5@10@15@:coiled-coil domain containing 74A;coiled-coil domain containing 74B@NA@NA
D36421@37242@37242@deletion@1@130955933@130956035@2@chr2:130955933-130956035@7.16@32@0@0@CNVR985.1@TUBA3E-001_1@27@27@27@:tubulin, alpha 3e@:GTPase activity;structural constituent of cytoskeleton;protein complex;GTP catabolic process;cytoplasm;microtubule cytoskeleton;protein polymerization;microtubule-based movement;structural molecule activity;cytoplasmic microtubule;GTP binding;microtubule;microtubule cytoskeleton organization;protein domain specific binding@NA
D36421@37492@37493@deletion@2@132288154@132289376@2@chr2:132288154-132289376@11.1@152@74@0.487@NA@CCDC74A-201_3, CCDC74A-201_4@12@11@13@:coiled-coil domain containing 74A@NA@NA
D36421@37495@37496@duplication@2@132290439@132290643@2@chr2:132290439-132290643@5.56@186@268@1.44@NA@CCDC74A-201_6, CCDC74A-201_7@5@5@5@:coiled-coil domain containing 74A@NA@NA
D36421@45689@45689@deletion@1@234621640@234622505@2@chr2:234621640-234622505@7.26@366@221@0.604@NA@UGT1A5-001_1@0@0@0@:UDP glucuronosyltransferase 1 family, polypeptide A8:UDP glucuronosyltransferase 1 family, polypeptide A10:UDP glucuronosyltransferase 1 family, polypeptide A9:UDP glucuronosyltransferase 1 family, polypeptide A7:UDP glucuronosyltransferase 1 family, polypeptide A6:UDP glucuronosyltransferase 1 family, polypeptide A5@:carbohydrate binding;xenobiotic glucuronidation;steroid metabolic process;negative regulation of cellular metabolic process;glucuronosyltransferase activity;fatty acid binding;negative regulation of steroid metabolic process;integral to membrane;fatty acid metabolic process;protein homodimerization activity;endoplasmic reticulum membrane;negative regulation of catalytic activity;metabolic process;negative regulation of fatty acid metabolic process;enzyme inhibitor activity;drug binding;transferase activity, transferring hexosyl groups;intracellular membrane-bounded organelle;drug metabolic process;retinoic acid binding;enzyme binding;protein heterodimerization activity;carbohydrate metabolic process;retinoic acid metabolic process;flavone metabolic process;flavonoid glucuronidation;lipid glycosylation;steroid binding;coumarin metabolic process:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;enzyme binding;protein heterodimerization activity;flavone metabolic process;carbohydrate metabolic process;cellular glucuronidation;protein kinase C binding;integral to membrane;lipid glycosylation;protein homodimerization activity;endoplasmic reticulum membrane;metabolic process:carbohydrate binding;xenobiotic glucuronidation;glucuronosyltransferase activity;integral to membrane;protein homodimerization activity;endoplasmic reticulum membrane;negative regulation of catalytic activity;metabolic process;negative regulation of fatty acid metabolic process;enzyme inhibitor activity;transferase activity, transferring hexosyl groups;drug metabolic process;intracellular membrane-bounded organelle;retinoic acid binding;small molecule metabolic process;enzyme binding;protein heterodimerization activity;cellular lipid metabolic process;carbohydrate metabolic process;retinoic acid metabolic process;flavone metabolic process;flavonoid glucuronidation;xenobiotic metabolic process;lipid glycosylation:carbohydrate binding;xenobiotic glucuronidation;glucuronosyltransferase activity;protein kinase C binding;integral to membrane;excretion;protein homodimerization activity;endoplasmic reticulum membrane;negative regulation of catalytic activity;metabolic process;negative regulation of fatty acid metabolic process;enzyme inhibitor activity;drug binding;transferase activity, transferring hexosyl groups;drug metabolic process;retinoic acid binding;endoplasmic reticulum;enzyme binding;protein heterodimerization activity;carbohydrate metabolic process;retinoic acid metabolic process;flavone metabolic process;flavonoid glucuronidation;lipid glycosylation;coumarin metabolic process:carbohydrate binding;transferase activity, transferring hexosyl groups;intracellular membrane-bounded organelle;small molecule metabolic process;glucuronosyltransferase activity;enzyme binding;protein heterodimerization activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;protein homodimerization activity;endoplasmic reticulum membrane;metabolic process:carbohydrate binding;transferase activity, transferring hexosyl groups;intracellular membrane-bounded organelle;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
D36421@46353@46356@duplication@4@241631264@241636720@2@chr2:241631264-241636720@5.69@72@125@1.74@NA@AQP12A-201_1, AQP12A-201_2, AQP12A-201_3, AQP12A-201_4@43@25@71@:aquaporin 12A@:transport;integral to membrane;transporter activity;membrane@NA
D36421@46737@46741@deletion@5@242918231@242946622@2@chr2:242918231-242946622@10.4@139@63@0.453@CNVR1236.6@AC093642-001_6, AC093642-201_1, AC093642-201_2, AC093642-201_3, AC093642-201_4@3.4@2@4@NA@NA@NA
D36421@47662@47663@duplication@2@11925055@11925573@3@chr3:11925055-11925573@7.48@85@154@1.81@NA@AC090958-001_9, AC090958-001_10@9.5@9@10@NA@NA@NA
D36421@61531@61535@duplication@5@195345501@195378241@3@chr3:195345501-195378241@19.2@1981@2799@1.41@NA@ENST00000457750_2, AC233280-201_5, AC233280-201_6, AC233280-201_7, AC233280-201_8@82.8@56@93@:mucin 20, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane@NA
D36421@61547@61550@duplication@4@195390959@195398172@3@chr3:195390959-195398172@10.8@457@649@1.42@CNVR1703.1@SDHALP2-001_5, SDHALP2-001_6, SDHALP2-001_7, SDHALP2-001_8@81.75@73@92@:mucin 20, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane@NA
D36421@61560@61570@duplication@11@195410625@195456611@3@chr3:195410625-195456611@18.6@1591@2171@1.36@CNVR1703.1, CNVR1703.2, CNVR1703.6@SDHALP2-001_14, SDHALP2-001_15, AC069513-013_1, AC069513-013_2, AC069513-013_3, AC069513-013_4, AC069513-013_5, MUC20-201_1, MUC20-201_2, MUC20-201_3, MUC20-201_4@44@38@57@:mucin 20, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane@NA
D36421@61572@61572@duplication@1@195473642@195474252@3@chr3:195473642-195474252@4.72@262@370@1.41@CNVR1703.1, CNVR1703.2, CNVR1703.5, CNVR1703.4@MUC4-203_26@34@34@34@:mucin 4, cell surface associated@:ErbB-2 class receptor binding;Golgi lumen;cell-matrix adhesion;post-translational protein modification;extracellular matrix structural constituent;protein binding;O-glycan processing;cellular protein metabolic process;proteinaceous extracellular matrix;integral to plasma membrane;membrane;extracellular matrix constituent, lubricant activity;biological_process@NA
D36421@61631@61646@duplication@16@195692302@195702772@3@chr3:195692302-195702772@12.8@672@914@1.36@CNVR1707.1, CNVR1707.2@SDHALP1-002_9, SDHALP1-002_10, SDHALP1-002_11, SDHALP1-002_12, SDHALP1-002_13, SDHALP1-002_14, SDHALP1-002_15, ENST00000354937_10, ENST00000354937_11, ENST00000354937_12, ENST00000354937_13, ENST00000354937_14, ENST00000354937_15, ENST00000354937_16, ENST00000366437_1, ENST00000366437_2, ENST00000366437_3@28.625@13@43@NA@NA@NA
D36421@61648@61649@deletion@2@195703956@195704123@3@chr3:195703956-195704123@6.57@202@120@0.594@CNVR1707.1, CNVR1707.2@SDHALP1-002_8, ENST00000354937_9@32.5@32@33@NA@NA@NA
D36421@61654@61659@duplication@6@195710985@195712661@3@chr3:195710985-195712661@10.6@196@306@1.56@CNVR1707.1, CNVR1707.2@SDHALP1-002_3, SDHALP1-002_4, SDHALP1-002_5, ENST00000354937_4, ENST00000354937_5, ENST00000354937_6@46.5@27@64@NA@NA@NA
D36421@61666@61666@deletion@1@195724782@195725105@3@chr3:195724782-195725105@13.2@85@14@0.165@CNVR1707.1@AC024937-001_2@3@3@3@NA@NA@NA
D36421@64682@64686@deletion@5@49553086@49559427@4@chr4:49553086-49559427@8.55@93@38@0.409@NA@AC119751-202_1, AC119751-202_2, AC119751-202_3, AC119751-202_4, AC119751-202_5@24.2@8@34@NA@NA@NA
D36421@65354@65360@deletion@7@70146221@70160768@4@chr4:70146221-70160768@144@719@4@0.00556@CNVR1957.2, CNVR1957.1@UGT2B28-201_1, UGT2B28-201_2, UGT2B28-201_3, UGT2B28-201_4, UGT2B28-201_5, UGT2B28-201_6, UGT2B28-201_7@69.1428571428571@65@71@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
D36421@65799@65801@deletion@3@75312253@75316250@4@chr4:75312253-75316250@17.7@133@32@0.241@NA@AREG-001_2, AREG-001_3, AREG-001_4@36.3333333333333@28@52@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
D36421@65805@65809@duplication@5@75482008@75490487@4@chr4:75482008-75490487@15.4@110@245@2.23@NA@AREGB-201_2, AREGB-201_3, AREGB-201_4, AREGB-201_5, AREGB-201_6@43.4@30@56@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
D36421@70819@70822@duplication@4@733869@748675@5@chr5:733869-748675@13.7@564@807@1.43@CNVR2280.3@ZDHHC11B-201_5, ZDHHC11B-201_6, ZDHHC11B-201_7, ZDHHC11B-201_8@81.5@66@96@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
D36421@70838@70838@deletion@1@840612@840766@5@chr5:840612-840766@6.25@340@210@0.618@CNVR2280.3, CNVR2280.8@ZDHHC11-201_5@23@23@23@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
D36421@73648@73648@duplication@1@68840733@68840947@5@chr5:68840733-68840947@4.6@116@179@1.54@CNVR2494.7, CNVR2494.4, CNVR2494.46@OCLN-202_6@2@2@2@:occludin@:S-adenosylmethionine metabolic process;cell-cell junction organization;cellular component disassembly involved in execution phase of apoptosis;response to testosterone stimulus;tight junction;integral to membrane;cell junction;plasma membrane;apoptotic process;thiopurine S-methyltransferase activity;S-adenosylhomocysteine metabolic process;apical plasma membrane;protein complex assembly;cytosol;cell-cell junction;protein binding;structural molecule activity;response to organic cyclic compound;apicolateral plasma membrane@: BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;
D36421@73817@73819@duplication@3@70370032@70375796@5@chr5:70370032-70375796@7.96@68@138@2.03@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.8, CNVR2494.1, CNVR2494.37@AC044797-201_3, AC044797-201_4, AC044797-201_5@121.333333333333@119@124@NA@NA@NA
D36421@78044@78044@deletion@1@147553799@147553934@5@chr5:147553799-147553934@22.9@109@0@0@CNVR2637.2, CNVR2637.1@AC116334-001_3@78@78@78@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
D36421@79566@79569@duplication@4@175386532@175392159@5@chr5:175386532-175392159@13.8@208@347@1.67@NA@THOC3-001_3, THOC3-001_4, THOC3-001_5, THOC3-001_6@138.25@46@182@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
D36421@80019@80019@deletion@1@177163582@177163611@5@chr5:177163582-177163611@6.01@53@17@0.321@NA@FAM153A-204_12@78@78@78@:family with sequence similarity 153, member A@NA@NA
D36421@80022@80024@deletion@3@177166603@177168334@5@chr5:177166603-177168334@15.9@82@6@0.0732@NA@FAM153A-204_7, FAM153A-204_8, FAM153A-204_9@94@86@106@:family with sequence similarity 153, member A@NA@NA
D36421@80033@80036@deletion@4@177302598@177305850@5@chr5:177302598-177305850@14@64@0@0@NA@AC106795-201_1, AC106795-201_2, AC106795-201_3, AC106795-201_4@88.5@85@92@NA@NA@NA
D36421@80143@80143@deletion@1@178154002@178154127@5@chr5:178154002-178154127@4.71@267@170@0.637@NA@ZNF354A-001_3@6@6@6@:zinc finger protein 354A@:intracellular;kidney development;DNA binding;regulation of transcription from RNA polymerase II promoter;sensory perception of sound;response to hypoxia;regulation of transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity;response to folic acid;negative regulation of transcription from RNA polymerase II promoter;nucleolus;nucleolar fragmentation;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
D36421@80482@80483@duplication@2@180376320@180416078@5@chr5:180376320-180416078@5.88@198@286@1.44@CNVR2719.1@BTNL8-202_8, BTNL3-202_1@107@106@108@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
D36421@83577@83615@duplication@39@31962024@31975627@6@chr6:31962024-31975627@204@1612@3614@2.24@CNVR2843.6, CNVR2843.3@C4A-001_20, C4A-001_21, C4A-001_22, C4A-001_23, C4A-001_24, C4A-001_25, C4A-001_26, C4A-001_27, C4A-001_28, C4A-001_29, C4A-001_30, C4A-001_31, C4A-001_32, C4A-001_33, C4A-001_34, C4A-001_35, C4A-001_36, C4A-001_37, C4A-001_38, C4A-001_39, C4A-001_40, C4A-001_41, ENST00000458633_1, ENST00000458633_2, CYP21A1P-001_1, CYP21A1P-001_2, CYP21A1P-001_3, CYP21A1P-001_4, CYP21A1P-001_5, CYP21A1P-001_6, CYP21A1P-001_7, CYP21A1P-001_8, AL645922-201_1, AL645922-201_2, AL645922-201_3, AL645922-201_4, AL645922-201_5, AL645922-201_6, AL645922-201_7@45.974358974359@2@121@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
D36421@83668@83676@duplication@9@32008185@32010609@6@chr6:32008185-32010609@14.7@362@544@1.5@CNVR2843.6, CNVR2843.5@TNXB-201_39, TNXB-201_40, TNXB-201_41, TNXB-201_42, TNXB-201_43, TNXB-201_44, CYP21A2-002_8, CYP21A2-002_9, CYP21A2-002_10@37.3333333333333@21@46@:cytochrome P450, family 21, subfamily A, polypeptide 2:tenascin-X-like;tenascin XB@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
D36421@83683@83683@duplication@1@32012785@32013104@6@chr6:32012785-32013104@8.07@85@166@1.95@CNVR2843.6, CNVR2843.5@TNXB-201_32@13@13@13@:tenascin-X-like;tenascin XB@:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
D36421@83911@83923@deletion@13@32485122@32525964@6@chr6:32485122-32525964@37.6@455@203@0.446@CNVR2845.21, CNVR2845.25, CNVR2845.43, CNVR2845.24@HLA-DRB5-001_1, HLA-DRB5-001_2, HLA-DRB5-001_3, HLA-DRB5-001_4, HLA-DRB5-001_5, HLA-DRB5-001_6, HLA-DRB6-002_2, HLA-DRB6-002_3, HLA-DRB6-002_4, HLA-DRB6-002_5, HLA-DRB6-002_6, AL713966-201_2, AL713966-201_3@156.076923076923@114@189@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D36421@83926@83928@duplication@3@32546548@32548634@6@chr6:32546548-32548634@5.27@144@212@1.47@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.5, CNVR2845.4@HLA-DRB1-001_4, HLA-DRB1-001_5, HLA-DRB1-001_6@82@56@105@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
D36421@83944@83945@deletion@2@32630133@32632845@6@chr6:32630133-32632845@6.39@102@51@0.5@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20, CNVR2845.31, CNVR2845.64@HLA-DQB1-003_3, ENST00000443574_1@106.5@101@112@:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
D36421@84706@84710@deletion@5@35754777@35765089@6@chr6:35754777-35765089@8.68@873@609@0.698@CNVR2861.1@C6orf127-001_2, C6orf127-001_3, CLPS-001_1, CLPS-001_2, CLPS-001_3@39@30@43@:colipase-like 1:colipase, pancreatic@:extracellular region;enzyme activator activity;digestion;lipid catabolic process:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
D36421@92590@92594@deletion@5@160132511@160133143@6@chr6:160132511-160133143@46.3@499@183@0.367@CNVR3127.2, CNVR3127.1@ENST00000442642_3, ENST00000442642_4, ENST00000442642_5, ENST00000442642_6, ENST00000442642_7@94@56@112@:superoxide dismutase 2, mitochondrial;uncharacterized LOC100129518@:response to reactive oxygen species;oxidation-reduction process;mitochondrion;negative regulation of cell proliferation;neuron development;negative regulation of fat cell differentiation;removal of superoxide radicals;response to gamma radiation;response to L-ascorbic acid;response to lipopolysaccharide;response to nutrient levels;response to zinc ion;protein homotetramerization;post-embryonic development;iron ion homeostasis;hemopoiesis;aging;mitochondrial inner membrane;age-dependent response to reactive oxygen species;response to drug;oxygen binding;mitochondrial nucleoid;vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure;apoptotic process;superoxide metabolic process;response to superoxide;detection of oxygen;response to silicon dioxide;cytoplasm;response to stress;respiratory electron transport chain;superoxide anion generation;protein homooligomerization;regulation of mitochondrial membrane potential;positive regulation of nitric oxide biosynthetic process;response to manganese ion;regulation of blood pressure;metal ion binding;negative regulation of apoptotic process;response to cadmium ion;response to oxidative stress;liver development;regulation of catalytic activity;negative regulation of fibroblast proliferation;response to selenium ion;age-dependent response to oxidative stress;response to electrical stimulus;mitochondrial matrix;identical protein binding;mitochondrion organization;response to hyperoxia;vasodilation;response to hydrogen peroxide;superoxide dismutase activity;heart development;negative regulation of neuron apoptotic process;erythrophore differentiation;locomotory behavior;DNA binding;release of cytochrome c from mitochondria;response to axon injury;oxygen homeostasis;response to activity;glutathione metabolic process;hydrogen peroxide metabolic process;hydrogen peroxide biosynthetic process;regulation of transcription from RNA polymerase II promoter;response to hypoxia;protein binding;manganese ion binding;cellular response to ethanol@: MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6; MVCD6
D36421@93075@93077@deletion@3@167594123@167596397@6@chr6:167594123-167596397@6.51@90@40@0.444@NA@TCP10L2-001_6, AL121935-201_7, AL121935-201_8@7@3@9@:t-complex 10;t-complex 10-like 2@NA@NA
D36421@93099@93101@deletion@3@167790036@167794825@6@chr6:167790036-167794825@8.4@179@101@0.564@NA@TCP10-001_3, TCP10-001_4, TCP10-001_5@77@52@103@:t-complex 10@:cytosol@NA
D36421@94190@94192@duplication@3@5959482@5963594@7@chr7:5959482-5963594@9.66@353@521@1.48@NA@C7orf28A-001_12, C7orf28A-001_13, C7orf28A-001_14@72.3333333333333@71@73@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D36421@94212@94217@duplication@6@6006496@6018328@7@chr7:6006496-6018328@13.7@323@502@1.55@NA@RSPH10B-002_1, RSPH10B-002_2, RSPH10B-002_3, PMS2-001_13, PMS2-001_14, PMS2-001_15@25.5@12@51@:radial spoke head 10 homolog B (Chlamydomonas):PMS2 postmeiotic segregation increased 2 (S. cerevisiae)@:response to drug;DNA binding;MutSalpha complex binding;ATP binding;mismatch repair;DNA repair;mismatched DNA binding;ATPase activity;nucleus;mismatch repair complex;reciprocal meiotic recombination;ATP catabolic process;single-stranded DNA binding;response to DNA damage stimulus;single base insertion or deletion binding;protein binding;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;MutLalpha complex;endonuclease activity@: COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4; MISMATCH REPAIR CANCER SYNDROME
D36421@94412@94420@deletion@9@6786669@6797563@7@chr7:6786669-6797563@11.3@361@209@0.579@NA@ENST00000338780_12, ENST00000338780_13, ENST00000338780_14, PMS2CL-002_12, PMS2CL-002_13, PMS2CL-002_14, RSPH10B2-204_1, RSPH10B2-204_2, RSPH10B2-204_3@39.6666666666667@5@90@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D36421@94430@94439@deletion@10@6819243@6836574@7@chr7:6819243-6836574@35.1@473@205@0.433@NA@RSPH10B2-204_13, RSPH10B2-204_14, RSPH10B2-204_15, RSPH10B2-204_16, RSPH10B2-204_17, RSPH10B2-204_18, RSPH10B2-204_19, RSPH10B2-204_20, ENST00000429267_1, ENST00000429267_2@19.8@16@26@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D36421@94442@94444@deletion@3@6840581@6844687@7@chr7:6840581-6844687@26.6@125@1@0.008@NA@C7orf28B-001_12, C7orf28B-001_13, C7orf28B-001_14@117.666666666667@114@121@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D36421@96578@96584@duplication@7@38385060@38398764@7@chr7:38385060-38398764@46.2@1331@2080@1.56@CNVR3354.3, CNVR3354.1@TRGV5P-001_1, TRGV5-001_1, TRGV5-001_2, TRGV4-001_1, TRGV4-001_2, TRGV3-001_1, TRGV3-001_2@9.57142857142857@4@14@@:protein binding:protein binding:protein binding;immune response;peptide antigen binding;plasma membrane;MHC protein binding@NA
D36421@97991@97994@duplication@4@62758072@62758771@7@chr7:62758072-62758771@19.2@429@676@1.58@NA@AC006455-201_2, AC006455-201_3, ENST00000444809_2, ENST00000444809_3@160@151@171@NA@NA@NA
D36421@98014@98018@deletion@5@62904582@62917064@7@chr7:62904582-62917064@37.2@601@257@0.428@NA@ZNF734-201_1, ZNF734-201_2, ZNF734-201_3, ZNF734-201_4, ZNF734-201_5@76.6@1@102@NA@NA@NA
D36421@98172@98174@duplication@3@64533821@64534227@7@chr7:64533821-64534227@10@40@112@2.8@NA@RP11-460N20-001_11, RP11-460N20-001_12, ENST00000501153_3@100.666666666667@100@101@NA@NA@NA
D36421@98215@98216@deletion@2@65150574@65154417@7@chr7:65150574-65154417@7.6@113@56@0.496@NA@INTS4L2-001_5, INTS4L2-001_6@29.5@3@56@NA@NA@NA
D36421@99035@99035@deletion@1@74172294@74172334@7@chr7:74172294-74172334@14.9@69@0@0@NA@GTF2I-001_33@25@25@25@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
D36421@99454@99454@duplication@1@76063357@76063473@7@chr7:76063357-76063473@6.53@92@163@1.77@CNVR3462.1@ZP3-002_6@10@10@10@:zona pellucida glycoprotein 3 (sperm receptor)@:negative regulation of transcription, DNA-dependent;manganese ion transmembrane transporter activity;intracellular protein transport;proteinaceous extracellular matrix;plasma membrane;positive regulation of acrosome reaction;outer acrosomal membrane;protein kinase C signaling cascade;manganese ion transmembrane transport;intracellular signal transduction;humoral immune response mediated by circulating immunoglobulin;negative regulation of binding of sperm to zona pellucida;positive regulation of inflammatory response;endoplasmic reticulum;signal transducer activity;perinuclear region of cytoplasm;secretory granule;positive regulation of transcription, DNA-dependent;positive regulation of ovarian follicle development;positive regulation of interferon-gamma production;carbohydrate binding;manganese ion transport;positive regulation of antral ovarian follicle growth;extracellular matrix;positive regulation of leukocyte migration;positive regulation of humoral immune response;extracellular space;blastocyst formation;integral to membrane;store-operated calcium channel activity;oocyte development;multivesicular body;phosphatidylinositol-mediated signaling;acrosomal vesicle;positive regulation of protein kinase B signaling cascade;Golgi apparatus;positive regulation of calcium ion import;positive regulation of protein kinase activity;positive regulation of acrosomal vesicle exocytosis;positive regulation of interleukin-4 production;cytoplasm;protein binding;binding of sperm to zona pellucida;positive regulation of phosphatidylinositol biosynthetic process;extracellular region;positive regulation of T cell proliferation;acrosin binding;positive regulation of type IV hypersensitivity;egg coat formation@NA
D36421@99489@99490@duplication@2@76240773@76241131@7@chr7:76240773-76241131@18.3@221@421@1.9@CNVR3463.10@POMZP3-003_6, POMZP3-003_7@43.5@41@46@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
D36421@102116@102130@duplication@15@102114810@102136652@7@chr7:102114810-102136652@9.38@223@342@1.53@CNVR3518.1@POLR2J-001_1, POLR2J-001_2, POLR2J-001_3, AC093668-201_2, RASA4B-007_16, RASA4B-007_17, RASA4B-007_18, RASA4B-007_19, RASA4B-007_20, RASA4B-007_21, RASA4B-007_22, RASA4B-007_23, RASA4B-007_24, RASA4B-007_25, RASA4B-007_26@36.8666666666667@10@91@:polymerase (RNA) II (DNA directed) polypeptide J, 13.3kDa:RAS p21 protein activator 4B@:nucleoplasm;DNA binding;DNA repair;protein dimerization activity;nucleus;viral reproduction;gene expression;transcription initiation from RNA polymerase II promoter;7-methylguanosine mRNA capping;protein phosphorylation;LRR domain binding;protein kinase activity;DNA-directed RNA polymerase II, core complex;nucleotide-excision repair;transcription from RNA polymerase II promoter;DNA-directed RNA polymerase activity;protein binding;transcription-coupled nucleotide-excision repair;RNA splicing;mRNA splicing, via spliceosome;transcription, DNA-dependent;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction@NA
D36421@102188@102193@duplication@6@102277476@102279647@7@chr7:102277476-102279647@10.1@266@404@1.52@CNVR3518.1@ENST00000340457_4, ENST00000340457_5, ENST00000340457_6, POLR2J2-001_7, POLR2J2-001_8, POLR2J2-001_9@62.1666666666667@46@77@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
D36421@105785@105785@deletion@1@143969540@143969609@7@chr7:143969540-143969609@12.3@185@77@0.416@CNVR3598.4, CNVR3598.9@RP4-798C17-001_12@37@37@37@:Rho guanine nucleotide exchange factor (GEF) 35@NA@NA
D36421@105798@105801@deletion@4@143975408@143979628@7@chr7:143975408-143979628@7.8@46@8@0.174@CNVR3598.4, CNVR3598.9@RP4-798C17-001_4, RP4-798C17-001_5, ENST00000378112_5, ENST00000378112_6@96.5@58@135@:Rho guanine nucleotide exchange factor (GEF) 35@NA@NA
D36421@105819@105829@deletion@11@144059753@144072769@7@chr7:144059753-144072769@27.8@695@407@0.586@CNVR3598.4, CNVR3598.5, CNVR3598.11@ARHGEF5-001_2, ARHGEF5-001_3, ARHGEF5-001_4, ARHGEF5-001_5, ARHGEF5-001_6, ARHGEF5-001_7, ARHGEF5-001_8, ARHGEF5-001_9, ARHGEF5-001_10, ARHGEF5-001_11, ARHGEF5-001_12@72.0909090909091@39@104@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
D36421@107424@107437@deletion@14@7272384@7345700@8@chr8:7272384-7345700@18.2@636@404@0.635@CNVR3771.8, CNVR3771.10, CNVR3771.4@DEFB4P-001_1, DEFB4P-001_2, DEFB103A-001_1, DEFB103A-001_2, SPAG11-003_1, SPAG11-003_2, SPAG11-003_3, SPAG11-003_4, DEFB104B-001_1, DEFB104B-001_2, DEFB106B-001_1, DEFB106B-001_2, DEFB105B-001_1, DEFB105B-001_2@34.3571428571429@4@91@:defensin, beta 4B;defensin, beta 4A:defensin, beta 103B;defensin, beta 103A:sperm associated antigen 11B:defensin, beta 104A;defensin, beta 104B:defensin, beta 106B;defensin, beta 106A:defensin, beta 105B;defensin, beta 105A@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
D36421@109572@109585@duplication@14@39311571@39349528@8@chr8:39311571-39349528@20.8@357@571@1.6@CNVR3859.1@ADAM3A-005_11, ADAM3A-005_12, ADAM3A-005_13, ADAM3A-005_14, ADAM3A-005_15, ADAM3A-005_16, ADAM3A-005_17, ADAM3A-005_18, ADAM3A-005_19, ADAM3A-005_20, ADAM3A-005_21, ADAM3A-009_7, ADAM3A-009_8, ADAM3A-009_9@120.5@98@136@NA@NA@NA
D36421@117397@117398@duplication@2@40702654@40703263@9@chr9:40702654-40703263@6.28@28@76@2.71@NA@FAM75A3-202_3, FAM75A3-202_4@32@29@35@:SPATA31 subfamily A, member 3@:integral to membrane@NA
D36421@117587@117609@duplication@23@43313716@43853617@9@chr9:43313716-43853617@57.4@710@1330@1.87@NA@BX649597-201_1, BX649597-201_3, RP11-186G6-001_1, RP11-186G6-001_2, FAM75A6-201_1, FAM75A6-201_2, FAM75A6-201_3, FAM75A6-201_4, CNTNAP3B-001_1, CNTNAP3B-001_2, CNTNAP3B-001_3, CNTNAP3B-001_4, CNTNAP3B-001_5, CNTNAP3B-001_6, CNTNAP3B-001_7, CNTNAP3B-001_8, CNTNAP3B-001_9, CNTNAP3B-001_10, CNTNAP3B-001_11, CNTNAP3B-001_12, RP11-24B13-001_1, RP11-24B13-001_2@89.1818181818182@49@132@:SPATA31 subfamily A, member 6:contactin associated protein-like 3B;contactin associated protein-like 3@:integral to membrane:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
D36421@117792@117792@deletion@1@65595070@65595188@9@chr9:65595070-65595188@15.6@74@1@0.0135@CNVR4312.5@RP11-203I2-001_3@34@34@34@NA@NA@NA
D36421@118854@118857@duplication@4@84545372@84560148@9@chr9:84545372-84560148@10.5@395@607@1.54@CNVR4364.1@ENST00000427387_1, RP11-383M4-201_4, ENST00000334208_1, ENST00000334208_2, ENST00000334208_3@20@17@27@NA@NA@NA
D36421@121601@121604@deletion@4@117085945@117087433@9@chr9:117085945-117087433@17.2@1413@892@0.631@CNVR4448.1@ORM1-001_2, ORM1-001_3, ORM1-001_4, ORM1-001_5@88.25@84@90@:orosomucoid 1@:protein binding;extracellular space;regulation of immune system process;transport;inflammatory response;extracellular region;acute-phase response@NA
D36421@124041@124041@deletion@1@135944445@135944647@9@chr9:135944445-135944647@5.82@34@5@0.147@CNVR4502.1@CEL-201_9@22@22@22@:carboxyl ester lipase (bile salt-stimulated lipase)@:intestinal lipid catabolic process;pancreatic juice secretion;catalytic activity;extracellular space;heparin binding;sterol esterase activity;carboxylesterase activity;metabolic process;ceramide catabolic process;hydrolase activity;small molecule metabolic process;acylglycerol lipase activity;lipid metabolic process;cytoplasm;protein esterification;cytosol;retinyl-palmitate esterase activity;fatty acid catabolic process;extracellular region;triglyceride lipase activity;lipid digestion;triglyceride metabolic process;cholesterol catabolic process;intestinal cholesterol absorption@: MATURITY-ONSET DIABETES OF THE YOUNG; MODY; MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION;
D36421@124532@124532@duplication@1@138479850@138479944@9@chr9:138479850-138479944@7.19@13@63@4.85@CNVR4531.1@RP11-98L5-001_1@2@2@2@NA@NA@NA
D36421@126909@126909@deletion@1@17840632@17842868@10@chr10:17840632-17842868@8.97@41@0@0@NA@FAM23A-201_5@108@108@108@:transmembrane protein 236;transmembrane protein 236-like@:integral to membrane@NA
D36421@126911@126914@duplication@4@17865075@17882806@10@chr10:17865075-17882806@15.3@208@374@1.8@NA@MRC1L1-001_2, MRC1L1-001_3, MRC1L1-001_4, MRC1L1-001_5@14@12@20@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
D36421@126918@126920@deletion@3@17898254@17905693@10@chr10:17898254-17905693@6.42@135@72@0.533@NA@MRC1L1-001_9, MRC1L1-001_10, MRC1L1-001_11@5@5@5@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
D36421@126937@126951@deletion@15@17949552@18138694@10@chr10:17949552-18138694@57.1@371@69@0.186@NA@MRC1L1-001_28, MRC1L1-001_29, MRC1L1-001_30, FAM23B-202_1, FAM23B-202_2, FAM23B-202_3, FAM23B-202_4, FAM23B-202_5, MRC1-001_1, MRC1-001_2, MRC1-001_3, MRC1-001_4, MRC1-001_5, MRC1-001_6, MRC1-001_7@36.4@5@107@:macrophage mannose receptor 1-like:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D36421@126953@126956@duplication@4@18145173@18152612@10@chr10:18145173-18152612@7.18@27@79@2.93@NA@MRC1-001_9, MRC1-001_10, MRC1-001_11, RP11-457D2-001_2@18.5@18@20@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D36421@126974@126975@duplication@2@18196465@18198277@10@chr10:18196465-18198277@7.93@47@109@2.32@NA@MRC1-001_28, MRC1-001_29@15@3@27@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D36421@129021@129030@deletion@10@48020452@48055019@10@chr10:48020452-48055019@99.6@498@13@0.0261@CNVR4715.2@ASAH2C-201_1, ASAH2C-201_2, ASAH2C-201_3, ASAH2C-201_4, ASAH2C-201_5, ASAH2C-201_6, ASAH2C-201_7, ASAH2C-201_8, ASAH2C-201_9, ASAH2C-201_10@64.3@50@90@@:ceramidase activity;sphingolipid metabolic process@NA
D36421@129460@129478@duplication@19@51361725@51465940@10@chr10:51361725-51465940@58.9@440@990@2.25@NA@ENST00000404618_1, ENST00000404618_2, ENST00000404618_3, ENST00000404618_4, ENST00000432221_1, ENST00000432221_2, ENST00000432221_3, ENST00000432221_4, TIMM23B-202_1, TIMM23B-202_2, TIMM23B-202_3, TIMM23B-202_4, TIMM23B-202_5, TIMM23B-202_6, TIMM23B-202_7, TIMM23B-202_10, AGAP7-201_9@73.3529411764706@8@142@:translocase of inner mitochondrial membrane 23 homolog B (yeast):ArfGAP with GTPase domain, ankyrin repeat and PH domain 7@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
D36421@129509@129521@deletion@13@51603186@51631957@10@chr10:51603186-51631957@21.8@700@426@0.609@NA@TIMM23-202_1, TIMM23-202_2, TIMM23-202_3, TIMM23-202_4, TIMM23-202_5, TIMM23-202_6, TIMM23-202_7, TIMM23-202_8, TIMM23-202_9, TIMM23-202_10, ENST00000456092_1, ENST00000456092_2, ENST00000456092_3@10.5384615384615@0@29@:translocase of inner mitochondrial membrane 23 homolog B (yeast):translocase of inner mitochondrial membrane 23 homolog B (yeast);translocase of inner mitochondrial membrane 23 homolog (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:mitochondrion;mitochondrial inner membrane;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;mitochondrial intermembrane space;integral to mitochondrial inner membrane;intracellular protein transport;protein binding;integral to membrane;cellular protein metabolic process;protein targeting to mitochondrion@NA
D36421@129604@129611@duplication@8@51965744@51994313@10@chr10:51965744-51994313@41.7@163@492@3.02@NA@ASAH2-201_5, ASAH2-201_6, ASAH2-201_7, ASAH2-201_8, ASAH2-201_9, ASAH2-201_10, ASAH2-201_11, ASAH2-201_12@147.125@53@186@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
D36421@131595@131601@deletion@7@81462985@81472508@10@chr10:81462985-81472508@7.08@35@2@0.0571@CNVR4815.2, CNVR4815.4@FAM22B-201_1, FAM22B-201_2, FAM22B-201_3, FAM22B-201_4, FAM22B-201_5, FAM22B-201_6, FAM22B-201_7@87.2857142857143@84@90@NA@NA@NA
D36421@132335@132335@deletion@1@92678624@92678730@10@chr10:92678624-92678730@6.41@123@62@0.504@NA@ANKRD1-001_4@0@0@0@:ankyrin repeat domain 1 (cardiac muscle)@:nucleoplasm;positive regulation of DNA damage response, signal transduction by p53 class mediator;response to muscle stretch;cellular response to transforming growth factor beta stimulus;R-SMAD binding;cytoplasmic part;cellular response to organic cyclic compound;cardiac muscle tissue morphogenesis;cellular response to mechanical stimulus;myofibril;nucleus;cellular response to drug;cellular response to lipopolysaccharide;p53 binding;cytosol;cellular response to interleukin-1;cellular response to hypoxia;transcription factor binding;DNA binding;transcription corepressor activity;cellular response to tumor necrosis factor;histone deacetylase binding;transcription factor complex;negative regulation of DNA biosynthetic process;positive regulation of transcription from RNA polymerase II promoter;RNA polymerase II transcription coactivator activity;RNA polymerase II transcription factor binding;small molecule metabolic process;titin binding;cellular lipid metabolic process;regulation of transcription from RNA polymerase II promoter;cytoplasm;protein binding;negative regulation of transcription from RNA polymerase II promoter;positive regulation of neuron projection development;positive regulation of protein secretion;I band;sarcomere organization;positive regulation of apoptotic process@: TOTAL ANOMALOUS PULMONARY VENOUS RETURN 1; TAPVR1
D36421@137395@137397@duplication@3@1264660@1269935@11@chr11:1264660-1269935@6.22@750@973@1.3@CNVR5008.1@MUC5B-203_48, MUC5B-203_49, MUC5B-203_50@3.33333333333333@2@4@:mucin 5B, oligomeric mucus/gel-forming@:extracellular matrix structural constituent;protein binding;O-glycan processing;extracellular region;cellular protein metabolic process;cell adhesion;Golgi lumen;post-translational protein modification@: PULMONARY FIBROSIS, IDIOPATHIC; IPF
D36421@141187@141188@deletion@2@48600990@48601883@11@chr11:48600990-48601883@7.2@32@0@0@CNVR5165.1@AC134982-201_1, AC134982-201_2@128@128@128@NA@NA@NA
D36421@145895@145902@duplication@8@89501984@89537642@11@chr11:89501984-89537642@9.63@485@673@1.39@NA@TRIM77-201_8, ENST00000375974_1, TRIM49-201_3, TRIM49-201_4, TRIM49-201_5, TRIM49-201_6, TRIM49-201_7, TRIM49-201_8@43@34@56@:tripartite motif containing 49@:protein binding;intracellular;DNA binding;zinc ion binding@NA
D36421@145971@145983@deletion@13@89768378@89806559@11@chr11:89768378-89806559@24.5@173@43@0.249@NA@ENST00000432771_3, ENST00000432771_4, ENST00000432771_5, ENST00000432771_6, ENST00000432771_7, ENST00000432771_8, ENST00000436580_1, ENST00000436580_2, ENST00000436580_3, ENST00000436580_4, ENST00000436580_5, ENST00000436580_6, ENST00000436580_7@88.2307692307692@82@104@:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;DNA binding;zinc ion binding@NA
D36421@149289@149289@duplication@1@176051@176603@12@chr12:176051-176603@5.12@85@142@1.67@CNVR5380.1, CNVR5380.4, CNVR5380.3@IQSEC3-201_1@11@11@11@:IQ motif and Sec7 domain 3;IQ motif and SEC7 domain-containing protein 3-like@:phospholipid binding;inhibitory synapse;intracellular;ARF guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;protein binding;cell junction;nucleus;regulation of ARF protein signal transduction;postsynaptic membrane@NA
D36421@150493@150493@duplication@1@7966399@7967131@12@chr12:7966399-7967131@5.88@190@287@1.51@NA@SLC2A14-202_12@11@11@11@:NECAP endocytosis associated 1:solute carrier family 2 (facilitated glucose transporter), member 14@:coated pit;protein binding;endocytosis;protein transport;clathrin vesicle coat;plasma membrane;membrane:multicellular organismal development;cell differentiation;substrate-specific transmembrane transporter activity;transport;folic acid binding;glucose transmembrane transporter activity;transmembrane transport;spermatogenesis;reduced folate carrier activity;integral to membrane;transmembrane transporter activity;membrane@NA
D36421@150775@150776@duplication@2@9446260@9447115@12@chr12:9446260-9447115@11.9@139@257@1.85@NA@DDX11L8-201_2, DDX11L8-201_3@30@18@42@NA@NA@NA
D36421@150825@150841@deletion@17@9590001@9707352@12@chr12:9590001-9707352@143@817@97@0.119@CNVR5429.1@DDX12-203_1, DDX12-203_2, DDX12-203_3, DDX12-203_4, AC006432-201_1, AC006432-201_2, AC006432-201_3, AC006432-201_4, AC006432-201_5, AC006432-201_6, AC006432-201_7, AC006432-201_8, AC006432-201_9, AC006432-201_11, AC006432-201_12, AC006432-201_13@21.25@7@29@NA@NA@NA
D36421@154067@154075@deletion@9@52845325@52866065@12@chr12:52845325-52866065@69.2@1711@895@0.523@NA@KRT6B-201_1, KRT6C-202_3, KRT6C-202_4, KRT6C-202_5, KRT6C-202_6, KRT6C-202_7, KRT6C-202_8, KRT6C-202_9, KRT6C-202_10@8.77777777777778@0@45@:keratin 6B:keratin 6C@:keratin filament;structural constituent of cytoskeleton;ectoderm development:intermediate filament;structural molecule activity;keratin filament;cytoskeleton organization@: PACHYONYCHIA CONGENITA, TYPE 2; PC2
D36421@161970@161971@duplication@2@21742129@21746644@13@chr13:21742129-21746644@10.8@489@737@1.51@NA@C13orf3-007_3, C13orf3-007_4@2@0@4@:spindle and kinetochore associated complex subunit 3@:spindle microtubule;chromosome segregation;cytoplasm;mitosis;protein binding;regulation of microtubule polymerization or depolymerization;cell division;condensed chromosome outer kinetochore@NA
D36421@162131@162132@duplication@2@24468280@24471146@13@chr13:24468280-24471146@8.95@367@530@1.44@NA@RP11-45B20-002_3, RP11-45B20-002_4@20@4@36@:C1q and tumor necrosis factor related protein 9B@:collagen;protein binding@NA
D36421@166697@166707@deletion@11@19553367@19589683@14@chr14:19553367-19589683@15.4@128@40@0.312@CNVR6072.1@POTEG-201_1, POTEG-201_2, POTEG-201_3, POTEG-201_4, POTEG-201_5, POTEG-201_6, POTEG-201_7, POTEG-201_8, POTEG-201_9, POTEG-201_10, POTEG-201_11@98@55@141@:POTE ankyrin domain family, member G@:protein binding@NA
D36421@166756@166757@deletion@2@20145923@20147387@14@chr14:20145923-20147387@7.94@731@504@0.689@CNVR6072.6, CNVR6072.12, CNVR6072.14@ENST00000398231_1, ENST00000398231_2@92@92@92@NA@NA@NA
D36421@169040@169040@deletion@1@51355544@51355622@14@chr14:51355544-51355622@6.53@91@40@0.44@NA@ABHD12B-201_9@0@0@0@:phosphorylase, glycogen, liver:microRNA 4454;abhydrolase domain containing 12B@:carbohydrate binding;glycogen metabolic process;pyridoxal phosphate binding;vitamin binding;glucose binding;AMP binding;ATP binding;glucose homeostasis;glycogen phosphorylase activity;5-phosphoribose 1-diphosphate biosynthetic process;plasma membrane;protein homodimerization activity;glucose metabolic process;glycogen catabolic process;drug binding;phosphorylase activity;small molecule metabolic process;bile acid binding;carbohydrate metabolic process;cytoplasm;cytosol;purine nucleobase binding:serine-type peptidase activity;proteolysis;aminopeptidase activity;acylglycerol lipase activity@: GLYCOGEN STORAGE DISEASE VI
D36421@173404@173440@duplication@37@106066280@106174456@14@chr14:106066280-106174456@70.2@3048@4359@1.43@CNVR6294.46, CNVR6294.20, CNVR6294.43, CNVR6294.65, CNVR6294.66@AL928742-201_1, AL928742-201_2, AL928742-201_3, AL928742-201_4, IGHE-001_1, IGHE-001_2, IGHE-001_3, IGHE-001_4, IGHG4-001_1, IGHG4-001_2, IGHG4-001_3, IGHG4-001_4, IGHG2-002_1, IGHG2-002_2, IGHG2-002_3, IGHG2-002_4, IGHG2-002_5, IGHGP-001_1, IGHGP-001_2, IGHGP-001_3, IGHGP-001_4, IGHGP-001_5, IGHGP-001_6, AL928761-201_1, AL928761-201_2, AL928761-201_3, AL928761-201_4, AL928768-201_1, AL928768-201_2, AL928768-201_3, ENST00000457994_1, ENST00000457994_2, ENST00000457994_3, IGHA1-002_1, IGHA1-002_2, IGHA1-002_3, IGHA1-002_4@5.86486486486486@2@9@@:antigen binding;protein binding;immune response:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response:antigen binding;protein binding;immune response;protein-chromophore linkage@NA
D36421@173501@173502@deletion@2@106478134@106478412@14@chr14:106478134-106478412@12@114@39@0.342@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV3-6-210_6, IGHV4-4-001_2@17@17@17@@:protein binding@NA
D36421@173508@173513@deletion@6@106539081@106559976@14@chr14:106539081-106559976@118@593@8@0.0135@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8-001_1, IGHV1-8-001_2, IGHV3-9-001_1, IGHV3-9-001_2, IGHV2-10-001_1, IGHV2-10-001_2@22.3333333333333@17@24@@:protein binding:protein binding@NA
D36421@173566@173569@deletion@4@106815724@106825478@14@chr14:106815724-106825478@9.26@297@170@0.572@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.56, CNVR6294.51@IGHV3-33-001_1, IGHV3-33-001_2, IGHV3-33-2-001_1, IGHV3-33-2-001_2@6@2@15@@:protein binding@NA
D36421@173590@173591@duplication@2@106899046@106899494@14@chr14:106899046-106899494@6.35@186@275@1.48@CNVR6294.26, CNVR6294.56, CNVR6294.18@IGHV3-41-001_1, IGHV3-41-001_2@10.5@10@11@NA@NA@NA
D36421@173605@173606@duplication@2@106974508@106974810@14@chr14:106974508-106974810@5.11@359@484@1.35@CNVR6294.56, CNVR6294.16, CNVR6294.87@AB019438-201_2, IGHV3-47-201_2@0@0@0@NA@NA@NA
D36421@173635@173636@deletion@2@107095128@107095663@14@chr14:107095128-107095663@15@74@3@0.0405@CNVR6294.56, CNVR6294.16, CNVR6294.91@IGHV4-61-001_1, IGHV4-61-001_2@17@17@17@@:protein binding@NA
D36421@174406@174410@duplication@5@29008591@29009297@15@chr15:29008591-29009297@10.8@530@737@1.39@NA@ENST00000456510_1, ENST00000456510_2, ENST00000456510_3, ENST00000456510_4, ENST00000456510_5@23.6@18@26@NA@NA@NA
D36421@174505@174507@deletion@3@30663303@30665349@15@chr15:30663303-30665349@8.4@298@191@0.641@CNVR6337.1@CHRFAM7A-202_6, CHRFAM7A-202_7, CHRFAM7A-202_8@53.6666666666667@44@68@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
D36421@174659@174665@duplication@7@32449811@32702862@15@chr15:32449811-32702862@8.94@267@382@1.43@CNVR6345.1@CHRNA7-205_6, CHRNA7-205_7, CHRNA7-205_8, CHRNA7-205_9, CHRNA7-205_10, ENST00000321578_3, ENST00000321578_4@65.5714285714286@31@133@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion:golgin A8 family, member J@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity:Golgi apparatus@NA
D36421@174964@174973@deletion@10@34701845@34813824@15@chr15:34701845-34813824@194@1033@10@0.00968@CNVR6351.3@ENST00000443488_1, ENST00000443488_2, AC027139-201_1, AC027139-201_2, AC027139-201_3, AC027139-201_4, AC027139-201_5, ENST00000444260_1, ENST00000444260_2, ENST00000444260_3@39.9@21@49@:golgin A8 family, member A@:Golgi cisterna membrane;Golgi apparatus@NA
D36421@174997@174998@deletion@2@34848067@34849021@15@chr15:34848067-34849021@5.73@137@76@0.555@CNVR6351.3, CNVR6351.2@ENST00000427526_1, ENST00000427526_2@17@12@22@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
D36421@176446@176447@deletion@2@44019381@44021029@15@chr15:44019381-44021029@5.79@53@18@0.34@NA@CATSPER2P1-001_11, CATSPER2P1-001_12@2@1@3@NA@NA@NA
D36421@176697@176697@deletion@1@45365565@45367044@15@chr15:45365565-45367044@6.08@27@0@0@CNVR6373.1@SORD-001_9@0@0@0@:sorbitol dehydrogenase@:carbohydrate binding;oxidation-reduction process;transferase activity, transferring acyl groups other than amino-acyl groups;mitochondrion;flagellum;L-xylitol catabolic process;extracellular space;oxidoreductase activity;NAD binding;sorbitol metabolic process;mitochondrial membrane;glucose metabolic process;sperm motility;fructose biosynthetic process;cilium;nucleotide binding;L-xylitol metabolic process;L-iditol 2-dehydrogenase activity;sorbitol catabolic process;membrane;zinc ion binding@NA
D36421@185015@185024@duplication@10@18532089@18550287@16@chr16:18532089-18550287@14.6@508@742@1.46@NA@NOMO2-201_10, NOMO2-201_11, NOMO2-201_12, NOMO2-201_13, NOMO2-201_14, NOMO2-201_15, NOMO2-201_16, NOMO2-201_17, NOMO2-201_18, NOMO2-201_19@17.6@7@23@:NODAL modulator 2@:carbohydrate binding;protein binding;integral to membrane;carboxypeptidase activity;endoplasmic reticulum membrane@NA
D36421@186368@186369@deletion@2@28711499@28712933@16@chr16:28711499-28712933@11.1@50@0@0@CNVR6686.3, CNVR6686.1, CNVR6686.2@AC145285-201_1, AC145285-201_2@60@59@61@:eukaryotic translation initiation factor 3, subunit C@:cytosol;protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;cellular protein metabolic process;binding;gene expression;translation;translation initiation factor activity@NA
D36421@187521@187534@duplication@14@32896559@32949372@16@chr16:32896559-32949372@9.96@266@387@1.45@CNVR6702.1@AC138915-201_1, AC142086-201_1, AC142086-201_2, ENST00000423205_1, ENST00000423205_2, ENST00000423205_3, ENST00000423205_4, ENST00000423205_5, ENST00000423205_6, ENST00000423205_7, ENST00000423205_8, ENST00000423205_9, ENST00000423205_10, ENST00000423205_11@21.2857142857143@10@34@NA@NA@NA
D36421@187570@187582@duplication@13@33740805@33783526@16@chr16:33740805-33783526@11.8@597@829@1.39@CNVR6703.17, CNVR6703.1, CNVR6703.23@ENST00000450856_1, ENST00000450856_2, ENST00000450856_3, ENST00000380145_1, ENST00000380145_2, AC133561-201_1, AC133561-201_2, AC133561-201_3, AC133561-201_4, AC133561-201_5, AC133561-201_6, AC133561-201_7, AC133561-201_8@24.4615384615385@8@52@NA@NA@NA
D36421@188229@188241@deletion@13@55798611@55820017@16@chr16:55798611-55820017@117@550@0@0@CNVR6730.1@CES4-202_2, CES4-202_3, CES4-202_4, CES4-202_5, CES4-202_6, CES4-202_7, CES4-202_8, CES4-202_9, CES4-202_10, CES4-202_11, AC147362-203_1, AC147362-203_2, AC147362-203_3@102.692307692308@83@123@NA@NA@NA
D36421@188251@188260@duplication@10@55844431@55862884@16@chr16:55844431-55862884@64.9@1549@2507@1.62@CNVR6731.1@CES1-203_2, CES1-203_3, CES1-203_4, CES1-203_5, CES1-203_6, CES1-203_7, CES1-203_8, CES1-203_9, CES1-203_10, CES1-203_11@26.7@12@33@:carboxylesterase 1;liver carboxylesterase 1-like@:hydrolase activity;methyl salicylate esterase activity;response to toxin;methylumbelliferyl-acetate deacetylase activity;endoplasmic reticulum lumen;retinyl-palmitate esterase activity;methyl jasmonate esterase activity;metabolic process;carboxylesterase activity;methyl indole-3-acetate esterase activity@: CARBOXYLESTERASE 1; CES1
D36421@189930@189930@deletion@1@70010214@70010636@16@chr16:70010214-70010636@10.3@54@4@0.0741@CNVR6762.3, CNVR6762.2@AC026468-201_8@10@10@10@NA@NA@NA
D36421@189958@189989@deletion@32@70161165@70219880@16@chr16:70161165-70219880@98.1@4562@2745@0.602@CNVR6764.1, CNVR6764.3@AC009060-202_4, AC009060-202_5, AC009060-202_6, AC009060-202_7, AC009060-202_8, AC009060-202_9, AC009060-202_10, AC009060-202_11, AC009060-202_12, AC009060-202_13, AC009060-202_14, AC009060-202_15, AC009060-202_16, AC009060-202_17, AC009060-202_18, AC009060-202_19, AC009060-201_1, AC009060-201_2, AC009060-201_3, AC009060-201_4, AC009060-201_5, CLEC18C-201_1, CLEC18C-201_2, CLEC18C-201_3, CLEC18C-201_4, CLEC18C-201_5, CLEC18C-201_6, CLEC18C-201_7, CLEC18C-201_8, CLEC18C-201_9, CLEC18C-201_10, CLEC18C-201_11@52.0625@15@77@:pyruvate dehydrogenase phosphatase regulatory subunit:C-type lectin domain family 18, member C@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix:carbohydrate binding;protein binding;extracellular region@NA
D36421@190530@190533@deletion@4@74394533@74415597@16@chr16:74394533-74415597@6.64@357@229@0.641@CNVR6778.2, CNVR6778.1@AC009053-202_1, AC009053-202_2, NPIPL2-202_1, NPIPL2-202_2@52.5@46@57@@:extracellular region@NA
D36421@195051@195052@duplication@2@15642037@15642145@17@chr17:15642037-15642145@5.82@335@460@1.37@CNVR7003.1@ZNF286-002_10, TBC1D26-201_8@11@11@11@:zinc finger protein 286A:TBC1 domain family, member 26@:nucleus;intracellular;DNA binding;transcription, DNA-dependent;regulation of transcription, DNA-dependent;zinc ion binding;nucleic acid binding:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular@NA
D36421@195229@195270@deletion@42@16664741@16751464@17@chr17:16664741-16751464@133@2615@1348@0.515@NA@CCDC144A-202_13, CCDC144A-202_14, CCDC144A-202_15, CCDC144A-202_16, CCDC144A-202_17, CCDC144A-202_18, AC022596-003_1, AC022596-003_2, AC022596-003_3, AC022596-003_4, AC022596-003_5, AC022596-003_6, AC022596-003_7, AC022596-003_8, AC022596-003_9, AC022596-003_10, AC022596-003_11, AC022596-001_1, AC022596-001_2, AC022596-001_3, AC022596-001_4, AC022596-001_5, AC022596-001_6, AC022596-001_7, AC022596-001_8, ENST00000414673_1, ENST00000414673_2, ENST00000414673_3, ENST00000414673_4, ENST00000414673_5, ENST00000414673_6, ENST00000414673_7, ENST00000414673_8, KRT17P1-001_1, KRT17P1-001_2, KRT17P1-001_3, KRT17P1-001_4, KRT17P1-001_5, KRT17P1-001_6, KRT17P1-001_7, ENST00000429445_5, ENST00000429445_6@78.4761904761905@45@120@:coiled-coil domain containing 144A@NA@NA
D36421@195691@195747@duplication@57@18331724@18457581@17@chr17:18331724-18457581@170@1499@3093@2.06@NA@ENST00000326333_2, ENST00000326333_3, ENST00000326333_4, ENST00000326333_5, ENST00000326333_6, ENST00000326333_7, ENST00000326333_8, ENST00000399124_1, ENST00000399124_2, ENST00000399124_3, ENST00000399124_4, ENST00000399124_5, ENST00000399124_6, ENST00000399124_7, ENST00000399124_8, ENST00000411877_1, ENST00000411877_2, ENST00000411877_4, LGALS9C-201_1, LGALS9C-201_2, LGALS9C-201_3, LGALS9C-201_4, LGALS9C-201_5, LGALS9C-201_6, LGALS9C-201_7, LGALS9C-201_8, LGALS9C-201_9, LGALS9C-201_10, LGALS9C-201_11, ENST00000426269_1, ENST00000426269_2, ENST00000426269_3, ENST00000426269_4, ENST00000426269_5, AC107983-001_1, AC107983-001_2, AC107983-001_3, AC107983-001_4, AC107983-001_5, AC107983-001_6, AC107983-001_7, AC107983-001_8, AC107983-001_9, AC107983-001_10, ENST00000456184_1, ENST00000456184_2, CCDC144B-201_14, CCDC144B-201_15, CCDC144B-201_16, CCDC144B-201_17, CCDC144B-201_18, ENST00000447265_11, ENST00000447265_12, ENST00000447265_13, ENST00000447265_14, ENST00000447265_15@134.017857142857@79@203@:lectin, galactoside-binding, soluble, 9C:protein FAM106B-like@:carbohydrate binding@NA
D36421@195757@195759@deletion@3@18498037@18498176@17@chr17:18498037-18498176@14.6@260@131@0.504@NA@CCDC144B-201_8, CCDC144B-201_9, ENST00000447265_5@1@1@1@NA@NA@NA
D36421@195871@195874@deletion@4@18996780@19036053@17@chr17:18996780-19036053@12.9@215@99@0.46@CNVR7018.2, CNVR7018.3, CNVR7018.1@AC007952-202_2, AC007952-202_3, GRAPL-203_1, GRAPL-203_2@26@4@92@:GRB2-related adaptor protein-like@:protein binding@NA
D36421@196148@196158@duplication@11@20349980@20361698@17@chr17:20349980-20361698@32.4@295@594@2.01@CNVR7021.1, CNVR7021.3@ENST00000458685_5, ENST00000411468_6, LGALS9B-201_3, LGALS9B-201_4, LGALS9B-201_5, LGALS9B-201_6, LGALS9B-201_7, LGALS9B-201_8, LGALS9B-201_9, LGALS9B-201_10, LGALS9B-201_11@72.2727272727273@20@103@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
D36421@197726@197728@deletion@3@34539180@34539966@17@chr17:34539180-34539966@14.1@67@1@0.0149@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1-202_2, CCL4L1-202_3, CCL4L1-202_4@118@113@122@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
D36421@200259@200264@deletion@6@43585590@43592892@17@chr17:43585590-43592892@16.2@464@261@0.562@CNVR7113.4, CNVR7113.6, CNVR7113.2@AC091132-201_1, AC091132-201_2, AC091132-201_3, AC091132-201_4, AC091132-201_5, ENST00000339474_3@94.1666666666667@81@127@NA@NA@NA
D36421@200337@200340@deletion@4@44399690@44409348@17@chr17:44399690-44409348@6.51@43@9@0.209@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A-001_7, LRRC37A-001_8, LRRC37A-001_9, LRRC37A-001_10@144.75@141@154@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
D36421@200343@200344@deletion@2@44414664@44414935@17@chr17:44414664-44414935@8.12@37@0@0@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A-001_13, LRRC37A-001_14@195@194@196@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
D36421@200356@200363@duplication@8@44618175@44633017@17@chr17:44618175-44633017@19.4@710@1067@1.5@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2-201_7, LRRC37A2-201_8, LRRC37A2-201_9, LRRC37A2-201_10, LRRC37A2-201_11, LRRC37A2-201_12, LRRC37A2-201_13, LRRC37A2-201_14@81@67@98@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
D36421@209136@209136@deletion@1@107475@107556@19@chr19:107475-107556@6.62@65@23@0.354@CNVR7451.1, CNVR7451.3@OR4F17-202_2@18@18@18@:olfactory receptor, family 4, subfamily F, member 17@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
D36421@212893@212893@deletion@1@12543887@12544012@19@chr19:12543887-12544012@5.43@74@33@0.446@CNVR7541.1@ZNF443-201_2@2@2@2@:zinc finger protein 443@:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding:intracellular;DNA binding;regulation of transcription, DNA-dependent;response to stress;induction of apoptosis;nucleus;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding@NA
D36421@213493@213494@deletion@2@14508472@14508748@19@chr19:14508472-14508748@13.2@95@23@0.242@NA@CD97-205_8, CD97-205_9@10.5@7@14@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
D36421@213635@213635@deletion@1@14877792@14877922@19@chr19:14877792-14877922@5.78@53@18@0.34@NA@EMR2-209_6@4@4@4@:egf-like module containing, mucin-like, hormone receptor-like 2@:transmembrane signaling receptor activity;inflammatory response;G-protein coupled receptor activity;ruffle membrane;integral to membrane;plasma membrane;cell surface receptor signaling pathway;neuropeptide signaling pathway;granulocyte chemotaxis;cell migration;leading edge membrane;G-protein coupled receptor signaling pathway;protein binding;cell adhesion;membrane;calcium ion binding;chondroitin sulfate binding@NA
D36421@215138@215138@deletion@1@20607594@20607776@19@chr19:20607594-20607776@6.24@81@35@0.432@CNVR7571.1@ENST00000440763_1@6@6@6@NA@NA@NA
D36421@215928@215928@duplication@1@35862253@35863856@19@chr19:35862253-35863856@7.95@183@298@1.63@CNVR7627.1@FFAR3-001_2@102@102@102@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
D36421@217289@217298@deletion@10@40366030@40384168@19@chr19:40366030-40384168@50.2@637@283@0.444@CNVR7639.2@FCGBP-201_21, FCGBP-201_22, FCGBP-201_23, FCGBP-201_24, FCGBP-201_25, FCGBP-201_26, FCGBP-201_27, FCGBP-201_28, FCGBP-201_29, FCGBP-201_30@79.1@5@155@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D36421@217301@217310@duplication@10@40389654@40408136@19@chr19:40389654-40408136@23.5@397@643@1.62@CNVR7639.2, CNVR7639.3@FCGBP-201_9, FCGBP-201_10, FCGBP-201_11, FCGBP-201_12, FCGBP-201_13, FCGBP-201_14, FCGBP-201_15, FCGBP-201_16, FCGBP-201_17, FCGBP-201_18@75.8@5@127@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D36421@218118@218131@duplication@14@43256840@43348652@19@chr19:43256840-43348652@37.2@1076@1647@1.53@NA@PSG8-001_1, PSG8-001_2, PSG8-001_3, PSG8-001_4, PSG8-001_5, PSG8-001_6, CEACAMP6-001_1, CEACAMP6-001_2, CEACAMP6-001_3, AC004603-001_1, AC004603-001_2, AC004603-001_3, AC004603-001_4, PSG1-202_7@10.4285714285714@7@17@:pregnancy specific beta-1-glycoprotein 8@:protein binding;extracellular region@NA
D36421@218185@218185@deletion@1@43715945@43716628@19@chr19:43715945-43716628@6.22@59@20@0.339@CNVR7658.5, CNVR7658.1@CEACAMP10-001_9@41@41@41@:pregnancy specific beta-1-glycoprotein 9@:protein binding;extracellular region;female pregnancy;defense response@NA
D36421@221218@221221@duplication@4@54801929@54803754@19@chr19:54801929-54803754@12.3@750@1033@1.38@CNVR7722.1@LILRA3-003_7, LILRA3-003_8, LILRA3-003_9, LILRA3-003_10@108.25@107@109@:leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3@:antigen binding;signal transduction;protein binding;extracellular region;plasma membrane;receptor activity;defense response@NA
D36421@221399@221408@duplication@10@55270062@55279337@19@chr19:55270062-55279337@13.4@1325@1737@1.31@CNVR7725.2, CNVR7725.1@KIR2DL3-201_5, KIR2DL3-201_6, KIR2DL3-201_7, KIR2DL3-201_8, KIR2DP1-001_4, KIR2DP1-001_5, KIR2DP1-001_6, KIR2DP1-001_7, KIR2DP1-001_8, KIR2DP1-001_9@117.1@98@126@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity@NA
D36421@221415@221417@duplication@3@55294376@55295318@19@chr19:55294376-55295318@11.2@743@1023@1.38@CNVR7725.2, CNVR7725.1@KIR2DL1-002_7, KIR2DL1-002_8, KIR2DL1-002_9@39.3333333333333@38@41@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
D36421@221873@221873@deletion@1@56531743@56531798@19@chr19:56531743-56531798@4.83@247@155@0.628@NA@NLRP5-001_6@1@1@1@:NLR family, pyrin domain containing 5@:fertilization;mitochondrion;regulation of protein stability;regulation of RNA stability;embryo implantation;in utero embryonic development;protein complex;ATP binding;apical cortex;cell cortex;cytosol;protein binding;nucleolus;cellular protein complex assembly;organ morphogenesis@NA
D36421@222068@222069@deletion@2@58003184@58003369@19@chr19:58003184-58003369@5.78@55@20@0.364@CNVR7748.1@ZNF419-202_5, ZNF419-202_6@0@0@0@:zinc finger protein 419@:intracellular;DNA binding;regulation of transcription, DNA-dependent;cytoplasm;nucleolus;nucleus;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding@NA
D36421@222594@222594@deletion@1@1895747@1896102@20@chr20:1895747-1896102@7.85@129@60@0.465@CNVR7764.2@SIRPA-201_3@34@34@34@:signal-regulatory protein alpha@:blood coagulation;protein binding;integral to membrane;SH3 domain binding;cell adhesion;plasma membrane;membrane;leukocyte migration@NA
D36421@228815@228815@duplication@1@10793871@10793944@21@chr21:10793871-10793944@4.63@189@273@1.44@CNVR7947.10, CNVR7947.4@AF254982-201_1@8@8@8@NA@NA@NA
D36421@231961@231994@deletion@34@16340506@16427060@22@chr22:16340506-16427060@154@1265@258@0.204@CNVR8071.2, CNVR8071.3@LA16c-59E1-001_3, LA16c-59E1-001_4, LA16c-59E1-001_5, LA16c-59E1-001_6, LA16c-59E1-001_7, LA16c-2F2-001_1, LA16c-2F2-001_2, LA16c-2F2-001_3, LA16c-2F2-001_4, LA16c-2F2-001_5, LA16c-2F2-001_6, LA16c-2F2-001_7, LA16c-2F2-001_8, LA16c-2F2-001_9, LA16c-2F2-001_10, LA16c-2F2-001_11, ENST00000428118_1, ENST00000428118_2, ENST00000428118_3, ENST00000412729_2, ENST00000412729_3, ENST00000412729_4, LA16c-60G3-201_1, LA16c-60G3-201_2, LA16c-60G3-201_3, LA16c-60G3-201_4, LA16c-60G3-201_5, LA16c-60G3-201_6, LA16c-23H5-004_1, LA16c-23H5-004_2, LA16c-23H5-004_3, LA16c-23H5-001_1, LA16c-23H5-001_2, LA16c-23H5-001_3@41.8823529411765@22@76@NA@NA@NA
D36421@232761@232788@duplication@28@20377671@20475157@22@chr22:20377671-20475157@19.5@216@383@1.77@CNVR8094.9, CNVR8094.4, CNVR8094.10@AC023490-001_1, AC023490-001_2, AC023490-005_1, AC023490-005_2, AC023490-005_3, AC023490-005_4, AC023490-005_5, AC023490-005_6, PI4KAP1-204_1, PI4KAP1-204_2, PI4KAP1-204_3, PI4KAP1-204_4, PI4KAP1-204_5, PI4KAP1-204_6, PI4KAP1-204_7, PI4KAP1-204_8, PI4KAP1-204_9, PI4KAP1-204_10, PI4KAP1-204_11, PI4KAP1-204_12, PI4KAP1-204_13, PI4KAP1-204_14, PI4KAP1-204_15, PI4KAP1-204_16, ENST00000434754_1, ENST00000434754_2, ENST00000434754_3, ENST00000434754_4@155.25@117@172@:RIMS binding protein 3@:protein binding@NA
D36421@233470@233471@deletion@2@23241801@23241913@22@chr22:23241801-23241913@6.34@149@84@0.564@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11@D87015-202_1, BCRL4-001_4@0@0@0@NA@NA@NA
D36421@233473@233474@duplication@2@23247264@23248971@22@chr22:23247264-23248971@10.6@94@188@2@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11@BCRL4-001_6, BCRL4-001_7@0@0@0@@:protein binding@NA
D36421@233731@233754@deletion@24@24345655@24394850@22@chr22:24345655-24394850@209@997@4@0.00401@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTTP1-001_1, GSTTP1-001_2, ENST00000421902_1, ENST00000421902_2, ENST00000448902_1, ENST00000448902_2, ENST00000448902_3, ENST00000448902_4, ENST00000448902_5, ENST00000329210_1, ENST00000329210_2, ENST00000329210_3, ENST00000329210_4, ENST00000439866_1, ENST00000439866_2, GSTT1-009_1, GSTT1-009_2, GSTT1-009_3, GSTT1-009_4, GSTT1-009_5, ENST00000439996_1, ENST00000439996_2, GSTTP2-001_4, GSTTP2-001_5@130.833333333333@109@149@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
D36421@236766@236767@deletion@2@42536568@42537350@22@chr22:42536568-42537350@17.7@142@38@0.268@CNVR8168.1, CNVR8168.3, CNVR8168.4@CYP2D7P1-202_8, CYP2D7P1-202_9@11@10@12@@:oxidation-reduction process;electron carrier activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;heme binding@NA
D62018@616@619@deletion@4@1656279@1666275@1@chr1:1656279-1666275@8.2@145@78@0.538@CNVR17.1@RP1-283E3-001_2, SLC35E2-002_6, SLC35E2-002_7, ENST00000424604_1@26.75@24@32@:solute carrier family 35, member E2@:integral to membrane;membrane@NA
D62018@2296@2303@deletion@8@12853354@12888665@1@chr1:12853354-12888665@11.2@259@151@0.583@CNVR72.3, CNVR72.10@PRAMEF1-001_2, PRAMEF1-001_3, PRAMEF1-001_4, RP5-845O24-001_1, RP5-845O24-001_2, PRAMEF11-001_2, PRAMEF11-001_3, PRAMEF11-001_4@17.375@17@18@:PRAME family member 1:PRAME family member 11@:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent:retinoic acid receptor binding;negative regulation of apoptotic process;negative regulation of cell differentiation;positive regulation of cell proliferation;negative regulation of retinoic acid receptor signaling pathway;negative regulation of transcription, DNA-dependent@NA
D62018@2901@2906@duplication@6@16907242@16913757@1@chr1:16907242-16913757@7.92@197@291@1.48@CNVR93.3, CNVR93.6@NBPF1-201_11, NBPF1-201_12, NBPF1-201_13, NBPF1-201_14, NBPF1-201_15, NBPF1-201_16@39.3333333333333@32@48@NA@NA@NA
D62018@2951@2966@duplication@16@17013828@17046653@1@chr1:17013828-17046653@48.6@1460@2150@1.47@CNVR93.3, CNVR93.15, CNVR93.4@RP1-163M9-001_1, RP1-163M9-001_2, ESPNP-002_1, ESPNP-002_2, ESPNP-002_3, ESPNP-002_4, ESPNP-002_5, ESPNP-002_6, ESPNP-002_7, ESPNP-002_8, ESPNP-002_9, ESPNP-002_10, ESPNP-002_11, AL021920-201_1, AL021920-201_2, AL021920-201_3@43.1875@38@46@NA@NA@NA
D62018@2996@2998@duplication@3@17183209@17197629@1@chr1:17183209-17197629@6.68@283@392@1.39@CNVR94.2, CNVR94.1, CNVR94.4@ENST00000414128_2, ENST00000414128_3, ENST00000356370_2, ENST00000438002_1@16@9@21@NA@NA@NA
D62018@3004@3018@duplication@15@17248447@17272102@1@chr1:17248447-17272102@25.5@711@1039@1.46@CNVR94.4, CNVR94.5@CROCC-201_1, CROCC-201_2, CROCC-201_3, CROCC-201_4, CROCC-201_5, CROCC-201_6, CROCC-201_7, CROCC-201_8, CROCC-201_9, CROCC-201_10, CROCC-201_11, CROCC-201_12, CROCC-201_13, CROCC-201_14, CROCC-201_15@77.8666666666667@67@85@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
D62018@4452@4459@duplication@8@25611066@25648454@1@chr1:25611066-25648454@17@628@883@1.41@CNVR116.1, CNVR116.2@RHD-202_2, RHD-202_3, RHD-202_4, RHD-202_5, RHD-202_6, RHD-202_7, RHD-202_8, RHD-202_9@125.125@121@128@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
D62018@4477@4477@deletion@1@25735176@25735361@1@chr1:25735176-25735361@8.5@38@0@0@CNVR117.1@RHCE-005_4@56@56@56@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
D62018@12416@12425@deletion@10@104202984@104234233@1@chr1:104202984-104234233@19.2@87@0@0@CNVR266.3, CNVR266.1, CNVR266.15@AMY1A-001_7, AMY1A-001_8, AMY1A-001_9, AMY1A-001_10, AMY1A-001_11, AMY1B-001_7, AMY1B-001_8, AMY1B-001_9, AMY1B-001_10, AMY1B-001_11@123.8@109@154@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D62018@12445@12446@duplication@2@104297123@104297437@1@chr1:104297123-104297437@14.3@181@326@1.8@CNVR266.3, CNVR266.5@AMY1C-201_7, AMY1C-201_8@77@75@79@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D62018@12929@12936@deletion@8@110230474@110236368@1@chr1:110230474-110236368@67.5@318@6@0.0189@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1-001_1, GSTM1-001_2, GSTM1-001_3, GSTM1-001_4, GSTM1-001_5, GSTM1-001_6, GSTM1-001_7, GSTM1-001_8@191.375@187@194@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
D62018@14492@14495@duplication@4@144621449@144679973@1@chr1:144621449-144679973@6.32@193@278@1.44@NA@AL592284-001_12, WI2-1896O14-001_1, WI2-1896O14-001_2, WI2-1896O14-001_3@4@2@5@NA@NA@NA
D62018@14541@14542@duplication@2@144915447@144916750@1@chr1:144915447-144916750@6.05@177@257@1.45@NA@PDE4DIP-203_16, PDE4DIP-203_17@0@0@0@:phosphodiesterase 4D interacting protein;uncharacterized LOC101060344;myomegalin-like@:Golgi apparatus;binding;centrosome;enzyme binding;cytoplasm;protein binding;myofibril;cellular protein complex assembly;nucleus@NA
D62018@15461@15462@duplication@2@149400065@149400543@1@chr1:149400065-149400543@6.27@114@180@1.58@CNVR350.1@HIST2H3PS2-001_1, RP5-998N21-002_1@75@75@75@NA@NA@NA
D62018@16280@16280@duplication@1@152573269@152573493@1@chr1:152573269-152573493@9.36@60@138@2.3@CNVR358.1@LCE3C-201_2@102@102@102@:late cornified envelope 3C@:keratinization@NA
D62018@21372@21372@deletion@1@196797202@196797377@1@chr1:196797202-196797377@7.59@70@24@0.343@CNVR459.1@CFHR1-001_4@119@119@119@:complement factor H-related 1:complement factor H-related 2@:extracellular space;complement activation:extracellular region@NA
D62018@23045@23045@duplication@1@207741171@207741388@1@chr1:207741171-207741388@6.97@150@238@1.59@CNVR485.1, CNVR485.2@CR1-201_25@16@16@16@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
D62018@33560@33560@deletion@1@87408191@87408267@2@chr2:87408191-87408267@6.18@51@16@0.314@CNVR861.2@AC083899-001_24@85@85@85@NA@NA@NA
D62018@34183@34184@duplication@2@96652501@96652955@2@chr2:96652501-96652955@8.82@121@210@1.74@NA@AC073995-001_2, AC073995-001_3@4@4@4@:ankyrin repeat domain-containing protein 36A-like@:ion channel inhibitor activity;protein binding@NA
D62018@34540@34541@deletion@2@97818243@97820479@2@chr2:97818243-97820479@10.8@151@70@0.464@CNVR886.2@ENST00000461153_14, ENST00000461153_15@13@12@14@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
D62018@45387@45390@deletion@4@233273213@233274159@2@chr2:233273213-233274159@7.63@104@50@0.481@NA@ALPPL2-001_7, ALPPL2-001_8, ALPPL2-001_9, ALPPL2-001_10@30@16@58@:alkaline phosphatase, placental-like 2@:phosphatase activity;catalytic activity;phosphorylation;plasma membrane;metabolic process;membrane;anchored to membrane;alkaline phosphatase activity;metal ion binding@NA
D62018@61530@61552@duplication@23@195341820@195400859@3@chr3:195341820-195400859@23.9@1841@2463@1.34@NA@ENST00000457750_1, ENST00000457750_2, AC233280-201_1, AC233280-201_2, AC233280-201_3, AC233280-201_4, AC233280-201_5, AC233280-201_6, AC233280-201_7, AC233280-201_8, AC069513-001_1, AC069513-001_2, AC069513-001_3, SDHALP2-001_1, SDHALP2-001_2, SDHALP2-001_3, SDHALP2-001_4, SDHALP2-001_5, SDHALP2-001_6, SDHALP2-001_7, SDHALP2-001_8, SDHALP2-001_9, SDHALP2-001_10@79.6086956521739@20@93@:mucin 20, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane@NA
D62018@64676@64686@duplication@11@49240042@49559427@4@chr4:49240042-49559427@14.9@184@324@1.76@NA@ENST00000428211_1, ENST00000428211_2, ENST00000428211_3, ENST00000428211_4, AC119752-201_1, AC119752-201_2, AC119751-202_1, AC119751-202_3, AC119751-202_4, AC119751-202_5@27.6@16@43@NA@NA@NA
D62018@65315@65320@duplication@6@69402904@69434246@4@chr4:69402904-69434246@13.5@386@562@1.46@CNVR1953.1@UGT2B17-001_1, UGT2B17-001_2, UGT2B17-001_3, UGT2B17-001_4, UGT2B17-001_5, UGT2B17-001_6@124.5@118@134@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
D62018@65354@65360@duplication@7@70146221@70160768@4@chr4:70146221-70160768@15.5@447@654@1.46@CNVR1957.2, CNVR1957.1@UGT2B28-201_1, UGT2B28-201_2, UGT2B28-201_3, UGT2B28-201_4, UGT2B28-201_5, UGT2B28-201_6, UGT2B28-201_7@69.1428571428571@65@71@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
D62018@65799@65801@deletion@3@75312253@75316250@4@chr4:75312253-75316250@14.8@95@18@0.189@NA@AREG-001_2, AREG-001_3, AREG-001_4@36.3333333333333@28@52@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
D62018@65805@65807@duplication@3@75482008@75486007@4@chr4:75482008-75486007@11@69@153@2.22@NA@AREGB-201_2, AREGB-201_3, AREGB-201_4@50.3333333333333@45@56@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
D62018@69469@69469@duplication@1@155508666@155508810@4@chr4:155508666-155508810@18.7@199@420@2.11@NA@FGA-202_4@0@0@0@:fibrinogen alpha chain@:platelet degranulation;platelet alpha granule;cell cortex;extracellular space;protein polymerization;blood coagulation;eukaryotic cell surface binding;fibrinogen complex;plasma membrane;receptor binding;platelet activation;response to calcium ion;platelet alpha granule lumen;external side of plasma membrane;protein binding, bridging;signal transduction;protein binding;extracellular region@: AMYLOIDOSIS, FAMILIAL VISCERAL; AFIBRINOGENEMIA, CONGENITAL; FIBRINOGEN, A ALPHA POLYPEPTIDE; FGA
D62018@70687@70694@duplication@8@190945524@190963790@4@chr4:190945524-190963790@28.9@464@816@1.76@CNVR2258.3@FRG2-201_1, FRG2-201_2, FRG2-201_3, FRG2-201_4, U85056-201_1, U85056-201_2, U85056-201_3, U85056-201_4@39.75@15@58@:FSHD region gene 2-like;FSHD region gene 2@:nucleus@NA
D62018@73781@73796@duplication@16@70247770@70308746@5@chr5:70247770-70308746@12.9@488@698@1.43@CNVR2494.41, CNVR2494.14, CNVR2494.30, CNVR2494.20, CNVR2494.62@SMN1-001_8, SMN1-001_9, NAIP-001_4, NAIP-001_5, NAIP-001_6, NAIP-001_7, NAIP-001_8, NAIP-001_9, NAIP-001_10, NAIP-001_11, NAIP-001_12, NAIP-001_13, NAIP-001_14, NAIP-001_15, NAIP-001_16, NAIP-001_17@5.8125@0@32@:survival of motor neuron 2, centromeric;survival of motor neuron 1, telomeric:baculoviral IAP repeat-containing protein 1-like;NLR family, apoptosis inhibitory protein@:nucleoplasm;ncRNA metabolic process;Cajal body;RNA metabolic process;spliceosomal complex;cytoplasm;cytosol;protein binding;cell death;spliceosomal complex assembly;RNA binding;mRNA processing;nucleus;gene expression;spliceosomal snRNP assembly:negative regulation of apoptotic process;inflammatory response;basolateral plasma membrane;nucleoside-triphosphatase activity;cysteine-type endopeptidase inhibitor activity;intracellular;nucleotide binding;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;ATP binding;cytoplasm;innate immune response;protein binding;negative regulation of neuron apoptotic process;metal ion binding;nervous system development@: SPINAL MUSCULAR ATROPHY, TYPE II; SMA2; SPINAL MUSCULAR ATROPHY, TYPE I; SMA1; SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4; SPINAL MUSCULAR ATROPHY, TYPE III; SMA3
D62018@79567@79571@deletion@5@175388056@175395303@5@chr5:175388056-175395303@6.8@115@61@0.53@NA@THOC3-001_1, THOC3-001_2, THOC3-001_3, THOC3-001_4, THOC3-001_5@85@5@182@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
D62018@80022@80024@deletion@3@177166603@177168334@5@chr5:177166603-177168334@11.5@55@2@0.0364@NA@FAM153A-204_7, FAM153A-204_8, FAM153A-204_9@94@86@106@:family with sequence similarity 153, member A@NA@NA
D62018@80481@80484@deletion@4@180376241@180420161@5@chr5:180376241-180420161@6.74@198@121@0.611@CNVR2719.1@BTNL8-202_7, BTNL8-202_8, BTNL3-202_1, BTNL3-202_2@106.75@105@108@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
D62018@82490@82506@duplication@17@29856246@29894698@6@chr6:29856246-29894698@14.7@575@797@1.39@CNVR2829.7, CNVR2829.2, CNVR2829.3@HLA-H-001_3, HLA-H-001_4, HLA-H-001_5, HLA-H-001_6, HLA-H-001_7, HLA-16-001_1, HLA-16-001_2, HLA-16-001_3, HLA-16-001_4, AL645929-201_5, AL645929-201_6, BAT1P1-001_1, BAT1P1-001_2, MCCD1P1-001_1, MCCD1P1-001_2, HLA-K-001_1, HLA-K-001_2@46.1764705882353@41@51@NA@NA@NA
D62018@83607@83613@duplication@7@31974589@31975248@6@chr6:31974589-31975248@7.71@370@502@1.36@CNVR2843.6, CNVR2843.3@CYP21A1P-001_5, CYP21A1P-001_6, CYP21A1P-001_7, AL645922-201_3, AL645922-201_4, AL645922-201_5, AL645922-201_6@113.142857142857@109@121@NA@NA@NA
D62018@83643@83645@deletion@3@31996472@31997116@6@chr6:31996472-31997116@7.11@119@61@0.513@CNVR2843.6, CNVR2843.5@C4B-001_26, C4B-001_27, C4B-001_28@17@15@19@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
D62018@83910@83946@duplication@37@32441204@32634448@6@chr6:32441204-32634448@134@1378@2598@1.89@CNVR2845.21, CNVR2845.25@HLA-DRB9-001_1, HLA-DRB5-001_1, HLA-DRB5-001_2, HLA-DRB5-001_3, HLA-DRB5-001_4, HLA-DRB5-001_5, HLA-DRB5-001_6, HLA-DRB6-002_1, HLA-DRB6-002_2, HLA-DRB6-002_3, HLA-DRB6-002_4, HLA-DRB6-002_5, HLA-DRB6-002_6, AL713966-201_1, AL713966-201_2, AL713966-201_3, HLA-DRB1-001_1, HLA-DRB1-001_2, HLA-DRB1-001_3, HLA-DRB1-001_4, HLA-DRB1-001_5, HLA-DRB1-001_6, HLA-DQA1-002_1, HLA-DQA1-002_2, HLA-DQA1-002_3, HLA-DQA1-002_4, HLA-DQA1-002_5, HLA-DQA1-002_6, HLA-DQB1-003_2, HLA-DQB1-003_3, HLA-DQB1-003_4, HLA-DQB1-003_5, HLA-DQB1-003_6, XXbac-BPG254F23-001_1, XXbac-BPG254F23-001_2, ENST00000443574_1, ENST00000443574_2@122.918918918919@44@189@:major histocompatibility complex, class II, DR beta 5:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
D62018@84707@84710@duplication@4@35755646@35765089@6@chr6:35755646-35765089@6.76@508@671@1.32@CNVR2861.1@C6orf127-001_3, CLPS-001_1, CLPS-001_2, CLPS-001_3@38.75@30@43@:colipase-like 1:colipase, pancreatic@:extracellular region;enzyme activator activity;digestion;lipid catabolic process:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
D62018@92589@92591@deletion@3@160132299@160132774@6@chr6:160132299-160132774@9.36@185@100@0.541@CNVR3127.2, CNVR3127.1@ENST00000442642_6, ENST00000442642_7, ENST00000442642_8@107.333333333333@104@112@:superoxide dismutase 2, mitochondrial;uncharacterized LOC100129518@:response to reactive oxygen species;oxidation-reduction process;mitochondrion;negative regulation of cell proliferation;neuron development;negative regulation of fat cell differentiation;removal of superoxide radicals;response to gamma radiation;response to L-ascorbic acid;response to lipopolysaccharide;response to nutrient levels;response to zinc ion;protein homotetramerization;post-embryonic development;iron ion homeostasis;hemopoiesis;aging;mitochondrial inner membrane;age-dependent response to reactive oxygen species;response to drug;oxygen binding;mitochondrial nucleoid;vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure;apoptotic process;superoxide metabolic process;response to superoxide;detection of oxygen;response to silicon dioxide;cytoplasm;response to stress;respiratory electron transport chain;superoxide anion generation;protein homooligomerization;regulation of mitochondrial membrane potential;positive regulation of nitric oxide biosynthetic process;response to manganese ion;regulation of blood pressure;metal ion binding;negative regulation of apoptotic process;response to cadmium ion;response to oxidative stress;liver development;regulation of catalytic activity;negative regulation of fibroblast proliferation;response to selenium ion;age-dependent response to oxidative stress;response to electrical stimulus;mitochondrial matrix;identical protein binding;mitochondrion organization;response to hyperoxia;vasodilation;response to hydrogen peroxide;superoxide dismutase activity;heart development;negative regulation of neuron apoptotic process;erythrophore differentiation;locomotory behavior;DNA binding;release of cytochrome c from mitochondria;response to axon injury;oxygen homeostasis;response to activity;glutathione metabolic process;hydrogen peroxide metabolic process;hydrogen peroxide biosynthetic process;regulation of transcription from RNA polymerase II promoter;response to hypoxia;protein binding;manganese ion binding;cellular response to ethanol@: MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6; MVCD6
D62018@94182@94189@duplication@8@5940488@5958532@7@chr7:5940488-5958532@20.5@646@929@1.44@NA@C7orf28A-001_4, C7orf28A-001_5, C7orf28A-001_6, C7orf28A-001_7, C7orf28A-001_8, C7orf28A-001_9, C7orf28A-001_10, C7orf28A-001_11@31.125@27@36@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D62018@94201@94208@duplication@8@5983544@5998710@7@chr7:5983544-5998710@13.7@275@442@1.61@NA@RSPH10B-002_7, RSPH10B-002_8, RSPH10B-002_9, RSPH10B-002_10, RSPH10B-002_11, RSPH10B-002_12, RSPH10B-002_13, RSPH10B-002_14@8.75@8@11@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D62018@94424@94425@deletion@2@6805339@6806509@7@chr7:6805339-6806509@9.98@120@49@0.408@NA@RSPH10B2-204_7, RSPH10B2-204_8@12@12@12@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D62018@94438@94439@deletion@2@6836201@6836574@7@chr7:6836201-6836574@6.92@50@13@0.26@NA@RSPH10B2-204_20, ENST00000429267_1@25.5@25@26@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D62018@94446@94452@deletion@7@6851585@6863798@7@chr7:6851585-6863798@16@590@377@0.639@NA@C7orf28B-001_4, C7orf28B-001_5, C7orf28B-001_6, C7orf28B-001_7, C7orf28B-001_8, C7orf28B-001_9, C7orf28B-001_10@39.1428571428571@33@43@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D62018@96579@96584@deletion@6@38388958@38398764@7@chr7:38388958-38398764@81.6@863@348@0.403@CNVR3354.3, CNVR3354.1@TRGV5-001_1, TRGV5-001_2, TRGV4-001_1, TRGV4-001_2, TRGV3-001_1, TRGV3-001_2@10.5@6@14@@:protein binding:protein binding:protein binding;immune response;peptide antigen binding;plasma membrane;MHC protein binding@NA
D62018@97907@97922@deletion@16@57063663@57128541@7@chr7:57063663-57128541@11.5@117@47@0.402@NA@TNRC18C-202_3, TNRC18C-202_4, TNRC18C-202_5, TNRC18C-202_6, TNRC18C-202_7, TNRC18C-202_8, TNRC18C-202_9, TNRC18C-202_10, TNRC18C-202_11, ENST00000398760_1, ENST00000398760_2, ENST00000398760_3, ENST00000398760_4, ENST00000398760_5, RP11-220H4-201_2, RP11-220H4-201_3@114.625@21@166@NA@NA@NA
D62018@97991@97994@deletion@4@62758072@62758771@7@chr7:62758072-62758771@80@384@2@0.00521@NA@AC006455-201_2, AC006455-201_3, ENST00000444809_2, ENST00000444809_3@160@151@171@NA@NA@NA
D62018@98015@98016@duplication@2@62910199@62910898@7@chr7:62910199-62910898@22.5@225@469@2.08@NA@ZNF734-201_2, ZNF734-201_3@102@102@102@NA@NA@NA
D62018@98688@98688@duplication@1@72613728@72613825@7@chr7:72613728-72613825@4.68@14@46@3.29@NA@RP11-396K3-001_18@1@1@1@NA@NA@NA
D62018@99454@99454@deletion@1@76063357@76063473@7@chr7:76063357-76063473@9.76@66@14@0.212@CNVR3462.1@ZP3-002_6@10@10@10@:zona pellucida glycoprotein 3 (sperm receptor)@:negative regulation of transcription, DNA-dependent;manganese ion transmembrane transporter activity;intracellular protein transport;proteinaceous extracellular matrix;plasma membrane;positive regulation of acrosome reaction;outer acrosomal membrane;protein kinase C signaling cascade;manganese ion transmembrane transport;intracellular signal transduction;humoral immune response mediated by circulating immunoglobulin;negative regulation of binding of sperm to zona pellucida;positive regulation of inflammatory response;endoplasmic reticulum;signal transducer activity;perinuclear region of cytoplasm;secretory granule;positive regulation of transcription, DNA-dependent;positive regulation of ovarian follicle development;positive regulation of interferon-gamma production;carbohydrate binding;manganese ion transport;positive regulation of antral ovarian follicle growth;extracellular matrix;positive regulation of leukocyte migration;positive regulation of humoral immune response;extracellular space;blastocyst formation;integral to membrane;store-operated calcium channel activity;oocyte development;multivesicular body;phosphatidylinositol-mediated signaling;acrosomal vesicle;positive regulation of protein kinase B signaling cascade;Golgi apparatus;positive regulation of calcium ion import;positive regulation of protein kinase activity;positive regulation of acrosomal vesicle exocytosis;positive regulation of interleukin-4 production;cytoplasm;protein binding;binding of sperm to zona pellucida;positive regulation of phosphatidylinositol biosynthetic process;extracellular region;positive regulation of T cell proliferation;acrosin binding;positive regulation of type IV hypersensitivity;egg coat formation@NA
D62018@99489@99489@deletion@1@76240773@76240909@7@chr7:76240773-76240909@7.87@93@38@0.409@CNVR3463.10@POMZP3-003_7@46@46@46@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
D62018@100847@100848@duplication@2@97599084@97599158@7@chr7:97599084-97599158@5.15@198@278@1.4@NA@AC004967-201_2, ENST00000453589_5@0@0@0@NA@NA@NA
D62018@101723@101725@deletion@3@100334108@100334973@7@chr7:100334108-100334973@8.45@270@165@0.611@CNVR3509.1@ZAN-001_4, ZAN-001_5, ZAN-001_6@85.6666666666667@81@89@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
D62018@102130@102130@deletion@1@102136589@102136652@7@chr7:102136589-102136652@10.1@98@34@0.347@CNVR3518.1@RASA4B-007_16@49@49@49@:RAS p21 protein activator 4B@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction@NA
D62018@102187@102193@deletion@7@102257074@102279647@7@chr7:102257074-102279647@8.48@223@131@0.587@CNVR3518.1@RASA4-001_1, ENST00000340457_4, ENST00000340457_5, ENST00000340457_6, POLR2J2-001_7, POLR2J2-001_8, POLR2J2-001_9@59.7142857142857@45@77@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
D62018@102615@102623@duplication@9@105894812@105925639@7@chr7:105894812-105925639@10.7@898@1171@1.3@NA@PBEF1-001_1, PBEF1-001_2, PBEF1-001_3, PBEF1-001_4, PBEF1-001_5, PBEF1-001_6, PBEF1-001_7, PBEF1-001_8, PBEF1-001_9@1.22222222222222@0@3@:nicotinamide phosphoribosyltransferase@:nicotinate phosphoribosyltransferase activity;small molecule metabolic process;positive regulation of nitric-oxide synthase biosynthetic process;NAD metabolic process;cytoplasm;cell-cell signaling;NAD biosynthetic process;cytosol;signal transduction;cytokine activity;positive regulation of cell proliferation;water-soluble vitamin metabolic process;nicotinate-nucleotide diphosphorylase (carboxylating) activity;nicotinamide metabolic process;vitamin metabolic process;nicotinamide phosphoribosyltransferase activity@NA
D62018@103919@103919@duplication@1@128128157@128128216@7@chr7:128128157-128128216@4.99@41@83@2.02@NA@METTL2B-001_5@0@0@0@:methyltransferase like 2B@:methyltransferase activity;metabolic process@NA
D62018@103927@103928@deletion@2@128218946@128220149@7@chr7:128218946-128220149@6.23@172@102@0.593@NA@RP11-274B21-001_4, RP11-274B21-001_5@0@0@0@NA@NA@NA
D62018@105338@105338@deletion@1@141786457@141786518@7@chr7:141786457-141786518@8.3@37@0@0@CNVR3585.3, CNVR3585.2, CNVR3585.1, CNVR3585.4@MGAM-007_57@134@134@134@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
D62018@105785@105795@deletion@11@143969540@143974431@7@chr7:143969540-143974431@14.4@392@236@0.602@CNVR3598.4, CNVR3598.9@RP4-798C17-001_7, RP4-798C17-001_8, RP4-798C17-001_9, RP4-798C17-001_10, RP4-798C17-001_11, RP4-798C17-001_12, ENST00000378112_8, ENST00000378112_9, ENST00000378112_10, ENST00000378112_11, ENST00000378112_12@92.0909090909091@37@137@:Rho guanine nucleotide exchange factor (GEF) 35@NA@NA
D62018@105798@105799@duplication@2@143975408@143975569@7@chr7:143975408-143975569@5.54@6@40@6.67@CNVR3598.4, CNVR3598.9@RP4-798C17-001_5, ENST00000378112_6@135@135@135@:Rho guanine nucleotide exchange factor (GEF) 35@NA@NA
D62018@105819@105827@deletion@9@144059753@144070378@7@chr7:144059753-144070378@24.6@448@231@0.516@CNVR3598.4, CNVR3598.5, CNVR3598.11@ARHGEF5-001_2, ARHGEF5-001_3, ARHGEF5-001_4, ARHGEF5-001_5, ARHGEF5-001_6, ARHGEF5-001_7, ARHGEF5-001_8, ARHGEF5-001_9, ARHGEF5-001_10@78.4444444444444@65@104@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
D62018@109573@109585@duplication@13@39312860@39349528@8@chr8:39312860-39349528@20.4@273@459@1.68@CNVR3859.1@ADAM3A-005_11, ADAM3A-005_12, ADAM3A-005_13, ADAM3A-005_14, ADAM3A-005_15, ADAM3A-005_16, ADAM3A-005_17, ADAM3A-005_18, ADAM3A-005_19, ADAM3A-005_20, ADAM3A-009_7, ADAM3A-009_8, ADAM3A-009_9@119.846153846154@98@136@NA@NA@NA
D62018@116854@116857@deletion@4@35662945@35664490@9@chr9:35662945-35664490@12.8@193@95@0.492@NA@C9orf100-004_4, C9orf100-004_5, C9orf100-004_6, C9orf100-004_7@0@0@0@:Rho guanine nucleotide exchange factor (GEF) 39@:positive regulation of cell migration;phospholipid binding;protein binding;plasma membrane;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity@NA
D62018@117602@117602@deletion@1@43818043@43818185@9@chr9:43818043-43818185@5.68@90@44@0.489@CNVR4294.1@CNTNAP3B-001_7@91@91@91@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
D62018@126909@126909@deletion@1@17840632@17842868@10@chr10:17840632-17842868@6.32@28@0@0@NA@FAM23A-201_5@108@108@108@:transmembrane protein 236;transmembrane protein 236-like@:integral to membrane@NA
D62018@126946@126956@duplication@11@18112046@18152612@10@chr10:18112046-18152612@10.4@214@327@1.53@NA@MRC1-001_2, MRC1-001_3, MRC1-001_4, MRC1-001_5, MRC1-001_6, MRC1-001_7, MRC1-001_8, MRC1-001_9, MRC1-001_10, MRC1-001_11, RP11-457D2-001_2@22.6363636363636@16@34@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D62018@128828@128829@duplication@2@46927785@46934899@10@chr10:46927785-46934899@7.82@37@95@2.57@CNVR4712.9, CNVR4712.2, CNVR4712.7@FAM35B-001_6, FAM35B-001_7@53@34@72@NA@NA@NA
D62018@128913@128913@deletion@1@47409855@47410082@10@chr10:47409855-47410082@6.33@63@23@0.365@CNVR4712.9, CNVR4712.1@FAM35B2-201_6@47@47@47@NA@NA@NA
D62018@129021@129026@deletion@6@48020452@48033106@10@chr10:48020452-48033106@11.8@257@144@0.56@CNVR4715.2@ASAH2C-201_5, ASAH2C-201_6, ASAH2C-201_7, ASAH2C-201_8, ASAH2C-201_9, ASAH2C-201_10@65.8333333333333@57@73@@:ceramidase activity;sphingolipid metabolic process@NA
D62018@129460@129478@duplication@19@51361725@51465940@10@chr10:51361725-51465940@42.4@304@655@2.15@NA@ENST00000404618_1, ENST00000404618_2, ENST00000404618_3, ENST00000404618_4, ENST00000432221_1, ENST00000432221_2, ENST00000432221_3, ENST00000432221_4, TIMM23B-202_1, TIMM23B-202_2, TIMM23B-202_3, TIMM23B-202_4, TIMM23B-202_5, TIMM23B-202_6, TIMM23B-202_7, TIMM23B-202_10, AGAP7-201_9@73.3529411764706@8@142@:translocase of inner mitochondrial membrane 23 homolog B (yeast):ArfGAP with GTPase domain, ankyrin repeat and PH domain 7@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:phospholipid binding;protein binding;ARF GTPase activator activity;zinc ion binding;regulation of ARF GTPase activity@NA
D62018@129508@129519@deletion@12@51589227@51623902@10@chr10:51589227-51623902@9.97@236@139@0.589@NA@NCOA4-207_12, TIMM23-202_1, TIMM23-202_2, TIMM23-202_3, TIMM23-202_4, TIMM23-202_5, TIMM23-202_6, TIMM23-202_7, TIMM23-202_8, TIMM23-202_10, ENST00000456092_1@7.72727272727273@0@29@:translocase of inner mitochondrial membrane 23 homolog B (yeast):nuclear receptor coactivator 4:translocase of inner mitochondrial membrane 23 homolog B (yeast);translocase of inner mitochondrial membrane 23 homolog (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:male gonad development;transcription coactivator activity;positive regulation of transcription, DNA-dependent;response to hormone stimulus;nucleus;androgen receptor signaling pathway;transcription, DNA-dependent;androgen receptor binding:mitochondrion;mitochondrial inner membrane;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;mitochondrial intermembrane space;integral to mitochondrial inner membrane;intracellular protein transport;protein binding;integral to membrane;cellular protein metabolic process;protein targeting to mitochondrion@: THYROID CARCINOMA, PAPILLARY
D62018@129605@129609@duplication@5@51970585@51978391@10@chr10:51970585-51978391@18.3@82@213@2.6@NA@ASAH2-201_7, ASAH2-201_8, ASAH2-201_9, ASAH2-201_10, ASAH2-201_11@181.2@176@186@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
D62018@135726@135730@deletion@5@124348462@124353115@10@chr10:124348462-124353115@13@358@213@0.595@CNVR4912.4, CNVR4912.3, CNVR4912.2@DMBT1-002_17, DMBT1-002_18, DMBT1-002_19, DMBT1-002_20, DMBT1-002_21@50.2@48@51@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
D62018@136769@136770@deletion@2@135437401@135439504@10@chr10:135437401-135439504@48.8@372@77@0.207@CNVR4989.11, CNVR4989.4@FRG2B-202_3, FRG2B-202_4@23.5@18@29@:FSHD region gene 2 family, member B@:nucleus@NA
D62018@138032@138033@deletion@2@5270600@5271118@11@chr11:5270600-5271118@4.92@35@9@0.257@NA@HBG1-201_1, HBG1-201_2@94.5@83@106@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
D62018@145962@145964@deletion@3@89726706@89729449@11@chr11:89726706-89729449@6.52@51@15@0.294@NA@TRIM53-202_5, TRIM53-202_6, TRIM53-202_7@22.6666666666667@21@26@NA@NA@NA
D62018@150778@150783@deletion@6@9450373@9454871@12@chr12:9450373-9454871@10.8@133@60@0.451@NA@DDX11L8-201_5, DDX11L8-201_6, DDX11L8-201_7, DDX11L8-201_8, DDX11L8-201_9, DDX11L8-201_10@67.8333333333333@55@78@NA@NA@NA
D62018@150785@150787@deletion@3@9456573@9458354@12@chr12:9456573-9458354@12.7@71@9@0.127@NA@DDX11L8-201_12, DDX11L8-201_13, DDX11L8-201_14@57@1@87@NA@NA@NA
D62018@154074@154074@deletion@1@52865458@52865517@12@chr12:52865458-52865517@8.26@159@81@0.509@NA@KRT6C-202_4@16@16@16@:keratin 6C@:intermediate filament;structural molecule activity;keratin filament;cytoskeleton organization@NA
D62018@158323@158325@deletion@3@105370529@105371806@12@chr12:105370529-105371806@29@311@112@0.36@CNVR5653.1@AC090051-201_1, AC090051-201_2, AC090051-201_3@22@22@22@NA@NA@NA
D62018@162215@162216@deletion@2@25144700@25144871@13@chr13:25144700-25144871@13.8@95@22@0.232@NA@ENST00000455130_2, ENST00000453498_4@10@10@10@NA@NA@NA
D62018@164539@164543@duplication@5@53103402@53106857@13@chr13:53103402-53106857@15.7@68@181@2.66@NA@RP11-78J21-201_12, RP11-78J21-201_13, RP11-78J21-201_14, RP11-78J21-201_15, RP11-78J21-201_16@113.8@107@117@NA@NA@NA
D62018@166756@166756@deletion@1@20145923@20147163@14@chr14:20145923-20147163@8.18@330@198@0.6@CNVR6072.6, CNVR6072.12, CNVR6072.14@ENST00000398231_1@92@92@92@NA@NA@NA
D62018@167225@167227@duplication@3@22675432@22689838@14@chr14:22675432-22689838@6.2@179@258@1.44@NA@ENST00000390461_1, ENST00000390461_2, ENST00000390462_1@3@3@3@@:protein binding:protein binding@NA
D62018@173508@173513@deletion@6@106539081@106559976@14@chr14:106539081-106559976@98.8@477@6@0.0126@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8-001_1, IGHV1-8-001_2, IGHV3-9-001_1, IGHV3-9-001_2, IGHV2-10-001_1, IGHV2-10-001_2@22.3333333333333@17@24@@:protein binding:protein binding@NA
D62018@173536@173542@deletion@7@106721281@106725734@14@chr14:106721281-106725734@22.7@749@429@0.573@CNVR6294.48, CNVR6294.24, CNVR6294.40, CNVR6294.38, CNVR6294.17, CNVR6294.23@AB019439-201_1, AB019439-201_2, IGHVIII-22-2-201_1, IGHVIII-22-2-201_2, IGHVIII-22-2-201_3, IGHV3-23-001_1, IGHV3-23-001_2@6.71428571428571@5@8@@:protein binding@NA
D62018@173560@173566@duplication@7@106800321@106816027@14@chr14:106800321-106816027@24.2@425@714@1.68@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.41@IGHV3-30-2-001_1, IGHV3-30-2-001_2, IGHV4-31-001_1, IGHV4-31-001_2, IGHV3-32-001_1, IGHV3-32-001_2, IGHV3-33-001_2@16.8571428571429@14@19@@:protein binding:protein binding@NA
D62018@173649@173651@duplication@3@107169933@107179131@14@chr14:107169933-107179131@8.82@545@741@1.36@CNVR6294.56, CNVR6294.6, CNVR6294.92, CNVR6294.93@IGHV1-69-001_1, IGHV1-69-001_2, IGHV2-70-001_2@5@5@5@@:protein binding:protein binding@NA
D62018@173682@173683@deletion@2@20444657@20446102@15@chr15:20444657-20446102@12@582@369@0.634@CNVR6295.15, CNVR6295.7, CNVR6295.13, CNVR6295.26@ENST00000400226_14, ENST00000400226_15@69@69@69@NA@NA@NA
D62018@173687@173689@deletion@3@20456632@20462709@15@chr15:20456632-20462709@8.32@377@245@0.65@CNVR6295.15, CNVR6295.7, CNVR6295.13, CNVR6295.26@ENST00000400226_8, ENST00000400226_9, ENST00000400226_10@78.3333333333333@75@80@NA@NA@NA
D62018@173816@173822@deletion@7@22332588@22473354@15@chr15:22332588-22473354@34.7@1214@712@0.586@CNVR6297.4, CNVR6297.17, CNVR6297.6@ENST00000438898_1, ENST00000438898_2, AC025884-201_1, AC010760-202_2, VSIG6-201_1, VSIG6-201_2@52.1666666666667@15@87@:olfactory receptor, family 4, subfamily M, member 2:olfactory receptor, family 4, subfamily N, member 4@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
D62018@174406@174410@duplication@5@29008591@29009297@15@chr15:29008591-29009297@12.6@388@557@1.44@NA@ENST00000456510_1, ENST00000456510_2, ENST00000456510_3, ENST00000456510_4, ENST00000456510_5@23.6@18@26@NA@NA@NA
D62018@174507@174507@deletion@1@30665183@30665349@15@chr15:30665183-30665349@13.7@103@25@0.243@CNVR6337.1@CHRFAM7A-202_6@44@44@44@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
D62018@174523@174523@deletion@1@30700113@30700196@15@chr15:30700113-30700196@6.15@140@77@0.55@NA@ENST00000327271_11@54@54@54@@:Golgi apparatus@NA
D62018@174660@174662@deletion@3@32450615@32455537@15@chr15:32450615-32455537@7.64@101@47@0.465@CNVR6345.2, CNVR6345.1@CHRNA7-205_7, CHRNA7-205_8, CHRNA7-205_9@97.6666666666667@54@133@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
D62018@176486@176491@duplication@6@44067506@44068122@15@chr15:44067506-44068122@6.48@642@828@1.29@NA@ELL3-001_4, ELL3-001_5, ELL3-001_6, SERINC4-007_10, SERINC4-007_11, SERINC4-007_12@0.333333333333333@0@1@:elongation factor RNA polymerase II-like 3@:spermatogenesis;transcription elongation factor complex;nucleolus;DNA-dependent transcription, elongation;nucleus;positive regulation of DNA-dependent transcription, elongation;transcription elongation from RNA polymerase II promoter;positive regulation of transcription from RNA polymerase II promoter:membrane@NA
D62018@187507@187518@deletion@12@32859168@32893409@16@chr16:32859168-32893409@17.1@538@332@0.617@CNVR6702.2, CNVR6702.1, CNVR6702.3@IGHV2OR16-5-001_2, AC138915-201_4, AC138915-201_5, AC138915-201_6, AC138915-201_7, AC138915-201_8, AC138915-201_9, AC138915-201_10, AC138915-201_11, AC138915-201_12, AC138915-201_13, AC138915-201_14@30.9166666666667@22@36@NA@NA@NA
D62018@187534@187539@deletion@6@32949300@33021236@16@chr16:32949300-33021236@10.7@168@82@0.488@CNVR6702.1@ENST00000423205_11, ENST00000423205_12, ENST00000423205_13, AC145350-201_1, AC145350-201_2, AC145350-201_3@7.66666666666667@0@14@NA@NA@NA
D62018@188261@188261@duplication@1@55866918@55867076@16@chr16:55866918-55867076@5.03@46@89@1.93@NA@CES1-203_1@10@10@10@:carboxylesterase 1;liver carboxylesterase 1-like@:hydrolase activity;methyl salicylate esterase activity;response to toxin;methylumbelliferyl-acetate deacetylase activity;endoplasmic reticulum lumen;retinyl-palmitate esterase activity;methyl jasmonate esterase activity;metabolic process;carboxylesterase activity;methyl indole-3-acetate esterase activity@: CARBOXYLESTERASE 1; CES1
D62018@195728@195747@duplication@20@18418662@18457581@17@chr17:18418662-18457581@25.2@433@683@1.58@NA@AC107983-001_1, AC107983-001_2, AC107983-001_3, AC107983-001_4, AC107983-001_5, AC107983-001_6, AC107983-001_7, AC107983-001_8, ENST00000456184_1, ENST00000456184_2, CCDC144B-201_14, CCDC144B-201_15, CCDC144B-201_16, CCDC144B-201_17, CCDC144B-201_18, ENST00000447265_11, ENST00000447265_12, ENST00000447265_13, ENST00000447265_14, ENST00000447265_15@129.8@126@133@:protein FAM106B-like@NA@NA
D62018@196150@196154@duplication@5@20353178@20356381@17@chr17:20353178-20356381@8.79@129@212@1.64@CNVR7021.1, CNVR7021.3@LGALS9B-201_7, LGALS9B-201_8, LGALS9B-201_9, LGALS9B-201_10, LGALS9B-201_11@94@75@103@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
D62018@197728@197728@deletion@1@34539901@34539966@17@chr17:34539901-34539966@8.39@38@0@0@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1-202_4@122@122@122@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
D62018@198033@198034@deletion@2@36352424@36353766@17@chr17:36352424-36353766@12.4@458@277@0.605@CNVR7083.3@AC183087-202_12, AC183087-202_13@61.5@59@64@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
D62018@200259@200260@duplication@2@43585590@43585906@17@chr17:43585590-43585906@6.71@144@221@1.53@CNVR7113.4, CNVR7113.6, CNVR7113.8, CNVR7113.2@AC091132-201_4, AC091132-201_5@81@81@81@NA@NA@NA
D62018@200324@200328@deletion@5@44360679@44364337@17@chr17:44360679-44364337@27.4@964@572@0.593@CNVR7114.3, CNVR7114.2, CNVR7114.10@ENST00000451529_1, ENST00000451529_2, ENST00000451529_3, ENST00000451529_4, ENST00000451529_5@54@11@90@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
D62018@200338@200349@duplication@12@44400321@44592688@17@chr17:44400321-44592688@19.7@82@225@2.74@CNVR7114.2, CNVR7114.1@LRRC37A-001_8, LRRC37A-001_9, LRRC37A-001_10, LRRC37A-001_11, LRRC37A-001_12, LRRC37A-001_13, LRRC37A-001_14, LRRC37A-001_15, AC005829-202_1, AC005829-202_2, AC005829-202_3, LRRC37A2-201_1@149.916666666667@114@196@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane@NA
D62018@200361@200363@deletion@3@44632520@44633017@17@chr17:44632520-44633017@12.3@104@32@0.308@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2-201_12, LRRC37A2-201_13, LRRC37A2-201_14@89.6666666666667@74@98@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
D62018@206352@206354@deletion@3@11629647@11644890@18@chr18:11629647-11644890@9.9@132@57@0.432@CNVR7257.1, CNVR7257.2@AMAC1L1-201_2, AP001120-201_1, AP001120-201_2@30@8@61@NA@NA@NA
D62018@215928@215928@deletion@1@35862253@35863856@19@chr19:35862253-35863856@6.1@124@66@0.532@CNVR7627.1@FFAR3-001_2@102@102@102@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
D62018@217594@217595@duplication@2@41324628@41327534@19@chr19:41324628-41327534@7.87@62@128@2.06@NA@CYP2F1P-001_5, CYP2F1P-001_6@0@0@0@NA@NA@NA
D62018@220700@220700@deletion@1@52149512@52149894@19@chr19:52149512-52149894@10@45@0@0@CNVR7702.1@SIGLEC5-201_2@14@14@14@:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 5:sialic acid binding Ig-like lectin 14@:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion:carbohydrate binding;protein binding;integral to membrane;cell adhesion;plasma membrane@NA
D62018@221167@221168@deletion@2@54724957@54726003@19@chr19:54724957-54726003@6.25@39@8@0.205@CNVR7721.3, CNVR7721.4@LILRB3-008_4, LILRB3-008_5@129.5@123@136@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D62018@221178@221178@deletion@1@54744152@54744453@19@chr19:54744152-54744453@6.32@221@132@0.597@CNVR7721.3, CNVR7721.6@LILRA6-002_6@54@54@54@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D62018@221396@221404@duplication@9@55266477@55278034@19@chr19:55266477-55278034@17.8@509@737@1.45@CNVR7725.2, CNVR7725.1@KIR2DL3-201_5, KIR2DL3-201_6, KIR2DP1-001_1, KIR2DP1-001_2, KIR2DP1-001_3, KIR2DP1-001_4, KIR2DP1-001_5, KIR2DP1-001_6, KIR2DP1-001_7@105.111111111111@85@125@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity@NA
D62018@221409@221434@duplication@26@55281279@55344254@19@chr19:55281279-55344254@81.5@2784@4009@1.44@CNVR7725.1, CNVR7725.3@KIR2DL4-001_1, KIR2DL4-001_2, KIR2DL4-001_3, KIR2DL4-001_4, KIR2DL4-001_5, KIR2DL4-001_6, KIR2DL4-001_7, KIR2DL4-001_8, KIR2DL1-002_1, KIR2DL1-002_2, KIR2DL1-002_3, KIR2DL1-002_4, KIR2DL1-002_5, KIR2DL1-002_6, KIR2DL1-002_7, KIR2DL1-002_8, KIR2DL1-002_9, KIR3DP1-001_1, KIR3DP1-001_2, KIR3DP1-001_3, KIR3DL1-201_1, KIR3DL1-201_2, KIR3DL1-201_3, KIR3DL1-201_4, KIR3DL1-201_5, KIR2DS4-001_1@41.3461538461538@22@110@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
D62018@221436@221437@deletion@2@55349033@55351155@19@chr19:55349033-55351155@12.1@186@89@0.478@CNVR7725.1, CNVR7725.6@KIR2DS4-001_3, KIR2DS4-001_4@67.5@67@68@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
D62018@221439@221441@duplication@3@55358641@55360024@19@chr19:55358641-55360024@48.4@698@1415@2.03@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4-001_6, KIR2DS4-001_7, KIR2DS4-001_8@96.3333333333333@85@102@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
D62018@221447@221448@deletion@2@55370536@55370585@19@chr19:55370536-55370585@5.19@130@76@0.585@CNVR7725.1, CNVR7725.6, CNVR7725.5@KIR3DL1-201_6, KIR3DL2-001_6@2@2@2@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane@NA
D62018@221822@221824@duplication@3@56280509@56284546@19@chr19:56280509-56284546@16.9@602@880@1.46@CNVR7734.1@ENST00000341750_1, ENST00000341750_2, ENST00000341750_3@37.6666666666667@30@47@:ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
D62018@228821@228832@duplication@12@10906743@10943021@21@chr21:10906743-10943021@17.9@2599@3338@1.28@CNVR7947.10, CNVR7947.6, CNVR7947.11@TPTE-006_21, TPTE-006_22, TPTE-006_23, TPTE-006_24, TPTE-006_25, TPTE-006_26, TPTE-006_27, TPTE-006_28, TPTE-006_29, TPTE-006_30, TPTE-006_31, TPTE-006_32@28.4166666666667@24@33@:transmembrane phosphatase with tensin homology@:phosphatase activity;ion channel activity;protein tyrosine phosphatase activity;ion transport;protein dephosphorylation;transmembrane transport;protein binding;signal transduction;integral to membrane;protein tyrosine/serine/threonine phosphatase activity;dephosphorylation;membrane;peptidyl-tyrosine dephosphorylation@NA
D62018@231958@231963@deletion@6@16287256@16341418@22@chr22:16287256-16341418@13@81@16@0.198@CNVR8071.2, CNVR8071.3@POTEH-002_1, LA16c-59E1-001_1, LA16c-59E1-001_2, LA16c-59E1-001_3, LA16c-59E1-001_4, LA16c-59E1-001_5@50.6666666666667@36@105@:POTE ankyrin domain family, member H@:protein binding@NA
D62018@233470@233472@deletion@3@23241801@23241987@22@chr22:23241801-23241987@6.84@112@58@0.518@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11@D87015-202_1, BCRL4-001_4, BCRL4-001_5@0@0@0@NA@NA@NA
D62018@236748@236769@deletion@22@42522505@42538055@22@chr22:42522505-42538055@42.3@1004@575@0.573@CNVR8168.1, CNVR8168.3, CNVR8168.4@RP4-669P10-201_4, RP4-669P10-201_5, RP4-669P10-201_6, RP4-669P10-201_7, CYP2D6-203_1, CYP2D6-203_2, CYP2D6-203_3, CYP2D6-203_4, CYP2D6-203_5, CYP2D6-203_6, CYP2D6-203_7, CYP2D6-203_8, CYP2D6-203_9, CYP2D6-203_10, ENST00000428786_1, ENST00000428786_2, ENST00000428786_3, CYP2D7P1-202_6, CYP2D7P1-202_7, CYP2D7P1-202_8, CYP2D7P1-202_9, CYP2D7P1-202_10@16.4545454545455@2@30@:cytochrome P450, family 2, subfamily D, polypeptide 6@:oxidation-reduction process;mitochondrion;alkaloid catabolic process;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;drug catabolic process;endoplasmic reticulum membrane;response to organic substance;oxidative demethylation;endoplasmic reticulum;alkaloid metabolic process;negative regulation of binding;heme binding;xenobiotic metabolic process;dopamine metabolic process;steroid metabolic process;isoquinoline alkaloid metabolic process;arachidonic acid monooxygenase activity;arachidonic acid metabolic process;steroid 21-monooxygenase activity;negative regulation of cellular organofluorine metabolic process;oxidoreductase activity;monoterpenoid metabolic process;heterocycle metabolic process;drug binding;drug metabolic process;electron carrier activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;coumarin metabolic process:oxidation-reduction process;electron carrier activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;heme binding@: DRUG METABOLISM, POOR, CYP2D6-RELATED
D62018@236814@236820@duplication@7@42905036@42910786@22@chr22:42905036-42910786@8.52@392@535@1.36@CNVR8171.2, CNVR8171.3@SERHL-001_8, SERHL-001_9, SERHL-001_10, SERHL-001_11, RRP7A-001_5, RRP7A-001_6, RRP7A-001_7@41.1428571428571@38@43@:ribosomal RNA processing 7 homolog A (S. cerevisiae)@:RNA binding;nucleotide binding@NA
D62925@3775@3777@deletion@3@21806546@21808263@1@chr1:21806546-21808263@9.57@160@83@0.519@CNVR107.2, CNVR107.1@NBPF3-003_15, NBPF3-003_16, NBPF3-003_17@78.6666666666667@62@91@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 3@:cytoplasm@NA
D62925@4452@4461@duplication@10@25611066@25655628@1@chr1:25611066-25655628@60.9@823@1453@1.77@CNVR116.1, CNVR116.2@RHD-202_2, RHD-202_3, RHD-202_4, RHD-202_5, RHD-202_6, RHD-202_7, RHD-202_8, RHD-202_9, RHD-202_10, RHD-202_11@123@113@128@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
D62925@4477@4477@deletion@1@25735176@25735361@1@chr1:25735176-25735361@20.2@94@0@0@CNVR117.1@RHCE-005_4@56@56@56@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
D62925@11246@11246@duplication@1@89477432@89477711@1@chr1:89477432-89477711@5.86@169@252@1.49@CNVR244.1@GBP3-001_7@54@54@54@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
D62925@11376@11376@deletion@1@90460676@90460833@1@chr1:90460676-90460833@5.1@140@82@0.586@NA@ZNF326-001_1@0@0@0@:zinc finger protein 326@:RNA polymerase II core binding;DNA binding;nuclear matrix;protein binding;positive regulation of transcription, DNA-dependent;regulation of DNA-dependent transcription, elongation;mRNA processing;DBIRD complex;nucleus;RNA splicing;transcription, DNA-dependent;zinc ion binding@NA
D62925@12424@12425@duplication@2@104233918@104234233@1@chr1:104233918-104234233@5.24@51@95@1.86@CNVR266.3, CNVR266.5@AMY1B-001_7, AMY1B-001_8@154@154@154@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D62925@12445@12446@duplication@2@104297123@104297437@1@chr1:104297123-104297437@13.4@290@456@1.57@CNVR266.3, CNVR266.5@AMY1C-201_7, AMY1C-201_8@77@75@79@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D62925@12929@12936@deletion@8@110230474@110236368@1@chr1:110230474-110236368@90@414@0@0@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1-001_1, GSTM1-001_2, GSTM1-001_3, GSTM1-001_4, GSTM1-001_5, GSTM1-001_6, GSTM1-001_7, GSTM1-001_8@191.375@187@194@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
D62925@14493@14495@duplication@3@144676872@144679973@1@chr1:144676872-144679973@7.91@288@406@1.41@CNVR337.1@WI2-1896O14-001_1, WI2-1896O14-001_2, WI2-1896O14-001_3@4.66666666666667@4@5@NA@NA@NA
D62925@16280@16280@deletion@1@152573269@152573493@1@chr1:152573269-152573493@16.3@75@0@0@CNVR358.1@LCE3C-201_2@102@102@102@:late cornified envelope 3C@:keratinization@NA
D62925@18680@18684@duplication@5@161592988@161600997@1@chr1:161592988-161600997@29.6@756@1146@1.52@CNVR383.1@FCGR3B-001_1, FCGR3B-001_2, FCGR3B-001_3, FCGR3B-001_4, FCGR3B-001_5@36.6@34@40@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIIb, receptor (CD16b)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction:IgG binding;protein binding;extracellular region;immune response;plasma membrane;anchored to membrane@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
D62925@21362@21365@duplication@4@196743977@196757529@1@chr1:196743977-196757529@9.61@423@582@1.38@CNVR459.1@CFHR3-001_1, CFHR3-001_2, CFHR3-001_3, CFHR3-001_4@94@85@100@:complement factor H-related 3@:extracellular space@NA
D62925@21367@21374@duplication@8@196762449@196801320@1@chr1:196762449-196801320@45.5@1064@1672@1.57@CNVR459.1@CFHR3-001_6, CFHR1-001_1, CFHR1-001_2, CFHR1-001_3, CFHR1-001_4, CFHR1-001_5, CFHR1-001_6, CFHR2-201_1@96.25@85@119@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
D62925@24160@24160@deletion@1@223727670@223727696@1@chr1:223727670-223727696@4.6@22@1@0.0455@NA@CAPN8-202_24@0@0@0@:calpain 8@:proteolysis;Golgi apparatus;intracellular;calcium-dependent cysteine-type endopeptidase activity;calcium ion binding@NA
D62925@33520@33520@deletion@1@87239638@87241105@2@chr2:87239638-87241105@8.41@38@0@0@NA@RGPD1-001_23@110@110@110@:RANBP2-like and GRIP domain containing 1:plasminogen-like B1;plasminogen-like B2@:protein binding;intracellular;intracellular transport;protein targeting to Golgi:extracellular region@NA
D62925@33542@33543@deletion@2@87365381@87365581@2@chr2:87365381-87365581@12.5@116@41@0.353@CNVR861.2@AC083899-001_6, AC083899-001_7@13@11@15@NA@NA@NA
D62925@33558@33564@deletion@7@87404273@87414366@2@chr2:87404273-87414366@29.7@352@150@0.426@CNVR861.2@AC083899-001_22, AC083899-001_23, AC083899-001_24, AC083899-001_25, AC083899-001_26, AC083899-001_27, AC083899-001_28@67@45@85@NA@NA@NA
D62925@34092@34101@deletion@10@96457910@96459922@2@chr2:96457910-96459922@17.9@222@99@0.446@NA@AC008268-201_2, AC008268-201_3, AC008268-201_4, AC008268-201_5, AC008268-201_6, ENST00000444924_1, ENST00000444924_2, ENST00000444924_3, ENST00000444924_4, ENST00000444924_5@60.9@26@104@NA@NA@NA
D62925@34212@34213@duplication@2@96697783@96698114@2@chr2:96697783-96698114@9.51@113@200@1.77@NA@GPAT2-205_3, GPAT2-205_4@75.5@75@76@:glycerol-3-phosphate acyltransferase 2, mitochondrial@:glycerol-3-phosphate O-acyltransferase activity;mitochondrion;phospholipid metabolic process;triglyceride biosynthetic process;glycerophospholipid biosynthetic process;small molecule metabolic process;transferase activity, transferring acyl groups;mitochondrial outer membrane;phosphatidic acid biosynthetic process;integral to membrane;glycerol-3-phosphate metabolic process;CDP-diacylglycerol biosynthetic process;membrane;metabolic process;phospholipid biosynthetic process@NA
D62925@34565@34578@duplication@14@97867941@97881235@2@chr2:97867941-97881235@12.8@688@931@1.35@CNVR886.1@ENST00000461153_39, ENST00000461153_40, ENST00000461153_41, ENST00000461153_42, ENST00000461153_43, ENST00000461153_44, ENST00000461153_45, ENST00000461153_46, ENST00000461153_47, ENST00000461153_48, ENST00000461153_49, ENST00000461153_50, ENST00000461153_51, ENST00000461153_52@53.0714285714286@29@65@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
D62925@34615@34631@deletion@17@98127603@98162325@2@chr2:98127603-98162325@39.6@212@20@0.0943@CNVR888.3@ANKRD36B-001_23, ANKRD36B-001_24, ANKRD36B-001_25, ANKRD36B-001_26, ANKRD36B-001_27, ANKRD36B-001_28, ANKRD36B-001_29, ANKRD36B-001_30, ANKRD36B-001_31, ANKRD36B-001_32, ANKRD36B-001_33, ANKRD36B-001_34, ANKRD36B-001_35, ANKRD36B-001_36, ANKRD36B-001_37, ANKRD36B-001_38, ANKRD36B-001_39@130.058823529412@64@154@NA@NA@NA
D62925@45387@45388@deletion@2@233273213@233273549@2@chr2:233273213-233273549@4.92@115@66@0.574@NA@ALPPL2-001_7, ALPPL2-001_8@42.5@27@58@:alkaline phosphatase, placental-like 2@:phosphatase activity;catalytic activity;phosphorylation;plasma membrane;metabolic process;membrane;anchored to membrane;alkaline phosphatase activity;metal ion binding@NA
D62925@58545@58549@deletion@5@151531827@151546273@3@chr3:151531827-151546273@34.8@878@480@0.547@CNVR1586.1@AADAC-001_1, AADAC-001_2, AADAC-001_3, AADAC-001_4, AADAC-001_5@2.4@2@3@:arylacetamide deacetylase@:hydrolase activity;serine hydrolase activity;deacetylase activity;positive regulation of triglyceride catabolic process;catalytic activity;retinyl-palmitate esterase activity;lipase activity;integral to membrane;triglyceride lipase activity;endoplasmic reticulum membrane;carboxylesterase activity;metabolic process@NA
D62925@59389@59392@duplication@4@168838846@168840516@3@chr3:168838846-168840516@6.38@449@590@1.31@NA@EVI1-201_6, EVI1-201_7, MDS1-004_6, MDS1-004_7@1@1@1@:MDS1 and EVI1 complex locus@:histone deacetylase complex;cell differentiation;inflammatory response;nuclear speck;DNA binding;response to external stimulus;negative regulation of transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity;embryonic forelimb morphogenesis;pericardium development;embryonic hindlimb morphogenesis;hematopoietic stem cell proliferation;renal system development;forebrain development;nucleus;apoptotic process;protein homodimerization activity;positive regulation of transcription from RNA polymerase II promoter;post-embryonic development;regulation of cell cycle;intracellular;in utero embryonic development;negative regulation of programmed cell death;regulation of cell proliferation;negative regulation of JNK cascade;protein binding;positive regulation of transcription, DNA-dependent;neutrophil homeostasis;transcription, DNA-dependent;response to bacterium;zinc ion binding;nucleic acid binding@NA
D62925@61530@61569@deletion@40@195341820@195453444@3@chr3:195341820-195453444@163@4058@2294@0.565@CNVR1703.1@ENST00000457750_1, ENST00000457750_2, AC233280-201_1, AC233280-201_2, AC233280-201_3, AC233280-201_4, AC233280-201_5, AC233280-201_6, AC233280-201_7, AC233280-201_8, AC069513-001_1, AC069513-001_2, AC069513-001_3, SDHALP2-001_1, SDHALP2-001_2, SDHALP2-001_3, SDHALP2-001_4, SDHALP2-001_5, SDHALP2-001_6, SDHALP2-001_7, SDHALP2-001_8, SDHALP2-001_9, SDHALP2-001_10, SDHALP2-001_11, SDHALP2-001_12, SDHALP2-001_13, SDHALP2-001_14, SDHALP2-001_15, ENST00000430928_1, ENST00000430928_2, ENST00000430928_4, AC069513-013_1, AC069513-013_2, AC069513-013_3, AC069513-013_4, AC069513-013_5, MUC20-201_1, MUC20-201_2, MUC20-201_3@66.7435897435897@20@93@:mucin 20, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane@NA
D62925@65316@65320@duplication@5@69416397@69434246@4@chr4:69416397-69434246@27@857@1294@1.51@CNVR1953.1@UGT2B17-001_1, UGT2B17-001_2, UGT2B17-001_3, UGT2B17-001_4, UGT2B17-001_5@125.6@118@134@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
D62925@68947@68947@duplication@1@145041645@145041742@4@chr4:145041645-145041742@11.3@96@200@2.08@NA@GYPA-205_2@8@8@8@:glycophorin B (MNS blood group):glycophorin A (MNS blood group)@:integral to membrane;plasma membrane;integral to plasma membrane:external side of plasma membrane;integral to membrane;cytoskeletal anchoring at plasma membrane;plasma membrane;molecular_function;protein homodimerization activity;integral to plasma membrane;cellular_component;identical protein binding;membrane;biological_process;regulation of response to osmotic stress;virus-host interaction@: BLOOD GROUP--Ss LOCUS; Ss: MALARIA, SUSCEPTIBILITY TO; BLOOD GROUP--MN LOCUS; MN
D62925@70688@70688@deletion@1@190947541@190947617@4@chr4:190947541-190947617@14.9@254@117@0.461@CNVR2258.3@FRG2-201_3@26@26@26@:FSHD region gene 2-like;FSHD region gene 2@:nucleus@NA
D62925@70822@70824@duplication@3@748521@755215@5@chr5:748521-755215@6.05@156@231@1.48@CNVR2280.3@ZDHHC11B-201_3, ZDHHC11B-201_4, ZDHHC11B-201_5@89@84@96@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
D62925@70837@70840@deletion@4@837482@847731@5@chr5:837482-847731@15.3@732@469@0.641@CNVR2280.3, CNVR2280.8@ZDHHC11-201_3, ZDHHC11-201_4, ZDHHC11-201_5, ZDHHC11-201_6@21.25@15@29@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
D62925@71896@71900@deletion@5@34182787@34193054@5@chr5:34182787-34193054@14.4@403@237@0.588@CNVR2430.2, CNVR2430.1@ENST00000380721_1, ENST00000502234_2, AC138409-201_1, AC138409-201_2, AC138409-201_3@45.2@35@49@NA@NA@NA
D62925@73727@73749@duplication@23@69717564@69805434@5@chr5:69717564-69805434@29.9@83@302@3.64@CNVR2494.17, CNVR2494.3@GTF2H2B-201_4, GTF2H2B-201_5, GTF2H2B-201_6, GTF2H2B-201_7, GTF2H2B-201_8, GTF2H2B-201_9, GTF2H2B-201_10, GTF2H2B-201_11, GTF2H2B-201_12, GTF2H2B-201_13, GTF2H2B-201_14, GTF2H2B-201_15, GTF2H2B-201_16, AC146944-201_1, AC146944-201_2, AC146944-201_3, AC146944-201_4, AC146944-203_1, AC146944-203_2, AC146944-203_3, AC146944-203_4, ENST00000456583_1, ENST00000456583_2@133.391304347826@83@173@NA@NA@NA
D62925@73817@73821@duplication@5@70370032@70389020@5@chr5:70370032-70389020@22.7@127@305@2.4@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.8, CNVR2494.1, CNVR2494.37@AC044797-201_1, AC044797-201_2, AC044797-201_3, AC044797-201_4, AC044797-201_5@120.4@100@138@NA@NA@NA
D62925@80021@80021@deletion@1@177166116@177166139@5@chr5:177166116-177166139@6.8@132@69@0.523@NA@FAM153A-204_10@81@81@81@:family with sequence similarity 153, member A@NA@NA
D62925@80049@80052@duplication@4@177469198@177474283@5@chr5:177469198-177474283@9.12@233@345@1.48@NA@FAM153C-202_7, FAM153C-202_8, FAM153C-202_9, FAM153C-202_10@2.5@2@3@NA@NA@NA
D62925@80560@80560@deletion@1@292099@292561@6@chr6:292099-292561@6.42@225@136@0.604@CNVR2728.1, CNVR2728.2@DUSP22-001_1@13@13@13@:dual specificity phosphatase 22;dual specificity protein phosphatase 22-like@:protein dephosphorylation;transforming growth factor beta receptor signaling pathway;positive regulation of JNK cascade;protein tyrosine/serine/threonine phosphatase activity;nucleus;apoptotic process;multicellular organismal development;phosphatase activity;protein tyrosine phosphatase activity;regulation of cell proliferation;cytoplasm;cell proliferation;inactivation of MAPK activity;protein binding;negative regulation of transcription from RNA polymerase II promoter;dephosphorylation@NA
D62925@83577@83588@duplication@12@31962024@31965542@6@chr6:31962024-31965542@15.1@465@667@1.43@CNVR2843.6, CNVR2843.3@C4A-001_20, C4A-001_21, C4A-001_22, C4A-001_23, C4A-001_24, C4A-001_25, C4A-001_26, C4A-001_27, C4A-001_28, C4A-001_29, C4A-001_30, C4A-001_31@11.5833333333333@2@17@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
D62925@83637@83645@deletion@9@31994762@31997116@6@chr6:31994762-31997116@27.8@317@133@0.42@CNVR2843.6, CNVR2843.5@C4B-001_20, C4B-001_21, C4B-001_22, C4B-001_23, C4B-001_24, C4B-001_25, C4B-001_26, C4B-001_27, C4B-001_28@13.8888888888889@10@19@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
D62925@83911@83915@deletion@5@32485122@32489952@6@chr6:32485122-32489952@23.1@178@54@0.303@CNVR2845.21, CNVR2845.25, CNVR2845.30@HLA-DRB5-001_2, HLA-DRB5-001_3, HLA-DRB5-001_4, HLA-DRB5-001_5, HLA-DRB5-001_6@184.2@177@189@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D62925@83917@83921@duplication@5@32520492@32522749@6@chr6:32520492-32522749@12.7@229@359@1.57@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.29@HLA-DRB6-002_3, HLA-DRB6-002_4, HLA-DRB6-002_5, HLA-DRB6-002_6, AL713966-201_3@130.6@114@144@NA@NA@NA
D62925@83928@83930@deletion@3@32548525@32552156@6@chr6:32548525-32552156@8.6@314@203@0.646@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.5, CNVR2845.54@HLA-DRB1-001_2, HLA-DRB1-001_3, HLA-DRB1-001_4@72@56@100@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
D62925@83944@83945@deletion@2@32630133@32632845@6@chr6:32630133-32632845@6.48@115@61@0.53@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20, CNVR2845.31, CNVR2845.64@HLA-DQB1-003_3, ENST00000443574_1@106.5@101@112@:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
D62925@84059@84062@deletion@4@33052729@33054977@6@chr6:33052729-33054977@29.8@515@264@0.513@CNVR2846.4, CNVR2846.3, CNVR2846.5@HLA-DPB1-201_3, HLA-DPB1-201_4, HLA-DPB1-201_5, HLA-DPB1-201_6@13.5@3@24@:major histocompatibility complex, class II, DP beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D62925@84706@84710@deletion@5@35754777@35765089@6@chr6:35754777-35765089@24.6@905@551@0.609@CNVR2861.1@C6orf127-001_2, C6orf127-001_3, CLPS-001_1, CLPS-001_2, CLPS-001_3@39@30@43@:colipase-like 1:colipase, pancreatic@:extracellular region;enzyme activator activity;digestion;lipid catabolic process:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
D62925@92591@92594@duplication@4@160132717@160133143@6@chr6:160132717-160133143@24.4@420@682@1.62@CNVR3127.2, CNVR3127.1@ENST00000442642_3, ENST00000442642_4, ENST00000442642_5, ENST00000442642_6@89.5@56@106@:superoxide dismutase 2, mitochondrial;uncharacterized LOC100129518@:response to reactive oxygen species;oxidation-reduction process;mitochondrion;negative regulation of cell proliferation;neuron development;negative regulation of fat cell differentiation;removal of superoxide radicals;response to gamma radiation;response to L-ascorbic acid;response to lipopolysaccharide;response to nutrient levels;response to zinc ion;protein homotetramerization;post-embryonic development;iron ion homeostasis;hemopoiesis;aging;mitochondrial inner membrane;age-dependent response to reactive oxygen species;response to drug;oxygen binding;mitochondrial nucleoid;vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure;apoptotic process;superoxide metabolic process;response to superoxide;detection of oxygen;response to silicon dioxide;cytoplasm;response to stress;respiratory electron transport chain;superoxide anion generation;protein homooligomerization;regulation of mitochondrial membrane potential;positive regulation of nitric oxide biosynthetic process;response to manganese ion;regulation of blood pressure;metal ion binding;negative regulation of apoptotic process;response to cadmium ion;response to oxidative stress;liver development;regulation of catalytic activity;negative regulation of fibroblast proliferation;response to selenium ion;age-dependent response to oxidative stress;response to electrical stimulus;mitochondrial matrix;identical protein binding;mitochondrion organization;response to hyperoxia;vasodilation;response to hydrogen peroxide;superoxide dismutase activity;heart development;negative regulation of neuron apoptotic process;erythrophore differentiation;locomotory behavior;DNA binding;release of cytochrome c from mitochondria;response to axon injury;oxygen homeostasis;response to activity;glutathione metabolic process;hydrogen peroxide metabolic process;hydrogen peroxide biosynthetic process;regulation of transcription from RNA polymerase II promoter;response to hypoxia;protein binding;manganese ion binding;cellular response to ethanol@: MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6; MVCD6
D62925@94190@94199@duplication@10@5959482@5978461@7@chr7:5959482-5978461@22.9@830@1182@1.42@NA@C7orf28A-001_12, C7orf28A-001_13, C7orf28A-001_14, C7orf28A-001_15, RSPH10B-002_16, RSPH10B-002_17, RSPH10B-002_18, RSPH10B-002_19, RSPH10B-002_20, RSPH10B-002_21@34.9@12@73@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae):radial spoke head 10 homolog B (Chlamydomonas)@:lysosomal membrane@NA
D62925@94212@94218@duplication@7@6006496@6022623@7@chr7:6006496-6022623@17.7@324@522@1.61@NA@RSPH10B-002_1, RSPH10B-002_2, RSPH10B-002_3, PMS2-001_12, PMS2-001_13, PMS2-001_14, PMS2-001_15@22.7142857142857@6@51@:radial spoke head 10 homolog B (Chlamydomonas):PMS2 postmeiotic segregation increased 2 (S. cerevisiae)@:response to drug;DNA binding;MutSalpha complex binding;ATP binding;mismatch repair;DNA repair;mismatched DNA binding;ATPase activity;nucleus;mismatch repair complex;reciprocal meiotic recombination;ATP catabolic process;single-stranded DNA binding;response to DNA damage stimulus;single base insertion or deletion binding;protein binding;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;MutLalpha complex;endonuclease activity@: COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4; MISMATCH REPAIR CANCER SYNDROME
D62925@94410@94420@deletion@11@6785721@6797563@7@chr7:6785721-6797563@24.5@470@243@0.517@NA@ENST00000338780_11, ENST00000338780_12, ENST00000338780_13, ENST00000338780_14, PMS2CL-002_11, PMS2CL-002_12, PMS2CL-002_13, PMS2CL-002_14, RSPH10B2-204_1, RSPH10B2-204_2, RSPH10B2-204_3@46.6363636363636@5@90@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D62925@94433@94444@deletion@12@6825582@6844687@7@chr7:6825582-6844687@86.1@513@85@0.166@NA@RSPH10B2-204_16, RSPH10B2-204_17, RSPH10B2-204_18, RSPH10B2-204_19, RSPH10B2-204_20, RSPH10B2-204_21, ENST00000429267_1, ENST00000429267_2, C7orf28B-001_12, C7orf28B-001_13, C7orf28B-001_14, C7orf28B-001_15@61@18@121@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D62925@96560@96567@deletion@8@38301774@38356938@7@chr7:38301774-38356938@15.3@1432@983@0.686@NA@TRGC1-001_1, TRGC1-001_2, ENST00000501456_1, ENST00000501456_2, ENST00000499120_1, ENST00000499120_2, ENST00000499120_3, TRGV9-001_2@2.375@0@8@:TCR gamma alternate reading frame protein@:protein binding:protein binding:protein binding@NA
D62925@96579@96582@deletion@4@38388958@38394119@7@chr7:38388958-38394119@13.4@730@475@0.651@CNVR3354.3, CNVR3354.1@TRGV5-001_1, TRGV5-001_2, TRGV4-001_1, TRGV4-001_2@12.75@11@14@@:protein binding:protein binding@NA
D62925@97910@97918@duplication@9@57068812@57085674@7@chr7:57068812-57085674@8.2@98@168@1.71@NA@TNRC18C-202_6, TNRC18C-202_7, TNRC18C-202_8, TNRC18C-202_9, TNRC18C-202_10, TNRC18C-202_11, ENST00000398760_3, ENST00000398760_4, ENST00000398760_5@140.222222222222@29@166@NA@NA@NA
D62925@98215@98215@deletion@1@65150574@65150717@7@chr7:65150574-65150717@5.65@44@13@0.295@NA@INTS4L2-001_5@56@56@56@NA@NA@NA
D62925@99545@99545@deletion@1@76728229@76728269@7@chr7:76728229-76728269@14.8@84@10@0.119@NA@ENST00000398321_6@11@11@11@NA@NA@NA
D62925@101723@101726@duplication@4@100334108@100336237@7@chr7:100334108-100336237@12@511@714@1.4@CNVR3509.1@ZAN-001_4, ZAN-001_5, ZAN-001_6, ZAN-001_7@82@71@89@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
D62925@102116@102116@deletion@1@102114810@102114983@7@chr7:102114810-102114983@5.26@25@1@0.04@CNVR3518.1@POLR2J-001_3@91@91@91@:polymerase (RNA) II (DNA directed) polypeptide J, 13.3kDa@:nucleoplasm;DNA binding;DNA repair;protein dimerization activity;nucleus;viral reproduction;gene expression;transcription initiation from RNA polymerase II promoter;7-methylguanosine mRNA capping;protein phosphorylation;LRR domain binding;protein kinase activity;DNA-directed RNA polymerase II, core complex;nucleotide-excision repair;transcription from RNA polymerase II promoter;DNA-directed RNA polymerase activity;protein binding;transcription-coupled nucleotide-excision repair;RNA splicing;mRNA splicing, via spliceosome;transcription, DNA-dependent;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription@NA
D62925@102144@102145@duplication@2@102180464@102180539@7@chr7:102180464-102180539@5.09@117@176@1.5@CNVR3518.1@RASA4B-007_4, POLR2J3-003_7@96@96@96@:RAS p21 protein activator 4B:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
D62925@102166@102166@deletion@1@102219874@102220244@7@chr7:102219874-102220244@8.17@40@2@0.05@CNVR3518.1@ENST00000379336_1, RASA4-001_21@63@63@63@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
D62925@102192@102193@deletion@2@102279572@102279647@7@chr7:102279572-102279647@6.98@251@156@0.622@CNVR3518.1@ENST00000340457_4, POLR2J2-001_7@76.5@76@77@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
D62925@102231@102231@duplication@1@102412858@102412898@7@chr7:102412858-102412898@6.61@216@318@1.47@NA@FAM185A-201_6@0@0@0@:family with sequence similarity 185, member A@:cytoplasm@NA
D62925@104579@104579@deletion@1@134221805@134221910@7@chr7:134221805-134221910@6.56@91@42@0.462@NA@AKR1B10-001_6@2@2@2@:aldo-keto reductase family 1, member B10 (aldose reductase)@:steroid metabolic process;cellular aldehyde metabolic process;indanol dehydrogenase activity;daunorubicin metabolic process;retinal dehydrogenase activity;farnesol catabolic process;geranylgeranyl reductase activity;protein binding;extracellular region;aldo-keto reductase (NADP) activity;digestion;doxorubicin metabolic process;cellular_component;lysosome@NA
D62925@105315@105315@duplication@1@141760113@141760174@7@chr7:141760113-141760174@6.1@140@216@1.54@CNVR3585.3, CNVR3585.2@MGAM-007_34@8@8@8@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
D62925@105319@105335@duplication@17@141765137@141784445@7@chr7:141765137-141784445@34.3@1841@2501@1.36@CNVR3585.3, CNVR3585.2@MGAM-007_38, MGAM-007_39, MGAM-007_40, MGAM-007_41, MGAM-007_42, MGAM-007_43, MGAM-007_44, MGAM-007_45, MGAM-007_46, MGAM-007_47, MGAM-007_48, MGAM-007_49, MGAM-007_50, MGAM-007_51, MGAM-007_52, MGAM-007_53, MGAM-007_54@112.823529411765@38@125@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
D62925@105338@105338@deletion@1@141786457@141786518@7@chr7:141786457-141786518@10.7@50@1@0.02@CNVR3585.3, CNVR3585.2, CNVR3585.1, CNVR3585.4@MGAM-007_57@134@134@134@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
D62925@105519@105523@deletion@5@142458408@142482417@7@chr7:142458408-142482417@15.7@910@607@0.667@NA@PRSS1-204_2, PRSS1-204_3, PRSS1-204_4, PRSS1-204_5, PRSS1-204_6@70.8@5@115@:protease, serine, 1 (trypsin 1)@:extracellular matrix organization;catalytic activity;extracellular matrix disassembly;proteolysis;extracellular space;extracellular region;digestion;metal ion binding;serine-type endopeptidase activity@: PANCREATITIS, HEREDITARY; PCTT
D62925@105785@105801@deletion@17@143969540@143979628@7@chr7:143969540-143979628@26@624@350@0.561@CNVR3598.4, CNVR3598.9@RP4-798C17-001_4, RP4-798C17-001_5, RP4-798C17-001_6, RP4-798C17-001_7, RP4-798C17-001_8, RP4-798C17-001_9, RP4-798C17-001_10, RP4-798C17-001_11, RP4-798C17-001_12, ENST00000378112_5, ENST00000378112_6, ENST00000378112_7, ENST00000378112_8, ENST00000378112_9, ENST00000378112_10, ENST00000378112_11, ENST00000378112_12@88.5294117647059@37@137@:Rho guanine nucleotide exchange factor (GEF) 35@NA@NA
D62925@105819@105826@deletion@8@144059753@144069851@7@chr7:144059753-144069851@10.4@509@339@0.666@CNVR3598.4, CNVR3598.5, CNVR3598.11@ARHGEF5-001_2, ARHGEF5-001_3, ARHGEF5-001_4, ARHGEF5-001_5, ARHGEF5-001_6, ARHGEF5-001_7, ARHGEF5-001_8, ARHGEF5-001_9@77.875@65@104@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
D62925@107428@107435@duplication@8@7308087@7343923@8@chr8:7308087-7343923@20.8@619@923@1.49@CNVR3771.8, CNVR3771.10, CNVR3771.4@SPAG11-003_1, SPAG11-003_2, SPAG11-003_3, SPAG11-003_4, DEFB104B-001_1, DEFB104B-001_2, DEFB106B-001_1, DEFB106B-001_2@32.875@7@91@:sperm associated antigen 11B:defensin, beta 104A;defensin, beta 104B:defensin, beta 106B;defensin, beta 106A@:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
D62925@121600@121605@duplication@6@117085338@117088756@9@chr9:117085338-117088756@164@1283@3893@3.03@CNVR4448.1@ORM1-001_1, ORM1-001_2, ORM1-001_3, ORM1-001_4, ORM1-001_5, ORM1-001_6@81.6666666666667@52@90@:orosomucoid 1@:protein binding;extracellular space;regulation of immune system process;transport;inflammatory response;extracellular region;acute-phase response@NA
D62925@124047@124052@duplication@6@135957928@135960431@9@chr9:135957928-135960431@17.1@89@211@2.37@NA@CELP-002_1, CELP-002_2, CELP-002_3, AL162417-201_1, AL162417-201_2, AL162417-201_3@84.3333333333333@66@99@NA@NA@NA
D62925@124517@124517@deletion@1@138441156@138441178@9@chr9:138441156-138441178@5.13@66@30@0.455@CNVR4529.1@OBP2A-001_6@18@18@18@:odorant binding protein 2A@:odorant binding;sensory perception of chemical stimulus;response to stimulus;transport;extracellular region;sensory perception of smell;cellular_component@NA
D62925@126908@126918@duplication@11@17837922@17898363@10@chr10:17837922-17898363@34.6@523@877@1.68@NA@FAM23A-201_4, FAM23A-201_5, MRC1L1-001_1, MRC1L1-001_2, MRC1L1-001_3, MRC1L1-001_4, MRC1L1-001_5, MRC1L1-001_6, MRC1L1-001_7, MRC1L1-001_8, MRC1L1-001_9@19.6363636363636@5@108@:transmembrane protein 236;transmembrane protein 236-like:macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding@NA
D62925@126937@126938@duplication@2@17949552@17951364@10@chr10:17949552-17951364@6.9@102@167@1.64@NA@MRC1L1-001_28, MRC1L1-001_29@6@5@7@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
D62925@126941@126975@deletion@35@18060294@18198277@10@chr10:18060294-18198277@56.5@349@63@0.181@NA@FAM23B-202_2, FAM23B-202_3, FAM23B-202_4, FAM23B-202_5, MRC1-001_1, MRC1-001_2, MRC1-001_3, MRC1-001_4, MRC1-001_5, MRC1-001_6, MRC1-001_7, MRC1-001_8, MRC1-001_9, MRC1-001_10, MRC1-001_11, MRC1-001_12, MRC1-001_13, MRC1-001_14, MRC1-001_15, MRC1-001_16, MRC1-001_17, MRC1-001_18, MRC1-001_19, MRC1-001_20, MRC1-001_21, MRC1-001_22, MRC1-001_23, MRC1-001_24, MRC1-001_25, MRC1-001_26, MRC1-001_27, MRC1-001_28, MRC1-001_29, RP11-457D2-001_1, RP11-457D2-001_2@26.0285714285714@3@107@:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D62925@128731@128745@deletion@15@46242050@46272874@10@chr10:46242050-46272874@15.4@442@254@0.575@NA@FAM21C-203_8, FAM21C-203_9, FAM21C-203_10, FAM21C-203_11, FAM21C-203_12, FAM21C-203_13, FAM21C-203_14, FAM21C-203_15, FAM21C-203_16, FAM21C-203_17, FAM21C-203_18, FAM21C-203_19, FAM21C-203_20, FAM21C-203_21, FAM21C-203_22@3.2@0@25@:family with sequence similarity 21, member C@:endosome;protein binding;plasma membrane;retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
D62925@128825@128829@deletion@5@46918171@46934899@10@chr10:46918171-46934899@16.8@113@26@0.23@CNVR4712.9, CNVR4712.2, CNVR4712.7@FAM35B-001_3, FAM35B-001_4, FAM35B-001_5, FAM35B-001_6, FAM35B-001_7@53.6@34@72@NA@NA@NA
D62925@128913@128913@duplication@1@47409855@47410082@10@chr10:47409855-47410082@7.02@77@142@1.84@CNVR4712.9, CNVR4712.1@FAM35B2-201_6@47@47@47@NA@NA@NA
D62925@128920@128930@duplication@11@47605129@47634845@10@chr10:47605129-47634845@20.8@551@827@1.5@CNVR4713.1@ENST00000423803_7, ENST00000423803_8, ENST00000423803_9, ENST00000423803_10, ENST00000423803_11, ENST00000423803_12, ENST00000423803_13, ENST00000423803_14, ENST00000454837_2, ENST00000454837_3, ENST00000454837_4@22.8181818181818@21@25@NA@NA@NA
D62925@128979@128979@deletion@1@47758848@47758905@10@chr10:47758848-47758905@5.52@25@0@0@CNVR4714.1@ANXA8L2-001_10@154@154@154@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:calcium-dependent phospholipid binding;calcium ion binding@NA
D62925@129460@129463@deletion@4@51361725@51363788@10@chr10:51361725-51363788@54.2@256@2@0.00781@NA@ENST00000404618_3, ENST00000404618_4, ENST00000432221_3, ENST00000432221_4@132@121@142@NA@NA@NA
D62925@129468@129477@deletion@10@51371409@51391568@10@chr10:51371409-51391568@11.7@77@17@0.221@NA@TIMM23B-202_1, TIMM23B-202_2, TIMM23B-202_3, TIMM23B-202_4, TIMM23B-202_5, TIMM23B-202_6, TIMM23B-202_7, TIMM23B-202_8, TIMM23B-202_9, TIMM23B-202_10@24.8@0@119@:translocase of inner mitochondrial membrane 23 homolog B (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process@NA
D62925@129509@129511@duplication@3@51603186@51603447@10@chr10:51603186-51603447@6.2@62@114@1.84@NA@TIMM23-202_8, TIMM23-202_9, TIMM23-202_10@0@0@0@:translocase of inner mitochondrial membrane 23 homolog B (yeast):translocase of inner mitochondrial membrane 23 homolog B (yeast);translocase of inner mitochondrial membrane 23 homolog (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process:mitochondrion;mitochondrial inner membrane;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;mitochondrial intermembrane space;integral to mitochondrial inner membrane;intracellular protein transport;protein binding;integral to membrane;cellular protein metabolic process;protein targeting to mitochondrion@NA
D62925@129572@129586@deletion@15@51847037@51877819@10@chr10:51847037-51877819@9.62@43@0@0@NA@FAM21A-005_8, FAM21A-005_9, FAM21A-005_10, FAM21A-005_11, FAM21A-005_12, FAM21A-005_13, FAM21A-005_14, FAM21A-005_15, FAM21A-005_16, FAM21A-005_17, FAM21A-005_18, FAM21A-005_19, FAM21A-005_20, FAM21A-005_21, FAM21A-005_22@105.933333333333@93@123@:family with sequence similarity 21, member B;family with sequence similarity 21, member A@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
D62925@129605@129609@deletion@5@51970585@51978391@10@chr10:51970585-51978391@12.3@153@73@0.477@NA@ASAH2-201_7, ASAH2-201_8, ASAH2-201_9, ASAH2-201_10, ASAH2-201_11@181.2@176@186@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
D62925@131595@131601@deletion@7@81462985@81472508@10@chr10:81462985-81472508@8.17@40@2@0.05@CNVR4815.2, CNVR4815.4@FAM22B-201_1, FAM22B-201_2, FAM22B-201_3, FAM22B-201_4, FAM22B-201_5, FAM22B-201_6, FAM22B-201_7@87.2857142857143@84@90@NA@NA@NA
D62925@136770@136771@duplication@2@135439428@135439811@10@chr10:135439428-135439811@8.12@238@358@1.5@CNVR4989.11, CNVR4989.4@FRG2B-202_2, FRG2B-202_3@18@7@29@:FSHD region gene 2 family, member B@:nucleus@NA
D62925@141187@141188@deletion@2@48600990@48601883@11@chr11:48600990-48601883@7.12@32@0@0@CNVR5165.1@AC134982-201_1, AC134982-201_2@128@128@128@NA@NA@NA
D62925@145976@145976@deletion@1@89793419@89793440@11@chr11:89793419-89793440@4.67@47@18@0.383@NA@ENST00000436580_5@82@82@82@:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;DNA binding;zinc ion binding@NA
D62925@150775@150776@duplication@2@9446260@9447115@12@chr12:9446260-9447115@9.75@133@227@1.71@NA@DDX11L8-201_2, DDX11L8-201_3@30@18@42@NA@NA@NA
D62925@150778@150782@deletion@5@9450373@9453843@12@chr12:9450373-9453843@8.28@176@101@0.574@NA@DDX11L8-201_5, DDX11L8-201_6, DDX11L8-201_7, DDX11L8-201_8, DDX11L8-201_9@66.6@55@78@NA@NA@NA
D62925@150785@150786@deletion@2@9456573@9456804@12@chr12:9456573-9456804@14.8@105@24@0.229@NA@DDX11L8-201_12, DDX11L8-201_13@85@83@87@NA@NA@NA
D62925@150825@150826@deletion@2@9590001@9590856@12@chr12:9590001-9590856@10.7@186@94@0.505@NA@DDX12-203_3, DDX12-203_4@25@21@29@NA@NA@NA
D62925@150829@150841@duplication@13@9684189@9707352@12@chr12:9684189-9707352@27.5@465@741@1.59@CNVR5429.1@AC006432-201_1, AC006432-201_2, AC006432-201_3, AC006432-201_4, AC006432-201_5, AC006432-201_6, AC006432-201_7, AC006432-201_8, AC006432-201_9, AC006432-201_10, AC006432-201_11, AC006432-201_12, AC006432-201_13@22.2307692307692@15@25@NA@NA@NA
D62925@151021@151022@duplication@2@11034818@11035298@12@chr12:11034818-11035298@7.09@113@184@1.63@NA@PRH1-201_3, PRH1-201_4@10@10@10@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):proline-rich protein HaeIII subfamily 1@:extracellular space;visual perception:protein binding;extracellular space@NA
D62925@161726@161729@duplication@4@19949125@19955492@13@chr13:19949125-19955492@6.2@145@216@1.49@NA@ENST00000446672_10, ENST00000446672_11, ENST00000446672_12, ENST00000446672_13@0@0@0@NA@NA@NA
D62925@162228@162229@duplication@2@25169929@25169998@13@chr13:25169929-25169998@6.44@46@96@2.09@CNVR5826.1@RP11-556N21-001_9, ENST00000453498_11@65@65@65@NA@NA@NA
D62925@162314@162314@deletion@1@25528913@25529008@13@chr13:25528913-25529008@8.23@67@20@0.299@NA@TPTE2P1-001_5@2@2@2@NA@NA@NA
D62925@164459@164470@duplication@12@52803463@52832726@13@chr13:52803463-52832726@10.9@121@214@1.77@NA@THSD1P-203_17, THSD1P-203_18, THSD1P-203_19, THSD1P-203_20, THSD1P-203_21, THSD1P-203_22, ENST00000403471_8, ENST00000403471_9, ENST00000403471_10, ENST00000403471_11, ENST00000403471_12, ENST00000403471_13@19@6@28@NA@NA@NA
D62925@166746@166759@deletion@14@20019702@20147678@14@chr14:20019702-20147678@30.7@1562@1007@0.645@CNVR6072.6, CNVR6072.12, CNVR6072.14@AL589182-203_1, AL929601-201_1, AL929601-201_2, AL929601-201_3, AL929601-201_4, AL512310-201_1, AL512310-201_2, AL512310-201_3, AL512310-201_4, AL512310-201_5, ENST00000398231_1, ENST00000398231_2, ENST00000398231_3, ENST00000398231_4@89.2142857142857@58@102@:POTE ankyrin domain family, member M@:protein binding@NA
D62925@167216@167224@deletion@9@22600701@22671263@14@chr14:22600701-22671263@14.3@1220@847@0.694@NA@ENST00000390456_2, ENST00000390457_1, ENST00000390457_2, ENST00000390458_1, ENST00000390458_2, ENST00000390459_1, ENST00000390459_2, ENST00000390460_1, ENST00000390460_2@2.77777777777778@2@3@@:protein binding:protein binding:protein binding:protein binding:protein binding@NA
D62925@167232@167252@deletion@21@22739856@22938607@14@chr14:22739856-22938607@75.1@3922@2544@0.649@NA@TRAC-204_1, TRAC-204_2, AE000661-201_1, AE000661-201_2, ENST00000390465_1, ENST00000390465_2, ENST00000390466_1, ENST00000390466_2, ENST00000390467_1, ENST00000390467_2, ENST00000390468_1, ENST00000390468_2, ENST00000390469_1, ENST00000390469_2, ENST00000499790_1, ENST00000499790_2, ENST00000390477_1, ENST00000390477_2, ENST00000390477_3, ENST00000390478_1, ENST00000390478_2@5.33333333333333@4@7@@:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:integral to membrane:protein binding@NA
D62925@173501@173502@deletion@2@106478134@106478412@14@chr14:106478134-106478412@18@146@42@0.288@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV3-6-210_6, IGHV4-4-001_2@17@17@17@@:protein binding@NA
D62925@173512@173555@duplication@44@106559548@106781018@14@chr14:106559548-106781018@249@6276@9789@1.56@CNVR6294.48, CNVR6294.24, CNVR6294.40@IGHV2-10-001_1, IGHV2-10-001_2, IGHV3-11-001_1, IGHV3-11-001_2, IGHV1-12-001_1, IGHV1-12-001_2, IGHV3-13-001_1, IGHV3-13-001_2, IGHV3-15-001_1, IGHV3-15-001_2, IGHV3-16-001_1, IGHV3-16-001_2, IGHV1-17-001_1, IGHV1-17-001_2, IGHV1-18-001_1, IGHV1-18-001_2, IGHV3-20-001_1, IGHV3-20-001_2, IGHV3-21-001_1, IGHV3-21-001_2, IGHV3-22-001_1, IGHV3-22-001_2, AB019439-201_1, AB019439-201_2, IGHVIII-22-2-201_1, IGHVIII-22-2-201_3, IGHV3-23-001_1, IGHV3-23-001_2, IGHV1-24-001_1, IGHV1-24-001_2, AB019439-002_1, AB019439-002_2, IGHV3-25-001_1, IGHV3-25-001_2, IGHV2-26-001_1, IGHV2-26-001_2, IGHV7-27-001_1, IGHV7-27-001_2, IGHV4-28-001_1, IGHV4-28-001_2@3.925@1@22@:uncharacterized LOC100653243;uncharacterized LOC642131@:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding@NA
D62925@173562@173567@deletion@6@106805211@106816254@14@chr14:106805211-106816254@16.4@541@326@0.603@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.41@IGHV4-31-001_1, IGHV4-31-001_2, IGHV3-32-001_1, IGHV3-32-001_2, IGHV3-33-001_1, IGHV3-33-001_2@14.6666666666667@5@18@@:protein binding:protein binding@NA
D62925@173590@173591@deletion@2@106899046@106899494@14@chr14:106899046-106899494@11.2@170@81@0.476@CNVR6294.26, CNVR6294.56, CNVR6294.18@IGHV3-41-001_1, IGHV3-41-001_2@10.5@10@11@NA@NA@NA
D62925@173651@173652@duplication@2@107178822@107179339@14@chr14:107178822-107179339@7.77@450@613@1.36@CNVR6294.6, CNVR6294.92@IGHV2-70-001_1, IGHV2-70-001_2@4.5@4@5@@:protein binding@NA
D62925@173697@173698@deletion@2@20588370@20588710@15@chr15:20588370-20588710@14@516@312@0.605@CNVR6295.15, CNVR6295.7, CNVR6295.3, CNVR6295.10, CNVR6295.5@HERC2P3-014_27, AC026495-201_26@70@63@77@NA@NA@NA
D62925@173729@173734@deletion@6@20662560@20663213@15@chr15:20662560-20663213@11.3@467@298@0.638@CNVR6295.15@HERC2P3-014_9, HERC2P3-014_10, HERC2P3-014_11, AC026495-201_8, AC026495-201_9, AC026495-201_10@97.1666666666667@91@106@NA@NA@NA
D62925@176432@176433@duplication@2@44002591@44002976@15@chr15:44002591-44002976@10.1@150@255@1.7@NA@AC011330-201_13, AC011330-201_14@28@16@40@:stereocilin@:detection of mechanical stimulus involved in sensory perception of sound;stereocilium bundle tip;stereocilium;cell surface;kinocilium;auditory receptor cell stereocilium organization@: DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16; DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY
D62925@179308@179310@deletion@3@72954595@72956853@15@chr15:72954595-72956853@7.08@32@0@0@CNVR6443.1@GOLGA6-001_11, GOLGA6-001_12, GOLGA6-001_13@96.6666666666667@95@99@:golgin A6 family, member B@:Golgi apparatus@NA
D62925@180187@180188@deletion@2@79065427@79066643@15@chr15:79065427-79066643@7.21@37@3@0.0811@NA@ADAMTS7-201_13, ADAMTS7-201_14@5@0@10@:A disintegrin and metalloproteinase with thrombospondin motifs 7-like;ADAM metallopeptidase with thrombospondin type 1 motif, 7@:metallopeptidase activity;extracellular matrix;proteolysis;peptidase activity;proteinaceous extracellular matrix;metalloendopeptidase activity;cell surface;zinc ion binding@NA
D62925@183378@183378@duplication@1@2672693@2672767@16@chr16:2672693-2672767@7.51@61@125@2.05@CNVR6602.2@AC141586-201_6@57@57@57@NA@NA@NA
D62925@185587@185587@deletion@1@21742160@21742252@16@chr16:21742160-21742252@18.4@135@30@0.222@CNVR6668.5, CNVR6668.2, CNVR6668.7@OTOA-001_20@10@10@10@:otoancorin@:proteinaceous extracellular matrix;apical plasma membrane;sensory perception of sound;anchored to membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22
D62925@185593@185598@deletion@6@21764350@21809180@16@chr16:21764350-21809180@9.54@284@171@0.602@CNVR6668.5, CNVR6668.2, CNVR6668.7@OTOA-001_26, OTOA-001_27, OTOA-001_28, AC092375-201_5, AC092375-201_6, AC092375-201_7@17.5@3@62@:otoancorin@:proteinaceous extracellular matrix;apical plasma membrane;sensory perception of sound;anchored to membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22
D62925@186302@186303@deletion@2@28425026@28426458@16@chr16:28425026-28426458@6.25@106@55@0.519@CNVR6684.2, CNVR6684.3, CNVR6684.1@AC138894-201_1, AC138894-201_2@25.5@22@29@NA@NA@NA
D62925@187527@187528@deletion@2@32936755@32937067@16@chr16:32936755-32937067@6.97@50@13@0.26@CNVR6702.1@ENST00000423205_4, ENST00000423205_5@26.5@19@34@NA@NA@NA
D62925@188261@188261@deletion@1@55866918@55867076@16@chr16:55866918-55867076@15.8@76@2@0.0263@NA@CES1-203_1@10@10@10@:carboxylesterase 1;liver carboxylesterase 1-like@:hydrolase activity;methyl salicylate esterase activity;response to toxin;methylumbelliferyl-acetate deacetylase activity;endoplasmic reticulum lumen;retinyl-palmitate esterase activity;methyl jasmonate esterase activity;metabolic process;carboxylesterase activity;methyl indole-3-acetate esterase activity@: CARBOXYLESTERASE 1; CES1
D62925@189930@189931@deletion@2@70010214@70012016@16@chr16:70010214-70012016@12.1@57@1@0.0175@CNVR6762.3, CNVR6762.2@AC026468-201_7, AC026468-201_8@6.5@3@10@NA@NA@NA
D62925@189957@189973@duplication@17@70154366@70195206@16@chr16:70154366-70195206@84.1@4463@6323@1.42@CNVR6764.1, CNVR6764.3@AC009060-202_3, AC009060-202_4, AC009060-202_5, AC009060-202_6, AC009060-202_7, AC009060-202_8, AC009060-202_9, AC009060-202_10, AC009060-202_11, AC009060-202_12, AC009060-202_13, AC009060-202_14, AC009060-202_15, AC009060-202_16, AC009060-202_17, AC009060-202_18, AC009060-202_19, AC009060-201_3, AC009060-201_4, AC009060-201_5@71.5882352941177@65@77@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
D62925@189989@189989@deletion@1@70219790@70219880@16@chr16:70219790-70219880@9.3@59@11@0.186@CNVR6764.1, CNVR6764.5@CLEC18C-201_11@19@19@19@:C-type lectin domain family 18, member C@:carbohydrate binding;protein binding;extracellular region@NA
D62925@190431@190432@deletion@2@72092155@72093088@16@chr16:72092155-72093088@6.6@200@121@0.605@CNVR6769.1, CNVR6769.2@HP-201_5, HP-201_6@21.5@17@26@:thioredoxin-like 4B:haptoglobin:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:cellular iron ion homeostasis;negative regulation of oxidoreductase activity;catalytic activity;negative regulation of hydrogen peroxide catabolic process;positive regulation of cell death;haptoglobin-hemoglobin complex;extracellular space;proteolysis;response to hydrogen peroxide;extracellular region;hemoglobin binding;defense response;serine-type endopeptidase activity:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@: ANHAPTOGLOBINEMIA; AHP
D62925@190530@190549@duplication@20@74394533@74452197@16@chr16:74394533-74452197@33.4@812@1243@1.53@CNVR6778.2@AC009053-202_1, AC009053-202_2, NPIPL2-202_1, NPIPL2-202_2, NPIPL2-202_3, NPIPL2-202_4, NPIPL2-202_5, NPIPL2-202_6, NPIPL2-202_7, CLEC18B-202_3, CLEC18B-202_4, CLEC18B-202_5, CLEC18B-202_6, CLEC18B-202_7, CLEC18B-202_8, CLEC18B-202_9, CLEC18B-202_10, CLEC18B-202_11, CLEC18B-202_12, CLEC18B-202_13@57.3@46@63@:C-type lectin domain family 18, member B@:extracellular region:carbohydrate binding;protein binding;extracellular region@NA
D62925@195003@195004@deletion@2@15498064@15498205@17@chr17:15498064-15498205@5.66@132@76@0.576@NA@CDRT1-201_10, TRIM16-202_19@6@6@6@:CMT1A duplicated region transcript 1@:protein binding;molecular_function;cellular_component;biological_process:protein binding;intracellular;zinc ion binding;cytoplasm@NA
D62925@195017@195018@deletion@2@15517149@15517348@17@chr17:15517149-15517348@20.9@306@138@0.451@NA@CDRT1-201_3, TRIM16-202_12@38@38@38@:CMT1A duplicated region transcript 1@:protein binding;molecular_function;cellular_component;biological_process:protein binding;intracellular;zinc ion binding;cytoplasm@NA
D62925@195785@195785@deletion@1@18585519@18585573@17@chr17:18585519-18585573@5.54@37@8@0.216@NA@FOXO3B-201_1@30@30@30@:zinc finger protein 286B@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding@NA
D62925@195870@195871@duplication@2@18996289@18996940@17@chr17:18996289-18996940@6.6@177@266@1.5@CNVR7018.4, CNVR7018.2, CNVR7018.6@AC007952-202_1, AC007952-202_2@92.5@92@93@NA@NA@NA
D62925@197728@197728@deletion@1@34539901@34539966@17@chr17:34539901-34539966@13.3@61@0@0@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1-202_4@122@122@122@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
D62925@198654@198657@deletion@4@38565640@38566315@17@chr17:38565640-38566315@6.74@103@52@0.505@NA@TOP2A-204_10, TOP2A-204_11, TOP2A-204_12, TOP2A-204_13@0@0@0@:topoisomerase (DNA) II alpha 170kDa@:DNA topoisomerase complex (ATP-hydrolyzing);nucleoplasm;positive regulation of viral genome replication;mitotic cell cycle;sequence-specific DNA binding;ATP binding;positive regulation of retroviral genome replication;condensed chromosome;DNA repair;protein C-terminus binding;nucleus;DNA-dependent DNA replication;viral integration complex;embryonic cleavage;DNA topoisomerase (ATP-hydrolyzing) activity;enzyme binding;mitotic cell cycle G2/M transition decatenation checkpoint;chromatin binding;synaptonemal complex;mitotic recombination;apoptotic chromosome condensation;nucleolus;structure-specific DNA binding;DNA replication;response to parathyroid hormone stimulus;sister chromatid segregation;nuclear chromosome;aging;chromosome segregation;response to drug;chromosome condensation;DNA binding;ubiquitin binding;protein kinase C binding;histone deacetylase binding;DNA topological change;chromosome;DNA-dependent ATPase activity;DNA ligation;protein homodimerization activity;phosphatidylinositol-mediated signaling;positive regulation of transcription from RNA polymerase II promoter;drug binding;centriole;protein heterodimerization activity;response to DNA damage stimulus;protein complex;protein binding;resolution of meiotic recombination intermediates;positive regulation of apoptotic process@NA
D62925@200337@200349@deletion@13@44399690@44592688@17@chr17:44399690-44592688@22.2@154@40@0.26@CNVR7114.2, CNVR7114.1@LRRC37A-001_7, LRRC37A-001_8, LRRC37A-001_9, LRRC37A-001_10, LRRC37A-001_11, LRRC37A-001_12, LRRC37A-001_13, LRRC37A-001_14, LRRC37A-001_15, AC005829-202_1, AC005829-202_2, AC005829-202_3, LRRC37A2-201_1@149.230769230769@114@196@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane@NA
D62925@213493@213494@deletion@2@14508472@14508748@19@chr19:14508472-14508748@7.2@79@33@0.418@NA@CD97-205_8, CD97-205_9@10.5@7@14@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
D62925@215928@215928@deletion@1@35862253@35863856@19@chr19:35862253-35863856@20.8@160@37@0.231@CNVR7627.1@FFAR3-001_2@102@102@102@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
D62925@217293@217297@duplication@5@40373947@40382827@19@chr19:40373947-40382827@8.57@265@377@1.42@CNVR7639.2@FCGBP-201_22, FCGBP-201_23, FCGBP-201_24, FCGBP-201_25, FCGBP-201_26@130.8@105@155@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D62925@217595@217595@duplication@1@41327389@41327534@19@chr19:41327389-41327534@9.25@61@137@2.25@NA@CYP2F1P-001_5@0@0@0@NA@NA@NA
D62925@218700@218748@duplication@49@45826081@45901598@19@chr19:45826081-45901598@223@6177@9209@1.49@NA@CKM-201_1, KLC3-001_1, KLC3-001_2, KLC3-001_3, KLC3-001_4, KLC3-001_5, KLC3-001_6, KLC3-001_7, KLC3-001_8, KLC3-001_9, KLC3-001_10, KLC3-001_11, KLC3-001_12, KLC3-001_13, ERCC2-001_1, ERCC2-001_2, ERCC2-001_3, ERCC2-001_4, ERCC2-001_5, ERCC2-001_6, ERCC2-001_7, ERCC2-001_8, ERCC2-001_9, ERCC2-001_10, ERCC2-001_11, ERCC2-001_12, ERCC2-001_13, ERCC2-001_14, ERCC2-001_15, ERCC2-001_16, ERCC2-001_17, ERCC2-001_18, ERCC2-001_19, ERCC2-001_20, ERCC2-001_21, ERCC2-001_22, ERCC2-001_23, PPP1R13L-204_2, PPP1R13L-204_3, PPP1R13L-204_4, PPP1R13L-204_5, PPP1R13L-204_6, PPP1R13L-204_7, PPP1R13L-204_8, PPP1R13L-204_9, PPP1R13L-204_10, PPP1R13L-204_11, PPP1R13L-204_12, PPP1R13L-204_13@0.387755102040816@0@3@:creatine kinase, muscle:kinesin light chain 3:excision repair cross-complementing rodent repair deficiency, complementation group 2:protein phosphatase 1, regulatory subunit 13 like@:phosphocreatine biosynthetic process;small molecule metabolic process;creatine metabolic process;creatine kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;cytosol;cellular nitrogen compound metabolic process;kinase activity:microtubule binding;kinesin complex;microtubule motor activity;cardiolipin synthase activity;kinesin binding;cytoplasm;neuron projection;protein binding;microtubule-based flagellum;ciliary rootlet;microtubule:nucleoplasm;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;nucleotide-excision repair, DNA damage removal;transcription from RNA polymerase I promoter;SSL2-core TFIIH complex;ATP-dependent DNA helicase activity;RNA polymerase II carboxy-terminal domain kinase activity;nucleus;spindle;post-embryonic development;hydrolase activity, acting on acid anhydrides;spinal cord development;protein kinase activity;in utero embryonic development;transcription from RNA polymerase II promoter;multicellular organism growth;positive regulation of transcription, DNA-dependent;transcription-coupled nucleotide-excision repair;aging;cyclin-dependent protein kinase activating kinase holoenzyme complex;MMXD complex;apoptotic process;positive regulation of transcription from RNA polymerase II promoter;central nervous system myelin formation;7-methylguanosine mRNA capping;transcription initiation from RNA polymerase I promoter;4 iron, 4 sulfur cluster binding;protein phosphorylation;extracellular matrix organization;cytoplasm;hair cycle process;cell proliferation;ATP-dependent helicase activity;metal ion binding;nucleic acid binding;positive regulation of viral transcription;negative regulation of apoptotic process;response to oxidative stress;hair follicle maturation;induction of apoptosis;ATP binding;DNA repair;hematopoietic stem cell differentiation;protein C-terminus binding;viral reproduction;cell cycle checkpoint;gene expression;skin development;transcription elongation from RNA polymerase I promoter;response to UV;embryonic cleavage;nucleotide-excision repair, DNA incision;holo TFIIH complex;nucleotide-excision repair;transcription elongation from RNA polymerase II promoter;hair cell differentiation;termination of RNA polymerase I transcription;chromosome segregation;positive regulation of DNA binding;nucleobase-containing compound metabolic process;erythrocyte maturation;DNA binding;DNA-dependent ATPase activity;bone mineralization;5'-3' DNA helicase activity;protein N-terminus binding;virus-host interaction;transcription initiation from RNA polymerase II promoter;UV protection;response to hypoxia;protein binding:post-embryonic development;hair cycle;cardiac right ventricle morphogenesis;cardiac muscle contraction;transcription corepressor activity;cytoplasm;embryonic camera-type eye development;protein binding;multicellular organism growth;negative regulation of transcription from RNA polymerase II promoter;nucleus;apoptotic process;multicellular organismal homeostasis;transcription, DNA-dependent;ventricular cardiac muscle tissue development;transcription factor binding@: TRICHOTHIODYSTROPHY, PHOTOSENSITIVE; TTDP; XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD; CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2
D62925@221173@221183@duplication@11@54733728@54746618@19@chr19:54733728-54746618@15.4@1288@1693@1.31@CNVR7721.3, CNVR7721.4, CNVR7721.1, CNVR7721.6@AC010492-001_2, LILRA6-002_1, LILRA6-002_2, LILRA6-002_3, LILRA6-002_4, LILRA6-002_5, LILRA6-002_6, LILRA6-002_7, LILRA6-002_8, LILRA6-002_9, LILRA6-002_10@56@44@77@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D62925@221436@221437@duplication@2@55349033@55351155@19@chr19:55349033-55351155@6.74@258@365@1.41@CNVR7725.1, CNVR7725.6@KIR2DS4-001_3, KIR2DS4-001_4@67.5@67@68@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
D62925@221439@221441@deletion@3@55358641@55360024@19@chr19:55358641-55360024@28.8@1162@667@0.574@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4-001_6, KIR2DS4-001_7, KIR2DS4-001_8@96.3333333333333@85@102@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
D62925@221820@221823@duplication@4@56273160@56283457@19@chr19:56273160-56283457@16.3@1082@1468@1.36@CNVR7734.1@RFPL4A-201_2, RFPL4A-201_3, ENST00000341750_1, ENST00000341750_2@38.75@33@47@:ret finger protein-like 4A;ret finger protein-like 4A-like:ret finger protein-like 4A-like@:protein binding;zinc ion binding:protein binding;zinc ion binding@NA
D62925@222068@222069@duplication@2@58003184@58003369@19@chr19:58003184-58003369@6.08@57@107@1.88@CNVR7748.1@ZNF419-202_5, ZNF419-202_6@0@0@0@:zinc finger protein 419@:intracellular;DNA binding;regulation of transcription, DNA-dependent;cytoplasm;nucleolus;nucleus;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding@NA
D62925@222594@222594@deletion@1@1895747@1896102@20@chr20:1895747-1896102@10.1@134@58@0.433@CNVR7764.2@SIRPA-201_3@34@34@34@:signal-regulatory protein alpha@:blood coagulation;protein binding;integral to membrane;SH3 domain binding;cell adhesion;plasma membrane;membrane;leukocyte migration@NA
D62925@224466@224467@deletion@2@26061802@26065122@20@chr20:26061802-26065122@6.45@199@121@0.608@CNVR7823.4, CNVR7823.3, CNVR7823.5, CNVR7823.1@C20orf91-201_4, C20orf91-201_5@46.5@33@60@NA@NA@NA
D62925@233470@233472@duplication@3@23241801@23241987@22@chr22:23241801-23241987@5.29@157@225@1.43@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11@D87015-202_1, BCRL4-001_4, BCRL4-001_5@0@0@0@NA@NA@NA
D62925@233586@233586@deletion@1@23964280@23964364@22@chr22:23964280-23964364@10.7@201@100@0.498@CNVR8112.1@C22orf43-001_4@3@3@3@:chromosome 22 open reading frame 43@NA@NA
D62925@233700@233708@deletion@9@24283261@24302569@22@chr22:24283261-24302569@19.6@130@30@0.231@CNVR8114.6, CNVR8114.10, CNVR8114.12, CNVR8114.13@ENST00000443377_2, ENST00000443377_3, ENST00000440099_1, ENST00000440099_2, ENST00000440099_3, GSTT2B-002_2, GSTT2B-002_3, GSTT2B-002_4, GSTT2B-002_5@74.6666666666667@56@125@:glutathione S-transferase theta 2B (gene/pseudogene);glutathione S-transferase theta 2@:protein binding;glutathione transferase activity;nucleus;transferase activity;cytoplasm@NA
D62925@233731@233754@duplication@24@24345655@24394850@22@chr22:24345655-24394850@62.1@1056@1715@1.62@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTTP1-001_1, GSTTP1-001_2, ENST00000421902_1, ENST00000421902_2, ENST00000448902_1, ENST00000448902_2, ENST00000448902_3, ENST00000448902_4, ENST00000448902_5, ENST00000329210_1, ENST00000329210_2, ENST00000329210_3, ENST00000329210_4, ENST00000439866_1, ENST00000439866_2, GSTT1-009_1, GSTT1-009_2, GSTT1-009_3, GSTT1-009_4, GSTT1-009_5, ENST00000439996_1, ENST00000439996_2, GSTTP2-001_4, GSTTP2-001_5@130.833333333333@109@149@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
D62925@236750@236757@duplication@8@42523451@42525939@22@chr22:42523451-42525939@50.4@922@1492@1.62@CNVR8168.1, CNVR8168.3, CNVR8168.2@CYP2D6-203_1, CYP2D6-203_2, CYP2D6-203_3, CYP2D6-203_4, CYP2D6-203_5, CYP2D6-203_6, CYP2D6-203_7, CYP2D6-203_8@25.875@16@30@:cytochrome P450, family 2, subfamily D, polypeptide 6@:oxidation-reduction process;mitochondrion;alkaloid catabolic process;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;drug catabolic process;endoplasmic reticulum membrane;response to organic substance;oxidative demethylation;endoplasmic reticulum;alkaloid metabolic process;negative regulation of binding;heme binding;xenobiotic metabolic process;dopamine metabolic process;steroid metabolic process;isoquinoline alkaloid metabolic process;arachidonic acid monooxygenase activity;arachidonic acid metabolic process;steroid 21-monooxygenase activity;negative regulation of cellular organofluorine metabolic process;oxidoreductase activity;monoterpenoid metabolic process;heterocycle metabolic process;drug binding;drug metabolic process;electron carrier activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;coumarin metabolic process@: DRUG METABOLISM, POOR, CYP2D6-RELATED
D83732@483@511@deletion@29@1385071@1431583@1@chr1:1385071-1431583@149@2336@1130@0.484@NA@ATAD3C-202_1, ATAD3C-202_2, ATAD3C-202_3, ATAD3C-202_4, ATAD3C-202_5, ATAD3C-202_6, ATAD3C-202_7, ATAD3C-202_8, ATAD3C-202_9, ATAD3C-202_10, ATAD3C-202_11, ATAD3C-202_12, ATAD3C-202_13, ATAD3B-001_1, ATAD3B-001_2, ATAD3B-001_3, ATAD3B-001_4, ATAD3B-001_5, ATAD3B-001_6, ATAD3B-001_7, ATAD3B-001_8, ATAD3B-001_9, ATAD3B-001_10, ATAD3B-001_11, ATAD3B-001_12, ATAD3B-001_13, ATAD3B-001_14, ATAD3B-001_15, ATAD3B-001_16@12.7931034482759@8@26@:ATPase family, AAA domain containing 3C:ATPase family, AAA domain containing 3B@:four-way junction helicase activity;DNA repair;nucleoside-triphosphatase activity;nucleotide binding;DNA recombination;ATP binding:nucleoside-triphosphatase activity;mitochondrial inner membrane;nucleotide binding;ATP binding@NA
D83732@593@593@deletion@1@1607505@1607639@1@chr1:1607505-1607639@6.95@33@1@0.0303@CNVR17.1@RP11-345P4-003_4@10@10@10@:solute carrier family 35, member E2B@:integral to membrane;membrane;transmembrane transport@NA
D83732@1596@1597@duplication@2@9322120@9331397@1@chr1:9322120-9331397@19.4@1032@1510@1.46@NA@H6PD-001_4, H6PD-001_5@1@1@1@:hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)@:carbohydrate binding;glucose-6-phosphate dehydrogenase activity;NADP metabolic process;oxidation-reduction process;mitochondrion;intracellular membrane-bounded organelle;NADP binding;carbohydrate metabolic process;endoplasmic reticulum lumen;cytoplasm;pentose-phosphate shunt;response to alcohol;glucose 1-dehydrogenase [NAD(P)] activity;6-phosphogluconolactonase activity;glucose metabolic process@: CORTISONE REDUCTASE DEFICIENCY 1; CORTRD1
D83732@3004@3017@deletion@14@17248447@17270778@1@chr1:17248447-17270778@17.7@1115@749@0.672@CNVR94.4, CNVR94.5@CROCC-201_1, CROCC-201_2, CROCC-201_3, CROCC-201_4, CROCC-201_5, CROCC-201_6, CROCC-201_7, CROCC-201_8, CROCC-201_9, CROCC-201_10, CROCC-201_11, CROCC-201_12, CROCC-201_13, CROCC-201_14@78.5@67@85@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
D83732@4452@4461@deletion@10@25611066@25655628@1@chr1:25611066-25655628@11.1@1071@746@0.697@CNVR116.1, CNVR116.2@RHD-202_2, RHD-202_3, RHD-202_4, RHD-202_5, RHD-202_6, RHD-202_7, RHD-202_8, RHD-202_9, RHD-202_10, RHD-202_11@123@113@128@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
D83732@5120@5121@duplication@2@28832494@28832597@1@chr1:28832494-28832597@5.85@180@258@1.43@NA@SNHG3-001_1, RCC1-203_1@1@1@1@:regulator of chromosome condensation 1@:condensed nuclear chromosome;nucleoplasm;Ran guanyl-nucleotide exchange factor activity;chromosome segregation;histone binding;spindle assembly;regulation of S phase of mitotic cell cycle;G1/S transition of mitotic cell cycle;nucleus;viral reproduction;cell division;nucleosomal DNA binding;nuclear chromatin;cytoplasm;nuclear membrane;mitotic spindle organization;chromatin binding;mitosis;protein binding;regulation of mitosis@NA
D83732@8261@8264@duplication@4@47691117@47695024@1@chr1:47691117-47695024@6.98@219@313@1.43@NA@TAL1-001_2, TAL1-001_3, ENST00000422216_1, ENST00000422216_2@0@0@0@:T-cell acute lymphocytic leukemia 1@:histone deacetylase complex;RNA polymerase II distal enhancer sequence-specific DNA binding;regulation of stem cell maintenance;positive regulation of erythrocyte differentiation;astrocyte fate commitment;hematopoietic stem cell differentiation;myeloid cell differentiation;neuron differentiation;nucleus;nuclear chromatin;transcription regulatory region sequence-specific DNA binding;enzyme binding;regulation of cell proliferation;transcription from RNA polymerase II promoter;megakaryocyte differentiation;chromatin binding;positive regulation of transcription, DNA-dependent;positive regulation of chromatin assembly or disassembly;positive regulation of mitotic cell cycle;hemopoiesis;positive regulation of cell division;locomotory behavior;sequence-specific DNA binding RNA polymerase II transcription factor activity;DNA binding;platelet formation;erythrocyte maturation;sequence-specific DNA binding transcription factor activity;positive regulation of protein complex assembly;histone deacetylase binding;spinal cord association neuron differentiation;embryonic hemopoiesis;transcription factor complex;erythrocyte differentiation;protein dimerization activity;cell fate commitment;positive regulation of transcription from RNA polymerase II promoter;megakaryocyte development;E-box binding;regulation of mast cell differentiation;regulation of myeloid cell differentiation;angiogenesis;RNA polymerase II transcription factor binding;hemangioblast cell differentiation;generation of neurons;protein heterodimerization activity;Lsd1/2 complex;regulation of transcription from RNA polymerase II promoter;protein complex;definitive hemopoiesis;protein binding;negative regulation of transcription from RNA polymerase II promoter;basophil differentiation;transcription regulatory region DNA binding@NA
D83732@11245@11246@deletion@2@89476589@89477711@1@chr1:89476589-89477711@7.41@554@373@0.673@CNVR244.1@GBP3-001_7, GBP3-001_8@54@54@54@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
D83732@12424@12425@duplication@2@104233918@104234233@1@chr1:104233918-104234233@5.45@37@79@2.14@CNVR266.3, CNVR266.5@AMY1B-001_7, AMY1B-001_8@154@154@154@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D83732@12445@12446@deletion@2@104297123@104297437@1@chr1:104297123-104297437@27.7@281@97@0.345@CNVR266.3, CNVR266.5@AMY1C-201_7, AMY1C-201_8@77@75@79@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D83732@12928@12936@deletion@9@110225831@110236368@1@chr1:110225831-110236368@125@577@0@0@CNVR299.6, CNVR299.4, CNVR299.5@GSTM2-203_9, GSTM1-001_1, GSTM1-001_2, GSTM1-001_3, GSTM1-001_4, GSTM1-001_5, GSTM1-001_6, GSTM1-001_7, GSTM1-001_8@173.555555555556@31@194@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
D83732@18672@18673@deletion@2@161559354@161561189@1@chr1:161559354-161561189@5.41@245@158@0.645@CNVR383.1@FCGR2C-006_3, FCGR2C-006_4@53@49@57@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
D83732@18690@18692@duplication@3@161642767@161644615@1@chr1:161642767-161644615@10.1@115@210@1.83@CNVR383.1@FCGR2B-207_5, FCGR2B-207_6, ENST00000453111_1@11.3333333333333@5@19@:Fc fragment of IgG, low affinity IIb, receptor (CD32)@:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
D83732@21362@21371@duplication@10@196743977@196796136@1@chr1:196743977-196796136@27.8@899@1295@1.44@CNVR459.1@CFHR3-001_1, CFHR3-001_2, CFHR3-001_3, CFHR3-001_4, CFHR3-001_5, CFHR3-001_6, CFHR1-001_1, CFHR1-001_2, CFHR1-001_3, CFHR2-201_1@94.6@85@112@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
D83732@21373@21374@duplication@2@196799632@196801320@1@chr1:196799632-196801320@10.4@471@659@1.4@CNVR459.1@CFHR1-001_5, CFHR1-001_6@96.5@96@97@:complement factor H-related 1:complement factor H-related 2@:extracellular space;complement activation:extracellular region@NA
D83732@24160@24169@deletion@10@223727670@223740201@1@chr1:223727670-223740201@15@93@18@0.194@NA@CAPN8-202_15, CAPN8-202_16, CAPN8-202_17, CAPN8-202_18, CAPN8-202_19, CAPN8-202_20, CAPN8-202_21, CAPN8-202_22, CAPN8-202_23, CAPN8-202_24@0@0@0@:calpain 8@:proteolysis;Golgi apparatus;intracellular;calcium-dependent cysteine-type endopeptidase activity;calcium ion binding@NA
D83732@33520@33520@deletion@1@87239638@87241105@2@chr2:87239638-87241105@9.55@43@0@0@NA@RGPD1-001_23@110@110@110@:RANBP2-like and GRIP domain containing 1:plasminogen-like B1;plasminogen-like B2@:protein binding;intracellular;intracellular transport;protein targeting to Golgi:extracellular region@NA
D83732@33558@33565@duplication@8@87404273@87416182@2@chr2:87404273-87416182@8.12@397@536@1.35@CNVR861.2@AC083899-001_22, AC083899-001_23, AC083899-001_24, AC083899-001_25, AC083899-001_26, AC083899-001_27, AC083899-001_28, AC083899-001_29@61.25@21@85@NA@NA@NA
D83732@33599@33600@duplication@2@88055476@88056454@2@chr2:88055476-88056454@6.02@194@277@1.43@NA@PLGLB2-003_4, RGPD2-001_23@26@26@26@:plasminogen-like B1;plasminogen-like B2:RANBP2-like and GRIP domain containing 2@:extracellular region:protein binding;intracellular;intracellular transport;protein targeting to Golgi@NA
D83732@34094@34095@deletion@2@96458183@96458295@2@chr2:96458183-96458295@9.95@71@18@0.254@NA@AC008268-201_3, ENST00000444924_2@104@104@104@NA@NA@NA
D83732@34184@34184@duplication@1@96652842@96652955@2@chr2:96652842-96652955@8.35@152@248@1.63@NA@AC073995-001_2@4@4@4@:ankyrin repeat domain-containing protein 36A-like@:ion channel inhibitor activity;protein binding@NA
D83732@34540@34541@deletion@2@97818243@97820479@2@chr2:97818243-97820479@9.96@226@128@0.566@CNVR886.2@ENST00000461153_14, ENST00000461153_15@13@12@14@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
D83732@34565@34566@duplication@2@97867941@97868131@2@chr2:97867941-97868131@5.12@196@274@1.4@CNVR886.1@ENST00000461153_39, ENST00000461153_40@41@40@42@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
D83732@34620@34631@deletion@12@98152765@98162325@2@chr2:98152765-98162325@30.7@168@18@0.107@CNVR888.3@ANKRD36B-001_23, ANKRD36B-001_24, ANKRD36B-001_25, ANKRD36B-001_26, ANKRD36B-001_27, ANKRD36B-001_28, ANKRD36B-001_29, ANKRD36B-001_30, ANKRD36B-001_31, ANKRD36B-001_32, ANKRD36B-001_33, ANKRD36B-001_34@144.333333333333@121@154@NA@NA@NA
D83732@35218@35218@deletion@1@102967998@102968498@2@chr2:102967998-102968498@10.6@259@141@0.544@NA@IL1RL1-001_11@0@0@0@:interleukin 1 receptor-like 1:interleukin 18 receptor 1@:negative regulation of interferon-gamma production;immune response;interleukin-33 receptor activity;negative regulation of I-kappaB kinase/NF-kappaB cascade;positive regulation of macrophage activation;extracellular space;integral to membrane;interleukin-33 binding;cytokine-mediated signaling pathway;positive regulation of inflammatory response;positive regulation of interleukin-5 production;interleukin-1 receptor activity;negative regulation of T-helper 1 type immune response;intracellular;external side of plasma membrane;innate immune response;cytokine receptor activity;signal transduction;interleukin-33-mediated signaling pathway;protein binding;receptor signaling protein activity;positive regulation of chemokine secretion:immune response;interleukin-1 receptor activity;intracellular;innate immune response;signal transduction;protein binding;integral to membrane;plasma membrane;receptor activity@NA
D83732@37242@37242@deletion@1@130955933@130956035@2@chr2:130955933-130956035@7.4@35@1@0.0286@CNVR985.1@TUBA3E-001_1@27@27@27@:tubulin, alpha 3e@:GTPase activity;structural constituent of cytoskeleton;protein complex;GTP catabolic process;cytoplasm;microtubule cytoskeleton;protein polymerization;microtubule-based movement;structural molecule activity;cytoplasmic microtubule;GTP binding;microtubule;microtubule cytoskeleton organization;protein domain specific binding@NA
D83732@45386@45388@deletion@3@233272979@233273549@2@chr2:233272979-233273549@12.1@252@138@0.548@NA@ALPPL2-001_6, ALPPL2-001_7, ALPPL2-001_8@46.6666666666667@27@58@:alkaline phosphatase, placental-like 2@:phosphatase activity;catalytic activity;phosphorylation;plasma membrane;metabolic process;membrane;anchored to membrane;alkaline phosphatase activity;metal ion binding@NA
D83732@46353@46354@duplication@2@241631264@241631939@2@chr2:241631264-241631939@5.68@76@128@1.68@NA@AQP12A-201_1, AQP12A-201_2@27@25@29@:aquaporin 12A@:transport;integral to membrane;transporter activity;membrane@NA
D83732@46739@46741@deletion@3@242945880@242946622@2@chr2:242945880-242946622@7.18@122@64@0.525@CNVR1236.6@AC093642-201_2, AC093642-201_3, AC093642-201_4@4@4@4@NA@NA@NA
D83732@58729@58731@duplication@3@155481578@155493638@3@chr3:155481578-155493638@11.2@257@391@1.52@CNVR1590.1@C3orf33-003_5, C3orf33-003_6, C3orf33-003_7@0@0@0@:chromosome 3 open reading frame 33@:hydrolase activity, acting on ester bonds;integral to membrane;nucleic acid binding@NA
D83732@61531@61543@duplication@13@195345501@195385037@3@chr3:195345501-195385037@24.1@2188@2933@1.34@NA@ENST00000457750_2, AC233280-201_1, AC233280-201_2, AC233280-201_3, AC233280-201_4, AC233280-201_5, AC233280-201_6, AC233280-201_7, AC233280-201_8, AC069513-001_1, AC069513-001_2, AC069513-001_3, SDHALP2-001_1@82.8461538461538@56@93@:mucin 20, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane@NA
D83732@61549@61553@duplication@5@195395392@195403032@3@chr3:195395392-195403032@7.48@590@773@1.31@CNVR1703.1@SDHALP2-001_7, SDHALP2-001_8, SDHALP2-001_9, SDHALP2-001_10, ENST00000430928_4@68.8@53@75@:mucin 20, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane@NA
D83732@61567@61571@duplication@5@195447755@195464540@3@chr3:195447755-195464540@18.4@1738@2242@1.29@CNVR1703.1, CNVR1703.2, CNVR1703.5@MUC20-201_1, MUC20-201_2, MUC20-201_3, MUC20-201_4, MUC20-201_5@40.6@34@44@:mucin 20, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane@NA
D83732@61643@61654@duplication@12@195701270@195711148@3@chr3:195701270-195711148@21.3@1305@1735@1.33@CNVR1707.1, CNVR1707.2@SDHALP1-002_5, SDHALP1-002_6, SDHALP1-002_7, SDHALP1-002_8, SDHALP1-002_9, SDHALP1-002_10, ENST00000354937_7, ENST00000354937_8, ENST00000354937_9, ENST00000354937_10, ENST00000354937_11, ENST00000354937_12@33.3333333333333@18@44@NA@NA@NA
D83732@65315@65320@deletion@6@69402904@69434246@4@chr4:69402904-69434246@182@900@4@0.00444@CNVR1953.1@UGT2B17-001_1, UGT2B17-001_2, UGT2B17-001_3, UGT2B17-001_4, UGT2B17-001_5, UGT2B17-001_6@124.5@118@134@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
D83732@65355@65360@deletion@6@70146890@70160768@4@chr4:70146890-70160768@17.2@596@370@0.621@CNVR1957.2, CNVR1957.1@UGT2B28-201_2, UGT2B28-201_3, UGT2B28-201_4, UGT2B28-201_5, UGT2B28-201_6, UGT2B28-201_7@68.8333333333333@65@71@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
D83732@65799@65801@deletion@3@75312253@75316250@4@chr4:75312253-75316250@15.6@147@51@0.347@NA@AREG-001_2, AREG-001_3, AREG-001_4@36.3333333333333@28@52@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
D83732@65805@65807@duplication@3@75482008@75486007@4@chr4:75482008-75486007@10.3@102@192@1.88@NA@AREGB-201_2, AREGB-201_3, AREGB-201_4@50.3333333333333@45@56@:amphiregulin;amphiregulin B@:growth factor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;cell proliferation;epidermal growth factor receptor signaling pathway;extracellular space;protein binding;integral to membrane;cytokine activity;cell surface;positive regulation of DNA replication@NA
D83732@70827@70835@deletion@9@795876@825367@5@chr5:795876-825367@70.9@1764@979@0.555@CNVR2280.3@ZDHHC11-201_8, ZDHHC11-201_9, ZDHHC11-201_10, ZDHHC11-201_11, ZDHHC11-201_12, AC026740-202_1, AC026740-202_2, AC026740-202_3, AC026740-202_4@45.2222222222222@36@57@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
D83732@71898@71900@deletion@3@34190140@34193054@5@chr5:34190140-34193054@6.73@110@57@0.518@CNVR2430.2, CNVR2430.1, CNVR2430.3, CNVR2430.4@ENST00000502234_2, AC138409-201_1, AC138409-201_2, AC138409-201_3@47.3333333333333@45@49@NA@NA@NA
D83732@72598@72598@deletion@1@42629142@42629206@5@chr5:42629142-42629206@24.6@114@0@0@CNVR2445.1@GHR-001_3@16@16@16@:growth hormone receptor@:neuronal cell body;mitochondrion;proline-rich region binding;JAK-STAT cascade;growth factor binding;nucleus;succinate metabolic process;positive regulation of JAK-STAT cascade;JAK-STAT cascade involved in growth hormone signaling pathway;response to morphine;activation of MAPK activity;peptide hormone binding;response to estradiol stimulus;2-oxoglutarate metabolic process;valine metabolic process;response to cytokine stimulus;hormone-mediated signaling pathway;response to food;SH2 domain binding;oxaloacetate metabolic process;growth hormone receptor signaling pathway;allantoin metabolic process;integral to membrane;response to hormone stimulus;cartilage development involved in endochondral bone morphogenesis;positive regulation of peptidyl-tyrosine phosphorylation;receptor internalization;cytoplasm;cellular response to hormone stimulus;extracellular region;growth hormone receptor complex;positive regulation of tyrosine phosphorylation of Stat5 protein;regulation of multicellular organism growth;growth hormone receptor activity;positive regulation of tyrosine phosphorylation of Stat3 protein;response to peptide hormone stimulus;fatty acid metabolic process;creatinine metabolic process;plasma membrane;positive regulation of multicellular organism growth;receptor complex;protein phosphatase binding;protein kinase binding;creatine metabolic process;response to interleukin-1;response to cycloheximide;extracellular space;positive regulation of cell differentiation;activation of Janus kinase activity;taurine metabolic process;cellular response to insulin stimulus;integral to plasma membrane;protein homodimerization activity;negative regulation of neuron death;citrate metabolic process;endocytosis;isoleucine metabolic process;activation of JAK2 kinase activity;extrinsic to membrane;response to glucocorticoid stimulus;protein binding;insulin-like growth factor receptor signaling pathway;multicellular organismal metabolic process;cell surface@: HYPERCHOLESTEROLEMIA, FAMILIAL; LARON SYNDROME; SHORT STATURE, IDIOPATHIC, AUTOSOMAL
D83732@73727@73727@deletion@1@69717564@69717599@5@chr5:69717564-69717599@11.2@51@0@0@CNVR2494.17, CNVR2494.3@GTF2H2B-201_4@139@139@139@NA@NA@NA
D83732@73795@73796@duplication@2@70307104@70308746@5@chr5:70307104-70308746@9.79@589@822@1.4@CNVR2494.41, CNVR2494.14, CNVR2494.30, CNVR2494.20, CNVR2494.62, CNVR2494.8, CNVR2494.35@NAIP-001_4, NAIP-001_5@29.5@27@32@:baculoviral IAP repeat-containing protein 1-like;NLR family, apoptosis inhibitory protein@:negative regulation of apoptotic process;inflammatory response;basolateral plasma membrane;nucleoside-triphosphatase activity;cysteine-type endopeptidase inhibitor activity;intracellular;nucleotide binding;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;ATP binding;cytoplasm;innate immune response;protein binding;negative regulation of neuron apoptotic process;metal ion binding;nervous system development@NA
D83732@73817@73821@deletion@5@70370032@70389020@5@chr5:70370032-70389020@28.5@133@2@0.015@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.8, CNVR2494.1, CNVR2494.37@AC044797-201_1, AC044797-201_2, AC044797-201_3, AC044797-201_4, AC044797-201_5@120.4@100@138@NA@NA@NA
D83732@78044@78044@deletion@1@147553799@147553934@5@chr5:147553799-147553934@25.1@117@0@0@CNVR2637.2, CNVR2637.1@AC116334-001_3@78@78@78@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
D83732@79567@79568@duplication@2@175388056@175388438@5@chr5:175388056-175388438@12.7@65@160@2.46@NA@THOC3-001_4, THOC3-001_5@173.5@165@182@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
D83732@80561@80568@duplication@8@304630@367384@6@chr6:304630-367384@13.9@1895@2435@1.28@CNVR2728.1@DUSP22-001_2, DUSP22-001_3, DUSP22-001_4, DUSP22-001_5, DUSP22-001_6, DUSP22-001_7, DUSP22-001_8, AL357054-201_1@16.625@6@20@:dual specificity phosphatase 22;dual specificity protein phosphatase 22-like@:protein dephosphorylation;transforming growth factor beta receptor signaling pathway;positive regulation of JNK cascade;protein tyrosine/serine/threonine phosphatase activity;nucleus;apoptotic process;multicellular organismal development;phosphatase activity;protein tyrosine phosphatase activity;regulation of cell proliferation;cytoplasm;cell proliferation;inactivation of MAPK activity;protein binding;negative regulation of transcription from RNA polymerase II promoter;dephosphorylation@NA
D83732@83002@83003@duplication@2@31237745@31238263@6@chr6:31237745-31238263@14.4@314@493@1.57@CNVR2838.2, CNVR2838.1@HLA-C-006_4, HLA-C-006_5@25@25@25@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
D83732@83577@83617@deletion@41@31962024@31976177@6@chr6:31962024-31976177@142@1681@730@0.434@CNVR2843.6, CNVR2843.3@C4A-001_20, C4A-001_21, C4A-001_22, C4A-001_23, C4A-001_24, C4A-001_25, C4A-001_26, C4A-001_27, C4A-001_28, C4A-001_29, C4A-001_30, C4A-001_31, C4A-001_32, C4A-001_33, C4A-001_34, C4A-001_35, C4A-001_36, C4A-001_37, C4A-001_38, C4A-001_39, C4A-001_40, C4A-001_41, ENST00000458633_1, ENST00000458633_2, CYP21A1P-001_1, CYP21A1P-001_2, CYP21A1P-001_3, CYP21A1P-001_4, CYP21A1P-001_5, CYP21A1P-001_6, CYP21A1P-001_7, CYP21A1P-001_8, CYP21A1P-001_9, CYP21A1P-001_10, AL645922-201_1, AL645922-201_2, AL645922-201_3, AL645922-201_4, AL645922-201_5, AL645922-201_6, AL645922-201_7@48.1463414634146@2@121@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
D83732@83662@83663@duplication@2@32006501@32007026@6@chr6:32006501-32007026@5.19@96@149@1.55@CNVR2843.6, CNVR2843.5@CYP21A2-002_2, CYP21A2-002_3@16.5@15@18@:cytochrome P450, family 21, subfamily A, polypeptide 2@:oxidation-reduction process;electron carrier activity;response to antibiotic;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;steroid 21-monooxygenase activity;C21-steroid hormone biosynthetic process;heme binding;mineralocorticoid biosynthetic process;progesterone metabolic process;monooxygenase activity;cellular response to peptide hormone stimulus;iron ion binding@: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY
D83732@83910@83915@deletion@6@32441204@32489952@6@chr6:32441204-32489952@18.3@180@70@0.389@CNVR2845.21, CNVR2845.25, CNVR2845.30@HLA-DRB9-001_1, HLA-DRB5-001_2, HLA-DRB5-001_3, HLA-DRB5-001_4, HLA-DRB5-001_5, HLA-DRB5-001_6@160.833333333333@44@189@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D83732@83919@83927@deletion@9@32521635@32548048@6@chr6:32521635-32548048@17.7@248@119@0.48@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.5@HLA-DRB6-002_1, HLA-DRB6-002_2, HLA-DRB6-002_3, HLA-DRB6-002_4, AL713966-201_1, AL713966-201_2, AL713966-201_3, HLA-DRB1-001_5, HLA-DRB1-001_6@126.111111111111@85@167@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
D83732@83933@83946@deletion@14@32606691@32634448@6@chr6:32606691-32634448@90.6@972@389@0.4@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20@HLA-DQA1-002_2, HLA-DQA1-002_3, HLA-DQA1-002_4, HLA-DQA1-002_5, HLA-DQA1-002_6, HLA-DQB1-003_2, HLA-DQB1-003_3, HLA-DQB1-003_4, HLA-DQB1-003_5, HLA-DQB1-003_6, XXbac-BPG254F23-001_1, XXbac-BPG254F23-001_2, ENST00000443574_1, ENST00000443574_2@122.642857142857@80@146@:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
D83732@84706@84707@duplication@2@35754777@35755930@6@chr6:35754777-35755930@5.5@407@538@1.32@CNVR2861.1@C6orf127-001_2, C6orf127-001_3@41@40@42@:colipase-like 1@:extracellular region;enzyme activator activity;digestion;lipid catabolic process@NA
D83732@92593@92595@duplication@3@160132998@160133523@6@chr6:160132998-160133523@9.69@280@406@1.45@CNVR3127.2, CNVR3127.1@ENST00000442642_2, ENST00000442642_3, ENST00000442642_4@53@13@90@:superoxide dismutase 2, mitochondrial;uncharacterized LOC100129518@:response to reactive oxygen species;oxidation-reduction process;mitochondrion;negative regulation of cell proliferation;neuron development;negative regulation of fat cell differentiation;removal of superoxide radicals;response to gamma radiation;response to L-ascorbic acid;response to lipopolysaccharide;response to nutrient levels;response to zinc ion;protein homotetramerization;post-embryonic development;iron ion homeostasis;hemopoiesis;aging;mitochondrial inner membrane;age-dependent response to reactive oxygen species;response to drug;oxygen binding;mitochondrial nucleoid;vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure;apoptotic process;superoxide metabolic process;response to superoxide;detection of oxygen;response to silicon dioxide;cytoplasm;response to stress;respiratory electron transport chain;superoxide anion generation;protein homooligomerization;regulation of mitochondrial membrane potential;positive regulation of nitric oxide biosynthetic process;response to manganese ion;regulation of blood pressure;metal ion binding;negative regulation of apoptotic process;response to cadmium ion;response to oxidative stress;liver development;regulation of catalytic activity;negative regulation of fibroblast proliferation;response to selenium ion;age-dependent response to oxidative stress;response to electrical stimulus;mitochondrial matrix;identical protein binding;mitochondrion organization;response to hyperoxia;vasodilation;response to hydrogen peroxide;superoxide dismutase activity;heart development;negative regulation of neuron apoptotic process;erythrophore differentiation;locomotory behavior;DNA binding;release of cytochrome c from mitochondria;response to axon injury;oxygen homeostasis;response to activity;glutathione metabolic process;hydrogen peroxide metabolic process;hydrogen peroxide biosynthetic process;regulation of transcription from RNA polymerase II promoter;response to hypoxia;protein binding;manganese ion binding;cellular response to ethanol@: MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6; MVCD6
D83732@94211@94213@duplication@3@6005270@6007069@7@chr7:6005270-6007069@14@149@281@1.89@NA@RSPH10B-002_2, RSPH10B-002_3, RSPH10B-002_4@11@8@13@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D83732@94420@94421@deletion@2@6797226@6798791@7@chr7:6797226-6798791@13.1@251@126@0.502@NA@RSPH10B2-204_3, RSPH10B2-204_4@6.5@6@7@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D83732@94438@94441@duplication@4@6836201@6838911@7@chr7:6836201-6838911@12.1@229@358@1.56@NA@RSPH10B2-204_20, RSPH10B2-204_21, ENST00000429267_1, C7orf28B-001_15@70.75@25@117@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D83732@96581@96581@deletion@1@38393318@38393627@7@chr7:38393318-38393627@5.57@230@144@0.626@CNVR3354.3, CNVR3354.1@TRGV4-001_2@14@14@14@@:protein binding@NA
D83732@97907@97915@deletion@9@57063663@57076857@7@chr7:57063663-57076857@9.86@103@43@0.417@NA@TNRC18C-202_3, TNRC18C-202_4, TNRC18C-202_5, TNRC18C-202_6, TNRC18C-202_7, TNRC18C-202_8, TNRC18C-202_9, TNRC18C-202_10, TNRC18C-202_11@157.555555555556@139@166@NA@NA@NA
D83732@97993@97994@duplication@2@62758644@62758771@7@chr7:62758644-62758771@7.27@413@560@1.36@NA@AC006455-201_2, ENST00000444809_2@161@151@171@NA@NA@NA
D83732@98215@98215@deletion@1@65150574@65150717@7@chr7:65150574-65150717@7.93@40@3@0.075@NA@INTS4L2-001_5@56@56@56@NA@NA@NA
D83732@99031@99031@deletion@1@74167428@74167510@7@chr7:74167428-74167510@4.89@96@52@0.542@NA@GTF2I-001_29@35@35@35@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
D83732@99063@99063@deletion@1@74251404@74251506@7@chr7:74251404-74251506@6.18@28@0@0@NA@GTF2IRD2-002_2@8@8@8@:GTF2I repeat domain containing 2@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
D83732@99463@99465@duplication@3@76121472@76129838@7@chr7:76121472-76129838@6.52@79@136@1.72@CNVR3462.1@DTX2-001_6, DTX2-001_7, DTX2-001_8@51.3333333333333@22@69@:deltex homolog 2 (Drosophila)@:ligase activity;cytoplasm;nuclear membrane;Notch signaling pathway;protein binding;nucleus;zinc ion binding;protein ubiquitination@NA
D83732@99489@99490@duplication@2@76240773@76241131@7@chr7:76240773-76241131@11.1@255@390@1.53@CNVR3463.10@POMZP3-003_6, POMZP3-003_7@43.5@41@46@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
D83732@99544@99545@deletion@2@76723321@76728269@7@chr7:76723321-76728269@16.5@107@21@0.196@NA@ENST00000398321_6, ENST00000398321_7@13.5@11@16@NA@NA@NA
D83732@101721@101726@deletion@6@100331652@100336237@7@chr7:100331652-100336237@31.3@745@416@0.558@CNVR3509.1@ZAN-001_2, ZAN-001_3, ZAN-001_4, ZAN-001_5, ZAN-001_6, ZAN-001_7@81.6666666666667@71@89@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
D83732@102130@102130@deletion@1@102136589@102136652@7@chr7:102136589-102136652@5.95@155@89@0.574@CNVR3518.1@RASA4B-007_16@49@49@49@:RAS p21 protein activator 4B@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction@NA
D83732@102144@102145@duplication@2@102180464@102180539@7@chr7:102180464-102180539@17.8@154@308@2@CNVR3518.1@RASA4B-007_4, POLR2J3-003_7@96@96@96@:RAS p21 protein activator 4B:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
D83732@102166@102166@deletion@1@102219874@102220244@7@chr7:102219874-102220244@7.81@35@0@0@CNVR3518.1@ENST00000379336_1, RASA4-001_21@63@63@63@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
D83732@102192@102193@deletion@2@102279572@102279647@7@chr7:102279572-102279647@25.6@265@96@0.362@CNVR3518.1@ENST00000340457_4, POLR2J2-001_7@76.5@76@77@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
D83732@105321@105337@deletion@17@141765517@141786129@7@chr7:141765517-141786129@71@2263@1363@0.602@CNVR3585.3, CNVR3585.2@MGAM-007_40, MGAM-007_41, MGAM-007_42, MGAM-007_43, MGAM-007_44, MGAM-007_45, MGAM-007_46, MGAM-007_47, MGAM-007_48, MGAM-007_49, MGAM-007_50, MGAM-007_51, MGAM-007_52, MGAM-007_53, MGAM-007_54, MGAM-007_55, MGAM-007_56@119.941176470588@101@127@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
D83732@105339@105341@deletion@3@141791715@141793351@7@chr7:141791715-141793351@13.7@222@110@0.495@CNVR3585.3, CNVR3585.2@MGAM-007_58, MGAM-007_59, MGAM-007_60@91@79@101@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
D83732@105785@105791@deletion@7@143969540@143973535@7@chr7:143969540-143973535@34.5@584@283@0.485@CNVR3598.4, CNVR3598.9@RP4-798C17-001_9, RP4-798C17-001_10, RP4-798C17-001_11, RP4-798C17-001_12, ENST00000378112_10, ENST00000378112_11, ENST00000378112_12@89.2857142857143@37@127@:Rho guanine nucleotide exchange factor (GEF) 35@NA@NA
D83732@105798@105807@deletion@10@143975408@143984072@7@chr7:143975408-143984072@22.7@673@406@0.603@CNVR3598.4, CNVR3598.9@RP4-798C17-001_1, RP4-798C17-001_2, RP4-798C17-001_3, RP4-798C17-001_4, RP4-798C17-001_5, ENST00000378112_2, ENST00000378112_3, ENST00000378112_4, ENST00000378112_5, ENST00000378112_6@79.6@55@135@:Rho guanine nucleotide exchange factor (GEF) 35@NA@NA
D83732@105823@105826@deletion@4@144068256@144069851@7@chr7:144068256-144069851@10.4@322@196@0.609@CNVR3598.4, CNVR3598.5, CNVR3598.11@ARHGEF5-001_6, ARHGEF5-001_7, ARHGEF5-001_8, ARHGEF5-001_9@78.5@74@84@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
D83732@107428@107435@duplication@8@7308087@7343923@8@chr8:7308087-7343923@29@620@969@1.56@CNVR3771.8, CNVR3771.10, CNVR3771.4@SPAG11-003_1, SPAG11-003_2, SPAG11-003_3, SPAG11-003_4, DEFB104B-001_1, DEFB104B-001_2, DEFB106B-001_1, DEFB106B-001_2@32.875@7@91@:sperm associated antigen 11B:defensin, beta 104A;defensin, beta 104B:defensin, beta 106B;defensin, beta 106A@:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium@NA
D83732@107502@107516@duplication@15@7673083@7752293@8@chr8:7673083-7752293@19.3@772@1079@1.4@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@DEFB107A-001_1, DEFB105A-001_1, DEFB105A-001_2, DEFB105A-001_3, DEFB106A-001_1, DEFB106A-001_2, DEFB104A-001_1, DEFB104A-001_2, SPAG11A-207_1, SPAG11A-207_2, SPAG11A-207_3, SPAG11A-207_4, DEFB103B-001_1, DEFB103B-001_2, DEFB4-001_1@56.5333333333333@40@113@:defensin, beta 107B;defensin, beta 107A:defensin, beta 105B;defensin, beta 105A:defensin, beta 106B;defensin, beta 106A:defensin, beta 104A;defensin, beta 104B:sperm associated antigen 11A;sperm associated antigen 11B:defensin, beta 103B;defensin, beta 103A:defensin, beta 4B;defensin, beta 4A@:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response to bacterium:extracellular region;defense response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response@NA
D83732@107738@107738@deletion@1@12003180@12003210@8@chr8:12003180-12003210@4.77@27@4@0.148@CNVR3785.8, CNVR3785.5, CNVR3785.6, CNVR3785.2, CNVR3785.3@ENST00000438689_1@119@119@119@NA@NA@NA
D83732@109584@109585@deletion@2@39349346@39349528@8@chr8:39349346-39349528@11.3@51@0@0@CNVR3859.1@ADAM3A-005_11, ADAM3A-009_7@118@118@118@NA@NA@NA
D83732@117587@117592@deletion@6@43313716@43628074@9@chr9:43313716-43628074@44@207@4@0.0193@NA@BX649597-201_1, BX649597-201_3, RP11-186G6-001_1, RP11-186G6-001_2, FAM75A6-201_4@68.4@52@109@:SPATA31 subfamily A, member 6@:integral to membrane@NA
D83732@126909@126912@duplication@4@17840632@17869715@10@chr10:17840632-17869715@12@165@279@1.69@NA@FAM23A-201_5, MRC1L1-001_1, MRC1L1-001_2, MRC1L1-001_3@35.75@11@108@:transmembrane protein 236;transmembrane protein 236-like:macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding@NA
D83732@126938@126946@deletion@9@17951324@18112446@10@chr10:17951324-18112446@17.5@81@1@0.0123@NA@MRC1L1-001_29, MRC1L1-001_30, FAM23B-202_1, FAM23B-202_2, FAM23B-202_3, FAM23B-202_4, FAM23B-202_5, MRC1-001_1, MRC1-001_2@45.8888888888889@5@107@:macrophage mannose receptor 1-like:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D83732@128372@128372@deletion@1@42924566@42924600@10@chr10:42924566-42924600@10.6@103@36@0.35@NA@CCNYL2-201_7@0@0@0@@:regulation of cyclin-dependent protein kinase activity;protein kinase binding@NA
D83732@128979@128979@deletion@1@47758848@47758905@10@chr10:47758848-47758905@6.11@27@0@0@CNVR4714.1@ANXA8L2-001_10@154@154@154@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:calcium-dependent phospholipid binding;calcium ion binding@NA
D83732@129022@129028@deletion@7@48025302@48049022@10@chr10:48025302-48049022@14.3@347@201@0.579@CNVR4715.2@ASAH2C-201_3, ASAH2C-201_4, ASAH2C-201_5, ASAH2C-201_6, ASAH2C-201_7, ASAH2C-201_8, ASAH2C-201_9@69.4285714285714@58@90@@:ceramidase activity;sphingolipid metabolic process@NA
D83732@129460@129461@deletion@2@51361725@51361911@10@chr10:51361725-51361911@6.82@33@2@0.0606@NA@ENST00000404618_4, ENST00000432221_4@122@121@123@NA@NA@NA
D83732@129605@129611@duplication@7@51970585@51994313@10@chr10:51970585-51994313@14.8@188@320@1.7@NA@ASAH2-201_5, ASAH2-201_6, ASAH2-201_7, ASAH2-201_8, ASAH2-201_9, ASAH2-201_10, ASAH2-201_11@145.142857142857@53@186@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
D83732@137399@137399@deletion@1@1272414@1272974@11@chr11:1272414-1272974@9.96@387@232@0.599@CNVR5008.1@MUC5B-203_52@4@4@4@:mucin 5B, oligomeric mucus/gel-forming@:extracellular matrix structural constituent;protein binding;O-glycan processing;extracellular region;cellular protein metabolic process;cell adhesion;Golgi lumen;post-translational protein modification@: PULMONARY FIBROSIS, IDIOPATHIC; IPF
D83732@145896@145901@duplication@6@89515054@89536962@11@chr11:89515054-89536962@17.5@418@652@1.56@NA@TRIM77-201_8, TRIM49-201_4, TRIM49-201_5, TRIM49-201_6, TRIM49-201_7, TRIM49-201_8@42.3333333333333@36@51@:tripartite motif containing 49@:protein binding;intracellular;DNA binding;zinc ion binding@NA
D83732@145909@145920@deletion@12@89581401@89596236@11@chr11:89581401-89596236@20.8@262@116@0.443@NA@TRIM53L-202_5, TRIM53L-202_6, TRIM53L-202_7, AP005435-201_1, AP005435-201_2, AP005435-201_3, AP005435-201_4, AP005435-201_5, AP005435-201_6, AP005435-201_7, AP005435-201_8, AP005435-201_9@27.4166666666667@12@52@NA@NA@NA
D83732@145953@145964@duplication@12@89714613@89729449@11@chr11:89714613-89729449@22.9@121@288@2.38@NA@ENST00000442514_1, ENST00000442514_2, ENST00000442514_3, ENST00000442514_4, ENST00000442514_5, ENST00000442514_6, ENST00000442514_7, ENST00000442514_8, ENST00000442514_9, TRIM53-202_5, TRIM53-202_6, TRIM53-202_7@36.3333333333333@21@154@NA@NA@NA
D83732@145971@145983@deletion@13@89768378@89806559@11@chr11:89768378-89806559@25.7@186@49@0.263@NA@ENST00000432771_3, ENST00000432771_4, ENST00000432771_5, ENST00000432771_6, ENST00000432771_7, ENST00000432771_8, ENST00000436580_1, ENST00000436580_2, ENST00000436580_3, ENST00000436580_4, ENST00000436580_5, ENST00000436580_6, ENST00000436580_7@88.2307692307692@82@104@:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;DNA binding;zinc ion binding@NA
D83732@150778@150778@deletion@1@9450373@9450423@12@chr12:9450373-9450423@7.75@38@2@0.0526@NA@DDX11L8-201_5@78@78@78@NA@NA@NA
D83732@150785@150786@deletion@2@9456573@9456804@12@chr12:9456573-9456804@16.2@127@34@0.268@NA@DDX11L8-201_12, DDX11L8-201_13@85@83@87@NA@NA@NA
D83732@150829@150841@duplication@13@9684189@9707352@12@chr12:9684189-9707352@104@624@1468@2.35@CNVR5429.1@AC006432-201_1, AC006432-201_2, AC006432-201_3, AC006432-201_4, AC006432-201_5, AC006432-201_6, AC006432-201_7, AC006432-201_8, AC006432-201_9, AC006432-201_10, AC006432-201_11, AC006432-201_12, AC006432-201_13@22.2307692307692@15@25@NA@NA@NA
D83732@150968@150971@deletion@4@10583212@10587639@12@chr12:10583212-10587639@11@401@250@0.623@CNVR5430.1@KLRC2-201_3, KLRC2-201_4, KLRC2-201_5, KLRC2-201_6@62@51@67@:killer cell lectin-like receptor subfamily C, member 2@:carbohydrate binding:transmembrane signaling receptor activity;carbohydrate binding;protein binding;signal transduction;cellular defense response;integral to plasma membrane@NA
D83732@151034@151034@duplication@1@11244393@11244793@12@chr12:11244393-11244793@13.3@335@535@1.6@CNVR5434.1@TAS2R31-201_2@72@72@72@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
D83732@154155@154155@deletion@1@53086541@53086665@12@chr12:53086541-53086665@9.6@229@125@0.546@CNVR5537.1@KRT77-201_6@8@8@8@:keratin 77@:structural molecule activity;keratin filament;molecular_function;cellular_component;biological_process@NA
D83732@161352@161353@duplication@2@133067390@133084937@12@chr12:133067390-133084937@5.97@166@242@1.46@NA@FBRSL1-201_2, FBRSL1-201_3@0@0@0@:fibrosin-like 1@NA@NA
D83732@162127@162128@deletion@2@24465240@24465671@13@chr13:24465240-24465671@16.3@866@549@0.634@NA@RP11-45B20-002_6, ENST00000382133_3@29@29@29@:C1q and tumor necrosis factor related protein 9B@:collagen;protein binding@NA
D83732@162165@162167@duplication@3@24895136@24895583@13@chr13:24895136-24895583@7.46@436@592@1.36@NA@SPATA13-009_13, SPATA13-009_14, C1QTNF9-003_5, AL359736-201_2@93@27@126@:spermatogenesis associated 13:C1q and tumor necrosis factor related protein 9:C1QTNF9B antisense RNA 1@:lamellipodium assembly;phospholipid binding;Rac guanyl-nucleotide exchange factor activity;guanyl-nucleotide exchange factor activity;ruffle membrane;nucleus;regulation of cell migration;cell migration;regulation of Rho protein signal transduction;intracellular;Rho guanyl-nucleotide exchange factor activity;cytoplasm;filopodium assembly;filopodium;protein binding;lamellipodium:collagen;protein binding;hormone activity@NA
D83732@162228@162230@duplication@3@25169929@25171416@13@chr13:25169929-25171416@6.64@58@111@1.91@CNVR5826.1@RP11-556N21-001_9, ENST00000453498_11, ENST00000453498_12@44@2@65@NA@NA@NA
D83732@166688@166695@deletion@8@19411745@19488027@14@chr14:19411745-19488027@30.9@415@180@0.434@CNVR6072.1, CNVR6072.16, CNVR6072.3@CR383656-201_1, CR383656-201_2, CR383656-201_3, CR383656-201_4, CR383656-201_5, ENST00000442368_2, ENST00000442368_3, ENST00000442368_4@37.5@30@54@NA@NA@NA
D83732@166697@166699@duplication@3@19553367@19559165@14@chr14:19553367-19559165@12.5@69@163@2.36@CNVR6072.1@POTEG-201_1, POTEG-201_2, POTEG-201_3@122.333333333333@91@141@:POTE ankyrin domain family, member G@:protein binding@NA
D83732@167655@167656@deletion@2@24434973@24435193@14@chr14:24434973-24435193@10.9@237@131@0.553@NA@DHRS4-201_4, DHRS4-201_5@0@0@0@:dehydrogenase/reductase (SDR family) member 4@:steroid metabolic process;oxidation-reduction process;mitochondrion;protein tetramerization;oxidoreductase activity;peroxisomal membrane;nucleus;cellular ketone metabolic process;metabolic process;receptor binding;alcohol dehydrogenase [NAD(P)+] activity;peroxisome;nucleotide binding;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;3-keto sterol reductase activity;alcohol metabolic process;carbonyl reductase (NADPH) activity@NA
D83732@167663@167664@duplication@2@24470074@24470294@14@chr14:24470074-24470294@9.85@270@400@1.48@NA@DHRS4L2-001_4, DHRS4L2-001_5@7.5@7@8@:dehydrogenase/reductase (SDR family) member 4 like 2@:extracellular region;oxidoreductase activity;nucleotide binding;metabolic process@NA
D83732@173501@173502@deletion@2@106478134@106478412@14@chr14:106478134-106478412@18.7@127@28@0.22@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV3-6-210_6, IGHV4-4-001_2@17@17@17@@:protein binding@NA
D83732@173508@173513@duplication@6@106539081@106559976@14@chr14:106539081-106559976@45.6@716@1227@1.71@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8-001_1, IGHV1-8-001_2, IGHV3-9-001_1, IGHV3-9-001_2, IGHV2-10-001_1, IGHV2-10-001_2@22.3333333333333@17@24@@:protein binding:protein binding@NA
D83732@174406@174410@deletion@5@29008591@29009297@15@chr15:29008591-29009297@25.9@565@315@0.558@NA@ENST00000456510_1, ENST00000456510_2, ENST00000456510_3, ENST00000456510_4, ENST00000456510_5@23.6@18@26@NA@NA@NA
D83732@174505@174507@deletion@3@30663303@30665349@15@chr15:30663303-30665349@11.9@308@184@0.597@CNVR6337.1@CHRFAM7A-202_6, CHRFAM7A-202_7, CHRFAM7A-202_8@53.6666666666667@44@68@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
D83732@174964@174967@duplication@4@34701845@34781706@15@chr15:34701845-34781706@7.03@508@677@1.33@CNVR6351.3@ENST00000443488_1, ENST00000443488_2, AC027139-201_4, AC027139-201_5@32@21@45@:golgin A8 family, member A@:Golgi cisterna membrane;Golgi apparatus@NA
D83732@179313@179314@deletion@2@72958125@72958470@15@chr15:72958125-72958470@5.78@78@37@0.474@CNVR6443.1@GOLGA6-001_16, GOLGA6-001_17@17@11@23@:golgin A6 family, member B@:Golgi apparatus@NA
D83732@183364@183364@deletion@1@2627428@2627502@16@chr16:2627428-2627502@4.85@116@66@0.569@CNVR6601.1@PDPK1-003_7@2@2@2@:3-phosphoinositide dependent protein kinase-1@:3-phosphoinositide-dependent protein kinase activity;nucleoplasm;fibroblast growth factor receptor signaling pathway;protein tyrosine kinase activity;negative regulation of transforming growth factor beta receptor signaling pathway;negative regulation of toll-like receptor signaling pathway;regulation of endothelial cell migration;focal adhesion assembly;ATP binding;insulin receptor signaling pathway;plasma membrane;intracellular signal transduction;positive regulation of establishment of protein localization to plasma membrane;platelet activation;protein kinase activity;regulation of mast cell degranulation;cytosol;epidermal growth factor receptor signaling pathway;hyperosmotic response;nerve growth factor receptor signaling pathway;type B pancreatic cell development;synaptic transmission;regulation of apoptotic process;transcription, DNA-dependent;protein autophosphorylation;regulation of I-kappaB kinase/NF-kappaB cascade;protein kinase binding;T cell costimulation;insulin receptor binding;transferase activity, transferring phosphorus-containing groups;actin cytoskeleton organization;blood coagulation;negative regulation of protein kinase activity;cellular response to insulin stimulus;focal adhesion;phosphatidylinositol-mediated signaling;negative regulation of cardiac muscle cell apoptotic process;protein serine/threonine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;cytoplasm;activation of protein kinase B activity;protein binding;T cell receptor signaling pathway;cytoplasmic membrane-bounded vesicle;peptidyl-threonine phosphorylation;kinase activity@NA
D83732@183384@183384@deletion@1@2692232@2693298@16@chr16:2692232-2693298@21.5@99@0@0@CNVR6602.2@AC141586-201_1@50@50@50@NA@NA@NA
D83732@184597@184604@deletion@8@15091612@15110071@16@chr16:15091612-15110071@8@1552@1118@0.72@CNVR6646.1@PDXDC1-202_2, PDXDC1-202_3, PDXDC1-202_4, PDXDC1-202_5, PDXDC1-202_6, PDXDC1-202_7, PDXDC1-202_8, PDXDC1-202_9@19.75@19@21@:pyridoxal-dependent decarboxylase domain containing 1;pyridoxal-dependent decarboxylase domain-containing protein 1-like@:carboxylic acid metabolic process;pyridoxal phosphate binding;carboxy-lyase activity@NA
D83732@186368@186369@deletion@2@28711499@28712933@16@chr16:28711499-28712933@12@55@1@0.0182@CNVR6686.3, CNVR6686.1, CNVR6686.2@AC145285-201_1, AC145285-201_2@60@59@61@:eukaryotic translation initiation factor 3, subunit C@:cytosol;protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;cellular protein metabolic process;binding;gene expression;translation;translation initiation factor activity@NA
D83732@186582@186585@deletion@4@29468955@29469337@16@chr16:29468955-29469337@7.27@66@24@0.364@CNVR6690.2, CNVR6690.3, CNVR6690.4@GIYD1-001_4, GIYD1-001_5, SULT1A4-201_2, SULT1A4-201_3@12.5@12@13@:structure-specific endonuclease subunit SLX1-like;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae);SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae):sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3;sulfotransferase 1A3/1A4-like@:Slx1-Slx4 complex;5'-flap endonuclease activity;DNA repair;protein binding;DNA double-strand break processing involved in repair via single-strand annealing;double-strand break repair via homologous recombination;metal ion binding;crossover junction endodeoxyribonuclease activity:steroid metabolic process;small molecule metabolic process;sulfation;aryl sulfotransferase activity;cytoplasm;catecholamine metabolic process;cytosol;endoplasmic reticulum unfolded protein response;xenobiotic metabolic process;sulfotransferase activity;activation of signaling protein activity involved in unfolded protein response;3'-phosphoadenosine 5'-phosphosulfate metabolic process;flavonoid metabolic process@NA
D83732@188229@188235@deletion@7@55798611@55813653@16@chr16:55798611-55813653@28.7@414@199@0.481@CNVR6730.1@CES4-202_2, CES4-202_3, CES4-202_4, CES4-202_5, CES4-202_6, CES4-202_7, CES4-202_8@111@105@123@NA@NA@NA
D83732@189989@189989@deletion@1@70219790@70219880@16@chr16:70219790-70219880@8.26@57@13@0.228@CNVR6764.1, CNVR6764.5@CLEC18C-201_11@19@19@19@:C-type lectin domain family 18, member C@:carbohydrate binding;protein binding;extracellular region@NA
D83732@195232@195234@duplication@3@16675293@16678314@17@chr17:16675293-16678314@9.17@257@376@1.46@NA@CCDC144A-202_16, CCDC144A-202_17, CCDC144A-202_18@58.3333333333333@57@60@:coiled-coil domain containing 144A@NA@NA
D83732@195667@195668@deletion@2@18299882@18301287@17@chr17:18299882-18301287@5.57@82@40@0.488@CNVR7012.1@AL353997-001_6, AL353997-001_7@66@37@95@NA@NA@NA
D83732@195711@195716@deletion@6@18387191@18394638@17@chr17:18387191-18394638@16@173@71@0.41@CNVR7014.1@LGALS9C-201_2, LGALS9C-201_3, LGALS9C-201_4, LGALS9C-201_5, LGALS9C-201_6, LGALS9C-201_7@131@125@135@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
D83732@195726@195726@deletion@1@18414537@18416773@17@chr17:18414537-18416773@7.33@36@2@0.0556@NA@AC107983-001_10@129@129@129@NA@NA@NA
D83732@195728@195747@deletion@20@18418662@18457581@17@chr17:18418662-18457581@179@841@9@0.0107@NA@AC107983-001_1, AC107983-001_2, AC107983-001_3, AC107983-001_4, AC107983-001_5, AC107983-001_6, AC107983-001_7, AC107983-001_8, ENST00000456184_1, ENST00000456184_2, CCDC144B-201_14, CCDC144B-201_15, CCDC144B-201_16, CCDC144B-201_17, CCDC144B-201_18, ENST00000447265_11, ENST00000447265_12, ENST00000447265_13, ENST00000447265_14, ENST00000447265_15@129.8@126@133@:protein FAM106B-like@NA@NA
D83732@195871@195871@duplication@1@18996780@18996940@17@chr17:18996780-18996940@7.76@229@343@1.5@CNVR7018.4, CNVR7018.2, CNVR7018.6@AC007952-202_2@92@92@92@NA@NA@NA
D83732@196154@196158@duplication@5@20356332@20361698@17@chr17:20356332-20361698@7.45@168@254@1.51@CNVR7021.1, CNVR7021.3@LGALS9B-201_3, LGALS9B-201_4, LGALS9B-201_5, LGALS9B-201_6, LGALS9B-201_7@74.8@20@103@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
D83732@197726@197728@deletion@3@34539180@34539966@17@chr17:34539180-34539966@12.3@56@0@0@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1-202_2, CCL4L1-202_3, CCL4L1-202_4@118@113@122@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
D83732@198032@198043@deletion@12@36351805@36398303@17@chr17:36351805-36398303@154@4470@2397@0.536@CNVR7083.3@AC183087-202_3, AC183087-202_4, AC183087-202_5, AC183087-202_6, AC183087-202_7, AC183087-202_8, AC183087-202_9, AC183087-202_10, AC183087-202_11, AC183087-202_12, AC183087-202_13, AC183087-202_14@50.75@27@64@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
D83732@200259@200264@deletion@6@43585590@43592892@17@chr17:43585590-43592892@15.9@468@275@0.588@CNVR7113.4, CNVR7113.6, CNVR7113.2@AC091132-201_1, AC091132-201_2, AC091132-201_3, AC091132-201_4, AC091132-201_5, ENST00000339474_3@94.1666666666667@81@127@NA@NA@NA
D83732@200337@200340@deletion@4@44399690@44409348@17@chr17:44399690-44409348@9.04@48@5@0.104@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A-001_7, LRRC37A-001_8, LRRC37A-001_9, LRRC37A-001_10@144.75@141@154@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
D83732@200343@200344@deletion@2@44414664@44414935@17@chr17:44414664-44414935@9.76@44@0@0@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A-001_13, LRRC37A-001_14@195@194@196@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
D83732@210486@210489@duplication@4@4219590@4224812@19@chr19:4219590-4224812@31.5@542@895@1.65@NA@ANKRD24-203_18, ANKRD24-203_19, ANKRD24-203_20, ANKRD24-203_21@13@12@14@:ankyrin repeat domain 24@:protein binding@NA
D83732@213440@213442@duplication@3@14201141@14201300@19@chr19:14201141-14201300@7.23@98@164@1.67@CNVR7546.1@ENST00000269724_1, ENST00000269724_2, ENST00000269724_3@0@0@0@@:protein binding;sequence-specific DNA binding;nucleus@NA
D83732@213493@213494@duplication@2@14508472@14508748@19@chr19:14508472-14508748@24@96@277@2.89@NA@CD97-205_8, CD97-205_9@10.5@7@14@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
D83732@213632@213633@deletion@2@14876338@14876617@19@chr19:14876338-14876617@9.22@499@326@0.653@NA@EMR2-209_8, EMR2-209_9@3@3@3@:egf-like module containing, mucin-like, hormone receptor-like 2@:transmembrane signaling receptor activity;inflammatory response;G-protein coupled receptor activity;ruffle membrane;integral to membrane;plasma membrane;cell surface receptor signaling pathway;neuropeptide signaling pathway;granulocyte chemotaxis;cell migration;leading edge membrane;G-protein coupled receptor signaling pathway;protein binding;cell adhesion;membrane;calcium ion binding;chondroitin sulfate binding@NA
D83732@213635@213635@deletion@1@14877792@14877922@19@chr19:14877792-14877922@5.81@58@22@0.379@NA@EMR2-209_6@4@4@4@:egf-like module containing, mucin-like, hormone receptor-like 2@:transmembrane signaling receptor activity;inflammatory response;G-protein coupled receptor activity;ruffle membrane;integral to membrane;plasma membrane;cell surface receptor signaling pathway;neuropeptide signaling pathway;granulocyte chemotaxis;cell migration;leading edge membrane;G-protein coupled receptor signaling pathway;protein binding;cell adhesion;membrane;calcium ion binding;chondroitin sulfate binding@NA
D83732@217293@217297@duplication@5@40373947@40382827@19@chr19:40373947-40382827@23.6@331@562@1.7@CNVR7639.2@FCGBP-201_22, FCGBP-201_23, FCGBP-201_24, FCGBP-201_25, FCGBP-201_26@130.8@105@155@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D83732@217301@217306@deletion@6@40389654@40399856@19@chr19:40389654-40399856@44.9@307@72@0.235@CNVR7639.2, CNVR7639.3@FCGBP-201_13, FCGBP-201_14, FCGBP-201_15, FCGBP-201_16, FCGBP-201_17, FCGBP-201_18@112.333333333333@103@127@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D83732@217600@217608@duplication@9@41349703@41356242@19@chr19:41349703-41356242@48.5@1331@1991@1.5@CNVR7642.1@CYP2A6-204_2, CYP2A6-204_3, CYP2A6-204_4, CYP2A6-204_5, CYP2A6-204_6, CYP2A6-204_7, CYP2A6-204_8, CYP2A6-204_9, CYP2A6-204_10@10.4444444444444@7@17@:cytochrome P450, family 2, subfamily A, polypeptide 6@:coumarin 7-hydroxylase activity;steroid metabolic process;oxidation-reduction process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;endoplasmic reticulum membrane;drug metabolic process;electron carrier activity;small molecule metabolic process;exogenous drug catabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;enzyme binding;heme binding;xenobiotic metabolic process;iron ion binding;coumarin catabolic process;coumarin metabolic process@: CYTOCHROME P450, SUBFAMILY IIA, POLYPEPTIDE 6; CYP2A6
D83732@217667@217667@deletion@1@41627864@41628039@19@chr19:41627864-41628039@7.02@132@69@0.523@CNVR7644.1@CYP2F1-201_6@10@10@10@:cytochrome P450, family 2, subfamily F, polypeptide 1@:trichloroethylene metabolic process;oxidation-reduction process;aromatase activity;response to toxin;oxygen binding;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;endoplasmic reticulum membrane;naphthalene metabolic process;intracellular membrane-bounded organelle;electron carrier activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;heme binding;xenobiotic metabolic process;monooxygenase activity;iron ion binding@NA
D83732@218185@218185@deletion@1@43715945@43716628@19@chr19:43715945-43716628@4.68@58@26@0.448@CNVR7658.5, CNVR7658.1@CEACAMP10-001_9@41@41@41@:pregnancy specific beta-1-glycoprotein 9@:protein binding;extracellular region;female pregnancy;defense response@NA
D83732@220966@220966@deletion@1@53952767@53952888@19@chr19:53952767-53952888@12.1@94@25@0.266@NA@ZNF761-203_5@7@7@7@NA@NA@NA
D83732@221166@221176@duplication@11@54724400@54742966@19@chr19:54724400-54742966@68.3@699@1330@1.9@CNVR7721.3, CNVR7721.4, CNVR7721.1@LILRB3-008_1, LILRB3-008_2, LILRB3-008_3, LILRB3-008_4, LILRB3-008_5, LILRB3-008_6, AC010492-001_1, AC010492-001_2, LILRA6-002_8, LILRA6-002_9, LILRA6-002_10@84@44@136@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D83732@221178@221178@deletion@1@54744152@54744453@19@chr19:54744152-54744453@9.51@324@191@0.59@CNVR7721.3, CNVR7721.6@LILRA6-002_6@54@54@54@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D83732@221181@221182@deletion@2@54745904@54746407@19@chr19:54745904-54746407@8.55@331@202@0.61@CNVR7721.3, CNVR7721.6@LILRA6-002_2, LILRA6-002_3@71.5@66@77@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D83732@221218@221223@deletion@6@54801929@54804222@19@chr19:54801929-54804222@31.3@971@574@0.591@CNVR7722.1@LILRA3-003_5, LILRA3-003_6, LILRA3-003_7, LILRA3-003_8, LILRA3-003_9, LILRA3-003_10@108.5@107@109@:leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3@:antigen binding;signal transduction;protein binding;extracellular region;plasma membrane;receptor activity;defense response@NA
D83732@221396@221412@deletion@17@55266477@55286911@19@chr19:55266477-55286911@48@1896@1205@0.636@CNVR7725.2, CNVR7725.1@KIR2DL3-201_5, KIR2DL3-201_6, KIR2DL3-201_7, KIR2DL3-201_8, KIR2DP1-001_1, KIR2DP1-001_2, KIR2DP1-001_3, KIR2DP1-001_4, KIR2DP1-001_5, KIR2DP1-001_6, KIR2DP1-001_7, KIR2DP1-001_8, KIR2DP1-001_9, KIR2DL1-002_1, KIR2DL1-002_2, KIR2DL1-002_3, KIR2DL1-002_4@110.176470588235@85@126@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
D83732@222068@222069@deletion@2@58003184@58003369@19@chr19:58003184-58003369@5.07@52@21@0.404@CNVR7748.1@ZNF419-202_5, ZNF419-202_6@0@0@0@:zinc finger protein 419@:intracellular;DNA binding;regulation of transcription, DNA-dependent;cytoplasm;nucleolus;nucleus;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding@NA
D83732@222562@222564@deletion@3@1558986@1610283@20@chr20:1558986-1610283@71.6@370@6@0.0162@CNVR7763.1@SIRPB1-201_1, SIRPB1-201_2, SIRPG-005_6@60.3333333333333@0@128@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like:signal-regulatory protein gamma@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway:negative regulation of cell proliferation;positive regulation of T cell activation;positive regulation of cell-cell adhesion;intracellular;cell-cell signaling;protein binding;blood coagulation;integral to membrane;cell adhesion;plasma membrane;positive regulation of cell proliferation;membrane;intracellular signal transduction;leukocyte migration@NA
D83732@231958@231958@deletion@1@16287256@16287718@22@chr22:16287256-16287718@15.9@86@8@0.093@CNVR8071.2, CNVR8071.3, CNVR8071.9@POTEH-002_1@105@105@105@:POTE ankyrin domain family, member H@:protein binding@NA
D83732@231968@231971@deletion@4@16348074@16350632@22@chr22:16348074-16350632@23.7@671@372@0.554@CNVR8071.2, CNVR8071.3, CNVR8071.10@LA16c-2F2-001_3, LA16c-2F2-001_4, LA16c-2F2-001_5, LA16c-2F2-001_6@50.25@47@54@NA@NA@NA
D83732@232771@232783@deletion@13@20385728@20398724@22@chr22:20385728-20398724@16.4@126@37@0.294@CNVR8094.9, CNVR8094.4, CNVR8094.10@PI4KAP1-204_2, PI4KAP1-204_3, PI4KAP1-204_4, PI4KAP1-204_5, PI4KAP1-204_6, PI4KAP1-204_7, PI4KAP1-204_8, PI4KAP1-204_9, PI4KAP1-204_10, PI4KAP1-204_11, PI4KAP1-204_12, PI4KAP1-204_13, PI4KAP1-204_14@166.538461538462@155@172@NA@NA@NA
D86968@585@588@duplication@4@1573864@1599912@1@chr1:1573864-1599912@5.77@525@693@1.32@CNVR17.1@CDC2L2-208_12, CDC2L2-208_13, RP11-345P4-003_9, RP11-345P4-003_10@5.75@4@8@:cyclin-dependent kinase 11B:solute carrier family 35, member E2B@:protein serine/threonine kinase activity;protein tyrosine kinase activity;protein phosphorylation;protein kinase activity;cell division;transferase activity, transferring phosphorus-containing groups;ATP binding:integral to membrane;membrane;transmembrane transport@NA
D86968@612@619@deletion@8@1654029@1666275@1@chr1:1654029-1666275@11.9@527@334@0.634@CNVR17.1@CDC2L2-208_1, CDC2L2-208_2, CDC2L2-208_3, RP1-283E3-001_1, RP1-283E3-001_2, SLC35E2-002_6, SLC35E2-002_7, ENST00000424604_1@25.75@24@32@:cyclin-dependent kinase 11B;cyclin-dependent kinase 11A:solute carrier family 35, member E2@:protein serine/threonine kinase activity;regulation of cell growth;protein tyrosine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;protein kinase activity;transferase activity, transferring phosphorus-containing groups;ATP binding;cytoplasm;mitosis;apoptotic process;nucleus;regulation of mRNA processing;cyclin-dependent protein kinase activity;cell division:integral to membrane;membrane@NA
D86968@2889@2892@duplication@4@16891304@16893847@1@chr1:16891304-16893847@6@241@343@1.42@CNVR93.3, CNVR93.6, CNVR93.11@NBPF1-201_25, NBPF1-201_26, NBPF1-201_27, NBPF1-201_28@76.75@74@79@NA@NA@NA
D86968@2920@2946@duplication@27@16951876@16976445@1@chr1:16951876-16976445@69.9@5111@7001@1.37@CNVR93.3, CNVR93.6, CNVR93.12, CNVR93.7@CROCCL1-204_1, CROCCL1-204_2, CROCCL1-204_3, CROCCL1-204_4, CROCCL1-204_5, CROCCL1-204_6, CROCCL1-204_7, CROCCL1-204_8, CROCCL1-204_9, CROCCL1-204_10, RP5-1182A14-001_1, RP5-1182A14-001_2, RP5-1182A14-001_3, RP5-1182A14-001_4, RP5-1182A14-001_5, RP5-1182A14-001_6, RP5-1182A14-001_7, RP5-1182A14-001_8, RP5-1182A14-001_9, RP5-1182A14-001_10, RP5-1182A14-001_11, RP5-1182A14-001_12, RP5-1182A14-001_13, RP5-1182A14-001_14, RP5-1182A14-001_15, RP5-1182A14-001_16, RP5-1182A14-001_17@53.2222222222222@39@88@NA@NA@NA
D86968@3005@3005@deletion@1@17249160@17249294@1@chr1:17249160-17249294@6.55@527@330@0.626@CNVR94.4, CNVR94.5, CNVR94.6@CROCC-201_2@73@73@73@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
D86968@4452@4462@duplication@11@25611066@25664948@1@chr1:25611066-25664948@44.2@1233@1925@1.56@CNVR116.1, CNVR116.2@RHD-202_2, RHD-202_3, RHD-202_4, RHD-202_5, RHD-202_6, RHD-202_7, RHD-202_8, RHD-202_9, RHD-202_10, RHD-202_11, TMEM50A-001_1@112.818181818182@11@128@:chromosome 1 open reading frame 63:Rh blood group, D antigen:transmembrane protein 50A@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane:integral to membrane;endoplasmic reticulum;cytoplasm@NA
D86968@4477@4477@deletion@1@25735176@25735361@1@chr1:25735176-25735361@15.3@76@2@0.0263@CNVR117.1@RHCE-005_4@56@56@56@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
D86968@6746@6746@deletion@1@39987050@39987243@1@chr1:39987050-39987243@5.36@24@0@0@NA@BMP8A-001_4@53@53@53@:bone morphogenetic protein 8a@:cell differentiation;growth factor activity;extracellular space;growth;cytokine activity;cartilage development;ossification@NA
D86968@11245@11246@duplication@2@89476589@89477711@1@chr1:89476589-89477711@5.01@588@781@1.33@CNVR244.1@GBP3-001_7, GBP3-001_8@54@54@54@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
D86968@12424@12432@duplication@9@104233918@104256576@1@chr1:104233918-104256576@8.74@122@211@1.73@CNVR266.3, CNVR266.5@AMY1B-001_1, AMY1B-001_2, AMY1B-001_3, AMY1B-001_4, AMY1B-001_5, AMY1B-001_6, AMY1B-001_7, AMY1B-001_8, AMYP1-001_1@119.777777777778@107@154@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D86968@12476@12476@deletion@1@107963708@107963766@1@chr1:107963708-107963766@5.07@94@47@0.5@NA@NTNG1-203_7@2@2@2@:netrin G1@:protein binding;axonogenesis;anchored to plasma membrane;plasma membrane@NA
D86968@12929@12936@deletion@8@110230474@110236368@1@chr1:110230474-110236368@116@552@1@0.00181@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1-001_1, GSTM1-001_2, GSTM1-001_3, GSTM1-001_4, GSTM1-001_5, GSTM1-001_6, GSTM1-001_7, GSTM1-001_8@191.375@187@194@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
D86968@14493@14495@deletion@3@144676872@144679973@1@chr1:144676872-144679973@15.1@328@170@0.518@CNVR337.1@WI2-1896O14-001_1, WI2-1896O14-001_2, WI2-1896O14-001_3@4.66666666666667@4@5@NA@NA@NA
D86968@15201@15217@deletion@17@148008575@148025849@1@chr1:148008575-148025849@14.2@65@0@0@CNVR346.2, CNVR346.4@NBPF14-001_1, NBPF14-001_2, NBPF14-001_3, NBPF14-001_4, NBPF14-001_5, NBPF14-001_6, NBPF14-001_7, NBPF14-001_8, NBPF14-001_9, NBPF14-001_10, NBPF14-001_11, NBPF14-001_12, NBPF14-001_13, NBPF14-001_14, NBPF14-001_15, NBPF14-001_16, NBPF14-001_17@89.7058823529412@58@120@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
D86968@15460@15462@duplication@3@149398879@149400543@1@chr1:149398879-149400543@8.2@439@613@1.4@CNVR350.1@HIST2H3PS2-001_1, HIST2H3PS2-001_2, RP5-998N21-002_1@75.3333333333333@75@76@NA@NA@NA
D86968@21362@21374@duplication@13@196743977@196801320@1@chr1:196743977-196801320@38.2@1782@2545@1.43@CNVR459.1@CFHR3-001_1, CFHR3-001_2, CFHR3-001_3, CFHR3-001_4, CFHR3-001_5, CFHR3-001_6, CFHR1-001_1, CFHR1-001_2, CFHR1-001_3, CFHR1-001_4, CFHR1-001_5, CFHR1-001_6, CFHR2-201_1@96.7692307692308@85@119@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
D86968@23045@23045@duplication@1@207741171@207741388@1@chr1:207741171-207741388@10.9@272@471@1.73@CNVR485.1, CNVR485.2@CR1-201_25@16@16@16@:complement component (3b/4b) receptor 1 (Knops blood group)@:complement component C4b receptor activity;complement activation, classical pathway;negative regulation of complement activation, alternative pathway;innate immune response;negative regulation of serine-type endopeptidase activity;complement component C3b binding;negative regulation of complement activation, classical pathway;plasma membrane;integral to plasma membrane;complement component C3b receptor activity;complement component C4b binding;cell surface;regulation of complement activation;positive regulation of serine-type endopeptidase activity@: MALARIA, SUSCEPTIBILITY TO; KNOPS BLOOD GROUP SYSTEM; KN
D86968@24160@24164@duplication@5@223727670@223729472@1@chr1:223727670-223729472@14@77@190@2.47@NA@CAPN8-202_20, CAPN8-202_21, CAPN8-202_22, CAPN8-202_23, CAPN8-202_24@0@0@0@:calpain 8@:proteolysis;Golgi apparatus;intracellular;calcium-dependent cysteine-type endopeptidase activity;calcium ion binding@NA
D86968@33542@33545@deletion@4@87365381@87371357@2@chr2:87365381-87371357@12.2@186@92@0.495@CNVR861.2@AC083899-001_6, AC083899-001_7, AC083899-001_8, AC083899-001_9@14.5@11@17@NA@NA@NA
D86968@33832@33833@duplication@2@90192770@90193425@2@chr2:90192770-90193425@11.1@466@685@1.47@CNVR867.10, CNVR867.5, CNVR867.3, CNVR867.9, CNVR867.15@IGKV1D-13-001_1, IGKV1D-13-001_2@7@7@7@@:protein binding@NA
D86968@34540@34541@deletion@2@97818243@97820479@2@chr2:97818243-97820479@6.8@251@152@0.606@CNVR886.2@ENST00000461153_14, ENST00000461153_15@13@12@14@:ankyrin repeat domain 36C;ankyrin repeat domain 36@:protein binding@NA
D86968@35975@35975@deletion@1@112551657@112551709@2@chr2:112551657-112551709@7.72@99@40@0.404@CNVR928.1@ANAPC1-001_37@0@0@0@:anaphase-promoting complex subunit 1-like;anaphase promoting complex subunit 1@:nucleoplasm;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle;anaphase-promoting complex;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle spindle assembly checkpoint;cytosol;protein K11-linked ubiquitination;protein binding;mitosis;nucleus;cell cycle checkpoint;cell division;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle@NA
D86968@38877@38878@deletion@2@160634451@160634476@2@chr2:160634451-160634476@6.29@124@66@0.532@NA@CD302-002_6, LY75-002_38@1@1@1@:CD302 molecule:LY75-CD302 readthrough:lymphocyte antigen 75;LY75-CD302 readthrough@:carbohydrate binding;filopodium;cell cortex;integral to membrane;phagocytosis;microvillus:carbohydrate binding:carbohydrate binding;inflammatory response;endocytosis;immune response;receptor activity;integral to plasma membrane@NA
D86968@57041@57046@deletion@6@132276988@132280062@3@chr3:132276988-132280062@29.3@664@350@0.527@NA@ACAD11-001_18, ACAD11-001_19, ACAD11-001_20, NPHP3-205_44, NPHP3-205_45, NPHP3-205_46@2.66666666666667@2@3@:acyl-CoA dehydrogenase family, member 11:nephronophthisis 3 (adolescent)@:oxidation-reduction process;acyl-CoA dehydrogenase activity;oxidoreductase activity, acting on the CH-CH group of donors;mitochondrion;very-long-chain-acyl-CoA dehydrogenase activity;fatty acid beta-oxidation using acyl-CoA dehydrogenase;long-chain-acyl-CoA dehydrogenase activity;peroxisome;flavin adenine dinucleotide binding;transferase activity, transferring phosphorus-containing groups;oxidoreductase activity;medium-chain-acyl-CoA dehydrogenase activity;nucleus;mitochondrial membrane;metabolic process:photoreceptor cell maintenance;negative regulation of canonical Wnt receptor signaling pathway;cilium;ureter development;lipid metabolic process;protein binding;regulation of Wnt receptor signaling pathway, planar cell polarity pathway;regulation of planar cell polarity pathway involved in neural tube closure;cilium morphogenesis;primary cilium;maintenance of organ identity;Wnt receptor signaling pathway;determination of left/right symmetry;convergent extension involved in gastrulation;kidney morphogenesis@: NEPHRONOPHTHISIS 3; NPHP3; RENAL-HEPATIC-PANCREATIC DYSPLASIA; RHPD; MECKEL SYNDROME, TYPE 7; MKS7
D86968@60936@60937@deletion@2@186409332@186416404@3@chr3:186409332-186416404@6.95@136@70@0.515@CNVR1662.1, CNVR1662.2@RP11-795A2-001_4, ENST00000413467_1@5@5@5@NA@NA@NA
D86968@67884@67885@deletion@2@113502821@113502959@4@chr4:113502821-113502959@5.76@81@38@0.469@NA@AC023886-201_5, C4orf21-002_14@1@1@1@:chromosome 4 open reading frame 21@:integral to membrane;zinc ion binding@NA
D86968@68947@68947@deletion@1@145041645@145041742@4@chr4:145041645-145041742@5.39@112@58@0.518@NA@GYPA-205_2@8@8@8@:glycophorin B (MNS blood group):glycophorin A (MNS blood group)@:integral to membrane;plasma membrane;integral to plasma membrane:external side of plasma membrane;integral to membrane;cytoskeletal anchoring at plasma membrane;plasma membrane;molecular_function;protein homodimerization activity;integral to plasma membrane;cellular_component;identical protein binding;membrane;biological_process;regulation of response to osmotic stress;virus-host interaction@: BLOOD GROUP--Ss LOCUS; Ss: MALARIA, SUSCEPTIBILITY TO; BLOOD GROUP--MN LOCUS; MN
D86968@70816@70826@duplication@11@712144@767035@5@chr5:712144-767035@15.1@1692@2221@1.31@CNVR2280.3@ZDHHC11-201_13, ZDHHC11B-201_1, ZDHHC11B-201_2, ZDHHC11B-201_3, ZDHHC11B-201_4, ZDHHC11B-201_5, ZDHHC11B-201_6, ZDHHC11B-201_7, ZDHHC11B-201_8, ZDHHC11B-201_9, ZDHHC11B-201_10@72.8181818181818@34@96@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
D86968@71578@71579@duplication@2@17353993@17354545@5@chr5:17353993-17354545@5.27@90@146@1.62@CNVR2379.1@ENST00000421542_1, ENST00000421542_2@8@6@10@NA@NA@NA
D86968@78044@78044@deletion@1@147553799@147553934@5@chr5:147553799-147553934@23.8@116@0@0@CNVR2637.2, CNVR2637.1@AC116334-001_3@78@78@78@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
D86968@79566@79568@duplication@3@175386532@175388438@5@chr5:175386532-175388438@16.2@149@300@2.01@NA@THOC3-001_4, THOC3-001_5, THOC3-001_6@169@160@182@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
D86968@79578@79580@duplication@3@175523829@175525562@5@chr5:175523829-175525562@6.97@244@351@1.44@NA@FAM153B-201_7, FAM153B-201_8, FAM153B-201_9@18@17@20@:uncharacterized LOC100507387;family with sequence similarity 153, member B@NA@NA
D86968@80019@80019@deletion@1@177163582@177163611@5@chr5:177163582-177163611@6.32@66@24@0.364@NA@FAM153A-204_12@78@78@78@:family with sequence similarity 153, member A@NA@NA
D86968@80022@80024@deletion@3@177166603@177168334@5@chr5:177166603-177168334@16.8@98@14@0.143@NA@FAM153A-204_7, FAM153A-204_8, FAM153A-204_9@94@86@106@:family with sequence similarity 153, member A@NA@NA
D86968@80264@80264@duplication@1@179071802@179072048@5@chr5:179071802-179072048@4.76@476@659@1.38@NA@C5orf60-203_1@0@0@0@:chromosome 5 open reading frame 60@:integral to membrane@NA
D86968@80479@80486@deletion@8@180375357@180424410@5@chr5:180375357-180424410@9.07@727@494@0.68@CNVR2719.1@BTNL8-202_5, BTNL8-202_6, BTNL8-202_7, BTNL8-202_8, BTNL3-202_1, BTNL3-202_2, BTNL3-202_3@104.142857142857@93@108@:butyrophilin-like 8:butyrophilin-like 3@:protein binding;integral to membrane:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
D86968@83002@83004@deletion@3@31237745@31239109@6@chr6:31237745-31239109@19.5@503@270@0.537@CNVR2838.1@HLA-C-006_3, HLA-C-006_4, HLA-C-006_5@21@13@25@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
D86968@83014@83015@duplication@2@31323946@31324367@6@chr6:31323946-31324367@5.55@321@442@1.38@CNVR2841.12, CNVR2841.14, CNVR2841.8@HLA-B-201_4, HLA-B-201_5@64.5@59@70@:major histocompatibility complex, class I, B@:MHC class I protein complex;regulation of immune response;regulation of interleukin-12 production;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;regulation of T cell anergy;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;receptor binding;early endosome membrane;virus-host interaction;regulation of interleukin-6 production;regulation of dendritic cell differentiation;phagocytic vesicle membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO; SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1
D86968@83910@83913@deletion@4@32441204@32486444@6@chr6:32441204-32486444@7.41@60@19@0.317@CNVR2845.21, CNVR2845.25, CNVR2845.30@HLA-DRB9-001_1, HLA-DRB5-001_4, HLA-DRB5-001_5, HLA-DRB5-001_6@151.5@44@189@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D86968@83915@83915@deletion@1@32489684@32489952@6@chr6:32489684-32489952@10.2@48@1@0.0208@CNVR2845.21, CNVR2845.25, CNVR2845.30, CNVR2845.43@HLA-DRB5-001_2@177@177@177@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D86968@83919@83928@deletion@10@32521635@32548634@6@chr6:32521635-32548634@40@338@98@0.29@CNVR2845.21, CNVR2845.25, CNVR2845.24, CNVR2845.5@HLA-DRB6-002_1, HLA-DRB6-002_2, HLA-DRB6-002_3, HLA-DRB6-002_4, AL713966-201_1, AL713966-201_2, AL713966-201_3, HLA-DRB1-001_4, HLA-DRB1-001_5, HLA-DRB1-001_6@119.1@56@167@:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1@:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
D86968@83934@83946@deletion@13@32609089@32634448@6@chr6:32609089-32634448@79.2@1008@431@0.428@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20@HLA-DQA1-002_3, HLA-DQA1-002_4, HLA-DQA1-002_5, HLA-DQA1-002_6, HLA-DQB1-003_2, HLA-DQB1-003_3, HLA-DQB1-003_4, HLA-DQB1-003_5, HLA-DQB1-003_6, XXbac-BPG254F23-001_1, XXbac-BPG254F23-001_2, ENST00000443574_1, ENST00000443574_2@123.692307692308@80@146@:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
D86968@84708@84710@duplication@3@35762761@35765089@6@chr6:35762761-35765089@9.22@633@887@1.4@CNVR2861.1@CLPS-001_1, CLPS-001_2, CLPS-001_3@37.6666666666667@30@43@:colipase, pancreatic@:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
D86968@92589@92594@duplication@6@160132299@160133143@6@chr6:160132299-160133143@34.3@656@1103@1.68@CNVR3127.2, CNVR3127.1@ENST00000442642_3, ENST00000442642_4, ENST00000442642_5, ENST00000442642_6, ENST00000442642_7, ENST00000442642_8@95.6666666666667@56@112@:superoxide dismutase 2, mitochondrial;uncharacterized LOC100129518@:response to reactive oxygen species;oxidation-reduction process;mitochondrion;negative regulation of cell proliferation;neuron development;negative regulation of fat cell differentiation;removal of superoxide radicals;response to gamma radiation;response to L-ascorbic acid;response to lipopolysaccharide;response to nutrient levels;response to zinc ion;protein homotetramerization;post-embryonic development;iron ion homeostasis;hemopoiesis;aging;mitochondrial inner membrane;age-dependent response to reactive oxygen species;response to drug;oxygen binding;mitochondrial nucleoid;vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure;apoptotic process;superoxide metabolic process;response to superoxide;detection of oxygen;response to silicon dioxide;cytoplasm;response to stress;respiratory electron transport chain;superoxide anion generation;protein homooligomerization;regulation of mitochondrial membrane potential;positive regulation of nitric oxide biosynthetic process;response to manganese ion;regulation of blood pressure;metal ion binding;negative regulation of apoptotic process;response to cadmium ion;response to oxidative stress;liver development;regulation of catalytic activity;negative regulation of fibroblast proliferation;response to selenium ion;age-dependent response to oxidative stress;response to electrical stimulus;mitochondrial matrix;identical protein binding;mitochondrion organization;response to hyperoxia;vasodilation;response to hydrogen peroxide;superoxide dismutase activity;heart development;negative regulation of neuron apoptotic process;erythrophore differentiation;locomotory behavior;DNA binding;release of cytochrome c from mitochondria;response to axon injury;oxygen homeostasis;response to activity;glutathione metabolic process;hydrogen peroxide metabolic process;hydrogen peroxide biosynthetic process;regulation of transcription from RNA polymerase II promoter;response to hypoxia;protein binding;manganese ion binding;cellular response to ethanol@: MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6; MVCD6
D86968@94201@94201@duplication@1@5983544@5983622@7@chr7:5983544-5983622@5.26@165@251@1.52@NA@RSPH10B-002_14@10@10@10@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D86968@94410@94411@deletion@2@6785721@6785820@7@chr7:6785721-6785820@6.35@136@74@0.544@NA@ENST00000338780_11, PMS2CL-002_11@78@78@78@NA@NA@NA
D86968@94438@94440@duplication@3@6836201@6838397@7@chr7:6836201-6838397@9.89@160@267@1.67@NA@RSPH10B2-204_20, RSPH10B2-204_21, ENST00000429267_1, C7orf28B-001_15@85.6666666666667@25@117@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D86968@96205@96205@deletion@1@33195252@33195315@7@chr7:33195252-33195315@9.62@86@25@0.291@NA@BBS9-203_4@10@10@10@:Bardet-Biedl syndrome 9@:BBSome;fat cell differentiation;microtubule organizing center;cytoplasm;protein binding;response to stimulus;visual perception;nucleus;plasma membrane;molecular_function;cilium membrane@: WILMS TUMOR 5; WT5; BARDET-BIEDL SYNDROME; BBS
D86968@96331@96332@deletion@2@35204454@35204584@7@chr7:35204454-35204584@5.93@117@62@0.53@NA@DPY19L2-001_4, AC005400-201_5@6@6@6@NA@NA@NA
D86968@97912@97917@deletion@6@57071006@57084498@7@chr7:57071006-57084498@8.46@64@18@0.281@NA@TNRC18C-202_8, TNRC18C-202_9, TNRC18C-202_10, TNRC18C-202_11, ENST00000398760_4, ENST00000398760_5@155.5@144@166@NA@NA@NA
D86968@98173@98174@duplication@2@64533487@64534227@7@chr7:64533487-64534227@10.2@31@104@3.35@NA@RP11-460N20-001_11, RP11-460N20-001_12, ENST00000501153_3@101@101@101@NA@NA@NA
D86968@98215@98216@deletion@2@65150574@65154417@7@chr7:65150574-65154417@11.4@135@57@0.422@NA@INTS4L2-001_5, INTS4L2-001_6@29.5@3@56@NA@NA@NA
D86968@99233@99233@deletion@1@74991244@74991359@7@chr7:74991244-74991359@5.74@27@1@0.037@CNVR3456.1@STAG3L1-004_3@60@60@60@NA@NA@NA
D86968@99272@99273@deletion@2@75054920@75055736@7@chr7:75054920-75055736@4.97@89@47@0.528@NA@POM121C-001_8, POM121C-001_9@51@30@72@:POM121 transmembrane nucleoporin C@:nuclear membrane;protein binding;protein transport;endoplasmic reticulum membrane;nuclear pore;mRNA transport@NA
D86968@99455@99455@deletion@1@76069569@76069659@7@chr7:76069569-76069659@12.3@204@85@0.417@CNVR3462.1@ZP3-002_7@10@10@10@:zona pellucida glycoprotein 3 (sperm receptor)@:negative regulation of transcription, DNA-dependent;manganese ion transmembrane transporter activity;intracellular protein transport;proteinaceous extracellular matrix;plasma membrane;positive regulation of acrosome reaction;outer acrosomal membrane;protein kinase C signaling cascade;manganese ion transmembrane transport;intracellular signal transduction;humoral immune response mediated by circulating immunoglobulin;negative regulation of binding of sperm to zona pellucida;positive regulation of inflammatory response;endoplasmic reticulum;signal transducer activity;perinuclear region of cytoplasm;secretory granule;positive regulation of transcription, DNA-dependent;positive regulation of ovarian follicle development;positive regulation of interferon-gamma production;carbohydrate binding;manganese ion transport;positive regulation of antral ovarian follicle growth;extracellular matrix;positive regulation of leukocyte migration;positive regulation of humoral immune response;extracellular space;blastocyst formation;integral to membrane;store-operated calcium channel activity;oocyte development;multivesicular body;phosphatidylinositol-mediated signaling;acrosomal vesicle;positive regulation of protein kinase B signaling cascade;Golgi apparatus;positive regulation of calcium ion import;positive regulation of protein kinase activity;positive regulation of acrosomal vesicle exocytosis;positive regulation of interleukin-4 production;cytoplasm;protein binding;binding of sperm to zona pellucida;positive regulation of phosphatidylinositol biosynthetic process;extracellular region;positive regulation of T cell proliferation;acrosin binding;positive regulation of type IV hypersensitivity;egg coat formation@NA
D86968@99463@99465@duplication@3@76121472@76129838@7@chr7:76121472-76129838@5.79@92@150@1.63@CNVR3462.1@DTX2-001_6, DTX2-001_7, DTX2-001_8@51.3333333333333@22@69@:deltex homolog 2 (Drosophila)@:ligase activity;cytoplasm;nuclear membrane;Notch signaling pathway;protein binding;nucleus;zinc ion binding;protein ubiquitination@NA
D86968@99489@99490@duplication@2@76240773@76241131@7@chr7:76240773-76241131@16.7@298@522@1.75@CNVR3463.10@POMZP3-003_6, POMZP3-003_7@43.5@41@46@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
D86968@101721@101726@duplication@6@100331652@100336237@7@chr7:100331652-100336237@13.5@797@1104@1.39@CNVR3509.1@ZAN-001_2, ZAN-001_3, ZAN-001_4, ZAN-001_5, ZAN-001_6, ZAN-001_7@81.6666666666667@71@89@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
D86968@102130@102130@duplication@1@102136589@102136652@7@chr7:102136589-102136652@9.21@180@315@1.75@CNVR3518.1@RASA4B-007_16@49@49@49@:RAS p21 protein activator 4B@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction@NA
D86968@102166@102167@duplication@2@102219874@102223340@7@chr7:102219874-102223340@13.6@48@163@3.4@CNVR3518.1@ENST00000379336_1, RASA4-001_21@56@49@63@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
D86968@102177@102177@deletion@1@102235754@102235817@7@chr7:102235754-102235817@6.75@78@30@0.385@CNVR3518.1@RASA4-001_11@55@55@55@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
D86968@103919@103919@duplication@1@128128157@128128216@7@chr7:128128157-128128216@4.68@69@119@1.72@NA@METTL2B-001_5@0@0@0@:methyltransferase like 2B@:methyltransferase activity;metabolic process@NA
D86968@105321@105343@duplication@23@141765517@141794455@7@chr7:141765517-141794455@28.8@3067@3998@1.3@CNVR3585.3, CNVR3585.2@MGAM-007_40, MGAM-007_41, MGAM-007_42, MGAM-007_43, MGAM-007_44, MGAM-007_45, MGAM-007_46, MGAM-007_47, MGAM-007_48, MGAM-007_49, MGAM-007_50, MGAM-007_51, MGAM-007_52, MGAM-007_53, MGAM-007_54, MGAM-007_55, MGAM-007_56, MGAM-007_57, MGAM-007_58, MGAM-007_59, MGAM-007_60, MGAM-007_61, MGAM-007_62@108.086956521739@5@134@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
D86968@105772@105791@duplication@20@143883178@143973535@7@chr7:143883178-143973535@50.1@721@1485@2.06@CNVR3598.4, CNVR3598.7@ARHGEF5L-001_1, ARHGEF5L-001_2, RP4-545C24-003_1, RP4-545C24-003_2, RP4-545C24-003_3, RP4-545C24-003_4, RP4-545C24-003_5, RP4-545C24-003_6, OR2A20P-003_1, OR2A20P-003_2, OR2A20P-003_3, OR2A20P-003_4, OR2A20P-003_5, RP4-798C17-001_9, RP4-798C17-001_10, RP4-798C17-001_11, RP4-798C17-001_12, ENST00000378112_10, ENST00000378112_11, ENST00000378112_12@45.6@14@127@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:olfactory receptor, family 2, subfamily A, member 7:CTAGE family, member 6, pseudogene;CTAGE family, member 15, pseudogene@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane@NA
D86968@105798@105819@duplication@22@143975408@144062917@7@chr7:143975408-144062917@46.6@910@1497@1.65@CNVR3598.4@RP4-798C17-004_1, RP4-798C17-004_2, RP4-798C17-004_3, RP4-798C17-004_4, RP4-798C17-004_5, RP4-798C17-004_6, RP4-798C17-001_1, RP4-798C17-001_2, RP4-798C17-001_3, RP4-798C17-001_4, RP4-798C17-001_5, ENST00000378112_1, ENST00000378112_2, ENST00000378112_3, ENST00000378112_4, ENST00000378112_5, ENST00000378112_6, OR2A9P-002_1, OR2A9P-002_2, OR2A9P-002_3, ARHGEF5-001_1, ARHGEF5-001_2@49.0454545454545@14@135@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
D86968@105827@105827@deletion@1@144070290@144070378@7@chr7:144070290-144070378@21.4@113@5@0.0442@CNVR3598.4, CNVR3598.5, CNVR3598.11@ARHGEF5-001_10@83@83@83@:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
D86968@107425@107429@duplication@5@7274294@7308722@8@chr8:7274294-7308722@12@552@800@1.45@CNVR3771.8, CNVR3771.10, CNVR3771.4@DEFB4P-001_1, DEFB103A-001_1, DEFB103A-001_2, SPAG11-003_3, SPAG11-003_4@68@51@91@:defensin, beta 4B;defensin, beta 4A:defensin, beta 103B;defensin, beta 103A:sperm associated antigen 11B@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response@NA
D86968@107513@107513@deletion@1@7718170@7718505@8@chr8:7718170-7718505@4.99@148@84@0.568@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@SPAG11A-207_4@111@111@111@:sperm associated antigen 11A;sperm associated antigen 11B@:extracellular region;defense response@NA
D86968@118852@118854@duplication@3@84545017@84549914@9@chr9:84545017-84549914@14@453@786@1.74@CNVR4364.1@ENST00000427387_1, RP11-383M4-201_3, RP11-383M4-201_4@16.3333333333333@11@27@NA@NA@NA
D86968@126269@126269@deletion@1@9449789@9449825@10@chr10:9449789-9449825@5.59@41@10@0.244@NA@AL355591-202_3@0@0@0@NA@NA@NA
D86968@126909@126909@duplication@1@17840632@17842868@10@chr10:17840632-17842868@5.93@39@89@2.28@NA@FAM23A-201_5@108@108@108@:transmembrane protein 236;transmembrane protein 236-like@:integral to membrane@NA
D86968@126914@126920@deletion@7@17882694@17905693@10@chr10:17882694-17905693@6.71@451@295@0.654@NA@MRC1L1-001_5, MRC1L1-001_6, MRC1L1-001_7, MRC1L1-001_8, MRC1L1-001_9, MRC1L1-001_10, MRC1L1-001_11@6.42857142857143@5@12@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
D86968@126946@126947@duplication@2@18112046@18116669@10@chr10:18112046-18116669@5.32@71@126@1.77@NA@MRC1-001_2, MRC1-001_3@28.5@26@31@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D86968@126951@126956@duplication@6@18138510@18152612@10@chr10:18138510-18152612@11.2@144@256@1.78@NA@MRC1-001_7, MRC1-001_8, MRC1-001_9, MRC1-001_10, MRC1-001_11, RP11-457D2-001_2@19.6666666666667@18@26@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D86968@127835@127836@deletion@2@30978170@30978431@10@chr10:30978170-30978431@5.38@134@76@0.567@NA@ENST00000422642_3, ENST00000422642_4@0@0@0@NA@NA@NA
D86968@128825@128850@duplication@26@46918171@47098650@10@chr10:46918171-47098650@89.2@6861@10150@1.48@CNVR4712.9, CNVR4712.2, CNVR4712.7, CNVR4712.4@FAM35B-001_3, FAM35B-001_4, FAM35B-001_5, FAM35B-001_6, FAM35B-001_7, FAM35B-001_8, ENST00000424615_1, ENST00000424615_2, ENST00000430188_1, ENST00000430188_2, SYT15-203_1, SYT15-203_2, SYT15-203_3, SYT15-203_4, SYT15-203_6, SYT15-203_7, SYT15-203_8, SYT15-203_9, GPRIN2-001_1, GPRIN2-001_2, GPRIN2-001_3, PPYR1-201_1, PPYR1-201_2, PPYR1-201_3, RP11-314P12-001_3@24.52@15@72@:synaptotagmin XV:G protein regulated inducer of neurite outgrowth 2:pancreatic polypeptide receptor 1;neuropeptide Y receptor type 4-like@:protein binding;synaptic vesicle;integral to membrane;transporter activity;plasma membrane;membrane;extrinsic to membrane:blood circulation;peptide YY receptor activity;peptide binding;pancreatic polypeptide receptor activity;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;integral to membrane;digestion;plasma membrane;integral to plasma membrane;feeding behavior@NA
D86968@128897@128901@duplication@5@47253597@47259684@10@chr10:47253597-47259684@7.62@112@191@1.71@CNVR4712.9, CNVR4712.1@GLUDP8-001_1, GLUDP8-001_2, GLUDP8-001_3, RP11-144G6-201_1, RP11-144G6-201_2@14.8@8@20@NA@NA@NA
D86968@128979@128979@deletion@1@47758848@47758905@10@chr10:47758848-47758905@5.71@26@0@0@CNVR4714.1@ANXA8L2-001_10@154@154@154@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:calcium-dependent phospholipid binding;calcium ion binding@NA
D86968@129003@129007@deletion@5@47933809@47942085@10@chr10:47933809-47942085@6.8@31@0@0@CNVR4715.2, CNVR4715.1@FAM21B-201_20, FAM21B-201_21, FAM21B-201_22, FAM21B-201_23, FAM21B-201_24@175@165@185@:family with sequence similarity 21, member B@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
D86968@129021@129030@duplication@10@48020452@48055019@10@chr10:48020452-48055019@9.89@561@771@1.37@CNVR4715.2@ASAH2C-201_1, ASAH2C-201_2, ASAH2C-201_3, ASAH2C-201_4, ASAH2C-201_5, ASAH2C-201_6, ASAH2C-201_7, ASAH2C-201_8, ASAH2C-201_9, ASAH2C-201_10@64.3@50@90@@:ceramidase activity;sphingolipid metabolic process@NA
D86968@129460@129477@deletion@18@51361725@51391568@10@chr10:51361725-51391568@80.6@415@17@0.041@NA@ENST00000404618_1, ENST00000404618_2, ENST00000404618_3, ENST00000404618_4, ENST00000432221_1, ENST00000432221_2, ENST00000432221_3, ENST00000432221_4, TIMM23B-202_1, TIMM23B-202_2, TIMM23B-202_3, TIMM23B-202_4, TIMM23B-202_5, TIMM23B-202_6, TIMM23B-202_7, TIMM23B-202_8, TIMM23B-202_9, TIMM23B-202_10@68.7222222222222@0@142@:translocase of inner mitochondrial membrane 23 homolog B (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process@NA
D86968@129605@129611@deletion@7@51970585@51994313@10@chr10:51970585-51994313@19.5@208@86@0.413@NA@ASAH2-201_5, ASAH2-201_6, ASAH2-201_7, ASAH2-201_8, ASAH2-201_9, ASAH2-201_10, ASAH2-201_11@145.142857142857@53@186@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
D86968@135736@135736@deletion@1@124359582@124359610@10@chr10:124359582-124359610@6.11@255@150@0.588@CNVR4912.4, CNVR4912.3@DMBT1-002_27@7@7@7@:deleted in malignant brain tumors 1@:defense response to virus;calcium-dependent protein binding;pattern recognition receptor signaling pathway;blastocyst development;response to estrogen stimulus;tissue regeneration;proteinaceous extracellular matrix;protein transport;Gram-negative bacterial cell surface binding;positive regulation of epithelial cell differentiation;virus-host interaction;epithelial cell differentiation;induction of bacterial agglutination;phagocytic vesicle membrane;intracellular;Gram-positive bacterial cell surface binding;zymogen binding;innate immune response;cytoplasm;extrinsic to membrane;protein binding;zymogen granule membrane;extracellular region;scavenger receptor activity;pattern recognition receptor activity;inner cell mass cell proliferation;membrane@: GLIOMA SUSCEPTIBILITY 1; GLM1
D86968@139527@139527@duplication@1@18955060@18956211@11@chr11:18955060-18956211@6.12@955@1331@1.39@CNVR5091.2, CNVR5091.1@MRGPRX1-203_3@16@16@16@:MAS-related GPR, member X1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;acute-phase response;G-protein coupled receptor signaling pathway@NA
D86968@141273@141277@deletion@5@55032378@55038593@11@chr11:55032378-55038593@12.1@307@170@0.554@CNVR5178.5@TRIM48-201_2, TRIM48-201_3, TRIM48-201_4, TRIM48-201_5, TRIM48-201_6@51.2@48@61@:tripartite motif containing 48@:protein binding;intracellular;zinc ion binding@NA
D86968@145945@145980@deletion@36@89702620@89796166@11@chr11:89702620-89796166@34.1@340@132@0.388@NA@TRIM64-202_2, TRIM64-202_3, TRIM64-202_4, TRIM64-202_5, TRIM64-202_7, TRIM64-202_8, TRIM64-202_9, ENST00000442514_1, ENST00000442514_2, ENST00000442514_3, ENST00000442514_4, ENST00000442514_5, ENST00000442514_6, ENST00000442514_7, ENST00000442514_8, ENST00000442514_9, TRIM53-202_1, TRIM53-202_2, TRIM53-202_3, TRIM53-202_4, TRIM53-202_5, TRIM53-202_6, TRIM53-202_7, ENST00000432771_1, ENST00000432771_2, ENST00000432771_3, ENST00000432771_4, ENST00000432771_5, ENST00000436580_1, ENST00000436580_2, ENST00000436580_3, ENST00000436580_4, ENST00000436580_5, ENST00000436580_6, ENST00000436580_7@83.8@21@177@:tripartite motif containing 49D, pseudogene;tripartite motif containing 49-like 1;tripartite motif containing 49C;tripartite motif-containing protein 49-like protein 1-like@:protein binding;intracellular;DNA binding;zinc ion binding@NA
D86968@147534@147536@deletion@3@117077785@117079770@11@chr11:117077785-117079770@5.66@176@104@0.591@NA@PCSK7-201_13, PCSK7-201_14, PCSK7-201_15@10@9@11@:proprotein convertase subtilisin/kexin type 7@:proteolysis;integral to Golgi membrane;serine-type endopeptidase activity;peptide hormone processing@NA
D86968@150829@150841@duplication@13@9684189@9707352@12@chr12:9684189-9707352@13.9@632@872@1.38@CNVR5429.1@AC006432-201_1, AC006432-201_2, AC006432-201_3, AC006432-201_4, AC006432-201_5, AC006432-201_6, AC006432-201_7, AC006432-201_8, AC006432-201_9, AC006432-201_10, AC006432-201_11, AC006432-201_12, AC006432-201_13@22.2307692307692@15@25@NA@NA@NA
D86968@152226@152226@deletion@1@31249277@31249314@12@chr12:31249277-31249314@8.97@94@32@0.34@CNVR5483.1@DDX11-202_16@0@0@0@:DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11@:nucleoplasm;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;S phase of mitotic cell cycle;DNA binding;nucleobase-containing compound metabolic process;ATP binding;ATP-dependent DNA helicase activity;DNA helicase activity;midbody;RNA binding;DNA-dependent ATPase activity;nucleus;positive regulation of cell proliferation;virus-host interaction;nuclear chromatin;4 iron, 4 sulfur cluster binding;helicase activity;hydrolase activity, acting on acid anhydrides;DNA duplex unwinding;endoplasmic reticulum unfolded protein response;G2/M transition of mitotic cell cycle;protein binding;sister chromatid cohesion;activation of signaling protein activity involved in unfolded protein response;nucleolus;spindle pole;ATP-dependent helicase activity;metal ion binding;nucleic acid binding;mitotic sister chromatid segregation@: WARSAW BREAKAGE SYNDROME
D86968@152246@152246@deletion@1@31269977@31270151@12@chr12:31269977-31270151@7.95@73@23@0.315@CNVR5483.1@ENST00000266524_28@6@6@6@NA@NA@NA
D86968@152250@152251@deletion@2@31282655@31283524@12@chr12:31282655-31283524@7.09@211@122@0.578@CNVR5483.1@ENST00000266524_23, ENST00000266524_24@1@1@1@NA@NA@NA
D86968@154074@154076@duplication@3@52865458@52867176@12@chr12:52865458-52867176@5.86@429@573@1.34@NA@KRT6C-202_2, KRT6C-202_3, KRT6C-202_4@29.3333333333333@16@45@:keratin 6C@:intermediate filament;structural molecule activity;keratin filament;cytoskeleton organization@NA
D86968@162127@162128@deletion@2@24465240@24465671@13@chr13:24465240-24465671@10.6@1012@656@0.648@NA@RP11-45B20-002_6, ENST00000382133_3@29@29@29@:C1q and tumor necrosis factor related protein 9B@:collagen;protein binding@NA
D86968@162228@162230@deletion@3@25169929@25171416@13@chr13:25169929-25171416@5.87@68@29@0.426@CNVR5826.1@RP11-556N21-001_9, ENST00000453498_11, ENST00000453498_12@44@2@65@NA@NA@NA
D86968@166697@166699@duplication@3@19553367@19559165@14@chr14:19553367-19559165@18.8@78@240@3.08@CNVR6072.1@POTEG-201_1, POTEG-201_2, POTEG-201_3@122.333333333333@91@141@:POTE ankyrin domain family, member G@:protein binding@NA
D86968@173412@173414@duplication@3@106090689@106091717@14@chr14:106090689-106091717@5.9@466@626@1.34@CNVR6294.46, CNVR6294.20, CNVR6294.54, CNVR6294.43, CNVR6294.50, CNVR6294.61@IGHG4-001_2, IGHG4-001_3, IGHG4-001_4@6@6@6@@:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response@NA
D86968@173501@173503@deletion@3@106478134@106478604@14@chr14:106478134-106478604@27.6@179@31@0.173@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV3-6-210_6, IGHV4-4-001_1, IGHV4-4-001_2@13@5@17@@:protein binding@NA
D86968@173508@173514@deletion@7@106539081@106573538@14@chr14:106539081-106573538@166@1136@185@0.163@CNVR6294.36, CNVR6294.48, CNVR6294.24, CNVR6294.10, CNVR6294.34@IGHV1-8-001_1, IGHV1-8-001_2, IGHV3-9-001_1, IGHV3-9-001_2, IGHV2-10-001_1, IGHV2-10-001_2, IGHV3-11-001_2@20.4285714285714@9@24@@:protein binding:protein binding:protein binding@NA
D86968@173536@173542@duplication@7@106721281@106725734@14@chr14:106721281-106725734@17.1@1369@1863@1.36@CNVR6294.48, CNVR6294.24, CNVR6294.40, CNVR6294.38, CNVR6294.17, CNVR6294.23@AB019439-201_1, AB019439-201_2, IGHVIII-22-2-201_1, IGHVIII-22-2-201_2, IGHVIII-22-2-201_3, IGHV3-23-001_1, IGHV3-23-001_2@6.71428571428571@5@8@@:protein binding@NA
D86968@173556@173567@deletion@12@106787370@106816254@14@chr14:106787370-106816254@66@1449@673@0.464@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-29-001_1, IGHV3-29-001_2, IGHV3-30-001_1, IGHV3-30-001_2, IGHV3-30-2-001_1, IGHV3-30-2-001_2, IGHV4-31-001_1, IGHV4-31-001_2, IGHV3-32-001_1, IGHV3-32-001_2, IGHV3-33-001_1, IGHV3-33-001_2@15.3333333333333@5@19@@:protein binding:protein binding:protein binding@NA
D86968@173642@173642@deletion@1@107114151@107114275@14@chr14:107114151-107114275@7.84@254@139@0.547@CNVR6294.56, CNVR6294.16@IGHV3-64-001_1@0@0@0@@:protein binding@NA
D86968@173682@173689@duplication@8@20444657@20462709@15@chr15:20444657-20462709@16.5@2939@3854@1.31@CNVR6295.15, CNVR6295.7, CNVR6295.13, CNVR6295.26@ENST00000400226_8, ENST00000400226_9, ENST00000400226_10, ENST00000400226_11, ENST00000400226_12, ENST00000400226_13, ENST00000400226_14, ENST00000400226_15@68.5@30@80@NA@NA@NA
D86968@173692@173696@duplication@5@20466501@20482048@15@chr15:20466501-20482048@12.3@2057@2701@1.31@CNVR6295.15, CNVR6295.7, CNVR6295.13, CNVR6295.26@ENST00000400226_1, ENST00000400226_2, ENST00000400226_3, ENST00000400226_4, ENST00000400226_5@64.4@34@75@NA@NA@NA
D86968@173814@173822@duplication@9@22297500@22473354@15@chr15:22297500-22473354@51.3@2374@3741@1.58@CNVR6297.4, CNVR6297.17, CNVR6297.6@AC134980-201_1, AC134980-201_2, ENST00000438898_1, ENST00000438898_2, AC025884-201_1, AC010760-202_2, VSIG6-201_1, VSIG6-201_2@60.25@15@87@:olfactory receptor, family 4, subfamily M, member 2:olfactory receptor, family 4, subfamily N, member 4@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
D86968@174504@174507@deletion@4@30659623@30665349@15@chr15:30659623-30665349@15.2@455@276@0.607@CNVR6337.1@CHRFAM7A-202_6, CHRFAM7A-202_7, CHRFAM7A-202_8, CHRFAM7A-202_9@51.25@44@68@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
D86968@174967@174975@duplication@9@34781267@34820279@15@chr15:34781267-34820279@11.5@1081@1403@1.3@CNVR6351.3@AC027139-201_1, AC027139-201_2, AC027139-201_3, AC027139-201_4, ENST00000444260_1, ENST00000444260_2, ENST00000444260_3, GOLGA8B-201_23, GOLGA8B-201_24@43.6666666666667@31@49@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
D86968@180187@180187@duplication@1@79065427@79065546@15@chr15:79065427-79065546@4.78@43@86@2@NA@ADAMTS7-201_14@10@10@10@:A disintegrin and metalloproteinase with thrombospondin motifs 7-like;ADAM metallopeptidase with thrombospondin type 1 motif, 7@:metallopeptidase activity;extracellular matrix;proteolysis;peptidase activity;proteinaceous extracellular matrix;metalloendopeptidase activity;cell surface;zinc ion binding@NA
D86968@183359@183359@duplication@1@2607706@2607965@16@chr16:2607706-2607965@7.42@230@364@1.58@CNVR6601.1@PDPK1-003_2@3@3@3@:3-phosphoinositide dependent protein kinase-1@:3-phosphoinositide-dependent protein kinase activity;nucleoplasm;fibroblast growth factor receptor signaling pathway;protein tyrosine kinase activity;negative regulation of transforming growth factor beta receptor signaling pathway;negative regulation of toll-like receptor signaling pathway;regulation of endothelial cell migration;focal adhesion assembly;ATP binding;insulin receptor signaling pathway;plasma membrane;intracellular signal transduction;positive regulation of establishment of protein localization to plasma membrane;platelet activation;protein kinase activity;regulation of mast cell degranulation;cytosol;epidermal growth factor receptor signaling pathway;hyperosmotic response;nerve growth factor receptor signaling pathway;type B pancreatic cell development;synaptic transmission;regulation of apoptotic process;transcription, DNA-dependent;protein autophosphorylation;regulation of I-kappaB kinase/NF-kappaB cascade;protein kinase binding;T cell costimulation;insulin receptor binding;transferase activity, transferring phosphorus-containing groups;actin cytoskeleton organization;blood coagulation;negative regulation of protein kinase activity;cellular response to insulin stimulus;focal adhesion;phosphatidylinositol-mediated signaling;negative regulation of cardiac muscle cell apoptotic process;protein serine/threonine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;cytoplasm;activation of protein kinase B activity;protein binding;T cell receptor signaling pathway;cytoplasmic membrane-bounded vesicle;peptidyl-threonine phosphorylation;kinase activity@NA
D86968@183384@183384@deletion@1@2692232@2693298@16@chr16:2692232-2693298@24.4@123@2@0.0163@CNVR6602.2@AC141586-201_1@50@50@50@NA@NA@NA
D86968@185501@185501@deletion@1@21391315@21391537@16@chr16:21391315-21391537@4.94@60@25@0.417@NA@RUNDC2B-201_1@4@4@4@NA@NA@NA
D86968@187507@187518@deletion@12@32859168@32893409@16@chr16:32859168-32893409@9.71@1001@697@0.696@CNVR6702.2, CNVR6702.1, CNVR6702.3@IGHV2OR16-5-001_2, AC138915-201_4, AC138915-201_5, AC138915-201_6, AC138915-201_7, AC138915-201_8, AC138915-201_9, AC138915-201_10, AC138915-201_11, AC138915-201_12, AC138915-201_13, AC138915-201_14@30.9166666666667@22@36@NA@NA@NA
D86968@187602@187609@duplication@8@34489564@34682257@16@chr16:34489564-34682257@31.2@1221@1790@1.47@CNVR6708.1@ENST00000425453_1, ENST00000425453_2, ENST00000425453_3, ENST00000425453_4, ENST00000425453_6, AC018558-202_1, AC018558-202_2@13.4285714285714@2@20@NA@NA@NA
D86968@188232@188241@duplication@10@55806283@55820017@16@chr16:55806283-55820017@10.6@454@640@1.41@CNVR6730.1@CES4-202_5, CES4-202_6, CES4-202_7, CES4-202_8, CES4-202_9, CES4-202_10, CES4-202_11, AC147362-203_1, AC147362-203_2, AC147362-203_3@99.1@83@111@NA@NA@NA
D86968@190538@190551@duplication@14@74425291@74455444@16@chr16:74425291-74455444@10.2@540@741@1.37@CNVR6778.2, CNVR6778.3@NPIPL2-202_7, CLEC18B-202_1, CLEC18B-202_2, CLEC18B-202_3, CLEC18B-202_4, CLEC18B-202_5, CLEC18B-202_6, CLEC18B-202_7, CLEC18B-202_8, CLEC18B-202_9, CLEC18B-202_10, CLEC18B-202_11, CLEC18B-202_12, CLEC18B-202_13@53.6428571428571@27@63@:C-type lectin domain family 18, member B@:extracellular region:carbohydrate binding;protein binding;extracellular region@NA
D86968@191081@191083@duplication@3@83983868@83984282@16@chr16:83983868-83984282@8.87@182@289@1.59@NA@AC009063-201_1, AC009063-201_2, AC009063-201_3@1.33333333333333@0@2@:oxidative stress induced growth inhibitor 1@:oxidation-reduction process;multicellular organismal development;cell differentiation;growth factor activity;negative regulation of cell growth;oxidoreductase activity;cellular_component@NA
D86968@192798@192798@deletion@1@4439373@4439470@17@chr17:4439373-4439470@4.82@83@41@0.494@NA@SPNS2-201_10@1@1@1@:spinster homolog 2 (Drosophila)@:integral to membrane;transmembrane transporter activity;lipid transport;transmembrane transport@NA
D86968@195716@195718@deletion@3@18394589@18395860@17@chr17:18394589-18395860@5.64@258@163@0.632@CNVR7014.1@LGALS9C-201_7, LGALS9C-201_8, LGALS9C-201_9@138@135@140@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
D86968@195871@195871@duplication@1@18996780@18996940@17@chr17:18996780-18996940@10.3@266@453@1.7@CNVR7018.4, CNVR7018.2, CNVR7018.6@AC007952-202_2@92@92@92@NA@NA@NA
D86968@196128@196129@deletion@2@20303836@20305505@17@chr17:20303836-20305505@5.13@142@84@0.592@NA@AC008088-203_15, AC008088-203_16@1@1@1@NA@NA@NA
D86968@196152@196154@duplication@3@20355110@20356381@17@chr17:20355110-20356381@6.75@179@271@1.51@CNVR7021.1, CNVR7021.3@LGALS9B-201_7, LGALS9B-201_8, LGALS9B-201_9@100.333333333333@97@103@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
D86968@197726@197748@duplication@23@34539180@34641345@17@chr17:34539180-34641345@12.3@219@350@1.6@CNVR7077.1, CNVR7077.13, CNVR7077.19, CNVR7077.2@CCL3L1-205_1, CCL3L1-205_2, CCL3L1-205_3, CCL4L1-202_2, CCL4L1-202_3, CCL4L1-202_4, TBC1D3C-002_1, TBC1D3C-002_2, TBC1D3C-002_3, TBC1D3C-002_4, TBC1D3C-002_5, TBC1D3C-002_6, TBC1D3C-002_7, TBC1D3C-002_8, TBC1D3C-002_9, TBC1D3C-002_10, TBC1D3C-002_11, TBC1D3C-002_12, TBC1D3C-002_13, TBC1D3C-002_14, CCL4L2-202_1, CCL4L2-202_2, CCL4L2-202_3@96.1739130434783@34@136@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
D86968@198043@198044@duplication@2@36398220@36413071@17@chr17:36398220-36413071@4.91@262@372@1.42@CNVR7083.3@AC183087-202_2, AC183087-202_3@18.5@8@29@:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
D86968@200257@200266@duplication@10@43578687@43596019@17@chr17:43578687-43596019@12.8@564@796@1.41@CNVR7113.4, CNVR7113.6, CNVR7113.2@AC091132-201_1, AC091132-201_2, AC091132-201_3, AC091132-201_4, AC091132-201_5, AC091132-201_6, ENST00000253803_1, ENST00000339474_1, ENST00000339474_2, ENST00000339474_3@80.7@22@127@NA@NA@NA
D86968@200320@200328@deletion@9@44248223@44364337@17@chr17:44248223-44364337@58.9@3864@2318@0.6@CNVR7114.3, CNVR7114.2, CNVR7114.10@KIAA1267-201_1, KIAA1267-201_2, AC217773-201_1, AC217773-201_2, ENST00000451529_1, ENST00000451529_3, ENST00000451529_5@64.4285714285714@49@90@:KAT8 regulatory NSL complex subunit 1:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:histone acetyltransferase activity (H4-K8 specific);histone acetyltransferase activity (H4-K16 specific);histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase complex;histone H4-K5 acetylation;MLL1 complex;histone H4-K16 acetylation;protein binding;histone H4-K8 acetylation;nucleus:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
D86968@200337@200340@duplication@4@44399690@44409348@17@chr17:44399690-44409348@15@74@206@2.78@CNVR7114.3, CNVR7114.2, CNVR7114.1@LRRC37A-001_7, LRRC37A-001_8, LRRC37A-001_9, LRRC37A-001_10@144.75@141@154@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
D86968@200343@200349@duplication@7@44414664@44592688@17@chr17:44414664-44592688@15.8@90@226@2.51@CNVR7114.2, CNVR7114.1@LRRC37A-001_13, LRRC37A-001_14, LRRC37A-001_15, AC005829-202_1, AC005829-202_2, AC005829-202_3, LRRC37A2-201_1@161.142857142857@124@196@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane@NA
D86968@200361@200363@deletion@3@44632520@44633017@17@chr17:44632520-44633017@14.3@201@83@0.413@CNVR7114.2, CNVR7114.5, CNVR7114.4@LRRC37A2-201_12, LRRC37A2-201_13, LRRC37A2-201_14@89.6666666666667@74@98@:leucine rich repeat containing 37, member A2:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like@:protein binding;integral to membrane:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction@NA
D86968@202187@202191@deletion@5@60365650@60369395@17@chr17:60365650-60369395@8.73@537@356@0.663@NA@ENST00000424665_2, ENST00000424665_3, ENST00000424665_4, ENST00000424665_5, ENST00000424665_6@10.4@3@23@NA@NA@NA
D86968@213635@213635@deletion@1@14877792@14877922@19@chr19:14877792-14877922@5.26@68@29@0.426@NA@EMR2-209_6@4@4@4@:egf-like module containing, mucin-like, hormone receptor-like 2@:transmembrane signaling receptor activity;inflammatory response;G-protein coupled receptor activity;ruffle membrane;integral to membrane;plasma membrane;cell surface receptor signaling pathway;neuropeptide signaling pathway;granulocyte chemotaxis;cell migration;leading edge membrane;G-protein coupled receptor signaling pathway;protein binding;cell adhesion;membrane;calcium ion binding;chondroitin sulfate binding@NA
D86968@215928@215928@deletion@1@35862253@35863856@19@chr19:35862253-35863856@19.2@211@61@0.289@CNVR7627.1@FFAR3-001_2@102@102@102@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
D86968@217601@217608@duplication@8@41350538@41356242@19@chr19:41350538-41356242@35.9@1212@1829@1.51@CNVR7642.1@CYP2A6-204_2, CYP2A6-204_3, CYP2A6-204_4, CYP2A6-204_5, CYP2A6-204_6, CYP2A6-204_7, CYP2A6-204_8, CYP2A6-204_9@10.875@8@17@:cytochrome P450, family 2, subfamily A, polypeptide 6@:coumarin 7-hydroxylase activity;steroid metabolic process;oxidation-reduction process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;endoplasmic reticulum membrane;drug metabolic process;electron carrier activity;small molecule metabolic process;exogenous drug catabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;enzyme binding;heme binding;xenobiotic metabolic process;iron ion binding;coumarin catabolic process;coumarin metabolic process@: CYTOCHROME P450, SUBFAMILY IIA, POLYPEPTIDE 6; CYP2A6
D86968@221165@221165@deletion@1@54723740@54723786@19@chr19:54723740-54723786@5.29@60@24@0.4@NA@LILRB3-008_7@62@62@62@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D86968@221167@221171@deletion@5@54724957@54726912@19@chr19:54724957-54726912@14.7@182@78@0.429@CNVR7721.3, CNVR7721.4@LILRB3-008_1, LILRB3-008_2, LILRB3-008_3, LILRB3-008_4, LILRB3-008_5@115.4@98@136@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D86968@221219@221224@deletion@6@54802485@54804722@19@chr19:54802485-54804722@8.95@890@602@0.676@CNVR7722.1@LILRA3-003_4, LILRA3-003_5, LILRA3-003_6, LILRA3-003_7, LILRA3-003_8, LILRA3-003_9@105.666666666667@90@109@:leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3@:antigen binding;signal transduction;protein binding;extracellular region;plasma membrane;receptor activity;defense response@NA
D86968@221297@221297@deletion@1@55020247@55020296@19@chr19:55020247-55020296@6.38@30@1@0.0333@NA@LAIR2-001_4@3@3@3@:leukocyte-associated immunoglobulin-like receptor 2@:extracellular region@NA
D86968@221403@221409@duplication@7@55277931@55281337@19@chr19:55277931-55281337@10.8@1136@1501@1.32@CNVR7725.2, CNVR7725.1@KIR2DL3-201_6, KIR2DL3-201_7, KIR2DL3-201_8, KIR2DP1-001_7, KIR2DP1-001_8, KIR2DP1-001_9, KIR2DL1-002_1@123.428571428571@110@126@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
D86968@221439@221441@deletion@3@55358641@55360024@19@chr19:55358641-55360024@21.9@1329@771@0.58@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4-001_6, KIR2DS4-001_7, KIR2DS4-001_8@96.3333333333333@85@102@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
D86968@222066@222069@duplication@4@58002841@58003369@19@chr19:58002841-58003369@10.6@351@505@1.44@CNVR7748.1@ZNF419-202_3, ZNF419-202_4, ZNF419-202_5, ZNF419-202_6@0@0@0@:zinc finger protein 419@:intracellular;DNA binding;regulation of transcription, DNA-dependent;cytoplasm;nucleolus;nucleus;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding@NA
D86968@222563@222563@deletion@1@1569208@1569279@20@chr20:1569208-1569279@5.17@23@0@0@CNVR7763.1@SIRPB1-201_1@128@128@128@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
D86968@222594@222594@duplication@1@1895747@1896102@20@chr20:1895747-1896102@8.09@152@263@1.73@CNVR7764.2@SIRPA-201_3@34@34@34@:signal-regulatory protein alpha@:blood coagulation;protein binding;integral to membrane;SH3 domain binding;cell adhesion;plasma membrane;membrane;leukocyte migration@NA
D86968@228826@228849@deletion@24@10921936@11012983@21@chr21:10921936-11012983@21.6@4974@3614@0.727@CNVR7947.11@TPTE-006_8, TPTE-006_9, TPTE-006_10, TPTE-006_11, TPTE-006_12, TPTE-006_13, TPTE-006_14, TPTE-006_15, TPTE-006_16, TPTE-006_17, TPTE-006_18, TPTE-006_19, TPTE-006_20, TPTE-006_21, TPTE-006_22, TPTE-006_23, TPTE-006_24, TPTE-006_25, TPTE-006_26, TPTE-006_27, BAGE2-002_12, BAGE2-002_13, BAGE2-002_14, BAGE2-002_15@15.9166666666667@6@31@:transmembrane phosphatase with tensin homology@:phosphatase activity;ion channel activity;protein tyrosine phosphatase activity;ion transport;protein dephosphorylation;transmembrane transport;protein binding;signal transduction;integral to membrane;protein tyrosine/serine/threonine phosphatase activity;dephosphorylation;membrane;peptidyl-tyrosine dephosphorylation@NA
D86968@231128@231129@duplication@2@44834397@44837655@21@chr21:44834397-44837655@10.4@360@542@1.51@CNVR8029.1@SIK1-001_13, SIK1-001_14@1@1@1@:salt-inducible kinase 1@:intracellular protein kinase cascade;regulation of mitotic cell cycle;anoikis by p53 class mediator;negative regulation of gluconeogenesis;protein autophosphorylation;regulation of cell differentiation;protein kinase binding;protein tyrosine kinase activity;magnesium ion binding;transferase activity, transferring phosphorus-containing groups;anoikis;ATP binding;negative regulation of triglyceride biosynthetic process;histone deacetylase binding;negative regulation of CREB transcription factor activity;regulation of myotube differentiation;nucleus;cardiac muscle cell differentiation;protein serine/threonine kinase activity;protein phosphorylation;protein kinase activity;cytoplasm;cytosol;protein binding;negative regulation of transcription from RNA polymerase II promoter;regulation of sodium ion transport;cAMP response element binding protein binding;cell cycle;14-3-3 protein binding@NA
D86968@231958@231958@deletion@1@16287256@16287718@22@chr22:16287256-16287718@6.36@88@38@0.432@CNVR8071.2, CNVR8071.3, CNVR8071.9@POTEH-002_1@105@105@105@:POTE ankyrin domain family, member H@:protein binding@NA
D86968@231969@231975@deletion@7@16349379@16353977@22@chr22:16349379-16353977@12.2@736@469@0.637@CNVR8071.2, CNVR8071.3@LA16c-2F2-001_4, LA16c-2F2-001_5, LA16c-2F2-001_6, LA16c-2F2-001_7, LA16c-2F2-001_8, LA16c-2F2-001_9, LA16c-2F2-001_10@40.1428571428571@23@50@NA@NA@NA
D86968@232369@232371@duplication@3@18843775@18848563@22@chr22:18843775-18848563@7.19@51@109@2.14@CNVR8087.2, CNVR8087.7, CNVR8087.12, CNVR8087.10@AC008103-001_5, AC008103-001_6, AC008103-201_1@97.3333333333333@75@130@NA@NA@NA
D86968@232771@232778@duplication@8@20385728@20393605@22@chr22:20385728-20393605@11.1@117@213@1.82@CNVR8094.9, CNVR8094.4, CNVR8094.10@PI4KAP1-204_7, PI4KAP1-204_8, PI4KAP1-204_9, PI4KAP1-204_10, PI4KAP1-204_11, PI4KAP1-204_12, PI4KAP1-204_13, PI4KAP1-204_14@165.5@155@172@NA@NA@NA
D86968@233183@233188@deletion@6@21834050@21841962@22@chr22:21834050-21841962@6.94@144@79@0.549@CNVR8101.1@PI1KAP2-201_5, PI1KAP2-201_6, PI1KAP2-201_7, PI1KAP2-201_8, PI1KAP2-201_9, PI1KAP2-201_10@36.3333333333333@34@38@NA@NA@NA
D86968@233470@233471@duplication@2@23241801@23241913@22@chr22:23241801-23241913@5.87@171@254@1.49@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11@D87015-202_1, BCRL4-001_4@0@0@0@NA@NA@NA
D86968@233473@233474@deletion@2@23247264@23248971@22@chr22:23247264-23248971@6.19@127@68@0.535@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11@BCRL4-001_6, BCRL4-001_7@0@0@0@@:protein binding@NA
D86968@233586@233586@deletion@1@23964280@23964364@22@chr22:23964280-23964364@12.7@253@112@0.443@CNVR8112.1@C22orf43-001_4@3@3@3@:chromosome 22 open reading frame 43@NA@NA
D86968@233748@233754@deletion@7@24379363@24394850@22@chr22:24379363-24394850@9.28@566@375@0.663@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTTP1-001_1, GSTT1-009_1, GSTT1-009_2, GSTT1-009_3, GSTT1-009_4, GSTTP2-001_4, GSTTP2-001_5@131.714285714286@122@140@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
D86968@234040@234065@deletion@26@25678579@25907596@22@chr22:25678579-25907596@91.3@2199@1174@0.534@CNVR8120.1@RP3-462D8-001_1, CTA-246H3-001_1, CTA-246H3-001_2, ENST00000433457_1, ENST00000433457_2, ENST00000433457_4, CTA-246H3-201_1, CTA-246H3-201_2, CTA-246H3-201_3, CTA-246H3-201_4, CTA-246H3-201_5, LRP5L-001_1, LRP5L-001_2, LRP5L-001_3, LRP5L-001_4, LRP5L-001_5, LRP5L-001_6, LRP5L-001_7, LRP5L-001_8, CRYBB2P1-003_1, CRYBB2P1-003_2, CRYBB2P1-003_3, CRYBB2P1-003_4, CRYBB2P1-003_5, CRYBB2P1-003_6@12.4@2@16@:low density lipoprotein receptor-related protein 5-like@:Wnt-activated receptor activity;Wnt-protein binding;Wnt receptor signaling pathway involved in dorsal/ventral axis specification;canonical Wnt receptor signaling pathway@NA
D88892@2906@2908@deletion@3@16913547@16915559@1@chr1:16913547-16915559@5.79@99@53@0.535@CNVR93.3, CNVR93.6@NBPF1-201_9, NBPF1-201_10, NBPF1-201_11@30.3333333333333@24@42@NA@NA@NA
D88892@2931@2933@deletion@3@16972895@16973397@1@chr1:16972895-16973397@12.1@570@368@0.646@CNVR93.3, CNVR93.6, CNVR93.12, CNVR93.7, CNVR93.14, CNVR93.15@RP5-1182A14-001_2, RP5-1182A14-001_3, RP5-1182A14-001_4@40.3333333333333@39@42@NA@NA@NA
D88892@2942@2946@deletion@5@16975378@16976445@1@chr1:16975378-16976445@30.5@1013@615@0.607@CNVR93.3, CNVR93.6, CNVR93.12, CNVR93.7, CNVR93.14, CNVR93.15@RP5-1182A14-001_13, RP5-1182A14-001_14, RP5-1182A14-001_15, RP5-1182A14-001_16, RP5-1182A14-001_17@80.2@69@88@NA@NA@NA
D88892@2999@2999@deletion@1@17198306@17198669@1@chr1:17198306-17198669@10.2@187@94@0.503@CNVR94.1, CNVR94.4, CNVR94.8@ENST00000356370_1, ENST00000438002_1@21@21@21@NA@NA@NA
D88892@4452@4459@deletion@8@25611066@25648454@1@chr1:25611066-25648454@11.6@977@674@0.69@CNVR116.1, CNVR116.2@RHD-202_2, RHD-202_3, RHD-202_4, RHD-202_5, RHD-202_6, RHD-202_7, RHD-202_8, RHD-202_9@125.125@121@128@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
D88892@6813@6814@deletion@2@40229386@40229587@1@chr1:40229386-40229587@10.7@147@69@0.469@NA@PPIE-003_11, BMP8B-001_5@34@34@34@:peptidylprolyl isomerase E (cyclophilin E):bone morphogenetic protein 8b@:regulation of transcription, DNA-dependent;nucleotide binding;catalytic step 2 spliceosome;protein folding;protein binding;protein peptidyl-prolyl isomerization;peptidyl-prolyl cis-trans isomerase activity;cyclosporin A binding;RNA binding;mRNA splicing, via spliceosome;nucleus;nucleic acid binding:cell differentiation;growth factor activity;extracellular space;growth;extracellular region;cytokine activity;cartilage development;skeletal system development;ossification@NA
D88892@8220@8223@duplication@4@47512141@47516424@1@chr1:47512141-47516424@19@749@1059@1.41@NA@CYP4X1-001_9, CYP4X1-001_10, CYP4X1-001_11, CYP4X1-001_12@4.25@4@5@:cytochrome P450, family 4, subfamily X, polypeptide 1@:oxidation-reduction process;electron carrier activity;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;endoplasmic reticulum membrane;heme binding@NA
D88892@12416@12417@deletion@2@104202984@104203299@1@chr1:104202984-104203299@5.94@124@69@0.556@CNVR266.3, CNVR266.1@AMY1A-001_7, AMY1A-001_8@123.5@118@129@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D88892@12424@12425@duplication@2@104233918@104234233@1@chr1:104233918-104234233@8.73@40@103@2.58@CNVR266.3, CNVR266.5@AMY1B-001_7, AMY1B-001_8@154@154@154@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D88892@12929@12933@duplication@5@110230474@110231948@1@chr1:110230474-110231948@9.52@251@367@1.46@CNVR299.6, CNVR299.4, CNVR299.5@GSTM1-001_1, GSTM1-001_2, GSTM1-001_3, GSTM1-001_4, GSTM1-001_5@191.6@190@194@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
D88892@14493@14495@duplication@3@144676872@144679973@1@chr1:144676872-144679973@8.79@284@406@1.43@CNVR337.1@WI2-1896O14-001_1, WI2-1896O14-001_2, WI2-1896O14-001_3@4.66666666666667@4@5@NA@NA@NA
D88892@14522@14525@deletion@4@144867923@144874905@1@chr1:144867923-144874905@17.4@798@509@0.638@CNVR338.1, CNVR338.6@PDE4DIP-203_33, PDE4DIP-203_34, PDE4DIP-203_35, PDE4DIP-203_36@0@0@0@:phosphodiesterase 4D interacting protein;uncharacterized LOC101060344;myomegalin-like@:Golgi apparatus;binding;centrosome;enzyme binding;cytoplasm;protein binding;myofibril;cellular protein complex assembly;nucleus@NA
D88892@14534@14549@deletion@16@144903079@144923822@1@chr1:144903079-144923822@38.7@3584@2485@0.693@NA@PDE4DIP-203_9, PDE4DIP-203_10, PDE4DIP-203_11, PDE4DIP-203_12, PDE4DIP-203_13, PDE4DIP-203_14, PDE4DIP-203_15, PDE4DIP-203_16, PDE4DIP-203_17, PDE4DIP-203_18, PDE4DIP-203_19, PDE4DIP-203_20, PDE4DIP-203_21, PDE4DIP-203_22, PDE4DIP-203_23, PDE4DIP-203_24@0.6875@0@3@:phosphodiesterase 4D interacting protein;uncharacterized LOC101060344;myomegalin-like@:Golgi apparatus;binding;centrosome;enzyme binding;cytoplasm;protein binding;myofibril;cellular protein complex assembly;nucleus@NA
D88892@14553@14553@deletion@1@144955218@144955293@1@chr1:144955218-144955293@8.74@243@139@0.572@CNVR339.1@PDE4DIP-203_5@0@0@0@:phosphodiesterase 4D interacting protein;uncharacterized LOC101060344;myomegalin-like@:Golgi apparatus;binding;centrosome;enzyme binding;cytoplasm;protein binding;myofibril;cellular protein complex assembly;nucleus@NA
D88892@14563@14565@deletion@3@145139027@145209437@1@chr1:145139027-145209437@5.46@278@186@0.669@NA@AL359758-201_1, AL359758-201_2, NOTCH2NL-001_1@2.33333333333333@1@5@:notch 2 N-terminal like@:multicellular organismal development;cell differentiation;protein binding;Notch signaling pathway;extracellular region;calcium ion binding;cytoplasm:protein binding;calcium ion binding@NA
D88892@15397@15428@deletion@32@149036437@149106107@1@chr1:149036437-149106107@44.5@730@377@0.516@CNVR350.3, CNVR350.1@RP11-744H18-001_1, RP11-744H18-001_2, RP11-744H18-001_3, RP11-744H18-001_4, RP11-744H18-001_5, RP11-744H18-001_6, RP11-744H18-001_7, RP11-744H18-001_8, RP11-744H18-001_9, RP11-744H18-001_10, RP11-744H18-001_11, RP11-744H18-001_12, RP11-744H18-001_13, RP11-744H18-001_14, RP11-744H18-001_15, RP11-744H18-001_16, RP11-744H18-001_17, ENST00000401087_2, ENST00000401087_3, ENST00000401087_4, ENST00000401087_5, ENST00000401087_6, ENST00000401087_7, ENST00000401087_8, ENST00000401087_9, ENST00000401087_10, ENST00000401087_11, ENST00000401087_12, ENST00000401087_13, ENST00000401087_14, ENST00000401087_15, ENST00000401087_16@79.8125@11@87@NA@NA@NA
D88892@15456@15462@deletion@7@149375000@149400543@1@chr1:149375000-149400543@22.6@573@332@0.579@CNVR350.1@FCGR1C-201_4, FCGR1C-201_5, FCGR1C-201_6, ENST00000415338_1, HIST2H3PS2-001_1, HIST2H3PS2-001_2, RP5-998N21-002_1@73.7142857142857@70@76@NA@NA@NA
D88892@18672@18673@deletion@2@161559354@161561189@1@chr1:161559354-161561189@11.3@245@136@0.555@CNVR383.1@FCGR2C-006_3, FCGR2C-006_4@53@49@57@:Fc fragment of IgG, low affinity IIIa, receptor (CD16a):Fc fragment of IgG, low affinity IIb, receptor (CD32):Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene)@:IgG binding;protein binding;regulation of immune response;extracellular region;integral to membrane;immune response;plasma membrane;external side of plasma membrane:IgG binding;protein binding;signal transduction;regulation of immune response;integral to membrane;immune response;plasma membrane;virus-host interaction@: MALARIA, SUSCEPTIBILITY TO; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
D88892@24160@24164@duplication@5@223727670@223729472@1@chr1:223727670-223729472@13.9@62@162@2.61@NA@CAPN8-202_20, CAPN8-202_21, CAPN8-202_22, CAPN8-202_23, CAPN8-202_24@0@0@0@:calpain 8@:proteolysis;Golgi apparatus;intracellular;calcium-dependent cysteine-type endopeptidase activity;calcium ion binding@NA
D88892@24671@24675@deletion@5@227681164@227682526@1@chr1:227681164-227682526@7.79@87@37@0.425@NA@RP11-275O4-201_2, RP11-275O4-201_3, RP11-275O4-201_4, RP11-275O4-201_5, RP11-275O4-201_6@41.8@33@57@NA@NA@NA
D88892@33520@33520@deletion@1@87239638@87241105@2@chr2:87239638-87241105@8.45@41@2@0.0488@NA@RGPD1-001_23@110@110@110@:RANBP2-like and GRIP domain containing 1:plasminogen-like B1;plasminogen-like B2@:protein binding;intracellular;intracellular transport;protein targeting to Golgi:extracellular region@NA
D88892@33542@33542@deletion@1@87365381@87365416@2@chr2:87365381-87365416@5.65@47@15@0.319@CNVR861.2@AC083899-001_6@11@11@11@NA@NA@NA
D88892@33560@33564@deletion@5@87408191@87414366@2@chr2:87408191-87414366@40.5@289@68@0.235@CNVR861.2@AC083899-001_24, AC083899-001_25, AC083899-001_26, AC083899-001_27, AC083899-001_28@75.6@70@85@NA@NA@NA
D88892@33585@33585@deletion@1@88012880@88012957@2@chr2:88012880-88012957@5.25@111@61@0.55@CNVR861.3@AC093616-001_5@35@35@35@NA@NA@NA
D88892@33747@33748@deletion@2@89416835@89417336@2@chr2:89416835-89417336@25@305@118@0.387@CNVR866.7, CNVR866.10, CNVR866.11@IGKV1-17-001_1, IGKV1-17-001_2@1@0@2@@:protein binding@NA
D88892@33792@33795@deletion@4@89952794@89967678@2@chr2:89952794-89967678@16.2@120@33@0.275@CNVR867.4, CNVR867.10, CNVR867.11@IGKV1D-33-001_1, IGKV1D-33-001_2, IGKV1D-32-001_1, IGKV1D-32-001_2@7.75@7@8@@:protein binding@NA
D88892@33805@33805@deletion@1@90007868@90008146@2@chr2:90007868-90008146@9.56@318@187@0.588@CNVR867.10, CNVR867.1@IGKV1D-27-001_2@6@6@6@NA@NA@NA
D88892@33835@33835@deletion@1@90198897@90199191@2@chr2:90198897-90199191@6.86@140@75@0.536@CNVR867.10, CNVR867.5, CNVR867.3, CNVR867.9, CNVR867.15, CNVR867.2@IGKV1D-12-001_2@10@10@10@@:protein binding@NA
D88892@34094@34095@deletion@2@96458183@96458295@2@chr2:96458183-96458295@10.1@63@12@0.19@NA@AC008268-201_3, ENST00000444924_2@104@104@104@NA@NA@NA
D88892@34183@34184@duplication@2@96652501@96652955@2@chr2:96652501-96652955@10.3@178@292@1.64@NA@AC073995-001_2, AC073995-001_3@4@4@4@:ankyrin repeat domain-containing protein 36A-like@:ion channel inhibitor activity;protein binding@NA
D88892@37209@37209@deletion@1@130898733@130898870@2@chr2:130898733-130898870@7.35@84@35@0.417@NA@CCDC74B-001_4@15@15@15@:coiled-coil domain containing 74A;coiled-coil domain containing 74B@NA@NA
D88892@37492@37493@duplication@2@132288154@132289376@2@chr2:132288154-132289376@7.21@161@243@1.51@NA@CCDC74A-201_3, CCDC74A-201_4@12@11@13@:coiled-coil domain containing 74A@NA@NA
D88892@44909@44909@duplication@1@228243804@228244023@2@chr2:228243804-228244023@7.2@198@298@1.51@CNVR1156.1@TM4SF20-001_1@1@1@1@:transmembrane 4 L six family member 20@:integral to membrane;plasma membrane@NA
D88892@46349@46349@deletion@1@241622250@241622298@2@chr2:241622250-241622298@5.22@48@17@0.354@NA@AQP12B-003_1@30@30@30@:aquaporin 12B@:transport;integral to membrane;transporter activity;membrane@NA
D88892@47656@47657@deletion@2@11901951@11912903@3@chr3:11901951-11912903@9.43@120@55@0.458@NA@AC090958-001_3, AC090958-001_4@3@0@6@NA@NA@NA
D88892@61629@61630@duplication@2@195690173@195690293@3@chr3:195690173-195690293@14.1@375@566@1.51@CNVR1707.1, CNVR1707.2@SDHALP1-002_16, ENST00000354937_17@12@12@12@NA@NA@NA
D88892@61643@61656@duplication@14@195701270@195711609@3@chr3:195701270-195711609@33.2@1334@1854@1.39@CNVR1707.1, CNVR1707.2@SDHALP1-002_4, SDHALP1-002_5, SDHALP1-002_6, SDHALP1-002_7, SDHALP1-002_8, SDHALP1-002_9, SDHALP1-002_10, ENST00000354937_6, ENST00000354937_7, ENST00000354937_8, ENST00000354937_9, ENST00000354937_10, ENST00000354937_11, ENST00000354937_12@32.9285714285714@18@44@NA@NA@NA
D88892@61902@61904@duplication@3@197350985@197351069@3@chr3:197350985-197351069@5.79@118@180@1.53@CNVR1722.1@AC024560-005_3, AC024560-201_2, AC024560-201_3@22.6666666666667@22@23@NA@NA@NA
D88892@62726@62726@deletion@1@4158430@4158898@4@chr4:4158430-4158898@8.18@102@44@0.431@NA@AC011744-201_2@30@30@30@NA@NA@NA
D88892@64678@64678@duplication@1@49244728@49244949@4@chr4:49244728-49244949@6.74@133@210@1.58@NA@ENST00000428211_2@25@25@25@NA@NA@NA
D88892@65315@65320@duplication@6@69402904@69434246@4@chr4:69402904-69434246@46.1@884@1454@1.64@CNVR1953.1@UGT2B17-001_1, UGT2B17-001_2, UGT2B17-001_3, UGT2B17-001_4, UGT2B17-001_5, UGT2B17-001_6@124.5@118@134@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
D88892@70822@70822@duplication@1@748521@748675@5@chr5:748521-748675@9.54@115@208@1.81@CNVR2280.3@ZDHHC11B-201_5@96@96@96@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
D88892@71895@71900@duplication@6@34182208@34193054@5@chr5:34182208-34193054@21@440@694@1.58@CNVR2430.2, CNVR2430.1@AC138409-202_6, ENST00000380721_1, ENST00000502234_2, AC138409-201_1, AC138409-201_2, AC138409-201_3@41.3333333333333@22@49@NA@NA@NA
D88892@73727@73727@deletion@1@69717564@69717599@5@chr5:69717564-69717599@12.7@58@0@0@CNVR2494.17, CNVR2494.3@GTF2H2B-201_4@139@139@139@NA@NA@NA
D88892@73817@73821@deletion@5@70370032@70389020@5@chr5:70370032-70389020@29.1@133@0@0@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.8, CNVR2494.1, CNVR2494.37@AC044797-201_1, AC044797-201_2, AC044797-201_3, AC044797-201_4, AC044797-201_5@120.4@100@138@NA@NA@NA
D88892@78044@78044@deletion@1@147553799@147553934@5@chr5:147553799-147553934@21.8@101@0@0@CNVR2637.2, CNVR2637.1@AC116334-001_3@78@78@78@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
D88892@79567@79570@deletion@4@175388056@175394271@5@chr5:175388056-175394271@9.97@154@78@0.506@NA@THOC3-001_2, THOC3-001_3, THOC3-001_4, THOC3-001_5@105@27@182@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
D88892@80483@80487@deletion@5@180415903@180429786@5@chr5:180415903-180429786@7.79@433@288@0.665@CNVR2719.1@BTNL3-202_1, BTNL3-202_2, BTNL3-202_3, BTNL3-202_4, BTNL3-202_5@82@4@108@:butyrophilin-like 3@:protein binding;integral to membrane;molecular_function;cellular_component;biological_process@NA
D88892@82488@82495@deletion@8@29855352@29864703@6@chr6:29855352-29864703@36.9@944@545@0.577@CNVR2829.7, CNVR2829.2, CNVR2829.8, CNVR2829.3@HLA-H-001_1, HLA-H-001_2, HLA-H-001_3, HLA-H-001_4, HLA-H-001_5, HLA-H-001_6, HLA-H-001_7, HLA-16-001_1@47.875@44@51@NA@NA@NA
D88892@82506@82514@deletion@9@29894439@29909097@6@chr6:29894439-29909097@17@561@348@0.62@CNVR2829.7, CNVR2829.2, CNVR2829.3@AL645929-201_2, AL645929-201_3, AL645929-201_4, HLA-K-001_2, HLA-K-001_3, HLA-K-001_4, HLA-K-001_5, HLA-K-001_6, HLA-A-001_1@39.5555555555556@13@44@:major histocompatibility complex, class I, A@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO
D88892@83002@83003@duplication@2@31237745@31238263@6@chr6:31237745-31238263@27.3@297@575@1.94@CNVR2838.2, CNVR2838.1@HLA-C-006_4, HLA-C-006_5@25@25@25@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
D88892@83014@83018@duplication@5@31323946@31324990@6@chr6:31323946-31324990@32.4@599@957@1.6@CNVR2841.12, CNVR2841.14, CNVR2841.8@HLA-B-201_1, HLA-B-201_2, HLA-B-201_3, HLA-B-201_4, HLA-B-201_5@67.2@59@73@:major histocompatibility complex, class I, B@:MHC class I protein complex;regulation of immune response;regulation of interleukin-12 production;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;regulation of T cell anergy;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;receptor binding;early endosome membrane;virus-host interaction;regulation of interleukin-6 production;regulation of dendritic cell differentiation;phagocytic vesicle membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO; SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1
D88892@83611@83617@duplication@7@31975048@31976177@6@chr6:31975048-31976177@9.8@304@432@1.42@CNVR2843.6, CNVR2843.3@CYP21A1P-001_7, CYP21A1P-001_8, CYP21A1P-001_9, CYP21A1P-001_10, AL645922-201_5, AL645922-201_6, AL645922-201_7@108.714285714286@82@121@NA@NA@NA
D88892@83911@83919@deletion@9@32485122@32521744@6@chr6:32485122-32521744@25.8@228@78@0.342@CNVR2845.21, CNVR2845.25, CNVR2845.43@HLA-DRB5-001_1, HLA-DRB5-001_2, HLA-DRB5-001_3, HLA-DRB5-001_4, HLA-DRB5-001_5, HLA-DRB5-001_6, HLA-DRB6-002_4, HLA-DRB6-002_5, HLA-DRB6-002_6@156.444444444444@114@189@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D88892@83941@83946@duplication@6@32628134@32634448@6@chr6:32628134-32634448@10.2@349@490@1.4@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20, CNVR2845.31@HLA-DQB1-003_2, HLA-DQB1-003_3, HLA-DQB1-003_4, HLA-DQB1-003_5, XXbac-BPG254F23-001_2, ENST00000443574_1@110@80@128@:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
D88892@84062@84062@duplication@1@33054318@33054977@6@chr6:33054318-33054977@5.91@110@175@1.59@CNVR2846.3, CNVR2846.5@HLA-DPB1-201_6@18@18@18@:major histocompatibility complex, class II, DP beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D88892@87765@87765@duplication@1@76022115@76024919@6@chr6:76022115-76024919@16.1@2419@3444@1.42@NA@FILIP1-201_5@0@0@0@:filamin A interacting protein 1@NA@NA
D88892@92590@92593@deletion@4@160132511@160133097@6@chr6:160132511-160133097@23.3@484@263@0.543@CNVR3127.2, CNVR3127.1@ENST00000442642_4, ENST00000442642_5, ENST00000442642_6, ENST00000442642_7@103.5@90@112@:superoxide dismutase 2, mitochondrial;uncharacterized LOC100129518@:response to reactive oxygen species;oxidation-reduction process;mitochondrion;negative regulation of cell proliferation;neuron development;negative regulation of fat cell differentiation;removal of superoxide radicals;response to gamma radiation;response to L-ascorbic acid;response to lipopolysaccharide;response to nutrient levels;response to zinc ion;protein homotetramerization;post-embryonic development;iron ion homeostasis;hemopoiesis;aging;mitochondrial inner membrane;age-dependent response to reactive oxygen species;response to drug;oxygen binding;mitochondrial nucleoid;vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure;apoptotic process;superoxide metabolic process;response to superoxide;detection of oxygen;response to silicon dioxide;cytoplasm;response to stress;respiratory electron transport chain;superoxide anion generation;protein homooligomerization;regulation of mitochondrial membrane potential;positive regulation of nitric oxide biosynthetic process;response to manganese ion;regulation of blood pressure;metal ion binding;negative regulation of apoptotic process;response to cadmium ion;response to oxidative stress;liver development;regulation of catalytic activity;negative regulation of fibroblast proliferation;response to selenium ion;age-dependent response to oxidative stress;response to electrical stimulus;mitochondrial matrix;identical protein binding;mitochondrion organization;response to hyperoxia;vasodilation;response to hydrogen peroxide;superoxide dismutase activity;heart development;negative regulation of neuron apoptotic process;erythrophore differentiation;locomotory behavior;DNA binding;release of cytochrome c from mitochondria;response to axon injury;oxygen homeostasis;response to activity;glutathione metabolic process;hydrogen peroxide metabolic process;hydrogen peroxide biosynthetic process;regulation of transcription from RNA polymerase II promoter;response to hypoxia;protein binding;manganese ion binding;cellular response to ethanol@: MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6; MVCD6
D88892@94190@94195@deletion@6@5959482@5968026@7@chr7:5959482-5968026@23.3@954@603@0.632@NA@C7orf28A-001_12, C7orf28A-001_13, C7orf28A-001_14, C7orf28A-001_15, RSPH10B-002_20, RSPH10B-002_21@48.3333333333333@13@73@:CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae):radial spoke head 10 homolog B (Chlamydomonas)@:lysosomal membrane@NA
D88892@94200@94212@deletion@13@5982957@6006833@7@chr7:5982957-6006833@55.7@735@331@0.45@NA@RSPH10B-002_3, RSPH10B-002_4, RSPH10B-002_5, RSPH10B-002_6, RSPH10B-002_7, RSPH10B-002_8, RSPH10B-002_9, RSPH10B-002_10, RSPH10B-002_11, RSPH10B-002_12, RSPH10B-002_13, RSPH10B-002_14, RSPH10B-002_15@9.53846153846154@8@14@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D88892@94420@94432@duplication@13@6797226@6821108@7@chr7:6797226-6821108@32.3@732@1137@1.55@NA@RSPH10B2-204_3, RSPH10B2-204_4, RSPH10B2-204_5, RSPH10B2-204_6, RSPH10B2-204_7, RSPH10B2-204_8, RSPH10B2-204_9, RSPH10B2-204_10, RSPH10B2-204_11, RSPH10B2-204_12, RSPH10B2-204_13, RSPH10B2-204_14, RSPH10B2-204_15@11.3076923076923@6@19@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D88892@94438@94444@duplication@7@6836201@6844687@7@chr7:6836201-6844687@56.5@314@754@2.4@NA@RSPH10B2-204_20, RSPH10B2-204_21, ENST00000429267_1, C7orf28B-001_12, C7orf28B-001_13, C7orf28B-001_14, C7orf28B-001_15@90.8571428571429@25@121@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D88892@96196@96203@duplication@8@33134913@33185977@7@chr7:33134913-33185977@13.2@821@1098@1.34@NA@RP9-004_1, RP9-004_2, RP9-004_3, RP9-004_4, RP9-004_5, RP9-004_6, BBS9-203_1, BBS9-203_2@1@1@1@:retinitis pigmentosa 9 (autosomal dominant):Bardet-Biedl syndrome 9@:protein binding;nucleus;RNA splicing;zinc ion binding;nucleic acid binding;signal recognition particle receptor complex:BBSome;fat cell differentiation;microtubule organizing center;cytoplasm;protein binding;response to stimulus;visual perception;nucleus;plasma membrane;molecular_function;cilium membrane@: RETINITIS PIGMENTOSA; RP; RETINITIS PIGMENTOSA 9; RP9: WILMS TUMOR 5; WT5; BARDET-BIEDL SYNDROME; BBS
D88892@96579@96584@deletion@6@38388958@38398764@7@chr7:38388958-38398764@121@1288@508@0.394@CNVR3354.3, CNVR3354.1@TRGV5-001_1, TRGV5-001_2, TRGV4-001_1, TRGV4-001_2, TRGV3-001_1, TRGV3-001_2@10.5@6@14@@:protein binding:protein binding:protein binding;immune response;peptide antigen binding;plasma membrane;MHC protein binding@NA
D88892@97908@97917@deletion@10@57064289@57084498@7@chr7:57064289-57084498@9.58@107@46@0.43@NA@TNRC18C-202_4, TNRC18C-202_5, TNRC18C-202_6, TNRC18C-202_7, TNRC18C-202_8, TNRC18C-202_9, TNRC18C-202_10, TNRC18C-202_11, ENST00000398760_4, ENST00000398760_5@155.9@139@166@NA@NA@NA
D88892@97990@97994@duplication@5@62753052@62758771@7@chr7:62753052-62758771@68.9@602@1298@2.16@NA@AC006455-201_2, AC006455-201_3, AC006455-201_4, ENST00000444809_2, ENST00000444809_3, ENST00000444809_4@137@97@171@NA@NA@NA
D88892@98014@98026@deletion@13@62904582@62970547@7@chr7:62904582-62970547@82.3@594@137@0.231@NA@ZNF734-201_1, ZNF734-201_2, ZNF734-201_3, ZNF734-201_4, ZNF734-201_5, ZNF734-201_6, ZNF734-201_7, ZNF734-201_8, ENST00000434048_1, ENST00000434048_2, CTD-2526L21-201_1, CTD-2526L21-201_2, CTD-2526L21-201_3@75.3846153846154@1@102@NA@NA@NA
D88892@98621@98623@deletion@3@72440194@72440606@7@chr7:72440194-72440606@6.34@65@26@0.4@NA@ENST00000380778_1, ENST00000380778_2, STAG3L3-003_8@14@13@15@@:nucleus;binding@NA
D88892@99061@99063@deletion@3@74239464@74251506@7@chr7:74239464-74251506@6.66@34@3@0.0882@NA@GTF2IRD2-002_2, GTF2IRD2-002_3, GTF2IRD2-002_4@9@7@12@:GTF2I repeat domain containing 2@:nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
D88892@101721@101726@duplication@6@100331652@100336237@7@chr7:100331652-100336237@7.29@753@972@1.29@CNVR3509.1@ZAN-001_2, ZAN-001_3, ZAN-001_4, ZAN-001_5, ZAN-001_6, ZAN-001_7@81.6666666666667@71@89@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
D88892@102144@102145@deletion@2@102180464@102180539@7@chr7:102180464-102180539@13.1@152@64@0.421@CNVR3518.1@RASA4B-007_4, POLR2J3-003_7@96@96@96@:RAS p21 protein activator 4B:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
D88892@102166@102193@deletion@28@102219874@102279647@7@chr7:102219874-102279647@22.3@422@230@0.545@CNVR3518.1@ENST00000379336_1, RASA4-001_1, RASA4-001_2, RASA4-001_3, RASA4-001_4, RASA4-001_5, RASA4-001_6, RASA4-001_7, RASA4-001_8, RASA4-001_9, RASA4-001_10, RASA4-001_11, RASA4-001_12, RASA4-001_13, RASA4-001_14, RASA4-001_15, RASA4-001_16, RASA4-001_17, RASA4-001_18, RASA4-001_19, RASA4-001_20, RASA4-001_21, ENST00000340457_4, ENST00000340457_5, ENST00000340457_6, POLR2J2-001_7, POLR2J2-001_8, POLR2J2-001_9@45.7857142857143@28@77@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
D88892@102210@102210@deletion@1@102318934@102319304@7@chr7:102318934-102319304@8.54@240@138@0.575@CNVR3518.1@ENST00000379355_1@54@54@54@NA@NA@NA
D88892@104079@104081@deletion@3@128552716@128553229@7@chr7:128552716-128553229@7.72@106@51@0.481@CNVR3564.1@RP11-309L24-201_5, RP11-309L24-201_6, RP11-309L24-201_7@4.66666666666667@4@5@NA@NA@NA
D88892@105321@105342@deletion@22@141765517@141794298@7@chr7:141765517-141794298@111@2794@1593@0.57@CNVR3585.3, CNVR3585.2@MGAM-007_40, MGAM-007_41, MGAM-007_42, MGAM-007_43, MGAM-007_44, MGAM-007_45, MGAM-007_46, MGAM-007_47, MGAM-007_48, MGAM-007_49, MGAM-007_50, MGAM-007_51, MGAM-007_52, MGAM-007_53, MGAM-007_54, MGAM-007_55, MGAM-007_56, MGAM-007_57, MGAM-007_58, MGAM-007_59, MGAM-007_60, MGAM-007_61@112.772727272727@35@134@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
D88892@105521@105523@duplication@3@142481247@142482417@7@chr7:142481247-142482417@24.8@405@680@1.68@NA@PRSS1-204_4, PRSS1-204_5, PRSS1-204_6@114.333333333333@113@115@NA@NA@NA
D88892@105786@105799@deletion@14@143970528@143975569@7@chr7:143970528-143975569@12.1@439@288@0.656@CNVR3598.4, CNVR3598.9@RP4-798C17-001_5, RP4-798C17-001_6, RP4-798C17-001_7, RP4-798C17-001_8, RP4-798C17-001_9, RP4-798C17-001_10, RP4-798C17-001_11, ENST00000378112_6, ENST00000378112_7, ENST00000378112_8, ENST00000378112_9, ENST00000378112_10, ENST00000378112_11, ENST00000378112_12@96.5714285714286@53@137@:Rho guanine nucleotide exchange factor (GEF) 35@NA@NA
D88892@105804@105807@deletion@4@143980319@143984072@7@chr7:143980319-143984072@7.59@387@254@0.656@CNVR3598.4, CNVR3598.9@RP4-798C17-001_1, RP4-798C17-001_2, ENST00000378112_2, ENST00000378112_3@74.25@65@84@:Rho guanine nucleotide exchange factor (GEF) 35@NA@NA
D88892@107425@107429@deletion@5@7274294@7308722@8@chr8:7274294-7308722@31.7@455@202@0.444@CNVR3771.8, CNVR3771.10, CNVR3771.4@DEFB4P-001_1, DEFB103A-001_1, DEFB103A-001_2, SPAG11-003_3, SPAG11-003_4@68@51@91@:defensin, beta 4B;defensin, beta 4A:defensin, beta 103B;defensin, beta 103A:sperm associated antigen 11B@:chemotaxis;extracellular region;defense response to bacterium;immune response;Golgi lumen;G-protein coupled receptor signaling pathway;defense response;innate immune response:extracellular region;defense response to bacterium;Golgi lumen;positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria;defense response;innate immune response:spermatogenesis;defense response to bacterium;extracellular region;molecular_function;defense response@NA
D88892@107434@107434@duplication@1@7340028@7340275@8@chr8:7340028-7340275@4.95@38@77@2.03@CNVR3771.8, CNVR3771.10, CNVR3771.4@DEFB106B-001_2@11@11@11@:defensin, beta 106B;defensin, beta 106A@:extracellular region;defense response to bacterium@NA
D88892@107507@107507@deletion@1@7686329@7686576@8@chr8:7686329-7686576@6.97@59@19@0.322@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@DEFB106A-001_2@44@44@44@:defensin, beta 106B;defensin, beta 106A@:extracellular region;defense response to bacterium@NA
D88892@107512@107513@duplication@2@7717871@7718505@8@chr8:7717871-7718505@13@237@380@1.6@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@SPAG11A-207_3, SPAG11A-207_4@112@111@113@:sperm associated antigen 11A;sperm associated antigen 11B@:extracellular region;defense response@NA
D88892@109572@109585@deletion@14@39311571@39349528@8@chr8:39311571-39349528@81.6@373@0@0@CNVR3859.1@ADAM3A-005_11, ADAM3A-005_12, ADAM3A-005_13, ADAM3A-005_14, ADAM3A-005_15, ADAM3A-005_16, ADAM3A-005_17, ADAM3A-005_18, ADAM3A-005_19, ADAM3A-005_20, ADAM3A-005_21, ADAM3A-009_7, ADAM3A-009_8, ADAM3A-009_9@120.5@98@136@NA@NA@NA
D88892@117587@117589@duplication@3@43313716@43314503@9@chr9:43313716-43314503@9.47@205@311@1.52@CNVR4289.2@BX649597-201_1, BX649597-201_2, BX649597-201_3@46@18@61@NA@NA@NA
D88892@117602@117602@deletion@1@43818043@43818185@9@chr9:43818043-43818185@5.01@140@83@0.593@CNVR4294.1@CNTNAP3B-001_7@91@91@91@:contactin associated protein-like 3B;contactin associated protein-like 3@:protein binding;signal transduction;integral to membrane;cell adhesion;receptor binding@NA
D88892@121600@121604@deletion@5@117085338@117087433@9@chr9:117085338-117087433@22.7@1491@998@0.669@CNVR4448.1@ORM1-001_1, ORM1-001_2, ORM1-001_3, ORM1-001_4, ORM1-001_5@87.6@84@90@:orosomucoid 1@:protein binding;extracellular space;regulation of immune system process;transport;inflammatory response;extracellular region;acute-phase response@NA
D88892@126909@126909@duplication@1@17840632@17842868@10@chr10:17840632-17842868@4.87@32@69@2.16@NA@FAM23A-201_5@108@108@108@:transmembrane protein 236;transmembrane protein 236-like@:integral to membrane@NA
D88892@126950@126975@deletion@26@18134220@18198277@10@chr10:18134220-18198277@35@225@46@0.204@NA@MRC1-001_6, MRC1-001_7, MRC1-001_8, MRC1-001_9, MRC1-001_10, MRC1-001_11, MRC1-001_12, MRC1-001_13, MRC1-001_14, MRC1-001_15, MRC1-001_16, MRC1-001_17, MRC1-001_18, MRC1-001_19, MRC1-001_20, MRC1-001_21, MRC1-001_22, MRC1-001_23, MRC1-001_24, MRC1-001_25, MRC1-001_26, MRC1-001_27, MRC1-001_28, MRC1-001_29, RP11-457D2-001_1, RP11-457D2-001_2@16.5@3@27@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D88892@128825@128829@duplication@5@46918171@46934899@10@chr10:46918171-46934899@13.9@109@225@2.06@CNVR4712.9, CNVR4712.2, CNVR4712.7@FAM35B-001_3, FAM35B-001_4, FAM35B-001_5, FAM35B-001_6, FAM35B-001_7@53.6@34@72@NA@NA@NA
D88892@128913@128913@deletion@1@47409855@47410082@10@chr10:47409855-47410082@9.48@91@32@0.352@CNVR4712.9, CNVR4712.1@FAM35B2-201_6@47@47@47@NA@NA@NA
D88892@128920@128964@duplication@45@47605129@47729934@10@chr10:47605129-47729934@96.8@3792@5367@1.42@CNVR4713.1@ENST00000423803_1, ENST00000423803_2, ENST00000423803_3, ENST00000423803_4, ENST00000423803_5, ENST00000423803_6, ENST00000423803_7, ENST00000423803_8, ENST00000423803_9, ENST00000423803_10, ENST00000423803_11, ENST00000423803_12, ENST00000423803_13, ENST00000423803_14, ENST00000454837_1, ENST00000454837_2, ENST00000454837_3, ENST00000454837_4, ANTXRL-001_1, ANTXRL-001_2, ANTXRL-001_3, ANTXRL-001_4, ANTXRL-001_5, ANTXRL-001_6, ANTXRL-001_7, ANTXRL-001_8, ANTXRL-001_9, ANTXRL-001_10, ANTXRL-001_11, ANTXRL-001_12, ANTXRL-001_13, ANTXRL-001_14, ANTXRL-001_15, ANTXRL-001_16, ANTXRL-001_17, ANTXRL-001_18, ANTXRL-001_19, ANTXRL-001_20, CTGLF11P-001_1, CTGLF11P-001_2, CTGLF11P-001_3, CTGLF11P-001_4, CTGLF11P-001_5, CTGLF11P-001_6, CTGLF11P-001_7@28.6222222222222@17@75@@:protein binding;integral to membrane;receptor activity;metal ion binding@NA
D88892@128979@128979@deletion@1@47758848@47758905@10@chr10:47758848-47758905@5.76@26@0@0@CNVR4714.1@ANXA8L2-001_10@154@154@154@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:calcium-dependent phospholipid binding;calcium ion binding@NA
D88892@129460@129461@deletion@2@51361725@51361911@10@chr10:51361725-51361911@5.4@24@0@0@NA@ENST00000404618_4, ENST00000432221_4@122@121@123@NA@NA@NA
D88892@129605@129611@deletion@7@51970585@51994313@10@chr10:51970585-51994313@15.1@170@75@0.441@NA@ASAH2-201_5, ASAH2-201_6, ASAH2-201_7, ASAH2-201_8, ASAH2-201_9, ASAH2-201_10, ASAH2-201_11@145.142857142857@53@186@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
D88892@136770@136772@deletion@3@135439428@135440297@10@chr10:135439428-135440297@10.2@257@144@0.56@CNVR4989.11, CNVR4989.4@FRG2B-202_1, FRG2B-202_2, FRG2B-202_3@13@3@29@:FSHD region gene 2 family, member B@:nucleus@NA
D88892@138032@138033@deletion@2@5270600@5271118@11@chr11:5270600-5271118@10.8@49@0@0@NA@HBG1-201_1, HBG1-201_2@94.5@83@106@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
D88892@139432@139435@duplication@4@18425418@18426541@11@chr11:18425418-18426541@6.89@176@257@1.46@NA@LDHA-201_7, LDHA-201_8, LDHA-201_9, LDHA-201_10@0@0@0@:lactate dehydrogenase A@:oxidation-reduction process;mitochondrion;flagellum;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;catalytic activity;L-lactate dehydrogenase activity;oxidoreductase activity;glycolysis;small molecule metabolic process;carbohydrate metabolic process;nucleotide binding;cytoplasm;cytosol;cellular carbohydrate metabolic process;cellular response to extracellular stimulus;protein binding;pyruvate metabolic process@: GLYCOGEN STORAGE DISEASE XI; GSD11
D88892@145945@145964@deletion@20@89702620@89729449@11@chr11:89702620-89729449@18.1@142@43@0.303@NA@TRIM64-202_2, TRIM64-202_3, TRIM64-202_4, TRIM64-202_5, TRIM64-202_6, TRIM64-202_7, TRIM64-202_8, TRIM64-202_9, ENST00000442514_1, ENST00000442514_2, ENST00000442514_3, ENST00000442514_4, ENST00000442514_5, ENST00000442514_6, ENST00000442514_7, ENST00000442514_8, ENST00000442514_9, TRIM53-202_5, TRIM53-202_6, TRIM53-202_7@91.15@21@177@NA@NA@NA
D88892@150826@150841@deletion@16@9590609@9707352@12@chr12:9590609-9707352@119@742@140@0.189@CNVR5429.1@DDX12-203_1, DDX12-203_2, DDX12-203_3, AC006432-201_1, AC006432-201_2, AC006432-201_3, AC006432-201_4, AC006432-201_5, AC006432-201_6, AC006432-201_7, AC006432-201_8, AC006432-201_9, AC006432-201_11, AC006432-201_12, AC006432-201_13@20.7333333333333@7@25@NA@NA@NA
D88892@151027@151027@deletion@1@11083263@11083680@12@chr12:11083263-11083680@5.31@156@93@0.596@NA@PRH2-201_3@1@1@1@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):proline-rich protein HaeIII subfamily 2;proline-rich protein HaeIII subfamily 1@:extracellular space;visual perception:protein binding;extracellular space@NA
D88892@151034@151034@deletion@1@11244393@11244793@12@chr12:11244393-11244793@57.4@334@23@0.0689@CNVR5434.1@TAS2R31-201_2@72@72@72@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
D88892@151542@151546@deletion@5@21028171@21036537@12@chr12:21028171-21036537@26@412@202@0.49@NA@SLCO1B3-203_7, SLCO1B3-203_8, SLCO1B3-203_9, SLCO1B3-203_10, SLCO1B3-203_11@1@1@1@:solute carrier organic anion transporter family, member 1B3:solute carrier organic anion transporter family, member 1B7 (non-functional)@:bile acid and bile salt transport;transport;basolateral plasma membrane;small molecule metabolic process;transporter activity;organic anion transport;cytoplasm;bile acid metabolic process;transmembrane transport;organic anion transmembrane transporter activity;sodium-independent organic anion transport;integral to membrane;plasma membrane;integral to plasma membrane;membrane:transport;integral to membrane;transporter activity;membrane;transmembrane transport:transport;integral to membrane;transmembrane transporter activity;transporter activity;plasma membrane;membrane;transmembrane transport@: HYPERBILIRUBINEMIA, ROTOR TYPE; HBLRR
D88892@162165@162167@duplication@3@24895136@24895583@13@chr13:24895136-24895583@10.4@437@614@1.41@NA@SPATA13-009_13, SPATA13-009_14, C1QTNF9-003_5, AL359736-201_2@93@27@126@:spermatogenesis associated 13:C1q and tumor necrosis factor related protein 9:C1QTNF9B antisense RNA 1@:lamellipodium assembly;phospholipid binding;Rac guanyl-nucleotide exchange factor activity;guanyl-nucleotide exchange factor activity;ruffle membrane;nucleus;regulation of cell migration;cell migration;regulation of Rho protein signal transduction;intracellular;Rho guanyl-nucleotide exchange factor activity;cytoplasm;filopodium assembly;filopodium;protein binding;lamellipodium:collagen;protein binding;hormone activity@NA
D88892@164471@164478@deletion@8@52853978@52857493@13@chr13:52853978-52857493@12.1@284@164@0.577@NA@THSD1P-203_13, THSD1P-203_14, THSD1P-203_15, THSD1P-203_16, ENST00000403471_4, ENST00000403471_5, ENST00000403471_6, ENST00000403471_7@53@48@58@NA@NA@NA
D88892@164539@164543@duplication@5@53103402@53106857@13@chr13:53103402-53106857@21.4@121@283@2.34@NA@RP11-78J21-201_12, RP11-78J21-201_13, RP11-78J21-201_14, RP11-78J21-201_15, RP11-78J21-201_16@113.8@107@117@NA@NA@NA
D88892@170809@170811@deletion@3@74003820@74010454@14@chr14:74003820-74010454@49.5@349@84@0.241@CNVR6188.1, CNVR6188.4@ACOT1-201_1, ACOT1-201_2, ACOT1-201_3@109.666666666667@99@116@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
D88892@173404@173440@duplication@37@106066280@106174456@14@chr14:106066280-106174456@102@3143@4561@1.45@CNVR6294.46, CNVR6294.20, CNVR6294.43, CNVR6294.65, CNVR6294.66@AL928742-201_1, AL928742-201_2, AL928742-201_3, AL928742-201_4, IGHE-001_1, IGHE-001_2, IGHE-001_3, IGHE-001_4, IGHG4-001_1, IGHG4-001_2, IGHG4-001_3, IGHG4-001_4, IGHG2-002_1, IGHG2-002_2, IGHG2-002_3, IGHG2-002_4, IGHG2-002_5, IGHGP-001_1, IGHGP-001_2, IGHGP-001_3, IGHGP-001_4, IGHGP-001_5, IGHGP-001_6, AL928761-201_1, AL928761-201_2, AL928761-201_3, AL928761-201_4, AL928768-201_1, AL928768-201_2, AL928768-201_3, ENST00000457994_1, ENST00000457994_2, ENST00000457994_3, IGHA1-002_1, IGHA1-002_2, IGHA1-002_3, IGHA1-002_4@5.86486486486486@2@9@@:antigen binding;protein binding;immune response:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response:antigen binding;protein binding;immune response;protein-chromophore linkage@NA
D88892@173556@173568@duplication@13@106787370@106825338@14@chr14:106787370-106825338@131@1295@2809@2.17@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26@IGHV3-29-001_1, IGHV3-29-001_2, IGHV3-30-001_1, IGHV3-30-001_2, IGHV3-30-2-001_1, IGHV3-30-2-001_2, IGHV4-31-001_1, IGHV4-31-001_2, IGHV3-32-001_1, IGHV3-32-001_2, IGHV3-33-001_1, IGHV3-33-001_2, IGHV3-33-2-001_2@14.3076923076923@2@19@@:protein binding:protein binding:protein binding@NA
D88892@173653@173654@deletion@2@107183398@107183858@14@chr14:107183398-107183858@8.31@345@216@0.626@CNVR6294.6, CNVR6294.92@IGHV3-71-001_1, IGHV3-71-001_2@0.5@0@1@NA@NA@NA
D88892@173686@173687@duplication@2@20453920@20456787@15@chr15:20453920-20456787@6.45@259@361@1.39@CNVR6295.15, CNVR6295.7, CNVR6295.13, CNVR6295.26@ENST00000400226_10, ENST00000400226_11@72.5@70@75@NA@NA@NA
D88892@173819@173822@duplication@4@22466060@22473354@15@chr15:22466060-22473354@12.6@1463@1922@1.31@CNVR6297.4, CNVR6297.6@AC010760-202_1, AC010760-202_2, VSIG6-201_1, VSIG6-201_2@27@0@49@NA@NA@NA
D88892@174386@174388@deletion@3@28912344@28913502@15@chr15:28912344-28913502@10.3@94@33@0.351@CNVR6330.9@AC055876-201_21, AC055876-201_22, AC055876-201_23@20.3333333333333@19@23@NA@NA@NA
D88892@174503@174504@deletion@2@30653445@30659731@15@chr15:30653445-30659731@5.05@93@50@0.538@CNVR6337.1@CHRFAM7A-202_9, CHRFAM7A-202_10@47@44@50@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
D88892@174659@174669@duplication@11@32449811@32729803@15@chr15:32449811-32729803@17@284@451@1.59@CNVR6345.1@CHRNA7-205_6, CHRNA7-205_7, CHRNA7-205_8, CHRNA7-205_9, CHRNA7-205_10, ENST00000321578_1, ENST00000321578_2, ENST00000321578_3, ENST00000321578_4, AC135983-201_1, AC135983-201_2@61.5454545454545@31@133@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion:golgin A8 family, member J@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity:Golgi apparatus@NA
D88892@174965@174975@deletion@11@34702765@34820279@15@chr15:34702765-34820279@27.4@1055@659@0.625@CNVR6351.3@ENST00000443488_2, AC027139-201_1, AC027139-201_2, AC027139-201_3, AC027139-201_4, AC027139-201_5, ENST00000444260_1, ENST00000444260_2, ENST00000444260_3, GOLGA8B-201_23, GOLGA8B-201_24@41.3636363636364@22@49@:golgin A8 family, member A:golgin A8 family, member A;golgin A8 family, member B@:Golgi cisterna membrane;Golgi apparatus:Golgi cisterna membrane;Golgi apparatus@NA
D88892@180187@180187@deletion@1@79065427@79065546@15@chr15:79065427-79065546@7.22@34@1@0.0294@NA@ADAMTS7-201_14@10@10@10@:A disintegrin and metalloproteinase with thrombospondin motifs 7-like;ADAM metallopeptidase with thrombospondin type 1 motif, 7@:metallopeptidase activity;extracellular matrix;proteolysis;peptidase activity;proteinaceous extracellular matrix;metalloendopeptidase activity;cell surface;zinc ion binding@NA
D88892@183036@183037@duplication@2@2076890@2079784@16@chr16:2076890-2079784@7.47@156@240@1.54@NA@SLC9A3R2-203_1, SLC9A3R2-203_2@1@1@1@:solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 2@:PDZ domain binding;phosphatase binding;inner ear development;protein C-terminus binding;nucleus;plasma membrane;receptor binding;negative regulation of phosphatidylinositol 3-kinase cascade;endomembrane system;beta-catenin binding;apical plasma membrane;protein complex assembly;positive regulation of membrane potential;channel regulator activity;cytoplasm;protein binding@NA
D88892@184850@184853@deletion@4@16349579@16357073@16@chr16:16349579-16357073@35.3@540@249@0.461@NA@NOMO3-201_10, NOMO3-201_11, NOMO3-201_12, NOMO3-201_13@29.75@27@31@:NODAL modulator 3@:carbohydrate binding;integral to membrane;carboxypeptidase activity@NA
D88892@186368@186369@deletion@2@28711499@28712933@16@chr16:28711499-28712933@12.6@59@1@0.0169@CNVR6686.3, CNVR6686.1, CNVR6686.2@AC145285-201_1, AC145285-201_2@60@59@61@:eukaryotic translation initiation factor 3, subunit C@:cytosol;protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;cellular protein metabolic process;binding;gene expression;translation;translation initiation factor activity@NA
D88892@188231@188231@deletion@1@55803876@55804008@16@chr16:55803876-55804008@5.15@23@0@0@CNVR6730.1@CES4-202_4@123@123@123@NA@NA@NA
D88892@189930@189931@duplication@2@70010214@70012016@16@chr16:70010214-70012016@7.06@61@120@1.97@CNVR6762.3, CNVR6762.2@AC026468-201_7, AC026468-201_8@6.5@3@10@NA@NA@NA
D88892@190432@190432@deletion@1@72093015@72093088@16@chr16:72093015-72093088@16.5@232@99@0.427@CNVR6769.1, CNVR6769.2@HP-201_6@17@17@17@:thioredoxin-like 4B:haptoglobin:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:cellular iron ion homeostasis;negative regulation of oxidoreductase activity;catalytic activity;negative regulation of hydrogen peroxide catabolic process;positive regulation of cell death;haptoglobin-hemoglobin complex;extracellular space;proteolysis;response to hydrogen peroxide;extracellular region;hemoglobin binding;defense response;serine-type endopeptidase activity:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@: ANHAPTOGLOBINEMIA; AHP
D88892@190518@190519@duplication@2@74368792@74370605@16@chr16:74368792-74370605@6.97@338@474@1.4@CNVR6778.2, CNVR6778.1@AC009053-202_13, AC009053-202_14@15.5@15@16@NA@NA@NA
D88892@191081@191082@deletion@2@83983868@83984131@16@chr16:83983868-83984131@5.32@130@76@0.585@NA@AC009063-201_2, AC009063-201_3@2@2@2@:oxidative stress induced growth inhibitor 1@:oxidation-reduction process;multicellular organismal development;cell differentiation;growth factor activity;negative regulation of cell growth;oxidoreductase activity;cellular_component@NA
D88892@195009@195010@deletion@2@15508539@15508738@17@chr17:15508539-15508738@6.71@106@54@0.509@NA@CDRT1-201_7, TRIM16-202_16@20@20@20@:CMT1A duplicated region transcript 1@:protein binding;molecular_function;cellular_component;biological_process:protein binding;intracellular;zinc ion binding;cytoplasm@NA
D88892@195017@195018@deletion@2@15517149@15517348@17@chr17:15517149-15517348@12.9@315@178@0.565@NA@CDRT1-201_3, TRIM16-202_12@38@38@38@:CMT1A duplicated region transcript 1@:protein binding;molecular_function;cellular_component;biological_process:protein binding;intracellular;zinc ion binding;cytoplasm@NA
D88892@195026@195027@deletion@2@15539352@15546131@17@chr17:15539352-15546131@26.8@144@11@0.0764@NA@TRIM16-202_5, TRIM16-202_6@3@2@4@:tripartite motif containing 16@:protein binding;intracellular;zinc ion binding;cytoplasm:histone H4 acetylation;response to growth hormone stimulus;NACHT domain binding;DNA binding;positive regulation of keratinocyte differentiation;response to organophosphorus;interleukin-1 binding;PML body;positive regulation of interleukin-1 beta secretion;intracellular;regulation of transcription, DNA-dependent;response to retinoic acid;cytoplasm;positive regulation of transcription, DNA-dependent;protein binding;positive regulation of retinoic acid receptor signaling pathway;histone H3 acetylation;zinc ion binding;nucleic acid binding@NA
D88892@195716@195718@duplication@3@18394589@18395860@17@chr17:18394589-18395860@15.6@240@403@1.68@CNVR7014.1@LGALS9C-201_7, LGALS9C-201_8, LGALS9C-201_9@138@135@140@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
D88892@195796@195796@duplication@1@18630840@18631072@17@chr17:18630840-18631072@8.28@181@284@1.57@NA@TRIM16L-201_4@0@0@0@:tripartite motif containing 16-like@:protein binding;cytoplasm@NA
D88892@196144@196155@deletion@12@20346589@20356921@17@chr17:20346589-20356921@40.2@234@35@0.15@CNVR7021.1, CNVR7021.3@ENST00000458685_4, ENST00000458685_5, ENST00000411468_3, ENST00000411468_4, ENST00000411468_5, ENST00000411468_6, LGALS9B-201_6, LGALS9B-201_7, LGALS9B-201_8, LGALS9B-201_9, LGALS9B-201_10, LGALS9B-201_11@60.5@23@103@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
D88892@197726@197728@deletion@3@34539180@34539966@17@chr17:34539180-34539966@14@65@1@0.0154@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1-202_2, CCL4L1-202_3, CCL4L1-202_4@118@113@122@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
D88892@197745@197748@duplication@4@34625573@34641345@17@chr17:34625573-34641345@9.77@116@205@1.77@CNVR7077.1, CNVR7077.2, CNVR7077.12@CCL3L1-205_1, CCL4L2-202_1, CCL4L2-202_2, CCL4L2-202_3@60.25@39@71@:TBC1 domain family, member 3C;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3H-like;TBC1 domain family, member 3H:chemokine (C-C motif) ligand 3-like 1;chemokine (C-C motif) ligand 3-like 3:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:chemotaxis;extracellular space;inflammatory response;negative regulation of cell proliferation;extracellular region;immune response;chemokine activity:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
D88892@198032@198040@duplication@9@36351805@36367523@17@chr17:36351805-36367523@46.1@3685@4982@1.35@CNVR7083.3@AC183087-202_6, AC183087-202_7, AC183087-202_8, AC183087-202_9, AC183087-202_10, AC183087-202_11, AC183087-202_12, AC183087-202_13, AC183087-202_14@56.6666666666667@42@64@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
D88892@200255@200266@duplication@12@43559805@43596019@17@chr17:43559805-43596019@33@571@948@1.66@CNVR7113.4, CNVR7113.6@PLEKHM1-201_1, PLEKHM1-201_2, AC091132-201_1, AC091132-201_2, AC091132-201_3, AC091132-201_4, AC091132-201_5, AC091132-201_6, ENST00000253803_1, ENST00000339474_1, ENST00000339474_2, ENST00000339474_3@67.9166666666667@1@127@:pleckstrin homology domain containing, family M (with RUN domain) member 1@:phospholipid binding;protein binding;intracellular;metal ion binding;cytoplasm;intracellular signal transduction@: OSTEOPETROSIS, AUTOSOMAL RECESSIVE 6; OPTB6
D88892@200326@200344@deletion@19@44363278@44414935@17@chr17:44363278-44414935@20.6@1327@914@0.689@CNVR7114.3, CNVR7114.2, CNVR7114.1@ENST00000451529_1, ENST00000451529_3, LRRC37A-001_1, LRRC37A-001_2, LRRC37A-001_3, LRRC37A-001_4, LRRC37A-001_5, LRRC37A-001_6, LRRC37A-001_7, LRRC37A-001_8, LRRC37A-001_9, LRRC37A-001_10, LRRC37A-001_11, LRRC37A-001_12, LRRC37A-001_13, LRRC37A-001_14, AC005829-202_4, AC005829-202_5@118.888888888889@46@196@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
D88892@201839@201840@deletion@2@57656835@57657241@17@chr17:57656835-57657241@26.9@124@0@0@NA@DHX40-203_12, DHX40-203_13@7.5@3@12@:DEAH (Asp-Glu-Ala-His) box polypeptide 40@:transport;helicase activity;intracellular;ATP-dependent helicase activity;nucleic acid binding;ATP binding@NA
D88892@201936@201936@duplication@1@58072983@58074334@17@chr17:58072983-58074334@7.62@152@241@1.59@NA@AC005702-201_4@1@1@1@NA@NA@NA
D88892@205726@205726@deletion@1@117045@117305@18@chr18:117045-117305@16.5@265@120@0.453@NA@ENST00000400614_3@26@26@26@NA@NA@NA
D88892@208951@208951@deletion@1@72672144@72672711@18@chr18:72672144-72672711@5.73@222@138@0.622@NA@AC100783-201_2@0@0@0@:zinc finger protein 407@:intracellular;nucleus;DNA binding;regulation of transcription, DNA-dependent;transcription, DNA-dependent;zinc ion binding;nucleic acid binding@NA
D88892@213372@213373@deletion@2@14070581@14070882@19@chr19:14070581-14070882@15.9@352@191@0.543@NA@DCAF15-201_9, DCAF15-201_10@8.5@0@17@:DDB1 and CUL4 associated factor 15@:protein ubiquitination@NA
D88892@215928@215928@duplication@1@35862253@35863856@19@chr19:35862253-35863856@17.9@199@391@1.96@CNVR7627.1@FFAR3-001_2@102@102@102@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
D88892@217290@217305@duplication@16@40367300@40398511@19@chr19:40367300-40398511@21.2@875@1207@1.38@CNVR7639.2@FCGBP-201_14, FCGBP-201_15, FCGBP-201_16, FCGBP-201_17, FCGBP-201_18, FCGBP-201_19, FCGBP-201_20, FCGBP-201_21, FCGBP-201_22, FCGBP-201_23, FCGBP-201_24, FCGBP-201_25, FCGBP-201_26, FCGBP-201_27, FCGBP-201_28, FCGBP-201_29@94.4375@13@155@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D88892@218213@218214@duplication@2@43865329@43865732@19@chr19:43865329-43865732@4.93@110@166@1.51@NA@AC005392-201_1, AC005392-201_2@4.5@1@8@@:blood coagulation;plasma membrane;anchored to membrane;leukocyte migration@NA
D88892@220209@220210@duplication@2@50463396@50464193@19@chr19:50463396-50464193@5.21@491@642@1.31@NA@SIGLEC11-001_2, SIGLEC11-001_3@25.5@25@26@:sialic acid binding Ig-like lectin 11@:carbohydrate binding;protein binding;integral to membrane;cell adhesion@NA
D88892@220212@220214@deletion@3@50472859@50473865@19@chr19:50472859-50473865@15.7@386@214@0.554@NA@SIGLEC16-202_1, SIGLEC16-202_2, SIGLEC16-202_3@63.6666666666667@56@68@NA@NA@NA
D88892@220493@220493@deletion@1@51330920@51331072@19@chr19:51330920-51331072@6.46@99@48@0.485@NA@KLK15-202_2@0@0@0@:kallikrein-related peptidase 15@:serine-type peptidase activity;proteolysis;extracellular region;catalytic activity;serine-type endopeptidase activity@NA
D88892@221167@221168@deletion@2@54724957@54726003@19@chr19:54724957-54726003@6.86@49@13@0.265@CNVR7721.3, CNVR7721.4@LILRB3-008_4, LILRB3-008_5@129.5@123@136@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D88892@221218@221224@deletion@7@54801929@54804722@19@chr19:54801929-54804722@31.9@1011@607@0.6@CNVR7722.1@LILRA3-003_4, LILRA3-003_5, LILRA3-003_6, LILRA3-003_7, LILRA3-003_8, LILRA3-003_9, LILRA3-003_10@105.857142857143@90@109@:leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3@:antigen binding;signal transduction;protein binding;extracellular region;plasma membrane;receptor activity;defense response@NA
D88892@221396@221413@deletion@18@55266477@55290115@19@chr19:55266477-55290115@61@2047@1246@0.609@CNVR7725.2, CNVR7725.1@KIR2DL3-201_5, KIR2DL3-201_6, KIR2DL3-201_7, KIR2DL3-201_8, KIR2DP1-001_1, KIR2DP1-001_2, KIR2DP1-001_3, KIR2DP1-001_4, KIR2DP1-001_5, KIR2DP1-001_6, KIR2DP1-001_7, KIR2DP1-001_8, KIR2DP1-001_9, KIR2DL1-002_1, KIR2DL1-002_2, KIR2DL1-002_3, KIR2DL1-002_4, KIR2DL1-002_5@108.277777777778@76@126@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
D88892@221821@221824@deletion@4@56273966@56284546@19@chr19:56273966-56284546@27.8@1607@1057@0.658@CNVR7734.1@RFPL4A-201_3, ENST00000341750_1, ENST00000341750_2, ENST00000341750_3@36.5@30@47@:ret finger protein-like 4A;ret finger protein-like 4A-like:ret finger protein-like 4A-like@:protein binding;zinc ion binding:protein binding;zinc ion binding@NA
D88892@222563@222563@deletion@1@1569208@1569279@20@chr20:1569208-1569279@5.22@23@0@0@CNVR7763.1@SIRPB1-201_1@128@128@128@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
D88892@231958@231958@deletion@1@16287256@16287718@22@chr22:16287256-16287718@18.8@86@0@0@CNVR8071.2, CNVR8071.3, CNVR8071.9@POTEH-002_1@105@105@105@:POTE ankyrin domain family, member H@:protein binding@NA
D88892@233183@233188@deletion@6@21834050@21841962@22@chr22:21834050-21841962@9.25@122@57@0.467@CNVR8101.1@PI1KAP2-201_5, PI1KAP2-201_6, PI1KAP2-201_7, PI1KAP2-201_8, PI1KAP2-201_9, PI1KAP2-201_10@36.3333333333333@34@38@NA@NA@NA
D88892@236123@236123@deletion@1@39357394@39357687@22@chr22:39357394-39357687@5.99@52@17@0.327@CNVR8164.1@APOBEC3A-001_4@23@23@23@:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A;APOBEC3A and APOBEC3B deletion hybrid@:cytidine deamination;defense response to virus;negative regulation of viral genome replication;DNA cytosine deamination;clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine;catalytic activity;DNA demethylation;cytoplasm;innate immune response;cytidine deaminase activity;nucleus;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;cellular response to xenobiotic stimulus;zinc ion binding;negative regulation of transposition@NA
D88892@236767@236767@deletion@1@42537164@42537350@22@chr22:42537164-42537350@11.4@96@29@0.302@CNVR8168.1, CNVR8168.3, CNVR8168.4@CYP2D7P1-202_8@12@12@12@@:oxidation-reduction process;electron carrier activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;heme binding@NA
D9646@2945@2946@deletion@2@16976104@16976445@1@chr1:16976104-16976445@7.43@370@231@0.624@CNVR93.3, CNVR93.6, CNVR93.12, CNVR93.7, CNVR93.14, CNVR93.15@RP5-1182A14-001_16, RP5-1182A14-001_17@77@69@85@NA@NA@NA
D9646@2952@2966@duplication@15@17014873@17046653@1@chr1:17014873-17046653@11.2@1676@2153@1.28@CNVR93.3, CNVR93.15, CNVR93.4@RP1-163M9-001_1, ESPNP-002_1, ESPNP-002_2, ESPNP-002_3, ESPNP-002_4, ESPNP-002_5, ESPNP-002_6, ESPNP-002_7, ESPNP-002_8, ESPNP-002_9, ESPNP-002_10, ESPNP-002_11, AL021920-201_1, AL021920-201_2, AL021920-201_3@43.3333333333333@38@46@NA@NA@NA
D9646@3005@3007@duplication@3@17249160@17256527@1@chr1:17249160-17256527@6.62@534@717@1.34@CNVR94.4, CNVR94.5, CNVR94.6@CROCC-201_2, CROCC-201_3, CROCC-201_4@77@73@81@:ciliary rootlet coiled-coil, rootletin@:centriole;centrosome organization;centrosome;kinesin binding;actin cytoskeleton;cytoplasm;protein binding;vesicle-mediated transport;structural molecule activity;ciliary rootlet;protein localization;plasma membrane;cell cycle;cell projection organization;membrane@NA
D9646@3777@3779@duplication@3@21808092@21809812@1@chr1:21808092-21809812@5.88@130@200@1.54@CNVR107.2, CNVR107.1@NBPF3-003_17, NBPF3-003_18, NBPF3-003_19@93@83@111@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 3@:cytoplasm@NA
D9646@4448@4461@deletion@14@25579800@25655628@1@chr1:25579800-25655628@178@933@40@0.0429@CNVR116.1@C1orf63-002_1, RP11-335G20-001_1, RP11-335G20-001_2, RHD-202_1, RHD-202_2, RHD-202_3, RHD-202_4, RHD-202_5, RHD-202_6, RHD-202_7, RHD-202_8, RHD-202_9, RHD-202_10, RHD-202_11@109.714285714286@6@128@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
D9646@4477@4477@duplication@1@25735176@25735361@1@chr1:25735176-25735361@6.91@83@157@1.89@CNVR117.1@RHCE-005_4@56@56@56@:Rh blood group, CcEe antigens@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@: BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE; RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
D9646@6813@6814@deletion@2@40229386@40229587@1@chr1:40229386-40229587@4.95@140@82@0.586@NA@PPIE-003_11, BMP8B-001_5@34@34@34@:peptidylprolyl isomerase E (cyclophilin E):bone morphogenetic protein 8b@:regulation of transcription, DNA-dependent;nucleotide binding;catalytic step 2 spliceosome;protein folding;protein binding;protein peptidyl-prolyl isomerization;peptidyl-prolyl cis-trans isomerase activity;cyclosporin A binding;RNA binding;mRNA splicing, via spliceosome;nucleus;nucleic acid binding:cell differentiation;growth factor activity;extracellular space;growth;extracellular region;cytokine activity;cartilage development;skeletal system development;ossification@NA
D9646@11245@11246@duplication@2@89476589@89477711@1@chr1:89476589-89477711@7.28@502@708@1.41@CNVR244.1@GBP3-001_7, GBP3-001_8@54@54@54@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
D9646@12391@12403@duplication@13@104115687@104162407@1@chr1:104115687-104162407@19.5@680@999@1.47@CNVR266.8, CNVR266.3@AMY2B-001_5, AMY2B-001_6, AMY2B-001_7, AMY2B-001_8, AMY2B-001_9, AMY2B-001_10, AMY2B-001_11, AMY2B-001_12, AMY2A-202_1, AMY2A-202_2, AMY2A-202_3, AMY2A-202_4, AMY2A-202_5@44@26@74@:actin, gamma 1 pseudogene 4;amylase, alpha 2B (pancreatic):amylase, alpha 2A (pancreatic)@:extracellular region;cation binding;digestion;carbohydrate metabolic process;catalytic activity;alpha-amylase activity;metal ion binding:chloride ion binding;cation binding;small molecule metabolic process;carbohydrate metabolic process;catalytic activity;extracellular space;polysaccharide digestion;extracellular region;carbohydrate catabolic process;alpha-amylase activity;calcium ion binding@NA
D9646@12416@12425@deletion@10@104202984@104234233@1@chr1:104202984-104234233@16.2@152@54@0.355@CNVR266.3, CNVR266.1, CNVR266.15@AMY1A-001_7, AMY1A-001_8, AMY1A-001_9, AMY1A-001_10, AMY1A-001_11, AMY1B-001_7, AMY1B-001_8, AMY1B-001_9, AMY1B-001_10, AMY1B-001_11@123.8@109@154@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary):amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D9646@12445@12446@duplication@2@104297123@104297437@1@chr1:104297123-104297437@12.1@288@465@1.61@CNVR266.3, CNVR266.5@AMY1C-201_7, AMY1C-201_8@77@75@79@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D9646@12928@12936@duplication@9@110225831@110236368@1@chr1:110225831-110236368@66.9@484@1127@2.33@CNVR299.6, CNVR299.4, CNVR299.5@GSTM2-203_9, GSTM1-001_1, GSTM1-001_2, GSTM1-001_3, GSTM1-001_4, GSTM1-001_5, GSTM1-001_6, GSTM1-001_7, GSTM1-001_8@173.555555555556@31@194@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
D9646@14492@14495@deletion@4@144621449@144679973@1@chr1:144621449-144679973@15.8@304@151@0.497@NA@AL592284-001_12, WI2-1896O14-001_1, WI2-1896O14-001_2, WI2-1896O14-001_3@4@2@5@NA@NA@NA
D9646@19247@19247@deletion@1@168511233@168511346@1@chr1:168511233-168511346@7.05@49@11@0.224@NA@XCL2-001_2@2@2@2@:chemokine (C motif) ligand 2@:blood circulation;chemotaxis;extracellular space;signal transduction;extracellular region;immune response;chemokine activity@NA
D9646@21362@21371@duplication@10@196743977@196796136@1@chr1:196743977-196796136@40.3@875@1400@1.6@CNVR459.1@CFHR3-001_1, CFHR3-001_2, CFHR3-001_3, CFHR3-001_4, CFHR3-001_5, CFHR3-001_6, CFHR1-001_1, CFHR1-001_2, CFHR1-001_3, CFHR2-201_1@94.6@85@112@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
D9646@21373@21374@duplication@2@196799632@196801320@1@chr1:196799632-196801320@14@491@760@1.55@CNVR459.1@CFHR1-001_5, CFHR1-001_6@96.5@96@97@:complement factor H-related 1:complement factor H-related 2@:extracellular space;complement activation:extracellular region@NA
D9646@24160@24164@deletion@5@223727670@223729472@1@chr1:223727670-223729472@12.3@60@3@0.05@NA@CAPN8-202_20, CAPN8-202_21, CAPN8-202_22, CAPN8-202_23, CAPN8-202_24@0@0@0@:calpain 8@:proteolysis;Golgi apparatus;intracellular;calcium-dependent cysteine-type endopeptidase activity;calcium ion binding@NA
D9646@33712@33716@deletion@5@89156682@89185137@2@chr2:89156682-89185137@13.6@968@637@0.658@CNVR866.5, CNVR866.8, CNVR866.7@ENST00000452230_1, AC096579-209_6, AC096579-209_7, AC096579-209_8, IGKV4-1-001_1@0@0@0@@:regulation of immune response;complement activation;immune response;complement activation, classical pathway;innate immune response;antigen binding;protein binding;extracellular region;plasma membrane:regulation of immune response;complement activation;immune response;complement activation, classical pathway;innate immune response;antigen binding;protein binding;extracellular region;plasma membrane@: IMMUNOGLOBULIN KAPPA LIGHT CHAIN DEFICIENCY; IGKCD
D9646@33832@33835@duplication@4@90192770@90199191@2@chr2:90192770-90199191@12.7@476@699@1.47@CNVR867.10, CNVR867.5, CNVR867.3, CNVR867.9, CNVR867.15@IGKV1D-13-001_1, IGKV1D-13-001_2, IGKV1D-12-001_1, IGKV1D-12-001_2@8.25@7@10@@:protein binding:protein binding@NA
D9646@34094@34095@duplication@2@96458183@96458295@2@chr2:96458183-96458295@6.35@53@106@2@NA@AC008268-201_3, ENST00000444924_2@104@104@104@NA@NA@NA
D9646@34212@34213@deletion@2@96697783@96698114@2@chr2:96697783-96698114@10.4@107@40@0.374@NA@GPAT2-205_3, GPAT2-205_4@75.5@75@76@:glycerol-3-phosphate acyltransferase 2, mitochondrial@:glycerol-3-phosphate O-acyltransferase activity;mitochondrion;phospholipid metabolic process;triglyceride biosynthetic process;glycerophospholipid biosynthetic process;small molecule metabolic process;transferase activity, transferring acyl groups;mitochondrial outer membrane;phosphatidic acid biosynthetic process;integral to membrane;glycerol-3-phosphate metabolic process;CDP-diacylglycerol biosynthetic process;membrane;metabolic process;phospholipid biosynthetic process@NA
D9646@61531@61538@duplication@8@195345501@195378460@3@chr3:195345501-195378460@29.9@1970@2903@1.47@NA@ENST00000457750_2, AC233280-201_2, AC233280-201_3, AC233280-201_4, AC233280-201_5, AC233280-201_6, AC233280-201_7, AC233280-201_8@85.625@56@93@:mucin 20, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane@NA
D9646@61549@61550@duplication@2@195395392@195398172@3@chr3:195395392-195398172@8.71@337@494@1.47@CNVR1703.1@SDHALP2-001_7, SDHALP2-001_8@74@73@75@:mucin 20, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane@NA
D9646@61631@61647@duplication@17@195692302@195702772@3@chr3:195692302-195702772@14@840@1137@1.35@CNVR1707.1, CNVR1707.2@SDHALP1-002_9, SDHALP1-002_10, SDHALP1-002_11, SDHALP1-002_12, SDHALP1-002_13, SDHALP1-002_14, SDHALP1-002_15, ENST00000354937_10, ENST00000354937_11, ENST00000354937_12, ENST00000354937_13, ENST00000354937_14, ENST00000354937_15, ENST00000354937_16, ENST00000366437_1, ENST00000366437_2, ENST00000366437_3@29.2352941176471@13@43@NA@NA@NA
D9646@62414@62415@deletion@2@2044465@2044552@4@chr4:2044465-2044552@5.57@54@20@0.37@NA@NAT8L-201_2, C4orf48-201_3@0@0@0@:chromosome 4 open reading frame 48@:extracellular region@NA
D9646@65354@65360@duplication@7@70146221@70160768@4@chr4:70146221-70160768@16.5@716@1016@1.42@CNVR1957.2, CNVR1957.1@UGT2B28-201_1, UGT2B28-201_2, UGT2B28-201_3, UGT2B28-201_4, UGT2B28-201_5, UGT2B28-201_6, UGT2B28-201_7@69.1428571428571@65@71@:UDP glucuronosyltransferase 2 family, polypeptide B28@:carbohydrate binding;transferase activity, transferring hexosyl groups;endoplasmic reticulum;glucuronosyltransferase activity;carbohydrate metabolic process;xenobiotic metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process@NA
D9646@68946@68947@duplication@2@145040841@145041742@4@chr4:145040841-145041742@6.63@163@252@1.55@NA@GYPA-205_2, GYPA-205_3@7@6@8@:glycophorin B (MNS blood group):glycophorin A (MNS blood group)@:integral to membrane;plasma membrane;integral to plasma membrane:external side of plasma membrane;integral to membrane;cytoskeletal anchoring at plasma membrane;plasma membrane;molecular_function;protein homodimerization activity;integral to plasma membrane;cellular_component;identical protein binding;membrane;biological_process;regulation of response to osmotic stress;virus-host interaction@: BLOOD GROUP--Ss LOCUS; Ss: MALARIA, SUSCEPTIBILITY TO; BLOOD GROUP--MN LOCUS; MN
D9646@70821@70826@deletion@6@745300@767035@5@chr5:745300-767035@30.9@564@299@0.53@CNVR2280.3@ZDHHC11B-201_1, ZDHHC11B-201_2, ZDHHC11B-201_3, ZDHHC11B-201_4, ZDHHC11B-201_5, ZDHHC11B-201_6@85.1666666666667@74@96@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
D9646@71603@71610@duplication@8@21482257@21497350@5@chr5:21482257-21497350@8.65@261@382@1.46@CNVR2395.4, CNVR2395.2@AC138951-201_4, AC138951-201_5, AC138951-201_6, AC138951-202_2, ENST00000412250_1, ENST00000412250_2, ENST00000366374_1, ENST00000366374_2@89.875@40@108@NA@NA@NA
D9646@73727@73754@duplication@28@69717564@69807068@5@chr5:69717564-69807068@13.5@99@207@2.09@CNVR2494.17, CNVR2494.3@GTF2H2B-201_4, GTF2H2B-201_5, GTF2H2B-201_6, GTF2H2B-201_7, GTF2H2B-201_8, GTF2H2B-201_9, GTF2H2B-201_10, GTF2H2B-201_11, GTF2H2B-201_12, GTF2H2B-201_13, GTF2H2B-201_14, GTF2H2B-201_15, GTF2H2B-201_16, AC146944-201_1, AC146944-201_2, AC146944-201_3, AC146944-201_4, AC146944-203_1, AC146944-203_2, AC146944-203_3, AC146944-203_4, ENST00000456583_1, ENST00000456583_2, ENST00000456583_3, ENST00000456583_5, AC146944-202_1, AC146944-202_2@135.925925925926@83@173@NA@NA@NA
D9646@73812@73821@duplication@10@70357101@70389020@5@chr5:70357101-70389020@34.9@265@599@2.26@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.8, CNVR2494.1, CNVR2494.37@GTF2H2-202_1, GTF2H2-202_2, GTF2H2-202_3, GTF2H2-202_4, GTF2H2-202_5, AC044797-201_1, AC044797-201_2, AC044797-201_3, AC044797-201_4, AC044797-201_5@91.2@61@138@:general transcription factor IIH, polypeptide 2, 44kDa@:nucleoplasm;nucleotide-excision repair, DNA damage removal;transcription from RNA polymerase I promoter;DNA repair;RNA polymerase II carboxy-terminal domain kinase activity;nucleus;viral reproduction;translation;gene expression;transcription elongation from RNA polymerase I promoter;response to UV;holo TFIIH complex;protein kinase activity;nucleotide-excision repair;transcription from RNA polymerase II promoter;transcription-coupled nucleotide-excision repair;transcription, DNA-dependent;zinc ion binding;transcription elongation from RNA polymerase II promoter;termination of RNA polymerase I transcription;sequence-specific DNA binding transcription factor activity;G-protein coupled receptor internalization;DNA-dependent ATPase activity;protein N-terminus binding;transcription initiation from RNA polymerase I promoter;7-methylguanosine mRNA capping;transcription initiation from RNA polymerase II promoter;protein phosphorylation;translation factor activity, nucleic acid binding;regulation of transcription, DNA-dependent;core TFIIH complex;protein binding;positive regulation of viral transcription;nucleic acid binding@NA
D9646@78044@78044@duplication@1@147553799@147553934@5@chr5:147553799-147553934@15.5@116@300@2.59@CNVR2637.2, CNVR2637.1@AC116334-001_3@78@78@78@:serine peptidase inhibitor, Kazal type 14 (putative)@:serine-type endopeptidase inhibitor activity;protein binding;extracellular region@NA
D9646@79566@79568@duplication@3@175386532@175388438@5@chr5:175386532-175388438@11.4@129@237@1.84@NA@THOC3-001_4, THOC3-001_5, THOC3-001_6@169@160@182@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
D9646@82517@82521@deletion@5@29910536@29912394@6@chr6:29910536-29912394@17.9@689@414@0.601@CNVR2829.7, CNVR2829.2, CNVR2829.3@AL645929-201_1, HLA-A-001_4, HLA-A-001_5, HLA-A-001_6, HLA-A-001_7@19.8@17@22@:major histocompatibility complex, class I, A@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO
D9646@83002@83003@duplication@2@31237745@31238263@6@chr6:31237745-31238263@6.42@317@449@1.42@CNVR2838.2, CNVR2838.1@HLA-C-006_4, HLA-C-006_5@25@25@25@:major histocompatibility complex, class I, C@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;membrane@: PSORIASIS SUSCEPTIBILITY 1; PSORS1
D9646@83017@83018@duplication@2@31324480@31324990@6@chr6:31324480-31324990@5.09@176@254@1.44@CNVR2841.12, CNVR2841.14, CNVR2841.8@HLA-B-201_1, HLA-B-201_2@67@62@72@:major histocompatibility complex, class I, B@:MHC class I protein complex;regulation of immune response;regulation of interleukin-12 production;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;regulation of T cell anergy;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;receptor binding;early endosome membrane;virus-host interaction;regulation of interleukin-6 production;regulation of dendritic cell differentiation;phagocytic vesicle membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO; SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1
D9646@83614@83617@duplication@4@31975450@31976177@6@chr6:31975450-31976177@9.09@136@225@1.65@CNVR2843.6, CNVR2843.3@CYP21A1P-001_8, CYP21A1P-001_9, CYP21A1P-001_10, AL645922-201_7@103@82@116@NA@NA@NA
D9646@83683@83683@deletion@1@32012785@32013104@6@chr6:32012785-32013104@6.03@84@37@0.44@CNVR2843.6, CNVR2843.5@TNXB-201_32@13@13@13@:tenascin-X-like;tenascin XB@:integrin binding;extracellular matrix;cell-cell adhesion;elastic fiber assembly;collagen fibril organization;fibrillar collagen;actin cytoskeleton organization;extracellular space;heparin binding;proteinaceous extracellular matrix;fatty acid metabolic process;regulation of JUN kinase activity;receptor binding;intracellular;cell-matrix adhesion;extracellular matrix organization;lipid metabolic process;protein binding;signal transduction;extracellular region;collagen binding;cell adhesion;triglyceride metabolic process;fibril organization;collagen metabolic process@: EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY; EHLERS-DANLOS SYNDROME, TYPE III
D9646@83911@83946@duplication@36@32485122@32634448@6@chr6:32485122-32634448@244@1976@4511@2.28@CNVR2845.21, CNVR2845.25, CNVR2845.24@HLA-DRB5-001_1, HLA-DRB5-001_2, HLA-DRB5-001_3, HLA-DRB5-001_4, HLA-DRB5-001_5, HLA-DRB5-001_6, HLA-DRB6-002_1, HLA-DRB6-002_2, HLA-DRB6-002_3, HLA-DRB6-002_4, HLA-DRB6-002_5, HLA-DRB6-002_6, AL713966-201_1, AL713966-201_2, AL713966-201_3, HLA-DRB1-001_1, HLA-DRB1-001_2, HLA-DRB1-001_3, HLA-DRB1-001_4, HLA-DRB1-001_5, HLA-DRB1-001_6, HLA-DQA1-002_1, HLA-DQA1-002_2, HLA-DQA1-002_3, HLA-DQA1-002_4, HLA-DQA1-002_5, HLA-DQA1-002_6, HLA-DQB1-003_2, HLA-DQB1-003_3, HLA-DQB1-003_4, HLA-DQB1-003_5, HLA-DQB1-003_6, XXbac-BPG254F23-001_1, XXbac-BPG254F23-001_2, ENST00000443574_1, ENST00000443574_2@125.111111111111@56@189@:major histocompatibility complex, class II, DR beta 5:HLA class II histocompatibility antigen, DRB1-7 beta chain-like;major histocompatibility complex, class II, DR beta 1:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane:regulation of interleukin-10 secretion;negative regulation of interferon-gamma production;immune response;transport vesicle membrane;regulation of interleukin-4 production;protein tetramerization;peptide antigen binding;plasma membrane;antigen processing and presentation of exogenous peptide antigen via MHC class II;humoral immune response mediated by circulating immunoglobulin;MHC class II protein complex;antigen processing and presentation;inflammatory response to antigenic stimulus;membrane;negative regulation of T cell proliferation;T-helper 1 type immune response;T cell costimulation;detection of bacterium;integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;cytokine-mediated signaling pathway;external side of plasma membrane;lysosomal membrane;T cell receptor signaling pathway;protein binding;MHC class II receptor activity;immunoglobulin production involved in immunoglobulin mediated immune response;positive regulation of insulin secretion involved in cellular response to glucose stimulus;trans-Golgi network membrane:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@: SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1; HEPATITIS C VIRUS, SUSCEPTIBILITY TO
D9646@84706@84710@deletion@5@35754777@35765089@6@chr6:35754777-35765089@10.4@844@566@0.671@CNVR2861.1@C6orf127-001_2, C6orf127-001_3, CLPS-001_1, CLPS-001_2, CLPS-001_3@39@30@43@:colipase-like 1:colipase, pancreatic@:extracellular region;enzyme activator activity;digestion;lipid catabolic process:steroid metabolic process;post-embryonic development;small molecule metabolic process;retinoid metabolic process;lipid metabolic process;extracellular region;enzyme activator activity;digestion;lipid catabolic process;lipid digestion;response to food@NA
D9646@92588@92594@duplication@7@160131986@160133143@6@chr6:160131986-160133143@33.8@585@991@1.69@CNVR3127.2, CNVR3127.1@ENST00000442642_3, ENST00000442642_4, ENST00000442642_5, ENST00000442642_6, ENST00000442642_7, ENST00000442642_8, ENST00000442642_9@94.1428571428571@56@112@:superoxide dismutase 2, mitochondrial;uncharacterized LOC100129518@:response to reactive oxygen species;oxidation-reduction process;mitochondrion;negative regulation of cell proliferation;neuron development;negative regulation of fat cell differentiation;removal of superoxide radicals;response to gamma radiation;response to L-ascorbic acid;response to lipopolysaccharide;response to nutrient levels;response to zinc ion;protein homotetramerization;post-embryonic development;iron ion homeostasis;hemopoiesis;aging;mitochondrial inner membrane;age-dependent response to reactive oxygen species;response to drug;oxygen binding;mitochondrial nucleoid;vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure;apoptotic process;superoxide metabolic process;response to superoxide;detection of oxygen;response to silicon dioxide;cytoplasm;response to stress;respiratory electron transport chain;superoxide anion generation;protein homooligomerization;regulation of mitochondrial membrane potential;positive regulation of nitric oxide biosynthetic process;response to manganese ion;regulation of blood pressure;metal ion binding;negative regulation of apoptotic process;response to cadmium ion;response to oxidative stress;liver development;regulation of catalytic activity;negative regulation of fibroblast proliferation;response to selenium ion;age-dependent response to oxidative stress;response to electrical stimulus;mitochondrial matrix;identical protein binding;mitochondrion organization;response to hyperoxia;vasodilation;response to hydrogen peroxide;superoxide dismutase activity;heart development;negative regulation of neuron apoptotic process;erythrophore differentiation;locomotory behavior;DNA binding;release of cytochrome c from mitochondria;response to axon injury;oxygen homeostasis;response to activity;glutathione metabolic process;hydrogen peroxide metabolic process;hydrogen peroxide biosynthetic process;regulation of transcription from RNA polymerase II promoter;response to hypoxia;protein binding;manganese ion binding;cellular response to ethanol@: MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6; MVCD6
D9646@93099@93101@duplication@3@167790036@167794825@6@chr6:167790036-167794825@6.23@178@257@1.44@NA@TCP10-001_3, TCP10-001_4, TCP10-001_5@77@52@103@:t-complex 10@:cytosol@NA
D9646@94438@94444@duplication@7@6836201@6844687@7@chr7:6836201-6844687@22.3@323@552@1.71@NA@RSPH10B2-204_20, RSPH10B2-204_21, ENST00000429267_1, C7orf28B-001_12, C7orf28B-001_13, C7orf28B-001_14, C7orf28B-001_15@90.8571428571429@25@121@:radial spoke head 10 homolog B2 (Chlamydomonas);radial spoke head 10 homolog B (Chlamydomonas):CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae);CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)@:lysosomal membrane@NA
D9646@96579@96582@duplication@4@38388958@38394119@7@chr7:38388958-38394119@8.3@698@942@1.35@CNVR3354.3, CNVR3354.1@TRGV5-001_1, TRGV5-001_2, TRGV4-001_1, TRGV4-001_2@12.75@11@14@@:protein binding:protein binding@NA
D9646@96584@96584@duplication@1@38398540@38398764@7@chr7:38398540-38398764@5.42@121@194@1.6@CNVR3354.1@TRGV3-001_1@6@6@6@@:protein binding;immune response;peptide antigen binding;plasma membrane;MHC protein binding@NA
D9646@97908@97917@duplication@10@57064289@57084498@7@chr7:57064289-57084498@18.6@114@259@2.27@NA@TNRC18C-202_4, TNRC18C-202_5, TNRC18C-202_6, TNRC18C-202_7, TNRC18C-202_8, TNRC18C-202_9, TNRC18C-202_10, TNRC18C-202_11, ENST00000398760_4, ENST00000398760_5@155.9@139@166@NA@NA@NA
D9646@97991@97994@deletion@4@62758072@62758771@7@chr7:62758072-62758771@91@460@0@0@NA@AC006455-201_2, AC006455-201_3, ENST00000444809_2, ENST00000444809_3@160@151@171@NA@NA@NA
D9646@98015@98026@duplication@12@62910199@62970547@7@chr7:62910199-62970547@20.6@609@986@1.62@NA@ZNF734-201_2, ZNF734-201_3, ZNF734-201_4, ZNF734-201_5, ZNF734-201_6, ZNF734-201_7, ZNF734-201_8, ENST00000434048_1, ENST00000434048_2, CTD-2526L21-201_1, CTD-2526L21-201_2, CTD-2526L21-201_3@81.5833333333333@66@102@NA@NA@NA
D9646@98032@98037@deletion@6@63028123@63036185@7@chr7:63028123-63036185@8.22@303@187@0.617@NA@ENST00000417666_6, ENST00000417666_7, ENST00000417666_8, ENST00000417666_9, ENST00000417666_10, ENST00000417666_11@31.8333333333333@29@37@NA@NA@NA
D9646@98172@98174@deletion@3@64533821@64534227@7@chr7:64533821-64534227@5.25@35@8@0.229@NA@RP11-460N20-001_11, RP11-460N20-001_12, ENST00000501153_3@100.666666666667@100@101@NA@NA@NA
D9646@98192@98193@duplication@2@64646770@64646889@7@chr7:64646770-64646889@6.1@47@97@2.06@NA@INTS4L1-201_8, INTS4L1-201_9@51.5@51@52@NA@NA@NA
D9646@98215@98215@deletion@1@65150574@65150717@7@chr7:65150574-65150717@7.99@43@4@0.093@NA@INTS4L2-001_5@56@56@56@NA@NA@NA
D9646@99035@99035@deletion@1@74172294@74172334@7@chr7:74172294-74172334@6.66@69@25@0.362@NA@GTF2I-001_33@25@25@25@:general transcription factor IIi@:neuronal cell body;transcription initiation from RNA polymerase II promoter;mitogen-activated protein kinase binding;negative regulation of angiogenesis;DNA binding;embryo development;sequence-specific DNA binding transcription factor activity;cytoplasm;transcription from RNA polymerase II promoter;protein binding;signal transduction;nucleus;cell projection;reduction of cytosolic calcium ion concentration@NA
D9646@99133@99133@deletion@1@74582344@74582508@7@chr7:74582344-74582508@5.2@43@13@0.302@NA@NCF1C-001_4@49@49@49@NA@NA@NA
D9646@99489@99490@deletion@2@76240773@76241131@7@chr7:76240773-76241131@19.1@210@81@0.386@CNVR3463.10@POMZP3-003_6, POMZP3-003_7@43.5@41@46@:uroplakin 3B:POM121 and ZP3 fusion@:negative regulation of gene expression;integral to membrane;plasma membrane:molecular_function;cellular_component;biological_process@NA
D9646@101512@101514@deletion@3@99954375@99956703@7@chr7:99954375-99956703@9.01@373@225@0.603@NA@PILRB-001_14, PILRB-001_15, PILRB-001_16@0@0@0@:paired immunoglobin-like type 2 receptor beta@:protein binding;transmembrane receptor protein tyrosine kinase signaling pathway;activation of transmembrane receptor protein tyrosine kinase activity;integral to plasma membrane@NA
D9646@101721@101726@deletion@6@100331652@100336237@7@chr7:100331652-100336237@15.9@684@425@0.621@CNVR3509.1@ZAN-001_2, ZAN-001_3, ZAN-001_4, ZAN-001_5, ZAN-001_6, ZAN-001_7@81.6666666666667@71@89@:zonadhesin@:protein binding;binding of sperm to zona pellucida;cell-cell adhesion;integral to membrane;plasma membrane;membrane@NA
D9646@102144@102145@duplication@2@102180464@102180539@7@chr7:102180464-102180539@8.67@104@188@1.81@CNVR3518.1@RASA4B-007_4, POLR2J3-003_7@96@96@96@:RAS p21 protein activator 4B:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
D9646@102166@102166@deletion@1@102219874@102220244@7@chr7:102219874-102220244@6.44@29@0@0@CNVR3518.1@ENST00000379336_1, RASA4-001_21@63@63@63@:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
D9646@102192@102193@deletion@2@102279572@102279647@7@chr7:102279572-102279647@6.64@253@154@0.609@CNVR3518.1@ENST00000340457_4, POLR2J2-001_7@76.5@76@77@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4:uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J2@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity:integral to membrane:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
D9646@104579@104579@deletion@1@134221805@134221910@7@chr7:134221805-134221910@8.2@92@34@0.37@NA@AKR1B10-001_6@2@2@2@:aldo-keto reductase family 1, member B10 (aldose reductase)@:steroid metabolic process;cellular aldehyde metabolic process;indanol dehydrogenase activity;daunorubicin metabolic process;retinal dehydrogenase activity;farnesol catabolic process;geranylgeranyl reductase activity;protein binding;extracellular region;aldo-keto reductase (NADP) activity;digestion;doxorubicin metabolic process;cellular_component;lysosome@NA
D9646@105321@105343@deletion@23@141765517@141794455@7@chr7:141765517-141794455@498@2565@36@0.014@CNVR3585.3, CNVR3585.2@MGAM-007_40, MGAM-007_41, MGAM-007_42, MGAM-007_43, MGAM-007_44, MGAM-007_45, MGAM-007_46, MGAM-007_47, MGAM-007_48, MGAM-007_49, MGAM-007_50, MGAM-007_51, MGAM-007_52, MGAM-007_53, MGAM-007_54, MGAM-007_55, MGAM-007_56, MGAM-007_57, MGAM-007_58, MGAM-007_59, MGAM-007_60, MGAM-007_61, MGAM-007_62@108.086956521739@5@134@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
D9646@105521@105523@duplication@3@142481247@142482417@7@chr7:142481247-142482417@24.3@438@781@1.78@NA@PRSS1-204_4, PRSS1-204_5, PRSS1-204_6@114.333333333333@113@115@NA@NA@NA
D9646@105800@105803@duplication@4@143979376@143979884@7@chr7:143979376-143979884@5.86@249@348@1.4@CNVR3598.4, CNVR3598.9@RP4-798C17-001_3, RP4-798C17-001_4, ENST00000378112_4, ENST00000378112_5@57.25@55@58@:Rho guanine nucleotide exchange factor (GEF) 35@NA@NA
D9646@109572@109585@deletion@14@39311571@39349528@8@chr8:39311571-39349528@76.5@355@0@0@CNVR3859.1@ADAM3A-005_11, ADAM3A-005_12, ADAM3A-005_13, ADAM3A-005_14, ADAM3A-005_15, ADAM3A-005_16, ADAM3A-005_17, ADAM3A-005_18, ADAM3A-005_19, ADAM3A-005_20, ADAM3A-005_21, ADAM3A-009_7, ADAM3A-009_8, ADAM3A-009_9@120.5@98@136@NA@NA@NA
D9646@117389@117390@duplication@2@40503021@40504057@9@chr9:40503021-40504057@8.08@117@202@1.73@CNVR4272.1@ENST00000399669_5, ENST00000399669_6@7@3@11@NA@NA@NA
D9646@121600@121604@deletion@5@117085338@117087433@9@chr9:117085338-117087433@21.5@1456@947@0.65@CNVR4448.1@ORM1-001_1, ORM1-001_2, ORM1-001_3, ORM1-001_4, ORM1-001_5@87.6@84@90@:orosomucoid 1@:protein binding;extracellular space;regulation of immune system process;transport;inflammatory response;extracellular region;acute-phase response@NA
D9646@124047@124052@deletion@6@135957928@135960431@9@chr9:135957928-135960431@20.6@97@2@0.0206@NA@CELP-002_1, CELP-002_2, CELP-002_3, AL162417-201_1, AL162417-201_2, AL162417-201_3@84.3333333333333@66@99@NA@NA@NA
D9646@125889@125889@duplication@1@5202081@5202136@10@chr10:5202081-5202136@5.01@14@50@3.57@NA@AKR1CL1-202_5@4@4@4@:aldo-keto reductase family 1, member C-like 1@:oxidoreductase activity;cytoplasm@NA
D9646@126908@126918@duplication@11@17837922@17898363@10@chr10:17837922-17898363@32.3@526@909@1.73@NA@FAM23A-201_4, FAM23A-201_5, MRC1L1-001_1, MRC1L1-001_2, MRC1L1-001_3, MRC1L1-001_4, MRC1L1-001_5, MRC1L1-001_6, MRC1L1-001_7, MRC1L1-001_8, MRC1L1-001_9@19.6363636363636@5@108@:transmembrane protein 236;transmembrane protein 236-like:macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding@NA
D9646@126941@126956@deletion@16@18060294@18152612@10@chr10:18060294-18152612@59@290@7@0.0241@NA@FAM23B-202_2, FAM23B-202_3, FAM23B-202_4, FAM23B-202_5, MRC1-001_1, MRC1-001_2, MRC1-001_3, MRC1-001_4, MRC1-001_5, MRC1-001_6, MRC1-001_7, MRC1-001_8, MRC1-001_9, MRC1-001_10, MRC1-001_11, RP11-457D2-001_2@38.5@10@107@:transmembrane protein 236;transmembrane protein 236-like:mannose receptor, C type 1;macrophage mannose receptor 1-like@:integral to membrane:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D9646@128828@128828@deletion@1@46927785@46928012@10@chr10:46927785-46928012@6.45@67@24@0.358@CNVR4712.9, CNVR4712.2, CNVR4712.7@FAM35B-001_6@72@72@72@NA@NA@NA
D9646@129022@129028@deletion@7@48025302@48049022@10@chr10:48025302-48049022@11.1@323@193@0.598@CNVR4715.2@ASAH2C-201_3, ASAH2C-201_4, ASAH2C-201_5, ASAH2C-201_6, ASAH2C-201_7, ASAH2C-201_8, ASAH2C-201_9@69.4285714285714@58@90@@:ceramidase activity;sphingolipid metabolic process@NA
D9646@129460@129468@duplication@9@51361725@51371647@10@chr10:51361725-51371647@17.2@320@506@1.58@NA@ENST00000404618_1, ENST00000404618_2, ENST00000404618_3, ENST00000404618_4, ENST00000432221_1, ENST00000432221_2, ENST00000432221_3, ENST00000432221_4, TIMM23B-202_1@123.111111111111@109@142@:translocase of inner mitochondrial membrane 23 homolog B (yeast)@:intracellular protein transport;integral to membrane;molecular_function;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;mitochondrial inner membrane presequence translocase complex;cellular_component;biological_process@NA
D9646@129572@129586@deletion@15@51847037@51877819@10@chr10:51847037-51877819@9.55@45@1@0.0222@NA@FAM21A-005_8, FAM21A-005_9, FAM21A-005_10, FAM21A-005_11, FAM21A-005_12, FAM21A-005_13, FAM21A-005_14, FAM21A-005_15, FAM21A-005_16, FAM21A-005_17, FAM21A-005_18, FAM21A-005_19, FAM21A-005_20, FAM21A-005_21, FAM21A-005_22@105.933333333333@93@123@:family with sequence similarity 21, member B;family with sequence similarity 21, member A@:retrograde transport, endosome to Golgi;WASH complex;early endosome membrane;early endosome@NA
D9646@129605@129609@duplication@5@51970585@51978391@10@chr10:51970585-51978391@11.9@170@288@1.69@NA@ASAH2-201_7, ASAH2-201_8, ASAH2-201_9, ASAH2-201_10, ASAH2-201_11@181.2@176@186@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
D9646@136770@136771@deletion@2@135439428@135439811@10@chr10:135439428-135439811@7.51@235@130@0.553@CNVR4989.11, CNVR4989.4@FRG2B-202_2, FRG2B-202_3@18@7@29@:FSHD region gene 2 family, member B@:nucleus@NA
D9646@138032@138033@deletion@2@5270600@5271118@11@chr11:5270600-5271118@5.15@41@12@0.293@NA@HBG1-201_1, HBG1-201_2@94.5@83@106@:hemoglobin, gamma A@:cytosol;blood coagulation;oxygen transporter activity;iron ion binding;oxygen binding;heme binding;hemoglobin complex@NA
D9646@139527@139527@duplication@1@18955060@18956211@11@chr11:18955060-18956211@23@823@1765@2.14@CNVR5091.2, CNVR5091.1@MRGPRX1-203_3@16@16@16@:MAS-related GPR, member X1@:integral to membrane;G-protein coupled receptor activity;plasma membrane;acute-phase response;G-protein coupled receptor signaling pathway@NA
D9646@141315@141315@duplication@1@56216408@56217067@11@chr11:56216408-56217067@5.37@438@618@1.41@NA@AP002512-201_2@3@3@3@NA@NA@NA
D9646@145944@145962@duplication@19@89701674@89727385@11@chr11:89701674-89727385@11.5@95@188@1.98@NA@TRIM64-202_1, TRIM64-202_2, TRIM64-202_3, TRIM64-202_4, TRIM64-202_5, TRIM64-202_6, TRIM64-202_7, TRIM64-202_8, TRIM64-202_9, ENST00000442514_1, ENST00000442514_2, ENST00000442514_3, ENST00000442514_4, ENST00000442514_5, ENST00000442514_6, ENST00000442514_7, ENST00000442514_8, ENST00000442514_9, TRIM53-202_7@102.789473684211@21@177@NA@NA@NA
D9646@148314@148314@duplication@1@121232561@121233573@11@chr11:121232561-121233573@4.89@101@163@1.61@NA@AP002959-201_2@0@0@0@NA@NA@NA
D9646@150778@150783@deletion@6@9450373@9454871@12@chr12:9450373-9454871@12.5@206@103@0.5@NA@DDX11L8-201_5, DDX11L8-201_6, DDX11L8-201_7, DDX11L8-201_8, DDX11L8-201_9, DDX11L8-201_10@67.8333333333333@55@78@NA@NA@NA
D9646@150785@150786@deletion@2@9456573@9456804@12@chr12:9456573-9456804@14.1@102@21@0.206@NA@DDX11L8-201_12, DDX11L8-201_13@85@83@87@NA@NA@NA
D9646@151034@151034@duplication@1@11244393@11244793@12@chr12:11244393-11244793@9.48@364@582@1.6@CNVR5434.1@TAS2R31-201_2@72@72@72@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
D9646@151048@151052@duplication@5@11506043@11544583@12@chr12:11506043-11544583@24.2@567@945@1.67@CNVR5435.2, CNVR5435.1@PRB1-201_1, PRB1-201_2, PRB1-201_3, PRB1-201_4, PRB2-001_4@44@35@49@:proline-rich protein BstNI subfamily 1:proline-rich protein BstNI subfamily 2@:extracellular region;molecular_function;cellular_component;biological_process@NA
D9646@162127@162128@deletion@2@24465240@24465671@13@chr13:24465240-24465671@17.9@792@445@0.562@NA@RP11-45B20-002_6, ENST00000382133_3@29@29@29@:C1q and tumor necrosis factor related protein 9B@:collagen;protein binding@NA
D9646@162131@162131@deletion@1@24468280@24468341@13@chr13:24468280-24468341@10@161@69@0.429@NA@RP11-45B20-002_4@36@36@36@:C1q and tumor necrosis factor related protein 9B@:collagen;protein binding@NA
D9646@167655@167656@deletion@2@24434973@24435193@14@chr14:24434973-24435193@9.03@222@122@0.55@NA@DHRS4-201_4, DHRS4-201_5@0@0@0@:dehydrogenase/reductase (SDR family) member 4@:steroid metabolic process;oxidation-reduction process;mitochondrion;protein tetramerization;oxidoreductase activity;peroxisomal membrane;nucleus;cellular ketone metabolic process;metabolic process;receptor binding;alcohol dehydrogenase [NAD(P)+] activity;peroxisome;nucleotide binding;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;3-keto sterol reductase activity;alcohol metabolic process;carbonyl reductase (NADPH) activity@NA
D9646@170814@170815@duplication@2@74040094@74042360@14@chr14:74040094-74042360@6.68@455@617@1.36@CNVR6188.1, CNVR6188.5, CNVR6188.6@ACOT2-201_2, ACOT2-201_3@6.5@5@8@:acyl-CoA thioesterase 2@:acyl-CoA metabolic process;mitochondrion;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity;receptor binding@NA
D9646@173412@173414@deletion@3@106090689@106091717@14@chr14:106090689-106091717@15.1@374@204@0.545@CNVR6294.46, CNVR6294.20, CNVR6294.54, CNVR6294.43, CNVR6294.50, CNVR6294.61@IGHG4-001_2, IGHG4-001_3, IGHG4-001_4@6@6@6@@:antigen binding;protein binding;complement activation;extracellular region;immune response;membrane;complement activation, classical pathway;innate immune response@NA
D9646@173487@173500@deletion@14@106386975@106471724@14@chr14:106386975-106471724@47.4@1970@1175@0.596@CNVR6294.36, CNVR6294.48, CNVR6294.12@KIAA0125-204_3, KIAA0125-204_4, KIAA0125-204_5, KIAA0125-204_6, KIAA0125-204_7, IGHV6-1-001_1, IGHV6-1-001_2, ADAM6-001_1, ADAM6-001_2, IGHV1-2-001_1, IGHV1-2-001_2, IGHV1-3-001_1, IGHV1-3-001_2@1.46153846153846@0@4@:KIAA0125@:protein binding:protein binding:protein binding@NA
D9646@173503@173564@deletion@62@106478496@106812383@14@chr14:106478496-106812383@159@8749@5512@0.63@CNVR6294.48, CNVR6294.24, CNVR6294.40@IGHV4-4-001_1, IGHV2-5-001_1, IGHV2-5-001_2, IGHV3-7-001_1, IGHV3-7-001_2, IGHV1-8-001_1, IGHV1-8-001_2, IGHV3-9-001_1, IGHV3-9-001_2, IGHV2-10-001_2, IGHV3-11-001_1, IGHV3-11-001_2, IGHV1-12-001_1, IGHV1-12-001_2, IGHV3-13-001_1, IGHV3-13-001_2, IGHV3-15-001_1, IGHV3-15-001_2, IGHV3-16-001_1, IGHV3-16-001_2, IGHV1-17-001_2, IGHV1-18-001_1, IGHV1-18-001_2, IGHV3-20-001_1, IGHV3-20-001_2, IGHV3-21-001_1, IGHV3-21-001_2, IGHV3-22-001_1, IGHV3-22-001_2, AB019439-201_1, AB019439-201_2, IGHVIII-22-2-201_1, IGHVIII-22-2-201_3, IGHV3-23-001_1, IGHV3-23-001_2, IGHV1-24-001_1, IGHV1-24-001_2, AB019439-002_1, AB019439-002_2, IGHV3-25-001_1, IGHV3-25-001_2, IGHV2-26-001_1, IGHV2-26-001_2, IGHV7-27-001_1, IGHV7-27-001_2, IGHV4-28-001_1, IGHV4-28-001_2, IGHV3-29-001_1, IGHV3-29-001_2, IGHV3-30-001_1, IGHV3-30-001_2, IGHV3-30-2-001_1, IGHV3-30-2-001_2, IGHV4-31-001_1, IGHV4-31-001_2, IGHV3-32-001_2@6.98214285714286@0@24@:uncharacterized LOC100653243;uncharacterized LOC642131@:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding:protein binding@NA
D9646@173586@173593@deletion@8@106866408@106926725@14@chr14:106866408-106926725@42.6@1820@1115@0.613@CNVR6294.26, CNVR6294.56, CNVR6294.18@IGHV3-38-001_1, IGHV3-38-001_2, IGHV4-39-001_1, IGHV4-39-001_2, IGHV3-41-001_1, IGHV3-41-001_2, IGHV3-43-001_1, IGHV3-43-001_2@8.5@4@12@@:protein binding:protein binding:protein binding@NA
D9646@173686@173687@deletion@2@20453920@20456787@15@chr15:20453920-20456787@8.63@244@139@0.57@CNVR6295.15, CNVR6295.7, CNVR6295.13, CNVR6295.26@ENST00000400226_10, ENST00000400226_11@72.5@70@75@NA@NA@NA
D9646@173697@173698@deletion@2@20588370@20588710@15@chr15:20588370-20588710@9.67@563@353@0.627@CNVR6295.15, CNVR6295.7, CNVR6295.3, CNVR6295.10, CNVR6295.5@HERC2P3-014_27, AC026495-201_26@70@63@77@NA@NA@NA
D9646@173819@173823@deletion@5@22466060@22494464@15@chr15:22466060-22494464@7.38@1371@977@0.713@CNVR6297.4, CNVR6297.6@AC025884-201_2, AC010760-202_1, AC010760-202_2, VSIG6-201_1, VSIG6-201_2@22.6@0@49@NA@NA@NA
D9646@174315@174317@deletion@3@28599720@28600153@15@chr15:28599720-28600153@6.91@56@17@0.304@CNVR6329.4@AC091304-201_3, AC091304-201_4, AC091304-201_5@34.3333333333333@34@35@NA@NA@NA
D9646@174409@174410@deletion@2@29008952@29009297@15@chr15:29008952-29009297@5.47@365@240@0.658@NA@ENST00000456510_1, ENST00000456510_2@24.5@24@25@NA@NA@NA
D9646@176340@176341@duplication@2@43873202@43873587@15@chr15:43873202-43873587@7.32@576@793@1.38@CNVR6365.1@HISPPD2A-201_9, HISPPD2A-201_10@10@10@10@:diphosphoinositol pentakisphosphate kinase 1@:inositol hexakisphosphate 3-kinase activity;inositol hexakisphosphate 1-kinase activity;inositol metabolic process;diphosphoinositol-pentakisphosphate kinase activity;ATP binding;acid phosphatase activity;cytoplasm;cytosol;inositol hexakisphosphate 5-kinase activity;nucleus;kinase activity;inositol-1,3,4,5,6-pentakisphosphate kinase activity@NA
D9646@176695@176696@duplication@2@45361077@45364637@15@chr15:45361077-45364637@5.82@97@158@1.63@NA@SORD-001_7, SORD-001_8@1.5@0@3@:sorbitol dehydrogenase@:carbohydrate binding;oxidation-reduction process;transferase activity, transferring acyl groups other than amino-acyl groups;mitochondrion;flagellum;L-xylitol catabolic process;extracellular space;oxidoreductase activity;NAD binding;sorbitol metabolic process;mitochondrial membrane;glucose metabolic process;sperm motility;fructose biosynthetic process;cilium;nucleotide binding;L-xylitol metabolic process;L-iditol 2-dehydrogenase activity;sorbitol catabolic process;membrane;zinc ion binding@NA
D9646@180187@180187@deletion@1@79065427@79065546@15@chr15:79065427-79065546@4.9@30@5@0.167@NA@ADAMTS7-201_14@10@10@10@:A disintegrin and metalloproteinase with thrombospondin motifs 7-like;ADAM metallopeptidase with thrombospondin type 1 motif, 7@:metallopeptidase activity;extracellular matrix;proteolysis;peptidase activity;proteinaceous extracellular matrix;metalloendopeptidase activity;cell surface;zinc ion binding@NA
D9646@183359@183364@duplication@6@2607706@2627502@16@chr16:2607706-2627502@7.27@312@448@1.44@CNVR6601.1@PDPK1-003_2, PDPK1-003_3, PDPK1-003_4, PDPK1-003_5, PDPK1-003_6, PDPK1-003_7@1.16666666666667@0@3@:3-phosphoinositide dependent protein kinase-1@:3-phosphoinositide-dependent protein kinase activity;nucleoplasm;fibroblast growth factor receptor signaling pathway;protein tyrosine kinase activity;negative regulation of transforming growth factor beta receptor signaling pathway;negative regulation of toll-like receptor signaling pathway;regulation of endothelial cell migration;focal adhesion assembly;ATP binding;insulin receptor signaling pathway;plasma membrane;intracellular signal transduction;positive regulation of establishment of protein localization to plasma membrane;platelet activation;protein kinase activity;regulation of mast cell degranulation;cytosol;epidermal growth factor receptor signaling pathway;hyperosmotic response;nerve growth factor receptor signaling pathway;type B pancreatic cell development;synaptic transmission;regulation of apoptotic process;transcription, DNA-dependent;protein autophosphorylation;regulation of I-kappaB kinase/NF-kappaB cascade;protein kinase binding;T cell costimulation;insulin receptor binding;transferase activity, transferring phosphorus-containing groups;actin cytoskeleton organization;blood coagulation;negative regulation of protein kinase activity;cellular response to insulin stimulus;focal adhesion;phosphatidylinositol-mediated signaling;negative regulation of cardiac muscle cell apoptotic process;protein serine/threonine kinase activity;protein phosphorylation;regulation of transcription, DNA-dependent;cytoplasm;activation of protein kinase B activity;protein binding;T cell receptor signaling pathway;cytoplasmic membrane-bounded vesicle;peptidyl-threonine phosphorylation;kinase activity@NA
D9646@183378@183384@deletion@7@2672693@2693298@16@chr16:2672693-2693298@34.3@164@1@0.0061@CNVR6602.2@AC141586-001_4, AC141586-201_1, AC141586-201_2, AC141586-201_3, AC141586-201_4, AC141586-201_5, AC141586-201_6@34.4285714285714@19@57@NA@NA@NA
D9646@184533@184542@duplication@10@14951076@14969112@16@chr16:14951076-14969112@23.2@886@1311@1.48@NA@NOMO1-201_10, NOMO1-201_11, NOMO1-201_12, NOMO1-201_13, NOMO1-201_14, NOMO1-201_15, NOMO1-201_16, NOMO1-201_17, NOMO1-201_18, NOMO1-201_19@7.1@5@10@:NODAL modulator 1;nodal modulator 1-like@:carbohydrate binding;integral to membrane;carboxypeptidase activity;molecular_function;cellular_component;biological_process@NA
D9646@184851@184853@deletion@3@16349867@16357073@16@chr16:16349867-16357073@10.1@335@192@0.573@NA@NOMO3-201_11, NOMO3-201_12, NOMO3-201_13@29.3333333333333@27@31@:NODAL modulator 3@:carbohydrate binding;integral to membrane;carboxypeptidase activity@NA
D9646@186368@186369@deletion@2@28711499@28712933@16@chr16:28711499-28712933@11.6@53@0@0@CNVR6686.3, CNVR6686.1, CNVR6686.2@AC145285-201_1, AC145285-201_2@60@59@61@:eukaryotic translation initiation factor 3, subunit C@:cytosol;protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;cellular protein metabolic process;binding;gene expression;translation;translation initiation factor activity@NA
D9646@187500@187507@duplication@8@32486766@32859477@16@chr16:32486766-32859477@10.7@432@624@1.44@CNVR6701.7@AC138915-202_1, AC138915-202_3, AC138915-202_4, TP53TG3-202_1, IGHV2OR16-5-001_1, IGHV2OR16-5-001_2@33.1666666666667@18@44@:TP53 target 3B;TP53 target 3;TP53-target gene 3 protein-like;TP53 target 3C@:nucleus;cytoplasm@NA
D9646@187527@187533@duplication@7@32936755@32945317@16@chr16:32936755-32945317@7.46@145@226@1.56@CNVR6702.1@ENST00000423205_4, ENST00000423205_5, ENST00000423205_6, ENST00000423205_7, ENST00000423205_8, ENST00000423205_9, ENST00000423205_10@20.1428571428571@14@34@NA@NA@NA
D9646@187546@187548@duplication@3@33629704@33630421@16@chr16:33629704-33630421@12.7@927@1298@1.4@CNVR6703.17, CNVR6703.1, CNVR6703.6, CNVR6703.21@AC136428-201_1, AC136428-201_2, AC136428-201_3@22.3333333333333@18@29@NA@NA@NA
D9646@187570@187572@duplication@3@33740805@33752888@16@chr16:33740805-33752888@5.89@426@578@1.36@CNVR6703.17, CNVR6703.1, CNVR6703.23@ENST00000450856_1, ENST00000450856_2, ENST00000450856_3@8.66666666666667@8@10@NA@NA@NA
D9646@188229@188241@deletion@13@55798611@55820017@16@chr16:55798611-55820017@22.8@523@300@0.574@CNVR6730.1@CES4-202_2, CES4-202_3, CES4-202_4, CES4-202_5, CES4-202_6, CES4-202_7, CES4-202_8, CES4-202_9, CES4-202_10, CES4-202_11, AC147362-203_1, AC147362-203_2, AC147362-203_3@102.692307692308@83@123@NA@NA@NA
D9646@188251@188258@duplication@8@55844431@55857596@16@chr16:55844431-55857596@11.9@1061@1407@1.33@CNVR6731.1@CES1-203_4, CES1-203_5, CES1-203_6, CES1-203_7, CES1-203_8, CES1-203_9, CES1-203_10, CES1-203_11@29.25@23@33@:carboxylesterase 1;liver carboxylesterase 1-like@:hydrolase activity;methyl salicylate esterase activity;response to toxin;methylumbelliferyl-acetate deacetylase activity;endoplasmic reticulum lumen;retinyl-palmitate esterase activity;methyl jasmonate esterase activity;metabolic process;carboxylesterase activity;methyl indole-3-acetate esterase activity@: CARBOXYLESTERASE 1; CES1
D9646@189930@189930@deletion@1@70010214@70010636@16@chr16:70010214-70010636@12.1@56@0@0@CNVR6762.3, CNVR6762.2@AC026468-201_8@10@10@10@NA@NA@NA
D9646@189989@189989@deletion@1@70219790@70219880@16@chr16:70219790-70219880@5.5@54@19@0.352@CNVR6764.1, CNVR6764.5@CLEC18C-201_11@19@19@19@:C-type lectin domain family 18, member C@:carbohydrate binding;protein binding;extracellular region@NA
D9646@190670@190672@deletion@3@75256869@75257527@16@chr16:75256869-75257527@5.22@35@8@0.229@NA@CTRB1-001_3, CTRB1-001_4, CTRB1-001_5@34.3333333333333@23@40@:chymotrypsinogen B1@:extracellular space;proteolysis;extracellular region;digestion;extracellular matrix organization;catalytic activity;serine-type endopeptidase activity;extracellular matrix disassembly@NA
D9646@195234@195260@duplication@27@16676813@16735099@17@chr17:16676813-16735099@26.7@1427@1946@1.36@NA@CCDC144A-202_18, AC022596-003_1, AC022596-003_2, AC022596-003_3, AC022596-003_4, AC022596-003_5, AC022596-003_6, AC022596-003_7, AC022596-003_8, AC022596-003_9, AC022596-003_10, AC022596-003_11, AC022596-001_1, AC022596-001_2, AC022596-001_3, AC022596-001_4, AC022596-001_5, AC022596-001_6, AC022596-001_7, AC022596-001_8, ENST00000414673_2, ENST00000414673_3, ENST00000414673_4, ENST00000414673_5, ENST00000414673_6, ENST00000414673_7, ENST00000414673_8@81.5555555555556@60@97@:coiled-coil domain containing 144A@NA@NA
D9646@195703@195712@deletion@10@18344490@18389450@17@chr17:18344490-18389450@35@188@19@0.101@CNVR7014.1@ENST00000399124_3, ENST00000399124_4, ENST00000399124_5, ENST00000399124_6, ENST00000399124_7, ENST00000399124_8, ENST00000411877_4, LGALS9C-201_1, LGALS9C-201_2, LGALS9C-201_3@128.7@79@153@:lectin, galactoside-binding, soluble, 9C@:carbohydrate binding@NA
D9646@195719@195747@deletion@29@18396013@18457581@17@chr17:18396013-18457581@172@943@93@0.0986@NA@LGALS9C-201_10, LGALS9C-201_11, ENST00000426269_1, ENST00000426269_2, ENST00000426269_3, ENST00000426269_4, ENST00000426269_5, AC107983-001_1, AC107983-001_2, AC107983-001_3, AC107983-001_4, AC107983-001_5, AC107983-001_6, AC107983-001_7, AC107983-001_8, AC107983-001_9, AC107983-001_10, ENST00000456184_1, ENST00000456184_2, CCDC144B-201_14, CCDC144B-201_15, CCDC144B-201_16, CCDC144B-201_17, CCDC144B-201_18, ENST00000447265_11, ENST00000447265_12, ENST00000447265_13, ENST00000447265_14, ENST00000447265_15@130.068965517241@123@139@:lectin, galactoside-binding, soluble, 9C:protein FAM106B-like@:carbohydrate binding@NA
D9646@196144@196155@deletion@12@20346589@20356921@17@chr17:20346589-20356921@37.5@203@20@0.0985@CNVR7021.1, CNVR7021.3@ENST00000458685_4, ENST00000458685_5, ENST00000411468_3, ENST00000411468_4, ENST00000411468_5, ENST00000411468_6, LGALS9B-201_6, LGALS9B-201_7, LGALS9B-201_8, LGALS9B-201_9, LGALS9B-201_10, LGALS9B-201_11@60.5@23@103@:lectin, galactoside-binding, soluble, 9B@:carbohydrate binding@NA
D9646@197726@197728@deletion@3@34539180@34539966@17@chr17:34539180-34539966@14.1@65@0@0@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1-202_2, CCL4L1-202_3, CCL4L1-202_4@118@113@122@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
D9646@198033@198033@duplication@1@36352424@36352527@17@chr17:36352424-36352527@5.68@353@509@1.44@CNVR7083.3@AC183087-202_13@64@64@64@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
D9646@200259@200266@duplication@8@43585590@43596019@17@chr17:43585590-43596019@18.3@454@709@1.56@CNVR7113.4, CNVR7113.6, CNVR7113.2, CNVR7113.1@AC091132-201_1, AC091132-201_2, AC091132-201_3, AC091132-201_4, AC091132-201_5, ENST00000339474_1, ENST00000339474_2, ENST00000339474_3@94.875@81@127@NA@NA@NA
D9646@200327@200346@deletion@20@44363795@44430297@17@chr17:44363795-44430297@25.7@857@530@0.618@CNVR7114.3, CNVR7114.2, CNVR7114.1@ENST00000451529_1, LRRC37A-001_1, LRRC37A-001_2, LRRC37A-001_3, LRRC37A-001_4, LRRC37A-001_5, LRRC37A-001_6, LRRC37A-001_7, LRRC37A-001_8, LRRC37A-001_9, LRRC37A-001_10, LRRC37A-001_11, LRRC37A-001_12, LRRC37A-001_13, LRRC37A-001_14, LRRC37A-001_15, AC005829-202_3, AC005829-202_4, AC005829-202_5@124.105263157895@46@196@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane@NA
D9646@210546@210547@deletion@2@4354948@4355171@19@chr19:4354948-4355171@5.82@129@71@0.55@NA@MPND-202_7, MPND-202_8@1.5@1@2@:MPN domain containing@:peptidase activity;protein binding;proteolysis@NA
D9646@213493@213494@deletion@2@14508472@14508748@19@chr19:14508472-14508748@10.3@88@27@0.307@NA@CD97-205_8, CD97-205_9@10.5@7@14@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
D9646@213635@213635@duplication@1@14877792@14877922@19@chr19:14877792-14877922@6.06@55@112@2.04@NA@EMR2-209_6@4@4@4@:egf-like module containing, mucin-like, hormone receptor-like 2@:transmembrane signaling receptor activity;inflammatory response;G-protein coupled receptor activity;ruffle membrane;integral to membrane;plasma membrane;cell surface receptor signaling pathway;neuropeptide signaling pathway;granulocyte chemotaxis;cell migration;leading edge membrane;G-protein coupled receptor signaling pathway;protein binding;cell adhesion;membrane;calcium ion binding;chondroitin sulfate binding@NA
D9646@215928@215928@deletion@1@35862253@35863856@19@chr19:35862253-35863856@11.1@178@75@0.421@CNVR7627.1@FFAR3-001_2@102@102@102@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
D9646@217293@217297@duplication@5@40373947@40382827@19@chr19:40373947-40382827@24.7@297@549@1.85@CNVR7639.2@FCGBP-201_22, FCGBP-201_23, FCGBP-201_24, FCGBP-201_25, FCGBP-201_26@130.8@105@155@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D9646@217301@217306@deletion@6@40389654@40399856@19@chr19:40389654-40399856@40.2@297@78@0.263@CNVR7639.2, CNVR7639.3@FCGBP-201_13, FCGBP-201_14, FCGBP-201_15, FCGBP-201_16, FCGBP-201_17, FCGBP-201_18@112.333333333333@103@127@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D9646@217594@217595@deletion@2@41324628@41327534@19@chr19:41324628-41327534@5.49@81@39@0.481@NA@CYP2F1P-001_5, CYP2F1P-001_6@0@0@0@NA@NA@NA
D9646@220210@220210@duplication@1@50463811@50464193@19@chr19:50463811-50464193@8.58@399@617@1.55@NA@SIGLEC11-001_2@25@25@25@:sialic acid binding Ig-like lectin 11@:carbohydrate binding;protein binding;integral to membrane;cell adhesion@NA
D9646@220212@220218@deletion@7@50472859@50475359@19@chr19:50472859-50475359@61.7@658@241@0.366@NA@SIGLEC16-202_1, SIGLEC16-202_2, SIGLEC16-202_3, SIGLEC16-202_4, SIGLEC16-202_5, SIGLEC16-202_6, SIGLEC16-202_7@35.2857142857143@6@68@NA@NA@NA
D9646@220709@220709@duplication@1@52227180@52227222@19@chr19:52227180-52227222@6.73@33@87@2.64@NA@HAS1-201_1@1@1@1@:hyaluronan synthase 1@:hyaluronan synthase activity;transferase activity, transferring hexosyl groups;hyaluronan biosynthetic process;small molecule metabolic process;hyaluronan metabolic process;carbohydrate metabolic process;glycosaminoglycan metabolic process;glycosaminoglycan biosynthetic process;cellular response to platelet-derived growth factor stimulus;cell adhesion;plasma membrane;integral to plasma membrane;membrane;negative regulation of fibroblast migration@NA
D9646@221396@221412@deletion@17@55266477@55286911@19@chr19:55266477-55286911@48.5@1889@1155@0.611@CNVR7725.2, CNVR7725.1@KIR2DL3-201_5, KIR2DL3-201_6, KIR2DL3-201_7, KIR2DL3-201_8, KIR2DP1-001_1, KIR2DP1-001_2, KIR2DP1-001_3, KIR2DP1-001_4, KIR2DP1-001_5, KIR2DP1-001_6, KIR2DP1-001_7, KIR2DP1-001_8, KIR2DP1-001_9, KIR2DL1-002_1, KIR2DL1-002_2, KIR2DL1-002_3, KIR2DL1-002_4@110.176470588235@85@126@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
D9646@221819@221821@duplication@3@56270382@56274542@19@chr19:56270382-56274542@9.91@763@1046@1.37@CNVR7734.1@RFPL4A-201_1, RFPL4A-201_2, RFPL4A-201_3@32.6666666666667@26@39@:ret finger protein-like 4A;ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
D9646@221823@221824@deletion@2@56283164@56284546@19@chr19:56283164-56284546@19.5@798@479@0.6@CNVR7734.1@ENST00000341750_2, ENST00000341750_3@38.5@30@47@:ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
D9646@222068@222069@duplication@2@58003184@58003369@19@chr19:58003184-58003369@7.73@49@110@2.24@CNVR7748.1@ZNF419-202_5, ZNF419-202_6@0@0@0@:zinc finger protein 419@:intracellular;DNA binding;regulation of transcription, DNA-dependent;cytoplasm;nucleolus;nucleus;transcription, DNA-dependent;zinc ion binding;nucleic acid binding:intracellular;regulation of transcription, DNA-dependent;nucleic acid binding@NA
D9646@222594@222594@duplication@1@1895747@1896102@20@chr20:1895747-1896102@8.36@127@231@1.82@CNVR7764.2@SIRPA-201_3@34@34@34@:signal-regulatory protein alpha@:blood coagulation;protein binding;integral to membrane;SH3 domain binding;cell adhesion;plasma membrane;membrane;leukocyte migration@NA
D9646@228630@228633@deletion@4@62369176@62369414@20@chr20:62369176-62369414@7.94@237@141@0.595@CNVR7933.1@ZGPAT-012_9, ZGPAT-012_10, LIME1-201_3, LIME1-201_4@32@30@34@:zinc finger, CCCH-type with G patch domain:Lck interacting transmembrane adaptor 1@:sequence-specific DNA binding;negative regulation of transcription, DNA-dependent;sequence-specific DNA binding transcription factor activity;protein binding;nucleus;transcription, DNA-dependent;negative regulation of epidermal growth factor-activated receptor activity;zinc ion binding;nucleic acid binding:regulation of I-kappaB kinase/NF-kappaB cascade;regulation of NF-kappaB import into nucleus;protein kinase binding;regulation of transcription from RNA polymerase II promoter;B cell receptor complex;growth factor receptor binding;T cell receptor signaling pathway;B cell receptor signaling pathway;regulation of MAP kinase activity;integral to membrane;regulation of release of sequestered calcium ion into cytosol;regulation of phosphatidylinositol 3-kinase cascade@NA
D9646@232776@232783@deletion@8@20390271@20398724@22@chr22:20390271-20398724@10.8@50@1@0.02@CNVR8094.9, CNVR8094.4, CNVR8094.10@PI4KAP1-204_2, PI4KAP1-204_3, PI4KAP1-204_4, PI4KAP1-204_5, PI4KAP1-204_6, PI4KAP1-204_7, PI4KAP1-204_8, PI4KAP1-204_9@169.25@167@172@NA@NA@NA
D9646@233700@233708@duplication@9@24283261@24302569@22@chr22:24283261-24302569@22.4@145@338@2.33@CNVR8114.6, CNVR8114.10, CNVR8114.12, CNVR8114.13@ENST00000443377_2, ENST00000443377_3, ENST00000440099_1, ENST00000440099_2, ENST00000440099_3, GSTT2B-002_2, GSTT2B-002_3, GSTT2B-002_4, GSTT2B-002_5@74.6666666666667@56@125@:glutathione S-transferase theta 2B (gene/pseudogene);glutathione S-transferase theta 2@:protein binding;glutathione transferase activity;nucleus;transferase activity;cytoplasm@NA
D9646@233731@233754@deletion@24@24345655@24394850@22@chr22:24345655-24394850@207@990@0@0@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTTP1-001_1, GSTTP1-001_2, ENST00000421902_1, ENST00000421902_2, ENST00000448902_1, ENST00000448902_2, ENST00000448902_3, ENST00000448902_4, ENST00000448902_5, ENST00000329210_1, ENST00000329210_2, ENST00000329210_3, ENST00000329210_4, ENST00000439866_1, ENST00000439866_2, GSTT1-009_1, GSTT1-009_2, GSTT1-009_3, GSTT1-009_4, GSTT1-009_5, ENST00000439996_1, ENST00000439996_2, GSTTP2-001_4, GSTTP2-001_5@130.833333333333@109@149@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
D9646@236748@236757@deletion@10@42522505@42525939@22@chr22:42522505-42525939@51.6@990@492@0.497@CNVR8168.1, CNVR8168.3, CNVR8168.2@CYP2D6-203_1, CYP2D6-203_2, CYP2D6-203_3, CYP2D6-203_4, CYP2D6-203_5, CYP2D6-203_6, CYP2D6-203_7, CYP2D6-203_8, CYP2D6-203_9, CYP2D6-203_10@26.6@16@30@:cytochrome P450, family 2, subfamily D, polypeptide 6@:oxidation-reduction process;mitochondrion;alkaloid catabolic process;aromatase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;drug catabolic process;endoplasmic reticulum membrane;response to organic substance;oxidative demethylation;endoplasmic reticulum;alkaloid metabolic process;negative regulation of binding;heme binding;xenobiotic metabolic process;dopamine metabolic process;steroid metabolic process;isoquinoline alkaloid metabolic process;arachidonic acid monooxygenase activity;arachidonic acid metabolic process;steroid 21-monooxygenase activity;negative regulation of cellular organofluorine metabolic process;oxidoreductase activity;monoterpenoid metabolic process;heterocycle metabolic process;drug binding;drug metabolic process;electron carrier activity;small molecule metabolic process;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;monooxygenase activity;iron ion binding;coumarin metabolic process@: DRUG METABOLISM, POOR, CYP2D6-RELATED
D99945@1596@1597@duplication@2@9322120@9331397@1@chr1:9322120-9331397@61.8@1113@2061@1.85@NA@H6PD-001_4, H6PD-001_5@1@1@1@:hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)@:carbohydrate binding;glucose-6-phosphate dehydrogenase activity;NADP metabolic process;oxidation-reduction process;mitochondrion;intracellular membrane-bounded organelle;NADP binding;carbohydrate metabolic process;endoplasmic reticulum lumen;cytoplasm;pentose-phosphate shunt;response to alcohol;glucose 1-dehydrogenase [NAD(P)] activity;6-phosphogluconolactonase activity;glucose metabolic process@: CORTISONE REDUCTASE DEFICIENCY 1; CORTRD1
D99945@3761@3764@duplication@4@21786157@21786568@1@chr1:21786157-21786568@6.38@55@104@1.89@CNVR107.2, CNVR107.1@NBPF3-003_4, RP11-293F5-201_1, RP11-293F5-201_2, RP11-293F5-201_3@62.25@49@73@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 3@:cytoplasm@NA
D99945@3779@3779@duplication@1@21809638@21809812@1@chr1:21809638-21809812@11.1@51@131@2.57@CNVR107.2, CNVR107.1@NBPF3-003_19@111@111@111@:neuroblastoma breakpoint family member 20-like;neuroblastoma breakpoint family, member 3@:cytoplasm@NA
D99945@4451@4461@duplication@11@25599041@25655628@1@chr1:25599041-25655628@45.4@1084@1610@1.49@CNVR116.1, CNVR116.2@RHD-202_1, RHD-202_2, RHD-202_3, RHD-202_4, RHD-202_5, RHD-202_6, RHD-202_7, RHD-202_8, RHD-202_9, RHD-202_10, RHD-202_11@122.181818181818@113@128@:chromosome 1 open reading frame 63:Rh blood group, D antigen@:ammonium transport;integral to membrane;ammonium transmembrane transporter activity;integral to plasma membrane;membrane@NA
D99945@6747@6748@duplication@2@39987954@39988155@1@chr1:39987954-39988155@6.32@157@231@1.47@NA@BMP8A-001_5, RP11-69E11-006_5@25@25@25@:bone morphogenetic protein 8a@:cell differentiation;growth factor activity;extracellular space;growth;cytokine activity;cartilage development;ossification@NA
D99945@6813@6814@deletion@2@40229386@40229587@1@chr1:40229386-40229587@11.2@134@59@0.44@NA@PPIE-003_11, BMP8B-001_5@34@34@34@:peptidylprolyl isomerase E (cyclophilin E):bone morphogenetic protein 8b@:regulation of transcription, DNA-dependent;nucleotide binding;catalytic step 2 spliceosome;protein folding;protein binding;protein peptidyl-prolyl isomerization;peptidyl-prolyl cis-trans isomerase activity;cyclosporin A binding;RNA binding;mRNA splicing, via spliceosome;nucleus;nucleic acid binding:cell differentiation;growth factor activity;extracellular space;growth;extracellular region;cytokine activity;cartilage development;skeletal system development;ossification@NA
D99945@11245@11245@deletion@1@89476589@89476800@1@chr1:89476589-89476800@6.98@317@204@0.644@CNVR244.1@GBP3-001_8@54@54@54@:guanylate binding protein 3@:defense response to virus;GTP binding;GTPase activity;membrane;cytoplasm@NA
D99945@12424@12425@deletion@2@104233918@104234233@1@chr1:104233918-104234233@10.9@49@0@0@CNVR266.3, CNVR266.5@AMY1B-001_7, AMY1B-001_8@154@154@154@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D99945@12445@12446@duplication@2@104297123@104297437@1@chr1:104297123-104297437@13.2@318@478@1.5@CNVR266.3, CNVR266.5@AMY1C-201_7, AMY1C-201_8@77@75@79@:amylase, alpha 1A (salivary);amylase, alpha 1C (salivary);amylase, alpha 1B (salivary)@:cation binding;carbohydrate metabolic process;catalytic activity;protein binding;extracellular region;digestion;metal ion binding;alpha-amylase activity@NA
D99945@12927@12936@duplication@10@110224433@110236368@1@chr1:110224433-110236368@14.9@565@779@1.38@CNVR299.6, CNVR299.4, CNVR299.5@GSTM2-203_8, GSTM2-203_9, GSTM1-001_1, GSTM1-001_2, GSTM1-001_3, GSTM1-001_4, GSTM1-001_5, GSTM1-001_6, GSTM1-001_7, GSTM1-001_8@158.5@23@194@:glutathione S-transferase mu 2 (muscle):glutathione S-transferase mu 1@:protein binding;glutathione transferase activity;glutathione metabolic process;cytoplasm;xenobiotic catabolic process:cytosol;xenobiotic metabolic process;protein binding;glutathione transferase activity;small molecule metabolic process@NA
D99945@14091@14093@deletion@3@119981632@119981857@1@chr1:119981632-119981857@5.52@118@68@0.576@NA@RP5-871G17-201_1, RP5-871G17-201_2, RP5-871G17-201_3@0@0@0@NA@NA@NA
D99945@14493@14495@duplication@3@144676872@144679973@1@chr1:144676872-144679973@12.5@293@442@1.51@CNVR337.1@WI2-1896O14-001_1, WI2-1896O14-001_2, WI2-1896O14-001_3@4.66666666666667@4@5@NA@NA@NA
D99945@15201@15205@duplication@5@148008575@148011789@1@chr1:148008575-148011789@7.66@39@92@2.36@CNVR346.2, CNVR346.4@NBPF14-001_13, NBPF14-001_14, NBPF14-001_15, NBPF14-001_16, NBPF14-001_17@112@105@120@:neuroblastoma breakpoint family, member 14@:cytoplasm@NA
D99945@21362@21374@deletion@13@196743977@196801320@1@chr1:196743977-196801320@43.6@1689@1081@0.64@CNVR459.1@CFHR3-001_1, CFHR3-001_2, CFHR3-001_3, CFHR3-001_4, CFHR3-001_5, CFHR3-001_6, CFHR1-001_1, CFHR1-001_2, CFHR1-001_3, CFHR1-001_4, CFHR1-001_5, CFHR1-001_6, CFHR2-201_1@96.7692307692308@85@119@:complement factor H-related 3:complement factor H-related 1:complement factor H-related 2@:extracellular space:extracellular space;complement activation:extracellular region@NA
D99945@24160@24164@duplication@5@223727670@223729472@1@chr1:223727670-223729472@10@65@139@2.14@NA@CAPN8-202_20, CAPN8-202_21, CAPN8-202_22, CAPN8-202_23, CAPN8-202_24@0@0@0@:calpain 8@:proteolysis;Golgi apparatus;intracellular;calcium-dependent cysteine-type endopeptidase activity;calcium ion binding@NA
D99945@33560@33564@duplication@5@87408191@87414366@2@chr2:87408191-87414366@19.2@294@479@1.63@CNVR861.2@AC083899-001_24, AC083899-001_25, AC083899-001_26, AC083899-001_27, AC083899-001_28@75.6@70@85@NA@NA@NA
D99945@33830@33835@deletion@6@90160640@90199191@2@chr2:90160640-90199191@20.9@573@345@0.602@CNVR867.10, CNVR867.5, CNVR867.3, CNVR867.9@IGKV2D-14-001_1, IGKV2D-14-001_2, IGKV1D-13-001_1, IGKV1D-13-001_2, IGKV1D-12-001_1, IGKV1D-12-001_2@8@7@10@@:protein binding:protein binding@NA
D99945@34092@34095@deletion@4@96457910@96458295@2@chr2:96457910-96458295@13.5@228@122@0.535@NA@AC008268-201_2, AC008268-201_3, ENST00000444924_1, ENST00000444924_2@102.75@101@104@NA@NA@NA
D99945@34183@34184@duplication@2@96652501@96652955@2@chr2:96652501-96652955@10.1@188@298@1.59@NA@AC073995-001_2, AC073995-001_3@4@4@4@:ankyrin repeat domain-containing protein 36A-like@:ion channel inhibitor activity;protein binding@NA
D99945@34615@34631@duplication@17@98127603@98162325@2@chr2:98127603-98162325@14.2@163@284@1.74@CNVR888.3@ANKRD36B-001_23, ANKRD36B-001_24, ANKRD36B-001_25, ANKRD36B-001_26, ANKRD36B-001_27, ANKRD36B-001_28, ANKRD36B-001_29, ANKRD36B-001_30, ANKRD36B-001_31, ANKRD36B-001_32, ANKRD36B-001_33, ANKRD36B-001_34, ANKRD36B-001_35, ANKRD36B-001_36, ANKRD36B-001_37, ANKRD36B-001_38, ANKRD36B-001_39@130.058823529412@64@154@NA@NA@NA
D99945@37209@37210@duplication@2@130898733@130899955@2@chr2:130898733-130899955@12.7@183@304@1.66@NA@CCDC74B-001_3, CCDC74B-001_4@12.5@10@15@:coiled-coil domain containing 74A;coiled-coil domain containing 74B@NA@NA
D99945@37466@37466@deletion@1@132237644@132238089@2@chr2:132237644-132238089@4.89@134@80@0.597@NA@TUBA3D-002_4@2@2@2@:microRNA 4784;mitotic spindle organizing protein 2A:tubulin, alpha 3c;tubulin, alpha 3d@:gamma-tubulin ring complex;centrosome;spindle:microtubule-based process;structural constituent of cytoskeleton;protein folding;protein polymerization;cytoplasmic microtubule;GTP binding;microtubule cytoskeleton organization;GTPase activity;GTP catabolic process;protein complex;cytoplasm;microtubule cytoskeleton;protein binding;'de novo' posttranslational protein folding;cellular protein metabolic process;microtubule-based movement;structural molecule activity;microtubule;protein domain specific binding@NA
D99945@37492@37493@deletion@2@132288154@132289376@2@chr2:132288154-132289376@20.4@186@65@0.349@NA@CCDC74A-201_3, CCDC74A-201_4@12@11@13@:coiled-coil domain containing 74A@NA@NA
D99945@58545@58549@deletion@5@151531827@151546273@3@chr3:151531827-151546273@46.7@944@500@0.53@CNVR1586.1@AADAC-001_1, AADAC-001_2, AADAC-001_3, AADAC-001_4, AADAC-001_5@2.4@2@3@:arylacetamide deacetylase@:hydrolase activity;serine hydrolase activity;deacetylase activity;positive regulation of triglyceride catabolic process;catalytic activity;retinyl-palmitate esterase activity;lipase activity;integral to membrane;triglyceride lipase activity;endoplasmic reticulum membrane;carboxylesterase activity;metabolic process@NA
D99945@61549@61570@duplication@22@195395392@195456611@3@chr3:195395392-195456611@19.3@2270@2916@1.28@CNVR1703.1, CNVR1703.2@SDHALP2-001_7, SDHALP2-001_8, SDHALP2-001_9, SDHALP2-001_10, SDHALP2-001_11, SDHALP2-001_12, SDHALP2-001_13, SDHALP2-001_14, SDHALP2-001_15, ENST00000430928_1, ENST00000430928_2, ENST00000430928_4, AC069513-013_1, AC069513-013_2, AC069513-013_3, AC069513-013_4, AC069513-013_5, MUC20-201_1, MUC20-201_2, MUC20-201_3, MUC20-201_4@52.7142857142857@38@75@:mucin 20, cell surface associated@:microvillus membrane;apical plasma membrane;activation of MAPK activity;Golgi lumen;post-translational protein modification;protein binding;O-glycan processing;hepatocyte growth factor receptor signaling pathway;cellular protein metabolic process;extracellular region;protein homooligomerization;basal plasma membrane@NA
D99945@61572@61573@duplication@2@195473642@195475936@3@chr3:195473642-195475936@11.2@390@554@1.42@CNVR1703.1, CNVR1703.2, CNVR1703.5, CNVR1703.4@MUC4-203_25, MUC4-203_26@32@30@34@:mucin 4, cell surface associated@:ErbB-2 class receptor binding;Golgi lumen;cell-matrix adhesion;post-translational protein modification;extracellular matrix structural constituent;protein binding;O-glycan processing;cellular protein metabolic process;proteinaceous extracellular matrix;integral to plasma membrane;membrane;extracellular matrix constituent, lubricant activity;biological_process@NA
D99945@65315@65320@duplication@6@69402904@69434246@4@chr4:69402904-69434246@45.3@1040@1597@1.54@CNVR1953.1@UGT2B17-001_1, UGT2B17-001_2, UGT2B17-001_3, UGT2B17-001_4, UGT2B17-001_5, UGT2B17-001_6@124.5@118@134@:UDP glucuronosyltransferase 2 family, polypeptide B17@:carbohydrate binding;transferase activity, transferring hexosyl groups;steroid metabolic process;glucuronosyltransferase activity;carbohydrate metabolic process;integral to membrane;lipid glycosylation;endoplasmic reticulum membrane;metabolic process;membrane@: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
D99945@68947@68947@duplication@1@145041645@145041742@4@chr4:145041645-145041742@5.78@121@185@1.53@NA@GYPA-205_2@8@8@8@:glycophorin B (MNS blood group):glycophorin A (MNS blood group)@:integral to membrane;plasma membrane;integral to plasma membrane:external side of plasma membrane;integral to membrane;cytoskeletal anchoring at plasma membrane;plasma membrane;molecular_function;protein homodimerization activity;integral to plasma membrane;cellular_component;identical protein binding;membrane;biological_process;regulation of response to osmotic stress;virus-host interaction@: BLOOD GROUP--Ss LOCUS; Ss: MALARIA, SUSCEPTIBILITY TO; BLOOD GROUP--MN LOCUS; MN
D99945@70821@70822@deletion@2@745300@748675@5@chr5:745300-748675@30@317@130@0.41@CNVR2280.3@ZDHHC11B-201_5, ZDHHC11B-201_6@91@86@96@:zinc finger, DHHC-type containing 11;uncharacterized LOC100996904:zinc finger, DHHC-type containing 11B@:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding:integral to membrane;transferase activity, transferring acyl groups;zinc ion binding@NA
D99945@73727@73727@deletion@1@69717564@69717599@5@chr5:69717564-69717599@13.1@61@1@0.0164@CNVR2494.17, CNVR2494.3@GTF2H2B-201_4@139@139@139@NA@NA@NA
D99945@73817@73821@deletion@5@70370032@70389020@5@chr5:70370032-70389020@29.5@137@2@0.0146@CNVR2494.41, CNVR2494.14, CNVR2494.20, CNVR2494.8, CNVR2494.1, CNVR2494.37@AC044797-201_1, AC044797-201_2, AC044797-201_3, AC044797-201_4, AC044797-201_5@120.4@100@138@NA@NA@NA
D99945@79566@79568@duplication@3@175386532@175388438@5@chr5:175386532-175388438@18.3@133@273@2.05@NA@THOC3-001_4, THOC3-001_5, THOC3-001_6@169@160@182@:THO complex 3@:mRNA export from nucleus;protein binding;RNA binding;mRNA processing;RNA splicing;transcription export complex;intronless viral mRNA export from host nucleus@NA
D99945@82511@82515@duplication@5@29896218@29909874@6@chr6:29896218-29909874@6.89@277@380@1.37@CNVR2829.7, CNVR2829.2, CNVR2829.3@AL645929-201_2, HLA-K-001_5, HLA-K-001_6, HLA-A-001_1, HLA-A-001_2@31.2@13@44@:major histocompatibility complex, class I, A@:MHC class I protein complex;regulation of immune response;antigen processing and presentation of peptide antigen via MHC class I;immune response;ER to Golgi transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;early endosome membrane;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;phagocytic vesicle membrane;type I interferon-mediated signaling pathway;protein binding;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class I;MHC class I receptor activity;membrane@: SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO
D99945@83582@83585@duplication@4@31963498@31964378@6@chr6:31963498-31964378@20@304@496@1.63@CNVR2843.6, CNVR2843.3@C4A-001_25, C4A-001_26, C4A-001_27, C4A-001_28@16.5@16@17@:complement component 4A (Rodgers blood group)@:inflammatory response;complement activation;endopeptidase inhibitor activity;complement activation, classical pathway;innate immune response;protein binding;extracellular space;extracellular region;plasma membrane;regulation of complement activation@: COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM; COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
D99945@83641@83645@deletion@5@31995847@31997116@6@chr6:31995847-31997116@17.8@242@116@0.479@CNVR2843.6, CNVR2843.5@C4B-001_24, C4B-001_25, C4B-001_26, C4B-001_27, C4B-001_28@15.8@13@19@:complement component 4B (Chido blood group)@:protein binding;extracellular space;inflammatory response;complement activation;extracellular region;endopeptidase inhibitor activity@: COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD; SYSTEMIC LUPUS ERYTHEMATOSUS; SLE; BLOOD GROUP, CHIDO/RODGERS SYSTEM
D99945@83910@83923@deletion@14@32441204@32525964@6@chr6:32441204-32525964@70.3@539@155@0.288@CNVR2845.21, CNVR2845.25@HLA-DRB9-001_1, HLA-DRB5-001_1, HLA-DRB5-001_2, HLA-DRB5-001_3, HLA-DRB5-001_4, HLA-DRB5-001_5, HLA-DRB5-001_6, HLA-DRB6-002_2, HLA-DRB6-002_3, HLA-DRB6-002_4, HLA-DRB6-002_5, HLA-DRB6-002_6, AL713966-201_2, AL713966-201_3@148.071428571429@44@189@:major histocompatibility complex, class II, DR beta 5@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;late endosome membrane;Golgi membrane;interferon-gamma-mediated signaling pathway;endocytic vesicle membrane;plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;protein binding;T cell receptor signaling pathway;antigen processing and presentation;membrane;trans-Golgi network membrane@NA
D99945@83936@83946@duplication@11@32610389@32634448@6@chr6:32610389-32634448@19.3@653@914@1.4@CNVR2845.21, CNVR2845.25, CNVR2845.27, CNVR2845.22, CNVR2845.39, CNVR2845.20@HLA-DQA1-002_5, HLA-DQA1-002_6, HLA-DQB1-003_2, HLA-DQB1-003_3, HLA-DQB1-003_4, HLA-DQB1-003_5, HLA-DQB1-003_6, XXbac-BPG254F23-001_1, XXbac-BPG254F23-001_2, ENST00000443574_1, ENST00000443574_2@121.090909090909@80@146@:HLA class II histocompatibility antigen, DQ alpha 1 chain-like;major histocompatibility complex, class II, DQ alpha 1:HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DQ beta 1@:immune response;clathrin-coated endocytic vesicle membrane;ER to Golgi transport vesicle membrane;transport vesicle membrane;integral to lumenal side of endoplasmic reticulum membrane;T cell costimulation;Golgi membrane;interferon-gamma-mediated signaling pathway;integral to membrane;endocytic vesicle membrane;plasma membrane;integral to plasma membrane;cytokine-mediated signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal membrane;MHC class II protein complex;antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;T cell receptor signaling pathway;endosome membrane;MHC class II receptor activity;antigen processing and presentation;membrane;trans-Golgi network membrane:antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;protein binding;integral to membrane;antigen processing and presentation;immune response;membrane;MHC class II protein complex@NA
D99945@86427@86430@duplication@4@49437857@49440572@6@chr6:49437857-49440572@11.4@445@620@1.39@NA@CENPQ-001_2, CENPQ-001_3, CENPQ-001_4, CENPQ-001_5@1.75@1@2@:centromere protein Q@:nucleoplasm;mitotic cell cycle;cytosol;chromosome, centromeric region;mitotic prometaphase;M phase of mitotic cell cycle;nucleosome assembly;CenH3-containing nucleosome assembly at centromere@NA
D99945@92592@92594@duplication@3@160132858@160133143@6@chr6:160132858-160133143@5.87@322@429@1.33@CNVR3127.2, CNVR3127.1@ENST00000442642_3, ENST00000442642_4, ENST00000442642_5@84@56@106@:superoxide dismutase 2, mitochondrial;uncharacterized LOC100129518@:response to reactive oxygen species;oxidation-reduction process;mitochondrion;negative regulation of cell proliferation;neuron development;negative regulation of fat cell differentiation;removal of superoxide radicals;response to gamma radiation;response to L-ascorbic acid;response to lipopolysaccharide;response to nutrient levels;response to zinc ion;protein homotetramerization;post-embryonic development;iron ion homeostasis;hemopoiesis;aging;mitochondrial inner membrane;age-dependent response to reactive oxygen species;response to drug;oxygen binding;mitochondrial nucleoid;vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure;apoptotic process;superoxide metabolic process;response to superoxide;detection of oxygen;response to silicon dioxide;cytoplasm;response to stress;respiratory electron transport chain;superoxide anion generation;protein homooligomerization;regulation of mitochondrial membrane potential;positive regulation of nitric oxide biosynthetic process;response to manganese ion;regulation of blood pressure;metal ion binding;negative regulation of apoptotic process;response to cadmium ion;response to oxidative stress;liver development;regulation of catalytic activity;negative regulation of fibroblast proliferation;response to selenium ion;age-dependent response to oxidative stress;response to electrical stimulus;mitochondrial matrix;identical protein binding;mitochondrion organization;response to hyperoxia;vasodilation;response to hydrogen peroxide;superoxide dismutase activity;heart development;negative regulation of neuron apoptotic process;erythrophore differentiation;locomotory behavior;DNA binding;release of cytochrome c from mitochondria;response to axon injury;oxygen homeostasis;response to activity;glutathione metabolic process;hydrogen peroxide metabolic process;hydrogen peroxide biosynthetic process;regulation of transcription from RNA polymerase II promoter;response to hypoxia;protein binding;manganese ion binding;cellular response to ethanol@: MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6; MVCD6
D99945@93099@93099@deletion@1@167790036@167790193@6@chr6:167790036-167790193@5.2@27@3@0.111@NA@TCP10-001_5@103@103@103@:t-complex 10@:cytosol@NA
D99945@94211@94212@deletion@2@6005270@6006833@7@chr7:6005270-6006833@7.05@132@71@0.538@NA@RSPH10B-002_3, RSPH10B-002_4@10.5@8@13@:radial spoke head 10 homolog B (Chlamydomonas)@NA@NA
D99945@96581@96582@duplication@2@38393318@38394119@7@chr7:38393318-38394119@10@320@459@1.43@CNVR3354.3, CNVR3354.1@TRGV4-001_1, TRGV4-001_2@12.5@11@14@@:protein binding@NA
D99945@97910@97915@duplication@6@57068812@57076857@7@chr7:57068812-57076857@8.42@88@156@1.77@NA@TNRC18C-202_6, TNRC18C-202_7, TNRC18C-202_8, TNRC18C-202_9, TNRC18C-202_10, TNRC18C-202_11@156.666666666667@139@166@NA@NA@NA
D99945@98014@98016@deletion@3@62904582@62910898@7@chr7:62904582-62910898@16.8@288@149@0.517@NA@ZNF734-201_1, ZNF734-201_2, ZNF734-201_3@68.3333333333333@1@102@NA@NA@NA
D99945@98172@98174@duplication@3@64533821@64534227@7@chr7:64533821-64534227@12.2@31@110@3.55@NA@RP11-460N20-001_11, RP11-460N20-001_12, ENST00000501153_3@100.666666666667@100@101@NA@NA@NA
D99945@98192@98193@deletion@2@64646770@64646889@7@chr7:64646770-64646889@9.09@53@9@0.17@NA@INTS4L1-201_8, INTS4L1-201_9@51.5@51@52@NA@NA@NA
D99945@98604@98605@duplication@2@72419209@72419520@7@chr7:72419209-72419520@8.94@391@537@1.37@NA@POM121-003_16, NSUN5C-006_10, NSUN5C-006_11@5.5@5@6@:POM121 transmembrane nucleoporin@:glucose transport;nuclear envelope;small molecule metabolic process;carbohydrate metabolic process;mRNA transport;transmembrane transport;nuclear membrane;regulation of glucose transport;protein transport;viral reproduction;endoplasmic reticulum membrane;hexose transport;nuclear pore;cytokine-mediated signaling pathway@NA
D99945@98700@98701@duplication@2@72639916@72640087@7@chr7:72639916-72640087@5.95@90@146@1.62@NA@ENST00000338578_4, NCF1B-001_4@27@27@27@NA@NA@NA
D99945@99272@99273@deletion@2@75054920@75055736@7@chr7:75054920-75055736@7.64@96@44@0.458@NA@POM121C-001_8, POM121C-001_9@51@30@72@:POM121 transmembrane nucleoporin C@:nuclear membrane;protein binding;protein transport;endoplasmic reticulum membrane;nuclear pore;mRNA transport@NA
D99945@99454@99454@deletion@1@76063357@76063473@7@chr7:76063357-76063473@13.7@89@18@0.202@CNVR3462.1@ZP3-002_6@10@10@10@:zona pellucida glycoprotein 3 (sperm receptor)@:negative regulation of transcription, DNA-dependent;manganese ion transmembrane transporter activity;intracellular protein transport;proteinaceous extracellular matrix;plasma membrane;positive regulation of acrosome reaction;outer acrosomal membrane;protein kinase C signaling cascade;manganese ion transmembrane transport;intracellular signal transduction;humoral immune response mediated by circulating immunoglobulin;negative regulation of binding of sperm to zona pellucida;positive regulation of inflammatory response;endoplasmic reticulum;signal transducer activity;perinuclear region of cytoplasm;secretory granule;positive regulation of transcription, DNA-dependent;positive regulation of ovarian follicle development;positive regulation of interferon-gamma production;carbohydrate binding;manganese ion transport;positive regulation of antral ovarian follicle growth;extracellular matrix;positive regulation of leukocyte migration;positive regulation of humoral immune response;extracellular space;blastocyst formation;integral to membrane;store-operated calcium channel activity;oocyte development;multivesicular body;phosphatidylinositol-mediated signaling;acrosomal vesicle;positive regulation of protein kinase B signaling cascade;Golgi apparatus;positive regulation of calcium ion import;positive regulation of protein kinase activity;positive regulation of acrosomal vesicle exocytosis;positive regulation of interleukin-4 production;cytoplasm;protein binding;binding of sperm to zona pellucida;positive regulation of phosphatidylinositol biosynthetic process;extracellular region;positive regulation of T cell proliferation;acrosin binding;positive regulation of type IV hypersensitivity;egg coat formation@NA
D99945@99506@99509@duplication@4@76619588@76633625@7@chr7:76619588-76633625@8.55@138@220@1.59@CNVR3463.10@PMS2L11-203_2, PMS2L11-203_3, PMS2L11-203_4, PMS2L11-203_5@8@6@10@:uroplakin 3B@:negative regulation of gene expression;integral to membrane;plasma membrane@NA
D99945@99544@99545@deletion@2@76723321@76728269@7@chr7:76723321-76728269@18.7@111@18@0.162@NA@ENST00000398321_6, ENST00000398321_7@13.5@11@16@NA@NA@NA
D99945@102144@102145@deletion@2@102180464@102180539@7@chr7:102180464-102180539@14.2@150@60@0.4@CNVR3518.1@RASA4B-007_4, POLR2J3-003_7@96@96@96@:RAS p21 protein activator 4B:polymerase (RNA) II (DNA directed) polypeptide J3;uroplakin 3B-like:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2@:phospholipid binding;intracellular;GTPase activator activity;cytosol;signal transduction;protein binding;plasma membrane;regulation of small GTPase mediated signal transduction;metal ion binding;intracellular signal transduction:DNA-directed RNA polymerase activity;integral to membrane;nucleus;protein dimerization activity;DNA binding;transcription, DNA-dependent;intracellular signal transduction:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent@NA
D99945@102177@102177@deletion@1@102235754@102235817@7@chr7:102235754-102235817@7.67@69@24@0.348@CNVR3518.1@RASA4-001_11@55@55@55@:polymerase (RNA) II (DNA directed) polypeptide J3;polymerase (RNA) II (DNA directed) polypeptide J2:RAS p21 protein activator 4B;RAS p21 protein activator 4@:DNA-directed RNA polymerase activity;protein dimerization activity;DNA binding;transcription, DNA-dependent:phospholipid binding;intracellular;GTPase activator activity;cytoplasm;cytosol;intrinsic to internal side of plasma membrane;protein binding;signal transduction;regulation of small GTPase mediated signal transduction;negative regulation of Ras protein signal transduction;Ras GTPase activator activity;metal ion binding;intracellular signal transduction;positive regulation of Ras GTPase activity@NA
D99945@104579@104579@deletion@1@134221805@134221910@7@chr7:134221805-134221910@9.25@95@37@0.389@NA@AKR1B10-001_6@2@2@2@:aldo-keto reductase family 1, member B10 (aldose reductase)@:steroid metabolic process;cellular aldehyde metabolic process;indanol dehydrogenase activity;daunorubicin metabolic process;retinal dehydrogenase activity;farnesol catabolic process;geranylgeranyl reductase activity;protein binding;extracellular region;aldo-keto reductase (NADP) activity;digestion;doxorubicin metabolic process;cellular_component;lysosome@NA
D99945@105327@105333@deletion@7@141776005@141782372@7@chr7:141776005-141782372@19.7@1080@720@0.667@CNVR3585.3, CNVR3585.2@MGAM-007_46, MGAM-007_47, MGAM-007_48, MGAM-007_49, MGAM-007_50, MGAM-007_51, MGAM-007_52@122.714285714286@121@125@:maltase-glucoamylase (alpha-glucosidase)@:glucan 1,4-alpha-glucosidase activity;carbohydrate binding;small molecule metabolic process;apical plasma membrane;carbohydrate metabolic process;catalytic activity;starch catabolic process;polysaccharide digestion;integral to membrane;alpha-glucosidase activity;plasma membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;maltose alpha-glucosidase activity;amylase activity@NA
D99945@105785@105791@deletion@7@143969540@143973535@7@chr7:143969540-143973535@28.6@598@326@0.545@CNVR3598.4, CNVR3598.9@RP4-798C17-001_9, RP4-798C17-001_10, RP4-798C17-001_11, RP4-798C17-001_12, ENST00000378112_10, ENST00000378112_11, ENST00000378112_12@89.2857142857143@37@127@:Rho guanine nucleotide exchange factor (GEF) 35@NA@NA
D99945@105798@105822@deletion@25@143975408@144064449@7@chr7:143975408-144064449@26.8@917@575@0.627@CNVR3598.4@RP4-798C17-004_1, RP4-798C17-004_2, RP4-798C17-004_3, RP4-798C17-004_4, RP4-798C17-004_5, RP4-798C17-004_6, RP4-798C17-001_1, RP4-798C17-001_2, RP4-798C17-001_3, RP4-798C17-001_4, RP4-798C17-001_5, ENST00000378112_1, ENST00000378112_2, ENST00000378112_3, ENST00000378112_4, ENST00000378112_5, ENST00000378112_6, OR2A9P-002_1, OR2A9P-002_2, OR2A9P-002_3, ARHGEF5-001_1, ARHGEF5-001_2, ARHGEF5-001_3, ARHGEF5-001_4, ARHGEF5-001_5@52.76@14@135@:Rho guanine nucleotide exchange factor (GEF) 35:olfactory receptor 2A1/2A42-like;olfactory receptor, family 2, subfamily A, member 42;olfactory receptor, family 2, subfamily A, member 1:rho guanine nucleotide exchange factor 5-like;Rho guanine nucleotide exchange factor (GEF) 5@:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:phospholipid binding;positive regulation of podosome assembly;myeloid dendritic cell chemotaxis;intracellular;regulation of Rho protein signal transduction;Rho guanyl-nucleotide exchange factor activity;cytoplasm;actin cytoskeleton organization;positive regulation of Rho GTPase activity;protein binding;GTP binding;plasma membrane;regulation of Rho GTPase activity;intracellular signal transduction@NA
D99945@107511@107513@duplication@3@7706215@7718505@8@chr8:7706215-7718505@12.4@265@403@1.52@CNVR3772.4, CNVR3772.6, CNVR3772.8, CNVR3772.10, CNVR3772.13@SPAG11A-207_2, SPAG11A-207_3, SPAG11A-207_4@90@46@113@:sperm associated antigen 11A;sperm associated antigen 11B@:extracellular region;defense response@NA
D99945@109572@109580@duplication@9@39311571@39335463@8@chr8:39311571-39335463@31.2@295@547@1.85@CNVR3859.1@ADAM3A-005_13, ADAM3A-005_14, ADAM3A-005_15, ADAM3A-005_16, ADAM3A-005_17, ADAM3A-005_18, ADAM3A-005_19, ADAM3A-005_20, ADAM3A-005_21@128.555555555556@104@136@NA@NA@NA
D99945@116514@116514@deletion@1@34407444@34407463@9@chr9:34407444-34407463@7.65@171@96@0.561@NA@C9orf25-203_1@0@0@0@:family with sequence similarity 219, member A@NA@NA
D99945@117278@117279@deletion@2@38572005@38573127@9@chr9:38572005-38573127@8.4@126@63@0.5@NA@ANKRD18A-202_16, ANKRD18A-202_17@2.5@2@3@:ankyrin repeat domain 18A@:protein binding@NA
D99945@117389@117390@duplication@2@40503021@40504057@9@chr9:40503021-40504057@7.05@122@192@1.57@CNVR4272.1@ENST00000399669_5, ENST00000399669_6@7@3@11@NA@NA@NA
D99945@121601@121602@deletion@2@117085945@117086369@9@chr9:117085945-117086369@6.89@1065@758@0.712@CNVR4448.1@ORM1-001_2, ORM1-001_3@90@90@90@:orosomucoid 1@:protein binding;extracellular space;regulation of immune system process;transport;inflammatory response;extracellular region;acute-phase response@NA
D99945@124047@124052@deletion@6@135957928@135960431@9@chr9:135957928-135960431@18@87@4@0.046@NA@CELP-002_1, CELP-002_2, CELP-002_3, AL162417-201_1, AL162417-201_2, AL162417-201_3@84.3333333333333@66@99@NA@NA@NA
D99945@126909@126909@deletion@1@17840632@17842868@10@chr10:17840632-17842868@8.14@37@0@0@NA@FAM23A-201_5@108@108@108@:transmembrane protein 236;transmembrane protein 236-like@:integral to membrane@NA
D99945@126911@126918@duplication@8@17865075@17898363@10@chr10:17865075-17898363@27.4@522@811@1.55@NA@MRC1L1-001_2, MRC1L1-001_3, MRC1L1-001_4, MRC1L1-001_5, MRC1L1-001_6, MRC1L1-001_7, MRC1L1-001_8, MRC1L1-001_9@9.875@5@20@:macrophage mannose receptor 1-like@:carbohydrate binding@NA
D99945@126946@126975@deletion@30@18112046@18198277@10@chr10:18112046-18198277@76.2@385@27@0.0701@NA@MRC1-001_2, MRC1-001_3, MRC1-001_4, MRC1-001_5, MRC1-001_6, MRC1-001_7, MRC1-001_8, MRC1-001_9, MRC1-001_10, MRC1-001_11, MRC1-001_12, MRC1-001_13, MRC1-001_14, MRC1-001_15, MRC1-001_16, MRC1-001_17, MRC1-001_18, MRC1-001_19, MRC1-001_20, MRC1-001_21, MRC1-001_22, MRC1-001_23, MRC1-001_24, MRC1-001_25, MRC1-001_26, MRC1-001_27, MRC1-001_28, MRC1-001_29, RP11-457D2-001_1, RP11-457D2-001_2@18.1333333333333@3@34@:mannose receptor, C type 1;macrophage mannose receptor 1-like@:carbohydrate binding;endosome membrane;plasma membrane;receptor-mediated endocytosis;receptor activity;integral to plasma membrane;mannose binding@NA
D99945@128897@128901@deletion@5@47253597@47259684@10@chr10:47253597-47259684@6.5@101@52@0.515@CNVR4712.9, CNVR4712.1@GLUDP8-001_1, GLUDP8-001_2, GLUDP8-001_3, RP11-144G6-201_1, RP11-144G6-201_2@14.8@8@20@NA@NA@NA
D99945@128979@128979@deletion@1@47758848@47758905@10@chr10:47758848-47758905@4.73@21@0@0@CNVR4714.1@ANXA8L2-001_10@154@154@154@:annexin A8-like 2:uncharacterized LOC101060462;uncharacterized LOC100996760@:calcium-dependent phospholipid binding;calcium ion binding@NA
D99945@129030@129040@duplication@11@48054985@48175811@10@chr10:48054985-48175811@10.9@137@235@1.72@CNVR4716.1, CNVR4716.14@ASAH2C-201_1, CTD-2173J9-001_1, CTD-2173J9-001_2, CTSLL2-001_1, CTSLL2-001_2, CTSLL2-001_3, GLUDP6-001_1, GLUDP6-001_2, GLUDP6-001_3, CTD-2173J9-201_1, CTD-2173J9-201_2@81@50@143@@:ceramidase activity;sphingolipid metabolic process@NA
D99945@129460@129461@deletion@2@51361725@51361911@10@chr10:51361725-51361911@5.13@23@0@0@NA@ENST00000404618_4, ENST00000432221_4@122@121@123@NA@NA@NA
D99945@129605@129609@deletion@5@51970585@51978391@10@chr10:51970585-51978391@13@152@69@0.454@NA@ASAH2-201_7, ASAH2-201_8, ASAH2-201_9, ASAH2-201_10, ASAH2-201_11@181.2@176@186@:N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2@:mitochondrion;phospholipid metabolic process;small molecule metabolic process;sphingolipid metabolic process;signal transduction;ceramide metabolic process;integral to membrane;ceramidase activity;plasma membrane;apoptotic process;glycosphingolipid metabolic process@NA
D99945@145944@145964@deletion@21@89701674@89729449@11@chr11:89701674-89729449@18@135@39@0.289@NA@TRIM64-202_1, TRIM64-202_2, TRIM64-202_3, TRIM64-202_4, TRIM64-202_5, TRIM64-202_6, TRIM64-202_7, TRIM64-202_8, TRIM64-202_9, ENST00000442514_1, ENST00000442514_2, ENST00000442514_3, ENST00000442514_4, ENST00000442514_5, ENST00000442514_6, ENST00000442514_7, ENST00000442514_8, ENST00000442514_9, TRIM53-202_5, TRIM53-202_6, TRIM53-202_7@95.2380952380952@21@177@NA@NA@NA
D99945@147534@147536@duplication@3@117077785@117079770@11@chr11:117077785-117079770@6.58@158@235@1.49@NA@PCSK7-201_13, PCSK7-201_14, PCSK7-201_15@10@9@11@:proprotein convertase subtilisin/kexin type 7@:proteolysis;integral to Golgi membrane;serine-type endopeptidase activity;peptide hormone processing@NA
D99945@150776@150776@deletion@1@9447030@9447115@12@chr12:9447030-9447115@6.06@70@30@0.429@NA@DDX11L8-201_3@18@18@18@NA@NA@NA
D99945@150829@150842@deletion@14@9684189@9748018@12@chr12:9684189-9748018@99.2@562@80@0.142@CNVR5429.1@AC006432-201_1, AC006432-201_2, AC006432-201_3, AC006432-201_4, AC006432-201_5, AC006432-201_6, AC006432-201_7, AC006432-201_8, AC006432-201_9, AC006432-201_10, AC006432-201_11, AC006432-201_12, AC006432-201_13, KLRB1-201_6@20.7142857142857@1@25@:killer cell lectin-like receptor subfamily B, member 1@:transmembrane signaling receptor activity;carbohydrate binding;integral to membrane;plasma membrane;cell surface receptor signaling pathway@NA
D99945@150968@150973@deletion@6@10583212@10588593@12@chr12:10583212-10588593@110@687@121@0.176@CNVR5430.1@KLRC2-201_1, KLRC2-201_2, KLRC2-201_3, KLRC2-201_4, KLRC2-201_5, KLRC2-201_6@54.8333333333333@38@67@:killer cell lectin-like receptor subfamily C, member 2@:carbohydrate binding:transmembrane signaling receptor activity;carbohydrate binding;protein binding;signal transduction;cellular defense response;integral to plasma membrane@NA
D99945@151034@151034@duplication@1@11244393@11244793@12@chr12:11244393-11244793@12.1@362@538@1.49@CNVR5434.1@TAS2R31-201_2@72@72@72@:PRH1-PRR4 readthrough;proline rich 4 (lacrimal):taste receptor, type 2, member 14:taste receptor, type 2, member 43@:extracellular space;visual perception:bitter taste receptor activity;taste receptor activity;integral to membrane;sensory perception of taste;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of bitter taste:G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;motile cilium;taste receptor activity;bitter taste receptor activity;integral to membrane;sensory perception of taste;detection of chemical stimulus involved in sensory perception of bitter taste;cilium membrane@NA
D99945@154154@154155@deletion@2@53086207@53086665@12@chr12:53086207-53086665@14.4@401@237@0.591@CNVR5537.1@KRT77-201_6, KRT77-201_7@8@8@8@:keratin 77@:structural molecule activity;keratin filament;molecular_function;cellular_component;biological_process@NA
D99945@160045@160051@duplication@7@120875906@120884633@12@chr12:120875906-120884633@37.2@1190@1707@1.43@NA@COX6A1-001_1, COX6A1-001_2, COX6A1-001_3, TRIAP1-201_1, TRIAP1-201_2, GATC-201_1, GATC-201_2@0@0@0@:cytochrome c oxidase subunit VIa polypeptide 1:TP53 regulated inhibitor of apoptosis 1:glutamyl-tRNA(Gln) amidotransferase, subunit C@:generation of precursor metabolites and energy;small molecule metabolic process;cytochrome-c oxidase activity;mitochondrial inner membrane;mitochondrial respiratory chain complex IV;respiratory electron transport chain:cytochrome-c oxidase activity;mitochondrial inner membrane;regulation of translational fidelity;mitochondrial respiratory chain complex IV:negative regulation of apoptotic process;protein binding;mitochondrion;cysteine-type endopeptidase inhibitor activity involved in apoptotic process;DNA damage response, signal transduction by p53 class mediator;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;perinuclear region of cytoplasm;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest:mitochondrion;glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity;glutaminyl-tRNAGln biosynthesis via transamidation;glutamyl-tRNA(Gln) amidotransferase complex;regulation of translational fidelity;ATP binding;mitochondrial translation@NA
D99945@162127@162128@duplication@2@24465240@24465671@13@chr13:24465240-24465671@9.12@867@1134@1.31@NA@RP11-45B20-002_6, ENST00000382133_3@29@29@29@:C1q and tumor necrosis factor related protein 9B@:collagen;protein binding@NA
D99945@164539@164543@deletion@5@53103402@53106857@13@chr13:53103402-53106857@31.3@145@2@0.0138@NA@RP11-78J21-201_12, RP11-78J21-201_13, RP11-78J21-201_14, RP11-78J21-201_15, RP11-78J21-201_16@113.8@107@117@NA@NA@NA
D99945@166697@166707@duplication@11@19553367@19589683@14@chr14:19553367-19589683@13.2@133@242@1.82@CNVR6072.1@POTEG-201_1, POTEG-201_2, POTEG-201_3, POTEG-201_4, POTEG-201_5, POTEG-201_6, POTEG-201_7, POTEG-201_8, POTEG-201_9, POTEG-201_10, POTEG-201_11@98@55@141@:POTE ankyrin domain family, member G@:protein binding@NA
D99945@166746@166767@duplication@22@20019702@20337303@14@chr14:20019702-20337303@101@3272@4846@1.48@CNVR6072.6, CNVR6072.12, CNVR6072.14, CNVR6072.4@AL589182-203_1, AL929601-201_2, AL929601-201_3, AL929601-201_4, AL512310-201_1, AL512310-201_3, AL512310-201_4, AL512310-201_5, ENST00000398231_1, ENST00000398231_2, ENST00000398231_3, ENST00000398231_4, ENST00000398231_5, ENST00000398231_6, ENST00000334072_1, ENST00000334072_2, ENST00000426759_1, ENST00000426759_2, OR4K3P-201_1, OR4K3P-201_2@82.65@44@102@:POTE ankyrin domain family, member M:olfactory receptor, family 4, subfamily N, member 2:olfactory receptor, family 4, subfamily Q, member 3:olfactory receptor, family 4, subfamily M, member 1@:protein binding:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity:integral to membrane;G-protein coupled receptor activity;plasma membrane;G-protein coupled receptor signaling pathway;olfactory receptor activity@NA
D99945@167655@167656@deletion@2@24434973@24435193@14@chr14:24434973-24435193@7.89@242@149@0.616@NA@DHRS4-201_4, DHRS4-201_5@0@0@0@:dehydrogenase/reductase (SDR family) member 4@:steroid metabolic process;oxidation-reduction process;mitochondrion;protein tetramerization;oxidoreductase activity;peroxisomal membrane;nucleus;cellular ketone metabolic process;metabolic process;receptor binding;alcohol dehydrogenase [NAD(P)+] activity;peroxisome;nucleotide binding;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;3-keto sterol reductase activity;alcohol metabolic process;carbonyl reductase (NADPH) activity@NA
D99945@167663@167664@duplication@2@24470074@24470294@14@chr14:24470074-24470294@11.7@288@429@1.49@NA@DHRS4L2-001_4, DHRS4L2-001_5@7.5@7@8@:dehydrogenase/reductase (SDR family) member 4 like 2@:extracellular region;oxidoreductase activity;nucleotide binding;metabolic process@NA
D99945@170809@170810@deletion@2@74003820@74008400@14@chr14:74003820-74008400@37@170@0@0@CNVR6188.1, CNVR6188.4@ACOT1-201_1, ACOT1-201_2@115@114@116@:HEAT repeat containing 4:acyl-CoA thioesterase 1@:protein binding;binding:hydrolase activity;mitochondrion;acyl-CoA metabolic process;very long-chain fatty acid metabolic process;thiolester hydrolase activity;acyl-CoA hydrolase activity;cytosol;palmitoyl-CoA hydrolase activity;long-chain fatty acid metabolic process;carboxylesterase activity@NA
D99945@173500@173502@duplication@3@106471638@106478412@14@chr14:106471638-106478412@25.7@236@451@1.91@CNVR6294.36, CNVR6294.48, CNVR6294.12, CNVR6294.24@IGHV3-6-210_6, IGHV1-3-001_1, IGHV4-4-001_2@12.6666666666667@4@17@@:protein binding:protein binding@NA
D99945@173556@173566@deletion@11@106787370@106816027@14@chr14:106787370-106816027@46.4@1292@754@0.584@CNVR6294.48, CNVR6294.24, CNVR6294.38, CNVR6294.21, CNVR6294.28, CNVR6294.26, CNVR6294.53@IGHV3-29-001_1, IGHV3-29-001_2, IGHV3-30-001_1, IGHV3-30-001_2, IGHV3-30-2-001_1, IGHV3-30-2-001_2, IGHV4-31-001_1, IGHV4-31-001_2, IGHV3-32-001_1, IGHV3-32-001_2, IGHV3-33-001_2@16.2727272727273@13@19@@:protein binding:protein binding:protein binding@NA
D99945@173590@173591@deletion@2@106899046@106899494@14@chr14:106899046-106899494@15.3@169@69@0.408@CNVR6294.26, CNVR6294.56, CNVR6294.18@IGHV3-41-001_1, IGHV3-41-001_2@10.5@10@11@NA@NA@NA
D99945@173649@173649@duplication@1@107169933@107170236@14@chr14:107169933-107170236@5.04@471@618@1.31@CNVR6294.56, CNVR6294.6, CNVR6294.92@IGHV1-69-001_2@5@5@5@@:protein binding@NA
D99945@173681@173734@deletion@54@20433872@20663213@15@chr15:20433872-20663213@187@7598@4816@0.634@CNVR6295.15, CNVR6295.7@ENST00000400226_1, ENST00000400226_2, ENST00000400226_3, ENST00000400226_4, ENST00000400226_8, ENST00000400226_9, ENST00000400226_10, ENST00000400226_11, ENST00000400226_12, ENST00000400226_14, ENST00000400226_15, ENST00000400226_16, HERC2P3-014_9, HERC2P3-014_10, HERC2P3-014_11, HERC2P3-014_12, HERC2P3-014_13, HERC2P3-014_14, HERC2P3-014_15, HERC2P3-014_16, HERC2P3-014_17, HERC2P3-014_18, HERC2P3-014_19, HERC2P3-014_20, HERC2P3-014_21, HERC2P3-014_22, HERC2P3-014_23, HERC2P3-014_24, HERC2P3-014_25, HERC2P3-014_26, HERC2P3-014_27, AC026495-201_8, AC026495-201_9, AC026495-201_10, AC026495-201_11, AC026495-201_12, AC026495-201_13, AC026495-201_14, AC026495-201_15, AC026495-201_16, AC026495-201_17, AC026495-201_18, AC026495-201_19, AC026495-201_20, AC026495-201_21, AC026495-201_22, AC026495-201_23, AC026495-201_24, AC026495-201_25, AC026495-201_26@92.44@48@147@NA@NA@NA
D99945@173820@173822@deletion@3@22466365@22473354@15@chr15:22466365-22473354@11.3@617@409@0.663@CNVR6297.4, CNVR6297.6@AC010760-202_1, VSIG6-201_1, VSIG6-201_2@19.6666666666667@0@44@NA@NA@NA
D99945@174405@174410@deletion@6@28957424@29009297@15@chr15:28957424-29009297@31.8@610@332@0.544@NA@AC055876-202_1, ENST00000456510_1, ENST00000456510_2, ENST00000456510_4, ENST00000456510_5@21.2@6@26@:golgin A8 family, member M@:Golgi apparatus@NA
D99945@174507@174507@deletion@1@30665183@30665349@15@chr15:30665183-30665349@6.74@162@93@0.574@CNVR6337.1@CHRFAM7A-202_6@44@44@44@:CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:transport;integral to membrane;ion transport;postsynaptic membrane;membrane;extracellular ligand-gated ion channel activity@NA
D99945@174659@174659@duplication@1@32449811@32449977@15@chr15:32449811-32449977@6.62@56@109@1.95@CNVR6345.2, CNVR6345.1@CHRNA7-205_6@66@66@66@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
D99945@174661@174662@duplication@2@32451772@32455537@15@chr15:32451772-32455537@6.44@34@80@2.35@CNVR6345.2, CNVR6345.1@CHRNA7-205_8, CHRNA7-205_9@119.5@106@133@:cholinergic receptor, nicotinic, alpha 7 (neuronal);CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion@:cellular calcium ion homeostasis;transport;beta-amyloid binding;calcium ion transport;acetylcholine receptor activity;ion transport;acetylcholine-activated cation-selective channel activity;integral to membrane;chloride channel regulator activity;cell junction;plasma membrane;positive regulation of cell proliferation;protein homodimerization activity;acetylcholine-gated channel complex;response to chemical stimulus;activation of MAPK activity;negative regulation of tumor necrosis factor production;response to hypoxia;response to nicotine;acetylcholine binding;positive regulation of angiogenesis;signal transduction;memory;toxin binding;synaptic transmission;postsynaptic membrane;membrane;cognition;extracellular ligand-gated ion channel activity@NA
D99945@175657@175657@duplication@1@41870086@41871537@15@chr15:41870086-41871537@10.3@172@280@1.63@NA@TYRO3-001_19@2@2@2@:TYRO3 protein tyrosine kinase@:protein tyrosine kinase activity;platelet aggregation;negative regulation of toll-like receptor signaling pathway;ATP binding;vagina development;substrate adhesion-dependent cell spreading;nucleus;negative regulation of lymphocyte activation;endoplasmic reticulum membrane;phosphatidylinositol 3-kinase cascade;nuclear envelope;platelet activation;protein kinase activity;protein kinase B signaling cascade;neuron homeostasis;negative regulation of neuron apoptotic process;negative regulation of innate immune response;protein autophosphorylation;transmembrane receptor protein tyrosine kinase activity;apoptotic cell clearance;transferase activity, transferring phosphorus-containing groups;spermatogenesis;forebrain cell migration;integral to membrane;integral to plasma membrane;ovulation cycle;natural killer cell differentiation;phosphatidylinositol 3-kinase binding;negative regulation of inflammatory response;protein phosphorylation;receptor signaling protein tyrosine kinase activity;protein heterodimerization activity;secretion by cell;protein binding;signal transduction;cell adhesion;signal transduction by phosphorylation@NA
D99945@183378@183378@deletion@1@2672693@2672767@16@chr16:2672693-2672767@15.5@70@0@0@CNVR6602.2@AC141586-201_6@57@57@57@NA@NA@NA
D99945@185591@185595@duplication@5@21763258@21772051@16@chr16:21763258-21772051@9.19@151@240@1.59@CNVR6668.5, CNVR6668.2, CNVR6668.7@OTOA-001_24, OTOA-001_25, OTOA-001_26, OTOA-001_27, OTOA-001_28@43.6@15@62@:otoancorin@:proteinaceous extracellular matrix;apical plasma membrane;sensory perception of sound;anchored to membrane@: DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22
D99945@186302@186304@duplication@3@28425026@28468348@16@chr16:28425026-28468348@12.1@113@212@1.88@NA@AC138894-201_1, AC138894-201_2, NPIPL1-202_7@43.6666666666667@22@80@NA@NA@NA
D99945@186368@186369@deletion@2@28711499@28712933@16@chr16:28711499-28712933@15.2@69@0@0@CNVR6686.3, CNVR6686.1, CNVR6686.2@AC145285-201_1, AC145285-201_2@60@59@61@:eukaryotic translation initiation factor 3, subunit C@:cytosol;protein binding;eukaryotic translation initiation factor 3 complex;translational initiation;cellular protein metabolic process;binding;gene expression;translation;translation initiation factor activity@NA
D99945@187577@187583@duplication@7@33781225@33783964@16@chr16:33781225-33783964@7.4@146@221@1.51@CNVR6703.17, CNVR6703.1, CNVR6703.23, CNVR6703.4, CNVR6703.9@AC133561-201_3, AC133561-201_4, AC133561-201_5, AC133561-201_6, AC133561-201_7, AC133561-201_8, AC133561-201_9@40.1428571428571@21@52@NA@NA@NA
D99945@188228@188241@deletion@14@55794462@55820017@16@chr16:55794462-55820017@26.1@612@359@0.587@CNVR6730.1@CES4-202_1, CES4-202_2, CES4-202_3, CES4-202_4, CES4-202_5, CES4-202_6, CES4-202_7, CES4-202_8, CES4-202_9, CES4-202_10, CES4-202_11, AC147362-203_1, AC147362-203_2, AC147362-203_3@95.9285714285714@8@123@NA@NA@NA
D99945@188251@188258@duplication@8@55844431@55857596@16@chr16:55844431-55857596@13.6@1171@1513@1.29@CNVR6731.1@CES1-203_4, CES1-203_5, CES1-203_6, CES1-203_7, CES1-203_8, CES1-203_9, CES1-203_10, CES1-203_11@29.25@23@33@:carboxylesterase 1;liver carboxylesterase 1-like@:hydrolase activity;methyl salicylate esterase activity;response to toxin;methylumbelliferyl-acetate deacetylase activity;endoplasmic reticulum lumen;retinyl-palmitate esterase activity;methyl jasmonate esterase activity;metabolic process;carboxylesterase activity;methyl indole-3-acetate esterase activity@: CARBOXYLESTERASE 1; CES1
D99945@189961@189969@deletion@9@70164328@70178437@16@chr16:70164328-70178437@77.3@2168@1266@0.584@CNVR6764.1, CNVR6764.3@AC009060-202_7, AC009060-202_8, AC009060-202_9, AC009060-202_10, AC009060-202_11, AC009060-202_12, AC009060-202_13, AC009060-202_14, AC009060-202_15@74@70@77@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
D99945@189972@189973@deletion@2@70187296@70195206@16@chr16:70187296-70195206@39.8@1425@824@0.578@CNVR6764.1, CNVR6764.3@AC009060-202_18, AC009060-202_19, AC009060-201_3, AC009060-201_4, AC009060-201_5@70@69@71@:pyruvate dehydrogenase phosphatase regulatory subunit@:oxidation-reduction process;mitochondrion;small molecule metabolic process;cytoplasm;glycine catabolic process;pyruvate metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;oxidoreductase activity;aminomethyltransferase activity;mitochondrial matrix@NA
D99945@189981@189981@duplication@1@70211146@70211384@16@chr16:70211146-70211384@5.09@46@87@1.89@CNVR6764.1@CLEC18C-201_3@34@34@34@:C-type lectin domain family 18, member C@:carbohydrate binding;protein binding;extracellular region@NA
D99945@190432@190432@deletion@1@72093015@72093088@16@chr16:72093015-72093088@8.51@225@131@0.582@CNVR6769.1, CNVR6769.2@HP-201_6@17@17@17@:thioredoxin-like 4B:haptoglobin:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:cellular iron ion homeostasis;negative regulation of oxidoreductase activity;catalytic activity;negative regulation of hydrogen peroxide catabolic process;positive regulation of cell death;haptoglobin-hemoglobin complex;extracellular space;proteolysis;response to hydrogen peroxide;extracellular region;hemoglobin binding;defense response;serine-type endopeptidase activity:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@: ANHAPTOGLOBINEMIA; AHP
D99945@190434@190434@deletion@1@72097113@72097160@16@chr16:72097113-72097160@7.48@89@39@0.438@CNVR6769.1@HPR-202_1@26@26@26@:thioredoxin-like 4B:haptoglobin-related protein@:mitosis;mRNA processing;RNA splicing;spliceosomal complex;cell redox homeostasis:spherical high-density lipoprotein particle;proteolysis;extracellular region;hemoglobin binding;catalytic activity;serine-type endopeptidase activity@NA
D99945@190527@190528@deletion@2@74385940@74386277@16@chr16:74385940-74386277@37.7@310@89@0.287@CNVR6778.2, CNVR6778.1@AC009053-202_4, AC009053-202_5@23.5@21@26@NA@NA@NA
D99945@190530@190549@deletion@20@74394533@74452197@16@chr16:74394533-74452197@35.5@900@535@0.594@CNVR6778.2@AC009053-202_1, AC009053-202_2, NPIPL2-202_1, NPIPL2-202_2, NPIPL2-202_3, NPIPL2-202_4, NPIPL2-202_5, NPIPL2-202_6, NPIPL2-202_7, CLEC18B-202_3, CLEC18B-202_4, CLEC18B-202_5, CLEC18B-202_6, CLEC18B-202_7, CLEC18B-202_8, CLEC18B-202_9, CLEC18B-202_10, CLEC18B-202_11, CLEC18B-202_12, CLEC18B-202_13@57.3@46@63@:C-type lectin domain family 18, member B@:extracellular region:carbohydrate binding;protein binding;extracellular region@NA
D99945@195660@195669@duplication@10@18291535@18301934@17@chr17:18291535-18301934@8.37@167@254@1.52@CNVR7012.1@EVPLL-001_10, EVPLL-001_11, AL353997-001_1, AL353997-001_2, AL353997-001_3, AL353997-001_4, AL353997-001_5, AL353997-001_6, AL353997-001_7, AL353997-001_8@61.8@14@95@:envoplakin-like@NA@NA
D99945@195755@195759@deletion@5@18490982@18498176@17@chr17:18490982-18498176@22.4@268@117@0.437@NA@CCDC144B-201_8, CCDC144B-201_9, CCDC144B-201_10, ENST00000447265_5, ENST00000447265_6@2.6@1@5@NA@NA@NA
D99945@195813@195813@deletion@1@18681793@18682662@17@chr17:18681793-18682662@4.82@780@557@0.714@NA@FBXW10-201_14@2@2@2@:F-box/WD repeat-containing protein 10-like;F-box and WD repeat domain containing 10@:protein binding@NA
D99945@197726@197728@duplication@3@34539180@34539966@17@chr17:34539180-34539966@6.96@64@119@1.86@CNVR7077.1, CNVR7077.3, CNVR7077.6@CCL4L1-202_2, CCL4L1-202_3, CCL4L1-202_4@118@113@122@:chemokine (C-C motif) ligand 4-like 2;chemokine (C-C motif) ligand 4-like 1@:chemotaxis;extracellular space;inflammatory response;extracellular region;immune response;chemokine activity@NA
D99945@198032@198032@duplication@1@36351805@36351997@17@chr17:36351805-36351997@9.22@559@766@1.37@CNVR7083.3@AC183087-202_14@58@58@58@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
D99945@198035@198041@duplication@7@36357160@36375178@17@chr17:36357160-36375178@22.3@4162@5305@1.27@CNVR7083.3@AC183087-202_5, AC183087-202_6, AC183087-202_7, AC183087-202_8, AC183087-202_9, AC183087-202_10, AC183087-202_11@53.1428571428571@42@59@:TBC1 domain family, member 3F;TBC1 domain family member 3F-like;TBC1 domain family, member 3;TBC1 domain family member 3H-like;TBC1 domain family member 3G-like:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:Rab GTPase activator activity;regulation of Rab GTPase activity;intracellular:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
D99945@198043@198043@deletion@1@36398220@36398303@17@chr17:36398220-36398303@5.68@233@149@0.639@CNVR7083.3, CNVR7083.7@AC183087-202_3@29@29@29@:TBC1 domain family member 3F-like;TBC1 domain family, member 3;puromycin-sensitive aminopeptidase-like protein-like@:metallopeptidase activity;proteolysis;aminopeptidase activity;zinc ion binding@NA
D99945@200264@200264@duplication@1@43592018@43592892@17@chr17:43592018-43592892@6.92@272@383@1.41@CNVR7113.4, CNVR7113.6, CNVR7113.2, CNVR7113.1@ENST00000339474_3@99@99@99@NA@NA@NA
D99945@200337@200349@deletion@13@44399690@44592688@17@chr17:44399690-44592688@17.7@138@42@0.304@CNVR7114.2, CNVR7114.1@LRRC37A-001_7, LRRC37A-001_8, LRRC37A-001_9, LRRC37A-001_10, LRRC37A-001_11, LRRC37A-001_12, LRRC37A-001_13, LRRC37A-001_14, LRRC37A-001_15, AC005829-202_1, AC005829-202_2, AC005829-202_3, LRRC37A2-201_1@149.230769230769@114@196@:ADP-ribosylation factor-like 17A;ADP-ribosylation factor-like 17B;ADP-ribosylation factor-like protein 17-like:leucine rich repeat containing 37A:leucine rich repeat containing 37, member A2@:vesicle-mediated transport;Golgi apparatus;protein transport;GTP binding;intracellular;small GTPase mediated signal transduction:protein binding;integral to membrane:protein binding;integral to membrane@NA
D99945@201839@201840@deletion@2@57656835@57657241@17@chr17:57656835-57657241@24.2@112@1@0.00893@NA@DHX40-203_12, DHX40-203_13@7.5@3@12@:DEAH (Asp-Glu-Ala-His) box polypeptide 40@:transport;helicase activity;intracellular;ATP-dependent helicase activity;nucleic acid binding;ATP binding@NA
D99945@201936@201936@duplication@1@58072983@58074334@17@chr17:58072983-58074334@8.32@167@260@1.56@NA@AC005702-201_4@1@1@1@NA@NA@NA
D99945@213372@213373@deletion@2@14070581@14070882@19@chr19:14070581-14070882@7.79@339@220@0.649@NA@DCAF15-201_9, DCAF15-201_10@8.5@0@17@:DDB1 and CUL4 associated factor 15@:protein ubiquitination@NA
D99945@213493@213494@deletion@2@14508472@14508748@19@chr19:14508472-14508748@10.6@98@36@0.367@NA@CD97-205_8, CD97-205_9@10.5@7@14@:CD97 molecule@:transmembrane signaling receptor activity;neuropeptide signaling pathway;inflammatory response;immune response;G-protein coupled receptor activity;G-protein coupled receptor signaling pathway;cell-cell signaling;protein binding;extracellular space;integral to membrane;cell adhesion;plasma membrane;integral to plasma membrane;membrane;calcium ion binding;cell surface receptor signaling pathway;cellular component movement@NA
D99945@215928@215928@duplication@1@35862253@35863856@19@chr19:35862253-35863856@7.56@173@263@1.52@CNVR7627.1@FFAR3-001_2@102@102@102@@:integral to membrane;G-protein coupled receptor activity;integral to plasma membrane;G-protein coupled receptor signaling pathway@NA
D99945@217296@217297@deletion@2@40380121@40382827@19@chr19:40380121-40382827@10.2@46@0@0@CNVR7639.2@FCGBP-201_22, FCGBP-201_23@152@149@155@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D99945@217301@217305@duplication@5@40389654@40398511@19@chr19:40389654-40398511@13.9@365@530@1.45@CNVR7639.2, CNVR7639.3@FCGBP-201_14, FCGBP-201_15, FCGBP-201_16, FCGBP-201_17, FCGBP-201_18@113.6@103@127@:Fc fragment of IgG binding protein@:protein binding;extracellular region;cytoplasm@NA
D99945@218217@218218@deletion@2@43877355@43877758@19@chr19:43877355-43877758@8.76@100@44@0.44@NA@CD177P-201_1, CD177P-201_2@14.5@11@18@NA@NA@NA
D99945@220212@220213@duplication@2@50472859@50473438@19@chr19:50472859-50473438@5.75@251@347@1.38@NA@SIGLEC16-202_1, SIGLEC16-202_2@67.5@67@68@NA@NA@NA
D99945@221166@221167@deletion@2@54724400@54725252@19@chr19:54724400-54725252@9.65@176@93@0.528@CNVR7721.3, CNVR7721.4@LILRB3-008_5, LILRB3-008_6@121@106@136@:ribosomal protein S9:leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3:leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6@:translational termination;structural constituent of ribosome;small ribosomal subunit;ribosome;RNA metabolic process;mRNA metabolic process;translation regulator activity;RNA binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of cell proliferation;viral reproduction;translation;gene expression;viral infectious cycle;translational elongation;ribonucleoprotein complex;viral transcription;intracellular;cytoplasm;cytosol;protein binding;cytosolic small ribosomal subunit;translational initiation;cellular protein metabolic process;nucleolus;rRNA binding;SRP-dependent cotranslational protein targeting to membrane;regulation of translation:transmembrane signaling receptor activity;protein binding;negative regulation of osteoclast differentiation;receptor activity;integral to plasma membrane;defense response;cell surface receptor signaling pathway:protein binding;integral to membrane@NA
D99945@221218@221224@deletion@7@54801929@54804722@19@chr19:54801929-54804722@39.1@1080@638@0.591@CNVR7722.1@LILRA3-003_4, LILRA3-003_5, LILRA3-003_6, LILRA3-003_7, LILRA3-003_8, LILRA3-003_9, LILRA3-003_10@105.857142857143@90@109@:leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3@:antigen binding;signal transduction;protein binding;extracellular region;plasma membrane;receptor activity;defense response@NA
D99945@221396@221417@duplication@22@55266477@55295318@19@chr19:55266477-55295318@115@3212@4739@1.48@CNVR7725.2, CNVR7725.1@KIR2DL3-201_5, KIR2DL3-201_6, KIR2DL3-201_7, KIR2DL3-201_8, KIR2DP1-001_1, KIR2DP1-001_2, KIR2DP1-001_3, KIR2DP1-001_4, KIR2DP1-001_5, KIR2DP1-001_6, KIR2DP1-001_7, KIR2DP1-001_8, KIR2DP1-001_9, KIR2DL1-002_1, KIR2DL1-002_2, KIR2DL1-002_3, KIR2DL1-002_4, KIR2DL1-002_5, KIR2DL1-002_6, KIR2DL1-002_7, KIR2DL1-002_8, KIR2DL1-002_9@95.5@34@126@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4:killer cell immunoglobulin-like receptor 2DL2-like;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3:killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane:transmembrane signaling receptor activity;protein binding;signal transduction;regulation of immune response;cellular defense response;plasma membrane;integral to plasma membrane:regulation of immune response;immune response;antigen binding;protein binding;integral to membrane;plasma membrane;integral to plasma membrane;receptor activity:protein binding;regulation of immune response;natural killer cell inhibitory signaling pathway;immune response;plasma membrane;receptor activity;integral to plasma membrane@NA
D99945@221435@221437@deletion@3@55346536@55351155@19@chr19:55346536-55351155@55.2@303@33@0.109@CNVR7725.1, CNVR7725.6@KIR2DS4-001_2, KIR2DS4-001_3, KIR2DS4-001_4@63.3333333333333@55@68@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
D99945@221439@221441@duplication@3@55358641@55360024@19@chr19:55358641-55360024@89.3@1292@2498@1.93@CNVR7725.1, CNVR7725.6, CNVR7725.5, CNVR7725.10@KIR2DS4-001_6, KIR2DS4-001_7, KIR2DS4-001_8@96.3333333333333@85@102@:killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1:killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4@:regulation of immune response;immune response;plasma membrane;HLA-B specific inhibitory MHC class I receptor activity;integral to plasma membrane@NA
D99945@221824@221824@deletion@1@56283970@56284546@19@chr19:56283970-56284546@23.9@533@274@0.514@CNVR7734.1@ENST00000341750_3@30@30@30@:ret finger protein-like 4A-like@:protein binding;zinc ion binding@NA
D99945@222563@222563@deletion@1@1569208@1569279@20@chr20:1569208-1569279@5.22@23@0@0@CNVR7763.1@SIRPB1-201_1@128@128@128@:signal-regulatory protein beta 1;signal-regulatory protein beta-1-like;signal-regulatory protein beta-1 isoform 3-like@:protein binding:protein binding;signal transduction;integral to membrane;plasma membrane;integral to plasma membrane;cell surface receptor signaling pathway@NA
D99945@228819@228821@deletion@3@10899084@10907041@21@chr21:10899084-10907041@7.97@823@571@0.694@CNVR7947.10, CNVR7947.6, CNVR7947.11@ENST00000456889_1, ENST00000456889_2, TPTE-006_32@30@27@33@:transmembrane phosphatase with tensin homology@:phosphatase activity;ion channel activity;protein tyrosine phosphatase activity;ion transport;protein dephosphorylation;transmembrane transport;protein binding;signal transduction;integral to membrane;protein tyrosine/serine/threonine phosphatase activity;dephosphorylation;membrane;peptidyl-tyrosine dephosphorylation@NA
D99945@231958@231958@deletion@1@16287256@16287718@22@chr22:16287256-16287718@15.7@71@0@0@CNVR8071.2, CNVR8071.3, CNVR8071.9@POTEH-002_1@105@105@105@:POTE ankyrin domain family, member H@:protein binding@NA
D99945@232350@232353@deletion@4@18775046@18778743@22@chr22:18775046-18778743@7.42@111@56@0.505@CNVR8087.5, CNVR8087.2, CNVR8087.7@GGT3P-201_6, AC008132-201_2, AC008132-201_3, AC008132-201_4@96.25@89@104@NA@NA@NA
D99945@232769@232778@deletion@10@20383540@20393605@22@chr22:20383540-20393605@15.8@116@32@0.276@CNVR8094.9, CNVR8094.4, CNVR8094.10@PI4KAP1-204_7, PI4KAP1-204_8, PI4KAP1-204_9, PI4KAP1-204_10, PI4KAP1-204_11, PI4KAP1-204_12, PI4KAP1-204_13, PI4KAP1-204_14, PI4KAP1-204_15, PI4KAP1-204_16@162.6@148@172@NA@NA@NA
D99945@233257@233257@deletion@1@22312273@22312385@22@chr22:22312273-22312385@5.25@68@32@0.471@CNVR8102.1@ENST00000449517_5@1@1@1@:topoisomerase (DNA) III beta@:chromosome segregation;DNA topoisomerase type I activity;DNA binding;ATP binding;condensed chromosome;DNA topoisomerase activity;DNA topological change;chromosome;nucleus@NA
D99945@233473@233474@duplication@2@23247264@23248971@22@chr22:23247264-23248971@7.91@108@180@1.67@CNVR8103.2, CNVR8103.1, CNVR8103.6, CNVR8103.11@BCRL4-001_6, BCRL4-001_7@0@0@0@@:protein binding@NA
D99945@233700@233708@deletion@9@24283261@24302569@22@chr22:24283261-24302569@24.3@153@31@0.203@CNVR8114.6, CNVR8114.10, CNVR8114.12, CNVR8114.13@ENST00000443377_2, ENST00000443377_3, ENST00000440099_1, ENST00000440099_2, ENST00000440099_3, GSTT2B-002_2, GSTT2B-002_3, GSTT2B-002_4, GSTT2B-002_5@74.6666666666667@56@125@:glutathione S-transferase theta 2B (gene/pseudogene);glutathione S-transferase theta 2@:protein binding;glutathione transferase activity;nucleus;transferase activity;cytoplasm@NA
D99945@233743@233754@duplication@12@24373119@24394850@22@chr22:24373119-24394850@49@1005@1533@1.53@CNVR8114.13, CNVR8114.1, CNVR8114.7@GSTTP1-001_1, ENST00000439866_1, ENST00000439866_2, GSTT1-009_1, GSTT1-009_2, GSTT1-009_3, GSTT1-009_4, GSTT1-009_5, ENST00000439996_1, ENST00000439996_2, GSTTP2-001_4, GSTTP2-001_5@137.916666666667@122@149@:glutathione S-transferase theta 1@:glutathione peroxidase activity;response to drug;transferase activity;cytosol;protein binding;glutathione transferase activity;glutathione metabolic process;response to organic cyclic compound@NA
D99945@235423@235423@duplication@1@36597748@36597935@22@chr22:36597748-36597935@4.8@142@205@1.44@NA@APOL4-202_3@0@0@0@:apolipoprotein L, 4@:lipid binding;extracellular space;extracellular region;molecular_function;cellular_component;lipid transport;lipid metabolic process;lipoprotein metabolic process@NA
D99945@236125@236132@deletion@8@39358502@39388155@22@chr22:39358502-39388155@32.1@796@466@0.585@CNVR8164.1@APOBEC3A-001_6, APOBEC3B-003_1, APOBEC3B-003_2, APOBEC3B-003_3, APOBEC3B-003_4, APOBEC3B-003_5, APOBEC3B-003_6, APOBEC3B-003_7@33.5@18@37@:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A;APOBEC3A and APOBEC3B deletion hybrid:apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B@:cytidine deamination;defense response to virus;negative regulation of viral genome replication;DNA cytosine deamination;clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine;catalytic activity;DNA demethylation;cytoplasm;innate immune response;cytidine deaminase activity;nucleus;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;cellular response to xenobiotic stimulus;zinc ion binding;negative regulation of transposition:RNA binding;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;negative regulation of transposition;catalytic activity;zinc ion binding@NA
D99945@236811@236812@deletion@2@42898757@42899280@22@chr22:42898757-42899280@9.74@80@26@0.325@CNVR8171.2, CNVR8171.3@SERHL-001_5, SERHL-001_6@39@34@44@NA@NA@NA
D99945@236820@236822@deletion@3@42910690@42912143@22@chr22:42910690-42912143@7.54@169@99@0.586@CNVR8171.2, CNVR8171.3@RRP7A-001_3, RRP7A-001_4, RRP7A-001_5@35.6666666666667@34@38@:ribosomal RNA processing 7 homolog A (S. cerevisiae)@:RNA binding;nucleotide binding@NA
D99945@236829@236830@duplication@2@42952056@42952595@22@chr22:42952056-42952595@5.86@63@112@1.78@CNVR8171.2, CNVR8171.3@SERHL2-203_5, SERHL2-203_6@14@12@16@:serine hydrolase-like 2@:hydrolase activity;mitochondrion;peroxisome;cytoplasmic membrane-bounded vesicle;molecular_function;cellular_component;perinuclear region of cytoplasm;biological_process@NA
